Citrus Sinensis ID: 012462
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 463 | 2.2.26 [Sep-21-2011] | |||||||
| Q8LEB6 | 484 | Probable receptor-like pr | no | no | 0.974 | 0.931 | 0.661 | 1e-178 | |
| Q9SJG2 | 494 | Probable receptor-like pr | no | no | 0.952 | 0.892 | 0.650 | 1e-174 | |
| Q9LRP3 | 467 | Probable receptor-like pr | no | no | 0.961 | 0.952 | 0.631 | 1e-164 | |
| Q3EDL4 | 472 | Probable serine/threonine | no | no | 0.907 | 0.889 | 0.601 | 1e-145 | |
| Q6NKZ9 | 437 | Probable receptor-like se | no | no | 0.900 | 0.954 | 0.555 | 1e-130 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.833 | 0.543 | 0.425 | 9e-79 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.643 | 0.413 | 0.475 | 2e-78 | |
| Q9SGY7 | 718 | Putative proline-rich rec | no | no | 0.829 | 0.534 | 0.404 | 6e-78 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.609 | 0.432 | 0.510 | 3e-77 | |
| Q9C821 | 509 | Proline-rich receptor-lik | no | no | 0.626 | 0.569 | 0.486 | 2e-76 |
| >sp|Q8LEB6|Y5185_ARATH Probable receptor-like protein kinase At5g18500 OS=Arabidopsis thaliana GN=At5g18500 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 623 bits (1607), Expect = e-178, Method: Compositional matrix adjust.
Identities = 316/478 (66%), Positives = 390/478 (81%), Gaps = 27/478 (5%)
Query: 1 MGNNLNAELSKKTIFGIKVWEVIGISVALFIIIILSVLSFCLTSRKKSRRARNNL-PFS- 58
MG+ LN LS+ G+++WE+I I ++ +++L++ S LT R+K+ R+ +NL P S
Sbjct: 1 MGSGLNDTLSR-NYNGLELWEIIVIVLSAIFVVVLAI-SLWLTFRRKTSRSSSNLIPVSR 58
Query: 59 QIP-TVSKEIKEVRVEQVSTN-----------EFVQRDDKDGGSISGED-----SGSVTV 101
QIP +V +EIKE+RV++VS++ +F ++ + G E+ SGS
Sbjct: 59 QIPPSVPEEIKEIRVDEVSSSNGGNGYPSISEKFGDKEPEKGIKAESENGDSSRSGSFNH 118
Query: 102 YKP------SSSHPITAPSPLIGLPEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYG 155
+ SS++P+TAPSPL GLPEFS LGWGHWFTLRDL++ATN+FS++N++G+GGYG
Sbjct: 119 LEKKDGSSVSSANPLTAPSPLSGLPEFSHLGWGHWFTLRDLQMATNQFSRDNIIGDGGYG 178
Query: 156 VVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLV 215
VVYRGNL+NG+PVAVKK+LNN+GQA+K+FRVEVEAIGHVRHKNLVRLLGYC+EG RMLV
Sbjct: 179 VVYRGNLVNGTPVAVKKLLNNLGQADKDFRVEVEAIGHVRHKNLVRLLGYCMEGTQRMLV 238
Query: 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNI 275
YEYVNNGNLEQWL G ++H YLTWEAR+K+L+GTAKALAYLHEAIEPKVVHRDIKSSNI
Sbjct: 239 YEYVNNGNLEQWLRGDNQNHEYLTWEARVKILIGTAKALAYLHEAIEPKVVHRDIKSSNI 298
Query: 276 LIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLL 335
LIDD FN+K+SDFGLAKLLGA KS +TTRVMGTFGYVAPEYAN+GLLNEKSDVYSFGV+L
Sbjct: 299 LIDDKFNSKISDFGLAKLLGADKSFITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVL 358
Query: 336 LEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALR 395
LEAITGR PVD+ RP EV+LV+WLKMMV RRSEEVVDPN+E +PST ALKR+LLTALR
Sbjct: 359 LEAITGRYPVDYARPPPEVHLVEWLKMMVQQRRSEEVVDPNLETKPSTSALKRTLLTALR 418
Query: 396 CVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHRRTQGGTSMEIESQKENSDTDRSDY 453
CVDP SEKRP+MSQV RMLESEEYPI REDRR RR+Q GT+ + + + ++DTD+S+Y
Sbjct: 419 CVDPMSEKRPRMSQVARMLESEEYPIAREDRRRRRSQNGTTRDSDPPRNSTDTDKSEY 476
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SJG2|Y2296_ARATH Probable receptor-like protein kinase At2g42960 OS=Arabidopsis thaliana GN=At2g42960 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 611 bits (1576), Expect = e-174, Method: Compositional matrix adjust.
Identities = 314/483 (65%), Positives = 375/483 (77%), Gaps = 42/483 (8%)
Query: 3 NNLNAELSKKTIF----GIKVWEVIGISVALFIIIILSVLSFCLTSRKKSRRARNNLPFS 58
++LNAE+SKK F G+K+W + + V +FI++IL +LS +T R+KSRR+ + PF+
Sbjct: 5 SSLNAEMSKKISFFGLKGLKLWVWVCLVVGVFIVMILCILSLWITFRRKSRRSSSKFPFN 64
Query: 59 QIPTVSKEIKEVRVEQVSTNE---FVQRDDKDGG-------------------------- 89
QIP VSK+I+ R + + +++ +DK G
Sbjct: 65 QIPHVSKDIRVDRAGFQNPHPESLYIEMNDKSTGKTMMSHLGRTKSSDNDTLSQCSSVNH 124
Query: 90 ------SISGEDSGSVTVYKPSSSHPITAPSPLIGLPEFSQLGWGHWFTLRDLELATNRF 143
S SGE+ G + + P+TA SPL+GLPE S LGWGHWFTLRDLELATNRF
Sbjct: 125 HERACSSHSGEEGGFGSAGRQYGGGPVTA-SPLVGLPEISHLGWGHWFTLRDLELATNRF 183
Query: 144 SKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
+ NVLGEGGYGVVYRG L+NG+ VAVKK+LNN+GQAEKEFRVEVEAIGHVRHKNLVRLL
Sbjct: 184 APVNVLGEGGYGVVYRGKLVNGTEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLL 243
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEP 263
GYCIEG+HRMLVYEYVN+GNLEQWLHGAMR HG LTWEARMK++ GTA+ALAYLHEAIEP
Sbjct: 244 GYCIEGVHRMLVYEYVNSGNLEQWLHGAMRQHGNLTWEARMKIITGTAQALAYLHEAIEP 303
Query: 264 KVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLN 323
KVVHRDIK+SNILIDD+FNAK+SDFGLAKLL +G+SH+TTRVMGTFGYVAPEYANTGLLN
Sbjct: 304 KVVHRDIKASNILIDDEFNAKLSDFGLAKLLDSGESHITTRVMGTFGYVAPEYANTGLLN 363
Query: 324 EKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPST 383
EKSD+YSFGVLLLEAITGRDPVD+GRPA+EVNLV+WLKMMVG+RR+EEVVDP +E RPS
Sbjct: 364 EKSDIYSFGVLLLEAITGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPRLEPRPSK 423
Query: 384 RALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHRRTQGGTSMEIESQK 443
ALKR+LL +LRCVDP++EKRP+MSQV RMLES+E+P +E R R G MEI K
Sbjct: 424 SALKRALLVSLRCVDPEAEKRPRMSQVARMLESDEHPFHKERRNKRSKTAG--MEIVETK 481
Query: 444 ENS 446
+ S
Sbjct: 482 DES 484
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LRP3|Y3174_ARATH Probable receptor-like protein kinase At3g17420 OS=Arabidopsis thaliana GN=At3g17420 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 579 bits (1493), Expect = e-164, Method: Compositional matrix adjust.
Identities = 293/464 (63%), Positives = 363/464 (78%), Gaps = 19/464 (4%)
Query: 1 MGNNLNAELSKKTIFGI-KVWEVIGISVALFIIIILSVLSFCLTSRKKSRRAR-NNLPFS 58
M + L L+K+ +G+ ++WE+I I++ I+IL VLS L+ RKKS+R+ LP +
Sbjct: 1 MTSQLKRTLTKR--YGVLELWEIIVIALFAAFIVIL-VLSVWLSFRKKSKRSNATTLPVT 57
Query: 59 QIPTVSKEIKEVRVEQVSTN-----------EFVQRDDKDGGSISG--EDSGSVTVYKPS 105
Q P ++EIKE+ V+ S+N +FV+ D ++G SG E V + P
Sbjct: 58 QSPRFTEEIKEISVDHGSSNNNGTSYQTLDEKFVE-DIENGDKFSGSLEKKPLVGSHLPP 116
Query: 106 SSHPITAPSPLIGLPEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLING 165
S+ TAPSPL+GLPE S +GWGHWFTLRDL+LATN FSKE+++G+GGYGVVY G L N
Sbjct: 117 STPSTTAPSPLLGLPEVSHIGWGHWFTLRDLQLATNHFSKESIIGDGGYGVVYHGTLTNK 176
Query: 166 SPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLE 225
+PVAVKK+LNN GQA+K+FRVEVEAIGHVRHKNLVRLLGYC+EG HRMLVYEY+NNGNLE
Sbjct: 177 TPVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCVEGTHRMLVYEYMNNGNLE 236
Query: 226 QWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKV 285
QWLHG M H G+LTWEAR+KVL+GTAKALAYLHEAIEPKVVHRDIKSSNIL+DD+F+AK+
Sbjct: 237 QWLHGDMIHKGHLTWEARIKVLVGTAKALAYLHEAIEPKVVHRDIKSSNILMDDNFDAKL 296
Query: 286 SDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPV 345
SDFGLAKLLGA ++V+TRVMGTFGYVAPEYAN+GLLNEKSDVYS+GV+LLEAITGR PV
Sbjct: 297 SDFGLAKLLGADSNYVSTRVMGTFGYVAPEYANSGLLNEKSDVYSYGVVLLEAITGRYPV 356
Query: 346 DHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRP 405
D+ RP EV++V+WLK+MV ++ EEVVD +E++P+T LKR+LLTALRCVDPD++KRP
Sbjct: 357 DYARPKEEVHMVEWLKLMVQQKQFEEVVDKELEIKPTTSELKRALLTALRCVDPDADKRP 416
Query: 406 KMSQVVRMLESEEYPIVREDRRHRRTQGGTSMEIESQKENSDTD 449
KMSQV RMLES+EYP++ + R RR ES N D D
Sbjct: 417 KMSQVARMLESDEYPVMPREERRRRRNQNAETHRESTDTNKDND 460
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3EDL4|Y1154_ARATH Probable serine/threonine-protein kinase At1g01540 OS=Arabidopsis thaliana GN=At1g01540 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 515 bits (1326), Expect = e-145, Method: Compositional matrix adjust.
Identities = 267/444 (60%), Positives = 330/444 (74%), Gaps = 24/444 (5%)
Query: 5 LNAELSKKT-IFGIKVWEVIGISVALFIIIILSVLSFCLTSRKKSRRARNNLPFSQI--P 61
LN ELSK T IFG+++W VIGI + I+I L +LS CLTSR+K+R+ R + + I P
Sbjct: 9 LNTELSKPTSIFGLRLWVVIGILLGSLIVIALFLLSLCLTSRRKNRKPRADFASAAIATP 68
Query: 62 TVSKEIKEVRVEQVSTNEFVQRDDK-DGGSI-----------SGEDSGSVTVYKPSSSHP 109
+SKEIKE+ Q N+ V + + D G I SGE G+ + + +S
Sbjct: 69 PISKEIKEIVPAQ---NQSVPAEIQVDIGKIEHRVVFSDRVSSGESRGTASASETAS--- 122
Query: 110 ITAPSPLIGLPEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVA 169
+ S G PE S LGWG W+TLR+LE ATN +ENV+GEGGYG+VYRG L +G+ VA
Sbjct: 123 -YSGSGNCG-PEVSHLGWGRWYTLRELEAATNGLCEENVIGEGGYGIVYRGILTDGTKVA 180
Query: 170 VKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLH 229
VK +LNN GQAEKEF+VEVE IG VRHKNLVRLLGYC+EG +RMLVY++V+NGNLEQW+H
Sbjct: 181 VKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYDFVDNGNLEQWIH 240
Query: 230 GAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFG 289
G + LTW+ RM ++LG AK LAYLHE +EPKVVHRDIKSSNIL+D +NAKVSDFG
Sbjct: 241 GDVGDVSPLTWDIRMNIILGMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQWNAKVSDFG 300
Query: 290 LAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349
LAKLLG+ S+VTTRVMGTFGYVAPEYA TG+LNEKSD+YSFG+L++E ITGR+PVD+ R
Sbjct: 301 LAKLLGSESSYVTTRVMGTFGYVAPEYACTGMLNEKSDIYSFGILIMEIITGRNPVDYSR 360
Query: 350 PAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQ 409
P E NLVDWLK MVG+RRSEEVVDP I PS++ALKR LL ALRCVDPD+ KRPKM
Sbjct: 361 PQGETNLVDWLKSMVGNRRSEEVVDPKIPEPPSSKALKRVLLVALRCVDPDANKRPKMGH 420
Query: 410 VVRMLESEEYPIVREDRRHRRTQG 433
++ MLE+E+ + R++RR R G
Sbjct: 421 IIHMLEAEDL-LYRDERRTTRDHG 443
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6NKZ9|Y4345_ARATH Probable receptor-like serine/threonine-protein kinase At4g34500 OS=Arabidopsis thaliana GN=At4g34500 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 466 bits (1199), Expect = e-130, Method: Compositional matrix adjust.
Identities = 244/439 (55%), Positives = 308/439 (70%), Gaps = 22/439 (5%)
Query: 2 GNNLNAELSKKTIFGIKVWEVIGI-SVALFIIIILSVLSFCLTSRKKSRRARNNLPFSQI 60
G + + +K ++FG+ ++ VI I SV + +I +L L CL ++RR R I
Sbjct: 6 GGSHKSSTTKPSVFGLNLYLVIAICSVFILLISLLIFLFVCLNRVSRARRMRVKHSSGSI 65
Query: 61 PTVSKEIKEVRVEQVSTNEFVQRDDKDGGSISGEDSGSVTVYKPSSSHPIT--------A 112
P VSKEI E++ + +F+ DD G I E V V ++S T A
Sbjct: 66 PLVSKEISEIK----TVGKFINSDDSKG-KIGNE----VVVVVSATSKEATSGFDTLSVA 116
Query: 113 PSPLIGLPEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKK 172
S +G E +GWG W++L+DLE+AT FS +N++GEGGYGVVYR + +GS AVK
Sbjct: 117 SSGDVGTSE--AMGWGKWYSLKDLEIATRGFSDDNMIGEGGYGVVYRADFSDGSVAAVKN 174
Query: 173 ILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIH--RMLVYEYVNNGNLEQWLHG 230
+LNN GQAEKEF+VEVEAIG VRHKNLV L+GYC + RMLVYEY++NGNLEQWLHG
Sbjct: 175 LLNNKGQAEKEFKVEVEAIGKVRHKNLVGLMGYCADSAQSQRMLVYEYIDNGNLEQWLHG 234
Query: 231 AMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGL 290
+ LTW+ RMK+ +GTAK LAYLHE +EPKVVHRD+KSSNIL+D +NAKVSDFGL
Sbjct: 235 DVGPVSPLTWDIRMKIAIGTAKGLAYLHEGLEPKVVHRDVKSSNILLDKKWNAKVSDFGL 294
Query: 291 AKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
AKLLG+ S+VTTRVMGTFGYV+PEYA+TG+LNE SDVYSFGVLL+E ITGR PVD+ RP
Sbjct: 295 AKLLGSETSYVTTRVMGTFGYVSPEYASTGMLNECSDVYSFGVLLMEIITGRSPVDYSRP 354
Query: 351 AHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQV 410
E+NLVDW K MV SRR EEV+DP I+ P RALKR+LL LRC+D DS KRPKM Q+
Sbjct: 355 PGEMNLVDWFKGMVASRRGEEVIDPKIKTSPPPRALKRALLVCLRCIDLDSSKRPKMGQI 414
Query: 411 VRMLESEEYPIVREDRRHR 429
+ MLE+E++P E R ++
Sbjct: 415 IHMLEAEDFPFRPEHRSNQ 433
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 294 bits (753), Expect = 9e-79, Method: Compositional matrix adjust.
Identities = 177/416 (42%), Positives = 238/416 (57%), Gaps = 30/416 (7%)
Query: 16 GIKVWEVIGISVALFIIIILSVLSFCLTSRKKSRRARNNLPFSQIPTVSKEIKE--VRVE 73
G + + G ++A F +I L + F L RKK R +P + IK
Sbjct: 230 GYQGKTMAGFAIAGFAVIALMAVVF-LVRRKKKRNIDAYSDSQYLPPSNFSIKSDGFLYG 288
Query: 74 QVSTNEFV-------QRDDKDGGSISGEDSGSVTVYKPSSSHPITAPSPLIGLPEFSQLG 126
Q T + Q+ G S + G Y S S P +A +G
Sbjct: 289 QNPTKGYSGPGGYNSQQQSNSGNSFGSQRGGGG--YTRSGSAPDSA-----------VMG 335
Query: 127 WGH-WFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFR 185
G FT +L T FSK N+LGEGG+G VY+G L +G VAVK++ GQ ++EF+
Sbjct: 336 SGQTHFTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFK 395
Query: 186 VEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK 245
EVE I V H++LV L+GYCI R+L+YEYV N LE LHG R L W R++
Sbjct: 396 AEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGRP--VLEWARRVR 453
Query: 246 VLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRV 305
+ +G+AK LAYLHE PK++HRDIKS+NIL+DD+F A+V+DFGLAKL + ++HV+TRV
Sbjct: 454 IAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVSTRV 513
Query: 306 MGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDW----LK 361
MGTFGY+APEYA +G L ++SDV+SFGV+LLE ITGR PVD +P E +LV+W L
Sbjct: 514 MGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLH 573
Query: 362 MMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417
+ + E+VD +E + R + TA CV KRP+M QVVR L+SE
Sbjct: 574 KAIETGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRALDSE 629
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 293 bits (751), Expect = 2e-78, Method: Compositional matrix adjust.
Identities = 145/305 (47%), Positives = 208/305 (68%), Gaps = 7/305 (2%)
Query: 118 GLPEFSQLGWGHW-FTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNN 176
G P+ + LG G F+ +L T F+++N+LGEGG+G VY+G L +G VAVK++
Sbjct: 345 GTPDSAILGSGQTHFSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAG 404
Query: 177 VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHG 236
GQ ++EF+ EVE I V H++LV L+GYCI HR+L+YEYV+N LE LHG +
Sbjct: 405 SGQGDREFKAEVEIISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHG--KGLP 462
Query: 237 YLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296
L W R+++ +G+AK LAYLHE PK++HRDIKS+NIL+DD++ A+V+DFGLA+L
Sbjct: 463 VLEWSKRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDT 522
Query: 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNL 356
++HV+TRVMGTFGY+APEYA++G L ++SDV+SFGV+LLE +TGR PVD +P E +L
Sbjct: 523 TQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESL 582
Query: 357 VDWLKMM----VGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
V+W + + + + E++D +E R + R + TA CV KRP+M QVVR
Sbjct: 583 VEWARPLLLKAIETGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVR 642
Query: 413 MLESE 417
L+ +
Sbjct: 643 ALDCD 647
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 291 bits (746), Expect = 6e-78, Method: Compositional matrix adjust.
Identities = 170/420 (40%), Positives = 247/420 (58%), Gaps = 36/420 (8%)
Query: 7 AELSKKTIFGIKVWEVIGISVALFIIIILSVLSFCLTSRKKSRRARNN--LPFSQIPTVS 64
+ ++KT+ GI GI+ L I+ I V +K S R+N LP + +
Sbjct: 256 SNYTEKTVIGI------GIAGVLVILFIAGVFFVRRKQKKGSSSPRSNQYLPPANV---- 305
Query: 65 KEIKEVRVEQVSTNEFVQRDDKDG-GSISGEDSGSVTVYKPSSSHPITAPSPLIGLPEFS 123
V+T F+ K G G+ S ++S T + + P G P+ +
Sbjct: 306 ---------SVNTEGFIHYRQKPGNGNSSAQNSSPDT-------NSLGNPKHGRGTPDSA 349
Query: 124 QLGWGH-WFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEK 182
+G FT +L T F K V+GEGG+G VY+G L G PVA+K++ + + +
Sbjct: 350 VIGTSKIHFTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYR 409
Query: 183 EFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEA 242
EF+ EVE I V H++LV L+GYCI HR L+YE+V N L+ LHG ++ L W
Sbjct: 410 EFKAEVEIISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHG--KNLPVLEWSR 467
Query: 243 RMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVT 302
R+++ +G AK LAYLHE PK++HRDIKSSNIL+DD+F A+V+DFGLA+L +SH++
Sbjct: 468 RVRIAIGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARLNDTAQSHIS 527
Query: 303 TRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWL-- 360
TRVMGTFGY+APEYA++G L ++SDV+SFGV+LLE ITGR PVD +P E +LV+W
Sbjct: 528 TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEWARP 587
Query: 361 KMMVGSRRSE--EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEE 418
+++ + + EVVDP +E + + + TA CV + KRP+M QVVR L++ +
Sbjct: 588 RLIEAIEKGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRALDTRD 647
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 289 bits (739), Expect = 3e-77, Method: Compositional matrix adjust.
Identities = 148/290 (51%), Positives = 197/290 (67%), Gaps = 8/290 (2%)
Query: 131 FTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEA 190
FT +L ATN FS+ N+LG+GG+G V++G L +G VAVK++ GQ E+EF+ EVE
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEI 327
Query: 191 IGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT 250
I V H++LV L+GYC+ G+ R+LVYE+V N NLE LHG R + W R+K+ LG+
Sbjct: 328 ISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPT--MEWSTRLKIALGS 385
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
AK L+YLHE PK++HRDIK+SNILID F AKV+DFGLAK+ +HV+TRVMGTFG
Sbjct: 386 AKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFG 445
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370
Y+APEYA +G L EKSDV+SFGV+LLE ITGR PVD + +LVDW + ++ +R SE
Sbjct: 446 YLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLL-NRASE 504
Query: 371 E-----VVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
E + D + + R + A CV + +RP+MSQ+VR LE
Sbjct: 505 EGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALE 554
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C821|PEK15_ARATH Proline-rich receptor-like protein kinase PERK15 OS=Arabidopsis thaliana GN=PERK15 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 286 bits (733), Expect = 2e-76, Method: Compositional matrix adjust.
Identities = 145/298 (48%), Positives = 202/298 (67%), Gaps = 8/298 (2%)
Query: 123 SQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEK 182
S++G + FT DL AT+ FS N+LG+GG+G V+RG L++G+ VA+K++ + GQ E+
Sbjct: 124 SEIGQ-NLFTYEDLSKATSNFSNTNLLGQGGFGYVHRGVLVDGTLVAIKQLKSGSGQGER 182
Query: 183 EFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEA 242
EF+ E++ I V H++LV LLGYCI G R+LVYE+V N LE LH R + W
Sbjct: 183 EFQAEIQTISRVHHRHLVSLLGYCITGAQRLLVYEFVPNKTLEFHLHEKERP--VMEWSK 240
Query: 243 RMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVT 302
RMK+ LG AK LAYLHE PK +HRD+K++NILIDD + AK++DFGLA+ +HV+
Sbjct: 241 RMKIALGAAKGLAYLHEDCNPKTIHRDVKAANILIDDSYEAKLADFGLARSSLDTDTHVS 300
Query: 303 TRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP-AHEVNLVDWLK 361
TR+MGTFGY+APEYA++G L EKSDV+S GV+LLE ITGR PVD +P A + ++VDW K
Sbjct: 301 TRIMGTFGYLAPEYASSGKLTEKSDVFSIGVVLLELITGRRPVDKSQPFADDDSIVDWAK 360
Query: 362 -MMVGSRRS---EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
+M+ + + +VDP +E + R + A V +++RPKMSQ+VR E
Sbjct: 361 PLMIQALNDGNFDGLVDPRLENDFDINEMTRMVACAAASVRHSAKRRPKMSQIVRAFE 418
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 463 | ||||||
| 224124542 | 506 | predicted protein [Populus trichocarpa] | 0.995 | 0.911 | 0.834 | 0.0 | |
| 225450464 | 511 | PREDICTED: probable receptor-like protei | 0.993 | 0.900 | 0.816 | 0.0 | |
| 147780241 | 510 | hypothetical protein VITISV_037750 [Viti | 0.987 | 0.896 | 0.813 | 0.0 | |
| 224122836 | 521 | predicted protein [Populus trichocarpa] | 0.995 | 0.884 | 0.806 | 0.0 | |
| 225432165 | 513 | PREDICTED: probable receptor-like protei | 0.993 | 0.896 | 0.767 | 0.0 | |
| 356534985 | 506 | PREDICTED: probable receptor-like protei | 0.995 | 0.911 | 0.771 | 0.0 | |
| 357511739 | 514 | hypothetical protein MTR_7g111690 [Medic | 0.995 | 0.896 | 0.762 | 0.0 | |
| 356505741 | 510 | PREDICTED: probable receptor-like protei | 0.995 | 0.903 | 0.785 | 0.0 | |
| 356565467 | 503 | PREDICTED: probable receptor-like protei | 0.993 | 0.914 | 0.744 | 0.0 | |
| 388518751 | 501 | unknown [Medicago truncatula] | 0.987 | 0.912 | 0.705 | 0.0 |
| >gi|224124542|ref|XP_002330049.1| predicted protein [Populus trichocarpa] gi|222871474|gb|EEF08605.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 841 bits (2172), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 424/508 (83%), Positives = 444/508 (87%), Gaps = 47/508 (9%)
Query: 1 MGNNLNAELSKKT-IFGIKVWEVIGISVALFIIIILSVLSFCLTSRKKSRRARNNLPFSQ 59
M ++LNAELSKKT I G+KVWEVIGI VALFI+IILSVLSFCLTSRKKSRR RN+LP SQ
Sbjct: 1 MASDLNAELSKKTAILGLKVWEVIGICVALFIVIILSVLSFCLTSRKKSRRDRNHLPPSQ 60
Query: 60 IPTVSKEIKEVRVEQVSTNEFVQRD----------------------------------- 84
IPTVSKEI EVRVEQVSTNEFV RD
Sbjct: 61 IPTVSKEITEVRVEQVSTNEFVPRDGILLTIHDKSSDKESDKVLVHLGMGKVKNGDNMSR 120
Query: 85 -------DKDGGSISGED--SGSVTVYKPSSSHPITAPSPLIGLPEFSQLGWGHWFTLRD 135
+KD GS SGE+ SG VTVYKPSSS+PITAPSPL GLPEFS LGWGHWFTLRD
Sbjct: 121 SGSFHHLEKDCGSQSGEEGSSGKVTVYKPSSSYPITAPSPLSGLPEFSHLGWGHWFTLRD 180
Query: 136 LELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR 195
LELATNRFSKENVLGEGGYGVVY+G+LING+PVAVKKILNN+GQAEKEFRVEV+AIGHVR
Sbjct: 181 LELATNRFSKENVLGEGGYGVVYQGHLINGTPVAVKKILNNLGQAEKEFRVEVDAIGHVR 240
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
HKNLVRLLGYCIEG HR+LVYEYVNNGNLEQWLHGAMR HGYLTWEARMKVLLGTAKALA
Sbjct: 241 HKNLVRLLGYCIEGTHRILVYEYVNNGNLEQWLHGAMRQHGYLTWEARMKVLLGTAKALA 300
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE 315
YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE
Sbjct: 301 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE 360
Query: 316 YANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375
YANTGLLNEKSDVYSFGV+LLEAITGRDPVD+GRP HEVNLVDWLKMMVG+RRSEEVVDP
Sbjct: 361 YANTGLLNEKSDVYSFGVVLLEAITGRDPVDYGRPTHEVNLVDWLKMMVGNRRSEEVVDP 420
Query: 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHRRTQGGT 435
NIEVRPSTRALKR+LLTALRCVDPDSEKRPKMSQVVRMLESEEYPI REDRRHRRTQGG
Sbjct: 421 NIEVRPSTRALKRALLTALRCVDPDSEKRPKMSQVVRMLESEEYPIPREDRRHRRTQGG- 479
Query: 436 SMEIESQKENSDTDRSDYPGSRSESKRT 463
MEIESQKENSDTDRSDYPGSR+ES+ T
Sbjct: 480 -MEIESQKENSDTDRSDYPGSRTESRPT 506
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225450464|ref|XP_002280159.1| PREDICTED: probable receptor-like protein kinase At2g42960 [Vitis vinifera] gi|296089839|emb|CBI39658.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 821 bits (2120), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 414/507 (81%), Positives = 439/507 (86%), Gaps = 47/507 (9%)
Query: 1 MGNNLNAELSKKT-IFGIKVWEVIGISVALFIIIILSVLSFCLTSRKKSRRARNNLPFSQ 59
M +LNAELSKKT + G+KVWE+IGI VALFIIIIL VLS CLTSRKKSR +R+ LP +Q
Sbjct: 1 MTTDLNAELSKKTDVLGLKVWELIGIVVALFIIIILCVLSLCLTSRKKSRSSRDRLPVNQ 60
Query: 60 IPTVSKEIKEVRVEQVSTNEFVQRD----------------------------------- 84
IPTVSKEIKEVRVEQVSTNEFV RD
Sbjct: 61 IPTVSKEIKEVRVEQVSTNEFVPRDGILLTIHDKSSDKESDKVLVHLGMGKTKNGDNSSQ 120
Query: 85 -------DKDG-GSISGED--SGSVTVYKPSSSHPITAPSPLIGLPEFSQLGWGHWFTLR 134
+KDG GS SGE+ SG+VTVYKPSSS+PITAPSPL+GLPEFS LGWGHWFTLR
Sbjct: 121 SGSFHHLEKDGCGSQSGEEGSSGTVTVYKPSSSYPITAPSPLVGLPEFSHLGWGHWFTLR 180
Query: 135 DLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV 194
DLELATNRFSKENVLGEGGYGVVYRG LING+PVAVKKILNN+GQAEKEFRVEVEAIGHV
Sbjct: 181 DLELATNRFSKENVLGEGGYGVVYRGQLINGTPVAVKKILNNLGQAEKEFRVEVEAIGHV 240
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKAL 254
RHKNLVRLLGYCIEG HRMLVYEYV+NGNLEQWLHGAMR HG+LTW+ARMK+LLGTAKAL
Sbjct: 241 RHKNLVRLLGYCIEGTHRMLVYEYVSNGNLEQWLHGAMRQHGFLTWDARMKILLGTAKAL 300
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSH+TTRVMGTFGYVAP
Sbjct: 301 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHITTRVMGTFGYVAP 360
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVD 374
EYANTGLLNEKSDVYSFGV+LLEAITGRDPVD+GRPA EVNLVDWLKMMVGSRRSEEVVD
Sbjct: 361 EYANTGLLNEKSDVYSFGVVLLEAITGRDPVDYGRPAQEVNLVDWLKMMVGSRRSEEVVD 420
Query: 375 PNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHRRTQGG 434
PNIEVRPSTRALKR+LLTALRCVDPDSEKRPKM QVVRMLESEEYPI REDRRHRRTQ G
Sbjct: 421 PNIEVRPSTRALKRALLTALRCVDPDSEKRPKMGQVVRMLESEEYPIPREDRRHRRTQAG 480
Query: 435 TSMEIESQKENSDTDRSDYPGSRSESK 461
SMEIESQKENSDTD+S+ GSRSES+
Sbjct: 481 -SMEIESQKENSDTDQSENLGSRSESR 506
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147780241|emb|CAN65734.1| hypothetical protein VITISV_037750 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 815 bits (2104), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 410/504 (81%), Positives = 435/504 (86%), Gaps = 47/504 (9%)
Query: 1 MGNNLNAELSKKT-IFGIKVWEVIGISVALFIIIILSVLSFCLTSRKKSRRARNNLPFSQ 59
M +LNAELSKKT + G+KVWE+IGI VALFI+IIL VLS CLTSRKKSR +R+ LP +Q
Sbjct: 1 MTTDLNAELSKKTDVLGLKVWELIGIVVALFIVIILCVLSLCLTSRKKSRSSRDRLPVNQ 60
Query: 60 IPTVSKEIKEVRVEQVSTNEFVQRD----------------------------------- 84
IPTVSKEIKEVRVEQVSTNEFV RD
Sbjct: 61 IPTVSKEIKEVRVEQVSTNEFVPRDGILLTIHDKSSDKESDKVLVHLGMGKTKNGDNSSQ 120
Query: 85 -------DKDG-GSISGED--SGSVTVYKPSSSHPITAPSPLIGLPEFSQLGWGHWFTLR 134
+KDG GS SGE+ SG+VTVYKPSSS+PITAPSPL+GLPEFS LGWGHWFTLR
Sbjct: 121 SGSFHHLEKDGCGSQSGEEGSSGTVTVYKPSSSYPITAPSPLVGLPEFSHLGWGHWFTLR 180
Query: 135 DLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV 194
DLELATNRFSKENVLGEGGYGVVYRG LING+PVAVKKILNN+GQAEKEFRVEVEAIGHV
Sbjct: 181 DLELATNRFSKENVLGEGGYGVVYRGQLINGTPVAVKKILNNLGQAEKEFRVEVEAIGHV 240
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKAL 254
RHKNLVRLLGYCIEG HRMLVYEYV+NGNLEQWLHGAMR HG+LTW+ARMK+LLGTAKAL
Sbjct: 241 RHKNLVRLLGYCIEGTHRMLVYEYVSNGNLEQWLHGAMRQHGFLTWDARMKILLGTAKAL 300
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSH+TTRVMGTFGYVAP
Sbjct: 301 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHITTRVMGTFGYVAP 360
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVD 374
EYANTGLLNEKSDVYSFGV+LLEAITGRDPVD+GRPA EVNLVDWLKMMVGSRRSEEVVD
Sbjct: 361 EYANTGLLNEKSDVYSFGVVLLEAITGRDPVDYGRPAQEVNLVDWLKMMVGSRRSEEVVD 420
Query: 375 PNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHRRTQGG 434
PNIEVRPSTRALKR+LLTALRCVDPDSEKRPKM QVVRMLESEEYPI REDRRHRRTQ G
Sbjct: 421 PNIEVRPSTRALKRALLTALRCVDPDSEKRPKMGQVVRMLESEEYPIPREDRRHRRTQAG 480
Query: 435 TSMEIESQKENSDTDRSDYPGSRS 458
SMEIESQKENSDTD+S+ GSR
Sbjct: 481 -SMEIESQKENSDTDQSENLGSRC 503
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122836|ref|XP_002318928.1| predicted protein [Populus trichocarpa] gi|222857304|gb|EEE94851.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 807 bits (2084), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 420/521 (80%), Positives = 441/521 (84%), Gaps = 60/521 (11%)
Query: 1 MGNNLNAELSKKT-IFGIKVWEVIGISVALFIIIILSVLSFCLTSRKKSRRARNNLPFSQ 59
M N+LNAELSKKT I G+KVWEVIGI VALFIIIILSVLSFCLT RKKS+R RN LP SQ
Sbjct: 1 MANDLNAELSKKTAILGLKVWEVIGICVALFIIIILSVLSFCLTLRKKSKRDRNRLPLSQ 60
Query: 60 IPTVSKEIKEVRVEQVSTNEFVQRD----------------------------------- 84
IPT+SKEIKEVRVEQVSTNEFV RD
Sbjct: 61 IPTISKEIKEVRVEQVSTNEFVPRDGILLTIHDKSSDKESDKVLVHLGMGKGKNGGNMSK 120
Query: 85 -------DKDGGSISGED--SGSVTVYKPSSSHPITAPSPLIGLPEFSQLGWGHWFTLRD 135
+KD GS SGE+ SG+VTVYKPSSS+PITAPSPLIGLPEFS LGWGHWFTLRD
Sbjct: 121 SDSFHHLEKDCGSQSGEEGSSGTVTVYKPSSSYPITAPSPLIGLPEFSHLGWGHWFTLRD 180
Query: 136 LELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR 195
LELATNRFSKEN+LGEGGYGVVY+G+LING+PVAVKKILNN+GQAEKEFRVEVEAIGHVR
Sbjct: 181 LELATNRFSKENILGEGGYGVVYQGHLINGTPVAVKKILNNLGQAEKEFRVEVEAIGHVR 240
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
HKNLVRLLGYCIEG HRMLVYEYVNNGNLEQWLHGAMR HGYLTWEARMKVLLGTAKALA
Sbjct: 241 HKNLVRLLGYCIEGTHRMLVYEYVNNGNLEQWLHGAMRQHGYLTWEARMKVLLGTAKALA 300
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG----- 310
YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG
Sbjct: 301 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGQVLSA 360
Query: 311 ---------YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLK 361
YVAPEYAN+GLLNEKSDVYSFGV+LLE+ITGRDPVD+GRP HEVNLVDWLK
Sbjct: 361 SVFLLVLSLYVAPEYANSGLLNEKSDVYSFGVVLLESITGRDPVDYGRPTHEVNLVDWLK 420
Query: 362 MMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPI 421
MMVG+RRSEEV DPNIE RPSTRALKR+LLTALRCVDPDSEKRPKM QVVRMLESEEYP
Sbjct: 421 MMVGNRRSEEVADPNIEARPSTRALKRALLTALRCVDPDSEKRPKMGQVVRMLESEEYPF 480
Query: 422 VREDRRHRRTQGGTSMEIESQKENSDTDRSDYPGSRSESKR 462
REDRRHRRT+GG SMEIESQ+ENSDTDRSDYPGSRSES R
Sbjct: 481 PREDRRHRRTRGG-SMEIESQRENSDTDRSDYPGSRSESLR 520
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225432165|ref|XP_002267270.1| PREDICTED: probable receptor-like protein kinase At5g18500 [Vitis vinifera] gi|297736805|emb|CBI26006.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 766 bits (1977), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 386/503 (76%), Positives = 428/503 (85%), Gaps = 43/503 (8%)
Query: 1 MGNNLNAELSKKT-IFGIKVWEVIGISVALFIIIILSVLSFCLTSRKKSRRARNNLPFSQ 59
M + L AELSKKT +FG+KVW ++GI V +FI+IIL ++S CLTSRKKSRRA N +P SQ
Sbjct: 1 MASGLQAELSKKTFLFGLKVWVLVGIFVGVFIVIILLLMSLCLTSRKKSRRANNKIPLSQ 60
Query: 60 IPTVSKEIKEVRVEQVSTNE-------FVQRDD--------------------------- 85
IP +SKEIKEVRV+QVS + F+ +D
Sbjct: 61 IPAISKEIKEVRVDQVSADNCGPHDGVFLALNDKFSDKESEKVLIPTKNGDNSSQSGSFN 120
Query: 86 ---KDG-GSISGED--SGSVTVYKPSSSHPITAPSPLIGLPEFSQLGWGHWFTLRDLELA 139
KDG GS SGE+ SG++ VY+P SSHPITAPSPLIGLPEFS LGWGHWFTLRDLELA
Sbjct: 121 HVEKDGVGSQSGEEVGSGTINVYRP-SSHPITAPSPLIGLPEFSHLGWGHWFTLRDLELA 179
Query: 140 TNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNL 199
TNRFSKENVLGEGGYG+VYRG+LING+PVAVKK+LNN+GQAEKEFRVEVEAIGHVRHKNL
Sbjct: 180 TNRFSKENVLGEGGYGIVYRGHLINGTPVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNL 239
Query: 200 VRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE 259
VRLLGYCIEG HR+LVYEYVNNGNLEQWLHGAMR HGYLTWEARMK+LLGTAKALAYLHE
Sbjct: 240 VRLLGYCIEGTHRLLVYEYVNNGNLEQWLHGAMRQHGYLTWEARMKILLGTAKALAYLHE 299
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANT 319
AIEPKVVHRDIKSSNILIDD+FNAK+SDFGLAKLLGAG+SH+TTRVMGTFGYVAPEYAN+
Sbjct: 300 AIEPKVVHRDIKSSNILIDDEFNAKISDFGLAKLLGAGRSHITTRVMGTFGYVAPEYANS 359
Query: 320 GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEV 379
GLLNEKSDVYSFGV+LLEAITGRDPVD+GRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE
Sbjct: 360 GLLNEKSDVYSFGVVLLEAITGRDPVDYGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIET 419
Query: 380 RPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHRRTQGGTSMEI 439
RPST ALKR LLTALRCVDPD++KRPKMSQVVRMLESEEYPI REDRR RR+ G + E
Sbjct: 420 RPSTSALKRGLLTALRCVDPDADKRPKMSQVVRMLESEEYPIPREDRRRRRSHAGNN-EA 478
Query: 440 ESQKENSDTDRSDYPGSRSESKR 462
ESQ+ENSDTDRS+ P SR+E++R
Sbjct: 479 ESQRENSDTDRSEIPDSRAENRR 501
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356534985|ref|XP_003536030.1| PREDICTED: probable receptor-like protein kinase At5g18500-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 759 bits (1959), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 391/507 (77%), Positives = 423/507 (83%), Gaps = 46/507 (9%)
Query: 1 MGNNLNAELSKKT-IFGIKVWEVIGISVALFIIIILSVLSFCLTSRKKSRRARNNLPFSQ 59
MG +L AELS KT +FG+KVW++IGI+V LFI++IL VL FCL SRKK+RRARN +P +
Sbjct: 1 MGADLKAELSGKTFVFGLKVWQIIGIAVGLFIVVILCVLPFCLNSRKKTRRARNRVPATH 60
Query: 60 IPTVSKEIKEVRVEQVSTNEFVQRD-----------DKD--------------------- 87
IP VSKEI EVRVEQV N FV R+ DK+
Sbjct: 61 IPPVSKEITEVRVEQVPANGFVPREGILLTIHDKSSDKESDKVMLHLGVGKKKHGDSGSH 120
Query: 88 ----------GGSISGED--SGSVTVYKPSSSHPITAPSPLIGLPEFSQLGWGHWFTLRD 135
GGS SGE+ SG+V +Y PSSSHPITAPSPL GLPEFS LGWGHWFTLRD
Sbjct: 121 HSDSFHYLDGGGSQSGEEISSGTVGIYMPSSSHPITAPSPLSGLPEFSHLGWGHWFTLRD 180
Query: 136 LELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR 195
LELATNRFSKENV+GEGGYGVVYRG LING+PVAVKKILNN+GQAEKEFRVEVEAIGHVR
Sbjct: 181 LELATNRFSKENVIGEGGYGVVYRGQLINGTPVAVKKILNNIGQAEKEFRVEVEAIGHVR 240
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
HKNLVRLLGYCIEG HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEAR+K+LLGTAK LA
Sbjct: 241 HKNLVRLLGYCIEGTHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARIKILLGTAKGLA 300
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE 315
YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG+GKSHV TRVMGTFGYVAPE
Sbjct: 301 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGSGKSHVATRVMGTFGYVAPE 360
Query: 316 YANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375
YANTGLLNEKSDVYSFGV+LLEAITGRDPVD+GRPA EVN+VDWLK MVG+RRSEEVVDP
Sbjct: 361 YANTGLLNEKSDVYSFGVVLLEAITGRDPVDYGRPAQEVNMVDWLKTMVGNRRSEEVVDP 420
Query: 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHRRTQGGT 435
NIEV+PSTR LKR+LLTALRCVDPDSEKRPKM QVVR+LESEEYP+ REDRRHRR +G
Sbjct: 421 NIEVKPSTRVLKRTLLTALRCVDPDSEKRPKMGQVVRILESEEYPLAREDRRHRRNRGVN 480
Query: 436 SMEIESQKENSDTDRSDYPGSRSESKR 462
S EIES K+NSDTD SD GSRSES R
Sbjct: 481 S-EIESHKDNSDTDGSDIQGSRSESGR 506
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357511739|ref|XP_003626158.1| hypothetical protein MTR_7g111690 [Medicago truncatula] gi|355501173|gb|AES82376.1| hypothetical protein MTR_7g111690 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 758 bits (1956), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 391/513 (76%), Positives = 425/513 (82%), Gaps = 52/513 (10%)
Query: 1 MGNNLNAELSKKT-IFGIKVWEVIGISVALFIIIILSVLSFCLTSRKKSRRARNNLPFSQ 59
MG+NLNAELSKKT FGIKVWE+I I V L II+IL+VLS CLTSRKKSR+ARN +P ++
Sbjct: 1 MGSNLNAELSKKTSFFGIKVWEIIAIVVGLSIIVILTVLSICLTSRKKSRKARNEIPVTE 60
Query: 60 IPTVSKEIKEVRVEQVSTN----------------------------------------- 78
IP VSKEIKEVRVEQVSTN
Sbjct: 61 IPNVSKEIKEVRVEQVSTNGFTPRDGILLTIHDKSSDKESDKVMVHLGLGKKVKNGDSSS 120
Query: 79 ------EFVQRDDKDGGSISGED---SGSVTVYKPSS-SHPITAPSPLIGLPEFSQLGWG 128
++++RD G + SG+VTVYK SS S+P+TAPSPL GLPEFS LGWG
Sbjct: 121 HSDSFHQYMERDGGGGSHSQSGEEGSSGTVTVYKHSSASYPLTAPSPLSGLPEFSHLGWG 180
Query: 129 HWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEV 188
HWFTLRDLELATNRF+KENVLGEGGYGVVY+G LINGSPVAVKKILNN+GQAEKEFRVEV
Sbjct: 181 HWFTLRDLELATNRFAKENVLGEGGYGVVYKGQLINGSPVAVKKILNNIGQAEKEFRVEV 240
Query: 189 EAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL 248
EAIGHVRHKNLVRLLG+C+EG HR+LVYEYVNNGNLEQWLHGAMRHHGYLTWEAR+K+LL
Sbjct: 241 EAIGHVRHKNLVRLLGFCVEGTHRILVYEYVNNGNLEQWLHGAMRHHGYLTWEARIKILL 300
Query: 249 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT 308
GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT
Sbjct: 301 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT 360
Query: 309 FGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRR 368
FGYVAPEYANTGLLNEKSDVYSFGVLLLE ITGRDPVD+GRP +EVNLVDWLKMMVG+RR
Sbjct: 361 FGYVAPEYANTGLLNEKSDVYSFGVLLLEGITGRDPVDYGRPTNEVNLVDWLKMMVGNRR 420
Query: 369 SEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRH 428
SEEVVDPNIEV+PSTRALKR+LLTALRCVDPDSEKRPKMSQVVRMLESEEYP+ REDRRH
Sbjct: 421 SEEVVDPNIEVKPSTRALKRALLTALRCVDPDSEKRPKMSQVVRMLESEEYPLAREDRRH 480
Query: 429 RRTQGGTSMEIESQKENSDTDRSDYPGSRSESK 461
RR G S EI+SQ+E SDTDRS+ SR ES+
Sbjct: 481 RRRNQGGSAEIDSQREFSDTDRSEIQSSREESR 513
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356505741|ref|XP_003521648.1| PREDICTED: probable receptor-like protein kinase At5g18500-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 752 bits (1941), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 400/509 (78%), Positives = 426/509 (83%), Gaps = 48/509 (9%)
Query: 1 MGNNLNAELSKKT-IFGIKVWEVIGISVALFIIIILSVLSFCLTSRKKSRRARNNLPFSQ 59
MG+NLNAELSKKT IFG+KVWE+ GI V L II+ILSV+S CLTSRKKSR+ ++ +P SQ
Sbjct: 1 MGSNLNAELSKKTPIFGLKVWEIFGIVVGLSIIVILSVVSLCLTSRKKSRKDKDKIPLSQ 60
Query: 60 IPTVSKEIKEVRVEQVSTNEFVQRD----------------------------------- 84
IPTVSKEIKEVRVEQV TN F RD
Sbjct: 61 IPTVSKEIKEVRVEQVPTNVFAPRDGILLTIQDKSSDKESDKVMVHLGVGKMKNGDSGTH 120
Query: 85 -------DKDGG---SISGED--SGSVTVYKPSSSHPITAPSPLIGLPEFSQLGWGHWFT 132
+KDGG S SGE+ SG+VTVYK SSS+PITAPSPL GLPEFS LGWGHWFT
Sbjct: 121 SDSFHYIEKDGGVSHSQSGEEGSSGTVTVYKQSSSYPITAPSPLSGLPEFSHLGWGHWFT 180
Query: 133 LRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIG 192
LRDLELATNRFSKENVLGEGGYGVVYRG LING+PVAVKKILNN GQAEKEFRVEVEAIG
Sbjct: 181 LRDLELATNRFSKENVLGEGGYGVVYRGQLINGTPVAVKKILNNTGQAEKEFRVEVEAIG 240
Query: 193 HVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAK 252
HVRHKNLVRLLGYCIEG RMLVYEYVNNGNLEQWLHGAMRHHGYLTWEAR+K+LLGTAK
Sbjct: 241 HVRHKNLVRLLGYCIEGTLRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARIKILLGTAK 300
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
ALAYLHEAIEPKVVHRD+KSSNILIDDDFNAKVSDFGLAKLLGAGKS+VTTRVMGTFGYV
Sbjct: 301 ALAYLHEAIEPKVVHRDVKSSNILIDDDFNAKVSDFGLAKLLGAGKSYVTTRVMGTFGYV 360
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV 372
APEYANTGLLNEKSDVYSFGVLLLE ITGRDPVD+GRPA+EVNLVDWLKMMVG+RRSEEV
Sbjct: 361 APEYANTGLLNEKSDVYSFGVLLLEGITGRDPVDYGRPANEVNLVDWLKMMVGNRRSEEV 420
Query: 373 VDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHRRTQ 432
VDPNIEV+PSTRALKR+LLTALRCVDPDSEKRPKM QVVRMLESEEYP+ REDRRHRR
Sbjct: 421 VDPNIEVKPSTRALKRALLTALRCVDPDSEKRPKMGQVVRMLESEEYPLPREDRRHRRRN 480
Query: 433 GGTSMEIESQKENSDTDRSDYPGSRSESK 461
S EIESQKE SDTDRS+ SR E +
Sbjct: 481 REGSGEIESQKEYSDTDRSEIQDSREERR 509
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356565467|ref|XP_003550961.1| PREDICTED: probable receptor-like protein kinase At5g18500-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 722 bits (1864), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/501 (74%), Positives = 419/501 (83%), Gaps = 41/501 (8%)
Query: 1 MGNNLNAELSKKT-IFGIKVWEVIGISVALFIIIILSVLSFCLTSRKKSRRARNNLPFSQ 59
M ++LN+ LS++T +FG+K WE++GI V LFIIIIL V+S CLTSRKKSRR LP S
Sbjct: 1 MASDLNSGLSQETSVFGLKAWELMGIIVGLFIIIILVVISICLTSRKKSRRVNGMLPLSH 60
Query: 60 IPTVSKEIKEVRVEQVSTNE-------------FVQRDD--------------------- 85
+ +VS EIKE+RV+QVS N F RD
Sbjct: 61 MLSVSDEIKEIRVDQVSANNHPQNGAFVSLYDRFSDRDSEKVLIQTNNGENSSQSGSFVH 120
Query: 86 --KDGGSISGEDSG--SVTVYKPSSSHPITAPSPLIGLPEFSQLGWGHWFTLRDLELATN 141
KD GS SGE+SG SV+ Y+ SSSHPITAPSPL GLPEFS LGWGHWFTLRDLELATN
Sbjct: 121 LKKDDGSQSGEESGAKSVSTYR-SSSHPITAPSPLCGLPEFSHLGWGHWFTLRDLELATN 179
Query: 142 RFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVR 201
RFSK+NV+GEGGYGVVY+G LINGSPVAVKK+LNN+GQAEKEFRVEVEAIGHVRHKNLVR
Sbjct: 180 RFSKDNVIGEGGYGVVYQGQLINGSPVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVR 239
Query: 202 LLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
LLGYCIEG HR+LVYEYVNNGNLEQWLHGAMR +G+LTW+AR+K+LLGTAKALAYLHEAI
Sbjct: 240 LLGYCIEGTHRLLVYEYVNNGNLEQWLHGAMRQYGFLTWDARIKILLGTAKALAYLHEAI 299
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGL 321
EPKVVHRDIKSSNILIDDDFNAK+SDFGLAKLLGAGKSH+TTRVMGTFGYVAPEYAN+GL
Sbjct: 300 EPKVVHRDIKSSNILIDDDFNAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGL 359
Query: 322 LNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRP 381
LNEKSDVYSFGVLLLEAITGRDPVD+ RPA EVNLVDWLKMMVG+RR+EEVVDPNIE RP
Sbjct: 360 LNEKSDVYSFGVLLLEAITGRDPVDYSRPATEVNLVDWLKMMVGNRRAEEVVDPNIETRP 419
Query: 382 STRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHRRTQGGTSMEIES 441
ST +LKR+LLTALRCVDPDSEKRPKMSQVVRMLESEEYPI REDRR R++Q G +ME+E+
Sbjct: 420 STSSLKRALLTALRCVDPDSEKRPKMSQVVRMLESEEYPIPREDRRRRKSQAG-NMELEA 478
Query: 442 QKENSDTDRSDYPGSRSESKR 462
QKE SDT+ ++ P S+S +R
Sbjct: 479 QKETSDTEMTENPDSKSNGRR 499
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|388518751|gb|AFK47437.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 717 bits (1850), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 354/502 (70%), Positives = 409/502 (81%), Gaps = 45/502 (8%)
Query: 1 MGNNLNAELSKKT-IFGIKVWEVIGISVALFIIIILSVLSFCLTSRKKSRRARNNLPFSQ 59
M +NL++ LSKKT +FG++VWE++G+ V LFI+IIL ++S CLTS+KKSRR LP S
Sbjct: 1 MASNLSSRLSKKTSVFGLEVWELMGLIVGLFIVIILLLVSICLTSKKKSRRVNGLLPLSH 60
Query: 60 IPTVSKEIKEVRVEQVSTN-------------------------------------EFVQ 82
+VS+EIK+++++QVSTN FV
Sbjct: 61 RLSVSEEIKDIKMDQVSTNSHPQNGAFMSLYDKFNDKESEKILLHTKNGEYSSQSGSFVH 120
Query: 83 RDDKDGGSISGEDSG--SVTVYKPSSSHPITAPSPLIGLPEFSQLGWGHWFTLRDLELAT 140
+ GS SGE+SG SV+ ++PS +T+PSPL GLPEFS LGWGHWFTLRDLELAT
Sbjct: 121 IEKDAAGSQSGEESGAKSVSAHRPS----LTSPSPLSGLPEFSHLGWGHWFTLRDLELAT 176
Query: 141 NRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLV 200
N+FSK+N++GEGGYGVVY+G LING+PVA+KK+LNN+GQAEKEFRVEVEAIGHVRHKNLV
Sbjct: 177 NKFSKDNIIGEGGYGVVYQGQLINGNPVAIKKLLNNLGQAEKEFRVEVEAIGHVRHKNLV 236
Query: 201 RLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
RLLG+CIEG HR+L+YEYVNNGNLEQWLHGAMR +GYLTW+AR+K+LLGTAKALAYLHEA
Sbjct: 237 RLLGFCIEGTHRLLIYEYVNNGNLEQWLHGAMRQYGYLTWDARIKILLGTAKALAYLHEA 296
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTG 320
IEPKVVHRDIKSSNILIDDDFNAK+SDFGLAKLLGAGKSH+TTRVMGTFGYVAPEYAN+G
Sbjct: 297 IEPKVVHRDIKSSNILIDDDFNAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSG 356
Query: 321 LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVR 380
LLNEKSDVYSFGVLLLEAITGRDPVD+ R A EVNLVDWLKMMVG+R +EEVVDPNIE R
Sbjct: 357 LLNEKSDVYSFGVLLLEAITGRDPVDYNRSAAEVNLVDWLKMMVGNRHAEEVVDPNIETR 416
Query: 381 PSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHRRTQGGTSMEIE 440
PST ALKR LLTALRCVDPDSEKRPKMSQVVRMLESEEYPI REDRR RR S ++E
Sbjct: 417 PSTSALKRVLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIPREDRR-RRKSNARSTDVE 475
Query: 441 SQKENSDTDRSDYPGSRSESKR 462
QKE DTD+SD+P S+S +R
Sbjct: 476 MQKEAFDTDKSDHPDSKSNGRR 497
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 463 | ||||||
| TAIR|locus:2027559 | 492 | AT1G56720 [Arabidopsis thalian | 0.755 | 0.711 | 0.865 | 6.3e-179 | |
| TAIR|locus:2012325 | 466 | AT1G09440 [Arabidopsis thalian | 0.732 | 0.727 | 0.846 | 3.8e-168 | |
| TAIR|locus:2146203 | 484 | AT5G18500 [Arabidopsis thalian | 0.766 | 0.733 | 0.780 | 3.2e-162 | |
| TAIR|locus:2045620 | 494 | AT2G42960 [Arabidopsis thalian | 0.723 | 0.678 | 0.804 | 3.8e-157 | |
| TAIR|locus:2077730 | 512 | AT3G59110 [Arabidopsis thalian | 0.745 | 0.673 | 0.784 | 2.1e-154 | |
| TAIR|locus:2093591 | 467 | GPK1 "glyoxysomal protein kina | 0.961 | 0.952 | 0.612 | 1.9e-145 | |
| TAIR|locus:2025396 | 472 | AT1G01540 [Arabidopsis thalian | 0.982 | 0.963 | 0.554 | 2.9e-126 | |
| TAIR|locus:2132353 | 492 | AT4G02630 [Arabidopsis thalian | 0.883 | 0.831 | 0.548 | 2.1e-116 | |
| TAIR|locus:2139559 | 437 | AT4G34500 [Arabidopsis thalian | 0.911 | 0.965 | 0.532 | 3.9e-115 | |
| TAIR|locus:2159873 | 681 | PERK8 "proline-rich extensin-l | 0.671 | 0.456 | 0.468 | 3.2e-73 |
| TAIR|locus:2027559 AT1G56720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1587 (563.7 bits), Expect = 6.3e-179, Sum P(2) = 6.3e-179
Identities = 310/358 (86%), Positives = 331/358 (92%)
Query: 105 SSSHPITAPSPLIGLPEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLIN 164
SS + I PSPL GLPE S LGWGHWFTLRDLE ATNRFSKENV+GEGGYGVVYRG L+N
Sbjct: 142 SSLYNIATPSPLSGLPE-SHLGWGHWFTLRDLETATNRFSKENVIGEGGYGVVYRGELMN 200
Query: 165 GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNL 224
G+PVAVKKILN +GQAEKEFRVEV+AIGHVRHKNLVRLLGYCIEG HR+LVYEYVNNGNL
Sbjct: 201 GTPVAVKKILNQLGQAEKEFRVEVDAIGHVRHKNLVRLLGYCIEGTHRILVYEYVNNGNL 260
Query: 225 EQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAK 284
EQWLHGAMR HGYLTWEARMKVL+GT+KALAYLHEAIEPKVVHRDIKSSNILI+D+FNAK
Sbjct: 261 EQWLHGAMRQHGYLTWEARMKVLIGTSKALAYLHEAIEPKVVHRDIKSSNILINDEFNAK 320
Query: 285 VSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
VSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYAN+GLLNEKSDVYSFGV+LLEAITGRDP
Sbjct: 321 VSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRDP 380
Query: 345 VDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKR 404
VD+GRPAHEVNLVDWLKMMVG+RRSEEVVDPNIEV+P TR+LKR+LLTALRCVDPDS+KR
Sbjct: 381 VDYGRPAHEVNLVDWLKMMVGTRRSEEVVDPNIEVKPPTRSLKRALLTALRCVDPDSDKR 440
Query: 405 PKMSQVVRMLESEEYPIVREDRRHRRTQGGTSMEIESQKENSDTDRSDYPGSRSESKR 462
PKMSQVVRMLESEEYPI REDRR RT+ G SMEI NSDTD S P SRS+SKR
Sbjct: 441 PKMSQVVRMLESEEYPIPREDRRRSRTREG-SMEI-----NSDTDMST-PVSRSQSKR 491
|
|
| TAIR|locus:2012325 AT1G09440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1531 (544.0 bits), Expect = 3.8e-168, Sum P(2) = 3.8e-168
Identities = 297/351 (84%), Positives = 323/351 (92%)
Query: 112 APSPLIGLPEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVK 171
+PSPL GLPE S LGWGHWFTLRDLE+ATNRFSKENV+GEGGYGVVYRG L+NGS VAVK
Sbjct: 127 SPSPLSGLPE-SHLGWGHWFTLRDLEIATNRFSKENVIGEGGYGVVYRGELVNGSLVAVK 185
Query: 172 KILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA 231
KILN++GQAEKEFRVEV+AIGHVRHKNLVRLLGYCIEG +R+LVYEY+NNGNLE+WLHGA
Sbjct: 186 KILNHLGQAEKEFRVEVDAIGHVRHKNLVRLLGYCIEGTNRILVYEYMNNGNLEEWLHGA 245
Query: 232 MRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA 291
M+HHGYLTWEARMKVL GT+KALAYLHEAIEPKVVHRDIKSSNILIDD FNAK+SDFGLA
Sbjct: 246 MKHHGYLTWEARMKVLTGTSKALAYLHEAIEPKVVHRDIKSSNILIDDRFNAKISDFGLA 305
Query: 292 KLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPA 351
KLLG GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVL+LEAITGRDPVD+ RPA
Sbjct: 306 KLLGDGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLVLEAITGRDPVDYARPA 365
Query: 352 HEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVV 411
+EVNLV+WLKMMVGS+R EEV+DPNI VRP+TRALKR LLTALRC+DPDSEKRPKMSQVV
Sbjct: 366 NEVNLVEWLKMMVGSKRLEEVIDPNIAVRPATRALKRVLLTALRCIDPDSEKRPKMSQVV 425
Query: 412 RMLESEEYPIVREDRRHRRTQGGTSMEIESQKENSDTDRSDYPGSRSESKR 462
RMLESEEYP+ RE+RR RRTQ +ENSDTDRS P SRS+SKR
Sbjct: 426 RMLESEEYPVPREERRVRRTQ----------EENSDTDRSR-PVSRSQSKR 465
|
|
| TAIR|locus:2146203 AT5G18500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1497 (532.0 bits), Expect = 3.2e-162, Sum P(2) = 3.2e-162
Identities = 277/355 (78%), Positives = 322/355 (90%)
Query: 105 SSSHPITAPSPLIGLPEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLIN 164
SS++P+TAPSPL GLPEFS LGWGHWFTLRDL++ATN+FS++N++G+GGYGVVYRGNL+N
Sbjct: 128 SSANPLTAPSPLSGLPEFSHLGWGHWFTLRDLQMATNQFSRDNIIGDGGYGVVYRGNLVN 187
Query: 165 GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNL 224
G+PVAVKK+LNN+GQA+K+FRVEVEAIGHVRHKNLVRLLGYC+EG RMLVYEYVNNGNL
Sbjct: 188 GTPVAVKKLLNNLGQADKDFRVEVEAIGHVRHKNLVRLLGYCMEGTQRMLVYEYVNNGNL 247
Query: 225 EQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAK 284
EQWL G ++H YLTWEAR+K+L+GTAKALAYLHEAIEPKVVHRDIKSSNILIDD FN+K
Sbjct: 248 EQWLRGDNQNHEYLTWEARVKILIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDKFNSK 307
Query: 285 VSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+SDFGLAKLLGA KS +TTRVMGTFGYVAPEYAN+GLLNEKSDVYSFGV+LLEAITGR P
Sbjct: 308 ISDFGLAKLLGADKSFITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYP 367
Query: 345 VDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKR 404
VD+ RP EV+LV+WLKMMV RRSEEVVDPN+E +PST ALKR+LLTALRCVDP SEKR
Sbjct: 368 VDYARPPPEVHLVEWLKMMVQQRRSEEVVDPNLETKPSTSALKRTLLTALRCVDPMSEKR 427
Query: 405 PKMSQVVRMLESEEYPIVREDRRHRRTQGGTSMEIESQKENSDTDRSDYPGSRSE 459
P+MSQV RMLESEEYPI REDRR RR+Q GT+ + + + ++DTD+S+Y + E
Sbjct: 428 PRMSQVARMLESEEYPIAREDRRRRRSQNGTTRDSDPPRNSTDTDKSEYHDLKPE 482
|
|
| TAIR|locus:2045620 AT2G42960 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1446 (514.1 bits), Expect = 3.8e-157, Sum P(2) = 3.8e-157
Identities = 272/338 (80%), Positives = 310/338 (91%)
Query: 109 PITAPSPLIGLPEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPV 168
P+TA SPL+GLPE S LGWGHWFTLRDLELATNRF+ NVLGEGGYGVVYRG L+NG+ V
Sbjct: 150 PVTA-SPLVGLPEISHLGWGHWFTLRDLELATNRFAPVNVLGEGGYGVVYRGKLVNGTEV 208
Query: 169 AVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWL 228
AVKK+LNN+GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG+HRMLVYEYVN+GNLEQWL
Sbjct: 209 AVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHRMLVYEYVNSGNLEQWL 268
Query: 229 HGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDF 288
HGAMR HG LTWEARMK++ GTA+ALAYLHEAIEPKVVHRDIK+SNILIDD+FNAK+SDF
Sbjct: 269 HGAMRQHGNLTWEARMKIITGTAQALAYLHEAIEPKVVHRDIKASNILIDDEFNAKLSDF 328
Query: 289 GLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348
GLAKLL +G+SH+TTRVMGTFGYVAPEYANTGLLNEKSD+YSFGVLLLEAITGRDPVD+G
Sbjct: 329 GLAKLLDSGESHITTRVMGTFGYVAPEYANTGLLNEKSDIYSFGVLLLEAITGRDPVDYG 388
Query: 349 RPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMS 408
RPA+EVNLV+WLKMMVG+RR+EEVVDP +E RPS ALKR+LL +LRCVDP++EKRP+MS
Sbjct: 389 RPANEVNLVEWLKMMVGTRRAEEVVDPRLEPRPSKSALKRALLVSLRCVDPEAEKRPRMS 448
Query: 409 QVVRMLESEEYPIVREDRRHRRTQGGTSMEIESQKENS 446
QV RMLES+E+P +E RR++R++ MEI K+ S
Sbjct: 449 QVARMLESDEHPFHKE-RRNKRSKTA-GMEIVETKDES 484
|
|
| TAIR|locus:2077730 AT3G59110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1433 (509.5 bits), Expect = 2.1e-154, Sum P(2) = 2.1e-154
Identities = 276/352 (78%), Positives = 320/352 (90%)
Query: 110 ITAPSPLIGLPEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVA 169
+TA SPL+GLPE S LGWGHWFTLRDL+LATNRF+ ENV+GEGGYGVVY+G LING+ VA
Sbjct: 158 VTA-SPLVGLPEISHLGWGHWFTLRDLQLATNRFAAENVIGEGGYGVVYKGRLINGNDVA 216
Query: 170 VKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLH 229
VKK+LNN+GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG++RMLVYEYVN+GNLEQWLH
Sbjct: 217 VKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVNRMLVYEYVNSGNLEQWLH 276
Query: 230 GAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFG 289
GAM LTWEARMK+L+GTA+ALAYLHEAIEPKVVHRDIK+SNILIDDDFNAK+SDFG
Sbjct: 277 GAMGKQSTLTWEARMKILVGTAQALAYLHEAIEPKVVHRDIKASNILIDDDFNAKLSDFG 336
Query: 290 LAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349
LAKLL +G+SH+TTRVMGTFGYVAPEYANTGLLNEKSD+YSFGVLLLE ITGRDPVD+ R
Sbjct: 337 LAKLLDSGESHITTRVMGTFGYVAPEYANTGLLNEKSDIYSFGVLLLETITGRDPVDYER 396
Query: 350 PAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQ 409
PA+EVNLV+WLKMMVG+RR+EEVVD IE P+TRALKR+LL ALRCVDP+++KRPKMSQ
Sbjct: 397 PANEVNLVEWLKMMVGTRRAEEVVDSRIEPPPATRALKRALLVALRCVDPEAQKRPKMSQ 456
Query: 410 VVRMLESEEYPIVREDRRHRRTQGGTSMEI-ESQKENSDTDRSDYPGSRSES 460
VVRMLES+E+P RE+RR+R+++ SMEI E+ +E++DT + PG SE+
Sbjct: 457 VVRMLESDEHPF-REERRNRKSRTA-SMEIVETTEESADTSKG--PG-HSEN 503
|
|
| TAIR|locus:2093591 GPK1 "glyoxysomal protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1421 (505.3 bits), Expect = 1.9e-145, P = 1.9e-145
Identities = 284/464 (61%), Positives = 350/464 (75%)
Query: 1 MGNNLNAELSKKTIFGI-KVWEXXXXXXXXXXXXXXXXXXFCLTSRKKSRRAR-NNLPFS 58
M + L L+K+ +G+ ++WE + L+ RKKS+R+ LP +
Sbjct: 1 MTSQLKRTLTKR--YGVLELWEIIVIALFAAFIVILVLSVW-LSFRKKSKRSNATTLPVT 57
Query: 59 QIPTVSKEIKEVRVEQVSTN-----------EFVQRXXXXXXXXXXXXXX-XVTVYKPSS 106
Q P ++EIKE+ V+ S+N +FV+ V + P S
Sbjct: 58 QSPRFTEEIKEISVDHGSSNNNGTSYQTLDEKFVEDIENGDKFSGSLEKKPLVGSHLPPS 117
Query: 107 SHPITAPSPLIGLPEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGS 166
+ TAPSPL+GLPE S +GWGHWFTLRDL+LATN FSKE+++G+GGYGVVY G L N +
Sbjct: 118 TPSTTAPSPLLGLPEVSHIGWGHWFTLRDLQLATNHFSKESIIGDGGYGVVYHGTLTNKT 177
Query: 167 PVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQ 226
PVAVKK+LNN GQA+K+FRVEVEAIGHVRHKNLVRLLGYC+EG HRMLVYEY+NNGNLEQ
Sbjct: 178 PVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCVEGTHRMLVYEYMNNGNLEQ 237
Query: 227 WLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVS 286
WLHG M H G+LTWEAR+KVL+GTAKALAYLHEAIEPKVVHRDIKSSNIL+DD+F+AK+S
Sbjct: 238 WLHGDMIHKGHLTWEARIKVLVGTAKALAYLHEAIEPKVVHRDIKSSNILMDDNFDAKLS 297
Query: 287 DFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVD 346
DFGLAKLLGA ++V+TRVMGTFGYVAPEYAN+GLLNEKSDVYS+GV+LLEAITGR PVD
Sbjct: 298 DFGLAKLLGADSNYVSTRVMGTFGYVAPEYANSGLLNEKSDVYSYGVVLLEAITGRYPVD 357
Query: 347 HGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPK 406
+ RP EV++V+WLK+MV ++ EEVVD +E++P+T LKR+LLTALRCVDPD++KRPK
Sbjct: 358 YARPKEEVHMVEWLKLMVQQKQFEEVVDKELEIKPTTSELKRALLTALRCVDPDADKRPK 417
Query: 407 MSQVVRMLESEEYPIV-REDRRHRRTQGGTSMEIESQKENSDTD 449
MSQV RMLES+EYP++ RE+RR RR Q + ES N D D
Sbjct: 418 MSQVARMLESDEYPVMPREERRRRRNQNAETHR-ESTDTNKDND 460
|
|
| TAIR|locus:2025396 AT1G01540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1240 (441.6 bits), Expect = 2.9e-126, P = 2.9e-126
Identities = 258/465 (55%), Positives = 319/465 (68%)
Query: 5 LNAELSKKT-IFGIKVWEXXXXXXXXXXXXXXXXXXFCLTSRKKSRRARNNLPFSQI--P 61
LN ELSK T IFG+++W CLTSR+K+R+ R + + I P
Sbjct: 9 LNTELSKPTSIFGLRLWVVIGILLGSLIVIALFLLSLCLTSRRKNRKPRADFASAAIATP 68
Query: 62 TVSKEIKE-VRVEQVSTNEFVQRXXXXXXXXXXXXXXXVT-VYKPSSSHPITAPSPLIGL 119
+SKEIKE V + S +Q + + ++S TA G
Sbjct: 69 PISKEIKEIVPAQNQSVPAEIQVDIGKIEHRVVFSDRVSSGESRGTASASETASYSGSGN 128
Query: 120 --PEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNV 177
PE S LGWG W+TLR+LE ATN +ENV+GEGGYG+VYRG L +G+ VAVK +LNN
Sbjct: 129 CGPEVSHLGWGRWYTLRELEAATNGLCEENVIGEGGYGIVYRGILTDGTKVAVKNLLNNR 188
Query: 178 GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY 237
GQAEKEF+VEVE IG VRHKNLVRLLGYC+EG +RMLVY++V+NGNLEQW+HG +
Sbjct: 189 GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYDFVDNGNLEQWIHGDVGDVSP 248
Query: 238 LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297
LTW+ RM ++LG AK LAYLHE +EPKVVHRDIKSSNIL+D +NAKVSDFGLAKLLG+
Sbjct: 249 LTWDIRMNIILGMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLLGSE 308
Query: 298 KSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLV 357
S+VTTRVMGTFGYVAPEYA TG+LNEKSD+YSFG+L++E ITGR+PVD+ RP E NLV
Sbjct: 309 SSYVTTRVMGTFGYVAPEYACTGMLNEKSDIYSFGILIMEIITGRNPVDYSRPQGETNLV 368
Query: 358 DWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417
DWLK MVG+RRSEEVVDP I PS++ALKR LL ALRCVDPD+ KRPKM ++ MLE+E
Sbjct: 369 DWLKSMVGNRRSEEVVDPKIPEPPSSKALKRVLLVALRCVDPDANKRPKMGHIIHMLEAE 428
Query: 418 EYPIVREDRRHRRTQGGTSMEIESQKENSDTDRSDYPGSRSESKR 462
+ + R++RR R G S E + + S GSR ++
Sbjct: 429 DL-LYRDERRTTRDHG--SRERQETAVVAAGSESGESGSRHHQQK 470
|
|
| TAIR|locus:2132353 AT4G02630 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1147 (408.8 bits), Expect = 2.1e-116, P = 2.1e-116
Identities = 232/423 (54%), Positives = 304/423 (71%)
Query: 43 TSRKKSRRARNNLPFSQIPTVSKEIKEVR--VEQVSTNE---FVQRXXXXXXXXXXXXXX 97
+++ KS + + + +P VSKEI+E+R ++ T E QR
Sbjct: 50 SNKNKSLESSSKSNHTIVPVVSKEIQEIRPPIQPDPTPEPHQNQQREDDNKIHIEIGKDH 109
Query: 98 XVTV-----YKPSSSHPITAPSPLIGL--PEFSQLGWGHWFTLRDLELATNRFSKENVLG 150
+ + S S + L+ L PE S LGWGHW+TLR+LE++TN F+ ENV+G
Sbjct: 110 RIAYPERGGWTGSGSGSGSGDQGLLMLSGPEVSHLGWGHWYTLRELEVSTNGFADENVIG 169
Query: 151 EGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGI 210
+GGYG+VYRG L + S VA+K +LNN GQAEKEF+VEVEAIG VRHKNLVRLLGYC+EG
Sbjct: 170 QGGYGIVYRGVLEDKSMVAIKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCVEGA 229
Query: 211 HRMLVYEYVNNGNLEQWLHGA-MRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRD 269
HRMLVYEYV+NGNLEQW+HG + LTWE RM ++LGTAK L YLHE +EPKVVHRD
Sbjct: 230 HRMLVYEYVDNGNLEQWIHGGGLGFKSPLTWEIRMNIVLGTAKGLMYLHEGLEPKVVHRD 289
Query: 270 IKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVY 329
IKSSNIL+D +N+KVSDFGLAKLLG+ S+VTTRVMGTFGYVAPEYA+TG+LNE+SDVY
Sbjct: 290 IKSSNILLDKQWNSKVSDFGLAKLLGSEMSYVTTRVMGTFGYVAPEYASTGMLNERSDVY 349
Query: 330 SFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRS 389
SFGVL++E I+GR PVD+ R EVNLV+WLK +V +R +E V+DP + +PS R+LKR+
Sbjct: 350 SFGVLVMEIISGRSPVDYSRAPGEVNLVEWLKRLVTNRDAEGVLDPRMVDKPSLRSLKRT 409
Query: 390 LLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHRRTQGGTSMEIESQKENSDTD 449
LL ALRCVDP+++KRPKM ++ MLE+E+ + ++DRR+ GG + S + ++ +
Sbjct: 410 LLVALRCVDPNAQKRPKMGHIIHMLEAEDL-VSKDDRRNSGGGGGGIEQGRSPRRKTNVN 468
Query: 450 RSD 452
S+
Sbjct: 469 ESE 471
|
|
| TAIR|locus:2139559 AT4G34500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1135 (404.6 bits), Expect = 3.9e-115, P = 3.9e-115
Identities = 231/434 (53%), Positives = 292/434 (67%)
Query: 2 GNNLNAELSKKTIFGIKVWEXXXXXXXXXXXXXXXXXXF-CLTSRKKSRRARNNLPFSQI 60
G + + +K ++FG+ ++ F CL ++RR R I
Sbjct: 6 GGSHKSSTTKPSVFGLNLYLVIAICSVFILLISLLIFLFVCLNRVSRARRMRVKHSSGSI 65
Query: 61 PTVSKEIKEVRVEQVSTNEFVQRXXXXXXXXXXXXXXXVTVYKPSSSHPIT---APSPLI 117
P VSKEI E++ + +F+ K ++S T A S +
Sbjct: 66 PLVSKEISEIK----TVGKFINSDDSKGKIGNEVVVVVSATSKEATSGFDTLSVASSGDV 121
Query: 118 GLPEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNV 177
G E +GWG W++L+DLE+AT FS +N++GEGGYGVVYR + +GS AVK +LNN
Sbjct: 122 GTSE--AMGWGKWYSLKDLEIATRGFSDDNMIGEGGYGVVYRADFSDGSVAAVKNLLNNK 179
Query: 178 GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIH--RMLVYEYVNNGNLEQWLHGAMRHH 235
GQAEKEF+VEVEAIG VRHKNLV L+GYC + RMLVYEY++NGNLEQWLHG +
Sbjct: 180 GQAEKEFKVEVEAIGKVRHKNLVGLMGYCADSAQSQRMLVYEYIDNGNLEQWLHGDVGPV 239
Query: 236 GYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295
LTW+ RMK+ +GTAK LAYLHE +EPKVVHRD+KSSNIL+D +NAKVSDFGLAKLLG
Sbjct: 240 SPLTWDIRMKIAIGTAKGLAYLHEGLEPKVVHRDVKSSNILLDKKWNAKVSDFGLAKLLG 299
Query: 296 AGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVN 355
+ S+VTTRVMGTFGYV+PEYA+TG+LNE SDVYSFGVLL+E ITGR PVD+ RP E+N
Sbjct: 300 SETSYVTTRVMGTFGYVSPEYASTGMLNECSDVYSFGVLLMEIITGRSPVDYSRPPGEMN 359
Query: 356 LVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
LVDW K MV SRR EEV+DP I+ P RALKR+LL LRC+D DS KRPKM Q++ MLE
Sbjct: 360 LVDWFKGMVASRRGEEVIDPKIKTSPPPRALKRALLVCLRCIDLDSSKRPKMGQIIHMLE 419
Query: 416 SEEYPIVREDRRHR 429
+E++P E R ++
Sbjct: 420 AEDFPFRPEHRSNQ 433
|
|
| TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 719 (258.2 bits), Expect = 3.2e-73, Sum P(2) = 3.2e-73
Identities = 150/320 (46%), Positives = 209/320 (65%)
Query: 130 WFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVE 189
WF+ +L T+ FS++N+LGEGG+G VY+G L +G VAVK++ Q E+EF+ EVE
Sbjct: 326 WFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVE 385
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
I V H++LV L+GYCI HR+LVY+YV N L LH R +TWE R++V G
Sbjct: 386 IISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRP--VMTWETRVRVAAG 443
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG--KSHVTTRVMG 307
A+ +AYLHE P+++HRDIKSSNIL+D+ F A V+DFGLAK+ +HV+TRVMG
Sbjct: 444 AARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMG 503
Query: 308 TFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVG-- 365
TFGY+APEYA +G L+EK+DVYS+GV+LLE ITGR PVD +P + +LV+W + ++G
Sbjct: 504 TFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQA 563
Query: 366 --SRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES-EEYPIV 422
+ +E+VDP + + R + A CV + KRPKMSQVVR L++ EE +
Sbjct: 564 IENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALDTLEEATDI 623
Query: 423 REDRRHRRTQGGTSMEIESQ 442
R ++Q S + +Q
Sbjct: 624 TNGMRPGQSQVFDSRQQSAQ 643
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 463 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-55 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-50 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-50 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-50 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-50 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-48 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-48 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-39 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-37 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-37 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-34 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-32 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-31 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-30 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-29 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-28 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-28 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-27 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-27 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-26 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-26 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-26 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-25 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-24 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-24 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-24 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-23 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-23 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-22 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-22 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-22 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-21 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-21 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-21 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-20 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-20 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-20 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-20 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-20 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-19 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-19 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-18 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-18 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-18 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-18 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-18 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-18 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-17 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-17 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-16 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-16 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-16 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-16 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-16 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-15 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-15 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-15 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-15 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-15 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-14 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-14 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-12 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 9e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 8e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 7e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 6e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 5e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 8e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 9e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 4e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.002 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.002 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.002 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 183 bits (468), Expect = 1e-55
Identities = 74/193 (38%), Positives = 109/193 (56%), Gaps = 11/193 (5%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYC 206
LGEGG+G VY + G VA+K I + +E E+E + + H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 207 IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVV 266
+ H LV EY G+L+ L + G L+ + +++LL + L YLH ++
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 267 HRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YANTGLLNE 324
HRD+K NIL+D D+ K++DFGL+KLL + KS + T V GT Y+APE G +E
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSE 173
Query: 325 KSDVYSFGVLLLE 337
KSD++S GV+L E
Sbjct: 174 KSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 1e-50
Identities = 85/278 (30%), Positives = 126/278 (45%), Gaps = 29/278 (10%)
Query: 144 SKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNN-VGQAEKEFRVEVEAIGHVRHK 197
+ LGEG +G VY+G L VAVK + + Q +EF E + + H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
N+V+LLG C E +V EY+ G+L +L ++ L+ + L A+ + YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLR---KNRPKLSLSDLLSFALQIARGMEYL 118
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
+HRD+ + N L+ ++ K+SDFGL++ L + ++APE
Sbjct: 119 ESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESL 175
Query: 318 NTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376
G KSDV+SFGVLL E T G P G EV +++LK G R + P
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQPYP-GMSNEEV--LEYLK--NGYRLPQPPNCP- 229
Query: 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414
P L L+C D E RP S++V +L
Sbjct: 230 ----PELYDL------MLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 3e-50
Identities = 82/278 (29%), Positives = 133/278 (47%), Gaps = 32/278 (11%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKNL 199
+ LG G +G VY+ + G VAVK + + + ++ R E+ + + H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 200 VRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE 259
VRL+ + H LV EY G+L +L G L+ + K+ L + L YLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYL----SRGGPLSEDEAKKIALQILRGLEYLHS 116
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANT 319
++HRD+K NIL+D++ K++DFGLAK L S +TT V GT Y+APE
Sbjct: 117 N---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPE---- 168
Query: 320 GLLNE------KSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373
+L K DV+S GV+L E +TG+ P N++D L+++ +
Sbjct: 169 -VLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGE------NILDQLQLIR-RILGPPLE 220
Query: 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVV 411
+ + K L+ +C++ D KRP +++
Sbjct: 221 FDEPKWSSGSEEAK-DLIK--KCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 5e-50
Identities = 85/274 (31%), Positives = 129/274 (47%), Gaps = 26/274 (9%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLV 200
+ LGEG +G VY + G VA+K I + + + E++ + ++H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 201 RLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT-WEARMKVLLGTAKALAYLHE 259
RL + LV EY G+L L + G L+ EAR L AL YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL----KKRGRLSEDEAR-FYLRQILSALEYLHS 115
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANT 319
+VHRD+K NIL+D+D + K++DFGLA+ L G +TT V GT Y+APE
Sbjct: 116 K---GIVHRDLKPENILLDEDGHVKLADFGLARQLDPG-EKLTTFV-GTPEYMAPEVLLG 170
Query: 320 GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEV 379
+ D++S GV+L E +TG+ P + L++ K + + P ++
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPPFP-----GDDQLLELFKKIG--KPKPPFPPPEWDI 223
Query: 380 RPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413
P + L R LL DP EKR + ++
Sbjct: 224 SPEAKDLIRKLL----VKDP--EKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 6e-50
Identities = 84/284 (29%), Positives = 124/284 (43%), Gaps = 40/284 (14%)
Query: 144 SKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNV-GQAEKEFRVEVEAIGHVRHK 197
+ LGEG +G VY+G L VAVK + + Q +EF E + + H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
N+V+LLG C E M+V EY+ G+L +L L+ + L A+ + YL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLR--KNRPKELSLSDLLSFALQIARGMEYL 119
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
+HRD+ + N L+ ++ K+SDFGL++ L + ++APE
Sbjct: 120 ESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESL 176
Query: 318 NTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRR------SE 370
G KSDV+SFGVLL E T G +P G EV +++LK G R
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTLGEEPYP-GMSNAEV--LEYLKK--GYRLPKPPNCPP 231
Query: 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414
E+ L+C D E RP S++V +L
Sbjct: 232 ELYK-----------------LMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 3e-48
Identities = 91/289 (31%), Positives = 128/289 (44%), Gaps = 47/289 (16%)
Query: 147 NVLGEGGYGVVYRGNLINGS----PVAVKKILNNVGQAE-KEFRVEVEAIGHVRHKNLVR 201
LGEG +G VY+G L VAVK + + + E K+F E + + H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 202 LLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY-----LTWEARMKVLLGTAKALAY 256
LLG C E LV EY+ G+L +L + L+ + + + AK + Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 257 LHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTT-------RVMGTF 309
L K VHRD+ + N L+ +D K+SDFGL++ + + R M
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM--- 174
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSR- 367
APE G+ KSDV+SFGVLL E T G P G EV +++L+ G R
Sbjct: 175 ---APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYP-GLSNEEV--LEYLR--KGYRL 226
Query: 368 -RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
+ E D E+ L C D E RP S++V LE
Sbjct: 227 PKPEYCPDELYEL-------------MLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 164 bits (419), Expect = 6e-48
Identities = 89/278 (32%), Positives = 128/278 (46%), Gaps = 36/278 (12%)
Query: 148 VLGEGGYGVVYRGNLINGS-----PVAVKKILNNVGQAEK-EFRVEVEAIGHVRHKNLVR 201
LGEG +G VY+G L VAVK + + E+ EF E + + H N+VR
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 202 LLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
LLG C +G +V EY+ G+L +L +H LT + +++ L AK + YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLR---KHGEKLTLKDLLQMALQIAKGMEYLESK- 121
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF--GYVAPEYANT 319
VHRD+ + N L+ ++ K+SDFGL++ + + R G ++APE
Sbjct: 122 --NFVHRDLAARNCLVTENLVVKISDFGLSRDI-YEDDYYRKRGGGKLPIKWMAPESLKD 178
Query: 320 GLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378
G KSDV+SFGVLL E T G P G EV L+++ R
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEQPYP-GMSNEEV-----LELLEDGYRLP-------- 224
Query: 379 VRPS--TRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414
RP L L+ +C D E RP S++V L
Sbjct: 225 -RPENCPDELY-ELML--QCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 2e-39
Identities = 79/277 (28%), Positives = 127/277 (45%), Gaps = 33/277 (11%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAE-KEFRVEVEAIGHVRHKN 198
+++ +LG G +G VY + G +AVK + L+ + E + E+ + ++H N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 199 LVRLLGYCIEGIHRML-VY-EYVNNGNLEQWLH--GAMRHHGYLTWEARMKVLLG-TAKA 253
+VR G + L ++ EYV+ G+L L G + E ++ +
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP-------EPVIRKYTRQILEG 113
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVM-GTFGYV 312
LAYLH +VHRDIK +NIL+D D K++DFG AK LG ++ T + GT ++
Sbjct: 114 LAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM 170
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV 372
APE +D++S G ++E TG+ P E+ +GS S E
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGK------PPWSELGNPMAALYKIGS--SGEP 222
Query: 373 VDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQ 409
P I S A + L +C+ D +KRP +
Sbjct: 223 --PEIPEHLSEEA--KDFL--RKCLRRDPKKRPTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 1e-37
Identities = 57/204 (27%), Positives = 104/204 (50%), Gaps = 11/204 (5%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVR 201
F +G+GG+G VY+ + G VA+K I + +++ E++ + +H N+V+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 202 LLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARM-KVLLGTAKALAYLHEA 260
G ++ +V E+ + G+L+ ++ E+++ V K L YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKD----LLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTG 320
++HRDIK++NIL+ D K+ DFGL+ L K+ ++GT ++APE N
Sbjct: 118 ---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTMVGTPYWMAPEVINGK 172
Query: 321 LLNEKSDVYSFGVLLLEAITGRDP 344
+ K+D++S G+ +E G+ P
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 4e-37
Identities = 78/283 (27%), Positives = 130/283 (45%), Gaps = 39/283 (13%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRV-EVEAIGHVRHKN 198
++ +G+G +G VY +G +K+I L+N+ + E+E + EV+ + + H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+++ E +V EY + G+L Q + + E + + AL YLH
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE--- 315
K++HRDIK NI + + K+ DFG++K+L + T V GT Y++PE
Sbjct: 121 SR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQ 176
Query: 316 ---YANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV 372
Y N KSD++S G +L E T + P + L LK++ G
Sbjct: 177 NKPY------NYKSDIWSLGCVLYELCTLKHPFEGENLL---ELA--LKILKGQY----- 220
Query: 373 VDPNIEVRPST--RALKRSLLTALRCVDPDSEKRPKMSQVVRM 413
P I + S+ R L SLL D E+RP ++Q+++
Sbjct: 221 --PPIPSQYSSELRNLVSSLLQ------KDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 3e-34
Identities = 68/197 (34%), Positives = 104/197 (52%), Gaps = 12/197 (6%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 208
+G+G +G V G+ G VAVK + ++ A+ F E + +RH NLV+LLG ++
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQA-FLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 209 GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHR 268
G +V EY+ G+L +L R +T ++ L + + YL E VHR
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAV--ITLAQQLGFALDVCEGMEYLEEK---NFVHR 126
Query: 269 DIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDV 328
D+ + N+L+ +D AKVSDFGLAK A + + ++ + APE + KSDV
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKL--PVKWTAPEALREKKFSTKSDV 182
Query: 329 YSFGVLLLEAIT-GRDP 344
+SFG+LL E + GR P
Sbjct: 183 WSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-33
Identities = 68/214 (31%), Positives = 109/214 (50%), Gaps = 27/214 (12%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAE-KEFRVEVEAIGHVRHKN 198
+ +++G G +GVVY+G NL G VA+K+I L + + K E++ + +++H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHG--------YLTWEARMKVLLGT 250
+V+ +G ++ EY NG+L Q + + Y+ +VL G
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIK---KFGPFPESLVAVYVY-----QVLQG- 111
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
LAYLHE V+HRDIK++NIL D K++DFG+A L S V+GT
Sbjct: 112 ---LAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLND-VSKDDASVVGTPY 164
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
++APE + SD++S G ++E +TG P
Sbjct: 165 WMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 125 bits (313), Expect = 7e-32
Identities = 78/282 (27%), Positives = 121/282 (42%), Gaps = 23/282 (8%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRH-KN 198
+ LGEG +G VY + VA+K + L + + + F E++ + + H N
Sbjct: 2 YRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+L + + LV EYV+ G+LE L + G L+ + +L AL YLH
Sbjct: 60 IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLK-KIGRKGPLSESEALFILAQILSALEYLH 118
Query: 259 EAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVTTR-----VMGTFGYV 312
++HRDIK NIL+D D K+ DFGLAKLL S + +GT GY+
Sbjct: 119 SK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 313 APEYANTGLLNE---KSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
APE L SD++S G+ L E +TG P + + LK+++
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE--GEKNSSATSQTLKIILELPTP 233
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVV 411
+ LL + + D + R S +
Sbjct: 234 SLASPLSPSNPELISKAASDLLK--KLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 7e-31
Identities = 83/278 (29%), Positives = 129/278 (46%), Gaps = 45/278 (16%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRH 196
E F+ E LG G +G V+ G N VA+K + ++ +++F+ EV+A+ +RH
Sbjct: 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRH 61
Query: 197 KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA------MRHHGYLTWEARMKVLLGT 250
K+L+ L C G ++ E + G+L +L + + +
Sbjct: 62 KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQ--------V 113
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
A+ +AYL E +HRD+ + NIL+ +D KV+DFGLA+L+ K V
Sbjct: 114 AEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLI---KEDVYLSSDKKIP 167
Query: 311 Y--VAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEV-NLVD-------- 358
Y APE A+ G + KSDV+SFG+LL E T G+ P G HEV + +
Sbjct: 168 YKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYP-GMNNHEVYDQITAGYRMPCP 226
Query: 359 ------WLKMMVGSRRSEEVVDPNIEVRPSTRALKRSL 390
K+M+ +E E RPS +AL+ L
Sbjct: 227 AKCPQEIYKIMLECWAAEP------EDRPSFKALREEL 258
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 8e-30
Identities = 85/288 (29%), Positives = 133/288 (46%), Gaps = 22/288 (7%)
Query: 131 FTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEA 190
T+ D+ + +ENV+ G G Y+G I V K +N+V +
Sbjct: 683 ITINDILSSLK---EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSE---IAD 736
Query: 191 IGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT 250
+G ++H N+V+L+G C L++EY+ NL + L L+WE R K+ +G
Sbjct: 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGI 789
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
AKAL +LH P VV ++ I+ID + L LL T+ +
Sbjct: 790 AKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC-----TDTKCFISSA 843
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370
YVAPE T + EKSD+Y FG++L+E +TG+ P D H ++V+W + +
Sbjct: 844 YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG-SIVEWARYCYSDCHLD 902
Query: 371 EVVDPNIEVRPST--RALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416
+DP+I S + + AL C D RP + V++ LES
Sbjct: 903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-29
Identities = 81/275 (29%), Positives = 138/275 (50%), Gaps = 29/275 (10%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRV-EVEAIGHVRHKNL 199
F N +G+G +GVV++ + A+K+I L+ + + E+E + E + + +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 200 VRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAM--RHHGYLTWEARMKVLLGTAKALAYL 257
+R ++ +V EY NG+L + L W +++LLG LA+L
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAHL 117
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
H K++HRDIKS N+ +D N K+ D G+AKLL + T ++GT Y++PE
Sbjct: 118 HSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPELC 173
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNI 377
NEKSDV++ GV+L E TG+ P D ++ L+ LK++ G V P +
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFD---ANNQGALI--LKIIRG-------VFPPV 221
Query: 378 EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
+ ++ L + L+ +C+ D +RP Q++R
Sbjct: 222 S-QMYSQQLAQ-LID--QCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 67/209 (32%), Positives = 107/209 (51%), Gaps = 28/209 (13%)
Query: 146 ENVLGEGGYGVVYRGNL-INGSP---VAVKKILNNVGQAEKE---FRVEVEAIGHVRHKN 198
E V+G G +G V RG L + G VA+K + G ++K+ F E +G H N
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL--KAGSSDKQRLDFLTEASIMGQFDHPN 66
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHH-GYLTWEARMKVLLGTAKALAYL 257
++RL G + M++ EY+ NG+L+++L R + G T + +L G A + YL
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFL----RENDGKFTVGQLVGMLRGIASGMKYL 122
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG------Y 311
E VHRD+ + NIL++ + KVSDFGL++ L ++ TT+ G +
Sbjct: 123 SEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK-----GGKIPIRW 174
Query: 312 VAPEYANTGLLNEKSDVYSFGVLLLEAIT 340
APE SDV+SFG+++ E ++
Sbjct: 175 TAPEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-28
Identities = 70/268 (26%), Positives = 121/268 (45%), Gaps = 29/268 (10%)
Query: 148 VLGEGGYGVVYRGNLI-NGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLVRLLG- 204
VLG+G GVVY+ G A+KKI ++ + K+ E++ + +V+ G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 205 YCIEG-IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEP 263
+ EG I +V EY++ G+L ++ G + + K L YLH +
Sbjct: 68 FYKEGEIS--IVLEYMDGGSL----ADLLKKVGKIPEPVLAYIARQILKGLDYLHT--KR 119
Query: 264 KVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLN 323
++HRDIK SN+LI+ K++DFG++K+L T V GT Y++PE +
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYS 178
Query: 324 EKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPST 383
+D++S G+ LLE G+ P + ++M + + D P+
Sbjct: 179 YAADIWSLGLTLLECALGKFPFLPPGQP------SFFELM------QAICDGPPPSLPAE 226
Query: 384 RALK--RSLLTALRCVDPDSEKRPKMSQ 409
R ++ C+ D +KRP ++
Sbjct: 227 EFSPEFRDFIS--ACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 1e-27
Identities = 79/278 (28%), Positives = 130/278 (46%), Gaps = 41/278 (14%)
Query: 148 VLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYC 206
VLG+G YG+VY +L +A+K+I + + E+ +++H+N+V+ LG
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 207 IEGIHRMLVYEYVNNGNLEQWLH---GAMRHHGYLTWEARMK-----VLLGTAKALAYLH 258
E + E V G+L L G ++ + E + +L G L YLH
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDN-----EQTIIFYTKQILEG----LKYLH 125
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNA-KVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
+ ++VHRDIK N+L++ K+SDFG +K L AG + T GT Y+APE
Sbjct: 126 DN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL-AGINPCTETFTGTLQYMAPEVI 181
Query: 318 NTGL--LNEKSDVYSFGVLLLEAITGRDP-VDHGRPAHEVNLVDWLKMMVGSRRSEEVVD 374
+ G +D++S G ++E TG+ P ++ G P + V K +
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK-----------IH 230
Query: 375 PNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
P I S A ++ + LRC +PD +KR +++
Sbjct: 231 PEIPESLSAEA--KNFI--LRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 79/282 (28%), Positives = 128/282 (45%), Gaps = 37/282 (13%)
Query: 142 RFSKENVLGEGGYGVVYRGNLI-----NGSPVAVKKILNNVG-QAEKEFRVEVEAIGHVR 195
K VLG G +G VY+G I PVA+K + +A KE E + V
Sbjct: 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD 67
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLH---GAMRHHGYLTWEARMKVLLGTAK 252
H ++VRLLG C+ L+ + + G L ++ + L W ++ AK
Sbjct: 68 HPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AK 120
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV-TTRVMGTFGY 311
++YL E ++VHRD+ + N+L+ + K++DFGLAKLL + +
Sbjct: 121 GMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKW 177
Query: 312 VAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370
+A E + KSDV+S+GV + E +T G P + G PA E+ D L+ + E
Sbjct: 178 MALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE-GIPAVEIP--DLLE------KGE 228
Query: 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
+ P I T + + ++C D+E RP +++
Sbjct: 229 RLPQPPI----CTIDV---YMVLVKCWMIDAESRPTFKELIN 263
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 75/227 (33%), Positives = 109/227 (48%), Gaps = 42/227 (18%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKE-FRV----EVEAIGHVRH 196
+ K +GEG YG VY+ N G VA+KKI + EKE F + E++ + +RH
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRM---ENEKEGFPITAIREIKLLQKLRH 57
Query: 197 KNLVRLLGYCIE----GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEAR----MKVLL 248
N+VRL I+ +V+EY ++ L G + E++ MK LL
Sbjct: 58 PNIVRLKEIVTSKGKGSIY--MVFEY-----MDHDLTGLLDSPEVKFTESQIKCYMKQLL 110
Query: 249 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL-GAGKSHVTTRVMG 307
+ L YLH ++HRDIK SNILI++D K++DFGLA+ + T RV+
Sbjct: 111 ---EGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI- 163
Query: 308 TFGYVAPEYANTGLLNEKS-----DVYSFGVLLLEAITGRDPVDHGR 349
T Y PE LL D++S G +L E G+ P+ G
Sbjct: 164 TLWYRPPEL----LLGATRYGPEVDMWSVGCILAELFLGK-PIFQGS 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-26
Identities = 79/276 (28%), Positives = 119/276 (43%), Gaps = 36/276 (13%)
Query: 149 LGEGGYGVVYRGNLI--NGS--PVAVKKILNNVGQA-EKEFRVEVEAIGHVRHKNLVRLL 203
LG G +G V +G + +G VAVK + A +KEF E + + H +VRL+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWL--HGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
G C +G MLV E G L ++L + A +AYL
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLESK- 114
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF--GYVAPEYANT 319
VHRD+ + N+L+ + AK+SDFG+++ LGAG + G + + APE N
Sbjct: 115 --HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 320 GLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378
G + KSDV+S+GV L EA + G +P E+ + + M+ R P E
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSYG------AKPYGEMKGAEVIAMLESGERLPR---PE-E 222
Query: 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414
++ L C E RP S++
Sbjct: 223 CPQEIYSI------MLSCWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 4e-26
Identities = 76/219 (34%), Positives = 112/219 (51%), Gaps = 30/219 (13%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVK--KILNNVGQAEKEFRVEVEAIGHVRHKN 198
R+ + N +G G +G VY NL G +AVK +I +N + KE E++ + ++H N
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60
Query: 199 LVRLLGYCIEGIHRMLVY---EYVNNGNLEQWLHGAMRHHGYLTWEARMKV----LLGTA 251
LV+ G +E +HR VY EY + G LE+ L HG + E ++V LL
Sbjct: 61 LVKYYG--VE-VHREKVYIFMEYCSGGTLEELLE-----HGRILDEHVIRVYTLQLL--- 109
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRV---MGT 308
+ LAYLH +VHRDIK +NI +D + K+ DFG A L + + V GT
Sbjct: 110 EGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGT 166
Query: 309 FGYVAPEYANTGLLNEK---SDVYSFGVLLLEAITGRDP 344
Y+APE G +D++S G ++LE TG+ P
Sbjct: 167 PAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 4e-26
Identities = 67/207 (32%), Positives = 105/207 (50%), Gaps = 12/207 (5%)
Query: 147 NVLGEGGYGVVYRGNLIN-GSPVAVKKI-LNNVGQAEKEFRV-EVEAIGHVRHKNLVRLL 203
+G+G +G V + + G + K+I N+ + EK+ V EV + ++H N+VR
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 204 GYCI----EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE 259
I + ++ +V EY G+L Q + + Y+ E ++L AL H
Sbjct: 66 DRIIDRSNQTLY--IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 260 AIEPK--VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
+P V+HRD+K +NI +D + N K+ DFGLAK+LG S T V GT Y++PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQL 182
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGRDP 344
N +EKSD++S G L+ E P
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 6e-26
Identities = 67/199 (33%), Positives = 99/199 (49%), Gaps = 11/199 (5%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 208
LG G +G V+ G + VAVK L + + F E + + +RH LV+L C E
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVK-TLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 209 GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHR 268
+V EY++ G+L +L L + + A+ +AYL +HR
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGK--KLRLPQLVDMAAQIAEGMAYLESR---NYIHR 127
Query: 269 DIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF--GYVAPEYANTGLLNEKS 326
D+ + NIL+ ++ K++DFGLA+L+ T R F + APE AN G KS
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLI--EDDEYTAREGAKFPIKWTAPEAANYGRFTIKS 185
Query: 327 DVYSFGVLLLEAIT-GRDP 344
DV+SFG+LL E +T GR P
Sbjct: 186 DVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 7e-26
Identities = 72/214 (33%), Positives = 105/214 (49%), Gaps = 32/214 (14%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKE------FRVEVEAIGHVR 195
+ K LGEG YGVVY+ + G VA+KKI + E+E R E+ + ++
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN---EEEGIPSTALR-EISLLKELK 56
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEAR--MKVLLGTAKA 253
H N+V+LL LV+EY + +L+++L R + M LL +
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLD--KRPGPLSPNLIKSIMYQLL---RG 110
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
LAY H +++HRD+K NILI+ D K++DFGLA+ G T V+ T Y A
Sbjct: 111 LAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRA 166
Query: 314 PEYANTGLLNEKS-----DVYSFGVLLLEAITGR 342
PE LL K D++S G + E ITG+
Sbjct: 167 PEI----LLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 9e-26
Identities = 86/279 (30%), Positives = 130/279 (46%), Gaps = 46/279 (16%)
Query: 148 VLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI 207
++GEG +G V +G G VAVK I +V + F E + + HKNLVRLLG +
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 208 -EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVV 266
G++ +V E ++ GNL +L R ++ ++ L A+ + YL K+V
Sbjct: 70 HNGLY--IVMELMSKGNLVNFLR--TRGRALVSVIQLLQFSLDVAEGMEYLESK---KLV 122
Query: 267 HRDIKSSNILIDDDFNAKVSDFGLAKL--LGAGKSHVTTRVMGTFGYVAPEYANTGLLNE 324
HRD+ + NIL+ +D AKVSDFGLA++ +G S + + + APE +
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSS 176
Query: 325 KSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV-----VDPNIE 378
KSDV+S+GVLL E + GR P P + V E V ++P
Sbjct: 177 KSDVWSYGVLLWEVFSYGRAPY----PKMSLKEV-----------KECVEKGYRMEPPEG 221
Query: 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417
L S C + + +KRP ++ LE E
Sbjct: 222 CPADVYVLMTS------CWETEPKKRPSFHKLREKLEKE 254
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 8e-25
Identities = 61/200 (30%), Positives = 97/200 (48%), Gaps = 13/200 (6%)
Query: 148 VLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGY 205
+GEG G VY+ + G VA+KK+ L Q ++ E+ + +H N+V
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRK--QNKELIINEILIMKDCKHPNIVDYYDS 83
Query: 206 CIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK-VLLGTAKALAYLHEAIEPK 264
+ G +V EY++ G+L + ++ + E ++ V + L YLH
Sbjct: 84 YLVGDELWVVMEYMDGGSLTDIIT---QNFVRMN-EPQIAYVCREVLQGLEYLHSQ---N 136
Query: 265 VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNE 324
V+HRDIKS NIL+ D + K++DFG A L KS + V GT ++APE
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVIKRKDYGP 195
Query: 325 KSDVYSFGVLLLEAITGRDP 344
K D++S G++ +E G P
Sbjct: 196 KVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 76/278 (27%), Positives = 129/278 (46%), Gaps = 29/278 (10%)
Query: 142 RFSKENVLGEGGYG--VVYRGNLINGSPVAVKKILNNVGQAEKEFRV---EVEAIGHVRH 196
+ VLG+G +G +YR + S V K++ N +EKE R E+ + ++H
Sbjct: 1 HYIPIRVLGKGAFGEATLYR-RTEDDSLVVWKEV-NLTRLSEKERRDALNEIVILSLLQH 58
Query: 197 KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY 256
N++ + ++ ++ EY N G L + + E + L A++Y
Sbjct: 59 PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKI--VRQKGQLFEEEMVLWYLFQIVSAVSY 116
Query: 257 LHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEY 316
+H+A ++HRDIK+ NI + K+ DFG++K+LG+ S T V+GT Y++PE
Sbjct: 117 IHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPEL 172
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376
N KSD+++ G +L E +T + D P + V K++ G+
Sbjct: 173 CQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV-----KIVQGNY--------T 219
Query: 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414
V + L SL+ +L DP EKRP +V+
Sbjct: 220 PVVSVYSSEL-ISLVHSLLQQDP--EKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 85/283 (30%), Positives = 133/283 (46%), Gaps = 36/283 (12%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKIL---NNVGQAEKEFRV---EVEAIGHVRH 196
++K VLG+G YG VY G G +AVK++ +NV AEKE+ EV+ + ++H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 197 KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY 256
N+V+ LG C++ + E+V G++ + G L K +AY
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISS----ILNRFGPLPEPVFCKYTKQILDGVAY 117
Query: 257 LHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVM-----GTFGY 311
LH VVHRDIK +N+++ + K+ DFG A+ L H T M GT +
Sbjct: 118 LHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174
Query: 312 VAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMM--VGSRRS 369
+APE N KSD++S G + E TG+ P+ +D L M +G+ R
Sbjct: 175 MAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS---------MDRLAAMFYIGAHRG 225
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
+ P + S A+ +T+ C+ D +RP Q++R
Sbjct: 226 ---LMPRLPDSFSAAAI--DFVTS--CLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 66/216 (30%), Positives = 104/216 (48%), Gaps = 22/216 (10%)
Query: 148 VLGEGGYGVVYRGNLINGSP------VAVKKILN-NVGQAEKEFRVEVEAIGHVRHKNLV 200
LGEG +G V+ G + P VAVK + A K+F E E + + +H+N+V
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71
Query: 201 RLLGYCIEGIHRMLVYEYVNNGNLEQWL--HG--AMR------HHGYLTWEARMKVLLGT 250
+ G C EG ++V+EY+ +G+L ++L HG A G LT +++ +
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK-LLGAGKSHVTTRVMGTF 309
A + YL VHRD+ + N L+ D K+ DFG+++ + V M
Sbjct: 132 ASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPI 188
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
++ PE +SDV+SFGV+L E T G+ P
Sbjct: 189 RWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 61/207 (29%), Positives = 106/207 (51%), Gaps = 9/207 (4%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 208
+G G +G+V+ G + VA+K I +E++F E + + + H LV+L G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 209 GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHR 268
LV+E++ +G L +L G + E + + L + +AYL + V+HR
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESS---NVIHR 124
Query: 269 DIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDV 328
D+ + N L+ ++ KVSDFG+ + + + +T + +PE + + KSDV
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDV 184
Query: 329 YSFGVLLLEAIT-GRDPVDHGRPAHEV 354
+SFGVL+ E + G+ P ++ R EV
Sbjct: 185 WSFGVLMWEVFSEGKTPYEN-RSNSEV 210
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 81/288 (28%), Positives = 139/288 (48%), Gaps = 32/288 (11%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNL-ING---SPVAVKKILNNVGQAEKE---FRVEVE 189
E+ + +K+ V+G G +G V+RG L + G VA+K + G EK+ F E
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTL--KPGYTEKQRQDFLSEAS 58
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
+G H N++RL G + M++ EY+ NG L+++L H G + + +L G
Sbjct: 59 IMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLR---DHDGEFSSYQLVGMLRG 115
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
A + YL + VHRD+ + NIL++ + KVSDFGL+++L T G
Sbjct: 116 IAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI 172
Query: 310 G--YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR 367
+ APE SDV+SFG+++ E ++ + RP +++ + +K +
Sbjct: 173 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGE-----RPYWDMSNHEVMKAINDGF 227
Query: 368 RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
R +D PS A+ + + L+C D +RP+ +V +L+
Sbjct: 228 RLPAPMDC-----PS--AVYQLM---LQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 66/219 (30%), Positives = 105/219 (47%), Gaps = 34/219 (15%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVK--KILNNVGQAE---KEFRVEVEAIGHVR 195
R+ K +LG G +G VY G NL +G AVK + ++ + K+ E+ + ++
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEA-RM---KVLLGTA 251
H N+V+ LG E + + E V G+L ++ +G R+ ++LLG
Sbjct: 61 HPNIVQYLGTEREEDNLYIFLELVPGGSL----AKLLKKYGSFPEPVIRLYTRQILLG-- 114
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVM----- 306
L YLH+ VHRDIK +NIL+D + K++DFG+AK V
Sbjct: 115 --LEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAK-------QVVEFSFAKSFK 162
Query: 307 GTFGYVAPEYAN-TGLLNEKSDVYSFGVLLLEAITGRDP 344
G+ ++APE G +D++S G +LE TG+ P
Sbjct: 163 GSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 67/223 (30%), Positives = 112/223 (50%), Gaps = 31/223 (13%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGSP------VAVKKIL-NNVGQAEKEFRVEVEA 190
L+ RF +E LGEG +G VY+G L + VA+K + N + ++EFR E E
Sbjct: 4 LSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAEL 61
Query: 191 IGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRH--HGYLTWEARMKVLL 248
+ ++H N+V LLG C + +++EY+ +G+L ++L +R+ H + E+ + +
Sbjct: 62 MSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFL---VRNSPHSDVGAESGDETVK 118
Query: 249 GTAKALAYLHEAIE----------PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298
+ +LH AI+ VHRD+ + N L+ + K+SDFGL++
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRD---IY 175
Query: 299 SHVTTRVMGT----FGYVAPEYANTGLLNEKSDVYSFGVLLLE 337
S RV ++ PE G +SD++SFGV+L E
Sbjct: 176 SADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWE 218
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 67/209 (32%), Positives = 101/209 (48%), Gaps = 12/209 (5%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 208
LG G +G V+ G N +PVAVK L K+F E + + +RH L++L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKT-LKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 209 GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHR 268
+V E + G+L ++L G L + + A +AYL +HR
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQG--GAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHR 127
Query: 269 DIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF--GYVAPEYANTGLLNEKS 326
D+ + N+L+ ++ KV+DFGLA+++ + R F + APE A + KS
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIK--EDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185
Query: 327 DVYSFGVLLLEAIT-GRDPVDHGRPAHEV 354
DV+SFG+LL E +T GR P G EV
Sbjct: 186 DVWSFGILLTEIVTYGRMPYP-GMTNAEV 213
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 59/236 (25%), Positives = 95/236 (40%), Gaps = 47/236 (19%)
Query: 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVK---KILNNVGQAEKEFRVEVEAIGHV-R 195
+ F ++GEG + V A+K K + K ++E E + +
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 196 HKNLVRLLG--------YCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVL 247
H +++L Y V EY NG L Q +R +G L +
Sbjct: 61 HPGIIKLYYTFQDEENLY--------FVLEYAPNGELLQ----YIRKYGSLDEKCTRFYA 108
Query: 248 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVM- 306
AL YLH ++HRD+K NIL+D D + K++DFG AK+L S + +
Sbjct: 109 AEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDA 165
Query: 307 ------------------GTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
GT YV+PE N + SD+++ G ++ + +TG+ P
Sbjct: 166 TNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 67/210 (31%), Positives = 99/210 (47%), Gaps = 20/210 (9%)
Query: 147 NVLGEGGYGVVYRGNLIN-----GSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLV 200
LGEG +G V G VAVK + + Q +F E+E + + H+N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 201 RLLGYCIEGIHR---MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
+ G C E L+ EY+ +G+L +L RH + + + K + YL
Sbjct: 70 KYKGVC-EKPGGRSLRLIMEYLPSGSLRDYLQ---RHRDQINLKRLLLFSSQICKGMDYL 125
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG---TFGYVAP 314
+ +HRD+ + NIL++ + K+SDFGLAK+L K + + G F Y AP
Sbjct: 126 GSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-AP 181
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
E T + SDV+SFGV L E T DP
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFTYGDP 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 3e-23
Identities = 74/272 (27%), Positives = 112/272 (41%), Gaps = 53/272 (19%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQA----EKEFRVEVEAIGH----------V 194
LG+G +G V V+K A +K+ ++ + + H +
Sbjct: 1 LGKGSFGKVL----------LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI 50
Query: 195 RHKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAK 252
H +V+L Y + ++ LV EY G L + H + G + E R +
Sbjct: 51 NHPFIVKLH-YAFQTEEKLYLVLEYAPGGEL--FSH--LSKEGRFS-EERARFYAAEIVL 104
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
AL YLH +++RD+K NIL+D D + K++DFGLAK L + S T GT Y+
Sbjct: 105 ALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYL 160
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV 372
APE + D +S GVLL E +TG+ P K + + +
Sbjct: 161 APEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR----------KEIYEKILKDPL 210
Query: 373 VDPNIEVRPSTRALKRSLLTALRCVDPDSEKR 404
P S A R L++ L DP KR
Sbjct: 211 RFPEF---LSPEA--RDLISGLLQKDP--TKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 3e-23
Identities = 79/285 (27%), Positives = 117/285 (41%), Gaps = 50/285 (17%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRL 202
F KE LG G +GVV+ G VA+K I +E +F E + + + H NLV+L
Sbjct: 8 FLKE--LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQL 64
Query: 203 LGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIE 262
G C + +V EY+ NG L +L G L E + + +A+ YL
Sbjct: 65 YGVCTKQRPIFIVTEYMANGCLLNYLR---ERKGKLGTEWLLDMCSDVCEAMEYLESN-- 119
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG------YVAPEY 316
+HRD+ + N L+ +D KVSDFGLA+ + + + + G + PE
Sbjct: 120 -GFIHRDLAARNCLVGEDNVVKVSDFGLARYV------LDDQYTSSQGTKFPVKWAPPEV 172
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376
+ + KSDV+SFGVL+ E + KM + EVV+
Sbjct: 173 FDYSRFSSKSDVWSFGVLMWEVFSEG------------------KMPYERFSNSEVVE-- 212
Query: 377 IEVRPSTRALKRSLLTALR-------CVDPDSEKRPKMSQVVRML 414
V R L R L C E RP +++ L
Sbjct: 213 -SVSAGYR-LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 3e-23
Identities = 73/281 (25%), Positives = 113/281 (40%), Gaps = 43/281 (15%)
Query: 149 LGEGGYGVVYRGNLINGS----PVAVKKIL--NNVGQAEKEFRVEVEAIGHVRHKNLVRL 202
LG+G +GVV RG PVAVK L + + +F E + + H+NL+RL
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVK-CLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 203 LGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT----WEARMKVLLGTAKALAYLH 258
G + M+V E G+L L G+ + +++ A + YL
Sbjct: 62 YGVVLTH-PLMMVTELAPLGSLLDRLR--KDALGHFLISTLCDYAVQI----ANGMRYLE 114
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTT----RVMGTFGYVAP 314
+ +HRD+ + NIL+ D K+ DFGL + L + H +V F + AP
Sbjct: 115 SK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAP 169
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373
E T + SDV+ FGV L E T G +P + + +D + E +
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID--------KEGERLE 221
Query: 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414
P E P L+C + RP + + L
Sbjct: 222 RP--EACPQ-----DIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 3e-23
Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAE-KEFRV-EVEAIGHVRHK 197
N++ V+GEG YGVV + N G VA+KK + + K+ + EV+ + +RH+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
N+V L LV+EYV L + L G L +A + +A+AY
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVER-TLLELLE---ASPGGLPPDAVRSYIWQLLQAIAYC 116
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
H ++HRDIK NIL+ + K+ DFG A+ L A + T + T Y APE
Sbjct: 117 HSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPEL- 172
Query: 318 NTGLLNEKS-----DVYSFGVLLLEAITGR 342
L+ + + DV++ G ++ E + G
Sbjct: 173 ---LVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 9e-23
Identities = 71/291 (24%), Positives = 122/291 (41%), Gaps = 43/291 (14%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKIL---NNVGQAEKEFRVEVEAIGHVRHKNLVRLLG 204
+GEG YGVVY+ + + G VA+KKI + G + R E++ + + H N+++LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR-EIKLLKELNHPNIIKLLD 65
Query: 205 YCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK-VLLGTAKALAYLHEAIEP 263
LV+E+ ++ L+ ++ E+ +K L + LA+ H
Sbjct: 66 VFRHKGDLYLVFEF-----MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH--- 117
Query: 264 KVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YANTGLL 322
++HRD+K N+LI+ + K++DFGLA+ G T + T Y APE
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFG-SPVRPYTHYVVTRWYRAPELLLGDKGY 176
Query: 323 NEKSDVYSFGVLLLEAIT------GRDPVDH--------GRPAHEVNLVDWLKM------ 362
+ D++S G + E ++ G+ +D G P E W K
Sbjct: 177 STPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPE----VWPKFTSLARN 232
Query: 363 MVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413
S + + ++ P+ LL+ + DP KR Q +
Sbjct: 233 YKFSFPKKAGMPLP-KLFPNASPQALDLLSQMLHYDPH--KRITAEQALAH 280
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 1e-22
Identities = 70/273 (25%), Positives = 125/273 (45%), Gaps = 27/273 (9%)
Query: 142 RFSKENVLGEGGYGVVYRGNLINGSPV-AVKKI-LNNVGQAEKEFRV-EVEAIGHVRHKN 198
F LG+G YG VY+ ++ + A+K++ L ++ Q E+E V E+ + V H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
++ ++G +V EY G+L + + + + + ++ + + L LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYAN 318
E K++HRD+KS+NIL+ + K+ D G++K+L K ++ +GT Y+APE
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQIGTPHYMAPEVWK 174
Query: 319 TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378
+ KSD++S G LL E T P + R ++ K+ G P I
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPFE-ARSMQDLR----YKVQRGKY-------PPIP 222
Query: 379 VRPSTRALKRSLLTALR-CVDPDSEKRPKMSQV 410
S + L +R + + RP ++
Sbjct: 223 PIYS-----QDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 2e-22
Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 29/212 (13%)
Query: 149 LGEGGYGVVYRGNLIN------GSPVAVKKILNNVGQAEK-EFRVEVEAIGHVRHKNLVR 201
LG+G +G+VY G + VA+K + N E+ EF E + ++VR
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 202 LLGYCIEGIHRMLVYEYVNNGNLEQWLHGAM------RHHGYLTWEARMKVLLGTAKALA 255
LLG G ++V E + G+L+ +L G T + +++ A +A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL-------GAGKSHVTTRVMGT 308
YL K VHRD+ + N ++ +D K+ DFG+ + + GK + R M
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-- 188
Query: 309 FGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT 340
APE G+ KSDV+SFGV+L E T
Sbjct: 189 ----APESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 3e-22
Identities = 52/175 (29%), Positives = 89/175 (50%), Gaps = 20/175 (11%)
Query: 149 LGEGGYGVVYR-GNLINGSPVAVKKILN---NVGQAEKEFRVEVEAIGHVRHKNLVRLLG 204
+GEG +G+V++ + G VA+KK+ G + R E++A+ +H +V+LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR-EIKALQACQHPYVVKLLD 66
Query: 205 YCIEGIHRMLVYEYVNNGNLEQWLHGAMRH--HGYLTWEAR--MKVLLGTAKALAYLHEA 260
G +LV EY+ + L +R + + M++LL K +AY+H
Sbjct: 67 VFPHGSGFVLVMEYMPSD-----LSEVLRDEERPLPEAQVKSYMRMLL---KGVAYMHAN 118
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE 315
++HRD+K +N+LI D K++DFGLA+L + + + + T Y APE
Sbjct: 119 ---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 4e-22
Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 14/211 (6%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVR 201
F LGEG YG VY+ + G VA+K + V + +E E+ + +V+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDLQEIIKEISILKQCDSPYIVK 62
Query: 202 LLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK-VLLGTAKALAYLHEA 260
G + +V EY G++ M+ E + +L T K L YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSD----IMKITNKTLTEEEIAAILYQTLKGLEYLHSN 118
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLA-KLLGAGKSHVTTRVMGTFGYVAPEYANT 319
K +HRDIK+ NIL++++ AK++DFG++ +L T V+GT ++APE
Sbjct: 119 ---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQE 173
Query: 320 GLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
N K+D++S G+ +E G+ P P
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGKPPYSDIHP 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 4e-22
Identities = 74/275 (26%), Positives = 125/275 (45%), Gaps = 27/275 (9%)
Query: 147 NVLGEGGYGVVYRGNLI-NGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLVRLLG 204
V+G G VVY + N VA+K+I L + E R EV+A+ H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 205 YCIEGIHRMLVYEYVNNGNLEQWLHGAMRH---HGYLTWEARMKVLLGTAKALAYLHEAI 261
+ G LV Y++ G+L M+ G L VL K L YLH
Sbjct: 67 SFVVGDELWLVMPYLSGGSL----LDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN- 121
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL---GAGKSHVTTRVMGTFGYVAPEYAN 318
+HRDIK+ NIL+ +D + K++DFG++ L G V +GT ++APE
Sbjct: 122 --GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 319 TGL-LNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNI 377
+ K+D++SFG+ +E TG P P +V +M+ + ++
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAPY-SKYPPMKV-------LMLTLQNDPPSLETGA 231
Query: 378 EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
+ + +++ ++ + C+ D KRP ++++
Sbjct: 232 DYKKYSKSFRKMISL---CLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 4e-22
Identities = 65/221 (29%), Positives = 110/221 (49%), Gaps = 28/221 (12%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRV---------EVEAI 191
++ K ++G G +G VY G N +G +AVK++ A + R E+ +
Sbjct: 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALL 60
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWL--HGAMRHHGYLTWEARMKVLL- 248
++H+N+V+ LG ++ H + EYV G++ L +GA E ++ +
Sbjct: 61 KELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFE-------ETLVRNFVR 113
Query: 249 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR---- 304
K L YLH ++HRDIK +NIL+D+ K+SDFG++K L A T
Sbjct: 114 QILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARP 170
Query: 305 -VMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+ G+ ++APE K+D++S G L++E +TG+ P
Sbjct: 171 SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 6e-22
Identities = 71/279 (25%), Positives = 125/279 (44%), Gaps = 41/279 (14%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKE-FRVEVEAIGHVRHKNLVRLLGYCI 207
+G+G +G VY+G L + VAVK + + K F E E + H N+V+L+G C+
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPK-VV 266
+ +V E V G+L +L + LT + +++ L A + YL E K +
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLR---KKKNRLTVKKLLQMSLDAAAGMEYL----ESKNCI 115
Query: 267 HRDIKSSNILIDDDFNAKVSDFGLAK-------LLGAGKSHVTTRVMGTFGYVAPEYANT 319
HRD+ + N L+ ++ K+SDFG+++ + G + + + APE N
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIK------WTAPEALNY 169
Query: 320 GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEV 379
G +SDV+S+G+LL E + D G + ++++ E ++ +
Sbjct: 170 GRYTSESDVWSYGILLWETFSLGDTPYPG---------------MSNQQTRERIESGYRM 214
Query: 380 RP--STRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416
L+ L+C D E RP S++ L+
Sbjct: 215 PAPQLCPEEIYRLM--LQCWAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 7e-22
Identities = 65/225 (28%), Positives = 107/225 (47%), Gaps = 45/225 (20%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILN---NVGQAEKEFRVEVEAIGHVRHK 197
R+ +G G YGVV + G VA+KKI N ++ A++ R E++ + H+RH+
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHE 59
Query: 198 NLVRLL-------GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT 250
N++ LL ++ +V E +E LH ++ LT + ++ L
Sbjct: 60 NIIGLLDILRPPSPEDFNDVY--IVTEL-----METDLHKVIKSPQPLT-DDHIQYFLYQ 111
Query: 251 A-KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS-------HVT 302
+ L YLH A V+HRD+K SNIL++ + + K+ DFGLA+ + + +V
Sbjct: 112 ILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV 168
Query: 303 TRVMGTFGYVAPEYANTGLLNEKS-----DVYSFGVLLLEAITGR 342
TR Y APE LL+ D++S G + E +T +
Sbjct: 169 TRW-----YRAPEL----LLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 2e-21
Identities = 79/285 (27%), Positives = 121/285 (42%), Gaps = 36/285 (12%)
Query: 147 NVLGEGGYGVVYRGNLINGS------PVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNL 199
LG G +G VY G VAVK + + Q E +F +E + H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 200 VRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA---- 255
VRL+G E + R ++ E + G+L+ +L R MK LL A+ +A
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLREN-RPRPERPSSLTMKDLLFCARDVAKGCK 130
Query: 256 YLHEAIEPKVVHRDIKSSNILIDD---DFNAKVSDFGLAK-LLGAGKSHVTTRVMGTFGY 311
YL E +HRDI + N L+ AK++DFG+A+ + A R M +
Sbjct: 131 YLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKW 187
Query: 312 VAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370
+ PE G+ K+DV+SFGVLL E + G P GR EV ++ + G R
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYP-GRTNQEV-----MEFVTGGGR-- 239
Query: 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
+DP + C E RP + ++ ++
Sbjct: 240 --LDPPKGCPGPVYRIMT------DCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 2e-21
Identities = 72/214 (33%), Positives = 107/214 (50%), Gaps = 21/214 (9%)
Query: 133 LRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIG 192
+++L+L +G+G +G V G+ G+ VAVK I N+ + F E +
Sbjct: 5 MKELKL-------LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMT 54
Query: 193 HVRHKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
+RH NLV+LLG +E + +V EY+ G+L +L R L + +K L
Sbjct: 55 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVC 112
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGY 311
+A+ YL VHRD+ + N+L+ +D AKVSDFGL K + + V T
Sbjct: 113 EAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT--- 166
Query: 312 VAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
APE + KSDV+SFG+LL E + GR P
Sbjct: 167 -APEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 2e-21
Identities = 82/287 (28%), Positives = 131/287 (45%), Gaps = 32/287 (11%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGS----PVAVKKILNNVGQAEKE---FRVEVEA 190
+ + E V+G G +G V G L PVA+K + G EK+ F E
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTL--KAGYTEKQRRDFLSEASI 58
Query: 191 IGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT 250
+G H N++ L G + M+V EY+ NG+L+ +L +H G T + +L G
Sbjct: 59 MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLR---KHDGQFTVIQLVGMLRGI 115
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
A + YL + VHRD+ + NIL++ + KVSDFGL+++L T G
Sbjct: 116 ASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 172
Query: 311 --YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRR 368
+ APE SDV+S+G+++ E ++ + RP E++ D +K + R
Sbjct: 173 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE-----RPYWEMSNQDVIKAIEEGYR 227
Query: 369 SEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
+D AL + +L C D +RPK Q+V +L+
Sbjct: 228 LPAPMDCPA-------ALHQLMLD---CWQKDRNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 5e-21
Identities = 86/287 (29%), Positives = 128/287 (44%), Gaps = 46/287 (16%)
Query: 147 NVLGEGGYGVVYRGNLINGSPVAVK---KILNNVGQAEK--EFRVEVEAIGHVRHKNLVR 201
V+G+G +G VY G LI+ + K LN + E+ +F E + H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 202 LLGYCI--EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG----TAKALA 255
LLG C+ EG ++V Y+ +G+L ++ + +K L+G AK +
Sbjct: 61 LLGICLPSEGS-PLVVLPYMKHGDLRNFIRSETHN-------PTVKDLIGFGLQVAKGME 112
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG---KSHVTTRVMGTFGYV 312
YL K VHRD+ + N ++D+ F KV+DFGLA+ + H T ++
Sbjct: 113 YLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWM 169
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRR---S 369
A E T KSDV+SFGVLL E +T P P +V+ D ++ RR
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVDSFDITVYLLQGRRLLQP 224
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416
E DP EV L C P E RP S++V +E
Sbjct: 225 EYCPDPLYEV-------------MLSCWHPKPEMRPTFSELVSRIEQ 258
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 8e-21
Identities = 70/270 (25%), Positives = 124/270 (45%), Gaps = 22/270 (8%)
Query: 148 VLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEK-EFRVEVEAIGHVRHKNLVRLLGYC 206
+LG+G +G V++G L + +PVAVK ++ Q K +F E + H N+V+L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 207 IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVV 266
+ +V E V G+ +L + L + +K L A +AYL +
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLR---KKKDELKTKQLVKFALDAAAGMAYLESK---NCI 115
Query: 267 HRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKS 326
HRD+ + N L+ ++ K+SDFG+++ G + + APE N G + +S
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 327 DVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRAL 386
DV+S+G+LL E + + + + M ++++ E V+ + +
Sbjct: 176 DVWSYGILLWETFS-------------LGVCPYPGMT--NQQAREQVEKGYRMSCPQKCP 220
Query: 387 KRSLLTALRCVDPDSEKRPKMSQVVRMLES 416
RC D E RPK S++ + L +
Sbjct: 221 DDVYKVMQRCWDYKPENRPKFSELQKELAA 250
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 9e-21
Identities = 80/293 (27%), Positives = 129/293 (44%), Gaps = 44/293 (15%)
Query: 150 GEGG--YGVVYRGNLINGSPVAVKKILNNVGQA-EKEFRVEVEAIGHVRHKNLVRLLGYC 206
G GG Y V++R G A+K I N ++ E+E + V H N+V+
Sbjct: 85 GAGGTVYKVIHRPT---GRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF 141
Query: 207 IEGIHRMLVYEYVNNGNLEQWLHGA-MRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKV 265
++ E+++ G+LE G + +L AR ++L G +AYLH +
Sbjct: 142 DHNGEIQVLLEFMDGGSLE----GTHIADEQFLADVAR-QILSG----IAYLHRR---HI 189
Query: 266 VHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEK 325
VHRDIK SN+LI+ N K++DFG++++L + V GT Y++PE NT L +
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTDLNHGA 248
Query: 326 -----SDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVR 380
D++S GV +LE GR P GR DW +M S P E
Sbjct: 249 YDGYAGDIWSLGVSILEFYLGRFPFGVGRQG------DWASLMCAICMS----QPP-EAP 297
Query: 381 PSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHRRTQG 433
+ R ++ C+ + KR Q+++ +P + + + G
Sbjct: 298 ATASREFRHFIS--CCLQREPAKRWSAMQLLQ------HPFILRAQPGQGQGG 342
|
Length = 353 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 1e-20
Identities = 87/316 (27%), Positives = 147/316 (46%), Gaps = 35/316 (11%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEAI 191
L + VLG G +G VY+G + PVA+K + G +A EF E +
Sbjct: 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIM 63
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
+ H +LVRLLG C+ + LV + + +G L ++H H + + + + A
Sbjct: 64 ASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVH---EHKDNIGSQLLLNWCVQIA 119
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL-GAGKSHVTTRVMGTFG 310
K + YL E ++VHRD+ + N+L+ + K++DFGLA+LL G K +
Sbjct: 120 KGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 176
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
++A E + +SDV+S+GV + E +T G P D G P E+ D L+ +
Sbjct: 177 WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD-GIPTREIP--DLLE------KG 227
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHR 429
E + P I + ++C D++ RPK + L +E + R+ +R+
Sbjct: 228 ERLPQPPI-------CTIDVYMVMVKCWMIDADSRPKFKE----LAAEFSRMARDPQRYL 276
Query: 430 RTQGGTSMEIESQKEN 445
QG M++ S ++
Sbjct: 277 VIQGDDRMKLPSPNDS 292
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 60/201 (29%), Positives = 95/201 (47%), Gaps = 23/201 (11%)
Query: 147 NVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGY 205
+G G YG VY+ ++ G VA+K I G + + E+ + RH N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 206 CIEGIHRMLVYEYVNNGNLEQWLHGAMRHH------GYLTWEARMKVLLGTAKALAYLHE 259
+ +V EY G+L+ R Y+ E L G LAYLHE
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQ-VTRGPLSELQIAYVCRET----LKG----LAYLHE 119
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYAN- 318
+HRDIK +NIL+ +D + K++DFG++ L A + + + GT ++APE A
Sbjct: 120 T---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAV 175
Query: 319 --TGLLNEKSDVYSFGVLLLE 337
G + K D+++ G+ +E
Sbjct: 176 ERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 71/226 (31%), Positives = 108/226 (47%), Gaps = 62/226 (27%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKILN---NVGQAEKEFRVEV---EAIGHVRHKNLVR 201
LG+G YG+V++ + VA+KKI + N A++ FR E+ + +G H N+V+
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGD--HPNIVK 71
Query: 202 LLGYCIEGIHRM-------LVYEYVNNGNLEQWLHGAMR-------HHGYLTWEARMKVL 247
LL + + LV+EY +E LH +R H Y+ ++ L
Sbjct: 72 LLN-----VIKAENDKDIYLVFEY-----METDLHAVIRANILEDVHKRYIMYQ-----L 116
Query: 248 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVM- 306
L KAL Y+H V+HRD+K SNIL++ D K++DFGLA+ L + + V+
Sbjct: 117 L---KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLT 170
Query: 307 ---GTFGYVAPEYANTGLLNEKSDVYSFGV-------LLLEAITGR 342
T Y APE LL S Y+ GV +L E + G+
Sbjct: 171 DYVATRWYRAPEI----LL--GSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 2e-20
Identities = 67/275 (24%), Positives = 124/275 (45%), Gaps = 34/275 (12%)
Query: 145 KENVLGEGGYGVVYRG-NLINGSPVAVKKIL---NNVGQAEK---EFRVEVEAIGHVRHK 197
K LG G + Y+ ++ G+ +AVK++ N + E+ R E+ + + H
Sbjct: 4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHP 63
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
+++R+LG E H L E++ G++ L +G + + L+YL
Sbjct: 64 HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGLSYL 119
Query: 258 HEAIEPKVVHRDIKSSNILIDDD-FNAKVSDFGLAKLLGA---GKSHVTTRVMGTFGYVA 313
HE +++HRD+K +N+LID +++DFG A L A G +++GT ++A
Sbjct: 120 HEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373
PE DV+S G +++E T + P + + ++ + L+ + +
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA------- 229
Query: 374 DPNI--EVRPSTRALKRSLLTALRCVDPDSEKRPK 406
P+I + P R + LRC++ E RP
Sbjct: 230 -PSIPEHLSPGLRDV------TLRCLELQPEDRPP 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 80/258 (31%), Positives = 127/258 (49%), Gaps = 41/258 (15%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNV--GQAEKEFRVEVEAIGHVRHKN 198
F K N +GEG YG+VYR + +G VA+KK+ ++N G R E+ + ++RH N
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHPN 67
Query: 199 LVRLL----GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVL-LGTAKA 253
+V L G ++ I LV EY EQ L + + E+++K L L +
Sbjct: 68 IVELKEVVVGKHLDSI--FLVMEYC-----EQDLASLLDNMPTPFSESQVKCLMLQLLRG 120
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L YLHE ++HRD+K SN+L+ D K++DFGLA+ G +T +V+ T Y A
Sbjct: 121 LQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRA 176
Query: 314 PEYANTGLLNEKS-----DVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRR 368
PE LL + D+++ G +L E + + P+ G E+ +D + ++G+
Sbjct: 177 PEL----LLGCTTYTTAIDMWAVGCILAELLAHK-PLLPG--KSEIEQLDLIIQLLGT-- 227
Query: 369 SEEVVDPNIEVRPSTRAL 386
PN + P L
Sbjct: 228 ------PNESIWPGFSDL 239
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 3e-20
Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 22/215 (10%)
Query: 149 LGEGGYGVVYRGNLINGSP------VAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRL 202
LGEG +G V+ N P VAVK + A ++F+ E E + ++H+++VR
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 203 LGYCIEGIHRMLVYEYVNNGNLEQWLH-----------GAMRHHGYLTWEARMKVLLGTA 251
G C EG ++V+EY+ +G+L ++L G G LT + + A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK-LLGAGKSHVTTRVMGTFG 310
+ YL VHRD+ + N L+ K+ DFG+++ + V R M
Sbjct: 133 SGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
++ PE +SD++SFGV+L E T G+ P
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 4e-20
Identities = 71/281 (25%), Positives = 132/281 (46%), Gaps = 41/281 (14%)
Query: 142 RFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKE---FRVEVEAIGHVRHKN 198
++ K V+G G +G+V+ + + K + + E + E + + + H N
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
++ +E M+V EY G L +++ R + L + + + AL ++H
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQK--RCNSLLDEDTILHFFVQILLALHHVH 118
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNA-KVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
+ ++HRD+K+ NIL+D K+ DFG++K+L + KS T V+GT Y++PE
Sbjct: 119 TKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSS-KSKAYT-VVGTPCYISPELC 173
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGR-PAHEVNLVDWLKMM------VGSRRSE 370
N+KSD+++ G +L E + + + PA LV LK+M + R S
Sbjct: 174 EGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA----LV--LKIMSGTFAPISDRYSP 227
Query: 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVV 411
++ R L+ ++ +DP KRP++SQ++
Sbjct: 228 DL---------------RQLILSMLNLDPS--KRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 4e-20
Identities = 65/208 (31%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRH 196
E+ + ++ LG G YG VY G S K L +EF E + ++H
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 61
Query: 197 KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY 256
NLV+LLG C ++ E++ GNL +L R E VLL A ++
Sbjct: 62 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQISS 115
Query: 257 LHEAIEPK-VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT---FGYV 312
E +E K +HRD+ + N L+ ++ KV+DFGL++L+ T G +
Sbjct: 116 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWT 172
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAIT 340
APE + KSDV++FGVLL E T
Sbjct: 173 APESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 5e-20
Identities = 64/213 (30%), Positives = 110/213 (51%), Gaps = 25/213 (11%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILN------NVGQAEKEFRVEVEAIGHVR 195
+ + ++G G YG VYRG ++ G VA+K I+N +V ++E + + + +
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALK-IINLDTPDDDVSDIQREVAL-LSQLRQSQ 60
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHG---AMRHHGYLTWEARMKVLLGTAK 252
N+ + G ++G ++ EY G++ + A ++ + E VL+
Sbjct: 61 PPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIRE----VLV---- 112
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
AL Y+H+ V+HRDIK++NIL+ + N K+ DFG+A LL S +T V GT ++
Sbjct: 113 ALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWM 168
Query: 313 APEYANTG-LLNEKSDVYSFGVLLLEAITGRDP 344
APE G + K+D++S G+ + E TG P
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 7e-20
Identities = 71/214 (33%), Positives = 108/214 (50%), Gaps = 18/214 (8%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRH 196
E+ E LG+G +G V+ G NG+ K L + + F E + + +RH
Sbjct: 2 EIPRESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH 60
Query: 197 KNLVRLLGYCI---EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
+ LV+L Y + E I+ +V EY++ G+L +L G YL + + A
Sbjct: 61 EKLVQL--YAVVSEEPIY--IVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASG 114
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF--GY 311
+AY+ VHRD++++NIL+ ++ KV+DFGLA+L+ + T R F +
Sbjct: 115 MAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKW 169
Query: 312 VAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
APE A G KSDV+SFG+LL E T GR P
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 7e-20
Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 149 LGEGGYGVVYRGNLINGSP------VAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRL 202
LGEG +G V+ N SP VAVK + + A K+F+ E E + +++H+++V+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 203 LGYCIEGIHRMLVYEYVNNGNLEQWL--HG----------AMRHHGYLTWEARMKVLLGT 250
G C +G ++V+EY+ +G+L ++L HG + G L + +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK-LLGAGKSHVTTRVMGTF 309
A + YL VHRD+ + N L+ + K+ DFG+++ + V M
Sbjct: 133 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
++ PE +SDV+SFGV+L E T G+ P
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 8e-20
Identities = 74/284 (26%), Positives = 117/284 (41%), Gaps = 47/284 (16%)
Query: 149 LGEGGYGVVYRGNLIN---GSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRH-KNLVRLL 203
+G G +G V + +++ G+ +AVK+I + +K ++++ + +V+
Sbjct: 12 IGRGAFGTVNK--MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFY 69
Query: 204 G---------YCIE--GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAK 252
G C+E I Y+YV + E K+ + T K
Sbjct: 70 GALFREGDCWICMELMDISLDKFYKYVY-----------EVLKSVIPEEILGKIAVATVK 118
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
AL YL E E K++HRD+K SNIL+D + N K+ DFG++ L S TR G Y+
Sbjct: 119 ALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKTRDAGCRPYM 174
Query: 313 APEYANTGLLNE---KSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
APE + + +SDV+S G+ L E TG+ P + D L +V
Sbjct: 175 APERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVKGDPP 229
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413
E PS L D KRPK +++
Sbjct: 230 ILSNSEEREFSPSFVNFINLCLIK------DESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 62/204 (30%), Positives = 95/204 (46%), Gaps = 14/204 (6%)
Query: 147 NVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAE-KEFRVEVEAIGHVRHKNLVRLLG 204
LG G GVV + G +AVK I + +A K+ E++ + +V G
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 205 YCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPK 264
+ EY++ G+L++ L G + K+ + K L YLHE K
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILK---EVQGRIPERILGKIAVAVLKGLTYLHEKH--K 121
Query: 265 VVHRDIKSSNILIDDDFNAKVSDFGLAKLL--GAGKSHVTTRVMGTFGYVAPEYANTGLL 322
++HRD+K SNIL++ K+ DFG++ L K+ V GT Y+APE
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPERIQGNDY 176
Query: 323 NEKSDVYSFGVLLLEAITGRDPVD 346
+ KSD++S G+ L+E TGR P
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYP 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 1e-19
Identities = 72/284 (25%), Positives = 126/284 (44%), Gaps = 39/284 (13%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI----LNNVGQAEKEFRVEVEAIGHV 194
F E +G+G + VVY+ L++G VA+KK+ + + + + E++ + +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQL 59
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKAL 254
H N+++ L IE +V E + G+L + + + + K + AL
Sbjct: 60 DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
++H +++HRDIK +N+ I K+ D GL + + + + V GT Y++P
Sbjct: 120 EHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSP 175
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKM--------MVGS 366
E + N KSD++S G LL E + P ++NL K +
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFY----GDKMNLYSLCKKIEKCDYPPLPAD 231
Query: 367 RRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQV 410
SEE+ R L++ RC++PD EKRP +S V
Sbjct: 232 HYSEEL---------------RDLVS--RCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 1e-19
Identities = 80/281 (28%), Positives = 129/281 (45%), Gaps = 34/281 (12%)
Query: 146 ENVLGEGGYGVVYRGNL-ING---SPVAVKKILNNVGQAEK---EFRVEVEAIGHVRHKN 198
E V+G G +G V RG L + G VA+K + G EK +F E +G H N
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL--KSGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
++ L G + M++ E++ NG L+ +L ++ G T + +L G A + YL
Sbjct: 67 IIHLEGVVTKSRPVMIITEFMENGALDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYLS 123
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVT-TRVMG---TFGYVAP 314
E VHRD+ + NIL++ + KVSDFGL++ L S T T +G + AP
Sbjct: 124 EM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVD 374
E SDV+S+G+++ E ++ + RP +++ D + + R +
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGE-----RPYWDMSNQDVINAIEQDYR----LP 231
Query: 375 PNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
P ++ + L L C D RPK Q+V L+
Sbjct: 232 PPMDCPTALHQL------MLDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 93/336 (27%), Positives = 153/336 (45%), Gaps = 63/336 (18%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLI-NGS----PVAVKKILNNVG-QAEKEFRVEVEAI 191
L F K VLG G +G VY+G I G PVA+K++ +A KE E +
Sbjct: 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 63
Query: 192 GHVRHKNLVRLLGYC----IEGIHRMLVY----EYV--NNGNL-EQWLHGAMRHHGYLTW 240
V + ++ RLLG C ++ I +++ + +YV + N+ Q+L L W
Sbjct: 64 ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL---------LNW 114
Query: 241 EARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG-KS 299
++ AK + YL E ++VHRD+ + N+L+ + K++DFGLAKLLGA K
Sbjct: 115 CVQI------AKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE 165
Query: 300 HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVD 358
+ ++A E + +SDV+S+GV + E +T G P D G PA E++ +
Sbjct: 166 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI- 223
Query: 359 WLKMMVGSRRSEEVVDP---NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
+ E + P I+V + ++C D++ RPK R L
Sbjct: 224 -------LEKGERLPQPPICTIDV----------YMIMVKCWMIDADSRPKF----RELI 262
Query: 416 SEEYPIVREDRRHRRTQGGTSMEIESQKENSDTDRS 451
E + R+ +R+ QG M + S +++
Sbjct: 263 IEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRAL 298
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-19
Identities = 74/285 (25%), Positives = 125/285 (43%), Gaps = 46/285 (16%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKE----------FRVEVEA 190
++ K ++G+G YG VY N+ G +AVK++ A + R E+E
Sbjct: 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIET 61
Query: 191 IGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT 250
+ + H N+V+ LG+ + + EYV G++ L R +G +
Sbjct: 62 LKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL----RTYGRFEEQLVRFFTEQV 117
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVM-GTF 309
+ LAYLH ++HRD+K+ N+L+D D K+SDFG++K + M G+
Sbjct: 118 LEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSV 174
Query: 310 GYVAPEYANTGL--LNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMV--- 364
++APE ++ + K D++S G ++LE GR P W
Sbjct: 175 FWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP--------------WSDEEAIAA 220
Query: 365 ----GSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRP 405
G++RS + P++ + S AL L A C + + RP
Sbjct: 221 MFKLGNKRSAPPIPPDVSMNLSPVAL--DFLNA--CFTINPDNRP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 2e-19
Identities = 69/225 (30%), Positives = 109/225 (48%), Gaps = 16/225 (7%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEAI 191
L K +LG G +G V++G I PVA+K I + G Q +E + A+
Sbjct: 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAM 63
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
G + H +VRLLG C G LV + G+L + +H L + + + A
Sbjct: 64 GSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVR---QHRDSLDPQRLLNWCVQIA 119
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFG 310
K + YL E ++VHR++ + NIL+ D +++DFG+A LL K + +
Sbjct: 120 KGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK 176
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEV 354
++A E G +SDV+S+GV + E ++ G +P RP HEV
Sbjct: 177 WMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-HEV 220
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-19
Identities = 65/201 (32%), Positives = 101/201 (50%), Gaps = 16/201 (7%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKE-FRVEVEAIGHVRHKNLVRLLGYCI 207
LG G +G V+ G + VA+K + G E F E + ++H LVRL
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSL--KQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 208 -EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVV 266
E I+ ++ EY+ NG+L +L LT + + A+ +A++ +
Sbjct: 72 QEPIY--IITEYMENGSLVDFLKTPEGIK--LTINKLIDMAAQIAEGMAFIERK---NYI 124
Query: 267 HRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF--GYVAPEYANTGLLNE 324
HRD++++NIL+ + K++DFGLA+L+ + T R F + APE N G
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTI 182
Query: 325 KSDVYSFGVLLLEAIT-GRDP 344
KSDV+SFG+LL E +T GR P
Sbjct: 183 KSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 3e-19
Identities = 68/224 (30%), Positives = 100/224 (44%), Gaps = 37/224 (16%)
Query: 147 NVLGEGGYGVVYRGNLIN-------GSPVAVKKILNNVGQAEK-EFRVEVEAIGHVRHKN 198
N LG G +G VY G + VAVK + EK EF E + + H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY---LTWEARMKVLLGTAKALA 255
+V+LLG C+ + ++ E + G+L +L A LT + + + L AK
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 256 YLHEAIEPKVVHRDIKSSNILI-----DDDFNAKVSDFGLAKLL---------GAGKSHV 301
YL + +HRD+ + N L+ D D K+ DFGLA+ + G G V
Sbjct: 121 YLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 302 TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
++APE G +SDV+SFGVL+ E +T G+ P
Sbjct: 178 R--------WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 3e-19
Identities = 72/276 (26%), Positives = 129/276 (46%), Gaps = 23/276 (8%)
Query: 143 FSKENVLGEGGYGVVYRGN-LINGSPVAVKKI----LNNVGQAEKEFRVEVEAIGHVRHK 197
F E +G G + VYR L++G PVA+KK+ L + +A + E++ + + H
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMD-AKARADCIKEIDLLKQLNHP 62
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
N+++ IE +V E + G+L + + + + + K + AL ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
H +V+HRDIK +N+ I K+ D GL + + K+ ++GT Y++PE
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-KTTAAHSLVGTPYYMSPERI 178
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNI 377
+ N KSD++S G LL E + P +G D + + ++ E+ P +
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPF-YG---------DKMNLYSLCKKIEQCDYPPL 228
Query: 378 EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413
+ L R L+ C++PD EKRP ++ V +
Sbjct: 229 PSDHYSEEL-RQLVNM--CINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 3e-19
Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 28/217 (12%)
Query: 149 LGEGGYGVVYRGNLINGSP------VAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRL 202
LGEG +G V+ N P VAVK + + A K+F E E + +++H+++V+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 203 LGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHG-------------YLTWEARMKVLLG 249
G C+EG ++V+EY+ +G+L ++L R HG LT + +
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFL----RAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK-LLGAGKSHVTTRVMGT 308
A + YL VHRD+ + N L+ ++ K+ DFG+++ + V M
Sbjct: 129 IAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185
Query: 309 FGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
++ PE +SDV+S GV+L E T G+ P
Sbjct: 186 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 3e-19
Identities = 68/219 (31%), Positives = 112/219 (51%), Gaps = 34/219 (15%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKE------FRVEVEAIGHV 194
R+ K LGEG Y VVY+ + G VA+KKI + K+ R E++ + +
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR-EIKLLQEL 59
Query: 195 RHKNLVRLLG-YCIEG-IHRMLVYEYVNNGNLEQWLH-GAMRHHGYLTWEARMK-VLLGT 250
+H N++ LL + + I+ LV+E++ +LE+ + ++ LT A +K +L T
Sbjct: 60 KHPNIIGLLDVFGHKSNIN--LVFEFME-TDLEKVIKDKSIV----LT-PADIKSYMLMT 111
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
+ L YLH ++HRD+K +N+LI D K++DFGLA+ G+ +T +V+ T
Sbjct: 112 LRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRW 167
Query: 311 YVAPEYANTGLLNEKS-----DVYSFGVLLLEAITGRDP 344
Y APE L + D++S G + E + R P
Sbjct: 168 YRAPEL----LFGARHYGVGVDMWSVGCIFAELLL-RVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 5e-19
Identities = 62/214 (28%), Positives = 105/214 (49%), Gaps = 21/214 (9%)
Query: 148 VLGEGGYGVVYRGNLI--NGSP--VAVKKI-LNNVGQAE-KEFRVEVEAIGHVRHKNLVR 201
+LGEG +G V G L +GS VAVK + L+ +E +EF E + H N+++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 202 LLGYCIEGIHR------MLVYEYVNNGNLEQWLHGAMRHHG---YLTWEARMKVLLGTAK 252
L+G C E M++ ++ +G+L +L R G L + +K ++ A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL-YSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT-FGY 311
+ YL +HRD+ + N ++ +D V+DFGL+K + +G + R+ +
Sbjct: 125 GMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181
Query: 312 VAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
+A E + KSDV++FGV + E T G+ P
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 5e-19
Identities = 84/307 (27%), Positives = 128/307 (41%), Gaps = 53/307 (17%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNVGQAE-KEFRVEVE 189
EL +R + LGEG +G V + + S VAVK + ++ + + + E+E
Sbjct: 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEME 67
Query: 190 ---AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLH------------GAMRH 234
IG +HKN++ LLG C + +V EY +GNL +L
Sbjct: 68 MMKMIG--KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125
Query: 235 HGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294
LT + + A+ + +L K +HRD+ + N+L+ +D K++DFGLA+
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR-- 180
Query: 295 GAGKSHV-----TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHG 348
H+ TT ++APE + +SDV+SFGVLL E T G P G
Sbjct: 181 --DIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP-G 237
Query: 349 RPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMS 408
P E L LK G R +P + L C +RP
Sbjct: 238 IPVEE--LFKLLKE--GYRME----------KPQNCTQELYHLM-RDCWHEVPSQRPTFK 282
Query: 409 QVVRMLE 415
Q+V L+
Sbjct: 283 QLVEDLD 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 7e-19
Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAI-------GHVRHKNLV 200
LG+G +G VY ++ G +AVK++ E + EV A+ +++H+ +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQV--PFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 201 RLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
+ G + + EY+ G+++ L + +G LT K + + YLH
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQL----KAYGALTETVTRKYTRQILEGVEYLHSN 123
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVT--TRVMGTFGYVAPEYAN 318
+VHRDIK +NIL D N K+ DFG +K L S T V GT +++PE +
Sbjct: 124 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180
Query: 319 TGLLNEKSDVYSFGVLLLEAITGRDP 344
K+DV+S G ++E +T + P
Sbjct: 181 GEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 7e-19
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 15/208 (7%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRV---EVEAIGHVRH 196
F+ +G+G +G VY+ + VA+K I ++ +AE E E++ + R
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVI--DLEEAEDEIEDIQQEIQFLSQCRS 58
Query: 197 KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY 256
+ + G ++G ++ EY G+ L Y+ + R +VLLG L Y
Sbjct: 59 PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILR-EVLLG----LEY 113
Query: 257 LHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEY 316
LHE +HRDIK++NIL+ ++ + K++DFG++ L + S T V GT ++APE
Sbjct: 114 LHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEV 169
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+EK+D++S G+ +E G P
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 9e-19
Identities = 67/221 (30%), Positives = 102/221 (46%), Gaps = 22/221 (9%)
Query: 139 ATNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAI-GHVRH 196
T F V+GEG YG VY+ + G VA+K I++ + E+E + E + + H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSNH 62
Query: 197 KNLVRLLGYCIEGIHRM------LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT 250
N+ G I+ LV E G++ + G + L E +L T
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR--VMGT 308
+ LAYLHE KV+HRDIK NIL+ + K+ DFG++ L S + R +GT
Sbjct: 123 LRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL---DSTLGRRNTFIGT 176
Query: 309 FGYVAPE-----YANTGLLNEKSDVYSFGVLLLEAITGRDP 344
++APE + +SDV+S G+ +E G+ P
Sbjct: 177 PYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-18
Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRL 202
F KE LG G +GVV G VA+K I +E EF E + + + H+ LV+L
Sbjct: 8 FLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQL 64
Query: 203 LGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIE 262
G C + +V EY++NG L +L + +++ + +AYL
Sbjct: 65 YGVCTKQRPIYIVTEYMSNGCLLNYLREHGKR---FQPSQLLEMCKDVCEGMAYLESK-- 119
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF--GYVAPEYANTG 320
+ +HRD+ + N L+DD KVSDFGL++ + T+ V F + PE
Sbjct: 120 -QFIHRDLAARNCLVDDQGCVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLLYS 176
Query: 321 LLNEKSDVYSFGVLLLEAIT-GRDPVD 346
+ KSDV++FGVL+ E + G+ P +
Sbjct: 177 KFSSKSDVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 78/266 (29%), Positives = 124/266 (46%), Gaps = 32/266 (12%)
Query: 165 GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHR--MLVYEYVNNG 222
G VAVKK+ ++ + ++F E+E + ++H N+V+ G C R LV EY+ G
Sbjct: 33 GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYG 92
Query: 223 NLEQWLHGAMRHHGYLTWEARMKVLLGTA---KALAYLHEAIEPKVVHRDIKSSNILIDD 279
+L +L +H L + R K+LL + K + YL + VHRD+ + NIL++
Sbjct: 93 SLRDYL---QKHRERL--DHR-KLLLYASQICKGMEYLGSK---RYVHRDLATRNILVES 143
Query: 280 DFNAKVSDFGLAKLLGAGKSHVTTRVMG---TFGYVAPEYANTGLLNEKSDVYSFGVLLL 336
+ K+ DFGL K+L K + R G F Y APE + SDV+SFGV+L
Sbjct: 144 ENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLTESKFSVASDVWSFGVVLY 202
Query: 337 EAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSL------ 390
E T D P E +++MM ++ + +V IE+ + L
Sbjct: 203 ELFTYSD--KSCSPPAE-----FMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEI 255
Query: 391 -LTALRCVDPDSEKRPKMSQVVRMLE 415
C + D +RP S++ +E
Sbjct: 256 YAIMKECWNNDPSQRPSFSELALQVE 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 66/215 (30%), Positives = 98/215 (45%), Gaps = 33/215 (15%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKE------FRVEVEAIGHV 194
+ K +GEG YGVVY+ + + G VA+KKI L + E E R E+ + +
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRL----ETEDEGVPSTAIR-EISLLKEL 55
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARM--KVLLGTAK 252
H N+VRLL LV+E+ L+ L M + + L +
Sbjct: 56 NHPNIVRLLDVVHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQ 110
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
+AY H +V+HRD+K N+LID + K++DFGLA+ G T V+ T Y
Sbjct: 111 GIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYR 166
Query: 313 APEYANTGLLNEKS-----DVYSFGVLLLEAITGR 342
APE LL + D++S G + E + R
Sbjct: 167 APEI----LLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 3e-18
Identities = 71/215 (33%), Positives = 105/215 (48%), Gaps = 20/215 (9%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRH 196
E+ LG G +G V+ G + VAVK + E F E + + +RH
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRH 60
Query: 197 KNLVRLLGYCI---EGIHRMLVYEYVNNGNLEQWLH-GAMRHHGYLTWEARMKVLLGTAK 252
LV+L Y + E I+ +V EY++ G+L +L G R L + + A
Sbjct: 61 DKLVQL--YAVVSEEPIY--IVTEYMSKGSLLDFLKDGEGR---ALKLPNLVDMAAQVAA 113
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF--G 310
+AY+ +HRD++S+NIL+ D K++DFGLA+L+ + T R F
Sbjct: 114 GMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIK 168
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
+ APE A G KSDV+SFG+LL E +T GR P
Sbjct: 169 WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 3e-18
Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 42/216 (19%)
Query: 152 GGYGVVYRG-NLINGSPVAVK---------KILNNVGQAEKEFRVEVEAIGHVRHKNLVR 201
G YG V+ G A+K K + E++ + +V+
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILS------QAQSPYVVK 57
Query: 202 LLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
L Y +G + LV EY+ G+L L + G L + + AL YLH
Sbjct: 58 LY-YSFQGKKNLYLVMEYLPGGDLASLLE----NVGSLDEDVARIYIAEIVLALEYLHSN 112
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL--------LGAGKSHVTTRVMGTFGYV 312
++HRD+K NILID + + K++DFGL+K+ L + R++GT Y+
Sbjct: 113 ---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE-DKRIVGTPDYI 168
Query: 313 APEYANTGLLNE----KSDVYSFGVLLLEAITGRDP 344
APE +L + D +S G +L E + G P
Sbjct: 169 APEV----ILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 3e-18
Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 11/209 (5%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS----PVAVKKILNNVGQAEKE-FRVEVEAI 191
EL E +LG G +G + RG L S PVA+ + ++ F E +
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
G H N+VRL G G M+V EY++NG L+ +L +H G L M +L G A
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLR---KHEGQLVAGQLMGMLPGLA 117
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGY 311
+ YL E VH+ + + +L++ D K+S F + + + T +
Sbjct: 118 SGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLW 174
Query: 312 VAPEYANTGLLNEKSDVYSFGVLLLEAIT 340
APE + SDV+SFG+++ E ++
Sbjct: 175 AAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 5e-18
Identities = 61/203 (30%), Positives = 98/203 (48%), Gaps = 10/203 (4%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRL 202
F KE LG G +GVV+ G VA+K I N +E++F E + + + H LV+L
Sbjct: 8 FMKE--LGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQL 64
Query: 203 LGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIE 262
G C + +V E++ NG L +L + G L+ + + + + + YL
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLR---QRQGKLSKDMLLSMCQDVCEGMEYLERN-- 119
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL 322
+HRD+ + N L+ KVSDFG+ + + + ++ + PE N
Sbjct: 120 -SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKY 178
Query: 323 NEKSDVYSFGVLLLEAIT-GRDP 344
+ KSDV+SFGVL+ E T G+ P
Sbjct: 179 SSKSDVWSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 5e-18
Identities = 71/273 (26%), Positives = 120/273 (43%), Gaps = 28/273 (10%)
Query: 149 LGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEK-EFRVEVEAIGHVRHKNLVRLLGYC 206
+G G +G V+ G L + +PVAVK + K +F E + H N+VRL+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 207 IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPK-V 265
+ +V E V G+ +L ++K L+ + A E +E K
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPR-------LKVKELIQMVENAAAGMEYLESKHC 115
Query: 266 VHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT-FGYVAPEYANTGLLNE 324
+HRD+ + N L+ + K+SDFG+++ G T + + APE N G +
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSS 175
Query: 325 KSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPST 383
+SDV+SFG+LL EA + G P + + ++++ E ++ + +
Sbjct: 176 ESDVWSFGILLWEAFSLGAVPYAN----------------LSNQQTREAIEQGVRLPCPE 219
Query: 384 RALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416
RC + D +RP S V + L+S
Sbjct: 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 5e-18
Identities = 75/279 (26%), Positives = 122/279 (43%), Gaps = 32/279 (11%)
Query: 149 LGEGGYGVVYRGNLINGSP--VAVKKIL---NNVGQAEKEFRVEVEAI--------GHVR 195
LG G +G VY+ N +A+K+I G+ ++E + I +R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
H N+VR +E +V + + L + + T E + + AL
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE 315
YLH+ E ++VHRD+ +NI++ +D ++DFGLAK T V+GT Y PE
Sbjct: 128 YLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTILYSCPE 183
Query: 316 YANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375
EK+DV++FG +L + T + P + N++ +V E V +P
Sbjct: 184 IVKNEPYGEKADVWAFGCILYQMCTLQPPF------YSTNMLSLATKIV-----EAVYEP 232
Query: 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414
E S ++T C+ PD+E RP + QV M+
Sbjct: 233 LPEGMYSEDV--TDVIT--SCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 5e-18
Identities = 74/276 (26%), Positives = 118/276 (42%), Gaps = 24/276 (8%)
Query: 147 NVLGEGGYGVVYRGNLINGSPVAVKKILN--NVGQAEKEFRVEVEAIGHVRHKNLVRLLG 204
+ LGEG G V + L N + K + +K+ E+E + +V+ G
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 205 YCIEGIHRML--VYEYVNNGNLEQWLHGAMRHHGYLTWEARM-KVLLGTAKALAYLHEAI 261
++ + EY G+L+ ++ ++ G E + K+ K L+YLH
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR- 124
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGL 321
K++HRDIK SNIL+ K+ DFG++ L + T GT Y+APE
Sbjct: 125 --KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GTSFYMAPERIQGKP 179
Query: 322 LNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNL--VDWLKMMVGSRRSEEVVDPNIEV 379
+ SDV+S G+ LLE R P P E L ++ L +V E +P +
Sbjct: 180 YSITSDVWSLGLTLLEVAQNRFPFP---PEGEPPLGPIELLSYIVNMPNPELKDEPGNGI 236
Query: 380 RPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
+ S K + +C++ D +RP MLE
Sbjct: 237 KWS-EEFKDFI---KQCLEKDPTRRPTPWD---MLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 6e-18
Identities = 76/294 (25%), Positives = 122/294 (41%), Gaps = 42/294 (14%)
Query: 143 FSKEN-----VLGEGGYGVVY----RGNLING--SPVAVKKILN-NVGQAEKEFRVEVEA 190
F + N LG G +G V+ +G G + V VK + + EFR E++
Sbjct: 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 191 IGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY-----LTWEARMK 245
+ HKN+VRLLG C E ++ EY + G+L+Q+L L+ + ++
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121
Query: 246 VLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRV 305
+ A + +L A + VHRD+ + N L+ KVS L+K + + +
Sbjct: 122 LCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNA 178
Query: 306 MGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVG 365
+ ++APE + KSDV+SFGVL+ E T G L D
Sbjct: 179 LIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT------QGELPFY-GLSD------- 224
Query: 366 SRRSEEVVDP----NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
EEV++ +E+ R RC + + RP S++V L
Sbjct: 225 ----EEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 7e-18
Identities = 59/217 (27%), Positives = 106/217 (48%), Gaps = 27/217 (12%)
Query: 142 RFSKENVLGEGGYGVVYRGNLINGSP-----VAVKKILNNVGQAEKEFRV-EVEAIGHVR 195
R + ++L EG +G ++ G LI+ P V VK + ++ + + + E + +
Sbjct: 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLS 66
Query: 196 HKNLVRLLGYCIEGIHR-MLVYEYVNNGNLEQWL----HGAMRHHGYLTWEARMKVLLGT 250
H+N++ +L CIE ++Y Y+N GNL+ +L G + L+ + V +
Sbjct: 67 HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALS--TQQLVHMAI 124
Query: 251 --AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT 308
A ++YLH+ V+H+DI + N +ID++ K++D L++ L H +G
Sbjct: 125 QIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH----CLGD 177
Query: 309 -----FGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT 340
++A E + SDV+SFGVLL E +T
Sbjct: 178 NENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 8e-18
Identities = 64/204 (31%), Positives = 105/204 (51%), Gaps = 16/204 (7%)
Query: 149 LGEGGYGVVYRG---NLINGSPVAVKKILNNVGQA--EKEFRVEVEAIGHVRHKNLVRLL 203
LG G +G V +G + VAVK + N+ + E E + + + +VR++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEP 263
G C E MLV E G L ++L + + ++T + +++ + + YL E
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFL----QKNKHVTEKNITELVHQVSMGMKYLEET--- 114
Query: 264 KVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF--GYVAPEYANTGL 321
VHRD+ + N+L+ AK+SDFGL+K LGA +++ + G + + APE N
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174
Query: 322 LNEKSDVYSFGVLLLEAIT-GRDP 344
+ KSDV+SFGVL+ EA + G+ P
Sbjct: 175 FSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 8e-18
Identities = 76/293 (25%), Positives = 126/293 (43%), Gaps = 34/293 (11%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGN---LINGSP---VAVKKILNNVGQAEKE-FRVEVE 189
E N S LG G +G V L VAVK + +E+E E++
Sbjct: 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELK 90
Query: 190 AIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL 248
+ H+ H+N+V LLG C G +++ EY G+L +L + +LT E +
Sbjct: 91 IMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLR--RKRESFLTLEDLLSFSY 148
Query: 249 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV---TTRV 305
AK +A+L +HRD+ + N+L+ K+ DFGLA+ + ++V R+
Sbjct: 149 QVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL 205
Query: 306 MGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMV 364
++APE + +SDV+S+G+LL E + G +P P V+ + +
Sbjct: 206 --PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY----PGMPVDSKFYKLIKE 259
Query: 365 GSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417
G R ++ P C D D KRP Q+V+++ +
Sbjct: 260 GYRMAQPEHAP-----------AEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 1e-17
Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 14/203 (6%)
Query: 149 LGEGGYGVVYRGNLINGSP---VAVKKILNNVGQAEK-EFRVEVEAIGHVRHKNLVRLLG 204
LG G +G V +G VA+K + N ++ + E E E + + + +VR++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 205 YCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPK 264
C E MLV E + G L ++L G +T ++++ + + YL
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDE---ITVSNVVELMHQVSMGMKYLEGK---N 115
Query: 265 VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF--GYVAPEYANTGLL 322
VHRD+ + N+L+ + AK+SDFGL+K LGA S+ R G + + APE N
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175
Query: 323 NEKSDVYSFGVLLLEAIT-GRDP 344
+ +SDV+S+G+ + EA + G+ P
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 69/211 (32%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 145 KENVLGEGGYGVV--YRGNLIN---GSPVAVKKILNNVGQAEKE-FRVEVEAIGHVRHKN 198
K VLGEG +G V Y + N G VAVK + GQ ++ E+ + + H+N
Sbjct: 8 KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHEN 67
Query: 199 LVRLLGYCIEGIHR--MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY 256
+V+ G C E + L+ EYV G+L +L +H L + + +AY
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLP---KHK--LNLAQLLLFAQQICEGMAY 122
Query: 257 LHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG---TFGYVA 313
LH +HRD+ + N+L+D+D K+ DFGLAK + G + R G F Y A
Sbjct: 123 LHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-A 178
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
E + SDV+SFGV L E +T D
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLTHCDS 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 82.5 bits (203), Expect = 2e-17
Identities = 74/273 (27%), Positives = 129/273 (47%), Gaps = 29/273 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRV-EVEAIGHVRHKNL 199
RF K +G+G G VY ++ G VA+++ +N Q +KE + E+ + ++ N+
Sbjct: 24 RFEK---IGQGASGTVYTAMDVATGQEVAIRQ-MNLQQQPKKELIINEILVMRENKNPNI 79
Query: 200 VRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE 259
V L + G +V EY+ G+L + G + R + +AL +LH
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHS 134
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANT 319
+V+HRDIKS NIL+ D + K++DFG + +S + ++GT ++APE
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTR 190
Query: 320 GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEV 379
K D++S G++ +E I G P + P + L + + + E+ +P
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL-------IATNGTPELQNPE--- 240
Query: 380 RPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
A+ R L RC+D D EKR ++++
Sbjct: 241 --KLSAIFRDFLN--RCLDMDVEKRGSAKELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 64/226 (28%), Positives = 105/226 (46%), Gaps = 32/226 (14%)
Query: 148 VLGEGGYGVVYRGNL--INGSP----VAVKKILNNVGQAE-KEFRVEVEAIGHVRHKNLV 200
LGEG +G V + + G VAVK + N +E ++ E + V H +++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 201 RLLGYCIEGIHRMLVYEYVNNGNLEQWLH------------GAMRHHGYLTWEA----RM 244
+L G C + +L+ EY G+L +L R+ YL M
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 245 KVLLGTA----KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSH 300
L+ A + + YL E K+VHRD+ + N+L+ + K+SDFGL++ + S+
Sbjct: 127 GDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 301 VT-TRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
V ++ ++A E + +SDV+SFGVLL E +T G +P
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 146 ENVLGEGGYGVVYR------GNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV-RHKN 198
E+V+GEG +G V R G +N + +K+ + ++F E+E + + H N
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASE--NDHRDFAGELEVLCKLGHHPN 64
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA---------MRHHGYLTWEARMKVLLG 249
++ LLG C + + EY GNL +L + + HG + ++L
Sbjct: 65 IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
+ + E + +HRD+ + N+L+ ++ +K++DFGL++ G+ + MG
Sbjct: 125 ASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVKKTMGRL 180
Query: 310 G--YVAPEYANTGLLNEKSDVYSFGVLLLEAIT 340
++A E N + KSDV+SFGVLL E ++
Sbjct: 181 PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 61/225 (27%), Positives = 105/225 (46%), Gaps = 47/225 (20%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI--LNNVGQAEKEFRVEVEAIGHVRHKN 198
R+ + +GEG YG+V + G VA+KKI + ++ R E++ + +H+N
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-EIKILRRFKHEN 64
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQW-----LHGAMR-------HHGYLTWEARMKV 246
++ +L I R +E N+ + Q L+ ++ H Y ++
Sbjct: 65 IIGILD-----IIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQ----- 114
Query: 247 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVM 306
+ L Y+H A V+HRD+K SN+L++ + + K+ DFGLA++ A H T +
Sbjct: 115 ---ILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFL 166
Query: 307 ----GTFGYVAPEYANTGLLNEKS-----DVYSFGVLLLEAITGR 342
T Y APE +LN K D++S G +L E ++ R
Sbjct: 167 TEYVATRWYRAPEI----MLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 65/248 (26%), Positives = 111/248 (44%), Gaps = 60/248 (24%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQ---AEKEFRVEVEAIGHVR 195
TNR+ +G G +G+V + + G VA+KKI+ A++ +R E++ + H+R
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLR 67
Query: 196 HKNLVRLLGYCIE--------------GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWE 241
H+N++ L I +HR+L + ++ +L+ +R
Sbjct: 68 HENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILR-------- 119
Query: 242 ARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV 301
L Y+H A VVHRD+K SNILI+++ + K+ DFGLA++ +
Sbjct: 120 -----------GLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARI----QDPQ 161
Query: 302 TTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAIT------GRDPVDH------- 347
T + T Y APE T + + D++S G + E + G+D V+
Sbjct: 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDL 221
Query: 348 -GRPAHEV 354
G P +V
Sbjct: 222 LGTPPDDV 229
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 5e-17
Identities = 64/214 (29%), Positives = 97/214 (45%), Gaps = 43/214 (20%)
Query: 147 NVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVR---HKNL 199
+GEG YG VY+ +L G VA+KK+ L+ G R E+ + + H N+
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFEHPNI 63
Query: 200 VRLLGYCI-----EGIHRMLVYEYVNNGNLEQWLHGAMRHH---GYLTWEAR--MKVLLG 249
VRLL C + LV+E+V +Q L + G + M+ LL
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHV-----DQDLATYLSKCPKPGLPPETIKDLMRQLL- 117
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
+ + +LH ++VHRD+K NIL+ D K++DFGLA++ + T V+ T
Sbjct: 118 --RGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA--LTSVVVTL 170
Query: 310 GYVAPE------YANTGLLNEKSDVYSFGVLLLE 337
Y APE YA D++S G + E
Sbjct: 171 WYRAPEVLLQSSYATP------VDMWSVGCIFAE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 6e-17
Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 13/200 (6%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 208
LG G +G V+ G N + VAVK L + + F E + ++H LVRL +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKT-LKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 209 GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPK-VVH 267
++ EY+ G+L +L G + + A+ +AY IE K +H
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKS--DEGGKVLLPKLIDFSAQIAEGMAY----IERKNYIH 126
Query: 268 RDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF--GYVAPEYANTGLLNEK 325
RD++++N+L+ + K++DFGLA+++ + T R F + APE N G K
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFTIK 184
Query: 326 SDVYSFGVLLLEAIT-GRDP 344
SDV+SFG+LL E +T G+ P
Sbjct: 185 SDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 8e-17
Identities = 69/275 (25%), Positives = 126/275 (45%), Gaps = 21/275 (7%)
Query: 143 FSKENVLGEGGYGVVYRGN-LINGSPVAVKK--ILNNV-GQAEKEFRVEVEAIGHVRHKN 198
F E +G G + VYR L++ PVA+KK I + +A ++ E++ + + H N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+++ L IE +V E + G+L Q + + + K + A+ ++H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYAN 318
+V+HRDIK +N+ I K+ D GL + + K+ ++GT Y++PE +
Sbjct: 124 SR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPERIH 179
Query: 319 TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378
N KSD++S G LL E + P D + + ++ E+ P +
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPF----------YGDKMNLFSLCQKIEQCDYPPLP 229
Query: 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413
+ L R L++ C+ PD ++RP + V ++
Sbjct: 230 TEHYSEKL-RELVSM--CIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 9e-17
Identities = 70/228 (30%), Positives = 112/228 (49%), Gaps = 37/228 (16%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKE-FRV----EVE 189
+ ++F +GEG YG VY+ + G VA+KK+ L+N EKE F + E++
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDN----EKEGFPITAIREIK 58
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRM----------LVYEYVNNGNLEQWLHGAMRHHGYLT 239
+ + H+N+V L + + LV+EY+++ +L L + H
Sbjct: 59 ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDH 117
Query: 240 WEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299
++ MK LL + L Y H+ +HRDIK SNIL+++ K++DFGLA+L + +S
Sbjct: 118 IKSFMKQLL---EGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171
Query: 300 HVTTRVMGTFGYVAPEYANTGLLNEKS-----DVYSFGVLLLEAITGR 342
T + T Y PE LL E+ DV+S G +L E T +
Sbjct: 172 RPYTNKVITLWYRPPEL----LLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 65/214 (30%), Positives = 104/214 (48%), Gaps = 31/214 (14%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHKN 198
F K +GEG YGVVY+ N + G VA+KKI G R E+ + + H N
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 60
Query: 199 LVRLLGYCIEGIHR----MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKAL 254
+V+LL + IH LV+E+++ +L++++ + + L + L
Sbjct: 61 IVKLL----DVIHTENKLYLVFEFLHQ-DLKKFMDASPL--SGIPLPLIKSYLFQLLQGL 113
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
A+ H +V+HRD+K N+LI+ + K++DFGLA+ G T V+ T Y AP
Sbjct: 114 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAP 169
Query: 315 E------YANTGLLNEKSDVYSFGVLLLEAITGR 342
E Y +T + D++S G + E +T R
Sbjct: 170 EILLGCKYYSTAV-----DIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 72/240 (30%), Positives = 116/240 (48%), Gaps = 35/240 (14%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKILN---NVGQAEKEFRVEVEAIGHVRHKNLVRLLG 204
+G G YG+V N VA+KKI N N A++ R E++ + H+ H+N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAIKD 71
Query: 205 YCIEGIHRM------LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+ HR +VYE ++ LH +R L+ + L + L Y+H
Sbjct: 72 -IMPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH 125
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYAN 318
A V+HRD+K SN+L++ + + K+ DFGLA+ +T V+ T Y APE
Sbjct: 126 SA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPEL-- 179
Query: 319 TGLLNEKS-----DVYSFGVLLLEAITGRDPVDHGRP-AHEVNLVDWLKMMVGSRRSEEV 372
LLN DV+S G + E + GR P+ G+ H++ L+ L +GS E++
Sbjct: 180 --LLNCSEYTTAIDVWSVGCIFAE-LLGRKPLFPGKDYVHQLKLITEL---LGSPSEEDL 233
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 58/216 (26%), Positives = 105/216 (48%), Gaps = 30/216 (13%)
Query: 146 ENVLGEGGYGVVYRGNLINGS---PVAVKKILNNVGQAE-KEFRVEVEAI---GHVRHKN 198
++V+GEG +G V + + A+K++ + + ++F E+E + GH H N
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH--HPN 69
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHG------------AMRHHGYLTWEARMKV 246
++ LLG C + L EY +GNL +L A L+ + +
Sbjct: 70 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129
Query: 247 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVM 306
A+ + YL + + +HRD+ + NIL+ +++ AK++DFGL++ G+ + M
Sbjct: 130 AADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTM 182
Query: 307 GTFG--YVAPEYANTGLLNEKSDVYSFGVLLLEAIT 340
G ++A E N + SDV+S+GVLL E ++
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 79.8 bits (196), Expect = 1e-16
Identities = 73/273 (26%), Positives = 129/273 (47%), Gaps = 29/273 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRV-EVEAIGHVRHKNL 199
RF K +G+G G VY ++ G VA+K+ +N Q +KE + E+ + ++ N+
Sbjct: 23 RFEK---IGQGASGTVYTAIDIATGQEVAIKQ-MNLQQQPKKELIINEILVMRENKNPNI 78
Query: 200 VRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE 259
V L + G +V EY+ G+L + G + R + +AL +LH
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALDFLHS 133
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANT 319
+V+HRDIKS NIL+ D + K++DFG + +S +T V GT ++APE
Sbjct: 134 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTR 189
Query: 320 GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEV 379
K D++S G++ +E + G P + P + L + + + E+ +P
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-------IATNGTPELQNPE--- 239
Query: 380 RPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
A+ R L RC++ D ++R ++++
Sbjct: 240 --RLSAVFRDFLN--RCLEMDVDRRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 74/273 (27%), Positives = 130/273 (47%), Gaps = 26/273 (9%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRV-EVEAIGHVRHKNL 199
++++ +G+G G VY ++ G VA+K++ N Q +KE + E+ + +H N+
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIINEILVMRENKHPNI 78
Query: 200 VRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE 259
V L + G +V EY+ G+L + G + R + L +AL +LH
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-ECL----QALEFLHS 133
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANT 319
+V+HRDIKS NIL+ D + K++DFG + +S +T V GT ++APE
Sbjct: 134 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTR 189
Query: 320 GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEV 379
K D++S G++ +E + G P + P + L+ G+ P ++
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI----ATNGT--------PELQN 237
Query: 380 RPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
A+ R L RC++ D EKR ++++
Sbjct: 238 PEKLSAIFRDFLN--RCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 66/215 (30%), Positives = 108/215 (50%), Gaps = 21/215 (9%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNV--GQAEKEFRVEVEAIGHVRHKN 198
++K +GEG YGVVY+G N G VA+KKI L + G R E+ + ++H N
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR-EISLLKELQHPN 60
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V L ++ L++E+++ +L+++L ++ Y+ E L + + + H
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSM-DLKKYLD-SLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYAN 318
+V+HRD+K N+LID+ K++DFGLA+ G V T + T Y APE
Sbjct: 119 SR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEVVTLWYRAPEV-- 172
Query: 319 TGLLNEKS-----DVYSFGVLLLEAITGRDPVDHG 348
LL D++S G + E T + P+ HG
Sbjct: 173 --LLGSPRYSTPVDIWSIGTIFAEMATKK-PLFHG 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 57/226 (25%), Positives = 104/226 (46%), Gaps = 22/226 (9%)
Query: 137 ELATNRFSKENVLGEGGYGVVY-------------RGNLINGSP--VAVKKILNNVGQ-A 180
E + + LGEG +G V+ +G P VAVK + +V + A
Sbjct: 1 EFPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTA 60
Query: 181 EKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWL-----HGAMRHH 235
+F E++ + +++ N++RLLG C+ ++ EY+ NG+L Q+L H
Sbjct: 61 RNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHA 120
Query: 236 GYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295
+ + +L + + + VHRD+ + N L+ + + K++DFG+++ L
Sbjct: 121 NNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLY 180
Query: 296 AGKSH-VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT 340
+G + + R + ++A E G SDV++FGV L E T
Sbjct: 181 SGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 12/206 (5%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS----PVAVKKILNNVGQAEKE-FRVEVEAI 191
E+ + +GEG +G VY+G ++ VAVK N + +E F E +
Sbjct: 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIM 61
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
H ++V+L+G E +V E G L +L + L + + +
Sbjct: 62 RQFDHPHIVKLIGVITEN-PVWIVMELAPLGELRSYLQ---VNKYSLDLASLILYSYQLS 117
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGY 311
ALAYL + VHRDI + N+L+ K+ DFGL++ L + ++ +
Sbjct: 118 TALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKW 174
Query: 312 VAPEYANTGLLNEKSDVYSFGVLLLE 337
+APE N SDV+ FGV + E
Sbjct: 175 MAPESINFRRFTSASDVWMFGVCMWE 200
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-16
Identities = 66/217 (30%), Positives = 101/217 (46%), Gaps = 24/217 (11%)
Query: 148 VLGEGGYGVVY----RGNLINGSPVAVK-----KILNNVGQAEKEFRVEVEAIGHVRHKN 198
VLG G YG V+ G G A+K I+ AE R E + + VR
Sbjct: 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHT-RTERQVLEAVRRCP 65
Query: 199 LVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKALAY 256
+ L Y + ++ L+ +YVN G L L+ + T E+ ++V + AL +
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYVNGGELFTHLY----QREHFT-ESEVRVYIAEIVLALDH 120
Query: 257 LHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEY 316
LH+ +++RDIK NIL+D + + ++DFGL+K A + GT Y+APE
Sbjct: 121 LHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEV 177
Query: 317 ANTGLL--NEKSDVYSFGVLLLEAITGRDP--VDHGR 349
G ++ D +S GVL E +TG P VD +
Sbjct: 178 IRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ 214
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 4e-16
Identities = 66/202 (32%), Positives = 102/202 (50%), Gaps = 18/202 (8%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI- 207
LG+G +G V+ G + VA+K + E F E + + +RH LV L Y +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPL--YAVV 70
Query: 208 --EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKV 265
E I+ +V E++ G+L +L + L M + A +AY+
Sbjct: 71 SEEPIY--IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQI--ADGMAYIERM---NY 123
Query: 266 VHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF--GYVAPEYANTGLLN 323
+HRD++++NIL+ D+ K++DFGLA+L+ + T R F + APE A G
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 324 EKSDVYSFGVLLLEAIT-GRDP 344
KSDV+SFG+LL E +T GR P
Sbjct: 182 IKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 4e-16
Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 17/204 (8%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKE-FRVEVEAIGHVRHKNLVRLL-GYC 206
LG+G +G VY+ A KI+ + E E F VE++ + +H N+V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 207 IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVV 266
E +L+ E+ + G L+ + R LT V +AL +LH KV+
Sbjct: 73 YENKLWILI-EFCDGGALDSIMLELERG---LTEPQIRYVCRQMLEALNFLHSH---KVI 125
Query: 267 HRDIKSSNILIDDDFNAKVSDFGL-AKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL--- 322
HRD+K+ NIL+ D + K++DFG+ AK + T +GT ++APE
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDN 183
Query: 323 --NEKSDVYSFGVLLLEAITGRDP 344
+ K+D++S G+ L+E P
Sbjct: 184 PYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 4e-16
Identities = 69/208 (33%), Positives = 110/208 (52%), Gaps = 31/208 (14%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGY 205
LGEG Y VY+G N G VA+K+I + G R E+ + ++H+N+VRL
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHENIVRLH-- 64
Query: 206 CIEGIHR----MLVYEYVNNGNLEQWL--HGAMRHHGYLTWEARMKVLLGTAKALAYLHE 259
+ IH MLV+EY++ +L++++ HG T ++ LL K +A+ HE
Sbjct: 65 --DVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLL---KGIAFCHE 118
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANT 319
+V+HRD+K N+LI+ K++DFGLA+ G + + V+ T Y AP+
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDV--- 171
Query: 320 GLLNEKS-----DVYSFGVLLLEAITGR 342
LL ++ D++S G ++ E ITGR
Sbjct: 172 -LLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 4e-16
Identities = 65/220 (29%), Positives = 100/220 (45%), Gaps = 44/220 (20%)
Query: 142 RFSKENVLGEGGYGVVYR-GNLINGSPVAVKKILNNVGQAEKEFRV------EVEAIGHV 194
++ K + +GEG YGVV++ N G VA+KK + ++E + + E+ + +
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFV----ESEDDPVIKKIALREIRMLKQL 57
Query: 195 RHKNLVRLLGYCIEGIHRM----LVYEYVNN---GNLEQWLHGAMRHHGYLTWEARMKVL 247
+H NLV L IE R LV+EY ++ LE+ G H K++
Sbjct: 58 KHPNLVNL----IEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLI-------KKII 106
Query: 248 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG 307
T +A+ + H+ +HRD+K NILI K+ DFG A++L T V
Sbjct: 107 WQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-A 162
Query: 308 TFGYVAPEYANTGLL------NEKSDVYSFGVLLLEAITG 341
T Y APE LL DV++ G + E +TG
Sbjct: 163 TRWYRAPE-----LLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 4e-16
Identities = 70/273 (25%), Positives = 132/273 (48%), Gaps = 26/273 (9%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRV-EVEAIGHVRHKNL 199
++++ +G+G G V+ ++ G VA+K+I N Q +KE + E+ + +++ N+
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQI-NLQKQPKKELIINEILVMKELKNPNI 78
Query: 200 VRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE 259
V L + G +V EY+ G+L + + R + +AL +LH
Sbjct: 79 VNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL-----QALEFLHA 133
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANT 319
+V+HRDIKS N+L+ D + K++DFG + +S +T V GT ++APE
Sbjct: 134 N---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTR 189
Query: 320 GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEV 379
K D++S G++ +E + G P + P + L + + + E+ +P ++
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-------IATNGTPELQNPE-KL 241
Query: 380 RPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
P + R L RC++ D EKR ++++
Sbjct: 242 SP----IFRDFLN--RCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 5e-16
Identities = 62/228 (27%), Positives = 98/228 (42%), Gaps = 33/228 (14%)
Query: 149 LGEGGYGVVY---------------RGNLINGSP--VAVKKILNNVGQ-AEKEFRVEVEA 190
LGEG +G V+ N +P VAVK + + A ++F EV+
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 191 IGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT 250
+ + N+ RLLG C ++ EY+ NG+L Q+L + H T +
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFL----QKHVAETSGLACNSKSLS 128
Query: 251 AKALAYLHEAI--------EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK-SHV 301
L Y+ I VHRD+ + N L+ ++ K++DFG+++ L + V
Sbjct: 129 FSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188
Query: 302 TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT--GRDPVDH 347
R ++A E G KSDV++FGV L E +T P +H
Sbjct: 189 QGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 6e-16
Identities = 67/225 (29%), Positives = 112/225 (49%), Gaps = 29/225 (12%)
Query: 135 DLELATNRFSKENVLGEGGYGVVYRGNLI-----NGSPVAVKKILN-NVGQAEKEFRVEV 188
+L L+ RF +E LGE +G +Y+G+L + VA+K + + N Q EF+ E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 189 EAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRH-HGYLTWEARMKVL 247
+ + H N+V LLG + +++EY+N G+L ++L MR H + +
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFL--IMRSPHSDVGCSSDED-- 114
Query: 248 LGTAKALA----YLHEAIEPKV----------VHRDIKSSNILIDDDFNAKVSDFGLAK- 292
GT K+ +LH AI+ VH+D+ + NILI + + K+SD GL++
Sbjct: 115 -GTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSRE 173
Query: 293 LLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLE 337
+ A V + + ++ PE G + SD++SFGV+L E
Sbjct: 174 IYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWE 218
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 8e-16
Identities = 65/204 (31%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 165 GSPVAVKKILNNVGQAEKE---FRVEVEAIGHVRHKNLVRLL--GYCIEGIHRMLVYEYV 219
G VA+K + + + E + FR E + H N+V LL G G+ V+EYV
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFEYV 61
Query: 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILI-- 277
L + L G L +++L ALA H +VHRD+K NI++
Sbjct: 62 PGRTLREVLAA----DGALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQ 114
Query: 278 -DDDFNAKVSDFGLAKLL-GAGKSHV-----TTRVMGTFGYVAPEYANTGLLNEKSDVYS 330
+AKV DFG+ LL G + V TT V+GT Y APE + SD+Y+
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174
Query: 331 FGVLLLEAITGRDPVDHGRPAHEV 354
+G++ LE +TG+ V G E+
Sbjct: 175 WGLIFLECLTGQ-RVVQGASVAEI 197
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 9e-16
Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 28/206 (13%)
Query: 148 VLGEGGYGVVYR-GNLINGSPVAVKKILNNVGQAEKE---FRVEVEAIGHVRHKNLVRLL 203
++GEG YG+V + + G VA+KK L + + R E+ + +RH+NLV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR-EIRMLKQLRHENLVNLI 66
Query: 204 GYCIEGIHRMLVYEYVNN---GNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
LV+E+V++ +LE++ +G L K L + + + H
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-------LDESRVRKYLFQILRGIEFCHSH 119
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTG 320
++HRDIK NIL+ K+ DFG A+ L A V T + T Y APE
Sbjct: 120 ---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYTDYVATRWYRAPEL---- 171
Query: 321 LLNEKS-----DVYSFGVLLLEAITG 341
L+ + D+++ G L+ E +TG
Sbjct: 172 LVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 29/212 (13%)
Query: 149 LGEGGYGVVYRGN---LINGSP---VAVKKILNNVGQAEK-EFRVEVEAIGHVRHKNLVR 201
LG+G +G+VY GN +I G VAVK + + E+ EF E + ++VR
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 202 LLGYCIEGIHRMLVYEYVNNGNLEQWLHG----AMRHHGYL--TWEARMKVLLGTAKALA 255
LLG +G ++V E + +G+L+ +L A + G T + +++ A +A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL-------GAGKSHVTTRVMGT 308
YL+ K VHRD+ + N ++ DF K+ DFG+ + + GK + R M
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-- 188
Query: 309 FGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT 340
APE G+ SD++SFGV+L E +
Sbjct: 189 ----APESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 71/243 (29%), Positives = 112/243 (46%), Gaps = 30/243 (12%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLI--------NGSPVAVKKILNNVGQAE-KEFRVE 187
EL+ R + LGEG +G V I VAVK + ++ + + E
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSE 67
Query: 188 VEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY--------- 237
+E + + +HKN++ LLG C + ++ EY + GNL ++L A R G
Sbjct: 68 MEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLR-ARRPPGMDYSFDTCKL 126
Query: 238 ----LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK- 292
LT++ + A+ + YL K +HRD+ + N+L+ +D K++DFGLA+
Sbjct: 127 PEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARD 183
Query: 293 LLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPA 351
+ TT ++APE + +SDV+SFGVLL E T G P G P
Sbjct: 184 VHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP-GIPV 242
Query: 352 HEV 354
E+
Sbjct: 243 EEL 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 82/286 (28%), Positives = 132/286 (46%), Gaps = 27/286 (9%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILN---NVGQAEKEFRVEVEAIGHVRHK 197
R+ + V+G+G YGVV + G VA+KKI + +V A + R E++ + +RH
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR-EIKLLRLLRHP 59
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
++V + + R YV +E LH ++ + LT E L +AL Y+
Sbjct: 60 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYI 119
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK--LLGAGKSHVTTRVMGTFGYVAPE 315
H A V HRD+K NIL + D K+ DFGLA+ + T + T Y APE
Sbjct: 120 HTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 176
Query: 316 YANT--GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373
+ D++S G + E +TG+ P+ G+ V+ +D + ++G+
Sbjct: 177 LCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNV--VHQLDLITDLLGT------- 226
Query: 374 DPNIEVRPSTRALK-RSLLTALRCVDPD--SEKRPKM-SQVVRMLE 415
P+ E R K R L+++R P S+K P +R+LE
Sbjct: 227 -PSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLE 271
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 76/313 (24%), Positives = 128/313 (40%), Gaps = 66/313 (21%)
Query: 149 LGEGGYGVVYRGNLIN---------------GSP--VAVKKILNNVGQ-AEKEFRVEVEA 190
LGEG +G V+ ++N G P VAVK + + + A +F EV+
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 191 IGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT 250
+ ++ N++RLLG C++ ++ EY+ NG+L Q+L H E +
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL----SSHHLDDKEENGNDAVPP 128
Query: 251 AKAL------AYLHEAIEP----------KVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294
A L + LH A++ VHRD+ + N L+ ++ K++DFG+++ L
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 295 GAGKSH-VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHE 353
AG + + R + ++A E G SDV++FGV L E + + +P
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM----LCKEQP--- 241
Query: 354 VNLVDWLKMMVGSRRSEEVVDPNIEV-RPSTRALKRSLLTA---------LRCVDPDSEK 403
G E+V++ E R R + L+C D +
Sbjct: 242 ----------YGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRE 291
Query: 404 RPKMSQVVRMLES 416
RP S + L
Sbjct: 292 RPSFSDIHAFLTE 304
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-15
Identities = 73/275 (26%), Positives = 133/275 (48%), Gaps = 27/275 (9%)
Query: 142 RFSKENVLGEGGYG-VVYRGNLINGSPVAVKKI-LNNVGQAEK-EFRVEVEAIGHVRHKN 198
++ K +GEG +G + + +G +K+I ++ + E+ E R EV + +++H N
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEAR-MKVLLGTAKALAYL 257
+V+ E + +V +Y G+L + ++ G L E + + + AL ++
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINA---QRGVLFPEDQILDWFVQICLALKHV 117
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
H+ K++HRDIKS NI + D K+ DFG+A++L + T +GT Y++PE
Sbjct: 118 HDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART-CIGTPYYLSPEIC 173
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNI 377
N KSD+++ G +L E T + + G NLV LK++ GS P +
Sbjct: 174 ENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK---NLV--LKIIRGSY-------PPV 221
Query: 378 EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
S R+L++ L +P RP ++ ++
Sbjct: 222 SSHYSYDL--RNLVSQLFKRNP--RDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 69/230 (30%), Positives = 104/230 (45%), Gaps = 57/230 (24%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKE------FRVEVEAIGHVRHKNLVR 201
LGEG +G VY+ + G VA+KKIL + EK+ R E++ + ++H N+V
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHN---EKDGFPITALR-EIKILKKLKHPNVVP 71
Query: 202 LLGYCIE---------GIHRMLVYEYVN---NGNLE-QWLHGAMRH-HGYLTWEARMKVL 247
L+ +E G M V Y++ +G LE + Y M L
Sbjct: 72 LIDMAVERPDKSKRKRGSVYM-VTPYMDHDLSGLLENPSVKLTESQIKCY------MLQL 124
Query: 248 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL----------GAG 297
L + + YLHE ++HRDIK++NILID+ K++DFGLA+ G G
Sbjct: 125 L---EGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 298 KSHVTTRVMGTFGYVAPEYANTGLLNEKS-----DVYSFGVLLLEAITGR 342
+ T ++ T Y PE LL E+ D++ G + E T R
Sbjct: 179 GTRKYTNLVVTRWYRPPEL----LLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 70/260 (26%), Positives = 121/260 (46%), Gaps = 55/260 (21%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILN---NVGQAEKEFRVEVEAIGHVRHK 197
R+ +G G YGVV + +G VA+KKI + A++ R E++ + H +H
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRHFKHD 64
Query: 198 NLVRLLGYCI------EGIHRMLVYEYVNNGNLEQWLHGA-------MRHHGYLTWEARM 244
N++ + I + +V + + + +L +H +R+ Y
Sbjct: 65 NIIAIRD--ILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLY------- 114
Query: 245 KVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR 304
++L G L Y+H A V+HRD+K SN+L+++D ++ DFG+A+ L +
Sbjct: 115 QLLRG----LKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGL-SSSPTEHKY 166
Query: 305 VM----GTFGYVAPEYANTGLLNEKS---DVYSFGVLLLEAITGRDPVDHGRPAHEVNLV 357
M T Y APE + L E + D++S G + E + GR + G+ N V
Sbjct: 167 FMTEYVATRWYRAPELLLS--LPEYTTAIDMWSVGCIFAEML-GRRQLFPGK-----NYV 218
Query: 358 DWLKM---MVGSRRSEEVVD 374
LK+ ++GS SEEV++
Sbjct: 219 HQLKLILSVLGS-PSEEVLN 237
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 3e-15
Identities = 55/212 (25%), Positives = 103/212 (48%), Gaps = 24/212 (11%)
Query: 147 NVLGEGGYGVVYRGNLINGS---PVAVKKILNNVGQAE-KEFRVEVEAI---GHVRHKNL 199
+V+GEG +G V + + A+K++ + + ++F E+E + GH H N+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH--HPNI 58
Query: 200 VRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA---------MRHHGYLTWEARMKVLLGT 250
+ LLG C + L EY +GNL +L + + + + ++L
Sbjct: 59 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
A + + + +HRD+ + NIL+ +++ AK++DFGL++ G+ + MG
Sbjct: 119 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGRLP 174
Query: 311 --YVAPEYANTGLLNEKSDVYSFGVLLLEAIT 340
++A E N + SDV+S+GVLL E ++
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 66/272 (24%), Positives = 121/272 (44%), Gaps = 25/272 (9%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAE--KEFRVEVEAIGHVRHKNLVRLLGYC 206
LG G G V + I V KK+++ ++ K+ E++ + R +V G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 207 IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVV 266
+ + + E+++ G+L+ + G + E K+ + + L YL+ +++
Sbjct: 73 LNENNICMCMEFMDCGSLD----RIYKKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIM 126
Query: 267 HRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKS 326
HRDIK SNIL++ K+ DFG++ G + + +GT Y++PE G KS
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVS---GELINSIADTFVGTSTYMSPERIQGGKYTVKS 183
Query: 327 DVYSFGVLLLEAITGRDP-----VDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRP 381
DV+S G+ ++E G+ P +D + ++D L+ +V E P + P
Sbjct: 184 DVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV----QEP--PPRL---P 234
Query: 382 STRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413
S+ + C+ D +RP Q+ M
Sbjct: 235 SSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 62/202 (30%), Positives = 98/202 (48%), Gaps = 20/202 (9%)
Query: 149 LGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQAEKEFRV-EVEAIGHVRHKNLVRLLGYC 206
+GEG G+V + G VAVKK ++ Q +E EV + +H N+V +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKK-MDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85
Query: 207 IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVV 266
+ G +V E++ G L + H + E V L KAL++LH V+
Sbjct: 86 LVGDELWVVMEFLEGGALTD-----IVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVI 137
Query: 267 HRDIKSSNILIDDDFNAKVSDFG----LAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL 322
HRDIKS +IL+ D K+SDFG ++K + KS V GT ++APE +
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-----GTPYWMAPEVISRLPY 192
Query: 323 NEKSDVYSFGVLLLEAITGRDP 344
+ D++S G++++E + G P
Sbjct: 193 GTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 3e-15
Identities = 97/352 (27%), Positives = 149/352 (42%), Gaps = 61/352 (17%)
Query: 142 RFSKENVLGEGGYG-VVYRGNLINGSPVAVKKI--------LNNVGQAEKEFRVEVEAIG 192
++ VLG G G V+ + +G P AVK + N QAE + +
Sbjct: 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFS 92
Query: 193 HVR-HKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHG------AMRHHGYLTWEARM 244
V+ H++ + E + + LV +Y N G+L Q + R H EA +
Sbjct: 93 IVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREH-----EAGL 147
Query: 245 ---KVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV 301
+VLL +H ++HRDIKS+NIL+ + K+ DFG +K+ A S
Sbjct: 148 LFIQVLLA-------VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDD 200
Query: 302 TTRVM-GTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWL 360
R GT YVAPE ++K+D++S GVLL E +T + P D G EV
Sbjct: 201 VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD-GENMEEV----MH 255
Query: 361 KMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEY- 419
K + G DP + PS + ++TAL DP ++RP S+++ M + +
Sbjct: 256 KTLAGR------YDP---LPPSISPEMQEIVTALLSSDP--KRRPSSSKLLNMPICKLFI 304
Query: 420 PIVREDRRHRRTQGGTSME--------IESQKENSDTDRSDYPGSRSESKRT 463
+ E +TQ G S I+ K+ +R ES T
Sbjct: 305 SGLLEI---VQTQPGFSGPLRDTISRQIQQTKQLLQVERRRIVRQMEESLST 353
|
Length = 496 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 56/221 (25%), Positives = 97/221 (43%), Gaps = 41/221 (18%)
Query: 149 LGEGGYGVVYRGN---LINGSP---VAVKKILNNVG-QAEKEFRVEVEAIGHVRHKNLVR 201
+G+G +G V++ L+ P VAVK + + +F+ E + H N+V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 202 LLGYCIEGIHRMLVYEYVNNGNLEQWL------------HGAMRHHGY------LTWEAR 243
LLG C G L++EY+ G+L ++L H L+ +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 244 MKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL-------GA 296
+ + A +AYL E K VHRD+ + N L+ ++ K++DFGL++ + +
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLE 337
+ R M PE +SDV+++GV+L E
Sbjct: 190 ENDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWE 224
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 3e-15
Identities = 62/228 (27%), Positives = 113/228 (49%), Gaps = 29/228 (12%)
Query: 135 DLELATNRFSKENVLGEGGYGVVYRGNLINGSP------VAVKKILNNV-GQAEKEFRVE 187
++ L+T RF +E LGE +G VY+G+L +P VA+K + + G +EF+ E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 188 VEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRH-HGYLTWEARMKV 246
++H N+V LLG + +++ Y ++ +L ++L MR H + K
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFL--VMRSPHSDVGSTDDDKT 116
Query: 247 LLGTAKALAYLHEAIE----------PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296
+ T + ++H + VVH+D+ + N+L+ D N K+SD GL + + A
Sbjct: 117 VKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176
Query: 297 GKSHVTTRVMGT----FGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT 340
+ ++MG +++PE G + SD++S+GV+L E +
Sbjct: 177 ADYY---KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 3e-15
Identities = 70/287 (24%), Positives = 122/287 (42%), Gaps = 43/287 (14%)
Query: 149 LGEGGYGVVYRG---NLINGSPVAVKKILNNVGQAEK-EFRVEVEAIGHVRHKNLVRLLG 204
+G G +G V G ++ + V VK++ + E+ F EV+ + H N+++ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 205 YCIEGIHRMLVYEYVNNGNLEQWL---HGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
CIE I +LV E+ G+L+ +L G + RM + A L +LH+A
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEV--ASGLLWLHQA- 119
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLA-------KLLGAGKSHVTTRVMGTFGYVAP 314
+H D+ N + D + K+ D+GLA + V R ++AP
Sbjct: 120 --DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR------WLAP 171
Query: 315 EYAN-------TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR 367
E +KS+++S GV + E T D +P +++ LK +V +
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAAD-----QPYPDLSDEQVLKQVVREQ 226
Query: 368 RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414
++ P ++++ S R + L D E RP +V +L
Sbjct: 227 DI-KLPKPQLDLKYSDRWYEVMQFCWL-----DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 3e-15
Identities = 33/92 (35%), Positives = 48/92 (52%), Gaps = 5/92 (5%)
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
AL YLH ++HRDIK NIL+D+ + ++DF +A + +TT GT GY+
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYM 166
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
APE + D +S GV E + G+ P
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 4e-15
Identities = 81/284 (28%), Positives = 130/284 (45%), Gaps = 35/284 (12%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLI-NGS----PVAVKKILNNVG-QAEKEFRVEVEAI 191
L K VLG G +G VY+G I +G PVA+K + N +A KE E +
Sbjct: 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVM 63
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
V + RLLG C+ + LV + + G L L + + + + + A
Sbjct: 64 AGVGSPYVCRLLGICLTSTVQ-LVTQLMPYGCL---LDYVRENKDRIGSQDLLNWCVQIA 119
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTT---RVMGT 308
K ++YL E ++VHRD+ + N+L+ + K++DFGLA+LL ++ +V
Sbjct: 120 KGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV--P 174
Query: 309 FGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSR 367
++A E +SDV+S+GV + E +T G P D G PA E+ D L+
Sbjct: 175 IKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD-GIPAREIP--DLLE------ 225
Query: 368 RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVV 411
+ E + P I + ++C DSE RP+ ++V
Sbjct: 226 KGERLPQPPI-------CTIDVYMIMVKCWMIDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 5e-15
Identities = 63/224 (28%), Positives = 104/224 (46%), Gaps = 29/224 (12%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRG---NLINGSP---VAVKKILNNVGQAEK-EFRVEVE 189
E+A + + LG+G +G+VY G ++ P VA+K + E+ EF E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEA-----RM 244
+ ++VRLLG +G +++ E + G+L+ +L +A +M
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 245 KVLLG-TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL-------GA 296
+ G A +AYL+ K VHRD+ + N ++ +DF K+ DFG+ + +
Sbjct: 122 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT 340
GK + R M +PE G+ SDV+SFGV+L E T
Sbjct: 179 GKGLLPVRWM------SPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 6e-15
Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 30/214 (14%)
Query: 149 LGEGGYGVVYR-GNLINGSPVAVKKILNNVGQAE-KEFRVEVEAIGHVRH-KNLVRLLG- 204
LG G YGVV + ++ G+ +AVK+I V E K ++++ V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 205 --------YCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY 256
C+E V + +L+++ + + K+ + KAL Y
Sbjct: 69 LFREGDVWICME----------VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEY 118
Query: 257 LHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEY 316
LH + V+HRD+K SN+LI+ + K+ DFG++ L S T G Y+APE
Sbjct: 119 LHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTIDAGCKPYMAPER 174
Query: 317 ANTGL----LNEKSDVYSFGVLLLEAITGRDPVD 346
N L + KSDV+S G+ ++E TGR P D
Sbjct: 175 INPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 6e-15
Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 12/210 (5%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEF-RVEVEAIGHVRHKN 198
R+ +GEG +G +Y + +K+I L + EKE + EV + ++H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEAR-MKVLLGTAKALAYL 257
+V E +V EY + G+L + ++ R G L E + + + + L ++
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRIN---RQRGVLFSEDQILSWFVQISLGLKHI 117
Query: 258 HEAIEPKVVHRDIKSSNILIDDD-FNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEY 316
H+ K++HRDIKS NI + + AK+ DFG+A+ L T +GT Y++PE
Sbjct: 118 HDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT-CVGTPYYLSPEI 173
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVD 346
N K+D++S G +L E T + P +
Sbjct: 174 CQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 7e-15
Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 149 LGEGGYGVVYRGNLIN-GSPVAVKKILNN----VGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+GG+G V + G A KK L+ + E+ E + + V + L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKK-LDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSL 58
Query: 204 GYCIEG-IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTW-EARMKVLLGTAKALAYLHEAI 261
Y E LV +N G+L + + G + EAR + A+ + L
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDL----KYHIYNVGEPGFPEARA--IFYAAQIICGLEHLH 112
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGL 321
+ ++V+RD+K N+L+DD N ++SD GLA L GK GT GY+APE +
Sbjct: 113 QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEVLQGEV 170
Query: 322 LNEKSDVYSFGVLLLEAITGRDP 344
+ D ++ G L E I GR P
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 8e-15
Identities = 71/228 (31%), Positives = 113/228 (49%), Gaps = 45/228 (19%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKE---FRV----EVEAIGHV 194
+ K N + EG YGVVYR + G VA+KK+ + EKE F + E+ + +
Sbjct: 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKL-----KMEKEKEGFPITSLREINILLKL 61
Query: 195 RHKNLVRL----LGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHH--GYLTWEAR--MKV 246
+H N+V + +G ++ I+ +V EYV E L M +L E + M
Sbjct: 62 QHPNIVTVKEVVVGSNLDKIY--MVMEYV-----EHDLKSLMETMKQPFLQSEVKCLMLQ 114
Query: 247 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVM 306
LL +A+LH+ ++HRD+K+SN+L+++ K+ DFGLA+ G+ T V+
Sbjct: 115 LL---SGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV 168
Query: 307 GTFGYVAPEYANTGLLNEKS-----DVYSFGVLLLEAITGRDPVDHGR 349
T Y APE LL K D++S G + E +T + P+ G+
Sbjct: 169 -TLWYRAPEL----LLGAKEYSTAIDMWSVGCIFAELLT-KKPLFPGK 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 9e-15
Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 149 LGEGGYGVVYRGNLINGS---PVAVK--KILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LGEG +G V G L VAVK KI ++F E + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 204 GYCIEGIHR------MLVYEYVNNGNLEQWLHGAMRHHG--YLTWEARMKVLLGTAKALA 255
G C++ + +++ ++ +G+L +L + YL + +K + A +
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT-FGYVAP 314
YL +HRD+ + N +++++ N V+DFGL+K + G + R+ ++A
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 315 EYANTGLLNEKSDVYSFGVLLLE-AITGRDP 344
E + KSDV+SFGV + E A G+ P
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 9e-15
Identities = 62/206 (30%), Positives = 90/206 (43%), Gaps = 25/206 (12%)
Query: 149 LGEGGYGVVYR-GNLINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLG 204
LG GG+G V A+K + ++ E E + H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 205 YCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYL-TWEAR----MKVLLGTAKALAYLHE 259
+ + ++ EY G L W +R G + AR VL A YLH
Sbjct: 61 TFKDKKYIYMLMEYCLGGEL--W--TILRDRGLFDEYTARFYIACVVL-----AFEYLHN 111
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEY-AN 318
+++RD+K N+L+D + K+ DFG AK L +G+ T GT YVAPE N
Sbjct: 112 R---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK--TWTFCGTPEYVAPEIILN 166
Query: 319 TGLLNEKSDVYSFGVLLLEAITGRDP 344
G + D +S G+LL E +TGR P
Sbjct: 167 KG-YDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 78/306 (25%), Positives = 128/306 (41%), Gaps = 59/306 (19%)
Query: 149 LGEGGYGVVYRGNLINGSP--------VAVKKILNNVGQAE-KEFRVEVEAIGHV-RHKN 198
LGEG +G V R VAVK + +N + + E+E + + +HKN
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLH------------GAMRHHGYLTWEARMKV 246
++ LLG C + ++ EY GNL ++L L+++ +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 247 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV----- 301
A+ + YL + +HRD+ + N+L+ +D K++DFGLA+ G +
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLAR----GVHDIDYYKK 192
Query: 302 TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWL 360
T+ ++APE + +SDV+SFG+L+ E T G P G P E+
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP-GIPVEEL-----F 246
Query: 361 KMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALR-CVDPDSEKRPKMSQVVRMLE---- 415
K++ R + +PS L +R C +RP Q+V L+
Sbjct: 247 KLLREGHRMD---------KPSN--CTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295
Query: 416 --SEEY 419
SEEY
Sbjct: 296 AVSEEY 301
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 42/104 (40%), Positives = 59/104 (56%), Gaps = 8/104 (7%)
Query: 245 KVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR 304
K+ + KAL YL E + V+HRD+K SNIL+D N K+ DFG++ L K+ TR
Sbjct: 118 KMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TR 173
Query: 305 VMGTFGYVAPEYANTGLLNEK----SDVYSFGVLLLEAITGRDP 344
G Y+APE + N K +DV+S G+ L+E TG+ P
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 24/207 (11%)
Query: 148 VLGEGGYGVVYRGNLI----NGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLVRL 202
V+GEG +G R L+ + A+K+I L A ++ R E + ++H N+V
Sbjct: 7 VVGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAF 63
Query: 203 L-GYCIEGIHRMLVYEYVNNGNLEQWL---HGAM-RHHGYLTWEARMKVLLGTAKALAYL 257
+ +G H +V EY + G+L Q + G + L W +M + + ++
Sbjct: 64 KESFEADG-HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHI 116
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
HE +V+HRDIKS NI + + K+ DFG A+LL + ++ T V GT YV PE
Sbjct: 117 HEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIW 172
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGRDP 344
N KSD++S G +L E T + P
Sbjct: 173 ENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 65/243 (26%), Positives = 114/243 (46%), Gaps = 30/243 (12%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLI--------NGSPVAVKKILNNVGQAE-KEFRVE 187
E + ++ + LGEG +G V + VAVK + ++ + + + E
Sbjct: 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 70
Query: 188 VEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY--------- 237
+E + + +HKN++ LLG C + ++ EY + GNL ++L A R G
Sbjct: 71 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR-ARRPPGMEYSYDIARV 129
Query: 238 ----LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293
+T++ + A+ + YL K +HRD+ + N+L+ ++ K++DFGLA+
Sbjct: 130 PDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARD 186
Query: 294 LGAGKSH-VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPA 351
+ + TT ++APE + +SDV+SFGVL+ E T G P G P
Sbjct: 187 VNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP-GIPV 245
Query: 352 HEV 354
E+
Sbjct: 246 EEL 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 3e-14
Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 13/218 (5%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEF---RVEVEAIGHVRHKNL 199
F+K +G+G +G VY+G V KI++ + +AE E + E+ + +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIID-LEEAEDEIEDIQQEITVLSQCDSPYI 64
Query: 200 VRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE 259
R G ++G ++ EY+ G+ L Y+ +L K L YLH
Sbjct: 65 TRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILREILKGLDYLHS 119
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANT 319
+ +HRDIK++N+L+ + + K++DFG+A L + T V GT ++APE
Sbjct: 120 E---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQ 175
Query: 320 GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLV 357
+ K+D++S G+ +E G P P + L+
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 213
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 69/222 (31%), Positives = 94/222 (42%), Gaps = 57/222 (25%)
Query: 148 VLGEGGYGVVYRGNLI-NGSPVAVK-----KILNNVGQAEKEFRVEVEAIGHVRHKNLVR 201
LG G +G V +G A+K KI+ Q E E + +RH LV
Sbjct: 8 TLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKL-KQVEHVLN-EKRILQSIRHPFLVN 65
Query: 202 LLG--------YCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWE-ARM---KVLLG 249
L G Y LV EYV G L L R G AR +V+L
Sbjct: 66 LYGSFQDDSNLY--------LVMEYVPGGELFSHL----RKSGRFPEPVARFYAAQVVL- 112
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVM--- 306
AL YLH +V+RD+K N+L+D D K++DFG AK V R
Sbjct: 113 ---ALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAK-------RVKGRTYTLC 159
Query: 307 GTFGYVAPEYANTGLLNE---KS-DVYSFGVLLLEAITGRDP 344
GT Y+APE +L++ K+ D ++ G+L+ E + G P
Sbjct: 160 GTPEYLAPEI----ILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 70/247 (28%), Positives = 115/247 (46%), Gaps = 38/247 (15%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLI--------NGSPVAVKKILNNVGQAE-KEFRVE 187
E+ +R LGEG +G V I + VAVK + ++ + + + E
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISE 73
Query: 188 VEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY--------- 237
+E + + +HKN++ LLG C + ++ EY + GNL ++L A R G
Sbjct: 74 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR-ARRPPGMEYCYNPTQV 132
Query: 238 ----LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293
L+++ + A+ + YL K +HRD+ + N+L+ +D K++DFGLA+
Sbjct: 133 PEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 189
Query: 294 LGAGKSHVTTRVMGTFG-----YVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDH 347
+ H+ T G ++APE + +SDV+SFGVLL E T G P
Sbjct: 190 I----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP- 244
Query: 348 GRPAHEV 354
G P E+
Sbjct: 245 GVPVEEL 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 6e-14
Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 28/206 (13%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRV-EVEAIGHV-RHKNLVRLLGY 205
LG+G +G VY N G VA+KK+ E+ + EV+++ + H N+V+L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEV 66
Query: 206 CIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK-VLLGTAKALAYLHEAIEPK 264
E V+EY+ GNL Q + G E+ ++ ++ + LA++H+
Sbjct: 67 FRENDELYFVFEYME-GNLYQLM---KDRKGKPFSESVIRSIIYQILQGLAHIHKH---G 119
Query: 265 VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK---SHVTTRVMGTFGYVAPEYANTGL 321
HRD+K N+L+ K++DFGLA+ + + +V+TR Y APE L
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-----WYRAPEI----L 170
Query: 322 LNEKS-----DVYSFGVLLLEAITGR 342
L S D+++ G ++ E T R
Sbjct: 171 LRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 67/232 (28%), Positives = 105/232 (45%), Gaps = 40/232 (17%)
Query: 149 LGEGGYGVVYRGNLI---NGSPVAVKKILNNVGQ---AEKEFRVEVEAIGHVR-HKNLVR 201
LG+G YG+V VA+KKI N + A++ R E++ + H R HKN+
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR-ELKLLRHFRGHKNITC 66
Query: 202 LLGYCI---EGIHRMLVYEYVNNGNLEQWLHGAMR----HHGYLTWEARMKVLLGTAKAL 254
L I + + +YE + +L Q + H ++ +L G L
Sbjct: 67 LYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQ----ILCG----L 118
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVT---TRVMGTFGY 311
Y+H A V+HRD+K N+L++ D K+ DFGLA+ T + T Y
Sbjct: 119 KYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY 175
Query: 312 VAPEYANTGLLNEKS-----DVYSFGVLLLEAITGRDPVDHGRP-AHEVNLV 357
APE +L+ +S DV+S G +L E + GR PV G+ ++N +
Sbjct: 176 RAPEI----MLSFQSYTKAIDVWSVGCILAE-LLGRKPVFKGKDYVDQLNQI 222
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 7e-14
Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 25/211 (11%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G G+V + + G VAVKK+ N A++ +R E+ + V HK
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHK 80
Query: 198 NLVRLLGY-----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHH--GYLTWEARMKVLLGT 250
N++ LL +E + + + + NL Q +H + H YL ++ +L G
Sbjct: 81 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQ----MLCG- 135
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
+ +LH A ++HRD+K SNI++ D K+ DFGLA+ A + + T + T
Sbjct: 136 ---IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART--ACTNFMMTPYVVTRY 187
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAITG 341
Y APE E D++S G ++ E + G
Sbjct: 188 YRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 8e-14
Identities = 70/216 (32%), Positives = 93/216 (43%), Gaps = 40/216 (18%)
Query: 148 VLGEGGYGVVYRGNLINGSPV----AVKK--ILNN--VGQAEKEFRVEVEAIGHVRHKNL 199
VLG G +G V + A+KK I+ V E R+ E RH L
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRI-FETANSERHPFL 64
Query: 200 VRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRH-HGYLTWEARMK-----VLLGTAKA 253
V L H V EY G+L M H H + E R V+LG
Sbjct: 65 VNLFACFQTEDHVCFVMEYAAGGDL-------MMHIHTDVFSEPRAVFYAACVVLG---- 113
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L YLHE K+V+RD+K N+L+D + K++DFGL K G G T+ GT ++A
Sbjct: 114 LQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCGTPEFLA 169
Query: 314 PEYANTGLLNEKS-----DVYSFGVLLLEAITGRDP 344
PE +L E S D + GVL+ E + G P
Sbjct: 170 PE-----VLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 1e-13
Identities = 60/211 (28%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 148 VLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRV-----EVEAIGHVRHKNLVR 201
+LG+G +G VY ++ G +A K++ + E V E++ + +++H+ +V+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 202 LLGYCIEGIHRMLV--YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE 259
G + + L EY+ G+++ L + +G LT K + ++YLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQL----KAYGALTESVTRKYTRQILEGMSYLHS 124
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL------GAGKSHVTTRVMGTFGYVA 313
+ +VHRDIK +NIL D N K+ DFG +K L G G VT GT +++
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT----GTPYWMS 177
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
PE + K+DV+S G ++E +T + P
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 20/204 (9%)
Query: 149 LGEGGYGVVY------RGNLINGSPVAVKKIL-NNVGQAEKEFRVEVEAIGHVRHKNLVR 201
LGEG +G V G+ G VAVK + + G + + E+E + ++ H+N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDN-TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 202 LLGYCIEGIHR--MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE 259
G C E L+ E++ +G+L+++L R+ + + ++K + K + YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLP---RNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTT---RVMGTFGYVAPEY 316
+ VHRD+ + N+L++ + K+ DFGL K + K + T F Y APE
Sbjct: 128 R---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APEC 183
Query: 317 ANTGLLNEKSDVYSFGVLLLEAIT 340
SDV+SFGV L E +T
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 63/217 (29%), Positives = 111/217 (51%), Gaps = 27/217 (12%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKE-FRVEVEAIGHVRHKNLVRLLGYCI 207
LG+G +G VY+ +A K+++ + E E + VE++ + H N+V+LL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKALAYLHEAIEPKVV 266
+ ++ E+ G ++ + R LT E +++V+ T +AL YLHE K++
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERP---LT-EPQIRVVCKQTLEALNYLHEN---KII 125
Query: 267 HRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR---VMGTFGYVAPEY-----AN 318
HRD+K+ NIL D + K++DFG++ A + R +GT ++APE +
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVS----AKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 319 TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVN 355
+ K+DV+S G+ L+E + +P P HE+N
Sbjct: 182 DRPYDYKADVWSLGITLIE-MAQIEP-----PHHELN 212
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 1e-13
Identities = 67/257 (26%), Positives = 119/257 (46%), Gaps = 19/257 (7%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEF---RVEVEAIGHVRHKN 198
F+K +G+G +G V++G + VA+K I ++ +AE E + E+ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+ + G ++G ++ EY+ G+ L + +K +L K L YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIA--TMLKEIL---KGLDYLH 118
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYAN 318
K +HRDIK++N+L+ + + K++DFG+A L + T V GT ++APE
Sbjct: 119 SE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQ 174
Query: 319 TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLK--MMVG--SRRSEEVVD 374
+ K+D++S G+ +E G P P + L+ + G S+ +E +D
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFID 234
Query: 375 PNIEVRPSTRALKRSLL 391
+ PS R + LL
Sbjct: 235 ACLNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 23/217 (10%)
Query: 149 LGEGGYGVVYR-GNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV-RHKNLVRLLG-- 204
+G+G YG VY+ N +GS AVK IL+ + ++E E + + H N+V+ G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 205 ----YCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
+ G LV E N G++ + + G + L +L G L +LH
Sbjct: 89 YKADKLVGG-QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN 147
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE----- 315
+++HRD+K +NIL+ + K+ DFG++ L + + T V GT ++APE
Sbjct: 148 ---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACE 203
Query: 316 --YANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
Y + + + DV+S G+ +E G P+ P
Sbjct: 204 QQYDYS--YDARCDVWSLGITAIELGDGDPPLFDMHP 238
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 26/217 (11%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKIL---NNVGQAEKEFRVEVEAIGHVRHK 197
++ K +GEG YG V++ N VA+K++ ++ G R E+ + ++HK
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHK 59
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQW---LHGAMRHHGYLTWEARMKVLLGTAKAL 254
N+VRL LV+EY + +L+++ +G + ++ M LL K L
Sbjct: 60 NIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPE---IVKSFMFQLL---KGL 112
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
A+ H V+HRD+K N+LI+ + K++DFGLA+ G + V+ T Y P
Sbjct: 113 AFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPP 168
Query: 315 EYANTGLLNEKS-DVYSFGVLLLEAITGRDPVDHGRP 350
+ L S D++S G + E GRP
Sbjct: 169 DVLFGAKLYSTSIDMWSAGCIFAELANA------GRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFR---VEVEAIGHVRHK 197
F+ +G G +G VY ++ VA+KK+ + Q+ ++++ EV + +RH
Sbjct: 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHP 75
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
N + G + LV EY G+ L H L + G + LAYL
Sbjct: 76 NTIEYKGCYLREHTAWLVMEYCL-GSASDILE---VHKKPLQEVEIAAICHGALQGLAYL 131
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEY- 316
H + +HRDIK+ NIL+ + K++DFG A L+ S V GT ++APE
Sbjct: 132 HSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVI 183
Query: 317 --ANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+ G + K DV+S G+ +E + P
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 60/211 (28%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 148 VLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRV-----EVEAIGHVRHKNLVR 201
+LG+G +G VY + G +AVK++ + E V E++ + ++ H+ +V+
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 202 LLGYCIEGIHRML--VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE 259
G + + R L E++ G+++ L + +G LT K + ++YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQL----KSYGALTENVTRKYTRQILEGVSYLHS 124
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL------GAGKSHVTTRVMGTFGYVA 313
+ +VHRDIK +NIL D N K+ DFG +K L G G VT GT +++
Sbjct: 125 NM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT----GTPYWMS 177
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
PE + K+D++S G ++E +T + P
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 20/214 (9%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGS--------PVAVKKILNNVGQAEKEFRVEVEAIGHV 194
F VLG G YG V+ ++G V K + + + R E + + H+
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 195 RHKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAK 252
R + L Y + ++ L+ +Y+N G L L R E +++ G
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK-----EQEVQIYSGEIVL 116
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
AL +LH+ +++RDIK NIL+D + + ++DFGL+K + GT Y+
Sbjct: 117 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173
Query: 313 APEYANTGLL--NEKSDVYSFGVLLLEAITGRDP 344
AP+ G ++ D +S GVL+ E +TG P
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 26/214 (12%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRH 196
+++ K +GEG YGVVY+ + + +A+KKI + G R E+ + ++H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQH 60
Query: 197 KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARM--KVLLGTAKAL 254
N+VRL LV+EY L+ L M R+ L + +
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGI 115
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNA-KVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
AY H +V+HRD+K N+LID NA K++DFGLA+ G T V+ T Y A
Sbjct: 116 AYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRA 171
Query: 314 PEYANTGLLNEKS-----DVYSFGVLLLEAITGR 342
PE LL + D++S G + E + +
Sbjct: 172 PEI----LLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 14/212 (6%)
Query: 149 LGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI 207
+GEG G+V + +G VAVKK+ Q + EV + +H+N+V + +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVH 267
G +V E++ G L + H + E V L KAL+ LH V+H
Sbjct: 88 VGDELWVVMEFLEGGALTD-----IVTHTRMNEEQIAAVCLAVLKALSVLHAQ---GVIH 139
Query: 268 RDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR--VMGTFGYVAPEYANTGLLNEK 325
RDIKS +IL+ D K+SDFG + V R ++GT ++APE + +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKSLVGTPYWMAPELISRLPYGPE 196
Query: 326 SDVYSFGVLLLEAITGRDPVDHGRPAHEVNLV 357
D++S G++++E + G P + P + ++
Sbjct: 197 VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 60/199 (30%), Positives = 93/199 (46%), Gaps = 14/199 (7%)
Query: 149 LGEGGYGVV-YRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI 207
+GEG G+V G VAVKK+ Q + EV + H+N+V + +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVH 267
G +V E++ G L + H + E V L +AL+YLH V+H
Sbjct: 90 VGDELWVVMEFLEGGALTD-----IVTHTRMNEEQIATVCLSVLRALSYLHNQ---GVIH 141
Query: 268 RDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR--VMGTFGYVAPEYANTGLLNEK 325
RDIKS +IL+ D K+SDFG + V R ++GT ++APE + +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQV---SKEVPKRKSLVGTPYWMAPEVISRLPYGTE 198
Query: 326 SDVYSFGVLLLEAITGRDP 344
D++S G++++E I G P
Sbjct: 199 VDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 4e-13
Identities = 46/138 (33%), Positives = 71/138 (51%), Gaps = 9/138 (6%)
Query: 211 HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDI 270
H V EY+N G+L + + R +++ G L +LH+ +++RD+
Sbjct: 70 HLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICG----LQFLHKK---GIIYRDL 122
Query: 271 KSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYS 330
K N+L+D D + K++DFG+ K G+ +T GT Y+APE NE D +S
Sbjct: 123 KLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPEILKGQKYNESVDWWS 181
Query: 331 FGVLLLEAITGRDPVDHG 348
FGVLL E + G+ P HG
Sbjct: 182 FGVLLYEMLIGQSPF-HG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-13
Identities = 59/193 (30%), Positives = 93/193 (48%), Gaps = 12/193 (6%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI 207
+G G YG VY+ NL G AVK I G + E+ + +H N+V G +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVH 267
+ EY G+L+ H G L+ V T + LAYLH + +H
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLAYLHSKGK---MH 129
Query: 268 RDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA---NTGLLNE 324
RDIK +NIL+ D+ + K++DFG+A + A + + +GT ++APE A G N+
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS-FIGTPYWMAPEVAAVEKNGGYNQ 188
Query: 325 KSDVYSFGVLLLE 337
D+++ G+ +E
Sbjct: 189 LCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 6e-13
Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 148 VLGEGGYGVVYRGNLING---SPVAVKKILNNVGQAEKE-----FRVEVEAIGHVRHKNL 199
VLG G YG V+ + G + K+L +K R E + HVR
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 200 VRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKALAYL 257
+ L Y + ++ L+ +YV+ G E + H R + E ++ G AL +L
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGG--EMFTHLYQRDNFS---EDEVRFYSGEIILALEHL 121
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
H+ +V+RDIK NIL+D + + ++DFGL+K + + T GT Y+APE
Sbjct: 122 HKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178
Query: 318 NTGLLNEKS-DVYSFGVLLLEAITGRDP 344
+ K+ D +S G+L+ E +TG P
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 6e-13
Identities = 67/243 (27%), Positives = 117/243 (48%), Gaps = 38/243 (15%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRV----EVEAIGHVR 195
+++ K +G+G +G V++ + VA+KK+L + ++ F + E++ + ++
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVL--MENEKEGFPITALREIKILQLLK 69
Query: 196 HKNLVRLLGYC---IEGIHR-----MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVL 247
H+N+V L+ C +R LV+E+ + +L L + MK+L
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKML 128
Query: 248 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK----SHVTT 303
L L Y+H K++HRD+K++NILI D K++DFGLA+ K + T
Sbjct: 129 L---NGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTN 182
Query: 304 RVMGTFGYVAPEYANTGLLNEKS-----DVYSFGVLLLEAITGRDPVDHGRP-AHEVNLV 357
RV+ T Y PE LL E+ D++ G ++ E T R P+ G H++ L+
Sbjct: 183 RVV-TLWYRPPEL----LLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNTEQHQLTLI 236
Query: 358 DWL 360
L
Sbjct: 237 SQL 239
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 6e-13
Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 10/210 (4%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRH 196
E+ E LG G +G V+ + VAVK + E F E + ++H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQH 60
Query: 197 KNLVRLLGYCI-EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
LV+L E I+ ++ E++ G+L +L L + A+ +A
Sbjct: 61 DKLVKLHAVVTKEPIY--IITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMA 116
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE 315
++ + +HRD++++NIL+ K++DFGLA+++ + + APE
Sbjct: 117 FIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 173
Query: 316 YANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
N G KSDV+SFG+LL+E +T GR P
Sbjct: 174 AINFGSFTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 7e-13
Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 25/211 (11%)
Query: 148 VLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRV-----EVEAIGHVRHKNLVR 201
+LG G +G VY + G +AVK++ + E V E++ + ++RH +V+
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 202 LLGYCIEGIHRML--VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE 259
G + + L EY+ G+++ L + +G LT + + ++YLH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQL----KAYGALTENVTRRYTRQILQGVSYLHS 124
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK------LLGAGKSHVTTRVMGTFGYVA 313
+ +VHRDIK +NIL D N K+ DFG +K + G G VT GT +++
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT----GTPYWMS 177
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
PE + K+DV+S ++E +T + P
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 7e-13
Identities = 48/191 (25%), Positives = 80/191 (41%), Gaps = 33/191 (17%)
Query: 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSS 273
LV EY+N G+ + + G L + + + + LH+ ++HRDIK
Sbjct: 74 LVMEYLNGGDCASLI----KTLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPE 126
Query: 274 NILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGV 333
N+LID + K++DFGL++ + +GT Y+APE ++ SD +S G
Sbjct: 127 NLLIDQTGHLKLTDFGLSRN-----GLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGC 181
Query: 334 LLLEAITGRDPVDHGRPAH-----EVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKR 388
++ E + G P P ++W + + S E VD
Sbjct: 182 VIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEF-CSPEAVD-------------- 226
Query: 389 SLLTALRCVDP 399
L+ L C+DP
Sbjct: 227 -LINRLLCMDP 236
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 8e-13
Identities = 60/229 (26%), Positives = 107/229 (46%), Gaps = 22/229 (9%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIG-HVRHKNLVR 201
F ++G G YG VY+G + +A K+++ G E+E + E+ + + H+N+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 202 LLGYCIE----GI--HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARM--KVLLGTAKA 253
G I+ G+ LV E+ G++ + + W A + ++L G
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG---- 123
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L++LH+ KV+HRDIK N+L+ ++ K+ DFG++ L T +GT ++A
Sbjct: 124 LSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMA 179
Query: 314 PEYANT-----GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLV 357
PE + KSD++S G+ +E G P+ P + L+
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 228
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 79/290 (27%), Positives = 140/290 (48%), Gaps = 49/290 (16%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKE-FRVEVEAIGHVRHKNLVRLLG-YC 206
LG+G +G VY+ +A K++ + E E + VE+E + H +V+LLG +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 207 IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA-KALAYLHEAIEPKV 265
+G +++ E+ G ++ + R LT E +++V+ +AL YLH K+
Sbjct: 80 WDGKLWIMI-EFCPGGAVDAIMLELDRG---LT-EPQIQVICRQMLEALQYLHSM---KI 131
Query: 266 VHRDIKSSNILIDDDFNAKVSDFGLA----KLLGAGKSHVTTRVMGTFGYVAPEYANTGL 321
+HRD+K+ N+L+ D + K++DFG++ K L S + GT ++APE
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCET 186
Query: 322 LNE-----KSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376
+ + K+D++S G+ L+E + +P P HE+N + L + S +P
Sbjct: 187 MKDTPYDYKADIWSLGITLIE-MAQIEP-----PHHELNPMRVLLKIAKS-------EPP 233
Query: 377 IEVRPSTRALKRS--LLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVRE 424
+PS +++ L TAL D E RP +Q++ E+P V
Sbjct: 234 TLSQPSKWSMEFRDFLKTAL---DKHPETRPSAAQLL------EHPFVSS 274
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 66/213 (30%), Positives = 99/213 (46%), Gaps = 25/213 (11%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRH 196
R+ +G G G+V + + G VA+KK+ NV A++ +R E+ + V H
Sbjct: 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNH 74
Query: 197 KNLVRLLGYCI------EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL-G 249
KN++ LL E LV E ++ NL Q + + H RM LL
Sbjct: 75 KNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHE-------RMSYLLYQ 126
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
+ +LH A ++HRD+K SNI++ D K+ DFGLA+ AG S + T + T
Sbjct: 127 MLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTR 181
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAITGR 342
Y APE E D++S G ++ E I G
Sbjct: 182 YYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 60/229 (26%), Positives = 95/229 (41%), Gaps = 34/229 (14%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV----------RHKN 198
+G+GGYG V+ + + K + K ++ + HV + +
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMK------KSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLH--GAMRHHGYLTWEARMKVLLGTAKALAY 256
LV+LL + + L EYV G+ L+ G + + A M A+
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFE------AVDA 116
Query: 257 LHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEY 316
LHE +HRD+K N LID + K++DFGL+K G V+G+ Y+APE
Sbjct: 117 LHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEV 169
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEV--NLVDWLKMM 363
+ D +S G +L E + G P G +E NL W + +
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCGFPPFS-GSTPNETWENLKYWKETL 217
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 48/146 (32%), Positives = 71/146 (48%), Gaps = 13/146 (8%)
Query: 211 HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDI 270
+ V EY+N G+L + + +++ G L +LH +V+RD+
Sbjct: 70 NLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICG----LQFLHSK---GIVYRDL 122
Query: 271 KSSNILIDDDFNAKVSDFGLAK--LLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDV 328
K NIL+D D + K++DFG+ K +LG K T GT Y+APE N D
Sbjct: 123 KLDNILLDTDGHIKIADFGMCKENMLGDAK---TCTFCGTPDYIAPEILLGQKYNTSVDW 179
Query: 329 YSFGVLLLEAITGRDPVDHGRPAHEV 354
+SFGVLL E + G+ P HG E+
Sbjct: 180 WSFGVLLYEMLIGQSPF-HGHDEEEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 41/137 (29%), Positives = 65/137 (47%), Gaps = 10/137 (7%)
Query: 211 HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKALAYLHEAIEPKVVHRD 269
V EYVN G+L + + R E R + L +LHE +++RD
Sbjct: 70 RLFFVMEYVNGGDLMFHIQRSGRFD-----EPRARFYAAEIVLGLQFLHER---GIIYRD 121
Query: 270 IKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVY 329
+K N+L+D + + K++DFG+ K G T+ GT Y+APE + D +
Sbjct: 122 LKLDNVLLDSEGHIKIADFGMCK-EGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWW 180
Query: 330 SFGVLLLEAITGRDPVD 346
+ GVLL E + G+ P +
Sbjct: 181 ALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 63/245 (25%), Positives = 112/245 (45%), Gaps = 27/245 (11%)
Query: 132 TLRDLELATNR-----FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRV 186
+L D++L+ R F V+G G YG VY+G + +A K+++ E+E ++
Sbjct: 2 SLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL 61
Query: 187 EVEAIG-HVRHKNLVRLLGYCIEGI------HRMLVYEYVNNGNLEQWLHGAMRHHGYLT 239
E+ + + H+N+ G I+ LV E+ G++ + +
Sbjct: 62 EINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKED 121
Query: 240 WEARM--KVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297
W A + ++L G LA+LH KV+HRDIK N+L+ ++ K+ DFG++ L
Sbjct: 122 WIAYICREILRG----LAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 174
Query: 298 KSHVTTRVMGTFGYVAPEYANT-----GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAH 352
T +GT ++APE + +SD++S G+ +E G P+ P
Sbjct: 175 VGRRNT-FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR 233
Query: 353 EVNLV 357
+ L+
Sbjct: 234 ALFLI 238
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 52/159 (32%), Positives = 77/159 (48%), Gaps = 9/159 (5%)
Query: 203 LGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
L C + R+ LV EYVN G+L H M+ L E AL +LHE
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDL--MFH--MQRQRKLPEEHARFYAAEICIALNFLHER- 115
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGL 321
+++RD+K N+L+D D + K++D+G+ K G G T+ GT Y+APE
Sbjct: 116 --GIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRGEE 172
Query: 322 LNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWL 360
D ++ GVL+ E + GR P D ++N D+L
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYL 211
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 57/211 (27%), Positives = 102/211 (48%), Gaps = 11/211 (5%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILN-NVGQA-EKEFRVEVEAIGHV 194
EL + F K + LG G GVV++ + + +K+++ + A + E++ +
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKAL 254
+V G + E+++ G+L+Q L A G + + KV + K L
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGL 116
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
YL E + K++HRD+K SNIL++ K+ DFG++ G + +GT Y++P
Sbjct: 117 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSP 171
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAITGRDPV 345
E + +SD++S G+ L+E GR P+
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 64/240 (26%), Positives = 111/240 (46%), Gaps = 52/240 (21%)
Query: 140 TNRFS-KENVLGEGGYGVVYRG-NLINGSPVAVKKILNN------------VGQAEKEFR 185
+ R+ K LGEG YG V + + + G VA+KK+ VG F
Sbjct: 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFT 66
Query: 186 V--EVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEAR 243
E++ + ++H+N++ L+ +EG LV + + +L++ + +R LT E++
Sbjct: 67 TLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIR----LT-ESQ 120
Query: 244 MK-VLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG------- 295
+K +LL L LH+ +HRD+ +NI I+ K++DFGLA+ G
Sbjct: 121 VKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDT 177
Query: 296 -------AGKSHVTTRVMGTFGYVAPEYANTGLL------NEKSDVYSFGVLLLEAITGR 342
+ +T++V+ T Y APE LL + D++S G + E +TG+
Sbjct: 178 LSKDETMQRREEMTSKVV-TLWYRAPE-----LLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 149 LGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFR---VEVEAIGHVRHKNLVRLLG 204
LG+GG+G V + G A KK+ + K + VE + V H + L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLA 59
Query: 205 YCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWE-----ARMKVLLGTAKALAYLHE 259
Y + + + + NG G +R+H Y E + TA+ ++ L
Sbjct: 60 YAFQTKTDLCLVMTIMNG-------GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEH 112
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANT 319
+ ++++RD+K N+L+D+D N ++SD GLA L G+S T GT G++APE
Sbjct: 113 LHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQG 171
Query: 320 GLLNEKSDVYSFGVLLLEAITGRDP 344
+ D ++ GV L E I R P
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 59/233 (25%), Positives = 104/233 (44%), Gaps = 35/233 (15%)
Query: 137 ELATNRFSKENVLGEGGYGVV---------------YRGNLINGSP--VAVKKILNNVGQ 179
E R + + LGEG +G V + ++ P VAVK + + +
Sbjct: 1 EFPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK 60
Query: 180 -AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHH--G 236
A +F E++ + ++ N++RLL CI ++ EY+ NG+L Q+L RH
Sbjct: 61 NARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLS---RHEPQE 117
Query: 237 YLTWEARMKVLLGTAKALA--------YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDF 288
+ + T +A YL VHRD+ + N L+ ++ K++DF
Sbjct: 118 AAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADF 174
Query: 289 GLAKLLGAGKSH-VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT 340
G+++ L +G + + R + +++ E G SDV++FGV L E +T
Sbjct: 175 GMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 148 VLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEFR---VEVEAIGHVRHKNLVRLL 203
VLG+G +G V L +G AVK + +V + + E + R+ + L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 204 GYCIEGIHRML-VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKALAYLHEAI 261
C + R+ V E+VN G+L + + R EAR + AL +LH+
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD-----EARARFYAAEITSALMFLHDK- 115
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGL 321
+++RD+K N+L+D + + K++DFG+ K G T+ GT Y+APE L
Sbjct: 116 --GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIAPEILQEML 172
Query: 322 LNEKSDVYSFGVLLLEAITGRDPVD 346
D ++ GVLL E + G P +
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 64/222 (28%), Positives = 102/222 (45%), Gaps = 33/222 (14%)
Query: 149 LGEGGYGVVYR-GNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR-HKNLVRLLGY- 205
+G+G YG V++ N NGS AVK IL+ + ++E E + + H N+V+ G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 206 ----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY-LHEA 260
G LV E N G++ + G +L RM+ + +AY LHEA
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKG------FLKRGERMEEPI-----IAYILHEA 133
Query: 261 I-------EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
+ K +HRD+K +NIL+ + K+ DFG++ L + + T V GT ++A
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMA 192
Query: 314 PEYANT-----GLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
PE + + DV+S G+ +E G P+ P
Sbjct: 193 PEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 76/268 (28%), Positives = 117/268 (43%), Gaps = 36/268 (13%)
Query: 143 FSKENVLGEGGYGVV------YRGNLINGSPVAVKKILNNVGQA----EKEFRVEVEAIG 192
F + VLG+GG+G V G + + K+I G++ EK+ +V +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNS-- 59
Query: 193 HVRHKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
V L Y E + LV +N G+L+ ++ H G +E V A
Sbjct: 60 -----RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY----HMGEAGFEEGRAVFYA-A 109
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGY 311
+ L + + ++V+RD+K NIL+DD + ++SD GLA + G++ + RV GT GY
Sbjct: 110 EICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGY 167
Query: 312 VAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEE 371
+APE D ++ G LL E I G+ P + + V+ L V SE
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSE- 226
Query: 372 VVDPNIEVRPSTRALKRSLLTALRCVDP 399
+ S A RSL L C DP
Sbjct: 227 --------KFSPDA--RSLCKMLLCKDP 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 5e-12
Identities = 72/285 (25%), Positives = 113/285 (39%), Gaps = 48/285 (16%)
Query: 149 LGEGGYGVVYRGNLINGSPVA----------VKKILNNVGQAEKEFRVEVEAIGHVRHKN 198
LG+G + +Y+G L S + V K+L + + F + + HK+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
LV+L G C+ + M V EYV G L+ +LH +++ L W ++ V A AL YL
Sbjct: 63 LVKLYGVCVRDENIM-VEEYVKFGPLDVFLH-REKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 259 EAIEPKVVHRDIKSSNIL-IDDDFN------AKVSDFGLAKLLGAGKSHVTTRVMGTFGY 311
+ K+VH ++ NIL N K+SD G+ + + + R+ +
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS-REERVERI----PW 170
Query: 312 VAPEYANTGL--LNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
+APE G L +D +SFG LLE I L + S +
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLE-ICSNGEEP-------------LSTLSSSEKE 216
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414
D + P L + C D KRP ++R L
Sbjct: 217 RFYQDQHRLPMPDCAELANLINQ---CWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 7e-12
Identities = 65/208 (31%), Positives = 98/208 (47%), Gaps = 27/208 (12%)
Query: 149 LGEGGYGVVYRGNLIN-GSPVAVKKI----LNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG+GG+G V + N G A KK+ L EK +E E + V +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKS-GEKMALLEKEILEKVNSPFIVNL- 58
Query: 204 GYCIEG-IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARM---KVLLGTAK---ALAY 256
Y E H LV +N G+L ++H Y E + +V+ +A+ + +
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDL--------KYHIYNVGERGLEMERVIHYSAQITCGILH 110
Query: 257 LHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEY 316
LH +V+RD+K N+L+DD N ++SD GLA L GK+ T+ GT GY+APE
Sbjct: 111 LHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEI 165
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+ D ++ G + E + GR P
Sbjct: 166 LKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 8e-12
Identities = 42/123 (34%), Positives = 66/123 (53%), Gaps = 17/123 (13%)
Query: 228 LHGAMRHHGYLTWEARMK-----VLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFN 282
LH + HG + EA M+ ++LG L ++H VV+RD+K +NIL+D+ +
Sbjct: 84 LHYHLSQHGVFS-EAEMRFYAAEIILG----LEHMHNRF---VVYRDLKPANILLDEHGH 135
Query: 283 AKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKS-DVYSFGVLLLEAITG 341
++SD GLA K H + +GT GY+APE G+ + S D +S G +L + + G
Sbjct: 136 VRISDLGLACDFSKKKPHAS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
Query: 342 RDP 344
P
Sbjct: 193 HSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 25/213 (11%)
Query: 143 FSKENVLGEGGYGVV------YRGNLINGSPVAVKKILNNVGQA----EKEFRVEVEAIG 192
F + VLG+GG+G V G + + K+I G++ EK+ +V +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNS-- 59
Query: 193 HVRHKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
V L Y E + LV +N G+L+ ++ M + G+ + L A
Sbjct: 60 -----QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGF----EEERALFYAA 109
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGY 311
+ L L + V+RD+K NIL+DD + ++SD GLA + G+S + RV GT GY
Sbjct: 110 EILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-IRGRV-GTVGY 167
Query: 312 VAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+APE N D + G L+ E I G+ P
Sbjct: 168 MAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 56/199 (28%), Positives = 91/199 (45%), Gaps = 14/199 (7%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI 207
+GEG G+V +G VAVK + Q + EV + +H+N+V + +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVH 267
G ++ E++ G L + L E V +AL YLH V+H
Sbjct: 89 VGEELWVLMEFLQGGALTD-----IVSQTRLNEEQIATVCESVLQALCYLHSQ---GVIH 140
Query: 268 RDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR--VMGTFGYVAPEYANTGLLNEK 325
RDIKS +IL+ D K+SDFG + V R ++GT ++APE + +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSLVGTPYWMAPEVISRTPYGTE 197
Query: 326 SDVYSFGVLLLEAITGRDP 344
D++S G++++E + G P
Sbjct: 198 VDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 21/209 (10%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVK--KILNNVGQAEKEFRVEVEAIGHVRHK 197
+ + K LGEG Y VY+G + +NG VA+K ++ G R E + ++H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
N+V L LV+EYV+ +L Q++ +H G L E L + L+Y+
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHT-DLCQYMD---KHPGGLHPENVKLFLFQLLRGLSYI 119
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
H+ ++HRD+K N+LI D K++DFGLA+ SH + + T Y P+
Sbjct: 120 HQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVVTLWYRPPDV- 174
Query: 318 NTGLLNEKS-----DVYSFGVLLLEAITG 341
LL D++ G + +E I G
Sbjct: 175 ---LLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 60/207 (28%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 148 VLGEGGYGVVYRGNLINGSPVAVKKIL--------NNVGQAEKEFRVEVEAIGHVRHKNL 199
VLG+G +G V L V K+L ++V E R+ A H
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKH----PF 57
Query: 200 VRLLGYCIEGIHRML-VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKALAYL 257
+ L C + R+ V EYVN G+L + + + E R + AL +L
Sbjct: 58 LTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFD-----EPRSRFYAAEVTLALMFL 112
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
H V++RD+K NIL+D + + K++DFG+ K G TT GT Y+APE
Sbjct: 113 HRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAPEIL 168
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGRDP 344
D ++ GVL+ E + G+ P
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 64/256 (25%), Positives = 114/256 (44%), Gaps = 17/256 (6%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEF---RVEVEAIGHVRHKNL 199
F+K +G+G +G V++G V KI++ + +AE E + E+ + +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID-LEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 200 VRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE 259
+ G ++ ++ EY+ G+ L G L +L K L YLH
Sbjct: 65 TKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHS 119
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANT 319
K +HRDIK++N+L+ + K++DFG+A L + +GT ++APE
Sbjct: 120 E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNTFVGTPFWMAPEVIKQ 175
Query: 320 GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLV--DWLKMMVG--SRRSEEVVDP 375
+ K+D++S G+ +E G P P + L+ + + G S+ +E V+
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA 235
Query: 376 NIEVRPSTRALKRSLL 391
+ PS R + LL
Sbjct: 236 CLNKEPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 54/193 (27%), Positives = 93/193 (48%), Gaps = 12/193 (6%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI 207
+G G YG VY+ N+ G A+K I G+ + E+ + +H N+V G +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVH 267
+ E+ G+L+ H G L+ V T + L YLH + +H
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLHSKGK---MH 129
Query: 268 RDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA---NTGLLNE 324
RDIK +NIL+ D+ + K++DFG++ + A + + +GT ++APE A G N+
Sbjct: 130 RDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS-FIGTPYWMAPEVAAVERKGGYNQ 188
Query: 325 KSDVYSFGVLLLE 337
D+++ G+ +E
Sbjct: 189 LCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 42/129 (32%), Positives = 71/129 (55%), Gaps = 9/129 (6%)
Query: 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNIL 276
E+++ G+L+Q L A R + E KV + + LAYL E + +++HRD+K SNIL
Sbjct: 83 EHMDGGSLDQVLKEAKR----IPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNIL 136
Query: 277 IDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLL 336
++ K+ DFG++ G + +GT Y++PE + +SD++S G+ L+
Sbjct: 137 VNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLV 193
Query: 337 EAITGRDPV 345
E GR P+
Sbjct: 194 ELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 58/204 (28%), Positives = 104/204 (50%), Gaps = 13/204 (6%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLV 200
+ K + LGEG Y V++G + + + VA+K+I L + A EV + +++H N+V
Sbjct: 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIV 66
Query: 201 RLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL-GTAKALAYLHE 259
L LV+EY+++ +L+Q+L + G L +K+ + + L+Y H+
Sbjct: 67 TLHDIIHTERCLTLVFEYLDS-DLKQYLD----NCGNLMSMHNVKIFMFQLLRGLSYCHK 121
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YAN 318
K++HRD+K N+LI++ K++DFGLA+ + V+ T Y P+
Sbjct: 122 R---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLG 177
Query: 319 TGLLNEKSDVYSFGVLLLEAITGR 342
+ + D++ G +L E TGR
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 29/222 (13%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ +G G G+V + + VA+KK+ N A++ +R E+ + V HK
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 76
Query: 198 NLVRLLGY-----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL-GTA 251
N++ LL +E + + + + NL Q + + H RM LL
Sbjct: 77 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHE-------RMSYLLYQML 129
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGY 311
+ +LH A ++HRD+K SNI++ D K+ DFGLA+ AG S + T + T Y
Sbjct: 130 CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYY 184
Query: 312 VAPEYANTGLLNEKSDVYSFGVLLLEAI------TGRDPVDH 347
APE E D++S G ++ E + GRD +D
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 30/214 (14%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAE----KEFRVEVEAIGHVRH 196
R++ +G G YG V + G VA+KK L+ Q+E + +R E+ + H++H
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKK-LSRPFQSEIFAKRAYR-ELTLLKHMQH 73
Query: 197 KNLVRLL-----GYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT 250
+N++ LL + LV Y+ L M H L+ + ++
Sbjct: 74 ENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD-----LQKIMGHP--LSEDKVQYLVYQM 126
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS-HVTTRVMGTF 309
L Y+H A ++HRD+K N+ +++D K+ DFGLA+ A + +V TR
Sbjct: 127 LCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR----- 178
Query: 310 GYVAPEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
Y APE N N+ D++S G ++ E +TG+
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 19/210 (9%)
Query: 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKIL---NNVGQAEKEFRVEVEAIGHVRH 196
+R+ + +G G YG V G VA+KK+ + A++ +R E+ + H+ H
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDH 73
Query: 197 KNLVRLLGYCIEGIHRMLVYE-YVNNGNLEQWLHGAMRHHGYLTWEARMKVLL-GTAKAL 254
+N++ LL + Y+ + L+ ++ L+ + ++ L+ + L
Sbjct: 74 ENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQ-KLS-DDHIQFLVYQILRGL 131
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS-HVTTRVMGTFGYVA 313
Y+H A ++HRD+K SNI +++D K+ DFGLA+ + +V TR Y A
Sbjct: 132 KYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 183
Query: 314 PEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
PE N N+ D++S G ++ E +TG+
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 67/223 (30%), Positives = 103/223 (46%), Gaps = 51/223 (22%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV------R 195
+ K + LGEG Y VY+G + + G VA+K+I + E E AI +
Sbjct: 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEI-----RLEHEEGAPFTAIREASLLKDLK 61
Query: 196 HKNLVRLLGYCIEGIHR----MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL-GT 250
H N+V L + IH LV+EY++ +L+Q+ M G +++ L
Sbjct: 62 HANIVTLH----DIIHTKKTLTLVFEYLDT-DLKQY----MDDCGGGLSMHNVRLFLFQL 112
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG--- 307
+ LAY H+ +V+HRD+K N+LI + K++DFGLA+ KS V ++
Sbjct: 113 LRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR----AKS-VPSKTYSNEV 164
Query: 308 -TFGYVAP-------EYANTGLLNEKSDVYSFGVLLLEAITGR 342
T Y P EY+ T L D++ G + E TGR
Sbjct: 165 VTLWYRPPDVLLGSTEYS-TSL-----DMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 73/262 (27%), Positives = 108/262 (41%), Gaps = 39/262 (14%)
Query: 148 VLGEGGYG-VVYRGNLINGSPVAVKKILNNVGQAEKEFR---VEVEAIGHVRHKNLVRLL 203
+LG+G +G V+ G A+K + V A+ E E + + RH L L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL- 60
Query: 204 GYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT--AKALAYLHEA 260
Y + R+ V EY N G L + H + + E R + G AL YLH
Sbjct: 61 KYSFQTHDRLCFVMEYANGGEL--FFH--LSRERVFS-EDRAR-FYGAEIVSALGYLHSC 114
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTG 320
VV+RD+K N+++D D + K++DFGL K G GT Y+APE
Sbjct: 115 ---DVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDN 170
Query: 321 LLNEKSDVYSFGVLLLEAITGRDPV---DHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNI 377
D + GV++ E + GR P DH + E+ L++ ++ S E
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-LFELILMEEIRF--PRTLSPEA----- 222
Query: 378 EVRPSTRALKRSLLTALRCVDP 399
+SLL L DP
Sbjct: 223 ----------KSLLAGLLKKDP 234
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 23/209 (11%)
Query: 148 VLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV-----RHKNLVRL 202
V+G G Y V L + K++ + E V+ HV H LV L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 203 LGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWE-ARM---KVLLGTAKALAYL 257
C + R+ V E+V+ G+L H M+ L E AR ++ L AL +L
Sbjct: 62 HS-CFQTESRLFFVIEFVSGGDL--MFH--MQRQRKLPEEHARFYSAEISL----ALNFL 112
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
HE +++RD+K N+L+D + + K++D+G+ K G T+ GT Y+APE
Sbjct: 113 HER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIAPEIL 168
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGRDPVD 346
D ++ GVL+ E + GR P D
Sbjct: 169 RGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 27/213 (12%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++H+
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHE 76
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHH----GYLTWEARMKVLLGTAKA 253
N++ LL + E N+ L L GA ++ LT + ++ +
Sbjct: 77 NVIGLL----DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 132
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG---TFG 310
L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ H + G T
Sbjct: 133 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRW 182
Query: 311 YVAPEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
Y APE N N+ D++S G ++ E +TGR
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 40/131 (30%), Positives = 68/131 (51%), Gaps = 13/131 (9%)
Query: 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNIL 276
E+++ G+L+Q ++ G + K+ + + L YL E + K++HRD+K SNIL
Sbjct: 79 EHMDGGSLDQ----VLKKAGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNIL 132
Query: 277 IDDDFNAKVSDFGLAKLL--GAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVL 334
++ K+ DFG++ L S V TR Y++PE +SD++S G+
Sbjct: 133 VNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSPERLQGTHYTVQSDIWSLGLS 187
Query: 335 LLEAITGRDPV 345
L+E GR P+
Sbjct: 188 LVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 29/222 (13%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ +G G G+V + I VA+KK+ N A++ +R E+ + V HK
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHK 83
Query: 198 NLVRLLGY-----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL-GTA 251
N++ LL +E + + + + NL Q + + H RM LL
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE-------RMSYLLYQML 136
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGY 311
+ +LH A ++HRD+K SNI++ D K+ DFGLA+ AG S + T + T Y
Sbjct: 137 CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYY 191
Query: 312 VAPEYANTGLLNEKSDVYSFGVLLLEAIT------GRDPVDH 347
APE E D++S G ++ E I G D +D
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ 233
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 5e-11
Identities = 53/203 (26%), Positives = 101/203 (49%), Gaps = 20/203 (9%)
Query: 146 ENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVG-QAEKEFRVEVEAIGHVRHKNLVRLL 203
+ +LG G G VY+ +L+ +AVK I ++ + +K+ E+E + ++
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 204 G-YCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
G + +E +R+ + E+++ G+L+ ++ + H ++ + K L YL
Sbjct: 66 GAFFVE--NRISICTEFMDGGSLD--VYRKIPEH------VLGRIAVAVVKGLTYLWSL- 114
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGL 321
K++HRD+K SN+L++ K+ DFG++ L + + +GT Y+APE +
Sbjct: 115 --KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL---VNSIAKTYVGTNAYMAPERISGEQ 169
Query: 322 LNEKSDVYSFGVLLLEAITGRDP 344
SDV+S G+ +E GR P
Sbjct: 170 YGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 68/229 (29%), Positives = 110/229 (48%), Gaps = 42/229 (18%)
Query: 135 DLELATNRFSK-ENVLGEGGYGVVYRGNLINGSP-VAVKKILNNVGQAEKEFRVEVEAIG 192
D+ + N+ K N++G G +GVVY I+ S VA+KK+L + +E + +
Sbjct: 59 DINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI----MK 114
Query: 193 HVRHKNLVRLLGY----CI----EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARM 244
++ H N++ L Y C + I +V E++ Q +H M+H Y +
Sbjct: 115 NLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFI-----PQTVHKYMKH--YARNNHAL 167
Query: 245 KVLL------GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNA-KVSDFGLAKLLGAG 297
+ L +ALAY+H + HRD+K N+LID + + K+ DFG AK L AG
Sbjct: 168 PLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG 224
Query: 298 K---SHVTTRVMGTFGYVAPEYANTGLLNEKS--DVYSFGVLLLEAITG 341
+ S++ +R Y APE G N + D++S G ++ E I G
Sbjct: 225 QRSVSYICSRF-----YRAPELM-LGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 45/150 (30%), Positives = 75/150 (50%), Gaps = 23/150 (15%)
Query: 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK-----VLLGTAKALAYLHEAIEPKVVHR 268
+ + +N G+L H + HG + E M+ ++LG L ++H VV+R
Sbjct: 74 FILDLMNGGDL----HYHLSQHGVFS-EKEMRFYATEIILG----LEHMHNRF---VVYR 121
Query: 269 DIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKS-D 327
D+K +NIL+D+ + ++SD GLA K H + +GT GY+APE G + S D
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEVLQKGTAYDSSAD 178
Query: 328 VYSFGVLLLEAITGRDPVDH--GRPAHEVN 355
+S G +L + + G P + HE++
Sbjct: 179 WFSLGCMLFKLLRGHSPFRQHKTKDKHEID 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 8e-11
Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 39/220 (17%)
Query: 143 FSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEFR---VEVEAIGHVRHKN 198
FS +G G +G VY + N VA+KK+ + Q+ ++++ EV + +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 199 LVRLLGYCIEGIHRMLVYEY----------VNNGNLEQWLHGAMRHHGYLTWEARMKVLL 248
++ G + LV EY V+ L++ A+ H
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTH-------------- 122
Query: 249 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT 308
G + LAYLH ++HRD+K+ NIL+ + K+ DFG A ++ V GT
Sbjct: 123 GALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GT 174
Query: 309 FGYVAPEY---ANTGLLNEKSDVYSFGVLLLEAITGRDPV 345
++APE + G + K DV+S G+ +E + P+
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 9e-11
Identities = 44/144 (30%), Positives = 70/144 (48%), Gaps = 9/144 (6%)
Query: 211 HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDI 270
H V E++N G+L + R Y +++ G L +LH +++RD+
Sbjct: 70 HLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCG----LQFLHSK---GIIYRDL 122
Query: 271 KSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYS 330
K N+++D D + K++DFG+ K G + +T GT Y+APE D +S
Sbjct: 123 KLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQGLKYTFSVDWWS 181
Query: 331 FGVLLLEAITGRDPVDHGRPAHEV 354
FGVLL E + G+ P HG E+
Sbjct: 182 FGVLLYEMLIGQSPF-HGDDEDEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 59/204 (28%), Positives = 88/204 (43%), Gaps = 13/204 (6%)
Query: 148 VLGEGGYGVVYRGNLINGSPV----AVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
V+G G Y V L + VKK L N + + E + + L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 204 GYCIEGIHRML-VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIE 262
C + R+ V EYVN G+L H M+ L E + AL YLHE
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDL--MFH--MQRQRKLPEEHARFYSAEISLALNYLHER-- 115
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL 322
+++RD+K N+L+D + + K++D+G+ K G T+ GT Y+APE
Sbjct: 116 -GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 323 NEKSDVYSFGVLLLEAITGRDPVD 346
D ++ GVL+ E + GR P D
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 18/205 (8%)
Query: 148 VLGEGGYGVVYRGNLINGSPV----AVKKILNNVGQAEKEFRVEVE--AIGHVRHKNLVR 201
VLG+G +G V+ I G A+K + + R ++E + V H +V+
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 202 L-LGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT-AKALAYLHE 259
L + EG L+ +++ G+L L + + E +K L A AL +LH
Sbjct: 63 LHYAFQTEG-KLYLILDFLRGGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHS 116
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANT 319
+++RD+K NIL+D++ + K++DFGL+K + GT Y+APE N
Sbjct: 117 L---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK-AYSFCGTVEYMAPEVVNR 172
Query: 320 GLLNEKSDVYSFGVLLLEAITGRDP 344
+ +D +SFGVL+ E +TG P
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 63/282 (22%), Positives = 121/282 (42%), Gaps = 34/282 (12%)
Query: 149 LGEGGYGVVYRGNLINGSPVA---VKKILNNVGQAEK-EFRVEVEAIGHVRHKNLVRLLG 204
+G G +G V + + VA VK++ N E+ EF + + ++H N+++ LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 205 YCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPK 264
C+E I +LV+EY G+L+ +L H ++ A + ++H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---N 119
Query: 265 VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTT--RVMGTFGYVAPEYANT--- 319
+H D+ N + D KV D+G+ + ++ T ++APE
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWLAPELVGEFHG 178
Query: 320 GLL----NEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375
GL+ + S+V++ GV L E + +P ++ + L ++ ++ ++ P
Sbjct: 179 GLITAEQTKPSNVWALGVTLWELFE-----NAAQPYSHLSDREVLNHVIKDQQV-KLFKP 232
Query: 376 NIEVRPSTR---ALKRSLLTALRCVDPDSEKRPKMSQVVRML 414
+E+ S R L+ L+ EKR +V R+L
Sbjct: 233 QLELPYSERWYEVLQFCWLSP--------EKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 66/214 (30%), Positives = 100/214 (46%), Gaps = 18/214 (8%)
Query: 148 VLGEGGYG-VVYRGNLINGSPVAVK----KILNNVGQAEKEFRVEVEAI-GHVRHKNLVR 201
V+G+G +G V+ ++G AVK KI+ N + +K E + +V+H LV
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLN-RKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 202 LLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
L Y + ++ V ++VN G L + H R + AR A AL YLH
Sbjct: 61 L-HYSFQTTEKLYFVLDFVNGGEL--FFH-LQRERSFPEPRARFYAA-EIASALGYLHSI 115
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTG 320
+V+RD+K NIL+D + ++DFGL K G +S TT GT Y+APE
Sbjct: 116 ---NIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQ 171
Query: 321 LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEV 354
+ D + G +L E + G P + R E+
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPPF-YCRDVAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 25/213 (11%)
Query: 143 FSKENVLGEGGYGVV------YRGNLINGSPVAVKKILNNVGQA----EKEFRVEVEAIG 192
F VLG+GG+G V G + + K+I G+A EK +V +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNS-- 59
Query: 193 HVRHKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
V L Y E + LV +N G+L+ ++ M + G+ + + A
Sbjct: 60 -----RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGF----DEQRAIFYAA 109
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGY 311
+ L + ++V+RD+K NIL+DD + ++SD GLA + G++ V RV GT GY
Sbjct: 110 ELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGY 167
Query: 312 VAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+APE N D + G L+ E I G+ P
Sbjct: 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 45/148 (30%), Positives = 74/148 (50%), Gaps = 15/148 (10%)
Query: 203 LGYCIEGIHRM-LVYEYVNNGNLEQWLH--GAMRHHGYLTWEARMKVLLGTAKALAYLHE 259
L C + + R+ V EYVN G+L + G + + + A + V L +LH
Sbjct: 66 LHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISV------GLFFLHR 119
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVM-GTFGYVAPEYAN 318
+++RD+K N+++D + + K++DFG+ K VTTR GT Y+APE
Sbjct: 120 R---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIA 174
Query: 319 TGLLNEKSDVYSFGVLLLEAITGRDPVD 346
+ D +++GVLL E + G+ P D
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 39/220 (17%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPV-AVKKILNNVGQAEKEFR---VEVEAIGHVRHKN 198
F+ +G G +G VY + + V A+KK+ + Q+ ++++ EV+ + ++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 199 LVRLLGYCIEGIHRMLVYEY----------VNNGNLEQWLHGAMRHHGYLTWEARMKVLL 248
+ G + LV EY V+ L++ A+ H
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITH-------------- 132
Query: 249 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT 308
G + LAYLH ++HRDIK+ NIL+ + K++DFG A + S V GT
Sbjct: 133 GALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GT 184
Query: 309 FGYVAPEY---ANTGLLNEKSDVYSFGVLLLEAITGRDPV 345
++APE + G + K DV+S G+ +E + P+
Sbjct: 185 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 61/204 (29%), Positives = 93/204 (45%), Gaps = 17/204 (8%)
Query: 148 VLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEA-----IGHVRHKNLVR 201
V+G+G +G V + +G AVK +L +K+ + + A + +V+H LV
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVK-VLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 202 LLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
L Y + ++ V +YVN G L L R + AR A AL YLH
Sbjct: 61 L-HYSFQTADKLYFVLDYVNGGELFFHLQ---RERSFPEPRARFYAA-EIASALGYLHSL 115
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTG 320
+++RD+K NIL+D + ++DFGL K G S T+ GT Y+APE
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLRKQ 171
Query: 321 LLNEKSDVYSFGVLLLEAITGRDP 344
+ D + G +L E + G P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 149 LGEGGYGVVYRGNL---INGSPVAVKKILNNVG-QAEKEFRVEVEAIGHVRHKNLVRLLG 204
+G G +G V G + + V VK++ + Q + +F E + ++H NL++ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 205 YCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARM--KVLLGTAKALAYLHEAIE 262
C E +LV E+ G+L+ +L + R +T + ++ A L +LH+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLR-SCRKAELMTPDPTTLQRMACEIALGLLHLHKN-- 119
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTT-RVMGTFGYVAPEYAN--- 318
+H D+ N L+ D K+ D+GL+ +VT ++ ++APE +
Sbjct: 120 -NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 319 TGLL----NEKSDVYSFGVLLLEAIT-GRDPVDH 347
LL ++S+V+S GV + E G P H
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 17/200 (8%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGY 205
LGEG Y VY+G + ING VA+K I G R E + ++H N+V LL
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR-EASLLKGLKHANIV-LLHD 70
Query: 206 CIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPK 264
I + V+EY++ +L Q++ ++H G L + + LAY+H
Sbjct: 71 IIHTKETLTFVFEYMHT-DLAQYM---IQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---H 123
Query: 265 VVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNE 324
++HRD+K N+LI K++DFGLA+ ++ V+ T Y P+ G +
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPD-VLLGATDY 181
Query: 325 KS--DVYSFGVLLLEAITGR 342
S D++ G + +E + G+
Sbjct: 182 SSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 141 NRFSKENVLGEGGYGVVYRGNLINGSP-VAVKKILNNVGQAE-KEFRV-EVEAIGHVRHK 197
N+F V+GEG YGVV + VA+KK ++ E KE + E++ + ++ +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 198 NLVRLLGYCIEGIHR----MLVYEYVNNGNLEQWLHGAMRHH--GYLTWEARMKVLLGTA 251
N+V L E R LV+EYV LE + G + R +
Sbjct: 61 NIVELK----EAFRRRGKLYLVFEYVEKNMLE-----LLEEMPNGVPPEKVR-SYIYQLI 110
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGY 311
KA+ + H+ +VHRDIK N+LI + K+ DFG A+ L G + T + T Y
Sbjct: 111 KAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWY 167
Query: 312 VAPEYANTGLLNEKSDVYSFGVLLLEAITGR 342
+PE + D++S G +L E G+
Sbjct: 168 RSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 13/204 (6%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLV 200
+ K + LGEG Y VY+G + + + VA+K+I L + A EV + ++H N+V
Sbjct: 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67
Query: 201 RLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL-GTAKALAYLHE 259
L LV+EY++ +L+Q+L G +K+ L + L Y H
Sbjct: 68 TLHDIIHTEKSLTLVFEYLDK-DLKQYLDDC----GNSINMHNVKLFLFQLLRGLNYCHR 122
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YAN 318
KV+HRD+K N+LI++ K++DFGLA+ + V+ T Y P+
Sbjct: 123 R---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLG 178
Query: 319 TGLLNEKSDVYSFGVLLLEAITGR 342
+ + + D++ G + E TGR
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 34/95 (35%), Positives = 48/95 (50%), Gaps = 13/95 (13%)
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVM---GTF 309
A YLH +++RD+K N+L+D+ + KV+DFG AK V R GT
Sbjct: 130 AFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAK-------KVPDRTFTLCGTP 179
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
Y+APE + + D ++ GVLL E I G P
Sbjct: 180 EYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 17/204 (8%)
Query: 148 VLGEGGYG-VVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEA-----IGHVRHKNLVR 201
V+G+G +G V+ +GS AVK + +KE + + A + +++H LV
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKE-QNHIMAERNVLLKNLKHPFLVG 60
Query: 202 LLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
L Y + ++ V +YVN G L + H R +L AR A A+ YLH
Sbjct: 61 L-HYSFQTAEKLYFVLDYVNGGEL--FFH-LQRERCFLEPRARFYAA-EVASAIGYLHSL 115
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTG 320
+++RD+K NIL+D + ++DFGL K G T+ GT Y+APE
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAPEVLRKE 171
Query: 321 LLNEKSDVYSFGVLLLEAITGRDP 344
+ D + G +L E + G P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-10
Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 36/215 (16%)
Query: 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIG--------HVRHK--- 197
LG+G YG VY+ V V A KE R+E++ + HK
Sbjct: 9 LGKGNYGSVYK----------VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVS 58
Query: 198 -NLVRLLG-YCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
+V G + IEG M + EY++ G+L++ L+ + + ++ K L
Sbjct: 59 PYIVDFYGAFFIEGAVYMCM-EYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLK 116
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE 315
+L E E ++HRD+K +N+L++ + K+ DFG++ L A + +G Y+APE
Sbjct: 117 FLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN---IGCQSYMAPE 171
Query: 316 YANTGLLNE------KSDVYSFGVLLLEAITGRDP 344
+G N+ +SDV+S G+ +LE GR P
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 5e-10
Identities = 61/203 (30%), Positives = 92/203 (45%), Gaps = 16/203 (7%)
Query: 148 VLGEGGYG-VVYRGNLINGSPVAVKKILNNVGQAEKEFR---VEVEAIGHVRHKNLVRLL 203
+LG+G +G V+ +G A+K + V A+ E E + + RH L L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL- 60
Query: 204 GYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKALAYLHEAI 261
Y + R+ V EYVN G L + H + + E R + AL YLH
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGEL--FFHLSRER---VFSEDRTRFYGAEIVSALDYLHSG- 114
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGL 321
K+V+RD+K N+++D D + K++DFGL K G + GT Y+APE
Sbjct: 115 --KIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYLAPEVLEDND 171
Query: 322 LNEKSDVYSFGVLLLEAITGRDP 344
D + GV++ E + GR P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 5e-10
Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 25/213 (11%)
Query: 143 FSKENVLGEGGYGVVYRGNL-INGSPVAVKK-----ILNNVGQA----EKEFRVEVEAIG 192
F VLG+GG+G V + G A KK I G+A EK+ +V +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR- 60
Query: 193 HVRHKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
V L Y E + LV +N G+L+ ++ M + G+ E R + A
Sbjct: 61 ------FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYN-MGNPGFD--EER--AVFYAA 109
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGY 311
+ L + ++V+RD+K NIL+DD + ++SD GLA + G++ + RV GT GY
Sbjct: 110 EITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGY 167
Query: 312 VAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+APE D + G L+ E I G+ P
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 6e-10
Identities = 65/213 (30%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 149 LGEGGYGVVYRG-NLINGSP-VAVKKI---LNNVGQAEKEFRVEVEAIGHVR---HKNLV 200
+GEG YG V++ +L NG VA+K++ G R EV + H+ H N+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNVV 67
Query: 201 RLLGYC-IEGIHR----MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
RL C + R LV+E+V+ +L +L G T E ++ + L
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKV-PEPGVPT-ETIKDMMFQLLRGLD 124
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE 315
+LH +VVHRD+K NIL+ K++DFGLA++ T V+ T Y APE
Sbjct: 125 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRAPE 179
Query: 316 YANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348
D++S G + E R P+ G
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRG 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 6e-10
Identities = 61/234 (26%), Positives = 98/234 (41%), Gaps = 53/234 (22%)
Query: 150 GEGGYGVVYRGNLINGSP---VAVKKILNNVGQAEKEFRV--------EVEAIGHVRHKN 198
G G YG VY+ NG A+KK + +KE E+ + ++H+N
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKF-----KGDKEQYTGISQSACREIALLRELKHEN 63
Query: 199 LVRLLGYCIEGIHRM--LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKAL-- 254
+V L+ +E + L+++Y E L ++ H R+ + K+L
Sbjct: 64 VVSLVEVFLEHADKSVYLLFDYA-----EHDLWQIIKFH---RQAKRVSIPPSMVKSLLW 115
Query: 255 ------AYLHEAIEPKVVHRDIKSSNILIDDDFNA----KVSDFGLAKLLGAGKSHVTT- 303
YLH V+HRD+K +NIL+ + K+ D GLA+L A +
Sbjct: 116 QILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172
Query: 304 -RVMGTFGYVAPEYANTGLLNEKS-----DVYSFGVLLLEAITGRDPVDHGRPA 351
V+ T Y APE LL + D+++ G + E +T P+ GR A
Sbjct: 173 DPVVVTIWYRAPEL----LLGARHYTKAIDIWAIGCIFAELLTLE-PIFKGREA 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFR---VEVEAIGHVRHKNLVRLLG 204
+G G +G VY N VAVKK+ + Q ++++ EV+ + ++H N + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 205 YCIEGIHRMLVYEY----------VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKAL 254
++ LV EY V+ L++ A+ H G + L
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITH--------------GALQGL 134
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
AYLH ++HRDIK+ NIL+ + K++DFG A S V GT ++AP
Sbjct: 135 AYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAP 186
Query: 315 EY---ANTGLLNEKSDVYSFGVLLLEAITGRDPV 345
E + G + K DV+S G+ +E + P+
Sbjct: 187 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 7e-10
Identities = 66/252 (26%), Positives = 96/252 (38%), Gaps = 71/252 (28%)
Query: 141 NRFSKENVLGEGGYGVVYRGNLI----NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRH 196
+ F V+G G +G V+ L+ G A+K + K ++ I HVR
Sbjct: 1 DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLR-------KSDMIKRNQIAHVRA 50
Query: 197 KN----------LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKV 246
+ +V+L + H LV EY+ G+L L +R + AR
Sbjct: 51 ERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLL---IRKDVFPEETARFY- 106
Query: 247 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK-------- 298
A+ + L + +HRDIK NILID D + K++DFGL K + K
Sbjct: 107 ---IAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLND 163
Query: 299 ---------------SHVTTRVM-----GTFGYVAPE------YANTGLLNEKSDVYSFG 332
H RV GT Y+APE Y + D +S G
Sbjct: 164 SHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY------GLECDWWSLG 217
Query: 333 VLLLEAITGRDP 344
V+L E + G P
Sbjct: 218 VILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 8e-10
Identities = 50/151 (33%), Positives = 69/151 (45%), Gaps = 12/151 (7%)
Query: 211 HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDI 270
+ LV EY G+L L+ R+ E + L A+ + +H + VHRDI
Sbjct: 75 NLYLVMEYQPGGDLLSLLN---RYEDQFD-EDMAQFYL--AELVLAIHSVHQMGYVHRDI 128
Query: 271 KSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANT------GLLNE 324
K N+LID + K++DFG A L A K + +GT Y+APE T G
Sbjct: 129 KPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGV 188
Query: 325 KSDVYSFGVLLLEAITGRDPVDHGRPAHEVN 355
+ D +S GV+ E I GR P G A N
Sbjct: 189 ECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN 219
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 9e-10
Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 35/212 (16%)
Query: 149 LGEGGYGVVY-----RGNLINGSPVAVKKILN---NVGQAEKEFRVEVEAIGHVRHKNLV 200
+G G +GVV+ R +G VA+KK+ N N+ ++ FR E++ + +H N++
Sbjct: 8 IGYGAFGVVWSVTDPR----DGKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVL 62
Query: 201 RLLGYCIEGIHRMLVYE-YVNNGNLEQWLHGAMRHHGYLTWEARMKVLL-GTAKALAYLH 258
L ++ H E YV ++ LH + L+ + +KV L + L YLH
Sbjct: 63 SALD-ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSD-HVKVFLYQILRGLKYLH 120
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS-HVTTRVMGTFGYVAPE-- 315
A ++HRDIK N+L++ + K+ DFGLA++ +S H+T V+ + Y APE
Sbjct: 121 SA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAPEIL 176
Query: 316 -----YANTGLLNEKSDVYSFGVLLLEAITGR 342
Y + D++S G + E + R
Sbjct: 177 MGSRHYTS------AVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 15/160 (9%)
Query: 187 EVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKV 246
E + V H ++RL + ++ EYV G L +L + R + +
Sbjct: 51 EKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR------FSNSTGL 104
Query: 247 LLGT--AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR 304
+ AL YLH ++V+RD+K NIL+D + + K++DFG AK L T
Sbjct: 105 FYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKL----RDRTWT 157
Query: 305 VMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+ GT Y+APE + N+ D ++ G+L+ E + G P
Sbjct: 158 LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 20/202 (9%)
Query: 148 VLGEGGYGVVYRGNLI----NGSPVAVKKI-LNNVGQAE-KEFRVEVEAIGHVRHKNLVR 201
V+G+G YG V +L+ +G +KK+ L N + E K E + + ++H N+V
Sbjct: 7 VVGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV- 62
Query: 202 LLGYCIEGIHRML--VYEYVNNGNLEQWLHGAMRHHGYLTWEAR-MKVLLGTAKALAYLH 258
EG +L V + G+L H G L E + ++ + A AL YLH
Sbjct: 63 AYRESWEGEDGLLYIVMGFCEGGDL---YHKLKEQKGKLLPENQVVEWFVQIAMALQYLH 119
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYAN 318
E ++HRD+K+ N+ + KV D G+A++L + + + ++GT Y++PE +
Sbjct: 120 EK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVL-ENQCDMASTLIGTPYYMSPELFS 175
Query: 319 TGLLNEKSDVYSFGVLLLEAIT 340
N KSDV++ G + E T
Sbjct: 176 NKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 13/204 (6%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLV 200
+ K LGEG Y V++G + + + VA+K+I L + A EV + ++H N+V
Sbjct: 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67
Query: 201 RLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL-GTAKALAYLHE 259
L LV+EY++ +L+Q+ M G + +K+ L + LAY H
Sbjct: 68 TLHDIVHTDKSLTLVFEYLDK-DLKQY----MDDCGNIMSMHNVKIFLYQILRGLAYCHR 122
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YAN 318
KV+HRD+K N+LI++ K++DFGLA+ + V+ T Y P+
Sbjct: 123 R---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLG 178
Query: 319 TGLLNEKSDVYSFGVLLLEAITGR 342
+ + + D++ G + E +GR
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 45/147 (30%), Positives = 74/147 (50%), Gaps = 19/147 (12%)
Query: 206 CIEGIHRM-LVYEYVNNGNLEQWLH--GAMRHHGYLTWEARMKVLLGTAKALAYLHEAIE 262
C + + R+ V EYVN G+L + G + + + A + A L +LH
Sbjct: 69 CFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEI------AIGLFFLHSK-- 120
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAK--LLGAGKSHVTTRVM-GTFGYVAPEYANT 319
+++RD+K N+++D + + K++DFG+ K + G TTR GT Y+APE
Sbjct: 121 -GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG----KTTRTFCGTPDYIAPEIIAY 175
Query: 320 GLLNEKSDVYSFGVLLLEAITGRDPVD 346
+ D ++FGVLL E + G+ P D
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 63/263 (23%), Positives = 119/263 (45%), Gaps = 29/263 (11%)
Query: 149 LGEGGYGVVYRG--------NLINGSPVAVKKILNNVGQAEKEFRVEVEAI-GHVRHKNL 199
LG+G + +++G ++ + V + K+L+ + E E ++ + HK+L
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEV-LLKVLDKSHRNYSESFFEAASMMSQLSHKHL 61
Query: 200 VRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY-LH 258
V G C+ G ++V EYV G+L+ +L ++ ++W+ L AK LA+ LH
Sbjct: 62 VLNYGVCVCGDESIMVQEYVKFGSLDTYLK-KNKNLINISWK------LEVAKQLAWALH 114
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS-HVTTRVMGT--FGYVAPE 315
+ + H ++ + N+L+ + + K + KL G S V + + +V PE
Sbjct: 115 FLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPE 174
Query: 316 -YANTGLLNEKSDVYSFGVLLLEAITGRD-PVDHGRPAHEVNLVDWLKMMVGSRRSE--- 370
N L+ +D +SFG L E +G D P+ ++ + + + +E
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWTELAN 234
Query: 371 ---EVVDPNIEVRPSTRALKRSL 390
+ +D + RPS RA+ R L
Sbjct: 235 LINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 43/131 (32%), Positives = 59/131 (45%), Gaps = 8/131 (6%)
Query: 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSS 273
LV ++N G L H R + AR TA+ L L + V++RD+K
Sbjct: 70 LVLAFINGGEL---FHHLQREGRFDLSRARFY----TAELLCALENLHKFNVIYRDLKPE 122
Query: 274 NILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGV 333
NIL+D + + DFGL K L T GT Y+APE + D ++ GV
Sbjct: 123 NILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGV 181
Query: 334 LLLEAITGRDP 344
LL E +TG P
Sbjct: 182 LLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 66/212 (31%), Positives = 92/212 (43%), Gaps = 21/212 (9%)
Query: 148 VLGEGGYG-VVYRGNLINGSPVAVKKILNNVGQAEKEFR---VEVEAIGHVRHKNLVRLL 203
+LG+G +G V+ G A+K + V A+ E E + + RH L L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL- 60
Query: 204 GYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT--AKALAYLHEA 260
Y + R+ V EY N G L + H + R + AR G AL YLH
Sbjct: 61 KYAFQTHDRLCFVMEYANGGEL--FFHLS-RERVFTEERAR---FYGAEIVSALEYLHSR 114
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTG 320
VV+RDIK N+++D D + K++DFGL K G GT Y+APE
Sbjct: 115 ---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDN 170
Query: 321 LLNEKSDVYSFGVLLLEAITGRDPV---DHGR 349
D + GV++ E + GR P DH R
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 202
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 27/213 (12%)
Query: 142 RFSKENVLGEGGYGVV-YRGNLINGSPVAVKKILNNVGQ---AEKEFRVEVEAIGHVRHK 197
R+ +G G YG V + G+ VA+KK+ A++ +R E+ + H++H+
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHE 74
Query: 198 NLVRLLGY-----CIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL-GT 250
N++ LL ++ H LV ++ G + H L+ E R++ L+
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTD------LGKLMKHEKLS-EDRIQFLVYQM 127
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
K L Y+H A ++HRD+K N+ +++D K+ DFGLA+ S +T V+ T
Sbjct: 128 LKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVV-TRW 180
Query: 311 YVAPEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
Y APE N + D++S G ++ E +TG+
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 17/149 (11%)
Query: 203 LGYCIEGIHRM-LVYEYVNNGNLEQWLH--GAMRHHGYLTWEARMKVLLGTAKALAYLHE 259
L C + + R+ V EYVN G+L + G + + + A + + L +LH
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI------GLFFLHS 119
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL-LGAGKSHVTTRVM-GTFGYVAPEYA 317
+++RD+K N+++D + + K++DFG+ K + G VTT+ GT Y+APE
Sbjct: 120 K---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG---VTTKTFCGTPDYIAPEII 173
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGRDPVD 346
+ D ++FGVLL E + G+ P +
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 18/206 (8%)
Query: 148 VLGEGGYGVVYRGNLINGSP----VAVK-----KILNNVGQAEKEFRVEVEAIGHVRHKN 198
VLG+GGYG V++ + G+ A+K I+ N + + E + V+H
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRN-QKDTAHTKAERNILEAVKHPF 61
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V L+ G L+ EY++ G L ++H + G + L + AL +LH
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGEL--FMH--LEREGIFMEDTACFYLSEISLALEHLH 117
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYAN 318
+ +++RD+K NIL+D + K++DFGL K + VT GT Y+APE
Sbjct: 118 QQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTIEYMAPEILM 173
Query: 319 TGLLNEKSDVYSFGVLLLEAITGRDP 344
+ D +S G L+ + +TG P
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 7e-09
Identities = 57/206 (27%), Positives = 88/206 (42%), Gaps = 31/206 (15%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKI----------LNNVGQAEKEFRVEVEAIGHVRHK 197
+G G YG VY+ + +G VA+K + L+ V + R+E H
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLE-----AFDHP 62
Query: 198 NLVRLLGYCI-----EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYL-TWEARMKVLLGTA 251
N+VRL+ C LV+E+V+ +L +L T + M+ L
Sbjct: 63 NIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFL--- 118
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGY 311
+ L +LH +VHRD+K NIL+ K++DFGLA++ T V+ T Y
Sbjct: 119 RGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSC--QMALTPVVVTLWY 173
Query: 312 VAPEYANTGLLNEKSDVYSFGVLLLE 337
APE D++S G + E
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 8e-09
Identities = 54/209 (25%), Positives = 102/209 (48%), Gaps = 25/209 (11%)
Query: 142 RFSKENVLGEGGYGVVYRGNLINGSPVAVK--KILNNVGQAE------KEFRVEVEAIGH 193
R+ + LG+G +G VY + + VA + K+L + E + E + +
Sbjct: 1 RYILQQRLGKGSFGTVYL--VKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSK 58
Query: 194 VRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARM-----KVLL 248
+ H +V+ +E ++ EY +L+ L ++H G E ++ ++LL
Sbjct: 59 LDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLE-ELKHTGKTLSENQVCEWFIQLLL 117
Query: 249 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT 308
G + Y+H+ +++HRD+K+ NI + ++ K+ DFG+++LL G + T GT
Sbjct: 118 G----VHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTGT 168
Query: 309 FGYVAPEYANTGLLNEKSDVYSFGVLLLE 337
Y++PE + KSD++S G +L E
Sbjct: 169 PYYMSPEALKHQGYDSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 9e-09
Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 28/213 (13%)
Query: 149 LGEGGYGVVYRGNLINGS--PVAVK-----KILNNVGQAEKEFRVEVEAIGHVRHKNLVR 201
LG G +G V N PVA+K KI+ Q + F E + + ++ H V
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQ-KQVDHVFS-ERKILNYINHPFCVN 95
Query: 202 LLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
L G + + LV E+V G +L R + +++L YL
Sbjct: 96 LYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL----IFEYLQSL- 150
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGL 321
+V+RD+K N+L+D D K++DFG AK++ T + GT Y+APE L
Sbjct: 151 --NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLCGTPEYIAPEI----L 200
Query: 322 LN----EKSDVYSFGVLLLEAITGRDPVDHGRP 350
LN + +D ++ G+ + E + G P P
Sbjct: 201 LNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 9e-09
Identities = 63/204 (30%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 148 VLGEGGYG-VVYRGNLINGSPVAVKKILNNVGQAEKEFR---VEVEAIGHVRHKNLVRLL 203
+LG+G +G V+ G A+K + V A+ E E + + RH L L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL- 60
Query: 204 GYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT--AKALAYLHEA 260
Y + R+ V EY N G L + H + R + AR G AL YLH
Sbjct: 61 KYSFQTHDRLCFVMEYANGGEL--FFHLS-RERVFSEDRAR---FYGAEIVSALDYLHS- 113
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTG 320
E VV+RD+K N+++D D + K++DFGL K G GT Y+APE
Sbjct: 114 -EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDN 171
Query: 321 LLNEKSDVYSFGVLLLEAITGRDP 344
D + GV++ E + GR P
Sbjct: 172 DYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 55/219 (25%), Positives = 94/219 (42%), Gaps = 33/219 (15%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKIL---NNVGQAEKEFRVEVEAIGHVRHKN 198
+ K +GEG YG VY+ + G VA+KK + G R E+ + +
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR-EISLLQMLSESI 61
Query: 199 -LVRLLGYCIEGIHR-------MLVYEYVNNGNLEQWL--HGAMRHHGYLTWEARMKVLL 248
+VRLL +E + LV+EY+++ +L++++ +G L + +
Sbjct: 62 YIVRLL--DVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRP-LPAKTIKSFMY 117
Query: 249 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNA-KVSDFGLAKLLGAGKSHVTTRVMG 307
K +A+ H+ V+HRD+K N+L+D K++D GL + T ++
Sbjct: 118 QLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV- 173
Query: 308 TFGYVAPEYANTGLLNEKS-----DVYSFGVLLLEAITG 341
T Y APE LL D++S G + E
Sbjct: 174 TLWYRAPEV----LLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 56/190 (29%), Positives = 89/190 (46%), Gaps = 5/190 (2%)
Query: 156 VVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLV 215
V RG+ VA +LN+ QA R E+ + H +V+ +L+
Sbjct: 85 VATRGSDPKEKVVAKFVMLNDERQAAYA-RSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143
Query: 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNI 275
EY + G+L + + ++ H L ++ LL LA L E K++HRD+KS+NI
Sbjct: 144 MEYGSGGDLNKQIKQRLKEH--LPFQEYEVGLLFYQIVLA-LDEVHSRKMMHRDLKSANI 200
Query: 276 LIDDDFNAKVSDFGLAKLLGAGKS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVL 334
+ K+ DFG +K S V + GT Y+APE ++K+D++S GV+
Sbjct: 201 FLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVI 260
Query: 335 LLEAITGRDP 344
L E +T P
Sbjct: 261 LYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 46/137 (33%), Positives = 68/137 (49%), Gaps = 19/137 (13%)
Query: 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT-AKALAYLHEAIEPKVVHRDIKS 272
LV +Y++ G L + H ++ G + E R K + AL +LH+ +V+RD+K
Sbjct: 73 LVTDYMSGGEL--FWH--LQKEGRFS-EDRAKFYIAELVLALEHLHKY---DIVYRDLKP 124
Query: 273 SNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKS-----D 327
NIL+D + + DFGL+K + T GT Y+APE LL+EK D
Sbjct: 125 ENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEV----LLDEKGYTKHVD 179
Query: 328 VYSFGVLLLEAITGRDP 344
+S GVL+ E G P
Sbjct: 180 FWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 60/226 (26%), Positives = 96/226 (42%), Gaps = 40/226 (17%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLV 200
R+ LG G G+V+ + VAVKKI+ Q+ K E++ I + H N+V
Sbjct: 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIV 65
Query: 201 RLLGYCIEGIHRM--------------LVYEYVNNGNLEQWLHGAMRHHGYLTWEAR--M 244
++ + +V EY+ E L + AR M
Sbjct: 66 KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLSEEHARLFM 120
Query: 245 KVLLGTAKALAYLHEAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVTT 303
LL + L Y+H A V+HRD+K +N+ I+ +D K+ DFGLA+++ SH
Sbjct: 121 YQLL---RGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174
Query: 304 RVMG--TFGYVAPEYANTGLL-----NEKSDVYSFGVLLLEAITGR 342
G T Y +P LL + D+++ G + E +TG+
Sbjct: 175 LSEGLVTKWYRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 49/149 (32%), Positives = 69/149 (46%), Gaps = 23/149 (15%)
Query: 211 HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWE-ARMKVLLGTAKALAYLHEAIEPKVVHRD 269
H +V EYV G+ L ++ G L + ARM T AL YLH +VHRD
Sbjct: 75 HLCMVMEYVEGGDCATLL----KNIGALPVDMARMYFA-ETVLALEYLHNY---GIVHRD 126
Query: 270 IKSSNILIDDDFNAKVSDFGLAKL--------LGAGKSHVTTR------VMGTFGYVAPE 315
+K N+LI + K++DFGL+K+ L G TR V GT Y+APE
Sbjct: 127 LKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPE 186
Query: 316 YANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+ D ++ G++L E + G P
Sbjct: 187 VILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 56/203 (27%), Positives = 87/203 (42%), Gaps = 15/203 (7%)
Query: 148 VLGEGGYGVVYRGNLINGSPVAVKKILNNVG----QAEKEFRVEVEAI-GHVRHKNLVRL 202
V+G+G +G V K+L + EK E + +V+H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 203 LGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
+ + ++ V +Y+N G L + R +L AR A AL YLH
Sbjct: 62 -HFSFQTADKLYFVLDYINGGEL---FYHLQRERCFLEPRARFYAA-EIASALGYLHSL- 115
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGL 321
+V+RD+K NIL+D + ++DFGL K + T+ GT Y+APE +
Sbjct: 116 --NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 322 LNEKSDVYSFGVLLLEAITGRDP 344
+ D + G +L E + G P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 6e-08
Identities = 32/123 (26%), Positives = 56/123 (45%), Gaps = 18/123 (14%)
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGY 311
+ L YLH +++HRD+K+ NI I+D + D G A+ + + + GT
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--LAGTVET 222
Query: 312 VAPEYANTGLLNEKSDVYSFGVLLLEAI------------TGRDPVDHGRPAHEVNLVDW 359
APE N K+D++S G++L E + T + V +H + ++
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCH-SHLLKIIST 281
Query: 360 LKM 362
LK+
Sbjct: 282 LKV 284
|
Length = 357 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 7e-08
Identities = 51/220 (23%), Positives = 102/220 (46%), Gaps = 23/220 (10%)
Query: 143 FSKENVLGEGGYGVVYRGNLI----NGSPVAVKKILNNVGQAE--KEFRVEVEAIGHVRH 196
F+ +LG+G +G V L + VAVK + ++ + +EF E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 197 KNLVRLLGYCIEGIHR------MLVYEYVNNGNLEQWLHGAMRHHG----YLTWEARMKV 246
N+++L+G + + M++ ++ +G+L +L M G L + ++
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFL--LMSRIGEEPFTLPLQTLVRF 118
Query: 247 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVM 306
++ A + YL +HRD+ + N +++++ V+DFGL+K + +G +
Sbjct: 119 MIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCAS 175
Query: 307 G-TFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
++A E + SDV++FGV + E +T G+ P
Sbjct: 176 KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 7e-08
Identities = 50/268 (18%), Positives = 107/268 (39%), Gaps = 35/268 (13%)
Query: 157 VYRGNLINGSPVAV---KKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRM 213
+Y+G + N V + KK E++ + + N++++ G+ I+ + +
Sbjct: 36 IYKG-IFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 214 ----LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRD 269
L+ EY G L + L L+++ ++ + + K L L++ +++
Sbjct: 95 PRLSLILEYCTRGYLREVL----DKEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKN 148
Query: 270 IKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGL--LNEKSD 327
+ S + L+ +++ K+ GL K+L S + + Y + + N K D
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKIL----SSPPFKNVNFMVYFSYKMLNDIFSEYTIKDD 204
Query: 328 VYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALK 387
+YS GV+L E TG+ P ++ +L +++ N ++
Sbjct: 205 IYSLGVVLWEIFTGKIPFENLTTKEIYDL---------------IINKNNSLKLPLDCPL 249
Query: 388 RSLLTALRCVDPDSEKRPKMSQVVRMLE 415
C DS KRP + +++ L
Sbjct: 250 EIKCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (130), Expect = 8e-08
Identities = 58/238 (24%), Positives = 106/238 (44%), Gaps = 30/238 (12%)
Query: 135 DLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKE---FRVEVEAI 191
D E N + +G G +G V+ K ++ G E+E +EV +
Sbjct: 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVM 66
Query: 192 GHVRHKNLVRLLGYCIEGIHRML--VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
++HKN+VR + + ++ L + E+ + G+L + + + G + A + +
Sbjct: 67 RELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQ 126
Query: 250 TAKALAYLHEAIE----PKVVHRDIKSSNILID-------------DDFN----AKVSDF 288
ALAY H + +V+HRD+K NI + ++ N AK+ DF
Sbjct: 127 LLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDF 186
Query: 289 GLAKLLGAGKSHVTTRVMGTFGYVAPEYA--NTGLLNEKSDVYSFGVLLLEAITGRDP 344
GL+K +G + +GT Y +PE T ++KSD+++ G ++ E +G+ P
Sbjct: 187 GLSKNIGI--ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 26/220 (11%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEK--EFRVEVEAIGHVR-HKNLVRLLG 204
+GEG + V + + G A+K + + E+ R E++A+ + H N++RL+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR-EIQALRRLSPHPNILRLIE 65
Query: 205 YCIEGIHR--MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK-VLLGTAKALAYLHEAI 261
+ LV+E ++ L+ ++ E R+K + K+L ++H
Sbjct: 66 VLFDRKTGRLALVFEL-----MDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN- 119
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANT-G 320
+ HRDIK NILI DD K++DFG + G T + T Y APE T G
Sbjct: 120 --GIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYISTRWYRAPECLLTDG 174
Query: 321 LLNEKSDVYSFGVLLLEAIT------GRDPVDHGRPAHEV 354
K D+++ G + E ++ G + +D H+V
Sbjct: 175 YYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDV 214
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 54/221 (24%), Positives = 92/221 (41%), Gaps = 18/221 (8%)
Query: 133 LRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKE----FRVEV 188
+R L++ + V+G G +G V + V K+L+ ++ F E
Sbjct: 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 189 EAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL 248
+ + +V+L + + +V EY+ G+L + Y E K
Sbjct: 95 DIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN------YDVPEKWAKFY- 147
Query: 249 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA-KLLGAGKSHVTTRVMG 307
TA+ + L ++HRD+K N+L+D + K++DFG K+ G T V G
Sbjct: 148 -TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-G 205
Query: 308 TFGYVAPEYANT----GLLNEKSDVYSFGVLLLEAITGRDP 344
T Y++PE + G + D +S GV L E + G P
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 2e-07
Identities = 62/220 (28%), Positives = 96/220 (43%), Gaps = 33/220 (15%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNN---VGQAEKE-FRVEVEAIGHVRHKN 198
F V+G G +G V L N V KILN + +AE FR E + + + ++
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ- 61
Query: 199 LVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
+ L Y + + + LV +Y G+L LT ++ + L A YL
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDL-------------LTLLSKFEDRLPEDMARFYL 108
Query: 258 HEAI-------EPKVVHRDIKSSNILIDDDFNAKVSDFG-LAKLLGAGKSHVTTRVMGTF 309
E + + VHRDIK NIL+D + + +++DFG KL+ G + V GT
Sbjct: 109 AEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTP 167
Query: 310 GYVAPEYANT-----GLLNEKSDVYSFGVLLLEAITGRDP 344
Y++PE G + D +S GV + E + G P
Sbjct: 168 DYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 30/80 (37%), Positives = 48/80 (60%), Gaps = 7/80 (8%)
Query: 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSS 273
LV EY+ G+++ LH +GY E +K + A AL YLH ++HRD+K
Sbjct: 81 LVMEYLIGGDVKSLLH----IYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPD 133
Query: 274 NILIDDDFNAKVSDFGLAKL 293
N+LI ++ + K++DFGL+K+
Sbjct: 134 NMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 46/156 (29%), Positives = 76/156 (48%), Gaps = 23/156 (14%)
Query: 264 KVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV---TTRVMGTFGYVAPEYANTG 320
K +HRD+ + NIL+ ++ K+ DFGLA+ + +V + R+ ++APE
Sbjct: 194 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL--PLKWMAPESIFDK 251
Query: 321 LLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSR-RSEEVVDPNIE 378
+ +SDV+SFGVLL E + G P P ++N ++ G+R R+ E P I
Sbjct: 252 VYTTQSDVWSFGVLLWEIFSLGASPY----PGVQINEEFCQRLKDGTRMRAPENATPEI- 306
Query: 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414
++ L C D ++RP S +V +L
Sbjct: 307 ---------YRIM--LACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 59/248 (23%), Positives = 93/248 (37%), Gaps = 61/248 (24%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKN---- 198
F V+G G +G V + V KIL EKE +GH+R +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKE------QVGHIRAERDILV 56
Query: 199 ------LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAK 252
+V++ + ++ L+ E++ G++ L LT E + T
Sbjct: 57 EADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLL----MKKDTLTEEETQFYIAETVL 112
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTT--------- 303
A+ +H+ +HRDIK N+L+D + K+SDFGL G K+H T
Sbjct: 113 AIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCT--GLKKAHRTEFYRNLNHSL 167
Query: 304 ---------------------------RVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLL 336
+GT Y+APE N+ D +S GV++
Sbjct: 168 PSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227
Query: 337 EAITGRDP 344
E + G P
Sbjct: 228 EMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 45/156 (28%), Positives = 73/156 (46%), Gaps = 23/156 (14%)
Query: 264 KVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV---TTRVMGTFGYVAPEYANTG 320
K +HRD+ + NIL+ ++ K+ DFGLA+ + +V R+ ++APE
Sbjct: 193 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL--PLKWMAPESIFDK 250
Query: 321 LLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSR-RSEEVVDPNIE 378
+ +SDV+SFGVLL E + G P P +++ ++ G+R R+ E P I
Sbjct: 251 VYTTQSDVWSFGVLLWEIFSLGASPY----PGVQIDEEFCRRLKEGTRMRAPEYATPEI- 305
Query: 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414
L C + E RP S++V +L
Sbjct: 306 -----------YSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 53/211 (25%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHK 197
R+ +G G YG V + VAVKK+ ++ A + +R E+ + H++H+
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHMKHE 74
Query: 198 NLVRLL-----GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAK 252
N++ LL IE + + + + +L + L+ E ++ +
Sbjct: 75 NVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQK-----LSDEHVQFLIYQLLR 129
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
L Y+H A ++HRD+K SN+ +++D ++ DFGLA+ T + T Y
Sbjct: 130 GLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLAR----QADDEMTGYVATRWYR 182
Query: 313 APEYA-NTGLLNEKSDVYSFGVLLLEAITGR 342
APE N N+ D++S G ++ E + G+
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 7e-07
Identities = 45/153 (29%), Positives = 75/153 (49%), Gaps = 19/153 (12%)
Query: 193 HVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAK 252
V HK++V L G C+ + ++V E+V G L+ ++H R LT + KV A
Sbjct: 60 QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH---RKSDVLTTPWKFKVAKQLAS 116
Query: 253 ALAYLHEAIEPKVVHRDIKSSNIL-----IDDDFNA--KVSDFGLAKLLGAGKSHVTTRV 305
AL+YL + +VH ++ + NIL ID + K+SD G+ + + R+
Sbjct: 117 ALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP-ITVLSRQECVERI 172
Query: 306 MGTFGYVAPE-YANTGLLNEKSDVYSFGVLLLE 337
++APE ++ L+ +D +SFG L E
Sbjct: 173 ----PWIAPECVEDSKNLSIAADKWSFGTTLWE 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 62/239 (25%), Positives = 91/239 (38%), Gaps = 45/239 (18%)
Query: 142 RFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEF-RVEVEA--IGHVRHK 197
F K +LG+G G V+ L G A+K + + RV E + + H
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWE-ARM---KVLLGTAKA 253
L L + LV +Y G L + L + L+ E AR +VLL A
Sbjct: 62 FLPTLYASFQTETYLCLVMDYCPGGELFRLLQ--RQPGKCLSEEVARFYAAEVLL----A 115
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV------------ 301
L YLH +V+RD+K NIL+ + + +SDF L+K V
Sbjct: 116 LEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSS 172
Query: 302 -------------TTRVM---GTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+ R GT Y+APE + D ++ G+LL E + G P
Sbjct: 173 VNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 66/290 (22%), Positives = 113/290 (38%), Gaps = 57/290 (19%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAE---KEFRVEVEAIGHVRHKNLVRLLG 204
+G+GG G VY + + VA+KKI ++ + K F E + + H +V +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 205 YCIEGIHRMLVY---EYVNNGNLEQWLHGAMR-------HHGYLTWEARMKVLLGTAKAL 254
C +G VY Y+ L+ L + + A + + +
Sbjct: 70 ICSDG---DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK---------------S 299
Y+H V+HRD+K NIL+ + D+G A + S
Sbjct: 127 EYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 300 HVTT--RVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPV--DHGRPAHEVN 355
+T +++GT Y+APE +E +D+Y+ GV+L + +T P GR
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR------ 237
Query: 356 LVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSL-LTALRCVDPDSEKR 404
K+ +V+ IEV P R + L A++ + D +R
Sbjct: 238 -----KISY-----RDVILSPIEVAPY-REIPPFLSQIAMKALAVDPAER 276
|
Length = 932 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 49/183 (26%), Positives = 82/183 (44%), Gaps = 26/183 (14%)
Query: 237 YLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296
LT E + AK + +L K +HRD+ + NIL+ ++ K+ DFGLA+ +
Sbjct: 175 VLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYK 231
Query: 297 GKSHV---TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAH 352
+V R+ ++APE + +SDV+SFGVLL E + G P P
Sbjct: 232 DPDYVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY----PGV 285
Query: 353 EVNLVDWLKMMVGSR-RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVV 411
+++ ++ G+R R+ + P + T L C + +RP S++V
Sbjct: 286 KIDEEFCRRLKEGTRMRAPDYTTPEM------------YQTMLDCWHGEPSQRPTFSELV 333
Query: 412 RML 414
L
Sbjct: 334 EHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 43/154 (27%), Positives = 68/154 (44%), Gaps = 21/154 (13%)
Query: 266 VHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF---GYVAPEYANTGLL 322
VHRD+ + N+LI + K+ DFGLA+ + ++++ TF ++APE L
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKG--STFLPLKWMAPESIFNNLY 318
Query: 323 NEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRP 381
SDV+SFG+LL E T G P P +N + + G R ++
Sbjct: 319 TTLSDVWSFGILLWEIFTLGGTPY----PELPMNEQFYNAIKRGYRMAK----------- 363
Query: 382 STRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
A +C + E RP SQ+V ++
Sbjct: 364 PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVG 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 57/221 (25%), Positives = 93/221 (42%), Gaps = 18/221 (8%)
Query: 133 LRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNN---VGQAEKEFRVEVE 189
+RDL + + V+G G +G V + V K+L+ + +++ F E
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL 248
I + V L Y + + +V EY+ G+L M ++ AR
Sbjct: 95 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN----LMSNYDVPEKWARFY--- 147
Query: 249 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA-KLLGAGKSHVTTRVMG 307
TA+ + L +HRD+K N+L+D + K++DFG K+ G T V G
Sbjct: 148 -TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-G 205
Query: 308 TFGYVAPEYANT----GLLNEKSDVYSFGVLLLEAITGRDP 344
T Y++PE + G + D +S GV L E + G P
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 32/97 (32%), Positives = 46/97 (47%), Gaps = 9/97 (9%)
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGY 311
AL +H +HRD+K N+L+D + K++DFG + A G T V GT Y
Sbjct: 154 ALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDY 209
Query: 312 VAPEY----ANTGLLNEKSDVYSFGVLLLEAITGRDP 344
++PE G + D +S GV L E + G P
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 36/119 (30%), Positives = 50/119 (42%), Gaps = 43/119 (36%)
Query: 266 VHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTT---------------------- 303
+HRDIK N+L+D + K+SDFGL G KSH T
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCT--GLKKSHRTEFYRILSHALPSNFLDFISKPMS 180
Query: 304 ------------RVM-----GTFGYVAPE-YANTGLLNEKSDVYSFGVLLLEAITGRDP 344
R + GT Y+APE + TG N++ D +S GV++ E + G P
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 42/181 (23%), Positives = 80/181 (44%), Gaps = 23/181 (12%)
Query: 170 VKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRL--------LGYCIEGIHRMLVYEYVNN 221
+ K + +A + E+ A+G + H+N++++ Y I + +Y ++ +
Sbjct: 196 IAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYD 255
Query: 222 GNLEQWLHGAMRHHGYLTWEAR--MKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD 279
W + + R MK LL A+ Y+H+ K++HRDIK NI ++
Sbjct: 256 EAF-DWKDRPL------LKQTRAIMKQLLC---AVEYIHDK---KLIHRDIKLENIFLNC 302
Query: 280 DFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAI 339
D + DFG A + +GT +PE E +D++S G++LL+ +
Sbjct: 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362
Query: 340 T 340
+
Sbjct: 363 S 363
|
Length = 501 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 5e-06
Identities = 32/88 (36%), Positives = 47/88 (53%), Gaps = 8/88 (9%)
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
ALAYLH ++HRD+K+ NI +D+ NA + DFG A L A T + G G +
Sbjct: 197 ALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDA--HPDTPQCYGWSGTL 251
Query: 313 ---APEYANTGLLNEKSDVYSFGVLLLE 337
+PE K+D++S G++L E
Sbjct: 252 ETNSPELLALDPYCAKTDIWSAGLVLFE 279
|
Length = 392 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 6e-06
Identities = 37/109 (33%), Positives = 54/109 (49%), Gaps = 15/109 (13%)
Query: 246 VLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRV 305
+L G + L YLH+ +HR+IK+S+ILI D VS GL+ L ++ +V
Sbjct: 106 ILFGALRGLNYLHQN---GYIHRNIKASHILISGD--GLVSLSGLSHLYSLVRNGQKAKV 160
Query: 306 MGTFG--------YVAPEYANTGL--LNEKSDVYSFGVLLLEAITGRDP 344
+ F +++PE L N KSD+YS G+ E TGR P
Sbjct: 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 6e-06
Identities = 49/173 (28%), Positives = 80/173 (46%), Gaps = 28/173 (16%)
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT-- 308
AK +++L +HRD+ + NIL+ K+ DFGLA+ + ++V V G
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV---VKGNAR 277
Query: 309 --FGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVG 365
++APE + +SDV+S+G+LL E + G P P V+ + KM+
Sbjct: 278 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY----PGMPVD-SKFYKMIKE 332
Query: 366 SRRSEEVVDPNIEVRPSTR-ALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417
R + E PS + +S C D D KRP Q+V+++E +
Sbjct: 333 GYRML-----SPECAPSEMYDIMKS------CWDADPLKRPTFKQIVQLIEQQ 374
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 7e-06
Identities = 40/157 (25%), Positives = 73/157 (46%), Gaps = 23/157 (14%)
Query: 266 VHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT----FGYVAPEYANTGL 321
+HRD+ + N+L+ D AK+ DFGLA+ + ++V V G ++APE +
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV---VKGNARLPVKWMAPESIFDCV 290
Query: 322 LNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVR 380
+SDV+S+G+LL E + G+ P + ++V S+ + V R
Sbjct: 291 YTVQSDVWSYGILLWEIFSLGKSP--------------YPGILVNSKFYKMVKRGYQMSR 336
Query: 381 PSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417
P A C + + +RP SQ+ ++++ +
Sbjct: 337 PDF-APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 8e-06
Identities = 29/92 (31%), Positives = 44/92 (47%), Gaps = 3/92 (3%)
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGY 311
+A+ YLHE +++HRDIK+ NI I+ + + DFG A ++ GT
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIAT 249
Query: 312 VAPEYANTGLLNEKSDVYSFGVLLLEAITGRD 343
APE D++S G++L E T D
Sbjct: 250 NAPELLARDPYGPAVDIWSAGIVLFEMATCHD 281
|
Length = 391 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 83/358 (23%), Positives = 135/358 (37%), Gaps = 74/358 (20%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKE----FRVEVEAIGHVRHKN 198
F V+G G +G V + + KIL EKE R E + +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V++ + + L+ E++ G++ L M+ L+ EA + T A+ +H
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLL---MKKDT-LSEEATQFYIAETVLAIDAIH 118
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTT--------------- 303
+ +HRDIK N+L+D + K+SDFGL G K+H T
Sbjct: 119 QL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCT--GLKKAHRTEFYRNLTHNPPSDFSF 173
Query: 304 ---------------------RVMGTFGYVAPE-YANTGLLNEKSDVYSFGVLLLEAITG 341
+GT Y+APE + TG N+ D +S GV++ E + G
Sbjct: 174 QNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIG 232
Query: 342 RDPVDHGRPAHEV-NLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPD 400
P P +++W + V P + + + L T D
Sbjct: 233 YPPFCSETPQETYRKVMNW--------KETLVFPPEVPISEKAKDLILRFCT-------D 277
Query: 401 SEKRPKMSQVVRMLESEEYPIVRE-DRRH-RRTQGGTSMEIESQKENSDTDRSDYPGS 456
SE R + V E + +P D H R +EI+S + S+ D ++P S
Sbjct: 278 SENRIGSNGVE---EIKSHPFFEGVDWGHIRERPAAIPIEIKSIDDTSNFD--EFPES 330
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 41/156 (26%), Positives = 71/156 (45%), Gaps = 21/156 (13%)
Query: 191 IGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT 250
+ V H +L + G C+ G ++V E+V +G L+ L + G + ++ V
Sbjct: 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLR---KEKGRVPVAWKITVAQQL 126
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILI--------DDDFNAKVSDFGLAKLLGAGKSHVT 302
A AL+YL + +VH ++ + NIL+ F K+SD G++ +
Sbjct: 127 ASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPF-IKLSDPGVS-FTALSREERV 181
Query: 303 TRVMGTFGYVAPE-YANTGLLNEKSDVYSFGVLLLE 337
R+ ++APE L+ +D +SFG LLE
Sbjct: 182 ERI----PWIAPECVPGGNSLSTAADKWSFGTTLLE 213
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 64/285 (22%), Positives = 101/285 (35%), Gaps = 56/285 (19%)
Query: 164 NGSPVAVKKI-LNNVGQAE-KEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNN 221
+ VAVKKI L++ + + K + E+ ++H N++ + I +V +
Sbjct: 24 TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83
Query: 222 GNLEQWLHGAMRHHGY-LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDD 280
G+ E L H L A +L AL Y+H +HR +K+S+IL+ D
Sbjct: 84 GSCEDLLK---THFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGD 137
Query: 281 FNAKVSDFGLA-KLLGAGKSHVTTRVMGTFG-----YVAPEYANTGLL--NEKSDVYSFG 332
+S + ++ GK +++PE L NEKSD+YS G
Sbjct: 138 GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVG 197
Query: 333 V-------------------LLLEAITGRDPVDHGRPAHEVNLVD----WLKMMVGSRRS 369
+ +LLE + G P L+D L S+
Sbjct: 198 ITACELANGHVPFKDMPATQMLLEKVRGTVP----------CLLDKSTYPLYEDSMSQSR 247
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALR-----CVDPDSEKRPKMSQ 409
PN R+ C+ D E RP SQ
Sbjct: 248 SSNEHPNNRDSVDHPY-TRTFSEHFHQFVELCLQRDPESRPSASQ 291
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 36/122 (29%), Positives = 48/122 (39%), Gaps = 44/122 (36%)
Query: 266 VHRDIKSSNILIDDDFNAKVSDFGL---------AKLLGAGKSHVT-------------- 302
+HRDIK NILID D + K++DFGL +K G H
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 303 --------------TRVM-----GTFGYVAPE-YANTGLLNEKSDVYSFGVLLLEAITGR 342
R + GT Y+APE TG + D +S GV+L E + G+
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILYEMLVGQ 241
Query: 343 DP 344
P
Sbjct: 242 PP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 29/213 (13%)
Query: 148 VLGEGGYGVVYRGNLINGSPVAVKKILNN---VGQAEKE-FRVEVEAIGHVRHKNLVRLL 203
V+G G +G V + N V KILN + +AE FR E + + + + + L
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH 67
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE---A 260
+ + LV +Y G+L LT ++ + L A YL E A
Sbjct: 68 YAFQDENNLYLVMDYYVGGDL-------------LTLLSKFEDRLPEDMARFYLAEMVLA 114
Query: 261 IEP----KVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEY 316
I+ VHRDIK N+L+D + + +++DFG L A + + +GT Y++PE
Sbjct: 115 IDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEI 174
Query: 317 -----ANTGLLNEKSDVYSFGVLLLEAITGRDP 344
G + D +S GV + E + G P
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 21/155 (13%)
Query: 266 VHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF---GYVAPEYANTGLL 322
VHRD+ + N+L+ K+ DFGLA+ + ++V+ TF ++APE L
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG--STFLPVKWMAPESIFDNLY 316
Query: 323 NEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRP 381
SDV+S+G+LL E + G P P V+ + K+ G R ++ EV
Sbjct: 317 TTLSDVWSYGILLWEIFSLGGTPY----PGMIVDSTFYNKIKSGYRMAKPDHATQ-EVYD 371
Query: 382 STRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416
++C + + EKRP + ++ES
Sbjct: 372 ----------IMVKCWNSEPEKRPSFLHLSDIVES 396
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 52/218 (23%), Positives = 91/218 (41%), Gaps = 29/218 (13%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNN---VGQAEKE-FRVEVEAIGHVRHKN 198
F V+G G +G V + + + KILN + +AE FR E + + +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+ L + + LV +Y G+L LT ++ + L A Y+
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDL-------------LTLLSKFEDRLPEDMARFYIA 109
Query: 259 EAI-------EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGY 311
E + + VHRDIK N+L+D + + +++DFG + + ++ +GT Y
Sbjct: 110 EMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDY 169
Query: 312 VAPEYANT-----GLLNEKSDVYSFGVLLLEAITGRDP 344
++PE G + D +S GV + E + G P
Sbjct: 170 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 73/330 (22%), Positives = 129/330 (39%), Gaps = 49/330 (14%)
Query: 47 KSRRARNNLPFSQIPTVSKEIKEVRVEQVSTNEFVQRDDKDGGSISGEDSGSVTVYKPSS 106
+ N S T S+ R S + D G + + T ++
Sbjct: 28 SGNSPKANNSASTGQTTSRSTNSARR-SGSKRDRETATSTDSGRTKSHEGAATTKQATTT 86
Query: 107 --SHPITAPSPL-----IGLPEFSQLGWGHWFTL--RDLELATNRFSKENVLGEGGYG-V 156
++ AP P LP S GH++ + D++++T RF ++LGEG +G V
Sbjct: 87 PTTNVEVAPPPKKKKVTYALPNQS-REEGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKV 145
Query: 157 VYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKN------LVRLLGYCIEGI 210
V + AV KI+ NV + ++ ++E++ + VR + L+++ Y
Sbjct: 146 VEAWDRKRKEYCAV-KIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204
Query: 211 HRMLVYEYVNNGNLEQWL--HGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHR 268
M + L W+ HG H +L +++ T AL Y H E ++H
Sbjct: 205 GHMCIVMPKYGPCLLDWIMKHGPFSHR-HLA-----QIIFQTGVALDYFHT--ELHLMHT 256
Query: 269 DIKSSNILID----------------DDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
D+K NIL++ D ++ D G + H T ++ T Y
Sbjct: 257 DLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC----CDERHSRTAIVSTRHYR 312
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGR 342
+PE +D++S G ++ E TG+
Sbjct: 313 SPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 8e-05
Identities = 47/196 (23%), Positives = 81/196 (41%), Gaps = 30/196 (15%)
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA----MRHHGYLTWEARMKVLLGTAKA 253
N+V L Y + LV ++ G L W H + + W A M V A
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKL--WSHISKFLNIPEECVKRWAAEMVV------A 97
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFG-LAKLLGAGKSHVTTRVMGTFGYV 312
L LH +V RD+ +NIL+DD + +++ F +++ + + Y
Sbjct: 98 LDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YC 149
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDPVD---HGRPAH-EVNLVDWLKMMVGSRR 368
APE E D +S G +L E +TG+ V+ G H +N+ +W+ S
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWV-----SEE 204
Query: 369 SEEVVDPNIEVRPSTR 384
+ ++ ++ P+ R
Sbjct: 205 ARSLLQQLLQFNPTER 220
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 9e-05
Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 24/218 (11%)
Query: 149 LGEGGYGVVYRGNLINGSP---VAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGY 205
+G G YG VY+ +G A+K+I G + R E+ + ++H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI-EGTGISMSACR-EIALLRELKHPNVISLQKV 66
Query: 206 CIEGIHRM--LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY-----LH 258
+ R L+++Y + + W H H + +++ G K+L Y +H
Sbjct: 67 FLSHADRKVWLLFDYAEH---DLW-HIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122
Query: 259 EAIEPKVVHRDIKSSNILI----DDDFNAKVSDFGLAKLLGAGKSHVT--TRVMGTFGYV 312
V+HRD+K +NIL+ + K++D G A+L + + V+ TF Y
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 313 APEYANTGLLNEKS-DVYSFGVLLLEAITGRDPVDHGR 349
APE K+ D+++ G + E +T +P+ H R
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCR 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 24/218 (11%)
Query: 149 LGEGGYGVVYRGNLINGS---PVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGY 205
+G G YG VY+ +G A+K+I G + R E+ + ++H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQI-EGTGISMSACR-EIALLRELKHPNVIALQKV 66
Query: 206 CIEGIHRM--LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY-----LH 258
+ R L+++Y + + W H H + M++ K+L Y +H
Sbjct: 67 FLSHSDRKVWLLFDYAEH---DLW-HIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 259 EAIEPKVVHRDIKSSNILI----DDDFNAKVSDFGLAKLLGAGKSHVT--TRVMGTFGYV 312
V+HRD+K +NIL+ + K++D G A+L + + V+ TF Y
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 313 APEYANTGLLNEKS-DVYSFGVLLLEAITGRDPVDHGR 349
APE K+ D+++ G + E +T +P+ H R
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCR 219
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 4e-04
Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 19/153 (12%)
Query: 196 HKNLVRLLGYCIEGI-HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT-AKA 253
+ N ++L Y + + +L+ +Y+ +G+L L G L+ EA +K ++ +A
Sbjct: 68 NPNFIKLY-YSVTTLKGHVLIMDYIKDGDLFDLLK----KEGKLS-EAEVKKIIRQLVEA 121
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDD-DFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
L LH+ ++H DIK N+L D + D+GL K++G + GT Y
Sbjct: 122 LNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYF 173
Query: 313 APEYANTGLLNEKS-DVYSFGVLLLEAITGRDP 344
+PE G + S D ++ GVL E +TG+ P
Sbjct: 174 SPEKIK-GHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 19/35 (54%), Positives = 23/35 (65%), Gaps = 2/35 (5%)
Query: 266 VHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSH 300
+HRDIK NILID + K+SDFGL+ G K H
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLS--TGFHKQH 155
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 36/109 (33%), Positives = 48/109 (44%), Gaps = 15/109 (13%)
Query: 246 VLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRV 305
+L G KAL Y+H VHR +K+S+ILI D KV GL L RV
Sbjct: 106 ILQGVLKALDYIHHM---GYVHRSVKASHILISVD--GKVYLSGLRSNLSMINHGQRLRV 160
Query: 306 MGTF--------GYVAPEYANTGL--LNEKSDVYSFGVLLLEAITGRDP 344
+ F +++PE L + KSD+YS G+ E G P
Sbjct: 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 8e-04
Identities = 43/179 (24%), Positives = 66/179 (36%), Gaps = 61/179 (34%)
Query: 266 VHRDIKSSNILIDDDFNAKVSDFGL---------AKLLGAGKSHVTTRVM---------- 306
+HRDIK NILID D + K++DFGL +K G SH+ M
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKG-SHIRQDSMEPSDLWDDVS 181
Query: 307 ----------------------------GTFGYVAPEYANTGLLNEKSDVYSFGVLLLEA 338
GT Y+APE + D +S GV+L E
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241
Query: 339 ITGRDPVDHGRPAH-EVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRC 396
+ G+ P P ++ +++W + + P +++ P L+T L C
Sbjct: 242 LVGQPPFLAPTPTETQLKVINW--------ENTLHIPPQVKLSPEA----VDLITKLCC 288
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 32/113 (28%), Positives = 50/113 (44%), Gaps = 15/113 (13%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNL--INGSP----VAVKKILNNVGQAEKEFRV---E 187
E +R LG G +G V + + I S VAVK + G E++ E
Sbjct: 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKML--KEGATASEYKALMTE 60
Query: 188 VEAIGHV-RHKNLVRLLGYCIE-GIHRMLVYEYVNNGNLEQWLHGAMRHHGYL 238
++ + H+ H N+V LLG C + G M++ EY GNL +L + +
Sbjct: 61 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRS--KRECFS 111
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 35/141 (24%), Positives = 56/141 (39%), Gaps = 47/141 (33%)
Query: 266 VHRDIKSSNILIDDDFNAKVSDFGL---------AKLLGAG------------------- 297
+HRDIK NILID D + K++DFGL +K +G
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 298 ---------------KSH---VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAI 339
+ H + ++GT Y+APE + D +S GV+L E +
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 340 TGRDPVDHGRPAH-EVNLVDW 359
G+ P P ++ +++W
Sbjct: 243 VGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 6/88 (6%)
Query: 253 ALAYLH-EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL-GAGKSHVTTRVMGTFG 310
A+ Y+H E I +HRDIK+ N+L++ + + DFG A G+ + + GT
Sbjct: 272 AIDYIHGEGI----IHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVD 327
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEA 338
APE D++S G+++ EA
Sbjct: 328 TNAPEVLAGDPYTPSVDIWSAGLVIFEA 355
|
Length = 461 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 29/89 (32%), Positives = 44/89 (49%), Gaps = 8/89 (8%)
Query: 148 VLGEGGYGVVYR------GNLINGSPVAVKKILNNVGQAEKE-FRVEVEAIGHV-RHKNL 199
LG G +G V G N VAVK + + E+E E++ + H+ +HKN+
Sbjct: 45 TLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNI 104
Query: 200 VRLLGYCIEGIHRMLVYEYVNNGNLEQWL 228
V LLG C G +++ EY G+L +L
Sbjct: 105 VNLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 463 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.85 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.84 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.84 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.83 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.79 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.77 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.76 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.76 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.75 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.69 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.68 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.66 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.61 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.58 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.52 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.52 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.44 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.42 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.38 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.34 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.32 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.29 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.27 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.23 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.2 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.1 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.05 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.05 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.0 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.87 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.75 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.74 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.74 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.6 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.59 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.54 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.43 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.41 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.39 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.27 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.27 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.22 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.21 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.18 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.1 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.95 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.94 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.9 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.87 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.79 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.72 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.68 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.63 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.58 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.34 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.33 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.21 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.21 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.12 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.08 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.98 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.9 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.78 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.78 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.69 | |
| PLN02236 | 344 | choline kinase | 96.54 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.45 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.23 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.2 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.07 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.98 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.85 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.83 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.54 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.48 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.22 | |
| PF08693 | 40 | SKG6: Transmembrane alpha-helix domain; InterPro: | 94.79 | |
| PF01102 | 122 | Glycophorin_A: Glycophorin A; InterPro: IPR001195 | 94.58 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.24 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-54 Score=420.41 Aligned_cols=289 Identities=55% Similarity=0.922 Sum_probs=252.6
Q ss_pred CcccchHHHHHHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEE
Q 012462 128 GHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI 207 (463)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 207 (463)
...|++.++..++++|.-.+.||+|+||.||+|.+.+|..||||++.........+|.+|+.++.+++|||+|+|+|||.
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 45689999999999999999999999999999999889999999876544321556999999999999999999999999
Q ss_pred ECc-EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEe
Q 012462 208 EGI-HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVS 286 (463)
Q Consensus 208 ~~~-~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~ 286 (463)
+.+ +.+||||||++|+|.++|+..... .++|..+++||.++|+||+|||+.+.|.|+|||||++|||||+++++||+
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 988 599999999999999999864322 78999999999999999999999988899999999999999999999999
Q ss_pred ecccceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcC
Q 012462 287 DFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGS 366 (463)
Q Consensus 287 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 366 (463)
|||+|+..............||..|+|||++..+..+.|+|||||||+|+||+||+.|.+...+.....+.+|.......
T Consensus 220 DFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred CccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 99999765431111111117999999999999999999999999999999999999999877666667799999999888
Q ss_pred CCccccccCCCC-CCCCH-HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCC
Q 012462 367 RRSEEVVDPNIE-VRPST-RALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEE 418 (463)
Q Consensus 367 ~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~ 418 (463)
....+++|+.+. ..... .++.+...++++|++.+|.+||+|.||++.|+.+.
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 899999999976 33332 67888999999999999999999999999996653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-51 Score=376.02 Aligned_cols=252 Identities=27% Similarity=0.425 Sum_probs=206.7
Q ss_pred CCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcc-cchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECc-EEEEEEee
Q 012462 142 RFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILN-NVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGI-HRMLVYEY 218 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e~ 218 (463)
+++.++.||+|..|+||++.++ +++.+|+|++.. ......+++.+|++++++.+|||||.+||.|..+. ..+|+|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 4455678999999999999664 678899999943 34556688999999999999999999999999988 59999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE-AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
|++|+|.+++... +.+++..+-+++.+|++||.|||+ + +||||||||+|||++..|+|||||||.+......
T Consensus 160 MDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred cCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 9999999998543 569999999999999999999996 6 9999999999999999999999999999877554
Q ss_pred CceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCC
Q 012462 298 KSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNI 377 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (463)
...+++||..|||||.+.+..|+.++||||||++++|+.+|+.||.... ....+..+.+..++.+.... +...
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~-~~~~~~~~Ll~~Iv~~ppP~-lP~~-- 305 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN-PPYLDIFELLCAIVDEPPPR-LPEG-- 305 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC-CCCCCHHHHHHHHhcCCCCC-CCcc--
Confidence 4567899999999999999999999999999999999999999998652 12234444444444332211 1110
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 378 EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.+ ..++..+ +-.||++||.+||+++|++++
T Consensus 306 ~f---S~ef~~F---V~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 306 EF---SPEFRSF---VSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred cC---CHHHHHH---HHHHhcCCcccCCCHHHHhcC
Confidence 12 2233333 346999999999999999875
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-50 Score=388.71 Aligned_cols=257 Identities=33% Similarity=0.508 Sum_probs=207.3
Q ss_pred CCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchh--hHHHHHHHHHHHcCCCCCCcceEeeEEEECc-EEEEEEee
Q 012462 142 RFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQ--AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGI-HRMLVYEY 218 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e~ 218 (463)
.+.+.+.||+|+||+||+|.+.....||||++...... ..+.|.+|+.+|.+++|||||+++|+|.+.. ..++||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 34445669999999999999854444999999654322 2568999999999999999999999999887 78999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEEccCCCCceeEcCCC-CEEEeecccceecCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPK-VVHRDIKSSNILIDDDF-NAKVSDFGLAKLLGA 296 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-i~H~Dikp~Nill~~~~-~~kl~Dfg~a~~~~~ 296 (463)
+++|+|.++++.. ....+++..++.++.||++||.|||+. + ||||||||+|||++.++ ++||+|||+++....
T Consensus 122 ~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred CCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 9999999999764 456799999999999999999999999 7 99999999999999998 999999999987654
Q ss_pred CCceeeccccccCCCCchhhhc--cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccccc
Q 012462 297 GKSHVTTRVMGTFGYVAPEYAN--TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVD 374 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (463)
.. ...+...||+.|||||++. ...|+.|+||||||++||||+||+.||....+ ......+........+..
T Consensus 197 ~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~Rp~~p~ 269 (362)
T KOG0192|consen 197 SK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGLRPPIPK 269 (362)
T ss_pred cc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCCCCCCc
Confidence 32 2234468999999999999 56999999999999999999999999986543 222222222222222111
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCC
Q 012462 375 PNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEY 419 (463)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~ 419 (463)
. ....+..++.+||+.||..||++.+++..|+.+..
T Consensus 270 ~---------~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 270 E---------CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred c---------CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 1 22333444557999999999999999999987644
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=395.63 Aligned_cols=263 Identities=30% Similarity=0.466 Sum_probs=223.7
Q ss_pred HHHHHHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEE
Q 012462 134 RDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRM 213 (463)
Q Consensus 134 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 213 (463)
+.+++.++.+.+.+.||+|-||+||.|.+.....||+|.++.. ....+.|.+|+.+|++|+|+|||+++++|..+..+|
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piy 277 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIY 277 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceE
Confidence 4445666667778899999999999999987789999998664 344577889999999999999999999999988999
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
||||||+.|+|.+||+. .....+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+|||+|+.
T Consensus 278 IVtE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred EEEEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccc
Confidence 99999999999999976 3456789999999999999999999999 999999999999999999999999999997
Q ss_pred cCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCcccc
Q 012462 294 LGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV 372 (463)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (463)
..++.+.......-+..|.|||.+..+.++.|||||||||+||||+| |+.||.... ..+.+..+..+.+....
T Consensus 353 ~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms------n~ev~~~le~GyRlp~P 426 (468)
T KOG0197|consen 353 IGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS------NEEVLELLERGYRLPRP 426 (468)
T ss_pred cCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC------HHHHHHHHhccCcCCCC
Confidence 66665555555566889999999999999999999999999999999 888887543 34444555555443332
Q ss_pred ccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCC
Q 012462 373 VDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEE 418 (463)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~ 418 (463)
..+...++.+|..||+.+|++||||+.+...|+++.
T Consensus 427 ----------~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 427 ----------EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred ----------CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 224455667788899999999999999999998864
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=385.42 Aligned_cols=248 Identities=23% Similarity=0.402 Sum_probs=207.1
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEccc---chhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNN---VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
.+|...+.||+|||++||.++. ..|+.||+|++... .....+.+.+|+++.+.|+|||||+++++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999976 78999999998542 2445678889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
|+|..++|..+++ ..+.+++.+++.++.||+.||.|||++ +|+|||||..|+|++++.+|||+|||||.....
T Consensus 98 ELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999985 345799999999999999999999999 999999999999999999999999999998875
Q ss_pred CCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (463)
... ...+.||||.|.|||++....++..+||||+|||||-||+|++||+... +.+....+.... .
T Consensus 171 ~~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~------vkety~~Ik~~~----Y---- 235 (592)
T KOG0575|consen 171 DGE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT------VKETYNKIKLNE----Y---- 235 (592)
T ss_pred ccc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch------HHHHHHHHHhcC----c----
Confidence 432 3456899999999999999999999999999999999999999998543 222222222111 1
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
..+.. .......++.++|++||.+|||+.+|+.+
T Consensus 236 -~~P~~--ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 236 -SMPSH--LSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred -ccccc--cCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11111 11222334557999999999999999954
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-50 Score=407.74 Aligned_cols=263 Identities=26% Similarity=0.456 Sum_probs=220.9
Q ss_pred HHHHhcCCCccCeEeecCcEEEEEEEEc------CCCeEEEEEEcccchh-hHHHHHHHHHHHcCCCCCCcceEeeEEEE
Q 012462 136 LELATNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNVGQ-AEKEFRVEVEAIGHVRHKNLVRLLGYCIE 208 (463)
Q Consensus 136 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 208 (463)
.++.+.+.++.+.||+|+||+||+|+.. +...||||.+++.... .+.+|++|+++++.++|||||+|+|+|.+
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 3556677788899999999999999653 2457999999877655 77899999999999999999999999999
Q ss_pred CcEEEEEEeecCCCCHHHHHhhhhcC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEc
Q 012462 209 GIHRMLVYEYVNNGNLEQWLHGAMRH----------HGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILID 278 (463)
Q Consensus 209 ~~~~~lV~e~~~~g~L~~~l~~~~~~----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~ 278 (463)
++..|+|+|||..|+|.+||+..... ..+++..+.+.||.|||.||.||-++ .+|||||..+|+||.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVG 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceec
Confidence 99999999999999999999754221 22388899999999999999999999 999999999999999
Q ss_pred CCCCEEEeecccceecCCCCceeec-cccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccH
Q 012462 279 DDFNAKVSDFGLAKLLGAGKSHVTT-RVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNL 356 (463)
Q Consensus 279 ~~~~~kl~Dfg~a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~ 356 (463)
++..|||+|||+++.....+++... ...-+.+|||||.+..+.|+.+||||||||||||+++ |+.||.+....+...
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe- 716 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE- 716 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHH-
Confidence 9999999999999988777765544 4456889999999999999999999999999999998 999998765433222
Q ss_pred HHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 357 VDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.+. .++. +.....+...++.+|+.||+.+|.+||+|+||-..|+..
T Consensus 717 -----~i~-~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 717 -----CIR-AGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred -----HHH-cCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 222 2221 233344556777888899999999999999999988875
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=363.77 Aligned_cols=201 Identities=31% Similarity=0.558 Sum_probs=181.2
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEccc--chhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNN--VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
.+|.+.+.||.|+||+||+|++ .++..||||.+... ..+..+.+..|+.+|+.++|||||.+++++.+++.+|||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 5688888999999999999965 45789999999655 45566778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCC------CCEEEeecccc
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDD------FNAKVSDFGLA 291 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~------~~~kl~Dfg~a 291 (463)
||+||+|.+|++. .+.+++..+..++.||+.||++||++ +||||||||.||||+.+ -.+||+|||+|
T Consensus 90 yC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 90 YCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred eCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999964 44699999999999999999999999 99999999999999765 46899999999
Q ss_pred eecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Q 012462 292 KLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350 (463)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~ 350 (463)
+...... ...+.||++-|||||++..+.|+.|+|+||+|++||++++|+.||...+.
T Consensus 163 R~L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 163 RFLQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred hhCCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 9887543 45668999999999999999999999999999999999999999986553
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=369.53 Aligned_cols=254 Identities=27% Similarity=0.400 Sum_probs=203.4
Q ss_pred HhcCCCccCeEeecCcEEEEEE-EEcCCCeEEEEEEcccch-------hhHHHHHHHHHHHcCCCCCCcceEeeEEEECc
Q 012462 139 ATNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVG-------QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGI 210 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 210 (463)
..+.|.+.+.||+|+||.|-+| ...+|+.||||++..... .......+|+++|++|+|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4567888999999999999999 556899999999854321 12234568999999999999999999999999
Q ss_pred EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCC---CCEEEee
Q 012462 211 HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDD---FNAKVSD 287 (463)
Q Consensus 211 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~---~~~kl~D 287 (463)
..|+||||++||+|.+++- .++.+.+..-..++.|++.|+.|||+. ||+||||||+|||+..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecc
Confidence 9999999999999999984 456688888899999999999999999 99999999999999766 7899999
Q ss_pred cccceecCCCCceeeccccccCCCCchhhhccCCC---CccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHh
Q 012462 288 FGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL---NEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMV 364 (463)
Q Consensus 288 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 364 (463)
||+|+... ....+.++|||+.|.|||++.+..+ ..+.|+||+||+||-+++|.+||.+..... .+.+. +
T Consensus 323 FGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~eQ----I 394 (475)
T KOG0615|consen 323 FGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKEQ----I 394 (475)
T ss_pred cchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHHH----H
Confidence 99999875 3456788999999999999976533 348899999999999999999998755332 11111 1
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 365 GSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
..++.... + ....+...+.+.++.+||..||++|||+.|+|++
T Consensus 395 ~~G~y~f~--p----~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 395 LKGRYAFG--P----LQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred hcCccccc--C----hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 11111110 0 1112233455566779999999999999999875
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-50 Score=353.09 Aligned_cols=260 Identities=27% Similarity=0.391 Sum_probs=207.8
Q ss_pred cCCCccCeEeecCcEEEEEE-EEcCCCeEEEEEEccc--chhhHHHHHHHHHHHcCCCCCCcceEee-EEEECcE-EEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNN--VGQAEKEFRVEVEAIGHVRHKNLVRLLG-YCIEGIH-RMLV 215 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~-~~~~~~~-~~lV 215 (463)
.+|+++++||+|.||+||++ ...+|..||.|.+.-. +.+.......|+.+|++|+|||||++++ .|.++.+ ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 34777889999999999999 6678999999998532 2344567788999999999999999999 4555555 7999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEP-KVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
||||.+|+|...++.....++.+++..+|+++.|++.||.++|+..+. -|+||||||.||+++.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999998888888999999999999999999999994322 3899999999999999999999999999988
Q ss_pred CCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccccc
Q 012462 295 GAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVD 374 (463)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (463)
.... ......+|||.||+||.+.+.+|+.||||||+||++|||+.-+.||.+. ++...-..+... ....+
T Consensus 179 ~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI~qg-d~~~~-- 248 (375)
T KOG0591|consen 179 SSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKIEQG-DYPPL-- 248 (375)
T ss_pred cchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHHHcC-CCCCC--
Confidence 6543 4456789999999999999999999999999999999999999999864 233322222222 11111
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 012462 375 PNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416 (463)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~ 416 (463)
+..--...+..++..|++.||+.||+.-.++..+..
T Consensus 249 ------p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 249 ------PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred ------cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 111122233334456999999999996666555544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=341.07 Aligned_cols=265 Identities=25% Similarity=0.324 Sum_probs=204.0
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
++|+.+.++|+|+||+||+++.+ +|+.||||++.+.. ....+-..+|+++|++|+|+|+|.++.+|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46888889999999999999654 58999999996543 3344567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
||+. ++.+-|.. ....++...+.+++.|++.|+.|+|++ +++||||||+|||++.+|.+||||||+|+.....
T Consensus 82 ~~dh-TvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 82 YCDH-TVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred ecch-HHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 9987 44444543 334588999999999999999999999 9999999999999999999999999999987642
Q ss_pred CceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHH--------HHHH-hcCC
Q 012462 298 KSHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDW--------LKMM-VGSR 367 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~--------~~~~-~~~~ 367 (463)
....+..+.|.+|+|||++.+ ..|+..+||||+||++.||++|...|.+...-+....+.. ...+ ..+.
T Consensus 155 -gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 155 -GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred -cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 334567788999999999887 6899999999999999999999999987654433222211 0001 1111
Q ss_pred CccccccCCCCCCC-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 368 RSEEVVDPNIEVRP-----STRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 368 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
...-+.-|..+-.. ......-.+.++..||+.||.+|++.+|++.+
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 11111111111111 11122345566778999999999999999865
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=359.75 Aligned_cols=268 Identities=26% Similarity=0.422 Sum_probs=218.4
Q ss_pred HHHHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchh-hHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEE
Q 012462 136 LELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQ-AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 136 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 214 (463)
.++.+.+..+.++||+|-||.|.++....+..||||+++..... ...+|..|+++|.+|+||||+.++|+|..++.+++
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence 35677888999999999999999998877899999999776544 45899999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
|+|||++|+|.+|+...... .+.-....+|+.||+.||+||.+. +++||||.++|+|++.++++||+|||+++..
T Consensus 613 I~EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNL 687 (807)
T ss_pred HHHHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccccc
Confidence 99999999999999753222 245566778999999999999999 9999999999999999999999999999977
Q ss_pred CCCCcee-eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh--CCCCCCCCCCcccccHHHHHHHHhcCCCccc
Q 012462 295 GAGKSHV-TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT--GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEE 371 (463)
Q Consensus 295 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (463)
..++++. ..+.+-+.+|||||.+..++++.+||||+||++|||+++ ...||...+..+ .++-...+........
T Consensus 688 ysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~~~~ 764 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQGRQV 764 (807)
T ss_pred ccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCCcce
Confidence 6666544 345677899999999999999999999999999999875 788997654322 2222222222222111
Q ss_pred cccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 372 VVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
. .....-+...+++++++||..|-.+||+|+++...|++.
T Consensus 765 ~------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 765 V------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred e------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1 122223445566788899999999999999999999864
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=347.45 Aligned_cols=202 Identities=28% Similarity=0.409 Sum_probs=180.2
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 215 (463)
.++|+++++||+|+||+||.++. ..++.+|+|++.+.. ....+....|..+|.+++||+||+++-.|.+.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 45689999999999999999954 457899999985543 23456678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
+||+.||.|...|. ..+.|++..+..++..|+.||.|||++ +|+||||||+|||||++|+++|+|||+++...
T Consensus 104 ld~~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999994 456799999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 296 AGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
... ..+.++|||+.|||||++.+..|+..+|+||||+++|||++|..||....
T Consensus 177 ~~~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~ 229 (357)
T KOG0598|consen 177 KDG-DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED 229 (357)
T ss_pred cCC-CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc
Confidence 332 23556899999999999999999999999999999999999999998653
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-47 Score=356.15 Aligned_cols=263 Identities=23% Similarity=0.319 Sum_probs=207.8
Q ss_pred HhcCCCccCeEeecCcEEEEEE-EEcCCCeEEEEEEcccchhhHH-HHHHHHHHHcCCC-CCCcceEeeEEEECc-EEEE
Q 012462 139 ATNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEK-EFRVEVEAIGHVR-HKNLVRLLGYCIEGI-HRML 214 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~-~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~l 214 (463)
..+||.+.++||.|+||.||+| ...+|..||||+++......++ .-.+|+..|++|+ ||||+++.+++.+.+ .+|+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 3578999999999999999999 4567899999999765543332 3346999999998 999999999999888 9999
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
|||||+. +|.+++.++ +..|++..+..|+.||++||+|+|.+ |+.|||+||+|||+..+..+||+|||+|+..
T Consensus 88 VfE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eHHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence 9999976 999999763 66799999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCceeeccccccCCCCchhhh-ccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCC-----
Q 012462 295 GAGKSHVTTRVMGTFGYVAPEYA-NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRR----- 368 (463)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~----- 368 (463)
.... ..+..+.|.+|+|||++ +.+.|+.+.|||++|||++|+++-+..|.+..+.+...- +-...+...
T Consensus 161 ~Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~K---Ic~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 161 RSKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYK---ICEVLGTPDKDSWP 235 (538)
T ss_pred ccCC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHH---HHHHhCCCccccch
Confidence 6543 35667889999999976 567899999999999999999999999987664433211 111111111
Q ss_pred ------------ccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 012462 369 ------------SEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414 (463)
Q Consensus 369 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L 414 (463)
......-.+..-- .....+.+.++.+|+++||.+|||+.|++++-
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~-p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLL-PNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhC-cccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 1111100010000 11345556667789999999999999999864
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=343.18 Aligned_cols=263 Identities=24% Similarity=0.349 Sum_probs=205.5
Q ss_pred HhcCCCccCeEeecCcEEEEEEE-EcCCCeEEEEEEc-ccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGN-LINGSPVAVKKIL-NNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
....|++.++||.|..++||+|+ ...+..||||++. ++.....+.+++|+..++.++||||++++..|..+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 35679999999999999999994 4568999999994 334444688999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
.||.+|++.+++...... .+++..+..|++++++||.|||.+ |.||||||+.||||+.+|.|||+|||.+..+..
T Consensus 104 pfMa~GS~ldIik~~~~~--Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPD--GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred hhhcCCcHHHHHHHHccc--cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 999999999999876443 399999999999999999999999 999999999999999999999999999876654
Q ss_pred CCce---eeccccccCCCCchhhhcc--CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccc
Q 012462 297 GKSH---VTTRVMGTFGYVAPEYANT--GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEE 371 (463)
Q Consensus 297 ~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (463)
.... ....++||+.|||||++.. ..|+.|+||||||++..||.+|..||..-.+.. .+.....+.....
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk------vLl~tLqn~pp~~ 252 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK------VLLLTLQNDPPTL 252 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH------HHHHHhcCCCCCc
Confidence 3321 1256789999999999644 468999999999999999999999998654322 2222222211100
Q ss_pred cccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 372 VVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
. -..+.......-...+..++-.||++||++|||+++++++
T Consensus 253 ~-t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 253 L-TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred c-cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 0 0000000000111122333446999999999999999864
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-47 Score=375.47 Aligned_cols=259 Identities=29% Similarity=0.477 Sum_probs=219.3
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEEcC----CCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcE
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNLIN----GSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIH 211 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 211 (463)
++..+...+.++||.|.||.||+|+++- ...||||.++... .+...+|..|+.+|.+++||||++|.|+......
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P 704 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP 704 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence 3445567888999999999999997642 3589999997655 4556789999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccc
Q 012462 212 RMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA 291 (463)
Q Consensus 212 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a 291 (463)
.+||.|||++|+|+.||+. +.+.|.+.++..++++|+.||.||-+. ++|||||.++|||++.+..+|++|||++
T Consensus 705 vMIiTEyMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred eEEEhhhhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccce
Confidence 9999999999999999974 456799999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCceeec--cccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCC
Q 012462 292 KLLGAGKSHVTT--RVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRR 368 (463)
Q Consensus 292 ~~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 368 (463)
+...++.....+ .-.-+.+|.|||.+....++.+|||||||+||||.++ |..||.+.... +.++.+..+.+
T Consensus 779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ------dVIkaIe~gyR 852 (996)
T KOG0196|consen 779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ------DVIKAIEQGYR 852 (996)
T ss_pred eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH------HHHHHHHhccC
Confidence 987655422222 2234689999999999999999999999999999887 99999865433 33444444433
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 369 SEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
+++...+...+.++|+.||++|-.+||.|.||+..|+..
T Consensus 853 ----------LPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl 891 (996)
T KOG0196|consen 853 ----------LPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL 891 (996)
T ss_pred ----------CCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence 444555667788889999999999999999999999875
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-47 Score=363.54 Aligned_cols=254 Identities=28% Similarity=0.434 Sum_probs=206.2
Q ss_pred HHHHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEE
Q 012462 136 LELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 136 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 215 (463)
+++..+...-++-||.|+.|.||+|++ .++.||||++..-.. .+|+-|++|+||||+.|.|+|.....+|||
T Consensus 119 WeiPFe~IsELeWlGSGaQGAVF~Grl-~netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIi 190 (904)
T KOG4721|consen 119 WEIPFEEISELEWLGSGAQGAVFLGRL-HNETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYCII 190 (904)
T ss_pred ccCCHHHhhhhhhhccCcccceeeeec-cCceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeEEe
Confidence 445555556677899999999999988 679999998743222 278889999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
||||..|.|...|+ ....+.......|..+||.||.|||.+ .|||||||.-||||+.+..|||+|||.++...
T Consensus 191 MEfCa~GqL~~VLk----a~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~ 263 (904)
T KOG4721|consen 191 MEFCAQGQLYEVLK----AGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELS 263 (904)
T ss_pred eeccccccHHHHHh----ccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhh
Confidence 99999999999995 455688899999999999999999999 99999999999999999999999999998765
Q ss_pred CCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 296 AGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
.. .....++||..|||||++++.+.++|+|||||||||||||||..||.+-...-. +.+ +-.-
T Consensus 264 ~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI---------IwG------VGsN 326 (904)
T KOG4721|consen 264 DK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI---------IWG------VGSN 326 (904)
T ss_pred hh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee---------EEe------ccCC
Confidence 43 234468999999999999999999999999999999999999999975332110 000 0111
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCCCC
Q 012462 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPI 421 (463)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 421 (463)
.+.+.....+..-+..++..||+-.|..||+|++++.+|+-+...+
T Consensus 327 sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel 372 (904)
T KOG4721|consen 327 SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL 372 (904)
T ss_pred cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence 1222222333333444555799999999999999999998765544
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-46 Score=351.99 Aligned_cols=264 Identities=26% Similarity=0.336 Sum_probs=206.6
Q ss_pred hcCCCccCeEeecCcEEEEEE-EEcCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC--cEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG--IHRML 214 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 214 (463)
.+.|+.+++||+|+||.||+| +..+|+.||+|++..+. .....-..+||.+|++|+||||++|.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 356888899999999999999 55679999999996544 33345667899999999999999999998876 68899
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
|+|||++ +|.-++.. ..-.|++.++..++.|++.||+|||.+ +|+|||||.+|||||.+|.+||+|||||+++
T Consensus 196 VFeYMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEecccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence 9999987 99888853 334599999999999999999999999 9999999999999999999999999999988
Q ss_pred CCCCceeeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccc
Q 012462 295 GAGKSHVTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373 (463)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (463)
........+..+-|.+|+|||++.|. .|+...|+||.||||.||++|++.|.+.++.+.. ..+..+.+......+.
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl---~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQL---HKIFKLCGSPTEDYWP 345 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHH---HHHHHHhCCCChhccc
Confidence 77766667777889999999988774 7999999999999999999999999876643322 2222233222211111
Q ss_pred ----------cCCCCCCCCHHH-----HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 374 ----------DPNIEVRPSTRA-----LKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 374 ----------~~~~~~~~~~~~-----~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.+.........+ ....+.++-.+|..||.+|.|+.++|+.
T Consensus 346 ~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 346 VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 000000000111 1223444557999999999999999854
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=353.63 Aligned_cols=253 Identities=25% Similarity=0.344 Sum_probs=204.6
Q ss_pred HHhcCCCccCeEeecCcEEEEEEE-EcCCCeEEEEEEcccch---hhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEE
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGN-LINGSPVAVKKILNNVG---QAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHR 212 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 212 (463)
...++|.+.+.||+|+|++|++|+ ...++.+|||++.+..- ...+.+..|-++|.+| +||.|++|+-.|.|...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 345679999999999999999994 45789999998854332 2224566788888888 899999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccce
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~ 292 (463)
|+|+||+++|+|.++|+. .+.|++.....++.+|+.||+|||++ |||||||||+|||||.|++++|+|||.|+
T Consensus 150 YFvLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred EEEEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccc
Confidence 999999999999999964 46699999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCce----------ee--ccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHH
Q 012462 293 LLGAGKSH----------VT--TRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWL 360 (463)
Q Consensus 293 ~~~~~~~~----------~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~ 360 (463)
.+.+.... .. ..++||..|.+||++..+..+..+|+|+|||+||+|+.|.+||.+.++.....-
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqk---- 298 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQK---- 298 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHH----
Confidence 87543211 11 458999999999999999999999999999999999999999987664322211
Q ss_pred HHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 012462 361 KMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414 (463)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L 414 (463)
++.-...+++....... .++.+.|..||.+|+|.+||-++.
T Consensus 299 -----------I~~l~y~fp~~fp~~a~--dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 299 -----------IQALDYEFPEGFPEDAR--DLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred -----------HHHhcccCCCCCCHHHH--HHHHHHHccCccccccHHHHhhCc
Confidence 11111222333222222 233468889999999999998764
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-45 Score=354.30 Aligned_cols=251 Identities=26% Similarity=0.423 Sum_probs=202.3
Q ss_pred HHhcCCCccCeEeecCcEEEEEEE-EcCCCeEEEEEEccc----ch-hhHHHHHHHHHHHcCCC-CCCcceEeeEEEECc
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGN-LINGSPVAVKKILNN----VG-QAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGI 210 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 210 (463)
...++|.+.+.||+|+||+|++|. ..++..||+|.+... .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 345789999999999999999994 457899999966442 11 23456678999999998 999999999999999
Q ss_pred EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCC-CCEEEeecc
Q 012462 211 HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDD-FNAKVSDFG 289 (463)
Q Consensus 211 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~-~~~kl~Dfg 289 (463)
.+|+||||+.||+|.+++.. .+++.+..+..+++|++.|++|||++ +|+||||||+|||++.+ +++||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 99999999999999999953 56799999999999999999999999 99999999999999999 999999999
Q ss_pred cceecCCCCceeeccccccCCCCchhhhccCC-CC-ccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCC
Q 012462 290 LAKLLGAGKSHVTTRVMGTFGYVAPEYANTGL-LN-EKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR 367 (463)
Q Consensus 290 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 367 (463)
++.... .......+.||++.|+|||++.+.. |+ .++||||+||+||.|++|+.||++... ......+..
T Consensus 167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~------~~l~~ki~~-- 237 (370)
T KOG0583|consen 167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV------PNLYRKIRK-- 237 (370)
T ss_pred cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH------HHHHHHHhc--
Confidence 999874 2233456789999999999999977 75 789999999999999999999987321 111111111
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 012462 368 RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412 (463)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~ 412 (463)
.....+.... ......++.+||..||.+|+|+.++++
T Consensus 238 -------~~~~~p~~~~-S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 238 -------GEFKIPSYLL-SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred -------CCccCCCCcC-CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 1111111110 222333455799999999999999983
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=355.20 Aligned_cols=251 Identities=24% Similarity=0.404 Sum_probs=207.1
Q ss_pred hcCCCccCeEeecCcEEEEEE-EEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
...|....+||+|+.|.||.| +..+++.||||++........+-+.+|+.+|+.++|+|||.+++.|..++++|+||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 457888899999999999999 5567889999999666555667788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
|+||+|.|.+.. ..+++.++..|+++++.||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+....
T Consensus 352 m~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 352 MEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred cCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 999999998853 3499999999999999999999999 99999999999999999999999999998876544
Q ss_pred ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCC
Q 012462 299 SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (463)
. .....+||+.|||||++....|++|.||||||++++||+-|++||-...+-.. +..+..++ ..++..+.
T Consensus 424 ~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA------lyLIa~ng-~P~lk~~~-- 493 (550)
T KOG0578|consen 424 S-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIATNG-TPKLKNPE-- 493 (550)
T ss_pred C-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHH------HHHHhhcC-CCCcCCcc--
Confidence 3 45567899999999999999999999999999999999999999986443221 12222222 12221111
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 379 ~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.-...+.++ +.+||..|+++|+++.|||++
T Consensus 494 --klS~~~kdF---L~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 494 --KLSPELKDF---LDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred --ccCHHHHHH---HHHHhhcchhcCCCHHHHhcC
Confidence 112233333 347999999999999999975
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-45 Score=341.68 Aligned_cols=256 Identities=28% Similarity=0.408 Sum_probs=197.7
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECc--EEEEEEe
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGI--HRMLVYE 217 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lV~e 217 (463)
.++...+.||+|+||.||++... +|...|||.+........+.+.+|+.+|.+++|||||+++|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 34667789999999999999654 48999999985543333567889999999999999999999754444 6899999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC-CCCEEEeecccceecCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD-DFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~-~~~~kl~Dfg~a~~~~~ 296 (463)
|+++|+|.+++.... +.+++..+..++.||++||+|||++ +|+||||||+|||++. ++.+||+|||++.....
T Consensus 97 y~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 999999999996532 2699999999999999999999999 9999999999999999 79999999999987663
Q ss_pred --CCceeeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccc
Q 012462 297 --GKSHVTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373 (463)
Q Consensus 297 --~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (463)
..........||+.|||||++..+ ....++|||||||++.||+||+.||... .....++..........
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P--- 242 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLP--- 242 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCC---
Confidence 112223457899999999999853 3345999999999999999999999753 11222222222222111
Q ss_pred cCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 012462 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416 (463)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~ 416 (463)
.++....+. .-.++.+|+..||++||||.++|++.-.
T Consensus 243 ----~ip~~ls~~--a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 243 ----EIPDSLSDE--AKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred ----CCCcccCHH--HHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 112222111 2223447999999999999999987544
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=379.48 Aligned_cols=268 Identities=28% Similarity=0.439 Sum_probs=217.8
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc--CCC----eEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI--NGS----PVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHR 212 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~--~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 212 (463)
..+.++.+.||+|+||.||.|... +|. .||+|.+.... .+...+|.+|..+|++++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 455677889999999999999553 343 48999986543 45567899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecc
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRH---HGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFG 289 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg 289 (463)
+|++|||.+|+|..||+..+.. ...++..+++.++.|||+|+.||+++ ++|||||..+|+||++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999865321 34588999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCceeeccc-cccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCC
Q 012462 290 LAKLLGAGKSHVTTRV-MGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSR 367 (463)
Q Consensus 290 ~a~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 367 (463)
+|+.+....++..... .-+.+|||||.+..+.++.|+|||||||+|||++| |..||.+.... +.+......+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~------~v~~~~~~gg 921 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF------EVLLDVLEGG 921 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH------HHHHHHHhCC
Confidence 9997665554443332 45689999999999999999999999999999999 99999865432 2233233333
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCCCCccccc
Q 012462 368 RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDR 426 (463)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~~~ 426 (463)
+ +.+...+...++.+|..||+.+|++||+|..|++.+..+.......+.
T Consensus 922 R----------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~ 970 (1025)
T KOG1095|consen 922 R----------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIY 970 (1025)
T ss_pred c----------cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCcc
Confidence 2 223333445566778899999999999999999988887554444433
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=316.23 Aligned_cols=264 Identities=25% Similarity=0.346 Sum_probs=204.1
Q ss_pred cCCCccCeEeecCcEEEEEE-EEcCCCeEEEEEEcccchh--hHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQ--AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
.+|...++||+|.||.||+| +..+|+.||||+++..... ......+|++.|+.++|+||+.++++|...+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46888899999999999999 5578999999999644222 23456679999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
||+. +|...+++ ....++..++..++.++++||+|||.+ .|+||||||.|+|++.+|.+||+|||+++.+...
T Consensus 82 fm~t-dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9977 99999864 456789999999999999999999999 9999999999999999999999999999988765
Q ss_pred CceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccccc--
Q 012462 298 KSHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVD-- 374 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 374 (463)
...... .+-|.+|+|||++.| ..|+...||||.||++.||+-|.+-|.+.+.-+. ...+-...+......+.+
T Consensus 155 ~~~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ---L~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 155 NRIQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ---LSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred Cccccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH---HHHHHHHcCCCCcccCcccc
Confidence 433222 367999999998876 4799999999999999999998877776543222 111222222211111111
Q ss_pred -------------CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 012462 375 -------------PNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416 (463)
Q Consensus 375 -------------~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~ 416 (463)
+.... --..+....+.++.+||..||.+|+++.|++++=--
T Consensus 231 ~lpdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf 284 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKHPYF 284 (318)
T ss_pred ccccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcchhh
Confidence 00100 001122333566668999999999999999986433
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=349.90 Aligned_cols=269 Identities=26% Similarity=0.433 Sum_probs=211.4
Q ss_pred cchHHHHHHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEE
Q 012462 131 FTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 208 (463)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 208 (463)
.+..++++..+.+.+.+.||+|.||+||+|+|. ..||||++.... .+..+.|++|+..+++-+|.||+-++|+|..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 345778888899999999999999999999884 469999985543 3455789999999999999999999999998
Q ss_pred CcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeec
Q 012462 209 GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDF 288 (463)
Q Consensus 209 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Df 288 (463)
... .||+.+|+|-+|+.+|+.. ...|...+.+.|++||++||.|||.+ +|||+|||..|||+.+++.|||+||
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDF 532 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDF 532 (678)
T ss_pred Cce-eeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecc
Confidence 876 9999999999999999864 34599999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCC-CceeeccccccCCCCchhhhcc---CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHh
Q 012462 289 GLAKLLGAG-KSHVTTRVMGTFGYVAPEYANT---GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMV 364 (463)
Q Consensus 289 g~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 364 (463)
|++...... .........|...|||||+++. .+|++.|||||||+|+|||+||..||........ -.++
T Consensus 533 GLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI-------ifmV 605 (678)
T KOG0193|consen 533 GLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI-------IFMV 605 (678)
T ss_pred cceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe-------EEEe
Confidence 998643211 1122233457788999999864 5799999999999999999999999984332111 1112
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCCC
Q 012462 365 GSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYP 420 (463)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~~ 420 (463)
+.+.. ..+.........+++.++ +..||.+++++||.+.+|+..|+.....
T Consensus 606 GrG~l--~pd~s~~~s~~pk~mk~L---l~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 606 GRGYL--MPDLSKIRSNCPKAMKRL---LSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred ccccc--CccchhhhccCHHHHHHH---HHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 22110 111111112223344444 4469999999999999999998887553
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=351.08 Aligned_cols=263 Identities=27% Similarity=0.425 Sum_probs=202.1
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEE------cCCCeEEEEEEcccc-hhhHHHHHHHHHHHcCC-CCCCcceEeeEEEE
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNL------INGSPVAVKKILNNV-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIE 208 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 208 (463)
.+..++|++.++||+|+||.||+|.. ..+..||+|++.... ......+..|+.++.++ +||||++++++|..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 34567899999999999999999964 234689999986433 23345688899999999 89999999998876
Q ss_pred C-cEEEEEEeecCCCCHHHHHhhhhcC-----------------------------------------------------
Q 012462 209 G-IHRMLVYEYVNNGNLEQWLHGAMRH----------------------------------------------------- 234 (463)
Q Consensus 209 ~-~~~~lV~e~~~~g~L~~~l~~~~~~----------------------------------------------------- 234 (463)
. ...++||||+++|+|.+++......
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 4 4578999999999999999753210
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCce-eecccccc
Q 012462 235 -----HGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSH-VTTRVMGT 308 (463)
Q Consensus 235 -----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt 308 (463)
...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........ ......++
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 13478889999999999999999999 9999999999999999999999999999865332221 12233456
Q ss_pred CCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHH
Q 012462 309 FGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALK 387 (463)
Q Consensus 309 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (463)
..|+|||++.+..++.++|||||||+||||++ |..||....... ........... ... .. ....
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-----~~~~~~~~~~~-~~~-------~~--~~~~ 304 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-----EFCQRLKDGTR-MRA-------PE--NATP 304 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-----HHHHHHhcCCC-CCC-------CC--CCCH
Confidence 78999999999999999999999999999997 999997643211 11111111111 100 00 1112
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 388 RSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 388 ~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.+..++.+||+.||++|||+.|+++.|++.
T Consensus 305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 305 EIYRIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 344566689999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=344.53 Aligned_cols=252 Identities=23% Similarity=0.321 Sum_probs=201.0
Q ss_pred HhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccch---hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEE
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVG---QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 214 (463)
..++|+++.+||+|+||.||+|+. .+|..+|+|++.+..- .+.+.++.|-.+|...++|+||+++-.|.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 457899999999999999999954 5689999999866442 334567789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
||||++||++..+|. ..+.+++..+..++.+++.|++.||+. |+|||||||+|+|||..|++||+||||+.-.
T Consensus 219 iMEylPGGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEecCCccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchh
Confidence 999999999999994 566799999999999999999999999 9999999999999999999999999998532
Q ss_pred CCC----------------------Cce------------------------eeccccccCCCCchhhhccCCCCccchh
Q 012462 295 GAG----------------------KSH------------------------VTTRVMGTFGYVAPEYANTGLLNEKSDV 328 (463)
Q Consensus 295 ~~~----------------------~~~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv 328 (463)
... ... .....+|||.|+|||++.+..|+..+|+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 110 000 0112579999999999999999999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCCCcccc-cHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCC-
Q 012462 329 YSFGVLLLEAITGRDPVDHGRPAHEV-NLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPK- 406 (463)
Q Consensus 329 wSlGvvl~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs- 406 (463)
|||||||||||.|.+||...++.... .++.|-..+. .+.......+...++.+|+. ||++|.-
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~--------------fP~~~~~s~eA~DLI~rll~-d~~~RLG~ 436 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK--------------FPEEVDLSDEAKDLITRLLC-DPENRLGS 436 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc--------------CCCcCcccHHHHHHHHHHhc-CHHHhcCc
Confidence 99999999999999999987765443 2333322211 11111111334445567777 9999974
Q ss_pred --HHHHHH
Q 012462 407 --MSQVVR 412 (463)
Q Consensus 407 --~~ell~ 412 (463)
++||-+
T Consensus 437 ~G~~EIK~ 444 (550)
T KOG0605|consen 437 KGAEEIKK 444 (550)
T ss_pred ccHHHHhc
Confidence 666654
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=342.30 Aligned_cols=249 Identities=24% Similarity=0.420 Sum_probs=204.6
Q ss_pred cCCCccCeEeecCcEEEEEE-EEcCCCeEEEEEEccc-chhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNN-VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
..|...+.||+|.||.||+| ....++.||+|++.-. .....+++++|+.++.+++++||.++|+.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 34666789999999999999 4456889999999543 344567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
|.||++.+.|. ....+.+..+.-++++++.||.|||.. +.+|||||+.|||+..+|.+||+|||++-......
T Consensus 93 ~~gGsv~~lL~----~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 93 CGGGSVLDLLK----SGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred hcCcchhhhhc----cCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 99999999984 344558888888999999999999999 99999999999999999999999999998776543
Q ss_pred ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCC
Q 012462 299 SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (463)
.. ..+++||+.|||||++.+..|+.|+||||||++.+||.+|.+|+....+....-++ ..-..|.+.
T Consensus 166 ~r-r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI------------pk~~PP~L~ 232 (467)
T KOG0201|consen 166 KR-RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI------------PKSAPPRLD 232 (467)
T ss_pred hc-cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec------------cCCCCCccc
Confidence 33 36789999999999999989999999999999999999999999877664332211 111112222
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 379 ~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
. ...+.+.++ +..||++||+.||+|.+++++
T Consensus 233 ~-~~S~~~kEF---V~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 233 G-DFSPPFKEF---VEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred c-ccCHHHHHH---HHHHhhcCcccCcCHHHHhhh
Confidence 2 222233333 335999999999999999965
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=345.86 Aligned_cols=247 Identities=27% Similarity=0.420 Sum_probs=203.4
Q ss_pred cCCCccCeEeecCcEEEEEE-EEcCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
++|.+.+.||+|.||.||+| +..+.+.||+|.+.+.. .+..+.+.+|++++++++||||+.++++|+...+.|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 56888899999999999999 44567899999885433 3445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
|+.| +|..+|. ..+.++++.+..++.+++.||.|||++ +|+|||+||.|||++.++++|+||||+|+.+...
T Consensus 82 ~a~g-~L~~il~----~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILE----QDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhh-hHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 9976 9999995 456799999999999999999999999 9999999999999999999999999999987654
Q ss_pred CceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCC
Q 012462 298 KSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNI 377 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (463)
....+.+.|||-|||||++.+++|+..+|+||+||++||+++|++||.... +...++.+..+.. .+.
T Consensus 154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~d~v-----~~p- 220 (808)
T KOG0597|consen 154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILKDPV-----KPP- 220 (808)
T ss_pred -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhcCCC-----CCc-
Confidence 445667889999999999999999999999999999999999999997432 2233333322211 000
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 378 EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
......+ ..++...|.+||.+|.|..+++.+
T Consensus 221 --~~~S~~f---~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 221 --STASSSF---VNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred --ccccHHH---HHHHHHHhhcChhhcccHHHHhcC
Confidence 1112222 233335889999999999998764
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=333.67 Aligned_cols=249 Identities=24% Similarity=0.383 Sum_probs=206.8
Q ss_pred HhcCCCccCeEeecCcEEEEEEE-EcCCCeEEEEEEcccchh---hHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEE
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGN-LINGSPVAVKKILNNVGQ---AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 214 (463)
...||++.+.||+|.||+|-+|. ...|+.||||.+..+..+ +.-.+++|+++|..|+||||+.+|.+|++.+.+.|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 35689999999999999999994 478999999998665433 33457889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
||||..+|.|+||+.. .+.+++.++..+++||..|+.|+|.+ +++|||||.+|||+|.++++||+|||++.++
T Consensus 131 vMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 131 VMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred EEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhh
Confidence 9999999999999954 45699999999999999999999999 9999999999999999999999999999887
Q ss_pred CCCCceeeccccccCCCCchhhhccCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccc
Q 012462 295 GAGKSHVTTRVMGTFGYVAPEYANTGLL-NEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373 (463)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (463)
... ...+++||.+-|.+||++.+.+| ++..|-|||||+||-|+.|.+||++.. ....+.++..+ ...
T Consensus 204 ~~~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D------hk~lvrQIs~G----aYr 271 (668)
T KOG0611|consen 204 ADK--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD------HKRLVRQISRG----AYR 271 (668)
T ss_pred ccc--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch------HHHHHHHhhcc----ccc
Confidence 543 35678999999999999999988 578999999999999999999998643 22222222221 111
Q ss_pred cCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 012462 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414 (463)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L 414 (463)
.+. .+.. .-.++.+||-.||++|.|+.++..++
T Consensus 272 EP~--~PSd------A~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 272 EPE--TPSD------ASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred CCC--CCch------HHHHHHHHHhcCcccchhHHHHhhhh
Confidence 111 1111 12245578889999999999999876
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=351.87 Aligned_cols=268 Identities=30% Similarity=0.438 Sum_probs=211.7
Q ss_pred hHHHHHHhcCCCccCeEeecCcEEEEEEEEcC--C---CeEEEEEEcc---cchhhHHHHHHHHHHHcCCCCCCcceEee
Q 012462 133 LRDLELATNRFSKENVLGEGGYGVVYRGNLIN--G---SPVAVKKILN---NVGQAEKEFRVEVEAIGHVRHKNLVRLLG 204 (463)
Q Consensus 133 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~--~---~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 204 (463)
...+++..++..+.++||+|+||.||+|++.. + ..||+|.... .......+|.+|++++++++|||||++||
T Consensus 149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 34556677778888999999999999996543 2 2389998874 23556688999999999999999999999
Q ss_pred EEEECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEE
Q 012462 205 YCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAK 284 (463)
Q Consensus 205 ~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~k 284 (463)
++.....+++|||+|.||+|.++|... ...++..+++.++.+.+.||+|||++ +++||||..+|+|++.++.+|
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vK 302 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVK 302 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEE
Confidence 999999999999999999999999742 33699999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCceeec-cccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHH
Q 012462 285 VSDFGLAKLLGAGKSHVTT-RVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKM 362 (463)
Q Consensus 285 l~Dfg~a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~ 362 (463)
|+|||+++.... ..... ...-+.+|+|||.+....|+.++|||||||++||+++ |..||.+.... +....
T Consensus 303 ISDFGLs~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------~v~~k 374 (474)
T KOG0194|consen 303 ISDFGLSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------EVKAK 374 (474)
T ss_pred eCccccccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH------HHHHH
Confidence 999999886541 11111 1135789999999999999999999999999999999 88899865432 22222
Q ss_pred HhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCCCCcc
Q 012462 363 MVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVR 423 (463)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~ 423 (463)
....+..... +. ........++.+||..+|++||+|.++.+.|+........
T Consensus 375 I~~~~~r~~~-------~~--~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 375 IVKNGYRMPI-------PS--KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred HHhcCccCCC-------CC--CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 2122111111 11 1222333344489999999999999999999987665544
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=317.32 Aligned_cols=199 Identities=29% Similarity=0.418 Sum_probs=178.6
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccch---hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVG---QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
++|+..+.||.|+||+|.+++.+ +|..+|+|++....- .+.+...+|..+|+.+.||+++++++.|.+.+.+|+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 45788899999999999999654 578999998855432 23345667999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||.+||.|..+|+. .+.|++..++.++.||+.||+|||++ +|++|||||+|||+|.+|.+||+|||+|+....
T Consensus 124 eyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 99999999999964 45699999999999999999999999 999999999999999999999999999998754
Q ss_pred CCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~ 350 (463)
. +-+.||||.|+|||++....|+.++|+|||||++|||+.|.+||...++
T Consensus 197 r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 197 R----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred c----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 3 4568999999999999999999999999999999999999999987664
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=332.52 Aligned_cols=265 Identities=25% Similarity=0.420 Sum_probs=201.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEEcC-----------------CCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcce
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLIN-----------------GSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVR 201 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~ 201 (463)
.++|.+.++||+|+||.||+|.+.+ +..||+|.+.... .....++.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4678999999999999999996532 2369999886543 334567889999999999999999
Q ss_pred EeeEEEECcEEEEEEeecCCCCHHHHHhhhhc---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 012462 202 LLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMR---------------HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVV 266 (463)
Q Consensus 202 l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~---------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~ 266 (463)
+++++.+.+..++||||+.+|+|.+++..... ....+++..++.++.||+.||.|||+. +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 99999999999999999999999999864211 113478889999999999999999999 999
Q ss_pred EccCCCCceeEcCCCCEEEeecccceecCCCCce-eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh--CCC
Q 012462 267 HRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSH-VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT--GRD 343 (463)
Q Consensus 267 H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt--g~~ 343 (463)
||||||+|||++.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999865443321 2233456789999999998899999999999999999987 566
Q ss_pred CCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 012462 344 PVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416 (463)
Q Consensus 344 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~ 416 (463)
||...... .................... ..+ .....+..++.+||+.||++|||+.||.+.|++
T Consensus 241 p~~~~~~~---~~~~~~~~~~~~~~~~~~~~----~~~--~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTDE---QVIENAGEFFRDQGRQVYLF----RPP--PCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCHH---HHHHHHHHHhhhcccccccc----CCC--CCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 77654321 22222222111111100000 001 111234556678999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=352.46 Aligned_cols=259 Identities=25% Similarity=0.400 Sum_probs=212.8
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEEcCC-CeEEEEEEcccchhhHHHHHHHHHHHcCCC-CCCcceEeeE-EEE-----
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNLING-SPVAVKKILNNVGQAEKEFRVEVEAIGHVR-HKNLVRLLGY-CIE----- 208 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~-~~~----- 208 (463)
.+...++++.+.|.+|||+.||+|....+ ..+|+|++...+....+.+++|+++|++|. |+|||.+++. ...
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 45667888999999999999999977666 999999998777778889999999999995 9999999993 221
Q ss_pred -CcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEee
Q 012462 209 -GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSD 287 (463)
Q Consensus 209 -~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~D 287 (463)
.-+++|+||||.||.|-||+..+.... |++.++++|+.|+++|+++||.. .|+|||||||-+||||+.+++.||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~--lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTR--LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhcc--CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCc
Confidence 235689999999999999998765543 99999999999999999999985 77899999999999999999999999
Q ss_pred cccceecCCCCcee--------eccccccCCCCchhhh---ccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccH
Q 012462 288 FGLAKLLGAGKSHV--------TTRVMGTFGYVAPEYA---NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNL 356 (463)
Q Consensus 288 fg~a~~~~~~~~~~--------~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~ 356 (463)
||.+.......... .-...-|+.|+|||++ .+.+.++|+|||+|||+||-|+....||+....
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------ 263 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------ 263 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc------
Confidence 99986433222100 0012358999999976 577899999999999999999999999986532
Q ss_pred HHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 357 VDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
..+++....+++.......+..+|..||+.||.+||++-|++..+..+
T Consensus 264 -------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 264 -------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred -------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 233444555555555556666667789999999999999999888765
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=327.74 Aligned_cols=256 Identities=27% Similarity=0.419 Sum_probs=200.4
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc----CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI----NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 214 (463)
.++|++.+.||+|+||.||+|.+. .+..||+|.+.... ......+..|+..+.+++||||+++++++..+...++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 467889999999999999999653 35689999886543 2334678889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
||||+++|+|.+++.. ....+++..++.++.|++.||+|||+. +++||||||+|||++.++.++++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 9999999999999864 234689999999999999999999999 9999999999999999999999999987654
Q ss_pred CCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccc
Q 012462 295 GAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373 (463)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (463)
............++..|+|||.+.+..++.++|||||||++||+++ |..||...... +.+..........
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~------~~~~~~~~~~~~~--- 228 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ------DVIKAVEDGFRLP--- 228 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH------HHHHHHHCCCCCC---
Confidence 2221111112335678999999999999999999999999999875 99999754321 1222222111100
Q ss_pred cCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.... ....+..++.+||+.+|++||++.+|++.|...
T Consensus 229 -----~~~~--~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 229 -----APRN--CPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -----CCCC--CCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0111 122334456689999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=342.62 Aligned_cols=246 Identities=27% Similarity=0.368 Sum_probs=202.0
Q ss_pred CCccCeEeecCcEEEEEEE-EcCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 143 FSKENVLGEGGYGVVYRGN-LINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 143 ~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
|++.+.||.|+-|.|-+|+ ..+|+.+|||++.... ......+.+|+-+|+.+.|||++++|+++++..++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 6778899999999999994 4679999999985442 23345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+++|.|.+++. .++++++.++.+++.||+.|+.|||.. +|+||||||+|+|||..+++||+|||+|..-..+.
T Consensus 94 v~gGELFdylv----~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 94 VPGGELFDYLV----RKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred cCCchhHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 99999999994 467799999999999999999999999 99999999999999999999999999998754433
Q ss_pred ceeeccccccCCCCchhhhccCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCC
Q 012462 299 SHVTTRVMGTFGYVAPEYANTGLL-NEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNI 377 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (463)
...+-||.+.|.|||++.|.+| +.++||||.|||||.||||+.||++. ++...+... ..+...-.
T Consensus 167 --lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd------Nir~LLlKV-~~G~f~MP----- 232 (786)
T KOG0588|consen 167 --LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD------NIRVLLLKV-QRGVFEMP----- 232 (786)
T ss_pred --cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc------cHHHHHHHH-HcCcccCC-----
Confidence 3456799999999999999988 47999999999999999999999843 233333322 22221111
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 012462 378 EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414 (463)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L 414 (463)
.....+. ..++.+|++.||++|.|++||+++-
T Consensus 233 --s~Is~ea---QdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 233 --SNISSEA---QDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred --CcCCHHH---HHHHHHHhccCccccccHHHHhhCc
Confidence 1111222 2334479999999999999999874
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=330.11 Aligned_cols=245 Identities=19% Similarity=0.327 Sum_probs=194.2
Q ss_pred CeEeecCcEEEEEEEEcCCCeEEEEEEcccchhh---HHHHHHHHHHHcCCCCCCcceEeeEEEE----CcEEEEEEeec
Q 012462 147 NVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQA---EKEFRVEVEAIGHVRHKNLVRLLGYCIE----GIHRMLVYEYV 219 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lV~e~~ 219 (463)
..||+|++|.||+|.+ +|+.||||++....... .+.+.+|+.++.+++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999987 78999999986543222 4667799999999999999999999877 34678999999
Q ss_pred CCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCc
Q 012462 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299 (463)
Q Consensus 220 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 299 (463)
++|+|.+++.. ...+++...+.++.|++.||.|||+.. +++||||||+|||++.++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 99999999953 346889999999999999999999732 78899999999999999999999999998654321
Q ss_pred eeeccccccCCCCchhhhcc--CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCC
Q 012462 300 HVTTRVMGTFGYVAPEYANT--GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNI 377 (463)
Q Consensus 300 ~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (463)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||..... .+............
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~------- 241 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT------KEIYDLIINKNNSL------- 241 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCCC-------
Confidence 23467899999999976 6899999999999999999999999985432 12222222111111
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 378 EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
..+.. ....+..++.+||+.||++|||+.|+++.|+..
T Consensus 242 ~~~~~--~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 242 KLPLD--CPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred CCCCc--CcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 11101 112334456689999999999999999999875
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=328.01 Aligned_cols=251 Identities=23% Similarity=0.285 Sum_probs=197.0
Q ss_pred CCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 143 FSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 143 ~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
|+..+.||+|+||+||+|.. .+++.||+|.+.... ......+.+|+.++.+++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67788999999999999954 578999999885432 22234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+++|+|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 82 MNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred cCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 9999999887542 234589999999999999999999999 99999999999999999999999999998754322
Q ss_pred ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCC
Q 012462 299 SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (463)
......||..|+|||++.+..++.++|||||||++|||++|+.||......... ..+........ ..
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~--------~~ 223 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRVKEDQ--------EE 223 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHhhccc--------cc
Confidence 223457899999999999999999999999999999999999999865432111 11111111100 01
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 012462 379 VRPSTRALKRSLLTALRCVDPDSEKRPK-----MSQVVRM 413 (463)
Q Consensus 379 ~~~~~~~~~~~~~~~~~cl~~dP~~RPs-----~~ell~~ 413 (463)
..... ......++.+||+.||.+||+ +++++++
T Consensus 224 ~~~~~--s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 224 YSEKF--SEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred CCccC--CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 11111 112334556799999999997 7888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=328.96 Aligned_cols=266 Identities=24% Similarity=0.281 Sum_probs=199.3
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
++|++.+.||+|+||+||+|+.. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47899999999999999999764 57889999985432 2334567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
|++++.+..+.. ....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 999876655432 234689999999999999999999999 9999999999999999999999999999876443
Q ss_pred CceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHH---------HHHHHhcCCC
Q 012462 298 KSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVD---------WLKMMVGSRR 368 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~---------~~~~~~~~~~ 368 (463)
.........|++.|+|||++.+..++.++|||||||++|||++|+.||............. +.........
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 3222334578999999999999899999999999999999999999998644322111000 0000000000
Q ss_pred ccccccCCCCCCCCH------HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 369 SEEVVDPNIEVRPST------RALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 369 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
......+........ .....+..++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000000 011235556678999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=332.22 Aligned_cols=245 Identities=24% Similarity=0.305 Sum_probs=197.3
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999654 68899999985432 223456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+++|+|.+++.. .+.+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999853 34689999999999999999999999 999999999999999999999999999986543
Q ss_pred CCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (463)
. ....+|++.|+|||++.+..++.++|||||||++|||++|+.||...... ..........
T Consensus 154 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~------~~~~~i~~~~--------- 214 (291)
T cd05612 154 R----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF------GIYEKILAGK--------- 214 (291)
T ss_pred C----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC---------
Confidence 2 22356899999999999999999999999999999999999999764321 1112221111
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 012462 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPK-----MSQVVRM 413 (463)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs-----~~ell~~ 413 (463)
....... ......++.+||+.||.+||+ +++++++
T Consensus 215 ~~~~~~~--~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 215 LEFPRHL--DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred cCCCccC--CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1111111 112334556899999999995 8888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=335.40 Aligned_cols=200 Identities=27% Similarity=0.387 Sum_probs=174.9
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
.++|++.+.||+|+||.||++... ++..+|+|.+.... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 478999999999999999999654 57889999885442 3345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 9999999999853 345899999999999999999999852 6999999999999999999999999998765332
Q ss_pred CceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCC
Q 012462 298 KSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~ 348 (463)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 223456899999999999999999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=324.14 Aligned_cols=256 Identities=25% Similarity=0.426 Sum_probs=205.4
Q ss_pred HhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
..++|++.++||+|+||.||+|...++..||+|.+.... ...+.+..|+.++++++|+||+++++++.+.+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 356789999999999999999988788899999875432 3356788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+++++|.+++... ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 83 MAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 9999999998643 334588899999999999999999999 99999999999999999999999999998765433
Q ss_pred ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCC
Q 012462 299 SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNI 377 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (463)
........++..|+|||.+.+..++.++|||||||++|+|++ |..||...... ............ +..
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~------~~~~~~~~~~~~-----~~~ 226 (261)
T cd05072 158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS------DVMSALQRGYRM-----PRM 226 (261)
T ss_pred eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH------HHHHHHHcCCCC-----CCC
Confidence 222233345678999999998889999999999999999998 99999754321 111122211111 000
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 012462 378 EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416 (463)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~ 416 (463)
.. ....+..++.+||+.+|++||+++++++.|++
T Consensus 227 --~~---~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 227 --EN---CPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred --CC---CCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11 11234455668999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=343.03 Aligned_cols=263 Identities=27% Similarity=0.401 Sum_probs=202.7
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEE------cCCCeEEEEEEcccc-hhhHHHHHHHHHHHcCC-CCCCcceEeeEEEE
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNL------INGSPVAVKKILNNV-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIE 208 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 208 (463)
.+..++|++.+.||+|+||.||+|.+ .++..||||++.... ....+.+.+|+.++..+ +||||++++++|.+
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 34456799999999999999999953 235689999885433 33445688899999999 89999999999999
Q ss_pred CcEEEEEEeecCCCCHHHHHhhhhc-------------------------------------------------------
Q 012462 209 GIHRMLVYEYVNNGNLEQWLHGAMR------------------------------------------------------- 233 (463)
Q Consensus 209 ~~~~~lV~e~~~~g~L~~~l~~~~~------------------------------------------------------- 233 (463)
....++||||+++|+|.+++.....
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 9999999999999999999864321
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 234 ----------------HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 234 ----------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 012478889999999999999999999 9999999999999999999999999999876433
Q ss_pred Ccee-eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 298 KSHV-TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 298 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
.... .....++..|+|||++.+..++.++|||||||++|||++ |..||....... .... ......... .+
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~---~~~~~~~~~---~~ 339 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYK---MIKEGYRML---SP 339 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHH---HHHhCccCC---CC
Confidence 2211 122345678999999999999999999999999999998 888986543211 1111 111111100 00
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.... ..+..++.+||+.||++||++.|+++.|+..
T Consensus 340 ----~~~~---~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 ----ECAP---SEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ----CCCC---HHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0111 2344556689999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=338.10 Aligned_cols=253 Identities=23% Similarity=0.331 Sum_probs=199.6
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
++|++.+.||+|+||.||+|... +++.||+|++.... ......+..|+.++..++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36889999999999999999765 57899999985432 223456778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999853 34689999999999999999999999 999999999999999999999999999976543
Q ss_pred CCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (463)
......||+.|+|||++.+..++.++|||||||++|||++|..||......... ......... ...+.
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~------~~i~~~~~~--~~~~~ 221 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW------ENLKYWKET--LQRPV 221 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH------HHHHhcccc--ccCCC
Confidence 233457899999999999999999999999999999999999999764432111 111110000 00000
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
. ..+..........++.+||..+|.+||++++++++
T Consensus 222 ~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 222 Y-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred C-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0 00001112233445567999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=334.96 Aligned_cols=245 Identities=23% Similarity=0.311 Sum_probs=197.2
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++.+++||||+++++++.+++..|+||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888999999999999999664 57899999985432 123456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+.+|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 98 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999853 34688999999999999999999999 999999999999999999999999999987643
Q ss_pred CCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (463)
.. ...+||+.|+|||++.+..++.++|||||||++|||++|..||....+. ......... .
T Consensus 171 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~~-~-------- 231 (329)
T PTZ00263 171 RT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------RIYEKILAG-R-------- 231 (329)
T ss_pred Cc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH------HHHHHHhcC-C--------
Confidence 22 2357899999999999999999999999999999999999999754321 111112111 1
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 012462 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPK-----MSQVVRM 413 (463)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs-----~~ell~~ 413 (463)
...+.... .....++.+||+.||.+||+ +++++++
T Consensus 232 ~~~p~~~~--~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 232 LKFPNWFD--GRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred cCCCCCCC--HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11111111 12334556899999999997 6777765
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=305.63 Aligned_cols=248 Identities=25% Similarity=0.376 Sum_probs=203.4
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
++|++.+.||+|-||.||+|+. +++..||+|++.... ...+..+.+|+++-..|+||||+++|++|.+....||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 5688899999999999999954 466789999985432 234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||...|+|...|.+. ....+++.....++.|+|.||.|+|.. +|+||||||+|+|++..+.+||+|||-+.....
T Consensus 102 Eya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred EecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 999999999999753 445689999999999999999999999 999999999999999999999999999987543
Q ss_pred CCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (463)
+ ...+.|||..|.+||+..+..++...|+|++|++.||++.|..||+.....+... .+.. .++..|
T Consensus 177 ~---kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYk------rI~k----~~~~~p- 242 (281)
T KOG0580|consen 177 N---KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYK------RIRK----VDLKFP- 242 (281)
T ss_pred C---CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHH------HHHH----ccccCC-
Confidence 2 3456899999999999999999999999999999999999999998755222111 1110 111111
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.... .....++.+|+..+|.+|.+..|++.+
T Consensus 243 ----~~is--~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 243 ----STIS--GGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ----cccC--hhHHHHHHHHhccCccccccHHHHhhh
Confidence 1111 122234558999999999999999876
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=333.76 Aligned_cols=242 Identities=23% Similarity=0.282 Sum_probs=192.1
Q ss_pred CeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCCC
Q 012462 147 NVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNG 222 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 222 (463)
+.||+|+||.||+|.. .+|+.||+|++.... ......+..|+.++++++||||+++++++.+.+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999965 468899999986432 223345678999999999999999999999999999999999999
Q ss_pred CHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCceee
Q 012462 223 NLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVT 302 (463)
Q Consensus 223 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 302 (463)
+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~ 152 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccc
Confidence 99998853 45689999999999999999999999 99999999999999999999999999987532221 123
Q ss_pred ccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCC
Q 012462 303 TRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPS 382 (463)
Q Consensus 303 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (463)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........... ......
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~~~~~~---------~~~p~~ 217 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILMEE---------IRFPRT 217 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH------HHHHHHHHcCC---------CCCCCC
Confidence 346799999999999999999999999999999999999999975332 11111111111 011111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 012462 383 TRALKRSLLTALRCVDPDSEKRP-----KMSQVVRM 413 (463)
Q Consensus 383 ~~~~~~~~~~~~~cl~~dP~~RP-----s~~ell~~ 413 (463)
. ...+..++.+||+.||++|| ++.+++++
T Consensus 218 ~--~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 218 L--SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred C--CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 1 12233445589999999999 79998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=322.44 Aligned_cols=251 Identities=26% Similarity=0.426 Sum_probs=200.9
Q ss_pred cCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecC
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVN 220 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 220 (463)
++|++.+.||+|+||.||++.+.++..+|+|.+... ......+..|+.++++++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457888999999999999998888889999987543 2334678889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCce
Q 012462 221 NGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSH 300 (463)
Q Consensus 221 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 300 (463)
+|+|.+++... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 83 NGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 99999998642 23588999999999999999999999 9999999999999999999999999999865433222
Q ss_pred eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCC
Q 012462 301 VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEV 379 (463)
Q Consensus 301 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (463)
......++..|+|||++.+..++.++||||||+++|||++ |+.||..... .+.+......... ..+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~------~~~~~~i~~~~~~---~~~~--- 224 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN------YEVVEMISRGFRL---YRPK--- 224 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHCCCCC---CCCC---
Confidence 2222345668999999998889999999999999999999 8999975432 1222222222111 1111
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 012462 380 RPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414 (463)
Q Consensus 380 ~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L 414 (463)
.. ...+..++.+||+.+|++||++.++++.|
T Consensus 225 -~~---~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 -LA---SMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -CC---CHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 01 12345566789999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=349.34 Aligned_cols=252 Identities=20% Similarity=0.271 Sum_probs=202.5
Q ss_pred CCCccCeEeecCcEEEEEEEE-cC-CCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeec
Q 012462 142 RFSKENVLGEGGYGVVYRGNL-IN-GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYV 219 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~-~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 219 (463)
.|.+.+.||+|+||.||+|.. .+ +..||+|.+..........+..|+.+++.++||||++++++|...+..|+||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 488899999999999999954 33 5788888775555555567788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCc
Q 012462 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299 (463)
Q Consensus 220 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 299 (463)
++|+|.+++.........+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999999876545566789999999999999999999999 999999999999999999999999999987654322
Q ss_pred -eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCC
Q 012462 300 -HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378 (463)
Q Consensus 300 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (463)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+......... ...
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~~~~~~-~~~----- 292 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVLYGKYD-PFP----- 292 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCC-CCC-----
Confidence 223456799999999999999999999999999999999999999975432 1222222211110 000
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 012462 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412 (463)
Q Consensus 379 ~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~ 412 (463)
.... ..+..++.+||+.||++||++.+++.
T Consensus 293 -~~~s---~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 293 -CPVS---SGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -ccCC---HHHHHHHHHHhccChhhCcCHHHHHh
Confidence 0111 23344556899999999999999875
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=338.84 Aligned_cols=264 Identities=25% Similarity=0.386 Sum_probs=221.9
Q ss_pred hHHHHHHhcCCCccCeEeecCcEEEEEEEEcC-CCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcE
Q 012462 133 LRDLELATNRFSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIH 211 (463)
Q Consensus 133 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 211 (463)
.+.++..+.+....++||-|-||.||.|.|+. .-.||||.++.+ ....++|..|..+|+.++|||+|+|+|+|.....
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 47788889999999999999999999997754 568999998665 4556789999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccc
Q 012462 212 RMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA 291 (463)
Q Consensus 212 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a 291 (463)
+|||.|||..|+|.+||+.+. ...++...++.++.||..||+||..+ ++|||||..+|+|+.++..||++|||++
T Consensus 338 FYIiTEfM~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred eEEEEecccCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchh
Confidence 999999999999999998753 34477788899999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 292 KLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
+++..+.+........+..|.|||-+....++.|+|||+|||+|||+.| |..||.+-. +.+....+..+.+.
T Consensus 413 RlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------lSqVY~LLEkgyRM- 485 (1157)
T KOG4278|consen 413 RLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYGLLEKGYRM- 485 (1157)
T ss_pred hhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------HHHHHHHHhccccc-
Confidence 9987665555555556889999999999999999999999999999998 888887532 22222222222222
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCC
Q 012462 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEE 418 (463)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~ 418 (463)
.....+....+.+|+.||+++|.+||+|.|+-+.++...
T Consensus 486 ---------~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 486 ---------DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred ---------cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 222234456777888999999999999999998887753
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=343.06 Aligned_cols=245 Identities=26% Similarity=0.342 Sum_probs=196.6
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccch---hhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcE
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVG---QAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIH 211 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 211 (463)
.+.-++|.++++||+|.||+|+++.. .+++.+|||.+++..- .+.+..+.|..++... +||.++.++..|.+.++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 34457799999999999999999965 4578999999976542 3334566677776665 69999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccc
Q 012462 212 RMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA 291 (463)
Q Consensus 212 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a 291 (463)
+|+||||+.||++..+. ..+.|++..+..++..|+.||.|||++ +|||||||.+|||||.+|++||+|||++
T Consensus 444 l~fvmey~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred EEEEEEecCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccc
Confidence 99999999999954433 345699999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccc
Q 012462 292 KLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEE 371 (463)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (463)
+..-... ..+.++||||.|||||++.+..|+..+|+|||||+|||||.|..||.+.++.+..+. +..+ +
T Consensus 516 Ke~m~~g-~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fds------I~~d----~ 584 (694)
T KOG0694|consen 516 KEGMGQG-DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDS------IVND----E 584 (694)
T ss_pred cccCCCC-CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH------HhcC----C
Confidence 8754222 246779999999999999999999999999999999999999999997654432221 1111 1
Q ss_pred cccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 012462 372 VVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKM 407 (463)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~ 407 (463)
. ....-...+.+.++.++|.+||++|.-+
T Consensus 585 ~-------~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 585 V-------RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred C-------CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1 1111122344455668999999999855
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=321.98 Aligned_cols=257 Identities=28% Similarity=0.429 Sum_probs=205.2
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
+..++|++.+.||+|+||.||+|...++..||+|.+.... .....+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 4567799999999999999999987778899999885433 335678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
|+++++|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 82 LMKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred cccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 99999999998643 234689999999999999999999999 9999999999999999999999999999876533
Q ss_pred CceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccCC
Q 012462 298 KSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (463)
..........+..|+|||.+.+..++.++||||||+++|||++ |+.||...... .............
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~~~~~~~~~------ 224 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA------EVLQQVDQGYRMP------ 224 (261)
T ss_pred cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHHcCCCCC------
Confidence 2221222233467999999999899999999999999999999 99999754321 1111222111110
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 012462 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416 (463)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~ 416 (463)
... .....+..++.+||+.+|++||++.++++.|++
T Consensus 225 --~~~--~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 225 --CPP--GCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred --CCC--cCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 000 112334556668999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=339.21 Aligned_cols=196 Identities=21% Similarity=0.276 Sum_probs=169.6
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
+..++|++.+.||+|+||.||+|.. ..++.||+|... ...+.+|+.++++++||||++++++|......++|+
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 3456899999999999999999954 568899999642 234667999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
|++. ++|..++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 163 e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~ 234 (391)
T PHA03212 163 PRYK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVD 234 (391)
T ss_pred ecCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence 9995 689888753 34588999999999999999999999 999999999999999999999999999975433
Q ss_pred CCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDH 347 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 347 (463)
.........+||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 222223456799999999999999999999999999999999999988754
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=340.75 Aligned_cols=263 Identities=25% Similarity=0.411 Sum_probs=201.9
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEEc------CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCC-CCCCcceEeeEEEE
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIE 208 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 208 (463)
....++|++.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.+ +|+||++++++|..
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 344567999999999999999998642 23579999986543 33345678899999999 89999999999999
Q ss_pred CcEEEEEEeecCCCCHHHHHhhhhc-------------------------------------------------------
Q 012462 209 GIHRMLVYEYVNNGNLEQWLHGAMR------------------------------------------------------- 233 (463)
Q Consensus 209 ~~~~~lV~e~~~~g~L~~~l~~~~~------------------------------------------------------- 233 (463)
....++||||+++|+|.+++.....
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 9999999999999999999864211
Q ss_pred -----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCce-e
Q 012462 234 -----------HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSH-V 301 (463)
Q Consensus 234 -----------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~ 301 (463)
....+++..+++++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++........ .
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 112478889999999999999999999 9999999999999999999999999999865433221 1
Q ss_pred eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCC
Q 012462 302 TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVR 380 (463)
Q Consensus 302 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (463)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||....... . ...... ...... .+ .
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~---~~~~~~-~~~~~~--~~----~ 338 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--K---FYKMVK-RGYQMS--RP----D 338 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--H---HHHHHH-cccCcc--CC----C
Confidence 222335678999999999999999999999999999997 999997543211 1 111111 110000 00 0
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 381 PSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 381 ~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
... ..+..++.+||+.||++|||+.++++.|++.
T Consensus 339 ~~~---~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 339 FAP---PEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 011 2334456689999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=323.13 Aligned_cols=257 Identities=28% Similarity=0.469 Sum_probs=207.5
Q ss_pred HhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
...+|++.++||.|+||.||+|...++..+++|.+..........+..|+.+++.++||||+++++++.+....++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34568888999999999999998878999999998766555567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+++++|.+++... ....+++..++.++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 84 MEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred cccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 9999999999653 334689999999999999999999999 99999999999999999999999999997664332
Q ss_pred ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCC
Q 012462 299 SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNI 377 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (463)
.. .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... .............
T Consensus 159 ~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~~------- 224 (261)
T cd05148 159 YL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH------EVYDQITAGYRMP------- 224 (261)
T ss_pred cc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH------HHHHHHHhCCcCC-------
Confidence 11 223345778999999998899999999999999999998 89999754321 1111222111110
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 378 EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
........+..++.+||+.||++|||+.++++.|+.+
T Consensus 225 ---~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 225 ---CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ---CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 0011122344566789999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=327.95 Aligned_cols=262 Identities=23% Similarity=0.347 Sum_probs=196.1
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
++|++.++||+|+||+||+|.. .++..||+|.+.... ......+.+|+.++++++||||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 5689999999999999999965 467899999885432 22345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+++ +|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LDS-DLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCc-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 975 99998853 234578999999999999999999999 99999999999999999999999999997654322
Q ss_pred ceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCc--------
Q 012462 299 SHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS-------- 369 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------- 369 (463)
. ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||.......... .+.........
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELH---LIFRLLGTPTEETWPGITS 233 (288)
T ss_pred c-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCChHHhhcccc
Confidence 1 1233467899999998865 568999999999999999999999997654322111 11111100000
Q ss_pred ----cccccCCCCCCCCH----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 370 ----EEVVDPNIEVRPST----RALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 370 ----~~~~~~~~~~~~~~----~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.....+.....+.. ........++.+||+.||.+|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000000000 011233455668999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=303.20 Aligned_cols=266 Identities=24% Similarity=0.348 Sum_probs=211.6
Q ss_pred HHhcCCCccCeEeecCcEEEEEEE-EcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC-----cE
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGN-LINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG-----IH 211 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 211 (463)
+..+||.+.+.||+|||+-||++. ..+++.+|+|++.-...+..+..++|++..++++|||+++++++...+ ..
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 456899999999999999999994 557889999999877777788899999999999999999999987543 34
Q ss_pred EEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccc
Q 012462 212 RMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA 291 (463)
Q Consensus 212 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a 291 (463)
.|++++|...|+|.+.+......+..+++.+++.|+.+|++||.+||+. .+.+.||||||.|||+.+++.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCc
Confidence 7999999999999999998877777899999999999999999999997 334999999999999999999999999998
Q ss_pred eecCCCCce--------eeccccccCCCCchhhhc---cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHH
Q 012462 292 KLLGAGKSH--------VTTRVMGTFGYVAPEYAN---TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWL 360 (463)
Q Consensus 292 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~ 360 (463)
....-.-.. ....-..|..|+|||++. +...+.++|||||||+||+|+.|..||+..-..
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~--------- 247 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ--------- 247 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc---------
Confidence 754321100 011123588899999885 446788999999999999999999999742210
Q ss_pred HHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 361 KMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
++.-.-.+....+.++...+....+..++.+|++.||.+||++.+++..++..
T Consensus 248 ----GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 248 ----GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ----CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 11111122233333343333444555667789999999999999999998764
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=336.34 Aligned_cols=264 Identities=25% Similarity=0.422 Sum_probs=219.4
Q ss_pred hHHHHHHhcCCCccCeEeecCcEEEEEEEEc---CC--CeEEEEEEccc-chhhHHHHHHHHHHHcCCCCCCcceEeeEE
Q 012462 133 LRDLELATNRFSKENVLGEGGYGVVYRGNLI---NG--SPVAVKKILNN-VGQAEKEFRVEVEAIGHVRHKNLVRLLGYC 206 (463)
Q Consensus 133 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~---~~--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 206 (463)
.+++++.++...+.+.||.|-||.||+|... .| -.||||+-+.+ .....+.|..|..+|++++||||++++|+|
T Consensus 381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~ 460 (974)
T KOG4257|consen 381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVC 460 (974)
T ss_pred CCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeee
Confidence 4566777888888899999999999999542 23 36889988764 355567899999999999999999999999
Q ss_pred EECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEe
Q 012462 207 IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVS 286 (463)
Q Consensus 207 ~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~ 286 (463)
.+. ..|||||.++-|.|..||.. ....++......++.||+.||+|||+. ++|||||..+|||+....-|||+
T Consensus 461 ~e~-P~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLa 533 (974)
T KOG4257|consen 461 VEQ-PMWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLA 533 (974)
T ss_pred ecc-ceeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeec
Confidence 875 67999999999999999975 445699999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhc
Q 012462 287 DFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVG 365 (463)
Q Consensus 287 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 365 (463)
|||+++.+.+...+..+...-+..|||||.+.-..++.+||||-|||+|||++. |..||.+-...+..-.+
T Consensus 534 DFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i-------- 605 (974)
T KOG4257|consen 534 DFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI-------- 605 (974)
T ss_pred ccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe--------
Confidence 999999998887776666666889999999999999999999999999999987 99999876544332111
Q ss_pred CCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCC
Q 012462 366 SRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEY 419 (463)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~ 419 (463)
+..-..+....+...++.++.+||+.+|.+||.+.|+...|.++..
T Consensus 606 --------EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 606 --------ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred --------cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 1111122233345566677789999999999999999988877643
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=334.89 Aligned_cols=253 Identities=24% Similarity=0.276 Sum_probs=198.1
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccch---hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVG---QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
++|.+.+.||+|+||+||+|.. .+++.||+|++..... .....+..|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 3688899999999999999965 4688999999864322 23456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+++|+|.+++... ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999998642 34689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCceeeccccccCCCCchhhhc------cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 297 GKSHVTTRVMGTFGYVAPEYAN------TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
..........||+.|+|||++. ...++.++|||||||++|||++|..||....... ............
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~ 228 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYNNIMNFQRFL 228 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHHHHHcCCCcc
Confidence 4333333457899999999986 4567899999999999999999999997644221 112222111111
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.+.. .......+ ..++.+||+ +|.+||++.+++++
T Consensus 229 ~~~~----~~~~~~~~---~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 229 KFPE----DPKVSSDF---LDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CCCC----CCCCCHHH---HHHHHHHcc-ChhhCCCHHHHhCC
Confidence 1100 01112222 334446887 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=311.33 Aligned_cols=262 Identities=23% Similarity=0.296 Sum_probs=199.4
Q ss_pred CCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchh--hHHHHHHHHHHHcCCCCCCcceEeeEEEE--CcEEEEEE
Q 012462 142 RFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQ--AEKEFRVEVEAIGHVRHKNLVRLLGYCIE--GIHRMLVY 216 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lV~ 216 (463)
.|+.++.|++|+||.||+|++ .+++.||+|+++-+... -.-.-.+|+.+|.+++|||||.+-.+... -+..|+||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 477788999999999999954 56889999998543211 11234569999999999999999998763 45689999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
|||+. +|..++... ..+|...++..+..|+++|++|||.+ .|+|||||++|+|+++.|.+||+|||+|+.+..
T Consensus 157 e~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 157 EYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcC
Confidence 99987 999999754 35699999999999999999999999 999999999999999999999999999998876
Q ss_pred CCceeeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccccc-
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVD- 374 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 374 (463)
.. ...+..+-|.+|+|||++.+. .|+...|+||+|||+.||+++++.|.+....+..+ .+..+.+......+..
T Consensus 230 p~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~---~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 230 PL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLD---KIFKLLGTPSEAIWPGY 305 (419)
T ss_pred Cc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHH---HHHHHhCCCccccCCCc
Confidence 53 335667889999999988774 69999999999999999999999998766544332 2222222111110000
Q ss_pred ---C---CCCCC--C------CHH---HHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 012462 375 ---P---NIEVR--P------STR---ALKRSLLTALRCVDPDSEKRPKMSQVVRML 414 (463)
Q Consensus 375 ---~---~~~~~--~------~~~---~~~~~~~~~~~cl~~dP~~RPs~~ell~~L 414 (463)
+ ...+. + ... -...-+.++...|..||.+|.|++|.|++=
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~ 362 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHE 362 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccc
Confidence 0 00000 0 000 112334455578999999999999998763
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=329.67 Aligned_cols=242 Identities=25% Similarity=0.285 Sum_probs=191.3
Q ss_pred CeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCCC
Q 012462 147 NVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNG 222 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 222 (463)
+.||+|+||.||++.. .+|..||+|.+.... ......+..|+.+++.++||||++++++|...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3699999999999965 468899999986532 223345677999999999999999999999999999999999999
Q ss_pred CHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCceee
Q 012462 223 NLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVT 302 (463)
Q Consensus 223 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 302 (463)
+|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~ 152 (323)
T cd05595 81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccc
Confidence 99988853 34689999999999999999999999 99999999999999999999999999987532221 122
Q ss_pred ccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCC
Q 012462 303 TRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPS 382 (463)
Q Consensus 303 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (463)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......... ......
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~~~~~~---------~~~p~~ 217 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELILMEE---------IRFPRT 217 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHhcCC---------CCCCCC
Confidence 3457899999999999999999999999999999999999999754321 1111111111 011111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 012462 383 TRALKRSLLTALRCVDPDSEKRP-----KMSQVVRM 413 (463)
Q Consensus 383 ~~~~~~~~~~~~~cl~~dP~~RP-----s~~ell~~ 413 (463)
. ......++.+||+.||++|| ++.+++++
T Consensus 218 ~--~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 218 L--SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred C--CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 1 11223445579999999998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=333.02 Aligned_cols=251 Identities=24% Similarity=0.343 Sum_probs=204.9
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcE-EEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIH-RMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lV~ 216 (463)
++|..++++|+|+||.+++.+. .++..+++|++.-.. ...+....+|+.++++++|||||.+.+.|.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 5688899999999999999944 457789999984332 3344567889999999999999999999999888 89999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
+||+||+|.+.+... +...|+++.++.++.|++.|+.|||++ .|+|||||+.|||++.++.|+|+|||+|+.+..
T Consensus 84 ~Y~eGg~l~~~i~~~--k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQ--KGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 999999999999764 356699999999999999999999998 999999999999999999999999999999876
Q ss_pred CCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (463)
.. ......+||+.||+||++.+.+|+.|+|||||||++|||++-+.+|...+.. ..+....... ..+
T Consensus 159 ~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~------~Li~ki~~~~-----~~P- 225 (426)
T KOG0589|consen 159 ED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS------ELILKINRGL-----YSP- 225 (426)
T ss_pred ch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH------HHHHHHhhcc-----CCC-
Confidence 54 2345678999999999999999999999999999999999999999865422 1122222111 111
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
-.......+-.++..|++.+|+.||++.++|.+
T Consensus 226 ----lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 ----LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ----CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 111112223334557999999999999999976
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=318.97 Aligned_cols=252 Identities=26% Similarity=0.406 Sum_probs=200.7
Q ss_pred cCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecC
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVN 220 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 220 (463)
++|.+.+.||+|+||+||+|++.++..+|+|.+.... .....+.+|+.++.+++||||+++++++.+....++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4578889999999999999988777789999876433 334678889999999999999999999998888999999999
Q ss_pred CCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCce
Q 012462 221 NGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSH 300 (463)
Q Consensus 221 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 300 (463)
+++|.+++... ...+++..++.++.||+.||.|||+. +++|+||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 83 NGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 99999998642 23589999999999999999999999 9999999999999999999999999999876443322
Q ss_pred eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCC
Q 012462 301 VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEV 379 (463)
Q Consensus 301 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (463)
......++..|+|||.+.+..++.++|||||||++|||++ |..||...... ............. .+ .
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~~---~~--~- 224 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS------ETVEKVSQGLRLY---RP--H- 224 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH------HHHHHHhcCCCCC---CC--C-
Confidence 2222345678999999998889999999999999999998 99999654321 1111121111110 00 0
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 012462 380 RPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415 (463)
Q Consensus 380 ~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~ 415 (463)
.. ...+..++.+||+.||.+||++.++++.|+
T Consensus 225 -~~---~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 225 -LA---SEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -CC---CHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 11 234455566899999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=329.01 Aligned_cols=201 Identities=28% Similarity=0.409 Sum_probs=174.3
Q ss_pred HhcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
..++|++.++||+|+||.||+|.+. ++..+|+|.+.... ......+.+|++++++++||||++++++|.+++..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 4578999999999999999999664 57788888875442 234467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.. +|+|+||||+|||++.++.+||+|||++.....
T Consensus 83 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 83 EHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 99999999999853 345889999999999999999999742 799999999999999999999999999875532
Q ss_pred CCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~ 348 (463)
. ......|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 157 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred h---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 2 123356899999999999989999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=335.86 Aligned_cols=254 Identities=21% Similarity=0.271 Sum_probs=194.6
Q ss_pred CCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 142 RFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
.|++++.||+|+||+||+|.. .++..||+|++.... ......+..|+.++.+++||||+++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588899999999999999954 467899999985432 2334568889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++++||+|||++......
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999853 34588999999999999999999999 9999999999999999999999999997533110
Q ss_pred C----------------------------------------------ceeeccccccCCCCchhhhccCCCCccchhhhH
Q 012462 298 K----------------------------------------------SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSF 331 (463)
Q Consensus 298 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 331 (463)
. .......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 0 000123579999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 012462 332 GVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVV 411 (463)
Q Consensus 332 Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell 411 (463)
||++|||++|..||........ ............+ ... .....+...++.. +.|+..+|..||++.|++
T Consensus 235 G~il~elltG~~Pf~~~~~~~~------~~~i~~~~~~~~~-~~~---~~~s~~~~dli~~-ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTET------QLKVINWENTLHI-PPQ---VKLSPEAVDLITK-LCCSAEERLGRNGADDIK 303 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHH------HHHHHccccccCC-CCC---CCCCHHHHHHHHH-HccCcccccCCCCHHHHh
Confidence 9999999999999976442211 1111110000000 000 1112233333322 237778888899999998
Q ss_pred HH
Q 012462 412 RM 413 (463)
Q Consensus 412 ~~ 413 (463)
++
T Consensus 304 ~h 305 (381)
T cd05626 304 AH 305 (381)
T ss_pred cC
Confidence 76
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=326.03 Aligned_cols=253 Identities=24% Similarity=0.345 Sum_probs=195.9
Q ss_pred HhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccch--------------hhHHHHHHHHHHHcCCCCCCcceEe
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVG--------------QAEKEFRVEVEAIGHVRHKNLVRLL 203 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~niv~l~ 203 (463)
.-+.|++.+.||+|.||.|-+|+. .+++.||||++.+... ...+..++|+.+|++|+|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 347899999999999999999954 5688999999843211 1224788999999999999999999
Q ss_pred eEEEE--CcEEEEEEeecCCCCHHHHHhhhhcCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCC
Q 012462 204 GYCIE--GIHRMLVYEYVNNGNLEQWLHGAMRHHGY-LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDD 280 (463)
Q Consensus 204 ~~~~~--~~~~~lV~e~~~~g~L~~~l~~~~~~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~ 280 (463)
.+..+ .+.+|||+|||..|.+... ....+ +++.++++++++++.||+|||.+ +|+||||||+|+||+++
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~-----p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWC-----PPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSD 246 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccC-----CCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCC
Confidence 99875 4678999999999887653 23344 89999999999999999999999 99999999999999999
Q ss_pred CCEEEeecccceecCCCC----ceeeccccccCCCCchhhhccCC----CCccchhhhHHHHHHHHHhCCCCCCCCCCcc
Q 012462 281 FNAKVSDFGLAKLLGAGK----SHVTTRVMGTFGYVAPEYANTGL----LNEKSDVYSFGVLLLEAITGRDPVDHGRPAH 352 (463)
Q Consensus 281 ~~~kl~Dfg~a~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvvl~elltg~~pf~~~~~~~ 352 (463)
|++||+|||.+..+..+. .......+|||.|+|||+..++. .+.+.||||+||+||.|+.|+.||.+....
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~- 325 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL- 325 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH-
Confidence 999999999998763321 11223468999999999886632 356889999999999999999999764321
Q ss_pred cccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 012462 353 EVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414 (463)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L 414 (463)
+.... +.+..+.++........+-.+++++|++||++|.+..+|..+.
T Consensus 326 -----~l~~K---------Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 326 -----ELFDK---------IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred -----HHHHH---------HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 11111 1222233333222223333455689999999999999997765
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=337.78 Aligned_cols=252 Identities=25% Similarity=0.335 Sum_probs=199.1
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
++|.+.+.||+|+||+||+|... +++.||+|++.... ......+..|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999664 68999999985432 133456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+++++|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 99999999999864 25689999999999999999999999 999999999999999999999999999986543
Q ss_pred CC----------------------------ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCC
Q 012462 297 GK----------------------------SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348 (463)
Q Consensus 297 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~ 348 (463)
.. ........||+.|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 32 11223456899999999999999999999999999999999999999865
Q ss_pred CCcccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHH
Q 012462 349 RPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPK-MSQVVRM 413 (463)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs-~~ell~~ 413 (463)
... ............ . ..............++.+||. ||.+||+ +++++++
T Consensus 234 ~~~------~~~~~i~~~~~~--~-----~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQ------ETYNKIINWKES--L-----RFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHH------HHHHHHhccCCc--c-----cCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 421 111111110000 0 011100011223334557897 9999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=322.23 Aligned_cols=257 Identities=27% Similarity=0.483 Sum_probs=202.2
Q ss_pred cCCCccCeEeecCcEEEEEEEEcCC------CeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLING------SPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRM 213 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 213 (463)
++|++.+.||+|+||.||+|..... ..|++|.+.... ......+.+|+.++.+++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 4688889999999999999965332 479999885433 334467889999999999999999999999988999
Q ss_pred EEEeecCCCCHHHHHhhhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCC
Q 012462 214 LVYEYVNNGNLEQWLHGAMR------------HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDF 281 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~ 281 (463)
++|||+++++|.+++..... ....+++..++.++.|++.||.|||+. +++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 99999999999999965321 114588899999999999999999999 999999999999999999
Q ss_pred CEEEeecccceecCCCCc-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHH
Q 012462 282 NAKVSDFGLAKLLGAGKS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDW 359 (463)
Q Consensus 282 ~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~ 359 (463)
.++|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||...... +.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~------~~ 235 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ------EV 235 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH------HH
Confidence 999999999986543321 22233456888999999988899999999999999999998 99999764422 11
Q ss_pred HHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 012462 360 LKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416 (463)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~ 416 (463)
...+. ....... . ......+..++.+||+.||.+||++.||++.|+.
T Consensus 236 ~~~i~-~~~~~~~-------~--~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 IEMIR-SRQLLPC-------P--EDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHH-cCCcCCC-------c--ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111 1111110 0 1112344455668999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=319.66 Aligned_cols=256 Identities=25% Similarity=0.398 Sum_probs=202.2
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
...|.+.+.||+|+||.||+|.. ..+..||+|.+... .....++.+|+.+++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 44578888999999999999965 45788999987543 33456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+++++|.+++... ....+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 84 MTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred CCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 9999999998642 234589999999999999999999999 99999999999999999999999999998765432
Q ss_pred ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCC
Q 012462 299 SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNI 377 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (463)
........++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+...........
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~------~~~~~~~~~~~~~-------- 224 (263)
T cd05052 159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYELLEKGYRM-------- 224 (263)
T ss_pred eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHCCCCC--------
Confidence 222222334668999999999999999999999999999998 9999875322 1222222211110
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 378 EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
..... ....+..++.+||+.||++||++.++++.|+.+
T Consensus 225 ~~~~~--~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 ERPEG--CPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCC--CCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 00111 112344456689999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=315.39 Aligned_cols=262 Identities=27% Similarity=0.390 Sum_probs=199.7
Q ss_pred HhcCCCccCeEeecCcEEEEEE-EEcCCCeEEEEEEcc--cchhhHHHHHHHHHHHcCCCCCCcceEeeEEEE-----Cc
Q 012462 139 ATNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILN--NVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE-----GI 210 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~ 210 (463)
...+|...+.||+|+||.|+.| ...+|+.||||++.+ ......++..+|+++++.++|+||+.+++++.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3456666789999999999999 446789999999963 344556778889999999999999999999865 35
Q ss_pred EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccc
Q 012462 211 HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGL 290 (463)
Q Consensus 211 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~ 290 (463)
..|+|+|+|+. +|...++ ....++...+..++.|+++||.|+|+. +|+||||||.|+|++.+..+||+|||+
T Consensus 100 DvYiV~elMet-DL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 100 DVYLVFELMET-DLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred eeEEehhHHhh-HHHHHHH----cCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccc
Confidence 67999999954 8888884 445599999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCC-CceeeccccccCCCCchhhh-ccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCC
Q 012462 291 AKLLGAG-KSHVTTRVMGTFGYVAPEYA-NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRR 368 (463)
Q Consensus 291 a~~~~~~-~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 368 (463)
|+..... .....+..+.|.+|+|||++ ....|+...||||.||+|.||++|+..|.+...-+...+ +....+...
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~l---I~~~lGtP~ 248 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQL---ILELLGTPS 248 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHH---HHHhcCCCC
Confidence 9987542 12335667889999999976 456899999999999999999999999987543222211 111111100
Q ss_pred c-----------cccc-----cCCC----CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 012462 369 S-----------EEVV-----DPNI----EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414 (463)
Q Consensus 369 ~-----------~~~~-----~~~~----~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L 414 (463)
. ...+ .+.. .++... ...+.++.+||..||.+|+|++|.|++-
T Consensus 249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~---p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNAN---PLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCC---HHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 0 0000 0000 011112 2233444579999999999999998763
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=333.56 Aligned_cols=202 Identities=25% Similarity=0.357 Sum_probs=174.3
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
++|++.+.||+|+||+||+|.. .+++.||+|++.... ......+..|+.++.+++||||+++++.+.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4688899999999999999955 458899999985432 223356778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+++|+|.+++.. .+.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999853 35689999999999999999999999 999999999999999999999999999875432
Q ss_pred CCc----------------------------------eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCC
Q 012462 297 GKS----------------------------------HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGR 342 (463)
Q Consensus 297 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~ 342 (463)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 0012357999999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 012462 343 DPVDHGR 349 (463)
Q Consensus 343 ~pf~~~~ 349 (463)
.||....
T Consensus 234 ~Pf~~~~ 240 (363)
T cd05628 234 PPFCSET 240 (363)
T ss_pred CCCCCCC
Confidence 9997644
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=330.03 Aligned_cols=252 Identities=24% Similarity=0.290 Sum_probs=195.0
Q ss_pred CCCccCeEeecCcEEEEEEEE----cCCCeEEEEEEcccc----hhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEE
Q 012462 142 RFSKENVLGEGGYGVVYRGNL----INGSPVAVKKILNNV----GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHR 212 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 212 (463)
+|++.+.||+|+||+||+++. .++..||+|++.... ....+.+..|+.++..+ +||||+++++++.+.+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999965 357899999985432 22335677899999999 599999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccce
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~ 292 (463)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999999853 34589999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCceeeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccc
Q 012462 293 LLGAGKSHVTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEE 371 (463)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (463)
.............+||+.|+|||++.+. .++.++|||||||++|||++|..||......... ...........
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~~~---- 227 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SEVSRRILKCD---- 227 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--HHHHHHHhcCC----
Confidence 6543333333446799999999999865 4788999999999999999999999754322211 11111111110
Q ss_pred cccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 012462 372 VVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRP-----KMSQVVRM 413 (463)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP-----s~~ell~~ 413 (463)
+ ...... ......++.+||+.||++|| ++++++++
T Consensus 228 ---~--~~~~~~--~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 228 ---P--PFPSFI--GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ---C--CCCCCC--CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 0 011111 11223345589999999999 77788765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=332.89 Aligned_cols=246 Identities=23% Similarity=0.290 Sum_probs=196.8
Q ss_pred hcCCCccCeEeecCcEEEEEEEEcC--CCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLIN--GSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~~--~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 214 (463)
.++|++.+.||+|+||.||+|.... +..||+|.+.... ......+..|+.++..++||||+++++++.+....|+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3568889999999999999996533 3589999885432 2234567789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
||||+.+|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 109 v~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999853 34689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccccc
Q 012462 295 GAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVD 374 (463)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (463)
... ....+||+.|+|||++.+..++.++|||||||++|||++|..||....+. ..........
T Consensus 182 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~~~~~i~~~~------- 244 (340)
T PTZ00426 182 DTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL------LIYQKILEGI------- 244 (340)
T ss_pred CCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH------HHHHHHhcCC-------
Confidence 432 23457899999999999988999999999999999999999999764321 1111111111
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 012462 375 PNIEVRPSTRALKRSLLTALRCVDPDSEKRP-----KMSQVVRM 413 (463)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP-----s~~ell~~ 413 (463)
...+.... .....++.+||+.||++|+ ++++++++
T Consensus 245 --~~~p~~~~--~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 245 --IYFPKFLD--NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred --CCCCCCCC--HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 01111111 1223455689999999995 89998876
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=323.43 Aligned_cols=201 Identities=29% Similarity=0.407 Sum_probs=170.6
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccch-hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVG-QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
.++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367999999999999999999664 688999999854322 223456779999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
|+. ++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 995 588888753 334588999999999999999999999 9999999999999999999999999999764322
Q ss_pred CceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCC
Q 012462 298 KSHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHG 348 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~ 348 (463)
. .......+++.|+|||++.+ ..++.++|||||||++|||++|..||...
T Consensus 157 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 157 S-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred C-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2 12234568999999998865 45889999999999999999999999754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=322.37 Aligned_cols=258 Identities=26% Similarity=0.450 Sum_probs=203.3
Q ss_pred hcCCCccCeEeecCcEEEEEEEEcC------CCeEEEEEEcccchh-hHHHHHHHHHHHcCCCCCCcceEeeEEEECcEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLIN------GSPVAVKKILNNVGQ-AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHR 212 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 212 (463)
.++|.+.+.||+|+||.||+|...+ +..||+|.+...... ..+.+.+|++++.+++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3568888999999999999996533 478999998654433 457889999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhh----------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCC
Q 012462 213 MLVYEYVNNGNLEQWLHGAM----------RHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFN 282 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~ 282 (463)
++||||+++++|.+++.... .....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence 99999999999999997532 1234578999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCc-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHH
Q 012462 283 AKVSDFGLAKLLGAGKS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWL 360 (463)
Q Consensus 283 ~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~ 360 (463)
++|+|||++........ .......+++.|+|||++.+..++.++|||||||++|||++ |..||....... ..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~------~~ 234 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE------VI 234 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH------HH
Confidence 99999999986533221 11223345788999999999999999999999999999998 999997543221 11
Q ss_pred HHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 012462 361 KMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416 (463)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~ 416 (463)
..... ...... .......+..++.+||+.||++||++.|+++.|++
T Consensus 235 ~~~~~-~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 235 ECITQ-GRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHc-CCcCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 22211 111110 00112334455668999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=315.82 Aligned_cols=266 Identities=27% Similarity=0.469 Sum_probs=201.4
Q ss_pred CCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcC--CCCCCcceEeeEEEECc----EEEEEE
Q 012462 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGH--VRHKNLVRLLGYCIEGI----HRMLVY 216 (463)
Q Consensus 143 ~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~~~lV~ 216 (463)
.++.+++|+|.||.||+|.+ +++.||||++.. +....|.+|-++.+. +.|+||+++++.-.... +++||+
T Consensus 212 l~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhhHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 34467899999999999988 569999999843 344566667666654 68999999999876554 789999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEEccCCCCceeEcCCCCEEEeeccc
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI------EPKVVHRDIKSSNILIDDDFNAKVSDFGL 290 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------~~~i~H~Dikp~Nill~~~~~~kl~Dfg~ 290 (463)
||.+.|+|.+||.. ..++|....+|+..+++||+|||+.. +|.|+|||||++||||..|++..|+|||+
T Consensus 288 ~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 99999999999953 35999999999999999999999864 67899999999999999999999999999
Q ss_pred ceecCCCCc-eeeccccccCCCCchhhhccCC-CC-----ccchhhhHHHHHHHHHhCCCCCCCC-CC----------cc
Q 012462 291 AKLLGAGKS-HVTTRVMGTFGYVAPEYANTGL-LN-----EKSDVYSFGVLLLEAITGRDPVDHG-RP----------AH 352 (463)
Q Consensus 291 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~-----~~sDvwSlGvvl~elltg~~pf~~~-~~----------~~ 352 (463)
|..+..... ......+||.+|||||++.+.. +. .+.||||+|.|||||++...-+..+ .+ ..
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 998875542 2233468999999999997642 22 2689999999999999976544311 11 11
Q ss_pred cccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCCCC
Q 012462 353 EVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPI 421 (463)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 421 (463)
...+.+.....+..+....+.+....- .....+.+. +..||+.||+-|.|+.=+-+.+.+.....
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~h-~~~~~l~et---~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRKH-AGMAVLCET---IEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhcC-ccHHHHHHH---HHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 123334444445555555555544333 333444433 44699999999999999988887765444
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=315.49 Aligned_cols=257 Identities=23% Similarity=0.267 Sum_probs=204.6
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEEcC-CCeEEEEEEcccchh---hHHHHHHHHHHHcCCCCCCcceEeeEEEECcEE
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQ---AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHR 212 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 212 (463)
.+.-+.|++++.||.|.-|+||++++.+ +..+|+|++.+..-. ...+.+.|-+||+.++||.++.||..|+.+...
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~ 152 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS 152 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence 4445668888999999999999998754 478999998655433 234566799999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccce
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~ 292 (463)
|+|||||+||+|..+++. +..+.|++..+..++..|+.||+|||.. |||+|||||+||||-++|++.|+||.|+.
T Consensus 153 cl~meyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~ 227 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSL 227 (459)
T ss_pred EEEEecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccc
Confidence 999999999999998865 5677899999999999999999999999 99999999999999999999999999875
Q ss_pred ecCCC----------------------------------Cc---------------------eeeccccccCCCCchhhh
Q 012462 293 LLGAG----------------------------------KS---------------------HVTTRVMGTFGYVAPEYA 317 (463)
Q Consensus 293 ~~~~~----------------------------------~~---------------------~~~~~~~gt~~y~aPE~~ 317 (463)
..... .. .....++||-.|+|||++
T Consensus 228 ~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI 307 (459)
T KOG0610|consen 228 RCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI 307 (459)
T ss_pred cCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence 43110 00 012346899999999999
Q ss_pred ccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhcc
Q 012462 318 NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCV 397 (463)
Q Consensus 318 ~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl 397 (463)
.+...+.++|+|+|||+||||+.|..||.+......... ++...+.++.........-.++.+.|
T Consensus 308 ~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~N---------------Iv~~~l~Fp~~~~vs~~akDLIr~LL 372 (459)
T KOG0610|consen 308 RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRN---------------IVGQPLKFPEEPEVSSAAKDLIRKLL 372 (459)
T ss_pred ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHH---------------HhcCCCcCCCCCcchhHHHHHHHHHh
Confidence 999999999999999999999999999998664332211 11122222222223333444566788
Q ss_pred CCCCCCCCC----HHHHHHH
Q 012462 398 DPDSEKRPK----MSQVVRM 413 (463)
Q Consensus 398 ~~dP~~RPs----~~ell~~ 413 (463)
.+||++|.- +.||-++
T Consensus 373 vKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 373 VKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred ccChhhhhccccchHHhhcC
Confidence 999999998 7777653
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=370.09 Aligned_cols=260 Identities=32% Similarity=0.545 Sum_probs=208.5
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeec
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYV 219 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 219 (463)
..|...++||+|+||.||+|.. .++..||+|++....... ..|++.+++++||||++++++|.+....|+||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4577778999999999999976 578999999885433211 23578899999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCc
Q 012462 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299 (463)
Q Consensus 220 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 299 (463)
++|+|.++++ .++|..+..++.|++.||+|||..+.++|+||||||+||+++.++..++. ||.......
T Consensus 766 ~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--- 834 (968)
T PLN00113 766 EGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--- 834 (968)
T ss_pred CCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---
Confidence 9999999984 28899999999999999999996656699999999999999999988875 665543221
Q ss_pred eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCC
Q 012462 300 HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEV 379 (463)
Q Consensus 300 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (463)
.....+++.|+|||++.+..++.++|||||||++|||+||+.||..... .......|..............++.+..
T Consensus 835 --~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 835 --DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred --CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccC
Confidence 1123578999999999999999999999999999999999999964332 2345666666555444444445544422
Q ss_pred --CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCC
Q 012462 380 --RPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEE 418 (463)
Q Consensus 380 --~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~ 418 (463)
........+.+.++.+||+.||++||+|+|+++.|+.+.
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 233456667778888999999999999999999998763
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=330.58 Aligned_cols=242 Identities=24% Similarity=0.294 Sum_probs=192.2
Q ss_pred CeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCCC
Q 012462 147 NVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNG 222 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 222 (463)
+.||+|+||.||++.. .+++.||+|++.... ......+..|+.+++.++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999965 468899999986432 233456778999999999999999999999999999999999999
Q ss_pred CHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCceee
Q 012462 223 NLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVT 302 (463)
Q Consensus 223 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 302 (463)
+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 152 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATM 152 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccc
Confidence 99988843 34689999999999999999999999 99999999999999999999999999987543221 223
Q ss_pred ccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCC
Q 012462 303 TRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPS 382 (463)
Q Consensus 303 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (463)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......... ......
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~~~~~~~~~---------~~~p~~ 217 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILMED---------IKFPRT 217 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HHHHHhccCC---------ccCCCC
Confidence 3467999999999999999999999999999999999999999754321 1111111110 011111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 012462 383 TRALKRSLLTALRCVDPDSEKRP-----KMSQVVRM 413 (463)
Q Consensus 383 ~~~~~~~~~~~~~cl~~dP~~RP-----s~~ell~~ 413 (463)
. ...+..++.+||+.||++|| ++.|++++
T Consensus 218 ~--~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 218 L--SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred C--CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1 11233445579999999997 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=336.76 Aligned_cols=252 Identities=23% Similarity=0.320 Sum_probs=195.1
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
++|++.+.||+|+||+||+|... +++.||||++.... ......+..|+.++..++||||+++++++.++...|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46889999999999999999654 68899999985432 233356778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999853 34689999999999999999999999 999999999999999999999999999875432
Q ss_pred CCce-------------------------------------eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHH
Q 012462 297 GKSH-------------------------------------VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAI 339 (463)
Q Consensus 297 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ell 339 (463)
.... .....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 011246899999999999999999999999999999999
Q ss_pred hCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCC---HHHHHHH
Q 012462 340 TGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPK---MSQVVRM 413 (463)
Q Consensus 340 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs---~~ell~~ 413 (463)
+|..||....+.. .............. ... ....... ..++.+|+. +|.+|++ ++|++++
T Consensus 234 ~G~~Pf~~~~~~~------~~~~i~~~~~~~~~-~~~---~~~s~~~---~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 234 VGYPPFCSDNPQE------TYRKIINWKETLQF-PDE---VPLSPEA---KDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred cCCCCCCCCCHHH------HHHHHHcCCCccCC-CCC---CCCCHHH---HHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9999997654221 11111111110000 000 0111222 233445776 8999998 8888764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=321.36 Aligned_cols=249 Identities=32% Similarity=0.559 Sum_probs=190.9
Q ss_pred ccCeEeecCcEEEEEEEEc-----CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 145 KENVLGEGGYGVVYRGNLI-----NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 145 ~~~~lG~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
+.+.||.|.||.||+|.+. .+..|+||.+.... ....+.+.+|++.+.+++||||++++|++......++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3568999999999999776 25689999985533 33467899999999999999999999999988889999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+++|+|.++|... ....+++..++.++.||+.||.|||++ +++|+||+++|||++.++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999763 245689999999999999999999999 99999999999999999999999999998773322
Q ss_pred c-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccCC
Q 012462 299 S-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376 (463)
Q Consensus 299 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (463)
. ...........|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+............ .
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~------~~~~~~~~~~~~~~~-~---- 226 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD------NEEIIEKLKQGQRLP-I---- 226 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC------HHHHHHHHHTTEETT-S----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc------cccccccccccccce-e----
Confidence 2 22233456788999999999889999999999999999999 788886542 222223332221111 0
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 012462 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414 (463)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L 414 (463)
.. .....+..++.+||+.||++||+++++++.|
T Consensus 227 ---~~--~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 ---PD--NCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---BT--TSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---cc--chhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 00 1122334456689999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=323.24 Aligned_cols=262 Identities=24% Similarity=0.355 Sum_probs=190.8
Q ss_pred cCCCccCeEeecCcEEEEEEEEc--CCCeEEEEEEcccch--hhHHHHHHHHHHHcCC---CCCCcceEeeEEEE-----
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI--NGSPVAVKKILNNVG--QAEKEFRVEVEAIGHV---RHKNLVRLLGYCIE----- 208 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~----- 208 (463)
++|++.+.||+|+||+||+|... ++..||+|.+..... .....+.+|+.+++.+ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36889999999999999999652 467899998854321 2223455566666554 79999999999862
Q ss_pred CcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeec
Q 012462 209 GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDF 288 (463)
Q Consensus 209 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Df 288 (463)
....++||||+. ++|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 456799999996 5999988642 234589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCC
Q 012462 289 GLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRR 368 (463)
Q Consensus 289 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 368 (463)
|++...... .......|++.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+........
T Consensus 155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~---~~~i~~~~~~~~ 229 (290)
T cd07862 155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLPG 229 (290)
T ss_pred cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHHhCCCC
Confidence 999875433 223345689999999999988999999999999999999999999986543221 111111111000
Q ss_pred cccc------ccCCCC--CCCCHH-----HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 369 SEEV------VDPNIE--VRPSTR-----ALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 369 ~~~~------~~~~~~--~~~~~~-----~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.... ...... ...... .......++.+||+.||++|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0000 000000 000000 11223345668999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=315.51 Aligned_cols=260 Identities=24% Similarity=0.404 Sum_probs=206.4
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEccc---chhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNN---VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
++|++.+.||+|+||.||+|.. .++..||+|.+... .......+..|+.+++.++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4788999999999999999965 47899999987432 2333456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+++++|.+++.........+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999998865444455688999999999999999999999 999999999999999999999999999987643
Q ss_pred CCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (463)
... ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||..... +...+...........
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~~~~~~~~------ 227 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQKIEQCDYPP------ 227 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHHHhcCCCCC------
Confidence 321 12234688899999999888899999999999999999999999965332 1122222221111100
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
. +.......+..++.+||+.+|++||++.++++.|++.
T Consensus 228 ~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 L---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred C---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 0 0111123344556689999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=316.41 Aligned_cols=255 Identities=28% Similarity=0.421 Sum_probs=201.9
Q ss_pred HhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
..++|++.++||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++.. ...+++|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEY 81 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEe
Confidence 3467889999999999999999887888999998865332 34678899999999999999999998854 567999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+++++|.+++... ....+++..++.++.|++.||.|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 82 MSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 9999999998642 234589999999999999999999999 99999999999999999999999999998764432
Q ss_pred ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCC
Q 012462 299 SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNI 377 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (463)
........++..|+|||.+.+..++.++||||||+++|||++ |..||..... .+............
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~------~~~~~~~~~~~~~~------- 223 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN------REVLEQVERGYRMP------- 223 (260)
T ss_pred cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHHcCCCCC-------
Confidence 222222345678999999988889999999999999999999 8899965332 12222222111110
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 012462 378 EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416 (463)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~ 416 (463)
... .....+..++.+||+.+|++|||+.++++.|++
T Consensus 224 -~~~--~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 -CPQ--DCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -CCC--cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 011 112234556668999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=335.91 Aligned_cols=263 Identities=25% Similarity=0.382 Sum_probs=203.7
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEEcC------CCeEEEEEEcccc-hhhHHHHHHHHHHHcCCC-CCCcceEeeEEEE
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNLIN------GSPVAVKKILNNV-GQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIE 208 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~ 208 (463)
....++|.+.++||+|+||.||+|.... +..||||++.... ....+.+.+|+.+++++. ||||++++++|.+
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 4557789999999999999999996521 3469999986433 233467888999999996 9999999999999
Q ss_pred CcEEEEEEeecCCCCHHHHHhhhhc-------------------------------------------------------
Q 012462 209 GIHRMLVYEYVNNGNLEQWLHGAMR------------------------------------------------------- 233 (463)
Q Consensus 209 ~~~~~lV~e~~~~g~L~~~l~~~~~------------------------------------------------------- 233 (463)
....|+||||+++|+|.+++.....
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 9999999999999999999865321
Q ss_pred -------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCcee
Q 012462 234 -------------------------------------HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNIL 276 (463)
Q Consensus 234 -------------------------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nil 276 (463)
....+++..++.++.||+.||.|||+. +|+|+||||+|||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEE
Confidence 012477888999999999999999999 9999999999999
Q ss_pred EcCCCCEEEeecccceecCCCCce-eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccc
Q 012462 277 IDDDFNAKVSDFGLAKLLGAGKSH-VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEV 354 (463)
Q Consensus 277 l~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~ 354 (463)
++.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~- 348 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST- 348 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH-
Confidence 999999999999999865432221 1223456788999999999999999999999999999997 9999975432111
Q ss_pred cHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 355 NLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
. ........... .. ......+..++.+||+.||++||++.+|.+.|+..
T Consensus 349 -~---~~~~~~~~~~~--------~~--~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 349 -F---YNKIKSGYRMA--------KP--DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred -H---HHHHhcCCCCC--------CC--ccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 1 11111111100 00 11123345566789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=317.20 Aligned_cols=256 Identities=28% Similarity=0.418 Sum_probs=202.1
Q ss_pred HhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
..++|++.++||+|+||.||+|.+.++..||+|.+.... ...+.+..|+.++++++||||+++++++.+ ...++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 81 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence 356799999999999999999987777789999886432 234578889999999999999999998754 557999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+++|+|.+++... ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 82 MSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred CCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 9999999999642 234578999999999999999999999 99999999999999999999999999998765433
Q ss_pred ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCC
Q 012462 299 SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNI 377 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (463)
........++..|+|||...+..++.++|||||||++|||++ |..||....... ...........
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~------~~~~~~~~~~~-------- 222 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVERGYRM-------- 222 (262)
T ss_pred cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH------HHHHHhcCCCC--------
Confidence 222223346778999999988899999999999999999999 888887543211 11111111100
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 378 EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.........+..++.+||+.||++||++.++++.|++.
T Consensus 223 --~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 --PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred --CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 00111223445667789999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=327.34 Aligned_cols=248 Identities=27% Similarity=0.386 Sum_probs=190.1
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
++|+..++||+|+||.||+|... +++.||||.+.... ......+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 34666789999999999999654 68999999985433 33446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+++++|.+. ....+..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 154 ~~~~~L~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 154 MDGGSLEGT--------HIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred CCCCccccc--------ccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 999998653 2356778889999999999999999 99999999999999999999999999998764322
Q ss_pred ceeeccccccCCCCchhhhcc-----CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccc
Q 012462 299 SHVTTRVMGTFGYVAPEYANT-----GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (463)
. ......||..|+|||++.. ...+.++|||||||++|||++|+.||....... ............. .
T Consensus 223 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~-~--- 294 (353)
T PLN00034 223 D-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD---WASLMCAICMSQP-P--- 294 (353)
T ss_pred c-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc---HHHHHHHHhccCC-C---
Confidence 1 1234578999999998743 334568999999999999999999997433221 1111111111100 0
Q ss_pred cCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.... .....+..++.+||+.||++||++.|++++
T Consensus 295 ----~~~~--~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 295 ----EAPA--TASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ----CCCC--ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011 111233445568999999999999999885
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=325.83 Aligned_cols=245 Identities=24% Similarity=0.324 Sum_probs=190.1
Q ss_pred CCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHH---HcCCCCCCcceEeeEEEECcEEEEE
Q 012462 143 FSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEA---IGHVRHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 143 ~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~---l~~l~h~niv~l~~~~~~~~~~~lV 215 (463)
|++.+.||+|+||.||+|.. .+++.||||.+.... ....+.+..|+.+ +..++||||+++++++.+....|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 56788999999999999965 468899999986432 1223455556554 4567899999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
|||+++++|..++.. ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999988742 3589999999999999999999999 99999999999999999999999999987533
Q ss_pred CCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 296 AGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
... ......+|++.|+|||.+.+..++.++|||||||++|||++|+.||...... ...........
T Consensus 153 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~------~~~~~i~~~~~------- 218 (324)
T cd05589 153 GFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE------EVFDSIVNDEV------- 218 (324)
T ss_pred CCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCC-------
Confidence 221 2233467899999999999999999999999999999999999999754321 11222221111
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 012462 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRP-----KMSQVVRM 413 (463)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP-----s~~ell~~ 413 (463)
...... ......++.+||+.||.+|| ++.+++++
T Consensus 219 --~~p~~~--~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 219 --RYPRFL--SREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred --CCCCCC--CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 011111 12233456689999999999 56777654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=335.48 Aligned_cols=202 Identities=24% Similarity=0.331 Sum_probs=172.6
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
++|++.+.||+|+||.||+|+. .+++.||+|.+.... ......+.+|+.++.+++||||+++++.+.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3688999999999999999965 458899999885432 123456778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+++|+|.+++.. .+.+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..+..
T Consensus 81 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999999853 34688999999999999999999999 999999999999999999999999999753210
Q ss_pred CC------------------------------------------ceeeccccccCCCCchhhhccCCCCccchhhhHHHH
Q 012462 297 GK------------------------------------------SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVL 334 (463)
Q Consensus 297 ~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvv 334 (463)
.. .......+||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 00 000123579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCC
Q 012462 335 LLEAITGRDPVDHGR 349 (463)
Q Consensus 335 l~elltg~~pf~~~~ 349 (463)
+|||++|+.||....
T Consensus 234 lyell~G~~Pf~~~~ 248 (376)
T cd05598 234 LYEMLVGQPPFLADT 248 (376)
T ss_pred eeehhhCCCCCCCCC
Confidence 999999999998654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=333.22 Aligned_cols=202 Identities=24% Similarity=0.334 Sum_probs=172.8
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
++|.+.+.||+|+||+||++.. .+++.||+|++.... ......+..|++++.+++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688899999999999999954 568899999985432 223456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999853 34688999999999999999999999 999999999999999999999999999863321
Q ss_pred CCc----------------------------------------------eeeccccccCCCCchhhhccCCCCccchhhh
Q 012462 297 GKS----------------------------------------------HVTTRVMGTFGYVAPEYANTGLLNEKSDVYS 330 (463)
Q Consensus 297 ~~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS 330 (463)
... ......+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 000 0001246899999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCC
Q 012462 331 FGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 331 lGvvl~elltg~~pf~~~~ 349 (463)
|||++|||++|..||....
T Consensus 234 lGvil~elltG~~Pf~~~~ 252 (377)
T cd05629 234 LGAIMFECLIGWPPFCSEN 252 (377)
T ss_pred cchhhhhhhcCCCCCCCCC
Confidence 9999999999999997644
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=325.48 Aligned_cols=242 Identities=25% Similarity=0.350 Sum_probs=191.8
Q ss_pred CeEeecCcEEEEEEEE----cCCCeEEEEEEcccc----hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 147 NVLGEGGYGVVYRGNL----INGSPVAVKKILNNV----GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
+.||+|+||.||+++. ..++.||+|.+.... ......+..|+.+++.++||||++++++|.+++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999965 357889999985432 12234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+++++|.+++.. .+.+.+..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999998853 34588899999999999999999999 99999999999999999999999999987543222
Q ss_pred ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCC
Q 012462 299 SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (463)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........... ..
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~------~~~~~~~~~~~---------~~ 218 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR------KKTIDKILKGK---------LN 218 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH------HHHHHHHHcCC---------CC
Confidence 123345789999999999998899999999999999999999999975432 11222222111 11
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 012462 379 VRPSTRALKRSLLTALRCVDPDSEKRP-----KMSQVVRM 413 (463)
Q Consensus 379 ~~~~~~~~~~~~~~~~~cl~~dP~~RP-----s~~ell~~ 413 (463)
..... ...+..++.+||+.||++|| ++++++++
T Consensus 219 ~~~~~--~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 219 LPPYL--TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCC--CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 11111 12233455689999999999 78888774
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=316.05 Aligned_cols=256 Identities=29% Similarity=0.464 Sum_probs=202.2
Q ss_pred hcCCCccCeEeecCcEEEEEEEEcC----CCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLIN----GSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 214 (463)
.++|++.+.||+|+||+||+|.+.. ...||+|.+.... ......+..|+.++++++||||+++++++.+....++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3578899999999999999997642 3578999875433 3345678889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
||||+++++|.+++... ...+++..++.++.|++.||.|||+. +|+|+||||+|||+++++.++|+|||+++..
T Consensus 83 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 99999999999998642 34689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCc-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCcccc
Q 012462 295 GAGKS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV 372 (463)
Q Consensus 295 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (463)
..... .......++..|+|||.+.+..++.++||||||+++|||++ |..||...... ..............
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~~~- 229 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ------DVIKAVEDGYRLPP- 229 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH------HHHHHHHcCCCCCC-
Confidence 52221 11222345678999999998899999999999999999998 99999653321 11111211111110
Q ss_pred ccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 373 VDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.......+..++.+||+.+|++||++.||+++|+..
T Consensus 230 ---------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 230 ---------PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 001112344566689999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=320.11 Aligned_cols=260 Identities=22% Similarity=0.391 Sum_probs=201.3
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEEc------CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECc
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGI 210 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 210 (463)
+..++|++.+.||+|+||.||+|... .+..||+|++.... .....++.+|+.+++.++||||+++++++.++.
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45678999999999999999998653 24679999875432 234456888999999999999999999999999
Q ss_pred EEEEEEeecCCCCHHHHHhhhhcC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEE
Q 012462 211 HRMLVYEYVNNGNLEQWLHGAMRH------HGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAK 284 (463)
Q Consensus 211 ~~~lV~e~~~~g~L~~~l~~~~~~------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~k 284 (463)
..++||||+++++|.+++...... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence 999999999999999998653221 23467888999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCcee-eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHH
Q 012462 285 VSDFGLAKLLGAGKSHV-TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKM 362 (463)
Q Consensus 285 l~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~ 362 (463)
|+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||..... ......
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~------~~~~~~ 233 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN------EQVLRF 233 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHH
Confidence 99999987654332211 112345778999999998899999999999999999999 7888865432 122222
Q ss_pred HhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 012462 363 MVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416 (463)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~ 416 (463)
...... ... .. .....+..++.+||+.||++|||+.|+++.|++
T Consensus 234 ~~~~~~-~~~-------~~--~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 VMEGGL-LDK-------PD--NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHcCCc-CCC-------CC--CCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 221111 111 00 011234455668999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=325.14 Aligned_cols=257 Identities=28% Similarity=0.465 Sum_probs=200.0
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCC----eEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGS----PVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRM 213 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 213 (463)
..+|+..+.||+|+||.||+|.+. ++. .||+|.+.... .....++..|+.+++.++||||++++++|... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 356899999999999999999653 333 38999885433 34456788899999999999999999999865 568
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
+|+||+++|+|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 85 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence 999999999999998642 34588999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCcee-eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccc
Q 012462 294 LGAGKSHV-TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEE 371 (463)
Q Consensus 294 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (463)
........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.... .............
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~------~~~~~~~~~~~~~- 231 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS------EISSILEKGERLP- 231 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHhCCCCCC-
Confidence 65432211 122334678999999999999999999999999999998 99999754321 1111111111110
Q ss_pred cccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCC
Q 012462 372 VVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEY 419 (463)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~ 419 (463)
. .+ ........++.+||+.||++||++.+++..|.....
T Consensus 232 --~-----~~--~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 232 --Q-----PP--ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred --C-----CC--CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 0 01 111234556678999999999999999999887644
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=330.52 Aligned_cols=263 Identities=28% Similarity=0.434 Sum_probs=201.5
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEEc------CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCC-CCCCcceEeeEEEE
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIE 208 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 208 (463)
.+..++|++.+.||+|+||.||+|... .++.||+|++.... ....+.+..|+.++.++ +|+||++++++|..
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~ 82 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK 82 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence 344568999999999999999999532 24689999886433 22345677899999999 89999999998865
Q ss_pred -CcEEEEEEeecCCCCHHHHHhhhhcC-----------------------------------------------------
Q 012462 209 -GIHRMLVYEYVNNGNLEQWLHGAMRH----------------------------------------------------- 234 (463)
Q Consensus 209 -~~~~~lV~e~~~~g~L~~~l~~~~~~----------------------------------------------------- 234 (463)
+...+++|||+++++|.+++......
T Consensus 83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 45678999999999999998642110
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCcee-eccccccC
Q 012462 235 ----HGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV-TTRVMGTF 309 (463)
Q Consensus 235 ----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~ 309 (463)
...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.++|+|||++.......... .....++.
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 13588999999999999999999999 99999999999999999999999999998754332211 22344567
Q ss_pred CCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHH
Q 012462 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKR 388 (463)
Q Consensus 310 ~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (463)
.|+|||++.+..++.++|||||||+||||++ |..||......+. + ...+ ........ . ......
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~---~~~~-~~~~~~~~-------~--~~~~~~ 304 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--F---CRRL-KEGTRMRA-------P--EYATPE 304 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--H---HHHH-hccCCCCC-------C--ccCCHH
Confidence 8999999999999999999999999999998 9999975432211 1 1111 11111000 0 011234
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 389 SLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 389 ~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
+..++.+||+.+|++||++.|++++|+..
T Consensus 305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 305 IYSIMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 45667789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=315.47 Aligned_cols=256 Identities=25% Similarity=0.406 Sum_probs=203.6
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
+..++|++.++||+|+||.||+|...+++.||+|.+.... .....+..|+.++++++|+||+++++++. .+..+++||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 4567899999999999999999988888999999886443 33467888999999999999999999875 456899999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
|+.+++|.+++... ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 81 YMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred cCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 99999999998642 344689999999999999999999999 9999999999999999999999999999876533
Q ss_pred CceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccCC
Q 012462 298 KSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (463)
.........++..|+|||++....++.++||||||+++|||++ |+.||...... .....+...... .
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~~~~-~----- 223 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP------EVIQNLERGYRM-P----- 223 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH------HHHHHHHcCCCC-C-----
Confidence 2222233445778999999998889999999999999999999 99999754321 111111111111 0
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 012462 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416 (463)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~ 416 (463)
... .....+..++.+||+.+|++||+++++++.|+.
T Consensus 224 --~~~--~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 --RPD--NCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --CCC--CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 001 111234555668999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=322.73 Aligned_cols=240 Identities=23% Similarity=0.252 Sum_probs=189.0
Q ss_pred EeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCCCCH
Q 012462 149 LGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNL 224 (463)
Q Consensus 149 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 224 (463)
||+|+||.||+|... +++.||+|.+.... ......+..|+.++.+++||||+++++++.+.+..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999654 57899999985432 23345677899999999999999999999999999999999999999
Q ss_pred HHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCceeecc
Q 012462 225 EQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR 304 (463)
Q Consensus 225 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 304 (463)
.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.++|+|||+++...... .....
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 152 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT 152 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence 999853 34689999999999999999999999 99999999999999999999999999997543221 22344
Q ss_pred ccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHH
Q 012462 305 VMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTR 384 (463)
Q Consensus 305 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (463)
.+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........... .......
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~~~~~---------~~~~~~~- 216 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKILQEP---------LRFPDGF- 216 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHHHcCC---------CCCCCcC-
Confidence 6799999999999999999999999999999999999999975431 12222222111 1111111
Q ss_pred HHHHHHHHHhhccCCCCCCCCC---HHHHHHH
Q 012462 385 ALKRSLLTALRCVDPDSEKRPK---MSQVVRM 413 (463)
Q Consensus 385 ~~~~~~~~~~~cl~~dP~~RPs---~~ell~~ 413 (463)
......++.+||+.||.+||+ +.|++.+
T Consensus 217 -~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 217 -DRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred -CHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 112234455799999999986 4555543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=315.13 Aligned_cols=251 Identities=27% Similarity=0.416 Sum_probs=198.4
Q ss_pred cCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecC
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVN 220 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 220 (463)
.+|++.+.||+|+||.||+|.+.++..+|+|.+.... .....+..|+.++++++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 3477888999999999999988777789999875432 234567789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCce
Q 012462 221 NGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSH 300 (463)
Q Consensus 221 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 300 (463)
+++|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 83 NGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred CCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 99999998642 23689999999999999999999999 9999999999999999999999999999865432222
Q ss_pred eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCC
Q 012462 301 VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEV 379 (463)
Q Consensus 301 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (463)
......++..|+|||.+.+..++.++||||||+++|||++ |..||....... . .......... ..
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~---~~~~~~~~~~--------~~ 222 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---V---VESVSAGYRL--------YR 222 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---H---HHHHHcCCcC--------CC
Confidence 1222234567999999999999999999999999999999 899997543211 1 1111111110 00
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 012462 380 RPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414 (463)
Q Consensus 380 ~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L 414 (463)
... ....+..++.+||+.+|++|||+.|+++.|
T Consensus 223 ~~~--~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 PKL--APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCC--CCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 111 122455567789999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=311.21 Aligned_cols=265 Identities=23% Similarity=0.315 Sum_probs=200.9
Q ss_pred cCCCccCeEeecCcEEEEEEE-EcCCCeEEEEEEcccch--hhHHHHHHHHHHHcCCCCCC-cceEeeEEEECc------
Q 012462 141 NRFSKENVLGEGGYGVVYRGN-LINGSPVAVKKILNNVG--QAEKEFRVEVEAIGHVRHKN-LVRLLGYCIEGI------ 210 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~------ 210 (463)
..|+.+++||+|+||+||+|+ ..+|+.||+|++.-... .......+|+.++++|+|+| |+.+++++.+.+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 446677889999999999994 45788999999955433 23345667999999999999 999999999877
Q ss_pred EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccc
Q 012462 211 HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGL 290 (463)
Q Consensus 211 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~ 290 (463)
..++|+||++. +|..++.........++...+..++.||+.||+|||++ +|+||||||.||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 78999999966 99999976543224577789999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCc
Q 012462 291 AKLLGAGKSHVTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369 (463)
Q Consensus 291 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 369 (463)
|+...-.. ...+..++|.+|+|||++.+. .|+...||||+||++.||++++..|.+.... +....+-...+....
T Consensus 167 Ara~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~---~ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 167 ARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI---DQLFRIFRLLGTPNE 242 (323)
T ss_pred HHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH---HHHHHHHHHcCCCCc
Confidence 99765332 224556789999999999886 7999999999999999999999999876542 111112222211111
Q ss_pred ccc------ccCCCCCC--C----CHHH----HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 370 EEV------VDPNIEVR--P----STRA----LKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 370 ~~~------~~~~~~~~--~----~~~~----~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
..+ .+-...+. . .... ......++.+||+.+|.+|.|++.++++
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 100 00000000 0 0000 0234555668999999999999999987
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=326.85 Aligned_cols=242 Identities=23% Similarity=0.278 Sum_probs=190.9
Q ss_pred CeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCCC
Q 012462 147 NVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNG 222 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 222 (463)
+.||+|+||.||++.. .++..||+|.+.... ......+..|+.++..++||||+++++++.+.+..|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999954 568899999986432 223355677999999999999999999999999999999999999
Q ss_pred CHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCcee
Q 012462 223 NLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE-AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV 301 (463)
Q Consensus 223 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 301 (463)
+|.+++.. ...+++..+..++.||+.||.|||+ . +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (325)
T cd05594 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-AT 152 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cc
Confidence 99988843 3468999999999999999999997 7 99999999999999999999999999987543222 12
Q ss_pred eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCC
Q 012462 302 TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRP 381 (463)
Q Consensus 302 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (463)
.....||+.|+|||++.+..++.++|||||||++|||++|..||...... .......... .....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~------~~~~~i~~~~---------~~~p~ 217 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILMEE---------IRFPR 217 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH------HHHHHHhcCC---------CCCCC
Confidence 23457999999999999999999999999999999999999999754321 1111111110 01111
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 012462 382 STRALKRSLLTALRCVDPDSEKRP-----KMSQVVRM 413 (463)
Q Consensus 382 ~~~~~~~~~~~~~~cl~~dP~~RP-----s~~ell~~ 413 (463)
.. ...+..++.+||+.||++|+ ++.+++++
T Consensus 218 ~~--~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 218 TL--SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CC--CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 11 11233445579999999996 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=320.71 Aligned_cols=260 Identities=25% Similarity=0.449 Sum_probs=204.8
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc------CCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRM 213 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 213 (463)
.++|.+.+.||+|+||+||++... ++..+|+|.+..........+..|+.++.+++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 467888999999999999999642 24568999886655555678889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhh---------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEE
Q 012462 214 LVYEYVNNGNLEQWLHGAM---------RHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAK 284 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~k 284 (463)
+||||+++++|.+++.... .....+++..++.++.|++.||+|||++ +++||||||+|||+++++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 9999999999999986432 1223589999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCc-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHH
Q 012462 285 VSDFGLAKLLGAGKS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKM 362 (463)
Q Consensus 285 l~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~ 362 (463)
|+|||++........ .......++..|+|||.+.+..++.++|||||||++|+|++ |..||...... .....
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~------~~~~~ 234 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------EVIEC 234 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHH
Confidence 999999986543221 11223345778999999998899999999999999999998 89998654321 11122
Q ss_pred HhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCC
Q 012462 363 MVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEE 418 (463)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~ 418 (463)
..... .... + .... ..+..++.+||+.||.+|||++++++.|+.+.
T Consensus 235 i~~~~-~~~~--~----~~~~---~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 235 ITQGR-VLQR--P----RTCP---KEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HHcCC-cCCC--C----CCCC---HHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 22111 1100 0 0111 23455666899999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=327.84 Aligned_cols=200 Identities=29% Similarity=0.431 Sum_probs=167.7
Q ss_pred CCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC-----cEEE
Q 012462 142 RFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG-----IHRM 213 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~ 213 (463)
+|++.++||+|+||.||+|.. .++..||+|++.... ......+.+|+.++++++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 588899999999999999965 468999999885422 22345678899999999999999999988643 2479
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 689988853 34589999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCC--ceeeccccccCCCCchhhhcc--CCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 294 LGAGK--SHVTTRVMGTFGYVAPEYANT--GLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 294 ~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~ 212 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 43221 112234578999999999876 678999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=342.80 Aligned_cols=257 Identities=26% Similarity=0.343 Sum_probs=202.6
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECc----
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGI---- 210 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 210 (463)
...++|.+.+.||+|+||+||+|.. .+++.||||.+.... ......+..|+.++..++|+||+++++.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3457899999999999999999954 578999999985432 334456788999999999999999988775432
Q ss_pred ----EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEe
Q 012462 211 ----HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVS 286 (463)
Q Consensus 211 ----~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~ 286 (463)
..++||||+++|+|.+++.........+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEE
Confidence 36799999999999999976555556799999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCc-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhc
Q 012462 287 DFGLAKLLGAGKS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVG 365 (463)
Q Consensus 287 Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 365 (463)
|||+++....... ......+||+.|+|||++.+..++.++|||||||+||||++|+.||..... ...+.....
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~~~~~~~ 259 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEVMHKTLA 259 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhc
Confidence 9999987543221 223346799999999999999999999999999999999999999975432 222222222
Q ss_pred CCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 366 SRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
... .. ..... ...+..++.+||+.||.+||++.+++++
T Consensus 260 ~~~-~~-------~~~~~--~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 260 GRY-DP-------LPPSI--SPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCC-CC-------CCCCC--CHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111 10 01111 1223445568999999999999999865
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=332.70 Aligned_cols=206 Identities=21% Similarity=0.302 Sum_probs=176.1
Q ss_pred HHHHhcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcE
Q 012462 136 LELATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIH 211 (463)
Q Consensus 136 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 211 (463)
+....++|++.+.||+|+||.||++... +++.+|+|.+.... ......+..|+.+++.++||||+++++++.++..
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3445678999999999999999999664 57889999885321 2233457789999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccc
Q 012462 212 RMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA 291 (463)
Q Consensus 212 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a 291 (463)
.|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccc
Confidence 9999999999999999853 2478899999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCceeeccccccCCCCchhhhccC----CCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 292 KLLGAGKSHVTTRVMGTFGYVAPEYANTG----LLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
..............+||+.|+|||++.+. .++.++|||||||+||||++|+.||....
T Consensus 190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~ 251 (370)
T cd05621 190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 251 (370)
T ss_pred eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence 87654333233456799999999998764 37889999999999999999999997543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=334.38 Aligned_cols=255 Identities=19% Similarity=0.242 Sum_probs=198.3
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEE
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRM 213 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 213 (463)
...++|++.+.||+|+||.||+|.. .++..||+|.+.... ......+..|+.+++.++||||+++++++.+....|
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 4456799999999999999999965 467899999985422 123345678999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 120 lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 99999999999998853 2478889999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCceeeccccccCCCCchhhhccC----CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCc
Q 012462 294 LGAGKSHVTTRVMGTFGYVAPEYANTG----LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369 (463)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 369 (463)
............+||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ............
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~~~ 265 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMDHKNS 265 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCCCc
Confidence 654332223346799999999998653 4789999999999999999999999764321 112222211111
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 012462 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEK--RPKMSQVVRM 413 (463)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~--RPs~~ell~~ 413 (463)
. ..+...........++.+||+.+|.+ |+++.|++++
T Consensus 266 ~-------~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 266 L-------TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred C-------CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1 11111011122333455799999988 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=324.68 Aligned_cols=247 Identities=23% Similarity=0.306 Sum_probs=191.8
Q ss_pred CCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCC-CcceEeeEEEECcEEEEEE
Q 012462 142 RFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHK-NLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lV~ 216 (463)
+|++.+.||+|+||.||+|... +++.||+|++.... ......+..|..++..++|+ +|+++++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999654 56789999986432 22345667788899888664 6888999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+++|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999998853 34588999999999999999999999 999999999999999999999999999875322
Q ss_pred CCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (463)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......... .
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~------~~~~~i~~~-~-------- 217 (324)
T cd05587 154 GG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED------ELFQSIMEH-N-------- 217 (324)
T ss_pred CC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHcC-C--------
Confidence 21 1233457899999999999999999999999999999999999999754321 111111111 0
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 012462 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKM-----SQVVRM 413 (463)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~-----~ell~~ 413 (463)
....... ......++.+||+.||.+|++. ++++++
T Consensus 218 ~~~~~~~--~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 218 VSYPKSL--SKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred CCCCCCC--CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0011111 1223445568999999999976 565543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=335.10 Aligned_cols=201 Identities=25% Similarity=0.337 Sum_probs=172.1
Q ss_pred CCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 142 RFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
+|+++++||+|+||+||+|.. .+++.||+|++.... ......+..|+.++++++||||+++++.+.+++..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588899999999999999965 467899999985432 2334567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
|+++|+|.+++.. .+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 9999999999853 34588999999999999999999999 9999999999999999999999999997532100
Q ss_pred C----------------------------------------------ceeeccccccCCCCchhhhccCCCCccchhhhH
Q 012462 298 K----------------------------------------------SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSF 331 (463)
Q Consensus 298 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 331 (463)
. .......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 000123578999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCC
Q 012462 332 GVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 332 Gvvl~elltg~~pf~~~~ 349 (463)
||+||||++|+.||....
T Consensus 235 Gvil~elltG~~Pf~~~~ 252 (382)
T cd05625 235 GVILYEMLVGQPPFLAQT 252 (382)
T ss_pred hHHHHHHHhCCCCCCCCC
Confidence 999999999999997644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=331.06 Aligned_cols=262 Identities=22% Similarity=0.298 Sum_probs=196.1
Q ss_pred CCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECc-----EEE
Q 012462 142 RFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGI-----HRM 213 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 213 (463)
+|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.... ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999965 578999999885432 233467788999999999999999999998776 789
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
+||||+. ++|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 58888774 345689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCceeeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHH-------------
Q 012462 294 LGAGKSHVTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDW------------- 359 (463)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~------------- 359 (463)
.............+++.|+|||++.+. .++.++|||||||++|||++|+.||....+......+..
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 654333333445678999999998774 578999999999999999999999986543322111100
Q ss_pred ---HH-HHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 360 ---LK-MMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 360 ---~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.. ..................... .......++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQ--ATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCC--CCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00 000000000000000000000 12234456668999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=314.14 Aligned_cols=257 Identities=30% Similarity=0.472 Sum_probs=205.8
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
+..++|.+.+.||+|+||.||+|...++..||+|.+.... ...+++..|+.++++++|+||+++++++.+....++|||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 4567899999999999999999988788899999886433 334678889999999999999999999998889999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
|+++++|.+++... ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 82 YMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred ccCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 99999999999652 234589999999999999999999999 9999999999999999999999999999876532
Q ss_pred CceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccCC
Q 012462 298 KSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (463)
..........+..|+|||.+.+..++.++||||||+++|||++ |+.||...... ..+...........
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~------~~~~~~~~~~~~~~----- 225 (261)
T cd05034 157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR------EVLEQVERGYRMPR----- 225 (261)
T ss_pred hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCCCCC-----
Confidence 2222222334678999999998889999999999999999998 99999654321 12222222111100
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 012462 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416 (463)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~ 416 (463)
... ....+..++.+||+.+|++||+++++++.|+.
T Consensus 226 ---~~~--~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 226 ---PPN--CPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---CCC--CCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 000 12234556668999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=319.69 Aligned_cols=261 Identities=25% Similarity=0.417 Sum_probs=205.9
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc------CCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRM 213 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 213 (463)
..+|.+.+.||+|+||.||+|... ++..+++|.+........+.+.+|+.++++++||||+++++++......+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 345788899999999999999642 34568899886665556678889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCC
Q 012462 214 LVYEYVNNGNLEQWLHGAMR------------HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDF 281 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~ 281 (463)
+||||+++++|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence 99999999999999964321 223589999999999999999999999 999999999999999999
Q ss_pred CEEEeecccceecCCCCc-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHH
Q 012462 282 NAKVSDFGLAKLLGAGKS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDW 359 (463)
Q Consensus 282 ~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~ 359 (463)
.++|+|||++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||....... .
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------~ 234 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE------V 234 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------H
Confidence 999999999976543321 11233456788999999999999999999999999999999 999986543221 1
Q ss_pred HHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCC
Q 012462 360 LKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEY 419 (463)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~ 419 (463)
......... ... .. .....+..++.+||+.||++||++.+|++.|+++..
T Consensus 235 ~~~~~~~~~-~~~-------~~--~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 235 IECITQGRV-LER-------PR--VCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHHhCCCC-CCC-------Cc--cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 111111111 110 00 011234456668999999999999999999988743
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=316.49 Aligned_cols=259 Identities=27% Similarity=0.379 Sum_probs=195.0
Q ss_pred CCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECc-----EEEEE
Q 012462 142 RFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGI-----HRMLV 215 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lV 215 (463)
.|.-.+++|.|+||.||+|... +++.||||++..+.. .-.+|+++|+.++|||||+++-+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 3566789999999999999654 468999999865432 2234899999999999999999887432 23589
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCC-CCEEEeecccceec
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDD-FNAKVSDFGLAKLL 294 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~-~~~kl~Dfg~a~~~ 294 (463)
||||+. +|.++++.....+..++...+.-+..||++||.|||+. +|+||||||.|+|+|.+ |.+||||||.|+..
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999977 99999987666677788889999999999999999998 99999999999999976 99999999999988
Q ss_pred CCCCceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcc---
Q 012462 295 GAGKSHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE--- 370 (463)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--- 370 (463)
..+... .....|.-|+|||.+.+ ..|+.+.||||.|||+.||+-|+.-|.+....+. +...++ +.+.....
T Consensus 177 ~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ--L~eIik-~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 177 VKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ--LVEIIK-VLGTPTREDIK 251 (364)
T ss_pred ccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH--HHHHHH-HhCCCCHHHHh
Confidence 765533 22345778999998876 5799999999999999999999999987543322 111111 11111100
Q ss_pred -------ccccCCCCCCC-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 371 -------EVVDPNIEVRP-----STRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 371 -------~~~~~~~~~~~-----~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
+...+.+...+ ......+.+.++.++|..+|.+|.++.|++.+
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 11111111111 11223445566678999999999999999854
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=323.48 Aligned_cols=249 Identities=23% Similarity=0.297 Sum_probs=191.9
Q ss_pred CeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEEEEEEeecCC
Q 012462 147 NVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNN 221 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 221 (463)
++||+|+||.||+|.. .++..||+|.+.... ......+..|..++..+ +||||++++++|.+....|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3699999999999965 467899999986432 22335577899999888 799999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCcee
Q 012462 222 GNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV 301 (463)
Q Consensus 222 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 301 (463)
|+|.+++.. .+.+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DT 152 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cc
Confidence 999988743 35699999999999999999999999 99999999999999999999999999987532211 12
Q ss_pred eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcc--cccHHHHHHHHhcCCCccccccCCCCC
Q 012462 302 TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAH--EVNLVDWLKMMVGSRRSEEVVDPNIEV 379 (463)
Q Consensus 302 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (463)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....++.......... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~ 224 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI--------RI 224 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC--------CC
Confidence 334678999999999999999999999999999999999999997432211 11222222222222111 11
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCC------HHHHHHH
Q 012462 380 RPSTRALKRSLLTALRCVDPDSEKRPK------MSQVVRM 413 (463)
Q Consensus 380 ~~~~~~~~~~~~~~~~cl~~dP~~RPs------~~ell~~ 413 (463)
+... ......++.+||+.||.+||+ +++++++
T Consensus 225 p~~~--~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 225 PRSL--SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCC--CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 1111 122344556899999999997 6677654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=320.64 Aligned_cols=263 Identities=28% Similarity=0.430 Sum_probs=205.4
Q ss_pred HHHHhcCCCccCeEeecCcEEEEEEEEcC------CCeEEEEEEcccc-hhhHHHHHHHHHHHcCC-CCCCcceEeeEEE
Q 012462 136 LELATNRFSKENVLGEGGYGVVYRGNLIN------GSPVAVKKILNNV-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCI 207 (463)
Q Consensus 136 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 207 (463)
+++..++|++.+.||+|+||.||++.... ...+|+|.+.... ......+.+|+.++.++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 35566789999999999999999996532 3578999886432 23345688899999999 8999999999999
Q ss_pred ECcEEEEEEeecCCCCHHHHHhhhh------------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCce
Q 012462 208 EGIHRMLVYEYVNNGNLEQWLHGAM------------RHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNI 275 (463)
Q Consensus 208 ~~~~~~lV~e~~~~g~L~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Ni 275 (463)
.+...+++|||+++|+|.+++.... .....+++..++.++.|++.||.|||+. +|+|+||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence 9999999999999999999986421 2345689999999999999999999999 999999999999
Q ss_pred eEcCCCCEEEeecccceecCCCCce-eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCccc
Q 012462 276 LIDDDFNAKVSDFGLAKLLGAGKSH-VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHE 353 (463)
Q Consensus 276 ll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~ 353 (463)
|++.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-- 241 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-- 241 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH--
Confidence 9999999999999999876543221 1222335678999999998899999999999999999998 99998754321
Q ss_pred ccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 354 VNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
............. .. ......+..++.+||+.||++|||+.|+++.|+.+
T Consensus 242 ----~~~~~~~~~~~~~--------~~--~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 242 ----ELFKLLKEGYRME--------KP--QNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ----HHHHHHHcCCcCC--------CC--CCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 1111111111100 01 11123445567789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=309.28 Aligned_cols=267 Identities=26% Similarity=0.334 Sum_probs=217.9
Q ss_pred chHHHHHHhcCCCccCeEeecCcEEEEEEEEc------CCCeEEEEEEcccchh-hHHHHHHHHHHHcCCCCCCcceEee
Q 012462 132 TLRDLELATNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNVGQ-AEKEFRVEVEAIGHVRHKNLVRLLG 204 (463)
Q Consensus 132 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~ 204 (463)
...++.+.+.|+++..++-+|.||.||.|.|. +.+.|.+|.++....+ +...+..|..++..+.|||+.++.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 36678888999999999999999999999543 3457888988766544 3467788999999999999999999
Q ss_pred EEEE-CcEEEEEEeecCCCCHHHHHhhhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC
Q 012462 205 YCIE-GIHRMLVYEYVNNGNLEQWLHGAMRH----HGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD 279 (463)
Q Consensus 205 ~~~~-~~~~~lV~e~~~~g~L~~~l~~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~ 279 (463)
++.+ ....++++.++..|+|..||..++.. .+.++..+...++.|++.|++|||++ +|+|.||..+|++|++
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehh
Confidence 9865 45678999999999999999855422 23466778889999999999999999 9999999999999999
Q ss_pred CCCEEEeecccceecCCCCceeecc-ccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHH
Q 012462 280 DFNAKVSDFGLAKLLGAGKSHVTTR-VMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLV 357 (463)
Q Consensus 280 ~~~~kl~Dfg~a~~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~ 357 (463)
..++||+|-.+++..-+.+++...+ ...+..||+||.+.+..|+..+|||||||+||||+| |+.||..-+| .
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP------f 505 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP------F 505 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH------H
Confidence 9999999999999877766554332 345789999999999999999999999999999999 9999975443 3
Q ss_pred HHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 358 DWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
+....+..+.+..... .+..+++.+|.-||+..|++||+++|++.-|.++
T Consensus 506 Em~~ylkdGyRlaQP~----------NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 506 EMEHYLKDGYRLAQPF----------NCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred HHHHHHhccceecCCC----------CCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 3333444444444333 3445677778889999999999999999988765
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=315.73 Aligned_cols=255 Identities=28% Similarity=0.445 Sum_probs=196.8
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCC----eEEEEEEcccch-hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGS----PVAVKKILNNVG-QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 214 (463)
++|++.+.||+|+||+||+|.+. +++ .+++|.+..... ....++..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46788899999999999999763 344 477787744332 233567778889999999999999998764 45789
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
++||+++|+|.+++.. ....+++..++.++.||+.||.|||+. +++|+||||+|||+++++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 9999999999999964 234689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCc-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCcccc
Q 012462 295 GAGKS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV 372 (463)
Q Consensus 295 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (463)
..... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+..+.. ..+. ...+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~----~~~~~~~-- 230 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VPDL----LEKGERL-- 230 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HHCCCcC--
Confidence 43322 12233456778999999998899999999999999999998 999997643221 1111 1111111
Q ss_pred ccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCC
Q 012462 373 VDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEE 418 (463)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~ 418 (463)
..+.. .......++.+||+.||++|||+.|+++.|....
T Consensus 231 ~~~~~-------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 231 AQPQI-------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred CCCCC-------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 11110 1123345566899999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=312.15 Aligned_cols=254 Identities=27% Similarity=0.419 Sum_probs=199.9
Q ss_pred hcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeec
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYV 219 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 219 (463)
.++|.+.+.||+|+||.||+|.+.++..+|+|.+.... .....+.+|+.++++++|||++++++++.. ...++||||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcC
Confidence 45688899999999999999988777789999875432 334678889999999999999999998754 5678999999
Q ss_pred CCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCc
Q 012462 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299 (463)
Q Consensus 220 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 299 (463)
.+++|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 83 GKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 999999999642 234588999999999999999999999 999999999999999999999999999987644322
Q ss_pred eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCC
Q 012462 300 HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378 (463)
Q Consensus 300 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (463)
.......++..|+|||...+..++.++||||||+++|||++ |..||...... ............ .
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~~~~~~~~--------~ 223 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR------EVLEQVERGYRM--------P 223 (260)
T ss_pred cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCCC--------C
Confidence 22223345678999999998889999999999999999999 89999754321 111112111110 0
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 012462 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416 (463)
Q Consensus 379 ~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~ 416 (463)
... .....+..++.+||+.||++||+++++++.|++
T Consensus 224 ~~~--~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQ--GCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCc--ccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 011 112234445568999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=308.99 Aligned_cols=265 Identities=25% Similarity=0.410 Sum_probs=202.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcC--CCCCCcceEeeEEEEC----cEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGH--VRHKNLVRLLGYCIEG----IHRM 213 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----~~~~ 213 (463)
.....+.+.||+|.||+||+|+| .|+.||||++.. .++..+.+|.++.+. |+|+||+.+++.-..+ .++|
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred hheeEEEEEecCccccceeeccc-cCCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 34567788999999999999998 789999999843 334566667777765 5999999999876543 3579
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEEccCCCCceeEcCCCCEEEeec
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI-----EPKVVHRDIKSSNILIDDDFNAKVSDF 288 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----~~~i~H~Dikp~Nill~~~~~~kl~Df 288 (463)
||.+|.+.|+|.|||.. ..++.+..++++..+|.||+|||... +|.|.|||||+.|||+..++.+.|+|+
T Consensus 286 LvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 99999999999999953 46899999999999999999999763 789999999999999999999999999
Q ss_pred ccceecCCCCce---eeccccccCCCCchhhhccCC----CC--ccchhhhHHHHHHHHHhC----------CCCCCCCC
Q 012462 289 GLAKLLGAGKSH---VTTRVMGTFGYVAPEYANTGL----LN--EKSDVYSFGVLLLEAITG----------RDPVDHGR 349 (463)
Q Consensus 289 g~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~~--~~sDvwSlGvvl~elltg----------~~pf~~~~ 349 (463)
|||......... ..+..+||.+|||||++...- +. ..+||||||.||||+.-. +.||.+..
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 999876554221 234568999999999996642 11 368999999999999752 56776654
Q ss_pred CcccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCC
Q 012462 350 PAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEE 418 (463)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~ 418 (463)
+.+. .+.+ +...+-..+..... .....+.+.+.....+|..||..||.-|.|+-.+-+.|.+..
T Consensus 441 p~DP-s~ee-MrkVVCv~~~RP~i---pnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 441 PSDP-SFEE-MRKVVCVQKLRPNI---PNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred CCCC-CHHH-HhcceeecccCCCC---CcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 4332 2222 22222222221111 122445667777777788899999999999999988887753
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=321.14 Aligned_cols=241 Identities=26% Similarity=0.361 Sum_probs=185.6
Q ss_pred CeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcC-CCCCCcceEeeEEEECcEEEEEEeecCC
Q 012462 147 NVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGH-VRHKNLVRLLGYCIEGIHRMLVYEYVNN 221 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lV~e~~~~ 221 (463)
+.||+|+||.||+|... +++.||+|.+.... ......+..|..++.. .+||||+++++++..+...++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999654 57889999986432 1223344556666654 4899999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCcee
Q 012462 222 GNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV 301 (463)
Q Consensus 222 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 301 (463)
|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 999998853 34589999999999999999999999 99999999999999999999999999998643322 22
Q ss_pred eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCC
Q 012462 302 TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRP 381 (463)
Q Consensus 302 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (463)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ............ ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~~---------~~~~ 217 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE------DELFDSILNDRP---------HFPR 217 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCC---------CCCC
Confidence 3446789999999999999999999999999999999999999975432 111122211100 0011
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 012462 382 STRALKRSLLTALRCVDPDSEKRPKMS-QVVR 412 (463)
Q Consensus 382 ~~~~~~~~~~~~~~cl~~dP~~RPs~~-ell~ 412 (463)
.. ......++.+||+.||++||++. ++++
T Consensus 218 ~~--~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 218 WI--SKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CC--CHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 11 11223345579999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=316.05 Aligned_cols=252 Identities=24% Similarity=0.285 Sum_probs=197.0
Q ss_pred CCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccch---hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 142 RFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVG---QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
+|++.++||+|+||+||++.. .+++.||+|++..... .....+.+|+.++++++||||+++++++.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 477889999999999999965 4688999999854322 223456779999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
|+.+|+|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999999888542 234589999999999999999999999 9999999999999999999999999999875432
Q ss_pred CceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCC
Q 012462 298 KSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNI 377 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (463)
.. .....|+..|+|||++.+..++.++|||||||++|||++|..||........ . ..+........ .
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~--~-~~~~~~~~~~~--------~ 222 (285)
T cd05605 156 ET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK--R-EEVERRVKEDQ--------E 222 (285)
T ss_pred Cc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH--H-HHHHHHhhhcc--------c
Confidence 21 2334789999999999988999999999999999999999999976432111 1 11111111100 0
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 012462 378 EVRPSTRALKRSLLTALRCVDPDSEKRP-----KMSQVVRM 413 (463)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~cl~~dP~~RP-----s~~ell~~ 413 (463)
..... .......++.+||+.||.+|| ++++++++
T Consensus 223 ~~~~~--~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 223 EYSEK--FSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccCcc--cCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 01111 112233456689999999999 88888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=314.74 Aligned_cols=248 Identities=24% Similarity=0.285 Sum_probs=192.4
Q ss_pred EeecCcEEEEEEEE-cCCCeEEEEEEcccch---hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCCCCH
Q 012462 149 LGEGGYGVVYRGNL-INGSPVAVKKILNNVG---QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNL 224 (463)
Q Consensus 149 lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 224 (463)
||+|+||+||++.. .+++.||+|.+..... ...+.+..|+.+++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999955 4688999999854322 1224567799999999999999999999999999999999999999
Q ss_pred HHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCceeecc
Q 012462 225 EQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR 304 (463)
Q Consensus 225 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 304 (463)
.+++.........+++..++.++.||+.||.|||+. +|+||||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 988865444456799999999999999999999999 999999999999999999999999999987644322 2334
Q ss_pred ccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHH
Q 012462 305 VMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTR 384 (463)
Q Consensus 305 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (463)
..||+.|+|||++.+..++.++|||||||++|||++|+.||........ .......... ........
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~---------~~~~~~~~-- 223 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRILN---------DSVTYPDK-- 223 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHhhcc---------cCCCCccc--
Confidence 5789999999999999999999999999999999999999975432111 1111111110 00111111
Q ss_pred HHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 012462 385 ALKRSLLTALRCVDPDSEKRP-----KMSQVVRM 413 (463)
Q Consensus 385 ~~~~~~~~~~~cl~~dP~~RP-----s~~ell~~ 413 (463)
....+..++.+||+.||++|| ++++++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 112233445579999999999 66777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=309.31 Aligned_cols=260 Identities=26% Similarity=0.423 Sum_probs=207.1
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEccc---chhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNN---VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
++|++.+.||+|+||.||+|... +|+.||+|.+... .......+.+|++++++++|+||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999665 7899999987532 2233567888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+++++|.+++.........+++..++.++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999875444456689999999999999999999999 999999999999999999999999999886543
Q ss_pred CCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (463)
.... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||.... ....+......... ...
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~-~~~----- 227 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIEKCD-YPP----- 227 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhhhhcCC-CCC-----
Confidence 3211 223467889999999998889999999999999999999999996433 12222222211110 000
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.+.......+..++.+||+.+|++||++.+|++.|+++
T Consensus 228 ---~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 228 ---LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred ---CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 00111122344556689999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=322.04 Aligned_cols=249 Identities=24% Similarity=0.313 Sum_probs=190.4
Q ss_pred CeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEEEEEEeecCC
Q 012462 147 NVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNN 221 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 221 (463)
+.||+|+||+||+|.. .+++.||+|.+.... ......+..|+.++.++ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999965 457899999986432 23335567788888776 899999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCcee
Q 012462 222 GNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV 301 (463)
Q Consensus 222 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 301 (463)
|+|..++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~ 152 (329)
T cd05618 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DT 152 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cc
Confidence 999988743 34689999999999999999999999 99999999999999999999999999987532221 12
Q ss_pred eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcc--cccHHHHHHHHhcCCCccccccCCCCC
Q 012462 302 TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAH--EVNLVDWLKMMVGSRRSEEVVDPNIEV 379 (463)
Q Consensus 302 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (463)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......++......... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--------~~ 224 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--------RI 224 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC--------CC
Confidence 334678999999999999999999999999999999999999996422111 11222222222211111 11
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCH------HHHHHH
Q 012462 380 RPSTRALKRSLLTALRCVDPDSEKRPKM------SQVVRM 413 (463)
Q Consensus 380 ~~~~~~~~~~~~~~~~cl~~dP~~RPs~------~ell~~ 413 (463)
+... ......++.+||+.||++||++ .+++++
T Consensus 225 p~~~--~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 225 PRSL--SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCC--CHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 1111 1223345568999999999984 666554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=319.67 Aligned_cols=249 Identities=24% Similarity=0.300 Sum_probs=192.3
Q ss_pred CeEeecCcEEEEEEEE-cCCCeEEEEEEcccch---hhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEEEEEEeecCC
Q 012462 147 NVLGEGGYGVVYRGNL-INGSPVAVKKILNNVG---QAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNN 221 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 221 (463)
+.||+|+||+||+|.. .+++.||+|++..... .....+..|+.++.++ +||||+++++++.+....|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999965 4578899999865322 2335577888888887 699999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCcee
Q 012462 222 GNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV 301 (463)
Q Consensus 222 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 301 (463)
|+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (327)
T cd05617 81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DT 152 (327)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cc
Confidence 999988743 34699999999999999999999999 99999999999999999999999999987532221 12
Q ss_pred eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCC
Q 012462 302 TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRP 381 (463)
Q Consensus 302 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (463)
....+||+.|+|||++.+..++.++|||||||+||||++|+.||.............++......... ..+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------~~p~ 224 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI--------RIPR 224 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC--------CCCC
Confidence 33467999999999999999999999999999999999999999754332222223333222221111 1111
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCH------HHHHHH
Q 012462 382 STRALKRSLLTALRCVDPDSEKRPKM------SQVVRM 413 (463)
Q Consensus 382 ~~~~~~~~~~~~~~cl~~dP~~RPs~------~ell~~ 413 (463)
.. ......++.+||+.||.+|+++ ++++++
T Consensus 225 ~~--~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 225 FL--SVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CC--CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 11 1123345568999999999984 566554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=321.56 Aligned_cols=242 Identities=23% Similarity=0.313 Sum_probs=188.9
Q ss_pred CeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEEEEEEeecCC
Q 012462 147 NVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNN 221 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 221 (463)
+.||+|+||+||+|... +++.||+|.+.... ......+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999654 57899999985432 22334566788888766 799999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCcee
Q 012462 222 GNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV 301 (463)
Q Consensus 222 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 301 (463)
|+|.+++.. ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~ 152 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KT 152 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cc
Confidence 999998853 34589999999999999999999999 99999999999999999999999999987643222 12
Q ss_pred eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCC
Q 012462 302 TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRP 381 (463)
Q Consensus 302 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (463)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........... ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~---------~~~~ 217 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAILNDEV---------VYPT 217 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHHHHHhcCCC---------CCCC
Confidence 33457899999999999999999999999999999999999999754321 12222221110 0111
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCH------HHHHHH
Q 012462 382 STRALKRSLLTALRCVDPDSEKRPKM------SQVVRM 413 (463)
Q Consensus 382 ~~~~~~~~~~~~~~cl~~dP~~RPs~------~ell~~ 413 (463)
. .......++.+||+.||++||++ ++++++
T Consensus 218 ~--~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 218 W--LSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred C--CCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 1 11223345567999999999998 565543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=337.34 Aligned_cols=262 Identities=23% Similarity=0.348 Sum_probs=192.4
Q ss_pred HhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC--------
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG-------- 209 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------- 209 (463)
...+|++.++||+|+||.||+|.. .+++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 346799999999999999999965 467899999885432 2234689999999999999999987532
Q ss_pred cEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCC-CEEEeec
Q 012462 210 IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDF-NAKVSDF 288 (463)
Q Consensus 210 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~-~~kl~Df 288 (463)
..+++||||+++ +|.+++.........+++..++.++.||+.||.|||+. +|+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence 245789999975 88888765545566799999999999999999999999 999999999999999664 7999999
Q ss_pred ccceecCCCCceeeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCC
Q 012462 289 GLAKLLGAGKSHVTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR 367 (463)
Q Consensus 289 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 367 (463)
|+++....... .....||+.|+|||++.+. .++.++|||||||+||||++|..||.+...... +...+. .....
T Consensus 216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~i~~-~~~~p 290 (440)
T PTZ00036 216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVRIIQ-VLGTP 290 (440)
T ss_pred ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHH-HhCCC
Confidence 99986543321 2335689999999988664 689999999999999999999999986543221 111111 10000
Q ss_pred C----------ccccccCCCCCCC-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 368 R----------SEEVVDPNIEVRP-----STRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 368 ~----------~~~~~~~~~~~~~-----~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
. ...+.-+...... ..........++.+||+.||.+|||+.|++++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0 0000000000000 00011244556678999999999999999854
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=317.73 Aligned_cols=202 Identities=25% Similarity=0.328 Sum_probs=172.9
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
++|++.+.||+|+||+||++... +++.||+|.+.... ......+..|+.++..++|+||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46889999999999999999654 58899999985421 223355778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+++|+|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999853 234589999999999999999999999 999999999999999999999999999977654
Q ss_pred CCceeeccccccCCCCchhhhcc-----CCCCccchhhhHHHHHHHHHhCCCCCCCC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANT-----GLLNEKSDVYSFGVLLLEAITGRDPVDHG 348 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~pf~~~ 348 (463)
.........+||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 33322333468999999999863 45788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=312.21 Aligned_cols=255 Identities=26% Similarity=0.365 Sum_probs=198.6
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
.++|++.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.++.+++||||+++++++......++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35789999999999999999965 56788999988655444556778899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+|+||+|+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 88 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999998853 34689999999999999999999999 99999999999999999999999999998664322
Q ss_pred ceeeccccccCCCCchhhhc---cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 299 SHVTTRVMGTFGYVAPEYAN---TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
. ......++..|+|||.+. ...++.++|||||||++|||++|+.||....+...... +... ....+
T Consensus 161 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~------~~~~----~~~~~ 229 (267)
T cd06646 161 A-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL------MSKS----NFQPP 229 (267)
T ss_pred c-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee------eecC----CCCCC
Confidence 1 122346788999999874 44578899999999999999999999965432211100 0000 00011
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 012462 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414 (463)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L 414 (463)
...... .....+..++.+||+.+|++||++++++++|
T Consensus 230 ~~~~~~--~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KLKDKT--KWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCcccc--ccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 111000 1112344556689999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=315.55 Aligned_cols=262 Identities=26% Similarity=0.394 Sum_probs=205.6
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEEcC-----CCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEE-Cc
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNLIN-----GSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE-GI 210 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~ 210 (463)
+..++|++.+.||+|+||.||+|...+ +..|++|++.... ......+.+|+.++++++||||+++++++.. +.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 346789999999999999999997655 6889999886443 3445678889999999999999999998776 46
Q ss_pred EEEEEEeecCCCCHHHHHhhhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEe
Q 012462 211 HRMLVYEYVNNGNLEQWLHGAMRH----HGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVS 286 (463)
Q Consensus 211 ~~~lV~e~~~~g~L~~~l~~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~ 286 (463)
..++++||+++++|.+++...... ...+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEEC
Confidence 778999999999999998754222 14689999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCcee-eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHh
Q 012462 287 DFGLAKLLGAGKSHV-TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMV 364 (463)
Q Consensus 287 Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 364 (463)
|||+++.+....... .....++..|+|||++.+..++.++|||||||++||+++ |+.||....+. ++.....
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~ 233 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF------EMAAYLK 233 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH------HHHHHHH
Confidence 999998654333221 122345678999999998899999999999999999999 99999754321 2222222
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCC
Q 012462 365 GSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEE 418 (463)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~ 418 (463)
....... .. .....+..++.+||..||++|||+.++++.|+++.
T Consensus 234 ~~~~~~~--------~~--~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 234 DGYRLAQ--------PI--NCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred cCCCCCC--------CC--cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1111110 00 01123455667899999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=317.27 Aligned_cols=262 Identities=26% Similarity=0.373 Sum_probs=198.4
Q ss_pred cCCCccCeEeecCcEEEEEEEE-----cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEE--CcEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-----INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE--GIHRM 213 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~ 213 (463)
.+|++.+.||+|+||.||++.. .++..||+|.+........+.+..|+.++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 5688899999999999999964 3578999999876655556788899999999999999999998754 34678
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
+||||+++++|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 84 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccc
Confidence 999999999999998642 34589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCcee--eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCccc---------ccHHHHHHH
Q 012462 294 LGAGKSHV--TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHE---------VNLVDWLKM 362 (463)
Q Consensus 294 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~---------~~~~~~~~~ 362 (463)
........ .....++..|+|||++.+..++.++|||||||++|||++|..|+........ ......+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence 64432211 1112234569999999988999999999999999999998877643221000 000000111
Q ss_pred HhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 363 MVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
..... ............+..++.+||+.+|++|||+.||++.|+.+
T Consensus 238 ~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 238 LLKNN---------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHhcC---------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11110 00001111122344556689999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=327.18 Aligned_cols=203 Identities=28% Similarity=0.377 Sum_probs=173.9
Q ss_pred hcCCCccCeEeecCcEEEEEE-EEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCC-C-----CCcceEeeEEEECcEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR-H-----KNLVRLLGYCIEGIHR 212 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~~ 212 (463)
..+|++++.||+|+||.|.+| +..+++.||||++++.. .-..+...|+.+|..|+ | -|+|+++++|...++.
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 348999999999999999999 55679999999986653 33445556899998886 4 3899999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCC--CEEEeeccc
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDF--NAKVSDFGL 290 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~--~~kl~Dfg~ 290 (463)
|||+|.+.. +|.+||+. .+...++...+..++.||+.||.+||+. +|||+||||+||||.+.+ .|||+|||.
T Consensus 264 ciVfELL~~-NLYellK~--n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 264 CIVFELLST-NLYELLKN--NKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred eeeehhhhh-hHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccc
Confidence 999999955 99999976 3455699999999999999999999999 999999999999997643 699999999
Q ss_pred ceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCccc
Q 012462 291 AKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHE 353 (463)
Q Consensus 291 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~ 353 (463)
|........ ..+.+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+..+.+.
T Consensus 338 Sc~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQ 396 (586)
T KOG0667|consen 338 SCFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQ 396 (586)
T ss_pred ccccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHH
Confidence 987654322 44677889999999999999999999999999999999888887665443
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=310.43 Aligned_cols=257 Identities=24% Similarity=0.407 Sum_probs=203.1
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
++..++|++.+.||+|+||.||+|...++..+++|.+... ......+.+|+.++++++|+||+++++++.+ ...+++|
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 3456789999999999999999998777888999987543 2334678889999999999999999999887 6789999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+++++|.+++... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 80 EFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 999999999998642 234578899999999999999999998 999999999999999999999999999986644
Q ss_pred CCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
..........++..|+|||++....++.++|+|||||++|++++ |..||...... ....+ ...... ..
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~---~~~~~~-~~---- 223 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRA---LERGYR-MP---- 223 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHH---HhCCCC-CC----
Confidence 33222223345678999999998889999999999999999999 99999754321 11111 111110 00
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 012462 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416 (463)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~ 416 (463)
... .....+..++.+||+.+|++||++.++++.|+.
T Consensus 224 ---~~~--~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 ---RPE--NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---Ccc--cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 001 112234455668999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=310.94 Aligned_cols=260 Identities=25% Similarity=0.402 Sum_probs=204.6
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
++|++.+.||+|+||.||+|.. .++..++||.+.... .....++.+|+.+++.++||||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3578888999999999999964 578999999875422 233457888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+++++|.+++.........+++..++.++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999875444456789999999999999999999999 999999999999999999999999999876543
Q ss_pred CCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (463)
... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ........... ..+.
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~------~~~~ 227 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIEQC------DYPP 227 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhhhhcC------CCCC
Confidence 321 123346889999999999888999999999999999999999999653221 11111111111 0011
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.... .....+..++.+||+.||++|||+.+|++.+++.
T Consensus 228 ~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 228 LPSD---HYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCcc---cccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1111 1122334455689999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=323.48 Aligned_cols=242 Identities=24% Similarity=0.301 Sum_probs=190.1
Q ss_pred CeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEEEEEEeecCC
Q 012462 147 NVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNN 221 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 221 (463)
++||+|+||.||+|... +++.||+|.+.... ......+..|.+++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999664 57899999986432 22334566788888765 899999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCcee
Q 012462 222 GNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV 301 (463)
Q Consensus 222 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 301 (463)
|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VT 152 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cc
Confidence 999988853 34589999999999999999999999 99999999999999999999999999987643222 22
Q ss_pred eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCC
Q 012462 302 TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRP 381 (463)
Q Consensus 302 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (463)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........... ..+ ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~------~~~~~i~~~~~----~~p----~~ 218 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED------DLFESILHDDV----LYP----VW 218 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH------HHHHHHHcCCC----CCC----CC
Confidence 33457899999999999999999999999999999999999999764321 12222221110 000 00
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCC-------CHHHHHHH
Q 012462 382 STRALKRSLLTALRCVDPDSEKRP-------KMSQVVRM 413 (463)
Q Consensus 382 ~~~~~~~~~~~~~~cl~~dP~~RP-------s~~ell~~ 413 (463)
... ....++.+||+.||++|| ++++++++
T Consensus 219 ~~~---~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 219 LSK---EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCH---HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 112 233445579999999999 78888765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=314.62 Aligned_cols=257 Identities=25% Similarity=0.413 Sum_probs=199.1
Q ss_pred cCCCccCeEeecCcEEEEEEEE-----cCCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-----INGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 214 (463)
.+|++.+.||+|+||+||+|.+ ..+..|++|.+.... ......+.+|+.++++++||||+++++++......|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4578889999999999999964 245789999986433 3334678889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhc-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCC
Q 012462 215 VYEYVNNGNLEQWLHGAMR-------------HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDF 281 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~ 281 (463)
||||+++++|.+++..... ....+++..++.++.|++.||.|||++ +++|+||||+|||++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 9999999999999853211 123478899999999999999999999 999999999999999999
Q ss_pred CEEEeecccceecCCCCc-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHH
Q 012462 282 NAKVSDFGLAKLLGAGKS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDW 359 (463)
Q Consensus 282 ~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~ 359 (463)
.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||....+. ..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~------~~ 235 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ------EV 235 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH------HH
Confidence 999999999986543321 12223345678999999988889999999999999999998 99999754321 11
Q ss_pred HHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 012462 360 LKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416 (463)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~ 416 (463)
..... ...... .... ....+..++.+||+.||++||++.++++.|..
T Consensus 236 ~~~~~-~~~~~~-------~~~~--~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 236 IEMVR-KRQLLP-------CSED--CPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHH-cCCcCC-------CCCC--CCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111 111110 0111 11233445568999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=322.78 Aligned_cols=241 Identities=23% Similarity=0.296 Sum_probs=188.5
Q ss_pred CCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccch---hhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEEEEEE
Q 012462 142 RFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVG---QAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 216 (463)
+|.+.+.||+|+||.||+|... ++..||+|.+..... .....+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999654 567999999864321 2223455677777766 6899999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+++|+|.+++.. ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999998853 34589999999999999999999999 999999999999999999999999999975432
Q ss_pred CCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (463)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..........
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~------~~~~~i~~~~--------- 217 (323)
T cd05616 154 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIMEHN--------- 217 (323)
T ss_pred CC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC---------
Confidence 22 1233467899999999999999999999999999999999999999754321 1111121111
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 012462 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKM 407 (463)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~ 407 (463)
...+.. .......++.+||+.||++|++.
T Consensus 218 ~~~p~~--~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 VAYPKS--MSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCCc--CCHHHHHHHHHHcccCHHhcCCC
Confidence 011111 11233445668999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=319.54 Aligned_cols=241 Identities=25% Similarity=0.344 Sum_probs=186.7
Q ss_pred CeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcC-CCCCCcceEeeEEEECcEEEEEEeecCC
Q 012462 147 NVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGH-VRHKNLVRLLGYCIEGIHRMLVYEYVNN 221 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lV~e~~~~ 221 (463)
+.||+|+||.||+|... +|..||+|.+.... ......+..|..++.. ++||||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999654 57899999986432 1233455667777765 4899999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCcee
Q 012462 222 GNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV 301 (463)
Q Consensus 222 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 301 (463)
|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.++|+|||+++...... ..
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NR 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cc
Confidence 999998853 34689999999999999999999999 99999999999999999999999999987532221 22
Q ss_pred eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCC
Q 012462 302 TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRP 381 (463)
Q Consensus 302 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (463)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......... +... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~------~~~~~~~~~~-------~~~~-~~ 218 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED------ELFESIRVDT-------PHYP-RW 218 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC-------CCCC-CC
Confidence 34467899999999999999999999999999999999999999754321 1111111110 0000 00
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 012462 382 STRALKRSLLTALRCVDPDSEKRPKMS-QVVR 412 (463)
Q Consensus 382 ~~~~~~~~~~~~~~cl~~dP~~RPs~~-ell~ 412 (463)
... ....++.+||+.||++||++. ++++
T Consensus 219 ~~~---~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 219 ITK---ESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred CCH---HHHHHHHHHccCCHHHcCCChHHHHc
Confidence 112 233445579999999999984 5553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=315.98 Aligned_cols=267 Identities=26% Similarity=0.390 Sum_probs=196.9
Q ss_pred CC-CccCeEeecCcEEEEEEEE-----cCCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC--cEE
Q 012462 142 RF-SKENVLGEGGYGVVYRGNL-----INGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG--IHR 212 (463)
Q Consensus 142 ~~-~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 212 (463)
|| ++.+.||+|+||+||++.. .++..||+|.+.... ......+.+|++++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 44 8889999999999988642 357789999886543 23456788899999999999999999988753 457
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccce
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~ 292 (463)
++||||+++++|.+++.. ..+++..++.++.|++.||.|||++ +|+|+||||+|||++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred EEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccc
Confidence 899999999999999853 2489999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCce--eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 293 LLGAGKSH--VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 293 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
........ ......++..|+|||.+.+..++.++||||||+++|||++|..||........ ................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLI 234 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhh
Confidence 66433211 11223456679999999888899999999999999999999999865432100 0000000000000000
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
...+..............+..++.+||+.+|++|||++++++.|+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 00000001110111123445566689999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=328.51 Aligned_cols=261 Identities=20% Similarity=0.258 Sum_probs=199.1
Q ss_pred hHHHHHHhcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEE
Q 012462 133 LRDLELATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 208 (463)
Q Consensus 133 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 208 (463)
+.++....++|++.+.||+|+||.||++... +++.+|+|.+.... ......+..|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4455666789999999999999999999654 57889999885322 2233457789999999999999999999999
Q ss_pred CcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeec
Q 012462 209 GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDF 288 (463)
Q Consensus 209 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Df 288 (463)
+...++||||+++|+|.+++.. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence 9999999999999999998853 2478889999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCceeeccccccCCCCchhhhccC----CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHh
Q 012462 289 GLAKLLGAGKSHVTTRVMGTFGYVAPEYANTG----LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMV 364 (463)
Q Consensus 289 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 364 (463)
|++..............+||+.|+|||++.+. .++.++|||||||++|||++|..||..... ........
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~ 260 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIM 260 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHHH
Confidence 99987654333233456799999999998754 378899999999999999999999975432 11222222
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHHH
Q 012462 365 GSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEK--RPKMSQVVRML 414 (463)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~--RPs~~ell~~L 414 (463)
.......+.. ........ ..++.+||..++.+ |++++|++++.
T Consensus 261 ~~~~~~~~~~----~~~~s~~~---~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 261 NHKNSLTFPD----DNDISKEA---KNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred cCCCcccCCC----cCCCCHHH---HHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 2111111111 01112222 23344688744433 78999998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=314.39 Aligned_cols=257 Identities=26% Similarity=0.439 Sum_probs=201.2
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc------CCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRM 213 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 213 (463)
..+|.+.++||+|+||.||++... ++..+++|.+..........+..|+++++.++|+||+++++++.+....+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 456788899999999999999532 35678999887665566678999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhhc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCC
Q 012462 214 LVYEYVNNGNLEQWLHGAMR-----------HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFN 282 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~ 282 (463)
++|||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++|+||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence 99999999999999865321 113488999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCce-eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHH
Q 012462 283 AKVSDFGLAKLLGAGKSH-VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWL 360 (463)
Q Consensus 283 ~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~ 360 (463)
++|+|||++......... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||....... ..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~ 234 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE------AI 234 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH------HH
Confidence 999999999765433211 1222345678999999999999999999999999999998 899986543221 11
Q ss_pred HHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 012462 361 KMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415 (463)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~ 415 (463)
.......... .+ .... ..+..++.+||+.||++||++.+|++.|+
T Consensus 235 ~~~~~~~~~~---~~----~~~~---~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 235 ECITQGRELE---RP----RTCP---PEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHcCccCC---CC----CCCC---HHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1111111110 00 1111 22334556899999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=315.75 Aligned_cols=257 Identities=26% Similarity=0.435 Sum_probs=199.3
Q ss_pred CCCccCeEeecCcEEEEEEEEc------CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEE
Q 012462 142 RFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 214 (463)
+|++.+.||+|+||.||+|... ....+++|.+.... ......+.+|+.+++.++||||+++++.|...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778889999999999999653 22468888875443 2334678889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhc--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCc
Q 012462 215 VYEYVNNGNLEQWLHGAMR--------------------HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSN 274 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~N 274 (463)
|+||+.+++|.+++..... ....+++..++.++.|++.||.|||+. +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 9999999999999864321 123578999999999999999999999 99999999999
Q ss_pred eeEcCCCCEEEeecccceecCCCCce-eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcc
Q 012462 275 ILIDDDFNAKVSDFGLAKLLGAGKSH-VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAH 352 (463)
Q Consensus 275 ill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~ 352 (463)
||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||....+.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 99999999999999999765332221 1222345678999999988889999999999999999998 99999654322
Q ss_pred cccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 353 EVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.+.. ......... ........+..++.+||+.+|++||++.|+++.|+++
T Consensus 237 --~~~~---~~~~~~~~~----------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 237 --RLFN---LLKTGYRME----------RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred --HHHH---HHhCCCCCC----------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 1111 111111100 0011112344566789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=306.48 Aligned_cols=247 Identities=28% Similarity=0.447 Sum_probs=194.9
Q ss_pred CeEeecCcEEEEEEEEcCCCeEEEEEEcccch-hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCCCCHH
Q 012462 147 NVLGEGGYGVVYRGNLINGSPVAVKKILNNVG-QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLE 225 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 225 (463)
++||+|+||.||+|...++..+|+|.+..... .....+.+|+.++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999887889999998765432 33456888999999999999999999999999999999999999999
Q ss_pred HHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCceeeccc
Q 012462 226 QWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRV 305 (463)
Q Consensus 226 ~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 305 (463)
+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++..............
T Consensus 81 ~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRK---KKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 98853 234588999999999999999999999 999999999999999999999999999976543322112222
Q ss_pred cccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHH
Q 012462 306 MGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTR 384 (463)
Q Consensus 306 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (463)
.++..|+|||++.+..++.++||||||+++|++++ |..||....... ........... .....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~------~~~~~~~~~~~--------~~~~~-- 218 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ------AREQVEKGYRM--------SCPQK-- 218 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH------HHHHHHcCCCC--------CCCCC--
Confidence 34667999999998889999999999999999998 999997543211 11111111110 00111
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 012462 385 ALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415 (463)
Q Consensus 385 ~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~ 415 (463)
....+..++.+||+.+|++||++.|+++.|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 1233445566899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=313.77 Aligned_cols=259 Identities=27% Similarity=0.426 Sum_probs=200.0
Q ss_pred HhcCCCccCeEeecCcEEEEEEEEcC------CCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcE
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNLIN------GSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIH 211 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 211 (463)
..++|.+.+.||+|+||.||+|.+.+ +..|++|.+.... ......+..|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34678899999999999999996643 5678889875433 3344678889999999999999999999999888
Q ss_pred EEEEEeecCCCCHHHHHhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCC---CEEE
Q 012462 212 RMLVYEYVNNGNLEQWLHGAMR---HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDF---NAKV 285 (463)
Q Consensus 212 ~~lV~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~---~~kl 285 (463)
.++||||+++++|.+++..... ....+++..++.++.||+.||.|||+. +++|+||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999865421 123589999999999999999999999 999999999999998754 5999
Q ss_pred eecccceecCCCCcee-eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHH
Q 012462 286 SDFGLAKLLGAGKSHV-TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMM 363 (463)
Q Consensus 286 ~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 363 (463)
+|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |..||...... ......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~------~~~~~~ 234 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ------EVMEFV 234 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHH
Confidence 9999998763322111 112234567999999998999999999999999999997 99999754322 112222
Q ss_pred hcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 012462 364 VGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416 (463)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~ 416 (463)
....... .... ....+..++.+||+.+|++||++.+|+++|++
T Consensus 235 ~~~~~~~--------~~~~--~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 235 TGGGRLD--------PPKG--CPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred HcCCcCC--------CCCC--CCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 2221111 0111 11234455668999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=314.05 Aligned_cols=265 Identities=23% Similarity=0.389 Sum_probs=200.2
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-----------------CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcce
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-----------------NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVR 201 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~ 201 (463)
.++|++.+.||+|+||.||++... ++..||+|.+.... ......+..|+.+++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 467999999999999999998532 23468999886543 334567889999999999999999
Q ss_pred EeeEEEECcEEEEEEeecCCCCHHHHHhhhhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCc
Q 012462 202 LLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRH-------HGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSN 274 (463)
Q Consensus 202 l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~N 274 (463)
+++++...+..++||||+++++|.+++...... ...+++..++.++.|++.||+|||+. +++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 999999999999999999999999998753211 13477889999999999999999999 99999999999
Q ss_pred eeEcCCCCEEEeecccceecCCCCce-eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh--CCCCCCCCCCc
Q 012462 275 ILIDDDFNAKVSDFGLAKLLGAGKSH-VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT--GRDPVDHGRPA 351 (463)
Q Consensus 275 ill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt--g~~pf~~~~~~ 351 (463)
||++.++.++|+|||++......... ......++..|+|||+..++.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 99999999999999999865433211 1222344678999999888889999999999999999998 77888654322
Q ss_pred ccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 012462 352 HEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416 (463)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~ 416 (463)
.. ................. +. .. .....+..++.+||+.||++||++.+|++.|++
T Consensus 241 ~~---~~~~~~~~~~~~~~~~~-~~---~~--~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 QV---IENTGEFFRDQGRQVYL-PK---PA--LCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HH---HHHHHHHHhhccccccC-CC---CC--CCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11 11111111110000000 00 01 111344456668999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=311.03 Aligned_cols=249 Identities=22% Similarity=0.357 Sum_probs=195.5
Q ss_pred CCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEccc-chhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeec
Q 012462 142 RFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNN-VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYV 219 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 219 (463)
+|++.+.||+|+||.||+|.. .++..||+|.+... .......+..|+.++.+++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 578889999999999999954 57889999988543 2344567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCc
Q 012462 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299 (463)
Q Consensus 220 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 299 (463)
++++|..+. .+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 82 DGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred CCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 999996542 377888999999999999999999 99999999999999999999999999998654321
Q ss_pred eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccc-cHHHHHHHHhcCCCccccccCCCC
Q 012462 300 HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEV-NLVDWLKMMVGSRRSEEVVDPNIE 378 (463)
Q Consensus 300 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 378 (463)
.....++..|+|||++.+..++.++|||||||++|+|++|+.||......... .............. . ...
T Consensus 150 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~-----~~~ 221 (279)
T cd06619 150 --AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP-P-----VLP 221 (279)
T ss_pred --ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC-C-----CCC
Confidence 23457899999999999989999999999999999999999999753322111 11111111111110 0 000
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 379 ~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
..... ..+..++.+||+.+|++||+++|++++
T Consensus 222 ~~~~~---~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 222 VGQFS---EKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCcCC---HHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 01111 233455668999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=314.57 Aligned_cols=260 Identities=26% Similarity=0.430 Sum_probs=203.1
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEEcC------CCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECc
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNLIN------GSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGI 210 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 210 (463)
+..++|.+.+.||+|+||.||+|.... +..||+|.+.... ......+.+|+.++..++||||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 445788999999999999999996532 3689999875443 234457888999999999999999999999999
Q ss_pred EEEEEEeecCCCCHHHHHhhhhc------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEE
Q 012462 211 HRMLVYEYVNNGNLEQWLHGAMR------HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAK 284 (463)
Q Consensus 211 ~~~lV~e~~~~g~L~~~l~~~~~------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~k 284 (463)
..++||||+++++|.+++..... ....+++..++.++.|++.||.|||+. +++|+||||+|||++.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEE
Confidence 99999999999999999865322 123478899999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCc-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHH
Q 012462 285 VSDFGLAKLLGAGKS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKM 362 (463)
Q Consensus 285 l~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~ 362 (463)
|+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||....... . ...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~---~~~ 233 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---V---LKF 233 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---H---HHH
Confidence 999999876543321 11223456788999999988889999999999999999998 999997543211 1 122
Q ss_pred HhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 012462 363 MVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416 (463)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~ 416 (463)
...... ... ... ....+..++.+||+.+|++|||+.++++.|++
T Consensus 234 ~~~~~~-~~~-------~~~--~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 234 VIDGGH-LDL-------PEN--CPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HhcCCC-CCC-------CCC--CCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 221111 111 000 12344556668999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=298.73 Aligned_cols=252 Identities=23% Similarity=0.339 Sum_probs=198.5
Q ss_pred hcCCCccCeEeecCcEEEEEE-EEcCCCeEEEEEEccc--chhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNN--VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
.+.|++-++||+|.|+.||++ ...+|+.+|+|.+... .....+++.+|+.+.+.|+||||+++.+.+.+....|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 456788889999999999998 5567899999987322 2335578889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC---CCCEEEeeccccee
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD---DFNAKVSDFGLAKL 293 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~---~~~~kl~Dfg~a~~ 293 (463)
|+|.|++|..-+-.. ..+++..+-.+++||++||.|+|.+ +|+|||+||+|+|+.. .--+||+|||++..
T Consensus 90 e~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999998665432 3478889999999999999999999 9999999999999953 34589999999998
Q ss_pred cCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccc
Q 012462 294 LGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373 (463)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (463)
... ......++|||.|||||+++..+|+..+|||+.||+||-|+.|..||.+..... +.+ .+.... .-+
T Consensus 163 l~~--g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r---lye---~I~~g~---yd~ 231 (355)
T KOG0033|consen 163 VND--GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYE---QIKAGA---YDY 231 (355)
T ss_pred eCC--ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH---HHH---HHhccc---cCC
Confidence 873 334566789999999999999999999999999999999999999998744221 111 111111 001
Q ss_pred cCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
+ ..+++...++.. .++.+||..||.+|.|+.|.|++
T Consensus 232 ~-~~~w~~is~~Ak---~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 232 P-SPEWDTVTPEAK---SLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred C-CcccCcCCHHHH---HHHHHHhccChhhhccHHHHhCC
Confidence 1 111122222222 23457999999999999999864
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=317.50 Aligned_cols=241 Identities=25% Similarity=0.328 Sum_probs=186.7
Q ss_pred CeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcC-CCCCCcceEeeEEEECcEEEEEEeecCC
Q 012462 147 NVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGH-VRHKNLVRLLGYCIEGIHRMLVYEYVNN 221 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lV~e~~~~ 221 (463)
+.||+|+||+||+|... +++.||+|.+.... ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999664 57889999986532 1223445567777765 4899999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCcee
Q 012462 222 GNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV 301 (463)
Q Consensus 222 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 301 (463)
|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++........ .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-K 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-c
Confidence 999998853 34588999999999999999999999 999999999999999999999999999875432221 2
Q ss_pred eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCC
Q 012462 302 TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRP 381 (463)
Q Consensus 302 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (463)
.....||+.|+|||++.+..++.++|||||||++|||++|..||...... ........... .... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~i~~~~~---~~~~-----~ 218 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE------ELFQSIRMDNP---CYPR-----W 218 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCC---CCCc-----c
Confidence 33457899999999999999999999999999999999999999754321 11111111100 0000 0
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 012462 382 STRALKRSLLTALRCVDPDSEKRPKMS-QVVR 412 (463)
Q Consensus 382 ~~~~~~~~~~~~~~cl~~dP~~RPs~~-ell~ 412 (463)
... ....++.+||+.||++||++. ++++
T Consensus 219 ~~~---~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 219 LTR---EAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCH---HHHHHHHHHhccCHhhcCCChHHHHc
Confidence 112 233445689999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=321.00 Aligned_cols=251 Identities=25% Similarity=0.330 Sum_probs=204.3
Q ss_pred hcCCCccCeEeecCcEEEEEEEEcC-CCeEEEEEEcccchh---hHHHHHHHHHHHcCCC-CCCcceEeeEEEECcEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQ---AEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 214 (463)
...|++.+.||+|.||.||++.... |+.+|+|.+...... ....+.+|+.+|+++. ||||+.+++.|++....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 4678889999999999999996654 999999999654432 3468899999999998 9999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCC----CCEEEeeccc
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDD----FNAKVSDFGL 290 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~----~~~kl~Dfg~ 290 (463)
|||++.||.|.+.+... .+++..+..++.|++.++.|||+. +|+||||||+|+|+... +.+|++|||+
T Consensus 114 vmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 99999999999998653 299999999999999999999999 99999999999999543 5799999999
Q ss_pred ceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 291 AKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 291 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
+..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||.+........ ..... ..
T Consensus 186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~i~~~-~~- 255 (382)
T KOG0032|consen 186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------AILRG-DF- 255 (382)
T ss_pred ceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------HHHcC-CC-
Confidence 998876 334667899999999999999999999999999999999999999998765332211 11111 11
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.+.. ..+........ .++.+|+..||.+|+|+.++|++
T Consensus 256 ~f~~--~~w~~is~~ak---d~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 DFTS--EPWDDISESAK---DFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CCCC--CCccccCHHHH---HHHHHhcccCcccCCCHHHHhcC
Confidence 1111 01111122222 23447999999999999999995
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=316.06 Aligned_cols=256 Identities=23% Similarity=0.383 Sum_probs=198.9
Q ss_pred CCCccCeEeecCcEEEEEEEEcC------CCeEEEEEEcccch-hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEE
Q 012462 142 RFSKENVLGEGGYGVVYRGNLIN------GSPVAVKKILNNVG-QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 214 (463)
+|.+.+.||+|+||.||+|...+ +..||+|++..... .....+..|+.++..++||||+++++++.+....++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 46677899999999999996532 46899999865432 234568889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhh------------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCC
Q 012462 215 VYEYVNNGNLEQWLHGAM------------RHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFN 282 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~ 282 (463)
++||+.+++|.+++.... .....+++..++.++.|++.||.|||+. +|+||||||.||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 999999999999985321 1123578899999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCc-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHH
Q 012462 283 AKVSDFGLAKLLGAGKS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWL 360 (463)
Q Consensus 283 ~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~ 360 (463)
+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||..... .++.
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~ 236 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------QDVI 236 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH------HHHH
Confidence 99999999886543221 12233446788999999988889999999999999999998 8888865332 2222
Q ss_pred HHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 012462 361 KMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416 (463)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~ 416 (463)
........ ... ... ....+..++.+||+.+|++||++.+++..|+.
T Consensus 237 ~~i~~~~~-~~~-------~~~--~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 EMIRNRQV-LPC-------PDD--CPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHcCCc-CCC-------CCC--CCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 22222211 100 111 11223445668999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=309.94 Aligned_cols=256 Identities=25% Similarity=0.413 Sum_probs=198.2
Q ss_pred CCccCeEeecCcEEEEEEEEcC----CCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcE-----
Q 012462 143 FSKENVLGEGGYGVVYRGNLIN----GSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIH----- 211 (463)
Q Consensus 143 ~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 211 (463)
|.+.+.||+|+||.||+|.... +..||+|.+.... ......+..|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5677899999999999996532 3679999986432 2334678889999999999999999999876554
Q ss_pred -EEEEEeecCCCCHHHHHhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeec
Q 012462 212 -RMLVYEYVNNGNLEQWLHGAMR--HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDF 288 (463)
Q Consensus 212 -~~lV~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Df 288 (463)
.++++||+++|+|..++..... ....+++..++.++.|++.||.|||+. +++|+||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 6899999999999999865321 224689999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCcee-eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcC
Q 012462 289 GLAKLLGAGKSHV-TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGS 366 (463)
Q Consensus 289 g~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 366 (463)
|+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.... .........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~------~~~~~~~~~ 231 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH------EIYDYLRHG 231 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcC
Confidence 9998765433221 112234678999999988899999999999999999999 88888654321 222222222
Q ss_pred CCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 367 RRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.... . .. .....+..++.+||+.||++||++.|+++.|++.
T Consensus 232 ~~~~-~-------~~--~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 NRLK-Q-------PE--DCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCC-C-------Cc--CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111 0 00 1122445556689999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=322.58 Aligned_cols=238 Identities=24% Similarity=0.312 Sum_probs=188.6
Q ss_pred CeEeecCcEEEEEEEE----cCCCeEEEEEEcccch--hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecC
Q 012462 147 NVLGEGGYGVVYRGNL----INGSPVAVKKILNNVG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVN 220 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 220 (463)
+.||+|+||.||+++. .+|+.||+|++..... .....+..|++++.+++||||+++++++.+....|+||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999854 3578999999864332 223456779999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCce
Q 012462 221 NGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSH 300 (463)
Q Consensus 221 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 300 (463)
+|+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....... .
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~ 153 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-K 153 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-C
Confidence 9999998843 34689999999999999999999999 99999999999999999999999999998654332 1
Q ss_pred eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCC
Q 012462 301 VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVR 380 (463)
Q Consensus 301 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (463)
......|++.|+|||++.+..++.++|||||||++|||++|+.||..... ........... ....
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~------~~~~~~i~~~~---------~~~p 218 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR------KETMTMILKAK---------LGMP 218 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH------HHHHHHHHcCC---------CCCC
Confidence 23346789999999999988899999999999999999999999975432 11122222111 0111
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 012462 381 PSTRALKRSLLTALRCVDPDSEKRPKMSQ 409 (463)
Q Consensus 381 ~~~~~~~~~~~~~~~cl~~dP~~RPs~~e 409 (463)
... ......++.+||+.||++||++.+
T Consensus 219 ~~~--~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 219 QFL--SPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCC--CHHHHHHHHHHhhcCHhHcCCCCC
Confidence 111 112334455899999999999555
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=307.95 Aligned_cols=247 Identities=27% Similarity=0.422 Sum_probs=192.3
Q ss_pred CeEeecCcEEEEEEEE-cCCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCCCCH
Q 012462 147 NVLGEGGYGVVYRGNL-INGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNL 224 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 224 (463)
+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|++++++++||||++++++|......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3689999999999965 468899999875433 33456788999999999999999999999999999999999999999
Q ss_pred HHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCceee-c
Q 012462 225 EQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVT-T 303 (463)
Q Consensus 225 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~ 303 (463)
.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++........... .
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRT---EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 999853 234589999999999999999999999 999999999999999999999999999875432211111 1
Q ss_pred cccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCC
Q 012462 304 RVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPS 382 (463)
Q Consensus 304 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (463)
....+..|+|||.+.+..++.++|||||||++|||++ |..||...... ............ . ...
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~------~~~~~~~~~~~~-~-------~~~- 219 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ------QTREAIEQGVRL-P-------CPE- 219 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH------HHHHHHHcCCCC-C-------Ccc-
Confidence 1123456999999999899999999999999999998 88888643321 111111111110 0 011
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 012462 383 TRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415 (463)
Q Consensus 383 ~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~ 415 (463)
.....+..++.+||+.+|++|||+.++++.|+
T Consensus 220 -~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 -LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred -cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 11223445566899999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=316.56 Aligned_cols=202 Identities=23% Similarity=0.295 Sum_probs=173.7
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
++|++.+.||+|+||+||+++.. +++.||+|.+.... ......+..|..++..++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999654 57889999885422 223345778899999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+++|+|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999642 34689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCceeeccccccCCCCchhhhcc-----CCCCccchhhhHHHHHHHHHhCCCCCCCC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANT-----GLLNEKSDVYSFGVLLLEAITGRDPVDHG 348 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~pf~~~ 348 (463)
.........+||+.|+|||++.+ ..++.++|||||||+||||++|+.||...
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 211 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence 43333334579999999999875 56788999999999999999999999754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=315.57 Aligned_cols=198 Identities=27% Similarity=0.395 Sum_probs=171.8
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
++|++.+.||+|+||.||++... ++..+|+|.+.... ......+.+|++++.+++||||++++++|.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999654 57788888875432 23345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE-AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
+++++|.+++.. ...+++..+..++.|++.||.|||+ . +++|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 81 MDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 999999999853 3568999999999999999999997 5 8999999999999999999999999998755322
Q ss_pred CceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCC
Q 012462 298 KSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~ 348 (463)
......++..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~ 201 (308)
T cd06615 154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP 201 (308)
T ss_pred ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCc
Confidence 123457889999999998888999999999999999999999999654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=309.34 Aligned_cols=251 Identities=25% Similarity=0.352 Sum_probs=197.1
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc-----hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV-----GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 214 (463)
++|++.+.||+|++|.||+|.. .+++.||+|.+.... ......+.+|++++++++||||+++++++.+....++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688899999999999999965 468999999875332 1223567889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
|+||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++...
T Consensus 82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999998853 34588999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCceee--ccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccc
Q 012462 295 GAGKSHVT--TRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV 372 (463)
Q Consensus 295 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (463)
........ ....++..|+|||.+.+..++.++||||||+++|||++|+.||....... . ...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~-~~~~~~~~~~~-- 226 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA-----A-IFKIATQPTNP-- 226 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH-----H-HHHHhccCCCC--
Confidence 43221111 23457889999999999889999999999999999999999997542211 1 11111111100
Q ss_pred ccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 373 VDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
..... ....+..++.+||+.+|.+|||+.|++++
T Consensus 227 -----~~~~~--~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 227 -----QLPSH--VSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -----CCCcc--CCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11111 11223445568999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=318.27 Aligned_cols=237 Identities=24% Similarity=0.321 Sum_probs=184.3
Q ss_pred CeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHH-HHcCCCCCCcceEeeEEEECcEEEEEEeecCC
Q 012462 147 NVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVE-AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNN 221 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 221 (463)
+.||+|+||+||+|.. .+|+.||+|++.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 3699999999999965 468899999985432 122234444544 56778999999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCcee
Q 012462 222 GNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV 301 (463)
Q Consensus 222 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 301 (463)
|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KT 152 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cc
Confidence 999998853 44689999999999999999999999 99999999999999999999999999987532221 22
Q ss_pred eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCC
Q 012462 302 TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRP 381 (463)
Q Consensus 302 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (463)
....+||+.|+|||++.+..++.++|||||||++|||++|..||..... ........... ....+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~---------~~~~~ 217 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEMYDNILNKP---------LRLKP 217 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH------HHHHHHHHcCC---------CCCCC
Confidence 3446789999999999999999999999999999999999999975432 12222222111 11111
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHH
Q 012462 382 STRALKRSLLTALRCVDPDSEKRPKMS 408 (463)
Q Consensus 382 ~~~~~~~~~~~~~~cl~~dP~~RPs~~ 408 (463)
.. ......++.+||+.||.+||++.
T Consensus 218 ~~--~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 NI--SVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CC--CHHHHHHHHHHhhcCHHhCCCCC
Confidence 11 12233455579999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=317.14 Aligned_cols=237 Identities=23% Similarity=0.300 Sum_probs=183.5
Q ss_pred CeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHH-HHcCCCCCCcceEeeEEEECcEEEEEEeecCC
Q 012462 147 NVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVE-AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNN 221 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 221 (463)
++||+|+||.||+|.. .+++.||+|.+.... ......+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999966 457899999985432 122334444544 57788999999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCcee
Q 012462 222 GNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV 301 (463)
Q Consensus 222 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 301 (463)
++|..++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (321)
T cd05603 81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ET 152 (321)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cc
Confidence 999988743 34588899999999999999999999 99999999999999999999999999987532221 22
Q ss_pred eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCC
Q 012462 302 TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRP 381 (463)
Q Consensus 302 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (463)
....+||+.|+|||++.+..++.++|||||||++|||++|..||..... .......... ......
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~---------~~~~~~ 217 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------SQMYDNILHK---------PLQLPG 217 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH------HHHHHHHhcC---------CCCCCC
Confidence 3446789999999999999999999999999999999999999975431 1122222211 011111
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHH
Q 012462 382 STRALKRSLLTALRCVDPDSEKRPKMS 408 (463)
Q Consensus 382 ~~~~~~~~~~~~~~cl~~dP~~RPs~~ 408 (463)
.. ......++.+||+.||.+||++.
T Consensus 218 ~~--~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 GK--TVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CC--CHHHHHHHHHHccCCHhhcCCCC
Confidence 11 12334456689999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=309.51 Aligned_cols=255 Identities=25% Similarity=0.408 Sum_probs=194.4
Q ss_pred CccCeEeecCcEEEEEEEEcCCC---eEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC------cEE
Q 012462 144 SKENVLGEGGYGVVYRGNLINGS---PVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG------IHR 212 (463)
Q Consensus 144 ~~~~~lG~G~~g~V~~~~~~~~~---~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~ 212 (463)
.+.+.||+|+||.||+|.+.+.. .||+|.+.... ......+..|+.+++.++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 45678999999999999765433 58999875432 33456788899999999999999999987532 245
Q ss_pred EEEEeecCCCCHHHHHhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccc
Q 012462 213 MLVYEYVNNGNLEQWLHGAM--RHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGL 290 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~ 290 (463)
+++|||+.+|+|.+++.... .....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.++|+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999999875322 1234589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcee-eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCC
Q 012462 291 AKLLGAGKSHV-TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRR 368 (463)
Q Consensus 291 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 368 (463)
++......... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||...... ...........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~~~~~~~~ 232 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS------EIYDYLRQGNR 232 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHHcCCC
Confidence 98765433211 122345778999999999999999999999999999999 88898653221 11122221111
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 369 SEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.. .... ....+..++.+||+.||++|||+.++++.|++.
T Consensus 233 ~~--------~~~~--~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 LK--------QPPD--CLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC--------CCCC--CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 10 0111 112344556689999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=316.74 Aligned_cols=260 Identities=26% Similarity=0.418 Sum_probs=202.1
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEEc------CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCC-CCCCcceEeeEEEEC
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEG 209 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 209 (463)
...++|.+.+.||+|+||.||+|... .+..||+|.+.... ....+.+.+|+.+++++ +||||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 44567999999999999999999642 24579999876443 33346788899999999 799999999999999
Q ss_pred cEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecc
Q 012462 210 IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFG 289 (463)
Q Consensus 210 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg 289 (463)
+..++||||+.+|+|.+++... ....+++.+++.++.|++.||.|||+. +|+|+||||+|||++.++.++|+|||
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCc
Confidence 9999999999999999998642 223489999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCc-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCC
Q 012462 290 LAKLLGAGKS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSR 367 (463)
Q Consensus 290 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 367 (463)
++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||........ .. . .....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~---~-~~~~~ 260 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FY---K-LIKEG 260 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HH---H-HHHcC
Confidence 9986543321 11223345778999999999999999999999999999998 9999975432211 11 1 11111
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 368 RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.... ...... ..+..++.+||+.+|++||++.|+++.|++.
T Consensus 261 ~~~~------~~~~~~---~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 YRMA------QPEHAP---AEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CcCC------CCCCCC---HHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0000 000111 2344556689999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=318.49 Aligned_cols=242 Identities=24% Similarity=0.318 Sum_probs=190.1
Q ss_pred CeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEEEEEEeecCC
Q 012462 147 NVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNN 221 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 221 (463)
+.||+|+||+||+|... ++..||+|.+.... ......+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999664 57899999986432 22334566788888777 799999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCcee
Q 012462 222 GNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV 301 (463)
Q Consensus 222 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 301 (463)
|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VT 152 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cc
Confidence 999988853 34689999999999999999999999 99999999999999999999999999987532222 12
Q ss_pred eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCC
Q 012462 302 TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRP 381 (463)
Q Consensus 302 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (463)
....+|++.|+|||++.+..++.++|||||||++|+|++|+.||..... ............ ....
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~------~~~~~~i~~~~~---------~~~~ 217 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE------DELFQSILEDEV---------RYPR 217 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH------HHHHHHHHcCCC---------CCCC
Confidence 2345789999999999999999999999999999999999999975431 111122211110 0111
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 012462 382 STRALKRSLLTALRCVDPDSEKRPKM-----SQVVRM 413 (463)
Q Consensus 382 ~~~~~~~~~~~~~~cl~~dP~~RPs~-----~ell~~ 413 (463)
. .......++.+||+.||.+||++ .+++++
T Consensus 218 ~--~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 218 W--LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred c--CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 1 11233445668999999999999 888764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=310.94 Aligned_cols=257 Identities=28% Similarity=0.438 Sum_probs=199.0
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCC----eEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGS----PVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRM 213 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 213 (463)
.++|++.++||+|+||+||+|.+ .++. .||+|.+.... ......+..|+.++..++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 45788899999999999999964 3444 48999885433 34456788899999999999999999999754 468
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
+++||+++|+|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence 99999999999999864 234689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCcee-eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccc
Q 012462 294 LGAGKSHV-TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEE 371 (463)
Q Consensus 294 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (463)
........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||...... .+..++. ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~---~~~~~~- 231 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIPDLLE---KGERLP- 231 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHH---CCCcCC-
Confidence 65432211 112234678999999998899999999999999999998 89998654321 1111111 111110
Q ss_pred cccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCC
Q 012462 372 VVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEY 419 (463)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~ 419 (463)
. . ......+..++.+||+.||++||++.++++.|+....
T Consensus 232 ~-------~--~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 232 Q-------P--PICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred C-------C--ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 0 0 0112234455668999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=311.56 Aligned_cols=265 Identities=26% Similarity=0.406 Sum_probs=202.8
Q ss_pred hcCCCccCeEeecCcEEEEEEEEcC-----------------CCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcce
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLIN-----------------GSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVR 201 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~ 201 (463)
.++|++.+.||+|+||.||+|.... +..||+|.+.... ......+..|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4678999999999999999986532 2458999886543 334567888999999999999999
Q ss_pred EeeEEEECcEEEEEEeecCCCCHHHHHhhhhc-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCc
Q 012462 202 LLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMR-------HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSN 274 (463)
Q Consensus 202 l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~N 274 (463)
+++++..++..++||||+.+++|.+++..... ....+++..++.++.|++.||+|||+. +++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 99999999999999999999999999965421 122589999999999999999999999 99999999999
Q ss_pred eeEcCCCCEEEeecccceecCCCCc-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh--CCCCCCCCCCc
Q 012462 275 ILIDDDFNAKVSDFGLAKLLGAGKS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT--GRDPVDHGRPA 351 (463)
Q Consensus 275 ill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt--g~~pf~~~~~~ 351 (463)
|+++.++.++|+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999986543322 12233456788999999988889999999999999999998 67788643321
Q ss_pred ccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 012462 352 HEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416 (463)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~ 416 (463)
.................... ... .....+..++.+||+.||++|||+.||++.|++
T Consensus 241 ---~~~~~~~~~~~~~~~~~~~~----~~~--~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 241 ---QVIENAGHFFRDDGRQIYLP----RPP--NCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred ---HHHHHHHhccccccccccCC----Ccc--CCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 11121111111111111000 011 111345566778999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=320.32 Aligned_cols=243 Identities=25% Similarity=0.302 Sum_probs=185.7
Q ss_pred CeEeecCcEEEEEEEEc-CCCeEEEEEEcccch---hhHHHHHHHH-HHHcCCCCCCcceEeeEEEECcEEEEEEeecCC
Q 012462 147 NVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVG---QAEKEFRVEV-EAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNN 221 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 221 (463)
+.||+|+||+||+|... +++.||+|.+..... .....+..|. .+++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999654 567899999854321 2223334443 456778999999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCcee
Q 012462 222 GNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV 301 (463)
Q Consensus 222 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 301 (463)
|+|.+++.. ...+.+..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~ 152 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GT 152 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CC
Confidence 999998853 34588889999999999999999999 99999999999999999999999999987543221 12
Q ss_pred eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCC
Q 012462 302 TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRP 381 (463)
Q Consensus 302 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (463)
....+||+.|+|||++.+..++.++|||||||++|||++|..||...... .......... ....+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~---------~~~~~ 217 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNILNKP---------LQLKP 217 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH------HHHHHHHhCC---------cCCCC
Confidence 34467999999999999999999999999999999999999999754321 1111111110 11111
Q ss_pred -CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 012462 382 -STRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415 (463)
Q Consensus 382 -~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~ 415 (463)
.... ...++.+||+.||.+||++.+.+..+.
T Consensus 218 ~~~~~---~~~li~~~l~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05602 218 NITNS---ARHLLEGLLQKDRTKRLGAKDDFMEIK 249 (325)
T ss_pred CCCHH---HHHHHHHHcccCHHHCCCCCCCHHHHh
Confidence 1122 233455799999999999875444433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=309.65 Aligned_cols=256 Identities=28% Similarity=0.497 Sum_probs=201.3
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCC---eEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGS---PVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~---~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 214 (463)
.++|+..+.||+|+||.||+|... ++. .+++|.+.... ......+..|++++.+++||||+++++++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 456888899999999999999764 233 68999875442 3345678889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
||||+++++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 84 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence 9999999999999863 235689999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCceeec--cccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccc
Q 012462 295 GAGKSHVTT--RVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEE 371 (463)
Q Consensus 295 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (463)
......... ....+..|+|||++.+..++.++|||||||++|||++ |..||..... ......+........
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~------~~~~~~i~~~~~~~~ 231 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN------HEVMKAINDGFRLPA 231 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH------HHHHHHHhcCCCCCC
Confidence 433221111 1223457999999998889999999999999999997 9999965432 122222221111110
Q ss_pred cccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 372 VVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
..........++.+||+.+|++||++.++++.|+++
T Consensus 232 ----------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 232 ----------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 011123345667789999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=328.59 Aligned_cols=264 Identities=25% Similarity=0.394 Sum_probs=202.5
Q ss_pred HHHHhcCCCccCeEeecCcEEEEEEEEc------CCCeEEEEEEcccch-hhHHHHHHHHHHHcCCC-CCCcceEeeEEE
Q 012462 136 LELATNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNVG-QAEKEFRVEVEAIGHVR-HKNLVRLLGYCI 207 (463)
Q Consensus 136 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~ 207 (463)
+++..++|.+.++||+|+||.||+|++. .+..||+|++..... .....+..|+.++.++. ||||++++++|.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 3455667888999999999999999753 245799999865432 22346888999999997 999999999999
Q ss_pred ECcEEEEEEeecCCCCHHHHHhhhhc------------------------------------------------------
Q 012462 208 EGIHRMLVYEYVNNGNLEQWLHGAMR------------------------------------------------------ 233 (463)
Q Consensus 208 ~~~~~~lV~e~~~~g~L~~~l~~~~~------------------------------------------------------ 233 (463)
.....++||||+++|+|.++++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999965321
Q ss_pred ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCC
Q 012462 234 ----------------------------------------HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSS 273 (463)
Q Consensus 234 ----------------------------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~ 273 (463)
....+++..++.++.||+.||.|||+. +++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence 112367788899999999999999998 9999999999
Q ss_pred ceeEcCCCCEEEeecccceecCCCCc-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCc
Q 012462 274 NILIDDDFNAKVSDFGLAKLLGAGKS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPA 351 (463)
Q Consensus 274 Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~ 351 (463)
|||+++++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 99999999999999999986532211 11223456788999999998889999999999999999998 89998653321
Q ss_pred ccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 352 HEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.. ............ .... ....+..++.+||+.+|++||+++||++.|+..
T Consensus 349 ~~-----~~~~~~~~~~~~--------~p~~--~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 349 EQ-----FYNAIKRGYRMA--------KPAH--ASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HH-----HHHHHHcCCCCC--------CCCC--CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 10 111111111110 0111 112344456689999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=323.94 Aligned_cols=200 Identities=24% Similarity=0.301 Sum_probs=171.5
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEEc---CCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEE
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNLI---NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 214 (463)
+...+|++.+.||+|+||.||++... .+..|++|.+... ....+|+.++++++||||+++++++......|+
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 34568999999999999999999543 3567999987542 234569999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
|||++. ++|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.++|+|||++...
T Consensus 164 v~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 164 VMPKYK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EehhcC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 999995 68988883 345699999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCc-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Q 012462 295 GAGKS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350 (463)
Q Consensus 295 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~ 350 (463)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+...
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 292 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQV 292 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCC
Confidence 43322 222346799999999999999999999999999999999999999976543
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=318.53 Aligned_cols=263 Identities=27% Similarity=0.425 Sum_probs=202.1
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEEc--------CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCC-CCCCcceEeeEE
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNLI--------NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYC 206 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 206 (463)
++..++|.+.+.||+|+||.||+|... ....+|+|.+.... .....++..|+.++..+ +||||+++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 344567999999999999999999642 23469999886432 33445678899999999 799999999999
Q ss_pred EECcEEEEEEeecCCCCHHHHHhhhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCc
Q 012462 207 IEGIHRMLVYEYVNNGNLEQWLHGAMR------------HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSN 274 (463)
Q Consensus 207 ~~~~~~~lV~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~N 274 (463)
...+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +++|+||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHh
Confidence 999999999999999999999975321 123588999999999999999999999 99999999999
Q ss_pred eeEcCCCCEEEeecccceecCCCCcee-eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcc
Q 012462 275 ILIDDDFNAKVSDFGLAKLLGAGKSHV-TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAH 352 (463)
Q Consensus 275 ill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~ 352 (463)
|+++.++.++|+|||++.......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-- 248 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-- 248 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH--
Confidence 999999999999999987654321111 112234568999999998889999999999999999998 8888864321
Q ss_pred cccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCC
Q 012462 353 EVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEE 418 (463)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~ 418 (463)
.+........... ..... ....+..++.+||..+|++||++.++++.|+++.
T Consensus 249 ----~~~~~~~~~~~~~--------~~~~~--~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 249 ----EELFKLLKEGHRM--------DKPSN--CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred ----HHHHHHHHcCCCC--------CCCCc--CCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 1222222211110 01111 1123344566899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=320.06 Aligned_cols=243 Identities=26% Similarity=0.332 Sum_probs=186.8
Q ss_pred CeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHH-HHcCCCCCCcceEeeEEEECcEEEEEEeecCC
Q 012462 147 NVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVE-AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNN 221 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 221 (463)
+.||+|+||+||+|.. .+|+.||+|++.... ......+..|.. +++.++||||+++++++...+..|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3699999999999955 468899999985432 122334445554 46778999999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCcee
Q 012462 222 GNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV 301 (463)
Q Consensus 222 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 301 (463)
|+|..++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 152 (325)
T cd05604 81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DT 152 (325)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CC
Confidence 99998874 345689999999999999999999999 99999999999999999999999999987532221 12
Q ss_pred eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCC
Q 012462 302 TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRP 381 (463)
Q Consensus 302 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (463)
....+||+.|+|||++.+..++.++|||||||++|||++|..||...... .......... ....+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~~~~~~---------~~~~~ 217 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------EMYDNILHKP---------LVLRP 217 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH------HHHHHHHcCC---------ccCCC
Confidence 33467899999999999999999999999999999999999999754321 1112221110 11111
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 012462 382 STRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414 (463)
Q Consensus 382 ~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L 414 (463)
. .......++.+||+.||.+||++++.++.+
T Consensus 218 ~--~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i 248 (325)
T cd05604 218 G--ASLTAWSILEELLEKDRQRRLGAKEDFLEI 248 (325)
T ss_pred C--CCHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence 1 112233455689999999999886444333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=332.70 Aligned_cols=203 Identities=25% Similarity=0.362 Sum_probs=164.8
Q ss_pred HHHHHHhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCC------CCCcceEeeEE
Q 012462 134 RDLELATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR------HKNLVRLLGYC 206 (463)
Q Consensus 134 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~ 206 (463)
.+++...++|++.++||+|+||+||+|.. ..++.||||++.... .....+..|+.++..++ |.+++.++++|
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 34455678999999999999999999965 457889999985432 22334445666655543 55689999988
Q ss_pred EEC-cEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEccCCCCceeEcCCC---
Q 012462 207 IEG-IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE-AIEPKVVHRDIKSSNILIDDDF--- 281 (463)
Q Consensus 207 ~~~-~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dikp~Nill~~~~--- 281 (463)
... .+.|+|||++ +++|.+++.. .+.+++..+..++.||+.||.|||+ . +|+||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVV 272 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccc
Confidence 764 5788999988 7789988853 3569999999999999999999997 6 999999999999998765
Q ss_pred -------------CEEEeecccceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCC
Q 012462 282 -------------NAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348 (463)
Q Consensus 282 -------------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~ 348 (463)
.+||+|||.+..... .....+||+.|+|||++.+..|+.++|||||||+||||++|+.||...
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 499999998764322 233467999999999999999999999999999999999999999765
Q ss_pred C
Q 012462 349 R 349 (463)
Q Consensus 349 ~ 349 (463)
.
T Consensus 349 ~ 349 (467)
T PTZ00284 349 D 349 (467)
T ss_pred C
Confidence 4
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=313.41 Aligned_cols=264 Identities=25% Similarity=0.403 Sum_probs=203.0
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEEc------CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG 209 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 209 (463)
++..++|++.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 345678999999999999999999543 24579999875433 23345677899999999999999999999999
Q ss_pred cEEEEEEeecCCCCHHHHHhhhhcC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCE
Q 012462 210 IHRMLVYEYVNNGNLEQWLHGAMRH------HGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNA 283 (463)
Q Consensus 210 ~~~~lV~e~~~~g~L~~~l~~~~~~------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~ 283 (463)
...++||||+++|+|.+++...... ...+.+..+..++.|++.||.|||++ +|+||||||+||+++.++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcE
Confidence 9999999999999999999753211 23456788899999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCce-eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHH
Q 012462 284 KVSDFGLAKLLGAGKSH-VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLK 361 (463)
Q Consensus 284 kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~ 361 (463)
+|+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+...
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~------~~~~~ 232 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN------EQVLK 232 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHH
Confidence 99999998865432211 1122345678999999998899999999999999999998 7888865322 12222
Q ss_pred HHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCC
Q 012462 362 MMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEY 419 (463)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~ 419 (463)
......... .... ....+..++.+||+.||++|||+.++++.|++...
T Consensus 233 ~~~~~~~~~--------~~~~--~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 233 FVMDGGYLD--------QPDN--CPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred HHHcCCCCC--------CCCC--CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 222211111 0001 11244555668999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=307.03 Aligned_cols=251 Identities=31% Similarity=0.473 Sum_probs=201.7
Q ss_pred hcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeec
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYV 219 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 219 (463)
.++|++.+.||.|+||.||+|.. .|+.||+|.+..... ..+.+..|+.++++++|+||+++++++.+....++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 45788899999999999999976 589999999866544 4567888999999999999999999999889999999999
Q ss_pred CCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCc
Q 012462 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299 (463)
Q Consensus 220 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 299 (463)
++++|.+++... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.++.......
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 83 AKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred CCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 999999998642 223689999999999999999999999 999999999999999999999999999987633221
Q ss_pred eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCC
Q 012462 300 HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378 (463)
Q Consensus 300 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (463)
....+..|+|||.+....++.++||||||+++|||++ |..||...... +........... ..
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~-~~------ 220 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------DVVPHVEKGYRM-EA------ 220 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHhcCCCC-CC------
Confidence 2334667999999988889999999999999999997 99999654321 111111111110 00
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 379 ~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
... ....+..++.+||+.+|++||++.++++.|+.+
T Consensus 221 -~~~--~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 221 -PEG--CPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -ccC--CCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 001 112344556689999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=313.36 Aligned_cols=265 Identities=24% Similarity=0.406 Sum_probs=199.4
Q ss_pred hcCCCccCeEeecCcEEEEEEEEcC---------------CCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEe
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLIN---------------GSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLL 203 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~ 203 (463)
.++|++.+.||+|+||.||++.... ...||+|.+.... ......+.+|++++.+++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4689999999999999999986532 1258999886543 33445788999999999999999999
Q ss_pred eEEEECcEEEEEEeecCCCCHHHHHhhhhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCce
Q 012462 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMR--------HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNI 275 (463)
Q Consensus 204 ~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Ni 275 (463)
+++......++||||+++++|.+++..... ....+++..++.++.|++.||.|||+. +++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 999999999999999999999999864211 112468899999999999999999999 999999999999
Q ss_pred eEcCCCCEEEeecccceecCCCCc-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh--CCCCCCCCCCcc
Q 012462 276 LIDDDFNAKVSDFGLAKLLGAGKS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT--GRDPVDHGRPAH 352 (463)
Q Consensus 276 ll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt--g~~pf~~~~~~~ 352 (463)
+++.++.+||+|||++........ .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999976543321 11223345778999999998889999999999999999998 667776543211
Q ss_pred cccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 012462 353 EVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416 (463)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~ 416 (463)
................... ..+. ....+..++.+||+.||++||++.++++.|++
T Consensus 241 ---~~~~~~~~~~~~~~~~~~~----~~~~--~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 ---VIENTGEFFRNQGRQIYLS----QTPL--CPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ---HHHHHHHhhhhccccccCC----CCCC--CCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1111111111100000000 0111 11345556778999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=309.39 Aligned_cols=256 Identities=28% Similarity=0.464 Sum_probs=200.4
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-C---CCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-N---GSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 214 (463)
.++|++.+.||+|+||.||+|... + +..+|+|.+.... ......+..|+.++.+++||||+++++++.+++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 357888999999999999999653 2 3368999875433 3344678889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
||||+++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+|||++.++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 83 VTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 9999999999999864 234589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCceee--ccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccc
Q 012462 295 GAGKSHVT--TRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEE 371 (463)
Q Consensus 295 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (463)
........ ....++..|+|||.+.+..++.++|+|||||++||+++ |..||......+ . ...........
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~---~~~~~~~~~~~- 229 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---V---IKAIEEGYRLP- 229 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---H---HHHHhCCCcCC-
Confidence 54322211 11223568999999998889999999999999999887 999997543221 1 11122111100
Q ss_pred cccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 372 VVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
... .....+..++.+||+.+|.+||++.++++.|+.+
T Consensus 230 -------~~~--~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 230 -------APM--DCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -------CCC--CCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 000 1112334556689999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=305.17 Aligned_cols=250 Identities=27% Similarity=0.404 Sum_probs=200.4
Q ss_pred CCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEccc--chhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 142 RFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNN--VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
+|++.+.||+|+||.||+|.. .++..|++|.+... .......+..|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 367788999999999999965 46889999987532 234456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+++++|.+++... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999999999753 235689999999999999999999999 99999999999999999999999999998765432
Q ss_pred ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCC
Q 012462 299 SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (463)
. ......+++.|+|||++.+..++.++|+|||||++|+|++|+.||...... ......... ....+
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~-~~~~~------ 221 (256)
T cd08529 156 N-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG------ALILKIIRG-VFPPV------ 221 (256)
T ss_pred c-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcC-CCCCC------
Confidence 2 223456889999999999999999999999999999999999999754311 111111111 11100
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 379 ~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.. .....+..++.+||+.+|++||++.+++++
T Consensus 222 -~~--~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 -SQ--MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -cc--ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 00 112334555668999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=308.80 Aligned_cols=249 Identities=26% Similarity=0.296 Sum_probs=191.8
Q ss_pred EeecCcEEEEEEEE-cCCCeEEEEEEcccch---hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCCCCH
Q 012462 149 LGEGGYGVVYRGNL-INGSPVAVKKILNNVG---QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNL 224 (463)
Q Consensus 149 lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 224 (463)
||+|+||.||++.. .+|+.+|+|.+..... .....+..|++++.+++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999965 4589999999854221 2234456699999999999999999999999999999999999999
Q ss_pred HHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCceeecc
Q 012462 225 EQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR 304 (463)
Q Consensus 225 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 304 (463)
.+++... ....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 153 (277)
T cd05607 81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ 153 (277)
T ss_pred HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence 9888542 234588999999999999999999999 99999999999999999999999999998764432 2233
Q ss_pred ccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHH
Q 012462 305 VMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTR 384 (463)
Q Consensus 305 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (463)
..|+..|+|||++.+..++.++|||||||++|||++|+.||...... .............. ... .......
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~----~~~---~~~~~~~ 224 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK--VAKEELKRRTLEDE----VKF---EHQNFTE 224 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch--hhHHHHHHHhhccc----ccc---ccccCCH
Confidence 56899999999999988999999999999999999999999754321 11111111111110 000 0011112
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 012462 385 ALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416 (463)
Q Consensus 385 ~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~ 416 (463)
....++.+||+.||++||+++|+++.+..
T Consensus 225 ---~~~~li~~~L~~~P~~R~~~~~~~~~~~~ 253 (277)
T cd05607 225 ---ESKDICRLFLAKKPEDRLGSREKNDDPRK 253 (277)
T ss_pred ---HHHHHHHHHhccCHhhCCCCccchhhhhc
Confidence 23445567999999999999887755544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=327.19 Aligned_cols=202 Identities=25% Similarity=0.352 Sum_probs=173.7
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
++|++.+.||+|+||+||+|.. .+++.||+|++.... ......+..|+.++..++||||+++++.+.+.+..|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3688889999999999999965 468899999985432 223456778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999999853 35689999999999999999999999 999999999999999999999999999875422
Q ss_pred CCc----------------------------------eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCC
Q 012462 297 GKS----------------------------------HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGR 342 (463)
Q Consensus 297 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~ 342 (463)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 110 0012357999999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 012462 343 DPVDHGR 349 (463)
Q Consensus 343 ~pf~~~~ 349 (463)
.||....
T Consensus 234 ~Pf~~~~ 240 (360)
T cd05627 234 PPFCSET 240 (360)
T ss_pred CCCCCCC
Confidence 9997654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=313.13 Aligned_cols=251 Identities=25% Similarity=0.376 Sum_probs=200.0
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
..+|++.+.||+|+||.||+|.. .++..|++|.+..........+..|+.+++.++|+||+++++.+..+...++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 35789999999999999999964 56889999998665555556788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+++++|.+++.. ..+++..++.++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 999999998853 3478999999999999999999999 99999999999999999999999999987654322
Q ss_pred ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCC
Q 012462 299 SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (463)
. ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+.. .......... .. ..
T Consensus 171 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~------~~~~~~~~~~-~~-----~~ 237 (296)
T cd06654 171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGT-PE-----LQ 237 (296)
T ss_pred c-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH------hHHHHhcCCC-CC-----CC
Confidence 1 1223468899999999998889999999999999999999999997543211 1111111111 00 01
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 379 ~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.... ....+..++.+||+.||++||++.+++++
T Consensus 238 ~~~~--~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 238 NPEK--LSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred Cccc--cCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 1111 11223445668999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=318.59 Aligned_cols=262 Identities=24% Similarity=0.373 Sum_probs=194.9
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
++|.+.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56889999999999999999654 67889999885432 22334567799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+++ +|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 975 88888754 234588999999999999999999999 99999999999999999999999999997654322
Q ss_pred ceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCc--------
Q 012462 299 SHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS-------- 369 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------- 369 (463)
. ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||......+..... .........
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 159 K-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI---FRLLGTPTEETWPGISS 234 (309)
T ss_pred c-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHHhCCCCHHHHhhhcc
Confidence 1 1223467899999998865 46889999999999999999999999765432211111 000000000
Q ss_pred -cc---cccCCCCCCC----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 370 -EE---VVDPNIEVRP----STRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 370 -~~---~~~~~~~~~~----~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.. ...+...... ..........++.+||+.||.+|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 00 0000000000 00011233456668999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=316.14 Aligned_cols=263 Identities=25% Similarity=0.430 Sum_probs=203.7
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEEc--------CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCC-CCCCcceEeeEE
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNLI--------NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYC 206 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 206 (463)
.+..++|.+.+.||+|+||.||+|... ++..||+|.+.... ......+..|+.++..+ +||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 344677888999999999999999631 23479999875433 33446788899999999 899999999999
Q ss_pred EECcEEEEEEeecCCCCHHHHHhhhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCc
Q 012462 207 IEGIHRMLVYEYVNNGNLEQWLHGAMR------------HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSN 274 (463)
Q Consensus 207 ~~~~~~~lV~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~N 274 (463)
......++||||+++|+|.+++..... ....+++..++.++.||+.||.|||++ +++|+||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccce
Confidence 999999999999999999999975321 123578899999999999999999999 99999999999
Q ss_pred eeEcCCCCEEEeecccceecCCCCce-eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcc
Q 012462 275 ILIDDDFNAKVSDFGLAKLLGAGKSH-VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAH 352 (463)
Q Consensus 275 ill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~ 352 (463)
|+++.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--- 244 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--- 244 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC---
Confidence 99999999999999999876433221 1222345678999999998889999999999999999998 788886432
Q ss_pred cccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCC
Q 012462 353 EVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEE 418 (463)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~ 418 (463)
...+............ .. .....+..++.+||+.+|.+||++.|+++.|+.+.
T Consensus 245 ---~~~~~~~~~~~~~~~~--------~~--~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 245 ---VEELFKLLKEGHRMDK--------PA--NCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred ---HHHHHHHHHcCCcCCC--------CC--CCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 2222222222211110 01 11223444566899999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=313.77 Aligned_cols=202 Identities=25% Similarity=0.309 Sum_probs=172.1
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
++|++.++||+|+||+||++... .++.+|+|.+.... ......+..|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999664 46789999884322 122345778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+++|+|.+++... ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 999999999999642 34589999999999999999999999 999999999999999999999999999976543
Q ss_pred CCceeeccccccCCCCchhhhc-----cCCCCccchhhhHHHHHHHHHhCCCCCCCC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYAN-----TGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~pf~~~ 348 (463)
.........+||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 3333333457999999999986 346889999999999999999999999754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=323.09 Aligned_cols=198 Identities=29% Similarity=0.356 Sum_probs=167.9
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECc------
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGI------ 210 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 210 (463)
.++|++.+.||+|+||.||++.. .+|..||+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 47899999999999999999955 468899999985432 233456778999999999999999999986543
Q ss_pred EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccc
Q 012462 211 HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGL 290 (463)
Q Consensus 211 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~ 290 (463)
..|+||||+.+ +|.+.+. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 100 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence 46999999965 6766653 2378899999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 291 AKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 291 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
++..... .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 170 a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 170 ARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred ccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 9764322 12234578999999999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=313.72 Aligned_cols=258 Identities=26% Similarity=0.371 Sum_probs=197.7
Q ss_pred cCCCccCeEeecCcEEEEEEEEcC-CC--eEEEEEEccc-chhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLIN-GS--PVAVKKILNN-VGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV 215 (463)
++|++.+.||+|+||.||+|...+ +. .+++|.+... .......+..|+.++.++ +||||+++++++.+....++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 568889999999999999996643 32 4688877542 233446788899999999 799999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCE
Q 012462 216 YEYVNNGNLEQWLHGAMR------------HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNA 283 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~ 283 (463)
+||+++++|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 999999999999964221 113588999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHH
Q 012462 284 KVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKM 362 (463)
Q Consensus 284 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~ 362 (463)
||+|||++....... .......+..|+|||.+.+..++.++|||||||++|||++ |..||...... .....
T Consensus 159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~------~~~~~ 230 (297)
T cd05089 159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA------ELYEK 230 (297)
T ss_pred EECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHH
Confidence 999999986432111 1111223557999999998899999999999999999997 99999754322 11222
Q ss_pred HhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCC
Q 012462 363 MVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEY 419 (463)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~ 419 (463)
....... ..... ....+..++.+||+.+|.+||++.++++.|+.+..
T Consensus 231 ~~~~~~~--------~~~~~--~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 231 LPQGYRM--------EKPRN--CDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred HhcCCCC--------CCCCC--CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 2111100 00111 11233455668999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=304.88 Aligned_cols=247 Identities=26% Similarity=0.430 Sum_probs=191.5
Q ss_pred eEeecCcEEEEEEEEc---CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCCCC
Q 012462 148 VLGEGGYGVVYRGNLI---NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGN 223 (463)
Q Consensus 148 ~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 223 (463)
.||+|+||.||+|.+. .+..||+|.+.... ....+.+.+|+.++++++||||+++++++.. ...++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999653 34569999885543 2334678899999999999999999998864 56799999999999
Q ss_pred HHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCceee-
Q 012462 224 LEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVT- 302 (463)
Q Consensus 224 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~- 302 (463)
|.+++.. ....+++..++.++.|++.||.|||++ +++|+||||+|||++.++.+||+|||++...........
T Consensus 81 L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 9999863 234689999999999999999999999 999999999999999999999999999986543322111
Q ss_pred -ccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCC
Q 012462 303 -TRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVR 380 (463)
Q Consensus 303 -~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (463)
....++..|+|||.+.+..++.++|||||||++|||++ |..||...... +.......... .. .+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~~~-~~-------~~ 220 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP------EVMSFIEQGKR-LD-------CP 220 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH------HHHHHHHCCCC-CC-------CC
Confidence 11223578999999988889999999999999999996 99999754322 12222221111 00 11
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 381 PSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 381 ~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.. ....+..++.+||+.||++||++.++.+.|+..
T Consensus 221 ~~--~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 AE--CPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CC--CCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 11 122333456689999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=306.29 Aligned_cols=252 Identities=26% Similarity=0.487 Sum_probs=200.0
Q ss_pred cCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecC
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVN 220 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 220 (463)
.+|++.+.||+|+||.||+|.+.++..+|+|.+.... .....+..|++++++++||||+++++++......++||||+.
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4577889999999999999987778899999875432 234578889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCce
Q 012462 221 NGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSH 300 (463)
Q Consensus 221 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 300 (463)
+++|.+++.. ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 83 HGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred CCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 9999999864 234588999999999999999999999 9999999999999999999999999999865433221
Q ss_pred eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCC
Q 012462 301 VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEV 379 (463)
Q Consensus 301 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (463)
......++..|+|||.+.+..++.++||||||+++|||++ |..||..... ............ ...+..
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~~~~~~~~---~~~~~~-- 225 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN------SEVVETINAGFR---LYKPRL-- 225 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH------HHHHHHHhCCCC---CCCCCC--
Confidence 1222335678999999998889999999999999999998 9999975331 122222211111 111111
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 012462 380 RPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415 (463)
Q Consensus 380 ~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~ 415 (463)
. ...+..++.+||+.+|++||++.++++.|.
T Consensus 226 --~---~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 --A---SQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred --C---CHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1 133455677899999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=318.14 Aligned_cols=241 Identities=23% Similarity=0.295 Sum_probs=188.0
Q ss_pred CCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCC-CCCcceEeeEEEECcEEEEEE
Q 012462 142 RFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 216 (463)
+|+..+.||+|+||+||+|.. .+++.||+|++.... ......+..|..++..+. |++|+++++++.+.+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 367788999999999999965 468899999886432 223345667888888775 578888999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+++|+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999998853 34699999999999999999999999 999999999999999999999999999875432
Q ss_pred CCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (463)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......... .
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~------~~~~~i~~~~-~------- 218 (323)
T cd05615 154 DG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED------ELFQSIMEHN-V------- 218 (323)
T ss_pred CC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC-C-------
Confidence 22 1233456899999999999999999999999999999999999999764321 1111111111 0
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 012462 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKM 407 (463)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~ 407 (463)
...... ......++.+||+.+|.+|++.
T Consensus 219 -~~p~~~--~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 -SYPKSL--SKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -CCCccC--CHHHHHHHHHHcccCHhhCCCC
Confidence 011111 1223445668999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=340.50 Aligned_cols=264 Identities=21% Similarity=0.390 Sum_probs=200.5
Q ss_pred HHHHhcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEccc--chhhHHHHHHHHHHHcCCCCCCcceEeeEEEE--Cc
Q 012462 136 LELATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNN--VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE--GI 210 (463)
Q Consensus 136 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~ 210 (463)
.+...++|++.+.||+|+||+||+|... .+..||+|.+... .......+..|+.++.+++||||++++++|.+ ..
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 3455678999999999999999999654 5678889987533 23344678889999999999999999998865 45
Q ss_pred EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeEEccCCCCceeEcC-------
Q 012462 211 HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIE----PKVVHRDIKSSNILIDD------- 279 (463)
Q Consensus 211 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~----~~i~H~Dikp~Nill~~------- 279 (463)
.+||||||+++|+|.++|.........+++..++.|+.||+.||.|||+... .+|+|+||||+||||+.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 6899999999999999997655555679999999999999999999998521 25999999999999964
Q ss_pred ----------CCCEEEeecccceecCCCCceeeccccccCCCCchhhhcc--CCCCccchhhhHHHHHHHHHhCCCCCCC
Q 012462 280 ----------DFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANT--GLLNEKSDVYSFGVLLLEAITGRDPVDH 347 (463)
Q Consensus 280 ----------~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~pf~~ 347 (463)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||||||||++|..||..
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 3458999999998654322 2234578999999999854 4588999999999999999999999975
Q ss_pred CCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHhcC
Q 012462 348 GRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR--MLESE 417 (463)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~--~L~~~ 417 (463)
... ....+..+... +.+....... .+..++.+||+.+|.+||++.|+|. .+...
T Consensus 246 ~~~-----~~qli~~lk~~--------p~lpi~~~S~---eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 246 ANN-----FSQLISELKRG--------PDLPIKGKSK---ELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CCc-----HHHHHHHHhcC--------CCCCcCCCCH---HHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 332 12222222111 0111111122 2344556799999999999999984 45443
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=342.09 Aligned_cols=260 Identities=23% Similarity=0.339 Sum_probs=199.4
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
++|++.++||+|+||.||+|... +++.||+|++.... ....+++.+|+.++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999654 58899999986432 233467888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecc
Q 012462 217 EYVNNGNLEQWLHGAMRH-------HGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFG 289 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg 289 (463)
||++||+|.+++...... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998653211 23356778899999999999999999 99999999999999999999999999
Q ss_pred cceecCCCC-----------------ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcc
Q 012462 290 LAKLLGAGK-----------------SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAH 352 (463)
Q Consensus 290 ~a~~~~~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~ 352 (463)
+++...... .......+||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 998652110 011123579999999999999999999999999999999999999997533211
Q ss_pred cccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHhcC
Q 012462 353 EVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRP-KMSQVVRMLESE 417 (463)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP-s~~ell~~L~~~ 417 (463)
.. . .. . ...+. ...+.......+..++.+||+.||++|| +++++++.|+..
T Consensus 239 i~----~-~~-----~---i~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 239 IS----Y-RD-----V---ILSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred hh----h-hh-----h---ccChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 10 0 00 0 00000 0000001112233456689999999996 577777777664
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=327.82 Aligned_cols=251 Identities=27% Similarity=0.416 Sum_probs=204.8
Q ss_pred CCCccCeEeecCcEEEEEEEEc--CCC--eEEEEEEcccchh-hHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 142 RFSKENVLGEGGYGVVYRGNLI--NGS--PVAVKKILNNVGQ-AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
...+.++||+|.||.|++|.|. +|+ .||||.+...... ...+|.+|+.+|.+|+|||+++|||++.+ ....+||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 3455678999999999999664 343 6899999765543 56899999999999999999999999987 6778999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
|+++.|+|.+.|+. .....|....+..++.|||.||.||..+ ++|||||..+|+||.....|||+||||.+.+..
T Consensus 190 ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 99999999999987 4556788899999999999999999999 999999999999999999999999999998765
Q ss_pred CCc-eeec-cccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccc
Q 012462 297 GKS-HVTT-RVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373 (463)
Q Consensus 297 ~~~-~~~~-~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (463)
+.. +.+. ...-+..|+|||.++...++.+||||+|||+||||+| |..||.+....... +.+-..
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL------~~iD~~------- 331 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQIL------KNIDAG------- 331 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHH------Hhcccc-------
Confidence 442 2222 2334678999999999999999999999999999999 88899876543222 211111
Q ss_pred cCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 012462 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414 (463)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L 414 (463)
-.+.....+..+++.++..||..+|++||||..|.+.+
T Consensus 332 ---erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 332 ---ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ---ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 11223334556778888899999999999999997443
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=321.50 Aligned_cols=262 Identities=26% Similarity=0.418 Sum_probs=199.3
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEE------cCCCeEEEEEEcccc-hhhHHHHHHHHHHHcCC-CCCCcceEeeEEEEC
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNL------INGSPVAVKKILNNV-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEG 209 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 209 (463)
+..++|++.+.||+|+||+||+|.+ .+++.||||.+.... ......+..|+.++.++ +||||++++++|...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 4457899999999999999999963 346789999986543 23345678899999999 789999999988654
Q ss_pred -cEEEEEEeecCCCCHHHHHhhhhc-------------------------------------------------------
Q 012462 210 -IHRMLVYEYVNNGNLEQWLHGAMR------------------------------------------------------- 233 (463)
Q Consensus 210 -~~~~lV~e~~~~g~L~~~l~~~~~------------------------------------------------------- 233 (463)
...++||||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 457899999999999999864211
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCc-eeecc
Q 012462 234 --------HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS-HVTTR 304 (463)
Q Consensus 234 --------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~ 304 (463)
....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++........ .....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 012467888999999999999999999 999999999999999999999999999976533221 11122
Q ss_pred ccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCCH
Q 012462 305 VMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPST 383 (463)
Q Consensus 305 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (463)
..++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ........... ... +. ..
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~~~~~~~-~~~--~~----~~- 307 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----EFCRRLKEGTR-MRA--PD----YT- 307 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-----HHHHHHhccCC-CCC--CC----CC-
Confidence 345678999999998899999999999999999997 999986533211 11111111111 000 00 01
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 384 RALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 384 ~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
...+..++.+||+.||++||++.||+++|+..
T Consensus 308 --~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 308 --TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred --CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 12345566789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=308.61 Aligned_cols=257 Identities=25% Similarity=0.370 Sum_probs=200.4
Q ss_pred HhcCCCccCeEeecCcEEEEEEEEcCC----CeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEE
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNLING----SPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRM 213 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~~~~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 213 (463)
..++|.+.+.||+|+||.||+|...+. ..|++|...... ....+.+.+|+.++++++||||+++++++.+ ...+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 345688889999999999999965432 468999876544 4455678899999999999999999999875 4578
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
+||||+++++|.+++... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++.
T Consensus 83 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 83 IVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred EEEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeee
Confidence 999999999999999642 33589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCcccc
Q 012462 294 LGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV 372 (463)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (463)
.............++..|+|||.+....++.++||||||+++|||++ |..||....... . ...........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~---~~~~~~~~~~~-- 228 (270)
T cd05056 157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND---V---IGRIENGERLP-- 228 (270)
T ss_pred cccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH---H---HHHHHcCCcCC--
Confidence 65443222223334568999999988889999999999999999986 999997543221 1 11111111110
Q ss_pred ccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCC
Q 012462 373 VDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEE 418 (463)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~ 418 (463)
.... ....+..++.+||..+|++|||+.++++.|+...
T Consensus 229 ------~~~~--~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 229 ------MPPN--CPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred ------CCCC--CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0111 1123444566899999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=311.82 Aligned_cols=259 Identities=23% Similarity=0.372 Sum_probs=201.6
Q ss_pred HhcCCCccCeEeecCcEEEEEEEEc------CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcE
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIH 211 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 211 (463)
..++|++.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.++++++||||+++++++.++..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3567899999999999999999753 46789999886543 3345678889999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhhc------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCC
Q 012462 212 RMLVYEYVNNGNLEQWLHGAMR------------------HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSS 273 (463)
Q Consensus 212 ~~lV~e~~~~g~L~~~l~~~~~------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~ 273 (463)
.++||||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence 9999999999999999964211 113478889999999999999999999 9999999999
Q ss_pred ceeEcCCCCEEEeecccceecCCCCce-eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCc
Q 012462 274 NILIDDDFNAKVSDFGLAKLLGAGKSH-VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPA 351 (463)
Q Consensus 274 Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~ 351 (463)
||+++.++.++|+|||++......... .......+..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~- 238 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH- 238 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence 999999999999999998765432211 1122234667999999998899999999999999999998 8888864332
Q ss_pred ccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 012462 352 HEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416 (463)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~ 416 (463)
.+........ .... ... .....+..++.+||+.||++|||+.|+++.|+.
T Consensus 239 -----~~~~~~~~~~-~~~~-------~~~--~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 -----EEVIYYVRDG-NVLS-------CPD--NCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -----HHHHHHHhcC-CCCC-------CCC--CCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1222222211 1110 000 112344556778999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=308.60 Aligned_cols=251 Identities=24% Similarity=0.309 Sum_probs=194.8
Q ss_pred CCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 143 FSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 143 ~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
|+..+.||+|+||.||++.. .+++.||+|.+.... ......+..|+.++++++|+||+++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 66778999999999999955 468899999885432 12234567799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+.+++|.+++... ....+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 9999999988642 234589999999999999999999999 99999999999999999999999999997654322
Q ss_pred ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCC
Q 012462 299 SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (463)
. .....|+..|+|||++.+..++.++|||||||++|+|++|..||......... ........... ...
T Consensus 157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~---~~~~~~~~~~~-~~~------ 224 (285)
T cd05630 157 T--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKEVQ-EEY------ 224 (285)
T ss_pred c--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH---HHHHhhhhhhh-hhc------
Confidence 1 22346899999999999999999999999999999999999999764321111 11111111000 000
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 012462 379 VRPSTRALKRSLLTALRCVDPDSEKRPK-----MSQVVRM 413 (463)
Q Consensus 379 ~~~~~~~~~~~~~~~~~cl~~dP~~RPs-----~~ell~~ 413 (463)
...... ....++.+||+.||++||| ++|++++
T Consensus 225 ~~~~~~---~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 225 SEKFSP---DARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred CccCCH---HHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 001112 2334455799999999999 8888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=303.84 Aligned_cols=250 Identities=23% Similarity=0.311 Sum_probs=198.4
Q ss_pred CCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEccc-chhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeec
Q 012462 142 RFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNN-VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYV 219 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 219 (463)
+|++.+.||+|+||.||++.. .++..+|+|.+... .....+.+..|+.+++.++|+||+++++.+.++...++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 477889999999999999965 46889999988432 2344567788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCc
Q 012462 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299 (463)
Q Consensus 220 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 299 (463)
++++|.+++... ....+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 999999988542 334588999999999999999999999 999999999999999999999999999986643221
Q ss_pred eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCC
Q 012462 300 HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEV 379 (463)
Q Consensus 300 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (463)
......+++.|+|||++.+..++.++|+||||+++|+|++|..||..... ........... ....
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~~~~~~~~~~-~~~~------- 220 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW------KNLILKVCQGS-YKPL------- 220 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH------HHHHHHHhcCC-CCCC-------
Confidence 22345688999999999998899999999999999999999999975332 11111111111 1101
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 380 RPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 380 ~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
... .......++.+||+.||++||++.+++..
T Consensus 221 ~~~--~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 PSH--YSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred Ccc--cCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 011 11223345668999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=307.89 Aligned_cols=255 Identities=28% Similarity=0.465 Sum_probs=198.1
Q ss_pred cCCCccCeEeecCcEEEEEEEEcC-C---CeEEEEEEccc-chhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLIN-G---SPVAVKKILNN-VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 215 (463)
+.|++.+.||+|+||.||+|.... + ..||+|.+... .......+..|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357788999999999999996543 3 35999988654 233456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
|||+++++|.+++... .+.+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999998642 34589999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCcee-ec-cc--cccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 296 AGKSHV-TT-RV--MGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 296 ~~~~~~-~~-~~--~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
...... .. .. ..+..|+|||.+.+..++.++|||||||++||+++ |..||...... .... .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~---~i~~~~~~~ 231 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVIN---AIEQDYRLP 231 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHH---HHHcCCcCC
Confidence 322111 11 11 12457999999999999999999999999999886 99999754321 1112 111111111
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
. .. .....+..++.+||+.+|++||++.+++..|+..
T Consensus 232 ~--------~~--~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 232 P--------PM--DCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred C--------cc--cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 01 1112334556689999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=308.61 Aligned_cols=251 Identities=24% Similarity=0.282 Sum_probs=194.2
Q ss_pred CCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccch---hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 143 FSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVG---QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 143 ~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
|+..+.||+|+||+||+|.. .+++.||+|.+..... .....+..|+.++++++|+||+++++.+.+++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 66678999999999999955 4688999998854322 2234567799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+.+++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 9999999888642 234699999999999999999999999 99999999999999999999999999997654322
Q ss_pred ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCC
Q 012462 299 SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (463)
......|+..|+|||++.+..++.++|+|||||++|||++|..||........ ....... ..... . .
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~--~~~~~~~-~~~~~--~------~ 223 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK--REEVDRR-VLETE--E------V 223 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHh-hhccc--c------c
Confidence 12335789999999999988999999999999999999999999975432111 1111111 11100 0 0
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 012462 379 VRPSTRALKRSLLTALRCVDPDSEKRPK-----MSQVVRM 413 (463)
Q Consensus 379 ~~~~~~~~~~~~~~~~~cl~~dP~~RPs-----~~ell~~ 413 (463)
..... ......++.+||+.||++||+ +.+++.+
T Consensus 224 ~~~~~--~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 224 YSAKF--SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred cCccC--CHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 11111 112334556799999999999 6666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=304.73 Aligned_cols=246 Identities=29% Similarity=0.417 Sum_probs=192.0
Q ss_pred eEeecCcEEEEEEEE---cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCCC
Q 012462 148 VLGEGGYGVVYRGNL---INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNG 222 (463)
Q Consensus 148 ~lG~G~~g~V~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 222 (463)
.||+|+||.||+|.+ .++..+|+|++.... ....+++..|+.+++.++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999954 356889999875433 234567888999999999999999999886 45678999999999
Q ss_pred CHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCcee-
Q 012462 223 NLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV- 301 (463)
Q Consensus 223 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~- 301 (463)
+|.+++.. ...+++..++.++.|++.||.|||+. +|+|+||||.||+++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999853 34589999999999999999999999 99999999999999999999999999998765433211
Q ss_pred -eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCC
Q 012462 302 -TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEV 379 (463)
Q Consensus 302 -~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (463)
.....++..|+|||.+....++.++|||||||++|||++ |..||...... .+......... ....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~i~~~~~-~~~~------ 220 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN------EVTQMIESGER-MECP------ 220 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHCCCC-CCCC------
Confidence 122234578999999988889999999999999999998 99999754321 22222222111 1110
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 380 RPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 380 ~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
..... .+..++.+||+.||++||++.+|.+.|++.
T Consensus 221 ~~~~~---~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 221 QRCPP---EMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCH---HHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 01112 233456689999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=314.94 Aligned_cols=263 Identities=26% Similarity=0.426 Sum_probs=202.1
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEEc--------CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCC-CCCCcceEeeEE
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNLI--------NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYC 206 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 206 (463)
....++|.+.+.||+|+||.||+|... ....+|+|.+.... ......+..|+.++.++ +||||++++++|
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 444578889999999999999999642 24568999876433 33445688899999999 699999999999
Q ss_pred EECcEEEEEEeecCCCCHHHHHhhhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCc
Q 012462 207 IEGIHRMLVYEYVNNGNLEQWLHGAMR------------HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSN 274 (463)
Q Consensus 207 ~~~~~~~lV~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~N 274 (463)
.+....++||||+++|+|.+++..... ....+++..+..++.|++.||.|||++ +++|+||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 164 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARN 164 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccccee
Confidence 998899999999999999999965321 124588999999999999999999999 99999999999
Q ss_pred eeEcCCCCEEEeecccceecCCCCcee-eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcc
Q 012462 275 ILIDDDFNAKVSDFGLAKLLGAGKSHV-TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAH 352 (463)
Q Consensus 275 ill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~ 352 (463)
||++.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~-- 242 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV-- 242 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH--
Confidence 999999999999999998654322111 112234567999999999899999999999999999999 8889865332
Q ss_pred cccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCC
Q 012462 353 EVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEE 418 (463)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~ 418 (463)
............. ..... ....+..++.+||+.||++||++.|+++.|+...
T Consensus 243 ----~~~~~~~~~~~~~--------~~~~~--~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 243 ----EELFKLLREGHRM--------DKPSN--CTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred ----HHHHHHHHcCCCC--------CCCCC--CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1112222211110 01111 1123334566899999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=323.72 Aligned_cols=244 Identities=31% Similarity=0.457 Sum_probs=196.8
Q ss_pred eEeecCcEEEEEEEEcC-CCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCCCCHHH
Q 012462 148 VLGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQ 226 (463)
Q Consensus 148 ~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~~ 226 (463)
+||+|.||+||.|++.+ ...+|||-+.........-+..|+.+.++|+|.|||+++|.|.+++.+-|.||-.+||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999996644 55789999877666666778889999999999999999999999999999999999999999
Q ss_pred HHhhhhcCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEc-CCCCEEEeecccceecCCCCceeec
Q 012462 227 WLHGAMRHHGYL--TWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVTT 303 (463)
Q Consensus 227 ~l~~~~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~ 303 (463)
+|+.. -+++ ++.++-.+..||++||.|||++ .|||||||-+|||++ -.|.+||+|||.++.... -...+.
T Consensus 662 LLrsk---WGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TE 734 (1226)
T KOG4279|consen 662 LLRSK---WGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTE 734 (1226)
T ss_pred HHHhc---cCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc-CCcccc
Confidence 99753 3456 7888999999999999999999 999999999999996 478999999999987653 344566
Q ss_pred cccccCCCCchhhhccC--CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCC
Q 012462 304 RVMGTFGYVAPEYANTG--LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRP 381 (463)
Q Consensus 304 ~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (463)
++.||..|||||++..+ .|+.++|||||||++.||.||++||-........ ...++-.... ...
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA------MFkVGmyKvH--------P~i 800 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA------MFKVGMYKVH--------PPI 800 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh------hhhhcceecC--------CCC
Confidence 78899999999999775 4889999999999999999999999754322211 1111111111 111
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 012462 382 STRALKRSLLTALRCVDPDSEKRPKMSQVVR 412 (463)
Q Consensus 382 ~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~ 412 (463)
...-......++++|+.+||.+||+++++|.
T Consensus 801 Peelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 1222333445567999999999999999985
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=306.76 Aligned_cols=240 Identities=25% Similarity=0.381 Sum_probs=185.4
Q ss_pred CeEeecCcEEEEEEEEcC-------------CCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEE
Q 012462 147 NVLGEGGYGVVYRGNLIN-------------GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRM 213 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 213 (463)
+.||+|+||.||+|.... ...|++|.+..........+..|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999996432 2258888875544444567788999999999999999999999988999
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCC-------EEEe
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFN-------AKVS 286 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~-------~kl~ 286 (463)
+||||+++++|..++.. ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 99999999999988753 234689999999999999999999999 9999999999999987664 8999
Q ss_pred ecccceecCCCCceeeccccccCCCCchhhhc-cCCCCccchhhhHHHHHHHHH-hCCCCCCCCCCcccccHHHHHHHHh
Q 012462 287 DFGLAKLLGAGKSHVTTRVMGTFGYVAPEYAN-TGLLNEKSDVYSFGVLLLEAI-TGRDPVDHGRPAHEVNLVDWLKMMV 364 (463)
Q Consensus 287 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~ell-tg~~pf~~~~~~~~~~~~~~~~~~~ 364 (463)
|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..||....... ... ..
T Consensus 155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~-~~ 222 (262)
T cd05077 155 DPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE------KER-FY 222 (262)
T ss_pred CCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH------HHH-HH
Confidence 99998754322 2235788899999886 567899999999999999998 5888876432111 000 11
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 012462 365 GSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415 (463)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~ 415 (463)
... . . ...+... .+..++.+||+.||++||++.+|++.|+
T Consensus 223 ~~~-~-~------~~~~~~~---~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 EGQ-C-M------LVTPSCK---ELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hcC-c-c------CCCCChH---HHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 110 0 0 0111222 3344566899999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=314.41 Aligned_cols=257 Identities=25% Similarity=0.394 Sum_probs=197.1
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCC--eEEEEEEcccc-hhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGS--PVAVKKILNNV-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 214 (463)
.++|++.+.||+|+||.||+|.+. ++. .+++|.+.... ......+.+|+.++.++ +||||+++++++.+.+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 356888899999999999999754 444 45777765432 33446788899999999 89999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCC
Q 012462 215 VYEYVNNGNLEQWLHGAMR------------HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFN 282 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~ 282 (463)
||||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 9999999999999965321 123588999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHH
Q 012462 283 AKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLK 361 (463)
Q Consensus 283 ~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~ 361 (463)
+||+|||++....... ......++..|+|||.+.+..++.++|||||||++|||+| |..||...... +...
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~ 234 (303)
T cd05088 163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYE 234 (303)
T ss_pred EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH------HHHH
Confidence 9999999986432111 1111234667999999988889999999999999999998 99999754321 1111
Q ss_pred HHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 362 MMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
......... .... ....+..++.+||+.+|++||++.++++.|+.+
T Consensus 235 ~~~~~~~~~--------~~~~--~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 235 KLPQGYRLE--------KPLN--CDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred HHhcCCcCC--------CCCC--CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111110000 0000 112334556689999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=300.86 Aligned_cols=250 Identities=33% Similarity=0.503 Sum_probs=199.4
Q ss_pred CeEeecCcEEEEEEEEcC----CCeEEEEEEcccchh-hHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCC
Q 012462 147 NVLGEGGYGVVYRGNLIN----GSPVAVKKILNNVGQ-AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNN 221 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 221 (463)
+.||+|+||.||+|.... +..|++|.+...... ....+..|++.+..++|+||+++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 368999999999996643 788999998654433 357788899999999999999999999999999999999999
Q ss_pred CCHHHHHhhhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 222 GNLEQWLHGAMRH-----HGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 222 g~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
++|.+++...... ...+++..++.++.|++.||+|||++ +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999754211 36799999999999999999999999 999999999999999999999999999987654
Q ss_pred CCc-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCcccccc
Q 012462 297 GKS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVD 374 (463)
Q Consensus 297 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (463)
... .......++..|+|||.+....++.++||||||+++|||++ |..||..... .............
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~~~~~----- 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN------EEVLEYLRKGYRL----- 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHHcCCCC-----
Confidence 321 12233457889999999988889999999999999999999 6999976532 1122222211110
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 012462 375 PNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415 (463)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~ 415 (463)
..... ....+..++.+||+.+|++|||+.|++++|+
T Consensus 227 ---~~~~~--~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 ---PKPEY--CPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCCcc--CChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 00111 1234455566899999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=310.04 Aligned_cols=253 Identities=28% Similarity=0.470 Sum_probs=196.2
Q ss_pred CCccCeEeecCcEEEEEEEEcC-CCeEEEEEEcccchhhH--HHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeec
Q 012462 143 FSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQAE--KEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYV 219 (463)
Q Consensus 143 ~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~--~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 219 (463)
|++.+.||+|+||+||++.... ++.+|+|.+........ .....|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5678899999999999997654 55899999866543322 23455999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCc
Q 012462 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299 (463)
Q Consensus 220 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 299 (463)
.+++|.+++. ....+++..++.++.|+++||.+||+. +++|+||||+||+++.++.++|+|||.+...... .
T Consensus 81 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~-~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN-N 152 (260)
T ss_dssp TTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTST-T
T ss_pred cccccccccc----ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc-c
Confidence 9999999996 234589999999999999999999999 9999999999999999999999999999864221 2
Q ss_pred eeeccccccCCCCchhhhc-cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCC
Q 012462 300 HVTTRVMGTFGYVAPEYAN-TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378 (463)
Q Consensus 300 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (463)
.......++..|+|||++. +..++.++||||||+++|+|++|..||......... .......... .......
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~---~~~~~~~~~~----~~~~~~~ 225 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQL---EIIEKILKRP----LPSSSQQ 225 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHH---HHHHHHHHTH----HHHHTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhh---hhhhhccccc----ccccccc
Confidence 2344567899999999998 888999999999999999999999999865211111 1111111000 0000000
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 379 ~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
..... ..+..++.+||+.||++||++.+++++
T Consensus 226 ~~~~~---~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 226 SREKS---EELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HTTSH---HHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred cchhH---HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01111 344555668999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=310.57 Aligned_cols=251 Identities=23% Similarity=0.383 Sum_probs=200.3
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
..+|++.+.||+|+||.||+|.. .+++.||+|.+........+.+..|+.+++.++|+||++++++|..+...++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36799999999999999999965 57899999998655545556788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+++++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||||+|||++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 98 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 999999998843 3478899999999999999999999 99999999999999999999999999998654332
Q ss_pred ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCC
Q 012462 299 SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (463)
.. .....+++.|+|||.+.+..++.++|+|||||++|+|++|..||....+..... ...... .+...
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~~~~------~~~~~ 236 (297)
T cd06656 170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNG------TPELQ 236 (297)
T ss_pred cC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eeccCC------CCCCC
Confidence 21 223467889999999999889999999999999999999999997543321110 000000 00001
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 379 ~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.... .......++.+||+.||++||++++++++
T Consensus 237 ~~~~--~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 237 NPER--LSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred Cccc--cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111 11223345568999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=308.35 Aligned_cols=258 Identities=27% Similarity=0.391 Sum_probs=200.2
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc------CCCeEEEEEEcccchh-hHHHHHHHHHHHcCCCCCCcceEeeEEEECcEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNVGQ-AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHR 212 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 212 (463)
.++|++.+.||+|+||.||+|+.. +...|++|.+...... ....+..|+.++++++|+||+++++++.+....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 357888999999999999999753 2457899987554333 456788999999999999999999999998899
Q ss_pred EEEEeecCCCCHHHHHhhhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEee
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRH-----HGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSD 287 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~D 287 (463)
++||||+++|+|.+++...... ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcc
Confidence 9999999999999999653211 12589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcC
Q 012462 288 FGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGS 366 (463)
Q Consensus 288 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 366 (463)
||++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ..+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~------~~~~~~~~- 233 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE------EVLNRLQA- 233 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH------HHHHHHHc-
Confidence 99987543332222333456778999999988889999999999999999999 88898643321 11111111
Q ss_pred CCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 012462 367 RRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415 (463)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~ 415 (463)
...... . .... ...+..++.+||+.+|++||++.|++..|.
T Consensus 234 ~~~~~~-~----~~~~---~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKLELP-V----PEGC---PSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcCCC-C----CCCC---CHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 111000 0 0111 123444566899999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=320.42 Aligned_cols=194 Identities=23% Similarity=0.333 Sum_probs=164.8
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
....+|++.+.||+|+||.||+|... ++..||+|..... ....|+.++++++||||+++++++......++||
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34567999999999999999999664 4678899974322 2245889999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
|++. ++|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 137 e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 137 PHYS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred EccC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence 9995 589888853 345689999999999999999999999 999999999999999999999999999975332
Q ss_pred CCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVD 346 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~ 346 (463)
.. ......||..|+|||++.+..++.++|||||||++|||+++..|+.
T Consensus 210 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 210 AP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred Cc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 21 2234568999999999999999999999999999999999666553
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=324.34 Aligned_cols=195 Identities=23% Similarity=0.267 Sum_probs=167.2
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
...|.+.+.||+|+||.||+|... .++.||||.... ..+.+|+.++++++|+||+++++++..+...++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999654 478899996422 2345799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+. ++|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 242 ~~-~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 242 YR-SDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred cC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 95 699888853 234699999999999999999999999 99999999999999999999999999998754322
Q ss_pred c-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCC
Q 012462 299 S-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDH 347 (463)
Q Consensus 299 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 347 (463)
. .......||..|+|||++.+..++.++|||||||+||||++|..|+..
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~ 364 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFS 364 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCccc
Confidence 1 122345799999999999999999999999999999999998876543
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=303.26 Aligned_cols=250 Identities=30% Similarity=0.437 Sum_probs=196.9
Q ss_pred hcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEE-ECcEEEEEEee
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI-EGIHRMLVYEY 218 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lV~e~ 218 (463)
..+|++.+.||+|+||.||++.. .|..|++|.+.... ..+.+..|+.++++++|+|++++++++. ++...++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 35688899999999999999976 57889999875432 3457888999999999999999999765 45678999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+++++|.+++... ....+++..++.++.|++.||+|||++ +++|+||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 82 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 9999999998642 233588999999999999999999999 99999999999999999999999999987643321
Q ss_pred ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCC
Q 012462 299 SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNI 377 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (463)
....++..|+|||++.+..++.++|||||||++|||++ |+.||.... ............. ...
T Consensus 157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~------~~~~~~~~~~~~~-~~~----- 220 (256)
T cd05082 157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDVVPRVEKGYK-MDA----- 220 (256)
T ss_pred ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHhcCCC-CCC-----
Confidence 22334668999999999899999999999999999998 999986432 1222222211111 100
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 378 EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.. .....+..++.+||+.+|++|||+.++++.|+++
T Consensus 221 --~~--~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 221 --PD--GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred --CC--CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 01 1112334456689999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=308.52 Aligned_cols=239 Identities=25% Similarity=0.385 Sum_probs=184.7
Q ss_pred eEeecCcEEEEEEEEcC-------------------------CCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceE
Q 012462 148 VLGEGGYGVVYRGNLIN-------------------------GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRL 202 (463)
Q Consensus 148 ~lG~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 202 (463)
.||+|+||.||+|.+.. ...|++|.+..........+..|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999996421 13588888755444445678889999999999999999
Q ss_pred eeEEEECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCC-
Q 012462 203 LGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDF- 281 (463)
Q Consensus 203 ~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~- 281 (463)
+++|.+....++||||+++|+|..++.. ..+.+++..+..++.||+.||+|||+. +|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence 9999999999999999999999998853 244688999999999999999999999 999999999999997644
Q ss_pred ------CEEEeecccceecCCCCceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHH-hCCCCCCCCCCccc
Q 012462 282 ------NAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAI-TGRDPVDHGRPAHE 353 (463)
Q Consensus 282 ------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~ell-tg~~pf~~~~~~~~ 353 (463)
.++++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||....+...
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3899999988643221 12346788999998865 56899999999999999985 69999976543221
Q ss_pred ccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 012462 354 VNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415 (463)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~ 415 (463)
..... ...... .+.. ..+..++.+||+.+|++||++.++++.|.
T Consensus 231 ---~~~~~---~~~~~~---------~~~~---~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ---ERFYE---KKHRLP---------EPSC---KELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ---HHHHH---hccCCC---------CCCC---hHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11111 000000 0111 23445666899999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=301.14 Aligned_cols=248 Identities=27% Similarity=0.444 Sum_probs=195.7
Q ss_pred CeEeecCcEEEEEEEEcCCCeEEEEEEcccchh-hHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCCCCHH
Q 012462 147 NVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQ-AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLE 225 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~ 225 (463)
++||+|+||.||+|...+++.|++|.+...... ....+..|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 369999999999998766999999988654433 4567889999999999999999999999999999999999999999
Q ss_pred HHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCceee-cc
Q 012462 226 QWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVT-TR 304 (463)
Q Consensus 226 ~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~~ 304 (463)
+++... ...+++..++.++.+++.||.|||++ +++|+||+|+||+++.++.++|+|||++........... ..
T Consensus 81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 998642 34588999999999999999999999 999999999999999999999999999976542221111 11
Q ss_pred ccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCCH
Q 012462 305 VMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPST 383 (463)
Q Consensus 305 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (463)
...+..|+|||.+.+..++.++|+|||||++|||++ |..||....... ........... ....
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~------~~~~~~~~~~~----------~~~~ 218 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ------TRERIESGYRM----------PAPQ 218 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH------HHHHHhcCCCC----------CCCc
Confidence 233567999999988899999999999999999999 888886543211 11111111000 0001
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 012462 384 RALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416 (463)
Q Consensus 384 ~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~ 416 (463)
.....+..++.+||..+|.+||++.||++.|+.
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 112345556668999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=296.97 Aligned_cols=253 Identities=25% Similarity=0.368 Sum_probs=199.4
Q ss_pred HhcCCCccCeEeecCcEEEEEE-EEcCCCeEEEEEEcccc--------hhhHHHHHHHHHHHcCC-CCCCcceEeeEEEE
Q 012462 139 ATNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV--------GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIE 208 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 208 (463)
..+.|...+.||.|..++|-++ ...+|..+|+|++.... ....+.-.+|+.+|+++ .||||+.+.++|+.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3456788889999999999888 45578899999884321 12223456799999997 79999999999999
Q ss_pred CcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeec
Q 012462 209 GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDF 288 (463)
Q Consensus 209 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Df 288 (463)
+.-.++|+|.|+.|.|.|+|.. .-.+++....+|+.|+.+|++|||.+ +|+||||||+|||++++.+++|+||
T Consensus 95 ~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred cchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence 9999999999999999999954 44589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCceeeccccccCCCCchhhhcc------CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 012462 289 GLAKLLGAGKSHVTTRVMGTFGYVAPEYANT------GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKM 362 (463)
Q Consensus 289 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 362 (463)
|++.....+. .....||||+|+|||.+.. ..|+...|+|++||+||-|+.|..||.+..+. -.+..
T Consensus 168 GFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm------lMLR~ 239 (411)
T KOG0599|consen 168 GFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM------LMLRM 239 (411)
T ss_pred ceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH------HHHHH
Confidence 9999887654 3567899999999998854 35788999999999999999999999864321 12222
Q ss_pred HhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 363 MVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
+..+ ... +. ..++.. .......++.+||+.||.+|.|++|+|.+
T Consensus 240 ImeG-kyq-F~--speWad---is~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 240 IMEG-KYQ-FR--SPEWAD---ISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHhc-ccc-cC--Ccchhh---ccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 2222 111 00 111111 11222334558999999999999999875
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=302.47 Aligned_cols=250 Identities=28% Similarity=0.423 Sum_probs=199.9
Q ss_pred cCCCccCeEeecCcEEEEEEEEcC-CCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeec
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYV 219 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 219 (463)
++|++.+.||+|+||.||+|...+ +..+++|.+..... ...+.+|++++++++||||+++++++.+....|+++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578889999999999999997754 78999998855432 678889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCc
Q 012462 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299 (463)
Q Consensus 220 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 299 (463)
++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 81 GAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 99999999863 235689999999999999999999999 999999999999999999999999999886543321
Q ss_pred eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCC
Q 012462 300 HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEV 379 (463)
Q Consensus 300 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (463)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||....+.... .. ...... .....
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~------~~-~~~~~~-----~~~~~ 221 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI------FM-IPNKPP-----PTLSD 221 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh------hh-hccCCC-----CCCCc
Confidence 222345788999999999989999999999999999999999999754332111 00 000000 01111
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 380 RPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 380 ~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.......+..++.+||+.||++|||+.|++++
T Consensus 222 --~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 222 --PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred --hhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 11111234455668999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=309.98 Aligned_cols=263 Identities=23% Similarity=0.347 Sum_probs=200.6
Q ss_pred hHHHHHHhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCC-CCCCcceEeeEEE---
Q 012462 133 LRDLELATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCI--- 207 (463)
Q Consensus 133 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~--- 207 (463)
++.+....++|++.+.||+|+||.||+|.. .+++.+|+|.+... ......+..|+.++..+ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 445556678999999999999999999955 45788999986442 23345677899999998 7999999999884
Q ss_pred --ECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEE
Q 012462 208 --EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKV 285 (463)
Q Consensus 208 --~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl 285 (463)
.+...++||||+++++|.+++.........+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEE
Confidence 34568999999999999998875444456689999999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCCceeeccccccCCCCchhhhcc-----CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHH
Q 012462 286 SDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANT-----GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWL 360 (463)
Q Consensus 286 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~ 360 (463)
+|||++........ ......|+..|+|||++.. ..++.++|||||||++|||++|+.||....+... .
T Consensus 166 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-----~- 238 (286)
T cd06638 166 VDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-----L- 238 (286)
T ss_pred ccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-----H-
Confidence 99999987643221 1223468899999998753 4578899999999999999999999975432111 0
Q ss_pred HHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 012462 361 KMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414 (463)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L 414 (463)
..... ........ ... ....+..++.+||+.||++|||+.|+++++
T Consensus 239 ~~~~~-~~~~~~~~-----~~~--~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 239 FKIPR-NPPPTLHQ-----PEL--WSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred hhccc-cCCCcccC-----CCC--cCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00000 00001111 110 112344456689999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=305.75 Aligned_cols=254 Identities=24% Similarity=0.346 Sum_probs=197.6
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
.++|++.+.||+|+||.||+|.. .+++.||+|.+..........+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 34677888999999999999965 46889999988655444456678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+++++|.+++.. .+.+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 88 CGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 999999998853 34689999999999999999999999 99999999999999999999999999987654322
Q ss_pred ceeeccccccCCCCchhhhc---cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 299 SHVTTRVMGTFGYVAPEYAN---TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
.......|+..|+|||++. ...++.++|||||||++|+|++|..||....+.... ...............
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~------~~~~~~~~~~~~~~~ 233 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------FLMTKSNFQPPKLKD 233 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH------HhhhccCCCCCcccc
Confidence 1223456899999999874 456889999999999999999999998654322111 111111111000000
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.. .... ....++.+||+.+|++||++++++++
T Consensus 234 ~~---~~~~---~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 234 KM---KWSN---SFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cC---CCCH---HHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00 1111 23345668999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=302.02 Aligned_cols=247 Identities=30% Similarity=0.468 Sum_probs=192.5
Q ss_pred CeEeecCcEEEEEEEEc-CC---CeEEEEEEcccch-hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCC
Q 012462 147 NVLGEGGYGVVYRGNLI-NG---SPVAVKKILNNVG-QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNN 221 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~-~~---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 221 (463)
++||+|+||.||+|.+. .+ ..+|+|.+..... ...+.+..|+.+++.++||||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999542 22 6899998865443 34567888999999999999999999876 4567999999999
Q ss_pred CCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCcee
Q 012462 222 GNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV 301 (463)
Q Consensus 222 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 301 (463)
++|.+++.. ...+++..++.++.|++.||.|||.. +++|+||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 999999963 23689999999999999999999999 99999999999999999999999999998764433221
Q ss_pred ec--cccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCC
Q 012462 302 TT--RVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378 (463)
Q Consensus 302 ~~--~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (463)
.. ...++..|+|||.+.+..++.++|||||||++|||++ |..||...... +............
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~------~~~~~~~~~~~~~-------- 218 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA------EVIAMLESGERLP-------- 218 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH------HHHHHHHcCCcCC--------
Confidence 11 1223467999999999899999999999999999998 99999754321 1122221111110
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 379 ~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.... ....+..++.+||+.+|++||++.++++.|+..
T Consensus 219 ~~~~--~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 RPEE--CPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCC--CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 0111 112344566689999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=305.58 Aligned_cols=261 Identities=24% Similarity=0.407 Sum_probs=199.3
Q ss_pred cCCCccCeEeecCcEEEEEEEE-----cCCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC--cEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-----INGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG--IHR 212 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 212 (463)
..|++.+.||+|+||.||++.. .++..||+|.+.... ......+.+|+.+++.++||||+++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3478889999999999999963 357889999986443 33446788999999999999999999998875 567
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccce
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~ 292 (463)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence 8999999999999998532 23589999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCc--eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCC---------cccccHHHHHH
Q 012462 293 LLGAGKS--HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP---------AHEVNLVDWLK 361 (463)
Q Consensus 293 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~---------~~~~~~~~~~~ 361 (463)
....... .......++..|+|||++.+..++.++|||||||++|||++++.|+..... ........+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 7643322 112234567789999999888899999999999999999998776543211 00111111111
Q ss_pred HHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 362 MMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
......... ... .....+..++.+||+.||++||++.++++.|+.+
T Consensus 238 ~~~~~~~~~--------~~~--~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEGKRLP--------RPP--NCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcCccCC--------CCC--CCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111111100 001 1123455566689999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=310.54 Aligned_cols=259 Identities=24% Similarity=0.347 Sum_probs=188.6
Q ss_pred CCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccch--hhHHHHHHHHHHHcCC---CCCCcceEeeEEEE-----Cc
Q 012462 142 RFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVG--QAEKEFRVEVEAIGHV---RHKNLVRLLGYCIE-----GI 210 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~~ 210 (463)
+|++.+.||+|+||+||+|.. .+++.||+|.+..... .....+..|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 588889999999999999965 4688999998854321 1123344566666554 79999999998864 34
Q ss_pred EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccc
Q 012462 211 HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGL 290 (463)
Q Consensus 211 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~ 290 (463)
..++||||+.+ +|.+++... ....+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 57899999975 899888642 234589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 291 AKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 291 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
+....... ......++..|+|||++.+..++.++|||||||++|||++|+.||........ +.. +..........
T Consensus 155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~~~-~~~~~~~~~~~ 229 (288)
T cd07863 155 ARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGK-IFDLIGLPPED 229 (288)
T ss_pred cccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--HHH-HHHHhCCCChh
Confidence 98654322 12335678999999999998999999999999999999999999975432211 111 11111000000
Q ss_pred cc----------ccCCC-----CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 371 EV----------VDPNI-----EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 371 ~~----------~~~~~-----~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.. ..+.. ...+. .......++.+||+.||++|||+.|++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPE--IEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcC--cCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 00000 00011 11223455668999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=310.69 Aligned_cols=250 Identities=24% Similarity=0.384 Sum_probs=199.8
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeec
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYV 219 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 219 (463)
.+|++.+.||.|+||.||+|.. .+++.|++|.+........+.+.+|+.+++.++||||+++++++......++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 5689999999999999999954 578999999986555455677888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCc
Q 012462 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299 (463)
Q Consensus 220 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 299 (463)
++++|.+++.. ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 99999998842 3489999999999999999999999 999999999999999999999999999876543322
Q ss_pred eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCC
Q 012462 300 HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEV 379 (463)
Q Consensus 300 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (463)
......++..|+|||.+.+..++.++|||||||++|+|++|+.||....+.. ......... .... ..
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~------~~~~~~~~~-~~~~-----~~ 237 (296)
T cd06655 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYLIATNG-TPEL-----QN 237 (296)
T ss_pred -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcC-Cccc-----CC
Confidence 1223467889999999998889999999999999999999999997644321 111111111 0000 01
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 380 RPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 380 ~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
... .......++.+||..||++||++.+++.+
T Consensus 238 ~~~--~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 238 PEK--LSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred ccc--CCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 111 11123345568999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=308.41 Aligned_cols=257 Identities=25% Similarity=0.372 Sum_probs=201.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
.++|++.+.||+|+||+||++... ++..||+|++.... ....+.+.+|++++..++||||+++++++......++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 456888899999999999999654 57889999875433 3445778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
|+++++|.+++.. .+.+++..+..++.+++.||.|||+.. +++|+||+|+||+++.++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 9999999998853 346899999999999999999999732 8999999999999999999999999998654322
Q ss_pred CceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcc-----cccHHHHHHHHhcCCCcccc
Q 012462 298 KSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAH-----EVNLVDWLKMMVGSRRSEEV 372 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 372 (463)
. .....++..|+|||++.+..++.++|||||||++|+|++|..||....... .....++..........
T Consensus 158 ~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 231 (284)
T cd06620 158 I---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP--- 231 (284)
T ss_pred c---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC---
Confidence 1 224578999999999988889999999999999999999999998644321 11122222222211100
Q ss_pred ccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 012462 373 VDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414 (463)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L 414 (463)
.+ +.......+..++.+||+.||++|||+.|++++.
T Consensus 232 ---~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 232 ---RL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred ---CC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 00 0011122344556689999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=301.95 Aligned_cols=255 Identities=27% Similarity=0.398 Sum_probs=201.9
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
.++|++.+.||+|+||.||+|.. .++..+++|.+........+.+..|+.++++++||||+++++++.+....+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 35788899999999999999965 45788999998665555567888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+.+++|.+++... ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 82 CGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred CCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 9999999988642 24689999999999999999999999 99999999999999999999999999987654321
Q ss_pred ceeeccccccCCCCchhhhccC---CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 299 SHVTTRVMGTFGYVAPEYANTG---LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
.......++..|+|||.+.+. .++.++||||||+++|||++|..||....+.... ....... ....
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~------~~~~~~~----~~~~ 224 (262)
T cd06613 156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL------FLISKSN----FPPP 224 (262)
T ss_pred -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhcc----CCCc
Confidence 122335678899999998776 8899999999999999999999999754422111 1111110 0000
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.. .........+..++.+||..+|.+|||+.+++.+
T Consensus 225 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 225 KL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred cc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 01 1111222344556678999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=316.42 Aligned_cols=265 Identities=28% Similarity=0.428 Sum_probs=204.7
Q ss_pred HHHHhcCCCccCeEeecCcEEEEEEEEcC--------CCeEEEEEEcccc-hhhHHHHHHHHHHHcCC-CCCCcceEeeE
Q 012462 136 LELATNRFSKENVLGEGGYGVVYRGNLIN--------GSPVAVKKILNNV-GQAEKEFRVEVEAIGHV-RHKNLVRLLGY 205 (463)
Q Consensus 136 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~ 205 (463)
+++...+|++.+.||+|+||.||+|.... +..||+|.+.... ......+..|+.++.++ +||||++++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 45556789999999999999999996421 2368999875433 33446788899999999 89999999999
Q ss_pred EEECcEEEEEEeecCCCCHHHHHhhhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCC
Q 012462 206 CIEGIHRMLVYEYVNNGNLEQWLHGAMR------------HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSS 273 (463)
Q Consensus 206 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~ 273 (463)
|......+++|||+++|+|.+++..... ....+++..++.++.|++.||.|||++ +++||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~ 163 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAAR 163 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccc
Confidence 9999999999999999999999865321 223578899999999999999999999 9999999999
Q ss_pred ceeEcCCCCEEEeecccceecCCCCce-eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCc
Q 012462 274 NILIDDDFNAKVSDFGLAKLLGAGKSH-VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPA 351 (463)
Q Consensus 274 Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~ 351 (463)
|||++.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-- 241 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-- 241 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC--
Confidence 999999999999999999865432211 1122234567999999999999999999999999999998 888886532
Q ss_pred ccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCC
Q 012462 352 HEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEY 419 (463)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~ 419 (463)
..+............ . .. .....+..++.+||+.+|++||++.|+++.|+.+..
T Consensus 242 ----~~~~~~~~~~~~~~~-~-------~~--~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 242 ----VEELFKLLKEGHRMD-K-------PA--NCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred ----HHHHHHHHHcCCCCC-C-------CC--CCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 222222222211110 0 11 111234455668999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=312.99 Aligned_cols=198 Identities=23% Similarity=0.336 Sum_probs=161.3
Q ss_pred cCeEeecCcEEEEEEEEc---CCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEE--CcEEEEEEeecC
Q 012462 146 ENVLGEGGYGVVYRGNLI---NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE--GIHRMLVYEYVN 220 (463)
Q Consensus 146 ~~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~~~ 220 (463)
.++||+|+||+||+|... ++..||+|.+.... ....+.+|+.++++++||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 358999999999999754 45789999885432 23456779999999999999999999864 456789999995
Q ss_pred CCCHHHHHhhhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeE----cCCCCEEEeecccc
Q 012462 221 NGNLEQWLHGAMR-----HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILI----DDDFNAKVSDFGLA 291 (463)
Q Consensus 221 ~g~L~~~l~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill----~~~~~~kl~Dfg~a 291 (463)
++|.+++..... ....+++..+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 589888753211 123588999999999999999999999 99999999999999 45678999999999
Q ss_pred eecCCCCc--eeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 292 KLLGAGKS--HVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 292 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
+....... .......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 87654321 12234578999999999876 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=301.79 Aligned_cols=248 Identities=28% Similarity=0.439 Sum_probs=195.1
Q ss_pred CeEeecCcEEEEEEEEcC--C--CeEEEEEEcccch-hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCC
Q 012462 147 NVLGEGGYGVVYRGNLIN--G--SPVAVKKILNNVG-QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNN 221 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 221 (463)
++||+|++|.||+|.+.+ + ..||+|.+..... ...+.+..|+..+++++||||+++++++.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999996643 2 2689999866555 556788899999999999999999999988 888999999999
Q ss_pred CCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCce-
Q 012462 222 GNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSH- 300 (463)
Q Consensus 222 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~- 300 (463)
++|.+++..... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++.........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999865321 4689999999999999999999999 9999999999999999999999999999876442211
Q ss_pred -eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCC
Q 012462 301 -VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378 (463)
Q Consensus 301 -~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (463)
......++..|+|||.+.+..++.++|||||||++|||++ |..||...... +.......... .. .
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~~~~~~~--~~-----~ 221 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS------QILKKIDKEGE--RL-----E 221 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHhcCC--cC-----C
Confidence 1122356788999999999899999999999999999998 99999654322 11111111110 00 0
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 012462 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415 (463)
Q Consensus 379 ~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~ 415 (463)
... .....+..++.+||+.+|++||++.++++.|.
T Consensus 222 ~~~--~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 RPE--ACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCc--cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 001 11223445566899999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=303.61 Aligned_cols=250 Identities=24% Similarity=0.330 Sum_probs=195.1
Q ss_pred CCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCC
Q 012462 143 FSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNN 221 (463)
Q Consensus 143 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 221 (463)
|++.+.||+|+||.||+|... ++..+++|.+..........+.+|+++++.++||||+++++++......++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 567788999999999999664 4678888888655555567788899999999999999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCcee
Q 012462 222 GNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV 301 (463)
Q Consensus 222 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 301 (463)
++|..++.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....... ..
T Consensus 87 ~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~ 159 (282)
T cd06643 87 GAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 159 (282)
T ss_pred CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-cc
Confidence 999988753 234689999999999999999999999 99999999999999999999999999987653321 12
Q ss_pred eccccccCCCCchhhhc-----cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCC
Q 012462 302 TTRVMGTFGYVAPEYAN-----TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376 (463)
Q Consensus 302 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (463)
.....++..|+|||++. +..++.++|||||||++|||++|+.||....+. ............ ..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~~~~-~~---- 228 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSEPP-TL---- 228 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH------HHHHHHhhcCCC-CC----
Confidence 23356889999999873 456788999999999999999999999753321 111111111110 01
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
..... ....+..++.+||+.||.+||++.+++++
T Consensus 229 -~~~~~--~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 229 -AQPSR--WSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred -CCccc--cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111 11233445668999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=303.92 Aligned_cols=255 Identities=27% Similarity=0.413 Sum_probs=199.2
Q ss_pred CCCccCeEeecCcEEEEEEEEcC--CCeEEEEEEcccc----------hhhHHHHHHHHHHHcC-CCCCCcceEeeEEEE
Q 012462 142 RFSKENVLGEGGYGVVYRGNLIN--GSPVAVKKILNNV----------GQAEKEFRVEVEAIGH-VRHKNLVRLLGYCIE 208 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~ 208 (463)
.|++.+.||+|+||.||+|.... +..+|+|.+.... .....++..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 37778899999999999997654 6789999874321 1223456678887765 799999999999999
Q ss_pred CcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEccCCCCceeEcCCCCEEEee
Q 012462 209 GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE-AIEPKVVHRDIKSSNILIDDDFNAKVSD 287 (463)
Q Consensus 209 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dikp~Nill~~~~~~kl~D 287 (463)
++..++||||+++++|.+++.........+++..++.++.|++.||.|||+ . +++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999986644455679999999999999999999996 5 899999999999999999999999
Q ss_pred cccceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCC
Q 012462 288 FGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR 367 (463)
Q Consensus 288 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 367 (463)
||++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||..... ...........
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~------~~~~~~~~~~~ 229 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM------LSLATKIVEAV 229 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH------HHHHHHHhhcc
Confidence 99998765432 23345688999999999988899999999999999999999999964321 11111111111
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 012462 368 RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416 (463)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~ 416 (463)
. ... ...... ..+..++.+||+.||++||++.|+..++++
T Consensus 230 ~-~~~-----~~~~~~---~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 230 Y-EPL-----PEGMYS---EDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred C-CcC-----CcccCC---HHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 1 100 000111 233445668999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=305.02 Aligned_cols=253 Identities=23% Similarity=0.320 Sum_probs=198.2
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
.++|++.++||+|+||.||+|... ++..+++|.+..........+..|+.+++.++||||+++++++..+...++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 367889999999999999999664 4789999998766555667788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+++++|..++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 91 ~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 91 CPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred CCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 999999888753 234589999999999999999999999 99999999999999999999999999987643221
Q ss_pred ceeeccccccCCCCchhhhc-----cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccc
Q 012462 299 SHVTTRVMGTFGYVAPEYAN-----TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (463)
.......+++.|+|||++. ...++.++|||||||++|||++|..||....+. ........... .
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~-~--- 233 (292)
T cd06644 165 -QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSEP-P--- 233 (292)
T ss_pred -cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHHHHHhcCCC-c---
Confidence 1123346788999999874 345788999999999999999999999653321 11111111111 0
Q ss_pred cCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
...... ........++.+||+.||++||++++++++
T Consensus 234 --~~~~~~--~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 234 --TLSQPS--KWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred --cCCCCc--ccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000011 111233445668999999999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=318.18 Aligned_cols=199 Identities=28% Similarity=0.336 Sum_probs=168.6
Q ss_pred HhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC------
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG------ 209 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 209 (463)
..++|++.+.||+|+||.||+|.. ..++.||+|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 357899999999999999999954 468899999985432 23345677899999999999999999988643
Q ss_pred cEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecc
Q 012462 210 IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFG 289 (463)
Q Consensus 210 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg 289 (463)
...++||||+++ +|.+++.. .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 356999999965 77776632 378899999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 290 LAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 290 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
+++...... ......+|..|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 165 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 165 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred ccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 998654321 2234578999999999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=304.22 Aligned_cols=250 Identities=25% Similarity=0.400 Sum_probs=191.6
Q ss_pred CeEeecCcEEEEEEEEcC-CC--eEEEEEEcccc-hhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEEEEEEeecCC
Q 012462 147 NVLGEGGYGVVYRGNLIN-GS--PVAVKKILNNV-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNN 221 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 221 (463)
+.||+|+||.||+|.+.+ +. .+++|.+.... ......+..|+.++.++ +||||++++++|......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999997644 33 46888775432 34456788899999999 899999999999999899999999999
Q ss_pred CCHHHHHhhhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecc
Q 012462 222 GNLEQWLHGAMR------------HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFG 289 (463)
Q Consensus 222 g~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg 289 (463)
|+|.+++..... ....+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999864321 123478999999999999999999998 99999999999999999999999999
Q ss_pred cceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCC
Q 012462 290 LAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRR 368 (463)
Q Consensus 290 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 368 (463)
++....... .......+..|+|||++....++.++|||||||++|||++ |..||..... .+..........
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~------~~~~~~~~~~~~ 229 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYEKLPQGYR 229 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH------HHHHHHHhCCCC
Confidence 986322111 1111223567999999988899999999999999999997 9999965332 111222211111
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 369 SEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.. ... .....+..++.+||+.||.+|||+.+++..|+.+
T Consensus 230 ~~--------~~~--~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 230 LE--------KPL--NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred CC--------CCC--cCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 10 000 1112344566689999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=311.70 Aligned_cols=201 Identities=27% Similarity=0.396 Sum_probs=169.8
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
++|++.+.||+|+||.||+|... ++..||+|.+.... ......+..|+.+++.++||||+++++++.+....++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56889999999999999999654 57899999885432 23345667899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+. ++|.+++... ...+++..+..++.||+.||.|||+. +|+|+||||+||+++.++.++|+|||++.......
T Consensus 86 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 97 5999888642 34588999999999999999999999 99999999999999999999999999997643322
Q ss_pred ceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 299 SHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
. ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 159 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~ 209 (301)
T cd07873 159 K-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST 209 (301)
T ss_pred C-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 1223456889999998865 457889999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=299.91 Aligned_cols=251 Identities=25% Similarity=0.358 Sum_probs=200.5
Q ss_pred CCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 142 RFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
+|+..+.||+|+||.||.++. .++..+++|.+.... ......+.+|+.++++++|+||+++++++.+....+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588899999999999999854 568899999875432 34456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+++++|.+++... ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 9999999998643 234689999999999999999999999 99999999999999999999999999998764433
Q ss_pred ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCC
Q 012462 299 SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (463)
. ......+++.|+|||.+.+..++.++||||||+++|||++|..||...... ........... ...
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~~~~~-~~~------ 221 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVKIVQGNY-TPV------ 221 (256)
T ss_pred c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHcCCC-CCC------
Confidence 2 233456899999999998888999999999999999999999999754321 11222221111 100
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 012462 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414 (463)
Q Consensus 379 ~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L 414 (463)
.... ......++.+||+.+|.+||+++++++++
T Consensus 222 ~~~~---~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 VSVY---SSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred cccc---CHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 0111 12334455689999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=318.79 Aligned_cols=198 Identities=29% Similarity=0.345 Sum_probs=168.3
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC------c
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG------I 210 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 210 (463)
.++|++.+.||+|+||.||+|.. ..++.||||++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 46899999999999999999954 467899999985432 23345677899999999999999999987543 3
Q ss_pred EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccc
Q 012462 211 HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGL 290 (463)
Q Consensus 211 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~ 290 (463)
..|+||||+++ +|.+++.. .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 57999999965 78777632 378899999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 291 AKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 291 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
++...... ......+|..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 173 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 173 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred ccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 98654322 2234578999999999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=302.86 Aligned_cols=253 Identities=24% Similarity=0.366 Sum_probs=188.1
Q ss_pred eEeecCcEEEEEEEEcC---CCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCCCC
Q 012462 148 VLGEGGYGVVYRGNLIN---GSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGN 223 (463)
Q Consensus 148 ~lG~G~~g~V~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 223 (463)
.||+|+||.||+|...+ +..+|+|.+.... ......+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999997543 3578999875543 2334578889999999999999999999999888999999999999
Q ss_pred HHHHHhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCcee-
Q 012462 224 LEQWLHGAMR-HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV- 301 (463)
Q Consensus 224 L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~- 301 (463)
|.+++..... .....++..++.++.|++.||+|||+. +++|+||||+||+++.+++++|+|||++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 9999975432 123467788889999999999999999 99999999999999999999999999987543322211
Q ss_pred eccccccCCCCchhhhccC-------CCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccc
Q 012462 302 TTRVMGTFGYVAPEYANTG-------LLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373 (463)
Q Consensus 302 ~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (463)
.....++..|+|||++.+. .++.++||||||+++|||++ |..||........ ....... ......
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~-~~~~~~ 231 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV------LTYTVRE-QQLKLP 231 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH------HHHHhhc-ccCCCC
Confidence 2234578889999998642 35789999999999999996 9999975432211 1111111 111111
Q ss_pred cCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 012462 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415 (463)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~ 415 (463)
.+.... ...... ..++.+|| .+|++|||++||+..|+
T Consensus 232 ~~~~~~-~~~~~~---~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 232 KPRLKL-PLSDRW---YEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCccCC-CCChHH---HHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 121111 112222 23445698 58999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=302.83 Aligned_cols=249 Identities=26% Similarity=0.440 Sum_probs=194.8
Q ss_pred CCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccch---------hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcE
Q 012462 142 RFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVG---------QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIH 211 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 211 (463)
+|.+...||+|+||.||+|.. .+++.+|+|.+..... ...+.+..|+.++++++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 477788999999999999955 4678999998854321 122467789999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccc
Q 012462 212 RMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA 291 (463)
Q Consensus 212 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a 291 (463)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999853 34588999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCce-----eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcC
Q 012462 292 KLLGAGKSH-----VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGS 366 (463)
Q Consensus 292 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 366 (463)
+........ ......++..|+|||.+.+..++.++|||||||++|+|++|+.||....... .+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~- 226 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ------AIFKIGE- 226 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH------HHHHHhc-
Confidence 876422111 1123457889999999998889999999999999999999999997543211 1111111
Q ss_pred CCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 367 RRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.. .+. .... ....+..++.+||+.||.+||++.|++++
T Consensus 227 ~~-----~~~--~~~~--~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 227 NA-----SPE--IPSN--ISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred cC-----CCc--CCcc--cCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 00 001 1111 11233344568999999999999999873
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=305.96 Aligned_cols=253 Identities=24% Similarity=0.414 Sum_probs=194.6
Q ss_pred HhcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccchhhHHHHHHHHHHHcCC-CCCCcceEeeEEEEC------c
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEG------I 210 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~------~ 210 (463)
+.++|++.+.||+|+||.||+|... +++.||+|.+.... .....+..|+.++.++ +|+||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4567888899999999999999654 57889999875432 3446778899999988 799999999998753 4
Q ss_pred EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccc
Q 012462 211 HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGL 290 (463)
Q Consensus 211 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~ 290 (463)
..|+||||+.+++|.+++... ....+++..+..++.|++.||+|||+. +|+|+||||+||++++++.++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCC
Confidence 679999999999999998642 234689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeccccccCCCCchhhhc-----cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhc
Q 012462 291 AKLLGAGKSHVTTRVMGTFGYVAPEYAN-----TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVG 365 (463)
Q Consensus 291 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 365 (463)
+....... .......|+..|+|||++. +..++.++|||||||++|||++|..||....+.. ... ....
T Consensus 158 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-----~~~-~~~~ 230 (272)
T cd06637 158 SAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-----ALF-LIPR 230 (272)
T ss_pred ceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-----HHH-HHhc
Confidence 98654322 1223456889999999986 3467889999999999999999999996433211 111 1111
Q ss_pred CCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 366 SRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
. .. .......... .+..++.+||..||.+|||+.+++++
T Consensus 231 ~-~~-----~~~~~~~~~~---~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 231 N-PA-----PRLKSKKWSK---KFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred C-CC-----CCCCCCCcCH---HHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 1 00 0010111112 33445668999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=301.54 Aligned_cols=262 Identities=25% Similarity=0.341 Sum_probs=201.1
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC--cEEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG--IHRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 216 (463)
++|+..+.||.|++|.||++.. .+++.+|+|.+.... ......+.+|++++++++||||++++++|.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 3678889999999999999966 457889999885433 23456788899999999999999999998653 4689999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+++++|.+++.........+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999998865444556689999999999999999999999 999999999999999999999999999875432
Q ss_pred CCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (463)
.. .....++..|+|||.+.+..++.++|||||||++|+|++|..||...... .....+......... ...+.+.
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~- 231 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP-PLGPIELLSYIVNMP-NPELKDE- 231 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC-CCChHHHHHHHhcCC-chhhccC-
Confidence 21 12345788999999999999999999999999999999999999865321 112222222222111 1111111
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
... .......+..++.+||+.+|++|||+.|++++
T Consensus 232 ~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 232 PGN--GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred CCC--CCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 000 01112234456668999999999999999874
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=302.81 Aligned_cols=262 Identities=24% Similarity=0.342 Sum_probs=197.2
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+..|+.++++++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999765 58899999885432 2233567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
|++++.|..++. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEK----NPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999988887763 334589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCC---------
Q 012462 298 KSHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR--------- 367 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--------- 367 (463)
.. ......++..|+|||.+.+ ..++.++||||||+++|||++|..||......+.. .. +.......
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~ 229 (286)
T cd07847 154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQL--YL-IRKTLGDLIPRHQQIFS 229 (286)
T ss_pred cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHH--HH-HHHHhCCCChHHhhhcc
Confidence 21 1223457889999999876 56789999999999999999999999765432211 11 11100000
Q ss_pred ---CccccccCCCCCCCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 368 ---RSEEVVDPNIEVRPST-----RALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 368 ---~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.......+........ ........++.+||+.+|++||++.|++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000000110000000 012334556678999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=304.54 Aligned_cols=256 Identities=28% Similarity=0.470 Sum_probs=199.9
Q ss_pred hcCCCccCeEeecCcEEEEEEEEcC-CC----eEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLIN-GS----PVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRM 213 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 213 (463)
..+|++.+.||+|+||+||+|.+.. |. .+|+|.+.... ......+.+|+.++++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 4568889999999999999996533 33 58899875543 3344678889999999999999999999987 6789
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
+||||+++|+|.+++.. ....+++..++.++.||+.||+|||+. +++|+||||+||+++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 85 LITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence 99999999999999864 234589999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCceee-ccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccc
Q 012462 294 LGAGKSHVT-TRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEE 371 (463)
Q Consensus 294 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (463)
......... ....++..|+|||.+....++.++|+||||+++||+++ |..||...... ++...........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~~~~~- 231 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV------EIPDLLEKGERLP- 231 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH------HHHHHHhCCCCCC-
Confidence 653322111 11223568999999988889999999999999999998 99999764321 1222222111110
Q ss_pred cccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCC
Q 012462 372 VVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEE 418 (463)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~ 418 (463)
. ... .......++.+||..||.+||++.++++.|.+..
T Consensus 232 --~-----~~~--~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 232 --Q-----PPI--CTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred --C-----CCC--CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0 110 1123445566899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=306.84 Aligned_cols=202 Identities=28% Similarity=0.434 Sum_probs=170.1
Q ss_pred CCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 142 RFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
+|++.+.||+|+||.||+|... ++..||+|++.... ......+..|+.++.+++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999664 68899999885432 22345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+. ++|.+++.... ....+++..++.++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 58988886432 235689999999999999999999999 99999999999999999999999999997654322
Q ss_pred ceeeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 299 SHVTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
.......+++.|+|||++.+. .++.++|||||||++|+|+||+.||....
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~ 206 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDS 206 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 112233568899999988654 57899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=301.44 Aligned_cols=256 Identities=28% Similarity=0.419 Sum_probs=196.2
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEE
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 215 (463)
+.+++.+.....||+|+||.||+|.. .++..|++|.+........+.+.+|+.++++++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 44455566667899999999999965 45678999988766555667888999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC-CCCEEEeecccce
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYL--TWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD-DFNAKVSDFGLAK 292 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~-~~~~kl~Dfg~a~ 292 (463)
+||+++++|.+++... ...+ ++..+..++.||+.||+|||+. +|+|+||||+||+++. ++.++|+|||++.
T Consensus 84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 84 MEQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 9999999999998642 1234 7888899999999999999999 9999999999999976 6799999999987
Q ss_pred ecCCCCceeeccccccCCCCchhhhccCC--CCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 293 LLGAGKSHVTTRVMGTFGYVAPEYANTGL--LNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
....... ......++..|+|||.+.+.. ++.++||||||+++|+|++|+.||......... .+...... .
T Consensus 158 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~~~~~~--~-- 229 (268)
T cd06624 158 RLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFKVGMFK--I-- 229 (268)
T ss_pred ecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hhhhhhhc--c--
Confidence 6543221 122345789999999986643 788999999999999999999999653221110 00000000 0
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.+ ..... ....+..++.+||+.+|.+|||+.|++++
T Consensus 230 ---~~--~~~~~--~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 230 ---HP--EIPES--LSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ---CC--CCCcc--cCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00 01111 11223445668999999999999999874
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=306.50 Aligned_cols=253 Identities=24% Similarity=0.350 Sum_probs=199.0
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
.++|++.+.||.|+||.||+|.. .++..+|+|.+..........+..|++++++++||||+++++++.++...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 35688899999999999999965 46789999998665555567788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+++++|.+++... ...+++..++.++.|++.||.|||+. +|+|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 84 CDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred cCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 9999999998642 34589999999999999999999999 99999999999999999999999999987643322
Q ss_pred ceeeccccccCCCCchhhhc-----cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccc
Q 012462 299 SHVTTRVMGTFGYVAPEYAN-----TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (463)
. ......++..|+|||.+. ...++.++||||||+++|||++|+.||...... ..+........
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~----- 225 (280)
T cd06611 158 Q-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVLLKILKSEP----- 225 (280)
T ss_pred c-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHHHHHhcCCC-----
Confidence 1 123346889999999875 345778999999999999999999999754321 11111111111
Q ss_pred cCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
+.+..... .......++.+||+.+|.+||++.+++++
T Consensus 226 -~~~~~~~~--~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 -PTLDQPSK--WSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -CCcCCccc--CCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 00111111 11123345568999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=299.09 Aligned_cols=250 Identities=22% Similarity=0.310 Sum_probs=196.9
Q ss_pred CCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEE-CcEEEEEEe
Q 012462 142 RFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE-GIHRMLVYE 217 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e 217 (463)
+|++.+.||+|++|.||++.. .+++.||+|++.... ....+.+..|++++++++|+|++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 478899999999999999965 457889999985432 2344567889999999999999999998764 446789999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
|+++++|.+++... ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 99999999998652 234689999999999999999999999 9999999999999999999999999999876432
Q ss_pred CceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCC
Q 012462 298 KSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNI 377 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (463)
. .......+++.|+|||++.+..++.++||||||+++|+|++|+.||..... ........... ....
T Consensus 156 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~~~~~~-~~~~----- 222 (257)
T cd08223 156 C-DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYRIIEGK-LPPM----- 222 (257)
T ss_pred C-CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHhcC-CCCC-----
Confidence 2 223345688999999999999999999999999999999999999974321 12222222111 1000
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 378 EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.. ........++.+||+.||++||++.+++++
T Consensus 223 --~~--~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 223 --PK--DYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred --cc--ccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11 111234455668999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=320.80 Aligned_cols=245 Identities=26% Similarity=0.402 Sum_probs=196.6
Q ss_pred CCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccch---hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 142 RFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVG---QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
.|+-++.||.|+||.||.|++ .+.+.||||++.-... +.-.++..|+..|.+++|||++.+.|+|......|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 466788999999999999954 5678999999854332 334578889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
||- |+-.|++.- ..+++.+..+..|+.+.+.||+|||++ +.||||||+.|||+++.|.|||+|||.+....+
T Consensus 107 YCl-GSAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P- 178 (948)
T KOG0577|consen 107 YCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP- 178 (948)
T ss_pred HHh-ccHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc-
Confidence 995 588888864 345799999999999999999999999 999999999999999999999999999876543
Q ss_pred CceeeccccccCCCCchhhh---ccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccccc
Q 012462 298 KSHVTTRVMGTFGYVAPEYA---NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVD 374 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (463)
...++|||.|||||++ ..+.|+-++||||||++..||.-.++|+...+. ...+..+..+..
T Consensus 179 ----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA------MSALYHIAQNes------ 242 (948)
T KOG0577|consen 179 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNES------ 242 (948)
T ss_pred ----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH------HHHHHHHHhcCC------
Confidence 4568999999999987 457899999999999999999999999875432 222222222211
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 375 PNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
|.+....-...+..++. .||++=|.+|||.++++++
T Consensus 243 PtLqs~eWS~~F~~Fvd---~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 243 PTLQSNEWSDYFRNFVD---SCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCCCchhHHHHHHHHH---HHHhhCcccCCcHHHHhhc
Confidence 12221222233333333 5999999999999999875
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=302.43 Aligned_cols=261 Identities=26% Similarity=0.406 Sum_probs=201.6
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-----CCCeEEEEEEcccchh-hHHHHHHHHHHHcCCCCCCcceEeeEEEE--CcEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-----NGSPVAVKKILNNVGQ-AEKEFRVEVEAIGHVRHKNLVRLLGYCIE--GIHR 212 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 212 (463)
..|++.+.||+|+||.||+|.+. .+..+|+|.+...... ....+..|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777889999999999999653 3678999998654432 46788999999999999999999999887 5578
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccce
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~ 292 (463)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 9999999999999999642 23589999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCce--eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCccc---------ccHHHHHH
Q 012462 293 LLGAGKSH--VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHE---------VNLVDWLK 361 (463)
Q Consensus 293 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~---------~~~~~~~~ 361 (463)
........ ......++..|+|||.+.+..++.++||||||+++|||++|..|+........ .....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 76532211 11122345679999999888999999999999999999999999865322110 00111111
Q ss_pred HHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 362 MMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
........ .........+..++.+||+.+|++|||+.||+++|+.+
T Consensus 238 ~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEGERL----------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcCCcC----------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111110 00111123455667789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=301.43 Aligned_cols=250 Identities=28% Similarity=0.416 Sum_probs=195.9
Q ss_pred CCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccc------hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEE
Q 012462 142 RFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNV------GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 215 (463)
+|++.+.||+|+||.||+|...+++.+|+|.+.... ......+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477888999999999999987788999999885332 12234678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 999999999999853 34588999999999999999999999 99999999999999999999999999987643
Q ss_pred CCC-----ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 296 AGK-----SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 296 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
... ........++..|+|||++.+..++.++|||||||++|+|++|..||....... .............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~ 228 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-----AMFYIGAHRGLMP 228 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-----HHHHhhhccCCCC
Confidence 211 111223468889999999999889999999999999999999999997533211 1111111001111
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 012462 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412 (463)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~ 412 (463)
. .... ....+..++.+||+.+|++||++.|+++
T Consensus 229 ~-------~~~~--~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 229 R-------LPDS--FSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred C-------CCCC--CCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1 1111 1122344566899999999999999986
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=303.95 Aligned_cols=249 Identities=24% Similarity=0.379 Sum_probs=198.9
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
++|++.+.||.|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888899999999999999654 67899999885443 33445678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+++++|.+++... .+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 9999999998532 689999999999999999999999 99999999999999999999999999998775432
Q ss_pred ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCC
Q 012462 299 SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (463)
.......++..|+|||.+.+..++.++||||||+++|+|++|..||....+. ......... ... .+.
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~------~~~~~~~~~-~~~-----~~~ 219 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM------RVLFLIPKN-NPP-----SLE 219 (274)
T ss_pred -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH------HHHHHhhhc-CCC-----CCc
Confidence 1223456788999999999988999999999999999999999999754321 111111111 111 111
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 379 ~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
... ....+..++.+||..+|++||++++++++
T Consensus 220 ~~~---~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 220 GNK---FSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ccc---cCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 110 11223445568999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=296.09 Aligned_cols=251 Identities=31% Similarity=0.486 Sum_probs=197.4
Q ss_pred CCccCeEeecCcEEEEEEEEcC-----CCeEEEEEEcccchh-hHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 143 FSKENVLGEGGYGVVYRGNLIN-----GSPVAVKKILNNVGQ-AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 143 ~~~~~~lG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
|++.+.||.|+||.||++...+ +..||+|.+...... ....+..|+.++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999996643 378999998654433 5678889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+++++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 9999999999986422 11289999999999999999999999 999999999999999999999999999987654
Q ss_pred CCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
..........++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ............. ..
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~------~~~~~~~~~~~~~-~~--- 225 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN------EEVLEYLKKGYRL-PK--- 225 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHhcCCCC-CC---
Confidence 43222222336789999999988889999999999999999998 7888865221 1222222211111 00
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 012462 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414 (463)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L 414 (463)
... ....+..++.+||+.||++|||+.|+++.|
T Consensus 226 ----~~~--~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 ----PEN--CPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----CCc--CCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 011 122344456689999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=309.50 Aligned_cols=253 Identities=23% Similarity=0.279 Sum_probs=198.0
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccchh---hHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQ---AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
++|++.+.||+|+||.||+|... ++..||+|.+...... ....+..|++++..++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999664 4899999998654322 3456888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+.+++|.+++.. .....+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 99999999999863 2345689999999999999999999999 999999999999999999999999999875432
Q ss_pred CCce----------------------------eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCC
Q 012462 297 GKSH----------------------------VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348 (463)
Q Consensus 297 ~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~ 348 (463)
.... ......|+..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 2110 111346788999999999988999999999999999999999999754
Q ss_pred CCcccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCC----HHHHHHH
Q 012462 349 RPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPK----MSQVVRM 413 (463)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs----~~ell~~ 413 (463)
.... . ....... .............+..++.+||+.||++||+ ++|++.+
T Consensus 236 ~~~~-----~-~~~~~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 236 NRDE-----T-FSNILKK---------EVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred chHH-----H-HHHHhcC---------CccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 3211 1 1111111 0111111112234445566899999999999 7776663
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=313.87 Aligned_cols=198 Identities=25% Similarity=0.384 Sum_probs=168.1
Q ss_pred HhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccch--hhHHHHHHHHHHHcCCCCCCcceEeeEEEEC------
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG------ 209 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 209 (463)
..++|++.+.||+|+||+||+|.. .++..||||++..... .....+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 457899999999999999999965 4678999999854322 2335577899999999999999999987643
Q ss_pred cEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecc
Q 012462 210 IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFG 289 (463)
Q Consensus 210 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg 289 (463)
...|++++++ +++|.+++. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCc
Confidence 3468999998 779988774 24589999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 290 LAKLLGAGKSHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 290 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 164 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 220 (343)
T cd07878 164 LARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND 220 (343)
T ss_pred cceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence 99875432 234568999999999876 578999999999999999999999997543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=298.68 Aligned_cols=253 Identities=22% Similarity=0.383 Sum_probs=186.2
Q ss_pred eEeecCcEEEEEEEEcCCC---eEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCCCC
Q 012462 148 VLGEGGYGVVYRGNLINGS---PVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGN 223 (463)
Q Consensus 148 ~lG~G~~g~V~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 223 (463)
.||+|+||+||+|...++. .+++|.+.... ....+.+.+|+.+++.++||||+++++.|.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 5899999999999654443 45566654332 3445688889999999999999999999999999999999999999
Q ss_pred HHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC-ceee
Q 012462 224 LEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK-SHVT 302 (463)
Q Consensus 224 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~-~~~~ 302 (463)
|.+++.........+++..++.++.||+.||+|||+. +++|+||||+|||++.++.++|+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999976433344567788889999999999999999 99999999999999999999999999986432211 1112
Q ss_pred ccccccCCCCchhhhcc-------CCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCcccccc
Q 012462 303 TRVMGTFGYVAPEYANT-------GLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVD 374 (463)
Q Consensus 303 ~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (463)
....++..|+|||++.. ..++.++|||||||++|||++ |..||..... .+.+....... .....+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~~~-~~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIKDQ-QVKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhhc-ccccCC
Confidence 34567889999998753 245779999999999999997 5667764332 11222222111 122222
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 012462 375 PNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415 (463)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~ 415 (463)
+.+... ....+ ..++..|| .+|++||++++|++.|.
T Consensus 232 ~~~~~~-~~~~~---~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLELP-YSERW---YEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccCCC-CcHHH---HHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 222211 12222 23444698 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=308.54 Aligned_cols=199 Identities=22% Similarity=0.256 Sum_probs=164.5
Q ss_pred ccCeEeec--CcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeec
Q 012462 145 KENVLGEG--GYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYV 219 (463)
Q Consensus 145 ~~~~lG~G--~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 219 (463)
++++||+| +|++||++.. .+|+.||+|++.... ......+..|+.+++.++||||++++++|.+++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7899999954 578999999985432 233456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCc
Q 012462 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299 (463)
Q Consensus 220 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 299 (463)
++|+|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999999998642 223589999999999999999999999 999999999999999999999999986543321110
Q ss_pred e------eeccccccCCCCchhhhcc--CCCCccchhhhHHHHHHHHHhCCCCCCCC
Q 012462 300 H------VTTRVMGTFGYVAPEYANT--GLLNEKSDVYSFGVLLLEAITGRDPVDHG 348 (463)
Q Consensus 300 ~------~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~pf~~~ 348 (463)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 0 0112346778999999876 46899999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=300.64 Aligned_cols=253 Identities=25% Similarity=0.379 Sum_probs=185.1
Q ss_pred eEeecCcEEEEEEEEcCC---CeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCCCC
Q 012462 148 VLGEGGYGVVYRGNLING---SPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGN 223 (463)
Q Consensus 148 ~lG~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 223 (463)
.||+|+||.||+|...++ ..+++|.+.... ......+.+|+..++.++||||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 589999999999965433 467888765433 2334567889999999999999999999999999999999999999
Q ss_pred HHHHHhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCce-e
Q 012462 224 LEQWLHGAMRH-HGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSH-V 301 (463)
Q Consensus 224 L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~ 301 (463)
|.+++...... ....++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++......... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999754321 23356788899999999999999999 9999999999999999999999999998754332211 1
Q ss_pred eccccccCCCCchhhhcc-------CCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccc
Q 012462 302 TTRVMGTFGYVAPEYANT-------GLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373 (463)
Q Consensus 302 ~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (463)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||....+. +.+........ ..+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~~~-~~~~ 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE------QVLKQVVREQD-IKLP 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHhhccC-ccCC
Confidence 123345778999998743 356789999999999999999 78888654321 11111121111 1111
Q ss_pred cCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 012462 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415 (463)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~ 415 (463)
.+.... ...... ..++..|| .||++|||+++|++.|.
T Consensus 232 ~~~~~~-~~~~~~---~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KPQLDL-KYSDRW---YEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCcccc-cCCHHH---HHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111111 111222 22344687 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=304.72 Aligned_cols=240 Identities=22% Similarity=0.368 Sum_probs=185.1
Q ss_pred CeEeecCcEEEEEEEEcC--------CCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 147 NVLGEGGYGVVYRGNLIN--------GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
+.||+|+||.||+|.... ...+++|.+........+.+..|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 368999999999996532 234888877554445556788899999999999999999999998899999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCC--------EEEeeccc
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFN--------AKVSDFGL 290 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~--------~kl~Dfg~ 290 (463)
+++|+|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+||+++.++. ++++|||+
T Consensus 81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999998642 23589999999999999999999999 9999999999999987765 69999998
Q ss_pred ceecCCCCceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCC-CCCCCCCCcccccHHHHHHHHhcCCC
Q 012462 291 AKLLGAGKSHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGR-DPVDHGRPAHEVNLVDWLKMMVGSRR 368 (463)
Q Consensus 291 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~ 368 (463)
+...... ....++..|+|||++.+ ..++.++|||||||++|||++|. .||....+. .........
T Consensus 155 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~------~~~~~~~~~-- 221 (258)
T cd05078 155 SITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ------KKLQFYEDR-- 221 (258)
T ss_pred ccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH------HHHHHHHcc--
Confidence 8654322 23457889999999876 45799999999999999999985 555432211 111111110
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 012462 369 SEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415 (463)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~ 415 (463)
. ..... ....+..++.+||+.||++|||++++++.|+
T Consensus 222 -~-------~~~~~--~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 -H-------QLPAP--KWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -c-------cCCCC--CcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 01111 1123445566899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=300.59 Aligned_cols=248 Identities=23% Similarity=0.387 Sum_probs=198.6
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
..|+..+.||+|+||.||+|... ++..||+|.+.... ......+..|+.++++++||||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35777889999999999999654 57899999875433 34456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+++++|.+++.. ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 84 LGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 999999998842 3588899999999999999999999 99999999999999999999999999997764332
Q ss_pred ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCC
Q 012462 299 SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (463)
. ......++..|+|||.+.+..++.++|+|||||++|||++|..||....+.... ...... .. +
T Consensus 156 ~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------~~~~~~-~~-----~--- 219 (277)
T cd06640 156 I-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL------FLIPKN-NP-----P--- 219 (277)
T ss_pred c-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh------hhhhcC-CC-----C---
Confidence 1 123345788899999999888999999999999999999999999754322111 111000 00 0
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 379 ~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.........+..++.+||+.+|++||++.+++++
T Consensus 220 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 -TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred -CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 0111223344556668999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=300.35 Aligned_cols=238 Identities=26% Similarity=0.421 Sum_probs=185.9
Q ss_pred CeEeecCcEEEEEEEEcCCC-----------eEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEE
Q 012462 147 NVLGEGGYGVVYRGNLINGS-----------PVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 215 (463)
+.||+|+||.||+|.+.+.. .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999765433 4777876443332 6778889999999999999999999988 778999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCC-------CEEEeec
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDF-------NAKVSDF 288 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~-------~~kl~Df 288 (463)
|||+++|+|.+++... ...+++..+..++.||+.||.|||+. +|+|+||||+|||++.++ .++|+||
T Consensus 79 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCC
Confidence 9999999999998642 22689999999999999999999999 999999999999999888 7999999
Q ss_pred ccceecCCCCceeeccccccCCCCchhhhccC--CCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhc
Q 012462 289 GLAKLLGAGKSHVTTRVMGTFGYVAPEYANTG--LLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVG 365 (463)
Q Consensus 289 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 365 (463)
|++..... .....++..|+|||.+.+. .++.++|||||||++|||++ |..||....... ...+ ...
T Consensus 153 g~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~~~---~~~ 221 (259)
T cd05037 153 GIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KERF---YQD 221 (259)
T ss_pred Cccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HHHH---Hhc
Confidence 99986543 1223467789999998876 78999999999999999999 577776543211 1111 110
Q ss_pred CCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 012462 366 SRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415 (463)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~ 415 (463)
.. .. . .+.. ..+..++.+||+.+|.+|||+.++++.|+
T Consensus 222 ~~---~~-----~-~~~~---~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 QH---RL-----P-MPDC---AELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CC---CC-----C-CCCc---hHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 00 0 1111 34455666899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=308.10 Aligned_cols=255 Identities=28% Similarity=0.496 Sum_probs=196.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCC----eEEEEEEcccch-hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGS----PVAVKKILNNVG-QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRM 213 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 213 (463)
.++|+..+.||+|+||.||+|.+. ++. .||+|.+..... ....++..|+.+++.++||||++++++|... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 356788899999999999999653 444 468887754432 3334688899999999999999999998764 467
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
+++||+++|+|.+++.. ....+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccc
Confidence 99999999999999864 233588999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCce-eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccc
Q 012462 294 LGAGKSH-VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEE 371 (463)
Q Consensus 294 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (463)
....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||....... ... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~---~~~~~~~~~- 231 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPD---LLEKGERLP- 231 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---HHHCCCCCC-
Confidence 6433221 1222345678999999999999999999999999999997 899997543211 111 111111110
Q ss_pred cccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 372 VVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
. ... .......++.+||..+|++||++.++++.|+.+
T Consensus 232 --~-----~~~--~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 232 --Q-----PPI--CTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred --C-----CCC--CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 000 112344556689999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=299.28 Aligned_cols=249 Identities=30% Similarity=0.441 Sum_probs=188.2
Q ss_pred CeEeecCcEEEEEEEEcC----CCeEEEEEEccc-chhhHHHHHHHHHHHcCCCCCCcceEeeEEE-ECcEEEEEEeecC
Q 012462 147 NVLGEGGYGVVYRGNLIN----GSPVAVKKILNN-VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI-EGIHRMLVYEYVN 220 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lV~e~~~ 220 (463)
+.||+|+||.||+|.+.+ ...||+|.+... .......+..|+.+++.++||||+++++++. .+...++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 368999999999996532 347899987442 2334567888999999999999999999876 3556789999999
Q ss_pred CCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCce
Q 012462 221 NGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSH 300 (463)
Q Consensus 221 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 300 (463)
+++|.+++... ...+.+..++.++.|++.||+|||+. +++|+||||+|||++.++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999998642 23467788899999999999999999 9999999999999999999999999999765332111
Q ss_pred ---eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhC-CCCCCCCCCcccccHHHHHHHHhcCCCccccccCC
Q 012462 301 ---VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITG-RDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376 (463)
Q Consensus 301 ---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (463)
......++..|+|||.+.+..++.++|||||||++|||++| ..||.... ................ +
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~------~~~~~~~~~~~~~~~~---~- 224 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD------SFDITVYLLQGRRLLQ---P- 224 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHhcCCCCCC---C-
Confidence 11223457789999999888999999999999999999995 55565322 1122222221111100 0
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
... ...+..++.+||+.+|++||++.++++.|++.
T Consensus 225 ---~~~---~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 225 ---EYC---PDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred ---CcC---CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 001 12344566689999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=299.48 Aligned_cols=250 Identities=24% Similarity=0.377 Sum_probs=191.8
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc-----hhhHHHHHHHHHHHcCCCCCCcceEeeEEEE--CcEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV-----GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE--GIHR 212 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 212 (463)
.+|+..+.||+|+||.||+|.. .++..|++|++.... ......+.+|+.++++++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4688899999999999999965 458899999874321 2233567889999999999999999999875 3567
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccce
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~ 292 (463)
++++||+++++|.+++.. ...+++...+.++.|++.||+|||+. +|+|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 899999999999999853 33588999999999999999999998 99999999999999999999999999987
Q ss_pred ecCCCCc--eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 293 LLGAGKS--HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 293 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
....... .......++..|+|||.+.+..++.++|||||||++|||++|+.||...... ...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~------~~~~~~~~~~~-- 226 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM------AAIFKIATQPT-- 226 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH------HHHHHHhcCCC--
Confidence 6532111 1112345788999999999988999999999999999999999999753211 11111111110
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.+ ..... ....+..+++||..+|++||+++|++++
T Consensus 227 ---~~--~~~~~---~~~~~~~li~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 227 ---NP--QLPSH---ISEHARDFLGCIFVEARHRPSAEELLRH 261 (266)
T ss_pred ---CC--CCchh---cCHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 11 11111 1112222336889999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=303.58 Aligned_cols=254 Identities=23% Similarity=0.383 Sum_probs=195.8
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
++|++.+.||+|+||.||++... ++..||+|.+.... ......+.+|+.++.+++||||+++++.+......++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36888899999999999999664 68999999885432 23346788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+++++|..++... .....+++..+..++.|++.||.|||+.. +|+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 9999999988642 12346899999999999999999999632 89999999999999999999999999987653221
Q ss_pred ceeeccccccCCCCchhhhccC------CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccc
Q 012462 299 SHVTTRVMGTFGYVAPEYANTG------LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV 372 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (463)
.....++..|+|||.+.+. .++.++|+|||||++|+|++|..||....... ....+...... ....
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~-~~~~- 229 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQLSAIVDG-DPPT- 229 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHHHHHhhc-CCCC-
Confidence 2234578899999998554 35789999999999999999999997543211 11111111111 1010
Q ss_pred ccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 373 VDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.... .......++.+||+.+|++||++.+++.+
T Consensus 230 ------~~~~--~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 230 ------LPSG--YSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ------CCcc--cCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1111 12233345568999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=327.02 Aligned_cols=204 Identities=19% Similarity=0.273 Sum_probs=162.7
Q ss_pred HhcCCCccCeEeecCcEEEEEEEEcC--CCeEEEEEE-----------------cccchhhHHHHHHHHHHHcCCCCCCc
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNLIN--GSPVAVKKI-----------------LNNVGQAEKEFRVEVEAIGHVRHKNL 199 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~~~--~~~vavK~~-----------------~~~~~~~~~~~~~e~~~l~~l~h~ni 199 (463)
..++|++.+.||+|+||+||++.... +..++.|.+ ..........+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45789999999999999999985432 222222211 01112234567889999999999999
Q ss_pred ceEeeEEEECcEEEEEEeecCCCCHHHHHhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEc
Q 012462 200 VRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMR-HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILID 278 (463)
Q Consensus 200 v~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~ 278 (463)
+++++++.+.+..|+|++++. ++|.+++..... .........+..++.||+.||.|||++ +|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 999999999999999999995 588887754221 122344667788999999999999999 999999999999999
Q ss_pred CCCCEEEeecccceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCC
Q 012462 279 DDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVD 346 (463)
Q Consensus 279 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~ 346 (463)
.++.+||+|||+++.+...........+||..|+|||++.+..++.++|||||||+||||++|..++.
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~ 369 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPI 369 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCc
Confidence 99999999999998775543333445679999999999999999999999999999999999886543
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=301.49 Aligned_cols=250 Identities=28% Similarity=0.466 Sum_probs=193.1
Q ss_pred eEeecCcEEEEEEEEcC-------CCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeec
Q 012462 148 VLGEGGYGVVYRGNLIN-------GSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYV 219 (463)
Q Consensus 148 ~lG~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 219 (463)
.||+|+||.||+|...+ +..+++|.+.... ......+.+|+.+++.++||||+++++++......++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 68999999999996542 2578999875433 234567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCC-----CEEEeecccc
Q 012462 220 NNGNLEQWLHGAMR---HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDF-----NAKVSDFGLA 291 (463)
Q Consensus 220 ~~g~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~-----~~kl~Dfg~a 291 (463)
++++|.+++..... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++ .++|+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 99999999975322 224478999999999999999999999 999999999999999877 8999999999
Q ss_pred eecCCCCc-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCc
Q 012462 292 KLLGAGKS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369 (463)
Q Consensus 292 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 369 (463)
........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||...... ............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~------~~~~~~~~~~~~ 232 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ------EVLQHVTAGGRL 232 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH------HHHHHHhcCCcc
Confidence 76543221 11122345678999999999999999999999999999998 99999743321 111111111100
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 012462 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416 (463)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~ 416 (463)
..... ....+..++.+||+.+|.+||++.++++.|++
T Consensus 233 --------~~~~~--~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 233 --------QKPEN--CPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred --------CCccc--chHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 01111 12234456668999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=298.15 Aligned_cols=252 Identities=26% Similarity=0.405 Sum_probs=199.5
Q ss_pred CCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEE--CcEEEEEE
Q 012462 142 RFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE--GIHRMLVY 216 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lV~ 216 (463)
+|++.+.||.|+||.||+|.. .++..||+|.+.... ....+.+..|+.++++++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477889999999999999954 567889999885432 3344568889999999999999999998764 45678999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCeEEccCCCCceeEcCCCCEEEeecccc
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH-----EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA 291 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH-----~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a 291 (463)
||+++++|.+++.........+++..++.++.||+.||.||| +. +++|+||+|+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999765555667999999999999999999999 66 9999999999999999999999999999
Q ss_pred eecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccc
Q 012462 292 KLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEE 371 (463)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (463)
........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ....... .......
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~-~~~~~~~ 229 (265)
T cd08217 158 KILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ------LQLASKI-KEGKFRR 229 (265)
T ss_pred ccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH------HHHHHHH-hcCCCCC
Confidence 87654332 12335689999999999988899999999999999999999999975431 1111111 1111111
Q ss_pred cccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 372 VVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
+ .. .....+..++.+||+.+|++||++++|+++
T Consensus 230 ~-------~~--~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 230 I-------PY--RYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred C-------cc--ccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0 11 112234455668999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=303.92 Aligned_cols=247 Identities=25% Similarity=0.405 Sum_probs=195.7
Q ss_pred CCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeec
Q 012462 142 RFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYV 219 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 219 (463)
.|+..+.||+|+||.||+|.. .++..||+|.+.... ....+.+..|+.++++++||||+++++++..+...++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 356667899999999999965 457789999875432 334467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCc
Q 012462 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299 (463)
Q Consensus 220 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 299 (463)
++++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999998842 4588999999999999999999999 999999999999999999999999999976543221
Q ss_pred eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCC
Q 012462 300 HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEV 379 (463)
Q Consensus 300 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (463)
......++..|+|||.+.+..++.++|||||||++|||++|..||....+... ..... ... .+..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~~~~-~~~-----~~~~-- 221 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV------LFLIP-KNS-----PPTL-- 221 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH------Hhhhh-cCC-----CCCC--
Confidence 12234578899999999998999999999999999999999999975432211 11111 110 0111
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 380 RPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 380 ~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
. ......+..++.+||+.+|++||++.+++++
T Consensus 222 ~--~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 E--GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred C--cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1 1112234455668999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=298.05 Aligned_cols=247 Identities=31% Similarity=0.493 Sum_probs=195.4
Q ss_pred cCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecC
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVN 220 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 220 (463)
++|++.+.||+|+||.||++.. .+..||+|.+.... ....+.+|+.++.+++||||+++++++... ..++||||+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4588899999999999999965 67889999885432 345788899999999999999999998765 4799999999
Q ss_pred CCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCce
Q 012462 221 NGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSH 300 (463)
Q Consensus 221 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 300 (463)
+++|.+++... ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 82 ~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 82 KGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred CCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 99999998653 234588999999999999999999998 9999999999999999999999999998764322
Q ss_pred eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCC
Q 012462 301 VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEV 379 (463)
Q Consensus 301 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (463)
......+..|+|||.+.+..++.++|+|||||++|||++ |+.||..... ............. ..
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~~~~~~~~~-~~------- 218 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL------KEVKECVEKGYRM-EP------- 218 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH------HHHHHHHhCCCCC-CC-------
Confidence 112234567999999998899999999999999999998 9999975432 1222222211111 00
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 012462 380 RPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416 (463)
Q Consensus 380 ~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~ 416 (463)
.. .....+..++.+||+.+|++||+++++++.|+.
T Consensus 219 ~~--~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 PE--GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CC--cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 01 111233455668999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=325.49 Aligned_cols=251 Identities=27% Similarity=0.448 Sum_probs=205.5
Q ss_pred CccCeEeecCcEEEEEEEE-cCC----CeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 144 SKENVLGEGGYGVVYRGNL-ING----SPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 144 ~~~~~lG~G~~g~V~~~~~-~~~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
..+++||+|+||+||+|.+ ..| -+||+|++.... .+...++..|+..|.+|+|||+++++++|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3467899999999999955 334 378999885543 445678899999999999999999999998765 789999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
|++.|+|.+|++. .+..+.....+.|+.||++||.|||.+ +++||||..+||||....++||.|||+++.....
T Consensus 778 ~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 778 LMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred hcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 9999999999985 445688999999999999999999999 9999999999999999999999999999987655
Q ss_pred Cc-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 298 KS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 298 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
.. .......-.+.|||-|.+....|+.++|||||||++||++| |..||.+....+..++. ..
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll----------------e~ 915 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL----------------EK 915 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH----------------hc
Confidence 43 22333345788999999999999999999999999999998 99999865433222221 11
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
...+....-...++..++.+||-.|+..||+|+++...+.+.
T Consensus 916 geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 916 GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 112333344566778888899999999999999999887664
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=297.46 Aligned_cols=250 Identities=22% Similarity=0.365 Sum_probs=198.8
Q ss_pred CCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEccc--chhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 142 RFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNN--VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
+|++.+.||+|+||.||++.. .+|+.||+|.+... ......++.+|+.++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 588899999999999999954 46789999988543 233446788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+.+++|.+++... ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999999988642 233578999999999999999999999 99999999999999999999999999998654322
Q ss_pred ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCC
Q 012462 299 SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (463)
. ......+++.|+|||++.+..++.++|+|||||++|+|++|+.||..... .+........... .
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~~~~~-~------- 220 (256)
T cd08218 156 E-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKIIRGSYP-P------- 220 (256)
T ss_pred h-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHHhcCCCC-C-------
Confidence 1 12234578899999999998999999999999999999999999975322 1222222221110 0
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 379 ~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
... .....+..++.+||+.+|.+||++.+++++
T Consensus 221 ~~~--~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 VSS--HYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred Ccc--cCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 001 112234445668999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=296.85 Aligned_cols=248 Identities=27% Similarity=0.380 Sum_probs=196.3
Q ss_pred CCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc-----hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEE
Q 012462 142 RFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV-----GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 215 (463)
+|+..+.||+|+||.||+|... ++..|++|.+.... ....+.+..|+.+++.++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777889999999999999665 78999999875432 23446788899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
+||+++++|.+++.. ...+++..++.++.||+.||.|||+. +++|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999853 34588999999999999999999999 99999999999999999999999999988754
Q ss_pred CCCceeeccccccCCCCchhhhccCC-CCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccccc
Q 012462 296 AGKSHVTTRVMGTFGYVAPEYANTGL-LNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVD 374 (463)
Q Consensus 296 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (463)
... ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||...... ..............
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~--- 222 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV------AAVFKIGRSKELPP--- 222 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH------HHHHHHHhcccCCC---
Confidence 332 223456889999999987766 899999999999999999999999754311 11111111011111
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 375 PNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
..... ...+..++.+||+.+|.+||++.+++++
T Consensus 223 ----~~~~~--~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 223 ----IPDHL--SDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ----cCCCc--CHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 11111 1223344568999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=307.87 Aligned_cols=255 Identities=22% Similarity=0.332 Sum_probs=197.8
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcc--cchhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEEE
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILN--NVGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHRM 213 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 213 (463)
.+....|+++++||+||.+.||++...+.+.+|+|++.. .+.+...-+.+|+.+|.+| .|.+||++++|-..++.+|
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 345677999999999999999999877778889888743 3345567899999999999 5999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
+||||-+ .+|..+|.... ..++.-.+..+..|++.|+.++|.+ ||||.||||.|+|+- .|.+||+|||.|..
T Consensus 437 mvmE~Gd-~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~a 508 (677)
T KOG0596|consen 437 MVMECGD-IDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANA 508 (677)
T ss_pred EEeeccc-ccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcc
Confidence 9999875 49999997532 2233237888999999999999999 999999999999886 46999999999998
Q ss_pred cCCCCcee-eccccccCCCCchhhhccCC-----------CCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHH
Q 012462 294 LGAGKSHV-TTRVMGTFGYVAPEYANTGL-----------LNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLK 361 (463)
Q Consensus 294 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~-----------~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 361 (463)
+....... ....+||+.||+||.+.... .+.+|||||||||||+|+.|+.||..- .+.+.-+.
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~-----~n~~aKl~ 583 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI-----INQIAKLH 583 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH-----HHHHHHHH
Confidence 76654332 34568999999999885432 457899999999999999999999731 12222222
Q ss_pred HHhcCCCccccccCCCCCC-CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 362 MMVGSRRSEEVVDPNIEVR-PSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.+.++.-++. +.......++.+|..||++||.+||+..|||++
T Consensus 584 ---------aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 584 ---------AITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ---------hhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 2233322111 111111225666778999999999999999975
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=298.23 Aligned_cols=249 Identities=27% Similarity=0.383 Sum_probs=202.4
Q ss_pred CCccCeEeecCcEEEEEE-EEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCC
Q 012462 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNN 221 (463)
Q Consensus 143 ~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 221 (463)
|.++++||+|+||.||+| ....|+.||||++.- ..+..++..|+.++++++.|++|++||.+.....+|+|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 566789999999999999 556799999998743 34567788899999999999999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCcee
Q 012462 222 GNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV 301 (463)
Q Consensus 222 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 301 (463)
|+..+.++. .+.++.+.++..++..-++||+|||.. .-+|||||..|||++.+|..||+|||++-.+.+. ...
T Consensus 113 GSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MAK 185 (502)
T KOG0574|consen 113 GSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MAK 185 (502)
T ss_pred CcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh-HHh
Confidence 999999975 456799999999999999999999999 8999999999999999999999999999765332 223
Q ss_pred eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCC
Q 012462 302 TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRP 381 (463)
Q Consensus 302 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (463)
..++.||+-|||||++..-.|+.++||||||++..||..|++||.+-.+....- ++. ..+...+..
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF-------MIP-------T~PPPTF~K 251 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF-------MIP-------TKPPPTFKK 251 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE-------ecc-------CCCCCCCCC
Confidence 456789999999999999999999999999999999999999998654432110 000 111111111
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 012462 382 STRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414 (463)
Q Consensus 382 ~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L 414 (463)
...=...+-.++.+||-++|++|-|+-+++++-
T Consensus 252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 111122333445679999999999999998763
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=315.46 Aligned_cols=240 Identities=21% Similarity=0.240 Sum_probs=181.1
Q ss_pred EeecCcEEEEEEEE-cCCCeEEEEEEcccchh---hHHHHHHHHHHHcCC---CCCCcceEeeEEEECcEEEEEEeecCC
Q 012462 149 LGEGGYGVVYRGNL-INGSPVAVKKILNNVGQ---AEKEFRVEVEAIGHV---RHKNLVRLLGYCIEGIHRMLVYEYVNN 221 (463)
Q Consensus 149 lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lV~e~~~~ 221 (463)
||+|+||+||+|.. .++..||+|++...... ....+..|..++..+ +||||+++++++.+....|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999965 45889999998543211 122344455665554 799999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCcee
Q 012462 222 GNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV 301 (463)
Q Consensus 222 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 301 (463)
|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.++|+|||++....... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~ 152 (330)
T cd05586 81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KT 152 (330)
T ss_pred ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CC
Confidence 999988853 45689999999999999999999999 99999999999999999999999999987543222 12
Q ss_pred eccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCC
Q 012462 302 TTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVR 380 (463)
Q Consensus 302 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (463)
....+||+.|+|||++.+. .++.++|||||||++|||++|..||..... ........... . .+ +. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~------~~~~~~i~~~~-~-~~--~~---~ 219 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT------QQMYRNIAFGK-V-RF--PK---N 219 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH------HHHHHHHHcCC-C-CC--CC---c
Confidence 3346799999999998764 489999999999999999999999975432 11122221111 0 00 00 0
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCC----CHHHHHH
Q 012462 381 PSTRALKRSLLTALRCVDPDSEKRP----KMSQVVR 412 (463)
Q Consensus 381 ~~~~~~~~~~~~~~~cl~~dP~~RP----s~~ell~ 412 (463)
.... ....++.+||+.||.+|| ++.++++
T Consensus 220 ~~~~---~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 220 VLSD---EGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred cCCH---HHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1112 223345589999999998 4666655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=307.19 Aligned_cols=197 Identities=23% Similarity=0.349 Sum_probs=160.2
Q ss_pred CeEeecCcEEEEEEEEc---CCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEE--CcEEEEEEeecCC
Q 012462 147 NVLGEGGYGVVYRGNLI---NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE--GIHRMLVYEYVNN 221 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~~~~ 221 (463)
.+||+|+||+||+|... .+..||+|.+.... ....+.+|+.++++++||||+++++++.. +...++||||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 57999999999999764 34689999885432 23456789999999999999999999854 5677999999865
Q ss_pred CCHHHHHhhhh-----cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeE----cCCCCEEEeecccce
Q 012462 222 GNLEQWLHGAM-----RHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILI----DDDFNAKVSDFGLAK 292 (463)
Q Consensus 222 g~L~~~l~~~~-----~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill----~~~~~~kl~Dfg~a~ 292 (463)
+|.+++.... .....+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 8888775321 1223588999999999999999999999 99999999999999 566799999999998
Q ss_pred ecCCCCc--eeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 293 LLGAGKS--HVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 293 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
....... .......+|+.|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 7654322 11234568999999999876 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=297.85 Aligned_cols=251 Identities=28% Similarity=0.417 Sum_probs=197.4
Q ss_pred CCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccch--hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 142 RFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
+|++.+.||+|+||.||+|.. .++..|++|.+..... .....+..|+.++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 588889999999999999965 4688999999865443 3557788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999999853 34588999999999999999999999 99999999999999999999999999998765432
Q ss_pred ceee---ccccccCCCCchhhhccCC---CCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccc
Q 012462 299 SHVT---TRVMGTFGYVAPEYANTGL---LNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV 372 (463)
Q Consensus 299 ~~~~---~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (463)
.... ....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... ........ ......
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-----~~~~~~~~-~~~~~~- 226 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-----FQIMFHVG-AGHKPP- 226 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-----HHHHHHHh-cCCCCC-
Confidence 2111 1346788999999998766 889999999999999999999999754211 11111111 111111
Q ss_pred ccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 012462 373 VDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412 (463)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~ 412 (463)
.+...........++.+||+.+|.+||++.+++.
T Consensus 227 ------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 227 ------IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ------CCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111111222334566899999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=297.42 Aligned_cols=257 Identities=28% Similarity=0.421 Sum_probs=200.3
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
++|++.+.||.|+||+||+|.. .++..+++|++.... ......+..|+++++.++|+||+++++.+......++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4688899999999999999965 467889999885432 33557788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+++++|.+++..... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999865321 24689999999999999999999999 99999999999999999999999999987665432
Q ss_pred ce---eeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccccc
Q 012462 299 SH---VTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVD 374 (463)
Q Consensus 299 ~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (463)
.. ......++..|+|||.+... .++.++|+|||||++|+|++|+.||....... .+.. ...... .
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~----~~~~~~-~---- 225 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLML----TLQNDP-P---- 225 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHH----HhcCCC-C----
Confidence 21 12334688999999998776 78999999999999999999999997543321 1111 111100 0
Q ss_pred CCCCCCCC-HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 375 PNIEVRPS-TRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 375 ~~~~~~~~-~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
....... .........++.+||+.||++||++++++++
T Consensus 226 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 226 -SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred -CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0111100 0112233455668999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=306.02 Aligned_cols=247 Identities=26% Similarity=0.366 Sum_probs=203.6
Q ss_pred cCCCccCeEeecCcEEEEEEE-EcCCCeEEEEEEcccch--hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 141 NRFSKENVLGEGGYGVVYRGN-LINGSPVAVKKILNNVG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
+-|.+.+.||+|.|..|-+|+ ...|..||||++.+..- .....+.+|++.|+.++|||||++|.+......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 457888899999999999994 46899999999854332 223467789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEc-CCCCEEEeecccceecCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~-~~~~~kl~Dfg~a~~~~~ 296 (463)
+-++|+|++|+-. ....+.+.-+.+++.||+.|+.|+|+. .+|||||||+||.+. .-|-|||+|||++..+.+
T Consensus 98 LGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 9999999999964 445699999999999999999999999 999999999998875 468899999999988766
Q ss_pred CCceeeccccccCCCCchhhhccCCCC-ccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLLN-EKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
+. ..++.||...|-|||++.+..|+ ++.||||||||||-|++|+.||...+..+.. ..++|.
T Consensus 172 G~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL---------------TmImDC 234 (864)
T KOG4717|consen 172 GK--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL---------------TMIMDC 234 (864)
T ss_pred cc--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh---------------hhhhcc
Confidence 54 35667999999999999999886 5789999999999999999999865543322 234444
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 012462 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412 (463)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~ 412 (463)
....+... ..+.-.++.+||..||.+|.+.+||+.
T Consensus 235 KYtvPshv--S~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 235 KYTVPSHV--SKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred cccCchhh--hHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 44333332 233344556899999999999999975
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=302.98 Aligned_cols=263 Identities=24% Similarity=0.359 Sum_probs=201.0
Q ss_pred chHHHHHHhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCC-CCCCcceEeeEEEEC
Q 012462 132 TLRDLELATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEG 209 (463)
Q Consensus 132 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 209 (463)
.+.++....++|++.+.||+|+||.||+|.. .+++.+|+|.+.... .....+..|+.++.++ +|||++++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 3455556678999999999999999999965 467899999875432 2345677789899888 899999999998754
Q ss_pred -----cEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEE
Q 012462 210 -----IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAK 284 (463)
Q Consensus 210 -----~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~k 284 (463)
...++||||+++++|.++++........+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEE
Confidence 357999999999999999875444456789999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCceeeccccccCCCCchhhhccC-----CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHH
Q 012462 285 VSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTG-----LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDW 359 (463)
Q Consensus 285 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~ 359 (463)
|+|||++........ ......++..|+|||++... .++.++|||||||++|||++|+.||....+.. .
T Consensus 169 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~------~ 241 (291)
T cd06639 169 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK------T 241 (291)
T ss_pred Eeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH------H
Confidence 999999876543221 12234678899999988643 36889999999999999999999997543211 1
Q ss_pred HHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 360 LKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
+...... ....... . ......+..++.+||+.+|++||++.|++++
T Consensus 242 ~~~~~~~-~~~~~~~-----~--~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 242 LFKIPRN-PPPTLLH-----P--EKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHHHhcC-CCCCCCc-----c--cccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111111 1111111 0 1111234455668999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=302.10 Aligned_cols=259 Identities=24% Similarity=0.398 Sum_probs=197.6
Q ss_pred hHHHHHHhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCC-CCCCcceEeeEEEE--
Q 012462 133 LRDLELATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIE-- 208 (463)
Q Consensus 133 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-- 208 (463)
+.++....++|++.+.||+|+||.||+|.. .+++.+|+|.+.... .....+..|+.++.++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 445555678899999999999999999965 467889999874432 3345677889998888 79999999999853
Q ss_pred ----CcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEE
Q 012462 209 ----GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAK 284 (463)
Q Consensus 209 ----~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~k 284 (463)
....+++|||+.+|+|.+++... ....+++..++.++.||+.||.|||+. +|+|+||+|+||++++++.++
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence 45789999999999999998653 234588888999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCceeeccccccCCCCchhhhc-----cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHH
Q 012462 285 VSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYAN-----TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDW 359 (463)
Q Consensus 285 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~ 359 (463)
|+|||++........ ......++..|+|||.+. ...++.++|||||||++|||++|..||....+.....
T Consensus 162 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~---- 236 (282)
T cd06636 162 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF---- 236 (282)
T ss_pred EeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh----
Confidence 999999876532211 123356889999999875 3467889999999999999999999997543221110
Q ss_pred HHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 360 LKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
..... ......... ....+..++.+||+.||.+||++.|++++
T Consensus 237 --~~~~~------~~~~~~~~~---~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 237 --LIPRN------PPPKLKSKK---WSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred --hHhhC------CCCCCcccc---cCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 00000 001111111 11234455668999999999999999763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=298.97 Aligned_cols=253 Identities=26% Similarity=0.377 Sum_probs=200.0
Q ss_pred CCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeec
Q 012462 142 RFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYV 219 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 219 (463)
+|+..+.||+|+||.||++... +++.|++|.+.... ......+.+|++++++++||||+++++.+......++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5777889999999999999664 58899999886543 344567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE-AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 220 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
++++|.+++... ...+++..+..++.|++.||+|||+ . +++|+||||+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 82 DGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred CCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 999999998643 2568999999999999999999999 8 99999999999999999999999999987553221
Q ss_pred ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCC
Q 012462 299 SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (463)
. ....++..|+|||.+.+..++.++||||||+++|+|++|..||...... .....+.+..........
T Consensus 156 ~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~-------- 223 (265)
T cd06605 156 A---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIVNEPPPR-------- 223 (265)
T ss_pred h---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHhcCCCCC--------
Confidence 1 1256788999999999999999999999999999999999999754321 122223332222211100
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 379 ~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.... .....+..++.+||..||++|||+.+++.+
T Consensus 224 ~~~~-~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 224 LPSG-KFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CChh-hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 0110 012233445668999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=305.40 Aligned_cols=248 Identities=24% Similarity=0.342 Sum_probs=194.7
Q ss_pred CCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCC
Q 012462 143 FSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNN 221 (463)
Q Consensus 143 ~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 221 (463)
|.....||+|+||.||++.. .++..||||.+........+.+..|+..++.++|+||+++++.+..++..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 44456799999999999965 46889999988655555566788899999999999999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCcee
Q 012462 222 GNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV 301 (463)
Q Consensus 222 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 301 (463)
++|.+++.. ..+++..++.++.||+.||.|||+. +|+||||||+||+++.++.++|+|||++........ .
T Consensus 104 ~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~ 174 (292)
T cd06658 104 GALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-K 174 (292)
T ss_pred CcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-c
Confidence 999998742 3488999999999999999999999 999999999999999999999999999875433221 1
Q ss_pred eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCC
Q 012462 302 TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRP 381 (463)
Q Consensus 302 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (463)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||........ +...... ..+......
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~~------~~~~~~~~~ 242 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA------MRRIRDN------LPPRVKDSH 242 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhc------CCCcccccc
Confidence 2334688999999999888899999999999999999999999975432111 1111110 011111111
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 382 STRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 382 ~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.. ...+..++.+||..||.+|||++|++++
T Consensus 243 ~~--~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 243 KV--SSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cc--CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11 1122334557999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=318.02 Aligned_cols=251 Identities=23% Similarity=0.359 Sum_probs=198.1
Q ss_pred CCCccCeEeecCcEEEEEEEEcC-CCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecC
Q 012462 142 RFSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVN 220 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 220 (463)
-|.++..||.|+||.||+|..++ +-..|.|.+........+++..|+++|..++||+||++++.|+..+.++++.|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 35566789999999999996544 44556787766667777899999999999999999999999998999999999999
Q ss_pred CCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCce
Q 012462 221 NGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSH 300 (463)
Q Consensus 221 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 300 (463)
||-....+.. -...+.+.++..++.|++.||.|||++ +|||||||+.|||++-+|.++|+|||++...... ..
T Consensus 113 GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~q 185 (1187)
T KOG0579|consen 113 GGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQ 185 (1187)
T ss_pred CchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH-Hh
Confidence 9999888754 345699999999999999999999999 9999999999999999999999999998653221 22
Q ss_pred eeccccccCCCCchhhh-----ccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 301 VTTRVMGTFGYVAPEYA-----NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 301 ~~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
....+.|||.|||||+. ...+|+.++||||||++|.||..+.+|-... +....+..+....... ++.|
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel------npMRVllKiaKSePPT-LlqP 258 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL------NPMRVLLKIAKSEPPT-LLQP 258 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc------chHHHHHHHhhcCCCc-ccCc
Confidence 34568999999999986 4578999999999999999999999887543 3333333333222211 1111
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
..-...+..+ +.+||.+||+.||++.+++++
T Consensus 259 ----S~Ws~~F~Df---Lk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 259 ----SHWSRSFSDF---LKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred ----chhhhHHHHH---HHHHHhcCCccCCCHHHHhhC
Confidence 1112233333 336999999999999999875
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=302.61 Aligned_cols=250 Identities=25% Similarity=0.388 Sum_probs=199.3
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeec
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYV 219 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 219 (463)
++|++.+.||+|+||.||++.. .++..|++|.+........+.+..|+.++++++||||+++++++...+..|+|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 6789999999999999999964 467899999985544444567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCc
Q 012462 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299 (463)
Q Consensus 220 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 299 (463)
++++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 99999999853 2478899999999999999999999 999999999999999999999999999876543322
Q ss_pred eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCC
Q 012462 300 HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEV 379 (463)
Q Consensus 300 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (463)
......+++.|+|||.+.+..++.++|||||||++|++++|+.||........... ..... ....
T Consensus 171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~~~--------~~~~ 235 (293)
T cd06647 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG--------TPEL 235 (293)
T ss_pred -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhcCC--------CCCC
Confidence 22334688899999999888899999999999999999999999976543221110 00000 0011
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 380 RPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 380 ~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.........+..++.+||+.+|++||++.+++.+
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111233445668999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=298.04 Aligned_cols=253 Identities=23% Similarity=0.432 Sum_probs=196.3
Q ss_pred CCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc------hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEE
Q 012462 142 RFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV------GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 214 (463)
+|+..+.||+|+||.||+|.. .++..||+|.+.... ....+.+..|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477788999999999999954 568899999885332 1234678889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCC-CEEEeeccccee
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDF-NAKVSDFGLAKL 293 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~-~~kl~Dfg~a~~ 293 (463)
|+||+.+++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||.+..
T Consensus 81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999999853 34688999999999999999999999 999999999999998776 599999999876
Q ss_pred cCCCCc---eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 294 LGAGKS---HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 294 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
...... .......++..|+|||.+.+..++.++||||||+++|+|++|..||........ ..............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~ 230 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LALIFKIASATTAP 230 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HHHHHHHhccCCCC
Confidence 643211 112234678899999999888899999999999999999999999965432211 11111111110000
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
... ......+..++.+||+.+|.+||++.+++++
T Consensus 231 -------~~~--~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 231 -------SIP--EHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred -------CCc--hhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 001 1112334445668999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=304.22 Aligned_cols=199 Identities=27% Similarity=0.432 Sum_probs=167.4
Q ss_pred CCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 142 RFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
+|++.+.||+|+||.||+|.. .+|..||+|.+.... ......+..|+.++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 578889999999999999965 468899999885432 12234667799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+. ++|.+++.. ....+++..++.++.||++||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 96 588887753 234589999999999999999999999 99999999999999999999999999998654322
Q ss_pred ceeeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCC
Q 012462 299 SHVTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHG 348 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~ 348 (463)
. ......++..|+|||++.+. .++.++|||||||++|||++|..||...
T Consensus 154 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~ 203 (284)
T cd07839 154 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 203 (284)
T ss_pred C-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 1 12234578899999988764 4789999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=299.58 Aligned_cols=260 Identities=25% Similarity=0.356 Sum_probs=197.5
Q ss_pred CCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 142 RFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
+|++.+.||+|+||.||+|.. .+|..|++|++.... ......+..|+.++++++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 578889999999999999965 468899999985443 33346788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+ +++|.+++... ...+++..++.++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 99999998642 35689999999999999999999999 99999999999999999999999999998765433
Q ss_pred ceeeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCc--------
Q 012462 299 SHVTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS-------- 369 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------- 369 (463)
........++..|+|||.+.+. .++.++|||||||++|||++|..||....... ..............
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHhhccC
Confidence 2223345688999999988654 46899999999999999999988886543211 11111111100000
Q ss_pred ----cccccCCC------CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 370 ----EEVVDPNI------EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 370 ----~~~~~~~~------~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.....+.. ...+. .......++.+||+.+|++||++++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPD--ASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCC--ccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000 00001 11344556668999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=302.45 Aligned_cols=245 Identities=25% Similarity=0.327 Sum_probs=196.2
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
++|++.+.||+|+||.||++... +++.||+|.+.... ......+..|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999654 58899999885432 223456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999999853 35689999999999999999999999 999999999999999999999999999987644
Q ss_pred CCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (463)
. .....+++.|+|||.+.+..++.++||||||+++|+|++|..||..... .......... .
T Consensus 154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~-~-------- 214 (290)
T cd05580 154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP------IQIYEKILEG-K-------- 214 (290)
T ss_pred C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhcC-C--------
Confidence 3 2334688999999999888889999999999999999999999975431 1111111111 1
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 012462 377 IEVRPSTRALKRSLLTALRCVDPDSEKRP-----KMSQVVRM 413 (463)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~cl~~dP~~RP-----s~~ell~~ 413 (463)
....... ...+..++.+||+.||.+|+ +++|++++
T Consensus 215 ~~~~~~~--~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 215 VRFPSFF--SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ccCCccC--CHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 0111111 12233445579999999999 77777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=304.95 Aligned_cols=201 Identities=28% Similarity=0.421 Sum_probs=170.7
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccch--hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
++|++.+.||+|+||.||+|... +++.||+|.+..... ...+.+..|+++++.++||||+++++++.++...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999765 578999998754322 234567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
|+++++|..+.. ....+++..++.++.||+.||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEK----YPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 999988888764 233489999999999999999999999 9999999999999999999999999999875443
Q ss_pred CceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 298 KSHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
. .......++..|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~ 205 (286)
T cd07846 154 G-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS 205 (286)
T ss_pred c-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc
Confidence 2 22233567889999998865 457889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=293.39 Aligned_cols=253 Identities=25% Similarity=0.394 Sum_probs=202.3
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccch-hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVG-QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
++|++.+.||+|++|.||+|... +++.|++|++..... .....+..|+..+.+++|+||+++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888899999999999999665 489999999865443 4457788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE-AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
+++++|.+++.. ...+++..++.++.|++.||.|||+ . +++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 999999999864 2568999999999999999999999 8 9999999999999999999999999999876543
Q ss_pred CceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCC
Q 012462 298 KSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNI 377 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (463)
... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ...+.......... .
T Consensus 154 ~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~---~~~~~~~~~~~~~~-~------- 221 (264)
T cd06623 154 LDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP---SFFELMQAICDGPP-P------- 221 (264)
T ss_pred CCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc---CHHHHHHHHhcCCC-C-------
Confidence 322 22345788999999999999999999999999999999999999765431 12222222221111 0
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 378 EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
..... .....+..++.+||+.+|++||++.|++++
T Consensus 222 ~~~~~-~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 SLPAE-EFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCcc-cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00111 011233444557999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=300.89 Aligned_cols=263 Identities=27% Similarity=0.364 Sum_probs=198.1
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
++|++.+.||+|+||.||+|... +++.|++|.+.... ....+.+..|++++++++|+||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 46888999999999999999664 57899999875432 2334678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
|++++.+..+.. ....+++..++.++.||+.||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEA----SPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 999866665542 334589999999999999999999999 9999999999999999999999999999876544
Q ss_pred CceeeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcC----------
Q 012462 298 KSHVTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGS---------- 366 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---------- 366 (463)
.........++..|+|||++.+. .++.++||||||+++|+|++|+.||......+. ..........
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ---LYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHhhhcc
Confidence 32233445678899999999888 889999999999999999999999975432211 1111111000
Q ss_pred --CCcc--ccccCCCCC----CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 367 --RRSE--EVVDPNIEV----RPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 367 --~~~~--~~~~~~~~~----~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.... ...+..... .........+..++.+||+.+|++||++++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0000 000000000 0000012345566778999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=296.30 Aligned_cols=250 Identities=24% Similarity=0.333 Sum_probs=190.6
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc-----hhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC--cEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV-----GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG--IHR 212 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 212 (463)
++|++.+.||+|+||.||+|.. .++..||+|.+.... ......+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688899999999999999965 458899999874321 22345778899999999999999999998763 467
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccce
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~ 292 (463)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 899999999999999853 23578899999999999999999999 99999999999999999999999999987
Q ss_pred ecCCCCc--eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 293 LLGAGKS--HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 293 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
....... .......++..|+|||.+.+..++.++|||||||++|||++|+.||...... .. .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~-~~~~~~~~~-- 226 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-----AA-IFKIATQPT-- 226 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-----HH-HHHHhcCCC--
Confidence 6432111 1122346888999999998888999999999999999999999999743211 11 111111110
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.+ .... ........++.+||. +|++||+++|++++
T Consensus 227 ---~~--~~~~--~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 ---NP--VLPP--HVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ---CC--CCch--hhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 00 0111 111223334456774 89999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=294.18 Aligned_cols=249 Identities=23% Similarity=0.397 Sum_probs=196.7
Q ss_pred CCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 142 RFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
+|+..+.||+|+||.||++.. .++..+|+|.+.... ......+..|+.++++++||||+++++.+..+...++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 578889999999999999955 467899999885432 23456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCC-CCEEEeecccceecCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDD-FNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~-~~~kl~Dfg~a~~~~~~ 297 (463)
+++++|.+++... ....+++..++.++.+++.||.|||++ +++|+||+|+||+++.+ +.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999999999653 234589999999999999999999999 99999999999999865 45799999999876433
Q ss_pred CceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCC
Q 012462 298 KSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNI 377 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (463)
. ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .......... ...+.+
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~~~~~~~-~~~~~~--- 223 (256)
T cd08220 156 S--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------ALVLKIMSGT-FAPISD--- 223 (256)
T ss_pred c--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HHHHHHHhcC-CCCCCC---
Confidence 2 122346788999999999888999999999999999999999999754321 1111111111 111100
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 378 EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
. ....+..++.+||+.+|++|||+.|++.+
T Consensus 224 ---~---~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 224 ---R---YSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ---C---cCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1 11233445668999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=299.71 Aligned_cols=201 Identities=28% Similarity=0.420 Sum_probs=168.7
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccch-hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVG-QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
++|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888999999999999999654 678999999854322 2234566799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+.+ +|.+++... ...+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~-~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LDT-DLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 975 999988642 34688999999999999999999999 99999999999999999999999999987543221
Q ss_pred ceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 299 SHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
. ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||....
T Consensus 158 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred c-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 1 1122346788999998865 458899999999999999999999997543
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=297.64 Aligned_cols=254 Identities=25% Similarity=0.401 Sum_probs=193.5
Q ss_pred CCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccch----------hhHHHHHHHHHHHcCCCCCCcceEeeEEEECc
Q 012462 142 RFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVG----------QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGI 210 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 210 (463)
+|.+.+.||+|+||.||+|.. .+++.||+|.+..... ...+.+..|+.++..++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 467788999999999999954 4688999998743211 11245778999999999999999999999999
Q ss_pred EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccc
Q 012462 211 HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGL 290 (463)
Q Consensus 211 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~ 290 (463)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 99999999999999999854 25689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCc-eeeccccccCCCCchhhhccCC--CCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCC
Q 012462 291 AKLLGAGKS-HVTTRVMGTFGYVAPEYANTGL--LNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR 367 (463)
Q Consensus 291 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 367 (463)
+........ .......++..|+|||.+.... ++.++|+||||+++|+|++|..||...... ..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~ 228 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------AAMFKLGNKR 228 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH------HHHHHhhccc
Confidence 976532211 1123346788999999987654 789999999999999999999999643211 1111111111
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 368 RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
....+ .... ... ....+..++.+||+.+|++||++.+++++
T Consensus 229 ~~~~~-~~~~--~~~--~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 SAPPI-PPDV--SMN--LSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cCCcC-Cccc--ccc--CCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 11111 1100 011 12233445568999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=296.81 Aligned_cols=256 Identities=23% Similarity=0.408 Sum_probs=195.2
Q ss_pred CCccCeEeecCcEEEEEEEEc----CCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECc------
Q 012462 143 FSKENVLGEGGYGVVYRGNLI----NGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGI------ 210 (463)
Q Consensus 143 ~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 210 (463)
|.+.+.||+|+||.||+|.+. .+..||+|.+.... ....+++.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999643 36789999885532 334567888999999999999999999886532
Q ss_pred EEEEEEeecCCCCHHHHHhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeec
Q 012462 211 HRMLVYEYVNNGNLEQWLHGAMR--HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDF 288 (463)
Q Consensus 211 ~~~lV~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Df 288 (463)
..++++||+.+|+|.+++..... ....+++..++.++.|++.||+|||+. +|+|+||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 23789999999999988754221 223478899999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCce-eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcC
Q 012462 289 GLAKLLGAGKSH-VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGS 366 (463)
Q Consensus 289 g~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 366 (463)
|+++........ ......+++.|++||.+.+..++.++|||||||++|||++ |..||...... .........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~------~~~~~~~~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS------EIYNYLIKG 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH------HHHHHHHcC
Confidence 999865433211 1122345678999999998889999999999999999999 88888653321 111112211
Q ss_pred CCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 367 RRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.... ... .....+..++.+||+.+|++||++.++++.|+.+
T Consensus 232 ~~~~--------~~~--~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NRLK--------QPP--DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CcCC--------CCC--CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1110 011 1123445566689999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=302.27 Aligned_cols=246 Identities=24% Similarity=0.330 Sum_probs=194.0
Q ss_pred ccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCCCC
Q 012462 145 KENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGN 223 (463)
Q Consensus 145 ~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 223 (463)
....||+|+||.||+|.. .++..||+|.+........+.+.+|+.++..++||||+++++++..++..++||||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 345799999999999965 4688999999855444455678889999999999999999999999999999999999999
Q ss_pred HHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCceeec
Q 012462 224 LEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTT 303 (463)
Q Consensus 224 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 303 (463)
|.+++.. ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....... ....
T Consensus 105 L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~ 175 (297)
T cd06659 105 LTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRK 175 (297)
T ss_pred HHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc-cccc
Confidence 9987742 3589999999999999999999999 99999999999999999999999999987554322 1123
Q ss_pred cccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCCH
Q 012462 304 RVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPST 383 (463)
Q Consensus 304 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (463)
...++..|+|||++.+..++.++|||||||++|||++|+.||....+.. .+...... ..... .......
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~-~~~~~----~~~~~~~ 244 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ------AMKRLRDS-PPPKL----KNAHKIS 244 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHhcc-CCCCc----cccCCCC
Confidence 3568899999999998889999999999999999999999997543211 11111111 00000 0001111
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 384 RALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 384 ~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
. .+..++.+||+.+|++||++++++++
T Consensus 245 ~---~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 245 P---VLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred H---HHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 2 23344557999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=297.49 Aligned_cols=256 Identities=28% Similarity=0.403 Sum_probs=197.7
Q ss_pred HhcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccchhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECc------
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGI------ 210 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~------ 210 (463)
..++|++.+.||+|+||.||+|... +++.+++|.+.... .....+..|+.+++++ +|+||+++++++.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 3578999999999999999999764 57789999875443 3346788999999998 7999999999997644
Q ss_pred EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccc
Q 012462 211 HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGL 290 (463)
Q Consensus 211 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~ 290 (463)
..++||||+++++|.+++.........+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence 47999999999999999876544456799999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeccccccCCCCchhhhcc-----CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhc
Q 012462 291 AKLLGAGKSHVTTRVMGTFGYVAPEYANT-----GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVG 365 (463)
Q Consensus 291 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 365 (463)
+....... .......++..|+|||++.. ..++.++|||||||+||+|++|..||...... ........
T Consensus 160 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~ 232 (275)
T cd06608 160 SAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM------RALFKIPR 232 (275)
T ss_pred ceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH------HHHHHhhc
Confidence 87654322 12233468889999998753 34678999999999999999999999743221 11111111
Q ss_pred CCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 366 SRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.. .. .. .........+..++.+||+.||++|||+.+++++
T Consensus 233 ~~-~~-----~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 233 NP-PP-----TL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred cC-CC-----CC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 10 00 11 1111111233445668999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=299.78 Aligned_cols=254 Identities=26% Similarity=0.393 Sum_probs=191.9
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc-hhhHHHHHHHHHH-HcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV-GQAEKEFRVEVEA-IGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
++|++.+.||+|+||.||+|... +|..||+|++.... ......+..|+.. ++.++||||+++++++..+...++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36888899999999999999654 68999999885443 2334455556665 556789999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
|++ |+|.+++.........+++..++.++.||+.||.|||++. +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 6999988765444567999999999999999999999843 8999999999999999999999999999865332
Q ss_pred CceeeccccccCCCCchhhhcc----CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccc
Q 012462 298 KSHVTTRVMGTFGYVAPEYANT----GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (463)
. ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...... . ..+........ ..+
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~-~~~~~~~~~~~-~~~- 228 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----F-QQLKQVVEEPS-PQL- 228 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----H-HHHHHHHhcCC-CCC-
Confidence 1 1223457889999998865 45688999999999999999999999643211 1 11111111100 000
Q ss_pred cCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.... ....+..++.+||..+|.+||++.+++++
T Consensus 229 ----~~~~---~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 229 ----PAEK---FSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred ----Cccc---cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001 11233445668999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=299.89 Aligned_cols=256 Identities=23% Similarity=0.294 Sum_probs=197.2
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccch---hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVG---QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
++|++.+.||+|+||.||++... .++.|++|.+..... .....+..|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999654 568899998854432 23456778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++....
T Consensus 81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999999853 34689999999999999999999999 999999999999999999999999999864211
Q ss_pred CC--------------ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 012462 297 GK--------------SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKM 362 (463)
Q Consensus 297 ~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 362 (463)
.. ........++..|+|||.+.+..++.++|+|||||++|||++|..||.+.... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~~ 227 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQ 227 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH
Confidence 00 00112245788999999998888999999999999999999999999754321 22222
Q ss_pred HhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 363 MVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
...... ..+.. .. .....+..++.+||+.||++||++.++.+.|+..
T Consensus 228 ~~~~~~----~~~~~--~~--~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 228 VISDDI----EWPEG--DE--ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred HHhccc----CCCCc--cc--cCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 211110 00000 00 1112234556689999999999976666666653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=296.63 Aligned_cols=248 Identities=26% Similarity=0.454 Sum_probs=194.9
Q ss_pred CCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCC---CCCcceEeeEEEECcEEEEEE
Q 012462 142 RFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVR---HKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lV~ 216 (463)
.|+..+.||+|+||.||+|.+ .++..||+|.+.... .....++..|+.++++++ |||++++++++.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999965 568899999885432 334456788999988886 999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+++++|.+++.. ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999998853 2589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
... ......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||........ .... ... ..+
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~~~~-~~~-----~~~ 220 (277)
T cd06917 154 NSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------MMLI-PKS-----KPP 220 (277)
T ss_pred Ccc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------hhcc-ccC-----CCC
Confidence 432 2233468889999998865 4578999999999999999999999975432111 1100 000 001
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.+.... ....+..++.+||+.||++||++.+++++
T Consensus 221 ~~~~~~---~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 221 RLEDNG---YSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCccc---CCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 111111 12234455668999999999999999863
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=298.34 Aligned_cols=261 Identities=26% Similarity=0.308 Sum_probs=194.9
Q ss_pred CCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchh-----hHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEE
Q 012462 142 RFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQ-----AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 215 (463)
+|++.+.||+|+||.||+|.. .+++.||+|.+...... ....+..|+.++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 477888999999999999965 46889999998654322 334567799999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
|||+ +++|.+++... ...+++..++.++.||++||.|||++ +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 88999998642 23699999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCC-------
Q 012462 296 AGKSHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR------- 367 (463)
Q Consensus 296 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~------- 367 (463)
.... ......++..|+|||.+.+ ..++.++|||||||++|||++|..||........ ...........
T Consensus 154 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 154 SPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ---LGKIFEALGTPTEENWPG 229 (298)
T ss_pred CCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH---HHHHHHHcCCCchhhhhh
Confidence 4321 1222346788999998854 4678999999999999999999877765432111 11110000000
Q ss_pred --CccccccCCCCCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 368 --RSEEVVDPNIEVRPS-----TRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 368 --~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
............... ......+..++.+||+.||++|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000000000 1112344556778999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=302.91 Aligned_cols=204 Identities=25% Similarity=0.359 Sum_probs=169.9
Q ss_pred CCCccCeEeecCcEEEEEEEEc---CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC--cEEE
Q 012462 142 RFSKENVLGEGGYGVVYRGNLI---NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG--IHRM 213 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 213 (463)
+|.+.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.++.+++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778889999999999999664 47899999986532 33345677799999999999999999999988 8899
Q ss_pred EEEeecCCCCHHHHHhhhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC----CCCEEEeec
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHH-GYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD----DFNAKVSDF 288 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~----~~~~kl~Df 288 (463)
+||||+.+ +|.+++....... ..+++..++.++.||+.||.|||+. +|+|+||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999965 7877775433332 3689999999999999999999999 9999999999999999 999999999
Q ss_pred ccceecCCCCc--eeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 289 GLAKLLGAGKS--HVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 289 g~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
|++........ .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 99986543322 11233467889999998866 457899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=296.57 Aligned_cols=248 Identities=25% Similarity=0.344 Sum_probs=196.2
Q ss_pred CCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCC
Q 012462 143 FSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNN 221 (463)
Q Consensus 143 ~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 221 (463)
|...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457899999999999964 46789999988654444556688899999999999999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCcee
Q 012462 222 GNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV 301 (463)
Q Consensus 222 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 301 (463)
++|.+++.. ..+++..+..++.|++.||+|||++ +++||||+|+||+++.++.++|+|||++........ .
T Consensus 101 ~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~ 171 (285)
T cd06648 101 GALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-R 171 (285)
T ss_pred CCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-c
Confidence 999998853 3588999999999999999999999 999999999999999999999999998875433221 1
Q ss_pred eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCC
Q 012462 302 TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRP 381 (463)
Q Consensus 302 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (463)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||....+. ......... ... ......
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~~~~~~-~~~-----~~~~~~ 239 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMKRIRDN-LPP-----KLKNLH 239 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHHhc-CCC-----CCcccc
Confidence 23346889999999999888999999999999999999999999754321 111111111 100 111010
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 382 STRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 382 ~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.....+..++.+||+.+|++||++.+++++
T Consensus 240 --~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 240 --KVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred --cCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 011234455668999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=299.52 Aligned_cols=202 Identities=26% Similarity=0.365 Sum_probs=168.3
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccch-hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVG-QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
.++|.+.+.||+|+||.||+|.. .++..||+|.+..... .....+.+|+.+++.++|+||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 36788999999999999999955 4688999999854432 223456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
|+. ++|.+++.. ....+.+..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 84 YMH-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred ccc-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 995 688777643 234578888999999999999999999 9999999999999999999999999998754322
Q ss_pred CceeeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 298 KSHVTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
.. ......+++.|+|||.+.+. .++.++|||||||++|||++|..||....
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 157 SQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred CC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 11 12234568899999998754 57889999999999999999999997543
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=294.34 Aligned_cols=247 Identities=23% Similarity=0.380 Sum_probs=195.8
Q ss_pred CCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeec
Q 012462 142 RFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYV 219 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 219 (463)
-|++.+.||+|+||.||+|.. .++..||+|.+.... ......+.+|+.++.+++||||+++++++.++...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 367788999999999999965 467899999875332 334467888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCc
Q 012462 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299 (463)
Q Consensus 220 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 299 (463)
++++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 85 GGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 99999998852 3588999999999999999999999 999999999999999999999999999876543221
Q ss_pred eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCC
Q 012462 300 HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEV 379 (463)
Q Consensus 300 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (463)
......++..|+|||.+.+..++.++|+|||||++|+|++|..||...... .......... .. . .
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~-~~-----~--~ 221 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------KVLFLIPKNN-PP-----T--L 221 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------HHHHHHhcCC-CC-----C--C
Confidence 122346788999999998888999999999999999999999999753321 1111111111 00 0 0
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 380 RPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 380 ~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
... ....+..++.+||+.+|.+||++.+++++
T Consensus 222 ~~~--~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 EGN--YSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred Ccc--cCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 111 11223345568999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=294.82 Aligned_cols=248 Identities=23% Similarity=0.289 Sum_probs=197.8
Q ss_pred CCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 142 RFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
+|++.+.||.|+||.||+|... ++..||+|.+.... ....+.+..|++++++++||||+++++.+.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999664 58899999885432 2345678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
|+.+++|.+++.. ...+++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999999853 24689999999999999999999999 9999999999999999999999999998865433
Q ss_pred CceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCC
Q 012462 298 KSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNI 377 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (463)
. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ............ ...
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~--~~~----- 220 (258)
T cd05578 154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQIRAKQETA--DVL----- 220 (258)
T ss_pred c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HHHHHHHHhccc--ccc-----
Confidence 2 223356788999999999888999999999999999999999999865432 111111111110 000
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCH--HHHHH
Q 012462 378 EVRPSTRALKRSLLTALRCVDPDSEKRPKM--SQVVR 412 (463)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~--~ell~ 412 (463)
.... ....+..++.+||+.||.+||++ +|+++
T Consensus 221 -~~~~--~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 221 -YPAT--WSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred -Cccc--CcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 0111 11334445668999999999999 66653
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=324.40 Aligned_cols=265 Identities=28% Similarity=0.429 Sum_probs=211.6
Q ss_pred HHHHHhcCCCccCeEeecCcEEEEEEEEc--------CCCeEEEEEEcccch-hhHHHHHHHHHHHcCC-CCCCcceEee
Q 012462 135 DLELATNRFSKENVLGEGGYGVVYRGNLI--------NGSPVAVKKILNNVG-QAEKEFRVEVEAIGHV-RHKNLVRLLG 204 (463)
Q Consensus 135 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~ 204 (463)
.+++..++..+.+.||+|.||.|++|... ....||||.++.... ...+.+..|+++|..+ .|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 45667777788889999999999999542 135799999876543 4557888999999998 6999999999
Q ss_pred EEEECcEEEEEEeecCCCCHHHHHhhhh---cC-------C--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCC
Q 012462 205 YCIEGIHRMLVYEYVNNGNLEQWLHGAM---RH-------H--GYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKS 272 (463)
Q Consensus 205 ~~~~~~~~~lV~e~~~~g~L~~~l~~~~---~~-------~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp 272 (463)
+|......++|+||+..|+|.+||+..+ .. . ..++..+.+.++.||+.||+||++. +++||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9999999999999999999999998765 00 1 1388999999999999999999999 999999999
Q ss_pred CceeEcCCCCEEEeecccceecCCCCceeecccc--ccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCC
Q 012462 273 SNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVM--GTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGR 349 (463)
Q Consensus 273 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~ 349 (463)
+|||+..+..+||+|||+++.......+....-. -+..|||||.+....|+.++|||||||+|||++| |..||.+..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 9999999999999999999976655544333222 3567999999999999999999999999999999 999997622
Q ss_pred CcccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 350 PAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.. .++. ..+..+.+... ...+..+.+.+|..||+.+|++||++.++++.|+..
T Consensus 527 ~~--~~l~---~~l~~G~r~~~----------P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 527 PT--EELL---EFLKEGNRMEQ----------PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred cH--HHHH---HHHhcCCCCCC----------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 11 1222 22222222221 112244556778889999999999999999999884
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=309.84 Aligned_cols=246 Identities=24% Similarity=0.406 Sum_probs=191.2
Q ss_pred CccCeEeecCcEEEEEE-EEcCCCeEEEEEE--cc--cchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcE--EEEEE
Q 012462 144 SKENVLGEGGYGVVYRG-NLINGSPVAVKKI--LN--NVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIH--RMLVY 216 (463)
Q Consensus 144 ~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~--~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lV~ 216 (463)
++.++||+|+|-+||+| +..+|-.||=-.+ .+ ......++|..|+.+|+.|+||||+++|+++.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34568999999999999 4445777762222 11 233445789999999999999999999999987554 67899
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC-CCCEEEeecccceecC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD-DFNAKVSDFGLAKLLG 295 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~-~~~~kl~Dfg~a~~~~ 295 (463)
|.+..|+|..|+.. .+..+...+..|++||++||.|||++ +|+|+|||||-.||||+. .|.|||+|+|||....
T Consensus 123 EL~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred ecccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 99999999999854 45588899999999999999999996 789999999999999975 5899999999999876
Q ss_pred CCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 296 AGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
... .....|||.|||||+.. ..|++.+||||||++|+||.|+.+||.... +..+..+....+.....+ ..
T Consensus 198 ~s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-----n~AQIYKKV~SGiKP~sl-~k 267 (632)
T KOG0584|consen 198 KSH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT-----NPAQIYKKVTSGIKPAAL-SK 267 (632)
T ss_pred ccc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC-----CHHHHHHHHHcCCCHHHh-hc
Confidence 443 34478999999999988 679999999999999999999999997543 222333333333222211 10
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
-...+. -.++.+|+.. ..+|||+.|+|.+
T Consensus 268 -----V~dPev---r~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 268 -----VKDPEV---REFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred -----cCCHHH---HHHHHHHhcC-chhccCHHHHhhC
Confidence 111222 2345579999 8999999999864
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=298.42 Aligned_cols=247 Identities=26% Similarity=0.368 Sum_probs=193.0
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 215 (463)
..+|+..+.||+|+||+||+|.. .+++.||+|.+.... ......+..|+.+++.++||||++++++|.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 35688899999999999999965 468899999885322 23345688899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
|||+. |+|.+++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 94 ~e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 94 MEYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HHhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 99996 588777753 234589999999999999999999999 99999999999999999999999999987653
Q ss_pred CCCceeeccccccCCCCchhhhc---cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccc
Q 012462 296 AGKSHVTTRVMGTFGYVAPEYAN---TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV 372 (463)
Q Consensus 296 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (463)
.. ....++..|+|||++. ...++.++||||||+++|||++|..||...... ...........
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~------~~~~~~~~~~~---- 231 (307)
T cd06607 167 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNDS---- 231 (307)
T ss_pred CC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH------HHHHHHhcCCC----
Confidence 32 2346788999999874 456889999999999999999999999754321 11111111110
Q ss_pred ccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 373 VDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
+... .......+..++.+||+.||++||++.+++.+
T Consensus 232 --~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 --PTLS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --CCCC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000 01112234455668999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=287.34 Aligned_cols=250 Identities=27% Similarity=0.429 Sum_probs=200.3
Q ss_pred CCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecC
Q 012462 142 RFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVN 220 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 220 (463)
.|...+.||+|++|.||++... ++..+++|++..........+.+|+.++++++|+||+++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677889999999999999764 688999999866554556788899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCce
Q 012462 221 NGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSH 300 (463)
Q Consensus 221 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 300 (463)
+++|.+++... ...+++..+..++.|++.||.|||.. +++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 99999998642 25689999999999999999999998 999999999999999999999999999987654332
Q ss_pred eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCC
Q 012462 301 VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVR 380 (463)
Q Consensus 301 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (463)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ........ ...... .
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~~~~~~-------~ 218 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM------KALFKIAT-NGPPGL-------R 218 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH------HHHHHHHh-cCCCCc-------C
Confidence 23456788999999999888999999999999999999999999754321 11111111 111111 0
Q ss_pred CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 381 PSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 381 ~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
........+..++.+||+.||++|||+.|++++
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 219 NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 011001233445568999999999999999874
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=296.54 Aligned_cols=258 Identities=16% Similarity=0.235 Sum_probs=182.9
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEEcCC----CeEEEEEEcccchhh--H---------HHHHHHHHHHcCCCCCCcceE
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNLING----SPVAVKKILNNVGQA--E---------KEFRVEVEAIGHVRHKNLVRL 202 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~--~---------~~~~~e~~~l~~l~h~niv~l 202 (463)
+..++|++.++||+|+||+||+|...++ ..+|+|......... + .....+...+..++|+||+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 4457899999999999999999976543 455666432211110 0 112223445667799999999
Q ss_pred eeEEEECc----EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEc
Q 012462 203 LGYCIEGI----HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILID 278 (463)
Q Consensus 203 ~~~~~~~~----~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~ 278 (463)
++++.... ..+++++++. .++.+++.. ....++..+..++.|++.||+|||+. +|+||||||+|||++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~ 160 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVD 160 (294)
T ss_pred EEeeeEecCCceEEEEEEehhc-cCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc
Confidence 99776543 3367888874 477776642 23367888999999999999999999 999999999999999
Q ss_pred CCCCEEEeecccceecCCCCc------eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcc
Q 012462 279 DDFNAKVSDFGLAKLLGAGKS------HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAH 352 (463)
Q Consensus 279 ~~~~~kl~Dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~ 352 (463)
.++.++|+|||+++....... .......||+.|+|||++.+..++.++|||||||+||||++|..||.......
T Consensus 161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~ 240 (294)
T PHA02882 161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG 240 (294)
T ss_pred CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence 999999999999987643211 11123468999999999999999999999999999999999999998653221
Q ss_pred cc-c--HHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 012462 353 EV-N--LVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415 (463)
Q Consensus 353 ~~-~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~ 415 (463)
.. . ..++...... ........... +..++..||+.+|++||++.++++.|+
T Consensus 241 ~~~~~~~~~~~~~~~~---------~~~~~~~~~~~---~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 241 NLIHAAKCDFIKRLHE---------GKIKIKNANKF---IYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHHhHHHHHHHhhh---------hhhccCCCCHH---HHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11 0 1111111111 11111122223 344455799999999999999998763
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=296.41 Aligned_cols=201 Identities=28% Similarity=0.436 Sum_probs=169.1
Q ss_pred CCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 142 RFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
+|+..+.||.|+||.||+|... ++..||||++.... ......+..|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999654 68899999885432 22335688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+. ++|.+++... ....+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 5899888642 345689999999999999999999999 99999999999999999999999999987654322
Q ss_pred ceeeccccccCCCCchhhhccCC-CCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 299 SHVTTRVMGTFGYVAPEYANTGL-LNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
. ......++..|+|||.+.+.. ++.++|||||||++|||+||+.||....
T Consensus 155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 205 (284)
T cd07860 155 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 205 (284)
T ss_pred c-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 1 122335688899999886644 6889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=294.44 Aligned_cols=253 Identities=26% Similarity=0.373 Sum_probs=200.1
Q ss_pred HhcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
..+.|+..+.||+|+||.||+|... ++..|++|.+..... ....+..|++.++.++|+||+++++++......++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 3566888899999999999999665 688999999865443 45678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
|+++++|.+++.... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 96 YMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred ccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 999999999997532 3699999999999999999999998 9999999999999999999999999998754432
Q ss_pred CceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCC
Q 012462 298 KSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNI 377 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (463)
.. ......++..|+|||.+.+..++.++|+|||||++|+|++|..||....+.. ......... ....
T Consensus 170 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~------~~~~~~~~~-~~~~----- 236 (286)
T cd06614 170 KS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR------ALFLITTKG-IPPL----- 236 (286)
T ss_pred hh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcC-CCCC-----
Confidence 21 1223457889999999998889999999999999999999999997533211 111111111 0100
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 378 EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
. ........+..++.+||+.+|.+||++.+++++
T Consensus 237 ~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 237 K--NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred c--chhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0 000011234445668999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=286.77 Aligned_cols=252 Identities=24% Similarity=0.370 Sum_probs=202.9
Q ss_pred CCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccch--hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 142 RFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
+|.+.+.||.|+||.||++... ++..|++|++..... .....+..|+++++.++|||++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5778899999999999999654 588999999865432 4556788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+++++|.+++.........+++..++.++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999976443356799999999999999999999999 99999999999999999999999999998765432
Q ss_pred ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCC
Q 012462 299 SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (463)
.......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||..... ........... ...+
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~~-~~~~------ 223 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL------LELALKILKGQ-YPPI------ 223 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH------HHHHHHHhcCC-CCCC------
Confidence 223345688899999999988899999999999999999999999975431 12222222111 1111
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 379 ~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.. .....+..++.+||+.+|++||++.+++++
T Consensus 224 -~~--~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 224 -PS--QYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -CC--CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 10 111233445668999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=295.05 Aligned_cols=264 Identities=23% Similarity=0.299 Sum_probs=192.4
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccch--hhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcE-----
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVG--QAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIH----- 211 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~----- 211 (463)
++|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.+++.+ +||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999654 688999998754322 2235677899999999 46999999999987665
Q ss_pred EEEEEeecCCCCHHHHHhhhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC-CCCEEEeecc
Q 012462 212 RMLVYEYVNNGNLEQWLHGAMRH-HGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD-DFNAKVSDFG 289 (463)
Q Consensus 212 ~~lV~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~-~~~~kl~Dfg 289 (463)
.|+||||+++ +|.+++...... ...+++..++.++.||+.||.|||+. +|+||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 899888654322 35689999999999999999999999 9999999999999998 8999999999
Q ss_pred cceecCCCCceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCC
Q 012462 290 LAKLLGAGKSHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRR 368 (463)
Q Consensus 290 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 368 (463)
++........ ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||....+... +....... .. .
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~~-~~-~ 231 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LLHIFKLL-GT-P 231 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHHh-CC-C
Confidence 9986543211 1122356788999998765 4578999999999999999999999975432211 11111100 00 0
Q ss_pred ccccccCC---------CCCCC-C-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 369 SEEVVDPN---------IEVRP-S-----TRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 369 ~~~~~~~~---------~~~~~-~-----~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
........ ....+ . ......+..++.+||+.||.+||++.|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000000 00000 0 0112234456668999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=289.97 Aligned_cols=250 Identities=23% Similarity=0.333 Sum_probs=200.8
Q ss_pred CCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 142 RFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
+|++.++||+|+||.||++.. .++..+++|.+.... ......+..|+.++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 478889999999999999954 467899999885432 23345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+++++|.+++.........+++..++.++.|++.||.|||+. +++|+||+|.||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999876544456789999999999999999999999 9999999999999999999999999999876543
Q ss_pred ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCC
Q 012462 299 SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (463)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...... ....... .......
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~-~~~~~~~------ 221 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ------DLRYKVQ-RGKYPPI------ 221 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHh-cCCCCCC------
Confidence 122345788999999999999999999999999999999999999754321 1111111 1111111
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 379 ~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
. ......+..++.+||+.+|++||++.+++++
T Consensus 222 -~--~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 222 -P--PIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -c--hhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0 1122334556668999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=296.85 Aligned_cols=256 Identities=26% Similarity=0.373 Sum_probs=191.2
Q ss_pred CCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCC-CCCcceEeeEEEECcEEEEEEee
Q 012462 142 RFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
+|+..+.||+|+||.||++.. .+++.||+|.+.... ......+..|+.++.++. |+||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 455567899999999999955 457899999885432 344567888999999985 99999999999998899999999
Q ss_pred cCCCCHHHHHhhh-hcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 219 VNNGNLEQWLHGA-MRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 219 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
+.. +|.++.... ......+++..+..++.|++.||+|||+.. +++||||||+||+++.++.++|+|||++......
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 854 766654321 122356899999999999999999999632 8999999999999999999999999999765432
Q ss_pred CceeeccccccCCCCchhhhccC---CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccccc
Q 012462 298 KSHVTTRVMGTFGYVAPEYANTG---LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVD 374 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (463)
.. .....++..|+|||.+.+. .++.++|||||||++|||++|+.||.... .....+....... ..
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~~-~~---- 229 (288)
T cd06616 162 IA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKGD-PP---- 229 (288)
T ss_pred Cc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCCC-CC----
Confidence 21 1233578899999998776 68999999999999999999999997532 1111111111111 00
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 375 PNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.+...........+..++.+||+.||++|||+++++++
T Consensus 230 -~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 230 -ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111111122234455668999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=299.81 Aligned_cols=263 Identities=25% Similarity=0.334 Sum_probs=193.1
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccch--hhHHHHHHHHHHHcCCCCCCcceEeeEEEEC--cEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG--IHRML 214 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 214 (463)
.++|++.+.||+|+||.||+|.. .+|+.||+|.+..... .....+.+|+.++.+++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 35789999999999999999965 4589999998854322 1223456799999999999999999998754 56799
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
||||+.+ +|.+++... ...+++..++.++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++...
T Consensus 86 v~e~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999964 898888642 35689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcc---
Q 012462 295 GAGKSHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE--- 370 (463)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--- 370 (463)
..... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......... ..+..........
T Consensus 159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~---~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 159 GLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQL---DLIIQLLGTPNESIWP 234 (309)
T ss_pred CCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcCCCChhhch
Confidence 54321 1222345788999998865 56789999999999999999999999765432211 1111111100000
Q ss_pred ---------ccccCCCCCCCC----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 371 ---------EVVDPNIEVRPS----TRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 371 ---------~~~~~~~~~~~~----~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
............ .........++.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000000000 0012233456668999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=296.38 Aligned_cols=261 Identities=26% Similarity=0.334 Sum_probs=195.5
Q ss_pred CCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC--cEEEEEEe
Q 012462 143 FSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG--IHRMLVYE 217 (463)
Q Consensus 143 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV~e 217 (463)
|++.+.||+|+||.||+|... ++..+|+|.+.... ......+..|+.++++++|+|++++++++.+. ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999665 47899999986553 33345677899999999999999999999988 88999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
|+++ +|.+++... ...+++..++.++.||+.||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 888887532 24689999999999999999999999 9999999999999999999999999999876544
Q ss_pred CceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccc----
Q 012462 298 KSHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV---- 372 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 372 (463)
.........++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ...+............
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ---LEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchhhccccc
Confidence 3222333456888999997765 4678999999999999999999999976443211 1111111100000000
Q ss_pred -------ccCCCCCCCCH----H--HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 373 -------VDPNIEVRPST----R--ALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 373 -------~~~~~~~~~~~----~--~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
........... . .......++.+||+.+|++||++++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000000000 0 13345666778999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=302.91 Aligned_cols=199 Identities=29% Similarity=0.356 Sum_probs=168.6
Q ss_pred HhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEccc--chhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC------
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNN--VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG------ 209 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 209 (463)
..++|+..+.||+|+||.||+|.. .+++.||+|.+... .......+.+|+.++++++||||++++++|...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 357899999999999999999965 46889999988542 223345677899999999999999999988643
Q ss_pred cEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecc
Q 012462 210 IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFG 289 (463)
Q Consensus 210 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg 289 (463)
...|+||||+. ++|.+.+.. .++...+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 35699999996 488887742 288899999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 290 LAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 290 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
+++...... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||....
T Consensus 164 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 164 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred cceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 998764322 1233467889999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=287.92 Aligned_cols=242 Identities=24% Similarity=0.318 Sum_probs=192.2
Q ss_pred EeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCCCCH
Q 012462 149 LGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNL 224 (463)
Q Consensus 149 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 224 (463)
||.|+||.||+|... ++..+++|.+.... ....+.+..|+.+++.++||||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999764 48899999985432 23446788999999999999999999999999999999999999999
Q ss_pred HHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCceeecc
Q 012462 225 EQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR 304 (463)
Q Consensus 225 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 304 (463)
.+++.. ...+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 999853 34588999999999999999999998 99999999999999999999999999998765432 1223
Q ss_pred ccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHH
Q 012462 305 VMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTR 384 (463)
Q Consensus 305 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (463)
..++..|+|||.+.+..++.++|+||||+++|+|++|..||..... +............... ..+...
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~-------~~~~~~- 219 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE----DPMEIYNDILKGNGKL-------EFPNYI- 219 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC----CHHHHHHHHhccCCCC-------CCCccc-
Confidence 4678899999999888899999999999999999999999976542 1122222222111100 111111
Q ss_pred HHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 012462 385 ALKRSLLTALRCVDPDSEKRPK-----MSQVVR 412 (463)
Q Consensus 385 ~~~~~~~~~~~cl~~dP~~RPs-----~~ell~ 412 (463)
...+..++.+||+.+|++||+ ++|+++
T Consensus 220 -~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 -DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred -CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 234455566899999999999 777776
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=284.51 Aligned_cols=251 Identities=29% Similarity=0.401 Sum_probs=199.8
Q ss_pred CCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccch--hhHHHHHHHHHHHcCCCCCCcceEeeEEEEC--cEEEEEE
Q 012462 142 RFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG--IHRMLVY 216 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 216 (463)
+|...+.||+|++|.||+|... ++..|++|.+..... ...+.+..|+.++++++||||+++++.+.+. ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999765 688999998855432 4457788999999999999999999999988 8899999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+++++|.+++... ..+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 999999999998642 3699999999999999999999998 999999999999999999999999999987654
Q ss_pred CCce-eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 297 GKSH-VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 297 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
.... ......++..|+|||.+.+..++.++||||||+++|+|++|..||.... +................
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~---- 224 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEPPE---- 224 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCCcC----
Confidence 4321 1233567889999999988889999999999999999999999997644 11111111111001111
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.... ....+..++.+||+.||++||++.+++.+
T Consensus 225 ---~~~~--~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 225 ---IPEH--LSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred ---CCcc--cCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 1111 12344455668999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=292.50 Aligned_cols=260 Identities=25% Similarity=0.355 Sum_probs=192.5
Q ss_pred CCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeec
Q 012462 143 FSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYV 219 (463)
Q Consensus 143 ~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 219 (463)
|++.+.||.|++|.||+|.. .+|..||+|++.... ......+.+|+.++++++|||++++++++.+....+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56778999999999999965 478999999885433 223356778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCc
Q 012462 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299 (463)
Q Consensus 220 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 299 (463)
+ ++|.+++.... ...+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 69999886432 23589999999999999999999999 999999999999999999999999999976543221
Q ss_pred eeeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCC--------Ccc
Q 012462 300 HVTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR--------RSE 370 (463)
Q Consensus 300 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--------~~~ 370 (463)
. .....++..|+|||++.+. .++.++||||||+++|+|++|+.||....... .+........... ...
T Consensus 155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhch
Confidence 1 1223568899999987654 57899999999999999999999997543211 1111111100000 000
Q ss_pred ccc-------cCCC-CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 371 EVV-------DPNI-EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 371 ~~~-------~~~~-~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
... .... ...+. ....+..++.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPN--LDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhcccccccchhhhcCC--CCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 0000 00000 11234456668999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=290.14 Aligned_cols=250 Identities=22% Similarity=0.370 Sum_probs=196.3
Q ss_pred CCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 142 RFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
+|++.+.||+|+||.||+|... +|..+|+|.+.... ....+.+.+|+.+++.++|+||+++++.+.+....++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5778899999999999999654 57889999885432 23345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCC-EEEeecccceecCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFN-AKVSDFGLAKLLGAG 297 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~-~kl~Dfg~a~~~~~~ 297 (463)
+++++|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||++++++. ++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999999998642 233579999999999999999999999 9999999999999998864 699999998766433
Q ss_pred CceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCC
Q 012462 298 KSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNI 377 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (463)
.. ......|++.|+|||.+.+..++.++|+||||+++|||++|..||..... ..+........ ...
T Consensus 156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~-~~~------ 221 (257)
T cd08225 156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKICQGY-FAP------ 221 (257)
T ss_pred cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhccc-CCC------
Confidence 21 12234578899999999888899999999999999999999999964321 22222222111 111
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 378 EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
..+.. ......++.+||+.+|++|||+.+++++
T Consensus 222 -~~~~~--~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 222 -ISPNF--SRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -CCCCC--CHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 01111 1234445568999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=300.73 Aligned_cols=262 Identities=23% Similarity=0.365 Sum_probs=192.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC-----cEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG-----IHR 212 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 212 (463)
.++|++.+.||+|+||.||+|.. .+|+.||+|.+.... ......+..|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999954 568899999885322 23345677899999999999999999987654 357
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccce
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~ 292 (463)
++|+||+.+ +|.+++. ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~-~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELMET-DLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhccc-CHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence 999999965 8887764 23589999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCce--eeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCc
Q 012462 293 LLGAGKSH--VTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369 (463)
Q Consensus 293 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 369 (463)
........ ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....... ....+.........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~ 231 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQ 231 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCH
Confidence 75432211 1233568899999998754 568999999999999999999999997543211 11111111110000
Q ss_pred ccc---cc-------CCCCCCC--C-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 370 EEV---VD-------PNIEVRP--S-----TRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 370 ~~~---~~-------~~~~~~~--~-----~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
... .. ....... . ......+..++.+||+.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 00 0000000 0 0012334566778999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=295.83 Aligned_cols=201 Identities=26% Similarity=0.367 Sum_probs=168.7
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccchh--hHHHHHHHHHHHcCCCCCCcceEeeEEEEC--cEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQ--AEKEFRVEVEAIGHVRHKNLVRLLGYCIEG--IHRMLV 215 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV 215 (463)
++|++.+.||+|+||.||+|... ++..+++|.+...... ....+.+|+.++.+++||||+++++++... ...|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999764 5788999998543322 223566799999999999999999999877 889999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
|||+.+ +|.+++... ...+++..++.++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 85 ~e~~~~-~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVEH-DLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcCc-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999974 999988642 23589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCceeeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 296 AGKSHVTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 296 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
.... ......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||....
T Consensus 158 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~ 211 (293)
T cd07843 158 SPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS 211 (293)
T ss_pred CCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 4321 12234578899999988764 46889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=288.03 Aligned_cols=202 Identities=29% Similarity=0.336 Sum_probs=176.5
Q ss_pred hcCCCccCeEeecCcEEEEEEE-EcCCCeEEEEEEcccchhhHHH---HHHHHHHHcCCCCCCcceEeeEEEECcEEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGN-LINGSPVAVKKILNNVGQAEKE---FRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~---~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 215 (463)
-++|..+++||+|.||+|.+++ ...++.+|+|++++......++ -..|-++|+..+||.+..+.-.|...+++|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 4678888999999999999994 4578999999987665433333 34588899999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
|||..||.|.-+|. ....+++.....+-..|+.||.|||+. +|++||||.+|+|+|.+|++||+|||+++.--
T Consensus 247 MeyanGGeLf~HLs----rer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLS----RERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEccCceEeeehh----hhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc
Confidence 99999999988884 345689999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 296 AGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
.. ...+..+||||.|+|||++....|+...|+|.+|||||||++|+.||....
T Consensus 320 ~~-g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d 372 (516)
T KOG0690|consen 320 KY-GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD 372 (516)
T ss_pred cc-cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc
Confidence 22 234677999999999999999999999999999999999999999998643
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=293.14 Aligned_cols=202 Identities=29% Similarity=0.449 Sum_probs=170.1
Q ss_pred CCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccch-hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeec
Q 012462 142 RFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVG-QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYV 219 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 219 (463)
+|++.+.||.|++|.||+|... +|..||+|.+..... .....+..|+.++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788899999999999999764 688999998865432 23456677999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCc
Q 012462 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299 (463)
Q Consensus 220 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 299 (463)
++ +|.+++.... ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 75 8988886432 234689999999999999999999999 999999999999999999999999999976543211
Q ss_pred eeeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 300 HVTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 300 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
......++..|++||++.+. .++.++|||||||++|+|++|..||....
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 205 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN 205 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 12234568899999988664 57889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=296.97 Aligned_cols=262 Identities=24% Similarity=0.327 Sum_probs=191.6
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECc-------
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGI------- 210 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------- 210 (463)
++|++.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++++++||||+++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 5689999999999999999965 468899999885432 222345567999999999999999999987643
Q ss_pred -EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecc
Q 012462 211 -HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFG 289 (463)
Q Consensus 211 -~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg 289 (463)
..++||||+.+ +|.+++.. ....+++..++.++.||+.||.|||++ +++|+||||+||+++.++.+||+|||
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCC
Confidence 45999999964 88887753 234589999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCce---eeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhc
Q 012462 290 LAKLLGAGKSH---VTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVG 365 (463)
Q Consensus 290 ~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 365 (463)
++......... ......++..|+|||.+.+. .++.++||||||+++|||++|..||....+..... .+..+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~---~~~~~~~ 241 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLT---LISQLCG 241 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhC
Confidence 99865432211 12234578889999988664 47889999999999999999999997654322111 1111111
Q ss_pred CCCccccccC--------CCCCCCC-----------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 366 SRRSEEVVDP--------NIEVRPS-----------TRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 366 ~~~~~~~~~~--------~~~~~~~-----------~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
... ...... ....... .........++.+||+.||.+|||+.|++++
T Consensus 242 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 242 SIT-PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred CCC-hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000 000000 0000000 0001223456778999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=292.08 Aligned_cols=258 Identities=22% Similarity=0.274 Sum_probs=190.1
Q ss_pred CCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCC-CCCcceEeeEEEEC--cEEEEEEe
Q 012462 143 FSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEG--IHRMLVYE 217 (463)
Q Consensus 143 ~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~e 217 (463)
|++.+.||+|+||.||+|.. .++..||+|++.... .........|+.++.++. |+||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56778999999999999964 468899999885432 222233446888888884 99999999999987 88999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
|+. ++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||+|+||+++. +.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 996 588888754 234689999999999999999999999 9999999999999999 99999999999866433
Q ss_pred CceeeccccccCCCCchhhhc-cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCC--------
Q 012462 298 KSHVTTRVMGTFGYVAPEYAN-TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRR-------- 368 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-------- 368 (463)
.. .....++..|+|||.+. +..++.++|||||||++|||++|..||......+ .............
T Consensus 153 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 153 PP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred CC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhc
Confidence 21 22345788999999764 4567889999999999999999999997654321 1111111111000
Q ss_pred ---ccccccCCCCCCC----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 369 ---SEEVVDPNIEVRP----STRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 369 ---~~~~~~~~~~~~~----~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
......+...... .......+..++.+||+.+|++||++++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000000000000 00123455666778999999999999999874
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=290.19 Aligned_cols=244 Identities=26% Similarity=0.308 Sum_probs=186.7
Q ss_pred EeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCCCCH
Q 012462 149 LGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNL 224 (463)
Q Consensus 149 lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 224 (463)
||+|+||+||+|.. .+|+.||+|.+.... ......+..|+++++.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999954 468899999885432 22334567799999999999999999999999999999999999999
Q ss_pred HHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCceeecc
Q 012462 225 EQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR 304 (463)
Q Consensus 225 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 304 (463)
.+++... ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~ 153 (277)
T cd05577 81 KYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKG 153 (277)
T ss_pred HHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccc
Confidence 9998643 224689999999999999999999999 99999999999999999999999999987654321 1223
Q ss_pred ccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHH
Q 012462 305 VMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTR 384 (463)
Q Consensus 305 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (463)
..++..|+|||++.+..++.++|||||||++|+|++|+.||......... .. +...... . ........
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~-~~~~~~~----~----~~~~~~~~- 221 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK--EE-LKRRTLE----M----AVEYPDKF- 221 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH--HH-HHhcccc----c----cccCCccC-
Confidence 45788999999998888999999999999999999999999754431111 11 1110000 0 00011111
Q ss_pred HHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 012462 385 ALKRSLLTALRCVDPDSEKRP-----KMSQVVR 412 (463)
Q Consensus 385 ~~~~~~~~~~~cl~~dP~~RP-----s~~ell~ 412 (463)
...+..++.+||+.||.+|| ++.++++
T Consensus 222 -~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 222 -SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred -CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 12233445689999999999 5555654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=296.02 Aligned_cols=266 Identities=24% Similarity=0.300 Sum_probs=195.0
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECc----
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGI---- 210 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 210 (463)
...++|++.+.||+|+||.||+|... +++.||+|.+.... ......+..|+.++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45578999999999999999999764 57899999885432 223356678999999999999999999987654
Q ss_pred ------EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEE
Q 012462 211 ------HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAK 284 (463)
Q Consensus 211 ------~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~k 284 (463)
..++|+||+++ +|.+++.. ....+++..++.++.|++.||.|||+. +|+|+||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence 78999999976 77777753 234689999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHH
Q 012462 285 VSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMM 363 (463)
Q Consensus 285 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 363 (463)
|+|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ....+...
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~---~~~~~~~~ 233 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA---QLELISRL 233 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHH
Confidence 99999998764433222223345778999998865 457899999999999999999999997543211 11111111
Q ss_pred hcCCCccccc-----------cCCCCC-----CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 364 VGSRRSEEVV-----------DPNIEV-----RPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 364 ~~~~~~~~~~-----------~~~~~~-----~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.......... +..... .........+..++.+||+.||.+||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111100000 000000 0000012334555668999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=292.58 Aligned_cols=245 Identities=25% Similarity=0.349 Sum_probs=193.1
Q ss_pred cCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCCCCH
Q 012462 146 ENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNL 224 (463)
Q Consensus 146 ~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 224 (463)
..+||+|+||.||++.. .++..||+|++..........+..|+.+++.++|+||+++++++..++..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 35799999999999965 46889999988654445566788899999999999999999999999999999999999999
Q ss_pred HHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCceeecc
Q 012462 225 EQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR 304 (463)
Q Consensus 225 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 304 (463)
.+++.. ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 105 ~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~ 175 (292)
T cd06657 105 TDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKS 175 (292)
T ss_pred HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccc
Confidence 997742 3488999999999999999999999 99999999999999999999999999987654322 11233
Q ss_pred ccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHH
Q 012462 305 VMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTR 384 (463)
Q Consensus 305 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (463)
..++..|+|||.+.+..++.++|+||||+++|+|++|..||....... . ........ ...+ ........
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~---~---~~~~~~~~-~~~~----~~~~~~~~ 244 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---A---MKMIRDNL-PPKL----KNLHKVSP 244 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H---HHHHHhhC-Cccc----CCcccCCH
Confidence 467889999999988889999999999999999999999997543211 1 11111110 0000 01111112
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 385 ALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 385 ~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.+..++.+||+.||.+||++.+++++
T Consensus 245 ---~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 245 ---SLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred ---HHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 23344558999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=293.86 Aligned_cols=249 Identities=23% Similarity=0.336 Sum_probs=192.7
Q ss_pred CCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 142 RFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
.|...+.||+|+||.||+|.. .++..||+|.+.... ......+..|+.++++++|||++++++++.++...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 367788999999999999965 467899999885332 2334568889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
|+.+ +|.+++.. ....+++..+..++.|++.||.|||+. +|+|+||+|+||+++.++.++|+|||++......
T Consensus 106 ~~~g-~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 106 YCLG-SASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred CCCC-CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 9964 88887753 234589999999999999999999999 9999999999999999999999999998754322
Q ss_pred CceeeccccccCCCCchhhhc---cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccccc
Q 012462 298 KSHVTTRVMGTFGYVAPEYAN---TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVD 374 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (463)
....++..|+|||.+. .+.++.++|||||||++|||++|..||...... .............
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~~~~~---- 243 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNESPT---- 243 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHHhccCCC----
Confidence 2346788999999873 456889999999999999999999998753211 1111111111100
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 375 PNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
..... ....+..++.+||+.+|.+||++.++++++-..
T Consensus 244 --~~~~~---~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 244 --LQSNE---WSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred --CCCcc---ccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 00011 112234455589999999999999999876443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=291.36 Aligned_cols=243 Identities=23% Similarity=0.291 Sum_probs=182.1
Q ss_pred eEeecCcEEEEEEEE-cCCCeEEEEEEcccch---hhHHHHHHHH---HHHcCCCCCCcceEeeEEEECcEEEEEEeecC
Q 012462 148 VLGEGGYGVVYRGNL-INGSPVAVKKILNNVG---QAEKEFRVEV---EAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVN 220 (463)
Q Consensus 148 ~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~---~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 220 (463)
.||+|+||.||++.. .+++.+|+|.+..... .....+..|. .++...+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999965 4578999998854321 1122233343 33444579999999999999999999999999
Q ss_pred CCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCce
Q 012462 221 NGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSH 300 (463)
Q Consensus 221 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 300 (463)
+++|.+++.. ...+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 9999998853 34699999999999999999999999 99999999999999999999999999987654322
Q ss_pred eeccccccCCCCchhhhc-cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCC
Q 012462 301 VTTRVMGTFGYVAPEYAN-TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEV 379 (463)
Q Consensus 301 ~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (463)
.....|+..|+|||.+. +..++.++|||||||++|||++|..||.......... +....... . ...
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~~~~------~--~~~ 218 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLTV------N--VEL 218 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH----HHHHhhcC------C--cCC
Confidence 12346899999999886 4568999999999999999999999997543222111 11111000 0 011
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHH
Q 012462 380 RPSTRALKRSLLTALRCVDPDSEKRP-----KMSQVVRML 414 (463)
Q Consensus 380 ~~~~~~~~~~~~~~~~cl~~dP~~RP-----s~~ell~~L 414 (463)
... ....+..++.+||+.||.+|| +++|++++-
T Consensus 219 ~~~--~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 219 PDS--FSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred ccc--cCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 111 112333445589999999999 699998763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=301.04 Aligned_cols=249 Identities=24% Similarity=0.372 Sum_probs=200.6
Q ss_pred HhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccch--hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEE
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 215 (463)
....|.+...||+|.|++|.+|+. .++..||+|.+.+... .....+.+|+++|..|+|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 346788999999999999999954 5689999998865432 2234578899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
|||+.+|.+++++. +++.+.+..+..++.|+..|++|||++ .|+|||||++||||+.+.++||+|||++..+.
T Consensus 134 ~eya~~ge~~~yl~----~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLV----KHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEeccCchhHHHHH----hcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec
Confidence 99999999999995 445567789999999999999999999 99999999999999999999999999999887
Q ss_pred CCCceeeccccccCCCCchhhhccCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccccc
Q 012462 296 AGKSHVTTRVMGTFGYVAPEYANTGLL-NEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVD 374 (463)
Q Consensus 296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (463)
.. ....++||++.|.|||++.+..| ++++|+||+|++||-|+.|..||++..-..-. ...+.
T Consensus 207 ~~--~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr---------------~rvl~ 269 (596)
T KOG0586|consen 207 YG--LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR---------------PRVLR 269 (596)
T ss_pred cc--ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc---------------chhee
Confidence 43 34667899999999999998876 57999999999999999999999975422110 01111
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 375 PNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
....++..... +.-.++.++|-.+|.+|++++++.++
T Consensus 270 gk~rIp~~ms~--dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 270 GKYRIPFYMSC--DCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eeecccceeec--hhHHHHHHhhccCccccCCHHHhhhh
Confidence 11111211111 11122346788999999999999764
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=303.27 Aligned_cols=261 Identities=23% Similarity=0.312 Sum_probs=193.7
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEccc--chhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC-----cE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNN--VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG-----IH 211 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 211 (463)
.++|.+.+.||+|+||+||+|.. .++..||+|.+... .......+..|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 35799999999999999999954 46899999988543 222345667799999999999999999988654 34
Q ss_pred EEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccc
Q 012462 212 RMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA 291 (463)
Q Consensus 212 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a 291 (463)
.|+|+||+. ++|.+++. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR----SSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999995 68988874 345699999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 292 KLLGAGKSHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
....... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....... ...............
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~ 231 (337)
T cd07858 156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH---QLKLITELLGSPSEE 231 (337)
T ss_pred cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCChH
Confidence 8654332 12233467889999998765 468999999999999999999999997543211 111111111000000
Q ss_pred ------------------ccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 371 ------------------EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 371 ------------------~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
......... ........+..++.+||+.+|++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 000000000 000112334566778999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=296.39 Aligned_cols=197 Identities=24% Similarity=0.297 Sum_probs=160.6
Q ss_pred CeEeec--CcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCC
Q 012462 147 NVLGEG--GYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNN 221 (463)
Q Consensus 147 ~~lG~G--~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 221 (463)
..||+| +||+||+|.. .+|+.||+|.+.... ....+.+..|+.+++.++||||++++++|..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 9999999965 578999999885432 23346788899999999999999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCcee
Q 012462 222 GNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV 301 (463)
Q Consensus 222 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 301 (463)
++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+|||++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999986532 23588999999999999999999999 99999999999999999999999998654322111000
Q ss_pred ------eccccccCCCCchhhhccC--CCCccchhhhHHHHHHHHHhCCCCCCCC
Q 012462 302 ------TTRVMGTFGYVAPEYANTG--LLNEKSDVYSFGVLLLEAITGRDPVDHG 348 (463)
Q Consensus 302 ------~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg~~pf~~~ 348 (463)
.....++..|+|||++.+. .++.++|||||||++|||++|..||...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 0112345679999998764 4789999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=283.86 Aligned_cols=248 Identities=28% Similarity=0.451 Sum_probs=198.4
Q ss_pred CCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccch--hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 142 RFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
+|++.+.||+|++|.||+|... +++.|++|.+..... .....+..|++++.+++|||++++++++.+....+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999654 678999999865543 3456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+++++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 999999999853 25689999999999999999999999 99999999999999999999999999998765443
Q ss_pred ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCC
Q 012462 299 SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (463)
.. .....++..|+|||...+..++.++||||||+++|+|++|..||..... ...... .... ....
T Consensus 154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~~~~~~-~~~~-~~~~------- 218 (254)
T cd06627 154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----MAALFR-IVQD-DHPP------- 218 (254)
T ss_pred cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHH-Hhcc-CCCC-------
Confidence 21 2334678899999999888889999999999999999999999975431 111111 1111 0000
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 379 ~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
..... ...+..++.+||+.+|++||++.+++.+
T Consensus 219 ~~~~~--~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 219 LPEGI--SPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred CCCCC--CHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 11111 1233345568999999999999999853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=286.56 Aligned_cols=250 Identities=22% Similarity=0.316 Sum_probs=191.6
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEccc-----chhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC--cEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNN-----VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG--IHR 212 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 212 (463)
.+|.+.+.||+|+||.||+|.. .++..||+|.+... .......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688899999999999999965 46889999987422 123345788899999999999999999998764 457
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccce
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~ 292 (463)
++++||+++++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 899999999999998853 34588999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCC--ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 293 LLGAGK--SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 293 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
...... ........++..|+|||.+.+..++.++|+|||||++|+|++|+.||...... ..+..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~ 228 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM------AAIFKIATQPTKP 228 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH------HHHHHHHcCCCCC
Confidence 653211 11122356889999999999888999999999999999999999999753211 1111111111000
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
..+.... .....++.+||. +|..||++.+++++
T Consensus 229 -------~~p~~~~--~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 229 -------MLPDGVS--DACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred -------CCCcccC--HHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 1111111 223334457998 57999999998864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=284.88 Aligned_cols=249 Identities=22% Similarity=0.269 Sum_probs=186.4
Q ss_pred HHHHHhcCCCccCeE--eecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcC-CCCCCcceEeeEEEECc
Q 012462 135 DLELATNRFSKENVL--GEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGH-VRHKNLVRLLGYCIEGI 210 (463)
Q Consensus 135 ~~~~~~~~~~~~~~l--G~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~ 210 (463)
+.....++|++.+.+ |+|+||.||++.. .++..+|+|.+........ |+..... .+||||++++++|...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 333344667777766 9999999999954 4678889998754322111 2222211 27999999999999999
Q ss_pred EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCC-CEEEeecc
Q 012462 211 HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDF-NAKVSDFG 289 (463)
Q Consensus 211 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~-~~kl~Dfg 289 (463)
..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++ .++|+|||
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg 155 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYG 155 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence 99999999999999999853 23699999999999999999999999 999999999999999998 99999999
Q ss_pred cceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCc
Q 012462 290 LAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369 (463)
Q Consensus 290 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 369 (463)
++....... ...++..|+|||++.+..++.++||||||+++|||++|..||..... .......+..... .
T Consensus 156 ~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~---~- 225 (267)
T PHA03390 156 LCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED-EELDLESLLKRQQ---K- 225 (267)
T ss_pred cceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc-chhhHHHHHHhhc---c-
Confidence 998654322 23578899999999998999999999999999999999999984432 2222222222110 0
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHH
Q 012462 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPK-MSQVVRM 413 (463)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs-~~ell~~ 413 (463)
. ..... .....+..++.+||+.+|.+||+ ++|++++
T Consensus 226 -~-----~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 226 -K-----LPFIK--NVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred -c-----CCccc--ccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 0 00011 11122334455799999999996 6998853
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=291.01 Aligned_cols=252 Identities=24% Similarity=0.306 Sum_probs=193.2
Q ss_pred CCCccCeEeecCcEEEEEEEE----cCCCeEEEEEEcccc----hhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEE
Q 012462 142 RFSKENVLGEGGYGVVYRGNL----INGSPVAVKKILNNV----GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHR 212 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 212 (463)
+|++.+.||+|+||.||+|.. .+|..||+|.+.... ....+.+..|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477888999999999999965 368899999985432 22345677899999999 699999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccce
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~ 292 (463)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+|||++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999999853 34588999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCceeeccccccCCCCchhhhccC--CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 293 LLGAGKSHVTTRVMGTFGYVAPEYANTG--LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
..............|+..|+|||.+.+. .++.++||||||+++|+|++|..||...... ...............
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~-- 229 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSEP-- 229 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhccCC--
Confidence 7644332223345688999999998653 4678999999999999999999999643221 112222222211110
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 012462 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRP-----KMSQVVRM 413 (463)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP-----s~~ell~~ 413 (463)
..... ....+..++.+||+.||++|| ++++++++
T Consensus 230 -------~~~~~--~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 230 -------PYPQE--MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -------CCCcc--CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 01111 112233455689999999997 67777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=289.60 Aligned_cols=257 Identities=25% Similarity=0.297 Sum_probs=197.5
Q ss_pred CCCccCeEeecCcEEEEEEEE----cCCCeEEEEEEcccc----hhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEE
Q 012462 142 RFSKENVLGEGGYGVVYRGNL----INGSPVAVKKILNNV----GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHR 212 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 212 (463)
+|++.+.||+|+||.||++.. .++..||+|.+.... ....+.+..|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 377788999999999999864 356789999885432 22335677899999999 699999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccce
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~ 292 (463)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999998853 34588999999999999999999999 99999999999999999999999999987
Q ss_pred ecCCCCceeeccccccCCCCchhhhccCC--CCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 293 LLGAGKSHVTTRVMGTFGYVAPEYANTGL--LNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
..............++..|+|||.+.+.. .+.++||||||+++|||++|..||...... ...............
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~-- 229 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ--NSQSEISRRILKSKP-- 229 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc--chHHHHHHHHHccCC--
Confidence 65443322223356889999999987655 788999999999999999999999643221 111122222221110
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCC
Q 012462 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEE 418 (463)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~ 418 (463)
...... ...+..++.+||+.||++|||++++.+.|+...
T Consensus 230 -------~~~~~~--~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~ 268 (288)
T cd05583 230 -------PFPKTM--SAEARDFIQKLLEKDPKKRLGANGADEIKNHPF 268 (288)
T ss_pred -------CCCccc--CHHHHHHHHHHhcCCHhhccCcchHHHHhcCcc
Confidence 011111 122334556899999999999988888777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=289.37 Aligned_cols=247 Identities=25% Similarity=0.365 Sum_probs=192.6
Q ss_pred EeecCcEEEEEEEEc-CCCeEEEEEEcccch---hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCCCCH
Q 012462 149 LGEGGYGVVYRGNLI-NGSPVAVKKILNNVG---QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNL 224 (463)
Q Consensus 149 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 224 (463)
||+|+||.||++... +|+.+++|.+..... .....+..|++++++++||||+++++.+..+...|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999775 489999998854433 3446788899999999999999999999999999999999999999
Q ss_pred HHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCc-----
Q 012462 225 EQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS----- 299 (463)
Q Consensus 225 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~----- 299 (463)
.+++... ..+++..++.++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 9998642 3689999999999999999999999 999999999999999999999999999876433211
Q ss_pred --eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCC
Q 012462 300 --HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNI 377 (463)
Q Consensus 300 --~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (463)
.......++..|+|||...+..++.++||||||+++|+|++|..||...... ......... ...
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~~-~~~------- 219 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------EIFQNILNG-KIE------- 219 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhcC-CcC-------
Confidence 1223346788999999998888999999999999999999999999754321 111122111 100
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 378 EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
..........+..++.+||+.+|.+|||+.++.+.|+..
T Consensus 220 -~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~ 258 (265)
T cd05579 220 -WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHP 258 (265)
T ss_pred -CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCc
Confidence 011100123334556689999999999996666555543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=274.83 Aligned_cols=252 Identities=27% Similarity=0.436 Sum_probs=192.8
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccch-hhHHHHHHHHHHHcCCC-CCCcceEeeEEEECcEEEEEEe
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVG-QAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e 217 (463)
++.+.+..||.|..|.||+++.. .|..+|||.+..... +..+++...+.++.+.+ +|+||+.+|+|..+...++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 33455678999999999999654 578999999966543 44467777888877664 8999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
.|.. .+..+|.. ..+++++..+-++...+++||.||.+++ +|+|||+||+|||+|+.|++||||||.+-.+-++
T Consensus 172 lMs~-C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 172 LMST-CAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHHH-HHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc
Confidence 9843 66666653 3456999999999999999999999875 9999999999999999999999999999776554
Q ss_pred CceeeccccccCCCCchhhhcc---CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccccc
Q 012462 298 KSHVTTRVMGTFGYVAPEYANT---GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVD 374 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (463)
.. .+...|-+.|||||.+.- ..|+.++||||||+.|+||.||+.||.+..- +.. .+.....+. ...++
T Consensus 246 kA--htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t--dFe---~ltkvln~e--PP~L~ 316 (391)
T KOG0983|consen 246 KA--HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT--DFE---VLTKVLNEE--PPLLP 316 (391)
T ss_pred cc--cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc--cHH---HHHHHHhcC--CCCCC
Confidence 43 344567889999998854 4689999999999999999999999986432 111 122222211 12222
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 375 PNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
....+.+ .+.++ +..||.+|+.+||...+++++
T Consensus 317 ~~~gFSp---~F~~f---v~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 317 GHMGFSP---DFQSF---VKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred cccCcCH---HHHHH---HHHHhhcCcccCcchHHHhcC
Confidence 2222332 23333 335999999999999999875
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=291.26 Aligned_cols=260 Identities=25% Similarity=0.331 Sum_probs=195.9
Q ss_pred CCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccch--hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeec
Q 012462 143 FSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYV 219 (463)
Q Consensus 143 ~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 219 (463)
|++.+.||+|++|.||+|.. .+++.+++|.+..... .....+..|+.++++++|+||+++++++.++...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56678999999999999965 4688999998855432 24467778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCc
Q 012462 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299 (463)
Q Consensus 220 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 299 (463)
++ +|.+++... ...+++..++.++.|++.||.|||+. +|+|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 75 888887642 35689999999999999999999999 99999999999999999999999999998765433
Q ss_pred eeeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCc---ccccc-
Q 012462 300 HVTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS---EEVVD- 374 (463)
Q Consensus 300 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~- 374 (463)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+. ............. .....
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ---LFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCchHhcccchhh
Confidence 122234578889999998776 789999999999999999999999975442111 1111000000000 00000
Q ss_pred --------CCCCCCC----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 375 --------PNIEVRP----STRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 375 --------~~~~~~~----~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
+...... .......+..++.+||+.||.+||++++++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000000 01123445566778999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=289.36 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=197.4
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCC-CCCcceEeeEEEECcEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV 215 (463)
++|.+.+.||+|+||.||+|... ++..|++|.+.... ......+..|+.++.+++ ||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999654 68999999885422 233466788999999998 99999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
||++.+++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 999999999999854 34699999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCc-------------------eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccH
Q 012462 296 AGKS-------------------HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNL 356 (463)
Q Consensus 296 ~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~ 356 (463)
.... .......++..|+|||......++.++||||||+++|++++|..||.......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---- 229 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL---- 229 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH----
Confidence 3221 12233467889999999988889999999999999999999999998654111
Q ss_pred HHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCH----HHHHHH
Q 012462 357 VDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKM----SQVVRM 413 (463)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~----~ell~~ 413 (463)
. ....... ........ ......++.+||+.+|.+||++ ++++++
T Consensus 230 -~-~~~~~~~---------~~~~~~~~--~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 230 -T-FQKILKL---------EYSFPPNF--PPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred -H-HHHHHhc---------CCCCCCcc--CHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 1 1111110 00111111 2233445668999999999999 777653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=285.29 Aligned_cols=244 Identities=22% Similarity=0.271 Sum_probs=183.9
Q ss_pred CeEeecCcEEEEEEEE-cCCCeEEEEEEcccch---hhHHHHHHHHHH-HcCCCCCCcceEeeEEEECcEEEEEEeecCC
Q 012462 147 NVLGEGGYGVVYRGNL-INGSPVAVKKILNNVG---QAEKEFRVEVEA-IGHVRHKNLVRLLGYCIEGIHRMLVYEYVNN 221 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 221 (463)
+.||+|+||.||+|.. .+++.||+|.+..... .....+..|..+ ....+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999965 4678999998854321 122234445444 3455899999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCcee
Q 012462 222 GNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV 301 (463)
Q Consensus 222 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 301 (463)
++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999999853 34689999999999999999999999 999999999999999999999999999875432
Q ss_pred eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCC
Q 012462 302 TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRP 381 (463)
Q Consensus 302 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (463)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||...... ............ . .. ....
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~--~-~~--~~~~ 218 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD------AVFDNILSRRIN--W-PE--EVKE 218 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhcccC--C-CC--cccc
Confidence 22346788999999998888999999999999999999999999754321 111111111100 0 00 0000
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 012462 382 STRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415 (463)
Q Consensus 382 ~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~ 415 (463)
.....+..++.+||+.||++||++.++.+.|.
T Consensus 219 --~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 219 --FCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred --cCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 11233445566899999999997765544443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=290.63 Aligned_cols=199 Identities=22% Similarity=0.233 Sum_probs=163.4
Q ss_pred ccCeEeecCcEEEEEEEEcCCCeEEEEEEccc--chhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCCC
Q 012462 145 KENVLGEGGYGVVYRGNLINGSPVAVKKILNN--VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNG 222 (463)
Q Consensus 145 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 222 (463)
+.+.+|.|+++.||++.. +++.||+|++... .......+..|+.+++.++|+||+++++++.+.+..+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344456666666666644 7899999998644 3344567889999999999999999999999999999999999999
Q ss_pred CHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCc---
Q 012462 223 NLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS--- 299 (463)
Q Consensus 223 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~--- 299 (463)
+|.+++... ....+++..+..++.|++.||.|||++ +|+|+||||+||+++.++.++|+|||.+........
T Consensus 85 ~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 85 SCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 999998753 233588999999999999999999999 999999999999999999999999998875532211
Q ss_pred ---eeeccccccCCCCchhhhcc--CCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 300 ---HVTTRVMGTFGYVAPEYANT--GLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 300 ---~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
.......++..|+|||++.. ..++.++|||||||++|||++|..||....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~ 214 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMP 214 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 01122356778999999876 358899999999999999999999997543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=297.12 Aligned_cols=262 Identities=24% Similarity=0.355 Sum_probs=193.6
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEE----CcEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE----GIHRM 213 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~ 213 (463)
++|++.+.||+|+||.||+|.. .++..||+|++.... ......+..|+.++++++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 6799999999999999999954 468999999985432 2334567779999999999999999998763 35679
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
+||||+. ++|.+++. ....+++..++.++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++..
T Consensus 85 lv~e~~~-~~l~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 85 VVMDLME-SDLHHIIH----SDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEehhh-hhHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 9999995 58988874 334589999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCc---eeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCC--
Q 012462 294 LGAGKS---HVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR-- 367 (463)
Q Consensus 294 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-- 367 (463)
...... .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ...+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~---~~~~~~~~g~~~~ 233 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ---LKLILSVLGSPSE 233 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH---HHHHHHHhCCChh
Confidence 543221 11234578899999998865 4688999999999999999999999975432211 11111110000
Q ss_pred ---------CccccccC-CCCCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 368 ---------RSEEVVDP-NIEVRPS-----TRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 368 ---------~~~~~~~~-~~~~~~~-----~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
........ ....... ......+..++.+||+.+|++||++.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000000 0000000 0012344556668999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=290.18 Aligned_cols=202 Identities=27% Similarity=0.393 Sum_probs=167.1
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccch--hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
++|++.+.||+|++|+||+|... +++.||+|.+..... .....+..|+.++++++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999654 688999998754322 233567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC-CCCEEEeecccceecCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD-DFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~-~~~~kl~Dfg~a~~~~~ 296 (463)
|++ ++|.+++... ....+++..++.++.||+.||+|||++ +++|+||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 5888877532 233467888999999999999999999 9999999999999985 56799999999976543
Q ss_pred CCceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
.. .......+++.|+|||++.+ ..++.++|||||||++|+|+||..||....
T Consensus 156 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~ 208 (294)
T PLN00009 156 PV-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS 208 (294)
T ss_pred Cc-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 11223456889999998866 457899999999999999999999997644
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=318.15 Aligned_cols=261 Identities=24% Similarity=0.302 Sum_probs=206.4
Q ss_pred hHHHHHHhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEE
Q 012462 133 LRDLELATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 208 (463)
Q Consensus 133 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 208 (463)
+.++....++|.++++||+|+||.|.+++. ..++.+|.|++.+.. ......|..|-.+|..-+.+=|+.++-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 567778889999999999999999999966 457788999875422 1233467788889888888899999999999
Q ss_pred CcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeec
Q 012462 209 GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDF 288 (463)
Q Consensus 209 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Df 288 (463)
..++|+|||||+||+|..++.. ...+++..+..++..|+.||.-||+. |+|||||||+|||||..|++||+||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk----~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSK----FDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred ccceEEEEecccCchHHHHHhh----cCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence 9999999999999999999853 33699999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCceeeccccccCCCCchhhhc----c-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHH
Q 012462 289 GLAKLLGAGKSHVTTRVMGTFGYVAPEYAN----T-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMM 363 (463)
Q Consensus 289 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 363 (463)
|.+..+.....-.....+|||.|.+||++. + +.|+..+|+||+||++|||+.|..||.... +++....+
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveTY~KI 293 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVETYGKI 293 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHHHHHH
Confidence 999988866666667789999999999984 2 579999999999999999999999997532 33322222
Q ss_pred hcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCC---HHHHHHHH
Q 012462 364 VGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPK---MSQVVRML 414 (463)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs---~~ell~~L 414 (463)
..-...-.+. .....+.....+...+. -+|+.|.. ++++-.+-
T Consensus 294 m~hk~~l~FP-~~~~VSeeakdLI~~ll-------~~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 294 MNHKESLSFP-DETDVSEEAKDLIEALL-------CDREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred hchhhhcCCC-cccccCHHHHHHHHHHh-------cChhhhcccccHHHHHhCc
Confidence 2222222222 12223333444433332 37788887 88887654
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=299.98 Aligned_cols=200 Identities=30% Similarity=0.411 Sum_probs=171.7
Q ss_pred CCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECc-----EEE
Q 012462 142 RFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGI-----HRM 213 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 213 (463)
+|++.+.||+|+||.||+|... ++..||+|++.... ....+.+..|+.+++.++|+||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888899999999999999764 48899999886543 334567888999999999999999999998775 789
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
+||||+. ++|.+++.. ...+++..++.++.||+.||+|||+. +|+|+||||.|||++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 488888753 34799999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCc--eeeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 294 LGAGKS--HVTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 294 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
...... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~ 211 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD 211 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence 654421 112334678899999999887 88999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=284.95 Aligned_cols=251 Identities=20% Similarity=0.303 Sum_probs=193.2
Q ss_pred CCCccCeEeecCcEEEEEEEEcC-CCeEEEEEEccc-----chhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEE
Q 012462 142 RFSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNN-----VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 215 (463)
+|.+.+.||+|+||.||++.... +..+++|.+... .......+..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58888999999999999996543 444556655321 122334566789999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
|||+++++|.+++.........+++..++.++.|++.||.|||+. +++|+||+|+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999999876545556799999999999999999999999 9999999999999975 569999999987754
Q ss_pred CCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 296 AGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||.... ........... ....
T Consensus 157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~~~-~~~~---- 224 (260)
T cd08222 157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIVEG-PTPS---- 224 (260)
T ss_pred CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHcC-CCCC----
Confidence 322 12233567889999999988889999999999999999999999996432 11111111111 0000
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.. .........++.+||+.+|++||++.|++++
T Consensus 225 ---~~--~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 225 ---LP--ETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ---Cc--chhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 01 1112234455668999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=296.53 Aligned_cols=263 Identities=25% Similarity=0.347 Sum_probs=192.1
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEccc--chhhHHHHHHHHHHHcCC-CCCCcceEeeEEEEC--cEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNN--VGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEG--IHRM 213 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~~~ 213 (463)
.++|++.+.||+|+||.||+|... ++..+|+|++... .......+..|+.++.++ +||||++++++|... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 467888999999999999999654 5789999988542 223335567799999999 999999999998653 4679
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
+||||+. ++|.+++.. ..+++..++.++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++..
T Consensus 86 lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 86 LVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 9999997 599888753 2688999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCc----eeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHH-----------
Q 012462 294 LGAGKS----HVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLV----------- 357 (463)
Q Consensus 294 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~----------- 357 (463)
...... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 543321 12234568899999998754 56788999999999999999999999754322111000
Q ss_pred -HHHHHHhcCCCccccccCC----CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 358 -DWLKMMVGSRRSEEVVDPN----IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 358 -~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
..+................ ....+. ....+..++.+||+.||++|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPK--ASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccC--CCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000000000000000 000001 12334556678999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=287.94 Aligned_cols=253 Identities=26% Similarity=0.396 Sum_probs=190.4
Q ss_pred HhcCCCccCeEeecCcEEEEEEEEcC-CCeEEEEEEcccc-hhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEEEEE
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNV-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV 215 (463)
..++|++.+.||+|+||.||+|.+.+ ++.||||.+.... ......+..|+.++.++ .||||++++++|.+....|+|
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 34668889999999999999997754 8899999986433 23344556677766666 599999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE-AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
|||+. ++|.+++.. ....+++..+..++.|++.||+|||+ . +|+||||+|+||++++++.++|+|||++...
T Consensus 93 ~e~~~-~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 93 MELMS-TCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred eeccC-cCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 99985 478777653 23468999999999999999999997 5 8999999999999999999999999998765
Q ss_pred CCCCceeeccccccCCCCchhhhccCC----CCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 295 GAGKSHVTTRVMGTFGYVAPEYANTGL----LNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
..... .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... .+.+........ .
T Consensus 166 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~~-~ 237 (296)
T cd06618 166 VDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEEP-P 237 (296)
T ss_pred cCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCCC-C
Confidence 43221 22335778999999987553 788999999999999999999999643211 111222221111 1
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.. .... .....+..++.+||+.||++||++.+++++
T Consensus 238 ~~-----~~~~--~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 238 SL-----PPNE--GFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CC-----CCCC--CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 0000 111234445668999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=289.92 Aligned_cols=249 Identities=25% Similarity=0.365 Sum_probs=191.9
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEccc---chhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNN---VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
..|+..+.||+|+||.||+|... ++..+++|.+... ......++..|+.+++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34777789999999999999654 5788999987532 2233456778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+. |+|.+++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 95 EYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 9996 588887753 234588999999999999999999999 999999999999999999999999999876543
Q ss_pred CCceeeccccccCCCCchhhhc---cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccc
Q 012462 297 GKSHVTTRVMGTFGYVAPEYAN---TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (463)
. ....++..|+|||.+. ...++.++|||||||++|+|++|..||...... ...........
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~----- 231 (308)
T cd06634 168 A-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNES----- 231 (308)
T ss_pred c-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH------HHHHHHhhcCC-----
Confidence 2 2346788999999874 356788999999999999999999998653211 11111111111
Q ss_pred cCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 012462 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416 (463)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~ 416 (463)
+..... .....+..++.+||+.+|++||++.+++++.-.
T Consensus 232 -~~~~~~---~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 232 -PALQSG---HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred -CCcCcc---cccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 000001 111223445668999999999999999987443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=285.61 Aligned_cols=242 Identities=23% Similarity=0.313 Sum_probs=182.6
Q ss_pred eEeecCcEEEEEEEE-cCCCeEEEEEEcccch---hhHHHHHHH---HHHHcCCCCCCcceEeeEEEECcEEEEEEeecC
Q 012462 148 VLGEGGYGVVYRGNL-INGSPVAVKKILNNVG---QAEKEFRVE---VEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVN 220 (463)
Q Consensus 148 ~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e---~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 220 (463)
.||+|+||.||+|.. .+++.||+|.+..... .....+..| +..+...+||||+.+++++.+.+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999965 4588999998854321 111223333 344555689999999999999999999999999
Q ss_pred CCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCce
Q 012462 221 NGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSH 300 (463)
Q Consensus 221 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 300 (463)
+++|.+++. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 999998884 345699999999999999999999999 99999999999999999999999999987654322
Q ss_pred eeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCC
Q 012462 301 VTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEV 379 (463)
Q Consensus 301 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (463)
.....|+..|+|||++.++ .++.++||||+||++|||++|+.||............ .... .. . ...
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~-~~------~--~~~ 218 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMTL-TM------A--VEL 218 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH---HHhh-cc------C--CCC
Confidence 2234689999999998754 6899999999999999999999999765332211110 0000 00 0 011
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 012462 380 RPSTRALKRSLLTALRCVDPDSEKRP-----KMSQVVRM 413 (463)
Q Consensus 380 ~~~~~~~~~~~~~~~~cl~~dP~~RP-----s~~ell~~ 413 (463)
.... ...+..++.+||..+|.+|| ++.+++++
T Consensus 219 ~~~~--s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 219 PDSF--SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCcC--CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 1111 12334445579999999999 99999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=285.95 Aligned_cols=261 Identities=24% Similarity=0.333 Sum_probs=190.4
Q ss_pred CCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccch--hhHHHHHHHHHHHcCC---CCCCcceEeeEEEECcE-----
Q 012462 143 FSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVG--QAEKEFRVEVEAIGHV---RHKNLVRLLGYCIEGIH----- 211 (463)
Q Consensus 143 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~----- 211 (463)
|++.+.||+|+||.||+|... ++..||+|.+..... .....+..|+.++.++ +||||+++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567789999999999999765 489999999853322 2234455677666554 69999999999988776
Q ss_pred EEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccc
Q 012462 212 RMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA 291 (463)
Q Consensus 212 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a 291 (463)
.+++|||+.+ +|.+++... ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~--~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKC--PKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999975 899988642 223589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcc-
Q 012462 292 KLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE- 370 (463)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~- 370 (463)
........ .....++..|+|||.+.+..++.++|+|||||++|||++|..||....... ................
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 230 (287)
T cd07838 155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIGLPSEEEW 230 (287)
T ss_pred eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcCCCChHhc
Confidence 87643321 123357889999999999999999999999999999999999997543221 1111111110000000
Q ss_pred --------ccccCCCCCCC---CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 371 --------EVVDPNIEVRP---STRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 371 --------~~~~~~~~~~~---~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
........... ..........++.+||+.||.+||+++|++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00000000000 00112334456678999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=295.99 Aligned_cols=201 Identities=27% Similarity=0.393 Sum_probs=166.0
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC---------
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG--------- 209 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------- 209 (463)
..+|.+.+.||.|+||.||+|.. .++..||+|++........+.+..|+.++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 36899999999999999999955 46889999998665555556788899999999999999999876543
Q ss_pred -----cEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEc-CCCCE
Q 012462 210 -----IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILID-DDFNA 283 (463)
Q Consensus 210 -----~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~-~~~~~ 283 (463)
...++||||+. ++|.+++.. ..+++..++.++.||+.||.|||+. +|+||||||+||+++ .++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence 35789999997 589887742 3588999999999999999999999 999999999999997 45678
Q ss_pred EEeecccceecCCCCce--eeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 284 KVSDFGLAKLLGAGKSH--VTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 284 kl~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
+|+|||++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~ 223 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH 223 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999865432111 1122357889999997654 568889999999999999999999997554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=287.96 Aligned_cols=244 Identities=25% Similarity=0.358 Sum_probs=189.4
Q ss_pred CCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 143 FSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 143 ~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
|...+.||+|+||+||+|.. .++..|++|.+.... ......+..|+.+++.++|||++++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66678899999999999965 467899999885322 22335677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+. ++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 103 ~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 95 588887753 234689999999999999999999999 999999999999999999999999999864321
Q ss_pred ceeeccccccCCCCchhhhc---cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 299 SHVTTRVMGTFGYVAPEYAN---TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
.....++..|+|||++. ...++.++|||||||++|+|++|..||....... .+........ ..
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~~~-~~---- 239 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNDS-PT---- 239 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHhcCC-CC----
Confidence 22356888999999974 4568889999999999999999999997543211 1111111111 00
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
....... ..+..++.+||+.+|.+||++.+++.+
T Consensus 240 -~~~~~~~---~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 240 -LQSNEWT---DSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -CCccccC---HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001111 123345558999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=275.24 Aligned_cols=203 Identities=23% Similarity=0.331 Sum_probs=168.6
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cC----CCeEEEEEEcccch--hhHHHHHHHHHHHcCCCCCCcceEeeEEEE-CcEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-IN----GSPVAVKKILNNVG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIE-GIHR 212 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~----~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~ 212 (463)
..|+....||+|.||.||+|.- +. ...+|+|+++.... ......-+|+.+++.++||||+.+..+|.+ +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 4588899999999999999932 22 23789999855421 222455679999999999999999999987 7788
Q ss_pred EEEEeecCCCCHHHHHhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCC----CCEEEee
Q 012462 213 MLVYEYVNNGNLEQWLHGAMR-HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDD----FNAKVSD 287 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~----~~~kl~D 287 (463)
++++||.+. +|.+.++-.+. ....++...+..|+.||+.|+.|||++ -|+||||||.|||+..+ |.|||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence 999999987 99998864432 235688999999999999999999999 99999999999999887 8999999
Q ss_pred cccceecCCCCce--eeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCC
Q 012462 288 FGLAKLLGAGKSH--VTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDH 347 (463)
Q Consensus 288 fg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~ 347 (463)
||+++.+...-.. ....++-|.+|+|||++.+. .|+.+.|||+.||++.||+|-.+.|.+
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 9999988654322 23456779999999988774 689999999999999999998888865
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=285.38 Aligned_cols=263 Identities=23% Similarity=0.292 Sum_probs=192.7
Q ss_pred CCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccch-hhHHHHHHHHHHHcCCC-CCCcceEeeEEEECcEEEEEEeec
Q 012462 143 FSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVG-QAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGIHRMLVYEYV 219 (463)
Q Consensus 143 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~ 219 (463)
|.+.+.||+|+||+||+|... +++.|++|++..... .......+|+..+.+++ |+||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567789999999999999764 478899998855432 22234456889999998 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCc
Q 012462 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299 (463)
Q Consensus 220 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 299 (463)
+|+|.+++... ....+++..++.++.|++.+|.|||++ +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 78999988642 234689999999999999999999999 999999999999999999999999999986643321
Q ss_pred eeeccccccCCCCchhhhc-cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccH----------HHHHHHHhcCCC
Q 012462 300 HVTTRVMGTFGYVAPEYAN-TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNL----------VDWLKMMVGSRR 368 (463)
Q Consensus 300 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~----------~~~~~~~~~~~~ 368 (463)
.....++..|+|||++. ...++.++|+||||+++|||++|+.||........... ..|.........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 22345788999999874 45578999999999999999999999976543221100 001000000000
Q ss_pred ccccccCCCCC--CC-CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 369 SEEVVDPNIEV--RP-STRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 369 ~~~~~~~~~~~--~~-~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
........... .. ..........++.+||+.||++||+++|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000000 00 00012345566778999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=289.87 Aligned_cols=205 Identities=28% Similarity=0.366 Sum_probs=179.3
Q ss_pred HHhcCCCccCeEeecCcEEEEEEE-EcCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEE
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGN-LINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRM 213 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 213 (463)
+..+.|..-++||+|+||.||-+. ..+|+-+|.|++.+.. ...+....+|-.+|.+++.+.||.+--.|++.+.+|
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 445778889999999999999984 3468899999884432 233455677999999999999999998999999999
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
+|+..|+||+|.-+|.... ...|++..++.++.+|+.||++||+. +||+|||||+|||+|+.|+++|+|+|+|..
T Consensus 262 lVLtlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred EEEEeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEe
Confidence 9999999999998886543 34699999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 294 LGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
+..+.. ....+||.+|||||++.+..|+...|+|||||+||||+.|+.||....
T Consensus 337 i~~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K 390 (591)
T KOG0986|consen 337 IPEGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK 390 (591)
T ss_pred cCCCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh
Confidence 876543 333489999999999999999999999999999999999999997543
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=292.64 Aligned_cols=264 Identities=25% Similarity=0.321 Sum_probs=193.8
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEE-CcEE
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE-GIHR 212 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~ 212 (463)
...+++|++.+.||+|+||.||+|.. .++..||+|++.... ....+.+..|+.++..++||||++++++|.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 34578899999999999999999954 478899999875422 2234567789999999999999999999875 5678
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccce
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~ 292 (463)
++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+. +|+|+||+|+||+++.++.++|+|||++.
T Consensus 86 ~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 9999998 5689888742 3478888999999999999999999 99999999999999999999999999987
Q ss_pred ecCCCCceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccH---------HHHHHH
Q 012462 293 LLGAGKSHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNL---------VDWLKM 362 (463)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~---------~~~~~~ 362 (463)
..... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........... .++...
T Consensus 157 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 157 IQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 54322 123457889999998765 5689999999999999999999999975432111100 000000
Q ss_pred HhcCCCccccccCCCCCCCCHH-----HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 363 MVGSRRSEEVVDPNIEVRPSTR-----ALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.........+..-......... ....+..++.+||+.+|++||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000000000000000 11344455668999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=294.02 Aligned_cols=262 Identities=22% Similarity=0.273 Sum_probs=191.8
Q ss_pred cCCCc-cCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhh--------------HHHHHHHHHHHcCCCCCCcceEee
Q 012462 141 NRFSK-ENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQA--------------EKEFRVEVEAIGHVRHKNLVRLLG 204 (463)
Q Consensus 141 ~~~~~-~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~l~~ 204 (463)
++|.. .+.||+|+||+||+|.. .+++.||+|++....... ...+.+|++++.+++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45654 56799999999999965 468899999885432211 124678999999999999999999
Q ss_pred EEEECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEE
Q 012462 205 YCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAK 284 (463)
Q Consensus 205 ~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~k 284 (463)
++...+..++||||+. |+|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence 9999999999999996 599998843 34589999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCC-------------ceeeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCC
Q 012462 285 VSDFGLAKLLGAGK-------------SHVTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350 (463)
Q Consensus 285 l~Dfg~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~ 350 (463)
|+|||++....... ........++..|+|||.+.+. .++.++|||||||++|||++|..||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999998654111 0111223467889999988764 468999999999999999999999976543
Q ss_pred cccccHHHHHHHHhcCCCcccccc--------CCCC-CCCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 351 AHEVNLVDWLKMMVGSRRSEEVVD--------PNIE-VRPST-----RALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~-~~~~~-----~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.. ....+...........+.. +... ..... ........++.+||+.+|++||++.|++.+
T Consensus 240 ~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 240 ID---QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HH---HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 21 1111111111111000000 0000 00000 012334456678999999999999999874
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=276.14 Aligned_cols=196 Identities=27% Similarity=0.435 Sum_probs=169.9
Q ss_pred cCeEeecCcEEEEEE-EEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEEEEEEeecCCCC
Q 012462 146 ENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGN 223 (463)
Q Consensus 146 ~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 223 (463)
.+.||+|+|+.|--+ ...+|..+|||++.+.....+.++.+|++++.++ .|+||+.++++|+++...|||||-|.||+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 368999999999988 6678999999999887778888889999999998 69999999999999999999999999999
Q ss_pred HHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCC---EEEeecccceecCCC---
Q 012462 224 LEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFN---AKVSDFGLAKLLGAG--- 297 (463)
Q Consensus 224 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~---~kl~Dfg~a~~~~~~--- 297 (463)
|...++. +..|++.++.++..+|+.||.|||.+ ||.||||||+|||...... +||+||.+..-+...
T Consensus 163 lLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 163 LLSHIQK----RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred HHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 9999864 45699999999999999999999999 9999999999999976654 799999887543211
Q ss_pred ---CceeeccccccCCCCchhhhc-----cCCCCccchhhhHHHHHHHHHhCCCCCCCC
Q 012462 298 ---KSHVTTRVMGTFGYVAPEYAN-----TGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348 (463)
Q Consensus 298 ---~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~pf~~~ 348 (463)
......+.+|+..|||||+.. ...|+.+.|.||||||||-|++|..||.+.
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~ 294 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH 294 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence 112234568899999999763 346899999999999999999999999763
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=302.42 Aligned_cols=202 Identities=31% Similarity=0.434 Sum_probs=173.4
Q ss_pred CCccCeEeecCcEEEEEEE-EcCCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC------cEEEE
Q 012462 143 FSKENVLGEGGYGVVYRGN-LINGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG------IHRML 214 (463)
Q Consensus 143 ~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~l 214 (463)
+...+.||+|+||.||+|+ ...|+.||||.+.... ....+...+|++++++|+|+|||+++++-++. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 3445789999999999997 5689999999986543 33456677899999999999999999986543 35689
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEc--CCC--CEEEeeccc
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILID--DDF--NAKVSDFGL 290 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~--~~~--~~kl~Dfg~ 290 (463)
|||||.+|+|...|+... +...+++.+.+.++.+++.||.|||++ +|+||||||.||++- ++| ..||+|||+
T Consensus 95 vmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 999999999999998653 445699999999999999999999999 999999999999983 334 369999999
Q ss_pred ceecCCCCceeeccccccCCCCchhhhc-cCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Q 012462 291 AKLLGAGKSHVTTRVMGTFGYVAPEYAN-TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350 (463)
Q Consensus 291 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~ 350 (463)
|+..+++. ....++||..|.+||+.. ...|+..+|.|||||++|++.||..||.....
T Consensus 171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~ 229 (732)
T KOG4250|consen 171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG 229 (732)
T ss_pred cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence 99887654 677889999999999998 48899999999999999999999999976543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=287.58 Aligned_cols=265 Identities=22% Similarity=0.277 Sum_probs=203.6
Q ss_pred HHHHHhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCC--CC----CcceEeeEEE
Q 012462 135 DLELATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR--HK----NLVRLLGYCI 207 (463)
Q Consensus 135 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~----niv~l~~~~~ 207 (463)
..+...++|.+...+|+|.||.|..+.+ ..+..||||+++. .....+..+.|++++.++. -| -++.+.++|.
T Consensus 83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~-V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN-VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHH-HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 3345589999999999999999999943 4478999998754 3444556667999999983 23 3788889999
Q ss_pred ECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEc---------
Q 012462 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILID--------- 278 (463)
Q Consensus 208 ~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~--------- 278 (463)
..++.|||+|.+ |-++.+||.. .+..+++...+..++.|++++++|||+. +++|.||||+|||+.
T Consensus 162 yrghiCivfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~ 235 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYN 235 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEec
Confidence 999999999998 6699999965 3456789999999999999999999999 999999999999983
Q ss_pred -----------CCCCEEEeecccceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCC
Q 012462 279 -----------DDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDH 347 (463)
Q Consensus 279 -----------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 347 (463)
.+..|+|+|||.|....... ...+.|..|+|||++.+-.|+.++||||+||||+||+||...|..
T Consensus 236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 236 PKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred cCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 23468999999998765443 346779999999999999999999999999999999999999987
Q ss_pred CCCcccccHHHHHHHHhcC-----------------CCc-----------cccccC----CCCCCCCHHHHHHHHHHHhh
Q 012462 348 GRPAHEVNLVDWLKMMVGS-----------------RRS-----------EEVVDP----NIEVRPSTRALKRSLLTALR 395 (463)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~-----------------~~~-----------~~~~~~----~~~~~~~~~~~~~~~~~~~~ 395 (463)
....+....++ .+.+. ++. ....++ .........+...++.++.+
T Consensus 312 Hen~EHLaMMe---rIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 312 HENLEHLAMME---RILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred CCcHHHHHHHH---HhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 65333221111 11110 000 000000 00112234456778888889
Q ss_pred ccCCCCCCCCCHHHHHHH
Q 012462 396 CVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 396 cl~~dP~~RPs~~ell~~ 413 (463)
||..||.+|+|+.|++.+
T Consensus 389 mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 389 MLEFDPARRITLREALSH 406 (415)
T ss_pred HHccCccccccHHHHhcC
Confidence 999999999999999875
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=315.52 Aligned_cols=251 Identities=25% Similarity=0.400 Sum_probs=183.3
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC---------
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG--------- 209 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------- 209 (463)
++|+.++.||+||||.||+++. -||+.+|||++.-.. ...-..+.+|+..+++|+|||||+++..+.+.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 4677788999999999999954 589999999995443 33345678899999999999999887432100
Q ss_pred --------------------------------------------------------------------------------
Q 012462 210 -------------------------------------------------------------------------------- 209 (463)
Q Consensus 210 -------------------------------------------------------------------------------- 209 (463)
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence
Q ss_pred ------------------------------cEEEEEEeecCCCCHHHHHhhhhcCCCCC-CHHHHHHHHHHHHHHHHHHH
Q 012462 210 ------------------------------IHRMLVYEYVNNGNLEQWLHGAMRHHGYL-TWEARMKVLLGTAKALAYLH 258 (463)
Q Consensus 210 ------------------------------~~~~lV~e~~~~g~L~~~l~~~~~~~~~~-~~~~~~~i~~~i~~~l~~LH 258 (463)
..+||=||||+.-.|.++++.. ... .....|+++++|++||.|+|
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N----~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN----HFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc----ccchhhHHHHHHHHHHHHHHHHHH
Confidence 0146779999887777776431 112 46788999999999999999
Q ss_pred hcCCCCeEEccCCCCceeEcCCCCEEEeecccceecC----C-------------CCceeeccccccCCCCchhhhccC-
Q 012462 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG----A-------------GKSHVTTRVMGTFGYVAPEYANTG- 320 (463)
Q Consensus 259 ~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~----~-------------~~~~~~~~~~gt~~y~aPE~~~~~- 320 (463)
+. |||||||||.||+++++..|||+|||++.... . ......+..+||.-|+|||++.+.
T Consensus 715 ~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 99 99999999999999999999999999998721 0 011124557899999999999765
Q ss_pred --CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccC
Q 012462 321 --LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVD 398 (463)
Q Consensus 321 --~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~ 398 (463)
.|+.|+|+|||||||+||+. ||.... +..... ..+. .+..+.. + ....+.......++.++++
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ERa~iL---~~LR-~g~iP~~--~----~f~~~~~~~e~slI~~Ll~ 856 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ERASIL---TNLR-KGSIPEP--A----DFFDPEHPEEASLIRWLLS 856 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchH--HHHHHH---Hhcc-cCCCCCC--c----ccccccchHHHHHHHHHhc
Confidence 49999999999999999986 565322 222221 1111 1111111 0 1112223333445668999
Q ss_pred CCCCCCCCHHHHHHH
Q 012462 399 PDSEKRPKMSQVVRM 413 (463)
Q Consensus 399 ~dP~~RPs~~ell~~ 413 (463)
.||.+|||+.|+|+.
T Consensus 857 hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 857 HDPSKRPTATELLNS 871 (1351)
T ss_pred CCCccCCCHHHHhhc
Confidence 999999999999763
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=289.83 Aligned_cols=205 Identities=27% Similarity=0.375 Sum_probs=171.1
Q ss_pred chHHHHHHhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEE
Q 012462 132 TLRDLELATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 208 (463)
Q Consensus 132 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 208 (463)
...++...+++|++.+.||+|+||.||+|.. .++..||+|++.... ....+.+.+|+.++.+++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3455666789999999999999999999954 578899999985432 2234567789999999999999999998864
Q ss_pred C------cEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCC
Q 012462 209 G------IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFN 282 (463)
Q Consensus 209 ~------~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~ 282 (463)
. ...+++++++ +++|.+++.. ..+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCC
Confidence 3 3467888887 7799887742 3489999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 283 AKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 283 ~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
++|+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....
T Consensus 159 ~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 222 (345)
T cd07877 159 LKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 222 (345)
T ss_pred EEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999998764322 233467889999998866 568899999999999999999999997543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=290.00 Aligned_cols=198 Identities=26% Similarity=0.427 Sum_probs=167.5
Q ss_pred HhcCCCccCeEeecCcEEEEEEE-EcCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECc-----
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGN-LINGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGI----- 210 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 210 (463)
..++|++.+.||+|+||.||+|. ..++..||+|++.... ......+..|+.++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 46789999999999999999995 4578999999885432 223456778999999999999999999987543
Q ss_pred -EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecc
Q 012462 211 -HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFG 289 (463)
Q Consensus 211 -~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg 289 (463)
..++||||+ +++|.+++. ...+++..++.++.||+.||.|||+. +|+||||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence 458999999 779988874 23589999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 290 LAKLLGAGKSHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 290 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
++...... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||....
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 220 (343)
T cd07880 164 LARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD 220 (343)
T ss_pred cccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99865432 223457889999998876 458899999999999999999999997543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=289.21 Aligned_cols=264 Identities=25% Similarity=0.326 Sum_probs=190.7
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccchh--hHHHHHHHHHHHcCCCCCCcceEeeEEEECc------
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQ--AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGI------ 210 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 210 (463)
.++|++.+.||+|+||.||+|... +++.+|+|.+...... ....+.+|+++++.++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999654 6789999988543221 2345677999999999999999999875433
Q ss_pred --EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeec
Q 012462 211 --HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDF 288 (463)
Q Consensus 211 --~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Df 288 (463)
..++|+||+.+ +|...+.. ....+++..+..++.|+++||.|||+. +|+|+||||+||+++.++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 46899999965 77777653 234699999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCce----------eeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHH
Q 012462 289 GLAKLLGAGKSH----------VTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLV 357 (463)
Q Consensus 289 g~a~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~ 357 (463)
|++......... ..+...+++.|+|||.+.+. .++.++|||||||++|||++|+.||...........
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~- 238 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL- 238 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-
Confidence 999765432111 11234568889999987654 588999999999999999999999975443211111
Q ss_pred HHHHHHhcCCCc---------ccccc--CCCCCCCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 358 DWLKMMVGSRRS---------EEVVD--PNIEVRPST-----RALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 358 ~~~~~~~~~~~~---------~~~~~--~~~~~~~~~-----~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
+......... ....+ ......... .....+..++.+||+.||.+|||+.|++.+
T Consensus 239 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 239 --IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred --HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 1100000000 00000 000000000 011334556678999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=325.73 Aligned_cols=252 Identities=29% Similarity=0.374 Sum_probs=197.8
Q ss_pred hcCCCccCeEeecCcEEEEEE-EEcCCCeEEEEEEcccch--hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
+-|++....||.|.||.||-| ...+|.-.|+|-+.-+.. ...+.+..|+.++..++|||+|+++|+-...+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 346777889999999999999 556788999998854433 33356778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
|||.+|+|.+.+. ..+-.++.....+..|++.|++|||++ |||||||||.||+|+.+|.+|++|||.|..+..
T Consensus 1314 EyC~~GsLa~ll~----~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLE----HGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHhccCcHHHHHH----hcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecC
Confidence 9999999999984 334466777778899999999999999 999999999999999999999999999998765
Q ss_pred CCce---eeccccccCCCCchhhhccCC---CCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 297 GKSH---VTTRVMGTFGYVAPEYANTGL---LNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 297 ~~~~---~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
.... ......||+.|||||++.+.. ..-++||||||||+.||+||+.||..... +. .+...++-+..+
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn--e~----aIMy~V~~gh~P 1460 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN--EW----AIMYHVAAGHKP 1460 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc--hh----HHHhHHhccCCC
Confidence 4321 123568999999999997643 45689999999999999999999974321 11 123334444433
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.+... ... +-..++-.||..||.+|.++.|++++
T Consensus 1461 q~P~~---ls~------~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1461 QIPER---LSS------EGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred CCchh---hhH------hHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 33222 111 22223447999999999999988875
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=271.66 Aligned_cols=253 Identities=23% Similarity=0.266 Sum_probs=189.3
Q ss_pred hcCCCcc-CeEeecCcEEEEEE-EEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCC-CCCCcceEeeEEEE----CcEE
Q 012462 140 TNRFSKE-NVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIE----GIHR 212 (463)
Q Consensus 140 ~~~~~~~-~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~~ 212 (463)
+++|++. ++||-|-.|.|..+ ...+++.+|+|++.+. ...++|+++.-.. .|||||.++++|.+ ...+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 4556653 58999999999998 4457899999987543 3344566664433 79999999999864 3556
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC---CCCEEEeecc
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD---DFNAKVSDFG 289 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~---~~~~kl~Dfg 289 (463)
++|||.|+||.|...+.+. ....|++.++..|+.||+.|+.|||+. +|.||||||+|+|... |-.+||+|||
T Consensus 135 LiVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred EeeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccc
Confidence 7899999999999999763 455699999999999999999999999 9999999999999964 5579999999
Q ss_pred cceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCc
Q 012462 290 LAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369 (463)
Q Consensus 290 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 369 (463)
+|+.... .....+.|-|+.|.|||++....|+...|+||+||+||-|++|.+||......... - .+....+.
T Consensus 210 FAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais---p---gMk~rI~~ 281 (400)
T KOG0604|consen 210 FAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---P---GMKRRIRT 281 (400)
T ss_pred cccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC---h---hHHhHhhc
Confidence 9987543 23345678899999999999999999999999999999999999999754321100 0 00111111
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
...--+..+++.-.+. ...++...|..+|.+|.|+.+++.+
T Consensus 282 gqy~FP~pEWs~VSe~---aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 282 GQYEFPEPEWSCVSEA---AKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred cCccCCChhHhHHHHH---HHHHHHHHhcCCchhheeHHHhhcC
Confidence 1111122222222222 2333446889999999999999864
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=282.82 Aligned_cols=258 Identities=26% Similarity=0.376 Sum_probs=194.3
Q ss_pred CCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeec
Q 012462 143 FSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYV 219 (463)
Q Consensus 143 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 219 (463)
|+..+.||+|+||.||+|... +++.+++|.+.... ......+..|+.++++++|+||+++++++.+....++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456778999999999999664 48999999986543 233456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCc
Q 012462 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299 (463)
Q Consensus 220 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 299 (463)
. ++|.+++... ...+++..++.++.|++.||.|||+. +|+|+||+|+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 5999998643 14689999999999999999999999 999999999999999999999999999987644322
Q ss_pred eeeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCC----------
Q 012462 300 HVTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRR---------- 368 (463)
Q Consensus 300 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~---------- 368 (463)
......++..|+|||.+.+. .++.++|||||||++|||++|..||........ ...+........
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCCCcHHHHHhhccc
Confidence 12233457789999998776 789999999999999999999999976432111 111111000000
Q ss_pred --ccccccCC----C-CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 369 --SEEVVDPN----I-EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 369 --~~~~~~~~----~-~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
........ . ...+. ....+..++.+||+.||++||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 230 PDYKPTFPKFPPKDLEKVLPR--LDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccccccCccchHHhccc--ccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000000 0 00001 12345566678999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=290.28 Aligned_cols=196 Identities=27% Similarity=0.409 Sum_probs=164.3
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC------c
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG------I 210 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 210 (463)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++.... ......+..|+.+++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 46899999999999999999965 468999999885432 22234577899999999999999999998754 3
Q ss_pred EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccc
Q 012462 211 HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGL 290 (463)
Q Consensus 211 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~ 290 (463)
..++|+||+.. +|..++ ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 46899999964 777654 12488999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 291 AKLLGAGKSHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 291 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....
T Consensus 164 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 164 ARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred CcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 8764322 223467889999999876 468899999999999999999999997643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=285.84 Aligned_cols=259 Identities=26% Similarity=0.431 Sum_probs=195.2
Q ss_pred HHhcCCCccCeEeecCcEEEEEE-EEcCCCeEEEEEEccc-chhh------HHHHHHHHHHHcCCCCCCcceEeeEEE-E
Q 012462 138 LATNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNN-VGQA------EKEFRVEVEAIGHVRHKNLVRLLGYCI-E 208 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~-~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~-~ 208 (463)
...+||-++++||+|+|+.||+| ++...+.||||+-.-+ ...+ .+...+|..+.+.|+||.||++|++|. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 34578999999999999999999 6677899999975322 1111 123557999999999999999999986 5
Q ss_pred CcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEc---CCCCEEE
Q 012462 209 GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILID---DDFNAKV 285 (463)
Q Consensus 209 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~---~~~~~kl 285 (463)
.+.+|-|+|||+|.+|.-||. .+..+++.++..|+.||+.||.||.+. .|+|||-||||.|||+- ..|.+||
T Consensus 540 tdsFCTVLEYceGNDLDFYLK----QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLK----QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred cccceeeeeecCCCchhHHHH----hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEe
Confidence 677889999999999999995 456799999999999999999999884 78999999999999994 4588999
Q ss_pred eecccceecCCCCc------eeeccccccCCCCchhhhccC----CCCccchhhhHHHHHHHHHhCCCCCCCCCCccccc
Q 012462 286 SDFGLAKLLGAGKS------HVTTRVMGTFGYVAPEYANTG----LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVN 355 (463)
Q Consensus 286 ~Dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~ 355 (463)
+|||+++.++.... ..+....||.+|++||++.-+ ..+.|+||||.||++|..+.|+.||.+.....
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--- 691 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--- 691 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH---
Confidence 99999998865432 234457899999999987433 46789999999999999999999998644221
Q ss_pred HHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 012462 356 LVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412 (463)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~ 412 (463)
+.+....-... . ...+++-.....+...++.+||+.--++|....++..
T Consensus 692 --dILqeNTIlkA-t-----EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 692 --DILQENTILKA-T-----EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred --HHHhhhchhcc-e-----eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 11111110000 1 1111211111222333466899999999988777643
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=287.76 Aligned_cols=200 Identities=29% Similarity=0.368 Sum_probs=163.7
Q ss_pred CCCccCeEeecCcEEEEEEEEc-C--CCeEEEEEEcccc--hhhHHHHHHHHHHHcCC-CCCCcceEeeEEEEC----cE
Q 012462 142 RFSKENVLGEGGYGVVYRGNLI-N--GSPVAVKKILNNV--GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEG----IH 211 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~~ 211 (463)
+|.+.+.||+|+||.||++... . +..||+|++.... ....+.+..|+.++.++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778889999999999999654 3 6789999885432 22345677899999998 599999999975432 45
Q ss_pred EEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccc
Q 012462 212 RMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA 291 (463)
Q Consensus 212 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a 291 (463)
.++++||+. ++|.+++. ....+++..++.++.||+.||.|||+. +++|+||||+|||++.++.++|+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 688899885 68998884 345689999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCce---eeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 292 KLLGAGKSH---VTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 292 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
......... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||....
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~ 214 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD 214 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence 865432211 1233568999999998765 468999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=281.94 Aligned_cols=206 Identities=26% Similarity=0.340 Sum_probs=174.6
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHH---HHHHHHHHHcCC-CCCCcceEeeEEEECcE
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEK---EFRVEVEAIGHV-RHKNLVRLLGYCIEGIH 211 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~---~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 211 (463)
.+...+|.++.+||+|+||+|.+|.. -+.+.+|||+++.+.-.+.+ --..|-++|+.. +-|.+++++.+|..-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 34456788899999999999999943 44678999998765432222 233466676665 46789999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccc
Q 012462 212 RMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA 291 (463)
Q Consensus 212 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a 291 (463)
+|+||||+.||+|.-.++. -+.+.+..+..+|..|+-||-|||++ +|++||||..|||++.+|++||+|||++
T Consensus 425 LyFVMEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmc 497 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC 497 (683)
T ss_pred eeeEEEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccc
Confidence 9999999999999988854 45588889999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Q 012462 292 KLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350 (463)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~ 350 (463)
+..-... ..+.++||||.|+|||++..++|+..+|+|||||+||||+.|+.||++..+
T Consensus 498 KEni~~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE 555 (683)
T KOG0696|consen 498 KENIFDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 555 (683)
T ss_pred cccccCC-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 8643332 345678999999999999999999999999999999999999999997654
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=291.56 Aligned_cols=257 Identities=24% Similarity=0.341 Sum_probs=192.4
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcE-----
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIH----- 211 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 211 (463)
.++|++.+.||+|+||.||+|... ++..||+|++.... ......+..|+.++++++||||+++++++.....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 568999999999999999999664 57899999875432 2233566779999999999999999998876554
Q ss_pred -EEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccc
Q 012462 212 -RMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGL 290 (463)
Q Consensus 212 -~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~ 290 (463)
.++|+||+ +++|.+++.. ..+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||+
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccc
Confidence 89999999 6699998853 4589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCc
Q 012462 291 AKLLGAGKSHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369 (463)
Q Consensus 291 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 369 (463)
+...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......... ..+...... ..
T Consensus 165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~---~~i~~~~~~-~~ 236 (343)
T cd07851 165 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQL---KRIMNLVGT-PD 236 (343)
T ss_pred ccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHhcCC-CC
Confidence 9865432 233467889999998865 46789999999999999999999999764432111 100000000 00
Q ss_pred ccc------------ccCC-CCCCCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 370 EEV------------VDPN-IEVRPST-----RALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 370 ~~~------------~~~~-~~~~~~~-----~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
..+ .... ....... .....+..++.+||+.||++|||+.||+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000 0000 0000000 012344556778999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=311.61 Aligned_cols=145 Identities=30% Similarity=0.453 Sum_probs=129.4
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
++|.+.++||+|+||+||+|... +++.||+|++.... ......+..|+.++..++||||+++++++......|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57889999999999999999664 68899999985432 223466788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccce
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~ 292 (463)
||+.+++|.+++.. .+.+++..++.++.||+.||.|||.. +|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999853 34588999999999999999999999 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=273.08 Aligned_cols=239 Identities=26% Similarity=0.299 Sum_probs=189.1
Q ss_pred EeecCcEEEEEEEEc-CCCeEEEEEEcccch---hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCCCCH
Q 012462 149 LGEGGYGVVYRGNLI-NGSPVAVKKILNNVG---QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNL 224 (463)
Q Consensus 149 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 224 (463)
||+|+||.||++... +++.+++|.+..... .....+..|+.++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999664 588999998854432 2345788899999999999999999999999999999999999999
Q ss_pred HHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCceeecc
Q 012462 225 EQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR 304 (463)
Q Consensus 225 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 304 (463)
.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 152 (250)
T cd05123 81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT 152 (250)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence 999853 33589999999999999999999998 99999999999999999999999999998764432 12334
Q ss_pred ccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHH
Q 012462 305 VMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTR 384 (463)
Q Consensus 305 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (463)
..++..|+|||...+..++.++|+||||+++|+|++|..||..... .......... ........
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~---------~~~~~~~~- 216 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKILKD---------PLRFPEFL- 216 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhcC---------CCCCCCCC-
Confidence 5678899999999888889999999999999999999999975432 1111111111 01111111
Q ss_pred HHHHHHHHHhhccCCCCCCCCCH---HHHHH
Q 012462 385 ALKRSLLTALRCVDPDSEKRPKM---SQVVR 412 (463)
Q Consensus 385 ~~~~~~~~~~~cl~~dP~~RPs~---~ell~ 412 (463)
...+..++.+||..||++||++ +++++
T Consensus 217 -~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 217 -SPEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred -CHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 2233445668999999999999 55543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=250.72 Aligned_cols=200 Identities=26% Similarity=0.417 Sum_probs=169.1
Q ss_pred CCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 142 RFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
+|...++||+|.||+||+|+. ..++.||+|++.-+. ........+|+.+++.++|.|||+++++...+..+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 466678999999999999954 567899999985432 33345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
|+. +|..|... -++.++.+.+..++.|+++||.|+|++ ++.|||+||.|+|++.+|++|++|||+++.++-..
T Consensus 83 cdq-dlkkyfds---lng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hhH-HHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 965 88888753 456799999999999999999999999 99999999999999999999999999999876543
Q ss_pred ceeeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHh-CCCCCCCCC
Q 012462 299 SHVTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAIT-GRDPVDHGR 349 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~ellt-g~~pf~~~~ 349 (463)
.. ....+-|.+|++|.++.+. -|+...|+||.||++.|+.. |++.|.+..
T Consensus 156 rc-ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d 207 (292)
T KOG0662|consen 156 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207 (292)
T ss_pred Ee-eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc
Confidence 22 3334569999999998775 58889999999999999987 666666544
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=272.74 Aligned_cols=256 Identities=25% Similarity=0.354 Sum_probs=192.7
Q ss_pred CCccCeEeecCcEEEEEE-EEcCCCeEEEEEEcccc-hhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEEEEEEeec
Q 012462 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYV 219 (463)
Q Consensus 143 ~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~ 219 (463)
.+-+..||.|+||+|++- ....|+..|||++.... ...++++..|.+...+- +.||||++||.+..++..|+.||+|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 344567999999999998 44578999999996544 35667788888775554 7999999999999999999999999
Q ss_pred CCCCHHHHHhh-hhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 220 NNGNLEQWLHG-AMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 220 ~~g~L~~~l~~-~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+- +|..+... .......+++..+-.|....+.||.||.... .|+|||+||+|||++..|.+||||||.+-....+
T Consensus 146 d~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S- 221 (361)
T KOG1006|consen 146 DI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS- 221 (361)
T ss_pred hh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH-
Confidence 54 77765432 2223456899988899999999999998765 8999999999999999999999999998655432
Q ss_pred ceeeccccccCCCCchhhhcc--CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCC
Q 012462 299 SHVTTRVMGTFGYVAPEYANT--GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (463)
...+.-.|-..|||||.+.. ..|+.+|||||||++|||+.||+.||.... ++.+.+.+.+......-..+
T Consensus 222 -iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-----svfeql~~Vv~gdpp~l~~~-- 293 (361)
T KOG1006|consen 222 -IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-----SVFEQLCQVVIGDPPILLFD-- 293 (361)
T ss_pred -HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-----HHHHHHHHHHcCCCCeecCc--
Confidence 12233356778999998854 358999999999999999999999997643 24455555554433222211
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.+.......+.. ++-.||-+|-++||.+.+++++
T Consensus 294 ~~~~~~s~~~~~---fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 294 KECVHYSFSMVR---FINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ccccccCHHHHH---HHHHHhhcccccCcchhhhhcC
Confidence 111112223333 3445999999999999998764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=274.83 Aligned_cols=264 Identities=22% Similarity=0.283 Sum_probs=197.0
Q ss_pred hcCCCccCeEeecCcEEEEEE-EEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCC-----CC---CcceEeeEEE---
Q 012462 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR-----HK---NLVRLLGYCI--- 207 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~---niv~l~~~~~--- 207 (463)
.+||.+.++||.|-|++||+| +.++.+.||+|+++.. ..-.+....||++|++++ |+ +||+|++.|.
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 489999999999999999999 5567789999987543 333344556899988872 33 6999999997
Q ss_pred -ECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEc--------
Q 012462 208 -EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILID-------- 278 (463)
Q Consensus 208 -~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~-------- 278 (463)
++.+.|+|+|++ |.+|..++... ..+.++...+..|++||+.||.|||..| +|||.||||+|||+.
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~ 230 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAK 230 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhh
Confidence 467899999999 67999998753 3456999999999999999999999998 999999999999994
Q ss_pred --------------------------------------------------------------------------------
Q 012462 279 -------------------------------------------------------------------------------- 278 (463)
Q Consensus 279 -------------------------------------------------------------------------------- 278 (463)
T Consensus 231 ~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n 310 (590)
T KOG1290|consen 231 DAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRIN 310 (590)
T ss_pred hhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCC
Confidence
Q ss_pred ---------------------------C---------------------------------------------------C
Q 012462 279 ---------------------------D---------------------------------------------------D 280 (463)
Q Consensus 279 ---------------------------~---------------------------------------------------~ 280 (463)
. +
T Consensus 311 ~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~d 390 (590)
T KOG1290|consen 311 GNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECD 390 (590)
T ss_pred ccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccc
Confidence 0 0
Q ss_pred CCEEEeecccceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcc----cccH
Q 012462 281 FNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAH----EVNL 356 (463)
Q Consensus 281 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~----~~~~ 356 (463)
-.+||+|||-|.+.... .+.-..|..|+|||++.+..|+..+||||++|++|||+||...|+...... +..+
T Consensus 391 i~vKIaDlGNACW~~kh----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHi 466 (590)
T KOG1290|consen 391 IRVKIADLGNACWVHKH----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHI 466 (590)
T ss_pred eeEEEeeccchhhhhhh----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHH
Confidence 13688888888765432 333457899999999999999999999999999999999999997543221 1111
Q ss_pred HHHHHH--------HhcCCCccccccCC--------CCCC-----------CCHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 012462 357 VDWLKM--------MVGSRRSEEVVDPN--------IEVR-----------PSTRALKRSLLTALRCVDPDSEKRPKMSQ 409 (463)
Q Consensus 357 ~~~~~~--------~~~~~~~~~~~~~~--------~~~~-----------~~~~~~~~~~~~~~~cl~~dP~~RPs~~e 409 (463)
...+.. ...+....++++.. +... ...++..++..++.-||+.+|++||||.+
T Consensus 467 A~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~ 546 (590)
T KOG1290|consen 467 ALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQ 546 (590)
T ss_pred HHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHH
Confidence 111111 12223333444322 1111 12334445555566799999999999999
Q ss_pred HHHH
Q 012462 410 VVRM 413 (463)
Q Consensus 410 ll~~ 413 (463)
.|++
T Consensus 547 cl~h 550 (590)
T KOG1290|consen 547 CLKH 550 (590)
T ss_pred HhcC
Confidence 9864
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=249.71 Aligned_cols=214 Identities=28% Similarity=0.417 Sum_probs=179.3
Q ss_pred cchHHHHHHhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc-hhhHHHHHHHHHHHcCC-CCCCcceEeeEEE
Q 012462 131 FTLRDLELATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCI 207 (463)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 207 (463)
+....+++..+.......||+|++|.|-+-++ .+|...|+|.+.... .+.++++..|+.+..+. .+|.+|.++|...
T Consensus 36 I~~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~ 115 (282)
T KOG0984|consen 36 IGDRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF 115 (282)
T ss_pred EecCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh
Confidence 34445666777777788999999999988754 678999999996544 34556777788886665 7999999999998
Q ss_pred ECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEee
Q 012462 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSD 287 (463)
Q Consensus 208 ~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~D 287 (463)
.....++.||.|+. +|..|........+.+++..+-+|+..|..||.|||++. .++|||+||+|||++.+|++|+||
T Consensus 116 regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCD 192 (282)
T KOG0984|consen 116 REGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICD 192 (282)
T ss_pred ccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcc
Confidence 88999999999966 999998887788889999999999999999999999976 899999999999999999999999
Q ss_pred cccceecCCCCceeeccccccCCCCchhhhcc----CCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 288 FGLAKLLGAGKSHVTTRVMGTFGYVAPEYANT----GLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 288 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
||.+-...++-. .+--.|-..|||||.+.. ..|+.+|||||||+.+.||.+++.||+...
T Consensus 193 FGIsG~L~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 193 FGISGYLVDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred cccceeehhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 999977654321 111245678999998743 378999999999999999999999998643
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=292.80 Aligned_cols=254 Identities=26% Similarity=0.413 Sum_probs=203.4
Q ss_pred HhcCCCccCeEeecCcEEEEEEE-EcCCCeEEEEEEcccchhhHHHHHHHHHHHcCC-CCCCcceEeeEEEE-----CcE
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGN-LINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIE-----GIH 211 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-----~~~ 211 (463)
.++.|++.++||.|.+|.||+++ ..+++.+|+|+... ....++++..|.++++.+ +|||++.++|+|.. +++
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~-~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDP-TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecC-CccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 35668899999999999999994 45678888887643 344556777788888877 79999999999873 578
Q ss_pred EEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccc
Q 012462 212 RMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA 291 (463)
Q Consensus 212 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a 291 (463)
+|||||||.+|+..|+++... ...+.|..+..|++.++.||.+||.+ .++|||||-.|||++.++.|||+|||++
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvS 170 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVS 170 (953)
T ss_pred EEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeee
Confidence 999999999999999998764 66799999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCceeeccccccCCCCchhhhccC-----CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcC
Q 012462 292 KLLGAGKSHVTTRVMGTFGYVAPEYANTG-----LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGS 366 (463)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 366 (463)
....... ....+..||+.|||||++... .|+..+|+||||++..||--|.+|+.+..+... +.
T Consensus 171 aQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra---------LF-- 238 (953)
T KOG0587|consen 171 AQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA---------LF-- 238 (953)
T ss_pred eeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh---------hc--
Confidence 8775433 234457899999999998543 477899999999999999999999987554321 11
Q ss_pred CCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 367 RRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
....+|...+.....=..++..++..||.+|-++||++.+++++
T Consensus 239 ---~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 239 ---LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ---cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11122222223233334445555667999999999999999875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=287.47 Aligned_cols=240 Identities=24% Similarity=0.288 Sum_probs=185.8
Q ss_pred hcCCCccCeEeecCcEEEEEE-EEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEEEEEEe
Q 012462 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e 217 (463)
++.|++...+|.|+|+.|-.+ ...+++..++|++..... +...|+.++... +||||+++.+.+.++.+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 567888889999999999988 445688999999855422 222355555444 79999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeE-cCCCCEEEeecccceecCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILI-DDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill-~~~~~~kl~Dfg~a~~~~~ 296 (463)
.+.|+-|.+.+.. ...+. ..+..|+.+|+.|+.|||.+ |++||||||+|||+ +..++++|+|||.++....
T Consensus 397 ~l~g~ell~ri~~----~~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 397 LLDGGELLRRIRS----KPEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hccccHHHHHHHh----cchhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999988776642 22233 67778999999999999999 99999999999999 6999999999999987654
Q ss_pred CCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (463)
. ....+-|..|.|||++....|++++||||||++||+||+|+.||...... .+. ...+......
T Consensus 469 ~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----~ei-~~~i~~~~~s------ 532 (612)
T KOG0603|consen 469 S----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----IEI-HTRIQMPKFS------ 532 (612)
T ss_pred h----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----HHH-HHhhcCCccc------
Confidence 4 22346688999999999999999999999999999999999999865533 111 1111111111
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
..-...... ++..||+.||.+||++.++..+
T Consensus 533 ---~~vS~~AKd---Ll~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 533 ---ECVSDEAKD---LLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ---cccCHHHHH---HHHHhccCChhhCcChhhhccC
Confidence 111122222 3446999999999999999754
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=281.35 Aligned_cols=244 Identities=25% Similarity=0.383 Sum_probs=190.5
Q ss_pred cCeEeecCcEEEEEEE-EcCCCeEEEEEEccc--chhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCCC
Q 012462 146 ENVLGEGGYGVVYRGN-LINGSPVAVKKILNN--VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNG 222 (463)
Q Consensus 146 ~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 222 (463)
.++||.|-||+||-|. .++|+.||||++.+. ..+.+..+++|+.+|++++||.||.+...|+..+..++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 5789999999999994 457999999998442 345567899999999999999999999999999999999999955
Q ss_pred CHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCC---CCEEEeecccceecCCCCc
Q 012462 223 NLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDD---FNAKVSDFGLAKLLGAGKS 299 (463)
Q Consensus 223 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~---~~~kl~Dfg~a~~~~~~~~ 299 (463)
+..+.+.. ...+.+++.....++.||+.||.|||.+ +|+|+||||+|||+... .++||||||+|+.+...
T Consensus 648 DMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-- 720 (888)
T KOG4236|consen 648 DMLEMILS--SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-- 720 (888)
T ss_pred hHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh--
Confidence 65555533 3456799999999999999999999999 99999999999999643 57999999999998643
Q ss_pred eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCC
Q 012462 300 HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEV 379 (463)
Q Consensus 300 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (463)
......+||+.|+|||+++++.|...-|+||.||++|.-++|..||..... +-+. +.+........++.+.
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-----IndQ----IQNAaFMyPp~PW~ei 791 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-----INDQ----IQNAAFMYPPNPWSEI 791 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-----hhHH----hhccccccCCCchhhc
Confidence 345567999999999999999999999999999999999999999975432 1111 1121222222333333
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 012462 380 RPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412 (463)
Q Consensus 380 ~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~ 412 (463)
.+.. +.++...|+..-++|-|...-+.
T Consensus 792 s~~A------idlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 792 SPEA------IDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred CHHH------HHHHHHHHHHHHHHhcchHhhcc
Confidence 3222 23333456666677777766543
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=268.84 Aligned_cols=219 Identities=19% Similarity=0.172 Sum_probs=170.0
Q ss_pred cCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCCCCHHHHHhh
Q 012462 152 GGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHG 230 (463)
Q Consensus 152 G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~ 230 (463)
|.||.||++.. .+++.+|+|.+.... .+..|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 88999999954 568899999985532 222344444556799999999999999999999999999999999853
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCceeeccccccCC
Q 012462 231 AMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310 (463)
Q Consensus 231 ~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~ 310 (463)
...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++++|||.+...... .....++..
T Consensus 79 ----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~ 147 (237)
T cd05576 79 ----FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENM 147 (237)
T ss_pred ----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcc
Confidence 23489999999999999999999999 9999999999999999999999999988655432 122345778
Q ss_pred CCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHH
Q 012462 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSL 390 (463)
Q Consensus 311 y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (463)
|+|||.+.+..++.++||||+|+++|||++|..||........ .. .....+... .....
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------~~-------~~~~~~~~~--~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------TH-------TTLNIPEWV--SEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------cc-------cccCCcccC--CHHHH
Confidence 9999999888899999999999999999999988753221000 00 000111111 12233
Q ss_pred HHHhhccCCCCCCCCCH
Q 012462 391 LTALRCVDPDSEKRPKM 407 (463)
Q Consensus 391 ~~~~~cl~~dP~~RPs~ 407 (463)
.++.+||+.||++||++
T Consensus 207 ~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 207 SLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHccCCHHHhcCC
Confidence 45568999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=284.57 Aligned_cols=207 Identities=26% Similarity=0.359 Sum_probs=180.8
Q ss_pred cCCCccCeEeecCcEEEEEEEEcCCC-eEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLINGS-PVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~~~~-~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
.+++.+..||-|+||.|=++...... .+|+|.+++.. ..+++.+..|-.+|..++.|.||++|-.|.+....|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45666778999999999999765443 48888775432 344566778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
|-|-||.|+..|+ ..+.|+..+...++..+++|++|||++ +||+|||||+|++++.+|-+||.|||+|+.+..
T Consensus 500 EaClGGElWTiLr----dRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 500 EACLGGELWTILR----DRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HhhcCchhhhhhh----hcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 9999999999995 456799999999999999999999999 999999999999999999999999999998876
Q ss_pred CCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccH
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNL 356 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~ 356 (463)
+. .+-++|||+.|.|||++.+...+..+|.||||+++|||++|.+||.+..+....++
T Consensus 573 g~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ 630 (732)
T KOG0614|consen 573 GR--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL 630 (732)
T ss_pred CC--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH
Confidence 54 35578999999999999999999999999999999999999999998776554433
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=263.69 Aligned_cols=271 Identities=24% Similarity=0.367 Sum_probs=197.9
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEE--------C
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE--------G 209 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~ 209 (463)
+.|+...++|+|.||.||+|+. +.|+.||+|++.-.. ..-.....+|+++|..|.|+|++.++..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 4577778999999999999954 457788988764321 1122344569999999999999999998753 2
Q ss_pred cEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecc
Q 012462 210 IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFG 289 (463)
Q Consensus 210 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg 289 (463)
..+|+||.+|+. +|..+|.. ....++..++.+++.++..||.|+|.. .|+|||+|+.|+||+.+|.+||+|||
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence 457999999977 89888853 235689999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCc---eeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhc
Q 012462 290 LAKLLGAGKS---HVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVG 365 (463)
Q Consensus 290 ~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 365 (463)
+++.+...+. ...+..+-|.+|++||.+.+ ..|+++.|||..||+|.||+|+.+-+.+.+......++. .+.+
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is---~LcG 246 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS---QLCG 246 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH---HHhc
Confidence 9987654332 22344567999999998766 579999999999999999999999998776544443332 3332
Q ss_pred CCCcccccc-------CCCCCCC--------CHHHH------HHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCCCC
Q 012462 366 SRRSEEVVD-------PNIEVRP--------STRAL------KRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPI 421 (463)
Q Consensus 366 ~~~~~~~~~-------~~~~~~~--------~~~~~------~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 421 (463)
+.....+.+ ..++..+ ....+ ...+.++-.++..||.+|+++.+++.+.-....+.
T Consensus 247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~ 323 (376)
T KOG0669|consen 247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPM 323 (376)
T ss_pred cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCc
Confidence 221111100 0111110 00011 12334455699999999999999998764444333
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=292.83 Aligned_cols=263 Identities=20% Similarity=0.243 Sum_probs=168.2
Q ss_pred HhcCCCccCeEeecCcEEEEEEEEcC-----CCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeE------EE
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNLIN-----GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGY------CI 207 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~~ 207 (463)
..++|++.++||+|+||.||+|.+.+ +..||+|++...... +....+ .+....+.++..++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 45789999999999999999997643 689999987543211 111111 1112222222222221 24
Q ss_pred ECcEEEEEEeecCCCCHHHHHhhhhcC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCC
Q 012462 208 EGIHRMLVYEYVNNGNLEQWLHGAMRH----------------HGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIK 271 (463)
Q Consensus 208 ~~~~~~lV~e~~~~g~L~~~l~~~~~~----------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik 271 (463)
.....++||||+.+++|.+++...... ........+..++.||+.||.|||+. +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 566789999999999999998642100 00112344668999999999999999 99999999
Q ss_pred CCceeEcC-CCCEEEeecccceecCCCCceeeccccccCCCCchhhhccC----------------------CCCccchh
Q 012462 272 SSNILIDD-DFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTG----------------------LLNEKSDV 328 (463)
Q Consensus 272 p~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sDv 328 (463)
|+|||++. ++.+||+|||+++.............++++.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 68999999999987654444444567889999999965332 23456799
Q ss_pred hhHHHHHHHHHhCCCCCCCCCC-------cccccHHHHHHHHhcCCCccccccCCCC-CCCCHHHHHHHHHHHhhccCCC
Q 012462 329 YSFGVLLLEAITGRDPVDHGRP-------AHEVNLVDWLKMMVGSRRSEEVVDPNIE-VRPSTRALKRSLLTALRCVDPD 400 (463)
Q Consensus 329 wSlGvvl~elltg~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~cl~~d 400 (463)
|||||+||||+++..|+..... ....+...|....... ...+.. .... ..... .....++.+||+.|
T Consensus 363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~d~~~---~~~~dLi~~mL~~d 437 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR-ASPDLR-RGFEVLDLDG---GAGWELLKSMMRFK 437 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc-cchhhh-hhhhhccccc---hHHHHHHHHHccCC
Confidence 9999999999997766542100 0001111121111000 000000 0000 00001 11224566899999
Q ss_pred CCCCCCHHHHHHH
Q 012462 401 SEKRPKMSQVVRM 413 (463)
Q Consensus 401 P~~RPs~~ell~~ 413 (463)
|++|||++|++++
T Consensus 438 P~kR~ta~e~L~H 450 (566)
T PLN03225 438 GRQRISAKAALAH 450 (566)
T ss_pred cccCCCHHHHhCC
Confidence 9999999999986
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=259.70 Aligned_cols=250 Identities=24% Similarity=0.325 Sum_probs=193.0
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEE
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHR 212 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 212 (463)
+.-++|.++++||+|+|++|.++++. ..+.+|+|++++.. .++.+-.+.|-.+..+- +||.+|.+..+|.....+
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 44578999999999999999999664 56788999885532 22233344555555544 899999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccce
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~ 292 (463)
++|.||.+||+|.-.++ ....++++.+..+...|+.||.|||+. ||++||||..|+|+|..|++||+|+|+++
T Consensus 327 ffvieyv~ggdlmfhmq----rqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred EEEEEEecCcceeeehh----hhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhh
Confidence 99999999999987774 345699999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCC-CcccccHHHHHHHHhcCCCccc
Q 012462 293 LLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGR-PAHEVNLVDWLKMMVGSRRSEE 371 (463)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~ 371 (463)
.--.. ...+.++||||.|.|||++++..|+...|+|+|||+|+||+.|+.||+.-. ...+.+-.+++.+.+-+..
T Consensus 400 e~l~~-gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq--- 475 (593)
T KOG0695|consen 400 EGLGP-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ--- 475 (593)
T ss_pred cCCCC-CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc---
Confidence 64322 234667999999999999999999999999999999999999999997532 2223344455444433222
Q ss_pred cccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCC
Q 012462 372 VVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRP 405 (463)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP 405 (463)
+.++.+.. .+...+...-|++||.+|.
T Consensus 476 -----iriprsls--vkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 476 -----IRIPRSLS--VKASHVLKGFLNKDPKERL 502 (593)
T ss_pred -----ccccceee--hhhHHHHHHhhcCCcHHhc
Confidence 12221111 1112233357899999985
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=256.81 Aligned_cols=237 Identities=29% Similarity=0.409 Sum_probs=189.1
Q ss_pred CcEEEEEEEEc-CCCeEEEEEEcccchhh-HHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCCCCHHHHHhh
Q 012462 153 GYGVVYRGNLI-NGSPVAVKKILNNVGQA-EKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHG 230 (463)
Q Consensus 153 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~ 230 (463)
+||.||+|... +++.+++|.+....... .+.+..|++.+++++|+||+++++++......++++||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999775 48999999986554433 67888999999999999999999999999999999999999999999854
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCceeeccccccCC
Q 012462 231 AMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310 (463)
Q Consensus 231 ~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~ 310 (463)
. ..+++..++.++.+++.++.|||+. +++|+||+|+||+++.++.++|+|||.+....... ......++..
T Consensus 81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 R----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred c----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 2 2388999999999999999999999 99999999999999999999999999998765432 2334567889
Q ss_pred CCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHH-HHHHH
Q 012462 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTR-ALKRS 389 (463)
Q Consensus 311 y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 389 (463)
|++||.+.+..++.++||||||+++|+|++|..||...... .............. ..... ....+
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-----~~~~~~~~~~~~~~---------~~~~~~~~~~~ 217 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-----LELFKKIGKPKPPF---------PPPEWKISPEA 217 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-----HHHHHHHhccCCCC---------ccccccCCHHH
Confidence 99999999888999999999999999999999999753211 11111111111000 00000 12344
Q ss_pred HHHHhhccCCCCCCCCCHHHHHH
Q 012462 390 LLTALRCVDPDSEKRPKMSQVVR 412 (463)
Q Consensus 390 ~~~~~~cl~~dP~~RPs~~ell~ 412 (463)
..++.+||..+|++||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 55666899999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=275.45 Aligned_cols=207 Identities=25% Similarity=0.359 Sum_probs=174.3
Q ss_pred hcCCCccCeEeecCcEEEEEEEEcC-CCeEEEEEEcccch---hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNVG---QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 215 (463)
..-|..++.||-|+||+|.+++..+ ...+|.|.+.+.+- ......+.|-.||+.-+.+-||+||-.|.+++.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 3457778889999999999995544 56788998855432 2334567789999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
|+|++||++..+|.. -+.|.+..+..++..+..|+++.|.. |+|||||||+|||||.+|++||+||||+.-+.
T Consensus 708 MdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred EeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccce
Confidence 999999999999853 35688999999999999999999999 99999999999999999999999999985331
Q ss_pred ---CCCce--------------------------------------eeccccccCCCCchhhhccCCCCccchhhhHHHH
Q 012462 296 ---AGKSH--------------------------------------VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVL 334 (463)
Q Consensus 296 ---~~~~~--------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvv 334 (463)
+.+++ .....+||+.|+|||++....|++.+|+||.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 11110 0123579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCccc
Q 012462 335 LLEAITGRDPVDHGRPAHE 353 (463)
Q Consensus 335 l~elltg~~pf~~~~~~~~ 353 (463)
||||+.|+.||...++...
T Consensus 861 l~em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGET 879 (1034)
T ss_pred HHHHhhCCCCccCCCCCcc
Confidence 9999999999988776543
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=279.08 Aligned_cols=206 Identities=24% Similarity=0.339 Sum_probs=154.1
Q ss_pred HhcCCCccCeEeecCcEEEEEEEE-----------------cCCCeEEEEEEcccchhhHHH--------------HHHH
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNL-----------------INGSPVAVKKILNNVGQAEKE--------------FRVE 187 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~e 187 (463)
..++|++.++||+|+||+||+|.. .+++.||||++........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999953 235679999985433222222 3346
Q ss_pred HHHHcCCCCCCc-----ceEeeEEEE--------CcEEEEEEeecCCCCHHHHHhhhhc--------------------C
Q 012462 188 VEAIGHVRHKNL-----VRLLGYCIE--------GIHRMLVYEYVNNGNLEQWLHGAMR--------------------H 234 (463)
Q Consensus 188 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lV~e~~~~g~L~~~l~~~~~--------------------~ 234 (463)
+.++.+++|.++ ++++++|.. ....++||||+++++|.++++.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 667777766544 677777753 3567999999999999999874211 0
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCceeeccccccCCCCch
Q 012462 235 HGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314 (463)
Q Consensus 235 ~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aP 314 (463)
...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...............+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12356778899999999999999999 999999999999999999999999999976543322111222347899999
Q ss_pred hhhccCC--------------------CC--ccchhhhHHHHHHHHHhCCC-CCCC
Q 012462 315 EYANTGL--------------------LN--EKSDVYSFGVLLLEAITGRD-PVDH 347 (463)
Q Consensus 315 E~~~~~~--------------------~~--~~sDvwSlGvvl~elltg~~-pf~~ 347 (463)
|.+.... |+ .+.||||+||++|+|++|.. ||..
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 9875432 11 24799999999999999875 6653
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=279.04 Aligned_cols=247 Identities=29% Similarity=0.430 Sum_probs=185.9
Q ss_pred CCccCeEeecCcEE-EEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEEEEEEeecC
Q 012462 143 FSKENVLGEGGYGV-VYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVN 220 (463)
Q Consensus 143 ~~~~~~lG~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~ 220 (463)
|.-.+++|.|+.|+ ||+|.. +|+.||||++... ......+|+..|+.. .|||||++++.-.+.+..||+.|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 33456799999875 688876 7899999998543 334566799999887 69999999999999999999999996
Q ss_pred CCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC---C--CCEEEeecccceecC
Q 012462 221 NGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD---D--FNAKVSDFGLAKLLG 295 (463)
Q Consensus 221 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~---~--~~~kl~Dfg~a~~~~ 295 (463)
. +|.+++...............+.+..|++.||++||+. +|+||||||.||||+. + ..++|+|||+++...
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5 99999976311111122245677899999999999998 9999999999999976 2 468999999999987
Q ss_pred CCCcee--eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhC-CCCCCCCCCcccccHHHHHHHHhcCCCcccc
Q 012462 296 AGKSHV--TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITG-RDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV 372 (463)
Q Consensus 296 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (463)
.+.... ..+..||.+|+|||.+....-+.++||||||||+|+.++| .+||......+ .+ +..+....
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~N-------Il~~~~~L-- 732 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-AN-------ILTGNYTL-- 732 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-hh-------hhcCccce--
Confidence 765433 3356799999999999998888899999999999999995 99997543211 11 11111111
Q ss_pred ccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 373 VDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
....+...+ ....++.+|++++|..||++.+|+.+
T Consensus 733 ----~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 733 ----VHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred ----eeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 111222212 33345568999999999999999865
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=257.00 Aligned_cols=269 Identities=22% Similarity=0.305 Sum_probs=199.4
Q ss_pred CCccCeEeecCcEEEEEEE-EcCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC-----cEEEE
Q 012462 143 FSKENVLGEGGYGVVYRGN-LINGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG-----IHRML 214 (463)
Q Consensus 143 ~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~l 214 (463)
.+-.+.||.|+||.||.+. -.+|+.||+|++.+-. -...+.+.+|++++..++|.|++..+++..-. .++|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 4456789999999999984 4679999999985422 23456778899999999999999998876543 24578
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
+.|.|.. +|...+ -....++...+.-++.||++||.|||+. +|.||||||.|+|++.+..+||||||+++..
T Consensus 135 ~TELmQS-DLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 135 LTELMQS-DLHKII----VSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHh-hhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccccccccc
Confidence 8888854 777766 3556788899999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCceeeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHH---------HHHHh
Q 012462 295 GAGKSHVTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDW---------LKMMV 364 (463)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~---------~~~~~ 364 (463)
+......++..+-|..|+|||++.+. .|+...||||.||++.||+..+..|....+....+++.- ++...
T Consensus 207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence 76665556666778999999998774 689999999999999999999999987665544433321 11111
Q ss_pred cCCCccccc----cCC----CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCC
Q 012462 365 GSRRSEEVV----DPN----IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEY 419 (463)
Q Consensus 365 ~~~~~~~~~----~~~----~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~ 419 (463)
.+.+..-+. .+. ..+..........+.+...++.+||++|.+..+.+.++...+-
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 111111000 010 1111111122223334446899999999999999887765443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=270.32 Aligned_cols=215 Identities=27% Similarity=0.272 Sum_probs=181.1
Q ss_pred cccchHHHHHHhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCC------CCCcce
Q 012462 129 HWFTLRDLELATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR------HKNLVR 201 (463)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~ 201 (463)
.+|.+.-.++...+|.+....|+|-|++|..|.. ..|..||||++.++. ...+.=..|+++|++|+ --|+++
T Consensus 420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 4677778889999999999999999999999954 457899999987653 23344456999999985 238999
Q ss_pred EeeEEEECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCC
Q 012462 202 LLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDF 281 (463)
Q Consensus 202 l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~ 281 (463)
++-.|...+++|||+|.+ ..+|.+.|..+.. +-.+....+..++.|+..||..|-.. +|+|.||||.|||+++..
T Consensus 499 l~r~F~hknHLClVFE~L-slNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k 573 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPL-SLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESK 573 (752)
T ss_pred HHHHhhhcceeEEEehhh-hchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCc
Confidence 999999999999999998 4599999987644 34588899999999999999999998 999999999999999865
Q ss_pred -CEEEeecccceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcc
Q 012462 282 -NAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAH 352 (463)
Q Consensus 282 -~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~ 352 (463)
.+||||||.|.....+. .+...-+..|.|||++.|.+|+...|+||.||+||||+||+..|.+.+..+
T Consensus 574 ~iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ 642 (752)
T KOG0670|consen 574 NILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQ 642 (752)
T ss_pred ceeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHH
Confidence 57999999998765443 222334556999999999999999999999999999999999999876543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=231.33 Aligned_cols=211 Identities=36% Similarity=0.577 Sum_probs=179.5
Q ss_pred EeecCcEEEEEEEEcC-CCeEEEEEEcccchh-hHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCCCCHHH
Q 012462 149 LGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQ-AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQ 226 (463)
Q Consensus 149 lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~~ 226 (463)
||+|.+|.||++...+ ++.+++|++...... ....+.+|+..++.+.|++|+++++++......++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999997644 899999998654432 34678889999999999999999999999889999999999999999
Q ss_pred HHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC-CCCEEEeecccceecCCCCceeeccc
Q 012462 227 WLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD-DFNAKVSDFGLAKLLGAGKSHVTTRV 305 (463)
Q Consensus 227 ~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~ 305 (463)
++.... ..+++..++.++.+++.++.+||+. +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 986421 4588999999999999999999999 9999999999999999 89999999999987654321 12234
Q ss_pred cccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHH
Q 012462 306 MGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTR 384 (463)
Q Consensus 306 ~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (463)
.+...|++||..... .++.++|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 578889999999887 788999999999999999
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 012462 385 ALKRSLLTALRCVDPDSEKRPKMSQVVRML 414 (463)
Q Consensus 385 ~~~~~~~~~~~cl~~dP~~RPs~~ell~~L 414 (463)
.....++.+|++.||++||++.++++.+
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2233445579999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-32 Score=259.81 Aligned_cols=196 Identities=23% Similarity=0.377 Sum_probs=167.3
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccchh-----hHH---HHHHHHHHHcCCC---CCCcceEeeEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQ-----AEK---EFRVEVEAIGHVR---HKNLVRLLGYCIE 208 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~---~~~~e~~~l~~l~---h~niv~l~~~~~~ 208 (463)
.+|..++.+|+|+||.|++|.++ +...|+||.+.+..-- ..+ .+-.|+.+|..|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45889999999999999999554 4678888987543211 111 2335999999997 9999999999999
Q ss_pred CcEEEEEEeec-CCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEee
Q 012462 209 GIHRMLVYEYV-NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSD 287 (463)
Q Consensus 209 ~~~~~lV~e~~-~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~D 287 (463)
++.+||+||-. ++.+|.+++. .+..+++..+..|+.||+.|+++||+. +|+|||||-+||.++.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE----~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE----FKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh----ccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence 99999999985 4568999984 456699999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCceeeccccccCCCCchhhhccCCC-CccchhhhHHHHHHHHHhCCCCCC
Q 012462 288 FGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL-NEKSDVYSFGVLLLEAITGRDPVD 346 (463)
Q Consensus 288 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~pf~ 346 (463)
||.+.....+. ...++||..|.|||++.+..| +..-|||++|++||-++....||.
T Consensus 714 fgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99998765443 556789999999999999877 667899999999999999999885
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=265.26 Aligned_cols=253 Identities=25% Similarity=0.374 Sum_probs=199.9
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
.++|++..++|.|.||.||+|++ ..++..|+|.++-.......-+++|+-+++..+||||+.++|.+...+..+++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 46789999999999999999954 57899999999877777777788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
|.+|+|.+..+ ..+++++.++..+++..++||+|||+. +-+|||||-.|||+++.|.+|++|||.+-.+...
T Consensus 94 cgggslQdiy~----~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat- 165 (829)
T KOG0576|consen 94 CGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT- 165 (829)
T ss_pred cCCCcccceee----ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh-
Confidence 99999999764 456799999999999999999999999 9999999999999999999999999998765432
Q ss_pred ceeeccccccCCCCchhhh---ccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 299 SHVTTRVMGTFGYVAPEYA---NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
......+.||+.|||||+. +.+.|.+.+|||++|+...|+---+.|..+..+ ...+..+....... +
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp------mr~l~LmTkS~~qp----p 235 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP------MRALFLMTKSGFQP----P 235 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch------HHHHHHhhccCCCC----C
Confidence 2234568899999999975 556799999999999999999877766543322 22333333322211 1
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 012462 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412 (463)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~ 412 (463)
.++......+... .++..|+.++|.+||+++.+|.
T Consensus 236 ~lkDk~kws~~fh--~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 236 TLKDKTKWSEFFH--NFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cccCCccchHHHH--HHHHHHhcCCCccCCChhhhee
Confidence 1111111122222 2233599999999999987765
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=239.19 Aligned_cols=196 Identities=29% Similarity=0.371 Sum_probs=165.1
Q ss_pred hcCCCccCeEeecCcEEEEEE-EEcCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC------c
Q 012462 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG------I 210 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 210 (463)
..||.-+..+|.|.- .|..| +.-.++.||+|++.... ....+...+|+.++..++|+||++++.+|.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 356777788999998 55555 55578999999984432 23346677899999999999999999998643 3
Q ss_pred EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccc
Q 012462 211 HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGL 290 (463)
Q Consensus 211 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~ 290 (463)
..|+|||+|+. +|...+.. .++-..+..++.|++.|+.|||+. +|+||||||+||++..+..+||.|||+
T Consensus 95 e~y~v~e~m~~-nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVILM------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred hHHHHHHhhhh-HHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchh
Confidence 46999999965 99988862 266788999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCC
Q 012462 291 AKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348 (463)
Q Consensus 291 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~ 348 (463)
++..... ..++..+.|..|.|||++.+..|.+.+||||+||++.||++|...|.+.
T Consensus 165 ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~ 220 (369)
T KOG0665|consen 165 ARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK 220 (369)
T ss_pred hcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc
Confidence 9865433 3466678899999999999988999999999999999999999999853
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=232.69 Aligned_cols=199 Identities=34% Similarity=0.491 Sum_probs=171.7
Q ss_pred CCccCeEeecCcEEEEEEEEcC-CCeEEEEEEcccchh-hHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecC
Q 012462 143 FSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQ-AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVN 220 (463)
Q Consensus 143 ~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 220 (463)
|.+.+.||+|++|.||++...+ +..+++|.+...... ..+.+..|++.+.+++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999997754 789999998665444 56788889999999999999999999998889999999999
Q ss_pred CCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCce
Q 012462 221 NGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSH 300 (463)
Q Consensus 221 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 300 (463)
+++|.+++.... ..+++..+..++.+++.++.+||+. +++|+||+|.||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 999999986421 1178999999999999999999999 9999999999999999999999999999876543211
Q ss_pred eeccccccCCCCchhhh-ccCCCCccchhhhHHHHHHHHHhCCCCCCC
Q 012462 301 VTTRVMGTFGYVAPEYA-NTGLLNEKSDVYSFGVLLLEAITGRDPVDH 347 (463)
Q Consensus 301 ~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 347 (463)
......++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22345678889999998 677788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=227.41 Aligned_cols=196 Identities=26% Similarity=0.439 Sum_probs=163.3
Q ss_pred hcCCCccCeEeecCcEEEEEEE-EcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCC-CCCcceEeeEEEEC--cEEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGN-LINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEG--IHRMLV 215 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lV 215 (463)
.++|++.+++|+|-|++||.|. ..+++.++||.++. -..+.+.+|+.+|..|. ||||++++++..+. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 3578889999999999999994 45778899998754 33467888999999995 99999999998865 345799
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCC-CCEEEeecccceec
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDD-FNAKVSDFGLAKLL 294 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~-~~~kl~Dfg~a~~~ 294 (463)
+||..+.+...+. ..++...+..++.+++.||.|||+. ||.|||+||.|+++|.. ..++|+|+|+|.+.
T Consensus 114 FE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhc
Confidence 9999987776654 2377788999999999999999999 99999999999999964 56999999999988
Q ss_pred CCCCceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Q 012462 295 GAGKSHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350 (463)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~ 350 (463)
.++... .-.+.+..|..||++.. ..|+..-|+|||||+|..|+..+.||-.+..
T Consensus 184 Hp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d 238 (338)
T KOG0668|consen 184 HPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 238 (338)
T ss_pred CCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC
Confidence 765432 22245667889998754 5688899999999999999999999977653
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=223.23 Aligned_cols=251 Identities=21% Similarity=0.364 Sum_probs=180.7
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccchhhHHHHHHHHHHHcCC-CCCCcceEeeE-EEECcEEEEEEe
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEFRVEVEAIGHV-RHKNLVRLLGY-CIEGIHRMLVYE 217 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~-~~~~~~~~lV~e 217 (463)
+.|.+.+.||+|.||.+-+++++ +.+.+++|.+... .....+|.+|...--.| .|.||+.-|++ |...+.+++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 46888899999999999999664 4567888876443 44567888888765555 58999998875 666777789999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEc--CCCCEEEeecccceecC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILID--DDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~--~~~~~kl~Dfg~a~~~~ 295 (463)
|++.|+|..-+.. ..+.+....+++.|++.|+.|+|++ ++||||||.+||||- +...+||||||+.+..+
T Consensus 103 ~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred cCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccC
Confidence 9999999987642 3478888999999999999999999 999999999999994 34579999999987654
Q ss_pred CCCceeeccccccCCCCchhhhccC-----CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 296 AGKSHVTTRVMGTFGYVAPEYANTG-----LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 296 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
... ....-+..|.+||+.... ...+.+|+|.||+++|.++||+.||.... ..+..+..|++-..+.. .
T Consensus 175 ~tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~-~~d~~Y~~~~~w~~rk~--~ 247 (378)
T KOG1345|consen 175 TTV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS-IMDKPYWEWEQWLKRKN--P 247 (378)
T ss_pred cee----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh-ccCchHHHHHHHhcccC--c
Confidence 321 122335679999976432 24678999999999999999999998433 33445555554433221 1
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
...+ .+.+-.+...+ +..+-+.++|++|--..++.++
T Consensus 248 ~~P~---~F~~fs~~a~r---~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 248 ALPK---KFNPFSEKALR---LFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred cCch---hhcccCHHHHH---HHHHhcCCcccccchhHHHHHH
Confidence 1111 11111222222 2335788999999655555443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-28 Score=227.40 Aligned_cols=202 Identities=28% Similarity=0.387 Sum_probs=165.9
Q ss_pred HHHHhcCCCccCeEeecCcEEEEEEEEc----CCCeEEEEEEcccchhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECc
Q 012462 136 LELATNRFSKENVLGEGGYGVVYRGNLI----NGSPVAVKKILNNVGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGI 210 (463)
Q Consensus 136 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 210 (463)
+....+.|...++||+|.|++||+|.+. .++.||+|.+.... ....+..|+++|..+ .+.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3445567899999999999999999543 46799999985533 235678899999998 6899999999999999
Q ss_pred EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC-CCCEEEeecc
Q 012462 211 HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD-DFNAKVSDFG 289 (463)
Q Consensus 211 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~-~~~~kl~Dfg 289 (463)
+..+|+||++.....+++.. ++...+..+++.++.||.++|.+ ||+||||||.|+|.+. .+.-.|+|||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred eeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEech
Confidence 99999999999999888743 67889999999999999999999 9999999999999975 5678999999
Q ss_pred cceecCCCC------c-------e------------------------------eeccccccCCCCchhhhcc-CCCCcc
Q 012462 290 LAKLLGAGK------S-------H------------------------------VTTRVMGTFGYVAPEYANT-GLLNEK 325 (463)
Q Consensus 290 ~a~~~~~~~------~-------~------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~ 325 (463)
+|....... . . ......||++|.|||++.. ..-+.+
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 997211000 0 0 0112468999999998865 445789
Q ss_pred chhhhHHHHHHHHHhCCCCCCCCC
Q 012462 326 SDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 326 sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
+||||.|||++-+++++.||-...
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~ 282 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAK 282 (418)
T ss_pred cceeeccceeehhhccccccccCc
Confidence 999999999999999999997543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=266.64 Aligned_cols=196 Identities=20% Similarity=0.253 Sum_probs=137.7
Q ss_pred CCCC-CCcceEeeEE-------EECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 012462 193 HVRH-KNLVRLLGYC-------IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPK 264 (463)
Q Consensus 193 ~l~h-~niv~l~~~~-------~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ 264 (463)
.++| +||++++++| ......++++|++ +++|.++|.. ....+++..++.++.||+.||+|||++ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQ---G 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 4455 6888888887 2334567788987 5699999963 234599999999999999999999999 9
Q ss_pred eEEccCCCCceeEcCC-------------------CCEEEeecccceecCCCCc---------------eeeccccccCC
Q 012462 265 VVHRDIKSSNILIDDD-------------------FNAKVSDFGLAKLLGAGKS---------------HVTTRVMGTFG 310 (463)
Q Consensus 265 i~H~Dikp~Nill~~~-------------------~~~kl~Dfg~a~~~~~~~~---------------~~~~~~~gt~~ 310 (463)
|+||||||+||||+.. +.+||+|||+++....... ......+||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 9999999999999654 4556666666653211000 00112357889
Q ss_pred CCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHH
Q 012462 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSL 390 (463)
Q Consensus 311 y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (463)
|||||++.+..|+.++|||||||+||||++|..|+.... .... ..... ...+.. ........
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~---~~~~~-----~~~~~~-----~~~~~~~~ 242 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMS---SLRHR-----VLPPQI-----LLNWPKEA 242 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHH---HHHHh-----hcChhh-----hhcCHHHH
Confidence 999999999999999999999999999999888765321 1111 11100 000000 01122234
Q ss_pred HHHhhccCCCCCCCCCHHHHHHH
Q 012462 391 LTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 391 ~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.++.+||+++|.+||++.|++++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhhc
Confidence 45668999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=204.66 Aligned_cols=166 Identities=23% Similarity=0.185 Sum_probs=124.2
Q ss_pred CCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCcee
Q 012462 222 GNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV 301 (463)
Q Consensus 222 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 301 (463)
|+|.+++.. ....+++..++.++.||+.||.|||+. + ||+|||++.++.+++ ||++.......
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 689999864 244699999999999999999999998 6 999999999999999 99998764322
Q ss_pred eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCC
Q 012462 302 TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRP 381 (463)
Q Consensus 302 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (463)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+..+...... .... ...
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~----~~~~-----~~~ 130 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLNGMPA----DDPR-----DRS 130 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHHHhcc----CCcc-----ccc
Confidence 257899999999999999999999999999999999999996543211 111111111110 0000 001
Q ss_pred CHHHH---HHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 382 STRAL---KRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 382 ~~~~~---~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
..... ..+..++.+||+.||.+||++.|+++++...
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 11111 1456667789999999999999999988654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=215.82 Aligned_cols=165 Identities=25% Similarity=0.271 Sum_probs=128.4
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEEc--CCCeEEEEEEccc-----chhhHHHHHHHHHHHcCCCCCCcce-EeeEEEEC
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNLI--NGSPVAVKKILNN-----VGQAEKEFRVEVEAIGHVRHKNLVR-LLGYCIEG 209 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~ 209 (463)
...++|.+.+.||+|+||+||+|... +++.||||++... .......+.+|++++++++|+|+++ +++ .
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~ 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----T 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----c
Confidence 34577999999999999999999654 5677899987532 1223466889999999999999985 443 2
Q ss_pred cEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccC-CCCceeEcCCCCEEEeec
Q 012462 210 IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDI-KSSNILIDDDFNAKVSDF 288 (463)
Q Consensus 210 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Di-kp~Nill~~~~~~kl~Df 288 (463)
...|+||||++|++|.. +. .. . ...++.++++||.|||+. +|+|||| ||+|||++.++.+||+||
T Consensus 91 ~~~~LVmE~~~G~~L~~-~~----~~---~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-AR----PH---G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred CCcEEEEEccCCCCHHH-hC----cc---c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEEC
Confidence 45799999999999963 21 11 1 146788999999999999 9999999 999999999999999999
Q ss_pred ccceecCCCCce-------eeccccccCCCCchhhhccC
Q 012462 289 GLAKLLGAGKSH-------VTTRVMGTFGYVAPEYANTG 320 (463)
Q Consensus 289 g~a~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 320 (463)
|+++.+...... ......++..|+|||.+...
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999876443211 11346788899999988543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-24 Score=210.69 Aligned_cols=258 Identities=19% Similarity=0.243 Sum_probs=188.4
Q ss_pred CCCccCeEeecCcEEEEEEEEcCC--CeEEEEEEcccchhhHHHHHHHHHHHcCCC----CCCcceEeeEE-EECcEEEE
Q 012462 142 RFSKENVLGEGGYGVVYRGNLING--SPVAVKKILNNVGQAEKEFRVEVEAIGHVR----HKNLVRLLGYC-IEGIHRML 214 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~----h~niv~l~~~~-~~~~~~~l 214 (463)
+|.+.++||+|+||.||++..... ..+|+|............+..|..++..+. -+++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999976553 478888765443332226667777777775 25899999998 47778899
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCC-----CCEEEeecc
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDD-----FNAKVSDFG 289 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~-----~~~kl~Dfg 289 (463)
||+.+ |.+|.++..... .+.++..+++.++.|++.+|.+||+. |++||||||.|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99998 779999875432 56799999999999999999999999 99999999999999865 469999999
Q ss_pred cce--ecCCCCc-----e-e-eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHH
Q 012462 290 LAK--LLGAGKS-----H-V-TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWL 360 (463)
Q Consensus 290 ~a~--~~~~~~~-----~-~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~ 360 (463)
+++ ....... . . ...+.||.+|+++.+..+...+.+.|+||++.++.|++.|..|+......... ..+
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~---~~~ 249 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK---SKF 249 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH---HHH
Confidence 998 3211111 0 1 22356999999999999999999999999999999999999999654432221 111
Q ss_pred HHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 361 KMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
........... ........+...+.. +-..+..++|....+...|++.
T Consensus 250 ~~~~~~~~~~~------~~~~~~~~~~~~~~~---~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 250 EKDPRKLLTDR------FGDLKPEEFAKILEY---IDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred HHHhhhhcccc------ccCCChHHHHHHHHH---hhccCCcCCCCHHHHHHHHHHH
Confidence 11111111110 111122333333332 4447889999999998887664
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-25 Score=197.06 Aligned_cols=246 Identities=23% Similarity=0.391 Sum_probs=182.2
Q ss_pred CccCeEeecCcEEEEEEEEcCCCeEEEEEEc--ccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCC
Q 012462 144 SKENVLGEGGYGVVYRGNLINGSPVAVKKIL--NNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNN 221 (463)
Q Consensus 144 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 221 (463)
.+..+|.+...|+.|+|+++. ..+++|++. ........+|..|.-.++-+.||||++++|.|....++.++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 334578999999999999965 455566653 23334456888899999999999999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEe--ecccceecCCCCc
Q 012462 222 GNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVS--DFGLAKLLGAGKS 299 (463)
Q Consensus 222 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~--Dfg~a~~~~~~~~ 299 (463)
|+|+..|+.. ..-..+..++.+++.+|++|++|||+. .|-|.---|....+++|++.+.+|+ |--++..
T Consensus 272 gslynvlhe~--t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq------ 342 (448)
T KOG0195|consen 272 GSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ------ 342 (448)
T ss_pred hHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee------
Confidence 9999999863 333467788999999999999999996 4445555789999999999988774 3222211
Q ss_pred eeeccccccCCCCchhhhccCCCC---ccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCC
Q 012462 300 HVTTRVMGTFGYVAPEYANTGLLN---EKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376 (463)
Q Consensus 300 ~~~~~~~gt~~y~aPE~~~~~~~~---~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (463)
.....-.+.||+||.+...+-+ ..+|+|||+++||||.|...||.+..+.+.-- +....+ + .
T Consensus 343 --e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm-----kialeg------l--r 407 (448)
T KOG0195|consen 343 --EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM-----KIALEG------L--R 407 (448)
T ss_pred --ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh-----hhhhcc------c--c
Confidence 1112346889999999876544 47899999999999999999998765543210 001111 0 1
Q ss_pred CCCCCC-HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 377 IEVRPS-TRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 377 ~~~~~~-~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
..+++. ...+.+++.+ |++.||.+||.+..++-.||..
T Consensus 408 v~ippgis~hm~klm~i---cmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 408 VHIPPGISRHMNKLMNI---CMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ccCCCCccHHHHHHHHH---HhcCCCCcCCCcceehhhHHHh
Confidence 122222 3445555444 9999999999999999888764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-24 Score=185.99 Aligned_cols=207 Identities=20% Similarity=0.276 Sum_probs=170.7
Q ss_pred HHhcCCCccCeEeecCcEEEEEE-EEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCC-CCcceEeeEEEECcEEEEE
Q 012462 138 LATNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRH-KNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lV 215 (463)
+..++|.++++||.|+||.+|.| ...+|..||||.-...... ..+..|..+...|++ ..|..+..+..+...-.+|
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 44678999999999999999999 5678999999976544332 445567788777754 6788888888888888999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCC---CCEEEeecccce
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDD---FNAKVSDFGLAK 292 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~---~~~kl~Dfg~a~ 292 (463)
|+.+ |.+|.+++.-+. ..++..+++-++-|++.-++|+|.+ +++||||||+|+|..-+ ..+.|+|||+|+
T Consensus 90 MdLL-GPsLEdLfnfC~---R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCS---RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eecc-CccHHHHHHHHh---hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchh
Confidence 9998 889999887553 3488999999999999999999999 99999999999999644 468999999998
Q ss_pred ecCCCCce------eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCccc
Q 012462 293 LLGAGKSH------VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHE 353 (463)
Q Consensus 293 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~ 353 (463)
.+.+.... ......||.+|.+--...+..-+.+.|+-|+|.+|.++.-|..||.+......
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk 229 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK 229 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH
Confidence 87554322 23457799999998877777778899999999999999999999987665433
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-22 Score=195.72 Aligned_cols=261 Identities=29% Similarity=0.415 Sum_probs=192.8
Q ss_pred CCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchh---hHHHHHHHHHHHcCCCCC-CcceEeeEEEECcEEEEEEee
Q 012462 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQ---AEKEFRVEVEAIGHVRHK-NLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 143 ~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lV~e~ 218 (463)
|.+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +|+++++++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999765 78899988554332 367788899999999888 799999999877778999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCC-CEEEeecccceecCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDF-NAKVSDFGLAKLLGAG 297 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~-~~kl~Dfg~a~~~~~~ 297 (463)
+.+++|.+++...... ..+.......++.|++.++.|+|.. +++|||+||+||+++..+ .++++|||.+......
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999776532111 3688999999999999999999999 999999999999999998 7999999999865443
Q ss_pred Cce-----eeccccccCCCCchhhhcc---CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCc
Q 012462 298 KSH-----VTTRVMGTFGYVAPEYANT---GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369 (463)
Q Consensus 298 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 369 (463)
... ......|+..|+|||.+.+ ..++...|+||+|++++++++|..||...... ................
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS--SATSQTLKIILELPTP 233 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc--ccHHHHHHHHHhcCCc
Confidence 321 2356789999999999987 57889999999999999999999997654421 0011111111111110
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
....................++.+|+..+|..|.+..+....
T Consensus 234 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 --SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred --ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001112233344557899999999998887764
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-24 Score=194.09 Aligned_cols=201 Identities=22% Similarity=0.323 Sum_probs=168.5
Q ss_pred cCCCccCeEeecCcEEEEEE-EEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEEEEEEee
Q 012462 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
-.|.+.++||+|.||..+.| .+.++++||||.-.. ......++.|....+.| ..++|...+-+..++.+-.||+|+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 46889999999999999999 567899999996422 23345566677777666 578999998887788888899999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCC-----CEEEeeccccee
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDF-----NAKVSDFGLAKL 293 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~-----~~kl~Dfg~a~~ 293 (463)
+ |.+|.|++.-+. ..|+..+++.+|.|++.-++|+|++ .+|+|||||+|+||...+ .+.|+|||+|+.
T Consensus 106 L-GPSLEDLFD~Cg---R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCG---RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred h-CcCHHHHHHHhc---CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 8 789999887553 4599999999999999999999999 999999999999997543 589999999998
Q ss_pred cCCCCce------eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Q 012462 294 LGAGKSH------VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350 (463)
Q Consensus 294 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~ 350 (463)
..+.... ......||.+||+--...+..-+.+.|+-|||-++++.|-|..||.+...
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 7654432 23457799999999998999899999999999999999999999987543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.7e-24 Score=190.89 Aligned_cols=174 Identities=14% Similarity=0.157 Sum_probs=136.7
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHH---------HHHHHHHHcCCCCCCcceEeeEEE
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKE---------FRVEVEAIGHVRHKNLVRLLGYCI 207 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~h~niv~l~~~~~ 207 (463)
.+..++|...++||.|+||.||++.. ++..+|+|.+.......+.. +.+|+..+.++.|++|..+.+++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 45678999999999999999999866 57789999986544333222 678999999999999999998866
Q ss_pred EC--------cEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC
Q 012462 208 EG--------IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD 279 (463)
Q Consensus 208 ~~--------~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~ 279 (463)
.. ...++||||++|.+|.++.. ++. ....+++.+|..||.. |++|||++|.||+++.
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSK 170 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeC
Confidence 43 34789999999999988731 222 2456999999999999 9999999999999999
Q ss_pred CCCEEEeecccceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh
Q 012462 280 DFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT 340 (463)
Q Consensus 280 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt 340 (463)
++ ++|+|||.......... ...++....|+.++|+||||+++..+..
T Consensus 171 ~g-i~liDfg~~~~~~e~~a-------------~d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKA-------------KDRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred CC-EEEEECCCcccccchhh-------------HHHHHHHhHhcccccccceeEeehHHHH
Confidence 88 99999998865432111 0114455567789999999999876543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-24 Score=222.32 Aligned_cols=252 Identities=22% Similarity=0.259 Sum_probs=181.6
Q ss_pred CccCeEeecCcEEEEEEEE-cCCCeEEEEEEc----ccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 144 SKENVLGEGGYGVVYRGNL-INGSPVAVKKIL----NNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 144 ~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~----~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
...+++|.|++|.|+.+.. ......+.|.+. ... ......+..|+.+-..+.|||++..+..+.+....+-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3467899999997777733 333444444332 111 111122556788888899999988888777766666669
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
|||++ +|..++.. ...+....+..++.|++.|+.|+|.. ||.|||||++|++++.+|.+||+|||.+..+..
T Consensus 401 E~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 99998853 34688889999999999999999999 999999999999999999999999999976643
Q ss_pred CCc---eeeccccccCCCCchhhhccCCCCc-cchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccc
Q 012462 297 GKS---HVTTRVMGTFGYVAPEYANTGLLNE-KSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV 372 (463)
Q Consensus 297 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (463)
... .....++|...|+|||++.+..|++ ..||||.|+++..|.+|+.||......+... ............
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~~~~~~ 547 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSDQRNIF 547 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhccccccccc
Confidence 322 4456789999999999999999987 5799999999999999999998655433211 000001000000
Q ss_pred ccCCCCCCCCHHHHHHH-HHHHhhccCCCCCCCCCHHHHHH
Q 012462 373 VDPNIEVRPSTRALKRS-LLTALRCVDPDSEKRPKMSQVVR 412 (463)
Q Consensus 373 ~~~~~~~~~~~~~~~~~-~~~~~~cl~~dP~~RPs~~ell~ 412 (463)
. ........+.+. -.++.++|+.||.+|.|+++|++
T Consensus 548 ~----~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 548 E----GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred c----ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0 001111222222 23344899999999999999986
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.8e-24 Score=219.33 Aligned_cols=254 Identities=23% Similarity=0.236 Sum_probs=179.4
Q ss_pred CCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccc-hhhHHHHHH---HHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 142 RFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNV-GQAEKEFRV---EVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~---e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
+|...+.||.+.|=+|.+|++..|. |+||++.+.. ......+.+ |++ ...++|||.+++.-+-....-.|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5667789999999999999887776 9999986544 222333333 344 445689999999888777777799999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC-
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA- 296 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~- 296 (463)
|..+ +|+|.| ..+..+...+...|+.|++.||..+|.. ||+|||||.+||||+.-.-+.|+||...+...-
T Consensus 102 yvkh-nLyDRl----STRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 102 YVKH-NLYDRL----STRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHhh-hhhhhh----ccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCC
Confidence 9966 999987 3455578888899999999999999999 999999999999999999999999987654321
Q ss_pred -CCc----eeeccccccCCCCchhhhccC----------C-CCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHH
Q 012462 297 -GKS----HVTTRVMGTFGYVAPEYANTG----------L-LNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDW 359 (463)
Q Consensus 297 -~~~----~~~~~~~gt~~y~aPE~~~~~----------~-~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~ 359 (463)
+.. ....+-....+|.|||.+... . .+++-||||+||++.||++ |++||.- .+.
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L---------SQL 244 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL---------SQL 244 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH---------HHH
Confidence 111 112222334679999977431 2 5678899999999999998 7888852 111
Q ss_pred HHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCCCC
Q 012462 360 LKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPI 421 (463)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 421 (463)
+..-..+....+.....++ .... -.+++.|++.||++|.+++++|+.-....+|-
T Consensus 245 ~aYr~~~~~~~e~~Le~Ie-d~~~------Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP~ 299 (1431)
T KOG1240|consen 245 LAYRSGNADDPEQLLEKIE-DVSL------RNLILSMIQRDPSKRLSAEDYLQKYRGLVFPE 299 (1431)
T ss_pred HhHhccCccCHHHHHHhCc-CccH------HHHHHHHHccCchhccCHHHHHHhhhccccHH
Confidence 1111111111111111111 1111 12344699999999999999999866665543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=180.70 Aligned_cols=140 Identities=15% Similarity=0.176 Sum_probs=108.0
Q ss_pred cCeEeecCcEEEEEEEEcCCCeEEEEEEcccchh--h------------------------HHHHHHHHHHHcCCCCCCc
Q 012462 146 ENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQ--A------------------------EKEFRVEVEAIGHVRHKNL 199 (463)
Q Consensus 146 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~ni 199 (463)
...||+|+||.||+|...+|+.||||++...... . ......|+..+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4579999999999998778999999998543211 0 1122348899999988776
Q ss_pred ceEeeEEEECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEEccCCCCceeEc
Q 012462 200 VRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL-HEAIEPKVVHRDIKSSNILID 278 (463)
Q Consensus 200 v~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~i~H~Dikp~Nill~ 278 (463)
.....+... ..+|||||++++++..... ....++...+..++.|++.+|.|+ |+. +|+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 443333222 2389999999877765432 234688999999999999999999 688 999999999999998
Q ss_pred CCCCEEEeecccceecC
Q 012462 279 DDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 279 ~~~~~kl~Dfg~a~~~~ 295 (463)
++.++|+|||++....
T Consensus 153 -~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 -DGKLYIIDVSQSVEHD 168 (190)
T ss_pred -CCcEEEEEccccccCC
Confidence 4789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.8e-21 Score=169.75 Aligned_cols=187 Identities=17% Similarity=0.101 Sum_probs=140.8
Q ss_pred ccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhh----HHHHHHHHHHHcCCC-CCCcceEeeEEEECcEEEEEEeec
Q 012462 145 KENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQA----EKEFRVEVEAIGHVR-HKNLVRLLGYCIEGIHRMLVYEYV 219 (463)
Q Consensus 145 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~ 219 (463)
+...|++|+||+||.+.. .+..++.+.+....... ...+.+|+++|++|+ |+++++++++ ...+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 346899999999998865 77888877764433211 235788999999995 5889999886 3469999999
Q ss_pred CCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccC-CCCceeEcCCCCEEEeecccceecCCCC
Q 012462 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDI-KSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 220 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Di-kp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
.|.+|.+.+.. ....++.|++.+|.++|+. ||+|||| ||.|||++.++.++|+|||++.......
T Consensus 81 ~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 81 AGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred cCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 99988654310 1135778999999999999 9999999 7999999999999999999998654332
Q ss_pred ce----e--------eccccccCCCCchhhhccC-CCC-ccchhhhHHHHHHHHHhCCCCCCCCCC
Q 012462 299 SH----V--------TTRVMGTFGYVAPEYANTG-LLN-EKSDVYSFGVLLLEAITGRDPVDHGRP 350 (463)
Q Consensus 299 ~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~sDvwSlGvvl~elltg~~pf~~~~~ 350 (463)
.. . ......++.|++|+...-. ..+ ...+.++.|+-+|.++|++.|+....+
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 10 0 0012257788888854332 223 577999999999999999998865443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=192.50 Aligned_cols=216 Identities=27% Similarity=0.458 Sum_probs=160.8
Q ss_pred HcCCCCCCcceEeeEEEECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe-EEcc
Q 012462 191 IGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKV-VHRD 269 (463)
Q Consensus 191 l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i-~H~D 269 (463)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.|.+.. ....+++.....++++|+.||.|||.. .| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence 3567999999999999999999999999999999999964 345589999999999999999999987 55 9999
Q ss_pred CCCCceeEcCCCCEEEeecccceecCCC-CceeeccccccCCCCchhhhccC-------CCCccchhhhHHHHHHHHHhC
Q 012462 270 IKSSNILIDDDFNAKVSDFGLAKLLGAG-KSHVTTRVMGTFGYVAPEYANTG-------LLNEKSDVYSFGVLLLEAITG 341 (463)
Q Consensus 270 ikp~Nill~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwSlGvvl~elltg 341 (463)
+++.|++++..+.+||+|||+....... .........-..-|.|||.+.+. ..+++.||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 9999999999999999999998766321 00111111234569999998764 146789999999999999999
Q ss_pred CCCCCCCCCcccc-cHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCC
Q 012462 342 RDPVDHGRPAHEV-NLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEY 419 (463)
Q Consensus 342 ~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~ 419 (463)
..||......... .++..+.. .......|.+.... .....++.++.+||..+|.+||+++++-..++....
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cCccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9999864433322 22222221 11122222222111 112245666778999999999999999988877643
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=3e-21 Score=172.64 Aligned_cols=141 Identities=18% Similarity=0.133 Sum_probs=110.2
Q ss_pred cCeEeecCcEEEEEEEEcCCCeEEEEEEcccchh--------------------------hHHHHHHHHHHHcCCCCCCc
Q 012462 146 ENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQ--------------------------AEKEFRVEVEAIGHVRHKNL 199 (463)
Q Consensus 146 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~ni 199 (463)
...||+|+||.||+|...+|+.||||++...... ....+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999998778999999998643210 01223568889999999987
Q ss_pred ceEeeEEEECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEccCCCCceeEc
Q 012462 200 VRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE-AIEPKVVHRDIKSSNILID 278 (463)
Q Consensus 200 v~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dikp~Nill~ 278 (463)
.....+.... .++||||++++++..... ....++......++.|++.++.++|+ . +|+||||||+|||++
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence 5544443332 489999999875543321 12347788999999999999999999 8 999999999999999
Q ss_pred CCCCEEEeecccceecCC
Q 012462 279 DDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 279 ~~~~~kl~Dfg~a~~~~~ 296 (463)
++.++|+|||++.....
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 88999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.3e-20 Score=173.39 Aligned_cols=199 Identities=23% Similarity=0.359 Sum_probs=130.3
Q ss_pred CCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCC----------CCcceEeeEEE-
Q 012462 143 FSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRH----------KNLVRLLGYCI- 207 (463)
Q Consensus 143 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h----------~niv~l~~~~~- 207 (463)
+...+.||.|+++.||.+.+. +++.+|+|.+.... ....+.+++|.-....+.+ -.++..++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 455678999999999999764 48999999984322 2234566666555544322 12333333222
Q ss_pred --------ECc--------EEEEEEeecCCCCHHHHHhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEc
Q 012462 208 --------EGI--------HRMLVYEYVNNGNLEQWLHGAMRH---HGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHR 268 (463)
Q Consensus 208 --------~~~--------~~~lV~e~~~~g~L~~~l~~~~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~ 268 (463)
... ..+++|+-+ .++|.+++...... ...+....++.+..|+++.+++||.. |++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 111 236788888 45998886542221 12244456677789999999999999 99999
Q ss_pred cCCCCceeEcCCCCEEEeecccceecCCCCceeeccccccCCCCchhhhcc--------CCCCccchhhhHHHHHHHHHh
Q 012462 269 DIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANT--------GLLNEKSDVYSFGVLLLEAIT 340 (463)
Q Consensus 269 Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwSlGvvl~ellt 340 (463)
||+|+|++++.+|.++|+||+.....+.. . .. ...+..|.+||.... -.++.+.|.|+||+++|.|.+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~--~-~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTR--Y-RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEE--E-EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCce--e-ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 99999999999999999999988765431 1 11 234678999997643 246788999999999999999
Q ss_pred CCCCCCCCC
Q 012462 341 GRDPVDHGR 349 (463)
Q Consensus 341 g~~pf~~~~ 349 (463)
|..||....
T Consensus 246 ~~lPf~~~~ 254 (288)
T PF14531_consen 246 GRLPFGLSS 254 (288)
T ss_dssp SS-STCCCG
T ss_pred ccCCCCCCC
Confidence 999998654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.3e-22 Score=193.95 Aligned_cols=186 Identities=29% Similarity=0.320 Sum_probs=153.7
Q ss_pred eEeecCcEEEEEEEE----cCCCeEEEEEEcccchh--hHHHHHHHHHHHcCCC-CCCcceEeeEEEECcEEEEEEeecC
Q 012462 148 VLGEGGYGVVYRGNL----INGSPVAVKKILNNVGQ--AEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGIHRMLVYEYVN 220 (463)
Q Consensus 148 ~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~ 220 (463)
.+|+|+||.|++++. ..|.-+|.|........ .......|..++..++ ||.++++.-.+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998743 24566777776443211 1113344677777776 9999999999999999999999999
Q ss_pred CCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCce
Q 012462 221 NGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSH 300 (463)
Q Consensus 221 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 300 (463)
+|.|...+. ....+.+.....+...++.+++++|.. +|+|+|+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l~----~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~- 152 (612)
T KOG0603|consen 81 GGDLFTRLS----KEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI- 152 (612)
T ss_pred cchhhhccc----cCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence 999988763 445578888888999999999999999 999999999999999999999999999987544322
Q ss_pred eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCC
Q 012462 301 VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDH 347 (463)
Q Consensus 301 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 347 (463)
.|||..|||||++. .....+|.||||++++||+||..||..
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 18999999999998 467899999999999999999999975
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.7e-21 Score=201.56 Aligned_cols=201 Identities=20% Similarity=0.232 Sum_probs=162.0
Q ss_pred hHHHHHHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCC---CCCcceEeeEEEEC
Q 012462 133 LRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR---HKNLVRLLGYCIEG 209 (463)
Q Consensus 133 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~ 209 (463)
..+.++....|.+.+.||+|+||+||+|...+|+.||+|.-+..... +|..-.+++.+|+ -+.|..+...+.-.
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 34556777889999999999999999998778999999987554432 2222333444444 23455555555556
Q ss_pred cEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEc-------CCCC
Q 012462 210 IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILID-------DDFN 282 (463)
Q Consensus 210 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~-------~~~~ 282 (463)
+..+||+||.+.|+|.++++ ..+.++|.-+..++.|++..+++||.. +||||||||+|+||. +..-
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred CcceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccc
Confidence 67799999999999999995 556799999999999999999999999 999999999999994 3446
Q ss_pred EEEeecccceecCCC-CceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCC
Q 012462 283 AKVSDFGLAKLLGAG-KSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRD 343 (463)
Q Consensus 283 ~kl~Dfg~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~ 343 (463)
++|+|||.+..+..- +.......++|-.+-.+|+..|.+|+...|.|.|+.+++-||.|++
T Consensus 840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 899999999765422 2234566788999999999999999999999999999999999873
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=175.97 Aligned_cols=199 Identities=23% Similarity=0.301 Sum_probs=134.9
Q ss_pred CCCCcceEeeEEEEC---------------------------cEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHH
Q 012462 195 RHKNLVRLLGYCIEG---------------------------IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVL 247 (463)
Q Consensus 195 ~h~niv~l~~~~~~~---------------------------~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~ 247 (463)
.|||||++.+.|.+. ..+|+||...+. +|.+++-. ...+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-----CCCchHHHHHHH
Confidence 599999999877532 346899999866 99999843 235667777899
Q ss_pred HHHHHHHHHHHhcCCCCeEEccCCCCceeE--cCCC--CEEEeecccceecCCCCc-----eeeccccccCCCCchhhhc
Q 012462 248 LGTAKALAYLHEAIEPKVVHRDIKSSNILI--DDDF--NAKVSDFGLAKLLGAGKS-----HVTTRVMGTFGYVAPEYAN 318 (463)
Q Consensus 248 ~~i~~~l~~LH~~~~~~i~H~Dikp~Nill--~~~~--~~kl~Dfg~a~~~~~~~~-----~~~~~~~gt~~y~aPE~~~ 318 (463)
.|+++|+.|||.+ ||.|||+|++|||+ ++|+ .+.|+|||++.......- ...-..-|...-||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 99999999999999 3333 578999999865433110 0112235777899999885
Q ss_pred cCCC------CccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHH
Q 012462 319 TGLL------NEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLT 392 (463)
Q Consensus 319 ~~~~------~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (463)
..+- -.|+|.|+.|.+.||+++...||....... .+...+ +..++ |. .+...+.. .-++
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~~r~Y--------qe~qL--Pa--lp~~vpp~--~rql 489 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LDTRTY--------QESQL--PA--LPSRVPPV--ARQL 489 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-echhhh--------hhhhC--CC--CcccCChH--HHHH
Confidence 5321 248999999999999999999998633211 111111 11111 11 11111111 1223
Q ss_pred HhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 393 ALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 393 ~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
+...|+.||++|++..-....|+-.
T Consensus 490 V~~lL~r~pskRvsp~iAANvl~Ls 514 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSPNIAANVLNLS 514 (598)
T ss_pred HHHHhcCCccccCCccHHHhHHHHH
Confidence 4468899999999977666665443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.5e-20 Score=164.25 Aligned_cols=134 Identities=19% Similarity=0.226 Sum_probs=104.5
Q ss_pred cCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCC-----CCCCcceEeeEEEECc---E-EEEEE
Q 012462 146 ENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV-----RHKNLVRLLGYCIEGI---H-RMLVY 216 (463)
Q Consensus 146 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~-~~lV~ 216 (463)
.+.||+|+||.||. .......+||++........+.+.+|+.++..+ .||||++++|++.++. . +.+|+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 46899999999996 333344479988654444567789999999999 5799999999999863 3 33789
Q ss_pred ee--cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEEccCCCCceeEcC----CCCEEEeecc
Q 012462 217 EY--VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKAL-AYLHEAIEPKVVHRDIKSSNILIDD----DFNAKVSDFG 289 (463)
Q Consensus 217 e~--~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l-~~LH~~~~~~i~H~Dikp~Nill~~----~~~~kl~Dfg 289 (463)
|| +.+++|.+++.. ..+++. ..++.+++.++ +|||++ +|+||||||+|||++. ++.++|+||+
T Consensus 85 e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 85 DFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred cCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 99 557999999953 125555 35677888777 999999 9999999999999973 3489999954
Q ss_pred cc
Q 012462 290 LA 291 (463)
Q Consensus 290 ~a 291 (463)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 43
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=3e-19 Score=164.68 Aligned_cols=142 Identities=16% Similarity=0.133 Sum_probs=110.2
Q ss_pred CCCccCeEeecCcEEEEEEE--EcCCCeEEEEEEcccchh------------------------hHHHHHHHHHHHcCCC
Q 012462 142 RFSKENVLGEGGYGVVYRGN--LINGSPVAVKKILNNVGQ------------------------AEKEFRVEVEAIGHVR 195 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~ 195 (463)
-|.+.+.||+|+||.||+|. ..+|+.||+|++...... ....+..|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47889999999999999997 568999999998543210 1123567999998886
Q ss_pred CC--CcceEeeEEEECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEEccCCC
Q 012462 196 HK--NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPK-VVHRDIKS 272 (463)
Q Consensus 196 h~--niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-i~H~Dikp 272 (463)
+. .+.+++++ . ..++||||+++++|..+.. ....+....+..++.|++.+|.+||.. + ++|+||||
T Consensus 109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRL----KDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe---c-CceEEEEEecCCccccccc----ccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 53 23444442 2 3489999999988876542 223455667789999999999999999 9 99999999
Q ss_pred CceeEcCCCCEEEeecccceecC
Q 012462 273 SNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 273 ~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
+||+++ ++.++|+|||.+....
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccC
Confidence 999999 8899999999987543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=159.06 Aligned_cols=134 Identities=19% Similarity=0.337 Sum_probs=112.9
Q ss_pred CeEeecCcEEEEEEEEcCCCeEEEEEEcccch--------hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 147 NVLGEGGYGVVYRGNLINGSPVAVKKILNNVG--------QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
+.||+|++|.||+|.. .|..|++|+...... .....+.+|+.++..+.|++|.....++.+....++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999977 778899998653321 1124577899999999999988877777777788999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
++|++|.+++... .. .+..++.+++.+|.++|+. +++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988531 12 7888999999999999999 999999999999999 78999999998864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.3e-18 Score=155.38 Aligned_cols=131 Identities=22% Similarity=0.379 Sum_probs=106.8
Q ss_pred eEeecCcEEEEEEEEcCCCeEEEEEEcccch--------hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeec
Q 012462 148 VLGEGGYGVVYRGNLINGSPVAVKKILNNVG--------QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYV 219 (463)
Q Consensus 148 ~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 219 (463)
.||+|+||.||+|.+ ++..|++|....... .....+.+|++++..+.|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 379999999999985 678999998643221 11255678999999998887666555666666779999999
Q ss_pred CCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 220 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
+|++|.+++.... . .++.+++.+|.+||+. +++|+|++|.||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~~-----~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN-----D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH-----H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999999874311 0 7899999999999999 999999999999999 889999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.6e-18 Score=153.25 Aligned_cols=139 Identities=21% Similarity=0.193 Sum_probs=108.5
Q ss_pred cCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccch----------------------hhHHHHHHHHHHHcCCCCCC
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVG----------------------QAEKEFRVEVEAIGHVRHKN 198 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~e~~~l~~l~h~n 198 (463)
..|.+.+.||+|+||.||++...+|+.||||++..... ........|+.++..+.|++
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 34888899999999999999877899999998643210 01123566888888887773
Q ss_pred --cceEeeEEEECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCcee
Q 012462 199 --LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNIL 276 (463)
Q Consensus 199 --iv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nil 276 (463)
++..++. ...++||||+++++|..+.. ......++.+++.++.++|+. +++|+||||+||+
T Consensus 95 i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~----------~~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nil 157 (198)
T cd05144 95 FPVPKPIDW----NRHAVVMEYIDGVELYRVRV----------LEDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNIL 157 (198)
T ss_pred CCCCceeec----CCceEEEEEeCCcchhhccc----------cccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEE
Confidence 4444442 34589999999999876532 033567889999999999998 9999999999999
Q ss_pred EcCCCCEEEeecccceecCC
Q 012462 277 IDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 277 l~~~~~~kl~Dfg~a~~~~~ 296 (463)
+++++.++|+|||++.....
T Consensus 158 l~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 158 VDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred EcCCCcEEEEECCccccCCC
Confidence 99999999999999965543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.4e-18 Score=176.15 Aligned_cols=138 Identities=21% Similarity=0.366 Sum_probs=112.3
Q ss_pred hcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccc--------hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNV--------GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIH 211 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 211 (463)
...|...+.||+|+||+||+|.+.. ..+++|+..... ......+.+|++++..++|++++....++.+...
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 3455678899999999999997744 445555432211 1123467889999999999999988888877777
Q ss_pred EEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccc
Q 012462 212 RMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA 291 (463)
Q Consensus 212 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a 291 (463)
.++||||+++++|.+++. ....++.+++.+|.+||+. +++||||||+|||+ .++.++|+|||++
T Consensus 411 ~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 899999999999999874 3467899999999999999 99999999999999 6789999999998
Q ss_pred eec
Q 012462 292 KLL 294 (463)
Q Consensus 292 ~~~ 294 (463)
+..
T Consensus 475 ~~~ 477 (535)
T PRK09605 475 KYS 477 (535)
T ss_pred ccC
Confidence 753
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.6e-19 Score=173.51 Aligned_cols=124 Identities=28% Similarity=0.487 Sum_probs=108.1
Q ss_pred cEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecc
Q 012462 210 IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFG 289 (463)
Q Consensus 210 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg 289 (463)
...|+.|++|...+|.+||... ......++...+.++.|++.|++| + +.+|+|+||.||+...+..+||+|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr-~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRR-RTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCC-CcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhh
Confidence 3568999999999999999643 233457788899999999999999 6 89999999999999999999999999
Q ss_pred cceecCCCC-----ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh
Q 012462 290 LAKLLGAGK-----SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT 340 (463)
Q Consensus 290 ~a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt 340 (463)
+........ ....+...||..||+||.+.+..|+.++||||||++|+||+.
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 998765443 223456789999999999999999999999999999999998
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.9e-19 Score=181.66 Aligned_cols=168 Identities=28% Similarity=0.389 Sum_probs=122.2
Q ss_pred cCCCccCeEeecCcEEEEEEEEcC-CCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeec
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYV 219 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 219 (463)
.+|..++.+..|+||.||+.+++. .+.+|.| +.++.-. +++ ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li----lRn---ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI----LRN---ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccchh----hhc---cccccCCccee-------------------
Confidence 457778999999999999997643 5677774 3222110 011 22222344333
Q ss_pred CCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC-
Q 012462 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK- 298 (463)
Q Consensus 220 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~- 298 (463)
|+-...+. .-+.++... +.+++|||+. +|+|||+||+|.+|+.-|++|++|||+++......
T Consensus 136 --gDc~tllk----~~g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 --GDCATLLK----NIGPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred --chhhhhcc----cCCCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 34444442 223344332 7799999999 99999999999999999999999999987532110
Q ss_pred -------------ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcc
Q 012462 299 -------------SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAH 352 (463)
Q Consensus 299 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~ 352 (463)
.......|||+.|.|||++....|+..+|+|++|+++||.+.|+.||.+.++.+
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee 265 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 265 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH
Confidence 011235699999999999999999999999999999999999999999876543
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.7e-16 Score=141.62 Aligned_cols=136 Identities=23% Similarity=0.251 Sum_probs=96.2
Q ss_pred cCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhh--HHH----------------------HHHHHHHHcCCCCC--Cc
Q 012462 146 ENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQA--EKE----------------------FRVEVEAIGHVRHK--NL 199 (463)
Q Consensus 146 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~e~~~l~~l~h~--ni 199 (463)
.+.||+|+||+||+|...+++.||||++....... ... ...|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999987789999999875432111 111 12345555444333 24
Q ss_pred ceEeeEEEECcEEEEEEeecCCCCHHHH-HhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEccCCCCceeE
Q 012462 200 VRLLGYCIEGIHRMLVYEYVNNGNLEQW-LHGAMRHHGYLTWEARMKVLLGTAKALAYLHE-AIEPKVVHRDIKSSNILI 277 (463)
Q Consensus 200 v~l~~~~~~~~~~~lV~e~~~~g~L~~~-l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dikp~Nill 277 (463)
.+.+++ ...++||||++++.+... +... . .. ..+..++.+++.++.++|. . +|+|+||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-R----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-h----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 444443 245899999998543211 1110 0 11 5678899999999999999 7 99999999999999
Q ss_pred cCCCCEEEeecccceecC
Q 012462 278 DDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 278 ~~~~~~kl~Dfg~a~~~~ 295 (463)
+ ++.++|+|||.+....
T Consensus 149 ~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 149 D-DGKVYIIDVPQAVEID 165 (187)
T ss_pred E-CCcEEEEECccccccc
Confidence 9 8999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.9e-16 Score=134.54 Aligned_cols=135 Identities=19% Similarity=0.168 Sum_probs=112.0
Q ss_pred ccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCC--CCcceEeeEEEECcEEEEEEeecCCC
Q 012462 145 KENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRH--KNLVRLLGYCIEGIHRMLVYEYVNNG 222 (463)
Q Consensus 145 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~~g 222 (463)
+.+.||+|.++.||++... +..+++|....... ...+..|+.++..+.| .+++++++++...+..+++|||+.++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEec-CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 3567999999999999874 47899998754433 4677889999998876 58999999888878889999999887
Q ss_pred CHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 223 NLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 223 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
.+..+ +......++.+++.+|+++|....++++|+|++|+||+++..+.++++|||.+..
T Consensus 79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 66542 4566677899999999999986434799999999999999999999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.1e-15 Score=141.23 Aligned_cols=134 Identities=21% Similarity=0.260 Sum_probs=104.1
Q ss_pred CeEe-ecCcEEEEEEEEcCCCeEEEEEEcccc-------------hhhHHHHHHHHHHHcCCCCCCc--ceEeeEEEECc
Q 012462 147 NVLG-EGGYGVVYRGNLINGSPVAVKKILNNV-------------GQAEKEFRVEVEAIGHVRHKNL--VRLLGYCIEGI 210 (463)
Q Consensus 147 ~~lG-~G~~g~V~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~~ 210 (463)
..|| .|+.|+||.+.. .+..++||.+.... ......+.+|+.++.+|.|++| +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4788 899999999977 47889999774211 1223567789999999988875 67777654322
Q ss_pred ----EEEEEEeecCC-CCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEE
Q 012462 211 ----HRMLVYEYVNN-GNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKV 285 (463)
Q Consensus 211 ----~~~lV~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl 285 (463)
..++|||++++ .+|.+++.. ..++.. .+.+|+.+|.+||+. ||+|+||||.|||++.++.++|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence 22599999997 699988743 234443 357899999999999 9999999999999999999999
Q ss_pred eeccccee
Q 012462 286 SDFGLAKL 293 (463)
Q Consensus 286 ~Dfg~a~~ 293 (463)
+|||.+..
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99998865
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.2e-17 Score=167.86 Aligned_cols=254 Identities=22% Similarity=0.280 Sum_probs=180.3
Q ss_pred CCCccCeEeecCcEEEEEEEEcCC--CeEEEEEEcccc--hhhHHHHHHHHHHHcCCC-CCCcceEeeEEEECcEEEEEE
Q 012462 142 RFSKENVLGEGGYGVVYRGNLING--SPVAVKKILNNV--GQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~~~~--~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 216 (463)
.|.+.+.||+|+|+.|-......+ ..+|+|.+.... .........|..+-..+. |+|++.+++...+.+..++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 356667799999999988855333 345555553322 222334445777777776 999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEEccCCCCceeEcCCC-CEEEeecccceec
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH-EAIEPKVVHRDIKSSNILIDDDF-NAKVSDFGLAKLL 294 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH-~~~~~~i~H~Dikp~Nill~~~~-~~kl~Dfg~a~~~ 294 (463)
+|..++++.+.+.. ......+...+..++.|+..++.|+| .. ++.|+||||+|.+++..+ .++++|||+|..+
T Consensus 101 ~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 101 SYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred Cccccccccccccc--CCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999999887621 11114566777889999999999999 77 999999999999999999 9999999999876
Q ss_pred CC--CCceeeccccc-cCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 295 GA--GKSHVTTRVMG-TFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 295 ~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
.. +........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+........ ....|.... ...
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~~~---~~~- 250 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKSNK---GRF- 250 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeecccc---ccc-
Confidence 55 33344455678 9999999998874 557789999999999999999999876543321 111111110 000
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 012462 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412 (463)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~ 412 (463)
...+...-......+..+++..+|..|.+.+++..
T Consensus 251 -------~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 251 -------TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred -------ccCccccCChhhhhcccccccCCchhccccccccc
Confidence 00111111111222333688899999999888743
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.1e-15 Score=137.93 Aligned_cols=209 Identities=20% Similarity=0.288 Sum_probs=143.6
Q ss_pred HHHHcCCCCCCcceEeeEEEEC-----cEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 012462 188 VEAIGHVRHKNLVRLLGYCIEG-----IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIE 262 (463)
Q Consensus 188 ~~~l~~l~h~niv~l~~~~~~~-----~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~ 262 (463)
+.-+-.+.|.|||+++.|+.+. ....++.|||..|+|..||+........+......+|+.||+.||.|||+ |+
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence 3344456799999999988654 34578999999999999999877777778889999999999999999998 68
Q ss_pred CCeEEccCCCCceeEcCCCCEEEeecccceecCCC----CceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHH
Q 012462 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG----KSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEA 338 (463)
Q Consensus 263 ~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~el 338 (463)
|.|+|+++..+.|++..+|-+|++--.- ...... .........+-+.|.|||.=.....+-++|||+||.+.+||
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap-~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAP-DSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCc-cccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 9999999999999999999998753211 111110 01111123456789999976666667799999999999999
Q ss_pred HhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 339 ITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 339 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
..+..--...... +.....+...... ....++ -..+.+|++..|..||+|++++.+.-.+
T Consensus 276 ailEiq~tnseS~--~~~ee~ia~~i~~--len~lq---------------r~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 276 AILEIQSTNSESK--VEVEENIANVIIG--LENGLQ---------------RGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred HHheeccCCCcce--eehhhhhhhheee--ccCccc---------------cCcCcccccCCCCCCcchhhhhcCceee
Confidence 8876432221111 1010000000000 000000 0123369999999999999998765443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.52 E-value=6.2e-14 Score=140.66 Aligned_cols=141 Identities=21% Similarity=0.235 Sum_probs=97.8
Q ss_pred CeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhH----------------------------------------HHHHH
Q 012462 147 NVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAE----------------------------------------KEFRV 186 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~~ 186 (463)
+.||.|++|.||+|++.+|+.||||+......... -++.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 57999999999999999999999999854321100 02333
Q ss_pred HHHHHcCC----CCCCcceEeeEEE-ECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHH-HHHHHHhc
Q 012462 187 EVEAIGHV----RHKNLVRLLGYCI-EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAK-ALAYLHEA 260 (463)
Q Consensus 187 e~~~l~~l----~h~niv~l~~~~~-~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~-~l~~LH~~ 260 (463)
|...+.++ .|.+-+.+-.++. .....++||||++|++|.++...... .. ....++..++. .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CC---CHHHHHHHHHHHHHHHHHhC
Confidence 44444433 2332233333332 23446899999999999887643211 12 23456666665 46788988
Q ss_pred CCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 261 ~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
|++|+|++|.||+++.++.++|+|||++.....
T Consensus 277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=7.8e-14 Score=138.19 Aligned_cols=248 Identities=25% Similarity=0.278 Sum_probs=179.0
Q ss_pred HhcCCCccCeEee--cCcEEEEEEEE---cCCCeEEEEEEcccch--hhHHHHHHHHHHHcCC-CCCCcceEeeEEEECc
Q 012462 139 ATNRFSKENVLGE--GGYGVVYRGNL---INGSPVAVKKILNNVG--QAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGI 210 (463)
Q Consensus 139 ~~~~~~~~~~lG~--G~~g~V~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 210 (463)
....|.....+|. |.+|.||.+.. .++..+|+|+-+.... .....-.+|+....++ .|+|.++.+..+...+
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence 3456777889999 99999999954 4678899997433222 2223333466666666 4999999999999999
Q ss_pred EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEEccCCCCceeEcCC-CCEEE
Q 012462 211 HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAK----ALAYLHEAIEPKVVHRDIKSSNILIDDD-FNAKV 285 (463)
Q Consensus 211 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~----~l~~LH~~~~~~i~H~Dikp~Nill~~~-~~~kl 285 (463)
..++=+|++. .+|.++.+. ....++...++..+.+... ||.++|.. +++|-|+||.||+...+ ...++
T Consensus 192 ~lfiqtE~~~-~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~ 264 (524)
T KOG0601|consen 192 ILFIQTELCG-ESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKL 264 (524)
T ss_pred cceeeecccc-chhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeec
Confidence 9999999995 688887764 2334777888888888888 99999999 99999999999999999 88999
Q ss_pred eecccceecCCCCc----eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCC--CCcccccHHHH
Q 012462 286 SDFGLAKLLGAGKS----HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG--RPAHEVNLVDW 359 (463)
Q Consensus 286 ~Dfg~a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~--~~~~~~~~~~~ 359 (463)
+|||+...+....- ....+..|...|++||+..+ .++..+|+|++|.++.+..+|..++..+ ..+....
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r---- 339 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR---- 339 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc----
Confidence 99999988765541 11233467888999998865 4688999999999999999988776544 2111110
Q ss_pred HHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 012462 360 LKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412 (463)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~ 412 (463)
....+.-........+. ..+..|++.+|..|++++.++.
T Consensus 340 -----------~~~ip~e~~~~~s~~l~---~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 340 -----------QGYIPLEFCEGGSSSLR---SVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -----------cccCchhhhcCcchhhh---hHHHHhcCcchhhhhHHHHHhc
Confidence 00000000111111222 2445799999999999888754
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.3e-12 Score=130.79 Aligned_cols=167 Identities=21% Similarity=0.254 Sum_probs=127.8
Q ss_pred EEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCH
Q 012462 161 NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTW 240 (463)
Q Consensus 161 ~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~ 240 (463)
+..++.+|.|...............+-++.++.++||||+++++.++.....|||+|.+. .|..++.. +..
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~ 103 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGK 103 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHH
Confidence 455788888888766555444556677888999999999999999999999999999974 67777754 335
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCceeeccccccCCCCchhhhccC
Q 012462 241 EARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTG 320 (463)
Q Consensus 241 ~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 320 (463)
..+..-+.||+.||.|||+.+ +++|++|....|+++..|+.||++|-++........ ......---.|..|+.+...
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCcc
Confidence 666778899999999999765 999999999999999999999999988765432211 01111112346677765433
Q ss_pred CCCccchhhhHHHHHHHHHhC
Q 012462 321 LLNEKSDVYSFGVLLLEAITG 341 (463)
Q Consensus 321 ~~~~~sDvwSlGvvl~elltg 341 (463)
. -..|.|-|||++||++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 2 346999999999999999
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.9e-13 Score=138.74 Aligned_cols=145 Identities=16% Similarity=0.157 Sum_probs=93.1
Q ss_pred hcCCCccCeEeecCcEEEEEEEEcC-CCeEEEEEEcccchh----------------------------------hHH--
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQ----------------------------------AEK-- 182 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~-- 182 (463)
...|+. +.||.|++|.||+|++.+ |+.||||++...... ..+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345665 689999999999999877 999999998643210 011
Q ss_pred ----HHHHHHHHHcCC----CCCCcceEeeEEEE-CcEEEEEEeecCCCCHHHHHhhhhcCC---CCCCHHHHHHHHHHH
Q 012462 183 ----EFRVEVEAIGHV----RHKNLVRLLGYCIE-GIHRMLVYEYVNNGNLEQWLHGAMRHH---GYLTWEARMKVLLGT 250 (463)
Q Consensus 183 ----~~~~e~~~l~~l----~h~niv~l~~~~~~-~~~~~lV~e~~~~g~L~~~l~~~~~~~---~~~~~~~~~~i~~~i 250 (463)
++.+|+..+.++ .+.+.+.+-.++.+ ....+|||||++|+.+.++-.-. ..+ ..+....+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~-~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALR-AAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHH-hcCCCHHHHHHHHHHHHHHHH
Confidence 123343333333 23333433333332 34568999999999998753211 111 012222333333333
Q ss_pred HHHHHHHHhcCCCCeEEccCCCCceeEcCCC----CEEEeecccceecCC
Q 012462 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDF----NAKVSDFGLAKLLGA 296 (463)
Q Consensus 251 ~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~----~~kl~Dfg~a~~~~~ 296 (463)
... |++|+|++|.||+++.++ .+++.|||++.....
T Consensus 277 -------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 -------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 345 999999999999999988 999999999987654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.38 E-value=1e-12 Score=115.21 Aligned_cols=130 Identities=20% Similarity=0.156 Sum_probs=93.6
Q ss_pred CeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcc-eEeeEEEECcEEEEEEeecCCCCHH
Q 012462 147 NVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLV-RLLGYCIEGIHRMLVYEYVNNGNLE 225 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lV~e~~~~g~L~ 225 (463)
+.|+.|.++.||+++. .+..+++|....... ....+..|+.++..+.+.+++ +++.+. ....++||||++|.++.
T Consensus 4 ~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 4689999999999976 478899998644321 223456788888877554444 455443 33458999999998765
Q ss_pred HHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 226 QWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI--EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 226 ~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
+.. . ....++.+++.+|+.||... ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 80 ~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 420 1 11345678999999999982 11259999999999999 67899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.34 E-value=2e-11 Score=108.01 Aligned_cols=136 Identities=17% Similarity=0.178 Sum_probs=97.3
Q ss_pred CeEeecCcEEEEEEEEcC-------CCeEEEEEEcccc----------------------hhhHHHHH----HHHHHHcC
Q 012462 147 NVLGEGGYGVVYRGNLIN-------GSPVAVKKILNNV----------------------GQAEKEFR----VEVEAIGH 193 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~~----~e~~~l~~ 193 (463)
..||.|--+.||.|...+ +..+|||..+... ....+.+. .|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999996543 4799999863210 01122233 68888888
Q ss_pred CCC--CCcceEeeEEEECcEEEEEEeecCCCCHHH-HHhhhhcCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEEcc
Q 012462 194 VRH--KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQ-WLHGAMRHHGYLTWEARMKVLLGTAKALAYL-HEAIEPKVVHRD 269 (463)
Q Consensus 194 l~h--~niv~l~~~~~~~~~~~lV~e~~~~g~L~~-~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~i~H~D 269 (463)
+.. -++..++++ ...+|||||+.+..+.. .+. ...++......+..+++.+|..| |.. +++|||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 743 456667764 34589999997643321 121 12245566777889999999999 788 999999
Q ss_pred CCCCceeEcCCCCEEEeecccceecC
Q 012462 270 IKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 270 ikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
|++.|||++ ++.+.|+|||.+....
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeCC
Confidence 999999997 4689999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.9e-11 Score=104.50 Aligned_cols=130 Identities=24% Similarity=0.405 Sum_probs=99.9
Q ss_pred eEeecCcEEEEEEEEcCCCeEEEEEEcccch---h-----hHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeec
Q 012462 148 VLGEGGYGVVYRGNLINGSPVAVKKILNNVG---Q-----AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYV 219 (463)
Q Consensus 148 ~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~---~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 219 (463)
.+++|+-+.+|.+.+ -|..+++|.-..+.. . ......+|+.++.++.--.|...+=++.+.....|+|||.
T Consensus 3 ~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 578999999999977 445577776533321 1 1234567899988876555555555566677778999999
Q ss_pred CCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 220 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
+|..|.+++... ...++..|-.-+.-||.. +|+||||.++||++..+. +.++|||++..
T Consensus 82 ~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999888532 245778888889999999 999999999999998775 99999999874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=5.3e-11 Score=101.23 Aligned_cols=143 Identities=18% Similarity=0.309 Sum_probs=106.1
Q ss_pred ccCeEeecCcEEEEEEEEcCCCeEEEEEEcccc--------hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 145 KENVLGEGGYGVVYRGNLINGSPVAVKKILNNV--------GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 145 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
.+..|-+|+-+.|+++.+ .|+...||.-..+. .-...+..+|++++.++.--.|.-..=++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 356899999999999977 67887888653321 112346678999998886555555555566666668999
Q ss_pred eecCC-CCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCC---CEEEeecccce
Q 012462 217 EYVNN-GNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDF---NAKVSDFGLAK 292 (463)
Q Consensus 217 e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~---~~kl~Dfg~a~ 292 (463)
||++| -++.+|+...... .........++.+|-+.+.-||.. +|+||||..+||++..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 99976 4788888654322 222333367899999999999999 999999999999996544 45899999986
Q ss_pred e
Q 012462 293 L 293 (463)
Q Consensus 293 ~ 293 (463)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.4e-12 Score=126.71 Aligned_cols=248 Identities=21% Similarity=0.227 Sum_probs=171.1
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEE--cCCCeEEEEEEcccchhhHHHH--HHHHHHHcCC-CCCCcceEeeEEEECcEE
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNL--INGSPVAVKKILNNVGQAEKEF--RVEVEAIGHV-RHKNLVRLLGYCIEGIHR 212 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~--~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 212 (463)
....+|..+..||.|.|+.|+.... .++..+++|.+.+.......++ ..|+.+...+ .|.+++.....+....+.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3445788889999999999999843 4677889998766543333222 2355555544 588888888888777788
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCC-CCEEEeecccc
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDD-FNAKVSDFGLA 291 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~-~~~kl~Dfg~a 291 (463)
|+=-|||.++++...+. ....+++..++++..|++.++.++|+. .++|+|++|+||++..+ +..+++|||++
T Consensus 342 ~ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred cCchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccc
Confidence 89999999998877662 233477888999999999999999999 99999999999999886 78899999998
Q ss_pred eecCCCCceeeccccccCCCC--chhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCc
Q 012462 292 KLLGAGKSHVTTRVMGTFGYV--APEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369 (463)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 369 (463)
..+.... ......-++. +++......+-.+.|+||||.-+.+.+++..--.......
T Consensus 415 t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~----------------- 473 (524)
T KOG0601|consen 415 TRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL----------------- 473 (524)
T ss_pred cccceec----ccccccccccccchhhccccccccccccccccccccccccCcccCcccccce-----------------
Confidence 6432211 1112233344 5555666678889999999999999999875433222111
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhc
Q 012462 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416 (463)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~ 416 (463)
.+........+... .....+...+...++..||.+.++..+.+.
T Consensus 474 -~i~~~~~p~~~~~~--~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 474 -TIRSGDTPNLPGLK--LQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred -eeecccccCCCchH--HhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 01111111111111 222223335889999999999988766543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=5.1e-10 Score=106.51 Aligned_cols=285 Identities=15% Similarity=0.134 Sum_probs=170.2
Q ss_pred ccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCC-CCCCcceEeeE------EEEC-cEEEEEE
Q 012462 145 KENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV-RHKNLVRLLGY------CIEG-IHRMLVY 216 (463)
Q Consensus 145 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~------~~~~-~~~~lV~ 216 (463)
..+.||+|+-+.+|-.- .-...+.|+..........+. +..|... .||-+-.-+.+ .-+. ...-++|
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 34679999999999752 112235576654433222222 2233332 56633221111 1112 2256788
Q ss_pred eecCCC-CHHHHHhh--hhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 217 EYVNNG-NLEQWLHG--AMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 217 e~~~~g-~L~~~l~~--~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
..+.+. ...+++.- .++......|..++++++.++.+.+-||.. |.+-||++++|+|+++++.+.|.|-.....
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceee
Confidence 887764 23333321 223344578999999999999999999999 999999999999999999999998665444
Q ss_pred cCCCCceeeccccccCCCCchhhhc-----cCCCCccchhhhHHHHHHHHHhC-CCCCCCCCCcccc--cH---HHHHHH
Q 012462 294 LGAGKSHVTTRVMGTFGYVAPEYAN-----TGLLNEKSDVYSFGVLLLEAITG-RDPVDHGRPAHEV--NL---VDWLKM 362 (463)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg-~~pf~~~~~~~~~--~~---~~~~~~ 362 (463)
...+ ......+|...|.+||.-. +-.-+..+|.|.||+++++|+.| ++||.+-...... .+ +.....
T Consensus 167 ~~ng--~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f 244 (637)
T COG4248 167 NANG--TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF 244 (637)
T ss_pred ccCC--ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence 3322 2344567899999999754 33456789999999999999986 9999863321110 01 110000
Q ss_pred HhcCCCcccccc--CCCCCCCCHHHHHHHHHHHhhccCC--CCCCCCCHHHHHHHHhcCCCCCccccc--ccccccCCCc
Q 012462 363 MVGSRRSEEVVD--PNIEVRPSTRALKRSLLTALRCVDP--DSEKRPKMSQVVRMLESEEYPIVREDR--RHRRTQGGTS 436 (463)
Q Consensus 363 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~cl~~--dP~~RPs~~ell~~L~~~~~~~~~~~~--~~~~~~~~~~ 436 (463)
........-... ....+.........++. +|+.. ++.-|||++.++..|......+.+.-. .|+.+....+
T Consensus 245 ~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~---qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~a~H~y~~hl~~ 321 (637)
T COG4248 245 AYASDQRRGLKPPPRSIPLSMLPPDVQALFQ---QAFTESGVATPRPTAKAWVAALDALRQQLKKCTVSAMHVYPVHLTD 321 (637)
T ss_pred eechhccCCCCCCCCCCChhhcCHHHHHHHH---HHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhcccccccCCCCC
Confidence 011110000000 01111111223333333 46553 467999999999999888777765543 4445555666
Q ss_pred cccccc
Q 012462 437 MEIESQ 442 (463)
Q Consensus 437 ~~~~~~ 442 (463)
+.++.-
T Consensus 322 CPwCa~ 327 (637)
T COG4248 322 CPWCAL 327 (637)
T ss_pred Cchhhh
Confidence 666554
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.20 E-value=8.1e-11 Score=107.76 Aligned_cols=142 Identities=22% Similarity=0.248 Sum_probs=106.5
Q ss_pred CeEeecCcEEEEEEEEcCCCeEEEEEEcccch-hhHHHHHHHHHHHcCCCC--CCcceEeeEEEECc---EEEEEEeecC
Q 012462 147 NVLGEGGYGVVYRGNLINGSPVAVKKILNNVG-QAEKEFRVEVEAIGHVRH--KNLVRLLGYCIEGI---HRMLVYEYVN 220 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~---~~~lV~e~~~ 220 (463)
+.|+.|.++.||++...+|..+++|....... .....+..|.+++..+.+ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999876668999998644322 134567889999988865 34677777766542 5689999999
Q ss_pred CCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 012462 221 NGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI--------------------------------------- 261 (463)
Q Consensus 221 ~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------- 261 (463)
|.++.+.+. ...++......++.+++++|..||+..
T Consensus 84 G~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLL-----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 988766431 024666777778888888888887521
Q ss_pred --------------CCCeEEccCCCCceeEcC--CCCEEEeeccccee
Q 012462 262 --------------EPKVVHRDIKSSNILIDD--DFNAKVSDFGLAKL 293 (463)
Q Consensus 262 --------------~~~i~H~Dikp~Nill~~--~~~~kl~Dfg~a~~ 293 (463)
...++|+|+.+.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.9e-11 Score=127.71 Aligned_cols=204 Identities=25% Similarity=0.287 Sum_probs=141.4
Q ss_pred CCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccch---hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 142 RFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVG---QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
.+.+.+-+-+|.++.++.+.- ..|...++|....... ...+....+-.++-..++|.++...-.+.-....+|+++
T Consensus 805 ~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~ 884 (1205)
T KOG0606|consen 805 GFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGH 884 (1205)
T ss_pred cceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhH
Confidence 345556678888998888732 2344444443321110 111112222222222344555544444445567799999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
|+.+++|...|+.. +..+.+.....+..+..+++|||.. .+.|+|++|.|.|...+++.+++|||+......-
T Consensus 885 ~~~~~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 885 YLNGGDLPSKLHNS----GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred HhccCCchhhhhcC----CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccc
Confidence 99999999988643 3466666677788889999999998 7999999999999999999999999843221100
Q ss_pred ---------------------C---c------eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCC
Q 012462 298 ---------------------K---S------HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDH 347 (463)
Q Consensus 298 ---------------------~---~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 347 (463)
. . .......+|+.|.+||.+.+......+|+|++|++++|.++|..||..
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 0 0 012235689999999999999999999999999999999999999987
Q ss_pred CCCcc
Q 012462 348 GRPAH 352 (463)
Q Consensus 348 ~~~~~ 352 (463)
..+..
T Consensus 1038 ~tpq~ 1042 (1205)
T KOG0606|consen 1038 ETPQQ 1042 (1205)
T ss_pred cchhh
Confidence 66544
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.05 E-value=4.7e-09 Score=98.21 Aligned_cols=141 Identities=16% Similarity=0.088 Sum_probs=100.2
Q ss_pred CeEeecCcEEEEEEEEcCCCeEEEEEEcccchh-----------hHHHHHHHHHHHcCCCCCC--cceEeeEEEE-----
Q 012462 147 NVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQ-----------AEKEFRVEVEAIGHVRHKN--LVRLLGYCIE----- 208 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~----- 208 (463)
+.+-.-....|++..+ +|+.++||........ ....+.+|...+.+|..-+ .+.++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4455555556777765 6789999976433211 1113667887777764333 3445555543
Q ss_pred CcEEEEEEeecCCC-CHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC-------C
Q 012462 209 GIHRMLVYEYVNNG-NLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD-------D 280 (463)
Q Consensus 209 ~~~~~lV~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~-------~ 280 (463)
....+||+|++++- +|.+++.... ....+......++.+++..+.-||.. ||+|+|+++.|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence 23468999999875 8999885321 23456677788999999999999999 9999999999999975 4
Q ss_pred CCEEEeeccccee
Q 012462 281 FNAKVSDFGLAKL 293 (463)
Q Consensus 281 ~~~kl~Dfg~a~~ 293 (463)
+.+.|+||+.+..
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6899999998753
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.1e-09 Score=104.95 Aligned_cols=169 Identities=19% Similarity=0.296 Sum_probs=126.8
Q ss_pred cEEEEEE-EEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEE----ECcEEEEEEeecCC-CCHHHH
Q 012462 154 YGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI----EGIHRMLVYEYVNN-GNLEQW 227 (463)
Q Consensus 154 ~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~~~lV~e~~~~-g~L~~~ 227 (463)
-.+.|++ ...+|..+++|++.............-+++++++.|+|||++.++|. .+..+++||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3578998 45689999999984332222222333578899999999999999876 34567899999876 577776
Q ss_pred Hhhhhc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 228 LHGAMR-----------HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 228 l~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
...... .+...++..+|.++.|++.||.++|+. |+.-+-|.+.+||++.+.+++|+..|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 533211 123467899999999999999999999 999999999999999999999998888765543
Q ss_pred CCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRD 343 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~ 343 (463)
... |.+.+ -++-|.=.||.+++.|.||..
T Consensus 446 d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DPT---------------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCC---------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 320 11111 246799999999999999853
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.00 E-value=4e-09 Score=93.04 Aligned_cols=126 Identities=25% Similarity=0.280 Sum_probs=82.2
Q ss_pred EEEEEEEcCCCeEEEEEEcccc--------------------------hhhHHHHHHHHHHHcCCCCC--CcceEeeEEE
Q 012462 156 VVYRGNLINGSPVAVKKILNNV--------------------------GQAEKEFRVEVEAIGHVRHK--NLVRLLGYCI 207 (463)
Q Consensus 156 ~V~~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~ 207 (463)
.||.|...+|..+|+|...... ........+|.+.|.++..- ++.+++++-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899988889999999864210 01113456799999998755 466666442
Q ss_pred ECcEEEEEEeecC--CCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeEEccCCCCceeEcCCCCEE
Q 012462 208 EGIHRMLVYEYVN--NGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY-LHEAIEPKVVHRDIKSSNILIDDDFNAK 284 (463)
Q Consensus 208 ~~~~~~lV~e~~~--~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~-LH~~~~~~i~H~Dikp~Nill~~~~~~k 284 (463)
..+|||||++ |..+..+.... ++......++.+++..+.. +|.. ||+||||.+.||+++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 2379999998 65554433211 1133456677788886665 4677 99999999999999988 999
Q ss_pred EeecccceecC
Q 012462 285 VSDFGLAKLLG 295 (463)
Q Consensus 285 l~Dfg~a~~~~ 295 (463)
|+|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.3e-08 Score=92.37 Aligned_cols=136 Identities=21% Similarity=0.184 Sum_probs=98.8
Q ss_pred CCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccc----------------------hhhHHHHHHHHHHHcCCCCC--C
Q 012462 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNV----------------------GQAEKEFRVEVEAIGHVRHK--N 198 (463)
Q Consensus 143 ~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~e~~~l~~l~h~--n 198 (463)
..+...||-|--+.||.|...+|.++|||.=.... .......++|.++|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45678999999999999998899999999532100 01122456789999888644 6
Q ss_pred cceEeeEEEECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEc
Q 012462 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILID 278 (463)
Q Consensus 199 iv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~ 278 (463)
+.+.+++ +...+||||.+|-.|... +++....-.++..|++-+.-+-.. ||+|||+++-||+++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~---------r~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRL---------RLDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT 236 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecc---------cCcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence 7777764 344799999998665432 123344445566666666655566 999999999999999
Q ss_pred CCCCEEEeecccceec
Q 012462 279 DDFNAKVSDFGLAKLL 294 (463)
Q Consensus 279 ~~~~~kl~Dfg~a~~~ 294 (463)
++|.+.++||-.+...
T Consensus 237 ~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 237 EDGDIVVIDWPQAVPI 252 (304)
T ss_pred cCCCEEEEeCcccccC
Confidence 9999999999776543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.75 E-value=1e-07 Score=86.21 Aligned_cols=106 Identities=23% Similarity=0.271 Sum_probs=81.2
Q ss_pred HHHHHHHHHHcCCCCC--CcceEeeEEEEC----cEEEEEEeecCCC-CHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHH
Q 012462 182 KEFRVEVEAIGHVRHK--NLVRLLGYCIEG----IHRMLVYEYVNNG-NLEQWLHGAMRHHGYLTWEARMKVLLGTAKAL 254 (463)
Q Consensus 182 ~~~~~e~~~l~~l~h~--niv~l~~~~~~~----~~~~lV~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l 254 (463)
....+|...+..|..- ..+..+++.... ...++|+|++++. +|.+++.... ..+......++.+++..+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARLI 131 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHHH
Confidence 4566677766666432 345566666542 2458999999874 7999886421 156667788999999999
Q ss_pred HHHHhcCCCCeEEccCCCCceeEcCCC---CEEEeecccceec
Q 012462 255 AYLHEAIEPKVVHRDIKSSNILIDDDF---NAKVSDFGLAKLL 294 (463)
Q Consensus 255 ~~LH~~~~~~i~H~Dikp~Nill~~~~---~~kl~Dfg~a~~~ 294 (463)
.-||.. ||+|+|+++.|||++.+. .+.++||+-++..
T Consensus 132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999 999999999999999887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.74 E-value=3.2e-09 Score=107.28 Aligned_cols=151 Identities=21% Similarity=0.284 Sum_probs=97.1
Q ss_pred HHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCceee--------ccccccCCCCchhhhc
Q 012462 247 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVT--------TRVMGTFGYVAPEYAN 318 (463)
Q Consensus 247 ~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~--------~~~~gt~~y~aPE~~~ 318 (463)
+.+++.||.|+|... ++||++|.|++|.++.++..||+.|+.+........... .-......|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 344558999999874 999999999999999999999999998865443211110 0112356899999999
Q ss_pred cCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhcc
Q 012462 319 TGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCV 397 (463)
Q Consensus 319 ~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl 397 (463)
+...+.++|+||+||++|-++. |+.-+.............. ........ ....-..++.+ -+.+++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~------~~~~~~~~----~s~~~p~el~~---~l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN------LLNAGAFG----YSNNLPSELRE---SLKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc------cccccccc----ccccCcHHHHH---HHHHHh
Confidence 9888999999999999999995 4444443221111111000 00000000 00111223333 344689
Q ss_pred CCCCCCCCCHHHHHH
Q 012462 398 DPDSEKRPKMSQVVR 412 (463)
Q Consensus 398 ~~dP~~RPs~~ell~ 412 (463)
..++..||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999997777644
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.6e-07 Score=83.44 Aligned_cols=138 Identities=17% Similarity=0.173 Sum_probs=101.4
Q ss_pred EeecCcEEEEEEEEcCCCeEEEEEEcccc------hhhHHHHHHHHHHHcCCCCC--CcceEeeEEE-E----CcEEEEE
Q 012462 149 LGEGGYGVVYRGNLINGSPVAVKKILNNV------GQAEKEFRVEVEAIGHVRHK--NLVRLLGYCI-E----GIHRMLV 215 (463)
Q Consensus 149 lG~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~-~----~~~~~lV 215 (463)
-|+||.+-|+.... +|..+.+|+..+.. +.....|.+|+..+.+|..- .+.+.+ ++. . ....+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 36789999999876 45578999864221 23457788899988887432 244444 332 1 1235799
Q ss_pred EeecCC-CCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCC--EEEeecccce
Q 012462 216 YEYVNN-GNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFN--AKVSDFGLAK 292 (463)
Q Consensus 216 ~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~--~kl~Dfg~a~ 292 (463)
+|-+.+ .+|.+++... ...+.+......++.+++..+.-||.. |+.|+|+.+.||+++.++. ++++||--++
T Consensus 104 Te~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997753 5898887532 223467777889999999999999999 9999999999999986667 9999997665
Q ss_pred e
Q 012462 293 L 293 (463)
Q Consensus 293 ~ 293 (463)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 4
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.60 E-value=1e-06 Score=78.69 Aligned_cols=140 Identities=14% Similarity=0.163 Sum_probs=93.4
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHH---------HHHHHHcCC---CCCCcceEee
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFR---------VEVEAIGHV---RHKNLVRLLG 204 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~---------~e~~~l~~l---~h~niv~l~~ 204 (463)
.+..++|...+++-......|.+-.. +|..+++|.........++.|. +++..+.++ .--....++-
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 35567888888888887777777765 6788999987655433333222 223322222 2222333332
Q ss_pred EEE-----ECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC
Q 012462 205 YCI-----EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD 279 (463)
Q Consensus 205 ~~~-----~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~ 279 (463)
+.. -....++||||++|..|.++.. ++. .++..+.+++.-||.. |++|||..|.|+++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~ 170 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSN 170 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEEC
Confidence 222 2234568999999988776531 222 2456677889999999 9999999999999996
Q ss_pred CCCEEEeeccccee
Q 012462 280 DFNAKVSDFGLAKL 293 (463)
Q Consensus 280 ~~~~kl~Dfg~a~~ 293 (463)
++ ++++||+..+.
T Consensus 171 ~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 171 NG-IRIIDTQGKRM 183 (229)
T ss_pred Cc-EEEEECccccc
Confidence 54 99999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.59 E-value=8.1e-07 Score=81.41 Aligned_cols=138 Identities=18% Similarity=0.211 Sum_probs=84.3
Q ss_pred CeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCC--cceEeeEEEECcEEEEEEeecCCCC-
Q 012462 147 NVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKN--LVRLLGYCIEGIHRMLVYEYVNNGN- 223 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~e~~~~g~- 223 (463)
..||+|..+.||+. .+..+++|...... ......+|.+++..+..-. +.+.+++..+.+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 46899999999984 35567788764422 3345677888888775333 5677888877778889999998863
Q ss_pred HHHHH---------------------hhhhcCCCCCCHHHHH-HHHH----------HHHH-HHHHHHhc-CCCCeEEcc
Q 012462 224 LEQWL---------------------HGAMRHHGYLTWEARM-KVLL----------GTAK-ALAYLHEA-IEPKVVHRD 269 (463)
Q Consensus 224 L~~~l---------------------~~~~~~~~~~~~~~~~-~i~~----------~i~~-~l~~LH~~-~~~~i~H~D 269 (463)
+...+ +..... ........ .+.. .+.. ...+|... ..+.++|+|
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~--~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCD--TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC--CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 21111 110000 01111100 0000 0111 12222211 134678999
Q ss_pred CCCCceeEcCCCCEEEeecccce
Q 012462 270 IKSSNILIDDDFNAKVSDFGLAK 292 (463)
Q Consensus 270 ikp~Nill~~~~~~kl~Dfg~a~ 292 (463)
+.|.||++++++ +.|+||+.+.
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcC
Confidence 999999999988 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=2.5e-07 Score=93.87 Aligned_cols=141 Identities=20% Similarity=0.235 Sum_probs=89.7
Q ss_pred CeEeecCcEEEEEEEEcCCCeEEEEEEcccchhh----------------------------------------HHHHHH
Q 012462 147 NVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQA----------------------------------------EKEFRV 186 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~~ 186 (463)
+-|+.++-|.||+|++.+|+.||||+........ +-++..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5799999999999999999999999975332100 001233
Q ss_pred HHHHHcCC----C-CCCcceEeeEEE-ECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 012462 187 EVEAIGHV----R-HKNLVRLLGYCI-EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260 (463)
Q Consensus 187 e~~~l~~l----~-h~niv~l~~~~~-~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~ 260 (463)
|..-+.++ + .++ +.+=.+|. -.....|+|||++|-.+.+...... ..++...+.....++. +..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~-v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~k~ia~~~~~~f--~~q~~~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPD-VYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDRKELAELLVRAF--LRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCC-eEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCHHHHHHHHHHHH--HHHHHhc
Confidence 43333333 1 232 22222332 2345589999999998888743211 2244333322222221 2222234
Q ss_pred CCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 261 ~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
|++|.|..|.||+++.+|.+.+.|||+......
T Consensus 285 ---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 ---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 999999999999999999999999999876654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.43 E-value=3.5e-06 Score=77.54 Aligned_cols=145 Identities=21% Similarity=0.206 Sum_probs=83.9
Q ss_pred cCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCC--CcceEeeEEEE---CcEEEEEEeecC
Q 012462 146 ENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHK--NLVRLLGYCIE---GIHRMLVYEYVN 220 (463)
Q Consensus 146 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~---~~~~~lV~e~~~ 220 (463)
++.|+.|..+.||+....+ ..+++|..... .....+..|..++..+... .+.+++.++.. ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3579999999999998766 69999986443 4456677788777776422 35667765433 335689999999
Q ss_pred CCCHHH----------------HHh---hhhcCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 012462 221 NGNLEQ----------------WLH---GAMRHHGYLTWEA---------RMKV------------LLGTAK-ALAYLHE 259 (463)
Q Consensus 221 ~g~L~~----------------~l~---~~~~~~~~~~~~~---------~~~i------------~~~i~~-~l~~LH~ 259 (463)
|..+.. ++. ........+.... .... ...+.. .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 111 1100111111110 0000 111222 3333332
Q ss_pred c----CCCCeEEccCCCCceeEc-CCCCEEEeeccccee
Q 012462 260 A----IEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKL 293 (463)
Q Consensus 260 ~----~~~~i~H~Dikp~Nill~-~~~~~kl~Dfg~a~~ 293 (463)
. ....++|+|+.|.|||++ +++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1 234799999999999999 666678999987753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.41 E-value=3.9e-06 Score=75.80 Aligned_cols=153 Identities=20% Similarity=0.209 Sum_probs=97.4
Q ss_pred chHHHHHHhcCCCccCe---EeecCcEEEEEEEEcCCCeEEEEEEcccchhhHH------------------------HH
Q 012462 132 TLRDLELATNRFSKENV---LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEK------------------------EF 184 (463)
Q Consensus 132 ~~~~~~~~~~~~~~~~~---lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~------------------------~~ 184 (463)
++..+....++..+.+. |..|--+.||+|...++..+|+|++........+ -.
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 34444444555555554 5567778999998778999999998533211100 11
Q ss_pred HHHHHHHcCCC--CCCcceEeeEEEECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 012462 185 RVEVEAIGHVR--HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIE 262 (463)
Q Consensus 185 ~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~ 262 (463)
..|+.-|.++. +=.+.+-+++. +-.|||||+...- .-...-..-.+.......+..++++.+.-|-..+
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g----~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a- 186 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDG----LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEA- 186 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCC----CCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhc-
Confidence 23555555552 33344555443 2379999985431 0000001112333367778888888888887632
Q ss_pred CCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 263 ~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
++||+||+.-|||+. ++.+.|+|||.|....
T Consensus 187 -~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 -GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred -CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 999999999999999 8899999999987654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.39 E-value=2e-08 Score=100.63 Aligned_cols=187 Identities=19% Similarity=0.131 Sum_probs=133.1
Q ss_pred CCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCC-cceEeeEEEECcEEEEEEeecCC
Q 012462 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKN-LVRLLGYCIEGIHRMLVYEYVNN 221 (463)
Q Consensus 143 ~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~e~~~~ 221 (463)
+...+-+++|++++++|.+-...+....+.+... ....-++++|.+++||| .+..++-+..++..+++++++.+
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST 318 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence 4445568999999999986544444445544322 44455889999999999 77777777777788999999988
Q ss_pred C-CHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCce
Q 012462 222 G-NLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSH 300 (463)
Q Consensus 222 g-~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 300 (463)
+ +-..-.. ...-.+...+...+++.-+++++++|+. .-+|+| ||+..+ +..+..||+....+....
T Consensus 319 ~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-- 385 (829)
T KOG0576|consen 319 GRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-- 385 (829)
T ss_pred CccccccCC---hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--
Confidence 7 2111100 0111133344455667778899999987 568998 777666 688999999987654432
Q ss_pred eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCC
Q 012462 301 VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDH 347 (463)
Q Consensus 301 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~ 347 (463)
......+++.|+|||+..+..+...-|+|++|+--.++--|..|-..
T Consensus 386 ~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 34456789999999999999999999999999877777777766543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.27 E-value=2.4e-05 Score=69.67 Aligned_cols=132 Identities=20% Similarity=0.309 Sum_probs=91.3
Q ss_pred cCeEeecCcEEEEEEEEcCCCeEEEEEEcccc----------------hhhHHHHHHHHHHHcCC------CCCCcceEe
Q 012462 146 ENVLGEGGYGVVYRGNLINGSPVAVKKILNNV----------------GQAEKEFRVEVEAIGHV------RHKNLVRLL 203 (463)
Q Consensus 146 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l------~h~niv~l~ 203 (463)
...||+|+.-.||. +.++....||+..... ....++..+|+.....+ .+.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 35799999999998 5667788999886544 11234445555544443 378899999
Q ss_pred eEEEECcEEEEEEeecCC------CCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeE
Q 012462 204 GYCIEGIHRMLVYEYVNN------GNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILI 277 (463)
Q Consensus 204 ~~~~~~~~~~lV~e~~~~------g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill 277 (463)
|+.+++.-.-+|+|.... .+|.+++.. +.++. . +...+-+-..||-.+ .|+.+|++|.||++
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~---~~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-----GGLTE-E---LRQALDEFKRYLLDH---HIVIRDLNPHNIVV 151 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-----CCccH-H---HHHHHHHHHHHHHHc---CCeecCCCcccEEE
Confidence 999999888999998643 267777732 23544 3 333344456677777 99999999999999
Q ss_pred cCC---C-CEEEee-cccc
Q 012462 278 DDD---F-NAKVSD-FGLA 291 (463)
Q Consensus 278 ~~~---~-~~kl~D-fg~a 291 (463)
... . .+.|+| ||..
T Consensus 152 ~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 152 QRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred EecCCCceEEEEEeCCCCc
Confidence 532 2 577777 5544
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.27 E-value=7.7e-06 Score=76.07 Aligned_cols=140 Identities=17% Similarity=0.138 Sum_probs=82.2
Q ss_pred EeecCc-EEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCC-CCCcceEeeEEEECcEEEEEEeecCCCCHHH
Q 012462 149 LGEGGY-GVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQ 226 (463)
Q Consensus 149 lG~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~g~L~~ 226 (463)
|-.|.. ..||+... ++..+++|...... ...+..|++++..+. +--+.+++++....+..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~-~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDG-KNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcC-CCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444444 78999865 34778888764322 334556777776663 3446678887776667799999999987764
Q ss_pred HH-------------------hhhhcCCCCCCH--HHHHHHHH--------------------HHHHHHHHHHhc----C
Q 012462 227 WL-------------------HGAMRHHGYLTW--EARMKVLL--------------------GTAKALAYLHEA----I 261 (463)
Q Consensus 227 ~l-------------------~~~~~~~~~~~~--~~~~~i~~--------------------~i~~~l~~LH~~----~ 261 (463)
.. +........+.. ........ .+...+..|-.. .
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 31 100000001110 00000000 011112222111 1
Q ss_pred CCCeEEccCCCCceeEcCCCCEEEeecccce
Q 012462 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292 (463)
Q Consensus 262 ~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~ 292 (463)
.+.++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 3468999999999999998878999999774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.4e-05 Score=87.25 Aligned_cols=149 Identities=16% Similarity=0.213 Sum_probs=91.0
Q ss_pred cCeEeecCcEEEEEEEEcCC---CeEEEEEEcccc-hhhHHHHHHHHHHHcCCC-CCCc--ceEeeEEEEC---cEEEEE
Q 012462 146 ENVLGEGGYGVVYRGNLING---SPVAVKKILNNV-GQAEKEFRVEVEAIGHVR-HKNL--VRLLGYCIEG---IHRMLV 215 (463)
Q Consensus 146 ~~~lG~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lV 215 (463)
.+.++.|.+..+|+....++ ..+++|+..... ......+.+|+++++.+. |.++ .+++.+|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999876544 367777653221 123456788999998885 6654 7788888764 356899
Q ss_pred EeecCCCCHHH--------------------H---HhhhhcC-------CCCCC--HHHHHHHH---------------H
Q 012462 216 YEYVNNGNLEQ--------------------W---LHGAMRH-------HGYLT--WEARMKVL---------------L 248 (463)
Q Consensus 216 ~e~~~~g~L~~--------------------~---l~~~~~~-------~~~~~--~~~~~~i~---------------~ 248 (463)
|||++|..+.+ . |+..... ..+.. ...+..+. .
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99998764321 1 1111000 00001 11121111 1
Q ss_pred HHHHHHHHHHhcCC--------CCeEEccCCCCceeEcC-CCC-EEEeecccceec
Q 012462 249 GTAKALAYLHEAIE--------PKVVHRDIKSSNILIDD-DFN-AKVSDFGLAKLL 294 (463)
Q Consensus 249 ~i~~~l~~LH~~~~--------~~i~H~Dikp~Nill~~-~~~-~kl~Dfg~a~~~ 294 (463)
.+...+.+|..+.. +.++|+|+++.||+++. ++. .-|.||.++..-
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 13334567755431 35999999999999985 333 579999987653
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.21 E-value=7.7e-06 Score=82.87 Aligned_cols=140 Identities=20% Similarity=0.246 Sum_probs=88.2
Q ss_pred CeEeecCcEEEEEEEEcCCCeEEEEEEcccchhh-------------------------------HH------HHHHHHH
Q 012462 147 NVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQA-------------------------------EK------EFRVEVE 189 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------------------------------~~------~~~~e~~ 189 (463)
+.||.-+.|.||+|++.+|+.||||+.+...... .+ +|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5799999999999999999999999865322110 01 1223332
Q ss_pred HHcC----CCCCC------cceEeeEEEECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 012462 190 AIGH----VRHKN------LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE 259 (463)
Q Consensus 190 ~l~~----l~h~n------iv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~ 259 (463)
-..+ +.|-+ |.+++-.+ .....|+||||+|..+.|.-.-. ...++...+..-+.+.. ++.
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~---~~gi~~~~i~~~l~~~~-----~~q 316 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAID---KRGISPHDILNKLVEAY-----LEQ 316 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHH---HcCCCHHHHHHHHHHHH-----HHH
Confidence 2222 23444 33443333 23558999999998777653211 12255554444333332 222
Q ss_pred cCCCCeEEccCCCCceeEc----CCCCEEEeecccceecCC
Q 012462 260 AIEPKVVHRDIKSSNILID----DDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 260 ~~~~~i~H~Dikp~Nill~----~~~~~kl~Dfg~a~~~~~ 296 (463)
....|++|+|=.|.||+++ .++.+.+-|||+......
T Consensus 317 If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 317 IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 2233999999999999998 367899999999876543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.18 E-value=7.2e-06 Score=70.08 Aligned_cols=128 Identities=20% Similarity=0.291 Sum_probs=88.0
Q ss_pred ccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcc-eEeeEEEECcEEEEEEeecCCCC
Q 012462 145 KENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLV-RLLGYCIEGIHRMLVYEYVNNGN 223 (463)
Q Consensus 145 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lV~e~~~~g~ 223 (463)
..+.||+|++|.||++.+ .|..+|+|+-..++ ....+..|++++..+.-.++. +++.|-.+ ++.|||+.|-.
T Consensus 26 v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~ 98 (201)
T COG2112 26 VEKELAKGTTSVVYLGEW-RGGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRP 98 (201)
T ss_pred hhhhhhcccccEEEEeec-cCceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcc
Confidence 356799999999999988 56699999765443 356778899988888765554 45554332 46699999988
Q ss_pred HHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCC-CCceeEcCCCCEEEeeccccee
Q 012462 224 LEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIK-SSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 224 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik-p~Nill~~~~~~kl~Dfg~a~~ 293 (463)
|.+.-... +... ...+++.---|... ||-|+.|. |...++..++.+.|+||.-|..
T Consensus 99 L~~~~~~~-------~rk~----l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIGG-------DRKH----LLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcc-------cHHH----HHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 87754321 2222 33444554445555 99999986 4444555555999999998873
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.10 E-value=1.3e-05 Score=70.97 Aligned_cols=104 Identities=23% Similarity=0.253 Sum_probs=80.0
Q ss_pred HHHHHHcCCCC-CCcceEeeEEEECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 012462 186 VEVEAIGHVRH-KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPK 264 (463)
Q Consensus 186 ~e~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ 264 (463)
.|.-+++.+.+ +++++++|+|-. ++|.||...+++...- .........+|..+.+||.++++.+.+|++...-.
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~-~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIY-RPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccc-cccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 36777777765 699999999932 7899999877654310 00011223789999999999999999999854336
Q ss_pred eEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 265 VVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 265 i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
+.-.|++++|+-+++++++|++|.......
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999876544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.95 E-value=8.9e-05 Score=70.99 Aligned_cols=76 Identities=9% Similarity=0.021 Sum_probs=54.6
Q ss_pred cCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCC---CCcceEeeEEEEC---cEEEEEEeec
Q 012462 146 ENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRH---KNLVRLLGYCIEG---IHRMLVYEYV 219 (463)
Q Consensus 146 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~---~~~~lV~e~~ 219 (463)
.+.||.|..+.||.....++ .+++|.... ......+..|...++.|.- -.+.+++++|... +..+||||++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 19 VECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 45799999999999866445 466776432 1133577788888877742 3678888887643 5679999999
Q ss_pred CCCCH
Q 012462 220 NNGNL 224 (463)
Q Consensus 220 ~~g~L 224 (463)
+++++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98754
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.94 E-value=4.5e-05 Score=70.47 Aligned_cols=73 Identities=16% Similarity=0.210 Sum_probs=43.6
Q ss_pred CeEeecCcE-EEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCC---CcceEeeEEEEC---cEEEEEEeec
Q 012462 147 NVLGEGGYG-VVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHK---NLVRLLGYCIEG---IHRMLVYEYV 219 (463)
Q Consensus 147 ~~lG~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~---~~~~lV~e~~ 219 (463)
+.|+.|+.. .||+. +..+++|.... ......+..|.+.+..+... -+..+++..... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457766666 58875 23567775433 22345677888888776421 244444443322 2347899999
Q ss_pred CCCCHH
Q 012462 220 NNGNLE 225 (463)
Q Consensus 220 ~~g~L~ 225 (463)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.0003 Score=62.25 Aligned_cols=125 Identities=25% Similarity=0.377 Sum_probs=87.5
Q ss_pred cCCCccCeEeecCc-EEEEEEEEcCCCeEEEEEEcccc-----------h----------hhHHHHHHHHHHHcCCC---
Q 012462 141 NRFSKENVLGEGGY-GVVYRGNLINGSPVAVKKILNNV-----------G----------QAEKEFRVEVEAIGHVR--- 195 (463)
Q Consensus 141 ~~~~~~~~lG~G~~-g~V~~~~~~~~~~vavK~~~~~~-----------~----------~~~~~~~~e~~~l~~l~--- 195 (463)
.+++.++.||.|.- |.||+++. +|..+|+|.+.... . .....|..|-+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67889999999999 99999987 78899999842100 0 01124667888777763
Q ss_pred CCCc--ceEeeEEEECc------------------EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 012462 196 HKNL--VRLLGYCIEGI------------------HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255 (463)
Q Consensus 196 h~ni--v~l~~~~~~~~------------------~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~ 255 (463)
+.++ ++.+||..-.. ..-||.||.+... .+.. .-+.+|.+-|.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~----~~~~~~~~dl~ 178 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQI----RDIPQMLRDLK 178 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccch----hHHHHHHHHHH
Confidence 5566 88999874220 1246777765432 1222 23556777788
Q ss_pred HHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccc
Q 012462 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA 291 (463)
Q Consensus 256 ~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a 291 (463)
.+|.. +|+-+|+++.|.. .=+|+|||.+
T Consensus 179 ~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 89999 9999999999975 3478999864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.87 E-value=5.6e-05 Score=81.41 Aligned_cols=197 Identities=23% Similarity=0.290 Sum_probs=135.8
Q ss_pred HHHHHHHHHcCCCCCCcceEeeEEEECcEE----EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 012462 183 EFRVEVEAIGHVRHKNLVRLLGYCIEGIHR----MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258 (463)
Q Consensus 183 ~~~~e~~~l~~l~h~niv~l~~~~~~~~~~----~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH 258 (463)
....|+..+.+..|+|++.++.|-.+.... .+..+++..-++...+. .-..++....+.+..++.+||.|+|
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q----~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ----SVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh----hccccCHHHHHHHHHHHhhhHHHHH
Confidence 344577778888999999999987654322 34567888888888774 4456889999999999999999999
Q ss_pred hcCCCCeEEccCCCC---ceeEcCCCCEEEe--ecccceecCCCCceeeccccccCCCCchhhhccCCCCcc--chhhhH
Q 012462 259 EAIEPKVVHRDIKSS---NILIDDDFNAKVS--DFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEK--SDVYSF 331 (463)
Q Consensus 259 ~~~~~~i~H~Dikp~---Nill~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--sDvwSl 331 (463)
.. ...|.-+..+ +--.+..+.+.++ ||+.+.......... ...-+..|.+||......++.+ .|+|.+
T Consensus 304 ~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 304 SL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred Hh---ccceeEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccccchhhhhhHHHHH
Confidence 98 6666666555 5555667777777 998887665433221 1234567889998877766554 799999
Q ss_pred HHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 012462 332 GVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVV 411 (463)
Q Consensus 332 Gvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell 411 (463)
|..+..+..|..+-...... ..+++. .... .......+|+..++++|+++.+++
T Consensus 379 gll~~~~~~~~~i~~~~~~~------------------~~~l~~-----~~~~---~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSAVP------------------VSLLDV-----LSTS---ELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHHhhhhhcCcccccccch------------------hhhhcc-----ccch---hhhhhhhhhcchhhhhccchhhhh
Confidence 99999999877543321100 000000 0000 122233479999999999999998
Q ss_pred HHH
Q 012462 412 RML 414 (463)
Q Consensus 412 ~~L 414 (463)
.+.
T Consensus 433 ~~~ 435 (1351)
T KOG1035|consen 433 THP 435 (1351)
T ss_pred hch
Confidence 865
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00033 Score=69.27 Aligned_cols=75 Identities=23% Similarity=0.285 Sum_probs=52.5
Q ss_pred CeEeecCcEEEEEEEEcCC-CeEEEEEEcccc-------hhhHHHHHHHHHHHcCCC---CCCcceEeeEEEECcEEEEE
Q 012462 147 NVLGEGGYGVVYRGNLING-SPVAVKKILNNV-------GQAEKEFRVEVEAIGHVR---HKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~~~-~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lV 215 (463)
+.||.|.+..||++...+| +.|+||.-.... ....+....|.+.|..+. -.++++++.+. .+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEEE
Confidence 5789999999999988776 489999753211 123456666777777652 24577777763 4557899
Q ss_pred EeecCCCC
Q 012462 216 YEYVNNGN 223 (463)
Q Consensus 216 ~e~~~~g~ 223 (463)
||++++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00016 Score=67.84 Aligned_cols=139 Identities=15% Similarity=0.114 Sum_probs=76.3
Q ss_pred EeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCc-ceEeeEEEECcEEEEEEeecCCCCHHH-
Q 012462 149 LGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNL-VRLLGYCIEGIHRMLVYEYVNNGNLEQ- 226 (463)
Q Consensus 149 lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~~~g~L~~- 226 (463)
+..|-...+|+... ++..+++|..........-+..+|..+++.+....+ .+++..+. -++||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 45677889998864 567888886533221111134567777777743333 34444432 368999998866532
Q ss_pred -------------H---HhhhhcCCCCCCHHH-HHHHHHHH---------HHHHHHHHhc-----CCCCeEEccCCCCce
Q 012462 227 -------------W---LHGAMRHHGYLTWEA-RMKVLLGT---------AKALAYLHEA-----IEPKVVHRDIKSSNI 275 (463)
Q Consensus 227 -------------~---l~~~~~~~~~~~~~~-~~~i~~~i---------~~~l~~LH~~-----~~~~i~H~Dikp~Ni 275 (463)
. |+........++... +..+..++ ...+..+-.. ..+.++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 1 111111111122211 11111111 1112222111 123589999999999
Q ss_pred eEcCCCCEEEeeccccee
Q 012462 276 LIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 276 ll~~~~~~kl~Dfg~a~~ 293 (463)
++++++ +.|+||..+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999877 78999998754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00028 Score=65.10 Aligned_cols=73 Identities=14% Similarity=0.097 Sum_probs=45.4
Q ss_pred CeEeecCcEEEEEEEEcC--CCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCC-cceEeeEEEECcEEEEEEeecCCCC
Q 012462 147 NVLGEGGYGVVYRGNLIN--GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKN-LVRLLGYCIEGIHRMLVYEYVNNGN 223 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~e~~~~g~ 223 (463)
+.|..|-...+|+....+ +..+++|....... ..-+..+|+.++..+...+ .+++++.+. + .+||||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCCCc
Confidence 467788888999987653 57888886543221 1122335777777764333 344544332 2 48999998876
Q ss_pred H
Q 012462 224 L 224 (463)
Q Consensus 224 L 224 (463)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.0022 Score=62.21 Aligned_cols=142 Identities=17% Similarity=0.193 Sum_probs=74.6
Q ss_pred CeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCC--CcceEee------EEEECcEEEEEEee
Q 012462 147 NVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHK--NLVRLLG------YCIEGIHRMLVYEY 218 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~------~~~~~~~~~lV~e~ 218 (463)
+.|+.|....+|+....+| .+++|++.. . ....+..|+.++..|... .+.+.+. +....+..+++++|
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~-~--~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFER-L--TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEecc-C--ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4567788789999876544 688887641 1 122333344444443211 1333332 12235567899999
Q ss_pred cCCCCHH-----HH---------HhhhhcCC-------CCCCH-HHHHH------------HHHH-HHHHHHHHHhc---
Q 012462 219 VNNGNLE-----QW---------LHGAMRHH-------GYLTW-EARMK------------VLLG-TAKALAYLHEA--- 260 (463)
Q Consensus 219 ~~~g~L~-----~~---------l~~~~~~~-------~~~~~-~~~~~------------i~~~-i~~~l~~LH~~--- 260 (463)
++|..+. ++ ++...... ..+.+ ..... .+.+ +...+..+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 9886431 11 11111110 01111 11111 1111 11122333211
Q ss_pred -CCCCeEEccCCCCceeEcCCCCEEEeecccce
Q 012462 261 -IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292 (463)
Q Consensus 261 -~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~ 292 (463)
...+++|+|+.+.||+++.+...-|+||+.+.
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 24589999999999999977656899999875
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.001 Score=63.77 Aligned_cols=143 Identities=18% Similarity=0.180 Sum_probs=82.7
Q ss_pred cCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCC--CcceEeeE------EEECcEEEEEEe
Q 012462 146 ENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHK--NLVRLLGY------CIEGIHRMLVYE 217 (463)
Q Consensus 146 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~------~~~~~~~~lV~e 217 (463)
.+.|..|....+|+... ++..+++|.... .....+..|+.++..+.+. .+.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~-~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTT-DSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEe-CCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 45677788889999865 445788887643 2234455567666666322 24444331 223456689999
Q ss_pred ecCCCCHHH----H----------HhhhhcCC-------CCCCHHHHH----------HHHHHHHHHHHHHHh----cCC
Q 012462 218 YVNNGNLEQ----W----------LHGAMRHH-------GYLTWEARM----------KVLLGTAKALAYLHE----AIE 262 (463)
Q Consensus 218 ~~~~g~L~~----~----------l~~~~~~~-------~~~~~~~~~----------~i~~~i~~~l~~LH~----~~~ 262 (463)
+++|..+.. . ++...... ....|.... .....+..++.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 998865421 1 11111100 011111110 011123344455543 123
Q ss_pred CCeEEccCCCCceeEcCCCCEEEeecccce
Q 012462 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292 (463)
Q Consensus 263 ~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~ 292 (463)
.+++|+|+.|.||++++++.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999998778999998875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.00017 Score=67.63 Aligned_cols=136 Identities=20% Similarity=0.148 Sum_probs=91.9
Q ss_pred CCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcc------cchh----------------hHHHHHHHHHHHcCCC-CC-
Q 012462 142 RFSKENVLGEGGYGVVYRGNLINGSPVAVKKILN------NVGQ----------------AEKEFRVEVEAIGHVR-HK- 197 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~------~~~~----------------~~~~~~~e~~~l~~l~-h~- 197 (463)
-+.+.+.||-|--+-+|.+-..+|.+.++|.-.- .... ..-....|+..|+.|. |-
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 3677889999999999999888899999884210 0000 0112334777776663 22
Q ss_pred CcceEeeEEEECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeE
Q 012462 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILI 277 (463)
Q Consensus 198 niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill 277 (463)
-+.+.+++ +..++|||++.+-.|...-+ ..+ ...+...+..-+--|-.+ |+||||..-=||++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~-------v~d---~~~ly~~lm~~Iv~la~~---GlIHgDFNEFNimv 235 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRH-------VED---PPTLYDDLMGLIVRLANH---GLIHGDFNEFNIMV 235 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeee-------cCC---hHHHHHHHHHHHHHHHHc---CceecccchheeEE
Confidence 24555554 34589999998877654321 122 223444455555666677 99999999999999
Q ss_pred cCCCCEEEeecccceec
Q 012462 278 DDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 278 ~~~~~~kl~Dfg~a~~~ 294 (463)
++++.++++||-.....
T Consensus 236 ~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQMVST 252 (465)
T ss_pred ecCCCEEEeechHhhcc
Confidence 99999999999765443
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0039 Score=60.07 Aligned_cols=144 Identities=19% Similarity=0.226 Sum_probs=79.3
Q ss_pred cCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCC--CcceEeeE------EEECcEEEEEEe
Q 012462 146 ENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHK--NLVRLLGY------CIEGIHRMLVYE 217 (463)
Q Consensus 146 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~------~~~~~~~~lV~e 217 (463)
.+.++.|....+|+....++ .+++|...... ....+..|++++..|... .+.+++.. ....+..+++++
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45577777789999876444 67788764321 123344455655555321 23343332 122456789999
Q ss_pred ecCCCCHH-----H---------HHhhhhcCC-----C---CCCHHHHH------------HHHHHHHHHHHHHHh----
Q 012462 218 YVNNGNLE-----Q---------WLHGAMRHH-----G---YLTWEARM------------KVLLGTAKALAYLHE---- 259 (463)
Q Consensus 218 ~~~~g~L~-----~---------~l~~~~~~~-----~---~~~~~~~~------------~i~~~i~~~l~~LH~---- 259 (463)
|++|..+. + .++...... . .-.|.... .....+...++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 99885431 1 112111110 0 01111100 011123344555542
Q ss_pred cCCCCeEEccCCCCceeEcCCCCEEEeecccce
Q 012462 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292 (463)
Q Consensus 260 ~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~ 292 (463)
....+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 224589999999999999998877899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.003 Score=60.50 Aligned_cols=141 Identities=15% Similarity=0.164 Sum_probs=93.6
Q ss_pred cCeEeecCcEEEEEEEEcCCCeEEEEEEcccc----------------------hhhHH----HHHHHHHHHcCCCCCCc
Q 012462 146 ENVLGEGGYGVVYRGNLINGSPVAVKKILNNV----------------------GQAEK----EFRVEVEAIGHVRHKNL 199 (463)
Q Consensus 146 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~----------------------~~~~~----~~~~e~~~l~~l~h~ni 199 (463)
...|..|--+-||.|...+|..+|||+.+... ....+ -...|++-|.+|+...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 34678888899999988899999999864210 01111 12346666666654443
Q ss_pred ceEeeEEEECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC
Q 012462 200 VRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD 279 (463)
Q Consensus 200 v~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~ 279 (463)
.-.--+... ...|||+|+.. +=+-. ..-....++...+..+-.+++.-|.-|.+.| ++||.||.--|+|+.
T Consensus 229 P~PePIlLk--~hVLVM~FlGr-dgw~a---PkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh- 299 (520)
T KOG2270|consen 229 PCPEPILLK--NHVLVMEFLGR-DGWAA---PKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH- 299 (520)
T ss_pred CCCCceeee--cceEeeeeccC-CCCcC---cccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-
Confidence 322211111 22699999853 21110 0112334777788889999999999998877 999999999998886
Q ss_pred CCCEEEeecccceecC
Q 012462 280 DFNAKVSDFGLAKLLG 295 (463)
Q Consensus 280 ~~~~kl~Dfg~a~~~~ 295 (463)
+|.+.|+|-+.+....
T Consensus 300 dG~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVEHD 315 (520)
T ss_pred CCEEEEEEccccccCC
Confidence 4589999998876544
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.21 E-value=5.6e-05 Score=83.25 Aligned_cols=158 Identities=15% Similarity=0.040 Sum_probs=116.0
Q ss_pred HHHHHcCCCCCCcceEeeEEE--ECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--C
Q 012462 187 EVEAIGHVRHKNLVRLLGYCI--EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI--E 262 (463)
Q Consensus 187 e~~~l~~l~h~niv~l~~~~~--~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--~ 262 (463)
|...++...|+++.....-.. +..+.+.+++|+.+|.+.+.+-........+....+...-.+...+..-+|... .
T Consensus 1279 e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg 1358 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLG 1358 (2724)
T ss_pred hhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCC
Confidence 444555567888776655443 234558899999999999998766555555655555444444355555555542 2
Q ss_pred CCeEEccCCCCceeEcCCCCEEEeecccceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCC
Q 012462 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGR 342 (463)
Q Consensus 263 ~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~ 342 (463)
.-.+|+++|+-|.+|..+..+|++++|+.+...+. ....+...+++-|+.|+....-.++.++|+|..|+-+|++.-|.
T Consensus 1359 ~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n 1437 (2724)
T KOG1826|consen 1359 NTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGN 1437 (2724)
T ss_pred ccchhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhccc
Confidence 23689999999999999999999999999843322 23344566788899999998888999999999999999998887
Q ss_pred CCC
Q 012462 343 DPV 345 (463)
Q Consensus 343 ~pf 345 (463)
.+|
T Consensus 1438 ~~f 1440 (2724)
T KOG1826|consen 1438 AYF 1440 (2724)
T ss_pred HHH
Confidence 665
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0031 Score=59.78 Aligned_cols=74 Identities=16% Similarity=0.241 Sum_probs=46.3
Q ss_pred ccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCC---CCCCcceEeeEEEECcEEEEEEeecCC
Q 012462 145 KENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV---RHKNLVRLLGYCIEGIHRMLVYEYVNN 221 (463)
Q Consensus 145 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lV~e~~~~ 221 (463)
..+.++-|....+|+.+ .+++.++||.-. ......|..|.+-|+.| .--.+++++++....+..+|||||++.
T Consensus 21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 34578999999999987 578899999764 22334566676666655 344678899988877778999999877
Q ss_pred C
Q 012462 222 G 222 (463)
Q Consensus 222 g 222 (463)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 6
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0046 Score=59.37 Aligned_cols=141 Identities=21% Similarity=0.244 Sum_probs=79.5
Q ss_pred CeEeecCcEEEEEEEEcC-------CCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCC-cceEeeEEEECcEEEEEEee
Q 012462 147 NVLGEGGYGVVYRGNLIN-------GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKN-LVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~e~ 218 (463)
+.|..|-...+|+....+ ++.+++|...... ....+..+|..++..+...+ ..++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 356667777999987654 4788889864432 22234455777766663222 3455655532 368999
Q ss_pred cCCCCHHHH-----------------HhhhhcCC-C----CCC--HHHHHH--------------------------HHH
Q 012462 219 VNNGNLEQW-----------------LHGAMRHH-G----YLT--WEARMK--------------------------VLL 248 (463)
Q Consensus 219 ~~~g~L~~~-----------------l~~~~~~~-~----~~~--~~~~~~--------------------------i~~ 248 (463)
++|..+... +|...... . ..+ +..+.. +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 888765321 11111110 0 010 111100 111
Q ss_pred HHHHHHHHHHh------cCCCCeEEccCCCCceeEcCC----CCEEEeecccce
Q 012462 249 GTAKALAYLHE------AIEPKVVHRDIKSSNILIDDD----FNAKVSDFGLAK 292 (463)
Q Consensus 249 ~i~~~l~~LH~------~~~~~i~H~Dikp~Nill~~~----~~~kl~Dfg~a~ 292 (463)
.+...+.+|-. .....++|+|+.+.||+++++ +.+.|+||..+.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22223334432 134478999999999999985 889999998874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0058 Score=58.45 Aligned_cols=146 Identities=18% Similarity=0.205 Sum_probs=79.7
Q ss_pred eEeecCcEEEEEEEEcCCCeEEEEEEc--ccchhhHHHHHHHHHHHcCCCC--CCcceEeeEEEECc--EEEEEEeecCC
Q 012462 148 VLGEGGYGVVYRGNLINGSPVAVKKIL--NNVGQAEKEFRVEVEAIGHVRH--KNLVRLLGYCIEGI--HRMLVYEYVNN 221 (463)
Q Consensus 148 ~lG~G~~g~V~~~~~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~--~~~lV~e~~~~ 221 (463)
.+..|..-.+|.... +++.+++. .. ...........+|+.+++.+.- --+...+++|.++. ..+.||+++.|
T Consensus 32 ~~~~G~sn~t~~~~~-~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veG 109 (321)
T COG3173 32 EISGGWSNDTFRLGD-TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEG 109 (321)
T ss_pred eccCCcccceEEEec-CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecc
Confidence 333333334444433 26777777 22 1223344556667777776632 23456677777766 66999999988
Q ss_pred CCHHH------------------HHhhh---hcCC-------CCCCHHHHHHHHH--------------HHHHHHHHHHh
Q 012462 222 GNLEQ------------------WLHGA---MRHH-------GYLTWEARMKVLL--------------GTAKALAYLHE 259 (463)
Q Consensus 222 g~L~~------------------~l~~~---~~~~-------~~~~~~~~~~i~~--------------~i~~~l~~LH~ 259 (463)
..+.+ +|... .... ......++..+.. ....-..+|+.
T Consensus 110 e~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~ 189 (321)
T COG3173 110 EVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEA 189 (321)
T ss_pred eeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHh
Confidence 42221 11100 0000 0000000111111 11222345544
Q ss_pred cC-----CCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 260 AI-----EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 260 ~~-----~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
+. .+.++|||+.+.|++++.++-+-+.||+++..-+
T Consensus 190 ~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 190 NRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred cCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 32 3569999999999999999889999999987644
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0066 Score=57.44 Aligned_cols=31 Identities=35% Similarity=0.561 Sum_probs=25.9
Q ss_pred CCeEEccCCCCceeEcCCCC-EEEeeccccee
Q 012462 263 PKVVHRDIKSSNILIDDDFN-AKVSDFGLAKL 293 (463)
Q Consensus 263 ~~i~H~Dikp~Nill~~~~~-~kl~Dfg~a~~ 293 (463)
+.++|+|+++.|||+++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 46999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.018 Score=56.98 Aligned_cols=73 Identities=12% Similarity=0.201 Sum_probs=48.7
Q ss_pred cCeEeecCcEEEEEEEEcCCCeEEEEEEcccch-------hhHHHHHHHHHHHcCCC---CCCcceEeeEEEECcEEEEE
Q 012462 146 ENVLGEGGYGVVYRGNLINGSPVAVKKILNNVG-------QAEKEFRVEVEAIGHVR---HKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 146 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lV 215 (463)
.+.||-|....||+... ++..++||.-..... ....+-..|...|..+. ..++.+++.++.+ ..+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEE
Confidence 45789999999999876 456799997641110 12233334566665442 2478889888874 45889
Q ss_pred EeecCC
Q 012462 216 YEYVNN 221 (463)
Q Consensus 216 ~e~~~~ 221 (463)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.034 Score=53.54 Aligned_cols=29 Identities=31% Similarity=0.423 Sum_probs=25.6
Q ss_pred CCeEEccCCCCceeEcCCCCEEEeecccce
Q 012462 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292 (463)
Q Consensus 263 ~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~ 292 (463)
.+++|||+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 48999999999999988 678999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.017 Score=56.18 Aligned_cols=72 Identities=18% Similarity=0.213 Sum_probs=46.0
Q ss_pred eEeecCcEEEEEEEEcCC-CeEEEEEEccc-------chhhHHHHHHHHHHHcCCC--CC-CcceEeeEEEECcEEEEEE
Q 012462 148 VLGEGGYGVVYRGNLING-SPVAVKKILNN-------VGQAEKEFRVEVEAIGHVR--HK-NLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 148 ~lG~G~~g~V~~~~~~~~-~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l~--h~-niv~l~~~~~~~~~~~lV~ 216 (463)
.||.|....||++...+| +.|+||.-... ..-..++...|.+.|.... -| .+++++.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999987554 58999975321 1223344555777765542 34 34445443 445567999
Q ss_pred eecCC
Q 012462 217 EYVNN 221 (463)
Q Consensus 217 e~~~~ 221 (463)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.023 Score=55.61 Aligned_cols=141 Identities=21% Similarity=0.231 Sum_probs=77.7
Q ss_pred eEeecCcEEEEEEEEcC-----CCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCc-ceEeeEEEECcEEEEEEeecCC
Q 012462 148 VLGEGGYGVVYRGNLIN-----GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNL-VRLLGYCIEGIHRMLVYEYVNN 221 (463)
Q Consensus 148 ~lG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~~~ 221 (463)
.|-.|-.-.+|+....+ +..|++|.......... +-.+|..++..+..-++ .++++.+..+ .|++|+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 45557778999986532 35788887644332211 22457777776643333 3556665332 57999877
Q ss_pred CCHHHH-----------------HhhhhcCCC--CCCHHHHHHHHHH-----------------HHHHHHHHHh-----c
Q 012462 222 GNLEQW-----------------LHGAMRHHG--YLTWEARMKVLLG-----------------TAKALAYLHE-----A 260 (463)
Q Consensus 222 g~L~~~-----------------l~~~~~~~~--~~~~~~~~~i~~~-----------------i~~~l~~LH~-----~ 260 (463)
.+|..- +|....... ...+..+..+..+ +...+..|.. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 665321 111100000 1112333233221 1112222221 1
Q ss_pred CCCCeEEccCCCCceeEcC-CCCEEEeeccccee
Q 012462 261 IEPKVVHRDIKSSNILIDD-DFNAKVSDFGLAKL 293 (463)
Q Consensus 261 ~~~~i~H~Dikp~Nill~~-~~~~kl~Dfg~a~~ 293 (463)
....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1336899999999999986 47899999988754
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.022 Score=54.73 Aligned_cols=102 Identities=19% Similarity=0.174 Sum_probs=70.0
Q ss_pred EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccc
Q 012462 211 HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGL 290 (463)
Q Consensus 211 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~ 290 (463)
..|++|++- |++|.- .....+++++.++.+.+..++-+..+. ..-|||+.-.||||+ +|+|-|+||-+
T Consensus 300 y~yl~~kdh-gt~is~--------ik~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 300 YLYLHFKDH-GTPISI--------IKADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred EEEEEEecC-Cceeee--------eecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeee
Confidence 446777765 445432 123578899999999888888887765 789999999999999 99999999999
Q ss_pred ceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhH
Q 012462 291 AKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSF 331 (463)
Q Consensus 291 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 331 (463)
++......... ....--|-.+.|. -+.+-|||-+
T Consensus 368 sRl~~~q~~is------y~rldhp~lF~G~-dd~QFeIYrl 401 (488)
T COG5072 368 SRLSYSQGIIS------YNRLDHPDLFNGV-DDYQFEIYRL 401 (488)
T ss_pred eecccCCceee------ccccCchhhhcCc-cceeeeHHHH
Confidence 99644332211 1123344455433 3556666654
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.054 Score=52.39 Aligned_cols=141 Identities=24% Similarity=0.302 Sum_probs=80.6
Q ss_pred eEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCC---CCC---cceEee----EEEECcEEEEEEe
Q 012462 148 VLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR---HKN---LVRLLG----YCIEGIHRMLVYE 217 (463)
Q Consensus 148 ~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~n---iv~l~~----~~~~~~~~~lV~e 217 (463)
.|.+ .-..+|+....+|+. ++|..... ....++..|+..+..|. .+= +..+=| ........+-|++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3444 556899998767776 77865443 44555666777776652 111 222212 1111226678999
Q ss_pred ecCCCCHHH------------H---HhhhhcCC--------CCCCHHH-------------HHHHHHHHHHHHHHHHhcC
Q 012462 218 YVNNGNLEQ------------W---LHGAMRHH--------GYLTWEA-------------RMKVLLGTAKALAYLHEAI 261 (463)
Q Consensus 218 ~~~~g~L~~------------~---l~~~~~~~--------~~~~~~~-------------~~~i~~~i~~~l~~LH~~~ 261 (463)
|++|..+.. + |+...+.. ....|.. -.....++...+..+....
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999877762 0 11111111 1122320 0113334444555555432
Q ss_pred ----CCC---eEEccCCCCceeEcCCCC-EEEeecccce
Q 012462 262 ----EPK---VVHRDIKSSNILIDDDFN-AKVSDFGLAK 292 (463)
Q Consensus 262 ----~~~---i~H~Dikp~Nill~~~~~-~kl~Dfg~a~ 292 (463)
... +||+|+.|.||+++.+.. +-+.||+-+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 223 899999999999999885 8999999875
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.08 Score=51.02 Aligned_cols=32 Identities=22% Similarity=0.315 Sum_probs=28.4
Q ss_pred CCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 262 ~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
..+++|+|+.+.|+|+++++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 34799999999999999999999999988753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.029 Score=50.19 Aligned_cols=137 Identities=16% Similarity=0.108 Sum_probs=82.7
Q ss_pred CeEEEEEEcccchh-hHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHH
Q 012462 166 SPVAVKKILNNVGQ-AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARM 244 (463)
Q Consensus 166 ~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 244 (463)
.+..+|++..-.-. ...-+..+..++++++ .|+++..- ++..+-++.|+|..... ....
T Consensus 86 G~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-------------~~~N--- 145 (308)
T PF07387_consen 86 GPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-------------NFSN--- 145 (308)
T ss_pred chhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-------------chhH---
Confidence 34566766433222 3455677888888765 47777632 33445689999854211 1111
Q ss_pred HHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCceeeccccccCCCCchhhhccCCCCc
Q 012462 245 KVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNE 324 (463)
Q Consensus 245 ~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 324 (463)
.+.. =+.+|.-.|+. ..+.+|||..|+||+.|..|.+||.|-+.-... +..|.-- .....++
T Consensus 146 ~i~a-gi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~~-------------~V~~vN~---~Y~~lT~ 207 (308)
T PF07387_consen 146 FITA-GIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLEN-------------QVNMVNI---EYESLTQ 207 (308)
T ss_pred HHHH-hHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhhh-------------eeeEEee---eccccCh
Confidence 1111 14567778853 448999999999999999999999998764210 1112211 1122466
Q ss_pred cchhhhHHHHHHHHHh
Q 012462 325 KSDVYSFGVLLLEAIT 340 (463)
Q Consensus 325 ~sDvwSlGvvl~ellt 340 (463)
++.+-+|=.-++++..
T Consensus 208 ~aE~~~fv~s~l~~v~ 223 (308)
T PF07387_consen 208 EAEVKVFVKSCLKLVE 223 (308)
T ss_pred HHHHHHHHHHHHHHHH
Confidence 7777777666676665
|
The function of this family is unknown. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.074 Score=47.98 Aligned_cols=75 Identities=19% Similarity=0.259 Sum_probs=51.0
Q ss_pred CeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCC---CCCCcceEeeEEEECcEEEEEEeecCCCC
Q 012462 147 NVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV---RHKNLVRLLGYCIEGIHRMLVYEYVNNGN 223 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lV~e~~~~g~ 223 (463)
+.+--|.--..|.... +..++.||.- .......|..|+.-|..| +--++.+++.+-.+..+.|+|+||++-+.
T Consensus 22 ~~v~gG~inea~~v~d-g~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 22 EEVSGGDINEAWRLRD-GTDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred cccCCccccceeEeec-CCcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 4455566566666543 5578899963 223345666666555444 44568888999889999999999998865
Q ss_pred HH
Q 012462 224 LE 225 (463)
Q Consensus 224 L~ 225 (463)
+.
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 54
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.85 E-value=0.014 Score=58.32 Aligned_cols=47 Identities=19% Similarity=0.247 Sum_probs=35.7
Q ss_pred HHHHHHHHHcCCCCCCcceEeeEEEEC-cEEEEEEeecCCCCHHHHHhh
Q 012462 183 EFRVEVEAIGHVRHKNLVRLLGYCIEG-IHRMLVYEYVNNGNLEQWLHG 230 (463)
Q Consensus 183 ~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lV~e~~~~g~L~~~l~~ 230 (463)
.+.-...+++.+.|+|+..++++-... ....+|+|++ +-+|.+.+..
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~ 75 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKT 75 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHh
Confidence 344456788888999999999887643 3457899999 5599998854
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.83 E-value=0.15 Score=57.34 Aligned_cols=143 Identities=20% Similarity=0.256 Sum_probs=77.3
Q ss_pred CeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCC-------CCCCcceEee-----EEEE-Cc--E
Q 012462 147 NVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV-------RHKNLVRLLG-----YCIE-GI--H 211 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-------~h~niv~l~~-----~~~~-~~--~ 211 (463)
+.|+ |..-.+|+....+|..+++|+...... ......|...+..| .-|.+++..+ .... ++ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 3464 456788998877788899998754322 22333344444333 2333333221 1111 22 4
Q ss_pred EEEEEeecCCCCHHHH-----------------HhhhhcC------CCCCCHHH-----------------HHHHHHHHH
Q 012462 212 RMLVYEYVNNGNLEQW-----------------LHGAMRH------HGYLTWEA-----------------RMKVLLGTA 251 (463)
Q Consensus 212 ~~lV~e~~~~g~L~~~-----------------l~~~~~~------~~~~~~~~-----------------~~~i~~~i~ 251 (463)
.+-+++|++|..|.+. ++..... ...+.|.. ...++.++.
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 5678999999777651 1111110 01122211 112222333
Q ss_pred HHHH-----HHHhcCCCCeEEccCCCCceeEcCCC--CEE-Eeeccccee
Q 012462 252 KALA-----YLHEAIEPKVVHRDIKSSNILIDDDF--NAK-VSDFGLAKL 293 (463)
Q Consensus 252 ~~l~-----~LH~~~~~~i~H~Dikp~Nill~~~~--~~k-l~Dfg~a~~ 293 (463)
.... .+. ....++||+|+.+.|||++.++ .+. |+|||.+..
T Consensus 188 ~~~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 188 ARFERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 2222 121 2345899999999999999875 555 999998754
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.41 Score=46.46 Aligned_cols=70 Identities=14% Similarity=0.020 Sum_probs=40.9
Q ss_pred cCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCC---CCCcceEe---e--EEEECcEEEEEEeecCCCC
Q 012462 152 GGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR---HKNLVRLL---G--YCIEGIHRMLVYEYVNNGN 223 (463)
Q Consensus 152 G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~---~--~~~~~~~~~lV~e~~~~g~ 223 (463)
+.-..||+....++..+++|..... ......+..|++.+..|. -| ++... | +...++..+.|+++++|..
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gip-v~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIP-VVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCC-CCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 4457899998777888898976422 223445555666655442 22 22211 1 1223456788999988763
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.48 E-value=0.071 Score=51.89 Aligned_cols=142 Identities=17% Similarity=0.215 Sum_probs=75.4
Q ss_pred CeEeecCcEEEEEEEEcC----CCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCc-ceEeeEEEECcEEEEEEeecCC
Q 012462 147 NVLGEGGYGVVYRGNLIN----GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNL-VRLLGYCIEGIHRMLVYEYVNN 221 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~~~ 221 (463)
+.|..|-...+|+....+ +..|++|........ .-+-.+|..+++.+..-++ .++++++. ++ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 345557777889886433 237888876443221 1122457777776644344 45666553 22 58899877
Q ss_pred CCHHH-------H----------HhhhhcC-CC-CCCHHHHHHHHHHH----------------------HHHHHHHHhc
Q 012462 222 GNLEQ-------W----------LHGAMRH-HG-YLTWEARMKVLLGT----------------------AKALAYLHEA 260 (463)
Q Consensus 222 g~L~~-------~----------l~~~~~~-~~-~~~~~~~~~i~~~i----------------------~~~l~~LH~~ 260 (463)
..|.. . +|..... .. +..+..+..+..++ ..-+..+...
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 65421 1 1111000 00 11223322222221 1112222211
Q ss_pred -----CCCCeEEccCCCCceeEcC-CCCEEEeeccccee
Q 012462 261 -----IEPKVVHRDIKSSNILIDD-DFNAKVSDFGLAKL 293 (463)
Q Consensus 261 -----~~~~i~H~Dikp~Nill~~-~~~~kl~Dfg~a~~ 293 (463)
...-++|+|+.+.|||+++ ++.++++||..|-.
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1124789999999999975 57899999988754
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.22 E-value=0.087 Score=51.97 Aligned_cols=74 Identities=15% Similarity=0.211 Sum_probs=48.3
Q ss_pred cCeEeecCcEEEEEEEEcC-CCeEEEEEEccc------chhhHHHHHHHHHHHcCCC--CC-CcceEeeEEEECcEEEEE
Q 012462 146 ENVLGEGGYGVVYRGNLIN-GSPVAVKKILNN------VGQAEKEFRVEVEAIGHVR--HK-NLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 146 ~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~------~~~~~~~~~~e~~~l~~l~--h~-niv~l~~~~~~~~~~~lV 215 (463)
.+.||-|.-.-||++.+.+ ++.|+||.-... -.-..++...|.+.|+.+. -| ++++++.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 3578999999999998643 568999975321 1223455566777776552 34 45556544 44456789
Q ss_pred EeecCC
Q 012462 216 YEYVNN 221 (463)
Q Consensus 216 ~e~~~~ 221 (463)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999854
|
|
| >PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ] | Back alignment and domain information |
|---|
Probab=94.79 E-value=0.0037 Score=39.12 Aligned_cols=26 Identities=23% Similarity=0.286 Sum_probs=11.6
Q ss_pred HHHHHHHHHHHHHHHHHHhhheeeee
Q 012462 21 EVIGISVALFIIIILSVLSFCLTSRK 46 (463)
Q Consensus 21 ~~ig~~~~~~~~~~l~i~~~~~~~r~ 46 (463)
+.+|+++.++++++++++++++++||
T Consensus 13 Ia~~VvVPV~vI~~vl~~~l~~~~rR 38 (40)
T PF08693_consen 13 IAVGVVVPVGVIIIVLGAFLFFWYRR 38 (40)
T ss_pred EEEEEEechHHHHHHHHHHhheEEec
Confidence 33444444444444444444444444
|
This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis []. |
| >PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane | Back alignment and domain information |
|---|
Probab=94.58 E-value=0.025 Score=45.56 Aligned_cols=17 Identities=29% Similarity=0.663 Sum_probs=7.3
Q ss_pred HHHHHHHhhheeeeecc
Q 012462 32 IIILSVLSFCLTSRKKS 48 (463)
Q Consensus 32 ~~~l~i~~~~~~~r~~~ 48 (463)
++++++++||++|+||+
T Consensus 78 Ig~Illi~y~irR~~Kk 94 (122)
T PF01102_consen 78 IGIILLISYCIRRLRKK 94 (122)
T ss_dssp HHHHHHHHHHHHHHS--
T ss_pred HHHHHHHHHHHHHHhcc
Confidence 34444555555444443
|
Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.24 E-value=0.42 Score=47.38 Aligned_cols=74 Identities=16% Similarity=0.318 Sum_probs=42.0
Q ss_pred CeEeecCcEEEEEEEEcCC--Ce-----EEEEEEcccchhhHHHHHHHHHHHcCCCCCCc-ceEeeEEEECcEEEEEEee
Q 012462 147 NVLGEGGYGVVYRGNLING--SP-----VAVKKILNNVGQAEKEFRVEVEAIGHVRHKNL-VRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~ 218 (463)
+.|..|-...+|++...++ .. |.++.. .......-+-.+|+.+++.+...++ .++++.+.. ++|+||
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~-g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef 130 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKS-STYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW 130 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEec-cCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence 3555688889999865443 22 333322 1111111122447778877754444 456666642 689999
Q ss_pred cCCCCHH
Q 012462 219 VNNGNLE 225 (463)
Q Consensus 219 ~~~g~L~ 225 (463)
++|.+|.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9887653
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 463 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-66 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-65 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-52 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-51 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-40 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-39 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-39 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-38 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-27 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-26 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-25 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-25 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-23 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-23 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-22 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-22 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-22 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-22 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-22 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-22 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-22 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-21 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-21 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-21 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-21 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-21 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-21 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-21 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-21 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-21 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-21 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-21 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-21 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-21 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-20 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-20 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-20 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-20 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-20 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-20 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-19 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-19 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-19 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-19 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-19 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-19 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-19 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-19 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-19 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-19 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-19 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-19 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-19 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-19 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-19 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-19 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-19 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-19 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-19 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-18 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-18 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-18 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-18 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-18 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-18 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-18 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-18 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-18 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-18 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-18 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-18 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-18 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-18 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-18 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-18 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-18 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-18 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-18 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-18 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-18 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-18 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-18 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-18 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-18 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-18 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-18 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-18 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-18 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-17 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-17 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-17 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-17 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-17 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-17 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-17 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-17 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-17 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-17 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-17 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 9e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 9e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-15 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-15 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-14 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-14 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-14 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-14 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-14 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 8e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 9e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-13 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-13 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-13 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-13 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-13 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-13 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-13 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-13 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-13 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-13 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-13 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-13 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-13 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-13 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-13 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-13 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-13 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-13 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-12 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-12 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-12 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-12 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-12 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-12 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-12 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-12 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-12 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-12 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-12 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-12 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-12 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-12 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-12 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-12 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-12 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-12 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-12 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-12 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-12 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-12 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-12 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-12 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 9e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 9e-12 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 9e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-11 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-11 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-11 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 8e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-11 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 8e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 9e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 9e-11 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 9e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 9e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-10 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-10 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-10 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-10 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 8e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 9e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 9e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-09 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-09 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 9e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 9e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 8e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-07 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 8e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 9e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 9e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 9e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-06 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-06 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-06 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-06 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-06 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-06 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-06 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-06 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-06 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-06 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-06 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-06 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 503 bits (1297), Expect = e-179
Identities = 131/315 (41%), Positives = 201/315 (63%), Gaps = 5/315 (1%)
Query: 119 LPEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVG 178
PE LG F+LR+L++A++ FS +N+LG GG+G VY+G L +G+ VAVK++
Sbjct: 9 DPEVH-LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERT 67
Query: 179 QA-EKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY 237
Q E +F+ EVE I H+NL+RL G+C+ R+LVY Y+ NG++ L
Sbjct: 68 QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPP 127
Query: 238 LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297
L W R ++ LG+A+ LAYLH+ +PK++HRD+K++NIL+D++F A V DFGLAKL+
Sbjct: 128 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 187
Query: 298 KSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHE--VN 355
+HVTT V GT G++APEY +TG +EK+DV+ +GV+LLE ITG+ D R A++ V
Sbjct: 188 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247
Query: 356 LVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
L+DW+K ++ ++ E +VD +++ +++ + AL C +RPKMS+VVRMLE
Sbjct: 248 LLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
Query: 416 SEEYPIVREDRRHRR 430
+ R + +
Sbjct: 308 GDGLA-ERWEEWQKE 321
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 484 bits (1249), Expect = e-172
Identities = 115/313 (36%), Positives = 180/313 (57%), Gaps = 5/313 (1%)
Query: 105 SSSHPITAPSPLIGLPE-FSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLI 163
S + S L + + L DLE ATN F + ++G G +G VY+G L
Sbjct: 2 GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61
Query: 164 NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGN 223
+G+ VA+K+ Q +EF E+E + RH +LV L+G+C E +L+Y+Y+ NGN
Sbjct: 62 DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121
Query: 224 LEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNA 283
L++ L+G+ ++WE R+++ +G A+ L YLH ++HRD+KS NIL+D++F
Sbjct: 122 LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVP 178
Query: 284 KVSDFGLAKL-LGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGR 342
K++DFG++K ++H++T V GT GY+ PEY G L EKSDVYSFGV+L E + R
Sbjct: 179 KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238
Query: 343 DPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSE 402
+ P VNL +W + + E++VDPN+ + +L++ TA++C+ SE
Sbjct: 239 SAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSE 298
Query: 403 KRPKMSQVVRMLE 415
RP M V+ LE
Sbjct: 299 DRPSMGDVLWKLE 311
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 410 bits (1057), Expect = e-143
Identities = 106/300 (35%), Positives = 168/300 (56%), Gaps = 21/300 (7%)
Query: 129 HWFTLRDLELATNRFSKE------NVLGEGGYGVVYRGNLINGSPVAVKK----ILNNVG 178
H F+ +L+ TN F + N +GEGG+GVVY+G +N + VAVKK +
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTE 71
Query: 179 QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYL 238
+ +++F E++ + +H+NLV LLG+ +G LVY Y+ NG+L L + L
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC-LDGTPPL 130
Query: 239 TWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG- 297
+W R K+ G A + +LH E +HRDIKS+NIL+D+ F AK+SDFGLA+
Sbjct: 131 SWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 298 KSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLV 357
++ +T+R++GT Y+APE G + KSD+YSFGV+LLE ITG VD R L+
Sbjct: 188 QTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLLL 244
Query: 358 DWLKMMVGSRRS-EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416
D + + ++ E+ +D + S +++ A +C+ KRP + +V ++L+
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMNDADS-TSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 296 bits (760), Expect = 4e-98
Identities = 74/309 (23%), Positives = 126/309 (40%), Gaps = 30/309 (9%)
Query: 131 FTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEA 190
+L + V G +G V++ + VAVK I + + EV +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVK-IFPIQDKQSWQNEYEVYS 71
Query: 191 IGHVRHKNLVRLLGYCIEG----IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKV 246
+ ++H+N+++ +G G + L+ + G+L +L ++W +
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCHI 126
Query: 247 LLGTAKALAYLHEAI-------EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299
A+ LAYLHE I +P + HRDIKS N+L+ ++ A ++DFGLA AGKS
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 300 HV-TTRVMGTFGYVAPEYANTGLLNE-----KSDVYSFGVLLLEAITGRDPVDHGRPAHE 353
T +GT Y+APE + + + D+Y+ G++L E + D +
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 354 VNLVDWLKMMVGSRRSEEVV-----DPNIEVRPSTRALKRSLL-TALRCVDPDSEKRPKM 407
+ + + +EVV P + A L T C D D+E R
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306
Query: 408 SQVVRMLES 416
V +
Sbjct: 307 GCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 2e-69
Identities = 71/324 (21%), Positives = 119/324 (36%), Gaps = 49/324 (15%)
Query: 131 FTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVE- 189
+ L + ++G G YG VY+G+L + PVAVK + F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSF---ANRQNFINEKNI 58
Query: 190 -AIGHVRHKNLVRLLGYCIEG-----IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEAR 243
+ + H N+ R + + +LV EY NG+L ++L W +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-----SDWVSS 113
Query: 244 MKVLLGTAKALAYLHEAIE------PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297
++ + LAYLH + P + HRD+ S N+L+ +D +SDFGL+ L
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 298 K-------SHVTTRVMGTFGYVAPEYANTGL-------LNEKSDVYSFGVLLLEAITGRD 343
+ + +GT Y+APE + ++ D+Y+ G++ E
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 344 PVDHGRPAHEVNLVDWLKMMVGSRRSEE-----VVD----PNIEVRPSTRALKRSLLTAL 394
+ G E + + VG+ + E V P +L L
Sbjct: 234 DLFPGESVPEYQMA--FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKET 291
Query: 395 --RCVDPDSEKRPKMSQVVRMLES 416
C D D+E R +
Sbjct: 292 IEDCWDQDAEARLTAQXAEERMAE 315
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 6e-69
Identities = 81/308 (26%), Positives = 141/308 (45%), Gaps = 25/308 (8%)
Query: 113 PSPLIGLPEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKK 172
P +P L + D+++ + + +G G +G V+R +GS VAVK
Sbjct: 9 PMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKI 67
Query: 173 IL--NNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHG 230
++ + + EF EV + +RH N+V +G + + +V EY++ G+L + LH
Sbjct: 68 LMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK 127
Query: 231 AMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGL 290
+ L R+ + AK + YLH P +VHR++KS N+L+D + KV DFGL
Sbjct: 128 SGARE-QLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185
Query: 291 AKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
++L + + GT ++APE NEKSDVYSFGV+L E T + P +
Sbjct: 186 SRLKASTFLSSKSAA-GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN--- 241
Query: 351 AHEVNLVDWLKMMVGSRRSEEVVDPNI--EVRPSTRALKRSLLTALRCVDPDSEKRPKMS 408
++ +++ V E+ + +++ C + KRP +
Sbjct: 242 ------LNPAQVVAA------VGFKCKRLEIPRNLNPQVAAIIE--GCWTNEPWKRPSFA 287
Query: 409 QVVRMLES 416
++ +L
Sbjct: 288 TIMDLLRP 295
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 3e-67
Identities = 85/301 (28%), Positives = 132/301 (43%), Gaps = 37/301 (12%)
Query: 146 ENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGY 205
E V+G G +GVV + VA+K+I + K F VE+ + V H N+V+L G
Sbjct: 13 EEVVGRGAFGVVCKAKW-RAKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 206 CIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKV 265
C+ + LV EY G+L LHGA Y T M L ++ +AYLH +
Sbjct: 70 CLNPV--CLVMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 266 VHRDIKSSNILIDDDFN-AKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNE 324
+HRD+K N+L+ K+ DFG A T G+ ++APE +E
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNKGSAAWMAPEVFEGSNYSE 182
Query: 325 KSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPS-- 382
K DV+S+G++L E IT R P + ++ + R V RP
Sbjct: 183 KCDVFSWGIILWEVITRRKP--------------FDEIGGPAFRIMWAVHNGT--RPPLI 226
Query: 383 ---TRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES--EEYPIVREDRRHRRTQGGTSM 437
+ ++ SL+T RC D +RP M ++V+++ +P E ++
Sbjct: 227 KNLPKPIE-SLMT--RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPG 283
Query: 438 E 438
E
Sbjct: 284 E 284
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 3e-66
Identities = 85/302 (28%), Positives = 141/302 (46%), Gaps = 46/302 (15%)
Query: 134 RDLELATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAE-------KEFR 185
R LA N E +G+GG+G+V++G L+ + S VA+K ++ + E +EF+
Sbjct: 12 RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ 71
Query: 186 VEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK 245
EV + ++ H N+V+L G +V E+V G+L L + W +++
Sbjct: 72 REVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLL---DKAHPIKWSVKLR 126
Query: 246 VLLGTAKALAYLHEAIEPKVVHRDIKSSNILID-----DDFNAKVSDFGLAKLLGAGKSH 300
++L A + Y+ P +VHRD++S NI + AKV+DFGL++ H
Sbjct: 127 LMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVH 181
Query: 301 VTTRVMGTFGYVAPE--YANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVD 358
+ ++G F ++APE A EK+D YSF ++L +TG P D +
Sbjct: 182 SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IK 237
Query: 359 WLKMMV--GSRRSEEVVDPNIEVRPST--RALKRSLLTALRCVDPDSEKRPKMSQVVRML 414
++ M+ G R P I P L R+++ C D +KRP S +V+ L
Sbjct: 238 FINMIREEGLR-------PTI---PEDCPPRL-RNVIE--LCWSGDPKKRPHFSYIVKEL 284
Query: 415 ES 416
Sbjct: 285 SE 286
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 3e-64
Identities = 68/287 (23%), Positives = 117/287 (40%), Gaps = 38/287 (13%)
Query: 146 ENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLG 204
VLG+G +G + G + +K+++ + ++ F EV+ + + H N+++ +G
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 205 YCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPK 264
+ + EY+ G L + W R+ A +AYLH
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLHSM---N 128
Query: 265 VVHRDIKSSNILIDDDFNAKVSDFGLAKLL-------------GAGKSHVTTRVMGTFGY 311
++HRD+ S N L+ ++ N V+DFGLA+L+ V+G +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 312 VAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEE 371
+APE N +EK DV+SFG++L E I + P ++
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV----------RG 238
Query: 372 VVDPNI--EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416
+D PS + +RC D D EKRP ++ LE+
Sbjct: 239 FLDRYCPPNCPPSFFPI------TVRCCDLDPEKRPSFVKLEHWLET 279
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 5e-63
Identities = 72/285 (25%), Positives = 120/285 (42%), Gaps = 40/285 (14%)
Query: 146 ENVLGEGGYGVVYRGNLINGSPVAVKKIL----NNVGQAEKEFRVEVEAIGHVRHKNLVR 201
E ++G GG+G VYR G VAVK ++ Q + R E + ++H N++
Sbjct: 12 EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 202 LLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
L G C++ + LV E+ G L + L G + + + + A+ + YLH+
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVLSGKR-----IPPDILVNWAVQIARGMNYLHDEA 125
Query: 262 EPKVVHRDIKSSNILIDDDF--------NAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
++HRD+KSSNILI K++DFGLA+ ++ + G + ++A
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMSAA-GAYAWMA 182
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE--E 371
PE + ++ SDV+S+GVLL E +TG P V +
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV-----AMNKLALPIPS 237
Query: 372 VVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416
L+ C +PD RP + ++ L +
Sbjct: 238 TCPEPF----------AKLME--DCWNPDPHSRPSFTNILDQLTT 270
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 9e-63
Identities = 64/280 (22%), Positives = 111/280 (39%), Gaps = 36/280 (12%)
Query: 146 ENVLGEGGYGVVYRGNLINGSPVAVKKIL--NNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
L E G +++G G+ + VK + + + ++F E + H N++ +L
Sbjct: 15 LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 204 GYCIE--GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
G C H L+ ++ G+L LH + +K L A+ +A+LH +
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV--VDQSQAVKFALDMARGMAFLH-TL 130
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE---YAN 318
EP + + S +++ID+D A++S + S + M +VAPE
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVK------FSFQSPGRMYAPAWVAPEALQKKP 184
Query: 319 TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378
+D++SF VLL E +T P V + R P I
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV-----ALEGLR------PTI- 232
Query: 379 VRPST--RALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416
P + + L+ C++ D KRPK +V +LE
Sbjct: 233 --PPGISPHVSK-LMK--ICMNEDPAKRPKFDMIVPILEK 267
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 6e-59
Identities = 71/279 (25%), Positives = 129/279 (46%), Gaps = 30/279 (10%)
Query: 146 ENVLGEGGYGVVYRGNLINGSPVAVKKIL--NNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
+G G +G VY+G +G VAVK + Q + F+ EV + RH N++ +
Sbjct: 29 GQRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEP 263
GY +V ++ +L LH + + + TA+ + YLH
Sbjct: 87 GYSTAP-QLAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLHA---K 139
Query: 264 KVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPE---YANT 319
++HRD+KS+NI + +D K+ DFGLA SH ++ G+ ++APE ++
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199
Query: 320 GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEV 379
+ +SDVY+FG++L E +TG+ P + ++ + + GS P++
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM----VGRGSLS------PDLSK 249
Query: 380 RPST--RALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416
S + +KR L+ C+ ++RP +++ +E
Sbjct: 250 VRSNCPKRMKR-LMA--ECLKKKRDERPSFPRILAEIEE 285
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 2e-58
Identities = 59/300 (19%), Positives = 112/300 (37%), Gaps = 39/300 (13%)
Query: 132 TLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKIL--NNVGQAEKEFRVEVE 189
L++ ++ + ++G+G +G VY G +G VA++ I + K F+ EV
Sbjct: 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRW-HG-EVAIRLIDIERDNEDQLKAFKREVM 81
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
A RH+N+V +G C+ H ++ L + L ++
Sbjct: 82 AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQE 138
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL----LGAGKSHVTTRV 305
K + YLH ++H+D+KS N+ D+ ++DFGL + +
Sbjct: 139 IVKGMGYLH---AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQ 194
Query: 306 MGTFGYVAPEYANTGLL---------NEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNL 356
G ++APE ++ SDV++ G + E P +
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ 254
Query: 357 VDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416
+ G + + I + + L C + E+RP ++++ MLE
Sbjct: 255 MGT-----GMKPN----LSQIGMGKEISDI------LLFCWAFEQEERPTFTKLMDMLEK 299
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 2e-58
Identities = 69/311 (22%), Positives = 126/311 (40%), Gaps = 47/311 (15%)
Query: 134 RDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVE--AI 191
RD+ L +G+G YG V+RG+ G VAVK + + EK + E E
Sbjct: 8 RDITL-------LECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNT 56
Query: 192 GHVRHKNLVRLLGYCIEGIHR----MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVL 247
+RH+N++ + + H L+ Y G+L +L L + ++++
Sbjct: 57 VMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIV 111
Query: 248 LGTAKALAYLHEAIE-----PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVT 302
L A LA+LH I P + HRD+KS NIL+ + ++D GLA + + +
Sbjct: 112 LSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLD 171
Query: 303 TRVM---GTFGYVAPE------YANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGR---- 349
GT Y+APE + ++ D+++FG++L E
Sbjct: 172 VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231
Query: 350 PAHEVN----LVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRP 405
P ++V + ++ +V + + P+ +L + L+ C + R
Sbjct: 232 PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAK-LMK--ECWYQNPSARL 288
Query: 406 KMSQVVRMLES 416
++ + L
Sbjct: 289 TALRIKKTLTK 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 6e-58
Identities = 74/325 (22%), Positives = 123/325 (37%), Gaps = 48/325 (14%)
Query: 118 GLPEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNV 177
GLP Q + +++ +G+G YG V+ G G VAVK
Sbjct: 26 GLPLLVQ-----RTIAKQIQM-------VKQIGKGRYGEVWMGKW-RGEKVAVKVFFT-- 70
Query: 178 GQAEKEFRVEVE--AIGHVRHKNLVRLLGYCIEG----IHRMLVYEYVNNGNLEQWLHGA 231
E + E E +RH+N++ + I+G L+ +Y NG+L +L
Sbjct: 71 -TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK-- 127
Query: 232 MRHHGYLTWEARMKVLLGTAKALAYLHEAIE-----PKVVHRDIKSSNILIDDDFNAKVS 286
L ++ +K+ + L +LH I P + HRD+KS NIL+ + ++
Sbjct: 128 ---STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184
Query: 287 DFGLAKLLGAGKSHV---TTRVMGTFGYVAPE------YANTGLLNEKSDVYSFGVLLLE 337
D GLA + + V +GT Y+ PE N +D+YSFG++L E
Sbjct: 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWE 244
Query: 338 AITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVD-----PNIEVRPSTRALKRSLL- 391
R +++ D + E+V P+ R S+ R +
Sbjct: 245 VAR-RCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGK 303
Query: 392 TALRCVDPDSEKRPKMSQVVRMLES 416
C + R +V + L
Sbjct: 304 LMTECWAHNPASRLTALRVKKTLAK 328
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 3e-57
Identities = 76/364 (20%), Positives = 139/364 (38%), Gaps = 60/364 (16%)
Query: 82 QRDDKDGGSISGEDSGSVTVYKPSSSHPITAPSPLIGLPEFSQLGWGHWFTLRDLELATN 141
+ D IS + +Y ++S + GLP Q R + L
Sbjct: 1 EDPSLDRPFISEGTTLKDLIYDMTTSGSGS------GLPLLVQ-----RTIARTIVL--- 46
Query: 142 RFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVE--AIGHVRHKNL 199
+ +G+G +G V+RG G VAVK + + E+ + E E +RH+N+
Sbjct: 47 ----QESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENI 98
Query: 200 VRLLGYCI----EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
+ + LV +Y +G+L +L+ +T E +K+ L TA LA
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLA 153
Query: 256 YLHEAIE-----PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVT---TRVMG 307
+LH I P + HRD+KS NIL+ + ++D GLA + + +G
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 213
Query: 308 TFGYVAPE------YANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLK 361
T Y+APE +++D+Y+ G++ E R + +++ D +
Sbjct: 214 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLVP 272
Query: 362 MMVGSRRSEEVV---------DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
+VV + + R + + ++ C + R ++ +
Sbjct: 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAK-IMR--ECWYANGAARLTALRIKK 329
Query: 413 MLES 416
L
Sbjct: 330 TLSQ 333
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 4e-41
Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 11/208 (5%)
Query: 141 NRFSKENVLGEGGYGVVYRGN-LINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRH 196
R+ + LG GG VY I VA+K I + K F EV + H
Sbjct: 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70
Query: 197 KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY 256
+N+V ++ E LV EY+ L +++ HG L+ + + + +
Sbjct: 71 QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI----ESHGPLSVDTAINFTNQILDGIKH 126
Query: 257 LHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEY 316
H+ ++VHRDIK NILID + K+ DFG+AK L T V+GT Y +PE
Sbjct: 127 AHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQ 183
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDP 344
A +E +D+YS G++L E + G P
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 6e-41
Identities = 76/332 (22%), Positives = 126/332 (37%), Gaps = 51/332 (15%)
Query: 105 SSSHPITAPSPLIGLPEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLIN 164
S+ P+T S ++ + W L +G G +G V+ G L
Sbjct: 87 STQQPLTKKSGVVLHRAVPKDKW---------VLNHEDLVLGEQIGRGNFGEVFSGRLRA 137
Query: 165 GS-PVAVKKILNNVGQAEK-EFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNG 222
+ VAVK + K +F E + H N+VRL+G C + +V E V G
Sbjct: 138 DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 197
Query: 223 NLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFN 282
+ +L L + ++++ A + YL +HRD+ + N L+ +
Sbjct: 198 DFLTFLR---TEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNV 251
Query: 283 AKVSDFGLAKLLGAGKSHVTTRVMGTFGYV-----APEYANTGLLNEKSDVYSFGVLLLE 337
K+SDFG+++ V G V APE N G + +SDV+SFG+LL E
Sbjct: 252 LKISDFGMSREE---ADGVYAASGGL-RQVPVKWTAPEALNYGRYSSESDVWSFGILLWE 307
Query: 338 AIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPST--RALKRSLLTAL 394
+ G P + + + R P A+ R +
Sbjct: 308 TFSLGASPYP-NLSNQQT-----REFVEKGGRLP---------CPELCPDAVFRLM---E 349
Query: 395 RCVDPDSEKRPKMSQVVRMLESEEYPIVREDR 426
+C + +RP S + + L+S I + R
Sbjct: 350 QCWAYEPGQRPSFSTIYQELQS----IRKRHR 377
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-40
Identities = 64/237 (27%), Positives = 108/237 (45%), Gaps = 20/237 (8%)
Query: 112 APSPLIGLPEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVK 171
P P + LG+G W E+ + LG G +GVV G VA+K
Sbjct: 1 GPLGSKNAPSTAGLGYGSW------EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIK 54
Query: 172 KILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGA 231
++ +E EF E + + ++ H+ LV+L G C + ++ EY+ NG L +L
Sbjct: 55 -MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-- 111
Query: 232 MRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA 291
+ +++ +A+ YL + +HRD+ + N L++D KVSDFGL+
Sbjct: 112 -EMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLS 167
Query: 292 KLLGAGKSHVTTRVMGTFGYV---APEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
+ + T +G+ V PE + KSD+++FGVL+ E + G+ P
Sbjct: 168 RYV---LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-40
Identities = 67/305 (21%), Positives = 116/305 (38%), Gaps = 48/305 (15%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLI-----NGSPVAVKKILNNVGQAEKEFRVEVEAI 191
+ LG+G +G V G+ VAVK++ ++ +++F+ E++ +
Sbjct: 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL 78
Query: 192 GHVRHKNLVRLLGYCIEGIHR--MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
+ +V+ G + LV EY+ +G L +L RH L +
Sbjct: 79 KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ---RHRARLDASRLLLYSSQ 135
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
K + YL + VHRD+ + NIL++ + + K++DFGLAKLL K + R G
Sbjct: 136 ICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 192
Query: 310 --GYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGS 366
+ APE + + + +SDV+SFGV+L E T + +
Sbjct: 193 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP---- 248
Query: 367 RRSEEVVDPNIEVRPSTRALKR---------------SLLTALRCVDPDSEKRPKMSQVV 411
+ L+ L+ C P + RP S +
Sbjct: 249 --------ALSRLL---ELLEEGQRLPAPPACPAEVHELM--KLCWAPSPQDRPSFSALG 295
Query: 412 RMLES 416
L+
Sbjct: 296 PQLDM 300
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-40
Identities = 69/307 (22%), Positives = 118/307 (38%), Gaps = 49/307 (15%)
Query: 134 RDLELATNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIG 192
+ + + LGEGG+ V L +G A+K+IL + Q +E + E +
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR 81
Query: 193 HVRHKNLVRLLGYCIEGIHRM----LVYEYVNNGNLEQWLHGAMRHHGYLTWEAR-MKVL 247
H N++RL+ YC+ L+ + G L + +LT E + + +L
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLT-EDQILWLL 140
Query: 248 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVM- 306
LG + L +H HRD+K +NIL+ D+ + D G +
Sbjct: 141 LGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 307 -------GTFGYVAPE----YANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVN 355
T Y APE ++ ++E++DV+S G +L + G P D +
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCV-IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256
Query: 356 LVDWLKMMVG------SRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQ 409
L + R S + L S++T VDP +RP +
Sbjct: 257 A---LAVQNQLSIPQSPRHSSAL-----------WQLLNSMMT----VDP--HQRPHIPL 296
Query: 410 VVRMLES 416
++ LE+
Sbjct: 297 LLSQLEA 303
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-40
Identities = 64/277 (23%), Positives = 122/277 (44%), Gaps = 36/277 (12%)
Query: 140 TNRFSKEN-VLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKE-FRVEVEAIGHVR 195
RF K + +G G + VY+G + VA ++ + ++E++ F+ E E + ++
Sbjct: 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ 83
Query: 196 HKNLVRLLGYCIEGIHRM----LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
H N+VR + LV E + +G L+ +L + + +
Sbjct: 84 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQIL 139
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
K L +LH P ++HRD+K NI I + K+ D GLA L ++ V+GT
Sbjct: 140 KGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPE 195
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS- 369
++APE +E DVY+FG+ +LE T P + A ++ + ++ G + +
Sbjct: 196 FMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQI----YRRVTSGVKPAS 250
Query: 370 -EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRP 405
++V P + + ++ C+ + ++R
Sbjct: 251 FDKVAIPEV----------KEII--EGCIRQNKDERY 275
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-40
Identities = 68/228 (29%), Positives = 107/228 (46%), Gaps = 28/228 (12%)
Query: 141 NRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEAIGHV 194
F K VLG G +G VY+G I PVA+K++ +A KE E + V
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKAL 254
+ ++ RLLG C+ L+ + + G L ++ H + + + + AK +
Sbjct: 75 DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGM 130
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRV-------MG 307
YL + ++VHRD+ + N+L+ + K++DFGLAKLLGA + M
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM- 186
Query: 308 TFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEV 354
A E + +SDV+S+GV + E +T G P D G PA E+
Sbjct: 187 -----ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEI 228
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 4e-40
Identities = 65/221 (29%), Positives = 108/221 (48%), Gaps = 13/221 (5%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRH 196
+ + + +G G +G+V+ G +N VA+K + +E++F E E + + H
Sbjct: 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIK-TIREGAMSEEDFIEEAEVMMKLSH 62
Query: 197 KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY 256
LV+L G C+E LV E++ +G L +L G E + + L + +AY
Sbjct: 63 PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAY 119
Query: 257 LHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGY--VAP 314
L EA V+HRD+ + N L+ ++ KVSDFG+ + + T+ F +P
Sbjct: 120 LEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASP 174
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEV 354
E + + KSDV+SFGVL+ E + G+ P + R EV
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE-NRSNSEV 214
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 6e-40
Identities = 77/251 (30%), Positives = 109/251 (43%), Gaps = 28/251 (11%)
Query: 108 HPITAPSPLIGLPEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSP 167
P + EF + GW L +G+G +G V G+ G+
Sbjct: 169 KPKVMEGTVAAQDEFYRSGW---------ALNMKELKLLQTIGKGEFGDVMLGDY-RGNK 218
Query: 168 VAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHR-MLVYEYVNNGNLEQ 226
VAVK I + F E + +RH NLV+LLG +E +V EY+ G+L
Sbjct: 219 VAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD 276
Query: 227 WLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVS 286
+L R L + +K L +A+ YL VHRD+ + N+L+ +D AKVS
Sbjct: 277 YLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVS 331
Query: 287 DFGLAKLLGAGKSHVTTRVMGTFGY--VAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRD 343
DFGL K +T+ G APE + KSDV+SFG+LL E + GR
Sbjct: 332 DFGLT------KEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 385
Query: 344 PVDHGRPAHEV 354
P P +V
Sbjct: 386 PY-PRIPLKDV 395
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 7e-40
Identities = 64/301 (21%), Positives = 119/301 (39%), Gaps = 39/301 (12%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLI-----NGSPVAVKKILNNVGQAEKEFRVEVEAI 191
+ LG+G +G V G VAVKK+ ++ + ++F E+E +
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 192 GHVRHKNLVRLLGYCIEGIHR--MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
++H N+V+ G C R L+ EY+ G+L +L +H + ++
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQ 122
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
K + YL + +HRD+ + NIL++++ K+ DFGL K+L K + G
Sbjct: 123 ICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES 179
Query: 310 --GYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR 367
+ APE + SDV+SFGV+L E T + M+G+
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--------FMRMIGND 231
Query: 368 RSEEVVDPNIEVRPSTRALKR------------SLLTALRCVDPDSEKRPKMSQVVRMLE 415
+ ++ + + R ++ C + + +RP + ++
Sbjct: 232 KQGQM--IVFHLIELLKNNGRLPRPDGCPDEIYMIM--TECWNNNVNQRPSFRDLALRVD 287
Query: 416 S 416
Sbjct: 288 Q 288
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-39
Identities = 67/337 (19%), Positives = 144/337 (42%), Gaps = 44/337 (13%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEF-RVEVEAIGHVRHK 197
++ + +GEG +G + +G +K+I ++ + E+E R EV + +++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
N+V+ E +V +Y G+L + ++ + + + + AL ++
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRIN--AQKGVLFQEDQILDWFVQICLALKHV 141
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-- 315
H+ K++HRDIKS NI + D ++ DFG+A++L + + GT Y++PE
Sbjct: 142 HD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEIC 197
Query: 316 ----YANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEE 371
Y N KSD+++ G +L E T + ++ + + ++
Sbjct: 198 ENKPY------NNKSDIWALGCVLYELCTLK------HAFEAGSMKNLVLKIISGSF--- 242
Query: 372 VVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVV-------RMLESEEYPIVRE 424
P + + S RSL++ L +P RP ++ ++ R+ + ++ E
Sbjct: 243 ---PPVSLHYSYDL--RSLVSQLFKRNP--RDRPSVNSILEKGFIAKRIEKFLSPQLIAE 295
Query: 425 DRRHRRTQGGTSMEIESQKENSDTDRSDYPGSRSESK 461
+ + S I +++ S + ++ +K
Sbjct: 296 EFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITK 332
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-39
Identities = 66/219 (30%), Positives = 108/219 (49%), Gaps = 19/219 (8%)
Query: 145 KENVLGEGGYGVVYRGNLINGS---PVAVK--KILNNVGQAEKEFRVEVEAIGHVRHKNL 199
++ LG G +G V +G VAVK K N + E E + + + +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 200 VRLLGYCI-EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
VR++G C E MLV E G L ++L + + ++ + ++++ + + YL
Sbjct: 81 VRMIGICEAESW--MLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLE 134
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF--GYVAPEY 316
E+ VHRD+ + N+L+ AK+SDFGL+K L A +++ + G + + APE
Sbjct: 135 ES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 191
Query: 317 ANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEV 354
N + KSDV+SFGVL+ EA + G+ P G EV
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYR-GMKGSEV 229
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-39
Identities = 64/301 (21%), Positives = 120/301 (39%), Gaps = 39/301 (12%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLI-----NGSPVAVKKILNNVGQAEKEFRVEVEAI 191
+ LG+G +G V G VAVKK+ ++ + ++F E+E +
Sbjct: 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 96
Query: 192 GHVRHKNLVRLLGYCIEGIHR--MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
++H N+V+ G C R L+ EY+ G+L +L +H + ++
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQ 153
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
K + YL + +HRD+ + NIL++++ K+ DFGL K+L K + + G
Sbjct: 154 ICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES 210
Query: 310 --GYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR 367
+ APE + SDV+SFGV+L E T + M+G+
Sbjct: 211 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--------FMRMIGND 262
Query: 368 RSEEVVDPNIEVRPSTRALKR------------SLLTALRCVDPDSEKRPKMSQVVRMLE 415
+ ++ + + R ++ C + + +RP + ++
Sbjct: 263 KQGQM--IVFHLIELLKNNGRLPRPDGCPDEIYMIM--TECWNNNVNQRPSFRDLALRVD 318
Query: 416 S 416
Sbjct: 319 Q 319
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-39
Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 17/214 (7%)
Query: 141 NRFSKENVLGEGGYGVVYRGN-LINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRH 196
+R+ +LG GG V+ L + VAVK + L FR E + + H
Sbjct: 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 197 KNLVRLLGYCIE----GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAK 252
+V + G +V EYV+ L + G +T + ++V+ +
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADACQ 127
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTT--RVMGTFG 310
AL + H+ ++HRD+K +NI+I KV DFG+A+ + + VT V+GT
Sbjct: 128 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
Y++PE A ++ +SDVYS G +L E +TG P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-39
Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 8/211 (3%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEF-RVEVEAIGHVRHK 197
+ +G G YG + +G + K++ ++ +AEK+ EV + ++H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 198 NLVRLLGYCIEGIHRML--VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
N+VR I+ + L V EY G+L + + YL E ++V+ AL
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 256 YLHE--AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
H V+HRD+K +N+ +D N K+ DFGLA++L S T V GT Y++
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMS 184
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
PE N NEKSD++S G LL E P
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-39
Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 20/221 (9%)
Query: 128 GHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVE 187
GH EL + LG G +GVV G VAVK ++ +E EF E
Sbjct: 1 GHM------ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVK-MIKEGSMSEDEFFQE 53
Query: 188 VEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVL 247
+ + + H LV+ G C + +V EY++NG L +L H L +++
Sbjct: 54 AQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLR---SHGKGLEPSQLLEMC 110
Query: 248 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG 307
+ +A+L + +HRD+ + N L+D D KVSDFG+ + + +G
Sbjct: 111 YDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYV---LDDQYVSSVG 164
Query: 308 T---FGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
T + APE + + KSDV++FG+L+ E + G+ P
Sbjct: 165 TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-39
Identities = 81/338 (23%), Positives = 135/338 (39%), Gaps = 43/338 (12%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEA 190
K VLG G +G V++G I PV +K I + G Q+ + + A
Sbjct: 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLA 68
Query: 191 IGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT 250
IG + H ++VRLLG C LV +Y+ G+L + +H G L + + +
Sbjct: 69 IGSLDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVR---QHRGALGPQLLLNWGVQI 124
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT-- 308
AK + YL E +VHR++ + N+L+ +V+DFG+A LL +
Sbjct: 125 AKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS--EAKT 179
Query: 309 -FGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGS 366
++A E + G +SDV+S+GV + E +T G +P G EV D L+ G
Sbjct: 180 PIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYA-GLRLAEV--PDLLEK--GE 234
Query: 367 RRSEEVVDPNIEVRPS--TRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVRE 424
R + +P T + + ++C D RP ++ + R+
Sbjct: 235 RLA----------QPQICTIDVYMVM---VKCWMIDENIRPTFKELANEFTR----MARD 277
Query: 425 DRRHRRTQGGTSMEIESQKENSDTDRSDYPGSRSESKR 462
R+ + + I E E +
Sbjct: 278 PPRYLVIKRESGPGIAPGPEPHGLTNKKLEEVELEPEL 315
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 7e-39
Identities = 82/326 (25%), Positives = 141/326 (43%), Gaps = 44/326 (13%)
Query: 141 NRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVG-QAEKEFRVEVEAIGHV 194
F K VLG G +G VY+G I PVA+K++ +A KE E + V
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKAL 254
+ ++ RLLG C+ L+ + + G L ++ H + + + + AK +
Sbjct: 75 DNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGM 130
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT---FGY 311
YL + ++VHRD+ + N+L+ + K++DFGLAKLLGA + G +
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKW 185
Query: 312 VAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370
+A E + +SDV+S+GV + E +T G P D G PA E+ ++ R
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEI-----SSILEKGERLP 239
Query: 371 EVVDPNIEVRPS--TRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE-----SEEYPIVR 423
+P T + + ++C D++ RPK +++ + Y +++
Sbjct: 240 ---------QPPICTIDVYMIM---VKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQ 287
Query: 424 EDRRHRRTQGGTSMEIESQKENSDTD 449
D R S + + D D
Sbjct: 288 GDERMHLPSPTDSNFYRALMDEEDMD 313
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 8e-39
Identities = 73/241 (30%), Positives = 105/241 (43%), Gaps = 25/241 (10%)
Query: 118 GLPEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNV 177
+ + W L +G+G +G V G+ G+ VAVK I
Sbjct: 4 SVAAQDEFYRSGW------ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KN 54
Query: 178 GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHR-MLVYEYVNNGNLEQWLHGAMRHHG 236
+ F E + +RH NLV+LLG +E +V EY+ G+L +L R
Sbjct: 55 DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV- 113
Query: 237 YLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296
L + +K L +A+ YL VHRD+ + N+L+ +D AKVSDFGL K
Sbjct: 114 -LGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-- 167
Query: 297 GKSHVTTRVMGTFGY--VAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHE 353
+T+ G APE + KSDV+SFG+LL E + GR P P +
Sbjct: 168 ----SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY-PRIPLKD 222
Query: 354 V 354
V
Sbjct: 223 V 223
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 8e-39
Identities = 64/206 (31%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 146 ENVLGEGGYGVVYRGNLINGS---PVAVKKILNNVGQAEK-EFRVEVEAIGHVRHKNLVR 201
+ LG G +G V +G VA+K + +A+ E E + + + + +VR
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 202 LLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
L+G C MLV E G L ++L G + ++L + + YL E
Sbjct: 75 LIGVCQAEAL-MLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK- 129
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF--GYVAPEYANT 319
VHRD+ + N+L+ + AK+SDFGL+K LGA S+ T R G + + APE N
Sbjct: 130 --NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187
Query: 320 GLLNEKSDVYSFGVLLLEAIT-GRDP 344
+ +SDV+S+GV + EA++ G+ P
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-38
Identities = 65/291 (22%), Positives = 119/291 (40%), Gaps = 49/291 (16%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNL 199
F + ++G GG+G V++ + I+G +K++ ++ EV+A+ + H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNI 66
Query: 200 VRLLGYCIEGIHRM----------------LVYEYVNNGNLEQWLHGAMRHHGYLTWEAR 243
V G + + E+ + G LEQW+ R L
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE--KRRGEKLDKVLA 124
Query: 244 MKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTT 303
+++ K + Y+H K+++RD+K SNI + D K+ DFGL L +
Sbjct: 125 LELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS 181
Query: 304 RVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMM 363
GT Y++PE ++ ++ D+Y+ G++L E + A E +
Sbjct: 182 --KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV------CDTAFETSKF------ 227
Query: 364 VGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414
++ D I + ++LL L P E RP S+++R L
Sbjct: 228 -----FTDLRDGIISDIFDKKE--KTLLQKLLSKKP--EDRPNTSEILRTL 269
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 64/240 (26%), Positives = 103/240 (42%), Gaps = 16/240 (6%)
Query: 107 SHPITAPSPLIGLPEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGS 166
+P + + W E+ + ++ LG G YG VY G S
Sbjct: 194 HYPAPKRNKPT--IYGVSPNYDKW------EMERTDITMKHKLGGGQYGEVYEGVWKKYS 245
Query: 167 -PVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLE 225
VAVK L +EF E + ++H NLV+LLG C ++ E++ GNL
Sbjct: 246 LTVAVK-TLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 304
Query: 226 QWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKV 285
+L R ++ + + + A+ YL + +HR++ + N L+ ++ KV
Sbjct: 305 DYLRECNRQE--VSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKV 359
Query: 286 SDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
+DFGL++L+ + APE + KSDV++FGVLL E T G P
Sbjct: 360 ADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-38
Identities = 64/302 (21%), Positives = 116/302 (38%), Gaps = 41/302 (13%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLI-----NGSPVAVKKILNNVGQAE-KEFRVEVEA 190
+ LGEG +G V G VAVK + G + + E+E
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEI 76
Query: 191 IGHVRHKNLVRLLGYCIEGIHR--MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL 248
+ ++ H+N+V+ G C E L+ E++ +G+L+++L ++ + + ++K +
Sbjct: 77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP---KNKNKINLKQQLKYAV 133
Query: 249 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT 308
K + YL + VHRD+ + N+L++ + K+ DFGL K + K + T +
Sbjct: 134 QICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRD 190
Query: 309 F--GYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGS 366
+ APE SDV+SFGV L E +T D + M
Sbjct: 191 SPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM--- 247
Query: 367 RRSEEVVDPNIEVRPSTRALKR------------SLLTALRCVDPDSEKRPKMSQVVRML 414
+ + + KR L+ +C + R ++
Sbjct: 248 --------TVTRLVNTLKEGKRLPCPPNCPDEVYQLM--RKCWEFQPSNRTSFQNLIEGF 297
Query: 415 ES 416
E+
Sbjct: 298 EA 299
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-38
Identities = 57/246 (23%), Positives = 94/246 (38%), Gaps = 32/246 (13%)
Query: 104 PSSSHPITAPSPLIGLPEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRG-NL 162
P SH G +Q G + ++G GG G VY +
Sbjct: 16 PRGSHMDGTAESREG----TQFG---------------PYRLRRLVGRGGMGDVYEAEDT 56
Query: 163 INGSPVAVKKILNNVGQAEKEFRV----EVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218
+ VA+K +++ ++ FR E G ++ ++V + + +
Sbjct: 57 VRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRL 115
Query: 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILID 278
+N +L L R G L + ++ AL H A HRD+K NIL+
Sbjct: 116 INGVDLAAML----RRQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVS 168
Query: 279 DDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEA 338
D A + DFG+A K +GT Y+APE + ++D+Y+ +L E
Sbjct: 169 ADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYEC 228
Query: 339 ITGRDP 344
+TG P
Sbjct: 229 LTGSPP 234
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 68/219 (31%), Positives = 105/219 (47%), Gaps = 9/219 (4%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRH 196
E+ E LG+G +G V+ G + VA+K L + + F E + + +RH
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK-TLKPGTMSPEAFLQEAQVMKKLRH 238
Query: 197 KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY 256
+ LV+L E +V EY++ G+L +L G + L + + A +AY
Sbjct: 239 EKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAY 295
Query: 257 LHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEY 316
+ VHRD++++NIL+ ++ KV+DFGLA+L+ + + APE
Sbjct: 296 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 352
Query: 317 ANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEV 354
A G KSDV+SFG+LL E T GR P G EV
Sbjct: 353 ALYGRFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREV 390
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-38
Identities = 62/228 (27%), Positives = 98/228 (42%), Gaps = 18/228 (7%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS----PVAVKKILNNV---GQAEKEFRVEVE 189
+ LG+G +GVV RG S VAVK + +V +A +F EV
Sbjct: 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 73
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
A+ + H+NL+RL G + +V E G+L L +H G+ + +
Sbjct: 74 AMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQ 129
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
A+ + YL + +HRD+ + N+L+ K+ DFGL + L H +
Sbjct: 130 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 186
Query: 310 GY--VAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEV 354
+ APE T + SD + FGV L E T G++P G ++
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI-GLNGSQI 233
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-38
Identities = 73/300 (24%), Positives = 121/300 (40%), Gaps = 52/300 (17%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKN 198
+ F + VLG+G +G V + N ++ A+KKI + + EV + + H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILS-EVMLLASLNHQY 63
Query: 199 LVRLLGYCIEGIHRM-------------LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK 245
+VR +E + + + EY NG L +H + + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH---SENLNQQRDEYWR 120
Query: 246 VLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV---- 301
+ +AL+Y+H ++HRD+K NI ID+ N K+ DFGLAK + +
Sbjct: 121 LFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 302 ----------TTRVMGTFGYVAPE-YANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350
T+ + GT YVA E TG NEK D+YS G++ E I
Sbjct: 178 QNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--------F 228
Query: 351 AHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQV 410
+ + V+ LK + R P+ + + ++ L DP KRP +
Sbjct: 229 STGMERVNILKKL---RSVSIEFPPDFDDNKMKVE--KKIIRLLIDHDP--NKRPGARTL 281
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-37
Identities = 66/216 (30%), Positives = 102/216 (47%), Gaps = 14/216 (6%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS----PVAVKKILNNVGQAEK-EFRVEVEAI 191
EL S + V+G G +G V G L S VA+K + + ++ +F E +
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
G H N++RL G + M+V EY+ NG+L+ +L +H T + +L G A
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIA 157
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGY 311
+ YL + VHRD+ + NILI+ + KVSDFGL ++L T G
Sbjct: 158 SGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPI 214
Query: 312 --VAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
+PE SDV+S+G++L E ++ G P
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-37
Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 15/217 (6%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKILNNVGQAEK-EFRVEVEA 190
E+ + +++ V+G G +G VY+G L S PVA+K + + ++ +F E
Sbjct: 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 99
Query: 191 IGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT 250
+G H N++RL G + M++ EY+ NG L+++L G + + +L G
Sbjct: 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGI 156
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
A + YL VHRD+ + NIL++ + KVSDFGL+++L T G
Sbjct: 157 AAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 213
Query: 311 Y--VAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
APE + SDV+SFG+++ E +T G P
Sbjct: 214 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 2e-37
Identities = 68/219 (31%), Positives = 105/219 (47%), Gaps = 9/219 (4%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRH 196
E+ E LG+G +G V+ G + VA+K L + + F E + + +RH
Sbjct: 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK-TLKPGTMSPEAFLQEAQVMKKLRH 321
Query: 197 KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY 256
+ LV+L E +V EY++ G+L +L G + L + + A +AY
Sbjct: 322 EKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAY 378
Query: 257 LHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEY 316
+ VHRD++++NIL+ ++ KV+DFGLA+L+ + + APE
Sbjct: 379 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 435
Query: 317 ANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEV 354
A G KSDV+SFG+LL E T GR P G EV
Sbjct: 436 ALYGRFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREV 473
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-37
Identities = 67/216 (31%), Positives = 102/216 (47%), Gaps = 14/216 (6%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS----PVAVKKILNNVGQAEK-EFRVEVEAI 191
E+ +R E ++G G G V G L PVA+K + + ++ +F E +
Sbjct: 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIM 104
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
G H N++RL G G M+V EY+ NG+L+ +L H G T + +L G
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR---THDGQFTIMQLVGMLRGVG 161
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGY 311
+ YL + VHRD+ + N+L+D + KVSDFGL+++L T G
Sbjct: 162 AGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPI 218
Query: 312 --VAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
APE + SDV+SFGV++ E + G P
Sbjct: 219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-37
Identities = 72/300 (24%), Positives = 125/300 (41%), Gaps = 33/300 (11%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI--LNNVGQAEKEF-RVEVEAIGHVRH 196
F E +G G + VYR L++G PVA+KK+ + + + E++ + + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 197 KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY 256
N+++ IE +V E + G+L + + + + K + AL +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 257 LHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE- 315
+H +V+HRDIK +N+ I K+ D GL + + + + V GT Y++PE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207
Query: 316 -----YANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370
Y N KSD++S G LL E + P +G + +L K+
Sbjct: 208 IHENGY------NFKSDIWSLGCLLYEMAALQSPF-YGDKMNLYSLC--KKIEQCDY--- 255
Query: 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHRR 430
P + + L R L+ C++PD EKRP ++ V + + H
Sbjct: 256 ----PPLPSDHYSEEL-RQLVN--MCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHHH 308
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-37
Identities = 68/222 (30%), Positives = 106/222 (47%), Gaps = 15/222 (6%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRH 196
E+ LG G +G V+ G + VAVK L + F E + ++H
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVK-SLKQGSMSPDAFLAEANLMKQLQH 67
Query: 197 KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY 256
+ LVRL + ++ EY+ NG+L +L LT + + A+ +A+
Sbjct: 68 QRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAF 124
Query: 257 LHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT---FGYVA 313
+ E +HRD++++NIL+ D + K++DFGLA+L+ + + T G + A
Sbjct: 125 IEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTA 178
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEV 354
PE N G KSDV+SFG+LL E +T GR P G EV
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEV 219
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-37
Identities = 72/332 (21%), Positives = 121/332 (36%), Gaps = 54/332 (16%)
Query: 108 HPITAPSPLIGLPEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLIN--- 164
H L L + K LGEG +G V
Sbjct: 7 HHHHHHGALEVLFQGPGDPT---------VFHKRYLKKIRDLGEGHFGKVSLYCYDPTND 57
Query: 165 --GSPVAVKKILNNVG-QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHR--MLVYEYV 219
G VAVK + + G Q ++ E++ + + H+++++ G C + LV EYV
Sbjct: 58 GTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYV 117
Query: 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD 279
G+L +L H + + + +AYLH +HRD+ + N+L+D+
Sbjct: 118 PLGSLRDYL----PRHS-IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDN 169
Query: 280 DFNAKVSDFGLAKLLGAGKSHVTTRVMGTF--GYVAPEYANTGLLNEKSDVYSFGVLLLE 337
D K+ DFGLAK + G + R G + APE SDV+SFGV L E
Sbjct: 170 DRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYE 229
Query: 338 AIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKR-------- 388
+T E+ + +M + + +R
Sbjct: 230 LLTHCDSSQSPPTKFLELIGIAQGQM------------TVLRLTELLERGERLPRPDKCP 277
Query: 389 ----SLLTALRCVDPDSEKRPKMSQVVRMLES 416
L+ C + ++ RP ++ +L++
Sbjct: 278 AEVYHLM--KNCWETEASFRPTFENLIPILKT 307
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-37
Identities = 66/226 (29%), Positives = 103/226 (45%), Gaps = 21/226 (9%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS-PVAVKKILNNVGQAEKEFRVEVEAIGHVR 195
E+ + ++ LG G YG VY G S VAVK L +EF E + ++
Sbjct: 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK-TLKEDTMEVEEFLKEAAVMKEIK 67
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
H NLV+LLG C ++ E++ GNL +L R ++ + + + A+
Sbjct: 68 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAME 125
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG--KSHVTTRV----MGTF 309
YL + +HRD+ + N L+ ++ KV+DFGL++L+ +H +
Sbjct: 126 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT--- 179
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEV 354
APE + KSDV++FGVLL E T G P G +V
Sbjct: 180 ---APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQV 221
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-37
Identities = 34/306 (11%), Positives = 71/306 (23%), Gaps = 51/306 (16%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKIL---NNVGQAEKEFRVEVEAIGHVRHK 197
+ L G VV+ ++ A+K N + A + +
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 198 NLVRLLGYC--------------------------IEGIHRMLVYEYV--NNGNLEQWLH 229
+ + +L+ + L L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 230 GAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFG 289
G A + + A L +VH N+ I D + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVS 239
Query: 290 LAKLLGAGKSHVTTRVMGTFGYVAPEY--ANTGLLNEKSDVYSFGVLLLEAITGRDPVDH 347
+G Y E+ A+T + + G+ + P
Sbjct: 240 ALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295
Query: 348 GRPAHEVNLVDWLKMMVGSRRSEEVV-DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPK 406
P + W + + ++ + + + L L + D +R
Sbjct: 296 VTPGIK---GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFL------NFDRRRRLL 346
Query: 407 MSQVVR 412
+ +
Sbjct: 347 PLEAME 352
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-37
Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 15/222 (6%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRH 196
E+ E LG G +G V+ + VAVK + + + F E + ++H
Sbjct: 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVK-TMKPGSMSVEAFLAEANVMKTLQH 242
Query: 197 KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY 256
LV+L + ++ E++ G+L +L + A+ +A+
Sbjct: 243 DKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAF 299
Query: 257 LHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV---A 313
+ + +HRD++++NIL+ K++DFGLA+++ + + T G + A
Sbjct: 300 IEQR---NYIHRDLRAANILVSASLVCKIADFGLARVI---EDNEYTAREGAKFPIKWTA 353
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEV 354
PE N G KSDV+SFG+LL+E +T GR P G EV
Sbjct: 354 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY-PGMSNPEV 394
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 142 bits (358), Expect = 9e-37
Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 146 ENVLGEGGYGVVYRGNLINGS---PVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNLVR 201
+ LG G +G V +G VA+K + +E E + + + + +VR
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 202 LLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
L+G C MLV E G L ++L + ++L + + YL E
Sbjct: 401 LIGVCQAEAL-MLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK- 455
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGY--VAPEYANT 319
VHR++ + N+L+ + AK+SDFGL+K LGA S+ T R G + APE N
Sbjct: 456 --NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 513
Query: 320 GLLNEKSDVYSFGVLLLEAIT-GRDP 344
+ +SDV+S+GV + EA++ G+ P
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-36
Identities = 56/222 (25%), Positives = 92/222 (41%), Gaps = 29/222 (13%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKN 198
F LG GG+GVV+ N ++ A+K+I L N A ++ EV+A+ + H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 199 LVRLLGYCIEGIHRM------------LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKV 246
+VR +E + + NL+ W++ + +
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN-GRCTIEERERSVCLHI 123
Query: 247 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVM 306
L A+A+ +LH ++HRD+K SNI D KV DFGL + + T
Sbjct: 124 FLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 307 -----------GTFGYVAPEYANTGLLNEKSDVYSFGVLLLE 337
GT Y++PE + + K D++S G++L E
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-36
Identities = 47/221 (21%), Positives = 86/221 (38%), Gaps = 26/221 (11%)
Query: 141 NRFSKENVLGEGGYGVVYRGN--LINGSPVAVKKILNNVG--QAEKEFRVEVEAIGHVRH 196
++ + + GG G +Y +NG PV +K L + G +A+ E + + V H
Sbjct: 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLK-GLVHSGDAEAQAMAMAERQFLAEVVH 138
Query: 197 KNLVRLLGYCIEGIHRM-----LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
++V++ + +V EYV +L++ L + LL
Sbjct: 139 PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK------LPVAEAIAYLLEIL 192
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGY 311
AL+YLH +V+ D+K NI++ ++ K+ D G + + + GT G+
Sbjct: 193 PALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS-----FGYLYGTPGF 243
Query: 312 VAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAH 352
APE +D+Y+ G L +
Sbjct: 244 QAPEIV-RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG 283
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-35
Identities = 63/290 (21%), Positives = 108/290 (37%), Gaps = 65/290 (22%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRV-EVEAIGHV-R 195
T F + +G G +G V++ ++G A+K+ G +++ + EV A + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
H ++VR E H ++ EY N G+L + R Y +LL + L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDD-------------------FNAKVSDFGLAKLLGA 296
Y+H +VH DIK SNI I K+ D G + +
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 297 GKSHVTTRVMGTFGYVAPEYANTGLLNE------KSDVYSFGVLLLEAITGRDPVDHGRP 350
+ G ++A E +L E K+D+++ + ++ A +G
Sbjct: 187 PQVEE-----GDSRFLANE-----VLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ 236
Query: 351 AHEVN--------------LVDWLKMMVGSRRSEEVVDPNIEVRPSTRAL 386
HE+ + LK+M + P+ E RPS AL
Sbjct: 237 WHEIRQGRLPRIPQVLSQEFTELLKVM---------IHPDPERRPSAMAL 277
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-35
Identities = 86/372 (23%), Positives = 145/372 (38%), Gaps = 42/372 (11%)
Query: 71 RVEQVSTNEFVQRDDKDGGSISGEDSGSVTVYKPSSSHPITAPSPLIGLPEFSQLGWGHW 130
R V+ V R I + S ++YK + S + + S L
Sbjct: 17 RRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELV 76
Query: 131 FTLRDLELATNRF--SKENVLGEGGYGVVYRGNLINGS----PVAVKKILNNVGQAEK-E 183
++ + + + V+G G +G VY G L++ AVK + E +
Sbjct: 77 QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ 136
Query: 184 FRVEVEAIGHVRHKNLVRLLGYCIEGIH-RMLVYEYVNNGNLEQWLHGAMRHHGYLTWEA 242
F E + H N++ LLG C+ ++V Y+ +G+L ++ T +
Sbjct: 137 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKD 193
Query: 243 RMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVT 302
+ L AK + +L K VHRD+ + N ++D+ F KV+DFGLA+ + +
Sbjct: 194 LIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 250
Query: 303 TRVMGTFGYV-----APEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNL 356
T + A E T KSDV+SFGVLL E +T G P ++
Sbjct: 251 HN--KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-PDVNTFDI-- 305
Query: 357 VDWLKMMVGSRRSEEVVDPNIEVRPS--TRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414
++ RR +P L ++ L+C P +E RP S++V +
Sbjct: 306 ---TVYLLQGRRLL---------QPEYCPDPL-YEVM--LKCWHPKAEMRPSFSELVSRI 350
Query: 415 ESEEYPIVREDR 426
+ + E
Sbjct: 351 SAIFSTFIGEHY 362
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-35
Identities = 59/229 (25%), Positives = 96/229 (41%), Gaps = 25/229 (10%)
Query: 125 LGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGS----PVAVKKI-LNNVGQ 179
+G + +A +LGEG +G VY G N VAVK +
Sbjct: 2 MGGPQY------GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD 55
Query: 180 AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT 239
+++F E + ++ H ++V+L+G E ++ E G L +L R+ L
Sbjct: 56 NKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLE---RNKNSLK 111
Query: 240 WEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299
+ L KA+AYL VHRDI NIL+ K+ DFGL++ + +
Sbjct: 112 VLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYI---ED 165
Query: 300 HVTTRVMGT---FGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
+ T +++PE N SDV+ F V + E ++ G+ P
Sbjct: 166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-35
Identities = 63/289 (21%), Positives = 114/289 (39%), Gaps = 45/289 (15%)
Query: 141 NRFSKENVLGEGGYGVVYRGNLINGSPVAVKKI-LNNVGQAEKE-FRVEVEAIGHVRHKN 198
+S +G GG V++ A+K + L + +R E+ + ++ +
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 199 L--VRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT-WEAR--MKVLLGTAKA 253
+RL Y I + +V E N +L WL + + WE + K +L +A
Sbjct: 88 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWL----KKKKSIDPWERKSYWKNML---EA 139
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG-KSHVTTRVMGTFGYV 312
+ +H+ +VH D+K +N LI D K+ DFG+A + S V +GT Y+
Sbjct: 140 VHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195
Query: 313 APE-----------YANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLK 361
PE + ++ KSDV+S G +L G+ P K
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-------QISK 248
Query: 362 MMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQV 410
+ + E+ P+I + + + L DP ++R + ++
Sbjct: 249 LHAIIDPNHEIEFPDI-PEKDLQDVLKCCLK----RDP--KQRISIPEL 290
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-35
Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 17/222 (7%)
Query: 131 FTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGS----PVAVKKILNNVGQAEK-EFR 185
+ RD E+ R +GEG +G V++G ++ VA+K N + + +F
Sbjct: 5 SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL 64
Query: 186 VEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK 245
E + H ++V+L+G E ++ E G L +L L + +
Sbjct: 65 QEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQ---VRKYSLDLASLIL 120
Query: 246 VLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRV 305
+ ALAYL + VHRDI + N+L+ + K+ DFGL++ + S
Sbjct: 121 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKAS 175
Query: 306 MGTF--GYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
G ++APE N SDV+ FGV + E + G P
Sbjct: 176 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-35
Identities = 64/234 (27%), Positives = 105/234 (44%), Gaps = 30/234 (12%)
Query: 132 TLRDLELATNRFSKENVLGEGGYGVVYRGNLINGS----PVAVK--KILNNVGQAEKEFR 185
L D+ + N +LGEG +G V GNL VAVK K+ N+ + +EF
Sbjct: 25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFL 84
Query: 186 VEVEAIGHVRHKNLVRLLGYCIEG-----IHRMLVYEYVNNGNLEQWL--HGAMRHHGYL 238
E + H N++RLLG CIE M++ ++ G+L +L ++
Sbjct: 85 SEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHI 144
Query: 239 TWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG- 297
+ +K ++ A + YL +HRD+ + N ++ DD V+DFGL+K + +G
Sbjct: 145 PLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD 201
Query: 298 --KSHVTTRV----MGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
+ ++ + A E + KSDV++FGV + E T G P
Sbjct: 202 YYRQGRIAKMPVKWI------AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 134 bits (337), Expect = 5e-35
Identities = 45/309 (14%), Positives = 79/309 (25%), Gaps = 62/309 (20%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVK---KILNNVGQAEKEFRVEVEAIGHVR-- 195
+ VLG+ + G V A K+ + EV + +R
Sbjct: 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 196 -----------------------HKNLVRLLG----YCIEGIHRMLVYEYVNNGNLEQWL 228
K ++R+ + + N + L
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198
Query: 229 HGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDF 288
H L AR+++ L + LA LH +VH ++ +I++D ++ F
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGF 255
Query: 289 GLAKLLGAGKSHVTTRVMGTFGYVAPE-----YANTGLLNEKSDVYSFGVLLLEAITGRD 343
GA R A + L+ D ++ G+ +
Sbjct: 256 EHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
Query: 344 PVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEK 403
P SE + + RAL L E
Sbjct: 316 PNTDDAAL---------------GGSEWIFRSCKNIPQPVRALLEGFLR------YPKED 354
Query: 404 RPKMSQVVR 412
R Q +
Sbjct: 355 RLLPLQAME 363
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-35
Identities = 72/288 (25%), Positives = 114/288 (39%), Gaps = 40/288 (13%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKE-FRVEVEAIGHV-RHK 197
F + + LG G YG V++ + +G AVK+ G ++ EV + V +H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKALAY 256
VRL EG L E +L+Q L EA++ L T ALA+
Sbjct: 118 CCVRLEQAWEEGGILYLQTELCG-PSLQQHC---EAWGASLP-EAQVWGYLRDTLLALAH 172
Query: 257 LHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEY 316
LH +VH D+K +NI + K+ DFGL LG + G Y+APE
Sbjct: 173 LHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-GAGEVQE-GDPRYMAPEL 227
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376
+DV+S G+ +LE + G W ++ G + P
Sbjct: 228 LQGS-YGTAADVFSLGLTILEVACNMELPHGGE--------GWQQLRQG------YLPPE 272
Query: 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVRE 424
S+ RS+L ++PD + R ++ + P++R+
Sbjct: 273 FTAGLSSEL--RSVLV--MMLEPDPKLRATAEALLAL------PVLRQ 310
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 8e-35
Identities = 63/289 (21%), Positives = 114/289 (39%), Gaps = 45/289 (15%)
Query: 141 NRFSKENVLGEGGYGVVYRGNLINGSPVAVKKI-LNNVGQAEKE-FRVEVEAIGHVRHKN 198
+S +G GG V++ A+K + L + +R E+ + ++ +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 199 L--VRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT-WEAR--MKVLLGTAKA 253
+RL Y I + +V E N +L WL + + WE + K +L +A
Sbjct: 69 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWL----KKKKSIDPWERKSYWKNML---EA 120
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG-KSHVTTRVMGTFGYV 312
+ +H+ +VH D+K +N LI D K+ DFG+A + S V +GT Y+
Sbjct: 121 VHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 313 APE-----------YANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLK 361
PE + ++ KSDV+S G +L G+ P K
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-------QISK 229
Query: 362 MMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQV 410
+ + E+ P+I + + + L DP ++R + ++
Sbjct: 230 LHAIIDPNHEIEFPDI-PEKDLQDVLKCCLK----RDP--KQRISIPEL 271
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 9e-35
Identities = 78/296 (26%), Positives = 122/296 (41%), Gaps = 49/296 (16%)
Query: 146 ENVLGEGGYGVVYRGNLINGS----PVAVKKILNNVGQAEK-EFRVEVEAIGHVRHKNLV 200
V+G G +G VY G L++ AVK + E +F E + H N++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 201 RLLGYCIEGIH-RMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE 259
LLG C+ ++V Y+ +G+L ++ T + + L AK + YL
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKYLAS 146
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG------YVA 313
K VHRD+ + N ++D+ F KV+DFGLA+ + V G ++A
Sbjct: 147 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDM---YDKEYYSVHNKTGAKLPVKWMA 200
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV 372
E T KSDV+SFGVLL E +T G P ++ ++ RR
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-PDVNTFDI-----TVYLLQGRRLL-- 252
Query: 373 VDPNIEVRPS--TRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE-------SEEY 419
+P L ++ L+C P +E RP S++V + E Y
Sbjct: 253 -------QPEYCPDPL-YEVM--LKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 298
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 9e-35
Identities = 62/278 (22%), Positives = 112/278 (40%), Gaps = 35/278 (12%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI----LNNVGQAEKEFRVEVEAIGHVRH 196
R+ + LG+GG+ + + A K + L Q EK E+ + H
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM-EISIHRSLAH 74
Query: 197 KNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLT-WEARMKVLLGTAKAL 254
+++V G+ E + +V E +L + + LT EAR L
Sbjct: 75 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEAR-YYLRQIVLGC 128
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
YLH +V+HRD+K N+ +++D K+ DFGLA + + GT Y+AP
Sbjct: 129 QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAP 184
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVD 374
E + + + DV+S G ++ + G+ P + L + + + E
Sbjct: 185 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE------TSCLKETYLRI----KKNEYSI 234
Query: 375 PNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
P + P +L + +L D RP +++++
Sbjct: 235 PK-HINPVAASLIQKML------QTDPTARPTINELLN 265
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 9e-35
Identities = 63/301 (20%), Positives = 101/301 (33%), Gaps = 40/301 (13%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKN 198
+ + ++LG+G V+RG + G A+K + + E E + + HKN
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 199 LVRLLGYCIEGIHRMLVY---EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
+V+L E E+ G+L L +G E VL +
Sbjct: 69 IVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVVGGMN 126
Query: 256 YLHEAIEPKVVHRDIKSSNILI----DDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGY 311
+L E +VHR+IK NI+ D K++DFG A+ L + GT Y
Sbjct: 127 HLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-GTEEY 181
Query: 312 VAPEYANTGLL--------NEKSDVYSFGVLLLEAITGRDP-VDHGRPAHEVNL------ 356
+ P+ +L D++S GV A TG P P +
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 357 -------VDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQ 409
K G + + + + L +L + D EK Q
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQ--EKCWGFDQ 299
Query: 410 V 410
Sbjct: 300 F 300
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 64/308 (20%), Positives = 105/308 (34%), Gaps = 42/308 (13%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI--LNNVGQAEKEFRVEVEAIGHVRHK 197
+ + ++LG+G V+RG + G A+K ++ + + + R E E + + HK
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKKLNHK 67
Query: 198 NLVRLLGYCIEGIHRMLVY---EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKAL 254
N+V+L E E+ G+L L +G E VL +
Sbjct: 68 NIVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVVGGM 125
Query: 255 AYLHEAIEPKVVHRDIKSSNILI----DDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
+L E +VHR+IK NI+ D K++DFG A+ L + GT
Sbjct: 126 NHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-GTEE 180
Query: 311 YVAPEYANTGLL--------NEKSDVYSFGVLLLEAITGRDP-VDHGRPAHEVNL----- 356
Y+ P+ +L D++S GV A TG P P +
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240
Query: 357 --------VDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMS 408
K G + + + + L +L + D EK
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQ--EKCWGFD 298
Query: 409 QVVRMLES 416
Q
Sbjct: 299 QFFAETSD 306
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-34
Identities = 53/210 (25%), Positives = 90/210 (42%), Gaps = 18/210 (8%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI----LNNVGQAEKEFRVEVEAIGHVRH 196
R+ + LG+GG+ + + A K + L Q EK E+ + H
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM-EISIHRSLAH 100
Query: 197 KNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLT-WEARMKVLLGTAKAL 254
+++V G+ E + +V E +L + + LT EAR L
Sbjct: 101 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEAR-YYLRQIVLGC 154
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
YLH +V+HRD+K N+ +++D K+ DFGLA + + GT Y+AP
Sbjct: 155 QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAP 210
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
E + + + DV+S G ++ + G+ P
Sbjct: 211 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 52/235 (22%), Positives = 101/235 (42%), Gaps = 31/235 (13%)
Query: 132 TLRDLELATNRFSKENVLGEGGYGVVYRGNLINGS----PVAVK--KILNNVGQAEKEFR 185
L D+ + +F+ +LG+G +G V L VAVK K +EF
Sbjct: 14 KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFL 73
Query: 186 VEVEAIGHVRHKNLVRLLGYCIEG------IHRMLVYEYVNNGNLEQWL--HGAMRHHGY 237
E + H ++ +L+G + M++ ++ +G+L +L +
Sbjct: 74 REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN 133
Query: 238 LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297
L + ++ ++ A + YL +HRD+ + N ++ +D V+DFGL++ + +G
Sbjct: 134 LPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG 190
Query: 298 ---KSHVTTRV----MGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
+ +++ + A E L SDV++FGV + E +T G+ P
Sbjct: 191 DYYRQGCASKLPVKWL------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 69/281 (24%), Positives = 113/281 (40%), Gaps = 36/281 (12%)
Query: 142 RFSKENVLGEGGYGVVYRGNLINGSPVAVKKIL-NNVGQAEKEFRVEVEAIGHV-RHKNL 199
F ++VLG G G + + + VAVK+IL A++ EV+ + H N+
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR----EVQLLRESDEHPNV 80
Query: 200 VRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE 259
+R + + + E L++++ + +L E +L T LA+LH
Sbjct: 81 IRYFCTEKDRQFQYIAIELC-AATLQEYV--EQKDFAHLGLEPI-TLLQQTTSGLAHLHS 136
Query: 260 AIEPKVVHRDIKSSNILI-----DDDFNAKVSDFGLAKLLGAGKSHVTTR--VMGTFGYV 312
+VHRD+K NILI A +SDFGL K L G+ + R V GT G++
Sbjct: 137 L---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 313 APEY---ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
APE D++S G + I+ + N++ +
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL---------LGA 244
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQV 410
+ + E A R L+ + +DP +KRP V
Sbjct: 245 CSLDCLHPEKHEDVIA--RELIEKMIAMDP--QKRPSAKHV 281
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 3e-34
Identities = 69/290 (23%), Positives = 110/290 (37%), Gaps = 30/290 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKE-FRVEVEAIGHVRHKNL 199
+ + LG GG+G V R + G VA+K+ + +E + +E++ + + H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 200 VRLL------GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
V +L EY G+L ++L+ G R +L + A
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-TLLSDISSA 133
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNA---KVSDFGLAKLLGAGKSHVTTRVMGTFG 310
L YLHE +++HRD+K NI++ K+ D G AK L G T V GT
Sbjct: 134 LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFV-GTLQ 188
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHE----------VNLVDWL 360
Y+APE D +SFG L E ITG P + ++V +
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248
Query: 361 KMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQV 410
+ + S + PN + L + +R Q
Sbjct: 249 DLTGAVKFSSVLPTPN-HLSGILAGKLERWLQCMLMWHQ--RQRGTDPQN 295
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-34
Identities = 70/281 (24%), Positives = 112/281 (39%), Gaps = 46/281 (16%)
Query: 89 GSISGEDSGSVTVYKPSSSHPITAPSPLIGLPEFSQLGWGHWFTLRDLELATNRFSKENV 148
G++ S S T K S +P + +
Sbjct: 1 GAMGSGSSLSPTEGKGSGLQGHIIENPQYFSDACV------H------HIKRRDIVLKWE 48
Query: 149 LGEGGYGVVYRGNLINGSP------VAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRL 202
LGEG +G V+ N P VAVK + A ++F+ E E + ++H+++VR
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 203 LGYCIEGIHRMLVYEYVNNGNLEQWL-----------HGAMRHHGYLTWEARMKVLLGTA 251
G C EG ++V+EY+ +G+L ++L G G L + V A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL-------GAGKSHVTTR 304
+ YL VHRD+ + N L+ K+ DFG+++ + G++ + R
Sbjct: 169 AGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 305 VMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
M PE +SDV+SFGV+L E T G+ P
Sbjct: 226 WM------PPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-34
Identities = 63/241 (26%), Positives = 104/241 (43%), Gaps = 31/241 (12%)
Query: 135 DLELATNRFSKENVLGEGGYGVVYRGNLINGSP------VAVKKILNNVGQAEK-EFRVE 187
+ E+A + + LG+G +G+VY G VA+K + E+ EF E
Sbjct: 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 78
Query: 188 VEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEAR--MK 245
+ ++VRLLG +G +++ E + G+L+ +L A +
Sbjct: 79 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 138
Query: 246 VLLG----TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL------- 294
++ A +AYL+ K VHRD+ + N ++ +DF K+ DFG+ + +
Sbjct: 139 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 195
Query: 295 GAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHE 353
GK + R M +PE G+ SDV+SFGV+L E T P G +
Sbjct: 196 KGGKGLLPVRWM------SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY-QGLSNEQ 248
Query: 354 V 354
V
Sbjct: 249 V 249
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-34
Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 13/217 (5%)
Query: 134 RDLELATNRFSKENVLGEGGYGVVYRGNLINGS----PVAVKKILNNVGQAEK-EFRVEV 188
RD E+ R +GEG +G V++G ++ VA+K N + + +F E
Sbjct: 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 442
Query: 189 EAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL 248
+ H ++V+L+G E ++ E G L +L L + +
Sbjct: 443 LTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQ---VRKFSLDLASLILYAY 498
Query: 249 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT 308
+ ALAYL + VHRDI + N+L+ + K+ DFGL++ + + ++
Sbjct: 499 QLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 555
Query: 309 FGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
++APE N SDV+ FGV + E + G P
Sbjct: 556 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 9e-34
Identities = 63/230 (27%), Positives = 106/230 (46%), Gaps = 30/230 (13%)
Query: 133 LRDLELATNRFS--KENVLGEGGYGVVYRGNLINGS----PVAVKKILNNVGQAEK-EFR 185
++D+ + R + V+G+G +GVVY G I+ + A+K + + F
Sbjct: 11 VKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFL 70
Query: 186 VEVEAIGHVRHKNLVRLLGYCIEGI-HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARM 244
E + + H N++ L+G + ++ Y+ +G+L Q++ T + +
Sbjct: 71 REGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIR---SPQRNPTVKDLI 127
Query: 245 KVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG-----AGKS 299
L A+ + YL E K VHRD+ + N ++D+ F KV+DFGLA+ + + +
Sbjct: 128 SFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQ 184
Query: 300 HVTTRV----MGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
H R+ A E T KSDV+SFGVLL E +T G P
Sbjct: 185 HRHARLPVKWT------ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-34
Identities = 60/210 (28%), Positives = 93/210 (44%), Gaps = 18/210 (8%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI----LNNVGQAEKEFRVEVEAIGHVR 195
F LG+G +G VY + +A+K + L G + R EVE H+R
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLR 67
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT-WEARMKVLLGTAKAL 254
H N++RL GY + L+ EY G + + L + + A AL
Sbjct: 68 HPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTA-TYITELANAL 122
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
+Y H +V+HRDIK N+L+ K++DFG + + + GT Y+ P
Sbjct: 123 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-DL--CGTLDYLPP 176
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
E + +EK D++S GVL E + G+ P
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-33
Identities = 70/279 (25%), Positives = 119/279 (42%), Gaps = 34/279 (12%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI----LNNVGQAEKEFRVEVEAIGHVR 195
F N+LG+G + VYR ++ G VA+K I + G ++ EV+ ++
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN-EVKIHCQLK 69
Query: 196 HKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLT-WEARMKVLLGTAKA 253
H +++ L Y E + + LV E +NG + ++L + EAR +
Sbjct: 70 HPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLK---NRVKPFSENEAR-HFMHQIITG 124
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
+ YLH ++HRD+ SN+L+ + N K++DFGLA L T + GT Y++
Sbjct: 125 MLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYIS 180
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373
PE A +SDV+S G + + GR P D + + L + +
Sbjct: 181 PEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD------TDTVKNTLNKV----VLADYE 230
Query: 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
P+ + + L LL + R +S V+
Sbjct: 231 MPS-FLSIEAKDLIHQLL------RRNPADRLSLSSVLD 262
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-33
Identities = 70/306 (22%), Positives = 131/306 (42%), Gaps = 46/306 (15%)
Query: 134 RDLELATNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIG 192
+ +EL R VL EGG+ VY ++ +G A+K++L+N + + EV +
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMK 80
Query: 193 HVR-HKNLVRLLGYCIEGIHRM-------LVYEYVNNGNLEQWLHGAMRHHGYLTWEARM 244
+ H N+V+ G L+ + G L ++L M G L+ + +
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLK-KMESRGPLSCDTVL 139
Query: 245 KVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR 304
K+ T +A+ ++H +P ++HRD+K N+L+ + K+ DFG A + + +
Sbjct: 140 KIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSA 198
Query: 305 VM-----------GTFGYVAPE----YANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349
T Y PE Y+N + EK D+++ G +L + P + G
Sbjct: 199 QRRALVEEEITRNTTPMYRTPEIIDLYSNFP-IGEKQDIWALGCILYLLCFRQHPFEDGA 257
Query: 350 PAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQ 409
L+++ G + P+ +L R++L V+P E+R +++
Sbjct: 258 K---------LRIVNGKYS----IPPHDTQYTVFHSLIRAMLQ----VNP--EERLSIAE 298
Query: 410 VVRMLE 415
VV L+
Sbjct: 299 VVHQLQ 304
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-33
Identities = 54/212 (25%), Positives = 90/212 (42%), Gaps = 20/212 (9%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKN 198
+ + + +G G +G V+R + G AVKK+ + E E+ A +
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV--RLEVFRVE---ELVACAGLSSPR 111
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKALAYL 257
+V L G EG + E + G+L ++ G L E R LG + L YL
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSL----GQLIKQMGCLP-EDRALYYLGQALEGLEYL 166
Query: 258 HEAIEPKVVHRDIKSSNILIDDD-FNAKVSDFGLAKLLGAGKSHVTTR----VMGTFGYV 312
H +++H D+K+ N+L+ D A + DFG A L + + GT ++
Sbjct: 167 HTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHM 223
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
APE + K D++S ++L + G P
Sbjct: 224 APEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 63/289 (21%), Positives = 114/289 (39%), Gaps = 45/289 (15%)
Query: 141 NRFSKENVLGEGGYGVVYRGNLINGSPVAVKKI-LNNVGQAEKE-FRVEVEAIGHVRHKN 198
+S +G GG V++ A+K + L + +R E+ + ++ +
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 199 L--VRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT-WEAR--MKVLLGTAKA 253
+RL Y I + +V E N +L WL + + WE + K +L +A
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWL----KKKKSIDPWERKSYWKNML---EA 167
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG-KSHVTTRVMGTFGYV 312
+ +H+ +VH D+K +N LI D K+ DFG+A + S V +G Y+
Sbjct: 168 VHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYM 223
Query: 313 APE-----------YANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLK 361
PE + ++ KSDV+S G +L G+ P K
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-------QISK 276
Query: 362 MMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQV 410
+ + E+ P+I P + +L C+ D ++R + ++
Sbjct: 277 LHAIIDPNHEIEFPDI---PEKDL--QDVL--KCCLKRDPKQRISIPEL 318
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-33
Identities = 59/230 (25%), Positives = 103/230 (44%), Gaps = 31/230 (13%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS---PVAVKKILNNVGQAEK-EFRVEVEAIG 192
L N ++V+GEG +G V + + A+K++ + + +F E+E +
Sbjct: 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 80
Query: 193 HV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWL------------HGAMRHHGYLT 239
+ H N++ LLG C + L EY +GNL +L A L+
Sbjct: 81 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140
Query: 240 WEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299
+ + A+ + YL + + +HRD+ + NIL+ +++ AK++DFGL++
Sbjct: 141 SQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK 197
Query: 300 HVTTRV----MGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
R+ M A E N + SDV+S+GVLL E ++ G P
Sbjct: 198 KTMGRLPVRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-33
Identities = 62/320 (19%), Positives = 116/320 (36%), Gaps = 62/320 (19%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS--------PVAVKKILNNVGQAEKEFRVEV 188
++ LG+G + +++G V +K + + F
Sbjct: 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAA 63
Query: 189 EAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL 248
+ + HK+LV G C+ G +LV E+V G+L+ +L ++ + +++V
Sbjct: 64 SMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK---KNKNCINILWKLEVAK 120
Query: 249 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFN--------AKVSDFGLAKLLGAGKSH 300
A A+ +L E ++H ++ + NIL+ + + K+SD G++
Sbjct: 121 QLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS--------- 168
Query: 301 VTTRVMGTFGY-------VAPE-YANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPA 351
+ V PE N LN +D +SFG L E + G P+ +
Sbjct: 169 ---ITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS-ALDS 224
Query: 352 HEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVV 411
L+ + P L +L+ C+D + + RP ++
Sbjct: 225 QRK-----LQFYEDRHQLP---------APKAAEL-ANLI--NNCMDYEPDHRPSFRAII 267
Query: 412 RMLESEEYP-IVREDRRHRR 430
R L S P +V H
Sbjct: 268 RDLNSLFTPDLVPRGSHHHH 287
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-33
Identities = 70/298 (23%), Positives = 117/298 (39%), Gaps = 47/298 (15%)
Query: 141 NRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV-RHKNL 199
N E +LG G G V G PVAVK++L +E++ + H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNV 71
Query: 200 VRLLGYCIEGIHRMLVYEYVNNGNLEQWL--HGAMRHHGYLTWEARMK-VLLGTAKALAY 256
+R + E N NL+ + + L E +L A +A+
Sbjct: 72 IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 257 LHEAIEPKVVHRDIKSSNILID-------------DDFNAKVSDFGLAKLLGAGKSHVTT 303
LH K++HRD+K NIL+ ++ +SDFGL K L +G+S T
Sbjct: 131 LHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 304 RVM---GTFGYVAPE-------YANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAH 352
+ GT G+ APE L D++S G + ++ G+ P + +
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG-DKYSR 246
Query: 353 EVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQV 410
E N+ ++ + + + D ++ A L++ + DP KRP +V
Sbjct: 247 ESNI---IRGIFSLDEMKCLHDRSL----IAEA--TDLISQMIDHDP--LKRPTAMKV 293
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-33
Identities = 63/269 (23%), Positives = 104/269 (38%), Gaps = 37/269 (13%)
Query: 107 SHPITAPSPLIGLPEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGS 166
+H +P + E+ + LG G +G VY G +
Sbjct: 2 AHHHHHHNPNYCFAGKTSSISDLK------EVPRKNITLIRGLGHGAFGEVYEGQVSGMP 55
Query: 167 P------VAVKKILNNVGQAEK-EFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYV 219
VAVK + + ++ +F +E I H+N+VR +G ++ + R ++ E +
Sbjct: 56 NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELM 115
Query: 220 NNGNLEQWLHGAMRHHG---YLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNIL 276
G+L+ +L L + V A YL E +HRDI + N L
Sbjct: 116 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCL 172
Query: 277 ID---DDFNAKVSDFGLAKLL-------GAGKSHVTTRVMGTFGYVAPEYANTGLLNEKS 326
+ AK+ DFG+A+ + G + + + M PE G+ K+
Sbjct: 173 LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM------PPEAFMEGIFTSKT 226
Query: 327 DVYSFGVLLLEAIT-GRDPVDHGRPAHEV 354
D +SFGVLL E + G P + EV
Sbjct: 227 DTWSFGVLLWEIFSLGYMPY-PSKSNQEV 254
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-33
Identities = 67/221 (30%), Positives = 105/221 (47%), Gaps = 17/221 (7%)
Query: 132 TLRDLELATNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEA 190
L + + + VLG+G YG+VY G +L N +A+K+I + + E+
Sbjct: 13 DLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIAL 72
Query: 191 IGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWL---HGAMRHHGYLTWEARMKVL 247
H++HKN+V+ LG E + E V G+L L G ++ + ++L
Sbjct: 73 HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL 132
Query: 248 LGTAKALAYLHEAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVTTRVM 306
G L YLH+ ++VHRDIK N+LI+ K+SDFG +K L T
Sbjct: 133 EG----LKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FT 184
Query: 307 GTFGYVAPE---YANTGLLNEKSDVYSFGVLLLEAITGRDP 344
GT Y+APE G + +D++S G ++E TG+ P
Sbjct: 185 GTLQYMAPEIIDKGPRG-YGKAADIWSLGCTIIEMATGKPP 224
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-32
Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 18/210 (8%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI----LNNVGQAEKEFRVEVEAIGHVR 195
+ F LG+G +G VY N +A+K + L G + R E+E H+R
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRR-EIEIQSHLR 72
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT-WEARMKVLLGTAKAL 254
H N++R+ Y + L+ E+ G L + L + HG + + A AL
Sbjct: 73 HPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL----QKHGRFDEQRSATFMEE-LADAL 127
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
Y HE KV+HRDIK N+L+ K++DFG + + + T GT Y+ P
Sbjct: 128 HYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR-TM--CGTLDYLPP 181
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
E +EK D++ GVL E + G P
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-32
Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 35/225 (15%)
Query: 146 ENVLGEGGYGVVYRGNLINGSP------VAVKKILNNVGQAEKEFRVEVEAIGHVRHKNL 199
+ LGEG +G V+ N SP VAVK + + A K+F+ E E + +++H+++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 200 VRLLGYCIEGIHRMLVYEYVNNGNLEQWL------------HGAMRHHGYLTWEARMKVL 247
V+ G C +G ++V+EY+ +G+L ++L + G L + +
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 248 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL-------GAGKSH 300
A + YL VHRD+ + N L+ + K+ DFG+++ + G +
Sbjct: 140 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 301 VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
+ R M PE +SDV+SFGV+L E T G+ P
Sbjct: 197 LPIRWM------PPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-32
Identities = 71/309 (22%), Positives = 127/309 (41%), Gaps = 56/309 (18%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSP------VAVKKILNNV-GQAEKEFRVEVE 189
E++ + LGE +G VY+G+L +P VA+K + + G +EFR E
Sbjct: 5 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM 64
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWL------------HGAMRHHGY 237
++H N+V LLG + +++ Y ++G+L ++L
Sbjct: 65 LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124
Query: 238 LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL--- 294
L + ++ A + YL VVH+D+ + N+L+ D N K+SD GL + +
Sbjct: 125 LEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181
Query: 295 ----GAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGR 349
G S + R M APE G + SD++S+GV+L E + G P G
Sbjct: 182 DYYKLLGNSLLPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY-CGY 234
Query: 350 PAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPST--RALKRSLLTALRCVDPDSEKRPKM 407
+V ++M+ + P + +L+ + C + +RP+
Sbjct: 235 SNQDV-----VEMIRNRQVLP---------CPDDCPAWV-YALM--IECWNEFPSRRPRF 277
Query: 408 SQVVRMLES 416
+ L +
Sbjct: 278 KDIHSRLRA 286
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-31
Identities = 75/289 (25%), Positives = 121/289 (41%), Gaps = 53/289 (18%)
Query: 97 GSVTVYKPSSSHPITAPSPLIGLPEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGV 156
GS + S P+ A LPE + W E ++ + LGEG +G
Sbjct: 2 GSSHHHHHHSQDPMLAGVSEYELPEDPK-----W------EFPRDKLTLGKPLGEGAFGQ 50
Query: 157 VYRGNLI--------NGSPVAVKKILNNVGQAEK-EFRVEVEAIGHV-RHKNLVRLLGYC 206
V + VAVK + ++ + + + E+E + + +HKN++ LLG C
Sbjct: 51 VVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110
Query: 207 IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT-------------AKA 253
+ ++ EY + GNL ++L A R G +V A+
Sbjct: 111 TQDGPLYVIVEYASKGNLREYLR-ARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARG 169
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG---KSHVTTRV----M 306
+ YL K +HRD+ + N+L+ ++ K++DFGLA+ + K R+ M
Sbjct: 170 MEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM 226
Query: 307 GTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEV 354
APE + +SDV+SFGVL+ E T G P G P E+
Sbjct: 227 ------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIPVEEL 268
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 69/300 (23%), Positives = 116/300 (38%), Gaps = 46/300 (15%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSP------VAVKKILNNVGQAEK-EFRVEVE 189
E+ + LG G +G VY G + VAVK + + ++ +F +E
Sbjct: 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 126
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHG---YLTWEARMKV 246
I H+N+VR +G ++ + R ++ E + G+L+ +L L + V
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186
Query: 247 LLGTAKALAYLHEAIEPKVVHRDIKSSNILID---DDFNAKVSDFGLAKLLGAGKSHVTT 303
A YL E +HRDI + N L+ AK+ DFG+A+ +
Sbjct: 187 ARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI---YRAGYY 240
Query: 304 RVMGTFGYV-----APEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLV 357
R G + PE G+ K+D +SFGVLL E + G P + EV
Sbjct: 241 R-KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQEV--- 295
Query: 358 DWLKMMVGSRRSEEVVDPNIEVRPST--RALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
L+ + R + P + ++ +C E RP + ++ +E
Sbjct: 296 --LEFVTSGGRMD---------PPKNCPGPV-YRIM--TQCWQHQPEDRPNFAIILERIE 341
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-31
Identities = 61/253 (24%), Positives = 101/253 (39%), Gaps = 45/253 (17%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLING------SPVAVKKILNNVGQAEK-EFRVEVE 189
E LGEG +G V + + + VAVK + N +E + E
Sbjct: 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWL----HGAMRHHGYLTWEARMK 245
+ V H ++++L G C + +L+ EY G+L +L + G
Sbjct: 79 VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 246 VLLGT----------------AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFG 289
+ ++ + YL E K+VHRD+ + NIL+ + K+SDFG
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFG 195
Query: 290 LAKLL-------GAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-G 341
L++ + + + + M A E + +SDV+SFGVLL E +T G
Sbjct: 196 LSRDVYEEDSYVKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249
Query: 342 RDPVDHGRPAHEV 354
+P G P +
Sbjct: 250 GNPY-PGIPPERL 261
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-31
Identities = 46/315 (14%), Positives = 83/315 (26%), Gaps = 73/315 (23%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVK---KILNNVGQAEKEFRVEVEAIGHVR-- 195
+ VLG+ + G V A K+ + EV + +R
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 196 -----------------------HKNLVRLLG----YCIEGIHRMLVYEYVNNGNLEQWL 228
K ++R+ + + N + L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 229 HGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDF 288
H L AR+++ L + LA LH +VH ++ +I++D ++ F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGF 250
Query: 289 GLAKLLGAGKSHVTTRVMGTFGYVAPEY-----------ANTGLLNEKSDVYSFGVLLLE 337
GA + G+ PE L+ D ++ G+++
Sbjct: 251 EHLVRDGA-----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305
Query: 338 AITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCV 397
P+ SE + + RAL L
Sbjct: 306 IWCADLPITKDAA---------------LGGSEWIFRSCKNIPQPVRALLEGFL------ 344
Query: 398 DPDSEKRPKMSQVVR 412
E R Q +
Sbjct: 345 RYPKEDRLLPLQAME 359
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-31
Identities = 76/315 (24%), Positives = 133/315 (42%), Gaps = 49/315 (15%)
Query: 72 VEQVSTNEFVQRDDKDGGSISGEDSGSVTVYKPSSSHPITAPSP-LIGLPEFSQLGWGHW 130
V +++ ++R S + + + + ++ TA +P L G+ E+ W
Sbjct: 17 VHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKW 76
Query: 131 FTLRDLELATNRFSKENVLGEGGYGVVYRGNLI--------NGSPVAVKKILNNVGQAEK 182
E ++ + LGEG +G V + VAVK + ++ + +
Sbjct: 77 ------EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL 130
Query: 183 -EFRVEVEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTW 240
+ E+E + + +HKN++ LLG C + ++ EY + GNL ++L A R G
Sbjct: 131 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR-ARRPPGMEYS 189
Query: 241 EARMKVLLGT-------------AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSD 287
+V A+ + YL K +HRD+ + N+L+ ++ K++D
Sbjct: 190 YDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIAD 246
Query: 288 FGLAKLLGAG---KSHVTTRV----MGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT 340
FGLA+ + K R+ M APE + +SDV+SFGVL+ E T
Sbjct: 247 FGLARDINNIDYYKKTTNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 300
Query: 341 -GRDPVDHGRPAHEV 354
G P G P E+
Sbjct: 301 LGGSPY-PGIPVEEL 314
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 63/238 (26%), Positives = 97/238 (40%), Gaps = 40/238 (16%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLIN------GSPVAVKKILNNVGQAEK-EFRVEVE 189
E +R LG G +G V + VAVK + +E E++
Sbjct: 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 82
Query: 190 AIGHV-RHKNLVRLLGYC-IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVL 247
+ H+ H N+V LLG C G M++ E+ GNL +L + R+ A +
Sbjct: 83 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR-SKRNEFVPYKVAPEDLY 141
Query: 248 LGT-------------AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294
AK + +L K +HRD+ + NIL+ + K+ DFGLA+ +
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDI 198
Query: 295 -------GAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
G + + + M APE + +SDV+SFGVLL E + G P
Sbjct: 199 YKDPDYVRKGDARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 66/271 (24%), Positives = 108/271 (39%), Gaps = 47/271 (17%)
Query: 120 PEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSP------VAVKKI 173
P + ++ L LE N +GEG +G V++ P VAVK +
Sbjct: 26 PMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML 85
Query: 174 LNNVGQAEK-EFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAM 232
+ +F+ E + + N+V+LLG C G L++EY+ G+L ++L +M
Sbjct: 86 KEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLR-SM 144
Query: 233 RHHGYLTWEARMKVLLGT---------------------AKALAYLHEAIEPKVVHRDIK 271
H + A +AYL E K VHRD+
Sbjct: 145 SPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA 201
Query: 272 SSNILIDDDFNAKVSDFGLAKLL-------GAGKSHVTTRVMGTFGYVAPEYANTGLLNE 324
+ N L+ ++ K++DFGL++ + G + R M PE
Sbjct: 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWM------PPESIFYNRYTT 255
Query: 325 KSDVYSFGVLLLEAIT-GRDPVDHGRPAHEV 354
+SDV+++GV+L E + G P +G EV
Sbjct: 256 ESDVWAYGVVLWEIFSYGLQPY-YGMAHEEV 285
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-30
Identities = 59/241 (24%), Positives = 93/241 (38%), Gaps = 41/241 (17%)
Query: 135 DLELATNRFSKENVLGEGGYGVVYRGNLIN------GSPVAVKKILNNVGQAEK-EFRVE 187
E NR S LG G +G V VAVK + + E+ E
Sbjct: 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE 76
Query: 188 VEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKV 246
++ + ++ H N+V LLG C G +++ EY G+L +L R + + +
Sbjct: 77 LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR-RKRDSFICSKTSPAIM 135
Query: 247 LLGT---------------AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA 291
AK +A+L +HRD+ + NIL+ K+ DFGLA
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLA 192
Query: 292 KLLGAG---KSHVTTRV----MGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRD 343
+ + R+ M APE + +SDV+S+G+ L E + G
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFSLGSS 246
Query: 344 P 344
P
Sbjct: 247 P 247
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-30
Identities = 61/234 (26%), Positives = 98/234 (41%), Gaps = 35/234 (14%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNVGQAEK-EFRVEVE 189
E N LG G +G V VAVK + + EK E++
Sbjct: 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 190 AIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL 248
+ H+ +H+N+V LLG C G +++ EY G+L +L R A
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161
Query: 249 GT----------AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL---- 294
T A+ +A+L +HRD+ + N+L+ + AK+ DFGLA+ +
Sbjct: 162 STRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218
Query: 295 ---GAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
G + + + M APE + +SDV+S+G+LL E + G +P
Sbjct: 219 NYIVKGNARLPVKWM------APESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 69/290 (23%), Positives = 114/290 (39%), Gaps = 35/290 (12%)
Query: 130 WFTLRDLELATNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKE-FRV 186
F + + + LG G YG V + + A+K I +V +
Sbjct: 26 MFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE 85
Query: 187 EVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT-WEAR-- 243
EV + + H N+++L + + + LV E G L + H +A
Sbjct: 86 EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDE----IIHRMKFNEVDAAVI 141
Query: 244 MKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DDDFNAKVSDFGLAKLLGAGKSH 300
+K +L + YLH+ +VHRD+K N+L+ + D K+ DFGL+ + K
Sbjct: 142 IKQVLS---GVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-- 193
Query: 301 VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWL 360
+GT Y+APE +EK DV+S GV+L + G P G+ E+
Sbjct: 194 KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPF-GGQTDQEI----LR 247
Query: 361 KMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQV 410
K+ G + N+ S A + L+ + D +R Q
Sbjct: 248 KVEKGKYTFDSPEWKNV----SEGA--KDLIKQMLQFDSQ--RRISAQQA 289
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 70/249 (28%), Positives = 108/249 (43%), Gaps = 42/249 (16%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLIN--------GSPVAVKKILNNVGQAEK-EFRVE 187
EL +R LGEG +G V I + VAVK + ++ + + + E
Sbjct: 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 124
Query: 188 VEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKV 246
+E + + +HKN++ LLG C + ++ EY + GNL ++L A R G
Sbjct: 125 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ-ARRPPGLEYSYNPSHN 183
Query: 247 LLGT-------------AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293
A+ + YL K +HRD+ + N+L+ +D K++DFGLA+
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARD 240
Query: 294 LGAG---KSHVTTRV----MGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPV 345
+ K R+ M APE + +SDV+SFGVLL E T G P
Sbjct: 241 IHHIDYYKKTTNGRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 294
Query: 346 DHGRPAHEV 354
G P E+
Sbjct: 295 -PGVPVEEL 302
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-29
Identities = 61/243 (25%), Positives = 93/243 (38%), Gaps = 44/243 (18%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS------PVAVKKILNNVGQAEK-EFRVEVE 189
E VLG G +G V S VAVK + +E+ E++
Sbjct: 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100
Query: 190 AIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL 248
+ + H+N+V LLG C L++EY G+L +L E + L
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 249 GT-------------------AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFG 289
AK + +L VHRD+ + N+L+ K+ DFG
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFG 217
Query: 290 LAKLLGAG---KSHVTTRV----MGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-G 341
LA+ + + R+ M APE G+ KSDV+S+G+LL E + G
Sbjct: 218 LARDIMSDSNYVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFSLG 271
Query: 342 RDP 344
+P
Sbjct: 272 VNP 274
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 10/206 (4%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKN 198
F LGEG YG VY+ + G VA+K++ V +E E+ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPH 85
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+ G + +V EY G++ + + LT + +L T K L YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR---LRNKTLTEDEIATILQSTLKGLEYLH 142
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYAN 318
+ +HRDIK+ NIL++ + +AK++DFG+A L + T + GT ++APE
Sbjct: 143 FM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQ 198
Query: 319 TGLLNEKSDVYSFGVLLLEAITGRDP 344
N +D++S G+ +E G+ P
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 11/205 (5%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKNL 199
F+K +G+G +G V++G + VA+K I L ++ + E+ + +
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 200 VRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE 259
+ G ++ ++ EY+ G+ L G L +L K L YLH
Sbjct: 83 TKYYGSYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHS 137
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANT 319
K +HRDIK++N+L+ + K++DFG+A L + T +GT ++APE
Sbjct: 138 E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQ 193
Query: 320 GLLNEKSDVYSFGVLLLEAITGRDP 344
+ K+D++S G+ +E G P
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPP 218
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 10/206 (4%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKN 198
++++ +G+G G VY ++ G VA++++ ++ E+ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V L + G +V EY+ G+L + + V +AL +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLT-----DVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYAN 318
+V+HRDIKS NIL+ D + K++DFG + +S +T V GT ++APE
Sbjct: 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVT 189
Query: 319 TGLLNEKSDVYSFGVLLLEAITGRDP 344
K D++S G++ +E I G P
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 32/230 (13%), Positives = 69/230 (30%), Gaps = 22/230 (9%)
Query: 134 RDLELATNRFSKENVLGEGGYGVVYRG------NLINGSPVAVKKILNNVGQAEKEFRVE 187
+ +L + ++LGEG + VY + N +K
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 188 VEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWL-HGAMRHHGYLTWEARMKV 246
+E + ++ + +LV E + G L + + +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 247 LLGTAKALAYLHEAIEPKVVHRDIKSSNILI-----------DDDFNAKVSDFGLAKLLG 295
+ + +H+ +++H DIK N ++ D + D G + +
Sbjct: 178 AMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 296 A-GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
K + T T G+ E + N + D + + + G
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-28
Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 10/206 (4%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKN 198
+GEG G+V +G VAVK + Q + EV + +H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V + + G ++ E++ G L + L E V +ALAYLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALT-----DIVSQVRLNEEQIATVCEAVLQALAYLH 158
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYAN 318
V+HRDIKS +IL+ D K+SDFG + + V GT ++APE +
Sbjct: 159 A---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVIS 214
Query: 319 TGLLNEKSDVYSFGVLLLEAITGRDP 344
L + D++S G++++E + G P
Sbjct: 215 RSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-28
Identities = 57/223 (25%), Positives = 94/223 (42%), Gaps = 32/223 (14%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKE------FRVEVEAIG 192
++ K +GEG YG V++ N VA+K++ L++ + E R E+ +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD----DDEGVPSSALR-EICLLK 56
Query: 193 HVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TA 251
++HKN+VRL LV+E+ +Q L +K L
Sbjct: 57 ELKHKNIVRLHDVLHSDKKLTLVFEF-----CDQDLKKYFDSCNGDLDPEIVKSFLFQLL 111
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGY 311
K L + H V+HRD+K N+LI+ + K+++FGLA+ G + V+ T Y
Sbjct: 112 KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWY 167
Query: 312 VAPEYANTGLLNEKS-----DVYSFGVLLLEAITGRDPVDHGR 349
P+ L K D++S G + E P+ G
Sbjct: 168 RPPDV----LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 206
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 72/281 (25%), Positives = 122/281 (43%), Gaps = 36/281 (12%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKIL-NNVGQAEKEFRV--EVEAIGHVR 195
++R+ + VLG+G +G V + I G AVK I V Q + + EV+ + +
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT-WEAR--MKVLLGTAK 252
H N+++L + + + LV E G L + + +A ++ +L
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDE----IISRKRFSEVDAARIIRQVLS--- 137
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILI---DDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
+ Y+H+ K+VHRD+K N+L+ D N ++ DFGL+ A K +GT
Sbjct: 138 GITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD--KIGTA 192
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
Y+APE + G +EK DV+S GV+L ++G P +G +++ K+ G
Sbjct: 193 YYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPF-NGANEYDI----LKKVEKGKYTF 246
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQV 410
E + S + L R +L P R
Sbjct: 247 ELPQWKKVS--ESAKDLIRKML----TYVPS--MRISARDA 279
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 71/326 (21%), Positives = 116/326 (35%), Gaps = 50/326 (15%)
Query: 103 KPSSSHPITAPSPLIGLPEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRG-N 161
SS + P + + + K LG G YG V
Sbjct: 6 HHSSGRENLYFQGIAINPG--------MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKE 57
Query: 162 LINGSPVAVKKI-------------LNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 208
S A+K I N+ + +E E+ + + H N+++L +
Sbjct: 58 KNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED 117
Query: 209 GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT-AKALAYLHEAIEPKVVH 267
+ LV E+ G L + + + E ++ + YLH+ +VH
Sbjct: 118 KKYFYLVTEFYEGGELFEQI----INRHKFD-ECDAANIMKQILSGICYLHKH---NIVH 169
Query: 268 RDIKSSNILI---DDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNE 324
RDIK NIL+ + N K+ DFGL+ +GT Y+APE NE
Sbjct: 170 RDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPE-VLKKKYNE 226
Query: 325 KSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTR 384
K DV+S GV++ + G P G+ ++ K+ G + NI S
Sbjct: 227 KCDVWSCGVIMYILLCGYPPF-GGQNDQDI----IKKVEKGKYYFDFNDWKNI----SDE 277
Query: 385 ALKRSLLTALRCVDPDSEKRPKMSQV 410
A + L+ + D + KR +
Sbjct: 278 A--KELIKLMLTYDYN--KRCTAEEA 299
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-28
Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 17/204 (8%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKIL-NNVGQAEKEFRVEVEAIGHVRHK 197
+ F + LG G +G V+ +G +K I + ++ E+E + + H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT-WEAR--MKVLLGTAKAL 254
N++++ + + +V E G L + + A L+ MK ++ AL
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN---AL 137
Query: 255 AYLHEAIEPKVVHRDIKSSNILI---DDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGY 311
AY H VVH+D+K NIL K+ DFGLA+L + + T GT Y
Sbjct: 138 AYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS-TNAA-GTALY 192
Query: 312 VAPEYANTGLLNEKSDVYSFGVLL 335
+APE + K D++S GV++
Sbjct: 193 MAPEVFK-RDVTFKCDIWSAGVVM 215
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 7e-28
Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 20/203 (9%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKN 198
F VLG G + V+ + G A+K I + + E+ + ++H+N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT-WEAR--MKVLLGTAKALA 255
+V L H LV + V+ G L + G T +A ++ +L A+
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRI----LERGVYTEKDASLVIQQVLS---AVK 120
Query: 256 YLHEAIEPKVVHRDIKSSNILI---DDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
YLHE +VHRD+K N+L +++ ++DFGL+K+ ++ + + GT GYV
Sbjct: 121 YLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME---QNGIMSTACGTPGYV 174
Query: 313 APEYANTGLLNEKSDVYSFGVLL 335
APE ++ D +S GV+
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVIT 197
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-28
Identities = 55/216 (25%), Positives = 96/216 (44%), Gaps = 12/216 (5%)
Query: 136 LELATNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAE-KEFRVEVEAIGH 193
+E+ + LG G YGVV + ++ +G +AVK+I V E K ++++
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 194 -VRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAK 252
V V G + E ++ +L+++ + + + K+ + K
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
AL +LH + V+HRD+K SN+LI+ K+ DFG++ L G Y+
Sbjct: 121 ALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD--DVAKDIDAGCKPYM 176
Query: 313 APE----YANTGLLNEKSDVYSFGVLLLEAITGRDP 344
APE N + KSD++S G+ ++E R P
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 65/285 (22%), Positives = 115/285 (40%), Gaps = 45/285 (15%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKE-FRVEVEAIGHVRH 196
R++ +LG+G +G V + + I AVK I + + EVE + + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 197 KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT-WEAR--MKVLLGTAKA 253
N+++L + +V E G L + + +A +K +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEI----IKRKRFSEHDAARIIKQVFS---G 133
Query: 254 LAYLHEAIEPKVVHRDIKSSNILI---DDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
+ Y+H+ +VHRD+K NIL+ + D + K+ DFGL+ +GT
Sbjct: 134 ITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAY 188
Query: 311 YVAPE-----YANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVG 365
Y+APE Y +EK DV+S GV+L ++G P +G+ +++ ++ G
Sbjct: 189 YIAPEVLRGTY------DEKCDVWSAGVILYILLSGTPPF-YGKNEYDI----LKRVETG 237
Query: 366 SRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQV 410
+ I S A + L+ + P R +Q
Sbjct: 238 KYAFDLPQWRTI----SDDA--KDLIRKMLTFHPS--LRITATQC 274
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 49/301 (16%), Positives = 103/301 (34%), Gaps = 56/301 (18%)
Query: 148 VLGEGGYGVVYRGNLINGSPVAVKKI-----------------LNNVGQAEKEFRVEVEA 190
L +G + + + A+KK ++ +F+ E++
Sbjct: 38 TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 191 IGHVRHKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
I ++++ + G I + ++YEY+ N ++ ++ + L + +
Sbjct: 97 ITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFD----EYFFVLDKNYTCFIPIQ 151
Query: 250 TAK--------ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV 301
K + +Y+H E + HRD+K SNIL+D + K+SDFG ++ + K
Sbjct: 152 VIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK- 208
Query: 302 TTRVMGTFGYVAPE--YANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDW 359
+ GT+ ++ PE + K D++S G+ L P +++LV+
Sbjct: 209 GS--RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS-----LKISLVEL 261
Query: 360 LK----------MMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQ 409
+ + L +P +R
Sbjct: 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNP--AERITSED 319
Query: 410 V 410
Sbjct: 320 A 320
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 38/219 (17%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKE------FRVEVEAIGH 193
++ K +GEG YGVV++ N G VA+KK L + R E+ +
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLE---SEDDPVIKKIALR-EIRMLKQ 58
Query: 194 VRHKNLVRLLGYCIEGIHR----MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK-VLL 248
++H NLV LL E R LV+EY + + + + E +K +
Sbjct: 59 LKHPNLVNLL----EVFRRKRRLHLVFEY-----CDHTVLHELDRYQRGVPEHLVKSITW 109
Query: 249 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT 308
T +A+ + H+ +HRD+K NILI K+ DFG A+LL + V T
Sbjct: 110 QTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-T 165
Query: 309 FGYVAPEYANTGLLNEKS-----DVYSFGVLLLEAITGR 342
Y +PE L+ + DV++ G + E ++G
Sbjct: 166 RWYRSPEL----LVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 58/257 (22%), Positives = 100/257 (38%), Gaps = 45/257 (17%)
Query: 105 SSSHPITAPSPLIGLPEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRG-NLI 163
H T + G S + ++ R+ + LGEG YG VY+ + +
Sbjct: 5 HHHHMGTLEAQTQGPGSMSVSAAP---SATSID----RYRRITKLGEGTYGEVYKAIDTV 57
Query: 164 NGSPVAVKKI-LNNVGQAEKE------FRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216
VA+K+I L + E+E R EV + ++H+N++ L L++
Sbjct: 58 TNETVAIKRIRLEH----EEEGVPGTAIR-EVSLLKELQHRNIIELKSVIHHNHRLHLIF 112
Query: 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKALAYLHEAIEPKVVHRDIKSSNI 275
EY E L M + ++ +K L + + H + +HRD+K N+
Sbjct: 113 EY-----AENDLKKYMDKNPDVS-MRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNL 163
Query: 276 LIDDDFNA-----KVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKS---- 326
L+ + K+ DFGLA+ G T ++ T Y PE LL +
Sbjct: 164 LLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPEI----LLGSRHYSTS 218
Query: 327 -DVYSFGVLLLEAITGR 342
D++S + E +
Sbjct: 219 VDIWSIACIWAEMLMKT 235
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 11/210 (5%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAE-KEFRVEVEAIGHV 194
EL + F K + LG G GVV++ + +G +A K I + A + E++ +
Sbjct: 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 88
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKAL 254
+V G + E+++ G+L+Q ++ G + + KV + K L
Sbjct: 89 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ----VLKKAGRIPEQILGKVSIAVIKGL 144
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
YL E + K++HRD+K SNIL++ K+ DFG++ L ++ + V GT Y++P
Sbjct: 145 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFV-GTRSYMSP 199
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
E + +SD++S G+ L+E GR P
Sbjct: 200 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 50/206 (24%), Positives = 85/206 (41%), Gaps = 31/206 (15%)
Query: 148 VLGEGGYGVVYRG-NLINGSPVAVKKI----LNNVGQAEKE----FRVEVEAIGHVRHKN 198
LG G G V VA++ I E + E+E + + H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT-WEAR--MKVLLGTAKALA 255
++++ + + +V E + G L + + L + +L A+
Sbjct: 202 IIKIKNF-FDAEDYYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQML---LAVQ 253
Query: 256 YLHEAIEPKVVHRDIKSSNILI---DDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
YLHE ++HRD+K N+L+ ++D K++DFG +K+LG + + GT Y+
Sbjct: 254 YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLCGTPTYL 308
Query: 313 APE---YANTGLLNEKSDVYSFGVLL 335
APE T N D +S GV+L
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 57/214 (26%), Positives = 105/214 (49%), Gaps = 25/214 (11%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRV----EVEAIGHV 194
R+ K + LGEG + VY+ + VA+KKI L + +A+ E++ + +
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKA 253
H N++ LL + LV+++ +E L ++ + + + +K + T +
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDF-----METDLEVIIKDNSLVLTPSHIKAYMLMTLQG 124
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L YLH+ ++HRD+K +N+L+D++ K++DFGLAK G+ T +V+ T Y A
Sbjct: 125 LEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRWYRA 180
Query: 314 PEYANTGLLNEKS-----DVYSFGVLLLEAITGR 342
PE L + D+++ G +L E +
Sbjct: 181 PEL----LFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 60/218 (27%), Positives = 94/218 (43%), Gaps = 36/218 (16%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKE------FRVEVEAIGH 193
++ ++GEG YG+V + N G VA+KK L + + R E++ +
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLE---SDDDKMVKKIAMR-EIKLLKQ 80
Query: 194 VRHKNLVRLLGYCIEGIHR----MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
+RH+NLV LL E + LV+E+V++ + L L ++ K L
Sbjct: 81 LRHENLVNLL----EVCKKKKRWYLVFEFVDH-TILDDLE---LFPNGLDYQVVQKYLFQ 132
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
+ + H ++HRDIK NIL+ K+ DFG A+ L A V T
Sbjct: 133 IINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TR 188
Query: 310 GYVAPEYANTGLLNEKS-----DVYSFGVLLLEAITGR 342
Y APE L+ + DV++ G L+ E G
Sbjct: 189 WYRAPEL----LVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-27
Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 32/210 (15%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKIL--NNVGQAEKEFRVEVEAIGHVRH 196
R++ +LG+G +G V + + I AVK I + + EVE + + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 197 KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT-WEAR--MKVLLGTAKA 253
N+++L + +V E G L + + +A +K +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDE----IIKRKRFSEHDAARIIKQVFS---G 133
Query: 254 LAYLHEAIEPKVVHRDIKSSNILI---DDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
+ Y+H+ +VHRD+K NIL+ + D + K+ DFGL+ +GT
Sbjct: 134 ITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAY 188
Query: 311 YVAPE-----YANTGLLNEKSDVYSFGVLL 335
Y+APE Y +EK DV+S GV+L
Sbjct: 189 YIAPEVLRGTY------DEKCDVWSAGVIL 212
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-27
Identities = 60/208 (28%), Positives = 91/208 (43%), Gaps = 32/208 (15%)
Query: 148 VLGEGGYGVVYRG-NLINGSPVAVKKI---------LNNVGQAEKEFRVEVEAIGHV-RH 196
+LG G VV R + AVK I V + + EV+ + V H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 197 KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT-WEAR--MKVLLGTAKA 253
N+++L LV++ + G L +L L+ E R M+ LL +
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALL---EV 136
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
+ LH+ +VHRD+K NIL+DDD N K++DFG + L G V GT Y+A
Sbjct: 137 ICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSYLA 191
Query: 314 PE------YANTGLLNEKSDVYSFGVLL 335
PE N ++ D++S GV++
Sbjct: 192 PEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 9e-27
Identities = 62/229 (27%), Positives = 104/229 (45%), Gaps = 13/229 (5%)
Query: 134 RDLELATNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAE-KEFRVEVEAI 191
+ + +G G YG V + + +G +AVK+I + V + E K+ ++++ +
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74
Query: 192 GH-VRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARM-KVLLG 249
+V+ G + E ++ + +++ + E + K+ L
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
T KAL +L E K++HRDIK SNIL+D N K+ DFG++ L S TR G
Sbjct: 134 TVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD--SIAKTRDAGCR 189
Query: 310 GYVAPE----YANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEV 354
Y+APE A+ + +SDV+S G+ L E TGR P +
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ 238
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 56/227 (24%), Positives = 95/227 (41%), Gaps = 43/227 (18%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKN 198
+RF E + G+G +G V G G VA+KK++ + +E + ++ + + H N
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPN 80
Query: 199 LVRLLGYCI--------EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG- 249
+V+L I+ +V EYV LH R+ Y + +L
Sbjct: 81 IVQLQ-SYFYTLGERDRRDIYLNVVMEYV-----PDTLHRCCRN--YYRRQVAPPPILIK 132
Query: 250 -----TAKALAYLHEAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGK---SH 300
+++ LH V HRDIK N+L++ D K+ DFG AK L + ++
Sbjct: 133 VFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY 191
Query: 301 VTTRVMGTFGYVAPEYANTGLLNEKS-----DVYSFGVLLLEAITGR 342
+ +R Y APE + + D++S G + E + G
Sbjct: 192 ICSRY-----YRAPEL----IFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 66/307 (21%), Positives = 114/307 (37%), Gaps = 37/307 (12%)
Query: 48 SRRARNNLPFSQIPTVSKEIKEVRVEQVSTNEFVQRDDKDGGSISGEDSGSVTVYKPSSS 107
+N + +EI+ + R +D S S +
Sbjct: 7 HSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQP 66
Query: 108 HPITAPSPLIGLPEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRG-NLINGS 166
PE W ++ ++V+G G VV R + G
Sbjct: 67 KGTENLYFQSMGPEDELPDWAAAKEFYQ------KYDPKDVIGRGVSSVVRRCVHRATGH 120
Query: 167 PVAVKKI--------LNNVGQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGIHRMLVYE 217
AVK + + + + R E + V H +++ L+ LV++
Sbjct: 121 EFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFD 180
Query: 218 YVNNGNLEQWLHGAMRHHGYLT-WEAR--MKVLLGTAKALAYLHEAIEPKVVHRDIKSSN 274
+ G L +L L+ E R M+ LL +A+++LH +VHRD+K N
Sbjct: 181 LMRKGELFDYL----TEKVALSEKETRSIMRSLL---EAVSFLHAN---NIVHRDLKPEN 230
Query: 275 ILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE------YANTGLLNEKSDV 328
IL+DD+ ++SDFG + L G+ + GT GY+APE ++ D+
Sbjct: 231 ILLDDNMQIRLSDFGFSCHLEPGEK-LRELC-GTPGYLAPEILKCSMDETHPGYGKEVDL 288
Query: 329 YSFGVLL 335
++ GV+L
Sbjct: 289 WACGVIL 295
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 31/215 (14%)
Query: 141 NRFSKENVLGEGGYGVVYRGNLINGSPVAVKKI-LNNVGQAEKE------FRVEVEAIGH 193
++ K +GEG YGVVY+ G VA+K+I L+ E E R E+ +
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA----EDEGIPSTAIR-EISLLKE 75
Query: 194 VRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAK 252
+ H N+V L+ LV+E+ +E+ L + + ++++K+ L +
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEF-----MEKDLKKVLDENKTGLQDSQIKIYLYQLLR 130
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
+A+ H+ +++HRD+K N+LI+ D K++DFGLA+ G T V+ T Y
Sbjct: 131 GVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYR 186
Query: 313 APEYANTGLLNEKS-----DVYSFGVLLLEAITGR 342
AP+ L+ K D++S G + E ITG+
Sbjct: 187 APDV----LMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 26/221 (11%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKN 198
+ + + V+G G VV VA+K+I L + E E++A+ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNL----EQWLHGAMRHHGYLTWEARMKVLLGTAKAL 254
+V + LV + ++ G++ + + G L +L + L
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF-G--- 310
YLH+ +HRD+K+ NIL+ +D + +++DFG++ L G +V TF G
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 311 YVAPE-------YANTGLLNEKSDVYSFGVLLLEAITGRDP 344
++APE Y + K+D++SFG+ +E TG P
Sbjct: 192 WMAPEVMEQVRGY------DFKADIWSFGITAIELATGAAP 226
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 70/251 (27%), Positives = 111/251 (44%), Gaps = 26/251 (10%)
Query: 92 SGEDSGSVTVYKPSSSHPITAPSPLIGLPEFSQLGWGHWFTLRDLELATNRFSKENVLGE 151
SG D G+ +Y S S + +P + L +W + + ++ F E+ LG
Sbjct: 9 SGVDLGTENLYFQSMSSVTASAAP-----GTASLVPDYWIDGSNRDALSDFFEVESELGR 63
Query: 152 GGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGI 210
G +VYR P A+K + V +K R E+ + + H N+++L
Sbjct: 64 GATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT 121
Query: 211 HRMLVYEYVNNGNLEQWLHGAMRHHGYLT-WEAR--MKVLLGTAKALAYLHEAIEPKVVH 267
LV E V G L + GY + +A +K +L A+AYLHE +VH
Sbjct: 122 EISLVLELVTGGELFDRI----VEKGYYSERDAADAVKQILE---AVAYLHEN---GIVH 171
Query: 268 RDIKSSNILI---DDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNE 324
RD+K N+L D K++DFGL+K++ + V GT GY APE
Sbjct: 172 RDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LMKTVCGTPGYCAPEILRGCAYGP 229
Query: 325 KSDVYSFGVLL 335
+ D++S G++
Sbjct: 230 EVDMWSVGIIT 240
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 62/228 (27%), Positives = 107/228 (46%), Gaps = 40/228 (17%)
Query: 134 RDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGH 193
+ E ++ V+G G +GVV++ L+ VA+KK+L + R E++ +
Sbjct: 33 KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ---DKRFKNR-ELQIMRI 88
Query: 194 VRHKNLVRLLGYCIEGIHRM------LVYEYVNNGNLEQWLHGAMRHHGYLTW---EARM 244
V+H N+V L + + LV EYV + ++ A RH+ L +
Sbjct: 89 VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-----PETVYRASRHYAKLKQTMPMLLI 143
Query: 245 KVLL-GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNA-KVSDFGLAKLLGAGK---S 299
K+ + ++LAY+H + HRDIK N+L+D K+ DFG AK+L AG+ S
Sbjct: 144 KLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS 200
Query: 300 HVTTRVMGTFGYVAPEYANTGLLNEKS-----DVYSFGVLLLEAITGR 342
++ +R Y APE + + D++S G ++ E + G+
Sbjct: 201 YICSRY-----YRAPEL----IFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-26
Identities = 59/208 (28%), Positives = 86/208 (41%), Gaps = 30/208 (14%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKN 198
++ EN +G G +G V A KKI + F+ E+E + + H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT-WEAR--MKVLLGTAKALA 255
++RL + LV E G L + + H +A MK +L A+A
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGELFERV----VHKRVFRESDAARIMKDVL---SAVA 120
Query: 256 YLHEAIEPKVVHRDIKSSNILI---DDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
Y H+ V HRD+K N L D K+ DFGLA GK T+V GT YV
Sbjct: 121 YCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM-RTKV-GTPYYV 175
Query: 313 APE-----YANTGLLNEKSDVYSFGVLL 335
+P+ Y + D +S GV++
Sbjct: 176 SPQVLEGLY------GPECDEWSAGVMM 197
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 49/211 (23%), Positives = 95/211 (45%), Gaps = 13/211 (6%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKN 198
+ LG+G +G VY+ N G+ A K I + +++ VE+E + H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+LLG ++ E+ G ++ + LT V +AL +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIML---ELDRGLTEPQIQVVCRQMLEALNFLH 134
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYAN 318
+++HRD+K+ N+L+ + + +++DFG++ + +GT ++APE
Sbjct: 135 SK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIGTPYWMAPEVVM 190
Query: 319 TGLL-----NEKSDVYSFGVLLLEAITGRDP 344
+ + K+D++S G+ L+E P
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 51/206 (24%), Positives = 85/206 (41%), Gaps = 31/206 (15%)
Query: 148 VLGEGGYGVVYRG-NLINGSPVAVKKI----LNNVGQAEKE----FRVEVEAIGHVRHKN 198
LG G G V VA+K I E + E+E + + H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT-WEAR--MKVLLGTAKALA 255
++++ + + +V E + G L + + L + +L A+
Sbjct: 77 IIKIKNF-FDAEDYYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQMLL---AVQ 128
Query: 256 YLHEAIEPKVVHRDIKSSNILI---DDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
YLHE ++HRD+K N+L+ ++D K++DFG +K+LG + + GT Y+
Sbjct: 129 YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLCGTPTYL 183
Query: 313 APE---YANTGLLNEKSDVYSFGVLL 335
APE T N D +S GV+L
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 60/230 (26%), Positives = 101/230 (43%), Gaps = 19/230 (8%)
Query: 118 GLPEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRG-NLINGSPVAVK----- 171
G P S G G D L + + V+G+G + VV R N G AVK
Sbjct: 1 GSPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVA 60
Query: 172 KILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNL-EQWLHG 230
K ++ G + ++ + E ++H ++V LL +V+E+++ +L + +
Sbjct: 61 KFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKR 120
Query: 231 AMRHHGYLTWEAR--MKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DDDFNAKV 285
A Y A M+ +L +AL Y H+ ++HRD+K +L+ ++ K+
Sbjct: 121 ADAGFVYSEAVASHYMRQIL---EALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKL 174
Query: 286 SDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLL 335
FG+A LG RV GT ++APE + DV+ GV+L
Sbjct: 175 GGFGVAIQLGESGLVAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 41/223 (18%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKN 198
++ V+G G +GVVY+ +G VA+KK+L + R E++ + + H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKNR-ELQIMRKLDHCN 108
Query: 199 LVRLLGYCIEGIHRM------LVYEYVNNGNLEQWLHGAMRHHGYLTW---EARMKVLL- 248
+VRL + + LV +YV + ++ RH+ +K+ +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 249 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNA-KVSDFGLAKLLGAGK---SHVTTR 304
++LAY+H + HRDIK N+L+D D K+ DFG AK L G+ S++ +R
Sbjct: 164 QLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 220
Query: 305 VMGTFGYVAPEYANTGLLNEKS-----DVYSFGVLLLEAITGR 342
Y APE + DV+S G +L E + G+
Sbjct: 221 Y-----YRAPEL----IFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 63/221 (28%), Positives = 95/221 (42%), Gaps = 43/221 (19%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVE------AIGH 193
+ K + LGEG Y VY+G + + + VA+K+I R+E E AI
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI-----------RLEHEEGAPCTAIRE 50
Query: 194 V------RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVL 247
V +H N+V L LV+EY L++ L + G + +K+
Sbjct: 51 VSLLKDLKHANIVTLHDIIHTEKSLTLVFEY-----LDKDLKQYLDDCGNIINMHNVKLF 105
Query: 248 LG-TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVM 306
L + LAY H KV+HRD+K N+LI++ K++DFGLA+ V+
Sbjct: 106 LFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV 162
Query: 307 GTFGYVAPEYANTGLLNEKS-----DVYSFGVLLLEAITGR 342
T Y P+ LL D++ G + E TGR
Sbjct: 163 -TLWYRPPDI----LLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-26
Identities = 74/328 (22%), Positives = 123/328 (37%), Gaps = 48/328 (14%)
Query: 97 GSVTVYKPSSSHPITAPSPLIGLPEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGV 156
GS + SS + S + + ++ E +++ +LG GG+G
Sbjct: 2 GSSHHHHHHSSGLVPRGSHMAPCNDLHATKLA---PGKEKEPLESQYQVGPLLGSGGFGS 58
Query: 157 VYRG-NLINGSPVAVKKI----LNNVGQAEKEFRV--EVEAIGHVRHK--NLVRLLGYCI 207
VY G + + PVA+K + +++ G+ RV EV + V ++RLL +
Sbjct: 59 VYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118
Query: 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT-WEARMKVLLGTAKALAYLHEAIEPKVV 266
+L+ E Q L + G L AR +A+ + H V+
Sbjct: 119 RPDSFVLILERPEPV---QDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC---GVL 171
Query: 267 HRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLN-E 324
HRDIK NILID + K+ DFG LL GT Y PE+ +
Sbjct: 172 HRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVYSPPEWIRYHRYHGR 228
Query: 325 KSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTR 384
+ V+S G+LL + + G P +H EE++ + R
Sbjct: 229 SAAVWSLGILLYDMVCGDIPFEH---------------------DEEIIRGQVFFRQRVS 267
Query: 385 ALKRSLLTALRCVDPDSEKRPKMSQVVR 412
+ + L+ C+ RP ++
Sbjct: 268 SECQHLIR--WCLALRPSDRPTFEEIQN 293
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 5e-26
Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 22/200 (11%)
Query: 144 SKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR-HKNLVR 201
K+ LGEG + + + + + AVK I + E + E+ A+ H N+V+
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVK 70
Query: 202 LLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT-WEAR--MKVLLGTAKALAYLH 258
L + +H LV E +N G L + ++ + + EA M+ L+ A++++H
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFE----RIKKKKHFSETEASYIMRKLV---SAVSHMH 123
Query: 259 EAIEPKVVHRDIKSSNILI---DDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE 315
+ VVHRD+K N+L +D+ K+ DFG A+L + T T Y APE
Sbjct: 124 DV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPE 179
Query: 316 YANTGLLNEKSDVYSFGVLL 335
N +E D++S GV+L
Sbjct: 180 LLNQNGYDESCDLWSLGVIL 199
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-26
Identities = 67/276 (24%), Positives = 110/276 (39%), Gaps = 41/276 (14%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVK-----KILNNVGQAEKEFRVEVEAIGHVRHKNLVRL 202
LGEG YG V N + VAVK + ++ +KE + + H+N+V+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVKF 70
Query: 203 LGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT-WEARMKV--LLGTAKALAYLHE 259
G+ EG + L EY + G L + + +A+ L+ + YLH
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMA---GVVYLHG 123
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL--LGAGKSHVTTRVMGTFGYVAPE-Y 316
+ HRDIK N+L+D+ N K+SDFGLA + + + GT YVAPE
Sbjct: 124 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL 179
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376
E DV+S G++L + G P D + + ++P
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWD-----QPSDSCQEYSDWK---EKKTYLNPW 231
Query: 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
++ + AL +L + R + + +
Sbjct: 232 KKIDSAPLALLHKIL------VENPSARITIPDIKK 261
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 48/220 (21%), Positives = 76/220 (34%), Gaps = 22/220 (10%)
Query: 140 TNRFSKENVLGEG--GYGVVYRG-NLINGSPVAVKKILNNVGQAEKEF----RVEVEAIG 192
+ V+G+G V G V V++I N+ E + E+
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI--NLEACSNEMVTFLQGELHVSK 81
Query: 193 HVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAK 252
H N+V I +V ++ G+ + + + A +L G K
Sbjct: 82 LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLIC--THFMDGMNELAIAYILQGVLK 139
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
AL Y+H VHR +K+S+ILI D +S + + V
Sbjct: 140 ALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196
Query: 313 ------APEYANTGLL--NEKSDVYSFGVLLLEAITGRDP 344
+PE L + KSD+YS G+ E G P
Sbjct: 197 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 9e-26
Identities = 61/226 (26%), Positives = 103/226 (45%), Gaps = 44/226 (19%)
Query: 139 ATNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKE-------FRVEVEA 190
++++F + LG G Y VY+G N G VA+K++ + + E R E+
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV-----KLDSEEGTPSTAIR-EISL 56
Query: 191 IGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEAR------- 243
+ ++H+N+VRL LV+E+ ++ L M
Sbjct: 57 MKELKHENIVRLYDVIHTENKLTLVFEF-----MDNDLKKYMDSRTVGNTPRGLELNLVK 111
Query: 244 --MKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV 301
LL + LA+ HE K++HRD+K N+LI+ K+ DFGLA+ G +
Sbjct: 112 YFQWQLL---QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF 165
Query: 302 TTRVMGTFGYVAPEYANTGLLNEKS-----DVYSFGVLLLEAITGR 342
++ V+ T Y AP+ L+ ++ D++S G +L E ITG+
Sbjct: 166 SSEVV-TLWYRAPDV----LMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 1e-25
Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 25/209 (11%)
Query: 140 TNRFSKE----NVLGEGGYGVVYRG-NLINGSPVAVKKILNN--VGQAEKEFRVEVEAIG 192
+ +FS LG+G + VV R + G A K I + ++ E
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 193 HVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT-WEAR--MKVLLG 249
++H N+VRL E LV++ V G L + + + + +A ++ +L
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI----VAREFYSEADASHCIQQIL- 115
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILI---DDDFNAKVSDFGLAKLLGAGKSHVTTRVM 306
+++AY H +VHR++K N+L+ K++DFGLA +
Sbjct: 116 --ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFA 168
Query: 307 GTFGYVAPEYANTGLLNEKSDVYSFGVLL 335
GT GY++PE ++ D+++ GV+L
Sbjct: 169 GTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 1e-25
Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 31/215 (14%)
Query: 141 NRFSKENVLGEGGYGVVYRGNLINGSPVAVKKI-LNNVGQAEKE------FRVEVEAIGH 193
++ +GEG YGVVY+ G A+KKI L E E R E+ +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEK----EDEGIPSTTIR-EISILKE 56
Query: 194 VRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAK 252
++H N+V+L +LV+E+ L+Q L + K L
Sbjct: 57 LKHSNIVKLYDVIHTKKRLVLVFEH-----LDQDLKKLLDVCEGGLESVTAKSFLLQLLN 111
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
+AY H+ +V+HRD+K N+LI+ + K++DFGLA+ G T ++ T Y
Sbjct: 112 GIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYR 167
Query: 313 APEYANTGLLNEKS-----DVYSFGVLLLEAITGR 342
AP+ L+ K D++S G + E + G
Sbjct: 168 APDV----LMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 67/287 (23%), Positives = 104/287 (36%), Gaps = 51/287 (17%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI----LNNVGQAEKEFRVEVE------A 190
+ +LG+GG+G V+ G L + VA+K I + +E
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 191 IGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT-WEARMKVLLG 249
H ++RLL + MLV E Q L + G L +R
Sbjct: 92 GAGGGHPGVIRLLDWFETQEGFMLVLERPLPA---QDLFDYITEKGPLGEGPSR-CFFGQ 147
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVTTRVMGT 308
A+ + H VVHRDIK NILID AK+ DFG LL GT
Sbjct: 148 VVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD---GT 201
Query: 309 FGYVAPEYANTGL-LNEKSDVYSFGVLLLEAITGRDPVDHGR--PAHEVNLVDWLKMMVG 365
Y PE+ + + V+S G+LL + + G P + + E++ +
Sbjct: 202 RVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHV----- 256
Query: 366 SRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
S + +L+ RC+ P RP + +++
Sbjct: 257 ---SPDC---------------CALIR--RCLAPKPSSRPSLEEILL 283
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-25
Identities = 34/282 (12%), Positives = 80/282 (28%), Gaps = 52/282 (18%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGN-LINGSPVAVKKILNNVGQAE---KEFRVEVEAIGH 193
+A R+ G ++ VA+ + + +E +
Sbjct: 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSR 87
Query: 194 VRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
+ + R+L ++V E++ G+L++ + + ++ + A A
Sbjct: 88 IDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAA 141
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
H A V S + + D G L +
Sbjct: 142 ADAAHRA---GVALSIDHPSRVRVSID--------GDVVL-------------AYPATMP 177
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373
N + D+ G L + R P+ + + + + +
Sbjct: 178 DA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE-------RDTAGQPI 223
Query: 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
+P ++ ++ A R V D R S ++ +++
Sbjct: 224 EPA-DIDRDIPFQISAV--AARSVQGDGGIRSA-STLLNLMQ 261
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 28/215 (13%)
Query: 134 RDLELATNRFSKE----NVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEV 188
+ L + +F+ +G G Y V R + AVK I +++++ E+
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID----KSKRDPTEEI 66
Query: 189 EAIGH-VRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT-WEAR--M 244
E + +H N++ L +G + +V E + G L + + + EA +
Sbjct: 67 EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL----RQKFFSEREASAVL 122
Query: 245 KVLLGTAKALAYLHEAIEPKVVHRDIKSSNILI----DDDFNAKVSDFGLAKLLGAGKSH 300
+ K + YLH VVHRD+K SNIL + + ++ DFG AK L A
Sbjct: 123 FTIT---KTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176
Query: 301 VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLL 335
+ T T +VAPE + D++S GVLL
Sbjct: 177 LMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 62/230 (26%), Positives = 108/230 (46%), Gaps = 48/230 (20%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKE-FRV----EVEAIGH 193
+++ K +G+G +G V++ + G VA+KK+ + N EKE F + E++ +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN----EKEGFPITALREIKILQL 72
Query: 194 VRHKNLVRLLGYCIEGIHRM--------LVYEYVNNGNLEQWLHGAMRHHGYLTWEAR-- 243
++H+N+V L+ C LV+++ E L G + + +
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDF-----CEHDLAGLLSNVLVKFTLSEIK 127
Query: 244 --MKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV 301
M++LL L Y+H K++HRD+K++N+LI D K++DFGLA+ K+
Sbjct: 128 RVMQMLL---NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 181
Query: 302 ----TTRVMGTFGYVAPEYANTGLLNEKS-----DVYSFGVLLLEAITGR 342
T RV+ T Y PE LL E+ D++ G ++ E T
Sbjct: 182 PNRYTNRVV-TLWYRPPEL----LLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 20/218 (9%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV-RHK 197
F ++G G YG VY+G ++ G A+K +++ G E+E + E+ + H+
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKYSHHR 81
Query: 198 NLVRLLG-YCIEGIHRM-----LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
N+ G + + M LV E+ G++ + L E +
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK--NTKGNTLKEEWIAYICREIL 139
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGY 311
+ L++LH+ KV+HRDIK N+L+ ++ K+ DFG++ L T +GT +
Sbjct: 140 RGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYW 195
Query: 312 VAPE-----YANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+APE + KSD++S G+ +E G P
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 71/273 (26%), Positives = 123/273 (45%), Gaps = 40/273 (14%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKILN----NVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
+G+G + V +++ G VA+K I++ N +K FR EV + + H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIK-IIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKL- 79
Query: 204 GY-CIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLT-WEARMKVLLGTAKALAYLHEA 260
+ IE + L+ EY + G + +L HG + EAR A+ Y H+
Sbjct: 80 -FEVIETEKTLYLIMEYASGGEVFDYL----VAHGRMKEKEAR-SKFRQIVSAVQYCHQK 133
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YANT 319
++VHRD+K+ N+L+D D N K++DFG + G + G Y APE +
Sbjct: 134 ---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAFC-GAPPYAAPELFQGK 188
Query: 320 GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEV 379
+ DV+S GV+L ++G P D NL + + ++ + P +
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPFD------GQNLKELRERVLRGK----YRIPF-YM 237
Query: 380 RPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
L + L ++P KR + Q+++
Sbjct: 238 STDCENLLKRFLV----LNP--IKRGTLEQIMK 264
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 49/205 (23%), Positives = 92/205 (44%), Gaps = 21/205 (10%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKIL--NNVGQAEKEFRVEVEAIGHVRH 196
++ + + LG+G + VV R + G A K I + ++ E ++H
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 197 KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT-WEAR--MKVLLGTAKA 253
N+VRL E LV++ V G L + + + + +A ++ +L ++
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDI----VAREFYSEADASHCIQQIL---ES 140
Query: 254 LAYLHEAIEPKVVHRDIKSSNILI---DDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
+AY H +VHR++K N+L+ K++DFGLA + + GT G
Sbjct: 141 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWHGFAGTPG 195
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLL 335
Y++PE ++ D+++ GV+L
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 6e-25
Identities = 67/276 (24%), Positives = 110/276 (39%), Gaps = 41/276 (14%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVK-----KILNNVGQAEKEFRVEVEAIGHVRHKNLVRL 202
LGEG YG V N + VAVK + ++ +KE + + H+N+V+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVVKF 70
Query: 203 LGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT-WEARMKV--LLGTAKALAYLHE 259
G+ EG + L EY + G L + + +A+ L+ + YLH
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMA---GVVYLHG 123
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL--LGAGKSHVTTRVMGTFGYVAPE-Y 316
+ HRDIK N+L+D+ N K+SDFGLA + + + GT YVAPE
Sbjct: 124 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL 179
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376
E DV+S G++L + G P D + + ++P
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWD-----QPSDSCQEYSDWK---EKKTYLNPW 231
Query: 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
++ + AL +L + R + + +
Sbjct: 232 KKIDSAPLALLHKIL------VENPSARITIPDIKK 261
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 50/205 (24%), Positives = 89/205 (43%), Gaps = 20/205 (9%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKIL--NNVGQAEKEFRVEVEAIGHVRH 196
T + LG+G + VV R ++ G A I + ++ E ++H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 197 KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT-WEAR--MKVLLGTAKA 253
N+VRL E H L+++ V G L + + Y + +A ++ +L A
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDI----VAREYYSEADASHCIQQILE---A 122
Query: 254 LAYLHEAIEPKVVHRDIKSSNILI---DDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
+ + H+ VVHR++K N+L+ K++DFGLA + + GT G
Sbjct: 123 VLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPG 178
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLL 335
Y++PE + D+++ GV+L
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-25
Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 29/210 (13%)
Query: 145 KENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR-HKNLVRL 202
+E+VLGEG + V NLI AVK I G EVE + + H+N++ L
Sbjct: 17 QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 203 LGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT-WEAR--MKVLLGTAKALAYLHE 259
+ + E LV+E + G++ L + + EA ++ + AL +LH
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSI---LS-HIHKRRHFNELEASVVVQDVA---SALDFLHN 129
Query: 260 AIEPKVVHRDIKSSNILI---DDDFNAKVSDFGLAKLLGAGKSH--VTTRVM----GTFG 310
+ HRD+K NIL + K+ DF L + ++T + G+
Sbjct: 130 ---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186
Query: 311 YVAPE-----YANTGLLNEKSDVYSFGVLL 335
Y+APE + +++ D++S GV+L
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-25
Identities = 62/279 (22%), Positives = 108/279 (38%), Gaps = 41/279 (14%)
Query: 148 VLGEGGYGVVYRG-NLINGSPVAVKKI----LNNVGQAEKEFRVEVEAIGHVRHKNLVRL 202
+LGEG YG V + AVK + L + E + E++ + +RHKN+++L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 203 LGYCIEGIHRM------LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY 256
++ ++ +V EY G E + ++ + +A L Y
Sbjct: 72 ----VDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAH-GYFCQLIDGLEY 124
Query: 257 LHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS-HVTTRVMGTFGYVAPE 315
LH +VH+DIK N+L+ K+S G+A+ L + G+ + PE
Sbjct: 125 LHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 316 YANTGLLNE--KSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373
AN K D++S GV L TG P + N+ + +
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE------GDNIYKLFENI----GKGSYA 231
Query: 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
P + P L + +L + + KR + Q+ +
Sbjct: 232 IPG-DCGPPLSDLLKGML------EYEPAKRFSIRQIRQ 263
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 46/201 (22%), Positives = 81/201 (40%), Gaps = 15/201 (7%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKN 198
+ + LG G +GVV+R G K I + + E+ + + H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEAR--MKVLLGTAKALAY 256
L+ L + +L+ E+++ G L + A + E M+ L +
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACE---GLKH 164
Query: 257 LHEAIEPKVVHRDIKSSNILIDDDFNA--KVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
+HE +VH DIK NI+ + + K+ DFGLA L + + T + AP
Sbjct: 165 MHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTTATAEFAAP 219
Query: 315 EYANTGLLNEKSDVYSFGVLL 335
E + + +D+++ GVL
Sbjct: 220 EIVDREPVGFYTDMWAIGVLG 240
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 26/210 (12%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI------LNNVGQAEKEFRVEVEAIG 192
+ + LG G + +V + G A K I + G + +E EV +
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 193 HVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT-WEAR--MKVLLG 249
+RH N++ L +L+ E V+ G E L + LT EA +K +L
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGG--E--LFDFLAEKESLTEDEATQFLKQILD 119
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILI----DDDFNAKVSDFGLAKLLGAGKSHVTTRV 305
+ YLH ++ H D+K NI++ + K+ DFG+A + AG +
Sbjct: 120 ---GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--I 171
Query: 306 MGTFGYVAPEYANTGLLNEKSDVYSFGVLL 335
GT +VAPE N L ++D++S GV+
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 62/253 (24%), Positives = 106/253 (41%), Gaps = 22/253 (8%)
Query: 102 YKPSSSHPITAPSPLIGLPEFSQLGWGHWFTLRDLELATN---RFSKENVLGEGGYGVVY 158
Y ++ + + +P + G + +L + FS +G G +G VY
Sbjct: 12 YDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVY 71
Query: 159 RG-NLINGSPVAVKKILNNVGQAE---KEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRML 214
++ N VA+KK+ + Q+ ++ EV + +RH N ++ G + L
Sbjct: 72 FARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 131
Query: 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSN 274
V EY + H L V G + LAYLH ++HRD+K+ N
Sbjct: 132 VMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGN 184
Query: 275 ILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE---YANTGLLNEKSDVYSF 331
IL+ + K+ DFG A ++ S +GT ++APE + G + K DV+S
Sbjct: 185 ILLSEPGLVKLGDFGSASIMAPANS-----FVGTPYWMAPEVILAMDEGQYDGKVDVWSL 239
Query: 332 GVLLLEAITGRDP 344
G+ +E + P
Sbjct: 240 GITCIELAERKPP 252
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-24
Identities = 49/199 (24%), Positives = 88/199 (44%), Gaps = 11/199 (5%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKN 198
+ + LG G +GVV+R G+ A K ++ ++ R E++ + +RH
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
LV L + +++YE+++ G L + + H ++ + ++ + K L ++H
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKV---ADEHNKMSEDEAVEYMRQVCKGLCHMH 272
Query: 259 EAIEPKVVHRDIKSSNILI--DDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEY 316
E VH D+K NI+ K+ DFGL L + GT + APE
Sbjct: 273 EN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--SVKVTTGTAEFAAPEV 327
Query: 317 ANTGLLNEKSDVYSFGVLL 335
A + +D++S GVL
Sbjct: 328 AEGKPVGYYTDMWSVGVLS 346
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 57/286 (19%), Positives = 110/286 (38%), Gaps = 25/286 (8%)
Query: 58 SQIPTVSKEIKEVRVEQVSTNEFVQRDDKDGGSISGEDSGSVTVYKPSSSHPITAPSPLI 117
S + ++ + ++ + ++ S D K + + P
Sbjct: 10 SGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAP 69
Query: 118 GLPEFSQLGWGHWFTLRDLELATNRFS--KENVLGEGGYGVVYRG-NLINGSPVAVKKIL 174
P H + ++ K +LG G +G V++ G +A K I
Sbjct: 70 PAPF------DHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIK 123
Query: 175 NNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMR 233
+ ++E + E+ + + H NL++L E + + LV EYV+ G L +
Sbjct: 124 TRGMKDKEEVKNEISVMNQLDHANLIQLYDA-FESKNDIVLVMEYVDGGELFDRI--IDE 180
Query: 234 HHGYLTWEAR--MKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILI--DDDFNAKVSDFG 289
+ + MK + + ++H+ ++H D+K NIL D K+ DFG
Sbjct: 181 SYNLTELDTILFMKQICE---GIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFG 234
Query: 290 LAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLL 335
LA+ + GT ++APE N ++ +D++S GV+
Sbjct: 235 LARRYKPREKLKV--NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 56/229 (24%), Positives = 97/229 (42%), Gaps = 16/229 (6%)
Query: 134 RDLELATNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAE-KEFRVEVEAI 191
+ + N +G G G V++ G +AVK++ + + E K ++++ +
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 192 GH-VRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT 250
+V+ G I + E + + R G + K+ +
Sbjct: 78 LKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKK----RMQGPIPERILGKMTVAI 133
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
KAL YL E + V+HRD+K SNIL+D+ K+ DFG++ L R G
Sbjct: 134 VKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD--DKAKDRSAGCAA 189
Query: 311 YVAPE-----YANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEV 354
Y+APE + ++DV+S G+ L+E TG+ P + + EV
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV 238
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 26/210 (12%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI------LNNVGQAEKEFRVEVEAIG 192
+ + LG G + +V + G A K I + G + +E EV +
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 193 HVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT-WEAR--MKVLLG 249
V H N++ L +L+ E V+ G E L + L+ EA +K +L
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGG--E--LFDFLAQKESLSEEEATSFIKQILD 126
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILI----DDDFNAKVSDFGLAKLLGAGKSHVTTRV 305
+ YLH K+ H D+K NI++ + K+ DFGLA + G +
Sbjct: 127 ---GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNI 178
Query: 306 MGTFGYVAPEYANTGLLNEKSDVYSFGVLL 335
GT +VAPE N L ++D++S GV+
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 52/206 (25%), Positives = 84/206 (40%), Gaps = 29/206 (14%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV-RHKNL 199
+ SK+ VLG G G V + G A+K + ++ + R EV+ ++
Sbjct: 31 QLSKQ-VLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHI 84
Query: 200 VRLLGYCIEGIHRM----LVYEYVNNGNLEQWLHGAMRHHGYLT-WEAR--MKVLLGTAK 252
V +L H ++ E + G L R T EA M+ +
Sbjct: 85 VCILDVYENMHHGKRCLLIIMECMEGGELFS--RIQERGDQAFTEREAAEIMRDIG---T 139
Query: 253 ALAYLHEAIEPKVVHRDIKSSNILI---DDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
A+ +LH + HRD+K N+L + D K++DFG AK + T T
Sbjct: 140 AIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPC-YTP 193
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLL 335
YVAPE ++ D++S GV++
Sbjct: 194 YYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 54/210 (25%), Positives = 87/210 (41%), Gaps = 26/210 (12%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKIL------NNVGQAEKEFRVEVEAIG 192
+ + LG G + VV + G A K I + G + ++ EV +
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 193 HVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT-WEAR--MKVLLG 249
++H N++ L +L+ E V G E L + LT EA +K +L
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGG--E--LFDFLAEKESLTEEEATEFLKQILN 125
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILI----DDDFNAKVSDFGLAKLLGAGKSHVTTRV 305
+ YLH ++ H D+K NI++ K+ DFGLA + G +
Sbjct: 126 ---GVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNI 177
Query: 306 MGTFGYVAPEYANTGLLNEKSDVYSFGVLL 335
GT +VAPE N L ++D++S GV+
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 9e-24
Identities = 64/208 (30%), Positives = 103/208 (49%), Gaps = 24/208 (11%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKI----LNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG G +G V G + + G VAVK + + ++ K R E++ + RH ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR-EIQNLKLFRHPHIIKL- 76
Query: 204 GY-CIEGIHRM-LVYEYVNNGNLEQWL--HGAMRHHGYLTWEARMKVLLGTAKALAYLHE 259
Y I +V EYV+ G L ++ HG + EAR ++ A+ Y H
Sbjct: 77 -YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEM-----EAR-RLFQQILSAVDYCHR 129
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YAN 318
VVHRD+K N+L+D NAK++DFGL+ ++ G+ T+ G+ Y APE +
Sbjct: 130 H---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVISG 184
Query: 319 TGLLNEKSDVYSFGVLLLEAITGRDPVD 346
+ D++S GV+L + G P D
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLPFD 212
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 55/210 (26%), Positives = 87/210 (41%), Gaps = 26/210 (12%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI------LNNVGQAEKEFRVEVEAIG 192
+ + LG G + +V + G A K I + G +E EV +
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 193 HVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT-WEAR--MKVLLG 249
V H N++ L +L+ E V+ G L +L L+ EA +K +L
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL----AQKESLSEEEATSFIKQILD 126
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILI----DDDFNAKVSDFGLAKLLGAGKSHVTTRV 305
+ YLH K+ H D+K NI++ + K+ DFGLA + G +
Sbjct: 127 ---GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNI 178
Query: 306 MGTFGYVAPEYANTGLLNEKSDVYSFGVLL 335
GT +VAPE N L ++D++S GV+
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 1e-23
Identities = 43/227 (18%), Positives = 85/227 (37%), Gaps = 39/227 (17%)
Query: 205 YCIEGIHRMLVY---EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
++ +Y + NL+ W++ + + + A+A+ +LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMN-RRCSLEDREHGVCLHIFIQIAEAVEFLHSK- 183
Query: 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVT-----------TRVMGTFG 310
++HRD+K SNI D KV DFGL + + T T +GT
Sbjct: 184 --GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370
Y++PE + + K D++S G++L E + E + + R+
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFS------TQMERVRI-ITDV-----RNL 289
Query: 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417
+ + P + + +L P +RP+ + + +E+
Sbjct: 290 KFPLLFTQKYPQEHMMVQDML------SPSPTERPEATDI---IENA 327
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 58/229 (25%), Positives = 93/229 (40%), Gaps = 44/229 (19%)
Query: 139 ATNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAI----- 191
AT+R+ +G G YG VY+ + +G VA+K + + N + + +
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPN--GGGGGGGLPISTVREVAL 64
Query: 192 ----GHVRHKNLVRLLGYCIEGIHR-----MLVYEYVNNGNLEQWLHGAMRHHGYLTWEA 242
H N+VRL+ C LV+E+ ++Q L + A
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPA 119
Query: 243 R-----MKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297
M+ L + L +LH +VHRD+K NIL+ K++DFGLA++
Sbjct: 120 ETIKDLMRQFL---RGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ 173
Query: 298 KSHVTTRVMGTFGYVAPEYANTGLLNEK----SDVYSFGVLLLEAITGR 342
+ T V+ T Y APE LL D++S G + E +
Sbjct: 174 MAL-TPVVV-TLWYRAPEV----LLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 4e-23
Identities = 43/198 (21%), Positives = 81/198 (40%), Gaps = 20/198 (10%)
Query: 148 VLGEGGYGVVYRG-NLINGSPVAVKKIL-NNVGQAEKE-FRVEVEAIGHVRH-KNLVRLL 203
LG G + VV + + G A K + GQ + E+ + + ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 204 GYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT-WEAR--MKVLLGTAKALAYLHEA 260
+L+ EY G + ++ + +K +L + YLH+
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLC--LPELAEMVSENDVIRLIKQILE---GVYYLHQN 150
Query: 261 IEPKVVHRDIKSSNILI---DDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
+VH D+K NIL+ + K+ DFG+++ +G +MGT Y+APE
Sbjct: 151 ---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC--ELREIMGTPEYLAPEIL 205
Query: 318 NTGLLNEKSDVYSFGVLL 335
N + +D+++ G++
Sbjct: 206 NYDPITTATDMWNIGIIA 223
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 5e-23
Identities = 38/201 (18%), Positives = 83/201 (41%), Gaps = 16/201 (7%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKN 198
++ LG G +G+V+R + K + G + + E+ + RH+N
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRN 62
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEAR--MKVLLGTAKALAY 256
++ L ++++E+++ ++ + + E + + +AL +
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVC---EALQF 117
Query: 257 LHEAIEPKVVHRDIKSSNILIDDDFNA--KVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
LH + H DI+ NI+ ++ K+ +FG A+ L G + Y AP
Sbjct: 118 LHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--NFRLLFTAPEYYAP 172
Query: 315 EYANTGLLNEKSDVYSFGVLL 335
E +++ +D++S G L+
Sbjct: 173 EVHQHDVVSTATDMWSLGTLV 193
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 8e-23
Identities = 59/261 (22%), Positives = 89/261 (34%), Gaps = 60/261 (22%)
Query: 128 GHWFTLRDLELATNRFSKENVLGEGGYGVVYRG-NLINGSPVAVK-----KILNNVGQAE 181
+F L ++ + +G+G YGVV + A+K KI +
Sbjct: 13 NLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDV 72
Query: 182 KEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNL----------------- 224
+ + EV + + H N+ RL + + LV E + G+L
Sbjct: 73 ERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAM 132
Query: 225 --------------------EQWLHGAMRHHGYLTWEAR--MKVLLGTAKALAYLHEAIE 262
M+ + AL YLH
Sbjct: 133 DVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS---ALHYLHNQ-- 187
Query: 263 PKVVHRDIKSSNILIDDDFNA--KVSDFGLAKLLGAGKSH----VTTRVMGTFGYVAPEY 316
+ HRDIK N L + + K+ DFGL+K + +TT+ GT +VAPE
Sbjct: 188 -GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEV 245
Query: 317 ANTGLL--NEKSDVYSFGVLL 335
NT K D +S GVLL
Sbjct: 246 LNTTNESYGPKCDAWSAGVLL 266
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 61/250 (24%), Positives = 95/250 (38%), Gaps = 32/250 (12%)
Query: 103 KPSSSHPITAPSPLIGLPEFSQLGWGHWFTLRDLELATNRFSKE-----NVLGEGGYGVV 157
P P P P + + L++ N + VLG G G V
Sbjct: 19 PPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKV 78
Query: 158 YRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHRM-- 213
+ N A+K + Q + R EVE + ++VR++
Sbjct: 79 LQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133
Query: 214 --LVYEYVNNGNLEQWLHGAMRHHGYLT-WEAR--MKVLLGTAKALAYLHEAIEPKVVHR 268
+V E ++ G L R T EA MK + +A+ YLH + HR
Sbjct: 134 LLIVMECLDGGELFS--RIQDRGDQAFTEREASEIMKSIG---EAIQYLHSI---NIAHR 185
Query: 269 DIKSSNILI---DDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEK 325
D+K N+L + K++DFG AK + S +TT T YVAPE ++
Sbjct: 186 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPC-YTPYYVAPEVLGPEKYDKS 243
Query: 326 SDVYSFGVLL 335
D++S GV++
Sbjct: 244 CDMWSLGVIM 253
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 1e-22
Identities = 54/245 (22%), Positives = 97/245 (39%), Gaps = 61/245 (24%)
Query: 141 NRFSKENV-LGEGGYGVVYRG---NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV-- 194
+ F E +G G YG VY+ + + A+K+I + + + A +
Sbjct: 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI--------EGTGISMSACREIAL 71
Query: 195 ----RHKNLVRLLGYCIEGIHR--MLVYEYVNNGNLEQWLHGAMRHHGYLTWEAR----- 243
+H N++ L + R L+++Y E L ++ H +
Sbjct: 72 LRELKHPNVISLQKVFLSHADRKVWLLFDY-----AEHDLWHIIKFHRASKANKKPVQLP 126
Query: 244 -------MKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNA----KVSDFGLAK 292
+ +L + YLH V+HRD+K +NIL+ + K++D G A+
Sbjct: 127 RGMVKSLLYQIL---DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 180
Query: 293 LLGA---GKSHVTTRVMGTFGYVAPEYANTGLLNEKS-----DVYSFGVLLLEAITGRDP 344
L + + + V+ TF Y APE LL + D+++ G + E +T P
Sbjct: 181 LFNSPLKPLADLDPVVV-TFWYRAPEL----LLGARHYTKAIDIWAIGCIFAELLTSE-P 234
Query: 345 VDHGR 349
+ H R
Sbjct: 235 IFHCR 239
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 55/224 (24%), Positives = 98/224 (43%), Gaps = 37/224 (16%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR-HK 197
+ + LG G Y V+ N+ N V VK + V + +K R E++ + ++R
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-KPV-KKKKIKR-EIKILENLRGGP 91
Query: 198 NLVRLLGYCIEGIHRMLVY--EYVNNGNLEQWLHG-AMRHHGYLTWEARMKVLLGTAKAL 254
N++ L + + R E+VNN + +Q + +E +L KAL
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYE-----IL---KAL 143
Query: 255 AYLHEAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKS---HVTTRVMGTFG 310
Y H ++HRD+K N++ID + ++ D+GLA+ G+ V +R
Sbjct: 144 DYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY----- 195
Query: 311 YVAPEYANTGLLNEKS-----DVYSFGVLLLEAITGRDPVDHGR 349
+ PE L++ + D++S G +L I ++P HG
Sbjct: 196 FKGPEL----LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 235
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 3e-22
Identities = 64/230 (27%), Positives = 102/230 (44%), Gaps = 30/230 (13%)
Query: 130 WFTLRDLELATNRFSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQAEKEF---R 185
W L + + F VLG GG+G V+ + G A KK+ + K +
Sbjct: 174 WKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM 233
Query: 186 VEVEAIGHVRHKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARM 244
VE + + V + +V L Y E + LV +N G++ ++ + E R
Sbjct: 234 VEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRA 291
Query: 245 K-----VLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299
++ L +LH+ +++RD+K N+L+DDD N ++SD GLA L AG++
Sbjct: 292 IFYTAQIVS----GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT 344
Query: 300 HVTTRVMGTFGYVAPEYANTGLLNEKS-----DVYSFGVLLLEAITGRDP 344
GT G++APE LL + D ++ GV L E I R P
Sbjct: 345 KTKGYA-GTPGFMAPE-----LLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 4e-22
Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 28/210 (13%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKI----LNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LG G +G V G + + G VAVK + + ++ K R E++ + RH ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR-EIQNLKLFRHPHIIKL- 81
Query: 204 GY-CIEGIHRM-LVYEYVNNGNLEQWL--HGAMRHHGYLTWEARMKV--LLGTAKALAYL 257
Y I + +V EYV+ G L ++ +G + E+R +L + Y
Sbjct: 82 -YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEK-----ESRRLFQQILS---GVDYC 132
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-Y 316
H VVHRD+K N+L+D NAK++DFGL+ ++ G+ T+ G+ Y APE
Sbjct: 133 HRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVI 187
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVD 346
+ + D++S GV+L + G P D
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCGTLPFD 217
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 5e-22
Identities = 57/234 (24%), Positives = 91/234 (38%), Gaps = 60/234 (25%)
Query: 141 NRFSKENVLGEGGYGVVYRG--NLINGSPVAVKKILNNVGQAEKEFRVEVEAIG------ 192
++ +GEG YG V++ G VA+K++ RV+ G
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-----------RVQTGEEGMPLSTI 59
Query: 193 ----------HVRHKNLVRLL----GYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGY 237
H N+VRL + ++ LV+E+ ++Q L +
Sbjct: 60 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEH-----VDQDLTTYLDKVPE 114
Query: 238 LTWEAR-----MKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292
M LL + L +LH +VVHRD+K NIL+ K++DFGLA+
Sbjct: 115 PGVPTETIKDMMFQLL---RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 168
Query: 293 LLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEK----SDVYSFGVLLLEAITGR 342
+ + T+ V+ T Y APE LL D++S G + E +
Sbjct: 169 IYSFQMAL-TSVVV-TLWYRAPEV----LLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 9e-22
Identities = 59/225 (26%), Positives = 101/225 (44%), Gaps = 48/225 (21%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILN---NVGQAEKEFRVEVEAIGHVR 195
+ +G G YG V + +G VA+KK+ + A++ +R E+ + H++
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQ 81
Query: 196 HKNLVRLL-----GYCIEGIHRM-LVYEYVNNGNLEQWLHGAMR------HHGYLTWEAR 243
H+N++ LL + + LV + ++ L M YL ++
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPF-----MQTDLQKIMGLKFSEEKIQYLVYQ-- 134
Query: 244 MKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSH-VT 302
+L K L Y+H A VVHRD+K N+ +++D K+ DFGLA+ A + V
Sbjct: 135 ---ML---KGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV 185
Query: 303 TRVMGTFGYVAPEYANTGLLNEKS-----DVYSFGVLLLEAITGR 342
TR Y APE +L+ D++S G ++ E +TG+
Sbjct: 186 TRW-----YRAPEV----ILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-21
Identities = 66/304 (21%), Positives = 124/304 (40%), Gaps = 76/304 (25%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVK-----KILNNVGQAEKEFRV---------------- 186
+G+G YGVV N + + A+K K++ G +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 187 -----EVEAIGHVRHKNLVRLLGYCIEGI------HRMLVYEYVNNGNL-EQWLHGAMRH 234
E+ + + H N+V+L +E + H +V+E VN G + E +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKL----VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSE 136
Query: 235 HGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294
+AR K + YLH K++HRDIK SN+L+ +D + K++DFG++
Sbjct: 137 D-----QAR-FYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
Query: 295 GAGKSHVTTRVMGTFGYVAPEYANTGLLNE--------KSDVYSFGVLLLEAITGRDPVD 346
+ ++ V GT ++APE L+E DV++ GV L + G+ P
Sbjct: 188 KGSDALLSNTV-GTPAFMAPE-----SLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241
Query: 347 HGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPK 406
+ ++ + +S+ + P+ + + + L+T + +P E R
Sbjct: 242 ------DERIMCLHSKI----KSQALEFPD-QPDIAEDL--KDLITRMLDKNP--ESRIV 286
Query: 407 MSQV 410
+ ++
Sbjct: 287 VPEI 290
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 53/260 (20%), Positives = 100/260 (38%), Gaps = 75/260 (28%)
Query: 136 LELATNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV 194
LE ++ ++S LG G +G+V ++ +G A+KK+L + R E++ + +
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ---DPRYKNR-ELDIMKVL 57
Query: 195 RHKNLVRLLGYCIEGIHRM--------------------------------------LVY 216
H N+++L+ Y ++
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 217 EYVNNGNLEQWLHGAMRHHG----YLTWEARMKVLL-GTAKALAYLHEAIEPKVVHRDIK 271
EYV LH ++ + + + + +A+ ++H + HRDIK
Sbjct: 118 EYV-----PDTLHKVLKSFIRSGRSIP-MNLISIYIYQLFRAVGFIHSL---GICHRDIK 168
Query: 272 SSNILID-DDFNAKVSDFGLAKLLGAGK---SHVTTRVMGTFGYVAPEYANTGLLNEKS- 326
N+L++ D K+ DFG AK L + +++ +R Y APE +L
Sbjct: 169 PQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPEL----MLGATEY 219
Query: 327 ----DVYSFGVLLLEAITGR 342
D++S G + E I G+
Sbjct: 220 TPSIDLWSIGCVFGELILGK 239
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 35/219 (15%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILN---NVGQAEKEFRVEVEAIGHVR 195
R+ +G G G+V + I VA+KK+ N A++ +R E+ + V
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVN 82
Query: 196 HKNLVRLL-----GYCIEGIHRM-LVYEYVNNGNLEQWLHGAMR------HHGYLTWEAR 243
HKN++ LL +E + +V E ++ L ++ YL ++
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDVYIVMEL-----MDANLCQVIQMELDHERMSYLLYQ-- 135
Query: 244 MKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTT 303
+L + +LH A ++HRD+K SNI++ D K+ DFGLA+ AG S + T
Sbjct: 136 ---ML---CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMT 184
Query: 304 RVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGR 342
+ T Y APE E D++S G ++ E I G
Sbjct: 185 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 2e-21
Identities = 57/256 (22%), Positives = 103/256 (40%), Gaps = 59/256 (23%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILN---NVGQAEKEFRVEVEAIGHVR 195
+R+ +++G G YG V + + VA+KKIL ++ ++ R E+ + +
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAILNRLN 110
Query: 196 HKNLVRLLG-YCIEGIHRM----LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL-G 249
H ++V++L + + + +V E + R YLT E +K LL
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEI-----ADSDFKKLFRTPVYLT-ELHIKTLLYN 164
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
+ Y+H A ++HRD+K +N L++ D + KV DFGLA+ + ++ + +
Sbjct: 165 LLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221
Query: 310 --------------------GYV------APEYANTGLLNEKS-----DVYS----FGVL 334
G+V APE +L +++ DV+S F L
Sbjct: 222 EDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPEL----ILLQENYTEAIDVWSIGCIFAEL 277
Query: 335 LLEAITGRDPVDHGRP 350
L P
Sbjct: 278 LNMIKENVAYHADRGP 293
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 2e-21
Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 32/217 (14%)
Query: 143 FSKENVLGEGGYGVVYRGNLI-NGSPVAVKKI-------LNNVGQAEKEFRVEVEAIGHV 194
FS ++G GG+G VY G A+K + A E + + +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM-LSLVSTG 249
Query: 195 RHKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK-----VLL 248
+V + Y ++ + + +N G+L L HG + EA M+ ++L
Sbjct: 250 DCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFS-EADMRFYAAEIIL 303
Query: 249 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGT 308
L ++H VV+RD+K +NIL+D+ + ++SD GLA K H V GT
Sbjct: 304 ----GLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GT 353
Query: 309 FGYVAPEYANTGLLNEKS-DVYSFGVLLLEAITGRDP 344
GY+APE G+ + S D +S G +L + + G P
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 4e-21
Identities = 68/277 (24%), Positives = 104/277 (37%), Gaps = 47/277 (16%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVK-----KILN----NVGQAEKEFRVEVEAIGHVRHKN 198
LG G +G V+ + V VK K+L + K E+ + V H N
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL-EIAILSRVEHAN 90
Query: 199 LVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLT-WEARMKVLLGTAKALAY 256
++++L E LV E +G L+ L + H L A + A+ Y
Sbjct: 91 IIKVLDI-FENQGFFQLVMEKHGSG-LD--LFAFIDRHPRLDEPLAS-YIFRQLVSAVGY 145
Query: 257 LHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE- 315
L ++HRDIK NI+I +DF K+ DFG A L GK T GT Y APE
Sbjct: 146 LRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF--CGTIEYCAPEV 200
Query: 316 YANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375
+ +++S GV L + +P + + + + P
Sbjct: 201 LMGNPYRGPELEMWSLGVTLYTLVFEENPFC-----------ELEETVEA-----AIHPP 244
Query: 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
V +L LL P E+R + ++V
Sbjct: 245 Y-LVSKELMSLVSGLL------QPVPERRTTLEKLVT 274
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-21
Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKI----LNNVGQAEKEFRVEVEAIGHVRHKNLVRLL 203
LGEG +G V + VA+K I L + R E+ + +RH ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER-EISYLKLLRHPHIIKL- 74
Query: 204 GY-CIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLT-WEARMKV--LLGTAKALAYLH 258
Y I + +V EY G L ++ +T E R ++ A+ Y H
Sbjct: 75 -YDVITTPTDIVMVIEYAG-GELFDYI----VEKKRMTEDEGRRFFQQIIC---AIEYCH 125
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YA 317
K+VHRD+K N+L+DD+ N K++DFGL+ ++ G T+ G+ Y APE
Sbjct: 126 RH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVIN 180
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGRDPVD 346
+ DV+S G++L + GR P D
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 6e-21
Identities = 66/272 (24%), Positives = 107/272 (39%), Gaps = 33/272 (12%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI 207
+G G +GV + + VAVK I E R E+ +RH N+VR +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR-EIINHRSLRHPNIVRFKEVIL 86
Query: 208 EGIHRMLVYEYVNNGNLEQWL--HGAMRHHGYLTWEARMKV--LLGTAKALAYLHEAIEP 263
H ++ EY + G L + + G EAR LL ++Y H
Sbjct: 87 TPTHLAIIMEYASGGELYERICNAGRFSED-----EARFFFQQLLS---GVSYCHSM--- 135
Query: 264 KVVHRDIKSSNILIDDDF--NAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE-YANTG 320
++ HRD+K N L+D K+ DFG +K S + V GT Y+APE
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTV-GTPAYIAPEVLLRQE 193
Query: 321 LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVR 380
+ +DV+S GV L + G P + + + + S + P+ ++R
Sbjct: 194 YDGKIADVWSCGVTLYVMLVGAYPFE------DPEEPRDYRKTIQRILSVKYSIPD-DIR 246
Query: 381 PSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
S L++ + DP R + ++
Sbjct: 247 ISPEC--CHLISRIFVADP--ATRISIPEIKT 274
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 9e-21
Identities = 54/217 (24%), Positives = 90/217 (41%), Gaps = 32/217 (14%)
Query: 143 FSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEF---RVEVEAIGHVRHKN 198
F +LGEG + V + A+K + E + E + + + H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK-----VLLGTAKA 253
V+L + Y NG L +++ R G E + ++ A
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFD-ETCTRFYTAEIVS----A 142
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVM-GTFGYV 312
L YLH ++HRD+K NIL+++D + +++DFG AK+L GT YV
Sbjct: 143 LEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199
Query: 313 APEYANTGLLNEK-----SDVYSFGVLLLEAITGRDP 344
+PE LL EK SD+++ G ++ + + G P
Sbjct: 200 SPE-----LLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 2e-20
Identities = 59/223 (26%), Positives = 100/223 (44%), Gaps = 43/223 (19%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILN---NVGQAEKEFRVEVEAIGHVR 195
R+ +G G G+V + + VA+KK+ N A++ +R E+ + V
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVN 119
Query: 196 HKNLVRLL-----GYCIEGIHRM-LVYEYVNNGNLEQWLHGAMR------HHGYLTWEAR 243
HKN++ LL +E + LV E ++ L ++ YL ++
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMEL-----MDANLCQVIQMELDHERMSYLLYQ-- 172
Query: 244 MKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTT 303
+L + +LH A ++HRD+K SNI++ D K+ DFGLA+ AG S + T
Sbjct: 173 ---ML---CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMT 221
Query: 304 RVMGTFGYVAPEYANTGLLN----EKSDVYSFGVLLLEAITGR 342
+ T Y APE +L E D++S G ++ E + +
Sbjct: 222 PYVVTRYYRAPEV----ILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 57/239 (23%), Positives = 102/239 (42%), Gaps = 62/239 (25%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHK 197
+R+ LG GG G+V+ + VA+KKI L + + R E++ I + H
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLDHD 68
Query: 198 NLVRLL----------GYCIEGIHRM----LVYEYVNNGNLEQWLHGAMR-------HHG 236
N+V++ + + + +V EY +E L + H
Sbjct: 69 NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-----METDLANVLEQGPLLEEHAR 123
Query: 237 YLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLG 295
++ LL + L Y+H A V+HRD+K +N+ I+ +D K+ DFGLA+++
Sbjct: 124 LFMYQ-----LL---RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172
Query: 296 AGKSH-------VTTRVMGTFGYVAPEYANTGLLNEKS-----DVYSFGVLLLEAITGR 342
SH + T+ Y +P LL+ + D+++ G + E +TG+
Sbjct: 173 PHYSHKGHLSEGLVTK-----WYRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 49/241 (20%), Positives = 100/241 (41%), Gaps = 50/241 (20%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILN---NVGQAEKEFRVEVEAIGHVR 195
+ + ++++G G YG VY + VA+KK+ ++ ++ R E+ + ++
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EITILNRLK 83
Query: 196 HKNLVRLLGYCI-EGIHRM----LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG- 249
++RL I + + + +V E + L + +LT E +K +L
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEI-----ADSDLKKLFKTPIFLT-EEHIKTILYN 137
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
++HE+ ++HRD+K +N L++ D + KV DFGLA+ + + K +
Sbjct: 138 LLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194
Query: 310 ---------------GYV------APEYANTGLLNEKS-----DVYSFGVLLLEAITGRD 343
+V APE +L +++ D++S G + E +
Sbjct: 195 EEPGPHNKNLKKQLTSHVVTRWYRAPEL----ILLQENYTKSIDIWSTGCIFAELLNMLQ 250
Query: 344 P 344
Sbjct: 251 S 251
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 7e-20
Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 33/230 (14%)
Query: 130 WFTLRDLELATNRFSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQAEKEF---R 185
W L + N F + VLG+GG+G V + G A KK+ + K
Sbjct: 173 WKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL 232
Query: 186 VEVEAIGHVRHKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARM 244
E + + V + +V L Y E + LV +N G+L+ ++ EAR
Sbjct: 233 NEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIY---HMGQAGFPEARA 288
Query: 245 K-----VLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299
+ L LH ++V+RD+K NIL+DD + ++SD GLA + G++
Sbjct: 289 VFYAAEICC----GLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 341
Query: 300 HVTTRVMGTFGYVAPEYANTGLLNEKS-----DVYSFGVLLLEAITGRDP 344
+ RV GT GY+APE ++ + D ++ G LL E I G+ P
Sbjct: 342 -IKGRV-GTVGYMAPE-----VVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 8e-20
Identities = 61/230 (26%), Positives = 106/230 (46%), Gaps = 53/230 (23%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILN--NVGQAEKEFRVEVEAIGHVRH 196
R++ + +GEG YG+V + +N VA+KKI + ++ R E++ + RH
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRH 84
Query: 197 KNLVRLLG-YCIEGIHRM----LVYEYVNNGNLEQWLHGAMR-------HHGYLTWEARM 244
+N++ + I +M +V + +E L+ ++ H Y ++
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDL-----METDLYKLLKTQHLSNDHICYFLYQ--- 136
Query: 245 KVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSH---- 300
+L + L Y+H A V+HRD+K SN+L++ + K+ DFGLA++ H
Sbjct: 137 --IL---RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 188
Query: 301 ---VTTRVMGTFGYVAPEYANTGLLNEKS-----DVYSFGVLLLEAITGR 342
V TR Y APE +LN K D++S G +L E ++ R
Sbjct: 189 TEYVATR-----WYRAPEI----MLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 9e-20
Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 49/226 (21%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILN---NVGQAEKEFRVEVEAIGHVR 195
+ +G G YG V + G+ VA+KK+ + A++ +R E+ + H+R
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMR 82
Query: 196 HKNLVRLL-----GYCIEGIHRM-LVYEYVNNGNLEQWLHGAMR-------HHGYLTWEA 242
H+N++ LL ++ LV + + L M+ +L ++
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPF-----MGTDLGKLMKHEKLGEDRIQFLVYQ- 136
Query: 243 RMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS-HV 301
+L K L Y+H A ++HRD+K N+ +++D K+ DFGLA+ + + +V
Sbjct: 137 ----ML---KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV 186
Query: 302 TTRVMGTFGYVAPEYANTGLLNEKS-----DVYSFGVLLLEAITGR 342
TR Y APE +LN D++S G ++ E ITG+
Sbjct: 187 VTRW-----YRAPEV----ILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 58/232 (25%), Positives = 101/232 (43%), Gaps = 50/232 (21%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI--LNNVGQAEKEFRVEVEAIGHVRH 196
++ F +++LGEG YGVV + G VA+KKI + A + R E++ + H +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 197 KNLVRLLG-YCIEGIHRM----LVYEYVNNGNLEQWLHGAMR-------HHGYLTWEARM 244
+N++ + + ++ E ++ LH + H Y ++
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQEL-----MQTDLHRVISTQMLSDDHIQYFIYQ--- 120
Query: 245 KVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR 304
L +A+ LH + V+HRD+K SN+LI+ + + KV DFGLA+++ + +
Sbjct: 121 --TL---RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 305 VMGTF---GYV------APEYANTGLLNEKS-----DVYSFGVLLLEAITGR 342
+V APE +L DV+S G +L E R
Sbjct: 173 TGQQSGMVEFVATRWYRAPEV----MLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 55/236 (23%), Positives = 89/236 (37%), Gaps = 58/236 (24%)
Query: 140 TNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKE--FRVEVEA------- 190
+ ++ + + G YG V G G PVA+K++ N V
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 191 --IGHVRHKNLVRLLG----YCIEGIHRM-LVYEYVNNGNLEQWLHGAMR---------H 234
+ H H N++ L + +H++ LV E + L + H
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTEL-----MRTDLAQVIHDQRIVISPQH 135
Query: 235 HGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294
Y + +L L LHEA VVHRD+ NIL+ D+ + + DF LA+
Sbjct: 136 IQYFMYH-----IL---LGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLARED 184
Query: 295 GAGKS---HVTTRVMGTFGYVAPEYANTGLLNEKS-----DVYSFGVLLLEAITGR 342
A + +VT R Y APE ++ K D++S G ++ E +
Sbjct: 185 TADANKTHYVTHRW-----YRAPEL----VMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 60/226 (26%), Positives = 107/226 (47%), Gaps = 49/226 (21%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILN---NVGQAEKEFRVEVEAIGHVR 195
R+ + +G G YG V + G VAVKK+ ++ A++ +R E+ + H++
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK 86
Query: 196 HKNLVRLL-----GYCIEGIHRM-LVYEYVNNGNLEQWLHGAMR-------HHGYLTWEA 242
H+N++ LL +E + + LV + L+ ++ H +L ++
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHL-----MGADLNNIVKCQKLTDDHVQFLIYQ- 140
Query: 243 RMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS-HV 301
+L + L Y+H A ++HRD+K SN+ +++D K+ DFGLA+ + +V
Sbjct: 141 ----IL---RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV 190
Query: 302 TTRVMGTFGYVAPEYANTGLLNEKS-----DVYSFGVLLLEAITGR 342
TR Y APE +LN D++S G ++ E +TGR
Sbjct: 191 ATRW-----YRAPEI----MLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 65/247 (26%), Positives = 107/247 (43%), Gaps = 70/247 (28%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILN---NVGQAEKEFRVEVEAIGHVR 195
++ LG+G YG+V++ + G VAVKKI + N A++ FR E+ + +
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELS 66
Query: 196 -HKNLVRLLGYCIEGIHRM-------LVYEYVNNGNLEQWLHGAMR-------HHGYLTW 240
H+N+V LL + R LV++Y +E LH +R H Y+ +
Sbjct: 67 GHENIVNLLN-----VLRADNDRDVYLVFDY-----METDLHAVIRANILEPVHKQYVVY 116
Query: 241 EARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSH 300
+ L+ K + YLH ++HRD+K SNIL++ + + KV+DFGL++ +
Sbjct: 117 Q-----LI---KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165
Query: 301 VTTRVMGTF--------------GYV------APEYANTGLLNEKS-----DVYSFGVLL 335
+ YV APE LL D++S G +L
Sbjct: 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEI----LLGSTKYTKGIDMWSLGCIL 221
Query: 336 LEAITGR 342
E + G+
Sbjct: 222 GEILCGK 228
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 52/218 (23%), Positives = 93/218 (42%), Gaps = 44/218 (20%)
Query: 148 VLGEGGYGVVYRGNLI----NGSPVAVKKILNNVGQAEKEFR---VEVEAIGHVRHKNLV 200
+G+G +G V ++ A+K + E R E++ + + H LV
Sbjct: 22 AIGKGSFGKVC---IVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLV 78
Query: 201 RLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK-----VLLGTAKAL 254
L Y + M +V + + G+L L + + + E +K +++ AL
Sbjct: 79 NLW-YSFQDEEDMFMVVDLLLGGDLRYHL----QQNVHFK-EETVKLFICELVM----AL 128
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
YL +++HRD+K NIL+D+ + ++DF +A +L T + GT Y+AP
Sbjct: 129 DYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAP 183
Query: 315 EYANTGLLNEKS--------DVYSFGVLLLEAITGRDP 344
E + + + D +S GV E + GR P
Sbjct: 184 E-----MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 61/234 (26%), Positives = 98/234 (41%), Gaps = 54/234 (23%)
Query: 131 FTLRDLELATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEFRVEVE 189
L + LG G +G V +G+ A+K IL+ K+ V+++
Sbjct: 38 AQLDQFDRIK-------TLGTGSFGRVMLVKHKESGNHYAMK-ILD------KQKVVKLK 83
Query: 190 AIGH----------VRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLT 239
I H V LV+L + + +V EYV G E + H +R G +
Sbjct: 84 QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG--EMFSH--LRRIGRFS 139
Query: 240 WEARMK-----VLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294
E + ++L YLH +++RD+K N+LID +V+DFG AK +
Sbjct: 140 -EPHARFYAAQIVL----TFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 295 GAGKSHVTTRVMGTFGYVAPEYANTGLLNE---KS-DVYSFGVLLLEAITGRDP 344
T + GT +APE +L++ K+ D ++ GVL+ E G P
Sbjct: 192 K----GRTWTLCGTPEALAPEI----ILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 51/229 (22%), Positives = 90/229 (39%), Gaps = 29/229 (12%)
Query: 133 LRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPV-AVKKILNNVGQAEKE---FRVEV 188
L+++ L + F V+G G + V + V A+K + E FR E
Sbjct: 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREER 112
Query: 189 EAIGHVRHKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK-- 245
+ + + + + +L + + + + LV EY G+L L G +
Sbjct: 113 DVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLL----SKFGERIPAEMARFY 167
Query: 246 ---VLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVT 302
+++ A+ +H VHRDIK NIL+D + +++DFG L A + +
Sbjct: 168 LAEIVM----AIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS 220
Query: 303 TRVMGTFGYVAPEYANTGLLNEKSDVY-------SFGVLLLEAITGRDP 344
+GT Y++PE + Y + GV E G+ P
Sbjct: 221 LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 9e-16
Identities = 62/212 (29%), Positives = 91/212 (42%), Gaps = 34/212 (16%)
Query: 148 VLGEGGYGVVYRGNLINGSPV-AVKKILNNVGQAEKEF---RVEVEAIGHVRHKNLVRLL 203
+LG+G +G V A+K + V A+ E E + + RH L L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 204 GYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK-----VLLGTAKALAYL 257
Y + R+ V EY N G L + H + T E R + ++ AL YL
Sbjct: 72 -YAFQTHDRLCFVMEYANGGEL--FFH--LSRERVFT-EERARFYGAEIVS----ALEYL 121
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
H VV+RDIK N+++D D + K++DFGL K G GT Y+APE
Sbjct: 122 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPE-- 175
Query: 318 NTGLLNEKS-----DVYSFGVLLLEAITGRDP 344
+L + D + GV++ E + GR P
Sbjct: 176 ---VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 9e-16
Identities = 53/230 (23%), Positives = 95/230 (41%), Gaps = 33/230 (14%)
Query: 133 LRDLELATNRFSKENVLGEGGYGVVYRGNLI----NGSPVAVKKILNNVGQAEKE---FR 185
++ + L F V+G G +G V ++ A+K + E FR
Sbjct: 66 VKQMRLHREDFEILKVIGRGAFGEVA---VVKLKNADKVFAMKILNKWEMLKRAETACFR 122
Query: 186 VEVEAIGHVRHKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARM 244
E + + + K + L Y + + + LV +Y G+L L + L E
Sbjct: 123 EERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLL---SKFEDRLP-EEMA 177
Query: 245 K-----VLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299
+ +++ A+ +H+ VHRDIK NIL+D + + +++DFG L +
Sbjct: 178 RFYLAEMVI----AIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230
Query: 300 HVTTRVMGTFGYVAPE-----YANTGLLNEKSDVYSFGVLLLEAITGRDP 344
++ +GT Y++PE G + D +S GV + E + G P
Sbjct: 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 62/212 (29%), Positives = 87/212 (41%), Gaps = 33/212 (15%)
Query: 148 VLGEGGYGVVYRGNLINGSPVAVKKIL--------NNVGQAEKEFRVEVEAIGHVRHKNL 199
+LG+G +G V KIL + V E RV + + RH L
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRV----LQNSRHPFL 210
Query: 200 VRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG-TAKALAYL 257
L Y + R+ V EY N G L L + E R + AL YL
Sbjct: 211 TALK-YSFQTHDRLCFVMEYANGGELFFHLS----RERVFS-EDRARFYGAEIVSALDYL 264
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
H E VV+RD+K N+++D D + K++DFGL K G GT Y+APE
Sbjct: 265 HS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPE-- 319
Query: 318 NTGLLNEKS-----DVYSFGVLLLEAITGRDP 344
+L + D + GV++ E + GR P
Sbjct: 320 ---VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 3e-15
Identities = 58/220 (26%), Positives = 93/220 (42%), Gaps = 46/220 (20%)
Query: 148 VLGEGGYGVVY----RGNLINGSPVAVK-----KILNNVGQAE---KEFRVEVEAIGHVR 195
VLG+GGYG V+ G A+K I+ N E + + V+
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI----LEEVK 79
Query: 196 HKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK-----VLLG 249
H +V L+ Y + ++ L+ EY++ G L L G E + +
Sbjct: 80 HPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLE----REGIFM-EDTACFYLAEISM- 132
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
AL +LH+ +++RD+K NI+++ + K++DFGL K VT GT
Sbjct: 133 ---ALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCGTI 185
Query: 310 GYVAPEYANTGLLNEKS-----DVYSFGVLLLEAITGRDP 344
Y+APE +L D +S G L+ + +TG P
Sbjct: 186 EYMAPE-----ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 53/224 (23%), Positives = 94/224 (41%), Gaps = 24/224 (10%)
Query: 133 LRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNN---VGQAEKE-FRVEV 188
+RDL + + V+G G +G V + V K+L+ + +++ F E
Sbjct: 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 120
Query: 189 EAIGHVRHKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEAR---M 244
+ + +V+L Y + + +V EY+ G+L + ++ AR
Sbjct: 121 DIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM----SNYDVPEKWARFYTA 175
Query: 245 KVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR 304
+V+L AL +H +HRD+K N+L+D + K++DFG +
Sbjct: 176 EVVL----ALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 228
Query: 305 VMGTFGYVAPE----YANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+GT Y++PE G + D +S GV L E + G P
Sbjct: 229 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 6e-15
Identities = 45/204 (22%), Positives = 76/204 (37%), Gaps = 56/204 (27%)
Query: 148 VLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV-RHKNLVRLLGY 205
VLG G G V + N A+K + + + R EVE + ++VR++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 79
Query: 206 CIEGIHRM----LVYEYVNNGNL-----EQWLHGAMRHHGYLTWEAR--MKVLLGTAKAL 254
+V E ++ G L ++ + EA MK + +A+
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQDR------GDQAFTEREASEIMKSIG---EAI 130
Query: 255 AYLHEAIEPKVVHRDIKSSNILI---DDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGY 311
YLH + HRD+K N+L + K++DFG AK T Y
Sbjct: 131 QYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-------ETTGE-----KY 175
Query: 312 VAPEYANTGLLNEKSDVYSFGVLL 335
++ D++S GV++
Sbjct: 176 -----------DKSCDMWSLGVIM 188
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 9e-15
Identities = 57/216 (26%), Positives = 91/216 (42%), Gaps = 41/216 (18%)
Query: 148 VLGEGGYGVVYRGNLINGSPV-AVK-----KILNN--VGQAEKEFRVEVEAIGHVRHKNL 199
V+G+G +G V AVK IL E V ++ V+H L
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKN---VKHPFL 101
Query: 200 VRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK-----VLLGTAKA 253
V L + + ++ V +Y+N G L + H ++ E R + + A
Sbjct: 102 VGLH-FSFQTADKLYFVLDYINGGEL--FYH--LQRERCFL-EPRARFYAAEIAS----A 151
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L YLH +V+RD+K NIL+D + ++DFGL K + T+ GT Y+A
Sbjct: 152 LGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPEYLA 207
Query: 314 PEYANTGLLNEKS-----DVYSFGVLLLEAITGRDP 344
PE +L+++ D + G +L E + G P
Sbjct: 208 PE-----VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 9e-15
Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 44/221 (19%)
Query: 148 VLGEGGYGVVY----RGNLINGSPVAVK-----KILNNVGQAE---KEFRVEVEAIGHVR 195
VLG G YG V+ G A+K I+ E E +V +E I
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV-LEHIRQ-- 117
Query: 196 HKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK-----VLLG 249
LV L Y + ++ L+ +Y+N G L + H + T E ++ ++L
Sbjct: 118 SPFLVTLH-YAFQTETKLHLILDYINGGEL--FTH--LSQRERFT-EHEVQIYVGEIVL- 170
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
AL +LH+ +++RDIK NIL+D + + ++DFGL+K A ++ GT
Sbjct: 171 ---ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 224
Query: 310 GYVAPEYANTGLLNEKS------DVYSFGVLLLEAITGRDP 344
Y+AP+ + S D +S GVL+ E +TG P
Sbjct: 225 EYMAPDI----VRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 58/281 (20%), Positives = 91/281 (32%), Gaps = 76/281 (27%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLIN------GSPVAVKKILNNVGQAE-KEFRVE-- 187
E +R LG G +G V + VAVK + +E + E
Sbjct: 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 77
Query: 188 -----------VEAIGHV--------------RHKNLVRLL--------GYCIEGIHRML 214
V +G + NL L Y +G
Sbjct: 78 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQ 137
Query: 215 VYEYVNN-----------------------------GNLEQWLHGAMRHHGYLTWEARMK 245
+YV ++E+ + +LT E +
Sbjct: 138 GKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLIC 197
Query: 246 VLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV-TTR 304
AK + +L K +HRD+ + NIL+ + K+ DFGLA+ + +V
Sbjct: 198 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 254
Query: 305 VMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344
++APE + +SDV+SFGVLL E + G P
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 65/305 (21%), Positives = 106/305 (34%), Gaps = 40/305 (13%)
Query: 55 LPFSQIPTVSKEIKEVRVEQVSTNEFVQRDDKDGGSISGEDSGSVTVYKPSSSHPITAPS 114
S++ + + Q F +G + E K
Sbjct: 262 FGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEK 321
Query: 115 PLIGLPEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKIL 174
+ +F G L D VLG+G +G V + KIL
Sbjct: 322 TANTISKFDNNGNRDRMKLTDFNFLM-------VLGKGSFGKVMLSERKGTDELYAVKIL 374
Query: 175 --------NNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRM-LVYEYVNNGNLE 225
++V E RV + L +L C + + R+ V EYVN G+L
Sbjct: 375 KKDVVIQDDDVECTMVEKRVLALP---GKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLM 430
Query: 226 QWLHGAMRHHGYLTWEARMKVLLG-TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAK 284
+ G E A L +L +++RD+K N+++D + + K
Sbjct: 431 YHIQ----QVGRFK-EPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIK 482
Query: 285 VSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKS-----DVYSFGVLLLEAI 339
++DFG+ K T GT Y+APE ++ + D ++FGVLL E +
Sbjct: 483 IADFGMCK-ENIWDGVTTKTFCGTPDYIAPE-----IIAYQPYGKSVDWWAFGVLLYEML 536
Query: 340 TGRDP 344
G+ P
Sbjct: 537 AGQAP 541
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 1e-14
Identities = 65/238 (27%), Positives = 104/238 (43%), Gaps = 62/238 (26%)
Query: 131 FTLRDLELATNRFSKENVLGEGGYGVVYRGNLI----NGSPVAVKKILNNVGQAEKEFRV 186
++L+D ++ LG G +G V+ LI NG A+K +L KE V
Sbjct: 3 YSLQDFQI-------LRTLGTGSFGRVH---LIRSRHNGRYYAMK-VLK------KEIVV 45
Query: 187 EVEAIGH----------VRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHG 236
++ + H V H ++R+ G + ++ +Y+ G L L R
Sbjct: 46 RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL----RKSQ 101
Query: 237 YLTWEARMK-----VLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA 291
K V L AL YLH +++RD+K NIL+D + + K++DFG A
Sbjct: 102 RFP-NPVAKFYAAEVCL----ALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFA 153
Query: 292 KLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKS-----DVYSFGVLLLEAITGRDP 344
K + VT + GT Y+APE +++ K D +SFG+L+ E + G P
Sbjct: 154 KYVP----DVTYTLCGTPDYIAPE-----VVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 36/214 (16%)
Query: 148 VLGEGGYGVVY----RGNLINGSPVAVKKILNNVGQAEKEFRVEVE--AIGHVRHKNLVR 201
VLG+G +G V+ A+K + + R ++E + V H +V+
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 202 LLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK-----VLLGTAKALA 255
L Y + ++ L+ +++ G+L + + T E +K + L AL
Sbjct: 91 LH-YAFQTEGKLYLILDFLRGGDL--FTR--LSKEVMFT-EEDVKFYLAELAL----ALD 140
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE 315
+LH +++RD+K NIL+D++ + K++DFGL+K GT Y+APE
Sbjct: 141 HLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPE 196
Query: 316 YANTGLLNEKS-----DVYSFGVLLLEAITGRDP 344
++N + D +SFGVL+ E +TG P
Sbjct: 197 -----VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 4e-14
Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 41/216 (18%)
Query: 148 VLGEGGYGVVYRGNLINGSPV-AVK-----KILNN--VGQAEKEFRVEVEAIGHVRHKNL 199
V+G G Y V L + A+K + ++ + + E V +A H L
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA---SNHPFL 72
Query: 200 VRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK-----VLLGTAKA 253
V L C + R+ V EYVN G+L H M+ L E + + L A
Sbjct: 73 VGLH-SCFQTESRLFFVIEYVNGGDL--MFH--MQRQRKLP-EEHARFYSAEISL----A 122
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L YLHE +++RD+K N+L+D + + K++D+G+ K G T+ GT Y+A
Sbjct: 123 LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIA 178
Query: 314 PEYANTGLLNEKS-----DVYSFGVLLLEAITGRDP 344
PE +L + D ++ GVL+ E + GR P
Sbjct: 179 PE-----ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 7e-14
Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 41/216 (18%)
Query: 148 VLGEGGYGVVYRGNLINGSPV----AVKK--ILNN--VGQAEKEFRVEVEAIGHVRHKNL 199
V+G G Y V L + VKK + ++ + + E V +A H L
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA---SNHPFL 115
Query: 200 VRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK-----VLLGTAKA 253
V L C + R+ V EYVN G+L H M+ L E + + L A
Sbjct: 116 VGLH-SCFQTESRLFFVIEYVNGGDL--MFH--MQRQRKLP-EEHARFYSAEISL----A 165
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L YLHE +++RD+K N+L+D + + K++D+G+ K G T+ GT Y+A
Sbjct: 166 LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIA 221
Query: 314 PEYANTGLLNEKS-----DVYSFGVLLLEAITGRDP 344
PE +L + D ++ GVL+ E + GR P
Sbjct: 222 PE-----ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 7e-14
Identities = 54/220 (24%), Positives = 87/220 (39%), Gaps = 49/220 (22%)
Query: 148 VLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEFRVEVEAIGH-----------VR 195
+LG+G +G V+ A+K L K+ + + +
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIK-ALK------KDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 196 HKNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK-----VLLG 249
H L + + + V EY+N G+L + +R ++L
Sbjct: 77 HPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFD-LSRATFYAAEIIL- 129
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
L +LH +V+RD+K NIL+D D + K++DFG+ K T GT
Sbjct: 130 ---GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKTNTFCGTP 182
Query: 310 GYVAPEYANTGLLNEKS-----DVYSFGVLLLEAITGRDP 344
Y+APE +L + D +SFGVLL E + G+ P
Sbjct: 183 DYIAPE-----ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 9e-14
Identities = 54/216 (25%), Positives = 90/216 (41%), Gaps = 41/216 (18%)
Query: 148 VLGEGGYGVVYRGNLINGSPV-AVK-----KILNN--VGQAEKEFRVEVEAIGHVRHKNL 199
VLG+G +G V + AVK ++ + V E RV + L
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP---GKPPFL 83
Query: 200 VRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK-----VLLGTAKA 253
+L C + + R+ V EYVN G+L + G E + +
Sbjct: 84 TQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ----QVGRFK-EPHAVFYAAEIAI----G 133
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L +L +++RD+K N+++D + + K++DFG+ K T GT Y+A
Sbjct: 134 LFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDYIA 189
Query: 314 PEYANTGLLNEKS-----DVYSFGVLLLEAITGRDP 344
PE ++ + D ++FGVLL E + G+ P
Sbjct: 190 PE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 41/216 (18%)
Query: 148 VLGEGGYGVVYRGNLINGSPV-AVK-----KILNN--VGQAEKEFRVEVEAIGHVRHKNL 199
VLG+G +G V + + AVK IL + V E R+ A H L
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA---RNHPFL 86
Query: 200 VRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK-----VLLGTAKA 253
+L C + R+ V E+VN G+L H ++ EAR + ++ A
Sbjct: 87 TQLF-CCFQTPDRLFFVMEFVNGGDL--MFH--IQKSRRFD-EARARFYAAEIIS----A 136
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L +LH+ +++RD+K N+L+D + + K++DFG+ K G T GT Y+A
Sbjct: 137 LMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTPDYIA 192
Query: 314 PEYANTGLLNEKS-----DVYSFGVLLLEAITGRDP 344
PE +L E D ++ GVLL E + G P
Sbjct: 193 PE-----ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.9 bits (170), Expect = 2e-13
Identities = 32/216 (14%), Positives = 60/216 (27%), Gaps = 57/216 (26%)
Query: 138 LATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKIL--------NNVGQAEKEFRVEVE 189
L T + + +GEG +G V++ + +PVA+K I + + +E E+
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 190 ---------AIGHVRHKNLVRLLGYCI------------------------------EGI 210
R + + L +
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 211 HRMLVYEYVNNGN-LEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRD 269
+V E+ G LEQ + +L +LA + HRD
Sbjct: 136 QLFIVLEFEFGGIDLEQM------RTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRD 187
Query: 270 IKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRV 305
+ N+L+ K+ K + +
Sbjct: 188 LHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSI 223
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 52/312 (16%), Positives = 112/312 (35%), Gaps = 64/312 (20%)
Query: 138 LATNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNN---VGQAEKEFRV------- 186
R+ LG G + V+ +++N + VA+K + + AE E ++
Sbjct: 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDA 75
Query: 187 EVEAIGHVRHKNLVRLLGY----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEA 242
+ + ++++LL + G+H ++V+E V NL + H +
Sbjct: 76 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIK--KYEHRGIPLIY 132
Query: 243 RMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD------DFNAKVSDFGLAKLLGA 296
++ L Y+H ++H DIK N+L++ K++D G A
Sbjct: 133 VKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW--- 187
Query: 297 GKSHVTTRVMGTFGYVAPE------YANTGLLNEKSDVYSFGVLLLEAITGR---DPVDH 347
H T + Y +PE + +D++S L+ E ITG +P +
Sbjct: 188 YDEHYTNSIQTRE-YRSPEVLLGAPW------GCGADIWSTACLIFELITGDFLFEPDEG 240
Query: 348 GRPAHEVNLVDWLKMMVG------------SRRSEEVVDPNIEVRPSTRA----LKRSLL 391
+ D + ++ + + + +R ++ L+ L
Sbjct: 241 HSYTKD---DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT 297
Query: 392 TALRCVDPDSEK 403
+ ++++
Sbjct: 298 EKYKFSKDEAKE 309
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 51/223 (22%), Positives = 96/223 (43%), Gaps = 34/223 (15%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR 195
E +R+ ++++G+G +G V + + + VA+K I+ N + ++EV + +
Sbjct: 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK-IIKNKKAFLNQAQIEVRLLELMN 108
Query: 196 H------KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY--LTWEARMKVL 247
+V L + + H LV+E L L+ +R+ + ++ K
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNFRGVSLNLTRKFA 163
Query: 248 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNA--KVSDFGLAKLLGAGKSHVTTRV 305
AL +L E ++H D+K NIL+ + + K+ DFG + LG + +
Sbjct: 164 QQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG---QRIYQYI 219
Query: 306 MGTFGYVAPE------YANTGLLNEKSDVYSFGVLLLEAITGR 342
F Y +PE Y + D++S G +L+E TG
Sbjct: 220 QSRF-YRSPEVLLGMPY------DLAIDMWSLGCILVEMHTGE 255
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 67/325 (20%), Positives = 120/325 (36%), Gaps = 56/325 (17%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHK- 197
R+ V+G+G +G V + + VA+K ++ N + ++ E+ + H+R +
Sbjct: 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALK-MVRNEKRFHRQAAEEIRILEHLRKQD 154
Query: 198 -----NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY--LTWEARMKVLLGT 250
N++ +L H + +E L L+ ++ + + + K
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFE-----LLSMNLYELIKKNKFQGFSLPLVRKFAHSI 209
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNA--KVSDFGLAKLLGAGKSHVTTRVMGT 308
+ L LH+ +++H D+K NIL+ + KV DFG + V T +
Sbjct: 210 LQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH---QRVYTYIQSR 263
Query: 309 FGYVAPE------YANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKM 362
F Y APE Y D++S G +L E +TG P+ G + D L
Sbjct: 264 F-YRAPEVILGARY------GMPIDMWSLGCILAELLTGY-PLLPGE-----DEGDQLAC 310
Query: 363 MVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIV 422
M E++ PS + L S S+ P+ V + +
Sbjct: 311 M------IELLGM-----PSQKLLDASKRAKNFV---SSKGYPRYCTVTTLSDGSVVLNG 356
Query: 423 REDRRHRRTQGGTSMEIESQKENSD 447
RR + S E + + D
Sbjct: 357 GRSRRGKLRGPPESREWGNALKGCD 381
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 8e-10
Identities = 37/168 (22%), Positives = 61/168 (36%), Gaps = 34/168 (20%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVK--KILNNVGQAEKEFRVEVEAIGHVRHK 197
F +G G +G + G NL VA+K + + Q E+R +
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGD--- 65
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNG-NLEQWLHGAMRHHGYLTWEAR---MKVLLGTAK- 252
+ ++ + G + +V E + G +LE R +K +L A
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELL--GPSLED----------LFDLCDRTFSLKTVLMIAIQ 113
Query: 253 ---ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVS-----DFGLAK 292
+ Y+H +++RD+K N LI N DF LAK
Sbjct: 114 LISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 59/231 (25%), Positives = 93/231 (40%), Gaps = 50/231 (21%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVK--KILNNVGQAEKEFRVEVEAIGHVRHK 197
+ +GEG +GV++ G NL+N VA+K ++ Q E+R G
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCT--- 66
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNG-NLEQWLHGAMRHHGYLTWEAR---MKVLLGTAK- 252
+ + + EG+H +LV + + G +LE L R +K + AK
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLL--GPSLED----------LLDLCGRKFSVKTVAMAAKQ 114
Query: 253 ---ALAYLHEAIEPKVVHRDIKSSNILIDDDFNAK-----VSDFGLAK--LLGAGKSHVT 302
+ +HE +V+RDIK N LI + V DFG+ K K H+
Sbjct: 115 MLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP 171
Query: 303 TR----VMGTFGYVAPEYA--NTGLLNEKS---DVYSFGVLLLEAITGRDP 344
R + GT Y NT L E+S D+ + G + + + G P
Sbjct: 172 YREKKNLSGT-----ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 7e-08
Identities = 34/178 (19%), Positives = 56/178 (31%), Gaps = 37/178 (20%)
Query: 149 LGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAIGHVRHKNLVRLLG 204
+G GG+G++Y A + G E + K +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 205 YCIEGI---------------HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
GI +R +V E L L +G +L
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMER-----LGIDLQKISGQNGTFK----KSTVLQ 155
Query: 250 TA----KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKV--SDFGLAKLLGAGKSHV 301
L Y+HE + VH DIK++N+L+ +V +D+GL+ +H
Sbjct: 156 LGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 56/226 (24%), Positives = 90/226 (39%), Gaps = 42/226 (18%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVK--KILNNVGQAEKEFRVEVEAIGHVRHK 197
NR+ +G G +G +Y G ++ G VA+K + Q E ++ + +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI-YKMMQGGVG- 66
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNG-NLEQWLHGAMRHHGYLTWEAR---MKVLLGTAKA 253
+ + EG + ++V E + G +LE + +R +K +L A
Sbjct: 67 -IPTIRWCGAEGDYNVMVMELL--GPSLED----------LFNFCSRKFSLKTVLLLADQ 113
Query: 254 LAYLHEAIEPK-VVHRDIKSSNILIDDDFNAK---VSDFGLAK--LLGAGKSHVTTR--- 304
+ E I K +HRD+K N L+ + DFGLAK H+ R
Sbjct: 114 MISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 173
Query: 305 -VMGTFGYVAPEYA--NTGLLNEKS---DVYSFGVLLLEAITGRDP 344
+ GT YA NT L E+S D+ S G +L+ G P
Sbjct: 174 NLTGT-----ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 59/353 (16%), Positives = 114/353 (32%), Gaps = 88/353 (24%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVG----QAEKEFRVEVEAI--- 191
R+ LG G + V+ ++ VA+K ++ + A E R+ +++
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLL-KSVRNS 93
Query: 192 --GHVRHKNLVRLLGY----CIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMK 245
+ +V+LL + G H +V+E V +L +W+ ++ L K
Sbjct: 94 DPNDPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWII--KSNYQGLPLPCVKK 150
Query: 246 VLLGTAKALAYLHEAIEPKVVHRDIKSSNILI---------------------------- 277
++ + L YLH + +++H DIK NIL+
Sbjct: 151 IIQQVLQGLDYLHT--KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 278 ---------------------DDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEY 316
+ K++D G A H T + T Y + E
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW---VHKHFTEDIQ-TRQYRSLEV 264
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMV------------ 364
N +D++S + E TG + D + +++
Sbjct: 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV 324
Query: 365 GSRRSEEVVDPNIEVRPSTRALKRSLLTAL--RCVDPDSEKRPKMSQVVRMLE 415
+ S+E +++ T+ L L + E ++ MLE
Sbjct: 325 AGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLE 377
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 7e-07
Identities = 37/184 (20%), Positives = 70/184 (38%), Gaps = 46/184 (25%)
Query: 149 LGEGGYGVVYRG------NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRL 202
+G+GG+G +Y ++ + +P VK ++ G E + A + + +R
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 203 LGYCIEGI---------------HRMLVYEYVNNG-NLEQWLHGAMRHHGYLTWEAR--- 243
G+ +R ++ + G +L++ A+
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQK----------IYEANAKRFS 150
Query: 244 MKVLLGTA----KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKV--SDFGLAKLLGAG 297
K +L + L Y+HE + VH DIK+SN+L++ +V D+GLA
Sbjct: 151 RKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPE 207
Query: 298 KSHV 301
H
Sbjct: 208 GVHK 211
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 9e-07
Identities = 28/193 (14%), Positives = 62/193 (32%), Gaps = 48/193 (24%)
Query: 141 NRFSKENVLGEGGYGVVYRG---------NLINGSPVAVKKILNNVGQAEKEFRVEVEAI 191
++ ++ G++Y + ++K + G+ E A
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 192 GHVRHKNLVRLLGYCIEGI------------HRMLVYEYVNNG-NLEQWLHGAMRHHGYL 238
++ +L + I +R LV + G +L+ L
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQS----------AL 148
Query: 239 TWEARMKVLLGTAKALA--------YLHEAIEPKVVHRDIKSSNILIDDDFNAKV--SDF 288
+ + + +A +LHE + VH ++ + NI +D + ++V + +
Sbjct: 149 DVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGY 205
Query: 289 GLAKLLGAGKSHV 301
G A HV
Sbjct: 206 GFAFRYCPSGKHV 218
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 56/225 (24%), Positives = 91/225 (40%), Gaps = 40/225 (17%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVK--KILNNVGQAEKEFRVEVEAIGHVRHK 197
N+F +G G +G +Y G N+ VA+K + Q E ++ G
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGT--- 63
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAK----A 253
+ + + +EG + +LV + + +LE + R +K +L A
Sbjct: 64 GIPNVRWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRK-------LSLKTVLMLADQMINR 115
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAK---VSDFGLAKLL--GAGKSHVTTR---- 304
+ ++H +HRDIK N L+ A + DFGLAK + H+ R
Sbjct: 116 VEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172
Query: 305 VMGTFGYVAPEYA--NTGLLNEKS---DVYSFGVLLLEAITGRDP 344
+ GT YA NT L E+S D+ S G +L+ + G P
Sbjct: 173 LTGT-----ARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 66/347 (19%), Positives = 112/347 (32%), Gaps = 88/347 (25%)
Query: 128 GHWFTLRDLELATNRFSKENVLGEGGYGVVYRG--NLINGSPVAVKKILNNVGQAEKEFR 185
GH R + R+ LGEG +G V + S VA+K I N ++R
Sbjct: 7 GH-LVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-----GKYR 60
Query: 186 ----VEVEAIGHVRHK------NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHH 235
+E+ + ++ K V + + H + +E L + ++ +
Sbjct: 61 EAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFE-----LLGKNTFEFLKEN 115
Query: 236 GY--LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNA---------- 283
+ + AL +LHE ++ H D+K NIL +
Sbjct: 116 NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCE 172
Query: 284 ---------KVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL----NEKSDVYS 330
+V+DFG A H TT V Y PE +L + DV+S
Sbjct: 173 EKSVKNTSIRVADFGSATFDH---EHHTTIVATRH-YRPPE----VILELGWAQPCDVWS 224
Query: 331 FGVLLLEAITG------RDPVDH--------GRPAHEV------------NLVDWLKMMV 364
G +L E G + +H G + + W +
Sbjct: 225 IGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSS 284
Query: 365 GSRRSEEVVDPNIEVRPSTRALKRSLLTAL--RCVDPDSEKRPKMSQ 409
R +E P L+ L L R ++ D +R +++
Sbjct: 285 DGRYVKENCKPLKSYMLQDS-LEHVQLFDLMRRMLEFDPAQRITLAE 330
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 57/260 (21%), Positives = 93/260 (35%), Gaps = 73/260 (28%)
Query: 128 GHWFTLRDLELATNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFR- 185
H F+ + L N F +G+G +G V ++ N AVK + N K++
Sbjct: 23 VH-FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-----KKYTR 76
Query: 186 ---VEVEAIGHVRH-----KNLVRLLGY-------CIEGIHRMLVYEYVNNGNLEQWLHG 230
+E + + +++ N+V+ G C+ ++E L L+
Sbjct: 77 SAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCL-------IFE-----PLGPSLYE 124
Query: 231 AMRHHGY--LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDF 288
+ + Y E + KAL YL + + H D+K NIL+DD + K
Sbjct: 125 IITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLIT 181
Query: 289 GLAKLLGAGKSHVTTRVMGT----FG-----------------YVAPE------YANTGL 321
G T+ G FG Y APE +
Sbjct: 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGW----- 236
Query: 322 LNEKSDVYSFGVLLLEAITG 341
+ SD++SFG +L E TG
Sbjct: 237 -DVSSDMWSFGCVLAELYTG 255
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 68/357 (19%), Positives = 122/357 (34%), Gaps = 108/357 (30%)
Query: 128 GHWFTLRDLELATNRFSKENVLGEGGYGVVYRG--NLINGSPVAVKKILNNVGQAEKEFR 185
H + ++ + R+ + LGEG +G V + G VAVK + N +
Sbjct: 2 MH-LICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-----DRYC 55
Query: 186 ----VEVEAIGHVRHK------NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHH 235
E++ + H+ V++L + H +V+E L + ++ +
Sbjct: 56 EAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE-----LLGLSTYDFIKEN 110
Query: 236 GY--LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNA---------- 283
G+ + K+ K++ +LH K+ H D+K NIL
Sbjct: 111 GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRD 167
Query: 284 ---------KVSDFGLAKLLGAGKSHVT---TRVMGTFGYVAPEYANTGLL----NEKSD 327
KV DFG A + H T TR Y APE +L ++ D
Sbjct: 168 ERTLINPDIKVVDFGSATY--DDEHHSTLVSTRH-----YRAPE----VILALGWSQPCD 216
Query: 328 VYSFGVLLLEAITG------RDPVDH--------GRPAHEVNLVDWLKMMVGSRRSEEVV 373
V+S G +L+E G D +H G M+ +R+ +
Sbjct: 217 VWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPK--------HMIQKTRKRKYFH 268
Query: 374 DPNIE----------VRPSTRALKRSLLTA-----------LRCVDPDSEKRPKMSQ 409
++ V + + LK +L+ + ++ D KR + +
Sbjct: 269 HDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE 325
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 2e-04
Identities = 40/274 (14%), Positives = 80/274 (29%), Gaps = 63/274 (22%)
Query: 187 EVEAIGHVRH-KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQ---WLHGAMRHH------G 236
E++ I + + L + + +V ++V L +L ++
Sbjct: 50 EIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEV-LRINYKFLMSPIKTEQRQPSMM 108
Query: 237 YLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296
+ + L + A + + ++ + L++ V G+ G+
Sbjct: 109 TRMYIEQRDRLYNDNQVFAKYNVSRLQPY--LKLRQA--LLELRPAKNVLIDGVL---GS 161
Query: 297 GKSHVTTRVM-----------GTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPV 345
GK+ V V F + N N V LL I DP
Sbjct: 162 GKTWVALDVCLSYKVQCKMDFKIF------WLNLKNCNSPETVLEMLQKLLYQI---DPN 212
Query: 346 DHGRPAHEVN-------LVDWLKMMVGSRRSEE---VVDPNIEVRPSTRALK------RS 389
R H N + L+ ++ S+ E V+ V+ + +A +
Sbjct: 213 WTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLL---NVQ-NAKAWNAFNLSCKI 268
Query: 390 LLT-----ALRCVDPDSEKRPKMSQVVRMLESEE 418
LLT + + + L +E
Sbjct: 269 LLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDE 302
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 463 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.71 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.4 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.08 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.07 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.72 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.58 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.55 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.54 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.38 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.16 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.15 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.09 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.01 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.93 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.72 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.34 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.32 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.25 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.24 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.09 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.93 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.77 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.58 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.55 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 96.39 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.35 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 96.23 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 96.07 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.94 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 95.43 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.07 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 92.74 | |
| 2l8s_A | 54 | Integrin alpha-1; transmembrane region, detergent | 91.86 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 91.39 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 90.05 | |
| 2klu_A | 70 | T-cell surface glycoprotein CD4; cell membrane, di | 89.85 | |
| 1iij_A | 35 | ERBB-2 receptor protein-tyrosine kinase; alpha-hel | 88.5 | |
| 2knc_A | 54 | Integrin alpha-IIB; transmembrane signaling, prote | 81.86 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 80.21 | |
| 2l6w_A | 39 | Beta-type platelet-derived growth factor receptor; | 81.15 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-58 Score=439.02 Aligned_cols=260 Identities=24% Similarity=0.420 Sum_probs=211.9
Q ss_pred HhcCCCccCeEeecCcEEEEEEEEc------CCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEE
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHR 212 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 212 (463)
..++|.+.+.||+|+||+||+|++. ++..||||++........++|.+|++++++++|||||+++|+|.+++..
T Consensus 11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 3567889999999999999999764 4678999999776666778899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhh---------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCE
Q 012462 213 MLVYEYVNNGNLEQWLHGAM---------RHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNA 283 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~ 283 (463)
|||||||++|+|.++|+... .....+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcE
Confidence 99999999999999997532 2245699999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCce-eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHH
Q 012462 284 KVSDFGLAKLLGAGKSH-VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLK 361 (463)
Q Consensus 284 kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~ 361 (463)
||+|||+|+........ .....+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+... .+.+.
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~------~~~~~ 241 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN------NEVIE 241 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH------HHHHH
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH------HHHHH
Confidence 99999999876544332 2334568999999999999999999999999999999999 8999986432 22222
Q ss_pred HHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 362 MMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.......... +.. ....+..++.+||+.||++||||+||++.|+++
T Consensus 242 ~i~~~~~~~~--------p~~--~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 242 CITQGRVLQR--------PRT--CPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp HHHHTCCCCC--------CTT--CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHcCCCCCC--------Ccc--chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 3332222111 111 112344566789999999999999999999874
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-57 Score=438.72 Aligned_cols=259 Identities=25% Similarity=0.419 Sum_probs=205.2
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc------CCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRM 213 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 213 (463)
.++|.+.++||+|+||+||+|++. ++..||||++........++|.+|++++++++|||||+++|+|.+.+..|
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 456888899999999999999764 46789999997766666788999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhhc-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCC
Q 012462 214 LVYEYVNNGNLEQWLHGAMR-----------HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFN 282 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~ 282 (463)
||||||++|+|.++++.... ...++++..++.++.||+.||+|||++ +|+||||||+||||++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCc
Confidence 99999999999999975321 234699999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCc-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHH
Q 012462 283 AKVSDFGLAKLLGAGKS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWL 360 (463)
Q Consensus 283 ~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~ 360 (463)
+||+|||+++....... ...+..+||+.|||||++.+..|+.++|||||||+||||+| |+.||..... .+.+
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~------~~~~ 270 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN------TEAI 270 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH------HHHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH------HHHH
Confidence 99999999987654332 23345689999999999999999999999999999999999 8999976432 2222
Q ss_pred HHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 361 KMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
..+....+... +.. ....+..++.+||+.||++||||+||+++|+.+
T Consensus 271 ~~i~~g~~~~~--------p~~--~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 271 DCITQGRELER--------PRA--CPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp HHHHHTCCCCC--------CTT--CCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHcCCCCCC--------ccc--ccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 22322222111 111 112344566789999999999999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-57 Score=431.49 Aligned_cols=264 Identities=27% Similarity=0.444 Sum_probs=204.0
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEccc--chhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEE
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNN--VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 214 (463)
++..++|++.++||+|+||+||+|++. ..||||+++.. .....+.|.+|+.++++++|||||+++|+|.+ +..||
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 456678999999999999999999864 36999988533 23455789999999999999999999998865 56899
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
|||||++|+|.++|+. ....+++..++.++.||+.||+|||++ +|+||||||+||||++++++||+|||+|+..
T Consensus 109 VmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp EEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred EEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 9999999999999964 345699999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCC-ceeeccccccCCCCchhhhcc---CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCC-Cc
Q 012462 295 GAGK-SHVTTRVMGTFGYVAPEYANT---GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR-RS 369 (463)
Q Consensus 295 ~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~ 369 (463)
.... .......+||+.|||||++.+ .+|+.++|||||||+||||+||+.||.+..... .+....... ..
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~~~~~~~ 256 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMVGRGYAS 256 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHTTCCC
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCCC
Confidence 4322 233456789999999999964 468999999999999999999999997644221 111222221 11
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCCCC
Q 012462 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPI 421 (463)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 421 (463)
.... ..... ....+..++.+||+.||++||||.||++.|+.+..++
T Consensus 257 p~~~----~~~~~--~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 257 PDLS----KLYKN--CPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp CCST----TSCTT--SCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred CCcc----ccccc--chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 1111 11111 1123344566899999999999999999988765444
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-57 Score=436.75 Aligned_cols=259 Identities=24% Similarity=0.391 Sum_probs=209.3
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc------CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHR 212 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 212 (463)
..++++.++||+|+||+||+|.+. +++.||||++.... ....++|.+|+.++++++|||||+++|+|.+.+..
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 345777889999999999999763 46789999986543 34457899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCC
Q 012462 213 MLVYEYVNNGNLEQWLHGAMR------------HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDD 280 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~ 280 (463)
+||||||++|+|.++|..... ....+++..++.++.||+.||+|||++ +|+||||||+||||+++
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDK 181 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCC
Confidence 999999999999999965321 124589999999999999999999999 99999999999999999
Q ss_pred CCEEEeecccceecCCCC-ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHH
Q 012462 281 FNAKVSDFGLAKLLGAGK-SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVD 358 (463)
Q Consensus 281 ~~~kl~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~ 358 (463)
+++||+|||+++...... ....+..+||+.|||||++.++.|+.++|||||||+||||+| |..||.+... .+
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~------~~ 255 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------QD 255 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH------HH
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH------HH
Confidence 999999999998764332 223445689999999999999999999999999999999998 8999976432 22
Q ss_pred HHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 359 WLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.+.......... . +. .....+..++.+||+.||++||||.||++.|+..
T Consensus 256 ~~~~i~~~~~~~-~-------p~--~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 256 VVEMIRNRQVLP-C-------PD--DCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHHTTCCCC-C-------CT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHcCCCCC-C-------cc--cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 233333222211 1 11 1123345567789999999999999999999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-56 Score=432.92 Aligned_cols=251 Identities=25% Similarity=0.341 Sum_probs=206.0
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
..+|++.++||+|+||+||+|.. .+|+.||||++........+.+.+|+.++++++|||||+++++|.+.+.+||||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 35699999999999999999966 46899999999655444556788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
|+||+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+||||+.++++||+|||+|+......
T Consensus 153 ~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 153 LEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp CTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred CCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 999999999853 3599999999999999999999999 99999999999999999999999999999875432
Q ss_pred ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCC
Q 012462 299 SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (463)
......+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.... +.+..+..... +...
T Consensus 225 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~~~i~~~~~------~~~~ 291 (346)
T 4fih_A 225 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------KAMKMIRDNLP------PRLK 291 (346)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSSC------CCCS
T ss_pred -CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHcCCC------CCCC
Confidence 2345679999999999999999999999999999999999999999764321 22222222111 0111
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 379 ~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
... .....+..++.+||+.||++|||+.|++++
T Consensus 292 ~~~--~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 292 NLH--KVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp CGG--GSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccc--cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111 111223345568999999999999999874
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-56 Score=431.39 Aligned_cols=251 Identities=22% Similarity=0.364 Sum_probs=200.4
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
++|++++.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+.++++|+|||||++++++.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 6899999999999999999965 568999999985432 3445678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
||+||+|.+++.. .....+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999964 2345689999999999999999999999 9999999999999999999999999999876432
Q ss_pred CceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCC
Q 012462 298 KSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNI 377 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (463)
....+..+||+.|||||++.+..|+.++|||||||+||||+||+.||.+... .+.+......... .. .
T Consensus 179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~~~~~-~~---~- 246 (350)
T 4b9d_A 179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM------KNLVLKIISGSFP-PV---S- 246 (350)
T ss_dssp -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHTCCC-CC---C-
T ss_pred -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHcCCCC-CC---C-
Confidence 1223457899999999999999999999999999999999999999976432 2223333322211 10 0
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 378 EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
..... .+..++.+||+.||++|||+.|++++
T Consensus 247 --~~~s~---~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 247 --LHYSY---DLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp --TTSCH---HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --ccCCH---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01112 23345568999999999999999874
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-56 Score=422.36 Aligned_cols=246 Identities=21% Similarity=0.317 Sum_probs=203.7
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++|||||+++++|.+.+..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4699999999999999999965 568999999985432 234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
|||+||+|.+++.. .+.+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 112 Ey~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999964 34699999999999999999999999 999999999999999999999999999998754
Q ss_pred CC-ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 297 GK-SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 297 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
.. .......+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.+. ......+.....
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~~~~~------- 251 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------GLIFAKIIKLEY------- 251 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCC-------
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCC-------
Confidence 32 2335567999999999999999999999999999999999999999976432 122222222211
Q ss_pred CCCCCC-CHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 012462 376 NIEVRP-STRALKRSLLTALRCVDPDSEKRPKMSQVV 411 (463)
Q Consensus 376 ~~~~~~-~~~~~~~~~~~~~~cl~~dP~~RPs~~ell 411 (463)
..+. ... ....++.+||+.||++|||++|++
T Consensus 252 --~~p~~~s~---~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 --DFPEKFFP---KARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp --CCCTTCCH---HHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred --CCCcccCH---HHHHHHHHHccCCHhHCcChHHHc
Confidence 1111 112 233456689999999999999874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=411.35 Aligned_cols=245 Identities=24% Similarity=0.371 Sum_probs=194.4
Q ss_pred CccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEE----CcEEEEEE
Q 012462 144 SKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE----GIHRMLVY 216 (463)
Q Consensus 144 ~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lV~ 216 (463)
++.++||+|+||+||+|.+ .++..||+|++.... ....+.|.+|+.++++++|||||+++++|.+ ...+||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 5677899999999999965 458899999985432 3345678999999999999999999999875 35579999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEccCCCCceeEcC-CCCEEEeeccccee
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPK--VVHRDIKSSNILIDD-DFNAKVSDFGLAKL 293 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~Dikp~Nill~~-~~~~kl~Dfg~a~~ 293 (463)
|||++|+|.+++.. ...+++..+..++.||+.||+|||++ + |+||||||+||||+. ++.+||+|||+|+.
T Consensus 109 Ey~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 99999999999964 34699999999999999999999998 7 999999999999984 89999999999986
Q ss_pred cCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccc
Q 012462 294 LGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373 (463)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (463)
.... .....+||+.|||||++.+ .|+.++|||||||+||||+||+.||...... ............... .
T Consensus 182 ~~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-----~~~~~~i~~~~~~~~-~ 251 (290)
T 3fpq_A 182 KRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRRVTSGVKPAS-F 251 (290)
T ss_dssp CCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHHHTTTCCCGG-G
T ss_pred CCCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-----HHHHHHHHcCCCCCC-C
Confidence 4332 2445789999999999875 6999999999999999999999999754321 122222222211111 1
Q ss_pred cCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
+. ...++ +..++.+||+.||++|||++|++++
T Consensus 252 ~~-----~~~~~---~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 252 DK-----VAIPE---VKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GG-----CCCHH---HHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred Cc-----cCCHH---HHHHHHHHccCChhHCcCHHHHhcC
Confidence 10 11122 3345668999999999999999874
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-55 Score=430.21 Aligned_cols=268 Identities=26% Similarity=0.404 Sum_probs=214.9
Q ss_pred chHHHHHHhcCCCccCeEeecCcEEEEEEEEcC------CCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCC-CCcceEe
Q 012462 132 TLRDLELATNRFSKENVLGEGGYGVVYRGNLIN------GSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRH-KNLVRLL 203 (463)
Q Consensus 132 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h-~niv~l~ 203 (463)
....+++..++|++.+.||+|+||+||+|.+.. ++.||||++.... ....+.|.+|+.++.++.| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 356678889999999999999999999997643 2579999986544 3345678999999999965 9999999
Q ss_pred eEEEEC-cEEEEEEeecCCCCHHHHHhhhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccC
Q 012462 204 GYCIEG-IHRMLVYEYVNNGNLEQWLHGAMR------------HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDI 270 (463)
Q Consensus 204 ~~~~~~-~~~~lV~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Di 270 (463)
|+|.+. ..+|||||||++|+|.++|+.... ....+++..++.++.||+.||+|||++ +|+||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCcc
Confidence 999764 568999999999999999976432 134589999999999999999999999 9999999
Q ss_pred CCCceeEcCCCCEEEeecccceecCCCCc-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCC
Q 012462 271 KSSNILIDDDFNAKVSDFGLAKLLGAGKS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHG 348 (463)
Q Consensus 271 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~ 348 (463)
||+|||+++++.+||+|||+|+....... ......+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999997654433 33456789999999999999999999999999999999998 99999865
Q ss_pred CCcccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 349 RPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
..... + ...+....+.. . +.. ....+..++.+||+.||++||||.||+++|+.+
T Consensus 292 ~~~~~--~---~~~i~~g~~~~-~-------p~~--~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 292 KIDEE--F---CRRLKEGTRMR-A-------PDY--TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp CCSHH--H---HHHHHHTCCCC-C-------CTT--CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHHHH--H---HHHHHcCCCCC-C-------Ccc--CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 43211 1 12222221111 1 111 112344566789999999999999999999875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-55 Score=432.36 Aligned_cols=250 Identities=25% Similarity=0.356 Sum_probs=206.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
.++|++.++||+|+||+||+|.. .+|+.||||++........+.+.+|+.+|++++|||||+++++|.+.+.+||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 36799999999999999999965 46899999999655445556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
|+||+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+||||+.+|.+||+|||+|+......
T Consensus 230 ~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 230 LEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp CTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 999999999853 3499999999999999999999999 99999999999999999999999999999875432
Q ss_pred ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCC
Q 012462 299 SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (463)
......+||+.|||||++.+..|+.++|||||||+||||++|+.||.+... ...+..+..... +.+.
T Consensus 302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~~~~~------~~~~ 368 (423)
T 4fie_A 302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------LKAMKMIRDNLP------PRLK 368 (423)
T ss_dssp -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCC------CCCS
T ss_pred -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHcCCC------CCCc
Confidence 234567899999999999999999999999999999999999999976432 122222222211 1111
Q ss_pred CC-CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 379 VR-PSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 379 ~~-~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.. .....+ ..++.+||+.||++|||+.|++++
T Consensus 369 ~~~~~s~~~---~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 369 NLHKVSPSL---KGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp CTTSSCHHH---HHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccccCCHHH---HHHHHHHcCCChhHCcCHHHHhcC
Confidence 11 112223 334557999999999999999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-55 Score=418.56 Aligned_cols=251 Identities=23% Similarity=0.267 Sum_probs=199.9
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeec
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYV 219 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 219 (463)
+.|++.++||+|+||+||+|++ .+|+.||||++..... ..+|+.++++++|||||+++++|.+++.+|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 4578888999999999999965 4689999999864322 235999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCC-CEEEeecccceecCCCC
Q 012462 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDF-NAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 220 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~-~~kl~Dfg~a~~~~~~~ 298 (463)
+||+|.+++.. .+.+++..++.++.||+.||+|||++ +|+||||||+||||+.++ ++||+|||+|+......
T Consensus 133 ~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 133 EGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp TTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999999964 34699999999999999999999999 999999999999999987 69999999999765432
Q ss_pred ce----eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccccc
Q 012462 299 SH----VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVD 374 (463)
Q Consensus 299 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (463)
.. ....++||+.|||||++.+..|+.++|||||||+||||+||+.||......... . .+.......
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~---~i~~~~~~~---- 275 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC---L---KIASEPPPI---- 275 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH---H---HHHHSCCGG----
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH---H---HHHcCCCCc----
Confidence 11 123468999999999999999999999999999999999999999865543221 1 111111110
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 375 PNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
....+.. ...+..++.+||+.||++|||+.|++++|...
T Consensus 276 --~~~~~~~--s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 276 --REIPPSC--APLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp --GGSCTTS--CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --hhcCccC--CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 0111111 11233345589999999999999999988664
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-54 Score=413.02 Aligned_cols=266 Identities=23% Similarity=0.318 Sum_probs=199.4
Q ss_pred cCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECc----EEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGI----HRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lV~ 216 (463)
.+|.+.++||+|+||+||+|++ +|+.||||++.... .....+..|+..+.+++|||||+++++|.+.+ ..||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 3577889999999999999987 68999999985432 22233445666777899999999999998653 579999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEEccCCCCceeEcCCCCEEEeecccc
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA-----IEPKVVHRDIKSSNILIDDDFNAKVSDFGLA 291 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a 291 (463)
|||++|+|.++|+. ..+++..+++++.|++.||+|||++ ..++|+||||||+||||+.++++||+|||++
T Consensus 81 Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 99999999999964 3489999999999999999999975 2458999999999999999999999999999
Q ss_pred eecCCCCce---eeccccccCCCCchhhhccC------CCCccchhhhHHHHHHHHHhCCCCCCCCCCcc---------c
Q 012462 292 KLLGAGKSH---VTTRVMGTFGYVAPEYANTG------LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAH---------E 353 (463)
Q Consensus 292 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~---------~ 353 (463)
+........ .....+||+.|||||++.+. .++.++|||||||+||||+||..||....... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 877554322 12346899999999999764 46789999999999999999988775432111 1
Q ss_pred ccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 354 VNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
..................+. ...........+..++.+||+.||++||||.||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIP----NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCC----GGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred chHHHHHHHHhcccCCCCCC----ccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 12222222222221111111 0112233445566678899999999999999999999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-54 Score=407.91 Aligned_cols=246 Identities=23% Similarity=0.364 Sum_probs=187.6
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
++|++.+.||+|+||+||+|.. .+|+.||||++.... ......+.+|+.++++++|||||++++++.+.+..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5899999999999999999965 468999999985432 233467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+ +|+|.+++.. .+.+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 6799999853 45699999999999999999999999 999999999999999999999999999987643
Q ss_pred CCceeeccccccCCCCchhhhccCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLL-NEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
.. .....+||+.|||||++.+..| +.++|||||||+||||+||+.||.+... ............
T Consensus 165 ~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~------~~~~~~i~~~~~------- 229 (275)
T 3hyh_A 165 GN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI------PVLFKNISNGVY------- 229 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCC-------
T ss_pred CC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHcCCC-------
Confidence 32 3345789999999999998876 5799999999999999999999975431 222222222111
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
..+... ......++.+||+.||++|||++|++++
T Consensus 230 --~~p~~~--s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 230 --TLPKFL--SPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp --CCCTTS--CHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred --CCCCCC--CHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111111 1123345568999999999999999874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-55 Score=415.22 Aligned_cols=247 Identities=24% Similarity=0.306 Sum_probs=193.2
Q ss_pred cCCCccCeEeecCcEEEEEEEEc----CCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI----NGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 214 (463)
++|++.+.||+|+||+||+|+.. .++.||+|++.... ......+.+|+.++++++|||||++++++.+.+..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999653 46789999985432 1223467789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
|||||+||+|.+++.. .+.+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999964 34699999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccccc
Q 012462 295 GAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVD 374 (463)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (463)
.... ......+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.+. .+.+........
T Consensus 177 ~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~~~~------ 243 (304)
T 3ubd_A 177 IDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR------KETMTMILKAKL------ 243 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC------
T ss_pred cCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH------HHHHHHHHcCCC------
Confidence 4332 234457899999999999999999999999999999999999999976432 222222222111
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 012462 375 PNIEVRPSTRALKRSLLTALRCVDPDSEKRPKM-----SQVVR 412 (463)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~-----~ell~ 412 (463)
..+... ......++.+||+.||++|||+ +|+++
T Consensus 244 ---~~p~~~--s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 244 ---GMPQFL--SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ---CCCTTS--CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ---CCCCcC--CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 111111 1123345568999999999984 67765
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-53 Score=401.36 Aligned_cols=250 Identities=24% Similarity=0.408 Sum_probs=186.1
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECc--------
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGI-------- 210 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------- 210 (463)
++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+.++++++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 3588999999999999999965 468999999985433 344567889999999999999999999987543
Q ss_pred ----EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEe
Q 012462 211 ----HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVS 286 (463)
Q Consensus 211 ----~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~ 286 (463)
..|+|||||++|+|.+++.... ......+..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 3689999999999999996432 122356677899999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCce-----------eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCccccc
Q 012462 287 DFGLAKLLGAGKSH-----------VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVN 355 (463)
Q Consensus 287 Dfg~a~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~ 355 (463)
|||+|+........ ..+..+||+.|||||++.+..|+.++|||||||+||||++ ||.... .
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-----~ 232 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-----E 232 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----H
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----H
Confidence 99999876543211 1234689999999999999999999999999999999996 775321 1
Q ss_pred HHHHHHHHhcCCCccccccCCCCCCCCH-HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 356 LVDWLKMMVGSRRSEEVVDPNIEVRPST-RALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
....+...... . .++.. ........++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~-~----------~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 233 RVRTLTDVRNL-K----------FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHHHHHHTT-C----------CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHhcC-C----------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11111211111 1 11111 111233445668999999999999999873
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=397.32 Aligned_cols=263 Identities=24% Similarity=0.337 Sum_probs=199.2
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEE------Cc
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE------GI 210 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~ 210 (463)
.++|++.+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+.+|++++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 36899999999999999999965 568999999995432 3344678889999999999999999999764 35
Q ss_pred EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccc
Q 012462 211 HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGL 290 (463)
Q Consensus 211 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~ 290 (463)
..|||||||+ |+|.+++. ..+.+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~----~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CEEEEEECCS-EEHHHHHT----SSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEeCCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecce
Confidence 7899999996 68999984 356799999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCC---ceeeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcC
Q 012462 291 AKLLGAGK---SHVTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGS 366 (463)
Q Consensus 291 a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 366 (463)
|+.+.... .......+||+.|||||++.+. .|+.++||||+||++|||++|+.||.+....+ ....+......
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~---~l~~I~~~~g~ 281 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH---QLQLIMMVLGT 281 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH---HHHHHHHHHCC
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhcCC
Confidence 98764321 2234567999999999998775 57999999999999999999999998654222 11111111111
Q ss_pred CCcccccc-----------CCCC-CCCCHH-----HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 367 RRSEEVVD-----------PNIE-VRPSTR-----ALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 367 ~~~~~~~~-----------~~~~-~~~~~~-----~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
........ .... ...... .......++.+||..||++|||++|+|++
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 11000000 0000 000000 01233455668999999999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=385.67 Aligned_cols=291 Identities=43% Similarity=0.777 Sum_probs=246.5
Q ss_pred cccchHHHHHHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccch-hhHHHHHHHHHHHcCCCCCCcceEeeEEE
Q 012462 129 HWFTLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVG-QAEKEFRVEVEAIGHVRHKNLVRLLGYCI 207 (463)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 207 (463)
..++..++....++|++.+.||+|+||+||+|...+++.||||++..... .....+.+|+.+++.++||||+++++++.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 34678999999999999999999999999999887899999999865432 22236888999999999999999999999
Q ss_pred ECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEee
Q 012462 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSD 287 (463)
Q Consensus 208 ~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~D 287 (463)
+....++||||+++|+|.+++.........+++..++.++.|++.||.|||+.+.++|+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 99999999999999999999987655556799999999999999999999998777899999999999999999999999
Q ss_pred cccceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCC--CcccccHHHHHHHHhc
Q 012462 288 FGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGR--PAHEVNLVDWLKMMVG 365 (463)
Q Consensus 288 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~--~~~~~~~~~~~~~~~~ 365 (463)
||++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.... ........+|+.....
T Consensus 178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 257 (326)
T 3uim_A 178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257 (326)
T ss_dssp CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred CccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence 99999876555555556679999999999999899999999999999999999999996321 2233456666666556
Q ss_pred CCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCC
Q 012462 366 SRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEY 419 (463)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~ 419 (463)
........+..............+..++.+||+.||.+|||+.||+++|+....
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 666666666665555666777788888889999999999999999999997544
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=387.62 Aligned_cols=199 Identities=25% Similarity=0.369 Sum_probs=171.0
Q ss_pred HhcCCCccCeEeecCcEEEEEEEEc----CCCeEEEEEEcccchhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEEE
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNLI----NGSPVAVKKILNNVGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHRM 213 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 213 (463)
..++|++.++||+|+||+||+|+.+ .++.||+|++.... ....+.+|++++..+ +||||++++++|.+.++.|
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 4578999999999999999999653 36789999986543 345677899999988 6999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCC-CCEEEeecccce
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDD-FNAKVSDFGLAK 292 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~-~~~kl~Dfg~a~ 292 (463)
+||||+++|+|.+++. .+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+
T Consensus 97 lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 9999999999999883 389999999999999999999999 99999999999999876 799999999998
Q ss_pred ecCCCCc---------------------------eeeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCC
Q 012462 293 LLGAGKS---------------------------HVTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDP 344 (463)
Q Consensus 293 ~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p 344 (463)
....... ...+..+||+.|+|||++.+. .|+.++||||+||++|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 6543221 112345899999999999775 589999999999999999999999
Q ss_pred CCCCC
Q 012462 345 VDHGR 349 (463)
Q Consensus 345 f~~~~ 349 (463)
|....
T Consensus 247 f~~~~ 251 (361)
T 4f9c_A 247 FYKAS 251 (361)
T ss_dssp SSCCS
T ss_pred CCCCC
Confidence 97544
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=384.18 Aligned_cols=280 Identities=40% Similarity=0.696 Sum_probs=239.7
Q ss_pred HHHHHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEE
Q 012462 135 DLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 135 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 214 (463)
++....++|++.+.||+|+||+||+|.+.+++.||||++........+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 44456789999999999999999999988899999999876665666789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
||||+++|+|.+++.........+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 9999999999999865433344699999999999999999999999 9999999999999999999999999999875
Q ss_pred CCCC-ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccc
Q 012462 295 GAGK-SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373 (463)
Q Consensus 295 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (463)
.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....+........|..............
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (321)
T 2qkw_B 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV 269 (321)
T ss_dssp SSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSS
T ss_pred ccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhc
Confidence 4322 222334568999999999999999999999999999999999999999877777777777776666666666666
Q ss_pred cCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
++.............+..++.+||+.||++|||+.|++++|+..
T Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 270 DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp SSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 65554444556666777778899999999999999999999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=411.32 Aligned_cols=251 Identities=22% Similarity=0.344 Sum_probs=207.1
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeec
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYV 219 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 219 (463)
++|++.+.||+|+||+||+|.. .+|+.||+|++........+.+.+|+.+|+.++|||||+++++|.+...+|||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 5899999999999999999965 568999999997666566678889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCC--CCEEEeecccceecCCC
Q 012462 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDD--FNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 220 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~--~~~kl~Dfg~a~~~~~~ 297 (463)
+||+|.+++.. ..+.+++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+++.+...
T Consensus 237 ~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 237 SGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred CCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 99999999853 345699999999999999999999999 99999999999999854 89999999999987654
Q ss_pred CceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCC-CccccccCC
Q 012462 298 KSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR-RSEEVVDPN 376 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 376 (463)
. .....+||+.|||||++.+..|+.++|||||||+||||++|..||.+.... +.+..+.... ......
T Consensus 311 ~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~------~~~~~i~~~~~~~~~~~--- 379 (573)
T 3uto_A 311 Q--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLRNVKSCDWNMDDSA--- 379 (573)
T ss_dssp S--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHTTCCCCCSGG---
T ss_pred C--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHhCCCCCCccc---
Confidence 3 234568999999999999999999999999999999999999999764321 2222222221 111100
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
...... ....++.+||+.||.+|||+.|++++
T Consensus 380 --~~~~s~---~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 380 --FSGISE---DGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp --GTTSCH---HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --ccCCCH---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011112 23345668999999999999999985
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=406.84 Aligned_cols=249 Identities=23% Similarity=0.316 Sum_probs=197.3
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHH---HHHHHHHHHcCCCCCCcceEeeEEEECcEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEK---EFRVEVEAIGHVRHKNLVRLLGYCIEGIHR 212 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~---~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 212 (463)
-++|++.++||+|+||+||+|+. .+|+.||+|++.... ..... ..+.++.+++.++|||||+++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 36799999999999999999965 468999999985422 11122 233457788889999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccce
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~ 292 (463)
|||||||+||+|.++|.. .+.+++..+..++.||+.||+|||++ +|+||||||+||||+.+|++||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceee
Confidence 999999999999999964 34699999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccc
Q 012462 293 LLGAGKSHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEE 371 (463)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (463)
...... ....+||+.|||||++.+ ..|+.++|||||||+||||++|..||.+...... ...........
T Consensus 341 ~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~---~~i~~~i~~~~---- 410 (689)
T 3v5w_A 341 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRMTLTMA---- 410 (689)
T ss_dssp ECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH---HHHHHHHHHCC----
T ss_pred ecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHhhcCCC----
Confidence 875433 345799999999999964 5799999999999999999999999976433222 11111111111
Q ss_pred cccCCCCCCCC-HHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 012462 372 VVDPNIEVRPS-TRALKRSLLTALRCVDPDSEKRPK-----MSQVVRM 413 (463)
Q Consensus 372 ~~~~~~~~~~~-~~~~~~~~~~~~~cl~~dP~~RPs-----~~ell~~ 413 (463)
...+.. ..+ ...++.+||+.||.+|++ ++|+++|
T Consensus 411 -----~~~p~~~S~~---a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 411 -----VELPDSFSPE---LRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp -----CCCCTTSCHH---HHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred -----CCCCccCCHH---HHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 111111 122 334455799999999998 6887754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=360.32 Aligned_cols=251 Identities=24% Similarity=0.379 Sum_probs=205.0
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
.++|++.+.||+|+||+||+|.. .+++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46899999999999999999964 56899999998665555567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+++|+|.+++.. ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 999999999864 2489999999999999999999999 99999999999999999999999999998765443
Q ss_pred ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCC
Q 012462 299 SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (463)
. ......||+.|+|||++.+..++.++|||||||++|||++|..||....... ............ . .
T Consensus 171 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~~~~~~~~-~-----~ 237 (297)
T 3fxz_A 171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGTPE-L-----Q 237 (297)
T ss_dssp C-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHCSCC-C-----S
T ss_pred c-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCCCC-C-----C
Confidence 2 2345679999999999999999999999999999999999999997543211 111111111100 0 0
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 379 ~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
. .......+..++.+||+.||++|||+.|++++
T Consensus 238 ~--~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 238 N--PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp C--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred C--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0 01111223445668999999999999999874
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=358.01 Aligned_cols=256 Identities=27% Similarity=0.463 Sum_probs=208.8
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
.++|++.++||+|+||+||+|.+ .++..||+|++........+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 46789999999999999999976 45889999998776667778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+++++|.+++.. ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 89 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999964 245699999999999999999999999 99999999999999999999999999998764432
Q ss_pred cee-------------eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccc---cHHHHHHH
Q 012462 299 SHV-------------TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEV---NLVDWLKM 362 (463)
Q Consensus 299 ~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~---~~~~~~~~ 362 (463)
... ....+||+.|+|||++.+..++.++|||||||++|||++|..||....+.... ........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence 211 11457999999999999999999999999999999999999999764432211 11111111
Q ss_pred HhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCC
Q 012462 363 MVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEE 418 (463)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~ 418 (463)
.. . ...++ .+..++.+||+.||++|||+.|+++.|+...
T Consensus 243 ~~---------~--~~~~~------~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 243 YC---------P--PNCPP------SFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp TC---------C--TTCCT------THHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cC---------C--CCCCH------HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 0 01111 2334566899999999999999999998764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=363.77 Aligned_cols=266 Identities=30% Similarity=0.451 Sum_probs=201.4
Q ss_pred HHHHHHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcE
Q 012462 134 RDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIH 211 (463)
Q Consensus 134 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 211 (463)
.++++..++|++.+.||+|+||+||+|.. ++..||||++.... ....+.+.+|+.++++++||||+++++++.+...
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 34455567899999999999999999977 68899999986543 3344678899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEccCCCCceeEcCCCCEEEeecc
Q 012462 212 RMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPK--VVHRDIKSSNILIDDDFNAKVSDFG 289 (463)
Q Consensus 212 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~Dikp~Nill~~~~~~kl~Dfg 289 (463)
.++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+. + |+||||||+|||++.++.+||+|||
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg 184 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFG 184 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC
T ss_pred eEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCC
Confidence 999999999999999996421 112389999999999999999999999 8 9999999999999999999999999
Q ss_pred cceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCc
Q 012462 290 LAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369 (463)
Q Consensus 290 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 369 (463)
+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ............
T Consensus 185 ~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~------~~~~~~~~~~~~ 257 (309)
T 3p86_A 185 LSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA------QVVAAVGFKCKR 257 (309)
T ss_dssp ------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHHHHSCCC
T ss_pred CCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcCCC
Confidence 998654322 2233467899999999999999999999999999999999999999764322 111111111111
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCCC
Q 012462 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYP 420 (463)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~~ 420 (463)
..+. ..... .+..++.+||+.||.+|||+.|+++.|+.....
T Consensus 258 ~~~~------~~~~~---~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 258 LEIP------RNLNP---QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp CCCC------TTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred CCCC------ccCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1110 01112 234456689999999999999999999886443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=351.56 Aligned_cols=258 Identities=26% Similarity=0.399 Sum_probs=211.1
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
+..++|++.+.||+|+||.||+|+..++..||+|++.... ...+.+.+|+.++.+++||||+++++++.+....++|||
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred echhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 4467899999999999999999998888899999986543 334678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
|+++++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 84 YISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp CCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred ccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 99999999999753 23489999999999999999999999 9999999999999999999999999999877655
Q ss_pred CceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccCC
Q 012462 298 KSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (463)
.........+|+.|+|||++.+..++.++||||||+++|+|++ |..||...... ............. .+
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~~---~~- 227 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS------EVVLKVSQGHRLY---RP- 227 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHHHTTCCCC---CC-
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH------HHHHHHHcCCCCC---CC-
Confidence 4444444556788999999999899999999999999999999 99999754321 1122222111110 00
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCC
Q 012462 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEE 418 (463)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~ 418 (463)
..... .+..++.+||+.||++|||+.|+++.|+...
T Consensus 228 ---~~~~~---~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 228 ---HLASD---TIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp ---TTSCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred ---CcChH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 01112 3344566899999999999999999999874
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=370.19 Aligned_cols=261 Identities=25% Similarity=0.428 Sum_probs=208.1
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEEc--------CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCC-CCCCcceEeeEEE
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNLI--------NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCI 207 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 207 (463)
+..++|++.+.||+|+||+||+|.+. ++..||||++.... ......+.+|+.+++++ +||||++++++|.
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 34578999999999999999999753 34579999986543 33456788999999999 8999999999999
Q ss_pred ECcEEEEEEeecCCCCHHHHHhhhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCce
Q 012462 208 EGIHRMLVYEYVNNGNLEQWLHGAMR------------HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNI 275 (463)
Q Consensus 208 ~~~~~~lV~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Ni 275 (463)
+.+..|+||||+++|+|.+++..... ....+++..++.++.||+.||.|||++ +|+||||||+||
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NI 234 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV 234 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGE
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhE
Confidence 99999999999999999999975421 124589999999999999999999999 999999999999
Q ss_pred eEcCCCCEEEeecccceecCCCCc-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCccc
Q 012462 276 LIDDDFNAKVSDFGLAKLLGAGKS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHE 353 (463)
Q Consensus 276 ll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~ 353 (463)
|++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~- 313 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE- 313 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-
Confidence 999999999999999987654332 12233467889999999999999999999999999999999 999997644221
Q ss_pred ccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 354 VNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
+.. ......... ... .....+..++.+||+.||++||++.|+++.|+.+
T Consensus 314 --~~~---~~~~~~~~~--------~~~--~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 314 --LFK---LLKEGHRMD--------KPA--NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp --HHH---HHHTTCCCC--------CCT--TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHH---HHhcCCCCC--------CCC--CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 211 111111111 011 1112344456689999999999999999999875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=361.97 Aligned_cols=248 Identities=23% Similarity=0.352 Sum_probs=202.9
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46799999999999999999976 678999999985432 334567888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+++|+|.+++... +.+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 999999999998642 4599999999999999999999999 999999999999999999999999999986654
Q ss_pred CCceeeccccccCCCCchhhhccCCCC-ccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLLN-EKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
.. .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+... ............
T Consensus 167 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~~------- 231 (328)
T 3fe3_A 167 GG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL------KELRERVLRGKY------- 231 (328)
T ss_dssp SC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC-------
T ss_pred CC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC-------
Confidence 32 24556899999999999888775 799999999999999999999976432 222222222111
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
..+.. .......++.+||+.||.+|||++|++++
T Consensus 232 --~~p~~--~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 --RIPFY--MSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp --CCCTT--SCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred --CCCCC--CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 01111 11223345568999999999999999875
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=352.48 Aligned_cols=257 Identities=28% Similarity=0.479 Sum_probs=209.2
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
+..++|++.+.||+|+||+||+|.+.++..||+|++.... ...+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred eChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 3457899999999999999999998888999999986543 334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
|+++++|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 86 FMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp CCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 9999999999964 344689999999999999999999999 9999999999999999999999999999866543
Q ss_pred CceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccCC
Q 012462 298 KSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (463)
.........+|+.|+|||++.+..++.++||||||+++|+|++ |..||...... ............. .+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~------~~~~~~~~~~~~~---~~- 229 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDISTGFRLY---KP- 229 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTTCCCC---CC-
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH------HHHHHHhcCccCC---CC-
Confidence 3223334456788999999999999999999999999999999 99999754321 2222222211110 00
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
..... .+..++.+||+.||++|||+.|++++|+++
T Consensus 230 ---~~~~~---~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 230 ---RLAST---HVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp ---TTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CcCCH---HHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 11112 234455689999999999999999999875
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=350.66 Aligned_cols=263 Identities=27% Similarity=0.387 Sum_probs=204.0
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 215 (463)
.++|++.+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 57899999999999999999965 468899999984432 33446788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
|||+++++|.+++... +.+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 90 ~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 9999999999999642 4699999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 296 AGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
...........||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ................+.
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~~ 236 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHIQDSVPNVTTDV 236 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHHSSCCCCHHHHS
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhhccCCCcchhc
Confidence 44333344567999999999999999999999999999999999999999764321 111111211111110000
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHhcCCCCC
Q 012462 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRP-KMSQVVRMLESEEYPI 421 (463)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP-s~~ell~~L~~~~~~~ 421 (463)
. .... ..+..++.+||+.||.+|| +++++.+.|+......
T Consensus 237 ~---~~~~---~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 237 R---KDIP---QSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp C---TTSC---HHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred c---cCCC---HHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 0 0111 2234455689999999998 8999999999875433
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=359.29 Aligned_cols=259 Identities=30% Similarity=0.481 Sum_probs=205.5
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEEc----CCCeEEEEEEccc-chhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEE
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNLI----NGSPVAVKKILNN-VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHR 212 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 212 (463)
+..++|++.+.||+|+||+||+|.+. .+..||||++... .....+.+.+|+.++++++||||+++++++.+....
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 34578999999999999999999764 3445999998654 334456789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccce
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~ 292 (463)
++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 126 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp EEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 999999999999999964 335699999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCc--eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCc
Q 012462 293 LLGAGKS--HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369 (463)
Q Consensus 293 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 369 (463)
....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||...... ............
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~------~~~~~~~~~~~~ 273 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR------DVISSVEEGYRL 273 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH------HHHHHHHTTCCC
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH------HHHHHHHcCCCC
Confidence 7654322 12223456778999999999999999999999999999999 99999754321 222222222111
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCC
Q 012462 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEE 418 (463)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~ 418 (463)
.. .. .....+..++.+||+.||++|||+.|+++.|+.+.
T Consensus 274 ~~--------~~--~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 274 PA--------PM--GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp CC--------CT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC--------CC--CcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 10 00 11123344566899999999999999999998863
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=346.68 Aligned_cols=280 Identities=37% Similarity=0.626 Sum_probs=222.3
Q ss_pred ccchHHHHHHhcCCCcc------CeEeecCcEEEEEEEEcCCCeEEEEEEcccc----hhhHHHHHHHHHHHcCCCCCCc
Q 012462 130 WFTLRDLELATNRFSKE------NVLGEGGYGVVYRGNLINGSPVAVKKILNNV----GQAEKEFRVEVEAIGHVRHKNL 199 (463)
Q Consensus 130 ~~~~~~~~~~~~~~~~~------~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~ni 199 (463)
.|++.++...+++|... +.||+|+||.||+|.. +++.||+|++.... ....+.+.+|+.++++++||||
T Consensus 14 ~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 92 (307)
T 2nru_A 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL 92 (307)
T ss_dssp ECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTB
T ss_pred cccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCe
Confidence 36778888888888776 8999999999999976 78999999985432 3345678899999999999999
Q ss_pred ceEeeEEEECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC
Q 012462 200 VRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD 279 (463)
Q Consensus 200 v~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~ 279 (463)
+++++++.+.+..++||||+++++|.+++... .....+++..++.++.||+.||.|||+. +|+||||||+||+++.
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 93 VELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168 (307)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHTG-GGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred EEEEEEEecCCceEEEEEecCCCcHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcC
Confidence 99999999999999999999999999999753 2345699999999999999999999999 9999999999999999
Q ss_pred CCCEEEeecccceecCCCCc-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHH
Q 012462 280 DFNAKVSDFGLAKLLGAGKS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVD 358 (463)
Q Consensus 280 ~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~ 358 (463)
++.+||+|||++........ .......||+.|+|||++.+ .++.++||||||+++|+|++|..||.......... .
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~ 245 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL--D 245 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT--H
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH--H
Confidence 99999999999987654322 22344678999999998875 48899999999999999999999998655433221 2
Q ss_pred HHHHHhcC-CCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCC
Q 012462 359 WLKMMVGS-RRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEE 418 (463)
Q Consensus 359 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~ 418 (463)
+....... .......+.... .........+..++.+||+.||.+|||+.+++++|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 246 IKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 22222111 111222222221 223344555666777999999999999999999998753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=359.48 Aligned_cols=253 Identities=25% Similarity=0.370 Sum_probs=199.1
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
.++|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 367999999999999999999664 78899999985433 2334668889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
|+++|+|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 999999999874 345699999999999999999999999 9999999999999999999999999999865432
Q ss_pred C-ceeeccccccCCCCchhhhccCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 298 K-SHVTTRVMGTFGYVAPEYANTGLL-NEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 298 ~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
. .......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........ ....+ .......
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~----~~~~~~~----- 228 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDW----KEKKTYL----- 228 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHH----HTTCTTS-----
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHH----hcccccC-----
Confidence 2 222345689999999999988775 7799999999999999999999976443211 11111 1111100
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.+..........++.+||+.||++|||+.|++++
T Consensus 229 ----~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 229 ----NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0101111233445668999999999999999875
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=351.64 Aligned_cols=248 Identities=25% Similarity=0.338 Sum_probs=202.5
Q ss_pred CCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCC
Q 012462 143 FSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNN 221 (463)
Q Consensus 143 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 221 (463)
|...+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 677789999999999999775 6899999998765555667888999999999999999999999999999999999999
Q ss_pred CCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCcee
Q 012462 222 GNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV 301 (463)
Q Consensus 222 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 301 (463)
++|.+++.. ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++........ .
T Consensus 127 ~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~ 197 (321)
T 2c30_A 127 GALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-K 197 (321)
T ss_dssp CBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-C
T ss_pred CCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-c
Confidence 999998852 3599999999999999999999999 999999999999999999999999999987654322 2
Q ss_pred eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCC
Q 012462 302 TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRP 381 (463)
Q Consensus 302 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (463)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........... . ....
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~-~-----~~~~-- 263 (321)
T 2c30_A 198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV------QAMKRLRDSPP-P-----KLKN-- 263 (321)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSSC-C-----CCTT--
T ss_pred cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhcCCC-C-----CcCc--
Confidence 34567999999999999999999999999999999999999999754321 11222211111 0 0000
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 382 STRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 382 ~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.......+..++.+||+.||++|||+.|++++
T Consensus 264 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 264 SHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111223445568999999999999999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=369.62 Aligned_cols=259 Identities=24% Similarity=0.384 Sum_probs=207.0
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEE
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 214 (463)
.+..++|++.+.||+|+||.||+|.+. ++..||||.+.... ......+.+|+.++++++||||++++++|.+.+..++
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 455678999999999999999999775 68899999986543 2334568889999999999999999999999889999
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
||||+++|+|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 190 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp EEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 99999999999999743 23489999999999999999999999 9999999999999999999999999999875
Q ss_pred CCCCceee-ccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCcccc
Q 012462 295 GAGKSHVT-TRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV 372 (463)
Q Consensus 295 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (463)
........ ....+++.|+|||++.+..++.++|||||||++|||++ |..||...... .............
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~------~~~~~~~~~~~~~-- 335 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ------QTREFVEKGGRLP-- 335 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH------HHHHHHHTTCCCC--
T ss_pred CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCCCC--
Confidence 43322111 11235778999999999999999999999999999998 99999764321 1112222221111
Q ss_pred ccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 373 VDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.+.. ....+..++.+||+.||++|||+.++++.|+++
T Consensus 336 ------~~~~--~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 336 ------CPEL--CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp ------CCTT--CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCC--CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 0111 112344456689999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=359.41 Aligned_cols=270 Identities=26% Similarity=0.378 Sum_probs=207.5
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECc----EE
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGI----HR 212 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~ 212 (463)
.+..++|++.++||+|+||+||+|++ .++.||||++.... ........|+.++.+++||||+++++++.+.. ..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 20 YFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp EETTEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ccchhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 34467899999999999999999987 47999999985443 33445566899999999999999999998743 46
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------CCCeEEccCCCCceeEcCCCCEEE
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI-------EPKVVHRDIKSSNILIDDDFNAKV 285 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-------~~~i~H~Dikp~Nill~~~~~~kl 285 (463)
++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+.+ .++|+||||||+|||++.++.+||
T Consensus 98 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred EEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 999999999999999954 24899999999999999999999751 348999999999999999999999
Q ss_pred eecccceecCCCCc-eeeccccccCCCCchhhhccC-----CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccc-----
Q 012462 286 SDFGLAKLLGAGKS-HVTTRVMGTFGYVAPEYANTG-----LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEV----- 354 (463)
Q Consensus 286 ~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~----- 354 (463)
+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.........
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 99999987654432 223346799999999999873 5567899999999999999999999865433222
Q ss_pred -----cHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 355 -----NLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 355 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
....+............+. ...........+..++.+||+.||++|||+.|+++.|+.+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVHKKKRPVLR----DYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp HCSSCCHHHHHHHHTTSCCCCCCC----GGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hccCCchhhhhhhhhcccCCCCcc----ccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1222222222111111110 0111223344566677789999999999999999999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=377.72 Aligned_cols=262 Identities=23% Similarity=0.388 Sum_probs=211.3
Q ss_pred HHHHHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEE
Q 012462 135 DLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 135 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 214 (463)
.+++..++|++.+.||+|+||+||+|.+.++..||||++.... ...+.+.+|+.++++++||||+++++++. ....++
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI 259 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence 3456678899999999999999999998888999999986543 34678899999999999999999999986 567899
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
||||+++|+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 260 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp EECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred EEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 999999999999997432 22488999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccc
Q 012462 295 GAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373 (463)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (463)
............+|..|+|||++....++.++|||||||+||||++ |+.||...... +.............
T Consensus 335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~------~~~~~i~~~~~~~~-- 406 (454)
T 1qcf_A 335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP------EVIRALERGYRMPR-- 406 (454)
T ss_dssp CCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHHHHHHTCCCCC--
T ss_pred CCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCCCCC--
Confidence 4332222233456788999999999999999999999999999999 99999754321 22222222211111
Q ss_pred cCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCC
Q 012462 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEY 419 (463)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~ 419 (463)
.. .....+..++.+||+.||++|||+++|++.|++...
T Consensus 407 ------~~--~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 407 ------PE--NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp ------CT--TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred ------CC--CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 00 112234455668999999999999999999998754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=348.39 Aligned_cols=261 Identities=24% Similarity=0.380 Sum_probs=199.0
Q ss_pred hcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHc--CCCCCCcceEeeEEEEC----cEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIG--HVRHKNLVRLLGYCIEG----IHRM 213 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~l~~~~~~~----~~~~ 213 (463)
.++|++.+.||+|+||+||+|.. +++.||||++... ....+..|.+++. .++||||+++++++.+. ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46899999999999999999987 7899999998543 2334444555544 48999999999997653 4578
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEEccCCCCceeEcCCCCEEE
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH--------EAIEPKVVHRDIKSSNILIDDDFNAKV 285 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH--------~~~~~~i~H~Dikp~Nill~~~~~~kl 285 (463)
+||||+++|+|.+++. ...+++..++.++.||+.||.||| +. +|+||||||+|||++.++.+||
T Consensus 83 lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEE
T ss_pred EehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEE
Confidence 9999999999999994 235999999999999999999999 77 9999999999999999999999
Q ss_pred eecccceecCCCCcee---eccccccCCCCchhhhccC------CCCccchhhhHHHHHHHHHhC----------CCCCC
Q 012462 286 SDFGLAKLLGAGKSHV---TTRVMGTFGYVAPEYANTG------LLNEKSDVYSFGVLLLEAITG----------RDPVD 346 (463)
Q Consensus 286 ~Dfg~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvvl~elltg----------~~pf~ 346 (463)
+|||+++......... .....||+.|+|||++.+. .++.++|||||||++|||++| ..||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 9999998765443222 2334799999999999876 455799999999999999999 88886
Q ss_pred CCCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 347 HGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
...+... .................+.. ..........+..++.+||+.||++|||+.|+++.|+.+
T Consensus 235 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 235 DVVPNDP-SFEDMRKVVCVDQQRPNIPN----RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTSCSSC-CHHHHHHHHTTSCCCCCCCG----GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCCCc-chhhhhHHHhccCCCCCCCh----hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 5443322 22222222221111111110 001123345556667789999999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=347.47 Aligned_cols=272 Identities=23% Similarity=0.263 Sum_probs=209.6
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECc--EEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGI--HRMLV 215 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lV 215 (463)
.++|++.+.||+|+||+||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 467999999999999999999765 48899999986533 334567788999999999999999999998765 77999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeE----cCCCCEEEeecccc
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILI----DDDFNAKVSDFGLA 291 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill----~~~~~~kl~Dfg~a 291 (463)
|||+++++|.+++.... ....+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 99999999999997542 233499999999999999999999999 99999999999999 78888999999999
Q ss_pred eecCCCCceeeccccccCCCCchhhhc--------cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHH
Q 012462 292 KLLGAGKSHVTTRVMGTFGYVAPEYAN--------TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMM 363 (463)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 363 (463)
+...... ......||+.|+|||++. +..++.++|||||||++|||++|+.||......... ...+...
T Consensus 164 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~ 239 (319)
T 4euu_A 164 RELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKI 239 (319)
T ss_dssp EECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HHHHHHH
T ss_pred eecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HHHHHHH
Confidence 8765433 233457899999999986 578899999999999999999999999754432221 1222222
Q ss_pred hcCCCc---ccc---------ccCCCCC--CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCC
Q 012462 364 VGSRRS---EEV---------VDPNIEV--RPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEY 419 (463)
Q Consensus 364 ~~~~~~---~~~---------~~~~~~~--~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~ 419 (463)
...... ..+ +...... .........+..++.+||+.||++|||++|++++..+..-
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 211110 000 0001111 1122333344455668999999999999999999987643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=357.05 Aligned_cols=249 Identities=25% Similarity=0.280 Sum_probs=201.8
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 215 (463)
.++|++.+.||+|+||+||+|+.. +|+.||+|++.... ......+..|+.+++.++||||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 357899999999999999999764 68999999985432 23446678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 999999999999864 34589999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 296 AGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...........
T Consensus 157 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~-------- 221 (337)
T 1o6l_A 157 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELILMEE-------- 221 (337)
T ss_dssp CTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC--------
T ss_pred cCC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH------HHHHHHHHcCC--------
Confidence 222 224456899999999999999999999999999999999999999975432 11122222111
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 012462 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRP-----KMSQVVRM 413 (463)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP-----s~~ell~~ 413 (463)
...+... ......++.+||+.||++|| +++|++++
T Consensus 222 -~~~p~~~--s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 222 -IRFPRTL--SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -CCCCTTS--CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -CCCCCCC--CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 0111111 12233445579999999999 89999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=352.37 Aligned_cols=258 Identities=24% Similarity=0.391 Sum_probs=206.3
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
++..++|++.+.||+|+||+||+|.+.++..||+|++.... ...+.+.+|+.++.+++||||+++++++.+....++||
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 34567899999999999999999998888899999986543 23467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+++++|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 99 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 99 EYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp CCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred eccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 999999999999643 34599999999999999999999999 999999999999999999999999999986644
Q ss_pred CCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
..........+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... .............. +
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~------~~~~~~~~~~~~~~---~ 243 (283)
T 3gen_A 173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------ETAEHIAQGLRLYR---P 243 (283)
T ss_dssp HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHHHTTCCCCC---C
T ss_pred cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh------HHHHHHhcccCCCC---C
Confidence 33222333456788999999999999999999999999999998 99999754321 12222222111100 0
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.... ..+..++.+||+.||.+|||++|++++|+++
T Consensus 244 ----~~~~---~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 244 ----HLAS---EKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp ----TTCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CcCC---HHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 0111 2334456689999999999999999999875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=363.17 Aligned_cols=257 Identities=29% Similarity=0.467 Sum_probs=195.6
Q ss_pred HhcCCCccCeEeecCcEEEEEEEEc----CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEE
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNLI----NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRM 213 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 213 (463)
..++|++.+.||+|+||.||+|... ++..||||++.... ....+.+.+|+.++.+++||||+++++++.+....+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 4568999999999999999999764 56789999986543 344567899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
+||||+++|+|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 123 lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 99999999999999964 334699999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCcee--eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 294 LGAGKSHV--TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 294 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
........ .....+++.|+|||++.+..++.++|||||||++|||++ |+.||..... ..............
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~------~~~~~~i~~~~~~~ 270 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN------QDVIKAVDEGYRLP 270 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH------HHHHHHHHTTEECC
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCCCCC
Confidence 65432211 122345778999999999999999999999999999998 9999975432 12222222111110
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
........+..++.+||+.||++||++.|+++.|+.+
T Consensus 271 ----------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 271 ----------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp ----------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----------CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 0111122344556689999999999999999999876
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=356.69 Aligned_cols=251 Identities=24% Similarity=0.333 Sum_probs=202.8
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccch------hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVG------QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHR 212 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 212 (463)
.++|++.+.||+|+||+||+|... +|+.||+|.+..... ...+.+.+|+.++.+++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467999999999999999999664 588999999854332 1356788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCC----CEEEeec
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDF----NAKVSDF 288 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~----~~kl~Df 288 (463)
++||||+++|+|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHT----TCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 99999999999999984 345699999999999999999999999 999999999999998877 7999999
Q ss_pred ccceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCC
Q 012462 289 GLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRR 368 (463)
Q Consensus 289 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 368 (463)
|++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... .....+.....
T Consensus 164 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~------~~~~~i~~~~~ 235 (361)
T 2yab_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANITAVSY 235 (361)
T ss_dssp SSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHTTCC
T ss_pred CCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcCC
Confidence 9998765432 234567999999999999999999999999999999999999999764321 22222221110
Q ss_pred -ccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 369 -SEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 369 -~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
..... ..... .....++.+||..||++|||+.|++++
T Consensus 236 ~~~~~~-----~~~~s---~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 236 DFDEEF-----FSQTS---ELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp CCCHHH-----HTTSC---HHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCchh-----ccCCC---HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000 00111 223345568999999999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=351.11 Aligned_cols=263 Identities=23% Similarity=0.323 Sum_probs=201.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
.++|++.+.||+|+||+||+|...+++.||+|++.... ......+.+|+.++++++||||+++++++.+....++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 47899999999999999999988889999999985432 2234678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
|+++ +|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 100 ~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 100 FMEK-DLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CCSE-EHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred CCCC-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9975 88888753 344599999999999999999999999 9999999999999999999999999999876533
Q ss_pred CceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccccc--
Q 012462 298 KSHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVD-- 374 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 374 (463)
.. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ...+..............
T Consensus 173 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 173 VR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ---LPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp CC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH---HHHHHHHHCCCCTTTSGGGT
T ss_pred cc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHHCCCChHHhhhhh
Confidence 22 2334578999999999876 5689999999999999999999999986554322 222222222111111000
Q ss_pred -------CCCCC--CCCHH-----HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 375 -------PNIEV--RPSTR-----ALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 375 -------~~~~~--~~~~~-----~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
..... ..... .......++.+||+.||++|||++|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00000 00000 01234455668999999999999999974
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=378.43 Aligned_cols=263 Identities=25% Similarity=0.395 Sum_probs=213.5
Q ss_pred HHHHHhcCCCccCeEeecCcEEEEEEEEcC-CCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEE
Q 012462 135 DLELATNRFSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRM 213 (463)
Q Consensus 135 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 213 (463)
.+++..++|++.+.||+|+||.||+|.+.. +..||||.+.... ...+.+.+|+.++++++||||++++++|.+....+
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 292 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 292 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence 345566789999999999999999997764 7899999986543 34577889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
+||||+++|+|.+++... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 293 lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 367 (495)
T 1opk_A 293 IITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRL 367 (495)
T ss_dssp EEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEEC
T ss_pred EEEEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeeccccee
Confidence 999999999999999753 334589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCcccc
Q 012462 294 LGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV 372 (463)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (463)
.............++..|+|||++.+..++.++|||||||+||||++ |..||...... .+... +.......
T Consensus 368 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~~~---~~~~~~~~-- 439 (495)
T 1opk_A 368 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYEL---LEKDYRME-- 439 (495)
T ss_dssp CTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHH---HHTTCCCC--
T ss_pred ccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHH---HHcCCCCC--
Confidence 65443333344556789999999999999999999999999999999 99999765432 22221 11111110
Q ss_pred ccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCC
Q 012462 373 VDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEY 419 (463)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~ 419 (463)
... .....+..++.+||+.||++|||+.+|++.|+....
T Consensus 440 ------~~~--~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 440 ------RPE--GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp ------CCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred ------CCC--CCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 011 111234445668999999999999999999998754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=368.87 Aligned_cols=253 Identities=30% Similarity=0.434 Sum_probs=204.4
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECc-EEEEE
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGI-HRMLV 215 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lV 215 (463)
++..++|++.+.||+|+||.||+|.+ .++.||||++.... ..+.+.+|+.++++++||||+++++++.+.. ..++|
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 45567899999999999999999987 47899999986543 4567889999999999999999999988765 78999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
|||+++|+|.+++... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 266 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 9999999999999753 233479999999999999999999999 99999999999999999999999999998653
Q ss_pred CCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCcccccc
Q 012462 296 AGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVD 374 (463)
Q Consensus 296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (463)
.. .....++..|+|||++.+..++.++|||||||+||||++ |+.||....... ... .........
T Consensus 341 ~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~---~i~~~~~~~---- 406 (450)
T 1k9a_A 341 ST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP---RVEKGYKMD---- 406 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHH---HHHTTCCCC----
T ss_pred cc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---HHHcCCCCC----
Confidence 22 122357889999999999999999999999999999998 999998654332 211 122221111
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 375 PNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.+. .....+..++.+||+.||++|||+.++++.|+.+
T Consensus 407 ----~p~--~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 407 ----APD--GCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp ----CCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCC--cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 011 1122344556689999999999999999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=347.25 Aligned_cols=264 Identities=23% Similarity=0.388 Sum_probs=202.6
Q ss_pred HhcCCCccCeEeecCcEEEEEEEE-----cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC--cE
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNL-----INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG--IH 211 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~ 211 (463)
..++|++.+.||+|+||+||+|++ .+++.||||++........+.+.+|+.++.+++||||+++++++... ..
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 457899999999999999999974 35789999999776666667899999999999999999999998653 45
Q ss_pred EEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccc
Q 012462 212 RMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA 291 (463)
Q Consensus 212 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a 291 (463)
.++||||+++|+|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred eEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 79999999999999999753 23489999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCc--eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCc----------ccccHHHH
Q 012462 292 KLLGAGKS--HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPA----------HEVNLVDW 359 (463)
Q Consensus 292 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~----------~~~~~~~~ 359 (463)
........ .......++..|+|||++.+..++.++||||||+++|||++|..||...... ........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence 87654322 1122345677899999999999999999999999999999999998642110 00000011
Q ss_pred HHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCC
Q 012462 360 LKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEE 418 (463)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~ 418 (463)
........... ... .....+..++.+||+.||++|||+.|+++.|+.+.
T Consensus 242 ~~~~~~~~~~~--------~~~--~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 242 IELLKNNGRLP--------RPD--GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp HHHHHTTCCCC--------CCT--TCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhccCcCC--------CCc--CcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11111111111 011 11123444566899999999999999999998753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=356.45 Aligned_cols=256 Identities=20% Similarity=0.274 Sum_probs=203.8
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc-----hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV-----GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRM 213 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 213 (463)
.++|++.+.||+|+||+||+|.. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46799999999999999999965 468999999984321 123567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCC---EEEeeccc
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFN---AKVSDFGL 290 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~---~kl~Dfg~ 290 (463)
+||||+++++|.+++.........+++..++.++.||+.||.|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 99999999999998876555556689999999999999999999999 9999999999999987654 99999999
Q ss_pred ceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 291 AKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 291 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
+........ .....+||+.|+|||++.+..++.++|||||||++|+|++|..||..... .............
T Consensus 180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~i~~~~~~~ 251 (351)
T 3c0i_A 180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-------RLFEGIIKGKYKM 251 (351)
T ss_dssp CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-------HHHHHHHHTCCCC
T ss_pred eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-------HHHHHHHcCCCCC
Confidence 987754322 23446799999999999999999999999999999999999999975321 1111121111100
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.. . ...... ..+..++.+||+.||++|||+.|++++
T Consensus 252 ~~-~---~~~~~s---~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 252 NP-R---QWSHIS---ESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp CH-H---HHTTSC---HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred Cc-c---ccccCC---HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 0 000111 233445668999999999999999863
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=347.92 Aligned_cols=258 Identities=23% Similarity=0.370 Sum_probs=193.9
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEEcC----CCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcE
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNLIN----GSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIH 211 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 211 (463)
++..++|++.+.||+|+||.||+|.... +..||+|.+.... ....+.+.+|+.++++++||||+++++++. .+.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 89 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 89 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence 4456789999999999999999997643 3469999875533 344567889999999999999999999984 557
Q ss_pred EEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccc
Q 012462 212 RMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA 291 (463)
Q Consensus 212 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a 291 (463)
.++||||+++++|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS 163 (281)
T ss_dssp CEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----
T ss_pred cEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccc
Confidence 8999999999999999964 234689999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 292 KLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
...............+|+.|+|||++.+..++.++|||||||++|||++ |..||....... ... .........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~~---~i~~~~~~~ 237 (281)
T 1mp8_A 164 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIG---RIENGERLP 237 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH---HHHTTCCCC
T ss_pred cccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HHH---HHHcCCCCC
Confidence 8765443333334456789999999999999999999999999999997 999998654322 211 121111110
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
. . ..... .+..++.+||+.||++|||+.|+++.|+.+
T Consensus 238 -~-~-----~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 238 -M-P-----PNCPP---TLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp -C-C-----TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -C-C-----CCCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 0 11112 334456689999999999999999999875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=374.05 Aligned_cols=263 Identities=28% Similarity=0.421 Sum_probs=205.8
Q ss_pred HHHHHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEE
Q 012462 135 DLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 135 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 214 (463)
.+++..++|++.+.||+|+||.||+|.+.++..||||++.... ...+.+.+|+.++++++||||+++++++.+ ...++
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i 255 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 255 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence 3456678899999999999999999998877889999986543 335678999999999999999999999876 67899
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
||||+++|+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 256 v~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp EECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred EehhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceec
Confidence 999999999999996432 24589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccc
Q 012462 295 GAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373 (463)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (463)
............++..|+|||++.+..++.++|||||||+||||++ |+.||..... .+............
T Consensus 331 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~------~~~~~~i~~~~~~~--- 401 (452)
T 1fmk_A 331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLDQVERGYRMP--- 401 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHHTTCCCC---
T ss_pred CCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCCCCC---
Confidence 5433222334456889999999999999999999999999999999 9999975432 12222222221111
Q ss_pred cCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCCC
Q 012462 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYP 420 (463)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~~ 420 (463)
.... ....+..++.+||+.||++|||+++|++.|++....
T Consensus 402 -----~~~~--~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 402 -----CPPE--CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp -----CCTT--SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred -----CCCC--CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 0111 112344456689999999999999999999987543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-46 Score=363.86 Aligned_cols=268 Identities=26% Similarity=0.411 Sum_probs=210.8
Q ss_pred chHHHHHHhcCCCccCeEeecCcEEEEEEEEc------CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCC-CCCCcceEe
Q 012462 132 TLRDLELATNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHV-RHKNLVRLL 203 (463)
Q Consensus 132 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~ 203 (463)
....+++..++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.++.++ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 45677788899999999999999999999642 35789999996543 33446788999999999 799999999
Q ss_pred eEEEECcE-EEEEEeecCCCCHHHHHhhhhcC------------------------------------------------
Q 012462 204 GYCIEGIH-RMLVYEYVNNGNLEQWLHGAMRH------------------------------------------------ 234 (463)
Q Consensus 204 ~~~~~~~~-~~lV~e~~~~g~L~~~l~~~~~~------------------------------------------------ 234 (463)
+++.+.+. .++||||+++|+|.+++......
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 99987544 89999999999999999754321
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC-c
Q 012462 235 --------------HGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK-S 299 (463)
Q Consensus 235 --------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~-~ 299 (463)
...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++....... .
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 12288999999999999999999999 99999999999999999999999999998664332 2
Q ss_pred eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCC
Q 012462 300 HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378 (463)
Q Consensus 300 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (463)
.......||+.|+|||++.+..++.++|||||||++|||++ |..||........ .. .......... ..
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~---~~~~~~~~~~-~~----- 318 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FC---RRLKEGTRMR-AP----- 318 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--HH---HHHHHTCCCC-CC-----
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH--HH---HHHHcCCCCC-CC-----
Confidence 23344568899999999999999999999999999999998 9999976543221 11 1111111110 00
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 379 ~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
..... .+..++.+||+.||.+|||+.|++++|+.+
T Consensus 319 -~~~~~---~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 319 -DYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp -TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCH---HHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 11112 334456689999999999999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=352.32 Aligned_cols=262 Identities=27% Similarity=0.424 Sum_probs=208.8
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEE------cCCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNL------INGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG 209 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 209 (463)
++..++|.+.+.||+|+||.||+|.. .++..||+|++.... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 44567899999999999999999965 234789999986543 34456788999999999999999999999999
Q ss_pred cEEEEEEeecCCCCHHHHHhhhhc--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcc
Q 012462 210 IHRMLVYEYVNNGNLEQWLHGAMR--------------------HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRD 269 (463)
Q Consensus 210 ~~~~lV~e~~~~g~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~D 269 (463)
+..++||||+++++|.+++..... ....+++..++.++.||+.||.|||++ +|+|||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~d 175 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRD 175 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccc
Confidence 999999999999999999976432 123488999999999999999999999 999999
Q ss_pred CCCCceeEcCCCCEEEeecccceecCCCCce-eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCC
Q 012462 270 IKSSNILIDDDFNAKVSDFGLAKLLGAGKSH-VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDH 347 (463)
Q Consensus 270 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~ 347 (463)
|||+|||++.++.+||+|||++......... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876543322 2233457888999999999999999999999999999999 9999976
Q ss_pred CCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 348 GRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
..... .... ...... .... .... ..+..++.+||+.||++||++.|+++.|+.+
T Consensus 256 ~~~~~---~~~~---~~~~~~-~~~~------~~~~---~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 256 IPPER---LFNL---LKTGHR-MERP------DNCS---EEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp CCGGG---HHHH---HHTTCC-CCCC------TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCHHH---HHHH---hhcCCc-CCCC------ccCC---HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 54322 2111 111111 1000 1111 2334456689999999999999999999875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=357.55 Aligned_cols=267 Identities=23% Similarity=0.364 Sum_probs=211.5
Q ss_pred HHHHHHhcCCCccCeEeecCcEEEEEEEEc------CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEE
Q 012462 134 RDLELATNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYC 206 (463)
Q Consensus 134 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 206 (463)
..+++..++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 344566789999999999999999999764 34789999986543 34456789999999999999999999999
Q ss_pred EECcEEEEEEeecCCCCHHHHHhhhhcC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 012462 207 IEGIHRMLVYEYVNNGNLEQWLHGAMRH--------------------HGYLTWEARMKVLLGTAKALAYLHEAIEPKVV 266 (463)
Q Consensus 207 ~~~~~~~lV~e~~~~g~L~~~l~~~~~~--------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~ 266 (463)
.+.+..++||||+++|+|.+++...... ...+++..++.++.||+.||.|||++ +|+
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~iv 196 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV 196 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 9999999999999999999999753211 25689999999999999999999999 999
Q ss_pred EccCCCCceeEcCCCCEEEeecccceecCCCCc-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCC
Q 012462 267 HRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDP 344 (463)
Q Consensus 267 H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p 344 (463)
||||||+|||++.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 999999999999999999999999986543221 12234567899999999999999999999999999999999 9999
Q ss_pred CCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCC
Q 012462 345 VDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEY 419 (463)
Q Consensus 345 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~ 419 (463)
|..... ............ .... .... ..+..++.+||+.||++|||+.++++.|+++..
T Consensus 277 ~~~~~~------~~~~~~~~~~~~-~~~~------~~~~---~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 277 YYGMAH------EEVIYYVRDGNI-LACP------ENCP---LELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp TTTSCH------HHHHHHHHTTCC-CCCC------TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCCCh------HHHHHHHhCCCc-CCCC------CCCC---HHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 975432 122222222211 1110 0111 234445668999999999999999999998754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=359.30 Aligned_cols=251 Identities=23% Similarity=0.312 Sum_probs=196.2
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEE
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHR 212 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 212 (463)
+..++|++.+.||+|+||+||+|+.. +++.||+|++.... ......+..|..++..+ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 34578999999999999999999764 58899999986432 23345677899999887 799999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccce
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~ 292 (463)
|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++
T Consensus 100 ~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEcccccee
Confidence 9999999999999998643 4599999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccc
Q 012462 293 LLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV 372 (463)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (463)
...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... +....+....
T Consensus 173 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~~~----- 240 (353)
T 3txo_A 173 EGICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAILNDE----- 240 (353)
T ss_dssp CSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCC-----
T ss_pred ecccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH------HHHHHHHcCC-----
Confidence 643322 2344568999999999999999999999999999999999999999764321 2222222211
Q ss_pred ccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCH------HHHHHH
Q 012462 373 VDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKM------SQVVRM 413 (463)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~------~ell~~ 413 (463)
...+... ......++.+||+.||.+||++ +|++++
T Consensus 241 ----~~~p~~~--~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 241 ----VVYPTWL--HEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp ----CCCCTTS--CHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred ----CCCCCCC--CHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 1111111 1123344558999999999998 777763
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=361.77 Aligned_cols=264 Identities=28% Similarity=0.426 Sum_probs=210.6
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEEc--------CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCC-CCCCcceEeeEE
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNLI--------NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYC 206 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 206 (463)
++..++|.+.+.||+|+||+||+|... .+..||+|++.... ......+.+|+.+++++ +||||++++++|
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 445678999999999999999999752 23579999986543 33446788999999999 999999999999
Q ss_pred EECcEEEEEEeecCCCCHHHHHhhhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCc
Q 012462 207 IEGIHRMLVYEYVNNGNLEQWLHGAMR------------HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSN 274 (463)
Q Consensus 207 ~~~~~~~lV~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~N 274 (463)
.+.+..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+. +|+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcce
Confidence 999999999999999999999976431 124599999999999999999999999 99999999999
Q ss_pred eeEcCCCCEEEeecccceecCCCCc-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcc
Q 012462 275 ILIDDDFNAKVSDFGLAKLLGAGKS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAH 352 (463)
Q Consensus 275 ill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~ 352 (463)
||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~-- 299 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-- 299 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999987654322 22334567889999999999999999999999999999999 9999975432
Q ss_pred cccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCC
Q 012462 353 EVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEY 419 (463)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~ 419 (463)
................ ..... .+..++.+||+.||++|||++|+++.|+.+..
T Consensus 300 ----~~~~~~~~~~~~~~~~-------~~~~~---~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 300 ----EELFKLLKEGHRMDKP-------SNCTN---ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp ----HHHHHHHHTTCCCCCC-------SSCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHHHHHHcCCCCCCC-------ccCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 2222222222111110 11112 34445668999999999999999999988743
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=344.66 Aligned_cols=256 Identities=28% Similarity=0.462 Sum_probs=207.8
Q ss_pred HhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
..++|++.+.||+|+||.||+|...++..||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 3567999999999999999999888888999999865432 346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 85 MEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp CTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccc
Confidence 999999999964 234689999999999999999999999 99999999999999999999999999998654332
Q ss_pred ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCC
Q 012462 299 SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNI 377 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (463)
........++..|+|||++.+..++.++||||||+++|+|++ |..||..... .............. .+
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~i~~~~~~~---~~-- 227 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVEDISTGFRLY---KP-- 227 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTTCCCC---CC--
T ss_pred ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH------HHHHHHHhcCCcCC---CC--
Confidence 222234457788999999999999999999999999999999 8999975432 12222222221110 00
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 378 EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.... ..+..++.+||+.||++|||+.++++.|+++
T Consensus 228 --~~~~---~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 228 --RLAS---THVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp --TTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --ccCc---HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0111 2334456689999999999999999999875
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=363.11 Aligned_cols=253 Identities=22% Similarity=0.308 Sum_probs=201.4
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
.++|++.+.||+|+||+||+|.. .+|+.+|+|++.... ......+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 56799999999999999999955 568899999985443 234467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEc---CCCCEEEeeccccee
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILID---DDFNAKVSDFGLAKL 293 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~---~~~~~kl~Dfg~a~~ 293 (463)
||+.+|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++..
T Consensus 90 E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 90 DLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp CCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 99999999999864 35699999999999999999999999 999999999999998 568899999999987
Q ss_pred cCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccc
Q 012462 294 LGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373 (463)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (463)
..... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ............ +
T Consensus 163 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~~--~- 232 (444)
T 3soa_A 163 VEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH------RLYQQIKAGAYD--F- 232 (444)
T ss_dssp CCTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHTCCC--C-
T ss_pred ecCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH------HHHHHHHhCCCC--C-
Confidence 65432 2234568999999999999999999999999999999999999999754321 112222211110 0
Q ss_pred cCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
+.......... +..++.+||+.||++|||+.|++++
T Consensus 233 -~~~~~~~~s~~---~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 233 -PSPEWDTVTPE---AKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -CTTTTTTSCHH---HHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -CccccccCCHH---HHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00011111223 3344557999999999999999885
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=351.30 Aligned_cols=264 Identities=22% Similarity=0.403 Sum_probs=193.6
Q ss_pred HHHHHhcCCCccCeEeecCcEEEEEEEEcCCC----eEEEEEEccc--chhhHHHHHHHHHHHcCCCCCCcceEeeEEEE
Q 012462 135 DLELATNRFSKENVLGEGGYGVVYRGNLINGS----PVAVKKILNN--VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 208 (463)
Q Consensus 135 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~----~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 208 (463)
++.+..++|++.+.||+|+||+||+|...... .||||.+... .....+.+.+|+.++++++||||+++++++.+
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 34456688999999999999999999654432 7999988554 23445778899999999999999999999987
Q ss_pred CcEE------EEEEeecCCCCHHHHHhhhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCC
Q 012462 209 GIHR------MLVYEYVNNGNLEQWLHGAMRH--HGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDD 280 (463)
Q Consensus 209 ~~~~------~lV~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~ 280 (463)
.... ++||||+.+|+|.+++...... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCC
Confidence 7655 8999999999999999754322 23589999999999999999999999 99999999999999999
Q ss_pred CCEEEeecccceecCCCCc-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHH
Q 012462 281 FNAKVSDFGLAKLLGAGKS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVD 358 (463)
Q Consensus 281 ~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~ 358 (463)
+.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||....... ..
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~- 249 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---IY- 249 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH-
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---HH-
Confidence 9999999999987644322 11223456788999999999999999999999999999999 999998654322 11
Q ss_pred HHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 359 WLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
............ .... ..+..++.+||+.||++|||+.++++.|+++
T Consensus 250 --~~~~~~~~~~~~-------~~~~---~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 250 --NYLIGGNRLKQP-------PECM---EEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp --HHHHTTCCCCCC-------TTCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHhcCCCCCCC-------CccC---HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 112221111100 1111 2344556689999999999999999999886
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=344.14 Aligned_cols=252 Identities=27% Similarity=0.449 Sum_probs=192.1
Q ss_pred HhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccch----hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEE
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVG----QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 214 (463)
..++|++.+.||+|+||.||+|.+ .+..||||++..... ...+.+.+|+.+++.++||||+++++++.+....++
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred chhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 346899999999999999999987 588999998854322 234678889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC---eEEccCCCCceeEcC--------CCCE
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPK---VVHRDIKSSNILIDD--------DFNA 283 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~---i~H~Dikp~Nill~~--------~~~~ 283 (463)
||||+++++|.+++. ...+++..++.++.|++.||.|||+. + |+||||||+|||++. ++.+
T Consensus 84 v~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~ 155 (271)
T 3dtc_A 84 VMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKIL 155 (271)
T ss_dssp EEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred EEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcce
Confidence 999999999999984 34699999999999999999999999 7 999999999999986 7789
Q ss_pred EEeecccceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHH
Q 012462 284 KVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMM 363 (463)
Q Consensus 284 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 363 (463)
||+|||++....... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...... ......
T Consensus 156 kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~ 226 (271)
T 3dtc_A 156 KITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL------AVAYGV 226 (271)
T ss_dssp EECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHH
T ss_pred EEccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHhh
Confidence 999999998654332 22456899999999999999999999999999999999999999754321 111111
Q ss_pred hcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 364 VGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.......... .... ..+..++.+||+.||++|||+.|++++|+++
T Consensus 227 ~~~~~~~~~~------~~~~---~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 227 AMNKLALPIP------STCP---EPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HTSCCCCCCC------TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred hcCCCCCCCC------cccC---HHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1111111100 1111 2344456689999999999999999999863
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=364.42 Aligned_cols=263 Identities=22% Similarity=0.265 Sum_probs=206.5
Q ss_pred hHHHHHHhcCCCccCeEeecCcEEEEEEEEcC-CCeEEEEEEcccch---hhHHHHHHHHHHHcCCCCCCcceEeeEEEE
Q 012462 133 LRDLELATNRFSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNVG---QAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 208 (463)
Q Consensus 133 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 208 (463)
+.++.+..++|++.++||+|+||+||+|+... ++.||+|++..... .....+..|..++..++||||++++++|.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 45566677899999999999999999997754 68899999854221 122347789999999999999999999999
Q ss_pred CcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeec
Q 012462 209 GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDF 288 (463)
Q Consensus 209 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Df 288 (463)
....|+||||+++|+|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcch
Confidence 9999999999999999999964 245699999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCceeeccccccCCCCchhhhc-----cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHH
Q 012462 289 GLAKLLGAGKSHVTTRVMGTFGYVAPEYAN-----TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMM 363 (463)
Q Consensus 289 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 363 (463)
|+++.............+||+.|+|||++. ...|+.++|||||||+||||++|+.||....... ....+
T Consensus 220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~------~~~~i 293 (437)
T 4aw2_A 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKI 293 (437)
T ss_dssp TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHH
T ss_pred hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH------HHHhh
Confidence 999877655544455578999999999987 5678999999999999999999999998643221 11111
Q ss_pred hcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 012462 364 VGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEK--RPKMSQVVRM 413 (463)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~--RPs~~ell~~ 413 (463)
........+ +.. ........ ..++.+||..+|++ ||+++|++++
T Consensus 294 ~~~~~~~~~--p~~-~~~~s~~~---~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 294 MNHKERFQF--PTQ-VTDVSENA---KDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HTHHHHCCC--CSS-CCCSCHHH---HHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred hhccccccC--Ccc-cccCCHHH---HHHHHHHhcccccccCCCCHHHHhCC
Confidence 110000000 000 01112222 33455788888888 9999999875
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=354.49 Aligned_cols=253 Identities=19% Similarity=0.281 Sum_probs=204.1
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
.++|++.+.||+|+||.||+|... +++.||+|.+..........+.+|+.++..++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 367999999999999999999664 6889999998766555567888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC--CCCEEEeecccceecCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD--DFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~--~~~~kl~Dfg~a~~~~~ 296 (463)
+++|+|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||++.....
T Consensus 130 ~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 999999998853 234689999999999999999999999 9999999999999974 57899999999988754
Q ss_pred CCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (463)
... ....+||+.|+|||++.+..++.++|||||||++|||++|..||..... ...+......... ....
T Consensus 204 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~i~~~~~~---~~~~ 272 (387)
T 1kob_A 204 DEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------LETLQNVKRCDWE---FDED 272 (387)
T ss_dssp TSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHHCCCC---CCSS
T ss_pred Ccc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCC---CCcc
Confidence 332 2334789999999999999999999999999999999999999976432 1222222211110 0000
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
....... .+..++.+||+.||++|||+.|++++
T Consensus 273 -~~~~~s~---~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 273 -AFSSVSP---EAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp -TTTTSCH---HHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -ccccCCH---HHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0111122 33445668999999999999999975
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=361.51 Aligned_cols=261 Identities=25% Similarity=0.397 Sum_probs=206.3
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEEc------CCCeEEEEEEccc-chhhHHHHHHHHHHHcCCCCCCcceEeeEEEECc
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNN-VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGI 210 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 210 (463)
+..++|++.+.||+|+||+||+|.+. ++..||||++... .......+.+|+.++.+++||||+++++++.+..
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 34578999999999999999999743 4568999998543 3444567888999999999999999999999999
Q ss_pred EEEEEEeecCCCCHHHHHhhhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCC---CEE
Q 012462 211 HRMLVYEYVNNGNLEQWLHGAMR---HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDF---NAK 284 (463)
Q Consensus 211 ~~~lV~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~---~~k 284 (463)
..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++ .+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEE
Confidence 99999999999999999976432 224589999999999999999999999 999999999999999555 599
Q ss_pred EeecccceecCCCC-ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHH
Q 012462 285 VSDFGLAKLLGAGK-SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKM 362 (463)
Q Consensus 285 l~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~ 362 (463)
|+|||+++...... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||..... ......
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~------~~~~~~ 298 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------QEVLEF 298 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHH
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHH
Confidence 99999997543211 112234567899999999999999999999999999999998 9999976432 222222
Q ss_pred HhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 363 MVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.......... .... ..+..++.+||+.||++|||+.||+++|+..
T Consensus 299 i~~~~~~~~~-------~~~~---~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 299 VTSGGRMDPP-------KNCP---GPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp HHTTCCCCCC-------TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHcCCCCCCC-------ccCC---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 2222211110 0111 2334456689999999999999999999875
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=344.44 Aligned_cols=262 Identities=25% Similarity=0.358 Sum_probs=196.8
Q ss_pred cCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccch--hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
++|++.+.||+|+||+||+|...+++.||+|++..... .....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57899999999999999999887899999999854332 2236778899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+++ +|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 975 99998864 235689999999999999999999999 99999999999999999999999999998764322
Q ss_pred ceeeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccc-----
Q 012462 299 SHVTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV----- 372 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 372 (463)
. ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||....... ....+............
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGG
T ss_pred c-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHHCCCChhhchhhhc
Confidence 1 23345789999999998764 58999999999999999999999997643211 11111111111100000
Q ss_pred ---ccCCCCCCC-------CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 373 ---VDPNIEVRP-------STRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 373 ---~~~~~~~~~-------~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.++...... ..........++.+||+.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000000 00011233445668999999999999999874
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=349.29 Aligned_cols=251 Identities=24% Similarity=0.331 Sum_probs=202.1
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccch------hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVG------QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHR 212 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 212 (463)
.++|++.+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356999999999999999999764 588999999854322 1357788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCC----CEEEeec
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDF----NAKVSDF 288 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~----~~kl~Df 288 (463)
++||||+++++|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++ .+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHT----TSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 99999999999999985 345699999999999999999999999 999999999999999887 8999999
Q ss_pred ccceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCC-
Q 012462 289 GLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR- 367 (463)
Q Consensus 289 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~- 367 (463)
|++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..+.......
T Consensus 163 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~~~~~~~ 234 (326)
T 2y0a_A 163 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANVSAVNY 234 (326)
T ss_dssp TTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHHTCC
T ss_pred CCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH------HHHHHHHhcCC
Confidence 9998765432 233467999999999999999999999999999999999999999754321 1111111111
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 368 RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
...... ..... ..+..++.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~-----~~~~~---~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 235 EFEDEY-----FSNTS---ALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CCCHHH-----HTTSC---HHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CcCccc-----cccCC---HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000 00111 223345668999999999999999985
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=351.30 Aligned_cols=247 Identities=25% Similarity=0.381 Sum_probs=199.2
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 215 (463)
.++|.+.+.||+|+||+||+|.. .+++.||+|++.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36799999999999999999975 578899999985432 12235788899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
|||+ +|+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 88 ~E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 7899998864 24599999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCceeeccccccCCCCchhhhccCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccccc
Q 012462 296 AGKSHVTTRVMGTFGYVAPEYANTGLL-NEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVD 374 (463)
Q Consensus 296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (463)
... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......... ..+..
T Consensus 160 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~---------------~~i~~ 222 (336)
T 3h4j_B 160 DGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF---------------KKVNS 222 (336)
T ss_dssp TSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB---------------CCCCS
T ss_pred CCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH---------------HHHHc
Confidence 432 2344679999999999988776 68999999999999999999999764322211 01111
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 375 PNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.....+... ...+..++.+||+.||.+|||++|++++
T Consensus 223 ~~~~~p~~~--s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 223 CVYVMPDFL--SPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp SCCCCCTTS--CHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CCCCCcccC--CHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 111111111 1223445668999999999999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=351.77 Aligned_cols=259 Identities=15% Similarity=0.165 Sum_probs=205.7
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEEEEEEe
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e 217 (463)
.++|++.+.||+|+||+||+|.. .+++.||||.+..... ...+..|+.+++++ +||||+++++++.+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46799999999999999999965 5788999998854322 24577899999999 99999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCC-----EEEeecccce
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFN-----AKVSDFGLAK 292 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~-----~kl~Dfg~a~ 292 (463)
|+ +++|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++. +||+|||+++
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 86 LL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred eC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99 89999999743 45699999999999999999999999 9999999999999998887 9999999998
Q ss_pred ecCCCCce------eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcC
Q 012462 293 LLGAGKSH------VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGS 366 (463)
Q Consensus 293 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 366 (463)
........ .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..............+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence 76443221 124568999999999999999999999999999999999999999876433322222221111100
Q ss_pred CCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 367 RRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
..... .....+ .+..++.+||+.||.+||++.+|++.|++.
T Consensus 239 ~~~~~-------~~~~~p---~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 239 TPIEV-------LCENFP---EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp SCHHH-------HTTTCH---HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CCHHH-------HhccCh---HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 00000 001111 444556679999999999999999999765
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=358.43 Aligned_cols=261 Identities=20% Similarity=0.254 Sum_probs=206.1
Q ss_pred hHHHHHHhcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccch---hhHHHHHHHHHHHcCCCCCCcceEeeEEEE
Q 012462 133 LRDLELATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVG---QAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 208 (463)
Q Consensus 133 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 208 (463)
+.++....++|++.++||+|+||+||+|+.. +++.||+|++..... .....+..|+.++..++||||++++++|.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4455666789999999999999999999765 578999999854221 122347789999999999999999999999
Q ss_pred CcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeec
Q 012462 209 GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDF 288 (463)
Q Consensus 209 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Df 288 (463)
....|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++++||+||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecc
Confidence 9999999999999999999853 2489999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCceeeccccccCCCCchhhhccCC----CCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHh
Q 012462 289 GLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGL----LNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMV 364 (463)
Q Consensus 289 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 364 (463)
|+++.............+||+.|+|||++.+.. ++.++|||||||+||||++|+.||...... .....+.
T Consensus 213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~ 286 (410)
T 3v8s_A 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIM 286 (410)
T ss_dssp TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHH
T ss_pred ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh------hHHHHHH
Confidence 999887655444455678999999999998765 889999999999999999999999754321 1112221
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHHH
Q 012462 365 GSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEK--RPKMSQVVRML 414 (463)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~--RPs~~ell~~L 414 (463)
.......+ +. ........ ..++.+||+.+|.+ ||+++|++++-
T Consensus 287 ~~~~~~~~--p~--~~~~s~~~---~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 287 NHKNSLTF--PD--DNDISKEA---KNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp THHHHCCC--CT--TCCCCHHH---HHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred hccccccC--CC--cccccHHH---HHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 11000000 00 01112222 33455799999988 99999999863
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=353.81 Aligned_cols=252 Identities=22% Similarity=0.327 Sum_probs=201.6
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
.++|++.+.||+|+||.||+|.. .++..||+|++.... ......+.+|+.++++++||||+++++++.+....|+||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46799999999999999999965 468899999985432 334467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCC---CCEEEeeccccee
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDD---FNAKVSDFGLAKL 293 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~---~~~kl~Dfg~a~~ 293 (463)
||+++|+|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||++..
T Consensus 108 e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 108 DLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp CCCCSCBHHHHHT----TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred ecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 9999999999885 345699999999999999999999999 99999999999999865 4599999999987
Q ss_pred cCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccc
Q 012462 294 LGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373 (463)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (463)
..... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||..... ............. .
T Consensus 181 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~------~~~~~~i~~~~~~--~- 249 (362)
T 2bdw_A 181 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------HRLYAQIKAGAYD--Y- 249 (362)
T ss_dssp CTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCC--C-
T ss_pred ecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCCCC--C-
Confidence 65432 23456799999999999999999999999999999999999999975432 1112222111110 0
Q ss_pred cCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
+........ ..+..++.+||+.||++|||+.|++++
T Consensus 250 -~~~~~~~~~---~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 -PSPEWDTVT---PEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -CTTGGGGSC---HHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -CcccccCCC---HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000001111 233445668999999999999999875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=347.99 Aligned_cols=246 Identities=24% Similarity=0.336 Sum_probs=201.0
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 215 (463)
.++|++.+.||+|+||+||+|+.. +|+.||+|++.... ....+.+..|+.+++.++||||+++++++.+....|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357899999999999999999764 68999999985432 23345677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 999999999999964 34589999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 296 AGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|..||..... ...........
T Consensus 158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~-------- 219 (318)
T 1fot_A 158 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNAE-------- 219 (318)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHCC--------
T ss_pred Cc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC--------
Confidence 32 2346899999999999999999999999999999999999999975432 12222222211
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 012462 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRP-----KMSQVVRM 413 (463)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP-----s~~ell~~ 413 (463)
...+... ...+..++.+||+.||++|| +++|++++
T Consensus 220 -~~~p~~~--~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 220 -LRFPPFF--NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp -CCCCTTS--CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCCC--CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 1111111 11233445579999999999 89999864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=350.02 Aligned_cols=249 Identities=24% Similarity=0.352 Sum_probs=192.1
Q ss_pred hcCCCccCeEeecCcEEEEEEEE----cCCCeEEEEEEcccc----hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL----INGSPVAVKKILNNV----GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIH 211 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 211 (463)
.++|++.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+.++++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999976 478899999986542 2234567789999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccc
Q 012462 212 RMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA 291 (463)
Q Consensus 212 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a 291 (463)
.|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 9999999999999999864 24589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccc
Q 012462 292 KLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEE 371 (463)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (463)
+...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+....
T Consensus 169 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~---- 237 (327)
T 3a62_A 169 KESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK------KTIDKILKCK---- 237 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHTC----
T ss_pred cccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCC----
Confidence 7643322 2234567999999999999999999999999999999999999999754321 1122222111
Q ss_pred cccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 012462 372 VVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRP-----KMSQVVRM 413 (463)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP-----s~~ell~~ 413 (463)
....... ...+..++.+||+.||++|| ++.|++++
T Consensus 238 -----~~~p~~~--~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 238 -----LNLPPYL--TQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp -----CCCCTTS--CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred -----CCCCCCC--CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 1111111 12233445689999999999 78888875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=340.06 Aligned_cols=261 Identities=22% Similarity=0.336 Sum_probs=198.3
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
++|++.+.||+|+||+||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++.++...++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57899999999999999999764 58899999985433 3334678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
|+++ +|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9976 66666643 345699999999999999999999999 9999999999999999999999999999876533
Q ss_pred CceeeccccccCCCCchhhhccCC-CCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccc---
Q 012462 298 KSHVTTRVMGTFGYVAPEYANTGL-LNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV--- 373 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 373 (463)
. .......||+.|+|||++.+.. ++.++|||||||++|||++|..||...... ......+.............
T Consensus 155 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 155 V-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp C-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCCCTTTCTTGG
T ss_pred c-ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHHHhCCCChhhhhhhc
Confidence 2 2234457899999999997765 899999999999999999999887543321 11112121111111100000
Q ss_pred ---c-----------CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 374 ---D-----------PNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 374 ---~-----------~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
+ ......+. .......++.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPK--LNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTT--CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccccccCCcchhhcccc--cChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 00000001 11223345568999999999999999874
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=351.63 Aligned_cols=257 Identities=27% Similarity=0.450 Sum_probs=197.8
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCe----EEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSP----VAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRM 213 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 213 (463)
.++|++.+.||+|+||+||+|.+. +++. ||+|.+.... ....+.+.+|+.++++++||||++++++|.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 467999999999999999999753 4443 5778764332 344578889999999999999999999998765 78
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
+|+||+.+|+|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 99999999999999964 345699999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCce-eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccc
Q 012462 294 LGAGKSH-VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEE 371 (463)
Q Consensus 294 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (463)
....... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... +... .........
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~---~~~~~~~~~ 240 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSI---LEKGERLPQ 240 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH---HHTTCCCCC
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HHHH---HHcCCCCCC
Confidence 6543322 2233456889999999999999999999999999999999 999998654322 1111 111111110
Q ss_pred cccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCC
Q 012462 372 VVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEY 419 (463)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~ 419 (463)
. ......+..++.+||+.||++||++.|++++|+....
T Consensus 241 --------~--~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 241 --------P--PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp --------C--TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred --------C--ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0 1112234455668999999999999999999987643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=355.70 Aligned_cols=250 Identities=21% Similarity=0.301 Sum_probs=200.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 215 (463)
.++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++..++||||++++++|.+....|+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467999999999999999999654 57889999985432 23346788899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
|||+.+|+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 94 ~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp ECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 999999999999853 45699999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCceeeccccccCCCCchhhhcc---CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccc
Q 012462 296 AGKSHVTTRVMGTFGYVAPEYANT---GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV 372 (463)
Q Consensus 296 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (463)
... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||............ .......
T Consensus 167 ~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~---~~~~~~~----- 236 (384)
T 4fr4_A 167 RET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV---HTFETTV----- 236 (384)
T ss_dssp TTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHH---HHHHHCC-----
T ss_pred CCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHH---HHHhhcc-----
Confidence 432 3455789999999999864 45899999999999999999999999765433222221 1111110
Q ss_pred ccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 012462 373 VDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPK-MSQVVR 412 (463)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs-~~ell~ 412 (463)
...+... ...+..++.+||+.||.+||+ ++++++
T Consensus 237 ----~~~p~~~--s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 ----VTYPSAW--SQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ----CCCCTTS--CHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ----cCCCCcC--CHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0111111 123344556799999999998 777765
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=348.11 Aligned_cols=269 Identities=23% Similarity=0.319 Sum_probs=208.1
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEE----CcEE
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE----GIHR 212 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 212 (463)
+..++|++.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+.+++.++||||+++++++.. ....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 4457899999999999999999976 6789999999866656667788999999999999999999999873 3467
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccce
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~ 292 (463)
++||||+.+|+|.+++.........+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 899999999999999987655667899999999999999999999999 99999999999999999999999999987
Q ss_pred ecCCCCce--------eeccccccCCCCchhhhccCC---CCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHH
Q 012462 293 LLGAGKSH--------VTTRVMGTFGYVAPEYANTGL---LNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLK 361 (463)
Q Consensus 293 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 361 (463)
........ ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||........ .....
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~-- 259 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVALA-- 259 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHHH--
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhHH--
Confidence 65321100 012245799999999987654 68899999999999999999999953211110 11111
Q ss_pred HHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCCCCcc
Q 012462 362 MMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVR 423 (463)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~ 423 (463)
....... +. ..... ..+..++.+||+.||.+|||+.+++++|+.+..+...
T Consensus 260 -~~~~~~~-----~~--~~~~~---~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 310 (317)
T 2buj_A 260 -VQNQLSI-----PQ--SPRHS---SALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310 (317)
T ss_dssp -HHCC--C-----CC--CTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred -hhccCCC-----Cc--cccCC---HHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence 1110000 00 01111 2344456689999999999999999999998665543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=356.42 Aligned_cols=268 Identities=25% Similarity=0.382 Sum_probs=207.2
Q ss_pred HHHHhcCCCccCeEeecCcEEEEEEEEc------CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCC-CCCCcceEeeEEE
Q 012462 136 LELATNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCI 207 (463)
Q Consensus 136 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 207 (463)
+++..++|++.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.++.++ +||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 4556788999999999999999999752 34579999986443 23346788999999999 8999999999999
Q ss_pred ECcEEEEEEeecCCCCHHHHHhhhhcC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEc
Q 012462 208 EGIHRMLVYEYVNNGNLEQWLHGAMRH-------------------HGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHR 268 (463)
Q Consensus 208 ~~~~~~lV~e~~~~g~L~~~l~~~~~~-------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~ 268 (463)
+.+..++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+. +|+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence 999999999999999999999753221 13479999999999999999999999 99999
Q ss_pred cCCCCceeEcCCCCEEEeecccceecCCCCc-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCC
Q 012462 269 DIKSSNILIDDDFNAKVSDFGLAKLLGAGKS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVD 346 (463)
Q Consensus 269 Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~ 346 (463)
||||+|||++.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|||+| |..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999986643322 22344567889999999999999999999999999999998 999997
Q ss_pred CCCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCCCC
Q 012462 347 HGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPI 421 (463)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 421 (463)
....... .. ........... . .... ..+..++.+||+.||.+|||+.|++++|+......
T Consensus 277 ~~~~~~~--~~----~~~~~~~~~~~-----~-~~~~---~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 277 GIPVDAN--FY----KLIQNGFKMDQ-----P-FYAT---EEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp TCCCSHH--HH----HHHHTTCCCCC-----C-TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred cCCcHHH--HH----HHHhcCCCCCC-----C-CCCC---HHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 6543211 11 11111111000 0 0111 23344566899999999999999999999875543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=346.33 Aligned_cols=252 Identities=17% Similarity=0.273 Sum_probs=203.2
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
.++|++.+.||+|+||+||+|... ++..||+|.+... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999664 5788999988543 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC--CCCEEEeecccceecCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD--DFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~--~~~~kl~Dfg~a~~~~~ 296 (463)
+++|+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||++.....
T Consensus 83 ~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 83 ISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 999999999853 234699999999999999999999999 9999999999999987 78999999999988754
Q ss_pred CCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (463)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..+............ .
T Consensus 157 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~~~~~-~-- 225 (321)
T 1tki_A 157 GD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMNAEYTFDE-E-- 225 (321)
T ss_dssp TC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCCCCH-H--
T ss_pred CC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHHcCCCCCCh-h--
Confidence 43 233457899999999999988999999999999999999999999764321 222222211110000 0
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
..... ...+..++.+||+.||.+|||+.|++++
T Consensus 226 -~~~~~---s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 226 -AFKEI---SIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp -HHTTS---CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -hhccC---CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00011 1233455668999999999999999974
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=342.52 Aligned_cols=260 Identities=27% Similarity=0.416 Sum_probs=209.2
Q ss_pred HHHHHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEE
Q 012462 135 DLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 135 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 214 (463)
++++..++|++.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 84 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence 4456678899999999999999999998888899999986543 345678899999999999999999999864 46899
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
||||+++++|.+++.... ...+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 85 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp EEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 999999999999986422 12589999999999999999999999 9999999999999999999999999999887
Q ss_pred CCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccc
Q 012462 295 GAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373 (463)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (463)
............++..|+|||++.+..++.++||||||+++|||++ |+.||...... ..............
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~~~~~~~~~~~-- 231 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP------EVIQNLERGYRMVR-- 231 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHHHTTCCCCC--
T ss_pred cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH------HHHHHHhcccCCCC--
Confidence 6544333344567889999999998899999999999999999999 99999754321 22222222111100
Q ss_pred cCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
...... .+..++.+||+.||++|||+.++++.|++.
T Consensus 232 -----~~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 232 -----PDNCPE---ELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp -----CTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----cccccH---HHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 011112 334455679999999999999999999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=346.76 Aligned_cols=262 Identities=25% Similarity=0.406 Sum_probs=212.9
Q ss_pred HHHHHhcCCCccCeEeecCcEEEEEEEEcC-CCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEE
Q 012462 135 DLELATNRFSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRM 213 (463)
Q Consensus 135 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 213 (463)
++++..++|++.+.||+|+||+||+|.+.. +..||+|.+... ....+.+.+|+.++++++||||+++++++.+....+
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 345567889999999999999999997654 788999998654 334567888999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
+||||+++++|.+++... ....+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++..
T Consensus 86 ~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL 160 (288)
T ss_dssp EEEECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred EEEEcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCcccee
Confidence 999999999999999652 345699999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCcccc
Q 012462 294 LGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV 372 (463)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (463)
.............+|+.|+|||++.+..++.++||||||+++|+|++ |..||....... .... ..........
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~~~---~~~~~~~~~~ 234 (288)
T 3kfa_A 161 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYEL---LEKDYRMERP 234 (288)
T ss_dssp SCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHH---HHTTCCCCCC
T ss_pred ccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH---HhccCCCCCC
Confidence 66554444455567889999999999999999999999999999999 999997654322 2111 1111111000
Q ss_pred ccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCC
Q 012462 373 VDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEE 418 (463)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~ 418 (463)
.... ..+..++.+||+.||.+|||+.|+++.|+...
T Consensus 235 -------~~~~---~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 235 -------EGCP---EKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp -------TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCC---HHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 1111 23344566899999999999999999998753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=340.21 Aligned_cols=262 Identities=18% Similarity=0.219 Sum_probs=207.0
Q ss_pred HhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEEEEEE
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 216 (463)
..++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+|+.++..+ +|+|++++++++.+....++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 357899999999999999999965 578899999885432 234577789999988 8999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCC-----EEEeecccc
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFN-----AKVSDFGLA 291 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~-----~kl~Dfg~a 291 (463)
||+ +++|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++. +||+|||++
T Consensus 86 e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 86 DLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred Eec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 999 99999999643 34599999999999999999999999 9999999999999987776 999999999
Q ss_pred eecCCCCce------eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhc
Q 012462 292 KLLGAGKSH------VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVG 365 (463)
Q Consensus 292 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 365 (463)
......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 876543221 23456799999999999999999999999999999999999999987554333222222211111
Q ss_pred CCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCC
Q 012462 366 SRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEE 418 (463)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~ 418 (463)
........ .... ..+..++.+||+.||++||++++|++.|+++.
T Consensus 239 ~~~~~~~~------~~~~---~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 239 STPLRELC------AGFP---EEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp HSCHHHHT------TTSC---HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred CccHHHHH------hhCc---HHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 11101000 0111 23344556799999999999999999998763
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=351.00 Aligned_cols=257 Identities=27% Similarity=0.442 Sum_probs=196.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCe----EEEEEEccc-chhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSP----VAVKKILNN-VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRM 213 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 213 (463)
.++|++.+.||+|+||+||+|.+. +++. ||+|.+... .......+.+|+.++++++||||++++++|.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 478999999999999999999653 4554 467766433 2345678889999999999999999999998765 78
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
+|+||+.+|+|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 99999999999999974 345699999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCc-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccc
Q 012462 294 LGAGKS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEE 371 (463)
Q Consensus 294 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (463)
...... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||....... +... .........
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~---~~~~~~~~~ 240 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSI---LEKGERLPQ 240 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH---HHTTCCCCC
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHH---HHcCCCCCC
Confidence 643322 12233456788999999999999999999999999999999 999998654322 1111 111111110
Q ss_pred cccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCC
Q 012462 372 VVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEY 419 (463)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~ 419 (463)
...... .+..++.+||+.||.+||++.|+++.|+....
T Consensus 241 -------~~~~~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 241 -------PPICTI---DVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp -------CTTBCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred -------CccCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 011112 34445668999999999999999999998643
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=340.31 Aligned_cols=255 Identities=22% Similarity=0.336 Sum_probs=201.1
Q ss_pred hcCCCccCeEeecCcEEEEEEEEcC-C-------CeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLIN-G-------SPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIH 211 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 211 (463)
.++|++.+.||+|+||+||+|.... + ..||+|.+........+.+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 5679999999999999999996543 3 4699999876666667889999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCC--------E
Q 012462 212 RMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFN--------A 283 (463)
Q Consensus 212 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~--------~ 283 (463)
.++||||+++++|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++. +
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccccccccee
Confidence 99999999999999999753 23489999999999999999999999 9999999999999998887 9
Q ss_pred EEeecccceecCCCCceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 012462 284 KVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKM 362 (463)
Q Consensus 284 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 362 (463)
||+|||++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|..|+...... ......
T Consensus 161 kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-----~~~~~~ 230 (289)
T 4fvq_A 161 KLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-----QRKLQF 230 (289)
T ss_dssp EECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----HHHHHH
T ss_pred eeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-----HHHHHH
Confidence 9999999865432 223457899999999987 67899999999999999999965555432211 111111
Q ss_pred HhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCCCCc
Q 012462 363 MVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIV 422 (463)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 422 (463)
.......... ... .+..++.+||+.||++|||+.|++++|+++..+..
T Consensus 231 ~~~~~~~~~~------~~~------~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 231 YEDRHQLPAP------KAA------ELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp HHTTCCCCCC------SSC------TTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred hhccCCCCCC------CCH------HHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 1111111110 011 12344568999999999999999999999866543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=346.60 Aligned_cols=250 Identities=23% Similarity=0.327 Sum_probs=193.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccch--------------------------hhHHHHHHHHHHHc
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVG--------------------------QAEKEFRVEVEAIG 192 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~ 192 (463)
.++|++.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46899999999999999999965 4678999999854321 11246788999999
Q ss_pred CCCCCCcceEeeEEEE--CcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccC
Q 012462 193 HVRHKNLVRLLGYCIE--GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDI 270 (463)
Q Consensus 193 ~l~h~niv~l~~~~~~--~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Di 270 (463)
+++||||+++++++.+ ....++||||+++++|.+++ ....+++..++.++.||+.||.|||++ +|+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence 9999999999999987 56889999999999987754 235699999999999999999999999 9999999
Q ss_pred CCCceeEcCCCCEEEeecccceecCCCCceeeccccccCCCCchhhhccCC---CCccchhhhHHHHHHHHHhCCCCCCC
Q 012462 271 KSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGL---LNEKSDVYSFGVLLLEAITGRDPVDH 347 (463)
Q Consensus 271 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~elltg~~pf~~ 347 (463)
||+|||++.++.+||+|||++........ ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999987654332 234567999999999997765 47889999999999999999999975
Q ss_pred CCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 348 GRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
... ............ . . + ....... .+..++.+||+.||++|||+.|++++
T Consensus 243 ~~~------~~~~~~~~~~~~-~-~--~--~~~~~~~---~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 243 ERI------MCLHSKIKSQAL-E-F--P--DQPDIAE---DLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp SSH------HHHHHHHHHCCC-C-C--C--SSSCCCH---HHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred ccH------HHHHHHHhcccC-C-C--C--CccccCH---HHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 421 122222211110 0 0 0 0011122 23445568999999999999999763
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=356.32 Aligned_cols=256 Identities=24% Similarity=0.310 Sum_probs=197.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccch---hhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVG---QAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 214 (463)
.++|++.++||+|+||+||+|+.. +++.||+|++..... .....+..|..++.++ +||||++++++|.+....|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467999999999999999999765 577899999865432 2224577788888776 89999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
||||+++|+|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++++||+|||+++..
T Consensus 131 V~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 9999999999999864 24599999999999999999999999 9999999999999999999999999999863
Q ss_pred CCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCccc--ccHHHHHHHHhcCCCcccc
Q 012462 295 GAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHE--VNLVDWLKMMVGSRRSEEV 372 (463)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 372 (463)
... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+........
T Consensus 204 ~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~---- 278 (396)
T 4dc2_A 204 LRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---- 278 (396)
T ss_dssp CCT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC----
T ss_pred ccC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc----
Confidence 322 2234557899999999999999999999999999999999999999975332211 111111111111111
Q ss_pred ccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCH------HHHHHH
Q 012462 373 VDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKM------SQVVRM 413 (463)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~------~ell~~ 413 (463)
...+... ......++.+||+.||.+||++ +|++++
T Consensus 279 ----~~~p~~~--s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 279 ----IRIPRSL--SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp ----CCCCTTS--CHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred ----cCCCCcC--CHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 1111111 1223345568999999999996 566553
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=338.56 Aligned_cols=262 Identities=26% Similarity=0.455 Sum_probs=194.0
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEE
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 214 (463)
++..++|++.+.||+|+||+||+|... ..||+|++.... ....+.+.+|+.++++++||||+++++++ .....++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 455788999999999999999999753 469999985433 34456788999999999999999999965 4556899
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
||||+++++|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 97 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp EEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred EEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccc
Confidence 9999999999999863 345699999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCC-ceeeccccccCCCCchhhhc---cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 295 GAGK-SHVTTRVMGTFGYVAPEYAN---TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 295 ~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
.... ........||+.|+|||++. +..++.++||||||+++|+|++|+.||....... .............
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~~~~~ 245 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-----QIIEMVGRGSLSP 245 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH-----HHHHHHHHTSCCC
T ss_pred ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH-----HHHHHhcccccCc
Confidence 4321 22234457899999999986 6678899999999999999999999997644221 1111121111111
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCC
Q 012462 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEE 418 (463)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~ 418 (463)
..... ..... ..+..++.+||+.||++|||+.|+++.|+++.
T Consensus 246 ~~~~~---~~~~~---~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 246 DLSKV---RSNCP---KRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CTTSS---CTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred chhhc---cccCC---HHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 11000 01111 23344556799999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=346.68 Aligned_cols=251 Identities=22% Similarity=0.367 Sum_probs=195.2
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECc--------
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGI-------- 210 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------- 210 (463)
++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++||||++++++|.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 56899999999999999999775 78999999985433 345578899999999999999999999986643
Q ss_pred -------------------------------------------------EEEEEEeecCCCCHHHHHhhhhcCCCCCCHH
Q 012462 211 -------------------------------------------------HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWE 241 (463)
Q Consensus 211 -------------------------------------------------~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~ 241 (463)
..++||||+++++|.+++.... ......+.
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~ 164 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREHG 164 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-CccchhhH
Confidence 3799999999999999997532 22346777
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCc-----------eeeccccccCC
Q 012462 242 ARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS-----------HVTTRVMGTFG 310 (463)
Q Consensus 242 ~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-----------~~~~~~~gt~~ 310 (463)
.++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++........ ......+||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 8999999999999999999 999999999999999999999999999988754421 12234579999
Q ss_pred CCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHH
Q 012462 311 YVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSL 390 (463)
Q Consensus 311 y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (463)
|+|||++.+..++.++|||||||++|||++|..|+.. ........... .... ..........
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--------~~~~~~~~~~~-~~~~---------~~~~~~~~~~ 303 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--------RVRIITDVRNL-KFPL---------LFTQKYPQEH 303 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--------HHHHHHHHHTT-CCCH---------HHHHHCHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--------HHHHHHHhhcc-CCCc---------ccccCChhHH
Confidence 9999999999999999999999999999998766421 11111111111 1000 0011123334
Q ss_pred HHHhhccCCCCCCCCCHHHHHHH
Q 012462 391 LTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 391 ~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.++.+||+.||++|||+.|++++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCCCCcCCCHHHHhhc
Confidence 56668999999999999999874
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=355.02 Aligned_cols=253 Identities=22% Similarity=0.318 Sum_probs=191.4
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
.++|++.+.||+|+||+||+|... +++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 468999999999999999999765 68899999986533 2335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCC--EEEeecccceecCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFN--AKVSDFGLAKLLGA 296 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~--~kl~Dfg~a~~~~~ 296 (463)
+++|+|.+++.. .+.+++..++.++.||+.||.|||++ +|+||||||+|||++.++. +||+|||+++....
T Consensus 98 ~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 98 ASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999999864 23599999999999999999999999 9999999999999987765 99999999975432
Q ss_pred CCceeeccccccCCCCchhhhccCCCCcc-chhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEK-SDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
.. .....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||....... .....+........
T Consensus 171 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~~~~~~~~------- 239 (361)
T 3uc3_A 171 HS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRKTIQRILSVKY------- 239 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHHHHHHHHTTCC-------
T ss_pred cC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhcCCC-------
Confidence 21 2334579999999999988877655 899999999999999999998654322 22222222222111
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
...........+..++.+||+.||++|||+.|++++
T Consensus 240 --~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 240 --SIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp --CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred --CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 001100011233445668999999999999999975
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=352.90 Aligned_cols=205 Identities=21% Similarity=0.253 Sum_probs=177.6
Q ss_pred hcCCCccCeEeec--CcEEEEEEEEc-CCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEE
Q 012462 140 TNRFSKENVLGEG--GYGVVYRGNLI-NGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 140 ~~~~~~~~~lG~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 214 (463)
.++|++.++||+| +||+||+|... +++.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4689999999999 99999999765 68999999986443 3345678889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
||||+++|+|.+++... ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 104 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 99999999999999653 235599999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCc------eeeccccccCCCCchhhhcc--CCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 295 GAGKS------HVTTRVMGTFGYVAPEYANT--GLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 295 ~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
..... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 241 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence 32211 11223478999999999987 679999999999999999999999997644
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=349.15 Aligned_cols=264 Identities=26% Similarity=0.390 Sum_probs=209.6
Q ss_pred HHHHhcCCCccCeEeecCcEEEEEEEE------cCCCeEEEEEEcccch-hhHHHHHHHHHHHcCC-CCCCcceEeeEEE
Q 012462 136 LELATNRFSKENVLGEGGYGVVYRGNL------INGSPVAVKKILNNVG-QAEKEFRVEVEAIGHV-RHKNLVRLLGYCI 207 (463)
Q Consensus 136 ~~~~~~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 207 (463)
+++..++|++.+.||+|+||.||+|.+ .++..||+|.+..... ...+.+.+|+.++.++ +||||+++++++.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 345568899999999999999999975 2457899999865432 3457788999999999 9999999999999
Q ss_pred ECcEEEEEEeecCCCCHHHHHhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCC
Q 012462 208 EGIHRMLVYEYVNNGNLEQWLHGAMRH--------------HGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSS 273 (463)
Q Consensus 208 ~~~~~~lV~e~~~~g~L~~~l~~~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~ 273 (463)
+.+..++||||+++|+|.+++...... ...+++..++.++.||+.||.|||++ +|+||||||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~ 174 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAAR 174 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccc
Confidence 999999999999999999999754211 23589999999999999999999999 9999999999
Q ss_pred ceeEcCCCCEEEeecccceecCCCCce-eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCc
Q 012462 274 NILIDDDFNAKVSDFGLAKLLGAGKSH-VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPA 351 (463)
Q Consensus 274 Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~ 351 (463)
|||++.++.+||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 999999999999999999876544322 2334557889999999999999999999999999999999 99999765432
Q ss_pred ccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 352 HEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.. ....+ ...... .. ..... ..+..++.+||+.||.+|||+.|+++.|+..
T Consensus 255 ~~--~~~~~---~~~~~~--~~-----~~~~~---~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 255 SK--FYKMI---KEGFRM--LS-----PEHAP---AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp HH--HHHHH---HHTCCC--CC-----CTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hH--HHHHh---ccCCCC--CC-----cccCC---HHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 11 11111 111110 00 01111 2334456689999999999999999999875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=347.55 Aligned_cols=266 Identities=25% Similarity=0.339 Sum_probs=208.0
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-----cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEE--ECcEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-----INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI--EGIHR 212 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~ 212 (463)
.++|++.+.||+|+||.||+|.+ .++..||||++........+.+.+|+.++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 46899999999999999999974 457899999997766666778999999999999999999999987 45668
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccce
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~ 292 (463)
++||||+++++|.+++.... ..+++..++.++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccce
Confidence 99999999999999997532 3489999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCce--eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCc---------ccccHHHHHH
Q 012462 293 LLGAGKSH--VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPA---------HEVNLVDWLK 361 (463)
Q Consensus 293 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~---------~~~~~~~~~~ 361 (463)
........ ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||...... ..........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence 77544322 223346788899999999999999999999999999999999998643210 0011111111
Q ss_pred HHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCCCC
Q 012462 362 MMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPI 421 (463)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 421 (463)
......... .. ......+..++.+||+.||++|||+.|++++|+......
T Consensus 256 ~~~~~~~~~--------~~--~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 256 LLEEGQRLP--------AP--PACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHTTCCCC--------CC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred HhhcccCCC--------CC--CcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 111111110 01 111123344566899999999999999999999875433
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=378.37 Aligned_cols=264 Identities=28% Similarity=0.419 Sum_probs=211.5
Q ss_pred HHHHHHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEE
Q 012462 134 RDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRM 213 (463)
Q Consensus 134 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 213 (463)
..+++..++|++.++||+|+||.||+|.+.++..||||++.... ...+.|.+|+.++++++||||+++++++.+ ...+
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 34556678899999999999999999998888889999986543 335678999999999999999999999876 6789
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
+||||+.+|+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 338 lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 412 (535)
T ss_dssp EEECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred EeeehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEccccccee
Confidence 9999999999999996532 23589999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCcccc
Q 012462 294 LGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV 372 (463)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (463)
.............++..|+|||++.+..++.++|||||||+||||++ |+.||..... .+.+..+.......
T Consensus 413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~------~~~~~~i~~~~~~~-- 484 (535)
T 2h8h_A 413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLDQVERGYRMP-- 484 (535)
T ss_dssp CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH------HHHHHHHHTTCCCC--
T ss_pred cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCCCCC--
Confidence 54322222223456788999999999999999999999999999999 9999975432 12222222221111
Q ss_pred ccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCCC
Q 012462 373 VDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYP 420 (463)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~~ 420 (463)
.... ....+..++.+||+.||++|||+++|++.|+.....
T Consensus 485 ------~~~~--~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 485 ------CPPE--CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp ------CCTT--CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred ------CCCC--CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 0111 112344556689999999999999999999987543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=346.05 Aligned_cols=266 Identities=23% Similarity=0.325 Sum_probs=188.4
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
.++|++.+.||+|+||+||+|.. .+++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 35799999999999999999965 458899999985433 2234677889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 218 YVNNGNLEQWLHGAMR--HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
|++ |+|.+++..... ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 599999875432 224589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccc--
Q 012462 296 AGKSHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV-- 372 (463)
Q Consensus 296 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 372 (463)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ....+............
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE---QLKLIFDIMGTPNESLWPS 235 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCTTTCGG
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCChhHhhh
Confidence 3322 2334578999999999876 468999999999999999999999998654221 11112111111100000
Q ss_pred ------ccCCCCC--CCCH----------HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 373 ------VDPNIEV--RPST----------RALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 373 ------~~~~~~~--~~~~----------~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
..+.... .... .....+..++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0000000 0000 011234455668999999999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=350.54 Aligned_cols=245 Identities=23% Similarity=0.269 Sum_probs=200.9
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
++|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.+++.++||||+++++++.+....|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57999999999999999999764 68999999985432 233467888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+++|+|.+++... +.+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 999999999999642 3599999999999999999999999 999999999999999999999999999987643
Q ss_pred CCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (463)
. ....+||+.|+|||++.+..++.++|||||||++|||++|..||..... ......+.....
T Consensus 194 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~~-------- 255 (350)
T 1rdq_E 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIVSGKV-------- 255 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC--------
T ss_pred C----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH------HHHHHHHHcCCC--------
Confidence 2 2346799999999999999999999999999999999999999975432 122222222110
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 012462 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPK-----MSQVVRM 413 (463)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs-----~~ell~~ 413 (463)
..+... ...+..++.+||+.||.+||+ ++|++++
T Consensus 256 -~~p~~~--~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 256 -RFPSHF--SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -CCCTTC--CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCC--CHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 111111 122334556899999999998 8888765
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=353.46 Aligned_cols=269 Identities=17% Similarity=0.230 Sum_probs=201.1
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEEcC------CCeEEEEEEcccchhhH-----------HHHHHHHHHHcCCCCCCcc
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNLIN------GSPVAVKKILNNVGQAE-----------KEFRVEVEAIGHVRHKNLV 200 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv 200 (463)
...++|++.+.||+|+||+||+|.+.. ++.||||++........ ..+..|+..+..++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 345689999999999999999997754 47899999865432211 1233466678889999999
Q ss_pred eEeeEEEEC----cEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCcee
Q 012462 201 RLLGYCIEG----IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNIL 276 (463)
Q Consensus 201 ~l~~~~~~~----~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nil 276 (463)
++++++... ...++||||+ +++|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nil 184 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLL 184 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEE
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEE
Confidence 999998764 4579999999 9999999964 335699999999999999999999999 9999999999999
Q ss_pred Ec--CCCCEEEeecccceecCCCCce------eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCC
Q 012462 277 ID--DDFNAKVSDFGLAKLLGAGKSH------VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348 (463)
Q Consensus 277 l~--~~~~~kl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~ 348 (463)
++ .++.+||+|||+++........ .....+||+.|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 99 8999999999999876432211 113356999999999999999999999999999999999999999853
Q ss_pred CCcccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCC
Q 012462 349 RPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEY 419 (463)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~ 419 (463)
.... ............ ....+.+..+........ +..++.+||+.||.+||++.+|++.|++...
T Consensus 265 ~~~~--~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~---~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 265 LKDP--KYVRDSKIRYRE-NIASLMDKCFPAANAPGE---IAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp TTCH--HHHHHHHHHHHH-CHHHHHHHHSCTTCCCHH---HHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred ccCH--HHHHHHHHHhhh-hHHHHHHHhcccccCHHH---HHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 3221 111111111110 111111111111111223 3344557999999999999999999987643
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=349.81 Aligned_cols=271 Identities=23% Similarity=0.377 Sum_probs=213.7
Q ss_pred hHHHHHHhcCCCccCeEeecCcEEEEEEEEc------CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeE
Q 012462 133 LRDLELATNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGY 205 (463)
Q Consensus 133 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~ 205 (463)
..++++..++|++.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.++++++||||++++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 3455667789999999999999999999654 36789999986443 3344678899999999999999999999
Q ss_pred EEECcEEEEEEeecCCCCHHHHHhhhhc------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC
Q 012462 206 CIEGIHRMLVYEYVNNGNLEQWLHGAMR------HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD 279 (463)
Q Consensus 206 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~ 279 (463)
+.+....++||||+++|+|.+++..... ....+++..++.++.||+.||.|||++ +|+||||||+|||++.
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~ 173 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE 173 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECT
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcC
Confidence 9999999999999999999999975321 124578999999999999999999999 9999999999999999
Q ss_pred CCCEEEeecccceecCCCCc-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHH
Q 012462 280 DFNAKVSDFGLAKLLGAGKS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLV 357 (463)
Q Consensus 280 ~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~ 357 (463)
++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |..||..... .
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~ 247 (322)
T 1p4o_A 174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------E 247 (322)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------H
T ss_pred CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH------H
Confidence 99999999999986543322 11223456889999999999999999999999999999999 8999975432 1
Q ss_pred HHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCCCCc
Q 012462 358 DWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIV 422 (463)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 422 (463)
............. .. ..... .+..++.+||+.||.+|||+.|++++|+....+..
T Consensus 248 ~~~~~~~~~~~~~-~~------~~~~~---~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~ 302 (322)
T 1p4o_A 248 QVLRFVMEGGLLD-KP------DNCPD---MLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 302 (322)
T ss_dssp HHHHHHHTTCCCC-CC------TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTH
T ss_pred HHHHHHHcCCcCC-CC------CCCCH---HHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCC
Confidence 2222222221111 00 11112 23445668999999999999999999998766443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=359.10 Aligned_cols=263 Identities=22% Similarity=0.245 Sum_probs=205.3
Q ss_pred chHHHHHHhcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccch---hhHHHHHHHHHHHcCCCCCCcceEeeEEE
Q 012462 132 TLRDLELATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVG---QAEKEFRVEVEAIGHVRHKNLVRLLGYCI 207 (463)
Q Consensus 132 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 207 (463)
.+.+..+..++|++.+.||+|+||+||+|+.. +|+.||+|++..... .....+..|..++..++||||++++++|.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34555667789999999999999999999764 689999999854321 12234778999999999999999999999
Q ss_pred ECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEee
Q 012462 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSD 287 (463)
Q Consensus 208 ~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~D 287 (463)
+.+..|+||||+++|+|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEee
Confidence 999999999999999999999643 23699999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCceeeccccccCCCCchhhhc-------cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHH
Q 012462 288 FGLAKLLGAGKSHVTTRVMGTFGYVAPEYAN-------TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWL 360 (463)
Q Consensus 288 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~ 360 (463)
||+++.............+||+.|+|||++. ...|+.++|||||||++|||++|+.||....... ..
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~ 279 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE------TY 279 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HH
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH------HH
Confidence 9999887654443344568999999999987 4578999999999999999999999997643221 11
Q ss_pred HHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCC---CCHHHHHHH
Q 012462 361 KMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKR---PKMSQVVRM 413 (463)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~R---Ps~~ell~~ 413 (463)
..+..... ....+... ..... ....++.+||. +|.+| |+++|++++
T Consensus 280 ~~i~~~~~--~~~~p~~~-~~~s~---~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 280 GKIVHYKE--HLSLPLVD-EGVPE---EARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHHTHHH--HCCCC-----CCCH---HHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHHHhccc--CcCCCccc-cCCCH---HHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 11111000 00000000 01112 23344568999 99998 599999875
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=351.77 Aligned_cols=207 Identities=26% Similarity=0.314 Sum_probs=179.4
Q ss_pred chHHHHHHhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCC-----CCCcceEeeE
Q 012462 132 TLRDLELATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR-----HKNLVRLLGY 205 (463)
Q Consensus 132 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~~~ 205 (463)
++.+.....++|++.++||+|+||+||+|.. .+++.||||++... ......+..|+.++..+. ||||++++++
T Consensus 26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~ 104 (360)
T 3llt_A 26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGK 104 (360)
T ss_dssp CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence 4455566678999999999999999999976 46889999998542 344456677888888875 9999999999
Q ss_pred EEECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC------
Q 012462 206 CIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD------ 279 (463)
Q Consensus 206 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~------ 279 (463)
+...+..++||||+ +++|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||++.
T Consensus 105 ~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 105 FMYYDHMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEETTEEEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEE
T ss_pred eeECCeeEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccccccc
Confidence 99999999999999 88999999753 334599999999999999999999999 9999999999999975
Q ss_pred -------------------CCCEEEeecccceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh
Q 012462 280 -------------------DFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT 340 (463)
Q Consensus 280 -------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt 340 (463)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence 789999999999875432 234578999999999999999999999999999999999
Q ss_pred CCCCCCCCC
Q 012462 341 GRDPVDHGR 349 (463)
Q Consensus 341 g~~pf~~~~ 349 (463)
|+.||....
T Consensus 255 g~~pf~~~~ 263 (360)
T 3llt_A 255 GSLLFRTHE 263 (360)
T ss_dssp SSCSCCCSS
T ss_pred CCCCCCCCc
Confidence 999997644
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=349.02 Aligned_cols=255 Identities=24% Similarity=0.314 Sum_probs=198.5
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV 215 (463)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+..|..++.++ +||||+++++++.+....|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56899999999999999999764 57899999986532 23345677899999887 899999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
|||+++|+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++++||+|||+++...
T Consensus 89 ~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 9999999999998642 4599999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccc--cHHHHHHHHhcCCCccccc
Q 012462 296 AGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEV--NLVDWLKMMVGSRRSEEVV 373 (463)
Q Consensus 296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 373 (463)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....+........
T Consensus 162 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~----- 235 (345)
T 3a8x_A 162 RPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----- 235 (345)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-----
T ss_pred CCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-----
Confidence 222 2244568999999999999999999999999999999999999999753221111 11111111111111
Q ss_pred cCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCH------HHHHHH
Q 012462 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKM------SQVVRM 413 (463)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~------~ell~~ 413 (463)
...+... ......++.+||+.||.+||++ .|++++
T Consensus 236 ---~~~p~~~--s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 236 ---IRIPRSL--SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp ---CCCCTTS--CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred ---CCCCCCC--CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 1111111 1223344568999999999996 666654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=354.55 Aligned_cols=251 Identities=24% Similarity=0.321 Sum_probs=199.2
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcE
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIH 211 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 211 (463)
.+..++|++.+.||+|+||+||+|+.. +++.||+|++.... ......+..|..++..+ +||||+++++++.+...
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345678999999999999999999764 57899999985432 22345677788888876 89999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccc
Q 012462 212 RMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA 291 (463)
Q Consensus 212 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a 291 (463)
.|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++++||+|||++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhh
Confidence 99999999999999999642 4589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccc
Q 012462 292 KLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEE 371 (463)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (463)
+...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||...... .....+.....
T Consensus 166 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~~~~--- 235 (345)
T 1xjd_A 166 KENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE------ELFHSIRMDNP--- 235 (345)
T ss_dssp BCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCC---
T ss_pred hhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHHhCCC---
Confidence 8643322 2244578999999999999999999999999999999999999999754321 11222221110
Q ss_pred cccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 012462 372 VVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMS-QVVR 412 (463)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~-ell~ 412 (463)
..+... ......++.+||+.||++||++. ++++
T Consensus 236 ------~~p~~~--s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 236 ------FYPRWL--EKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp ------CCCTTS--CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ------CCCccc--CHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 011111 12233445689999999999997 6654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=349.94 Aligned_cols=251 Identities=22% Similarity=0.285 Sum_probs=200.1
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEE
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHR 212 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 212 (463)
+..++|++.+.||+|+||+||+|+.. +++.||+|++.... ......+..|..++..+ +||||+++++++.+.+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 34578999999999999999999765 47889999985432 23345677899999887 899999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccce
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~ 292 (463)
|+||||+++|+|.+++... +.+++..++.++.||+.||.|||++ +|+||||||+|||++.++++||+|||+++
T Consensus 97 ~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 9999999999999999642 3599999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccc
Q 012462 293 LLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV 372 (463)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (463)
...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+....
T Consensus 170 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~----- 237 (353)
T 2i0e_A 170 ENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIMEHN----- 237 (353)
T ss_dssp CCCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC-----
T ss_pred ccccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH------HHHHHHHHhCC-----
Confidence 643222 224457899999999999999999999999999999999999999975432 12222222211
Q ss_pred ccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 012462 373 VDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPK-----MSQVVRM 413 (463)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs-----~~ell~~ 413 (463)
...+... ......++.+||+.||.+||+ +++++++
T Consensus 238 ----~~~p~~~--s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 238 ----VAYPKSM--SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp ----CCCCTTS--CHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred ----CCCCCCC--CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1111111 122334556899999999995 5777764
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=339.10 Aligned_cols=260 Identities=20% Similarity=0.272 Sum_probs=195.9
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccch---hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVG---QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 215 (463)
.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999764 678999999854432 2346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
|||+++++|.+++... ..+++..++.++.|++.||.|||+. +|+|+||||+|||++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 9999999999999642 4589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCC-cccccc
Q 012462 296 AGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRR-SEEVVD 374 (463)
Q Consensus 296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 374 (463)
...........|++.|+|||++.+..++.++||||||+++|||++|+.||...... .+........ ......
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~ 258 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIPRPSTVR 258 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCCCGGGTS
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCCCccccC
Confidence 44333334567899999999999999999999999999999999999999753211 1111111111 111111
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHhcCCCCC
Q 012462 375 PNIEVRPSTRALKRSLLTALRCVDPDSEKRP-KMSQVVRMLESEEYPI 421 (463)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP-s~~ell~~L~~~~~~~ 421 (463)
+ .. .. .+..++.+||+.||++|| +++++++.|+......
T Consensus 259 ~--~~---~~---~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 259 P--GI---PV---AFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp T--TC---CT---HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred C--CC---CH---HHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 0 11 11 233345589999999999 9999999999875544
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=350.26 Aligned_cols=258 Identities=27% Similarity=0.421 Sum_probs=199.0
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCe----EEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSP----VAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRM 213 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 213 (463)
.++|++.+.||+|+||+||+|.+. ++.. ||+|.+.... ......+.+|+.++.+++||||+++++++.+ ...+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccE
Confidence 467999999999999999999754 4454 7777764332 2223456679999999999999999999864 5688
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
+||||+.+|+|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccc
Confidence 999999999999998642 34588999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCc-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccc
Q 012462 294 LGAGKS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEE 371 (463)
Q Consensus 294 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (463)
...... .......+|..|+|||++.+..++.++|||||||++|||++ |..||....... ... ..........
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~---~~~~~~~~~~ 238 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VPD---LLEKGERLAQ 238 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HHH---HHHTTCBCCC
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HHH---HHHcCCCCCC
Confidence 654332 22344567889999999999999999999999999999999 999998654322 111 1111111111
Q ss_pred cccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCCC
Q 012462 372 VVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYP 420 (463)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~~ 420 (463)
+. .... .+..++.+||+.||.+|||+.|++++|+.....
T Consensus 239 ---~~-~~~~------~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 239 ---PQ-ICTI------DVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp ---CT-TBCT------TTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred ---CC-cCcH------HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00 0111 123355689999999999999999999887543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=349.38 Aligned_cols=252 Identities=26% Similarity=0.375 Sum_probs=187.0
Q ss_pred HhcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
..++|++.+.||+|+||.||+|... +++.||||++.... ..+.+.+|+.++.+++||||++++++|.+....++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4578999999999999999999775 47889999986542 34567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC---CCCEEEeecccceec
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD---DFNAKVSDFGLAKLL 294 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~---~~~~kl~Dfg~a~~~ 294 (463)
|+++++|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++..
T Consensus 129 ~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 129 LVTGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCSCBHHHHHT----TCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 999999999985 345699999999999999999999999 9999999999999975 889999999999875
Q ss_pred CCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccccc
Q 012462 295 GAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVD 374 (463)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (463)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||....... ........... . ...
T Consensus 202 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~~i~~~~~-~-~~~ 272 (349)
T 2w4o_A 202 EHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ-----FMFRRILNCEY-Y-FIS 272 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH-----HHHHHHHTTCC-C-CCT
T ss_pred Cccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH-----HHHHHHHhCCC-c-cCC
Confidence 4322 2344678999999999999999999999999999999999999997543221 11122221111 0 000
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 375 PNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
+. ..... ..+..++.+||+.||++|||+.|++++
T Consensus 273 ~~--~~~~~---~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 273 PW--WDEVS---LNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TT--TTTSC---HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ch--hhhCC---HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 01111 233445668999999999999999874
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=338.01 Aligned_cols=254 Identities=25% Similarity=0.340 Sum_probs=197.8
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
.++|.+.+.||+|+||+||+|.. .++..||+|++.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 35799999999999999999966 468899999985543 3345788899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeE---cCCCCEEEeecccceec
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill---~~~~~~kl~Dfg~a~~~ 294 (463)
|+++|+|.+++.........+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999999999976555556799999999999999999999999 99999999999999 55688999999999865
Q ss_pred CCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccccc
Q 012462 295 GAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVD 374 (463)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (463)
.... ......||+.|+|||++. ..++.++|||||||++|||++|+.||...... ..............
T Consensus 178 ~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~~--- 245 (285)
T 3is5_A 178 KSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE------EVQQKATYKEPNYA--- 245 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCCC---
T ss_pred CCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH------HHHhhhccCCcccc---
Confidence 4332 233457899999999986 46899999999999999999999999764321 11111111111000
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 375 PNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
....+.... +..++.+||+.||++|||+.|++++
T Consensus 246 --~~~~~~~~~---~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 246 --VECRPLTPQ---AVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp --C--CCCCHH---HHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred --cccCcCCHH---HHHHHHHHccCChhhCcCHHHHhcC
Confidence 011112223 3345567999999999999999864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=339.12 Aligned_cols=262 Identities=24% Similarity=0.392 Sum_probs=203.2
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-----cCCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC--cE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-----INGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG--IH 211 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~ 211 (463)
.++|++.+.||+|+||.||+|.+ .+++.||+|++.... ......+.+|+.++++++||||+++++++.+. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 45688999999999999999973 467899999986433 33456788999999999999999999999876 66
Q ss_pred EEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccc
Q 012462 212 RMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA 291 (463)
Q Consensus 212 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a 291 (463)
.++||||+++++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccc
Confidence 89999999999999999643 34599999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCc--eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCC---------CcccccHHHHH
Q 012462 292 KLLGAGKS--HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGR---------PAHEVNLVDWL 360 (463)
Q Consensus 292 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~---------~~~~~~~~~~~ 360 (463)
........ .......+|..|+|||++.+..++.++||||||+++|+|++|..|+.... ...........
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 88765432 22334567888999999999999999999999999999999999865321 01111111222
Q ss_pred HHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 361 KMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.......... .... ....+..++.+||+.||.+|||+.|+++.|+..
T Consensus 254 ~~~~~~~~~~--------~~~~--~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 254 NTLKEGKRLP--------CPPN--CPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHHTTCCCC--------CCTT--CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhccCCCC--------CCCC--CCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 2222111111 0111 112334456689999999999999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=364.18 Aligned_cols=250 Identities=23% Similarity=0.266 Sum_probs=192.7
Q ss_pred HhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEE
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 214 (463)
..++|++.+.||+|+||.||+|.. .+|+.||||++.... ......+..|+.+++.++||||++++++|.+.+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 346799999999999999999965 468899999986432 2333567789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE-AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||+++.
T Consensus 226 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 226 VMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp EECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred EEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 9999999999999864 3459999999999999999999998 8 999999999999999999999999999986
Q ss_pred cCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccc
Q 012462 294 LGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373 (463)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (463)
..... ......+||+.|+|||++.+..++.++|||||||+||||++|+.||...... ...........
T Consensus 299 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~~~~----- 366 (446)
T 4ejn_A 299 GIKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILMEEI----- 366 (446)
T ss_dssp TCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCC-----
T ss_pred ccCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHHHHHHhCCC-----
Confidence 43322 2244578999999999999999999999999999999999999999754321 11222221110
Q ss_pred cCCCCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 012462 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRP-----KMSQVVRM 413 (463)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP-----s~~ell~~ 413 (463)
..+... ...+..++.+||+.||.+|| +++|++++
T Consensus 367 ----~~p~~~--~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 367 ----RFPRTL--GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp ----CCCTTS--CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----CCCccC--CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 111111 12234455689999999999 99999875
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=337.99 Aligned_cols=246 Identities=27% Similarity=0.418 Sum_probs=196.8
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 215 (463)
.++|++.+.||+|+||+||+|... ++..||+|++.... ......+.+|+.++++++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467999999999999999999654 56789999985432 22346788899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
|||+++++|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.++|+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp ECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 9999999999998643 3589999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 296 AGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|..||...... ...........
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~------- 224 (279)
T 3fdn_A 161 SS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVEF------- 224 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCC-------
T ss_pred cc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH------HHHHHHHhCCC-------
Confidence 32 233457899999999999999999999999999999999999999754321 11111111110
Q ss_pred CCCCCC-CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 376 NIEVRP-STRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 376 ~~~~~~-~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.... ... .+..++.+||+.||++|||++|++++
T Consensus 225 --~~~~~~~~---~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 225 --TFPDFVTE---GARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp --CCCTTSCH---HHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred --CCCCcCCH---HHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0111 112 23345568999999999999999975
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=343.04 Aligned_cols=262 Identities=24% Similarity=0.318 Sum_probs=196.3
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccch--hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
++|++.+.||+|+||+||+|... +|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57999999999999999999764 589999999855432 334667889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
|+++++|.+++. ....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~----~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDR----YQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHH----TSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHh----hhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 999999998874 345699999999999999999999999 9999999999999999999999999999876533
Q ss_pred CceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCC---------
Q 012462 298 KSHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR--------- 367 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--------- 367 (463)
.. ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||......... ..+.......
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 231 (311)
T 4agu_A 156 SD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL---YLIRKTLGDLIPRHQQVFS 231 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCHHHHHHHH
T ss_pred cc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhcccccccccccc
Confidence 22 2334578999999999876 67899999999999999999999999765432211 1111111110
Q ss_pred ---CccccccCCCCCCCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 368 ---RSEEVVDPNIEVRPST-----RALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 368 ---~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.......+........ .....+..++.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000000000000 011224455668999999999999999875
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=338.10 Aligned_cols=253 Identities=28% Similarity=0.501 Sum_probs=199.0
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhh-------HHHHHHHHHHHcCCCCCCcceEeeEEEECcE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQA-------EKEFRVEVEAIGHVRHKNLVRLLGYCIEGIH 211 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 211 (463)
.++|++.+.||+|+||+||+|.+ .+++.||+|++....... .+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 46899999999999999999976 478899999985432211 157889999999999999999999986655
Q ss_pred EEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEccCCCCceeEcCCCC-----EE
Q 012462 212 RMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPK--VVHRDIKSSNILIDDDFN-----AK 284 (463)
Q Consensus 212 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~Dikp~Nill~~~~~-----~k 284 (463)
++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+. + |+||||||+|||++.++. +|
T Consensus 97 -~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred -eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEE
Confidence 799999999999998863 345699999999999999999999999 8 999999999999988776 99
Q ss_pred EeecccceecCCCCceeeccccccCCCCchhhh--ccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 012462 285 VSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA--NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKM 362 (463)
Q Consensus 285 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 362 (463)
|+|||+++.... ......||+.|+|||++ ....++.++|||||||++|||++|+.||....... ......
T Consensus 170 l~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~ 241 (287)
T 4f0f_A 170 VADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINM 241 (287)
T ss_dssp ECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH----HHHHHH
T ss_pred eCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH----HHHHHH
Confidence 999999975433 23446789999999998 45567899999999999999999999997644322 111222
Q ss_pred HhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 363 MVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
........... .... ..+..++.+||+.||++|||+.|+++.|+++
T Consensus 242 ~~~~~~~~~~~------~~~~---~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 242 IREEGLRPTIP------EDCP---PRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHSCCCCCCC------TTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HhccCCCCCCC------cccC---HHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 22221111110 1111 2334456679999999999999999999863
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=335.94 Aligned_cols=252 Identities=22% Similarity=0.320 Sum_probs=201.1
Q ss_pred hcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC--cEEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG--IHRMLV 215 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV 215 (463)
.++|++.+.||+|+||+||+|.+ ++..||+|++.... ....+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 46799999999999999999987 58899999986543 34456789999999999999999999999876 778999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPK--VVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
|||+++|+|.+++... ....+++..++.++.||+.||.|||+. + |+||||||+|||++.++.++|+|||++..
T Consensus 88 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred ecccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceee
Confidence 9999999999999642 233589999999999999999999998 8 99999999999999999999999998764
Q ss_pred cCCCCceeeccccccCCCCchhhhccCCCCc---cchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 294 LGAGKSHVTTRVMGTFGYVAPEYANTGLLNE---KSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
... ....||+.|+|||++.+..++. ++|||||||++|||++|+.||...... .............
T Consensus 163 ~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~ 230 (271)
T 3kmu_A 163 FQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM------EIGMKVALEGLRP 230 (271)
T ss_dssp TSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH------HHHHHHHHSCCCC
T ss_pred ecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH------HHHHHHHhcCCCC
Confidence 322 2346899999999998765554 799999999999999999999754321 1112222121111
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCC
Q 012462 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEE 418 (463)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~ 418 (463)
... ..... .+..++.+||+.||++|||++|+++.|+.+.
T Consensus 231 ~~~------~~~~~---~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 231 TIP------PGISP---HVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CCC------TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCC------CCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 110 11112 2344556799999999999999999998753
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=342.26 Aligned_cols=260 Identities=27% Similarity=0.417 Sum_probs=205.9
Q ss_pred HhcCCCccC-eEeecCcEEEEEEEEc---CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEE
Q 012462 139 ATNRFSKEN-VLGEGGYGVVYRGNLI---NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRM 213 (463)
Q Consensus 139 ~~~~~~~~~-~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 213 (463)
..++|.+.+ .||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++.+++||||+++++++ ..+..+
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~ 85 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM 85 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence 356677776 9999999999999653 57789999986543 34557788999999999999999999999 556789
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
+||||+++++|.+++.. ....+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++..
T Consensus 86 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp EEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceee
Confidence 99999999999999863 345699999999999999999999999 999999999999999999999999999988
Q ss_pred cCCCCcee--eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 294 LGAGKSHV--TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 294 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
........ .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||....... ...........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~i~~~~~~- 232 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAFIEQGKRM- 232 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH------HHHHHHTTCCC-
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH------HHHHHhcCCcC-
Confidence 75443221 223456889999999998899999999999999999998 999997654321 11222221111
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCCCC
Q 012462 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPI 421 (463)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 421 (463)
. .... ....+..++.+||+.||++||++.+++++|+......
T Consensus 233 ~-------~~~~--~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 233 E-------CPPE--CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp C-------CCTT--CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred C-------CCCC--cCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 0 1111 1123344556899999999999999999998864433
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=359.52 Aligned_cols=248 Identities=25% Similarity=0.392 Sum_probs=202.3
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 215 (463)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 467999999999999999999764 78999999985432 12346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
|||+++|+|.+++. ..+.+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 95 ~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 95 MEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 99999999999984 345699999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCceeeccccccCCCCchhhhccCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccccc
Q 012462 296 AGKSHVTTRVMGTFGYVAPEYANTGLL-NEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVD 374 (463)
Q Consensus 296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (463)
... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...... ...........
T Consensus 168 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~------~~~~~i~~~~~------ 233 (476)
T 2y94_A 168 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP------TLFKKICDGIF------ 233 (476)
T ss_dssp TTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH------HHHHHHHTTCC------
T ss_pred ccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH------HHHHHHhcCCc------
Confidence 432 2345689999999999988766 68999999999999999999999764321 11222221110
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 375 PNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
..+... ...+..++.+||+.||++|||++|++++
T Consensus 234 ---~~p~~~--s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 234 ---YTPQYL--NPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp ---CCCTTC--CHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ---CCCccC--CHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 001110 1123445668999999999999999973
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=343.92 Aligned_cols=257 Identities=25% Similarity=0.372 Sum_probs=191.9
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcE----
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIH---- 211 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---- 211 (463)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.++.+++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46899999999999999999965 578899999986543 2334578899999999999999999999876543
Q ss_pred EEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccc
Q 012462 212 RMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA 291 (463)
Q Consensus 212 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a 291 (463)
.|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 4999999999999999964 24599999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCc--eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCc
Q 012462 292 KLLGAGKS--HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369 (463)
Q Consensus 292 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 369 (463)
........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ............
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~ 237 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPI 237 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCCCC
Confidence 87644322 2233457899999999999999999999999999999999999999754321 111122211111
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHH-HHHhc
Q 012462 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVV-RMLES 416 (463)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell-~~L~~ 416 (463)
.... ...... ..+..++.+||+.||++||++.+++ ..|..
T Consensus 238 ~~~~----~~~~~~---~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 238 PPSA----RHEGLS---ADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp CHHH----HSTTCC---HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred Cccc----ccCCCC---HHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 1000 000111 2233456689999999999766655 44433
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=346.27 Aligned_cols=252 Identities=23% Similarity=0.327 Sum_probs=194.6
Q ss_pred HhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCC--CCcceEeeEEEECcEEEE
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRH--KNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~l 214 (463)
..++|++.+.||+|+||.||+|...+++.||||++.... ....+.+.+|+.++.+++| |||+++++++.+....++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 457799999999999999999988889999999985432 3344678899999999976 999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
|||+ .+++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+++..
T Consensus 87 v~e~-~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 87 VMEC-GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EECC-CSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEeC-CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 9995 57899999964 35689999999999999999999999 999999999999997 578999999999876
Q ss_pred CCCCce-eeccccccCCCCchhhhcc-----------CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 012462 295 GAGKSH-VTTRVMGTFGYVAPEYANT-----------GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKM 362 (463)
Q Consensus 295 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 362 (463)
...... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ....+..
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~ 232 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHA 232 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHH
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHHH
Confidence 543221 2345679999999999865 6789999999999999999999999975322 1222222
Q ss_pred HhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 363 MVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.......... .... ...+..++.+||+.||.+|||+.|++++
T Consensus 233 ~~~~~~~~~~-------~~~~--~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 233 IIDPNHEIEF-------PDIP--EKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HHCTTSCCCC-------CCCS--CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhcCCcccCC-------cccC--CHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 2221111111 1111 1223445668999999999999999976
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=348.48 Aligned_cols=262 Identities=26% Similarity=0.437 Sum_probs=207.1
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEEc--------CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCC-CCCCcceEeeEE
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNLI--------NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYC 206 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 206 (463)
++..++|++.+.||+|+||.||+|.+. ++..||+|++.... ......+.+|+.+++++ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 345678999999999999999999763 46789999986543 33456788999999999 899999999999
Q ss_pred EECcEEEEEEeecCCCCHHHHHhhhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCc
Q 012462 207 IEGIHRMLVYEYVNNGNLEQWLHGAMR------------HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSN 274 (463)
Q Consensus 207 ~~~~~~~lV~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~N 274 (463)
.+.+..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+. +|+||||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccce
Confidence 999999999999999999999975422 123489999999999999999999999 99999999999
Q ss_pred eeEcCCCCEEEeecccceecCCCCce-eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcc
Q 012462 275 ILIDDDFNAKVSDFGLAKLLGAGKSH-VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAH 352 (463)
Q Consensus 275 ill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~ 352 (463)
||++.++.+||+|||++......... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-- 265 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-- 265 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH--
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH--
Confidence 99999999999999999876543322 2233456889999999999899999999999999999999 9999975432
Q ss_pred cccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 353 EVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
............... . .... ..+..++.+||+.||.+|||+.|+++.|+.+
T Consensus 266 ----~~~~~~~~~~~~~~~------~-~~~~---~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 266 ----EELFKLLKEGHRMDK------P-ANCT---NELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp ----HHHHHHHHHTCCCCC------C-TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHHHHhcCCCCCC------C-ccCC---HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 122222222211110 0 1111 2334456689999999999999999999886
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=352.30 Aligned_cols=251 Identities=21% Similarity=0.284 Sum_probs=187.2
Q ss_pred cCCCcc-CeEeecCcEEEEEEEEc-CCCeEEEEEEcccchhhHHHHHHHHHHHc-CCCCCCcceEeeEEEE----CcEEE
Q 012462 141 NRFSKE-NVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEFRVEVEAIG-HVRHKNLVRLLGYCIE----GIHRM 213 (463)
Q Consensus 141 ~~~~~~-~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~----~~~~~ 213 (463)
++|.+. ++||+|+||+||+|... +++.||||++... ..+.+|+.++. ..+||||++++++|.. ....|
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456665 68999999999999664 6889999998532 34556777764 4589999999999876 56789
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC---CCCEEEeeccc
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD---DFNAKVSDFGL 290 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~---~~~~kl~Dfg~ 290 (463)
+||||+++|+|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+
T Consensus 136 lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEeccc
Confidence 999999999999999642 234599999999999999999999999 9999999999999997 78999999999
Q ss_pred ceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccc-cHHHHHHHHhcCCCc
Q 012462 291 AKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEV-NLVDWLKMMVGSRRS 369 (463)
Q Consensus 291 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~ 369 (463)
++...... .....+||+.|+|||++.+..++.++|||||||+||||++|+.||......... .....+. ......
T Consensus 211 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~--~~~~~~ 286 (400)
T 1nxk_A 211 AKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR--MGQYEF 286 (400)
T ss_dssp CEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH--HTCCCC
T ss_pred ccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH--cCcccC
Confidence 98764322 234567899999999999999999999999999999999999999765433211 1111111 111000
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
+......... .+..++.+||+.||++|||+.|++++
T Consensus 287 -----~~~~~~~~s~---~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 287 -----PNPEWSEVSE---EVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp -----CTTTTTTSCH---HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----CCcccccCCH---HHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0001111122 33445668999999999999999985
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=337.47 Aligned_cols=263 Identities=25% Similarity=0.388 Sum_probs=199.2
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEccc---chhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNN---VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 215 (463)
.++|++.+.||+|+||.||+|.. .+|..||+|++... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35799999999999999999965 57899999998642 234456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
|||+++++|.+++.........+++..++.++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999976655667799999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 296 AGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||..... .............. ...
T Consensus 188 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~-~~~--- 258 (310)
T 2wqm_A 188 SKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEQCDY-PPL--- 258 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C----CHHHHHHHHHTTCS-CCC---
T ss_pred CCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----hHHHHHHHhhcccC-CCC---
Confidence 332 122345689999999999999999999999999999999999999975432 22222222222111 110
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCC
Q 012462 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEY 419 (463)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~ 419 (463)
....... .+..++.+||+.||++|||+.++++.|+++..
T Consensus 259 --~~~~~~~---~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 259 --PSDHYSE---ELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp --CTTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --cccccCH---HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 0011122 23445567999999999999999999988643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=334.80 Aligned_cols=251 Identities=22% Similarity=0.289 Sum_probs=201.4
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
.++|++.+.||+|+||.||+|... ++..||+|++........+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 467999999999999999999664 4678999998766556677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeE---cCCCCEEEeecccceecC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill---~~~~~~kl~Dfg~a~~~~ 295 (463)
+++++|.+++.. ...+++..++.++.|++.||.|||++ +|+|+||||+|||+ +.++.+||+|||++....
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 88 CTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 999999998864 34589999999999999999999999 99999999999999 788999999999998765
Q ss_pred CCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 296 AGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
... ......||+.|+|||++.+. ++.++||||||+++|||++|+.||...... ............. ...
T Consensus 161 ~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~-~~~- 229 (277)
T 3f3z_A 161 PGK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS------EVMLKIREGTFTF-PEK- 229 (277)
T ss_dssp TTS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCC-CHH-
T ss_pred Ccc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCCCCC-Cch-
Confidence 433 23345789999999998765 899999999999999999999999764321 1111111111100 000
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
..... ...+..++.+||+.||++|||+.|++++
T Consensus 230 --~~~~~---~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 230 --DWLNV---SPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp --HHTTS---CHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred --hhhcC---CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00011 1233445668999999999999999863
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=346.22 Aligned_cols=256 Identities=14% Similarity=0.164 Sum_probs=202.9
Q ss_pred HHHHHhcCCCccCeEeecCcEEEEEE------EEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCC---CCCcceEeeE
Q 012462 135 DLELATNRFSKENVLGEGGYGVVYRG------NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR---HKNLVRLLGY 205 (463)
Q Consensus 135 ~~~~~~~~~~~~~~lG~G~~g~V~~~------~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~ 205 (463)
++++..++|.+.+.||+|+||+||+| ....++.||+|++.... ..++..|+.++..++ |+||+.++++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 33455688999999999999999999 34568899999986543 345666777776665 9999999999
Q ss_pred EEECcEEEEEEeecCCCCHHHHHhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC-----
Q 012462 206 CIEGIHRMLVYEYVNNGNLEQWLHGAMR-HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD----- 279 (463)
Q Consensus 206 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~----- 279 (463)
+...+..|+||||+++|+|.+++..... ....+++..++.++.||+.||+|||+. +|+||||||+|||++.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCc
Confidence 9999999999999999999999975433 345699999999999999999999999 9999999999999998
Q ss_pred ------CCCEEEeecccceecCC-CCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcc
Q 012462 280 ------DFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAH 352 (463)
Q Consensus 280 ------~~~~kl~Dfg~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~ 352 (463)
++.+||+|||+++.... .........+||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 292 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence 89999999999986542 22334556789999999999999999999999999999999999999996432211
Q ss_pred cccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCC-CCHHHHHHHHhcC
Q 012462 353 EVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKR-PKMSQVVRMLESE 417 (463)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~R-Ps~~ell~~L~~~ 417 (463)
. .........+.......+ +..|++.+|.+| |+++++.+.|+..
T Consensus 293 ~------------------~~~~~~~~~~~~~~~~~~---~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 293 C------------------KPEGLFRRLPHLDMWNEF---FHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp E------------------EECSCCTTCSSHHHHHHH---HHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred e------------------eechhccccCcHHHHHHH---HHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 0 011111122333444443 346999999999 5788888877764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=333.50 Aligned_cols=252 Identities=22% Similarity=0.329 Sum_probs=201.2
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++++++||||+++++++.+....++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 47899999999999999999965 458899999985433 334467888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCC---EEEeeccccee
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFN---AKVSDFGLAKL 293 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~---~kl~Dfg~a~~ 293 (463)
||+++++|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+||+++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 999999999988642 4589999999999999999999999 9999999999999986655 99999999987
Q ss_pred cCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccc
Q 012462 294 LGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373 (463)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (463)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ............ .
T Consensus 158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~--~- 226 (284)
T 3kk8_A 158 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RLYAQIKAGAYD--Y- 226 (284)
T ss_dssp CCSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCCC--C-
T ss_pred cccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh------HHHHHHHhcccc--C-
Confidence 65432 233467899999999999999999999999999999999999999754321 111111111110 0
Q ss_pred cCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
+.......... +..++.+||+.||++|||+.|++++
T Consensus 227 -~~~~~~~~~~~---~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 227 -PSPEWDTVTPE---AKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp -CTTTTTTSCHH---HHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -CchhhcccCHH---HHHHHHHHcccChhhCCCHHHHhcC
Confidence 00011111222 3345557999999999999999874
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=347.67 Aligned_cols=270 Identities=17% Similarity=0.230 Sum_probs=198.9
Q ss_pred HhcCCCccCeEeecCcEEEEEEEEc----CCCeEEEEEEcccchhh-----------HHHHHHHHHHHcCCCCCCcceEe
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNLI----NGSPVAVKKILNNVGQA-----------EKEFRVEVEAIGHVRHKNLVRLL 203 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~l~ 203 (463)
..++|++.+.||+|+||+||+|... .+..||+|++....... ...+..|+..+..++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 3578999999999999999999775 57889999986543211 12355788899999999999999
Q ss_pred eEEEE----CcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC
Q 012462 204 GYCIE----GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD 279 (463)
Q Consensus 204 ~~~~~----~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~ 279 (463)
+++.+ ....|+||||+ +++|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+|||++.
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~ 186 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGY 186 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEES
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEcc
Confidence 99988 78889999999 99999998643 2699999999999999999999999 9999999999999998
Q ss_pred CC--CEEEeecccceecCCCCc------eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCc
Q 012462 280 DF--NAKVSDFGLAKLLGAGKS------HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPA 351 (463)
Q Consensus 280 ~~--~~kl~Dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~ 351 (463)
++ .+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 266 (345)
T 2v62_A 187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD 266 (345)
T ss_dssp SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence 87 999999999987643211 1124457999999999999999999999999999999999999999643221
Q ss_pred ccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCCCCc
Q 012462 352 HEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIV 422 (463)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 422 (463)
.. .......... ......... ......... .+..++.+||+.||++||++++|++.|++...+..
T Consensus 267 ~~-~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 331 (345)
T 2v62_A 267 PV-AVQTAKTNLL-DELPQSVLK-WAPSGSSCC---EIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLG 331 (345)
T ss_dssp HH-HHHHHHHHHH-HTTTHHHHH-HSCTTSCCH---HHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCC
T ss_pred cH-HHHHHHHhhc-ccccHHHHh-hccccccHH---HHHHHHHHHhhcCcccCCCHHHHHHHHhccCCccc
Confidence 11 1111111111 111110000 000001112 33445567999999999999999999999766543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=350.04 Aligned_cols=247 Identities=23% Similarity=0.317 Sum_probs=194.6
Q ss_pred cCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCCCCH
Q 012462 146 ENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNL 224 (463)
Q Consensus 146 ~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~L 224 (463)
.+.||+|+||.||+|.. .+|..||+|++........+.+.+|+.++.+++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 56899999999999965 46889999999776656667899999999999999999999999999999999999999999
Q ss_pred HHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeE--cCCCCEEEeecccceecCCCCceee
Q 012462 225 EQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILI--DDDFNAKVSDFGLAKLLGAGKSHVT 302 (463)
Q Consensus 225 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill--~~~~~~kl~Dfg~a~~~~~~~~~~~ 302 (463)
.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+++....... .
T Consensus 174 ~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~ 245 (373)
T 2x4f_A 174 FDRIIDE---SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--L 245 (373)
T ss_dssp HHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--C
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--c
Confidence 9988642 33589999999999999999999999 99999999999999 5678999999999987654332 2
Q ss_pred ccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCC
Q 012462 303 TRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPS 382 (463)
Q Consensus 303 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (463)
...+||+.|+|||++.+..++.++|||||||++|||++|..||...... ..+..+....... ... .....
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~~~~~~--~~~--~~~~~ 315 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA------ETLNNILACRWDL--EDE--EFQDI 315 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCCS--CSG--GGTTS
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhccCCC--Chh--hhccC
Confidence 3457999999999999999999999999999999999999999764321 2222222211110 000 00111
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 383 TRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 383 ~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.. .+..++.+||+.||.+|||+.|++++
T Consensus 316 ~~---~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 316 SE---EAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp CH---HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CH---HHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 12 33445668999999999999999973
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=337.59 Aligned_cols=256 Identities=26% Similarity=0.377 Sum_probs=199.7
Q ss_pred HhcCCCccCeEeecCcEEEEEEEEcCC----CeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEE
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNLING----SPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRM 213 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~~~~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 213 (463)
..++|++.+.||+|+||+||+|.+... ..||+|.+.... ....+.+.+|+.++++++||||+++++++.++ ..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence 357899999999999999999975432 359999886542 34457788999999999999999999998654 568
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
+||||+++++|.+++... ...+++..++.++.|++.||.|||++ +|+|+||||+|||++.++.+||+|||++..
T Consensus 89 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 999999999999999642 34589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCcccc
Q 012462 294 LGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV 372 (463)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (463)
.............+++.|+|||++.+..++.++||||||+++|||++ |+.||....... ....+ ........
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~~---~~~~~~~~- 235 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGVL---EKGDRLPK- 235 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHHH---HHTCCCCC-
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHHH---hcCCCCCC-
Confidence 65443333334557889999999999999999999999999999998 999997544322 22211 11111100
Q ss_pred ccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 373 VDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
+ .... ..+..++.+||+.||++|||+.|+++.|+++
T Consensus 236 --~----~~~~---~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 236 --P----DLCP---PVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp --C----TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --C----CCCC---HHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 0 0111 2234455689999999999999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=350.14 Aligned_cols=264 Identities=24% Similarity=0.412 Sum_probs=208.0
Q ss_pred HHHHhcCCCccCeEeecCcEEEEEEEEcC-C-----CeEEEEEEcccc-hhhHHHHHHHHHHHcCC-CCCCcceEeeEEE
Q 012462 136 LELATNRFSKENVLGEGGYGVVYRGNLIN-G-----SPVAVKKILNNV-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCI 207 (463)
Q Consensus 136 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 207 (463)
+++..++|++.+.||+|+||.||+|.... + ..||+|.+.... ......+.+|+.++.++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 34556889999999999999999997643 2 379999986543 33456788999999999 8999999999999
Q ss_pred ECcEEEEEEeecCCCCHHHHHhhhhc----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeE
Q 012462 208 EGIHRMLVYEYVNNGNLEQWLHGAMR----------HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILI 277 (463)
Q Consensus 208 ~~~~~~lV~e~~~~g~L~~~l~~~~~----------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill 277 (463)
+.+..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+. +|+||||||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEE
Confidence 99999999999999999999975422 134589999999999999999999999 99999999999999
Q ss_pred cCCCCEEEeecccceecCCCCc-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCccccc
Q 012462 278 DDDFNAKVSDFGLAKLLGAGKS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVN 355 (463)
Q Consensus 278 ~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~ 355 (463)
+.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-- 275 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-- 275 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--
Confidence 9999999999999986543322 22334557889999999999999999999999999999998 9999976443221
Q ss_pred HHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 356 LVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
....+ ....... .+ .... ..+..++.+||+.||.+|||+.|+++.|++.
T Consensus 276 ~~~~~---~~~~~~~---~~----~~~~---~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 276 FYKLV---KDGYQMA---QP----AFAP---KNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HHHHH---HHTCCCC---CC----TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHH---hcCCCCC---CC----CCCC---HHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 11111 1111100 00 0111 2334456689999999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=344.64 Aligned_cols=259 Identities=27% Similarity=0.465 Sum_probs=199.5
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEEcCC-----CeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcE
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNLING-----SPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIH 211 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 211 (463)
+..++|.+.+.||+|+||.||+|..... ..||+|.+.... ......+.+|+.++.+++||||+++++++.+...
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 120 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 120 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence 3456788899999999999999965432 359999986543 3345678899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccc
Q 012462 212 RMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA 291 (463)
Q Consensus 212 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a 291 (463)
.++||||+++++|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 121 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp EEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred cEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcc
Confidence 9999999999999999964 345699999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCce--eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCC
Q 012462 292 KLLGAGKSH--VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRR 368 (463)
Q Consensus 292 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 368 (463)
......... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ............
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~------~~~~~~~~~~~~ 268 (333)
T 1mqb_A 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN------HEVMKAINDGFR 268 (333)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTTCC
T ss_pred hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH------HHHHHHHHCCCc
Confidence 876543211 1222346788999999999999999999999999999999 9999975432 122222222211
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCC
Q 012462 369 SEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEE 418 (463)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~ 418 (463)
.... .... ..+..++.+||+.||++||++.++++.|+.+.
T Consensus 269 ~~~~-------~~~~---~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 269 LPTP-------MDCP---SAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp CCCC-------TTCB---HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCc-------ccCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1100 1111 23344566899999999999999999998764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=346.53 Aligned_cols=248 Identities=25% Similarity=0.349 Sum_probs=176.2
Q ss_pred cCeEeecCcEEEEEEEEc-CCCeEEEEEEcccchhhHHHHHHHHHHHcCCC-CCCcceEeeEEEECcEEEEEEeecCCCC
Q 012462 146 ENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGIHRMLVYEYVNNGN 223 (463)
Q Consensus 146 ~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~g~ 223 (463)
.+.||+|+||+||+|... +++.||||++... ....+.+|+.++..+. ||||+++++++.+....|+||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999664 6889999998543 3456778999999996 9999999999999999999999999999
Q ss_pred HHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCC---CEEEeecccceecCCCCce
Q 012462 224 LEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDF---NAKVSDFGLAKLLGAGKSH 300 (463)
Q Consensus 224 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~---~~kl~Dfg~a~~~~~~~~~ 300 (463)
|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||+++...... .
T Consensus 93 L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~ 164 (325)
T 3kn6_A 93 LFERIKK----KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-Q 164 (325)
T ss_dssp HHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-C
Confidence 9999964 35699999999999999999999999 999999999999997765 89999999998765432 2
Q ss_pred eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCccc-ccHHHHHHHHhcCCCccccccCCCCC
Q 012462 301 VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHE-VNLVDWLKMMVGSRRSEEVVDPNIEV 379 (463)
Q Consensus 301 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (463)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||........ ......+........ ..
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~---------~~ 235 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF---------SF 235 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC---------CC
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC---------CC
Confidence 23445789999999999999999999999999999999999999986543221 122222222222111 00
Q ss_pred CCCH--HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 380 RPST--RALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 380 ~~~~--~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.... .....+..++.+||+.||.+|||+.|++++
T Consensus 236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 1000 011234445668999999999999998754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=343.39 Aligned_cols=247 Identities=25% Similarity=0.302 Sum_probs=190.3
Q ss_pred HhcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc--hhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEEEE
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV--GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 214 (463)
..++|++.++||+|+||+||+|.+. +++.||||++.... ......+..|+..+.++ +||||++++++|.++...++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 3467999999999999999999775 68999999885432 22333444555555444 89999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
||||+ +++|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 135 v~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred EEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 99999 67999988653 34699999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccccc
Q 012462 295 GAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVD 374 (463)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (463)
.... ......||+.|+|||++.+ .++.++|||||||++|||++|..||.... .+ ..+........+ .
T Consensus 208 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~--------~~-~~~~~~~~~~~~-~ 274 (311)
T 3p1a_A 208 GTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE--------GW-QQLRQGYLPPEF-T 274 (311)
T ss_dssp C--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH--------HH-HHHTTTCCCHHH-H
T ss_pred ccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HH-HHHhccCCCccc-c
Confidence 5432 2334568999999999876 68999999999999999999977765321 11 111111111110 0
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 375 PNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
... ...+..++.+||+.||++|||+.|++++
T Consensus 275 -----~~~---~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 275 -----AGL---SSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp -----TTS---CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -----cCC---CHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 011 1234445668999999999999999874
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=345.29 Aligned_cols=268 Identities=27% Similarity=0.422 Sum_probs=210.3
Q ss_pred chHHHHHHhcCCCccCeEeecCcEEEEEEEE------cCCCeEEEEEEcccc-hhhHHHHHHHHHHHcCC-CCCCcceEe
Q 012462 132 TLRDLELATNRFSKENVLGEGGYGVVYRGNL------INGSPVAVKKILNNV-GQAEKEFRVEVEAIGHV-RHKNLVRLL 203 (463)
Q Consensus 132 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~ 203 (463)
....+++..++|++.+.||+|+||+||+|.+ .+++.||||.+.... ......+.+|+.++.++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3456667788999999999999999999964 245789999986543 33446788999999999 799999999
Q ss_pred eEEEECc-EEEEEEeecCCCCHHHHHhhhhcC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccC
Q 012462 204 GYCIEGI-HRMLVYEYVNNGNLEQWLHGAMRH------------HGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDI 270 (463)
Q Consensus 204 ~~~~~~~-~~~lV~e~~~~g~L~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Di 270 (463)
+++...+ ..++||||+++++|.+++...... ...+++..++.++.||+.||.|||+. +|+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccC
Confidence 9988754 489999999999999999753221 12388999999999999999999999 9999999
Q ss_pred CCCceeEcCCCCEEEeecccceecCCCCc-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCC
Q 012462 271 KSSNILIDDDFNAKVSDFGLAKLLGAGKS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHG 348 (463)
Q Consensus 271 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~ 348 (463)
||+|||++.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999987644332 23344567889999999999999999999999999999998 99999765
Q ss_pred CCcccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 349 RPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
..... . ........... . + ..... .+..++.+||+.||.+|||+.|++++|+.+
T Consensus 255 ~~~~~--~---~~~~~~~~~~~-~--~----~~~~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 255 KIDEE--F---CRRLKEGTRMR-A--P----DYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CCSHH--H---HHHHHHTCCCC-C--C----TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred chhHH--H---HHHhccCccCC-C--C----CCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 43221 1 11111111100 0 0 01112 334456689999999999999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=331.88 Aligned_cols=260 Identities=19% Similarity=0.255 Sum_probs=203.2
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEE-EECcEEEEEEe
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYC-IEGIHRMLVYE 217 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lV~e 217 (463)
.++|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+|+.++..++|++++..+.++ .+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46899999999999999999975 6789999998854432 24577899999999888766666655 66778899999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeE---cCCCCEEEeecccceec
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill---~~~~~~kl~Dfg~a~~~ 294 (463)
|+ +++|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||++...
T Consensus 86 ~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 86 LL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99 8999999963 234699999999999999999999999 99999999999999 48899999999999876
Q ss_pred CCCCce------eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCC
Q 012462 295 GAGKSH------VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRR 368 (463)
Q Consensus 295 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 368 (463)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+........
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 544321 12446799999999999999999999999999999999999999987554433333322221111100
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 369 SEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.... . .... ..+..++.+||+.||++|||+.++++.|++.
T Consensus 239 ~~~~-~-----~~~~---~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 239 IEVL-C-----KGYP---SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HHHH-T-----TTSC---HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred hHHH-H-----hhCC---HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 0000 0 0111 2334456689999999999999999999875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=347.75 Aligned_cols=263 Identities=24% Similarity=0.269 Sum_probs=198.9
Q ss_pred HHHHHhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEccc-----chhhHHHHHHHHHHHcCCCCCCcceEeeEEEE
Q 012462 135 DLELATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNN-----VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 208 (463)
Q Consensus 135 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 208 (463)
++....++|++.+.||+|+||+||+|.. .++..||+|++... .....+.+.+|+.++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 3455677899999999999999999965 46788999998543 23445678899999999999999999999999
Q ss_pred CcEEEEEEeecCCCCHHHHHhhhhcC------------------------------------CCCCCHHHHHHHHHHHHH
Q 012462 209 GIHRMLVYEYVNNGNLEQWLHGAMRH------------------------------------HGYLTWEARMKVLLGTAK 252 (463)
Q Consensus 209 ~~~~~lV~e~~~~g~L~~~l~~~~~~------------------------------------~~~~~~~~~~~i~~~i~~ 252 (463)
....++||||+++|+|.+++...... ...+++..++.++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999998532111 112457788899999999
Q ss_pred HHHHHHhcCCCCeEEccCCCCceeEcCCC--CEEEeecccceecCCCC---ceeeccccccCCCCchhhhcc--CCCCcc
Q 012462 253 ALAYLHEAIEPKVVHRDIKSSNILIDDDF--NAKVSDFGLAKLLGAGK---SHVTTRVMGTFGYVAPEYANT--GLLNEK 325 (463)
Q Consensus 253 ~l~~LH~~~~~~i~H~Dikp~Nill~~~~--~~kl~Dfg~a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~ 325 (463)
||.|||+. +|+||||||+|||++.++ .+||+|||++....... ........||+.|+|||++.+ ..++.+
T Consensus 180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 99999999 999999999999998776 89999999998754321 122345678999999999975 678999
Q ss_pred chhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCC
Q 012462 326 SDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRP 405 (463)
Q Consensus 326 sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP 405 (463)
+|||||||++|||++|+.||...... +............. .+ ...... ..+..++.+||+.||.+||
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~~~~--~~--~~~~~~---~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDA------DTISQVLNKKLCFE--NP--NYNVLS---PLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCTT--SG--GGGGSC---HHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcccccC--Cc--ccccCC---HHHHHHHHHHcCCChhHCC
Confidence 99999999999999999999754321 11222221111100 00 000011 2334455689999999999
Q ss_pred CHHHHHHH
Q 012462 406 KMSQVVRM 413 (463)
Q Consensus 406 s~~ell~~ 413 (463)
++.|++++
T Consensus 324 s~~~~l~h 331 (345)
T 3hko_A 324 DAMRALQH 331 (345)
T ss_dssp CHHHHHHS
T ss_pred CHHHHhcC
Confidence 99999874
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=349.27 Aligned_cols=251 Identities=22% Similarity=0.322 Sum_probs=195.1
Q ss_pred hcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEccc--chhhHHHHHHHHHHHcCCC--CCCcceEeeEEEECcEEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNN--VGQAEKEFRVEVEAIGHVR--HKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lV 215 (463)
..+|++.+.||+|+||+||+|...+++.||||++... .......+.+|+.++.+++ ||||+++++++...+..|+|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 4569999999999999999998878999999998543 2344577889999999986 59999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
|| +.+++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+++...
T Consensus 135 ~E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EE-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred Ee-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 99 567899999964 34689999999999999999999999 999999999999995 5899999999998765
Q ss_pred CCCc-eeeccccccCCCCchhhhcc-----------CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHH
Q 012462 296 AGKS-HVTTRVMGTFGYVAPEYANT-----------GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMM 363 (463)
Q Consensus 296 ~~~~-~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 363 (463)
.... ......+||+.|+|||++.+ ..++.++|||||||+||||++|+.||..... ....+...
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~~~ 280 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAI 280 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHH
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHHHH
Confidence 4322 12345679999999999875 4688999999999999999999999975331 12222222
Q ss_pred hcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 364 VGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
......... .... ...+..++.+||+.||.+|||+.|++++
T Consensus 281 ~~~~~~~~~-------~~~~--~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 281 IDPNHEIEF-------PDIP--EKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HCTTSCCCC-------CCCS--CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hCccccCCC-------Cccc--hHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 222111111 1111 1233445668999999999999999875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=350.77 Aligned_cols=260 Identities=28% Similarity=0.439 Sum_probs=193.0
Q ss_pred cCCCccCeEeecCcEEEEEEEEcC--C--CeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEE-CcEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLIN--G--SPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE-GIHRML 214 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~~--~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~l 214 (463)
..|.+.+.||+|+||+||+|.+.+ + ..||+|.+.... ......+.+|+.++++++||||++++++|.+ .+..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 346778899999999999996532 2 368999875432 3455788899999999999999999999764 457799
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
||||+++|+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 169 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccc
Confidence 9999999999999963 344588999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCce---eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 295 GAGKSH---VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 295 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
...... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||....... .... ........
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~---~~~~~~~~ 316 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY---LLQGRRLL 316 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHH---HHTTCCCC
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHH---HHcCCCCC
Confidence 433211 1233457789999999999999999999999999999999 677776544322 2211 11111110
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCCCCc
Q 012462 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIV 422 (463)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 422 (463)
.+ .... ..+..++.+||+.||++|||+.|+++.|+.+.....
T Consensus 317 ---~p----~~~~---~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 317 ---QP----EYCP---DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp ---CC----TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ---CC----CCCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 00 0111 234455668999999999999999999998754443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=332.53 Aligned_cols=249 Identities=25% Similarity=0.394 Sum_probs=180.1
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccch---hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVG---QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
++|++.+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 5699999999999999999976 5789999999854321 22467888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+++++|.+++.. ....+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 91 EMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp ECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 99999999999864 235689999999999999999999999 999999999999999999999999999987653
Q ss_pred CCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (463)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......... ......
T Consensus 165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---------------~~~~~~ 228 (278)
T 3cok_A 165 PHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN---------------KVVLAD 228 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSC
T ss_pred CCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH---------------HHhhcc
Confidence 322 1234578999999999999999999999999999999999999997644321110 000001
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
....... ...+..++.+||+.||++|||+.+++++
T Consensus 229 ~~~~~~~--~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 229 YEMPSFL--SIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp CCCCTTS--CHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cCCcccc--CHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 1111111 1233445668999999999999999874
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=337.09 Aligned_cols=252 Identities=23% Similarity=0.328 Sum_probs=202.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccch------hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVG------QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHR 212 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 212 (463)
.++|++.+.||+|+||.||+|... +|+.||+|.+..... ...+.+.+|+.++.+++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456999999999999999999764 588999999854332 1357788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCC----CEEEeec
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDF----NAKVSDF 288 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~----~~kl~Df 288 (463)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 999999999999999953 45689999999999999999999999 999999999999999888 7999999
Q ss_pred ccceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCC
Q 012462 289 GLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRR 368 (463)
Q Consensus 289 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 368 (463)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ...+........
T Consensus 164 g~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~i~~~~~ 235 (321)
T 2a2a_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANITSVSY 235 (321)
T ss_dssp TTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHTTCC
T ss_pred ccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhccc
Confidence 9998765432 23345789999999999999999999999999999999999999975432 122222221110
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 369 SEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.. .+.. ..... ..+..++.+||+.||++|||+.|++++
T Consensus 236 ~~---~~~~-~~~~~---~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 236 DF---DEEF-FSHTS---ELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CC---CHHH-HTTCC---HHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred cc---Chhh-hcccC---HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0000 00011 223445668999999999999999985
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=340.41 Aligned_cols=267 Identities=24% Similarity=0.351 Sum_probs=207.1
Q ss_pred HHHHHHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcC--CCCCCcceEeeEEEECc-
Q 012462 134 RDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGH--VRHKNLVRLLGYCIEGI- 210 (463)
Q Consensus 134 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~- 210 (463)
.......++|++.+.||+|+||.||+|.. +++.||||++... ....+..|.+++.. ++||||+++++++....
T Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 35 LVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred eecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 33455667899999999999999999987 6899999998543 34556677777766 79999999999998875
Q ss_pred ---EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEEccCCCCceeEcC
Q 012462 211 ---HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH--------EAIEPKVVHRDIKSSNILIDD 279 (463)
Q Consensus 211 ---~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH--------~~~~~~i~H~Dikp~Nill~~ 279 (463)
..++||||+++|+|.+++.. ..+++..++.++.|++.||.||| +. +|+||||||+|||++.
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKK 182 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECT
T ss_pred ccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECC
Confidence 78999999999999999963 24899999999999999999999 77 9999999999999999
Q ss_pred CCCEEEeecccceecCCCCce---eeccccccCCCCchhhhccC------CCCccchhhhHHHHHHHHHhC---------
Q 012462 280 DFNAKVSDFGLAKLLGAGKSH---VTTRVMGTFGYVAPEYANTG------LLNEKSDVYSFGVLLLEAITG--------- 341 (463)
Q Consensus 280 ~~~~kl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvvl~elltg--------- 341 (463)
++.+||+|||++......... ......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 262 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence 999999999999876544322 22445789999999999776 234689999999999999999
Q ss_pred -CCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 342 -RDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 342 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
..||....... .....+............+.. ..........+..++.+||+.||++|||+.|++++|+.+
T Consensus 263 ~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 263 YQLPYYDLVPSD-PSVEEMRKVVCEQKLRPNIPN----RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp CCCTTTTTSCSS-CCHHHHHHHHTTSCCCCCCCG----GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCccccCcCc-ccHHHHHHHHHHHHhCCCCcc----cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 77887544322 222233222222211111110 011224445566677789999999999999999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=332.82 Aligned_cols=260 Identities=18% Similarity=0.252 Sum_probs=199.8
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEE-EECcEEEEEEe
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYC-IEGIHRMLVYE 217 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lV~e 217 (463)
.++|++.+.||+|+||+||+|.. .+++.||||++..... ...+..|+.++..++|++++..+..+ .+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 47899999999999999999975 5788999998644322 23577799999999888777666655 67788899999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeE---cCCCCEEEeecccceec
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill---~~~~~~kl~Dfg~a~~~ 294 (463)
|+ +++|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||++...
T Consensus 86 ~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 86 LL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred cc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 99 8999999864 234599999999999999999999999 99999999999999 78999999999999876
Q ss_pred CCCCc------eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCC
Q 012462 295 GAGKS------HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRR 368 (463)
Q Consensus 295 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 368 (463)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+........
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 54332 122346789999999999999999999999999999999999999987554443333322221111100
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 369 SEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
..... .... ..+..++.+||+.||++|||+.++++.|++.
T Consensus 239 ~~~~~------~~~~---~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 239 IEVLC------KGYP---SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HHHHT------TTSC---HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred hhhhh------ccCC---HHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 00000 0011 2344456679999999999999999999875
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=345.61 Aligned_cols=260 Identities=23% Similarity=0.288 Sum_probs=195.4
Q ss_pred hcCCCcc-CeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEEEEEE
Q 012462 140 TNRFSKE-NVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 140 ~~~~~~~-~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 216 (463)
.++|++. +.||+|+||+||+|.. .+++.||||++..........+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3568874 7899999999999964 46899999999766555567888999999885 7999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCC---EEEeeccccee
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFN---AKVSDFGLAKL 293 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~---~kl~Dfg~a~~ 293 (463)
||+++++|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++. +||+|||++..
T Consensus 91 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp ECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 999999999999643 4589999999999999999999999 9999999999999998776 99999999876
Q ss_pred cCCCCc------eeeccccccCCCCchhhhcc-----CCCCccchhhhHHHHHHHHHhCCCCCCCCCCccccc-------
Q 012462 294 LGAGKS------HVTTRVMGTFGYVAPEYANT-----GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVN------- 355 (463)
Q Consensus 294 ~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~------- 355 (463)
...... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 532211 11223568999999999875 568899999999999999999999998654322100
Q ss_pred --HHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 356 --LVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 356 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
............ .. +... ..... ...+..++.+||+.||++|||+.|++++
T Consensus 244 ~~~~~~~~~i~~~~-~~-~~~~--~~~~~---~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 244 ACQNMLFESIQEGK-YE-FPDK--DWAHI---SCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHHCC-CC-CCHH--HHTTS---CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hHHHHHHHHHhccC-cc-cCch--hcccC---CHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 001111111111 00 0000 00001 1233455668999999999999999885
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=346.33 Aligned_cols=247 Identities=25% Similarity=0.353 Sum_probs=197.8
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 215 (463)
.++|+..+.||+|+||+||+|.. .+++.||||++.... ......+.+|+.++++++||||+++++++.+....++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35588999999999999999975 578899999985432 23345788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
|||+. |+|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 133 ~e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp EECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 99997 5888888542 35699999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCceeeccccccCCCCchhhhc---cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccc
Q 012462 296 AGKSHVTTRVMGTFGYVAPEYAN---TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV 372 (463)
Q Consensus 296 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (463)
. .....||+.|+|||++. +..++.++|||||||++|||++|+.||..... ...+..........
T Consensus 206 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~~~~~~~~~-- 272 (348)
T 1u5q_A 206 P-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNESPA-- 272 (348)
T ss_dssp S-----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCCCC--
T ss_pred C-----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcCCCC--
Confidence 3 23457899999999984 56789999999999999999999999975432 12222222221111
Q ss_pred ccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 373 VDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
......... +..++.+||+.||++|||+++++++
T Consensus 273 ----~~~~~~~~~---l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 273 ----LQSGHWSEY---FRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ----CCCTTSCHH---HHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ----CCCCCCCHH---HHHHHHHHcccChhhCcCHHHHhhC
Confidence 111111222 3344557999999999999999875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=338.00 Aligned_cols=267 Identities=25% Similarity=0.405 Sum_probs=199.8
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcC--CCCCCcceEeeEEEEC----c
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGH--VRHKNLVRLLGYCIEG----I 210 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----~ 210 (463)
....++|++.+.||+|+||.||+|.. .++.||||++.... ...+..|.+++.. ++||||+++++++.+. .
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 44567899999999999999999987 48999999985432 2334445555554 4999999999999987 7
Q ss_pred EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEEccCCCCceeEcCCCCEEE
Q 012462 211 HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI-----EPKVVHRDIKSSNILIDDDFNAKV 285 (463)
Q Consensus 211 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----~~~i~H~Dikp~Nill~~~~~~kl 285 (463)
..++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+.+ .++|+||||||+|||++.++.+||
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred ceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 88999999999999999953 24899999999999999999999752 348999999999999999999999
Q ss_pred eecccceecCCCCcee---eccccccCCCCchhhhccCCCCcc------chhhhHHHHHHHHHhC----------CCCCC
Q 012462 286 SDFGLAKLLGAGKSHV---TTRVMGTFGYVAPEYANTGLLNEK------SDVYSFGVLLLEAITG----------RDPVD 346 (463)
Q Consensus 286 ~Dfg~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------sDvwSlGvvl~elltg----------~~pf~ 346 (463)
+|||++.......... .....||+.|+|||++.+..++.+ +|||||||++|||++| ..||.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 9999998764432211 224579999999999988776665 9999999999999999 66665
Q ss_pred CCCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 347 HGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
....... ....... ............ ...........+..++.+||+.||++|||+.|++++|+.+
T Consensus 264 ~~~~~~~-~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 264 DLVPSDP-SYEDMRE-IVCIKKLRPSFP---NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp TTSCSSC-CHHHHHH-HHTTSCCCCCCC---GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhcCCCC-chhhhHH-HHhhhccCcccc---ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 4433221 1222211 111111111100 0011123445566677789999999999999999999875
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=341.44 Aligned_cols=265 Identities=24% Similarity=0.324 Sum_probs=195.1
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc-----hhhHHHHHHHHHHHcCC---CCCCcceEeeEEEE
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV-----GQAEKEFRVEVEAIGHV---RHKNLVRLLGYCIE 208 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~ 208 (463)
...++|++.+.||+|+||+||+|.. .+++.||+|++.... ......+.+|+.+++++ +||||++++++|..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 4467999999999999999999975 568899999985322 11123555677666655 59999999999987
Q ss_pred Cc-----EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCE
Q 012462 209 GI-----HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNA 283 (463)
Q Consensus 209 ~~-----~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~ 283 (463)
.. ..++||||+. ++|.+++... ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCE
Confidence 65 5799999996 5999998642 233499999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHH
Q 012462 284 KVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMM 363 (463)
Q Consensus 284 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 363 (463)
||+|||++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+...
T Consensus 160 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~ 234 (308)
T 3g33_A 160 KLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDL 234 (308)
T ss_dssp EECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH---HHHHHHHH
T ss_pred EEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHH
Confidence 999999998654322 2345678999999999999999999999999999999999999997644221 11112111
Q ss_pred hcCCCccccccC----C--C--CCCCCHH-----HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 364 VGSRRSEEVVDP----N--I--EVRPSTR-----ALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 364 ~~~~~~~~~~~~----~--~--~~~~~~~-----~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
............ . . ....... ....+..++.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 111111100000 0 0 0000000 11233445668999999999999999874
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=370.57 Aligned_cols=256 Identities=26% Similarity=0.404 Sum_probs=199.0
Q ss_pred HhcCCCccC-eEeecCcEEEEEEEEc---CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEE
Q 012462 139 ATNRFSKEN-VLGEGGYGVVYRGNLI---NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRM 213 (463)
Q Consensus 139 ~~~~~~~~~-~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 213 (463)
..+++.+.+ .||+|+||.||+|.+. ++..||||++.... ....+.+.+|+.++++++||||++++++|.+ +..+
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~ 411 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 411 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence 344555555 7999999999999664 45679999986543 3456789999999999999999999999976 5689
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
+||||+++|+|.+++.. ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 412 lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~ 485 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKA 485 (613)
T ss_dssp EEEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred EEEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence 99999999999999964 345699999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCcee--eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 294 LGAGKSHV--TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 294 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
........ .....+|+.|+|||++.+..++.++|||||||+||||++ |+.||....... ....+.......
T Consensus 486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~------~~~~i~~~~~~~ 559 (613)
T 2ozo_A 486 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAFIEQGKRME 559 (613)
T ss_dssp CC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH------HHHHHHTTCCCC
T ss_pred ccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH------HHHHHHcCCCCC
Confidence 64332211 122345689999999999999999999999999999998 999998654322 122222221111
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.... ....+..++.+||+.||++||++.+|++.|+..
T Consensus 560 --------~p~~--~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 560 --------CPPE--CPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp --------CCTT--CCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred --------CCCc--CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111 112344556689999999999999999999875
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=348.34 Aligned_cols=243 Identities=25% Similarity=0.363 Sum_probs=198.1
Q ss_pred HhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccch--------hhHHHHHHHHHHHcCCCCCCcceEeeEEEEC
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVG--------QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG 209 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 209 (463)
..++|++.+.||+|+||+||+|.. .+++.||||++..... .....+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 346899999999999999999964 5688999999854321 1233566799999999999999999999999
Q ss_pred cEEEEEEeecCCC-CHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeec
Q 012462 210 IHRMLVYEYVNNG-NLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDF 288 (463)
Q Consensus 210 ~~~~lV~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Df 288 (463)
+..++||||+.+| +|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFID----RHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHH----TCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999999777 9999985 345699999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCceeeccccccCCCCchhhhccCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCC
Q 012462 289 GLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL-NEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR 367 (463)
Q Consensus 289 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 367 (463)
|++........ ....+||+.|+|||++.+..+ +.++|||||||++|||++|..||.......
T Consensus 175 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------------- 237 (335)
T 3dls_A 175 GSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV--------------- 237 (335)
T ss_dssp TTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT---------------
T ss_pred ccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH---------------
Confidence 99987654432 334579999999999988877 889999999999999999999997422100
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 368 RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
....... ..... .+..++.+||+.||++|||+.|++++
T Consensus 238 --~~~~~~~---~~~~~---~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 238 --EAAIHPP---YLVSK---ELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp --TTCCCCS---SCCCH---HHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred --hhccCCC---cccCH---HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 01112 23445568999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=346.82 Aligned_cols=257 Identities=24% Similarity=0.297 Sum_probs=201.1
Q ss_pred hcCCCccCeEeecCcEEEEEEEE----cCCCeEEEEEEcccc----hhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECc
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL----INGSPVAVKKILNNV----GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGI 210 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 210 (463)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ......+..|+.++.++ +||||+++++++.+..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36799999999999999999976 368899999985432 12334566788899888 7999999999999999
Q ss_pred EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccc
Q 012462 211 HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGL 290 (463)
Q Consensus 211 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~ 290 (463)
..++||||+++++|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 999999999999999999642 3589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeccccccCCCCchhhhcc--CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCC
Q 012462 291 AKLLGAGKSHVTTRVMGTFGYVAPEYANT--GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRR 368 (463)
Q Consensus 291 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 368 (463)
++.............+||+.|+|||++.+ ..++.++|||||||+||||++|+.||........ .............
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~ 283 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILKSEP 283 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHHCCC
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhccCC
Confidence 98765433333445689999999999986 3578999999999999999999999975443222 2222222221110
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHHhc
Q 012462 369 SEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRP-----KMSQVVRMLES 416 (463)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP-----s~~ell~~L~~ 416 (463)
...... ...+..++.+||+.||.+|| +++|++++.--
T Consensus 284 ---------~~~~~~--~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f 325 (355)
T 1vzo_A 284 ---------PYPQEM--SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325 (355)
T ss_dssp ---------CCCTTS--CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred ---------CCCccc--CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence 011111 11233455689999999999 99999887543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=349.20 Aligned_cols=272 Identities=23% Similarity=0.262 Sum_probs=208.8
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECc--EEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGI--HRMLV 215 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lV 215 (463)
.++|++.++||+|+||+||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.. ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 467999999999999999999765 48999999986533 334567788999999999999999999998755 77999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeE----cCCCCEEEeecccc
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILI----DDDFNAKVSDFGLA 291 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill----~~~~~~kl~Dfg~a 291 (463)
|||+++|+|.+++.... ....+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 99999999999987542 233499999999999999999999999 99999999999999 77888999999999
Q ss_pred eecCCCCceeeccccccCCCCchhhhcc--------CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHH
Q 012462 292 KLLGAGKSHVTTRVMGTFGYVAPEYANT--------GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMM 363 (463)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 363 (463)
+...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ...+...
T Consensus 164 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~ 239 (396)
T 4eut_A 164 RELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKI 239 (396)
T ss_dssp EECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHHH
T ss_pred eEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHHH
Confidence 8765432 2334679999999999865 56788999999999999999999999754332211 1222222
Q ss_pred hcCCCcccc------------ccCCCCC--CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCC
Q 012462 364 VGSRRSEEV------------VDPNIEV--RPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEY 419 (463)
Q Consensus 364 ~~~~~~~~~------------~~~~~~~--~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~ 419 (463)
........+ +...... .........+..++.+||+.||++||++.|+++.++++..
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 222211100 0001111 1112333444456668999999999999999999987643
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=336.10 Aligned_cols=257 Identities=25% Similarity=0.389 Sum_probs=200.9
Q ss_pred CCccCeEeecCcEEEEEEEEc-----CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEE--CcEEEE
Q 012462 143 FSKENVLGEGGYGVVYRGNLI-----NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE--GIHRML 214 (463)
Q Consensus 143 ~~~~~~lG~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l 214 (463)
|++.+.||+|+||+||++.+. +++.||||++.... ......+.+|+.++++++||||+++++++.+ ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488999999999999988542 57889999986543 3445678899999999999999999999988 467899
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
||||+++++|.+++.. ..+++..++.++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||++...
T Consensus 113 v~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 9999999999999853 2389999999999999999999999 9999999999999999999999999999887
Q ss_pred CCCCce--eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCc---------ccccHHHHHHHH
Q 012462 295 GAGKSH--VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPA---------HEVNLVDWLKMM 363 (463)
Q Consensus 295 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~---------~~~~~~~~~~~~ 363 (463)
...... ......+|..|+|||++.+..++.++|||||||++|||++|..||...... ............
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence 654321 233456788899999999999999999999999999999999999643210 000111111111
Q ss_pred hcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 364 VGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
...... .........+..++.+||+.||++|||+.|+++.|+.+
T Consensus 265 ~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 265 ERGERL----------PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp HTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcccCC----------CCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 111110 00011112344556689999999999999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=340.85 Aligned_cols=267 Identities=27% Similarity=0.410 Sum_probs=198.5
Q ss_pred hHHHHHHhcCCCccCeEeecCcEEEEEEEEcC----CCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEE
Q 012462 133 LRDLELATNRFSKENVLGEGGYGVVYRGNLIN----GSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYC 206 (463)
Q Consensus 133 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 206 (463)
+.++.+..++|.+.+.||+|+||.||+|.... +..||+|.+.... ....+.+.+|+.++++++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 34455667889999999999999999996542 3479999985432 33446788999999999999999999999
Q ss_pred EECcE-----EEEEEeecCCCCHHHHHhhhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC
Q 012462 207 IEGIH-----RMLVYEYVNNGNLEQWLHGAM--RHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD 279 (463)
Q Consensus 207 ~~~~~-----~~lV~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~ 279 (463)
.+... .++||||+++++|.+++.... .....+++..++.++.||+.||.|||+. +|+||||||+|||++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~ 182 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRD 182 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECT
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcC
Confidence 86543 499999999999999985432 2345699999999999999999999999 9999999999999999
Q ss_pred CCCEEEeecccceecCCCCc-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHH
Q 012462 280 DFNAKVSDFGLAKLLGAGKS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLV 357 (463)
Q Consensus 280 ~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~ 357 (463)
++.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... ..
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~ 259 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MY 259 (313)
T ss_dssp TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HH
T ss_pred CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HH
Confidence 99999999999987644321 11223456889999999999999999999999999999999 889997654322 11
Q ss_pred HHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCC
Q 012462 358 DWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEE 418 (463)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~ 418 (463)
. ........... .... ..+..++.+||+.||.+|||+.+++++|+.+.
T Consensus 260 ~---~~~~~~~~~~~-------~~~~---~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 260 D---YLLHGHRLKQP-------EDCL---DELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp H---HHHTTCCCCCB-------TTCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H---HHHcCCCCCCC-------cccc---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 12211111100 1111 23444566899999999999999999998753
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=360.40 Aligned_cols=256 Identities=23% Similarity=0.293 Sum_probs=204.6
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEE
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRM 213 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 213 (463)
+..++|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.++.+++||||+++++++.+.+..|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 34577999999999999999999764 68999999985432 233456788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
+||||+++|+|.+++... ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++++||+|||+++.
T Consensus 261 lVmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVH 335 (576)
T ss_dssp EEECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEeccccee
Confidence 999999999999998642 234599999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccc
Q 012462 294 LGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373 (463)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (463)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|..||........ ........... .
T Consensus 336 ~~~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~--~~~i~~~i~~~-~----- 405 (576)
T 2acx_A 336 VPEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--REEVERLVKEV-P----- 405 (576)
T ss_dssp CCTTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC--HHHHHHHHHHC-C-----
T ss_pred cccCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh--HHHHHHHhhcc-c-----
Confidence 65433 23345899999999999999999999999999999999999999986543221 11111111111 0
Q ss_pred cCCCCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 012462 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRP-----KMSQVVRM 413 (463)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP-----s~~ell~~ 413 (463)
....... ......++.+||+.||.+|| +++|++++
T Consensus 406 ---~~~p~~~--s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 406 ---EEYSERF--SPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp ---CCCCTTS--CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ---ccCCccC--CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 0011111 12233445579999999999 78898865
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=342.44 Aligned_cols=258 Identities=25% Similarity=0.391 Sum_probs=199.9
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCe--EEEEEEcccc-hhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSP--VAVKKILNNV-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~--vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 214 (463)
.++|++.+.||+|+||.||+|... ++.. ||+|.+.... ......+.+|+.++.++ +||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 367899999999999999999654 4554 4899886432 33445788899999999 89999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhh------------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCC
Q 012462 215 VYEYVNNGNLEQWLHGAM------------RHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFN 282 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~ 282 (463)
||||+++++|.+++.... .....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCe
Confidence 999999999999997532 2234699999999999999999999999 9999999999999999999
Q ss_pred EEEeecccceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHH
Q 012462 283 AKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLK 361 (463)
Q Consensus 283 ~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~ 361 (463)
+||+|||++...... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||...... ....
T Consensus 181 ~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------~~~~ 252 (327)
T 1fvr_A 181 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYE 252 (327)
T ss_dssp EEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHH
T ss_pred EEEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH------HHHH
Confidence 999999999743221 11223456889999999999899999999999999999998 99999764321 1122
Q ss_pred HHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCC
Q 012462 362 MMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEE 418 (463)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~ 418 (463)
......... .... ....+..++.+||+.||.+|||+.|+++.|+...
T Consensus 253 ~~~~~~~~~--------~~~~--~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 253 KLPQGYRLE--------KPLN--CDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp HGGGTCCCC--------CCTT--BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhhcCCCCC--------CCCC--CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 221111110 0111 1123344566899999999999999999998753
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=358.75 Aligned_cols=256 Identities=24% Similarity=0.292 Sum_probs=204.6
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 215 (463)
.++|.+.+.||+|+||+||+|+.. +|+.||+|++.... ......+..|+.++.+++||||+++++++.+....|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999764 68999999985432 12345678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
|||+++|+|.+++.........+++..++.++.||+.||.|||++ +|+||||||+|||++.++++||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999976544455799999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 296 AGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
.... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||....... .............
T Consensus 341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~--~~~~~~~~i~~~~-------- 409 (543)
T 3c4z_A 341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQRVLEQA-------- 409 (543)
T ss_dssp TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC--CHHHHHHHHHHCC--------
T ss_pred CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch--hHHHHHHHHhhcc--------
Confidence 4332 2344689999999999999999999999999999999999999998654221 2222222222111
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 012462 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKM-----SQVVR 412 (463)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~-----~ell~ 412 (463)
...+... ......++.+||+.||++||++ .++++
T Consensus 410 -~~~p~~~--s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 410 -VTYPDKF--SPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp -CCCCTTS--CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred -cCCCccc--CHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 1111111 1223344557999999999975 66664
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=350.73 Aligned_cols=249 Identities=24% Similarity=0.292 Sum_probs=190.0
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccch---hhHHHHHHHHHH-HcCCCCCCcceEeeEEEECcEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVG---QAEKEFRVEVEA-IGHVRHKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~l 214 (463)
.++|++.+.||+|+||+||+|+.. ++..||+|++..... .....+..|..+ ++.++||||++++++|.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 467999999999999999999764 578899999855432 223445566666 567899999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
||||+++|+|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++++||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999999864 24589999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccccc
Q 012462 295 GAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVD 374 (463)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (463)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||..... ......+....
T Consensus 190 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~------- 255 (373)
T 2r5t_A 190 IEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILNKP------- 255 (373)
T ss_dssp BCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH------HHHHHHHHHSC-------
T ss_pred ccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHhcc-------
Confidence 3222 234457899999999999999999999999999999999999999975432 12222222111
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 375 PNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
....+... .....++.+||+.||.+||++.+.++.
T Consensus 256 --~~~~~~~~--~~~~~li~~lL~~dp~~R~~~~~~~~~ 290 (373)
T 2r5t_A 256 --LQLKPNIT--NSARHLLEGLLQKDRTKRLGAKDDFME 290 (373)
T ss_dssp --CCCCSSSC--HHHHHHHHHHTCSSGGGSTTTTTTHHH
T ss_pred --cCCCCCCC--HHHHHHHHHHcccCHHhCCCCCCCHHH
Confidence 11111111 123344557999999999998543333
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=336.47 Aligned_cols=258 Identities=29% Similarity=0.436 Sum_probs=198.0
Q ss_pred hcCCCccCeEeecCcEEEEEEEEcCC----CeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEE-ECcEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLING----SPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCI-EGIHRM 213 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~~~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~ 213 (463)
..+|++.+.||+|+||+||+|...++ ..||+|.+.... ......+.+|+.++++++||||+++++++. .+...+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 45688899999999999999975432 258999886533 344567889999999999999999999965 456779
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
+||||+++|+|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 104 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccc
Confidence 99999999999999963 345689999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCc---eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCc
Q 012462 294 LGAGKS---HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369 (463)
Q Consensus 294 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 369 (463)
...... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||....... ... ........
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~---~~~~~~~~ 251 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITV---YLLQGRRL 251 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHH---HHHTTCCC
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHH---HHhcCCCC
Confidence 644321 11233467889999999999999999999999999999999 555565433221 111 11111110
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCC
Q 012462 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEY 419 (463)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~ 419 (463)
. .+ ..... .+..++.+||+.||++|||+.|+++.|+.+..
T Consensus 252 ~---~~----~~~~~---~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 252 L---QP----EYCPD---PLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp C---CC----TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C---CC----ccCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0 00 11112 34445668999999999999999999988643
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=343.93 Aligned_cols=252 Identities=25% Similarity=0.320 Sum_probs=195.6
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccchhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEEEEEEe
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e 217 (463)
.++|++.+.||+|+||+||+|... +++.||+|.+...... ...|++++.++ +||||+++++++.+....|+|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 467999999999999999999664 5889999998554322 23477777776 79999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCC----CCEEEeeccccee
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDD----FNAKVSDFGLAKL 293 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~----~~~kl~Dfg~a~~ 293 (463)
|+++|+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||+.++ +.+||+|||++..
T Consensus 97 ~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 97 LMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 9999999999853 45699999999999999999999999 99999999999998543 3599999999987
Q ss_pred cCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccc
Q 012462 294 LGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373 (463)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (463)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|..||....... ............. ...
T Consensus 170 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~~~~i~~~~~-~~~- 243 (342)
T 2qr7_A 170 LRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT---PEEILARIGSGKF-SLS- 243 (342)
T ss_dssp CBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC---HHHHHHHHHHCCC-CCC-
T ss_pred CcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC---HHHHHHHHccCCc-ccC-
Confidence 654322 2345688999999999988889999999999999999999999998643222 2222222222111 000
Q ss_pred cCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.......... ...++.+||+.||++|||+.|++++
T Consensus 244 --~~~~~~~s~~---~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 244 --GGYWNSVSDT---AKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp --STTTTTSCHH---HHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred --ccccccCCHH---HHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000111222 3344557999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=336.03 Aligned_cols=258 Identities=24% Similarity=0.341 Sum_probs=203.4
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEE--CcEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE--GIHRML 214 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l 214 (463)
.++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357999999999999999999764 68899999985432 3445678899999999999999999998865 567899
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eEEccCCCCceeEcCCCCEEEeecc
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPK-----VVHRDIKSSNILIDDDFNAKVSDFG 289 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-----i~H~Dikp~Nill~~~~~~kl~Dfg 289 (463)
||||+++++|.+++.........+++..++.++.|++.||.|||+. + |+|+||||+|||++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999999999987655566799999999999999999999999 8 9999999999999999999999999
Q ss_pred cceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCc
Q 012462 290 LAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369 (463)
Q Consensus 290 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 369 (463)
++........ ......|++.|+|||++.+..++.++||||||+++|+|++|+.||..... ............
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~i~~~~~- 233 (279)
T 2w5a_A 162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ------KELAGKIREGKF- 233 (279)
T ss_dssp HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCC-
T ss_pred hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH------HHHHHHHhhccc-
Confidence 9987543321 12345689999999999999999999999999999999999999976432 111222221111
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
..+. ..... .+..++.+||+.||++|||+.|+++++...
T Consensus 234 ~~~~------~~~~~---~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 234 RRIP------YRYSD---ELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp CCCC------TTSCH---HHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred ccCC------cccCH---HHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 1110 01112 334455689999999999999999876543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=353.94 Aligned_cols=202 Identities=27% Similarity=0.418 Sum_probs=163.7
Q ss_pred HhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEccc--chhhHHHHHHHHHHHcCCC-CCCcceEeeEEEECc--EE
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNN--VGQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGI--HR 212 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~ 212 (463)
..++|++.+.||+|+||.||+|.. .+|+.||||++... .......+.+|+.++.++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 457899999999999999999965 56899999998543 2344566778999999996 999999999998544 68
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccce
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~ 292 (463)
|+||||++ ++|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 87 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 99999997 599998853 3589999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCC--------------------CceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 293 LLGAG--------------------KSHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 293 ~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
..... .....+..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 75331 1112344689999999999976 678999999999999999999999998654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=336.51 Aligned_cols=259 Identities=29% Similarity=0.409 Sum_probs=202.5
Q ss_pred HHHhcCCCccC-eEeecCcEEEEEEEEc---CCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECc
Q 012462 137 ELATNRFSKEN-VLGEGGYGVVYRGNLI---NGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGI 210 (463)
Q Consensus 137 ~~~~~~~~~~~-~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 210 (463)
.+..++|.+.+ .||+|+||+||+|.+. .+..||||++.... ....+.+.+|+.+++.++||||+++++++ +.+
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 34457788888 9999999999999542 35789999986543 23356788999999999999999999999 566
Q ss_pred EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccc
Q 012462 211 HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGL 290 (463)
Q Consensus 211 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~ 290 (463)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||+
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~ 163 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGL 163 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred CcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCc
Confidence 78999999999999999964 34599999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCcee--eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCC
Q 012462 291 AKLLGAGKSHV--TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSR 367 (463)
Q Consensus 291 a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 367 (463)
+.......... .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||...... ..........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~ 237 (291)
T 1xbb_A 164 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------EVTAMLEKGE 237 (291)
T ss_dssp CEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHHHTTC
T ss_pred ceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHHcCC
Confidence 98765443322 222346788999999999889999999999999999999 99999764321 1122222211
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCC
Q 012462 368 RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEY 419 (463)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~ 419 (463)
.. ... .... ..+..++.+||+.||++||++.++++.|++...
T Consensus 238 ~~-~~~------~~~~---~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 238 RM-GCP------AGCP---REMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp CC-CCC------TTCC---HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CC-CCC------CCCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11 000 1111 233445668999999999999999999988643
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=331.90 Aligned_cols=252 Identities=23% Similarity=0.388 Sum_probs=201.6
Q ss_pred HhcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEE---------
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE--------- 208 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------- 208 (463)
..++|++.+.||+|+||.||+|... +++.||+|.+.... ..+.+|+.++.+++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4567999999999999999999775 78999999986543 345679999999999999999998864
Q ss_pred -------CcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCC
Q 012462 209 -------GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDF 281 (463)
Q Consensus 209 -------~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~ 281 (463)
....++||||+++++|.+++... ....+++..++.++.||+.||.|||+. +|+|+||||+|||++.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCC
Confidence 44579999999999999999753 234699999999999999999999999 999999999999999999
Q ss_pred CEEEeecccceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHH
Q 012462 282 NAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLK 361 (463)
Q Consensus 282 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 361 (463)
.+||+|||++....... ......|++.|+|||++.+..++.++||||||+++|||++|..||... .....
T Consensus 160 ~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~~~~ 229 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SKFFT 229 (284)
T ss_dssp EEEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HHHHH
T ss_pred CEEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HHHHH
Confidence 99999999998765432 223456899999999999999999999999999999999999887421 11111
Q ss_pred HHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCCCCc
Q 012462 362 MMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIV 422 (463)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 422 (463)
.... .... ...... +..++.+||+.||.+|||+.|++++|+.......
T Consensus 230 ~~~~-~~~~---------~~~~~~---~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 230 DLRD-GIIS---------DIFDKK---EKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp HHHT-TCCC---------TTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred Hhhc-cccc---------ccCCHH---HHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 1111 1110 011122 3345568999999999999999999988765544
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=341.24 Aligned_cols=273 Identities=24% Similarity=0.403 Sum_probs=198.9
Q ss_pred hcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHH--HHHHHcCCCCCCcceEeeEEEE-----CcEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRV--EVEAIGHVRHKNLVRLLGYCIE-----GIHR 212 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~--e~~~l~~l~h~niv~l~~~~~~-----~~~~ 212 (463)
.++|++.+.||+|+||.||+|+. +++.||||++.... ...+.. |+..+..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46799999999999999999976 78999999985432 233333 4444556899999999986653 3366
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEEccCCCCceeEcCCCCEEEe
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI------EPKVVHRDIKSSNILIDDDFNAKVS 286 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------~~~i~H~Dikp~Nill~~~~~~kl~ 286 (463)
++||||+++|+|.+++... ..++..++.++.||+.||.|||+.+ .++|+||||||+|||++.++.+||+
T Consensus 88 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH-----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred EEEEecCCCCcHHHHHhhc-----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 8999999999999999542 3588999999999999999999762 3389999999999999999999999
Q ss_pred ecccceecCCCC-------ceeeccccccCCCCchhhhcc-------CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcc
Q 012462 287 DFGLAKLLGAGK-------SHVTTRVMGTFGYVAPEYANT-------GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAH 352 (463)
Q Consensus 287 Dfg~a~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~ 352 (463)
|||++....... .......+||+.|+|||++.+ ..++.++|||||||++|||++|..||.......
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 999998765322 112234579999999999987 456678999999999999999988775433221
Q ss_pred cc------------cHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCCC
Q 012462 353 EV------------NLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYP 420 (463)
Q Consensus 353 ~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~~ 420 (463)
.. ....+............+.. ...........+..++.+||+.||++|||++|+++.|+.+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE---AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT---TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHhhhcccCCCchHHHHHhhhcccccCCCCCc---ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 11 11111111111111111111 1112223344566667789999999999999999999997655
Q ss_pred Cccc
Q 012462 421 IVRE 424 (463)
Q Consensus 421 ~~~~ 424 (463)
+.+.
T Consensus 320 ~~~~ 323 (336)
T 3g2f_A 320 WERN 323 (336)
T ss_dssp CCC-
T ss_pred HHhc
Confidence 5443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=332.68 Aligned_cols=253 Identities=25% Similarity=0.363 Sum_probs=200.7
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
.++|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 357999999999999999999764 68899999985433 3445778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
|+++++|.+++. ....+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 999999998874 345699999999999999999999999 9999999999999999999999999999865432
Q ss_pred C-ceeeccccccCCCCchhhhccCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 298 K-SHVTTRVMGTFGYVAPEYANTGLL-NEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 298 ~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
. ........|++.|+|||++.+..+ +.++||||||+++|||++|+.||........ .... ....... ...
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~----~~~~~~~---~~~ 230 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSD----WKEKKTY---LNP 230 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHH----HHTTCTT---STT
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHH----hhhcccc---cCc
Confidence 2 122344678999999999987765 7799999999999999999999976543211 1111 1111100 000
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
..... ..+..++.+||+.||++|||+.|++++
T Consensus 231 ---~~~~~---~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 231 ---WKKID---SAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp ---GGGSC---HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---hhhcC---HHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 00111 223345668999999999999999874
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=334.29 Aligned_cols=257 Identities=26% Similarity=0.385 Sum_probs=199.2
Q ss_pred CCCccCeEeecCcEEEEEEEEcC-CC---eEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEE-EEE
Q 012462 142 RFSKENVLGEGGYGVVYRGNLIN-GS---PVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHR-MLV 215 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~~~-~~---~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~lV 215 (463)
.|...++||+|+||+||+|.+.+ +. .||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45667899999999999996533 22 69999986533 34456788999999999999999999999876655 899
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
|||+.+|+|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 102 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 999999999999964 345689999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCc---eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccc
Q 012462 296 AGKS---HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV 372 (463)
Q Consensus 296 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (463)
.... .......+|+.|+|||.+.+..++.++||||||+++|+|++|..|+...... ...... .........
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--~~~~~~---~~~~~~~~~- 249 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDLTHF---LAQGRRLPQ- 249 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--GGHHHH---HHTTCCCCC-
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--HHHHHH---hhcCCCCCC-
Confidence 3221 1223456788999999999999999999999999999999966665433221 122221 111111100
Q ss_pred ccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCC
Q 012462 373 VDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEY 419 (463)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~ 419 (463)
...... .+..++.+||+.||.+|||++++++.|+++..
T Consensus 250 ------~~~~~~---~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 287 (298)
T 3pls_A 250 ------PEYCPD---SLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287 (298)
T ss_dssp ------CTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CccchH---HHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 011112 33445668999999999999999999988643
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=328.42 Aligned_cols=249 Identities=23% Similarity=0.354 Sum_probs=196.3
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEE----CcEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE----GIHR 212 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 212 (463)
...|.+.+.||+|+||.||+|.. .++..||+|.+.... ......+.+|+.++++++||||+++++++.. ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 34578888999999999999965 457789999885432 3445678899999999999999999999875 4568
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEccCCCCceeEc-CCCCEEEeecc
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPK--VVHRDIKSSNILID-DDFNAKVSDFG 289 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~Dikp~Nill~-~~~~~kl~Dfg 289 (463)
++||||+++++|.+++... ..+++..++.++.||+.||.|||+. + |+|+||||+|||++ .++.+||+|||
T Consensus 105 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg 177 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred EEEEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence 9999999999999999642 4589999999999999999999998 8 99999999999998 78999999999
Q ss_pred cceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCc
Q 012462 290 LAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369 (463)
Q Consensus 290 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 369 (463)
++....... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||..... ..............
T Consensus 178 ~~~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~ 248 (290)
T 1t4h_A 178 LATLKRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYRRVTSGVKP 248 (290)
T ss_dssp GGGGCCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHHHHHTTTCCC
T ss_pred Ccccccccc---cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc-----HHHHHHHHhccCCc
Confidence 997544332 234578999999998875 589999999999999999999999975432 12222222222111
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
... . ..... .+..++.+||+.||.+|||+.|++++
T Consensus 249 ~~~-~-----~~~~~---~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 249 ASF-D-----KVAIP---EVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GGG-G-----GCCCH---HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccc-C-----CCCCH---HHHHHHHHHccCChhhCCCHHHHhhC
Confidence 111 1 01112 34455668999999999999999874
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=339.86 Aligned_cols=262 Identities=23% Similarity=0.336 Sum_probs=191.9
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccchhh-HHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQA-EKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
++|++.+.||+|+||+||+|... +++.||+|++....... ...+.+|+.++++++||||+++++++.+....++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57899999999999999999764 68899999985433211 12345699999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
++ |+|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CS-EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 97 5999988642 44699999999999999999999999 99999999999999999999999999998654332
Q ss_pred ceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccccc---
Q 012462 299 SHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVD--- 374 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 374 (463)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... ....+...........+..
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGG
T ss_pred -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHhchhhhc
Confidence 22334578999999999876 578999999999999999999999998654221 2222222221111110000
Q ss_pred ---------CCCCCCCC----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 375 ---------PNIEVRPS----TRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 375 ---------~~~~~~~~----~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
+....... ......+..++.+||+.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000 0001233455668999999999999999874
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=348.20 Aligned_cols=201 Identities=28% Similarity=0.419 Sum_probs=175.5
Q ss_pred HhcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
..++|++.+.||+|+||+||+|... ++..||+|++.... ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 3568999999999999999999764 68899999986543 344567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE-AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
||+++++|.+++... ..+++..+..++.|++.||.|||+ + +|+||||||+|||++.++.+||+|||++....
T Consensus 111 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp CCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred ECCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 999999999999643 358999999999999999999998 5 89999999999999999999999999987543
Q ss_pred CCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 296 AGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 184 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 234 (360)
T 3eqc_A 184 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234 (360)
T ss_dssp HH---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred cc---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 2334578999999999999999999999999999999999999997543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=344.88 Aligned_cols=262 Identities=16% Similarity=0.204 Sum_probs=200.8
Q ss_pred hcCCCccCeEeecCcEEEEEEEEcC---------CCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcce---------
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLIN---------GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVR--------- 201 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~--------- 201 (463)
.++|++.+.||+|+||.||+|.... ++.||+|.+... ..+.+|+.++.+++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4689999999999999999997653 789999998543 35677999999999998887
Q ss_pred ------EeeEEEE-CcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCc
Q 012462 202 ------LLGYCIE-GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSN 274 (463)
Q Consensus 202 ------l~~~~~~-~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~N 274 (463)
+++++.. +...++||||+ +++|.+++... ....+++..++.++.||+.||.|||++ +|+||||||+|
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N 189 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN 189 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence 6778876 77889999999 99999999753 235699999999999999999999999 99999999999
Q ss_pred eeEcCCC--CEEEeecccceecCCCCce------eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCC
Q 012462 275 ILIDDDF--NAKVSDFGLAKLLGAGKSH------VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVD 346 (463)
Q Consensus 275 ill~~~~--~~kl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~ 346 (463)
||++.++ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||+||||++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 9999999999876432211 1233578999999999999999999999999999999999999998
Q ss_pred CCCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCC
Q 012462 347 HGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEE 418 (463)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~ 418 (463)
...... ............. ...+............. +..++.+||+.||++|||++++++.|+.+.
T Consensus 270 ~~~~~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~---l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 270 NCLPNT-EDIMKQKQKFVDK--PGPFVGPCGHWIRPSET---LQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp GGTTCH-HHHHHHHHHHHHS--CCCEECTTSCEECCCHH---HHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred cCCcCH-HHHHHHHHhccCC--hhhhhhhccccCCCcHH---HHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 654221 1122221111111 11111111111111233 334455799999999999999999998763
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=341.35 Aligned_cols=249 Identities=19% Similarity=0.319 Sum_probs=201.7
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 215 (463)
.++|.+.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467999999999999999999764 47789999885432 34456788899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
|||+++++|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 120 ~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999999998854 24589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 296 AGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ...........
T Consensus 193 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~------- 258 (335)
T 2owb_A 193 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLRIKKNEY------- 258 (335)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCC-------
T ss_pred cCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH------HHHHHHhcCCC-------
Confidence 3322 233457899999999999999999999999999999999999999754321 11111111110
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
...... ...+..++.+||+.||++|||+.|++++
T Consensus 259 --~~~~~~--~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 259 --SIPKHI--NPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp --CCCTTS--CHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --CCCccC--CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011111 1123345568999999999999999873
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=345.27 Aligned_cols=258 Identities=23% Similarity=0.357 Sum_probs=187.8
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCC-CCCcceEeeEEE-------
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR-HKNLVRLLGYCI------- 207 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~------- 207 (463)
++...+|++.++||+|+||.||+|.+ .+++.||+|++..........+.+|+.++.++. ||||+++++++.
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 45567899999999999999999975 468899999986666666678889999999995 999999999995
Q ss_pred -ECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEccCCCCceeEcCCCCEE
Q 012462 208 -EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPK--VVHRDIKSSNILIDDDFNAK 284 (463)
Q Consensus 208 -~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~Dikp~Nill~~~~~~k 284 (463)
.....++||||+. |+|.+++.... ....+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+|
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEE
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEE
Confidence 3445789999996 69999987542 345699999999999999999999998 8 99999999999999999999
Q ss_pred EeecccceecCCCCce-----------eeccccccCCCCchhhh---ccCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Q 012462 285 VSDFGLAKLLGAGKSH-----------VTTRVMGTFGYVAPEYA---NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP 350 (463)
Q Consensus 285 l~Dfg~a~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~ 350 (463)
|+|||++......... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 9999999876543211 11134689999999998 567789999999999999999999999975432
Q ss_pred cccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCC
Q 012462 351 AHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEE 418 (463)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~ 418 (463)
... .. ... . .... ..... .+..++.+||+.||.+|||+.|++++|+.+.
T Consensus 259 ~~~------~~----~~~-~--~~~~---~~~~~---~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 259 LRI------VN----GKY-S--IPPH---DTQYT---VFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp -----------------C-C--CCTT---CCSSG---GGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHh------hc----Ccc-c--CCcc---cccch---HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 110 00 000 0 0000 01111 1234456899999999999999999998763
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=337.83 Aligned_cols=256 Identities=30% Similarity=0.478 Sum_probs=194.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeec
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYV 219 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 219 (463)
.++|++.+.||+|+||+||+|.+ .++.||+|++... ...+.+.+|+.++++++||||+++++++.+ ..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 46788999999999999999987 5789999988543 345678899999999999999999998863 479999999
Q ss_pred CCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCC-EEEeecccceecCCCC
Q 012462 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFN-AKVSDFGLAKLLGAGK 298 (463)
Q Consensus 220 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~-~kl~Dfg~a~~~~~~~ 298 (463)
++|+|.+++.... ....+++..++.++.|++.||.|||+....+|+||||||+|||++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH- 159 (307)
T ss_dssp TTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence 9999999996431 2234789999999999999999999922129999999999999998887 799999999765432
Q ss_pred ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCC
Q 012462 299 SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (463)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ............. ....
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~~~~-~~~~----- 226 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP----AFRIMWAVHNGTR-PPLI----- 226 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS----HHHHHHHHHTTCC-CCCB-----
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc----HHHHHHHHhcCCC-CCcc-----
Confidence 22346899999999999999999999999999999999999999754321 1111111221111 1110
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCC
Q 012462 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEY 419 (463)
Q Consensus 379 ~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~ 419 (463)
..... .+..++.+||+.||++|||+.|+++.|+....
T Consensus 227 -~~~~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 227 -KNLPK---PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp -TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred -cccCH---HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 11112 23445668999999999999999999987643
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=344.08 Aligned_cols=262 Identities=20% Similarity=0.296 Sum_probs=190.1
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccch--hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
.++|++.+.||+|+||+||+|.. .+++.||||++..... .....+.+|+.++++++||||+++++++.+....++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 46799999999999999999965 4688999999854432 22356778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEc-----CCCCEEEeecccc
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILID-----DDFNAKVSDFGLA 291 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~-----~~~~~kl~Dfg~a 291 (463)
||+++ +|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++
T Consensus 113 e~~~~-~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 113 EYAEN-DLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp ECCSE-EHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred ecCCC-CHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 99975 99999854 34599999999999999999999999 999999999999994 4556999999999
Q ss_pred eecCCCCceeeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 292 KLLGAGKSHVTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
........ ......||+.|+|||++.+. .++.++|||||||++|||++|..||....... .+.. +..........
T Consensus 185 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~-~~~~~~~~~~~ 260 (329)
T 3gbz_A 185 RAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID--QLFK-IFEVLGLPDDT 260 (329)
T ss_dssp HHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH-HHHHHCCCCTT
T ss_pred cccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH--HHHH-HHHHhCCCchh
Confidence 87653322 23345689999999999874 58999999999999999999999997643221 1111 11111110000
Q ss_pred cc---------ccCCCCC-CCCHH------HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 371 EV---------VDPNIEV-RPSTR------ALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 371 ~~---------~~~~~~~-~~~~~------~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.. ....... ..... ....+..++.+||+.||++|||++|++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 00 0000000 00000 11234456668999999999999999873
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=332.89 Aligned_cols=247 Identities=23% Similarity=0.332 Sum_probs=197.3
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc--hhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV--GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV 215 (463)
.++|++.+.||+|+||+||+|... +++.||+|++.... ......+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467999999999999999999765 78999999986532 33456777899999888 999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC----------------
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD---------------- 279 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~---------------- 279 (463)
|||+++++|.+++.........+++..++.++.||+.||.|||++ +|+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999976554456799999999999999999999999 9999999999999984
Q ss_pred ---CCCEEEeecccceecCCCCceeeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCccccc
Q 012462 280 ---DFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVN 355 (463)
Q Consensus 280 ---~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~ 355 (463)
...+||+|||++....... ...||+.|+|||++.+. .++.++|||||||++|+|++|..|+....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------ 235 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD------ 235 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH------
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh------
Confidence 4479999999998765432 23589999999999776 66789999999999999999988765321
Q ss_pred HHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 356 LVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
. ...... .....+. ..... .+..++.+||+.||++|||+.|++++
T Consensus 236 ~---~~~~~~-~~~~~~~------~~~~~---~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 236 Q---WHEIRQ-GRLPRIP------QVLSQ---EFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp H---HHHHHT-TCCCCCS------SCCCH---HHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred H---HHHHHc-CCCCCCC------cccCH---HHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1 111111 1111110 01112 23445567999999999999999874
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=354.37 Aligned_cols=243 Identities=17% Similarity=0.211 Sum_probs=187.4
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcc---cchhhHHHHHHHH---HHHcCCCCCCcceEe-------eE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILN---NVGQAEKEFRVEV---EAIGHVRHKNLVRLL-------GY 205 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~---~~~~~~~~~~~e~---~~l~~l~h~niv~l~-------~~ 205 (463)
.++|++.+.||+|+||+||+|.. .+|+.||||++.. ......+.+.+|+ .++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46789999999999999999975 5689999999853 2334557788999 556666899999998 66
Q ss_pred EEECc-----------------EEEEEEeecCCCCHHHHHhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 012462 206 CIEGI-----------------HRMLVYEYVNNGNLEQWLHGAMRH---HGYLTWEARMKVLLGTAKALAYLHEAIEPKV 265 (463)
Q Consensus 206 ~~~~~-----------------~~~lV~e~~~~g~L~~~l~~~~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i 265 (463)
+.+.+ ..|+||||+ +|+|.+++...... ...+++..++.++.||+.||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 66553 278999999 67999999754221 11244688889999999999999999 99
Q ss_pred EEccCCCCceeEcCCCCEEEeecccceecCCCCceeeccccccCCCCchhhhccC-----------CCCccchhhhHHHH
Q 012462 266 VHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTG-----------LLNEKSDVYSFGVL 334 (463)
Q Consensus 266 ~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwSlGvv 334 (463)
+||||||+|||++.++.+||+|||+++.... .....+| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986432 2345577 999999999887 89999999999999
Q ss_pred HHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 012462 335 LLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412 (463)
Q Consensus 335 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~ 412 (463)
||||++|+.||......... ..+.... ..... .+..++.+||+.||++|||+.|+++
T Consensus 303 l~elltg~~Pf~~~~~~~~~---------------~~~~~~~---~~~~~---~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGS---------------EWIFRSC---KNIPQ---PVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------CCS---------------GGGGSSC---CCCCH---HHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCcccccccch---------------hhhhhhc---cCCCH---HHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999754422211 1111100 11122 2344556899999999999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=339.26 Aligned_cols=264 Identities=23% Similarity=0.360 Sum_probs=204.9
Q ss_pred HhcCCCccCeEeecCcEEEEEEEE-----cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECc--E
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNL-----INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGI--H 211 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~ 211 (463)
..++|++.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+.++++++||||+++++++...+ .
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 356789999999999999999973 367899999997766666678999999999999999999999987543 6
Q ss_pred EEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccc
Q 012462 212 RMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA 291 (463)
Q Consensus 212 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a 291 (463)
.++||||+++++|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred eEEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcch
Confidence 79999999999999999642 34589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCcee--eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCC---------cccccHHHHH
Q 012462 292 KLLGAGKSHV--TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRP---------AHEVNLVDWL 360 (463)
Q Consensus 292 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~---------~~~~~~~~~~ 360 (463)
.......... .....++..|+|||++.+..++.++||||||+++|||++|..||..... .........+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 8775443221 2234567789999999998899999999999999999999999863210 0000001111
Q ss_pred HHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 361 KMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.......... ..... ....+..++.+||+.||++|||+.|+++.|+.+
T Consensus 273 ~~~~~~~~~~-------~~~~~--~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 273 IELLKNNGRL-------PRPDG--CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHHHTTCCC-------CCCTT--CCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhhcCCCC-------CCCCc--ccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111111100 00111 112344456689999999999999999999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=352.17 Aligned_cols=198 Identities=28% Similarity=0.339 Sum_probs=166.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEccc--chhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC------c
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNN--VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG------I 210 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 210 (463)
.++|++.+.||+|+||+||+|.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 47899999999999999999965 46889999998653 234456788899999999999999999999654 4
Q ss_pred EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccc
Q 012462 211 HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGL 290 (463)
Q Consensus 211 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~ 290 (463)
..|+||||+++ +|.+.+. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 67999999976 5777663 2389999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 291 AKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 291 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
++..... ......+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+..
T Consensus 211 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~ 267 (464)
T 3ttj_A 211 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267 (464)
T ss_dssp C-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9876543 22445689999999999999999999999999999999999999997643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=352.90 Aligned_cols=193 Identities=27% Similarity=0.403 Sum_probs=153.8
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEccc--chhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC-----cE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNN--VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG-----IH 211 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 211 (463)
.++|++.+.||+|+||+||+|.. .+++.||||++... .....+.+.+|+.++++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 36899999999999999999965 46899999998553 234456788999999999999999999998543 56
Q ss_pred EEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccc
Q 012462 212 RMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA 291 (463)
Q Consensus 212 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a 291 (463)
.|+||||+ +++|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 132 ~~lv~e~~-~~~L~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFR----TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCC-SEEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecc-ccchhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence 89999998 569999885 345699999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCc--------------------------eeeccccccCCCCchhhh-ccCCCCccchhhhHHHHHHHHHh
Q 012462 292 KLLGAGKS--------------------------HVTTRVMGTFGYVAPEYA-NTGLLNEKSDVYSFGVLLLEAIT 340 (463)
Q Consensus 292 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvvl~ellt 340 (463)
+....... ...+..+||+.|+|||++ .+..|+.++|||||||+||||++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 87643211 123456789999999976 56679999999999999999999
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=333.83 Aligned_cols=249 Identities=19% Similarity=0.319 Sum_probs=201.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 215 (463)
.++|.+.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467999999999999999999765 47889999885432 33456788899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+. +|+|+||||+|||++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 999999999998854 24589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 296 AGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... +..........
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~------- 232 (294)
T 2rku_A 167 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLRIKKNEY------- 232 (294)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTTCC-------
T ss_pred cCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhhccC-------
Confidence 3322 233457899999999999999999999999999999999999999754321 11111211110
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
...... ...+..++.+||+.||++|||+.|++++
T Consensus 233 --~~~~~~--~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 --SIPKHI--NPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp --CCCTTS--CHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --CCcccc--CHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 011111 1123345568999999999999999874
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=345.35 Aligned_cols=264 Identities=22% Similarity=0.320 Sum_probs=196.5
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC------
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG------ 209 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 209 (463)
+...++|++.+.||+|+||+||+|.. .+|+.||||++..... ...+|+.+++.++||||++++++|...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 45568899999999999999999965 5789999999855432 223589999999999999999998543
Q ss_pred --------------------------------cEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 012462 210 --------------------------------IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257 (463)
Q Consensus 210 --------------------------------~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~L 257 (463)
...++||||++ |+|.+.+.........+++..++.++.||+.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34789999997 599998877666677899999999999999999999
Q ss_pred HhcCCCCeEEccCCCCceeEc-CCCCEEEeecccceecCCCCceeeccccccCCCCchhhhccC-CCCccchhhhHHHHH
Q 012462 258 HEAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLL 335 (463)
Q Consensus 258 H~~~~~~i~H~Dikp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl 335 (463)
|+. +|+||||||+|||++ .++.+||+|||+++....... .....+|+.|+|||++.+. .++.++|||||||++
T Consensus 158 H~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 HSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 999 999999999999998 688999999999987654332 3345789999999998775 489999999999999
Q ss_pred HHHHhCCCCCCCCCCcccccHHHHHHHHhcCC----------CccccccCCCCCCC-----CHHHHHHHHHHHhhccCCC
Q 012462 336 LEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR----------RSEEVVDPNIEVRP-----STRALKRSLLTALRCVDPD 400 (463)
Q Consensus 336 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~cl~~d 400 (463)
|||++|+.||.+....+. +...+. ..... ......-+...... ..........++.+||+.|
T Consensus 233 ~ell~g~~pf~~~~~~~~--~~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQ--LVRIIQ-IMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHSSCSSCCSSHHHH--HHHHHH-HHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHhCCCCCCCCChHHH--HHHHHH-HhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 999999999986442211 111111 11100 00000001100000 0001123445566899999
Q ss_pred CCCCCCHHHHHHH
Q 012462 401 SEKRPKMSQVVRM 413 (463)
Q Consensus 401 P~~RPs~~ell~~ 413 (463)
|++|||+.|++++
T Consensus 310 P~~R~t~~e~l~h 322 (383)
T 3eb0_A 310 PDLRINPYEAMAH 322 (383)
T ss_dssp GGGSCCHHHHHTS
T ss_pred hhhCCCHHHHhcC
Confidence 9999999999864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=332.50 Aligned_cols=247 Identities=26% Similarity=0.388 Sum_probs=200.4
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 215 (463)
.++|++.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.++++++||||+++++++.+....++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 367999999999999999999764 56789999985432 22346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
|||+++++|.+++... ..+++..++.++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp ECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 9999999999998643 3589999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 296 AGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
... .....|++.|+|||++.+..++.++||||||+++|+|++|..||...... ..........
T Consensus 166 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~-------- 228 (284)
T 2vgo_A 166 SLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT------ETHRRIVNVD-------- 228 (284)
T ss_dssp SSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTTC--------
T ss_pred ccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh------HHHHHHhccc--------
Confidence 322 23457899999999999999999999999999999999999999754321 1122222111
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
....... ...+..++.+||+.||.+|||+.|++++
T Consensus 229 -~~~~~~~--~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 229 -LKFPPFL--SDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp -CCCCTTS--CHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred -cCCCCcC--CHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 1111111 1223345568999999999999999863
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=335.29 Aligned_cols=251 Identities=24% Similarity=0.348 Sum_probs=198.9
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
.++|.+.+.||+|+||.||+|... +|+.||+|.+..........+.+|+.++.+++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 467999999999999999999764 6899999998765544556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeE---cCCCCEEEeecccceecC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill---~~~~~~kl~Dfg~a~~~~ 295 (463)
+++++|.+++... ..+++..++.++.|++.||.|||+. +|+|+||||+||++ +.++.+||+|||++....
T Consensus 88 ~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 88 VSGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred CCCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 9999999998542 3589999999999999999999999 99999999999999 788999999999997543
Q ss_pred CCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 296 AGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ............ ...+
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~i~~~~~~--~~~~ 229 (304)
T 2jam_A 161 NG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES------KLFEKIKEGYYE--FESP 229 (304)
T ss_dssp CB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHCCCC--CCTT
T ss_pred CC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHcCCCC--CCcc
Confidence 22 223456899999999999999999999999999999999999999754321 112222211110 0000
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
....... .+..++.+||+.||++|||+.|++++
T Consensus 230 --~~~~~~~---~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 230 --FWDDISE---SAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp --TTTTSCH---HHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred --ccccCCH---HHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0011122 33445568999999999999999974
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=332.65 Aligned_cols=252 Identities=23% Similarity=0.336 Sum_probs=198.6
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccch------hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVG------QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHR 212 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 212 (463)
.++|++.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 356899999999999999999765 689999999854321 2357788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCC----CEEEeec
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDF----NAKVSDF 288 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~----~~kl~Df 288 (463)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+|+||||+||+++.++ .+||+||
T Consensus 84 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEec
Confidence 999999999999999964 24589999999999999999999999 999999999999998877 8999999
Q ss_pred ccceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCC
Q 012462 289 GLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRR 368 (463)
Q Consensus 289 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 368 (463)
|++....... ......+++.|+|||++.+..++.++||||||+++|+|++|..||...... ...........
T Consensus 157 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~ 228 (283)
T 3bhy_A 157 GIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ------ETLTNISAVNY 228 (283)
T ss_dssp TTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTTCC
T ss_pred ccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH------HHHHHhHhccc
Confidence 9998765432 233456899999999999999999999999999999999999999764321 11222211110
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 369 SEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.... . ..... ...+..++.+||+.||++|||+.|++++
T Consensus 229 ~~~~-~---~~~~~---~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 229 DFDE-E---YFSNT---SELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp CCCH-H---HHTTC---CHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred CCcc-h---hcccC---CHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 0000 0 00011 1223445668999999999999999973
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=338.07 Aligned_cols=261 Identities=18% Similarity=0.262 Sum_probs=201.2
Q ss_pred hHHHHHHhcCCCcc-CeEeecCcEEEEEEEEc-CCCeEEEEEEcccc--hhhHHHHHHHHHHHcCC-CCCCcceEeeEEE
Q 012462 133 LRDLELATNRFSKE-NVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV--GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCI 207 (463)
Q Consensus 133 ~~~~~~~~~~~~~~-~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 207 (463)
+...+...++|.+. +.||+|+||+||+|... +++.||+|++.... ......+.+|+.++..+ +||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 34556667788887 89999999999999664 58999999986533 23356788899999988 5799999999999
Q ss_pred ECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC---CCCEE
Q 012462 208 EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD---DFNAK 284 (463)
Q Consensus 208 ~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~---~~~~k 284 (463)
+....++||||+.+|+|.+++.. .....+++..++.++.||+.||+|||+. +|+||||||+|||++. ++.+|
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEE
T ss_pred eCCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEE
Confidence 99999999999999999998743 2345699999999999999999999999 9999999999999998 78999
Q ss_pred EeecccceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHh
Q 012462 285 VSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMV 364 (463)
Q Consensus 285 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 364 (463)
|+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ......
T Consensus 175 L~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~ 246 (327)
T 3lm5_A 175 IVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE------TYLNIS 246 (327)
T ss_dssp ECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH
T ss_pred EeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH------HHHHHH
Confidence 99999998765432 2334579999999999999999999999999999999999999997643211 111111
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 365 GSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.... . ... ......... +..++.+||+.||++|||++|++++
T Consensus 247 ~~~~-~-~~~--~~~~~~~~~---~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 247 QVNV-D-YSE--ETFSSVSQL---ATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HTCC-C-CCT--TTTTTSCHH---HHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred hccc-c-cCc--hhhcccCHH---HHHHHHHHcCCChhhCcCHHHHhCC
Confidence 1110 0 000 001111222 3344568999999999999999875
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=339.20 Aligned_cols=263 Identities=27% Similarity=0.408 Sum_probs=196.6
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 467999999999999999999764 48899999985433 233456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+++++|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 104 e~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLEL----FPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHH----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 9999998888764 344699999999999999999999999 999999999999999999999999999986543
Q ss_pred CCceeeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcC---------
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGS--------- 366 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--------- 366 (463)
.. .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||........ ...+......
T Consensus 177 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 252 (331)
T 4aaa_A 177 PG-EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ---LYHIMMCLGNLIPRHQELF 252 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCHHHHHHH
T ss_pred Cc-cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCCChhhhhHh
Confidence 32 223345789999999999875 789999999999999999999999976542211 1111111100
Q ss_pred ---CCccccccCCCCCCCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 367 ---RRSEEVVDPNIEVRPST-----RALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 367 ---~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
........+........ .....+..++.+||+.||++|||+.|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000011111111111 012334455668999999999999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=336.11 Aligned_cols=256 Identities=24% Similarity=0.316 Sum_probs=187.9
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccch-h-hHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEE
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVG-Q-AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 214 (463)
+..++|++.+.||+|+||+||+|.. .+++.||+|++..... . ....+..+...++.++||||+++++++.+.+..++
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 3457899999999999999999976 5788999999865422 2 22334445556788899999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
||||++ |+|.+++.........+++..++.++.|++.||.|||++. +|+||||||+|||++.++.+||+|||++...
T Consensus 84 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 84 CMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999997 4999988766566778999999999999999999999843 8999999999999999999999999999876
Q ss_pred CCCCceeeccccccCCCCchhhh----ccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 295 GAGKSHVTTRVMGTFGYVAPEYA----NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
.... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||...... ...+..........
T Consensus 161 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~ 233 (290)
T 3fme_A 161 VDDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-----FQQLKQVVEEPSPQ 233 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-----HHHHHHHHHSCCCC
T ss_pred cccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-----HHHHHHHhccCCCC
Confidence 4432 22334689999999996 5667899999999999999999999999753221 11112222221111
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 012462 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412 (463)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~ 412 (463)
. ....... .+..++.+||+.||++|||+.|+++
T Consensus 234 ~------~~~~~~~---~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 234 L------PADKFSA---EFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp C------CTTTSCH---HHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred c------ccccCCH---HHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1 0011122 2344566899999999999999987
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=333.57 Aligned_cols=249 Identities=23% Similarity=0.384 Sum_probs=202.4
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
.++|++.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.++.+++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 45789999999999999999965 468899999985433 3445788899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
|+++++|.+++. ...+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++......
T Consensus 101 ~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 101 YLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred eCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 999999999984 24689999999999999999999999 9999999999999999999999999999876543
Q ss_pred CceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCC
Q 012462 298 KSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNI 377 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (463)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|..||...... ........... .. .
T Consensus 173 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~-~~-----~ 239 (303)
T 3a7i_A 173 QI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM------KVLFLIPKNNP-PT-----L 239 (303)
T ss_dssp BC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCC-CC-----C
T ss_pred cc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH------HHHHHhhcCCC-CC-----C
Confidence 22 233457899999999999999999999999999999999999999754321 11111111111 10 0
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 378 EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
. ..... .+..++.+||+.||++|||+.|++++
T Consensus 240 ~-~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 240 E-GNYSK---PLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp C-SSCCH---HHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred c-cccCH---HHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0 01112 23445567999999999999999875
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=357.77 Aligned_cols=251 Identities=24% Similarity=0.355 Sum_probs=201.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 215 (463)
.++|++.+.||+|+||+||+|... +++.||||++.... ......+.+|+.++++++||||+++++++.+....++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467999999999999999999764 78999999985432 34467788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeE---cCCCCEEEeecccce
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DDDFNAKVSDFGLAK 292 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill---~~~~~~kl~Dfg~a~ 292 (463)
|||+.+|+|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||++.
T Consensus 105 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp ECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 999999999998853 45699999999999999999999999 99999999999999 567899999999998
Q ss_pred ecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccc
Q 012462 293 LLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV 372 (463)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (463)
...... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||...... ..+............
T Consensus 178 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~~~~~ 248 (484)
T 3nyv_A 178 HFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY------DILKKVEKGKYTFEL 248 (484)
T ss_dssp HBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCCCS
T ss_pred Eccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHcCCCCCCC
Confidence 765433 2344579999999999876 6899999999999999999999999764321 222222222111000
Q ss_pred ccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 373 VDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
. ...... ..+..++.+||+.||.+|||+.|++++
T Consensus 249 ~----~~~~~s---~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 249 P----QWKKVS---ESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp G----GGGGSC---HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred c----ccccCC---HHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 0 000111 223445668999999999999999864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=331.77 Aligned_cols=252 Identities=30% Similarity=0.434 Sum_probs=194.6
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC-cEEEEEE
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG-IHRMLVY 216 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lV~ 216 (463)
+..++|++.+.||+|+||+||+|.. .|+.||+|.+.... ..+.+.+|+.++++++||||+++++++.+. ...++||
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred CChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 3457899999999999999999987 58899999886433 456788899999999999999999997654 4689999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+++++|.+++.... ...+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred ecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 9999999999996532 22378999999999999999999999 999999999999999999999999999976543
Q ss_pred CCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
.. ....+++.|+|||++.+..++.++||||||+++|||++ |+.||....... .. ........ ...
T Consensus 170 ~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~---~~~~~~~~-~~~--- 235 (278)
T 1byg_A 170 TQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV---PRVEKGYK-MDA--- 235 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HH---HHHTTTCC-CCC---
T ss_pred cc----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HH---HHHhcCCC-CCC---
Confidence 21 22357889999999999999999999999999999998 999997643221 11 11111111 000
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
. .... ..+..++.+||+.||++|||+.|+++.|+.+
T Consensus 236 --~-~~~~---~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 236 --P-DGCP---PAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp --C-TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --c-ccCC---HHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 0 1111 2334455689999999999999999999875
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=349.17 Aligned_cols=199 Identities=25% Similarity=0.358 Sum_probs=166.9
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEccc--chhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC-----cE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNN--VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG-----IH 211 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 211 (463)
.++|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 46899999999999999999965 45788999998653 234456788999999999999999999999766 57
Q ss_pred EEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccc
Q 012462 212 RMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA 291 (463)
Q Consensus 212 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a 291 (463)
.|+||||+. ++|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK----TPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999996 59999985 345699999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCc---------------------eeeccccccCCCCchhhh-ccCCCCccchhhhHHHHHHHHHhCCCCCC
Q 012462 292 KLLGAGKS---------------------HVTTRVMGTFGYVAPEYA-NTGLLNEKSDVYSFGVLLLEAITGRDPVD 346 (463)
Q Consensus 292 ~~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvvl~elltg~~pf~ 346 (463)
+....... ...+..+||+.|+|||++ ....++.++|||||||+||||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 87654321 123557899999999986 56679999999999999999998655543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=342.30 Aligned_cols=263 Identities=22% Similarity=0.311 Sum_probs=198.8
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccch--hhHHHHHHHHHHHcCCCCCCcceEeeEEEE--------C
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIE--------G 209 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~ 209 (463)
++|++.+.||+|+||+||+|.. .+|+.||+|++..... .....+.+|+.+++.++||||+++++++.+ .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 6799999999999999999976 5789999998854332 224567789999999999999999999987 4
Q ss_pred cEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecc
Q 012462 210 IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFG 289 (463)
Q Consensus 210 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg 289 (463)
+..++||||+++ +|.+.+.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCC-CHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 468999999975 88887753 334599999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCC---ceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhc
Q 012462 290 LAKLLGAGK---SHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVG 365 (463)
Q Consensus 290 ~a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 365 (463)
++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||....... ....+.....
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~ 246 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH---QLALISQLCG 246 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhC
Confidence 998765322 122344578999999999876 468999999999999999999999998654222 2222222222
Q ss_pred CCCcccccc-------CCC----CCCCCH-HH------HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 366 SRRSEEVVD-------PNI----EVRPST-RA------LKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 366 ~~~~~~~~~-------~~~----~~~~~~-~~------~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
......... ... ...... .. ...+..++.+||+.||++|||+.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 111110000 000 000111 11 1224456678999999999999999985
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=328.25 Aligned_cols=254 Identities=28% Similarity=0.411 Sum_probs=195.4
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeec
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYV 219 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 219 (463)
++|.....||+|+||.||+|.. .++..||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3455566999999999999965 467899999987665556678889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC-CCCEEEeecccceecCCCC
Q 012462 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD-DFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 220 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~-~~~~kl~Dfg~a~~~~~~~ 298 (463)
++++|.+++.... ....+++..++.++.||+.||.|||+. +|+|+||||+||+++. ++.+||+|||++.......
T Consensus 102 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 102 PGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp SEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 9999999997532 233567899999999999999999999 9999999999999987 8999999999998764322
Q ss_pred ceeeccccccCCCCchhhhccCC--CCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCC
Q 012462 299 SHVTTRVMGTFGYVAPEYANTGL--LNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (463)
.......|++.|+|||++.+.. ++.++||||||+++|+|++|+.||........ ......... .. +.
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~-~~-----~~ 246 (295)
T 2clq_A 178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA----AMFKVGMFK-VH-----PE 246 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH----HHHHHHHHC-CC-----CC
T ss_pred -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH----HHHhhcccc-cc-----cc
Confidence 1233457899999999987654 78999999999999999999999964322111 111111100 00 00
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.. ..... .+..++.+||+.||++||++.|++++
T Consensus 247 ~~-~~~~~---~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 247 IP-ESMSA---EAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CC-TTSCH---HHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred cc-ccCCH---HHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 11112 23345568999999999999999864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=337.43 Aligned_cols=264 Identities=24% Similarity=0.399 Sum_probs=184.9
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEE
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 214 (463)
.+..++|++.+.||+|+||.||+|.. .+++.||||.+.... ......+.+|+.++.+++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 45568899999999999999999964 468899999875432 3344678889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhc----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccc
Q 012462 215 VYEYVNNGNLEQWLHGAMR----HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGL 290 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~ 290 (463)
||||+++++|.+++..... ....+++..++.++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999875322 234589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCc----eeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhc
Q 012462 291 AKLLGAGKS----HVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVG 365 (463)
Q Consensus 291 a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 365 (463)
+........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~~ 241 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL------MLTLQ 241 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH------HHHHT
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH------HHHhc
Confidence 976543211 11234578999999999876 56899999999999999999999999865432211 11111
Q ss_pred CCCcc-c--cccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 366 SRRSE-E--VVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 366 ~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
..... . ..+.. ....... .+..++.+||+.||.+|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~-~~~~~~~---~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 242 NDPPSLETGVQDKE-MLKKYGK---SFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp SSCCCTTC-----C-CCCCCCH---HHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cCCCccccccccch-hhhhhhH---HHHHHHHHHccCChhhCcCHHHHhhC
Confidence 11100 0 00000 0011122 23345567999999999999999874
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=339.21 Aligned_cols=261 Identities=25% Similarity=0.401 Sum_probs=201.9
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEE------cCCCeEEEEEEccc-chhhHHHHHHHHHHHcCCCCCCcceEeeEEEECc
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNL------INGSPVAVKKILNN-VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGI 210 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 210 (463)
+..++|++.+.||+|+||.||+|.+ .++..||||.+... .......+.+|+.++++++||||+++++++.+..
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 3457899999999999999999963 35678999998543 3345567888999999999999999999999999
Q ss_pred EEEEEEeecCCCCHHHHHhhhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC---CCCEE
Q 012462 211 HRMLVYEYVNNGNLEQWLHGAMRH---HGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD---DFNAK 284 (463)
Q Consensus 211 ~~~lV~e~~~~g~L~~~l~~~~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~---~~~~k 284 (463)
..++||||+++++|.+++...... ...+++..++.++.||+.||.|||+. +|+||||||+|||++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEE
Confidence 999999999999999999764321 24589999999999999999999999 9999999999999984 45699
Q ss_pred EeecccceecCCCCc-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHH
Q 012462 285 VSDFGLAKLLGAGKS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKM 362 (463)
Q Consensus 285 l~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~ 362 (463)
|+|||++........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||..... ......
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------~~~~~~ 257 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------QEVLEF 257 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHH
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH------HHHHHH
Confidence 999999976533221 12234567899999999999999999999999999999998 9999975432 122222
Q ss_pred HhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 363 MVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
......... . .... ..+..++.+||+.||.+||++.+++++|+..
T Consensus 258 ~~~~~~~~~----~---~~~~---~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 258 VTSGGRMDP----P---KNCP---GPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HHTTCCCCC----C---TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhcCCCCCC----C---CCCC---HHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 222211110 0 0111 2334456689999999999999999999875
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=336.09 Aligned_cols=195 Identities=26% Similarity=0.412 Sum_probs=170.8
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCC-CCCcceEeeEEEE--CcEEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIE--GIHRMLV 215 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lV 215 (463)
.++|++.+.||+|+||+||+|.. .+++.||+|++... ..+.+.+|+.+++++. ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 46799999999999999999965 57889999998543 3467888999999996 9999999999997 6678999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCC-CEEEeecccceec
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDF-NAKVSDFGLAKLL 294 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~-~~kl~Dfg~a~~~ 294 (463)
|||+.+++|.+++. .+++..++.++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||+++..
T Consensus 112 ~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 99999999999874 288999999999999999999999 999999999999999776 8999999999876
Q ss_pred CCCCceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 295 GAGKSHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 182 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~ 235 (330)
T 3nsz_A 182 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 235 (330)
T ss_dssp CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred CCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 54332 334578999999999877 678999999999999999999999996543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=353.90 Aligned_cols=251 Identities=24% Similarity=0.348 Sum_probs=195.4
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
.++|++.+.||+|+||+||+|... ++..||+|++.... ......+.+|+.+++.++||||++++++|.+....|+||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457999999999999999999764 67899999986433 233467888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC---CCCEEEeeccccee
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD---DFNAKVSDFGLAKL 293 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~---~~~~kl~Dfg~a~~ 293 (463)
||+.+|+|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||++..
T Consensus 116 e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 999999999988542 4589999999999999999999999 9999999999999976 45599999999987
Q ss_pred cCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccc
Q 012462 294 LGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373 (463)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (463)
..... .....+||+.|+|||++. ..++.++|||||||++|+|++|..||...... ..+...........
T Consensus 189 ~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~~~~-- 257 (494)
T 3lij_A 189 FENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ------EILRKVEKGKYTFD-- 257 (494)
T ss_dssp CBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCCCCC--
T ss_pred CCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCCCC--
Confidence 65432 234567999999999986 46999999999999999999999999764321 22222222111100
Q ss_pred cCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.+ ....... .+..++.+||+.||.+|||+.|++++
T Consensus 258 ~~--~~~~~s~---~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 258 SP--EWKNVSE---GAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp SG--GGTTSCH---HHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ch--hcccCCH---HHHHHHHHHCCCChhhCccHHHHhcC
Confidence 00 0111122 23345568999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=327.91 Aligned_cols=249 Identities=25% Similarity=0.402 Sum_probs=192.9
Q ss_pred HhcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEE
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 214 (463)
..++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++.+....++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3578999999999999999999765 68999999985432 2234578889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
||||+++++|.+++... ..+++..++.++.||+.||.|||++ +|+|+||||+||+++.++.+||+|||++...
T Consensus 89 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 99999999999999642 3589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCceeeccccccCCCCchhhhccCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccc
Q 012462 295 GAGKSHVTTRVMGTFGYVAPEYANTGLL-NEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373 (463)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (463)
.... ......+++.|+|||++.+..+ +.++||||||+++|+|++|..||..... ............ .
T Consensus 162 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~-~--- 229 (276)
T 2h6d_A 162 SDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV------PTLFKKIRGGVF-Y--- 229 (276)
T ss_dssp CC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC-C---
T ss_pred CCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH------HHHHHHhhcCcc-c---
Confidence 4432 2234568999999999988765 6899999999999999999999975321 111222211110 0
Q ss_pred cCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.+ ..... .+..++.+||+.||++|||+.|++++
T Consensus 230 ~~----~~~~~---~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 230 IP----EYLNR---SVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CC----TTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred Cc----hhcCH---HHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00 01112 23345568999999999999999985
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=339.01 Aligned_cols=257 Identities=25% Similarity=0.393 Sum_probs=202.3
Q ss_pred HHHHHhcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc--------hhhHHHHHHHHHHHcCC-CCCCcceEee
Q 012462 135 DLELATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV--------GQAEKEFRVEVEAIGHV-RHKNLVRLLG 204 (463)
Q Consensus 135 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~niv~l~~ 204 (463)
......++|++.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+.++.++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 33445678999999999999999999775 68999999985432 11235677899999998 8999999999
Q ss_pred EEEECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEE
Q 012462 205 YCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAK 284 (463)
Q Consensus 205 ~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~k 284 (463)
++......++||||+++++|.+++.. ...+++..++.++.||+.||.|||+. +|+|+||||+|||++.++.+|
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEE
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEE
Confidence 99999999999999999999999864 24599999999999999999999999 999999999999999999999
Q ss_pred EeecccceecCCCCceeeccccccCCCCchhhhcc------CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHH
Q 012462 285 VSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANT------GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVD 358 (463)
Q Consensus 285 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~ 358 (463)
|+|||++....... .....+||+.|+|||++.+ ..++.++|||||||++|||++|..||..... ..
T Consensus 241 l~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~------~~ 312 (365)
T 2y7j_A 241 LSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ------IL 312 (365)
T ss_dssp ECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HH
T ss_pred EEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH------HH
Confidence 99999998765432 2344679999999999863 3588999999999999999999999975432 11
Q ss_pred HHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 359 WLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.............. + ...... ..+..++.+||+.||++|||+.|++++
T Consensus 313 ~~~~i~~~~~~~~~--~--~~~~~~---~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 313 MLRMIMEGQYQFSS--P--EWDDRS---STVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHHHHHTCCCCCH--H--HHSSSC---HHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhCCCCCCC--c--ccccCC---HHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11222111110000 0 000111 223445668999999999999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=365.63 Aligned_cols=247 Identities=28% Similarity=0.410 Sum_probs=193.8
Q ss_pred CeEeecCcEEEEEEEEc---CCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCC
Q 012462 147 NVLGEGGYGVVYRGNLI---NGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNN 221 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 221 (463)
+.||+|+||+||+|.+. .+..||||++.... ....+++.+|+.++.+++||||++++++|.+ +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 37999999999999553 35789999986543 2345789999999999999999999999964 567899999999
Q ss_pred CCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCc--
Q 012462 222 GNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS-- 299 (463)
Q Consensus 222 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-- 299 (463)
|+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999953 34699999999999999999999999 999999999999999999999999999987654332
Q ss_pred eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCC
Q 012462 300 HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378 (463)
Q Consensus 300 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (463)
.......+|+.|+|||++.+..++.++|||||||+||||++ |+.||...... .....+....... .
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~------~~~~~i~~~~~~~-~------ 593 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------EVTAMLEKGERMG-C------ 593 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHHHTTCCCC-C------
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCCCC-C------
Confidence 12233456788999999999999999999999999999998 99999764422 1222222221111 0
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 379 ~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.. .....+..++.+||+.||++||++.+|++.|++.
T Consensus 594 -p~--~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 594 -PA--GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp -CT--TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -CC--CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 01 1112344556689999999999999999999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=343.58 Aligned_cols=252 Identities=12% Similarity=0.050 Sum_probs=177.4
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccch---hhHHHHHHH---HHHHcCCCCCCcceEe-------eEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVG---QAEKEFRVE---VEAIGHVRHKNLVRLL-------GYC 206 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e---~~~l~~l~h~niv~l~-------~~~ 206 (463)
.+|++.+.||+|+||+||+|.+. +++.||||++..... .....+..| +..+.. +||||++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 45888999999999999999764 788999999966432 334566777 455666 799987755 555
Q ss_pred EEC-----------------cEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCC
Q 012462 207 IEG-----------------IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEAR------MKVLLGTAKALAYLHEAIEP 263 (463)
Q Consensus 207 ~~~-----------------~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~------~~i~~~i~~~l~~LH~~~~~ 263 (463)
... ...|+||||++ |+|.+++..... .+.+..+ +.++.||+.||+|||++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~--- 213 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQSK--- 213 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---
Confidence 443 34799999998 899999976422 2455555 77889999999999999
Q ss_pred CeEEccCCCCceeEcCCCCEEEeecccceecCCCCceeeccccccCCCCchhhhcc--CCCCccchhhhHHHHHHHHHhC
Q 012462 264 KVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANT--GLLNEKSDVYSFGVLLLEAITG 341 (463)
Q Consensus 264 ~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg 341 (463)
+|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||+||||++|
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999876432 213456799999999987 6799999999999999999999
Q ss_pred CCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 012462 342 RDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412 (463)
Q Consensus 342 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~ 412 (463)
+.||....+...... ........................+..++.+||+.||++|||+.|+++
T Consensus 290 ~~Pf~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIKGSW--------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCTTCC--------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCcccccch--------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999987643221100 000000000111111110111223344566899999999999999975
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=343.79 Aligned_cols=203 Identities=23% Similarity=0.339 Sum_probs=156.4
Q ss_pred cCCCc-cCeEeecCcEEEEEEEEc---CCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEE--CcEEEE
Q 012462 141 NRFSK-ENVLGEGGYGVVYRGNLI---NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE--GIHRML 214 (463)
Q Consensus 141 ~~~~~-~~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l 214 (463)
+.|++ .++||+|+||+||+|... ++..||+|++.... ....+.+|+.++++++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34666 458999999999999865 47899999985432 23467789999999999999999999965 678899
Q ss_pred EEeecCCCCHHHHHhhhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeE----cCCCCEEE
Q 012462 215 VYEYVNNGNLEQWLHGAMR-----HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILI----DDDFNAKV 285 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill----~~~~~~kl 285 (463)
||||+. ++|.+++..... ....+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999996 488888764321 123489999999999999999999999 99999999999999 77899999
Q ss_pred eecccceecCCCCc--eeeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 286 SDFGLAKLLGAGKS--HVTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 286 ~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
+|||+++....... ......+||+.|+|||++.+. .++.++|||||||+||||++|+.||....
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 99999987653221 223456789999999999874 58999999999999999999999997544
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=331.59 Aligned_cols=253 Identities=25% Similarity=0.358 Sum_probs=196.8
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
...++|++.+.||+|+||.||+|... +|+.||+|.+.... ....+.+|+.++.+++||||+++++++.+....++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34578999999999999999999764 58999999986532 3356888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+++++|.+++.. ....+++..++.++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 104 e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 104 EYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp ECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred ecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 99999999999863 245699999999999999999999999 999999999999999999999999999987654
Q ss_pred CCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (463)
... ......|++.|+|||++.+..++.++||||||+++|+|++|..||...... ........... ...
T Consensus 178 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~-~~~---- 245 (314)
T 3com_A 178 TMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM------RAIFMIPTNPP-PTF---- 245 (314)
T ss_dssp TBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCC-CCC----
T ss_pred hcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCCC-ccc----
Confidence 322 233457899999999999999999999999999999999999999754321 11111111111 000
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
..... ....+..++.+||+.||.+|||+.+++++
T Consensus 246 -~~~~~--~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 246 -RKPEL--WSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp -SSGGG--SCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -CCccc--CCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000 11233445668999999999999999863
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=332.38 Aligned_cols=254 Identities=22% Similarity=0.320 Sum_probs=196.3
Q ss_pred HhcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
..++|++.+.||+|+||.||+|... ++..||+|.+..........+..|+.++..++||||+++++++.+.+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3578999999999999999999775 588999999866555566788899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
|+++++|.+++... ...+++..++.++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp CCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred eCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999998642 34599999999999999999999999 9999999999999999999999999997543211
Q ss_pred CceeeccccccCCCCchhhh-----ccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccc
Q 012462 298 KSHVTTRVMGTFGYVAPEYA-----NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV 372 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (463)
........||+.|+|||++ .+..++.++||||||+++|+|++|..||...... ...............
T Consensus 171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~ 243 (302)
T 2j7t_A 171 -LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSDPPTLL 243 (302)
T ss_dssp -HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCCCCCS
T ss_pred -ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH------HHHHHHhccCCcccC
Confidence 1112335689999999998 4677899999999999999999999999754321 112222222111100
Q ss_pred ccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 373 VDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
........+..++.+||+.||++|||+.|++++
T Consensus 244 --------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 244 --------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp --------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred --------CccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000111233445668999999999999999874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=345.74 Aligned_cols=261 Identities=25% Similarity=0.343 Sum_probs=194.3
Q ss_pred hcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcE------EE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIH------RM 213 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~~ 213 (463)
..+|++.+.||+|+||+||+|+...+..||+|++...... ..+|+.+++.++||||++++++|..... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 4579999999999999999998877778999998553321 2358999999999999999999965433 78
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEc-CCCCEEEeecccce
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAK 292 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~-~~~~~kl~Dfg~a~ 292 (463)
+||||+++ ++.+.+.........+++..++.++.||+.||+|||+. +|+||||||+|||++ .++.+||+|||+++
T Consensus 115 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 115 LVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 99999976 55555544444566799999999999999999999999 999999999999999 79999999999998
Q ss_pred ecCCCCceeeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCC---
Q 012462 293 LLGAGKSHVTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRR--- 368 (463)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 368 (463)
....... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+. +...+. ......
T Consensus 191 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~i~~-~~g~p~~~~ 265 (394)
T 4e7w_A 191 ILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVEIIK-VLGTPSREQ 265 (394)
T ss_dssp ECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH-HHCCCCHHH
T ss_pred cccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHH-HhCCCCHHH
Confidence 7644332 3345789999999998765 589999999999999999999999986542211 111111 100000
Q ss_pred -------ccccccCCCCCCCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 369 -------SEEVVDPNIEVRPST-----RALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 369 -------~~~~~~~~~~~~~~~-----~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
......+.....+.. .....+..++.+||+.||.+|||+.|++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000000000000000 011234555668999999999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=344.40 Aligned_cols=261 Identities=26% Similarity=0.352 Sum_probs=194.1
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC------cEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG------IHRM 213 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~ 213 (463)
.+|++.+.||+|+||.||+|.+. +|+.||||++..... ...+|++++++++||||++++++|... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46889999999999999999774 589999999854322 233589999999999999999998642 2357
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCC-CCEEEeecccce
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDD-FNAKVSDFGLAK 292 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~-~~~kl~Dfg~a~ 292 (463)
+||||+++ +|.+++.........+++..++.++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999975 78777765555567799999999999999999999999 99999999999999965 568999999998
Q ss_pred ecCCCCceeeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHh-------
Q 012462 293 LLGAGKSHVTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMV------- 364 (463)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~------- 364 (463)
....... ....+||+.|+|||++.+. .++.++|||||||+||||++|+.||.+....+ .+...+...-
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQI 281 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHHHH
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHH
Confidence 7654322 3345789999999998765 78999999999999999999999998644221 1111111100
Q ss_pred --cCCCccccccCCCCCCCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 365 --GSRRSEEVVDPNIEVRPST-----RALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 365 --~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.......+..+.....+.. ........++.+||+.||.+|||+.|++++
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0000111111111110000 011334556668999999999999999864
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=347.23 Aligned_cols=260 Identities=18% Similarity=0.238 Sum_probs=202.6
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCC-CCcceEeeEEEECcEEEEEEe
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRH-KNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e 217 (463)
.++|++.++||+|+||.||+|.+ .+++.||||++..... ...+..|++++..+.| ++|..+..++.+....++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46899999999999999999975 5689999998754332 2346779999999976 566667777788889999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeE---cCCCCEEEeecccceec
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill---~~~~~~kl~Dfg~a~~~ 294 (463)
|+ +++|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||| +.++.+||+|||+++..
T Consensus 84 ~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred CC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 99 89999999642 34699999999999999999999999 99999999999999 68899999999999876
Q ss_pred CCCCce------eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCC
Q 012462 295 GAGKSH------VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRR 368 (463)
Q Consensus 295 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 368 (463)
...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||..............+........
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 543321 12356799999999999999999999999999999999999999987554333222222211111111
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 369 SEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
...+.. ... ..+..++.+||+.||++||++.+|++.|+++
T Consensus 237 ~~~l~~------~~p---~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 237 IEALCR------GYP---TEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHHHHT------TSC---HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHhc------CCc---HHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 111000 111 2344556689999999999999999988775
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=338.49 Aligned_cols=265 Identities=24% Similarity=0.309 Sum_probs=194.7
Q ss_pred HhcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccchh-----hHHHHHHHHHHHcCCCCCCcceEeeEEEECcEE
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQ-----AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHR 212 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 212 (463)
..++|++.+.||+|+||.||+|... +|+.||||++...... ....+.+|+.++++++||||+++++++.+....
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3578999999999999999999764 5889999998543221 123677899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccce
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~ 292 (463)
++||||+++ +|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 88 ~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp EEEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred EEEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999976 89888853 334688999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCceeeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccc
Q 012462 293 LLGAGKSHVTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEE 371 (463)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (463)
...... ......++|+.|+|||++.+. .++.++|||||||++|||++|..||....... ....+...........
T Consensus 161 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~---~~~~i~~~~~~~~~~~ 236 (346)
T 1ua2_A 161 SFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQ 236 (346)
T ss_dssp TTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTT
T ss_pred eccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHcCCCChhh
Confidence 764332 223445789999999998664 58999999999999999999999997643211 1111111111111110
Q ss_pred ccc----C-CCC---CC-CC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 012462 372 VVD----P-NIE---VR-PS-----TRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414 (463)
Q Consensus 372 ~~~----~-~~~---~~-~~-----~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L 414 (463)
..+ + ... .. .. ......+..++.+||+.||++|||+.|++++-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 000 0 000 00 00 00113344556689999999999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=348.33 Aligned_cols=254 Identities=22% Similarity=0.319 Sum_probs=189.2
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccch--------hhHHHHHHHHHHHcCCCCCCcceEeeEEEE
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVG--------QAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 208 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 208 (463)
...++|.+.+.||+|+||+||+|.. .+++.||+|++..... .....+.+|+.++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 4568899999999999999999965 4578999999854321 11234778999999999999999999975
Q ss_pred CcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCC---CCEEE
Q 012462 209 GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDD---FNAKV 285 (463)
Q Consensus 209 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~---~~~kl 285 (463)
....++||||+++|+|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.+ +.+||
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTS----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred cCceEEEEEcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEE
Confidence 456899999999999988774 345699999999999999999999999 99999999999999754 45999
Q ss_pred eecccceecCCCCceeeccccccCCCCchhhhcc---CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 012462 286 SDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANT---GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKM 362 (463)
Q Consensus 286 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 362 (463)
+|||+++..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... .+...+
T Consensus 284 ~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~i-- 357 (419)
T 3i6u_A 284 TDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQI-- 357 (419)
T ss_dssp CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHHH--
T ss_pred eecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHHH--
Confidence 999999876432 23345689999999999853 678899999999999999999999997643221 222111
Q ss_pred HhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 363 MVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
. .......... .... ...+..++.+||+.||++|||+.|++++
T Consensus 358 -~-~~~~~~~~~~---~~~~---~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 358 -T-SGKYNFIPEV---WAEV---SEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp -H-TTCCCCCHHH---HTTS---CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -h-cCCCCCCchh---hccc---CHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 1 1111000000 0001 1234455668999999999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=352.69 Aligned_cols=252 Identities=24% Similarity=0.319 Sum_probs=197.9
Q ss_pred HhcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccch-------------hhHHHHHHHHHHHcCCCCCCcceEee
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVG-------------QAEKEFRVEVEAIGHVRHKNLVRLLG 204 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~l~~ 204 (463)
..++|.+.++||+|+||+||+|... ++..||+|++..... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3578999999999999999999764 578999999854321 23467889999999999999999999
Q ss_pred EEEECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCC---
Q 012462 205 YCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDF--- 281 (463)
Q Consensus 205 ~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~--- 281 (463)
+|.+....++||||+++|+|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCc
Confidence 999999999999999999999988642 4599999999999999999999999 999999999999998776
Q ss_pred CEEEeecccceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHH
Q 012462 282 NAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLK 361 (463)
Q Consensus 282 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 361 (463)
.+||+|||++....... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||...... ..+.
T Consensus 187 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~ 257 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ------DIIK 257 (504)
T ss_dssp SEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH
T ss_pred cEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHH
Confidence 69999999998765432 2344679999999999874 6899999999999999999999999864321 2222
Q ss_pred HHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 362 MMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
............ ...... ..+..++.+||+.||.+|||++|++++
T Consensus 258 ~i~~~~~~~~~~----~~~~~s---~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 258 KVEKGKYYFDFN----DWKNIS---DEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHHCCCCCCHH----HHTTSC---HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHcCCCCCCcc----ccCCCC---HHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 222211100000 000111 233445568999999999999999864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=344.52 Aligned_cols=199 Identities=22% Similarity=0.292 Sum_probs=171.0
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccchhhHHHHHHHHHHHcCC------CCCCcceEeeEEEECcEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEFRVEVEAIGHV------RHKNLVRLLGYCIEGIHR 212 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~~~ 212 (463)
..+|++.+.||+|+||+||+|... +++.||||++... ......+..|+.++..+ +|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 568999999999999999999654 5789999998653 23345566677666655 678999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCC--EEEeeccc
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFN--AKVSDFGL 290 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~--~kl~Dfg~ 290 (463)
++||||+. ++|.+++... ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+
T Consensus 175 ~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 99999996 6999998653 334599999999999999999999999 9999999999999999987 99999999
Q ss_pred ceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 291 AKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 291 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
+...... ....+||+.|+|||++.+..++.++|||||||+||||++|..||....
T Consensus 249 a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 249 SCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp CEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9865432 234578999999999999999999999999999999999999998654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=339.53 Aligned_cols=264 Identities=22% Similarity=0.246 Sum_probs=200.8
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCC--------CCCcceEeeEEE---
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR--------HKNLVRLLGYCI--- 207 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~--- 207 (463)
.++|++.++||+|+||+||+|.. .+++.||||++... ......+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 57899999999999999999965 45789999998643 344567788999988874 788999999987
Q ss_pred -ECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCC-----
Q 012462 208 -EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDF----- 281 (463)
Q Consensus 208 -~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~----- 281 (463)
+....++||||+ +++|.+++... ....+++..++.++.||+.||.|||+++ +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhh
Confidence 456789999999 66777776542 3356999999999999999999999853 899999999999999775
Q ss_pred --------------------------------------------CEEEeecccceecCCCCceeeccccccCCCCchhhh
Q 012462 282 --------------------------------------------NAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317 (463)
Q Consensus 282 --------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~ 317 (463)
.+||+|||++...... ....+||+.|+|||++
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhh
Confidence 8999999999876432 2345789999999999
Q ss_pred ccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH---HhcCC---------CccccccCCC--------
Q 012462 318 NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKM---MVGSR---------RSEEVVDPNI-------- 377 (463)
Q Consensus 318 ~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~---~~~~~---------~~~~~~~~~~-------- 377 (463)
.+..++.++|||||||+||||++|+.||..............+.. ..... ....+.....
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 999999999999999999999999999986554332222222111 11110 0000110000
Q ss_pred -----------CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 378 -----------EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 378 -----------~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
...........+..++.+||+.||++|||+.|++++
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 001123344556677789999999999999999874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=340.31 Aligned_cols=270 Identities=23% Similarity=0.309 Sum_probs=197.3
Q ss_pred chHHHHHHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccch-----------hhHHHHHHHHHHHcCCCCCCcc
Q 012462 132 TLRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVG-----------QAEKEFRVEVEAIGHVRHKNLV 200 (463)
Q Consensus 132 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~e~~~l~~l~h~niv 200 (463)
.+.++....++|++.+.||+|+||.||+|...+|..||||++..... ...+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 35677888899999999999999999999888899999999854221 2236788999999999999999
Q ss_pred eEeeEEEEC-----cEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCce
Q 012462 201 RLLGYCIEG-----IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNI 275 (463)
Q Consensus 201 ~l~~~~~~~-----~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Ni 275 (463)
++++++... ...|+||||+. |+|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI 165 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI 165 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence 999998653 36799999997 588888863 345699999999999999999999999 999999999999
Q ss_pred eEcCCCCEEEeecccceecCCCCceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccc
Q 012462 276 LIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEV 354 (463)
Q Consensus 276 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~ 354 (463)
|++.++.+||+|||++....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-- 241 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN-- 241 (362)
T ss_dssp EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--
T ss_pred EEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH--
Confidence 99999999999999997544322 2334578999999999877 678999999999999999999999998644221
Q ss_pred cHHHHHHHHhcCCCccc-----------cccCCC-CCCC-CH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 355 NLVDWLKMMVGSRRSEE-----------VVDPNI-EVRP-ST-----RALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 355 ~~~~~~~~~~~~~~~~~-----------~~~~~~-~~~~-~~-----~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
....+........... ...... .... .. .....+..++.+||+.||++|||+.|++++
T Consensus 242 -~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 242 -QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp -HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 1111111111110000 000000 0000 00 001234455668999999999999999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=353.43 Aligned_cols=251 Identities=23% Similarity=0.331 Sum_probs=198.7
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
.++|++.++||+|+||+||+|... +++.||||++.... ......+.+|+.++++++||||+++++++.+....|+||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 467999999999999999999764 68899999985322 234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEc---CCCCEEEeeccccee
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILID---DDFNAKVSDFGLAKL 293 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~---~~~~~kl~Dfg~a~~ 293 (463)
||+.+|+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++..
T Consensus 101 e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 999999999988643 4599999999999999999999999 999999999999995 566899999999986
Q ss_pred cCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccc
Q 012462 294 LGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373 (463)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (463)
..... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||...... ..+.............
T Consensus 174 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~~~~~~ 244 (486)
T 3mwu_A 174 FQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY------DILKRVETGKYAFDLP 244 (486)
T ss_dssp BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCCCSCSG
T ss_pred CCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCCCCCc
Confidence 64432 2344579999999999876 5899999999999999999999999764321 2222222211110000
Q ss_pred cCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
...... .....++.+||+.||.+|||+.|++++
T Consensus 245 ----~~~~~s---~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 245 ----QWRTIS---DDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp ----GGGGSC---HHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ----ccCCCC---HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 001111 223445668999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=327.34 Aligned_cols=250 Identities=22% Similarity=0.274 Sum_probs=195.0
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc----hhhHHHHHHHHHHHcCCCCCCcceEeeEEE--ECcEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV----GQAEKEFRVEVEAIGHVRHKNLVRLLGYCI--EGIHR 212 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~ 212 (463)
.++|++.+.||+|+||.||+|.. .++..||+|++.... ......+.+|+.++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 36899999999999999999966 467899999985432 234567889999999999999999999985 45578
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccce
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~ 292 (463)
++||||+.++ |.+++... ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999876 77777643 345699999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCC-ceeeccccccCCCCchhhhccCC--CCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCc
Q 012462 293 LLGAGK-SHVTTRVMGTFGYVAPEYANTGL--LNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369 (463)
Q Consensus 293 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 369 (463)
...... ........||+.|+|||++.+.. ++.++||||||+++|||++|+.||..... ............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~i~~~~~- 230 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI------YKLFENIGKGSY- 230 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCC-
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH------HHHHHHHhcCCC-
Confidence 765322 22234457899999999997644 37899999999999999999999975431 122222221110
Q ss_pred cccccCCCCCCC-CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 370 EEVVDPNIEVRP-STRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 370 ~~~~~~~~~~~~-~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.... ... .+..++.+||+.||.+|||+.|++++
T Consensus 231 --------~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 --------AIPGDCGP---PLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp --------CCCSSSCH---HHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --------CCCCccCH---HHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111 112 23345568999999999999999974
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=332.74 Aligned_cols=258 Identities=26% Similarity=0.386 Sum_probs=194.8
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc--CCC--eEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI--NGS--PVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHR 212 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 212 (463)
.++|++.+.||+|+||+||+|.+. ++. .||+|.+.... ....+.+.+|+.++.+++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 467999999999999999999753 233 58999885432 334567889999999999999999999998765 7
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccce
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~ 292 (463)
++||||+++++|.+++... ...+++..++.++.|++.||.|||++ +|+|+||||+|||++.++.+||+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence 8999999999999999753 23589999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCce--eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCc
Q 012462 293 LLGAGKSH--VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369 (463)
Q Consensus 293 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 369 (463)
........ ......+|..|+|||++.+..++.++||||||+++|+|++ |..||..... .............
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~~~~~ 243 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------SQILHKIDKEGER 243 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTSCCC
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH------HHHHHHHHccCCC
Confidence 76543322 1233457888999999999889999999999999999999 9999975432 1222222222111
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCC
Q 012462 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEY 419 (463)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~ 419 (463)
... ..... ..+..++.+||+.||++|||+.++++.|++...
T Consensus 244 ~~~------~~~~~---~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 244 LPR------PEDCP---QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp CCC------CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CCC------CcCcC---HHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 100 01111 234445668999999999999999999988644
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=338.18 Aligned_cols=255 Identities=22% Similarity=0.335 Sum_probs=191.3
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECc------
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGI------ 210 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 210 (463)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46899999999999999999966 568999999985432 334567889999999999999999999998653
Q ss_pred EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccc
Q 012462 211 HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGL 290 (463)
Q Consensus 211 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~ 290 (463)
..|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 7899999863 3589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCc
Q 012462 291 AKLLGAGKSHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369 (463)
Q Consensus 291 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 369 (463)
++..... ....++|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+. ...+.........
T Consensus 175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---l~~i~~~~g~~~~ 247 (367)
T 1cm8_A 175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ---LKEIMKVTGTPPA 247 (367)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCH
T ss_pred ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCH
Confidence 9876432 334578999999999877 6899999999999999999999999986432111 1111111110000
Q ss_pred ------------------cccccCCC-CC-CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 370 ------------------EEVVDPNI-EV-RPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 370 ------------------~~~~~~~~-~~-~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
........ .. .... .....++.+||+.||++|||++|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 248 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNAS---PLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCC---HHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCC---HHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 00000000 00 1111 233445568999999999999999985
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=364.99 Aligned_cols=251 Identities=22% Similarity=0.286 Sum_probs=201.1
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEE
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHR 212 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 212 (463)
+..++|++.++||+|+||+||+|... +++.||||++.... ......+..|..++..+ +||||+.+++++.+.+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 44578999999999999999999664 57889999986432 22345677799999887 799999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccce
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~ 292 (463)
|+||||+++|+|.+++... +.+++..++.++.||+.||+|||++ +|+||||||+||||+.++++||+|||+++
T Consensus 418 ~lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceee
Confidence 9999999999999999643 4599999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccc
Q 012462 293 LLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV 372 (463)
Q Consensus 293 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (463)
...... ......+||+.|+|||++.+..|+.++|||||||+||||++|+.||..... .+....+....
T Consensus 491 ~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~----- 558 (674)
T 3pfq_A 491 ENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIMEHN----- 558 (674)
T ss_dssp ECCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHSSC-----
T ss_pred ccccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH------HHHHHHHHhCC-----
Confidence 643322 234557899999999999999999999999999999999999999976432 22222222211
Q ss_pred ccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 012462 373 VDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKM-----SQVVRM 413 (463)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~-----~ell~~ 413 (463)
...+... ......++.+||+.||++||++ +||+++
T Consensus 559 ----~~~p~~~--s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 559 ----VAYPKSM--SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp ----CCCCTTS--CHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred ----CCCCccC--CHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 1111111 1223444557999999999997 777653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=327.57 Aligned_cols=252 Identities=25% Similarity=0.350 Sum_probs=199.4
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---------hhhHHHHHHHHHHHcCCC-CCCcceEeeEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---------GQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIE 208 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~ 208 (463)
.++|++.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++.++. ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 478999999999999999999764 57899999985432 122456778999999995 9999999999999
Q ss_pred CcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeec
Q 012462 209 GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDF 288 (463)
Q Consensus 209 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Df 288 (463)
....++||||+++++|.+++.. ...+++..++.++.||+.||.|||+. +++|+||||+||+++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred CCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence 9999999999999999999964 24589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCceeeccccccCCCCchhhhc------cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 012462 289 GLAKLLGAGKSHVTTRVMGTFGYVAPEYAN------TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKM 362 (463)
Q Consensus 289 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 362 (463)
|++....... ......+++.|+|||++. ...++.++||||||+++|+|++|..||..... ......
T Consensus 169 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~ 240 (298)
T 1phk_A 169 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------MLMLRM 240 (298)
T ss_dssp TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHH
T ss_pred cchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH------HHHHHH
Confidence 9998765432 233457899999999885 45688999999999999999999999975432 111222
Q ss_pred HhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 363 MVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
........ ..+ ... .....+..++.+||+.||++|||+.|++++
T Consensus 241 ~~~~~~~~--~~~--~~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 241 IMSGNYQF--GSP--EWD---DYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HHHTCCCC--CTT--TGG---GSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HhcCCccc--Ccc--ccc---ccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 22111100 000 000 111233445668999999999999999863
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=337.07 Aligned_cols=198 Identities=29% Similarity=0.345 Sum_probs=163.1
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECc------
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGI------ 210 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 210 (463)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46899999999999999999965 468899999986432 334467888999999999999999999997654
Q ss_pred EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccc
Q 012462 211 HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGL 290 (463)
Q Consensus 211 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~ 290 (463)
..|+||||+++ +|.+++. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 78999999975 8888874 2388999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 291 AKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 291 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
++...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 174 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 230 (371)
T 2xrw_A 174 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 98654322 2344678999999999999999999999999999999999999997643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=336.90 Aligned_cols=259 Identities=18% Similarity=0.302 Sum_probs=202.0
Q ss_pred hcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhh-----------------HHHHHHHHHHHcCCCCCCcceE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQA-----------------EKEFRVEVEAIGHVRHKNLVRL 202 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~niv~l 202 (463)
.++|++.+.||+|+||.||+|.. +++.||+|.+....... ...+.+|+.++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999988 89999999985432211 1778899999999999999999
Q ss_pred eeEEEECcEEEEEEeecCCCCHHHH------HhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEccCCCCce
Q 012462 203 LGYCIEGIHRMLVYEYVNNGNLEQW------LHGAMRHHGYLTWEARMKVLLGTAKALAYLHE-AIEPKVVHRDIKSSNI 275 (463)
Q Consensus 203 ~~~~~~~~~~~lV~e~~~~g~L~~~------l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dikp~Ni 275 (463)
++++.+.+..++||||+++++|.++ +.. .....+++..++.++.||+.||.|||+ . +|+|+||||+||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni 183 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI 183 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence 9999999999999999999999988 432 125679999999999999999999999 8 999999999999
Q ss_pred eEcCCCCEEEeecccceecCCCCceeeccccccCCCCchhhhccC-CCCc-cchhhhHHHHHHHHHhCCCCCCCCCCccc
Q 012462 276 LIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTG-LLNE-KSDVYSFGVLLLEAITGRDPVDHGRPAHE 353 (463)
Q Consensus 276 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDvwSlGvvl~elltg~~pf~~~~~~~~ 353 (463)
|++.++.+||+|||++...... ......|++.|+|||++.+. .++. ++|||||||++|||++|..||......
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-- 258 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-- 258 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--
T ss_pred EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--
Confidence 9999999999999999876443 23456789999999999887 6766 999999999999999999999865431
Q ss_pred ccHHHHHHHHhcCCCccccccCC------CCCC---CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 354 VNLVDWLKMMVGSRRSEEVVDPN------IEVR---PSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~------~~~~---~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.......... ......... .... ........+..++.+||+.||.+|||+.|++++
T Consensus 259 ---~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 259 ---VELFNNIRTK-NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp ---HHHHHHHTSC-CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ---HHHHHHHhcc-CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1112222211 111110000 0000 000111233455668999999999999999884
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=335.04 Aligned_cols=254 Identities=24% Similarity=0.378 Sum_probs=193.2
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCC-CCCCcceEeeEEEE------C
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIE------G 209 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~------~ 209 (463)
...++|++.+.||+|+||.||+|.. .+++.||+|++.... .....+.+|+.++.++ +||||+++++++.. .
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 99 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 99 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence 3467899999999999999999976 468899999985432 3346788899999998 89999999999987 4
Q ss_pred cEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecc
Q 012462 210 IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFG 289 (463)
Q Consensus 210 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg 289 (463)
...++||||+++++|.+++... ....+++..++.++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg 174 (326)
T 2x7f_A 100 DQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 174 (326)
T ss_dssp CEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCT
T ss_pred ceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCc
Confidence 6789999999999999999753 234689999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCceeeccccccCCCCchhhhc-----cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHh
Q 012462 290 LAKLLGAGKSHVTTRVMGTFGYVAPEYAN-----TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMV 364 (463)
Q Consensus 290 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~ 364 (463)
++....... .......||+.|+|||++. +..++.++|||||||++|+|++|..||...... .......
T Consensus 175 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~ 247 (326)
T 2x7f_A 175 VSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------RALFLIP 247 (326)
T ss_dssp TTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHH
T ss_pred CceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------HHHHHhh
Confidence 998654322 1223457899999999987 567899999999999999999999999754321 1111111
Q ss_pred cCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 365 GSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.... .. ......... +..++.+||+.||.+||++.|++++
T Consensus 248 ~~~~-~~-----~~~~~~~~~---l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 248 RNPA-PR-----LKSKKWSKK---FQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HSCC-CC-----CSCSCSCHH---HHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cCcc-cc-----CCccccCHH---HHHHHHHHhccChhhCCCHHHHhhC
Confidence 1111 11 111111222 3344557999999999999999974
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=333.22 Aligned_cols=264 Identities=22% Similarity=0.347 Sum_probs=200.2
Q ss_pred hHHHHHHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECc
Q 012462 133 LRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGI 210 (463)
Q Consensus 133 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 210 (463)
..++++..++|++.+.||+|+||.||+|... ..||+|++.... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEES--SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEc--CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 4556677889999999999999999999764 359999885432 222345677999999999999999999999999
Q ss_pred EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccc
Q 012462 211 HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGL 290 (463)
Q Consensus 211 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~ 290 (463)
..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred ceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCC
Confidence 99999999999999999853 234689999999999999999999999 999999999999998 67999999999
Q ss_pred ceecCCCC----ceeeccccccCCCCchhhhcc---------CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHH
Q 012462 291 AKLLGAGK----SHVTTRVMGTFGYVAPEYANT---------GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLV 357 (463)
Q Consensus 291 a~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~ 357 (463)
+....... ........|++.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------ 249 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE------ 249 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH------
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------
Confidence 87643211 112233468999999999864 45788999999999999999999999754321
Q ss_pred HHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCCC
Q 012462 358 DWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYP 420 (463)
Q Consensus 358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~~ 420 (463)
........... ..... ...+. .+..++.+||+.||++|||+.++++.|+.....
T Consensus 250 ~~~~~~~~~~~-~~~~~--~~~~~------~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 250 AIIWQMGTGMK-PNLSQ--IGMGK------EISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp HHHHHHHTTCC-CCCCC--SSCCT------THHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred HHHHHhccCCC-CCCCc--CCCCH------HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 12222222211 11111 01111 233445679999999999999999999997554
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=327.98 Aligned_cols=261 Identities=21% Similarity=0.297 Sum_probs=200.0
Q ss_pred HhcCCCccCeEeecCcEEEEEEEE--cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCC------CcceEeeEEEECc
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNL--INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHK------NLVRLLGYCIEGI 210 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~l~~~~~~~~ 210 (463)
..++|++.+.||+|+||+||+|.. .+++.||+|++... ......+.+|+.++..++|+ +++++++++.+.+
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 357899999999999999999975 36789999998543 33456677888888877554 5999999999999
Q ss_pred EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC-----------
Q 012462 211 HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD----------- 279 (463)
Q Consensus 211 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~----------- 279 (463)
..++||||+ +++|.+++... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC---
T ss_pred cEEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcc
Confidence 999999999 88999998653 234689999999999999999999999 9999999999999987
Q ss_pred --------CCCEEEeecccceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCc
Q 012462 280 --------DFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPA 351 (463)
Q Consensus 280 --------~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~ 351 (463)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred ccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 678999999999875432 23457899999999999999999999999999999999999999764422
Q ss_pred ccccHHHHHHHHhcCCCc--------cccc-cCCCC---------------------CCCCHHHHHHHHHHHhhccCCCC
Q 012462 352 HEVNLVDWLKMMVGSRRS--------EEVV-DPNIE---------------------VRPSTRALKRSLLTALRCVDPDS 401 (463)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~--------~~~~-~~~~~---------------------~~~~~~~~~~~~~~~~~cl~~dP 401 (463)
.. ...+......... .... ..... ..........+..++.+||+.||
T Consensus 241 ~~---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 317 (339)
T 1z57_A 241 EH---LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP 317 (339)
T ss_dssp HH---HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred HH---HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence 21 1111111111000 0000 00000 01112233455666778999999
Q ss_pred CCCCCHHHHHHH
Q 012462 402 EKRPKMSQVVRM 413 (463)
Q Consensus 402 ~~RPs~~ell~~ 413 (463)
++|||+.|++++
T Consensus 318 ~~Rpt~~ell~h 329 (339)
T 1z57_A 318 AKRITLREALKH 329 (339)
T ss_dssp TTSCCHHHHTTS
T ss_pred ccccCHHHHhcC
Confidence 999999999864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=335.52 Aligned_cols=204 Identities=25% Similarity=0.312 Sum_probs=171.1
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccchhhHHHHHHHHHHHcCCC-CC-----CcceEeeEEEEC
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR-HK-----NLVRLLGYCIEG 209 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~ 209 (463)
+...++|++.+.||+|+||+||+|... +++.||||++... ......+..|+.++..+. |+ +|+++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 344678999999999999999999654 5788999998643 233456677888877764 44 499999999999
Q ss_pred cEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEc--CCCCEEEee
Q 012462 210 IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILID--DDFNAKVSD 287 (463)
Q Consensus 210 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~--~~~~~kl~D 287 (463)
+..++||||+. ++|.+++... ....+++..++.++.|++.||.|||.+ ..+|+||||||+|||++ .++.+||+|
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred CceEEEEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 99999999996 5999999753 234589999999999999999999942 12899999999999995 578899999
Q ss_pred cccceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 288 FGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 288 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 205 FG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 205 FGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999876432 234578999999999999999999999999999999999999998654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=363.59 Aligned_cols=260 Identities=24% Similarity=0.382 Sum_probs=202.4
Q ss_pred HHHHHhcCCCccCeEeecCcEEEEEEEEcC----CCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC
Q 012462 135 DLELATNRFSKENVLGEGGYGVVYRGNLIN----GSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG 209 (463)
Q Consensus 135 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 209 (463)
+.++..++|++.+.||+|+||+||+|.+.. +..||+|++.... ....+.+.+|+.++++++||||+++++++. .
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 344556789999999999999999997643 3469999875433 344467889999999999999999999985 4
Q ss_pred cEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecc
Q 012462 210 IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFG 289 (463)
Q Consensus 210 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg 289 (463)
+..++||||+++|+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred CceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecC
Confidence 568999999999999999964 234589999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCC
Q 012462 290 LAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRR 368 (463)
Q Consensus 290 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 368 (463)
+++..............+|+.|+|||++.+..++.++|||||||++|||++ |..||...... +..........
T Consensus 537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~------~~~~~i~~~~~ 610 (656)
T 2j0j_A 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN------DVIGRIENGER 610 (656)
T ss_dssp CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHHTCC
T ss_pred CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHcCCC
Confidence 998765443333344567889999999999999999999999999999997 99999764322 22222222211
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 369 SEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.. .... ....+..++.+||+.||++|||+.|+++.|+.+
T Consensus 611 ~~--------~~~~--~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 611 LP--------MPPN--CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp CC--------CCTT--CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC--------CCcc--ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11 0111 112334456689999999999999999999875
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=334.81 Aligned_cols=262 Identities=23% Similarity=0.304 Sum_probs=197.9
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC-----cEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG-----IHR 212 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 212 (463)
.++|++.+.||+|+||.||+|... ++..||||++.... ......+.+|+.++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 468999999999999999999654 67889999986433 33446788999999999999999999999764 367
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccce
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~ 292 (463)
++||||+. |+|.+++.. ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 99999997 599998853 3499999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCce--eeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCc
Q 012462 293 LLGAGKSH--VTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369 (463)
Q Consensus 293 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 369 (463)
........ .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ...+.........
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~~ 253 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSPSQ 253 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH---HHHHHHHHCSCCH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH---HHHHHHHhCCCCH
Confidence 76533221 1234579999999998654 5589999999999999999999999986543322 2211111111100
Q ss_pred cccc-----------cCCC-CCCCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 370 EEVV-----------DPNI-EVRPST-----RALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 370 ~~~~-----------~~~~-~~~~~~-----~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.... .... ...... .....+..++.+||+.||++|||+.|++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0000 000000 001234455668999999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=330.61 Aligned_cols=253 Identities=23% Similarity=0.319 Sum_probs=193.9
Q ss_pred HhcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccch--------hhHHHHHHHHHHHcCCCCCCcceEeeEEEEC
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVG--------QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG 209 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 209 (463)
..++|++.+.||+|+||.||+|... +++.||||.+..... .....+.+|+.++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3467999999999999999999664 578999999854321 1224578899999999999999999998765
Q ss_pred cEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCC---EEEe
Q 012462 210 IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFN---AKVS 286 (463)
Q Consensus 210 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~---~kl~ 286 (463)
. .++||||+++++|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++. +||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp S-EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred c-eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEc
Confidence 5 899999999999999884 345699999999999999999999999 9999999999999987664 9999
Q ss_pred ecccceecCCCCceeeccccccCCCCchhhhc---cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHH
Q 012462 287 DFGLAKLLGAGKSHVTTRVMGTFGYVAPEYAN---TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMM 363 (463)
Q Consensus 287 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~ 363 (463)
|||++....... ......||+.|+|||++. ...++.++|||||||++|+|++|..||....... .+...+..
T Consensus 160 Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~- 234 (322)
T 2ycf_A 160 DFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQITS- 234 (322)
T ss_dssp CCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHHHH-
T ss_pred cCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHHHh-
Confidence 999998765332 223457899999999974 5678999999999999999999999997644322 22222111
Q ss_pred hcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 364 VGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
. ........ .... ...+..++.+||+.||++|||+.|++++
T Consensus 235 --~-~~~~~~~~---~~~~---~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 235 --G-KYNFIPEV---WAEV---SEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp --T-CCCCCHHH---HTTS---CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --C-ccccCchh---hhhc---CHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 1 00000000 0001 1234455668999999999999999874
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=334.80 Aligned_cols=270 Identities=23% Similarity=0.289 Sum_probs=189.1
Q ss_pred HHHHHhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcE--
Q 012462 135 DLELATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIH-- 211 (463)
Q Consensus 135 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-- 211 (463)
......++|++.+.||+|+||+||+|.. .++..||||++..... .......++..+..++||||++++++|.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 4456678999999999999999999976 4688999998855332 22345557777888899999999999976433
Q ss_pred -----EEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeEEccCCCCceeEcC-CCCE
Q 012462 212 -----RMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH--EAIEPKVVHRDIKSSNILIDD-DFNA 283 (463)
Q Consensus 212 -----~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH--~~~~~~i~H~Dikp~Nill~~-~~~~ 283 (463)
.++||||+++ +|.+.+.........+++..++.++.|++.||.||| +. +|+||||||+|||++. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcE
Confidence 7899999976 777666655456677999999999999999999999 87 9999999999999997 8999
Q ss_pred EEeecccceecCCCCceeeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 012462 284 KVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKM 362 (463)
Q Consensus 284 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 362 (463)
||+|||++....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ +......
T Consensus 172 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~~~~~~~ 247 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ--LHEIVRV 247 (360)
T ss_dssp EECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHH
T ss_pred EEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH--HHHHHHH
Confidence 999999998765433 23345789999999998665 489999999999999999999999986442211 1111110
Q ss_pred -----------HhcCCCccccccCC-CC-----CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 363 -----------MVGSRRSEEVVDPN-IE-----VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 363 -----------~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
...........+.. .. ..........+..++.+||+.||.+|||+.|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000000000000 00 00000122345556668999999999999999874
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=328.71 Aligned_cols=258 Identities=22% Similarity=0.330 Sum_probs=196.7
Q ss_pred hHHHHHHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEccc--chhhHHHHHHHHHHHcCCC--CCCcceEeeEEEE
Q 012462 133 LRDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNN--VGQAEKEFRVEVEAIGHVR--HKNLVRLLGYCIE 208 (463)
Q Consensus 133 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~ 208 (463)
+..+.+..++|++.+.||+|+||.||+|...+++.||+|++... .......+.+|+.++.+++ ||||+++++++.+
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 34445667889999999999999999998888999999998543 2344567889999999996 5999999999999
Q ss_pred CcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeec
Q 012462 209 GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDF 288 (463)
Q Consensus 209 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Df 288 (463)
....++||| +.+++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||+++ +.+||+||
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Df 170 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDF 170 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCC
T ss_pred CCEEEEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeec
Confidence 999999999 557899999964 34689999999999999999999999 9999999999999975 89999999
Q ss_pred ccceecCCCCce-eeccccccCCCCchhhhcc-----------CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccH
Q 012462 289 GLAKLLGAGKSH-VTTRVMGTFGYVAPEYANT-----------GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNL 356 (463)
Q Consensus 289 g~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~ 356 (463)
|++......... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .
T Consensus 171 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~ 245 (313)
T 3cek_A 171 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----Q 245 (313)
T ss_dssp SSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----H
T ss_pred cccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----H
Confidence 999876433221 2234578999999999875 4788899999999999999999999975432 1
Q ss_pred HHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 357 VDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
...+............. ..... .+..++.+||+.||++||++.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~------~~~~~---~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 246 ISKLHAIIDPNHEIEFP------DIPEK---DLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHHHHHHCTTSCCCCC------CCSCH---HHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHhcccccCCc------ccchH---HHHHHHHHHccCCcccCcCHHHHhcC
Confidence 12222222221111110 01112 23445567999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=322.14 Aligned_cols=252 Identities=29% Similarity=0.441 Sum_probs=188.9
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEE----------
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE---------- 208 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~---------- 208 (463)
.++|++.+.||+|+||.||+|.. .+++.||+|.+... ......+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 45789999999999999999976 47899999998543 3445678899999999999999999999865
Q ss_pred ---CcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEE
Q 012462 209 ---GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKV 285 (463)
Q Consensus 209 ---~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl 285 (463)
....++||||+++++|.+++.. ....+++..++.++.|++.||.|||++ +|+|+||||+|||++.++.+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred cccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEE
Confidence 3567999999999999999974 234578899999999999999999999 9999999999999999999999
Q ss_pred eecccceecCCCC-------------ceeeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCc
Q 012462 286 SDFGLAKLLGAGK-------------SHVTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGRPA 351 (463)
Q Consensus 286 ~Dfg~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~ 351 (463)
+|||++....... ........||+.|+|||++.+. .++.++|||||||++|||++ ||....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-- 232 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-- 232 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--
Confidence 9999998654321 1122345689999999999764 78999999999999999998 554211
Q ss_pred ccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 352 HEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.............. . ..+. .... ....+..++.+||+.||.+|||+.|++++
T Consensus 233 ---~~~~~~~~~~~~~~--~-~~~~--~~~~--~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 233 ---ERVNILKKLRSVSI--E-FPPD--FDDN--KMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp ---HHHHHHHHHHSTTC--C-CCTT--CCTT--TSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---hHHHHHHhcccccc--c-cCcc--cccc--chHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 11122222221110 0 0010 1111 11223345568999999999999999874
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=327.00 Aligned_cols=201 Identities=27% Similarity=0.396 Sum_probs=165.8
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEE-----------
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCI----------- 207 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----------- 207 (463)
.++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 478999999999999999999765 48899999987666666678889999999999999999999873
Q ss_pred ---ECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEc-CCCCE
Q 012462 208 ---EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILID-DDFNA 283 (463)
Q Consensus 208 ---~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~-~~~~~ 283 (463)
+....++||||+. |+|.+++. .+.+++..++.++.||+.||+|||+. +|+||||||+|||++ +++.+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeE
Confidence 3467899999997 59999884 24589999999999999999999999 999999999999997 56799
Q ss_pred EEeecccceecCCCCc--eeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 284 KVSDFGLAKLLGAGKS--HVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 284 kl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
||+|||++........ .......+|..|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 229 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence 9999999987543211 12233467899999998865 678999999999999999999999998654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=338.60 Aligned_cols=257 Identities=25% Similarity=0.336 Sum_probs=180.4
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEccc--chhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC------c
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNN--VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG------I 210 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 210 (463)
.++|++.+.||+|+||.||+|.. .+|+.||||++... .......+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47899999999999999999964 56889999998543 233456788899999999999999999999754 5
Q ss_pred EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccc
Q 012462 211 HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGL 290 (463)
Q Consensus 211 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~ 290 (463)
..|+|+|++ +++|.+++.. ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 579999999 6799988742 4599999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCc
Q 012462 291 AKLLGAGKSHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369 (463)
Q Consensus 291 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 369 (463)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..... ....+........
T Consensus 179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~p~- 250 (367)
T 2fst_X 179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRLVGTPG- 250 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCC-
T ss_pred ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCC-
Confidence 9865432 334578999999999877 678999999999999999999999997644211 1111111111100
Q ss_pred ccccc------------CCCCC-CCCHH-----HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 370 EEVVD------------PNIEV-RPSTR-----ALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 370 ~~~~~------------~~~~~-~~~~~-----~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.+... ..... ..... .......++.+||+.||++|||+.|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00000 00000 00000 01233455668999999999999999975
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=323.17 Aligned_cols=262 Identities=24% Similarity=0.360 Sum_probs=194.6
Q ss_pred HhcCCCccCeEeecCcEEEEEEEE--cCCCeEEEEEEcccchh--hHHHHHHHHHHHcCC---CCCCcceEeeEEE----
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNL--INGSPVAVKKILNNVGQ--AEKEFRVEVEAIGHV---RHKNLVRLLGYCI---- 207 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~niv~l~~~~~---- 207 (463)
..++|++.+.||+|+||.||+|.. .+++.||+|++...... ....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 357899999999999999999977 46788999988543221 122445566665554 8999999999987
Q ss_pred -ECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEe
Q 012462 208 -EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVS 286 (463)
Q Consensus 208 -~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~ 286 (463)
.....++||||+. |+|.+++... ....+++..++.++.||+.||.|||+. +|+|+||||+|||++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 4567899999997 5999998653 234589999999999999999999999 99999999999999999999999
Q ss_pred ecccceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcC
Q 012462 287 DFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGS 366 (463)
Q Consensus 287 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 366 (463)
|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+......
T Consensus 163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~ 237 (326)
T 1blx_A 163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGL 237 (326)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCC
T ss_pred cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHHcCC
Confidence 999998654321 233457899999999999999999999999999999999999999865422 111111111111
Q ss_pred CCccccc----------c-----CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 367 RRSEEVV----------D-----PNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 367 ~~~~~~~----------~-----~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
....... . +........ ...+..++.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDI--DELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSC--CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCcccCccccccchhhhcccCcchhhhccccC--CHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1000000 0 000001111 1223345668999999999999999864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=340.15 Aligned_cols=254 Identities=25% Similarity=0.361 Sum_probs=185.6
Q ss_pred cCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEEEEEEeec
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYV 219 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~ 219 (463)
+.|...+.||+|+||+||.+...+|+.||||++.... .+.+.+|+.++.++ +||||+++++++.+....|+||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 4456678899999999988777789999999985432 34567899999875 8999999999999999999999999
Q ss_pred CCCCHHHHHhhhhcCCCC---CCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCC-------------CCE
Q 012462 220 NNGNLEQWLHGAMRHHGY---LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDD-------------FNA 283 (463)
Q Consensus 220 ~~g~L~~~l~~~~~~~~~---~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~-------------~~~ 283 (463)
. |+|.+++......... ..+..++.++.||+.||+|||++ +|+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 6999999753221111 13345678999999999999999 99999999999999754 489
Q ss_pred EEeecccceecCCCCce---eeccccccCCCCchhhhcc-------CCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcc
Q 012462 284 KVSDFGLAKLLGAGKSH---VTTRVMGTFGYVAPEYANT-------GLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAH 352 (463)
Q Consensus 284 kl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~ 352 (463)
||+|||+++........ .....+||+.|+|||++.+ ..++.++|||||||++|||++ |..||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999987554321 1234579999999999976 678999999999999999999 999997543211
Q ss_pred cccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 353 EVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
... ........ .............+..++.+||+.||.+|||+.|++++
T Consensus 248 ----~~i---~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 248 ----SNI---IRGIFSLD-----EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp ----HHH---HHTCCCCC-----CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----HHH---hcCCCCcc-----cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 111 11111111 11111222333455566778999999999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=319.08 Aligned_cols=254 Identities=22% Similarity=0.319 Sum_probs=199.9
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEE
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRM 213 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 213 (463)
....++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++.+....+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 344578999999999999999999764 68899999985432 234567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCC---CCEEEeeccc
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDD---FNAKVSDFGL 290 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~---~~~kl~Dfg~ 290 (463)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+. +++|+||||+||+++.+ +.+||+|||+
T Consensus 98 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~ 170 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGL 170 (287)
T ss_dssp EEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred EEEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCc
Confidence 999999999999988642 3589999999999999999999999 99999999999999754 4799999999
Q ss_pred ceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 291 AKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 291 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
+........ .....+++.|+|||++.+. ++.++||||||+++|+|++|..||..... ..............
T Consensus 171 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~ 241 (287)
T 2wei_A 171 STCFQQNTK--MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNE------YDILKRVETGKYAF 241 (287)
T ss_dssp GGTBCCCSS--CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCC
T ss_pred ceeecCCCc--cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCCCC
Confidence 986543321 2334588999999998764 89999999999999999999999976432 12222222221111
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
... ....... .+..++.+||+.||++|||+.|++++
T Consensus 242 ~~~----~~~~~~~---~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 242 DLP----QWRTISD---DAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp CSG----GGTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred Cch----hhhhcCH---HHHHHHHHHcccChhhCcCHHHHhcC
Confidence 000 0011112 33445668999999999999999973
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=327.08 Aligned_cols=261 Identities=21% Similarity=0.273 Sum_probs=198.3
Q ss_pred HhcCCCccCeEeecCcEEEEEEEEc-CC-CeEEEEEEcccchhhHHHHHHHHHHHcCCCCCC------cceEeeEEEECc
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNLI-NG-SPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKN------LVRLLGYCIEGI 210 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~ 210 (463)
..++|++.+.||+|+||+||+|... ++ ..||+|++... ......+..|+.++++++|++ ++.+++++....
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 3578999999999999999999764 34 68999988543 344567778888888886655 999999999999
Q ss_pred EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeE-------------
Q 012462 211 HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILI------------- 277 (463)
Q Consensus 211 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill------------- 277 (463)
..++||||+ +++|.+++... ....+++..++.++.||+.||.|||++ +|+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eEEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccc
Confidence 999999999 66888877542 334699999999999999999999999 99999999999999
Q ss_pred ------cCCCCEEEeecccceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCc
Q 012462 278 ------DDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPA 351 (463)
Q Consensus 278 ------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~ 351 (463)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 66889999999999875432 23457899999999999999999999999999999999999999864422
Q ss_pred ccccHHHHHHHHhcCCCc---------cccccCCC---------------------CCCCCHHHHHHHHHHHhhccCCCC
Q 012462 352 HEVNLVDWLKMMVGSRRS---------EEVVDPNI---------------------EVRPSTRALKRSLLTALRCVDPDS 401 (463)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~---------~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~cl~~dP 401 (463)
. ....+......... ........ ...........+..++.+||+.||
T Consensus 246 ~---~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 246 E---HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp H---HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred H---HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 1 11111111111000 00000000 001111223355566778999999
Q ss_pred CCCCCHHHHHHH
Q 012462 402 EKRPKMSQVVRM 413 (463)
Q Consensus 402 ~~RPs~~ell~~ 413 (463)
++|||+.|++++
T Consensus 323 ~~Rpt~~e~l~h 334 (355)
T 2eu9_A 323 AQRITLAEALLH 334 (355)
T ss_dssp TTSCCHHHHTTS
T ss_pred hhCcCHHHHhcC
Confidence 999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=330.94 Aligned_cols=246 Identities=27% Similarity=0.385 Sum_probs=185.9
Q ss_pred HHHHHhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchh------hHHHHHHHHHHHcCC----CCCCcceEe
Q 012462 135 DLELATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQ------AEKEFRVEVEAIGHV----RHKNLVRLL 203 (463)
Q Consensus 135 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l----~h~niv~l~ 203 (463)
+.+...++|++.+.||+|+||.||+|.. .+++.||||++...... ....+..|+.++.++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 4455678899999999999999999965 46889999998543321 222345678877777 899999999
Q ss_pred eEEEECcEEEEEEee-cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEc-CCC
Q 012462 204 GYCIEGIHRMLVYEY-VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILID-DDF 281 (463)
Q Consensus 204 ~~~~~~~~~~lV~e~-~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~-~~~ 281 (463)
+++.+.+..++|||+ +.+++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+||+++ .++
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRG 177 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTT
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCC
Confidence 999999999999999 789999999964 23589999999999999999999999 999999999999999 889
Q ss_pred CEEEeecccceecCCCCceeeccccccCCCCchhhhccCCCC-ccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHH
Q 012462 282 NAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLN-EKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWL 360 (463)
Q Consensus 282 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~ 360 (463)
.+||+|||++....... .....|+..|+|||++.+..+. .++|||||||++|||++|+.||.... ..
T Consensus 178 ~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~- 245 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--------EI- 245 (312)
T ss_dssp EEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------HH-
T ss_pred eEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------HH-
Confidence 99999999998765432 3345689999999998877664 58999999999999999999996421 00
Q ss_pred HHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 361 KMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
... ........ ...+..++.+||+.||++|||+.|++++
T Consensus 246 ---~~~---------~~~~~~~~--~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 246 ---LEA---------ELHFPAHV--SPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ---HHT---------CCCCCTTS--CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---hhh---------ccCCcccC--CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00111111 1223445668999999999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=325.92 Aligned_cols=253 Identities=21% Similarity=0.247 Sum_probs=168.4
Q ss_pred hcCCCccC-eEeecCcEEEEEEEEc-CCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEE----CcEEE
Q 012462 140 TNRFSKEN-VLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE----GIHRM 213 (463)
Q Consensus 140 ~~~~~~~~-~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~ 213 (463)
.++|.+.+ +||+|+||+||+|... +++.||||++.... ....++ ...+..++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~e~---~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-KARQEV---DHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-HHHHHH---HHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-HHHHHH---HHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 46788855 6999999999999765 68999999985532 222222 233455699999999999976 45579
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC---CCCEEEeeccc
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD---DFNAKVSDFGL 290 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~---~~~~kl~Dfg~ 290 (463)
+||||+++|+|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+
T Consensus 103 lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 999999999999999752 234699999999999999999999999 9999999999999976 45599999999
Q ss_pred ceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 291 AKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 291 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
+....... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||........... . ...... .
T Consensus 178 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~-~~~~~~---~ 248 (336)
T 3fhr_A 178 AKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG--M-KRRIRL---G 248 (336)
T ss_dssp CEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred ceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh--H-HHhhhc---c
Confidence 98754322 3345789999999999888899999999999999999999999976443211100 0 000000 0
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
....+.......... +..++.+||+.||++|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~---~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 249 QYGFPNPEWSEVSED---AKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp --CCCTTTSTTCCHH---HHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccccCchhhccCCHH---HHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000011111111222 3345567999999999999999984
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=332.26 Aligned_cols=256 Identities=25% Similarity=0.326 Sum_probs=192.0
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEE----
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHR---- 212 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~---- 212 (463)
.++|.+.+.||+|+||+||+|.. .+|+.||||++.... ......+.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 46899999999999999999965 468899999986532 33356788899999999999999999999877654
Q ss_pred --EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccc
Q 012462 213 --MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGL 290 (463)
Q Consensus 213 --~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~ 290 (463)
++||||+. ++|.+++. ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 58888762 2499999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCc
Q 012462 291 AKLLGAGKSHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369 (463)
Q Consensus 291 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 369 (463)
++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+ ....+....... .
T Consensus 191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~-~ 262 (371)
T 4exu_A 191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVP-G 262 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCC-C
T ss_pred ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCC-c
Confidence 9865432 334578999999999887 688999999999999999999999997643211 111111111000 0
Q ss_pred cccccC------------CC-CCCCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 370 EEVVDP------------NI-EVRPST-----RALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 370 ~~~~~~------------~~-~~~~~~-----~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
...... .. ...... .....+..++.+||+.||++|||+.|++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000000 00 000000 011234455668999999999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=325.72 Aligned_cols=259 Identities=27% Similarity=0.388 Sum_probs=176.3
Q ss_pred HhcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc-hhhHHHHHHHHH-HHcCCCCCCcceEeeEEEECcEEEEE
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV-GQAEKEFRVEVE-AIGHVRHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lV 215 (463)
..++|++.+.||+|+||.||+|... +|+.||||++.... ......+..|+. +++.++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 3578999999999999999999764 68899999986543 233345555665 77788999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 216 YEYVNNGNLEQWLHGAMR-HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
|||+.+ +|.+++..... ....+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||++...
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 999975 88888764322 2567999999999999999999999842 8999999999999999999999999999866
Q ss_pred CCCCceeeccccccCCCCchhhh----ccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 295 GAGKSHVTTRVMGTFGYVAPEYA----NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
.... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||....... +.+...... ...
T Consensus 177 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~-~~~ 248 (327)
T 3aln_A 177 VDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQLTQVVKG-DPP 248 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCCCS-CCC
T ss_pred cccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HHHHHHhcC-CCC
Confidence 4332 12334689999999998 46678999999999999999999999997533210 000000000 000
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.+.. ........ .+..++.+||+.||++|||+.|++++
T Consensus 249 ~~~~--~~~~~~~~---~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 249 QLSN--SEEREFSP---SFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCC--CSSCCCCH---HHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCC--cccccCCH---HHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 0000 00011122 33445567999999999999999763
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=325.19 Aligned_cols=262 Identities=24% Similarity=0.318 Sum_probs=195.4
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC-----cEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG-----IHR 212 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 212 (463)
.++|++.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999764 58899999985433 33456778899999999999999999998754 678
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccce
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~ 292 (463)
++||||+. ++|.+++.. ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999997 599998853 3589999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCce---------eeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 012462 293 LLGAGKSH---------VTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKM 362 (463)
Q Consensus 293 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 362 (463)
........ .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ....+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~ 237 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH---QLLLIFG 237 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHH
Confidence 76532211 1223578999999998764 678999999999999999999999998643211 1111111
Q ss_pred HhcCCCcccccc------------CCCCC-CCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 363 MVGSRRSEEVVD------------PNIEV-RPST-----RALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 363 ~~~~~~~~~~~~------------~~~~~-~~~~-----~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
............ ..... .... .....+..++.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 111110000000 00000 0000 011233455668999999999999999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=326.23 Aligned_cols=264 Identities=20% Similarity=0.248 Sum_probs=195.9
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCC-----------CCCcceEeeEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR-----------HKNLVRLLGYCI 207 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~ 207 (463)
.++|++.+.||+|+||+||+|.. .+++.||||++... ......+..|+.++.++. ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46899999999999999999965 56889999998643 334466778888888775 899999999998
Q ss_pred ECc----EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEc-----
Q 012462 208 EGI----HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILID----- 278 (463)
Q Consensus 208 ~~~----~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~----- 278 (463)
... ..++||||+ +++|.+++... ....+++..++.++.||+.||.|||+++ +|+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCC
Confidence 654 789999999 88999999753 2345999999999999999999999943 899999999999994
Q ss_pred -CCCCEEEeecccceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHH
Q 012462 279 -DDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLV 357 (463)
Q Consensus 279 -~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~ 357 (463)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||............
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 4458999999999876432 23457899999999999999999999999999999999999999865432221111
Q ss_pred HHHHHH---hcCCCc---------cccccC--------CC-----------CCCCCHHHHHHHHHHHhhccCCCCCCCCC
Q 012462 358 DWLKMM---VGSRRS---------EEVVDP--------NI-----------EVRPSTRALKRSLLTALRCVDPDSEKRPK 406 (463)
Q Consensus 358 ~~~~~~---~~~~~~---------~~~~~~--------~~-----------~~~~~~~~~~~~~~~~~~cl~~dP~~RPs 406 (463)
..+..+ ...... ....+. .. ...........+..++.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 111111 110000 000000 00 00112333455566777999999999999
Q ss_pred HHHHHHH
Q 012462 407 MSQVVRM 413 (463)
Q Consensus 407 ~~ell~~ 413 (463)
+.|++++
T Consensus 328 ~~ell~h 334 (373)
T 1q8y_A 328 AGGLVNH 334 (373)
T ss_dssp HHHHHTC
T ss_pred HHHHhhC
Confidence 9999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=331.54 Aligned_cols=247 Identities=25% Similarity=0.389 Sum_probs=195.0
Q ss_pred HHHHHHhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchh------hHHHHHHHHHHHcCCC--CCCcceEee
Q 012462 134 RDLELATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQ------AEKEFRVEVEAIGHVR--HKNLVRLLG 204 (463)
Q Consensus 134 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~l~~ 204 (463)
.+.+...++|++.+.||+|+||.||+|.. .+++.||||.+...... ....+..|+.++++++ ||||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 34455678899999999999999999965 56889999998543211 2234566888888885 699999999
Q ss_pred EEEECcEEEEEEeecCC-CCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEc-CCCC
Q 012462 205 YCIEGIHRMLVYEYVNN-GNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILID-DDFN 282 (463)
Q Consensus 205 ~~~~~~~~~lV~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~-~~~~ 282 (463)
++.+.+..++|||++.+ ++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++ +++.
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~ 188 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGE 188 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTE
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCC
Confidence 99999999999999976 899999864 34589999999999999999999999 999999999999999 7899
Q ss_pred EEEeecccceecCCCCceeeccccccCCCCchhhhccCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHH
Q 012462 283 AKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL-NEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLK 361 (463)
Q Consensus 283 ~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~ 361 (463)
+||+|||++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... .
T Consensus 189 ~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------~--- 254 (320)
T 3a99_A 189 LKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------E--- 254 (320)
T ss_dssp EEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------H---
T ss_pred EEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------h---
Confidence 9999999998765432 334578999999999987766 688999999999999999999996421 0
Q ss_pred HHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 362 MMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
...... ... ..... .+..++.+||+.||++|||+.|++++
T Consensus 255 -~~~~~~---~~~-----~~~~~---~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 255 -IIRGQV---FFR-----QRVSS---ECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp -HHHCCC---CCS-----SCCCH---HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -hhcccc---ccc-----ccCCH---HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011100 000 11112 23445668999999999999999885
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=317.11 Aligned_cols=252 Identities=24% Similarity=0.333 Sum_probs=177.4
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccch-hh-HHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVG-QA-EKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
.++|++.+.||+|+||.||+|... +|+.||||++..... .. ...+..+..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467899999999999999999764 689999999865432 22 233444556788889999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE-AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
||+ ++.+..+... ....+++..++.++.||+.||.|||+ . +|+|+||||+|||++.++.+||+|||++....
T Consensus 104 e~~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 5566655532 23568999999999999999999998 6 89999999999999999999999999997654
Q ss_pred CCCceeeccccccCCCCchhhhc-----cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 296 AGKSHVTTRVMGTFGYVAPEYAN-----TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 296 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
... ......+|+.|+|||++. ...++.++|||||||++|||++|+.||...... ...+..........
T Consensus 177 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~ 249 (318)
T 2dyl_A 177 DDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQEEPPL 249 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHHSCCCC
T ss_pred CCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhccCCCC
Confidence 332 223456899999999984 567889999999999999999999999753321 12222222221111
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.. . ...... .+..++.+||+.||.+||++.|++++
T Consensus 250 -~~-~---~~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 250 -LP-G---HMGFSG---DFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp -CC-S---SSCCCH---HHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -CC-c---cCCCCH---HHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00 0 011122 23344568999999999999999863
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=336.07 Aligned_cols=252 Identities=25% Similarity=0.371 Sum_probs=185.8
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEEEEEE
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 216 (463)
+...+|.+.+.||+|+||+||.....+++.||||++..... ..+.+|+.+++++ +||||+++++++.+....|+||
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 34567888999999999997766667899999999855332 2245689999988 7999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC-----CCCEEEeecccc
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD-----DFNAKVSDFGLA 291 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~-----~~~~kl~Dfg~a 291 (463)
||+. |+|.+++... ...+.+..++.++.||+.||.|||+. +|+||||||+|||++. ...+||+|||++
T Consensus 98 E~~~-g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 98 ELCA-ATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp ECCS-EEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred ECCC-CCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 9996 5999998643 23345556778999999999999999 9999999999999953 336889999999
Q ss_pred eecCCCCc--eeeccccccCCCCchhhhc---cCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhc
Q 012462 292 KLLGAGKS--HVTTRVMGTFGYVAPEYAN---TGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVG 365 (463)
Q Consensus 292 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 365 (463)
+....... ......+||+.|+|||++. ...++.++|||||||++|||++ |..||...... .......
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-------~~~~~~~ 243 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-------QANILLG 243 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-------HHHHHTT
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-------HHHHHhc
Confidence 87654321 2234567999999999997 4567889999999999999999 99999643221 1111111
Q ss_pred CCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 366 SRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.... .. ..+..........++.+||+.||.+|||+.|++++
T Consensus 244 ~~~~-~~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 244 ACSL-DC------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp CCCC-TT------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cCCc-cc------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 1111 10 11111222334456668999999999999999853
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=324.51 Aligned_cols=196 Identities=28% Similarity=0.392 Sum_probs=165.9
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcE-----
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIH----- 211 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 211 (463)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 36799999999999999999965 468899999985532 2334678889999999999999999999987654
Q ss_pred -EEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccc
Q 012462 212 -RMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGL 290 (463)
Q Consensus 212 -~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~ 290 (463)
.++||||+. ++|.+++. ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999997 58877652 2489999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 291 AKLLGAGKSHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 291 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
+...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 173 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 228 (353)
T 3coi_A 173 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228 (353)
T ss_dssp TTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred ccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9765432 234578999999999877 678999999999999999999999997644
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=345.04 Aligned_cols=239 Identities=23% Similarity=0.338 Sum_probs=190.4
Q ss_pred HhcCCCccCeEeecCcEEEEEEEEc--CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcE----
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNLI--NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIH---- 211 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---- 211 (463)
..++|++.+.||+|+||+||+|.+. +++.||||++.... ......+..|+.++.+++||||++++++|...+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 3578999999999999999999775 58899999885433 3445678899999999999999999999987655
Q ss_pred -EEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccc
Q 012462 212 -RMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGL 290 (463)
Q Consensus 212 -~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~ 290 (463)
.|+||||+++++|.+++.. .+++..++.++.||+.||.|||++ +|+||||||+|||++.+ .+||+|||+
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred eeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEeccc
Confidence 6999999999999887632 599999999999999999999999 99999999999999986 999999999
Q ss_pred ceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 291 AKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 291 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
++..... ....||+.|+|||++.+.. +.++|||||||+||+|++|..||........
T Consensus 228 a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------------- 284 (681)
T 2pzi_A 228 VSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------------- 284 (681)
T ss_dssp CEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC-----------------
T ss_pred chhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc-----------------
Confidence 9876543 3457999999999987764 8899999999999999999988864211100
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHHHhc
Q 012462 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPK-MSQVVRMLES 416 (463)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs-~~ell~~L~~ 416 (463)
....+.......+..++.+||+.||++||+ ++++...|..
T Consensus 285 ------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 285 ------PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ------CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ------cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 000111111233445666899999999995 6666666654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=341.92 Aligned_cols=202 Identities=29% Similarity=0.447 Sum_probs=173.3
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEccc-chhhHHHHHHHHHHHcCCCCCCcceEeeEEEE------CcEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNN-VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE------GIHR 212 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~~ 212 (463)
++|++.+.||+|+||+||+|.. .+|+.||||++... .......+.+|+.++.+++||||+++++++.. ++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6899999999999999999965 46899999988654 33445678899999999999999999998765 6677
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCC---EEEeecc
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFN---AKVSDFG 289 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~---~kl~Dfg 289 (463)
++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++. +||+|||
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 99999999999999997532 233588999999999999999999999 9999999999999997765 9999999
Q ss_pred cceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCC
Q 012462 290 LAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348 (463)
Q Consensus 290 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~ 348 (463)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~ 226 (676)
T 3qa8_A 170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226 (676)
T ss_dssp CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcc
Confidence 998765432 234467999999999999999999999999999999999999999754
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=301.29 Aligned_cols=233 Identities=14% Similarity=0.103 Sum_probs=179.8
Q ss_pred HhcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEE
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 214 (463)
..++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++.+++||||+++++++.+.+..|+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 3478999999999999999999764 48899999986543 2334678889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
||||+++++|.+++.. + .....+..++.||+.||.|||++ +|+||||||+|||++.++.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-----
Confidence 9999999999999842 1 35567889999999999999999 99999999999999999999998543
Q ss_pred CCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccccc
Q 012462 295 GAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVD 374 (463)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (463)
|++ .++.++|||||||++|||++|+.||............ . .........
T Consensus 175 ----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~------~-~~~~~~~~~ 224 (286)
T 3uqc_A 175 ----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA------E-RDTAGQPIE 224 (286)
T ss_dssp ----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC------C-BCTTSCBCC
T ss_pred ----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH------H-HHhccCCCC
Confidence 333 3688999999999999999999999875543211000 0 000000000
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCC
Q 012462 375 PNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEY 419 (463)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~ 419 (463)
+........ ..+..++.+||+.||++| |+.|+++.|+....
T Consensus 225 ~~~~~~~~~---~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 225 PADIDRDIP---FQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp HHHHCTTSC---HHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred hhhcccCCC---HHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 000000111 223445668999999999 99999999988643
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=302.78 Aligned_cols=229 Identities=19% Similarity=0.265 Sum_probs=173.4
Q ss_pred cCCCcc-CeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHH-cCCCCCCcceEeeEEEE----CcEEE
Q 012462 141 NRFSKE-NVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAI-GHVRHKNLVRLLGYCIE----GIHRM 213 (463)
Q Consensus 141 ~~~~~~-~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~~ 213 (463)
++|.+. +.||+|+||.||+|.. .+++.||+|++... ..+.+|+.++ +.++||||+++++++.+ ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 457666 7899999999999965 56889999998542 3455677776 55699999999999987 67789
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC---CCCEEEeeccc
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD---DFNAKVSDFGL 290 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~---~~~~kl~Dfg~ 290 (463)
+||||+++|+|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+
T Consensus 92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 999999999999999752 334699999999999999999999999 9999999999999998 78999999999
Q ss_pred ceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 291 AKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 291 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
+.... +..++.++|||||||++|||++|+.||......... .....
T Consensus 167 a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~~~ 212 (299)
T 3m2w_A 167 AKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMKT 212 (299)
T ss_dssp CEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCC
T ss_pred ccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHHHH
Confidence 87542 134678999999999999999999999754321100 00001
Q ss_pred ccccCCCCCCCC--HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 371 EVVDPNIEVRPS--TRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 371 ~~~~~~~~~~~~--~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
............ ......+..++.+||+.||++|||+.|++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 213 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 111111111100 0012234445668999999999999999974
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=321.48 Aligned_cols=242 Identities=18% Similarity=0.205 Sum_probs=177.4
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccch---hhHHHHHHHHHHHcCCCC-CCcc---------e-----
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVG---QAEKEFRVEVEAIGHVRH-KNLV---------R----- 201 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h-~niv---------~----- 201 (463)
..|...+.||+|+||+||+|.+ .+|+.||||++..... ...+.+.+|+.++..+.| +|.. .
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 4577788999999999999974 5689999998863322 234678899999999877 3211 1
Q ss_pred -------EeeEEEE-----CcEEEEEEeecCCCCHHHHHhhh---hcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 012462 202 -------LLGYCIE-----GIHRMLVYEYVNNGNLEQWLHGA---MRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVV 266 (463)
Q Consensus 202 -------l~~~~~~-----~~~~~lV~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~ 266 (463)
+..++.. ....+++|+++ +++|.+++... ......+++..++.++.||+.||+|||++ +|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 1111111 12346777776 67999988532 12234578889999999999999999999 999
Q ss_pred EccCCCCceeEcCCCCEEEeecccceecCCCCceeeccccccCCCCchhhh----------ccCCCCccchhhhHHHHHH
Q 012462 267 HRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA----------NTGLLNEKSDVYSFGVLLL 336 (463)
Q Consensus 267 H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDvwSlGvvl~ 336 (463)
||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||+||
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999999875432 445678 999999999 5556888999999999999
Q ss_pred HHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 012462 337 EAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412 (463)
Q Consensus 337 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~ 412 (463)
||++|+.||......... ...+...... . ..+..++.+||+.||++||++.|+++
T Consensus 309 elltg~~Pf~~~~~~~~~---------------~~~~~~~~~~---~---~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGGS---------------EWIFRSCKNI---P---QPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHSSCCCCTTGGGSCS---------------GGGGSSCCCC---C---HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCCCCcchhhhH---------------HHHHhhcccC---C---HHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999999764432211 1111111111 1 23444566899999999999888764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=312.04 Aligned_cols=193 Identities=18% Similarity=0.206 Sum_probs=160.2
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccc--------hhhHHHHHHHHHHHcCCC---------CCCcc
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNV--------GQAEKEFRVEVEAIGHVR---------HKNLV 200 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~niv 200 (463)
+..++|++.+.||+|+||+||+|.. +|+.||||++.... ....+.+.+|+.+++.++ ||||+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 3456789999999999999999987 78999999985432 223366777888877774 88888
Q ss_pred eEeeEEE------------------------------ECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHH
Q 012462 201 RLLGYCI------------------------------EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT 250 (463)
Q Consensus 201 ~l~~~~~------------------------------~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i 250 (463)
++.+++. +....|+||||+++|++.+.+. ...+++..++.++.||
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi 170 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQL 170 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHH
Confidence 8777653 2678899999999997666552 2458999999999999
Q ss_pred HHHHHHHH-hcCCCCeEEccCCCCceeEcCCC--------------------CEEEeecccceecCCCCceeeccccccC
Q 012462 251 AKALAYLH-EAIEPKVVHRDIKSSNILIDDDF--------------------NAKVSDFGLAKLLGAGKSHVTTRVMGTF 309 (463)
Q Consensus 251 ~~~l~~LH-~~~~~~i~H~Dikp~Nill~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~ 309 (463)
+.||.||| +. +|+||||||+|||++.++ .+||+|||+++..... ..+||+
T Consensus 171 ~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~ 241 (336)
T 2vuw_A 171 TASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCD 241 (336)
T ss_dssp HHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCC
T ss_pred HHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEee
Confidence 99999999 89 999999999999999887 8999999999876432 347899
Q ss_pred CCCchhhhccCCCCccchhhhHHHH-HHHHHhCCCCCC
Q 012462 310 GYVAPEYANTGLLNEKSDVYSFGVL-LLEAITGRDPVD 346 (463)
Q Consensus 310 ~y~aPE~~~~~~~~~~sDvwSlGvv-l~elltg~~pf~ 346 (463)
.|+|||++.+.. +.++||||||++ .+++++|..||.
T Consensus 242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 999999998776 899999998777 777888998884
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-32 Score=283.68 Aligned_cols=185 Identities=17% Similarity=0.095 Sum_probs=131.3
Q ss_pred eEeecCcEEEEEE-EEcCCCeEEEEEEcccc----------hhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEEEEE
Q 012462 148 VLGEGGYGVVYRG-NLINGSPVAVKKILNNV----------GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 148 ~lG~G~~g~V~~~-~~~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV 215 (463)
..+.|++|.+..+ +..-|+.+++|.+.... ....++|.+|+++|+++ .|+||++++++++++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 3567777777665 44568999999985431 12335789999999999 799999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
|||++|++|.++|.. .+.++.. .|+.||+.||+|||++ ||+||||||+|||++.+|++||+|||+|+...
T Consensus 321 MEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 999999999999953 4557654 4789999999999999 99999999999999999999999999998765
Q ss_pred CCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCC
Q 012462 296 AGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344 (463)
Q Consensus 296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p 344 (463)
... ......+||+.|||||++.+. +..++|+||+|++++++.++..+
T Consensus 391 ~~~-~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 391 QDC-SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCC-ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 432 234457899999999999764 56789999999998887665444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.1e-29 Score=256.08 Aligned_cols=185 Identities=16% Similarity=0.220 Sum_probs=147.1
Q ss_pred CccCeEeecCcEEEEEEEEcCCCeEEEEEEcccch--------hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEE
Q 012462 144 SKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVG--------QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 144 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 215 (463)
...++||+|+||+||+|.. .+..+++|+...... ...+.+.+|++++++++||||+++..++...+..|+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3456899999999999954 678999998743221 1234578999999999999999777777777888999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
|||+++++|.+++.. ++.++.|++.||.|||++ +|+||||||+|||++. .+||+|||+++...
T Consensus 418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 999999999999853 568999999999999999 9999999999999999 99999999999875
Q ss_pred CCCcee------eccccccCCCCchhhhcc--CCCCccchhhhHHHHHHHHHhCCCCCC
Q 012462 296 AGKSHV------TTRVMGTFGYVAPEYANT--GLLNEKSDVYSFGVLLLEAITGRDPVD 346 (463)
Q Consensus 296 ~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~pf~ 346 (463)
...... ....+||+.|||||++.. ..|+..+|+|+..+-..+-+.++.+|.
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 432211 235689999999999977 568889999999999998888776663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.8e-25 Score=208.53 Aligned_cols=153 Identities=16% Similarity=0.095 Sum_probs=121.9
Q ss_pred HHHHHHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccch------------------hhHHHHHHHHHHHcCCC
Q 012462 134 RDLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVG------------------QAEKEFRVEVEAIGHVR 195 (463)
Q Consensus 134 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~ 195 (463)
..+......|.+.+.||+|+||.||+|.+.+|+.||+|.+..... .....+.+|+.++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 334444566778899999999999999887789999999853221 13456889999999998
Q ss_pred CCCcceEeeEEEECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCce
Q 012462 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNI 275 (463)
Q Consensus 196 h~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Ni 275 (463)
| +++.+++.. +..|+||||+++++|.+ +. . .....++.|++.||.|||+. +|+||||||+||
T Consensus 163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~--------~--~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NI 224 (282)
T 1zar_A 163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR--------V--ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNV 224 (282)
T ss_dssp --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC--------C--SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSE
T ss_pred --C-CCcCeEEec-cceEEEEEecCCCcHHH-cc--------h--hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHE
Confidence 5 666665544 45699999999999987 31 1 23457999999999999999 999999999999
Q ss_pred eEcCCCCEEEeecccceecCCCCceeeccccccCCCCchhhhcc
Q 012462 276 LIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANT 319 (463)
Q Consensus 276 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 319 (463)
|++ ++.+||+|||+++. +..++|||++..
T Consensus 225 Ll~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp EEE-TTEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred EEE-CCcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence 999 99999999999863 334789998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=7.5e-21 Score=177.51 Aligned_cols=137 Identities=20% Similarity=0.237 Sum_probs=106.4
Q ss_pred CCCccCeEeecCcEEEEEEEE-cCCCe--EEEEEEcccch------------------------hhHHHHHHHHHHHcCC
Q 012462 142 RFSKENVLGEGGYGVVYRGNL-INGSP--VAVKKILNNVG------------------------QAEKEFRVEVEAIGHV 194 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~-~~~~~--vavK~~~~~~~------------------------~~~~~~~~e~~~l~~l 194 (463)
-|++.+.||+|+||.||+|.. .+|+. ||||++..... .....+.+|+..+.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367788999999999999977 67888 99998643211 1123577899999999
Q ss_pred CCCCc--ceEeeEEEECcEEEEEEeecCC-C----CHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeE
Q 012462 195 RHKNL--VRLLGYCIEGIHRMLVYEYVNN-G----NLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH-EAIEPKVV 266 (463)
Q Consensus 195 ~h~ni--v~l~~~~~~~~~~~lV~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH-~~~~~~i~ 266 (463)
.|+++ +.++++ ...++||||+.+ | +|.++... .++..+..++.|++.||.||| +. +|+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---giv 193 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELV 193 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEE
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEE
Confidence 88754 344432 345899999942 3 77776432 224567789999999999999 88 999
Q ss_pred EccCCCCceeEcCCCCEEEeecccceec
Q 012462 267 HRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 267 H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
||||||+|||++. .++|+|||++...
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999998 9999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=9.7e-18 Score=162.89 Aligned_cols=140 Identities=12% Similarity=0.063 Sum_probs=100.2
Q ss_pred cCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccch--------------hhHH--------HHHHHHHHHcCCCCCC
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVG--------------QAEK--------EFRVEVEAIGHVRHKN 198 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~e~~~l~~l~h~n 198 (463)
.-|++.+.||+|+||.||+|...+|+.||||++..... .... ....|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34899999999999999999888999999998642110 0001 1234566666665444
Q ss_pred cceEeeEEEECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEc
Q 012462 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILID 278 (463)
Q Consensus 199 iv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~ 278 (463)
+....-+... ..+|||||++|++|..+. .......++.||+.+|.|||.. +||||||||.|||++
T Consensus 175 v~vp~p~~~~--~~~LVME~i~G~~L~~l~----------~~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 175 FPVPEPIAQS--RHTIVMSLVDALPMRQVS----------SVPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIR 239 (397)
T ss_dssp CSCCCEEEEE--TTEEEEECCSCEEGGGCC----------CCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE
T ss_pred CCCCeeeecc--CceEEEEecCCccHhhhc----------ccHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEe
Confidence 3222222222 237999999998875432 1123456889999999999999 999999999999998
Q ss_pred CCCC----------EEEeecccceecC
Q 012462 279 DDFN----------AKVSDFGLAKLLG 295 (463)
Q Consensus 279 ~~~~----------~kl~Dfg~a~~~~ 295 (463)
+++. +.|+||+-+....
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCCCcccccccccceEEEEeCCcccCC
Confidence 8773 8999999876543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=5.8e-13 Score=124.14 Aligned_cols=142 Identities=13% Similarity=0.068 Sum_probs=110.5
Q ss_pred cCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCC-CCCcceEeeEEEECcEEEEEEeec
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGIHRMLVYEYV 219 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~ 219 (463)
..|.+...++.|+++.||++.. +++.+++|............+.+|+.+++.+. +..+.++++++.+.+..|+||||+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i 92 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred ccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence 4688888888899999999975 47899999875432222345777888888773 677889999999998999999999
Q ss_pred CCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 012462 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI-------------------------------------- 261 (463)
Q Consensus 220 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-------------------------------------- 261 (463)
+|.+|.+.+. +......++.+++.+|..||+..
T Consensus 93 ~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 93 DGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp SSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred CCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 9999887531 11223468889999999999810
Q ss_pred ------------------CCCeEEccCCCCceeEcCCCCEEEeecccce
Q 012462 262 ------------------EPKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292 (463)
Q Consensus 262 ------------------~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~ 292 (463)
.+.++|+|++|.|||++++..+.|+||+.+.
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999876666799999775
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.21 E-value=1.2e-11 Score=114.78 Aligned_cols=129 Identities=20% Similarity=0.157 Sum_probs=93.7
Q ss_pred eecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCC--cceEeeEEEECcEEEEEEeecCCCCHHHH
Q 012462 150 GEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKN--LVRLLGYCIEGIHRMLVYEYVNNGNLEQW 227 (463)
Q Consensus 150 G~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~e~~~~g~L~~~ 227 (463)
+.|..+.||++...+|..+++|..... ....+..|+.+++.+.+.+ +.++++++.+++..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 355569999997767788999987543 2244667888877774434 566888888877889999999998773
Q ss_pred HhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------------
Q 012462 228 LHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI---------------------------------------------- 261 (463)
Q Consensus 228 l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------------- 261 (463)
.. . .. ...++.+++..|..||...
T Consensus 104 ~~----~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (264)
T 1nd4_A 104 SS----H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 173 (264)
T ss_dssp TS----C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred cC----c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence 11 0 11 1256677777777777641
Q ss_pred ---------CCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 262 ---------EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 262 ---------~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
.+.++|+|++|.||++++++.+.|+||+.+..
T Consensus 174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11399999999999998876677999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.08 E-value=8.4e-11 Score=111.93 Aligned_cols=183 Identities=17% Similarity=0.194 Sum_probs=121.3
Q ss_pred cCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCC-CCCC--cceEeeEEEECc---EEEEEEeec
Q 012462 146 ENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV-RHKN--LVRLLGYCIEGI---HRMLVYEYV 219 (463)
Q Consensus 146 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~n--iv~l~~~~~~~~---~~~lV~e~~ 219 (463)
.+.++.|....||+.. ..+++|..... .....+..|..+++.+ .+.. +..++....... ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4579999999999863 56888975432 3456788899888776 3332 344554443332 348999999
Q ss_pred CCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------
Q 012462 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA--------------------------------------- 260 (463)
Q Consensus 220 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~--------------------------------------- 260 (463)
+|.+|.+... ..++..++..++.+++..|..||+.
T Consensus 99 ~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 99 KGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 9988765321 1267777788888888888888861
Q ss_pred ----------------CCCCeEEccCCCCceeEcC--CCCEEEeecccceecCCCCceeeccccccCCC---Cchhhhcc
Q 012462 261 ----------------IEPKVVHRDIKSSNILIDD--DFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGY---VAPEYANT 319 (463)
Q Consensus 261 ----------------~~~~i~H~Dikp~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y---~aPE~~~~ 319 (463)
..+.++|+|++|.||++++ +..+.|+||+.+....... . ......+ ..|+....
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-D----l~~~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-D----FISLMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-H----HHTTCCTTTSCCHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-H----HHHHHhhccccCHHHHHH
Confidence 1235899999999999998 5567899999987643211 0 0001111 23332211
Q ss_pred -----CCC---------CccchhhhHHHHHHHHHhCCCCC
Q 012462 320 -----GLL---------NEKSDVYSFGVLLLEAITGRDPV 345 (463)
Q Consensus 320 -----~~~---------~~~sDvwSlGvvl~elltg~~pf 345 (463)
+.. ....+.|++|.++|.+.+|..+|
T Consensus 248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 12368999999999999998765
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.07 E-value=1.3e-10 Score=113.28 Aligned_cols=143 Identities=13% Similarity=0.152 Sum_probs=105.0
Q ss_pred ccCeEeecCcEEEEEEEEcCCCeEEEEEEc--ccc-hhhHHHHHHHHHHHcCCC--CCCcceEeeEEEEC---cEEEEEE
Q 012462 145 KENVLGEGGYGVVYRGNLINGSPVAVKKIL--NNV-GQAEKEFRVEVEAIGHVR--HKNLVRLLGYCIEG---IHRMLVY 216 (463)
Q Consensus 145 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lV~ 216 (463)
..+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.+. +..+++++.++.+. +..|+||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3567899999999999764 5678888764 221 122346777888888775 45678899988776 3479999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI----------------------------------- 261 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----------------------------------- 261 (463)
||++|..+.+. ....++......++.+++..|..||...
T Consensus 121 e~v~G~~l~~~------~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 121 EFVSGRVLWDQ------SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp ECCCCBCCCCT------TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EecCCeecCCC------ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 99998776431 1223678888899999999999999731
Q ss_pred --------------------CCCeEEccCCCCceeEcCCCC--EEEeecccceec
Q 012462 262 --------------------EPKVVHRDIKSSNILIDDDFN--AKVSDFGLAKLL 294 (463)
Q Consensus 262 --------------------~~~i~H~Dikp~Nill~~~~~--~kl~Dfg~a~~~ 294 (463)
.+.++|||+++.|||++.++. +.|+||+.+...
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 247999999999999997753 689999998753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.58 E-value=3.1e-07 Score=85.37 Aligned_cols=135 Identities=16% Similarity=0.118 Sum_probs=95.5
Q ss_pred eEeecCcE-EEEEEEEc-CCCeEEEEEEcccchhhHHHHHHHHHHHcCCC-CCCcceEeeEEEECcEEEEEEeecCCCCH
Q 012462 148 VLGEGGYG-VVYRGNLI-NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGIHRMLVYEYVNNGNL 224 (463)
Q Consensus 148 ~lG~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~g~L 224 (463)
.+..|..+ .||+.... ++..+++|+-.. ....++..|...|+.+. +--+.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45555555 68987554 456788997532 23456777888877663 33477889999999999999999999888
Q ss_pred HHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 012462 225 EQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI------------------------------------------- 261 (463)
Q Consensus 225 ~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------------------------------------------- 261 (463)
.+..... ......++.+++..|..||...
T Consensus 108 ~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 108 FQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred cccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 7764321 1223345666667777777530
Q ss_pred ------------CCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 262 ------------EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 262 ------------~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
.+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12379999999999999887778999998754
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.54 E-value=7e-07 Score=84.75 Aligned_cols=137 Identities=18% Similarity=0.143 Sum_probs=93.0
Q ss_pred cCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCC---CcceEeeEEE-ECcEEEEEEeecCC
Q 012462 146 ENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHK---NLVRLLGYCI-EGIHRMLVYEYVNN 221 (463)
Q Consensus 146 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lV~e~~~~ 221 (463)
.+.++.|....||+. |..+++|+.. .......+..|..++..+.+. .+.+.+.++. ..+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356889999999987 5778888742 223456788899999888642 3556666664 34456899999999
Q ss_pred CCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 012462 222 GNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA----------------------------------------- 260 (463)
Q Consensus 222 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~----------------------------------------- 260 (463)
.+|.+... ..++......++.+++..|..||+.
T Consensus 98 ~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 98 QILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp EECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred eECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 88765321 0133444444555555555555432
Q ss_pred ----------------CCCCeEEccCCCCceeEcC---CCCE-EEeecccceec
Q 012462 261 ----------------IEPKVVHRDIKSSNILIDD---DFNA-KVSDFGLAKLL 294 (463)
Q Consensus 261 ----------------~~~~i~H~Dikp~Nill~~---~~~~-kl~Dfg~a~~~ 294 (463)
..+.++|+|+++.||+++. ++.+ .|+||+.+...
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2335799999999999987 4554 89999988653
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.16 E-value=3.3e-06 Score=81.83 Aligned_cols=78 Identities=10% Similarity=-0.048 Sum_probs=51.2
Q ss_pred CeE-eecCcEEEEEEEEc-------CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCC-C--CCcceEeeEEEEC---
Q 012462 147 NVL-GEGGYGVVYRGNLI-------NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVR-H--KNLVRLLGYCIEG--- 209 (463)
Q Consensus 147 ~~l-G~G~~g~V~~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~--- 209 (463)
+.| +.|....+|+.... ++..+++|...... ......+..|+.+++.+. + -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 88889999998654 26678888753322 001234566777776663 2 3467788877654
Q ss_pred cEEEEEEeecCCCCH
Q 012462 210 IHRMLVYEYVNNGNL 224 (463)
Q Consensus 210 ~~~~lV~e~~~~g~L 224 (463)
+..++|||+++|..+
T Consensus 106 g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 106 GTPFFLMDYVEGVVP 120 (357)
T ss_dssp SSCEEEEECCCCBCC
T ss_pred CCceEEEEecCCCCh
Confidence 346899999988654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.15 E-value=1.7e-05 Score=75.98 Aligned_cols=142 Identities=18% Similarity=0.257 Sum_probs=78.2
Q ss_pred CeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCC-----CCCCcceEe-e--EEEECcEEEEEEee
Q 012462 147 NVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV-----RHKNLVRLL-G--YCIEGIHRMLVYEY 218 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~-~--~~~~~~~~~lV~e~ 218 (463)
+.|+.|..+.||+....+| .+++|...... ..+..|..++..| ..|.++... | +....+..++||+|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3466677889999976544 58899875421 2223334433333 234444311 1 22346778999999
Q ss_pred cCCCCHH--------------HHHhhhhcCC----------CCCCHHHH-------------------------------
Q 012462 219 VNNGNLE--------------QWLHGAMRHH----------GYLTWEAR------------------------------- 243 (463)
Q Consensus 219 ~~~g~L~--------------~~l~~~~~~~----------~~~~~~~~------------------------------- 243 (463)
++|..+. .-++...... ....|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986431 1122211111 00122211
Q ss_pred HHHHHHHHHHHHHHHh----------cCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 244 MKVLLGTAKALAYLHE----------AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 244 ~~i~~~i~~~l~~LH~----------~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
..+...+..++.+|+. ...+.++|+|+++.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 1111223445666653 1234899999999999998888999999998753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.09 E-value=8.8e-06 Score=76.31 Aligned_cols=81 Identities=20% Similarity=0.346 Sum_probs=56.7
Q ss_pred HhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCC-C--CCcceEeeEEEECcEEEEE
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR-H--KNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~lV 215 (463)
......-.+.+|.|..+.||+.+..+|+.|++|+...........|..|...|+.|. . --+++++++ + ..++|
T Consensus 13 ~G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv 88 (288)
T 3f7w_A 13 TGREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLA 88 (288)
T ss_dssp HCCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEE
T ss_pred cCCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEE
Confidence 344555677899999999999999999999999765443333456777887777663 2 124455544 2 23789
Q ss_pred EeecCCCC
Q 012462 216 YEYVNNGN 223 (463)
Q Consensus 216 ~e~~~~g~ 223 (463)
|||++++.
T Consensus 89 ~e~l~~~~ 96 (288)
T 3f7w_A 89 MEWVDERP 96 (288)
T ss_dssp EECCCCCC
T ss_pred EEeecccC
Confidence 99988764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.01 E-value=1.1e-05 Score=79.36 Aligned_cols=75 Identities=13% Similarity=0.108 Sum_probs=47.1
Q ss_pred cCeEeecCcEEEEEEEEc-CCCeEEEEEEcccch-------hhHHHHHHHHHHHcCCCC--C-CcceEeeEEEECcEEEE
Q 012462 146 ENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVG-------QAEKEFRVEVEAIGHVRH--K-NLVRLLGYCIEGIHRML 214 (463)
Q Consensus 146 ~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~-niv~l~~~~~~~~~~~l 214 (463)
.+.||.|.++.||++... +++.++||....... .....+..|.+++..+.. + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457999999999999643 468899997643211 112345667777766531 3 34455543 4455689
Q ss_pred EEeecCCC
Q 012462 215 VYEYVNNG 222 (463)
Q Consensus 215 V~e~~~~g 222 (463)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.93 E-value=3.5e-05 Score=72.96 Aligned_cols=139 Identities=19% Similarity=0.189 Sum_probs=90.1
Q ss_pred cCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCC---CCCcceEeeEEEECcEEEEEEeecCCC
Q 012462 146 ENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR---HKNLVRLLGYCIEGIHRMLVYEYVNNG 222 (463)
Q Consensus 146 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lV~e~~~~g 222 (463)
.+.|+.|.+..+|+... ++..+++|..... ....+..|...|+.|. ...+++++.++...+..++|||++++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 45799999999999975 5778889976432 3556777888777763 356788888888788899999999987
Q ss_pred CHH--------H---HHhhhhc--CCC----------------CCCHHHHH---HHH----------------HHHHHHH
Q 012462 223 NLE--------Q---WLHGAMR--HHG----------------YLTWEARM---KVL----------------LGTAKAL 254 (463)
Q Consensus 223 ~L~--------~---~l~~~~~--~~~----------------~~~~~~~~---~i~----------------~~i~~~l 254 (463)
.+. . -|+.... ..+ .-+|.... ++. ..++..+
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 541 1 1232211 000 01343321 111 1111111
Q ss_pred -HHHHh-cCCCCeEEccCCCCceeEcCCCCEEEeecc
Q 012462 255 -AYLHE-AIEPKVVHRDIKSSNILIDDDFNAKVSDFG 289 (463)
Q Consensus 255 -~~LH~-~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg 289 (463)
..|.. ...+.++|+|+.+.|++++.++ +.|.||.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23321 1256899999999999999887 8899984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.72 E-value=8.2e-05 Score=73.69 Aligned_cols=77 Identities=13% Similarity=0.117 Sum_probs=48.7
Q ss_pred CCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCceeeccccc--cCCCCchhhhccC---CCCccchhhhHHHHHH
Q 012462 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMG--TFGYVAPEYANTG---LLNEKSDVYSFGVLLL 336 (463)
Q Consensus 262 ~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~sDvwSlGvvl~ 336 (463)
.+.++|||+++.|||++.++ ++|+||+.+..-...- ....... ...|++|+..... ......++..+...+|
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~--Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF--DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH--HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH--HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 34899999999999999876 9999999887643211 0011111 2346666654321 1122355668888888
Q ss_pred HHHhC
Q 012462 337 EAITG 341 (463)
Q Consensus 337 elltg 341 (463)
+.+++
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 88765
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.34 E-value=0.0023 Score=60.47 Aligned_cols=144 Identities=15% Similarity=0.140 Sum_probs=76.6
Q ss_pred CeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCC-----CCCcceEe-e--EEEECcEEEEEEee
Q 012462 147 NVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR-----HKNLVRLL-G--YCIEGIHRMLVYEY 218 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~-~--~~~~~~~~~lV~e~ 218 (463)
+.|+.|....+|+....+| .+++|...... ....+..|+.++..|. -|.++... | +....+..++++++
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 3466788899999977555 68889775421 1123444555554442 23333211 1 12234567899999
Q ss_pred cCCCCHH-----H---------HHhhhhcCCC-----CC---CHHHHHH------------HHHHHHHHHHHHHhc----
Q 012462 219 VNNGNLE-----Q---------WLHGAMRHHG-----YL---TWEARMK------------VLLGTAKALAYLHEA---- 260 (463)
Q Consensus 219 ~~~g~L~-----~---------~l~~~~~~~~-----~~---~~~~~~~------------i~~~i~~~l~~LH~~---- 260 (463)
++|..+. . -++....... .. .|..... +...+...+.+++..
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 9885421 1 1222111100 01 1221100 011244455666542
Q ss_pred CCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 261 ~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
....++|+|+.+.|||++++..+.|+||+.+..
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 134799999999999999876668999987753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00063 Score=63.91 Aligned_cols=140 Identities=13% Similarity=0.077 Sum_probs=72.8
Q ss_pred cCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCc-ceEeeEEEECcEEEEEEeec-CCCC
Q 012462 146 ENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNL-VRLLGYCIEGIHRMLVYEYV-NNGN 223 (463)
Q Consensus 146 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~-~~g~ 223 (463)
.+.|+.|....+|+. ..+++|+....... ......|+.+++.+...++ .++++++ .+.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 567999999999998 66888876432111 1112346555554422222 4555443 33457899999 6544
Q ss_pred HHH---------------H---HhhhhcC-CCCCC-HHHHHHHHH--------------HHHHHHHHH----Hh-cCCCC
Q 012462 224 LEQ---------------W---LHGAMRH-HGYLT-WEARMKVLL--------------GTAKALAYL----HE-AIEPK 264 (463)
Q Consensus 224 L~~---------------~---l~~~~~~-~~~~~-~~~~~~i~~--------------~i~~~l~~L----H~-~~~~~ 264 (463)
|.. . +|..... ...+. +..+..+.. .+...+..+ .. ...+.
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 321 0 1111000 00011 111111111 111111111 11 12335
Q ss_pred eEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 265 VVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 265 i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
++|+|+.+.||+ ..++.+.|+||..+...
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 899999999999 66678899999988653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0011 Score=63.24 Aligned_cols=34 Identities=35% Similarity=0.357 Sum_probs=28.7
Q ss_pred CCCeEEccCCCCceeEcCC----CCEEEeecccceecC
Q 012462 262 EPKVVHRDIKSSNILIDDD----FNAKVSDFGLAKLLG 295 (463)
Q Consensus 262 ~~~i~H~Dikp~Nill~~~----~~~kl~Dfg~a~~~~ 295 (463)
.+.++|||+.+.|||++.+ +.+.|+||+.+..-.
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 3479999999999999875 689999999887543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0014 Score=62.11 Aligned_cols=143 Identities=16% Similarity=0.110 Sum_probs=78.9
Q ss_pred CeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCC--CcceEeeE-----EEECcEEEEEEeec
Q 012462 147 NVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHK--NLVRLLGY-----CIEGIHRMLVYEYV 219 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~-----~~~~~~~~lV~e~~ 219 (463)
..|+ |....||+....+|+.+++|...... .....+..|..++..+... .+++++.. ....+..++||+++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3576 88889999876667789999875321 1234455566666555211 13333332 22355668899999
Q ss_pred CCCCH-----HHH---------HhhhhcC-----CCCCCHHHH----HHH---------------HHHHHHHHHHHHhc-
Q 012462 220 NNGNL-----EQW---------LHGAMRH-----HGYLTWEAR----MKV---------------LLGTAKALAYLHEA- 260 (463)
Q Consensus 220 ~~g~L-----~~~---------l~~~~~~-----~~~~~~~~~----~~i---------------~~~i~~~l~~LH~~- 260 (463)
+|..+ ..+ ++..... ....++... ..+ ...+...+..+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 87432 111 2211111 011222111 001 11111223333322
Q ss_pred ---CCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 261 ---IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 261 ---~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
....++|||+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 233689999999999999 4 899999988754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0051 Score=54.04 Aligned_cols=169 Identities=14% Similarity=0.057 Sum_probs=89.7
Q ss_pred CCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCcee
Q 012462 222 GNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV 301 (463)
Q Consensus 222 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 301 (463)
-+|.+.|..+ +.+++++++|.++.|.+.+|.-+-... .-...=+.|..|++..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc---------
Confidence 4899999753 567999999999999999987762211 111233456899999999988764 1111
Q ss_pred eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCC
Q 012462 302 TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRP 381 (463)
Q Consensus 302 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (463)
.....+.|||... ...+.+.=|||||++||..+--..|=..... --..+...+..|..........|.......
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~eE~e-LS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~ 171 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENEERE-LSPPLEQLIDHMANTVEADGSNDEGYEAAE 171 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTEEEC-CCHHHHHHHHHHTTCCC-------------
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcccchh-hCHHHHHHHHHHHhcccccccccccccccc
Confidence 1122466888753 3446788999999999998874433221100 011333334444333111111111111000
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCC
Q 012462 382 STRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEY 419 (463)
Q Consensus 382 ~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~ 419 (463)
..+.... . ...+..|+++++|++.-+....
T Consensus 172 eg~~d~~------~--~~~~~~~~sl~~Vi~~C~~hl~ 201 (229)
T 2yle_A 172 EGLGDED------E--KRKISAIRSYRDVMKLCAAHLP 201 (229)
T ss_dssp -------------C--CSCCCCCCSHHHHHHHHHTTSS
T ss_pred ccccccc------c--cccccCcCCHHHHHHHHHhhcc
Confidence 0000000 0 1356789999999998877654
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0013 Score=65.22 Aligned_cols=71 Identities=15% Similarity=0.186 Sum_probs=45.9
Q ss_pred cCeEeecCcEEEEEEEEcC--------CCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCc-ceEeeEEEECcEEEEEE
Q 012462 146 ENVLGEGGYGVVYRGNLIN--------GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNL-VRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 146 ~~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~ 216 (463)
.+.|+.|....+|+....+ +..+++|+.... .....+..|..++..|...++ .++++.+. + .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence 3568888899999997643 478888876331 111344467777776632233 56776553 2 3899
Q ss_pred eecCCC
Q 012462 217 EYVNNG 222 (463)
Q Consensus 217 e~~~~g 222 (463)
||++|.
T Consensus 152 e~l~G~ 157 (429)
T 1nw1_A 152 EYIPSR 157 (429)
T ss_dssp CCCCEE
T ss_pred EEeCCc
Confidence 999763
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0016 Score=63.26 Aligned_cols=142 Identities=16% Similarity=0.160 Sum_probs=79.9
Q ss_pred CeEeecCcEEEEEEEEc--------CCCeEEEEEEcccchhhHHHHHHHHHHHcCCC-CCCcceEeeEEEECcEEEEEEe
Q 012462 147 NVLGEGGYGVVYRGNLI--------NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e 217 (463)
+.|..|-...+|+.... ++..+++|+.-. .......+.+|..+++.|. +.-..++++.+.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 46777888899998764 246788887522 1123345567888777663 2223566666543 28999
Q ss_pred ecCCCCHHH-----------H------Hhhhhc-CCCCCC--HHHHHHHHHHHHH-------------------HHHHHH
Q 012462 218 YVNNGNLEQ-----------W------LHGAMR-HHGYLT--WEARMKVLLGTAK-------------------ALAYLH 258 (463)
Q Consensus 218 ~~~~g~L~~-----------~------l~~~~~-~~~~~~--~~~~~~i~~~i~~-------------------~l~~LH 258 (463)
|++|.+|.. + |+.... ...... +..+.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 998754421 1 111100 011122 3455555544322 233333
Q ss_pred hc-----CCCCeEEccCCCCceeEcCC----CCEEEeeccccee
Q 012462 259 EA-----IEPKVVHRDIKSSNILIDDD----FNAKVSDFGLAKL 293 (463)
Q Consensus 259 ~~-----~~~~i~H~Dikp~Nill~~~----~~~kl~Dfg~a~~ 293 (463)
.. ....++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 21 12368999999999999876 7899999988754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.58 E-value=0.018 Score=54.96 Aligned_cols=32 Identities=22% Similarity=0.369 Sum_probs=28.2
Q ss_pred CCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 263 ~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
..++|+|+.+.||++++++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 47999999999999998889999999877653
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0089 Score=59.52 Aligned_cols=73 Identities=7% Similarity=0.045 Sum_probs=43.5
Q ss_pred cCeEeecCcEEEEEEEEcC-CCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCc-ceEeeEEEECcEEEEEEeecCCCC
Q 012462 146 ENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNL-VRLLGYCIEGIHRMLVYEYVNNGN 223 (463)
Q Consensus 146 ~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~~~g~ 223 (463)
.+.|+.|-...+|+....+ +..+++|+........ -+...|..++..|...++ .++++.+. + .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3468888889999997754 4678888763322111 111357777776654334 56777662 2 35999998743
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.39 E-value=0.0026 Score=39.99 Aligned_cols=27 Identities=26% Similarity=0.407 Sum_probs=11.8
Q ss_pred HHHHHHHHHHHHHHHHHhhheeeeecc
Q 012462 22 VIGISVALFIIIILSVLSFCLTSRKKS 48 (463)
Q Consensus 22 ~ig~~~~~~~~~~l~i~~~~~~~r~~~ 48 (463)
..|++++++++++++++.++++|||+.
T Consensus 13 A~gVVgGv~~v~ii~~~~~~~~RRRr~ 39 (44)
T 2l2t_A 13 AAGVIGGLFILVIVGLTFAVYVRRKSI 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEeehHHHHHHHHHHHHHHHHhhhhhh
Confidence 334444444444444444444444433
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.35 E-value=0.0026 Score=61.50 Aligned_cols=72 Identities=13% Similarity=0.055 Sum_probs=39.9
Q ss_pred CeEeecCcEEEEEEEEcC---------CCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCC-cceEeeEEEECcEEEEEE
Q 012462 147 NVLGEGGYGVVYRGNLIN---------GSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKN-LVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~ 216 (463)
+.|+.|....+|+....+ +..+++|+....... ..+...|..++..+...+ ..++++.+ . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 467788888999997643 267888875432211 112345666666553223 44666544 2 26899
Q ss_pred eecCCCC
Q 012462 217 EYVNNGN 223 (463)
Q Consensus 217 e~~~~g~ 223 (463)
||++|..
T Consensus 114 e~i~G~~ 120 (369)
T 3c5i_A 114 EWLYGDP 120 (369)
T ss_dssp ECCCSEE
T ss_pred EEecCCc
Confidence 9998753
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=96.23 E-value=0.0033 Score=39.45 Aligned_cols=29 Identities=21% Similarity=0.437 Sum_probs=14.3
Q ss_pred hhHHHHHHHHHHHHHHHHHHhhheeeeec
Q 012462 19 VWEVIGISVALFIIIILSVLSFCLTSRKK 47 (463)
Q Consensus 19 ~~~~ig~~~~~~~~~~l~i~~~~~~~r~~ 47 (463)
...++++++++++++++++++++++|||+
T Consensus 11 ~~~Ia~~vVGvll~vi~~l~~~~~~RRR~ 39 (44)
T 2jwa_A 11 LTSIISAVVGILLVVVLGVVFGILIKRRQ 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred ccchHHHHHHHHHHHHHHHHHHhheehhh
Confidence 34455555555555555544444444443
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.07 E-value=0.0022 Score=40.41 Aligned_cols=27 Identities=15% Similarity=0.290 Sum_probs=11.7
Q ss_pred HHHHHHHHHHHHHHHHHhhheeeeecc
Q 012462 22 VIGISVALFIIIILSVLSFCLTSRKKS 48 (463)
Q Consensus 22 ~ig~~~~~~~~~~l~i~~~~~~~r~~~ 48 (463)
..|++++++++++++++.++++|||+.
T Consensus 14 A~gVVgGv~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 14 ATGMVGALLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp THHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred EeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence 344444444444444444444444433
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=95.43 E-value=0.013 Score=35.78 Aligned_cols=17 Identities=18% Similarity=0.393 Sum_probs=9.1
Q ss_pred ccchhhHHHHHHHHHHH
Q 012462 15 FGIKVWEVIGISVALFI 31 (463)
Q Consensus 15 ~~~~~~~~ig~~~~~~~ 31 (463)
.+...+.+.|++++.++
T Consensus 6 ~~ls~GaIAGiVvG~v~ 22 (38)
T 2k1k_A 6 RGLTGGEIVAVIFGLLL 22 (38)
T ss_dssp TTCCHHHHHHHHHHHHH
T ss_pred CCCCCCceeeeehHHHH
Confidence 34455555666665543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.07 E-value=0.028 Score=55.27 Aligned_cols=142 Identities=13% Similarity=0.158 Sum_probs=79.9
Q ss_pred cCeEeecCcEEEEEEEEcC--------CCeEEEEEEcccchhhHHHHHHHHHHHcCCC-CCCcceEeeEEEECcEEEEEE
Q 012462 146 ENVLGEGGYGVVYRGNLIN--------GSPVAVKKILNNVGQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 146 ~~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 216 (463)
.+.|..|-...+|+....+ +..+++++.-..... .-+..+|..+++.+. +.-..++++.+ .+ ++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEE
Confidence 3467778888999997643 578888875332211 112234666665553 22245566533 22 7899
Q ss_pred eecCCCCHH-----------HH------Hhhhhc---------CCCCCCHHHHHHHHHHH-------------------H
Q 012462 217 EYVNNGNLE-----------QW------LHGAMR---------HHGYLTWEARMKVLLGT-------------------A 251 (463)
Q Consensus 217 e~~~~g~L~-----------~~------l~~~~~---------~~~~~~~~~~~~i~~~i-------------------~ 251 (463)
||++|..|. .. |+.... ...+.-+..+.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 999886531 10 111111 11111244443333222 2
Q ss_pred HHHHHHHhc---------------------CCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 252 KALAYLHEA---------------------IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 252 ~~l~~LH~~---------------------~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
..+.+|... ....++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 233333311 1236899999999999 8888999999988764
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.74 E-value=0.1 Score=32.49 Aligned_cols=13 Identities=15% Similarity=0.368 Sum_probs=5.8
Q ss_pred hhHHHHHHHHHHH
Q 012462 19 VWEVIGISVALFI 31 (463)
Q Consensus 19 ~~~~ig~~~~~~~ 31 (463)
.++++++++++++
T Consensus 13 ~~I~~~vv~Gv~l 25 (41)
T 2k9y_A 13 LAVIGGVAVGVVL 25 (41)
T ss_dssp THHHHHHHHHHHH
T ss_pred EEEEeehhHHHHH
Confidence 3344444444444
|
| >2l8s_A Integrin alpha-1; transmembrane region, detergent micelle, CE adhesion; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.86 E-value=0.17 Score=33.20 Aligned_cols=25 Identities=16% Similarity=0.527 Sum_probs=15.9
Q ss_pred cchhhHHHHHHHHHHHHHHHHHHhh
Q 012462 16 GIKVWEVIGISVALFIIIILSVLSF 40 (463)
Q Consensus 16 ~~~~~~~ig~~~~~~~~~~l~i~~~ 40 (463)
++.+|++++.+++.+++++++++++
T Consensus 6 ~vp~WiIi~svl~GLLLL~Lii~~L 30 (54)
T 2l8s_A 6 RVPLWVILLSAFAGLLLLMLLILAL 30 (54)
T ss_dssp CCCTHHHHHHHHHHHHHHHHHHHHH
T ss_pred cCchHHHHHHHHHHHHHHHHHHHHH
Confidence 5678888877776665555544443
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=91.39 E-value=0.28 Score=42.87 Aligned_cols=123 Identities=11% Similarity=0.091 Sum_probs=82.3
Q ss_pred HHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 012462 187 EVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVV 266 (463)
Q Consensus 187 e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~ 266 (463)
|+.+|. ..||+++.. .+-.+.+.+.+.++.-+.+ ..|- .-..++...+++++.+|+....+++.. +
T Consensus 36 el~LL~-~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~--~~f~-----~ik~~~~~eKlr~l~ni~~l~~~~~~r-----~ 101 (215)
T 4ann_A 36 LMYLLE-QHSPYFIDA-ELTELRDSFQIHYDINDNH--TPFD-----NIKSFTKNEKLRYLLNIKNLEEVNRTR-----Y 101 (215)
T ss_dssp GGGGGG-SCCTTBCCE-EEEECSSEEEEEECCCTTS--EEGG-----GGGGSCHHHHHHHHHHGGGGGGGGGSS-----E
T ss_pred HHHHHh-ccCCcccce-EEEEcccEEEEEEEcCccc--CCHH-----HHHhcCHHHHHHHHHHHHHHHHHhcCc-----e
Confidence 444443 368888877 5666677766666654422 2211 122378899999999999888666544 7
Q ss_pred EccCCCCceeEcCCCCEEEeecccceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCC
Q 012462 267 HRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVD 346 (463)
Q Consensus 267 H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~ 346 (463)
|--|.|+|++++.++.+++.-.|+-..+. |. .++...=.-.+=|++..+++++..|+
T Consensus 102 tf~L~P~NL~f~~~~~p~i~~RGik~~l~------------------P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 102 TFVLAPDELFFTRDGLPIAKTRGLQNVVD------------------PL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp ECCCSGGGEEECTTSCEEESCCEETTTBS------------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEEecceEEEcCCCCEEEEEccCccCCC------------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 88999999999999999999877643221 11 11112223456788888999988875
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=90.05 E-value=0.61 Score=40.93 Aligned_cols=115 Identities=9% Similarity=0.001 Sum_probs=76.6
Q ss_pred CCCCcceEeeEEEECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeEEccCCCC
Q 012462 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA-YLHEAIEPKVVHRDIKSS 273 (463)
Q Consensus 195 ~h~niv~l~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~-~LH~~~~~~i~H~Dikp~ 273 (463)
.||++ -..+-.+.+.+.+.++.-+++.=..-++ .++...+++++.+|+.... +++ .-+|--|.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCc
Confidence 67888 4444467777777777654432222332 2788999999999888776 554 3488899999
Q ss_pred ceeEcCCCCEEEeecccceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCC
Q 012462 274 NILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVD 346 (463)
Q Consensus 274 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~ 346 (463)
|++++.++.++|.-.|+-..+.+. =+.+|-+ +-.+=|++..++.++..|+
T Consensus 114 NL~f~~~~~p~i~hRGi~~~lpP~-------------e~~ee~f----------l~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKESLPPD-------------EWDDERL----------LREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETTTBSSC-------------SCCHHHH----------HHHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCcccCCCC-------------CCCHHHH----------HHHHHHHHHHHHcCCCCHH
Confidence 999999999999988764322110 0122211 2356678888888877664
|
| >2klu_A T-cell surface glycoprotein CD4; cell membrane, disulfide bond, HOST- virus interaction, immune response, immunoglobulin domain, lipoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.85 E-value=0.41 Score=32.45 Aligned_cols=16 Identities=31% Similarity=0.395 Sum_probs=7.0
Q ss_pred HHHHHHHHHHHHHHHH
Q 012462 21 EVIGISVALFIIIILS 36 (463)
Q Consensus 21 ~~ig~~~~~~~~~~l~ 36 (463)
+++|.+++++++..+.
T Consensus 12 ivlGg~~~lll~~glc 27 (70)
T 2klu_A 12 IVLGGVAGLLLFIGLG 27 (70)
T ss_dssp HHHHHHHHHHHHHHHH
T ss_pred HHHhHHHHHHHHHHHH
Confidence 4445554444433333
|
| >1iij_A ERBB-2 receptor protein-tyrosine kinase; alpha-helix-PI-bulge-alpha-helix, signaling protein; NMR {Synthetic} SCOP: j.35.1.1 | Back alignment and structure |
|---|
Probab=88.50 E-value=0.13 Score=30.43 Aligned_cols=19 Identities=26% Similarity=0.469 Sum_probs=7.6
Q ss_pred HHHHHHHHHHHhhheeeee
Q 012462 28 ALFIIIILSVLSFCLTSRK 46 (463)
Q Consensus 28 ~~~~~~~l~i~~~~~~~r~ 46 (463)
+++++++++..+.+++|||
T Consensus 16 glll~vii~l~~~~~iRRr 34 (35)
T 1iij_A 16 GVLLFLILVVVVGILIKRR 34 (35)
T ss_dssp HHHHHHHHTTTTTHHHHHC
T ss_pred HHHHHHHHHHHhheEEeec
Confidence 3434444443333333443
|
| >2knc_A Integrin alpha-IIB; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=81.86 E-value=0.93 Score=29.76 Aligned_cols=25 Identities=20% Similarity=0.438 Sum_probs=15.7
Q ss_pred cchhhHHHHHHHHHHHHHHHHHHhh
Q 012462 16 GIKVWEVIGISVALFIIIILSVLSF 40 (463)
Q Consensus 16 ~~~~~~~ig~~~~~~~~~~l~i~~~ 40 (463)
++.+|++++.+++.+++++++++++
T Consensus 9 ~vp~wiIi~svl~GLllL~li~~~L 33 (54)
T 2knc_A 9 AIPIWWVLVGVLGGLLLLTILVLAM 33 (54)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CcchHHHHHHHHHHHHHHHHHHHHH
Confidence 4678887777766665555544443
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=80.21 E-value=0.21 Score=49.58 Aligned_cols=62 Identities=8% Similarity=0.048 Sum_probs=19.3
Q ss_pred CccCeEeecCcEEEEEEEEcC-CCeEEE------EEEcccch--hhHHHHHHHHHHHcCCCCCCcceEeeEEEE
Q 012462 144 SKENVLGEGGYGVVYRGNLIN-GSPVAV------KKILNNVG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIE 208 (463)
Q Consensus 144 ~~~~~lG~G~~g~V~~~~~~~-~~~vav------K~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 208 (463)
.+.+.|| ||.||+|.+.. ..+||+ |....... +....+.+|..++..++|||+++.+++...
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 4566777 99999997754 367888 76543221 222457778888888999999999887653
|
| >2l6w_A Beta-type platelet-derived growth factor receptor; transmembrane helix, receptor tyrosine kinase, heptad repeat membrane protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=81.15 E-value=0.35 Score=29.02 Aligned_cols=25 Identities=28% Similarity=0.466 Sum_probs=12.5
Q ss_pred HHHHHHHHHHHHHHhhheeeeeccc
Q 012462 25 ISVALFIIIILSVLSFCLTSRKKSR 49 (463)
Q Consensus 25 ~~~~~~~~~~l~i~~~~~~~r~~~~ 49 (463)
.++++++++++++++++..+++|.|
T Consensus 13 avlal~vi~iisLIiLi~~w~qKPr 37 (39)
T 2l6w_A 13 AILALVVLTIISLIILIMLWQKKPR 37 (39)
Confidence 3334444455555555555555543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 463 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-75 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-72 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-69 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-69 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-68 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-67 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-67 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-67 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-65 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-65 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-64 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-64 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-64 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-63 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-62 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-61 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-61 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-61 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-61 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-61 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-60 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-60 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-59 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-59 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-59 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-59 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-58 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-57 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-57 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-55 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-54 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-54 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-52 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-52 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-50 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-50 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-49 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-49 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-48 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-48 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-47 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-47 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-47 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-46 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-46 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-46 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-46 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-45 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-45 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-45 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-43 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-41 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-41 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-40 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-39 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-35 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-31 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-21 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (597), Expect = 8e-75
Identities = 66/286 (23%), Positives = 124/286 (43%), Gaps = 22/286 (7%)
Query: 135 DLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV 194
D E+ + + +G G +G VY+G V + + Q + F+ EV +
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKAL 254
RH N++ +GY +V ++ +L LH + + TA+ +
Sbjct: 62 RHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGM 117
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK-SHVTTRVMGTFGYVA 313
YLH ++HRD+KS+NI + +D K+ DFGLA + SH ++ G+ ++A
Sbjct: 118 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 314 PEYA---NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370
PE + + +SDVY+FG++L E +TG+ P + ++ + M+ S
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI-----IFMVGRGYLSP 229
Query: 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416
++ + + L C+ ++RP Q++ +E
Sbjct: 230 DLSKVRSNCPKAMKRL------MAECLKKKRDERPLFPQILASIEL 269
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (578), Expect = 4e-72
Identities = 73/283 (25%), Positives = 117/283 (41%), Gaps = 26/283 (9%)
Query: 135 DLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV 194
+ E+ LG G +G V+ G + VAVK + + F E + +
Sbjct: 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQL 65
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKAL 254
+H+ LVRL + ++ EY+ NG+L +L LT + + A+ +
Sbjct: 66 QHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGM 122
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
A++ E +HRD++++NIL+ D + K++DFGLA+L+ + + AP
Sbjct: 123 AFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 179
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEV--NLVDWLKMMVGSRRSEEV 372
E N G KSDV+SFG+LL E +T G EV NL +M+ EE+
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL 239
Query: 373 VDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
C E RP + +LE
Sbjct: 240 YQ-----------------LMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 1e-69
Identities = 71/277 (25%), Positives = 120/277 (43%), Gaps = 26/277 (9%)
Query: 141 NRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLV 200
+ + +G G +G+V+ G +N VA+K I +E++F E E + + H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 201 RLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
+L G C+E LV+E++ +G L +L G E + + L + +AYL E
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEE- 119
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTG 320
V+HRD+ + N L+ ++ KVSDFG+ + + + +T + +PE +
Sbjct: 120 --ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 321 LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEV--NLVDWLKMMVGSRRSEEVVDPNIE 378
+ KSDV+SFGVL+ E + R EV ++ ++ S V
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQ---- 233
Query: 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
C E RP S+++R L
Sbjct: 234 -------------IMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 220 bits (560), Expect = 5e-69
Identities = 77/303 (25%), Positives = 129/303 (42%), Gaps = 39/303 (12%)
Query: 131 FTLRDLELATNRFSKE---------NVLGEGGYGVVYRGNLI----NGSPVAVKKI-LNN 176
FT D A F+KE V+G G +G V G+L VA+K +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 177 VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHG 236
+ ++F E +G H N++ L G + M++ E++ NG+L+ +L ++ G
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR---QNDG 123
Query: 237 YLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296
T + +L G A + YL + VHRD+ + NIL++ + KVSDFGL++ L
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 297 GKSHVTTR----VMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAH 352
S T + APE SDV+S+G+++ E ++ + P
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER-----PYW 235
Query: 353 EVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
++ D + + R + P ++ + L L C D RPK Q+V
Sbjct: 236 DMTNQDVINAIEQDYR----LPPPMDCPSALHQL------MLDCWQKDRNHRPKFGQIVN 285
Query: 413 MLE 415
L+
Sbjct: 286 TLD 288
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 4e-68
Identities = 68/294 (23%), Positives = 125/294 (42%), Gaps = 30/294 (10%)
Query: 146 ENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGY 205
+ +G+G +G V+RG G VAVK I ++ + E+ +RH+N++ +
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVK-IFSSREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 206 CIEG----IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI 261
+ LV +Y +G+L +L+ +T E +K+ L TA LA+LH I
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 262 -----EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV---TTRVMGTFGYVA 313
+P + HRD+KS NIL+ + ++D GLA + + +GT Y+A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 314 PEYANTGL------LNEKSDVYSFGVLLLEAITGRDP----VDHGRPAHEVNLVDWLKMM 363
PE + + +++D+Y+ G++ E D+ P +++ D
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 364 VGSRRSEEVVDPNIEVRPSTRALKRSLLT-ALRCVDPDSEKRPKMSQVVRMLES 416
+ E+ + PNI R + R + C + R ++ + L
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 1e-67
Identities = 63/306 (20%), Positives = 117/306 (38%), Gaps = 38/306 (12%)
Query: 136 LELATNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGH 193
+EL + F K + LG G GVV++ + +G +A K I L + E++ +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 194 VRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
+V G + E+++ G+L+Q L G + + KV + K
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKG 116
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L YL E + K++HRD+K SNIL++ K+ DFG++ L + +GT Y++
Sbjct: 117 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMS 171
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373
PE + +SD++S G+ L+E GR P+ + +
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231
Query: 374 DPNIEVRPSTRALKRSLLTA---------------------------LRCVDPDSEKRPK 406
P + + + +C+ + +R
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291
Query: 407 MSQVVR 412
+ Q++
Sbjct: 292 LKQLMV 297
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 1e-67
Identities = 74/284 (26%), Positives = 118/284 (41%), Gaps = 26/284 (9%)
Query: 135 DLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHV 194
E+ E LG+G +G V+ G + VA+K + + + F E + + +
Sbjct: 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKL 69
Query: 195 RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKAL 254
RH+ LV+L E +V EY++ G+L +L G YL + + A +
Sbjct: 70 RHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGM 126
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 314
AY+ VHRD++++NIL+ ++ KV+DFGLA+L+ + + AP
Sbjct: 127 AYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 183
Query: 315 EYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEV--NLVDWLKMMVGSRRSEEV 372
E A G KSDV+SFG+LL E T G EV + +M E +
Sbjct: 184 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 243
Query: 373 VDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416
D +C + E+RP + LE
Sbjct: 244 HD-----------------LMCQCWRKEPEERPTFEYLQAFLED 270
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 7e-67
Identities = 61/275 (22%), Positives = 111/275 (40%), Gaps = 26/275 (9%)
Query: 143 FSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRL 202
+ LG G +GVV G VA+K I +E EF E + + ++ H+ LV+L
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 203 LGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIE 262
G C + ++ EY+ NG L +L + +++ +A+ YL
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLES--- 118
Query: 263 PKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL 322
+ +HRD+ + N L++D KVSDFGL++ + + + + PE
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 323 NEKSDVYSFGVLLLEAITGRDPVDHGRPAHEV--NLVDWLKMMVGSRRSEEVVDPNIEVR 380
+ KSD+++FGVL+ E + E ++ L++ SE+V
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT------ 232
Query: 381 PSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
C +++RP ++ +
Sbjct: 233 -----------IMYSCWHEKADERPTFKILLSNIL 256
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 3e-65
Identities = 72/290 (24%), Positives = 129/290 (44%), Gaps = 33/290 (11%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS-----PVAVKKI-LNNVGQAEKEFRVEVEA 190
E+ + +++ V+G G +G VY+G L S PVA+K + + +F E
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 191 IGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT 250
+G H N++RL G + M++ EY+ NG L+++L G + + +L G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGI 119
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG--KSHVTTRVMGT 308
A + YL VHRD+ + NIL++ + KVSDFGL+++L ++ T+
Sbjct: 120 AAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176
Query: 309 FGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEV--NLVDWLKMMVGS 366
+ APE + SDV+SFG+++ E +T + HEV + D ++
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPM 236
Query: 367 RRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416
+ ++C + +RPK + +V +L+
Sbjct: 237 DCPSAIYQ-----------------LMMQCWQQERARRPKFADIVSILDK 269
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 5e-65
Identities = 79/282 (28%), Positives = 114/282 (40%), Gaps = 32/282 (11%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRH 196
L +G+G +G V G+ G+ VAVK I N+ + F E + +RH
Sbjct: 3 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRH 59
Query: 197 KNLVRLLGYCIEGIHRM-LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
NLV+LLG +E + +V EY+ G+L +L R L + +K L +A+
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAME 117
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE 315
YL VHRD+ + N+L+ +D AKVSDFGL K S + APE
Sbjct: 118 YLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPE 170
Query: 316 YANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEV--NLVDWLKMMVGSRRSEEVV 373
+ KSDV+SFG+LL E + P +V + KM V
Sbjct: 171 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY 230
Query: 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
+ C D+ RP Q+ LE
Sbjct: 231 E-----------------VMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 1e-64
Identities = 75/290 (25%), Positives = 125/290 (43%), Gaps = 29/290 (10%)
Query: 134 RDLELATNRFSKENV-LGEGGYGVVYRGNLI---NGSPVAVKKILNNVGQAE-KEFRVEV 188
+ L L + ++ LG G +G V +G VA+K + +A+ +E E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 189 EAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLL 248
+ + + + +VRL+G C + MLV E G L ++L G + ++L
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLH 116
Query: 249 GTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR--VM 306
+ + YL E VHRD+ + N+L+ + AK+SDFGL+K LGA S+ T R
Sbjct: 117 QVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 307 GTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGS 366
+ APE N + +SDV+S+GV + EA++ P ++ + + +
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK-----PYKKMKGPEVMAFIEQG 228
Query: 367 RRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416
+R E E P AL C E RP V + + +
Sbjct: 229 KRME----CPPECPPELYAL------MSDCWIYKWEDRPDFLTVEQRMRA 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 208 bits (529), Expect = 1e-64
Identities = 66/283 (23%), Positives = 118/283 (41%), Gaps = 22/283 (7%)
Query: 135 DLELATNRFSKENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNVGQAEKEFRVEVEAIGH 193
E+ + ++ LG G YG VY G VAVK + + + E EF E +
Sbjct: 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKE 69
Query: 194 VRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
++H NLV+LLG C ++ E++ GNL +L + ++ + + + A
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSA 127
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
+ YL + +HRD+ + N L+ ++ KV+DFGL++L+ + A
Sbjct: 128 MEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 184
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373
PE + KSDV++FGVLL E T G +V E++
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---------------YELL 229
Query: 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416
+ + + ++ C + RP +++ + E+
Sbjct: 230 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 207 bits (528), Expect = 3e-64
Identities = 72/312 (23%), Positives = 121/312 (38%), Gaps = 48/312 (15%)
Query: 133 LRDLELATNRFSKENVLGEGGYGVVYRG------NLINGSPVAVKKI-LNNVGQAEKEFR 185
L LE N +GEG +G V++ + VAVK + + +F+
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 186 VEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY-------- 237
E + + N+V+LLG C G L++EY+ G+L ++L H
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 238 ------------LTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKV 285
L+ ++ + A +AYL E K VHRD+ + N L+ ++ K+
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKI 181
Query: 286 SDFGLAKLL-GAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP 344
+DFGL++ + A ++ PE +SDV+++GV+L E +
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 345 VDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALK-RSLLTALRCVDPDSEK 403
+G EV V D NI P L+ +L+ C
Sbjct: 242 PYYGMAHEEV--------------IYYVRDGNILACPENCPLELYNLM--RLCWSKLPAD 285
Query: 404 RPKMSQVVRMLE 415
RP + R+L+
Sbjct: 286 RPSFCSIHRILQ 297
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 2e-63
Identities = 66/277 (23%), Positives = 111/277 (40%), Gaps = 24/277 (8%)
Query: 143 FSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKE-FRVEVEAIGHVRHKNL 199
+ +G G YG + +G + K++ ++ +AEK+ EV + ++H N+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 200 VRLLGYCIEGIHRML--VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
VR I+ + L V EY G+L + + YL E ++V+ AL
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 258 HE--AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE 315
H V+HRD+K +N+ +D N K+ DFGLA++L S +GT Y++PE
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSPE 184
Query: 316 YANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375
N NEKSD++S G LL E P + R +
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI----------REGKFRRI 234
Query: 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
+ R ++ RP + +++
Sbjct: 235 PYRYSDELNEI------ITRMLNLKDYHRPSVEEILE 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 6e-62
Identities = 77/280 (27%), Positives = 122/280 (43%), Gaps = 30/280 (10%)
Query: 146 ENVLGEGGYGVVYRGNLINGS----PVAVKKILNNVGQAE-KEFRVEVEAIGHVRHKNLV 200
V+G G +G VY G L++ AVK + E +F E + H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 201 RLLGYCIEG-IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE 259
LLG C+ ++V Y+ +G+L + T + + L AK + +L
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNF---IRNETHNPTVKDLIGFGLQVAKGMKFLAS 148
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS---HVTTRVMGTFGYVAPEY 316
K VHRD+ + N ++D+ F KV+DFGLA+ + + H T ++A E
Sbjct: 149 ---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376
T KSDV+SFGVLL E +T P P +VN D ++ RR ++ P
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPE 257
Query: 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416
+ L+C P +E RP S++V + +
Sbjct: 258 -YCPDPLYEV------MLKCWHPKAEMRPSFSELVSRISA 290
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 2e-61
Identities = 75/290 (25%), Positives = 119/290 (41%), Gaps = 34/290 (11%)
Query: 145 KENVLGEGGYGVVYRGNLIN---GSPVAVKKILNNVGQAE--KEFRVEVEAIGHVRHKNL 199
++ LG G +G V +G VAVK + N E E + + + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 200 VRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE 259
VR++G C MLV E G L ++L + ++ + ++++ + + YL E
Sbjct: 71 VRMIGICEAE-SWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE 125
Query: 260 AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTR--VMGTFGYVAPEYA 317
VHRD+ + N+L+ AK+SDFGL+K L A +++ + + APE
Sbjct: 126 ---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEV--NLVDWLKMMVGSRRSEEVVDP 375
N + KSDV+SFGVL+ EA + G EV L +M + E+ D
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD- 241
Query: 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVRED 425
C D E RP + V L + Y +V E
Sbjct: 242 ----------------LMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 275
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 199 bits (508), Expect = 4e-61
Identities = 69/300 (23%), Positives = 118/300 (39%), Gaps = 42/300 (14%)
Query: 120 PEFSQLGWGHWFTLRDLELATNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVG 178
P+ ++L F D E FS +G G +G VY ++ N VA+KK+ +
Sbjct: 2 PDVAEL-----FFKDDPE---KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK 53
Query: 179 QAE---KEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHH 235
Q+ ++ EV + +RH N ++ G + LV EY + H
Sbjct: 54 QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HK 109
Query: 236 GYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295
L V G + LAYLH ++HRD+K+ NIL+ + K+ DFG A ++
Sbjct: 110 KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM- 165
Query: 296 AGKSHVTTRVMGTFGYVAPEYA---NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAH 352
+GT ++APE + G + K DV+S G+ +E + P
Sbjct: 166 ----APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK------PPLF 215
Query: 353 EVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
+N + L + ++E + R C+ + RP +++
Sbjct: 216 NMNAMSALYHIA---QNESPALQSGHWSEYFRNF------VDSCLQKIPQDRPTSEVLLK 266
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 7e-61
Identities = 71/304 (23%), Positives = 114/304 (37%), Gaps = 40/304 (13%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNVGQAEKE-FRVEVE 189
E NR S LG G +G V VAVK + + E+E E++
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78
Query: 190 AIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRH-------------- 234
+ ++ H N+V LLG C G +++ EY G+L +L
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 235 HGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294
L E + AK +A+L +HRD+ + NIL+ K+ DFGLA+ +
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 295 GAGKSH-VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHE 353
++ V ++APE + +SDV+S+G+ L E + G P
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 354 VNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413
+K E ++ C D D KRP Q+V++
Sbjct: 256 K-FYKMIKEGFRMLSPEHAPAEMYDI-------------MKTCWDADPLKRPTFKQIVQL 301
Query: 414 LESE 417
+E +
Sbjct: 302 IEKQ 305
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 8e-61
Identities = 69/309 (22%), Positives = 114/309 (36%), Gaps = 45/309 (14%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLINGS------PVAVKKILNNVGQAEKE-FRVEVE 189
E VLG G +G V S VAVK + +E+E E++
Sbjct: 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 92
Query: 190 AIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRH-------------- 234
+ + H+N+V LLG C L++EY G+L +L
Sbjct: 93 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152
Query: 235 -----HGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFG 289
LT+E + AK + +L VHRD+ + N+L+ K+ DFG
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFG 209
Query: 290 LAKLLGAGKSHVT-TRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHG 348
LA+ + + ++V ++APE G+ KSDV+S+G+LL E +
Sbjct: 210 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN---- 265
Query: 349 RPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMS 408
P + + ++ ++ +D + C DS KRP
Sbjct: 266 -PYPGIPVDANFYKLI---QNGFKMDQPFYATEEIYII------MQSCWAFDSRKRPSFP 315
Query: 409 QVVRMLESE 417
+ L +
Sbjct: 316 NLTSFLGCQ 324
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 8e-61
Identities = 68/276 (24%), Positives = 113/276 (40%), Gaps = 31/276 (11%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRH 196
F LG+G +G VY + +A+K + E + R EVE H+RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 197 KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY 256
N++RL GY + L+ EY G + + L + + A AL+Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSY 121
Query: 257 LHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEY 316
H +V+HRDIK N+L+ K++DFG + S T + GT Y+ PE
Sbjct: 122 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTTLCGTLDYLPPEM 175
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376
+ +EK D++S GVL E + G+ P + + ++ +E D
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD-- 233
Query: 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
L++ R + + +RP + +V+
Sbjct: 234 -------------LIS--RLLKHNPSQRPMLREVLE 254
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 2e-60
Identities = 63/280 (22%), Positives = 117/280 (41%), Gaps = 32/280 (11%)
Query: 142 RFSK-ENVLGEGGYGVVYRG-NLINGSPVAVKKILNN--VGQAEKEFRVEVEAIGHVRHK 197
RF K + +G G + VY+G + VA ++ + + F+ E E + ++H
Sbjct: 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68
Query: 198 NLVRLLGYCIEGI----HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
N+VR + +LV E + +G L+ +L + + K
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKG 124
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDD-DFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYV 312
L +LH P ++HRD+K NI I + K+ D GLA L ++ V+GT ++
Sbjct: 125 LQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFM 180
Query: 313 APEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV 372
APE +E DVY+FG+ +LE T P + A + + + V ++V
Sbjct: 181 APEMYEEKY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRVTSGVKPASFDKV 237
Query: 373 VDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
P + + ++ C+ + ++R + ++
Sbjct: 238 AIPEV----------KEII--EGCIRQNKDERYSIKDLLN 265
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 2e-60
Identities = 78/313 (24%), Positives = 137/313 (43%), Gaps = 37/313 (11%)
Query: 143 FSKENVLGEGGYGVVYRGNLIN-----GSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRH 196
F K VLG G +G VY+G I PVA+K++ +A KE E + V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 197 KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY 256
++ RLLG C+ L+ + + G L + H + + + + AK + Y
Sbjct: 71 PHVCRLLGICLTS-TVQLITQLMPFGCLLDY---VREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 257 LHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG-KSHVTTRVMGTFGYVAPE 315
L + ++VHRD+ + N+L+ + K++DFGLAKLLGA K + ++A E
Sbjct: 127 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 316 YANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEV--NLVDWLKMMVGSRRSEEVV 373
+ +SDV+S+GV + E +T G PA E+ L ++ + +V
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY 243
Query: 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHRRTQG 433
++C D++ RPK +++ + R+ +R+ QG
Sbjct: 244 M-----------------IMVKCWMIDADSRPKFRELIIEFSK----MARDPQRYLVIQG 282
Query: 434 GTSMEIESQKENS 446
M + S +++
Sbjct: 283 DERMHLPSPTDSN 295
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-59
Identities = 64/292 (21%), Positives = 122/292 (41%), Gaps = 37/292 (12%)
Query: 141 NRFSKENVLGEGGYGVVYRGNLINGS---PVAVKKI-LNNVGQAEKEFRVEVEAIGHV-R 195
N ++V+GEG +G V + + A+K++ ++F E+E + +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHH------------GYLTWEAR 243
H N++ LLG C + L EY +GNL +L + L+ +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 244 MKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTT 303
+ A+ + YL + + +HRD+ + NIL+ +++ AK++DFGL++ T
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184
Query: 304 RVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMM 363
++A E N + SDV+S+GVLL E ++ P + + + +
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAELYEKL 239
Query: 364 VGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
R E+ ++ + EV +C +RP +Q++ L
Sbjct: 240 PQGYRLEKPLNCDDEVYD----------LMRQCWREKPYERPSFAQILVSLN 281
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 2e-59
Identities = 65/279 (23%), Positives = 118/279 (42%), Gaps = 27/279 (9%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKN 198
+ + LG+G +G VY+ N A K I + +++ VE++ + H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+LL + ++ E+ G ++ + LT V T AL YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVML---ELERPLTESQIQVVCKQTLDALNYLH 127
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA- 317
+ K++HRD+K+ NIL D + K++DFG++ + + GT ++APE
Sbjct: 128 DN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVM 183
Query: 318 ----NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373
+ K+DV+S G+ L+E P HE+N + L + S
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIE------PPHHELNPMRVLLKIAKSEPPTLAQ 237
Query: 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
S+ + L +C++ + + R SQ+++
Sbjct: 238 PSRW----SSNF--KDFLK--KCLEKNVDARWTTSQLLQ 268
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 2e-59
Identities = 68/297 (22%), Positives = 121/297 (40%), Gaps = 31/297 (10%)
Query: 135 DLELATNRFSKENVLGEGGYGVVYRGNLIN----GSPVAVKKILNNVGQAEKE-FRVEVE 189
D E+ R +GEG +G V++G ++ VA+K N + +E F E
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 190 AIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
+ H ++V+L+G E ++ E G L + L + +
Sbjct: 61 TMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSF---LQVRKYSLDLASLILYAYQ 116
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
+ ALAYL + VHRDI + N+L+ + K+ DFGL++ + + ++
Sbjct: 117 LSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 173
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
++APE N SDV+ FGV + E + P V D + + R
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK-----PFQGVKNNDVIGRIENGERL 228
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDR 426
+ PN P+ +L +C D +RP+ +++ L + I+ E++
Sbjct: 229 P--MPPNCP--PTLYSL------MTKCWAYDPSRRPRFTELKAQLST----ILEEEK 271
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 5e-59
Identities = 66/276 (23%), Positives = 111/276 (40%), Gaps = 25/276 (9%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVEVEAIGHVRHKN 198
+ LGEG YG V N + VAVK + + + + E+ + H+N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+ G+ EG + L EY + G L + + + + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG-KSHVTTRVMGTFGYVAPEYA 317
+ HRDIK N+L+D+ N K+SDFGLA + + + ++ GT YVAPE
Sbjct: 121 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 318 NTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376
E DV+S G++L + G P D D + + + ++P
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS--------DSCQEYSDWKEKKTYLNPW 229
Query: 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
++ + AL +L +P R + + +
Sbjct: 230 KKIDSAPLALLHKIL----VENP--SARITIPDIKK 259
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 1e-58
Identities = 67/274 (24%), Positives = 122/274 (44%), Gaps = 24/274 (8%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKN 198
++++ +G+G G VY ++ G VA++++ ++ E+ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V L + G +V EY+ G+L + + V +AL +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLH 133
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYAN 318
+V+HRDIKS NIL+ D + K++DFG + +S +T V GT ++APE
Sbjct: 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVT 189
Query: 319 TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378
K D++S G++ +E I G P N + L ++ + P ++
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGE------PPYLNENPLRALYLIATNGT------PELQ 237
Query: 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
A+ R L RC+D D EKR ++++
Sbjct: 238 NPEKLSAIFRDFLN--RCLDMDVEKRGSAKELLQ 269
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 1e-57
Identities = 67/284 (23%), Positives = 107/284 (37%), Gaps = 30/284 (10%)
Query: 141 NRFSKENVLGEGGYGVVYRGNLI----NGSPVAVKKILNNV---GQAEKEFRVEVEAIGH 193
LG+G +GVV RG VAVK + +V +A +F EV A+
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 194 VRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
+ H+NL+RL G + +V E G+L +H G+ + + A+
Sbjct: 68 LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDR---LRKHQGHFLLGTLSRYAVQVAEG 123
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSH--VTTRVMGTFGY 311
+ YL + +HRD+ + N+L+ K+ DFGL + L H + F +
Sbjct: 124 MGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 312 VAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEE 371
APE T + SD + FGV L E T P +N L + + E
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKID---KEGE 232
Query: 372 VVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415
+ + + ++C E RP + L
Sbjct: 233 RLPRPEDCPQDIYNV------MVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 190 bits (484), Expect = 3e-57
Identities = 65/335 (19%), Positives = 125/335 (37%), Gaps = 38/335 (11%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNL 199
+ + LG G +GVV+R G+ A K ++ ++ R E++ + +RH L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 200 VRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE 259
V L + +++YE+++ G L + + H ++ + ++ + K L ++HE
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHE 142
Query: 260 AIEPKVVHRDIKSSNILIDDDFN--AKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
VH D+K NI+ + K+ DFGL L +S T GT + APE A
Sbjct: 143 N---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVA 197
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNI 377
+ +D++S GVL ++G P + + ++ I
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR-----NVKSCDWNMDDSAFSGI 252
Query: 378 EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR--------------MLESEEYPIVR 423
S + + + + D R + Q + + S Y +R
Sbjct: 253 ----SEDG--KDFIR--KLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIR 304
Query: 424 EDRRHRRTQGGTSMEIESQKENSDTDRSDYPGSRS 458
+ + + + + N + R P S
Sbjct: 305 DSIKTKYDAWPEPLPPLGRISNYSSLRKHRPQEYS 339
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 5e-55
Identities = 68/304 (22%), Positives = 123/304 (40%), Gaps = 32/304 (10%)
Query: 135 DLELATNRFSKENVLGEGGYGVVYRG------NLINGSPVAVKKILNNVGQAEK-EFRVE 187
+ E+A + + LG+G +G+VY G + VA+K + E+ EF E
Sbjct: 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73
Query: 188 VEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGY------LTWE 241
+ ++VRLLG +G +++ E + G+L+ +L +
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 242 ARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS-H 300
+++ A +AYL+ K VHRD+ + N ++ +DF K+ DFG+ + +
Sbjct: 134 KMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 301 VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWL 360
+ + +++PE G+ SDV+SFGV+L E T + G +V
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV----LR 246
Query: 361 KMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYP 420
+M G D L C + + RP +++ ++ E P
Sbjct: 247 FVMEGGLL-----DKPDNCPDMLFEL------MRMCWQYNPKMRPSFLEIISSIKEEMEP 295
Query: 421 IVRE 424
RE
Sbjct: 296 GFRE 299
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 2e-54
Identities = 74/304 (24%), Positives = 125/304 (41%), Gaps = 45/304 (14%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRGNLI--------NGSPVAVKKILNNVGQAE-KEFRVE 187
EL +R LGEG +G V I + VAVK + ++ + + + E
Sbjct: 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 68
Query: 188 VEAIGHV-RHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLH------------GAMRH 234
+E + + +HKN++ LLG C + ++ EY + GNL ++L +
Sbjct: 69 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 235 HGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294
L+ + + A+ + YL K +HRD+ + N+L+ +D K++DFGLA+ +
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 295 GAGKSHVTTRVM-GTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHE 353
+ T ++APE + +SDV+SFGVLL E T G P E
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245
Query: 354 V--NLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVV 411
+ L + +M S + E+ C +RP Q+V
Sbjct: 246 LFKLLKEGHRMDKPSNCTNELYM-----------------MMRDCWHAVPSQRPTFKQLV 288
Query: 412 RMLE 415
L+
Sbjct: 289 EDLD 292
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 8e-54
Identities = 72/302 (23%), Positives = 114/302 (37%), Gaps = 39/302 (12%)
Query: 137 ELATNRFSKENVLGEGGYGVVYRG------NLINGSPVAVKKILNNVGQAE-KEFRVEVE 189
E +R LG G +G V VAVK + +E + E++
Sbjct: 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 68
Query: 190 AIGH-VRHKNLVRLLGYCIE-GIHRMLVYEYVNNGNLEQWLHG------------AMRHH 235
+ H H N+V LLG C + G M++ E+ GNL +L +
Sbjct: 69 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128
Query: 236 GYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295
+LT E + AK + +L K +HRD+ + NIL+ + K+ DFGLA+ +
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIY 185
Query: 296 AGKSHV-TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEV 354
+V ++APE + +SDV+SFGVLL E + P V
Sbjct: 186 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGV 240
Query: 355 NLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRML 414
+ + + D P L C + +RP S++V L
Sbjct: 241 KIDEEFCRRLKEGTRMRAPD---YTTPEMYQT------MLDCWHGEPSQRPTFSELVEHL 291
Query: 415 ES 416
+
Sbjct: 292 GN 293
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 178 bits (453), Expect = 1e-52
Identities = 56/326 (17%), Positives = 117/326 (35%), Gaps = 31/326 (9%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNL 199
+ + LG G +GVV+R G K I + + E+ + + H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 200 VRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE 259
+ L + +L+ E+++ G L + ++ + + + L ++HE
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHE 145
Query: 260 AIEPKVVHRDIKSSNILID--DDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
+VH DIK NI+ + + K+ DFGLA L + T + APE
Sbjct: 146 H---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEIV 200
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNI 377
+ + +D+++ GVL ++G P + V + +
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV-----------KRCDWEFDE 249
Query: 378 EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHRRTQGGTSM 437
+ S + + + + KR + + E+P ++ D + ++ +S
Sbjct: 250 DAFSSVSPEAKDFIK--NLLQKEPRKRLTVHDAL------EHPWLKGDHSNLTSRIPSS- 300
Query: 438 EIESQKENSDTDRSDYPGSRSESKRT 463
++ +D+P + R
Sbjct: 301 RYNKIRQKIKEKYADWPAPQPAIGRI 326
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 2e-52
Identities = 60/298 (20%), Positives = 108/298 (36%), Gaps = 32/298 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAE---KEFRVEVEAIGHVRHK 197
F +LGEG + V L A+K + E E + + + H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
V+L + Y NG L +++ G AL YL
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 124
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA-GKSHVTTRVMGTFGYVAPEY 316
H ++HRD+K NIL+++D + +++DFG AK+L K +GT YV+PE
Sbjct: 125 HG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376
+ SD+++ G ++ + + G P G + L+ + + D
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD-- 239
Query: 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVRE---DRRHRRT 431
L+ + + D+ KR ++ + +P + H++T
Sbjct: 240 -------------LVE--KLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQT 282
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 171 bits (434), Expect = 2e-50
Identities = 66/288 (22%), Positives = 116/288 (40%), Gaps = 30/288 (10%)
Query: 130 WFTLRDLELATNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI-LNNVGQAEKEFRVE 187
W D+ + + +VLG G + V + VA+K I + E E
Sbjct: 1 WKQAEDIR---DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENE 57
Query: 188 VEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVL 247
+ + ++H N+V L G H L+ + V+ G L + G+ T +++
Sbjct: 58 IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI----VEKGFYTERDASRLI 113
Query: 248 LGTAKALAYLHEAIEPKVVHRDIKSSNILI---DDDFNAKVSDFGLAKLLGAGKSHVTTR 304
A+ YLH + +VHRD+K N+L D+D +SDFGL+K+ G V +
Sbjct: 114 FQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLST 168
Query: 305 VMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMV 364
GT GYVAPE ++ D +S GV+ + G P ++ N + ++
Sbjct: 169 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY------PPFYDENDAKLFEQIL 222
Query: 365 GSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
+ + + + + ++ D EKR Q ++
Sbjct: 223 -----KAEYEFDSPYWDDISDSAKDFIR--HLMEKDPEKRFTCEQALQ 263
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 169 bits (429), Expect = 6e-50
Identities = 71/287 (24%), Positives = 126/287 (43%), Gaps = 31/287 (10%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQ---AEKEFRVEVEAIGHVR 195
++R+ +LG GG V+ +L VAVK + ++ + FR E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 196 HKNLVRLLGYCIE----GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
H +V + G +V EYV+ L +H G +T + ++V+
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADAC 121
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV--TTRVMGTF 309
+AL + H+ ++HRD+K +NI+I KV DFG+A+ + + V T V+GT
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
Y++PE A ++ +SDVYS G +L E +TG P + V V
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGDSPVSVAYQHV----R 228
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPK-MSQVVRMLE 415
E+ + P+ + L + L+ + + E R + +++ L
Sbjct: 229 EDPIPPSARHEGLSADLDAVV---LKALAKNPENRYQTAAEMRADLV 272
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 1e-49
Identities = 50/329 (15%), Positives = 117/329 (35%), Gaps = 34/329 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLV 200
++ LG G +G+V+R + K + G + + E+ + RH+N++
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNIL 64
Query: 201 RLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
L ++++E+++ ++ + ++ L + + +AL +LH
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLH-- 119
Query: 261 IEPKVVHRDIKSSNILIDDDFNA--KVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYAN 318
+ H DI+ NI+ ++ K+ +FG A+ L G + Y APE
Sbjct: 120 -SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQ 176
Query: 319 TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378
+++ +D++S G L+ ++G +P + + + E
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI-----------MNAEYTFDEE 225
Query: 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR------MLESEEYPIVREDRRHRRTQ 432
+ R + + + R S+ ++ +E ++R + R
Sbjct: 226 AFKEISIEAMDFVD--RLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYH 283
Query: 433 GGTSMEIESQKENSDTDRSDYPGSRSESK 461
++ + R G+ K
Sbjct: 284 TLIKKDLNMVVSAA---RISCGGAIRSQK 309
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 167 bits (423), Expect = 5e-49
Identities = 62/286 (21%), Positives = 110/286 (38%), Gaps = 39/286 (13%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---------LNNVGQAEKEFRVEVEAI 191
+ + +LG G VV R + AVK I V + + EV+ +
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 192 GHVR-HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGT 250
V H N+++L LV++ + G L +L L+ + K++
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRAL 119
Query: 251 AKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
+ + LH+ +VHRD+K NIL+DDD N K++DFG + L G+ V GT
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPS 174
Query: 311 YVAPEYANTGLL------NEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMV 364
Y+APE + ++ D++S GV++ + G P H + + ++
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI------- 227
Query: 365 GSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQV 410
+ L++ R + +KR +
Sbjct: 228 ----MSGNYQFGSPEWDDYSDTVKDLVS--RFLVVQPQKRYTAEEA 267
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (418), Expect = 3e-48
Identities = 46/287 (16%), Positives = 100/287 (34%), Gaps = 29/287 (10%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNL 199
NR+ +G G +G +Y G ++ G VA+K V + +E + ++
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLE--CVKTKHPQLHIESKIYKMMQGGVG 64
Query: 200 VRLLGYCI-EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+ + +C EG + ++V E + + + + + + + + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLF----NFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 259 EAIEPKVVHRDIKSSNILI---DDDFNAKVSDFGLAKLLGAGKSHV------TTRVMGTF 309
+HRD+K N L+ + DFGLAK ++H + GT
Sbjct: 121 SK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
Y + + + D+ S G +L+ G + +
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNL-------GSLPWQGLKAATKRQKYERISE 230
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416
+++ P + + + L C + +P S + ++ +
Sbjct: 231 KKMSTPIEVLCKGYPSEFATYLN--FCRSLRFDDKPDYSYLRQLFRN 275
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 166 bits (422), Expect = 5e-48
Identities = 60/277 (21%), Positives = 102/277 (36%), Gaps = 32/277 (11%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI---LNNVGQAEKEFRVEVEAI---GH 193
N FS ++G GG+G VY G A+K + + Q E E +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 194 VRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
+V + + + +N G+L L HG +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILG 119
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
L ++H VV+RD+K +NIL+D+ + ++SD GLA K +GT GY+A
Sbjct: 120 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMA 173
Query: 314 PEYANTGL-LNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV 372
PE G+ + +D +S G +L + + G P + + + + + +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--DRMTLTMAVELPDS 231
Query: 373 VDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQ 409
P + RSLL + D +R
Sbjct: 232 FSPEL----------RSLLE--GLLQRDVNRRLGCLG 256
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 162 bits (411), Expect = 3e-47
Identities = 57/286 (19%), Positives = 104/286 (36%), Gaps = 21/286 (7%)
Query: 141 NRFSKENVLGEGGYGVVYRGNLINGSPVAVKKIL--NNVGQAEKEFRVEVEAIGHVRHKN 198
++ +GEG YGVVY+ G A+KKI E+ + ++H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+L +LV+E+++ G L LL +AY H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQ----DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYAN 318
+ +V+HRD+K N+LI+ + K++DFGLA+ G T ++ +
Sbjct: 118 D---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 319 TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378
+ + D++S G + E + G A ++ + + S+ V +
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 379 VRPSTRALKRSLLTAL------------RCVDPDSEKRPKMSQVVR 412
T + L + + D +R Q +
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 4e-47
Identities = 64/292 (21%), Positives = 121/292 (41%), Gaps = 23/292 (7%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAE-KEFRVEVEAIGHVRHK 197
R++ + +GEG YG+V + +N VA+KKI Q + E++ + RH+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
N++ + + Y+ + L+ ++ L+ + L + L Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYI 125
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVT--TRVMGTFGYVAPE 315
H A V+HRD+K SN+L++ + K+ DFGLA++ H T + T Y APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 316 YANTGLL-NEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLV----------DWLKMMV 364
+ D++S G +L E ++ R ++N + D ++
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 365 GSRRSEEVVDPNIEVRPSTRALKRSLLTAL----RCVDPDSEKRPKMSQVVR 412
R+ + P+ P R + AL + + + KR ++ Q +
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 5e-47
Identities = 63/277 (22%), Positives = 101/277 (36%), Gaps = 30/277 (10%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKE---FRVEVEAIGHV-R 195
F +LG+G +G V+ A+K + +V + + VE +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 196 HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALA 255
H L + + V EY+N G+L + + L
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEIILGLQ 117
Query: 256 YLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE 315
+LH +V+RD+K NIL+D D + K++DFG+ K G + T GT Y+APE
Sbjct: 118 FLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPE 173
Query: 316 YANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375
N D +SFGVLL E + G+ P + + +E D
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD- 232
Query: 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
LL ++ + EKR + +R
Sbjct: 233 --------------LL--VKLFVREPEKRLGVRGDIR 253
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-46
Identities = 63/283 (22%), Positives = 108/283 (38%), Gaps = 33/283 (11%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKI------LNNVGQAEKEFRVEVEAIGH 193
+ + LG G + VV + G A K I + G + ++ EV +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 194 VRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKA 253
++H N++ L +L+ E V G L + + LT E + L
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDF----LAEKESLTEEEATEFLKQILNG 125
Query: 254 LAYLHEAIEPKVVHRDIKSSNILIDDD----FNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
+ YLH ++ H D+K NI++ D K+ DFGLA + G + GT
Sbjct: 126 VYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTP 180
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
+VAPE N L ++D++S GV+ ++G P + S
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----------QETLANVS 229
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
+ E +T AL + + R + D +KR + ++
Sbjct: 230 AVNYEFEDEYFSNTSALAKDFIR--RLLVKDPKKRMTIQDSLQ 270
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 161 bits (407), Expect = 3e-46
Identities = 65/283 (22%), Positives = 115/283 (40%), Gaps = 39/283 (13%)
Query: 131 FTLRDLELATNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKE---FRV 186
++L+D ++ LG G +G V+ + NG A+K + + K+
Sbjct: 1 YSLQDFQI-------LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND 53
Query: 187 EVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKV 246
E + V H ++R+ G + ++ +Y+ G L L + R + +V
Sbjct: 54 ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV 113
Query: 247 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVM 306
L L +++RD+K NIL+D + + K++DFG AK + VT +
Sbjct: 114 CL-------ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLC 162
Query: 307 GTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGS 366
GT Y+APE +T N+ D +SFG+L+ E + G P + ++
Sbjct: 163 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP 222
Query: 367 RRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQ 409
+E+V D LL+ R + D +R Q
Sbjct: 223 FFNEDVKD---------------LLS--RLITRDLSQRLGNLQ 248
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 4e-46
Identities = 58/291 (19%), Positives = 105/291 (36%), Gaps = 24/291 (8%)
Query: 139 ATNRFSKENVLGEGGYGVVYRGNLI--NGSPVAVKKILNNVGQAEKEFRVEVEA-----I 191
A ++ +GEG YG V++ + G VA+K++ G+ E +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 192 GHVRHKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQW--LHGAMRHHGYLTWEARMKVLLG 249
H N+VRL C + +++Q + + E ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTF 309
+ L +LH +VVHRD+K NIL+ K++DFGLA++ + T V+ T
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTL 179
Query: 310 GYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLV----------DW 359
Y APE D++S G + E + ++ + DW
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 360 LKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQV 410
+ + R++ + T + L+C+ + KR
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 7e-46
Identities = 62/289 (21%), Positives = 112/289 (38%), Gaps = 29/289 (10%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLV 200
++ V+G G +GVVY+ +G VA+KK+L + ++ E++ + + H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIV 76
Query: 201 RLLGYCIEG------IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKAL 254
RL + ++ LV +YV H R L + ++L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSL 135
Query: 255 AYLHEAIEPKVVHRDIKSSNILIDDD-FNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVA 313
AY+H + HRDIK N+L+D D K+ DFG AK L G+ +V+ + +
Sbjct: 136 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAP 191
Query: 314 PEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWL-------KMMVGS 366
DV+S G +L E + G+ ++ + + ++ +
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 367 RRSEEVVDPNIEVRPSTRALKRSLLTAL-----RCVDPDSEKRPKMSQV 410
E P I+ P T+ + R ++ R +
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 9e-46
Identities = 65/286 (22%), Positives = 104/286 (36%), Gaps = 25/286 (8%)
Query: 142 RFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKN 198
F K +GEG YGVVY+ N + G VA+KKI + E+ + + H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+V+LL LV+E+++ + + L + LA+ H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDA---SALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 259 EAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYAN 318
+V+HRD+K N+LI+ + K++DFGLA+ G T V+ +
Sbjct: 120 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 319 TGLLNEKSDVYSFGVLLLEAITGRDPVD--------------HGRPAHEVNLVDWLKMMV 364
+ D++S G + E +T R G P V
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 365 GSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQV 410
+ +V P RSLL+ + + D KR
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLS--QMLHYDPNKRISAKAA 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 6e-45
Identities = 66/283 (23%), Positives = 106/283 (37%), Gaps = 43/283 (15%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKE------FRVEVEAIGH 193
+++ +LG GG+G VY G + + PVA+K + + E +EV +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 194 VR--HKNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
V ++RLL + +L+ E + G L E
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF---ITERGALQEELARSFFWQVL 120
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFG 310
+A+ + H V+HRDIK NILID + K+ DFG LL K V T GT
Sbjct: 121 EAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 174
Query: 311 YVAPEY-ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
Y PE+ + V+S G+LL + + G P +H
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH---------------------D 213
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
EE++ + R + + L+ C+ RP ++
Sbjct: 214 EEIIRGQVFFRQRVSSECQHLIR--WCLALRPSDRPTFEEIQN 254
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 7e-45
Identities = 62/285 (21%), Positives = 111/285 (38%), Gaps = 26/285 (9%)
Query: 147 NVLGEGGYGVVYRG-NLINGSPVAVKKI-----LNNVGQAEKEFRVEVEAIGHVRHKNLV 200
+ LGEG + VY+ + VA+KKI + E++ + + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 201 RLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
LL + LV++++ + LT +L T + L YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVII----KDNSLVLTPSHIKAYMLMTLQGLEYLHQ- 118
Query: 261 IEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANT- 319
++HRD+K +N+L+D++ K++DFGLAK G+ T +V T Y APE
Sbjct: 119 --HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGA 175
Query: 320 GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLV----------DWLKMMVGSRRS 369
+ D+++ G +L E + + ++ + W M
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 370 EEVVDPNIEVRPSTRALKRSLLTAL-RCVDPDSEKRPKMSQVVRM 413
P I + A LL + + R +Q ++M
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 8e-45
Identities = 60/290 (20%), Positives = 106/290 (36%), Gaps = 27/290 (9%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKIL--NNVGQAEKEFRVEVEAIGHVRHK 197
++ K +GEG YG V++ N VA+K++ ++ E+ + ++HK
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
N+VRL LV+E+ + +G L E L K L +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
H V+HRD+K N+LI+ + K+++FGLA+ G + V+ +
Sbjct: 118 HS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEV-----------NLVDWLKMMVGS 366
L + D++S G + E P+ G + W M
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 367 RRSEEVVDPN----IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412
+ P + V P A R LL + + +R + ++
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQ--NLLKCNPVQRISAEEALQ 282
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-43
Identities = 66/315 (20%), Positives = 124/315 (39%), Gaps = 34/315 (10%)
Query: 146 ENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLG 204
VLG G G V + N A+K + + +A +E + A + ++VR++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKML-QDCPKARREVELHWRAS---QCPHIVRIVD 72
Query: 205 YC----IEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEA 260
++V E ++ G L + R T +++ +A+ YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSI 130
Query: 261 IEPKVVHRDIKSSNILIDDDFN---AKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
+ HRD+K N+L K++DFG AK + S T T YVAPE
Sbjct: 131 ---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVL 185
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNI 377
++ D++S GV++ + G P H + + +K + + E
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYS---NHGLAISPGMKTRIRMGQYEFPNPEWS 242
Query: 378 EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIVREDRRHRRTQGGTSM 437
EV + L R+LL + +R +++ + +P + + + +T TS
Sbjct: 243 EVSEEVKMLIRNLLK------TEPTQRMTITEFM------NHPWIMQSTKVPQTPLHTSR 290
Query: 438 EIESQKENSDTDRSD 452
++ KE + + +
Sbjct: 291 VLKEDKERWEDVKEE 305
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 151 bits (381), Expect = 8e-43
Identities = 47/289 (16%), Positives = 92/289 (31%), Gaps = 31/289 (10%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRH-KN 198
+ +GEG +GV++ G NL+N VA+K + R E +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTG 62
Query: 199 LVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLH 258
+ + + EG+H +LV + + + + + + +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLD----LCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 259 EAIEPKVVHRDIKSSNILIDDDFN-----AKVSDFGLAKLLGAGKSHV------TTRVMG 307
E +V+RDIK N LI + V DFG+ K + + G
Sbjct: 119 EK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 308 TFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR 367
T Y++ + + D+ + G + + + G P + A + +
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK---- 231
Query: 368 RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLES 416
+ P E+ + R + D P + +
Sbjct: 232 ---KQSTPLRELCAGFPEEFYKYMHYARNLAFD--ATPDYDYLQGLFSK 275
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 2e-41
Identities = 55/287 (19%), Positives = 108/287 (37%), Gaps = 23/287 (8%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILN--NVGQAEKEFRVEVEAIGHVRHK 197
+ +G G YG V + G+ VA+KK+ K E+ + H+RH+
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 198 NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYL 257
N++ LL ++ G + H L + ++ K L Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 258 HEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYA 317
H ++HRD+K N+ +++D K+ DFGLA+ S +T V+ +
Sbjct: 138 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD---SEMTGYVVTRWYRAPEVIL 191
Query: 318 NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLV----------DWLKMMVGSR 367
N + D++S G ++ E ITG+ ++ + ++
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251
Query: 368 RSEEVVDPNIEVRPSTRALKRSLLTAL----RCVDPDSEKRPKMSQV 410
++ P +E + L + A+ + + D+E+R +
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 3e-41
Identities = 59/300 (19%), Positives = 115/300 (38%), Gaps = 37/300 (12%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKIL--NNVGQAEKEFRVEVEAIGHVRHK 197
+++ K +G+G +G V++ + G VA+KK+L N E++ + ++H+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 198 NLVRLLGYCIEGIHRM--------LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLG 249
N+V L+ C LV+++ + + T +V+
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVM-- 123
Query: 250 TAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS---HVTTRVM 306
L L+ K++HRD+K++N+LI D K++DFGLA+ K+ + T +
Sbjct: 124 -QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 307 GTFGYVAPE-YANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVG 365
T Y PE D++ G ++ E T + H++ L+ L +
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242
Query: 366 SRRSEEVVDPNIE-----VRPSTRALKRSLLTAL----------RCVDPDSEKRPKMSQV 410
V + + V+ R +K L + + + D +R
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 9e-40
Identities = 67/273 (24%), Positives = 96/273 (35%), Gaps = 29/273 (10%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKE---FRVEVEAIGHVRH 196
N F +LG+G +G V G A+K + V A+ E E + + RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 197 KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY 256
L L V EY N G L L T E AL Y
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEY 120
Query: 257 LHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEY 316
LH VV+RDIK N+++D D + K++DFGL K + + GT Y+APE
Sbjct: 121 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEV 176
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376
D + GV++ E + GR P + L+ ++ S E
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKS-- 234
Query: 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQ 409
LL + D ++R
Sbjct: 235 -------------LLA--GLLKKDPKQRLGGGP 252
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 142 bits (358), Expect = 6e-39
Identities = 57/238 (23%), Positives = 93/238 (39%), Gaps = 15/238 (6%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKE---FRVEVEAIGHVRH 196
++F + LG G +G V + +G+ A+K + K+ E + V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 197 KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY 256
LV+L + + +V EYV G + L G + Y
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEY 156
Query: 257 LHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEY 316
LH +++RD+K N+LID +V+DFG AK T + GT +APE
Sbjct: 157 LHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWTLCGTPEALAPEI 209
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVD 374
+ N+ D ++ GVL+ E G P +P + K+ S S ++ D
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKD 267
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 132 bits (333), Expect = 1e-35
Identities = 59/297 (19%), Positives = 114/297 (38%), Gaps = 42/297 (14%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR-HKN 198
+ + LG G Y V+ N+ N V VK + +K+ + E++ + ++R N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPN 91
Query: 199 LVRLLGYCIEGIHRM--LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY 256
++ L + + R LV+E+VNN + +Q + LT + KAL Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQ-------LYQTLTDYDIRFYMYEILKALDY 144
Query: 257 LHEAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPE 315
H ++HRD+K N++ID + ++ D+GLA+ G+ + + + + PE
Sbjct: 145 CHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPE 199
Query: 316 -YANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEV-----------NLVDWLKMM 363
+ + + D++S G +L I ++P HG ++ +L D++
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259
Query: 364 VGSRRSEEVVDPNIEVRPSTRALKRSLLTAL----------RCVDPDSEKRPKMSQV 410
R S L + + D + R +
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 1e-35
Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 31/280 (11%)
Query: 141 NRFSKENVLGEGGYGVVYRGNLI----NGSPVAVKKI----LNNVGQAEKEFRVEVEAIG 192
F VLG G YG V+ I G A+K + + + + R E + +
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 193 HVRHK-NLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
H+R LV L L+ +Y+N G L L R T +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIV 139
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGY 311
AL +LH+ +++RDIK NIL+D + + ++DFGL+K A ++ GT Y
Sbjct: 140 LALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 196
Query: 312 VAPEYANTGL--LNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369
+AP+ G ++ D +S GVL+ E +TG P + + S
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-----------S 245
Query: 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQ 409
++ AL + L+ R + D +KR
Sbjct: 246 RRILKSEPPYPQEMSALAKDLIQ--RLLMKDPKKRLGCGP 283
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 1e-34
Identities = 62/290 (21%), Positives = 109/290 (37%), Gaps = 27/290 (9%)
Query: 140 TNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAE--KEFRVEVEAIGHVRH 196
R+ + +G G YG V + G VAVKK+ K E+ + H++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 197 KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY 256
+N++ LL + +L + LT + ++ + L Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 257 LHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEY 316
+H ++HRD+K SN+ +++D K+ DFGLA+ +T V +
Sbjct: 137 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAPEIM 190
Query: 317 ANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLV----------DWLKMMVGS 366
N N+ D++S G ++ E +TGR ++ L+ K+ S
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 367 RRSEEVVDPNI------EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQV 410
R+ + V L LL + + DS+KR +Q
Sbjct: 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLE--KMLVLDSDKRITAAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 3e-32
Identities = 65/306 (21%), Positives = 110/306 (35%), Gaps = 46/306 (15%)
Query: 141 NRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHK 197
R+ +G G G+V + + VA+KK+ K E+ + V HK
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 198 NLVRLLGYCI------EGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTA 251
N++ LL E LV E ++ + L E +L
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ-------VIQMELDHERMSYLLYQML 129
Query: 252 KALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGY 311
+ +LH ++HRD+K SNI++ D K+ DFGLA+ AG S + T + T Y
Sbjct: 130 CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYY 184
Query: 312 VAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLV---------DWLKM 362
APE E D++S G ++ E + + + N V +++K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 363 MVGSRRSEEVVDPNIEVRPSTRALKRSLLTAL----------------RCVDPDSEKRPK 406
+ + R+ P + SL A + + D KR
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304
Query: 407 MSQVVR 412
+ ++
Sbjct: 305 VDDALQ 310
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 122 bits (306), Expect = 1e-31
Identities = 41/242 (16%), Positives = 80/242 (33%), Gaps = 18/242 (7%)
Query: 138 LATNRFSKENVLGEGGYGVVYRG-NLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRH 196
R+ LG G + V+ +++N + VA+K + + E E++ + V
Sbjct: 10 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE-AAEDEIKLLQRVND 68
Query: 197 KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQW------------LHGAMRHHGYLTWEARM 244
+ + I ++L + N H +
Sbjct: 69 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 128
Query: 245 KVLLGTAKALAYLHEAIEPKVVHRDIKSSNILID-DDFNAKVSDFGLAKLLGAGKSHVTT 303
++ L Y+H ++H DIK N+L++ D + +A L A
Sbjct: 129 QISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 186
Query: 304 R-VMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKM 362
+ T Y +PE +D++S L+ E ITG + D +
Sbjct: 187 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246
Query: 363 MV 364
++
Sbjct: 247 II 248
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.5 bits (216), Expect = 8e-21
Identities = 27/159 (16%), Positives = 51/159 (32%), Gaps = 21/159 (13%)
Query: 147 NVLGEGGYGVVYRGNLINGSPVAVK----------KILNNVGQAEKEFRVEVEAIGHVRH 196
++GEG V+ VK K+ + F V
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 197 KNLVRLLGYCIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAY 256
+ L +L G + VY + N L + + + + VL + +A
Sbjct: 66 RALQKLQGLAV-----PKVYAWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEVAK 118
Query: 257 LHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295
+ +VH D+ N+L+ + + DF + +G
Sbjct: 119 FY---HRGIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVG 153
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 463 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.69 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.1 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.53 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.2 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.29 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.14 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-55 Score=412.65 Aligned_cols=263 Identities=25% Similarity=0.431 Sum_probs=202.4
Q ss_pred HHHHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEccc--chhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEE
Q 012462 136 LELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNN--VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRM 213 (463)
Q Consensus 136 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 213 (463)
+++..++|++.+.||+|+||+||+|++. ..||||++... .....+.|.+|+.++++++|||||++++++.+ ...+
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~ 79 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLA 79 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEE
Confidence 3556788999999999999999999753 46999998543 34455789999999999999999999998754 5689
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
+||||+++|+|.+++.. ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 80 lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~ 153 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATV 153 (276)
T ss_dssp EEEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred EEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceee
Confidence 99999999999999964 345699999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCC-ceeeccccccCCCCchhhhcc---CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCc
Q 012462 294 LGAGK-SHVTTRVMGTFGYVAPEYANT---GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369 (463)
Q Consensus 294 ~~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 369 (463)
..... ........||+.|||||++.+ ..|+.++|||||||+||||+||+.||.+...... ...........
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~-----~~~~~~~~~~~ 228 (276)
T d1uwha_ 154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-----IIFMVGRGYLS 228 (276)
T ss_dssp ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-----HHHHHHHTSCC
T ss_pred ccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH-----HHHHHhcCCCC
Confidence 65432 233455789999999999864 3589999999999999999999999986543221 11111112111
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCC
Q 012462 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEE 418 (463)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~ 418 (463)
....... ....+ .+..++.+||+.||++|||++||+++|+.+.
T Consensus 229 p~~~~~~---~~~~~---~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 229 PDLSKVR---SNCPK---AMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp CCGGGSC---TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred Ccchhcc---ccchH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1111110 01112 3344566899999999999999999998753
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-55 Score=408.10 Aligned_cols=256 Identities=27% Similarity=0.446 Sum_probs=197.4
Q ss_pred hcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeec
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYV 219 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 219 (463)
.++|++.+.||+|+||+||+|.+.+++.||||++... ....++|.+|+.++++++||||++++|+|.+.+..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 3578899999999999999999888889999998653 344578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCc
Q 012462 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299 (463)
Q Consensus 220 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 299 (463)
++|+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 83 EHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp TTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 99999999864 345689999999999999999999999 999999999999999999999999999987765444
Q ss_pred eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCC
Q 012462 300 HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEV 379 (463)
Q Consensus 300 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (463)
.......||+.|+|||++.+..|+.++|||||||+||||+|+..|+.... .....+.......... .+.
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-----~~~~~~~~i~~~~~~~---~p~--- 225 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-----SNSEVVEDISTGFRLY---KPR--- 225 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-----CHHHHHHHHHHTCCCC---CCT---
T ss_pred eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC-----CHHHHHHHHHhcCCCC---Ccc---
Confidence 44445678999999999999999999999999999999999544443222 1122222222221111 110
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 380 RPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 380 ~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
... ..+..++.+||+.||++|||++||+++|+++
T Consensus 226 -~~~---~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 226 -LAS---THVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp -TSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -ccC---HHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 111 2344566789999999999999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-55 Score=412.71 Aligned_cols=261 Identities=26% Similarity=0.403 Sum_probs=210.8
Q ss_pred HHHHHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEE
Q 012462 135 DLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 135 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 214 (463)
++++..++|++.+.||+|+||+||+|.++++..||||++.... ...+.|.+|+.++++++|||||+++|++.+ +..++
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i 84 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence 4456678899999999999999999998888899999986543 345679999999999999999999998754 56799
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
||||+++|+|.+++.... ...+++..++.++.||+.||.|||++ +|+||||||+||||++++.+||+|||+|+..
T Consensus 85 v~Ey~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp EEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeCCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEc
Confidence 999999999999875432 23589999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccccc
Q 012462 295 GAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVD 374 (463)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (463)
............||+.|+|||++.+..++.++|||||||+||||+||..|+..... ..+.+...........
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-----~~~~~~~i~~~~~~~~--- 231 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-----NPEVIQNLERGYRMVR--- 231 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHHHHHHHHTTCCCCC---
T ss_pred cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHhcCCCCC---
Confidence 66555555567799999999999999999999999999999999997666543321 1222222222211110
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 375 PNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
+ ..... .+..++.+||+.||++|||+.||++.|++.
T Consensus 232 p----~~~~~---~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 232 P----DNCPE---ELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp C----TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred c----ccChH---HHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 0 11112 344556689999999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-54 Score=409.69 Aligned_cols=250 Identities=25% Similarity=0.377 Sum_probs=205.1
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeec
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYV 219 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 219 (463)
++|++.+.||+|+||+||+|.. .+|+.||||++........+.+.+|+.++++++||||+++++++.+.+..|+||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 5799999999999999999965 568999999986555555678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCc
Q 012462 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299 (463)
Q Consensus 220 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 299 (463)
++|+|.+++.. ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++++||+|||+++.......
T Consensus 100 ~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp TTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 99999998753 3599999999999999999999999 999999999999999999999999999998754332
Q ss_pred eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCCC
Q 012462 300 HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEV 379 (463)
Q Consensus 300 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (463)
.....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.... ..+.......... ...
T Consensus 172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~~~~~~------~~~ 238 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTPE------LQN 238 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSCC------CSS
T ss_pred -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH------HHHHHHHhCCCCC------CCC
Confidence 344568999999999999999999999999999999999999999754321 1122222111110 111
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 380 RPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 380 ~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
... ....+..++.+||+.||++|||+.|++++
T Consensus 239 ~~~--~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 239 PEK--LSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp GGG--SCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred ccc--CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111 11223345568999999999999999864
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-55 Score=409.20 Aligned_cols=252 Identities=24% Similarity=0.349 Sum_probs=199.7
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
++|++.+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+++..|+||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 5699999999999999999976 468999999985433 33346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+++|+|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 85 ~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 85 CSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 99999999884 345699999999999999999999999 99999999999999999999999999998765433
Q ss_pred -ceeeccccccCCCCchhhhccCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCC
Q 012462 299 -SHVTTRVMGTFGYVAPEYANTGLL-NEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376 (463)
Q Consensus 299 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (463)
.......+||+.|||||++.+..+ +.++|||||||+||||++|+.||........ . ............ +.
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--~---~~~~~~~~~~~~---~~ 229 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--E---YSDWKEKKTYLN---PW 229 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH--H---HHHHHTTCTTST---TG
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH--H---HHHHhcCCCCCC---cc
Confidence 223455789999999999988876 5789999999999999999999976443211 1 111111111110 00
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
..... ....++.+||+.||++|||++|++++
T Consensus 230 ---~~~s~---~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 230 ---KKIDS---APLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp ---GGSCH---HHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---ccCCH---HHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 01112 23345568999999999999999763
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-54 Score=401.07 Aligned_cols=255 Identities=24% Similarity=0.388 Sum_probs=211.5
Q ss_pred hcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeec
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYV 219 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 219 (463)
.++|++.++||+|+||+||+|++++++.||||++.... ...++|.+|+.++++++||||++++|+|.+++..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 36799999999999999999998888899999986543 34568999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCc
Q 012462 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299 (463)
Q Consensus 220 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 299 (463)
++|+|.+++... ...+++..+++++.||++||.|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 82 ANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp TTEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred CCCcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 999999997643 34589999999999999999999999 999999999999999999999999999987665544
Q ss_pred eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCC
Q 012462 300 HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378 (463)
Q Consensus 300 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (463)
.......+|+.|+|||++.+..++.++|||||||++|||+| |+.||...... +.........+.. .+.
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~------~~~~~i~~~~~~~---~p~-- 224 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------ETAEHIAQGLRLY---RPH-- 224 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH------HHHHHHHTTCCCC---CCT--
T ss_pred eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH------HHHHHHHhCCCCC---Ccc--
Confidence 44445678999999999999999999999999999999998 89999765422 2222232221111 111
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 379 ~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
... ..+..++.+||+.||++|||++|++++|.++
T Consensus 225 --~~~---~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 225 --LAS---EKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp --TCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred --ccc---HHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 111 2344556689999999999999999999764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-55 Score=415.25 Aligned_cols=263 Identities=25% Similarity=0.375 Sum_probs=214.2
Q ss_pred HHHHHhcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEE
Q 012462 135 DLELATNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRM 213 (463)
Q Consensus 135 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 213 (463)
.+++..++|++.+.||+|+||+||+|.+. +++.||||++.... ...+++.+|+.++++++|||||+++++|.+++..+
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 34566788999999999999999999765 57889999886543 34567899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
+||||+++|+|.+++.. .....+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 90 iv~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp EEEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred EEeecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceee
Confidence 99999999999999865 2345799999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccc
Q 012462 294 LGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373 (463)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (463)
.............|++.|+|||++.+..|+.++|||||||++|||++|..||...... ..............
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~-----~~~~~~i~~~~~~~--- 236 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYELLEKDYRME--- 236 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----HHHHHHHHTTCCCC---
T ss_pred cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH-----HHHHHHHhcCCCCC---
Confidence 7655544455566899999999999999999999999999999999987777543321 11122222221111
Q ss_pred cCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCC
Q 012462 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEE 418 (463)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~ 418 (463)
.... ....+..++.+||+.||++|||+.|+++.|+.+.
T Consensus 237 -----~~~~--~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 237 -----RPEG--CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp -----CCTT--CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -----CCcc--chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1111 1123445566899999999999999999998764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-54 Score=404.31 Aligned_cols=245 Identities=27% Similarity=0.427 Sum_probs=202.1
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
++|++.+.||+|+||+||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46899999999999999999764 68899999985432 234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 86 Ey~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 99999999999964 34599999999999999999999999 999999999999999999999999999987654
Q ss_pred CCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (463)
.. ....+||+.|+|||++.+..|+.++|||||||+||||++|+.||..... ............
T Consensus 159 ~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~-------- 221 (263)
T d2j4za1 159 SR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------QETYKRISRVEF-------- 221 (263)
T ss_dssp CC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTTCC--------
T ss_pred Cc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH------HHHHHHHHcCCC--------
Confidence 32 3446799999999999999999999999999999999999999975432 122222222110
Q ss_pred CCCCC-CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 377 IEVRP-STRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 377 ~~~~~-~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
..+. .... +..++.+||+.||++|||++|++++
T Consensus 222 -~~p~~~s~~---~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 222 -TFPDFVTEG---ARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp -CCCTTSCHH---HHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -CCCccCCHH---HHHHHHHHccCCHhHCcCHHHHHcC
Confidence 1111 1122 3344558999999999999999873
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=406.34 Aligned_cols=256 Identities=23% Similarity=0.348 Sum_probs=193.3
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEE--CcEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE--GIHRMLV 215 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lV 215 (463)
++|++.+.||+|+||+||+|+. .+|+.||||.+.... ....+.+.+|+.++++++||||+++++++.+ ....|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5699999999999999999965 468899999985432 3344678899999999999999999999865 4567999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI--EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
|||+++|+|.+++.........+++..++.++.||+.||.|||+.. ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999876556678999999999999999999999971 11399999999999999999999999999987
Q ss_pred cCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccc
Q 012462 294 LGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373 (463)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (463)
..... ......+||+.|+|||++.+..|+.++|||||||++|||+||+.||..... .+......... ...+.
T Consensus 164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~------~~~~~~i~~~~-~~~~~ 235 (269)
T d2java1 164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ------KELAGKIREGK-FRRIP 235 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHTC-CCCCC
T ss_pred cccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH------HHHHHHHHcCC-CCCCC
Confidence 65432 234457899999999999999999999999999999999999999975432 12222222211 11110
Q ss_pred cCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
....++ +..++.+||+.||++|||+.|++++
T Consensus 236 ------~~~s~~---l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 236 ------YRYSDE---LNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp ------TTSCHH---HHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------cccCHH---HHHHHHHHcCCChhHCcCHHHHHhC
Confidence 011122 3344568999999999999999864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.8e-54 Score=408.35 Aligned_cols=256 Identities=27% Similarity=0.452 Sum_probs=195.7
Q ss_pred hcCCCccCeEeecCcEEEEEEEEcC-CC---eEEEEEEccc-chhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLIN-GS---PVAVKKILNN-VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~---~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 214 (463)
.++|++.++||+|+||+||+|.+.. ++ .||||++... .....+.|.+|+.++++++|||||+++|+|.+.+..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 4568888999999999999997642 32 5889987543 33455679999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
|||||++|+|.+++.. ..+.+++..++.++.||+.||.|||++ +|+||||||+||||+.++++||+|||+++..
T Consensus 105 v~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEc
Confidence 9999999999998863 345699999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCcee----eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCc
Q 012462 295 GAGKSHV----TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369 (463)
Q Consensus 295 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 369 (463)
....... .....||+.|||||++.+..++.++|||||||+||||+| |+.||.+.... +.+.........
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~------~~~~~i~~~~~~ 252 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ------DVINAIEQDYRL 252 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTTCCC
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCCC
Confidence 5432211 123457899999999999999999999999999999998 89999764422 222333322221
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.. +. .....+..++.+||+.||++|||+.||++.|+.+
T Consensus 253 ~~--------~~--~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 253 PP--------PM--DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp CC--------CT--TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CC--------Cc--cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11 11 1112334456689999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-54 Score=405.42 Aligned_cols=252 Identities=24% Similarity=0.321 Sum_probs=203.2
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeec
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYV 219 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 219 (463)
+.|++.+.||+|+||+||+|.+ .++..||||++........+.+.+|++++++++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 4689999999999999999976 468899999987655566678889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCc
Q 012462 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299 (463)
Q Consensus 220 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 299 (463)
++|+|.+++... ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 92 ~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~- 164 (288)
T d2jfla1 92 AGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI- 164 (288)
T ss_dssp TTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-
Confidence 999999987642 34699999999999999999999999 99999999999999999999999999997653221
Q ss_pred eeeccccccCCCCchhhhc-----cCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccccc
Q 012462 300 HVTTRVMGTFGYVAPEYAN-----TGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVD 374 (463)
Q Consensus 300 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (463)
......+||+.|+|||++. +..|+.++|||||||+||||+||+.||....+... +......... .
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~------~~~i~~~~~~-~--- 234 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV------LLKIAKSEPP-T--- 234 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------HHHHHHSCCC-C---
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH------HHHHHcCCCC-C---
Confidence 1234568999999999984 45689999999999999999999999986543321 1112222110 0
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 375 PNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
+..... ....+..++.+||+.||++|||++|++++
T Consensus 235 --~~~~~~--~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 235 --LAQPSR--WSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp --CSSGGG--SCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred --CCcccc--CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 010111 11233345568999999999999999874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-54 Score=417.19 Aligned_cols=202 Identities=28% Similarity=0.417 Sum_probs=178.4
Q ss_pred HHhcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEE
Q 012462 138 LATNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 138 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 215 (463)
+..++|++.++||+|+||+||+|.. .+|+.||+|++.... ......+.+|+.++++++|||||+++++|.+..+.|+|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3467899999999999999999976 468899999985432 34456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE-AIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
|||+++|+|.+++.. .+.+++..+..++.||+.||.|||+ + +|+||||||+|||++.++++||+|||+|+..
T Consensus 83 mEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp EECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence 999999999999964 2459999999999999999999996 6 8999999999999999999999999999865
Q ss_pred CCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 295 GAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||....
T Consensus 156 ~~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 156 IDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp HHH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred CCC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 432 2345689999999999999999999999999999999999999997654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=391.92 Aligned_cols=247 Identities=24% Similarity=0.390 Sum_probs=195.0
Q ss_pred CC-CccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEE----CcEEE
Q 012462 142 RF-SKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE----GIHRM 213 (463)
Q Consensus 142 ~~-~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~ 213 (463)
|| ++.++||+|+||+||+|.+. ++..||+|++.... ....+.+.+|++++++++|||||+++++|.+ ....|
T Consensus 9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred CEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence 44 56778999999999999664 57899999985432 3345678899999999999999999999875 45679
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEEccCCCCceeEc-CCCCEEEeeccc
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPK--VVHRDIKSSNILID-DDFNAKVSDFGL 290 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~Dikp~Nill~-~~~~~kl~Dfg~ 290 (463)
+||||+++|+|.+++.. ...+++..++.++.||+.||+|||++ + |+||||||+|||++ +++.+||+|||+
T Consensus 89 ivmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGl 161 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 161 (270)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCc
Confidence 99999999999999964 34599999999999999999999998 7 99999999999996 578999999999
Q ss_pred ceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 291 AKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 291 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
++..... .....+||+.|||||++.+ .|+.++|||||||++|||++|+.||...... ..............
T Consensus 162 a~~~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-----~~~~~~i~~~~~~~ 232 (270)
T d1t4ha_ 162 ATLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRRVTSGVKPA 232 (270)
T ss_dssp GGGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHHHTTTCCCG
T ss_pred ceeccCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-----HHHHHHHHcCCCCc
Confidence 9864432 2345689999999999876 5999999999999999999999999754321 12222222221111
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.+ + ....++ +..++.+||+.||++|||++|++++
T Consensus 233 ~~-~-----~~~~~~---~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 233 SF-D-----KVAIPE---VKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp GG-G-----GCCCHH---HHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cc-C-----ccCCHH---HHHHHHHHccCCHhHCcCHHHHhCC
Confidence 11 1 111122 3345668999999999999999874
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-53 Score=401.16 Aligned_cols=257 Identities=26% Similarity=0.412 Sum_probs=204.9
Q ss_pred HhcCCCccCe-EeecCcEEEEEEEEc---CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEE
Q 012462 139 ATNRFSKENV-LGEGGYGVVYRGNLI---NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRM 213 (463)
Q Consensus 139 ~~~~~~~~~~-lG~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 213 (463)
..++|.+.+. ||+|+||+||+|.+. ++..||||++.... ....++|.+|++++++++|||||+++|+|.+ +..|
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~ 84 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 84 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence 3456777774 999999999999653 34579999986543 3445789999999999999999999999865 4679
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
+||||+++|+|.+++.. ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 85 lvmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp EEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhc
Confidence 99999999999999853 345699999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCcee--eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 294 LGAGKSHV--TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 294 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
........ .....||+.|+|||++.+..++.++|||||||++|||+| |+.||...... +.........+..
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~------~~~~~i~~~~~~~ 232 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP------EVMAFIEQGKRME 232 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH------HHHHHHHTTCCCC
T ss_pred ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCCCC
Confidence 76543322 234568999999999999999999999999999999998 99999865432 1222222222211
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCC
Q 012462 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEE 418 (463)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~ 418 (463)
. ++. ....+..++.+||+.||++||||.+|++.|+...
T Consensus 233 -~-------p~~--~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 233 -C-------PPE--CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp -C-------CTT--CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -C-------CCc--CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1 111 1123345566899999999999999999988653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=410.74 Aligned_cols=261 Identities=26% Similarity=0.392 Sum_probs=204.6
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEEcCC------CeEEEEEEcccc-hhhHHHHHHHHHHHcCC-CCCCcceEeeEEEE
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNLING------SPVAVKKILNNV-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIE 208 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 208 (463)
++..++|++.++||+|+||+||+|++... ..||+|.+.... ......+.+|+.++.++ +|||||+++++|.+
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 45567899999999999999999976432 258999885433 33446788899999988 89999999999999
Q ss_pred CcEEEEEEeecCCCCHHHHHhhhhc-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEcc
Q 012462 209 GIHRMLVYEYVNNGNLEQWLHGAMR-------------------HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRD 269 (463)
Q Consensus 209 ~~~~~lV~e~~~~g~L~~~l~~~~~-------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~D 269 (463)
.+..++|||||++|+|.++++.... ....+++..++.++.||+.||+|||++ +|+|||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRD 189 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD 189 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence 9999999999999999999975321 123589999999999999999999999 999999
Q ss_pred CCCCceeEcCCCCEEEeecccceecCCCCc-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCC
Q 012462 270 IKSSNILIDDDFNAKVSDFGLAKLLGAGKS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDH 347 (463)
Q Consensus 270 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~ 347 (463)
|||+|||++.++.+||+|||+|+....... .......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987654432 23445678999999999999999999999999999999998 8999976
Q ss_pred CCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHh
Q 012462 348 GRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLE 415 (463)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~ 415 (463)
...... + ........... .+.. ....+..++.+||+.||++|||++||+++|.
T Consensus 270 ~~~~~~--~----~~~~~~~~~~~-------~p~~--~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 270 IPVDAN--F----YKLIQNGFKMD-------QPFY--ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCCSHH--H----HHHHHTTCCCC-------CCTT--CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCHHHH--H----HHHHhcCCCCC-------CCCc--CCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 443211 1 11222211110 1111 1123445566899999999999999999985
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=402.41 Aligned_cols=262 Identities=27% Similarity=0.399 Sum_probs=204.5
Q ss_pred HHHHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEE
Q 012462 136 LELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 136 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV 215 (463)
+++..++|++.+.||+|+||+||+|.+.++..||||++... ....+.|.+|+.++++++|||||+++|+|.+ +..++|
T Consensus 12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv 89 (285)
T d1fmka3 12 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 89 (285)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEE
Confidence 34556789999999999999999999888889999998543 3445789999999999999999999999854 567999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
|||+++|+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+||||+.++++||+|||+++...
T Consensus 90 ~Ey~~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~ 164 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 164 (285)
T ss_dssp ECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred EEecCCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhcc
Confidence 99999999999986532 34599999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 296 AGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
...........||+.|+|||++.+..++.++|||||||+||||++|..||..... ..+.+.......... .
T Consensus 165 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-----~~~~~~~i~~~~~~~-~--- 235 (285)
T d1fmka3 165 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-----NREVLDQVERGYRMP-C--- 235 (285)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHHHHHHHHTTCCCC-C---
T ss_pred CCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-----HHHHHHHHHhcCCCC-C---
Confidence 5544444556789999999999999999999999999999999997777654332 222233332222111 1
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCC
Q 012462 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEY 419 (463)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~ 419 (463)
.... ...+..++.+||+.||++|||+++|++.|+....
T Consensus 236 ----~~~~--~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 236 ----PPEC--PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp ----CTTS--CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred ----Cccc--CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 1111 1234455668999999999999999999988643
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-53 Score=397.96 Aligned_cols=257 Identities=26% Similarity=0.447 Sum_probs=198.1
Q ss_pred hcCCCccCeEeecCcEEEEEEEEcCC-----CeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLING-----SPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRM 213 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 213 (463)
.+.|+..++||+|+||+||+|.+..+ ..||||++.... .....+|.+|+.++++++|||||+++|+|.+....+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 45688889999999999999976542 369999985543 334567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
+||||+.+++|.+++.. ....+++..++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.
T Consensus 86 ~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 86 IITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhc
Confidence 99999999999998763 345699999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCc--eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccc
Q 012462 294 LGAGKS--HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEE 371 (463)
Q Consensus 294 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (463)
...... .......||+.|+|||++.+..++.++|||||||+||||++|..|+...... ...+.......+...
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-----~~~~~~i~~~~~~~~ 234 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----HEVMKAINDGFRLPT 234 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHHHTTCCCCC
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-----HHHHHHHhccCCCCC
Confidence 654322 2233456899999999999999999999999999999999977666543321 222222222221111
Q ss_pred cccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 372 VVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
+. .....+..++.+||+.||++||||.||++.|+.+
T Consensus 235 --------~~--~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 235 --------PM--DCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp --------CT--TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred --------ch--hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 11 1112344566789999999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.9e-52 Score=405.65 Aligned_cols=251 Identities=22% Similarity=0.341 Sum_probs=206.1
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeec
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYV 219 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 219 (463)
++|++.+.||+|+||+||+|.. .+|+.||||++........+.+.+|+.++++++|||||++++++.+.+..|+|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5799999999999999999966 468999999997666666678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEc--CCCCEEEeecccceecCCC
Q 012462 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILID--DDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 220 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~--~~~~~kl~Dfg~a~~~~~~ 297 (463)
++|+|.+++.. ..+.+++..++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++.....
T Consensus 106 ~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 106 SGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 99999999853 345699999999999999999999999 999999999999996 4688999999999987654
Q ss_pred CceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCC-ccccccCC
Q 012462 298 KSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRR-SEEVVDPN 376 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 376 (463)
.. ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+... .+.+........ .....
T Consensus 180 ~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~~~~~--- 248 (350)
T d1koaa2 180 QS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND------DETLRNVKSCDWNMDDSA--- 248 (350)
T ss_dssp SC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCCSCCGG---
T ss_pred cc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCCCCccc---
Confidence 32 3446799999999999999999999999999999999999999975432 122222222111 11000
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
...... .+..++.+||+.||++|||++|++++
T Consensus 249 --~~~~s~---~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 249 --FSGISE---DGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp --GGGCCH---HHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred --ccCCCH---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001112 23345668999999999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-53 Score=400.73 Aligned_cols=248 Identities=21% Similarity=0.324 Sum_probs=199.6
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
++|++.+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5699999999999999999976 468999999985432 233467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+++|+|.+++.. .+.+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+....
T Consensus 88 Ey~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 99999999998864 34699999999999999999999999 999999999999999999999999999998754
Q ss_pred CC-ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 297 GK-SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 297 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
.. .......+||+.|+|||++.+..|+.++|||||||+||||++|+.||...... ...........
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i~~~~~------- 227 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY------LIFQKIIKLEY------- 227 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHTTCC-------
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH------HHHHHHHcCCC-------
Confidence 32 22344568999999999999999999999999999999999999999864321 22222222110
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 012462 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVR 412 (463)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~ 412 (463)
..+... ......++.+||+.||++|||++|+++
T Consensus 228 --~~p~~~--s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 --DFPEKF--FPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp --CCCTTC--CHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred --CCCccC--CHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 111111 122344566899999999999999754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=392.65 Aligned_cols=247 Identities=28% Similarity=0.407 Sum_probs=195.5
Q ss_pred CeEeecCcEEEEEEEEcC---CCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeecCC
Q 012462 147 NVLGEGGYGVVYRGNLIN---GSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYVNN 221 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~~---~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 221 (463)
++||+|+||+||+|.+.+ ++.||||++.... ....+.+.+|+.++++++|||||+++|+|.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999997643 4579999985432 3345679999999999999999999999965 457899999999
Q ss_pred CCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCcee
Q 012462 222 GNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHV 301 (463)
Q Consensus 222 g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 301 (463)
|+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999999853 45699999999999999999999999 99999999999999999999999999999765543322
Q ss_pred --eccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCCC
Q 012462 302 --TTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIE 378 (463)
Q Consensus 302 --~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (463)
.....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.... +.........+..
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~------~~~~~i~~~~~~~-------- 230 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------EVTAMLEKGERMG-------- 230 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHHHTTCCCC--------
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH------HHHHHHHcCCCCC--------
Confidence 234578999999999999999999999999999999998 89999864321 2222222222111
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 379 VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 379 ~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.+.. ....+..++.+||+.||++|||+.+|++.|+..
T Consensus 231 ~p~~--~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 231 CPAG--CPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCTT--CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCcc--cCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 1111 112334556689999999999999999988764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-52 Score=399.42 Aligned_cols=252 Identities=25% Similarity=0.380 Sum_probs=187.6
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
.++|++.+.||+|+||+||+|... +|+.||||++.... ......+.+|+.++++++||||+++++++.+++..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 567999999999999999999764 68899999986443 2334567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEc---CCCCEEEeecccceec
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILID---DDFNAKVSDFGLAKLL 294 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~---~~~~~kl~Dfg~a~~~ 294 (463)
||+||+|.+++. ..+.+++..+..++.||+.||+|||++ +|+||||||+|||+. +++.+||+|||+++..
T Consensus 88 ~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHH----TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhh----cccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 999999999995 345699999999999999999999999 999999999999994 5789999999999876
Q ss_pred CCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccccc
Q 012462 295 GAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVD 374 (463)
Q Consensus 295 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (463)
.... .....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.... .............. .
T Consensus 161 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i~~~~~~~~--~ 230 (307)
T d1a06a_ 161 DPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA------KLFEQILKAEYEFD--S 230 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHTTCCCCC--T
T ss_pred cCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHhccCCCCC--C
Confidence 5432 234568999999999999999999999999999999999999999754321 11222222211100 0
Q ss_pred CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 375 PNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
+ ......+ .+..++.+||+.||++|||++|++++
T Consensus 231 ~--~~~~~s~---~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 231 P--YWDDISD---SAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp T--TTTTSCH---HHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred c--cccCCCH---HHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0 0011112 23345568999999999999999985
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-51 Score=400.52 Aligned_cols=252 Identities=19% Similarity=0.269 Sum_probs=206.0
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEeec
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEYV 219 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 219 (463)
++|++.+.||+|+||+||+|.. .+|+.||||++..........+.+|+.++++++|||||+++++|.+++..|+|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5799999999999999999965 568999999987665556678889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEc--CCCCEEEeecccceecCCC
Q 012462 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILID--DDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 220 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~--~~~~~kl~Dfg~a~~~~~~ 297 (463)
++|+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+||||+ .++.+||+|||+|......
T Consensus 109 ~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 109 SGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 99999987742 344699999999999999999999999 999999999999998 6789999999999987654
Q ss_pred CceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCCC
Q 012462 298 KSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNI 377 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (463)
.. .....||+.|+|||++.+..|+.++|||||||+||||+||+.||.+.... ..+..+...... + +..
T Consensus 183 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~~~--~--~~~ 250 (352)
T d1koba_ 183 EI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETLQNVKRCDWE--F--DED 250 (352)
T ss_dssp SC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHHCCCC--C--CSS
T ss_pred Cc--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC--C--Ccc
Confidence 32 34457899999999999999999999999999999999999999754321 222222221110 0 000
Q ss_pred CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 378 EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
........ +..++.+||+.||.+|||+.|++++
T Consensus 251 ~~~~~s~~---~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 251 AFSSVSPE---AKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp TTTTSCHH---HHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccCCCHH---HHHHHHHHccCChhHCcCHHHHhcC
Confidence 01111222 3345668999999999999999885
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=394.93 Aligned_cols=258 Identities=23% Similarity=0.380 Sum_probs=195.3
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEEcC----CCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcE
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNLIN----GSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIH 211 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 211 (463)
++..++|++.+.||+|+||+||+|.+.. +..||||.+.... ....+.+.+|+.++++++||||++++++|. .+.
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 81 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 81 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCe
Confidence 4556789999999999999999997643 3468888875433 334567899999999999999999999996 467
Q ss_pred EEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccc
Q 012462 212 RMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA 291 (463)
Q Consensus 212 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a 291 (463)
.|+||||+++|+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 82 ~~iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a 155 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS 155 (273)
T ss_dssp CEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----
T ss_pred EEEEEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhh
Confidence 8999999999999998753 345699999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 292 KLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
+..............||+.|+|||++.+..++.++|||||||+||||+| |..||....... +.. .........
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~---~i~~~~~~~ 229 (273)
T d1mp8a_ 156 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIG---RIENGERLP 229 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH---HHHTTCCCC
T ss_pred eeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHH---HHHcCCCCC
Confidence 8776544444455678999999999999999999999999999999998 899997655332 221 222221111
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 371 EVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.++.. ...+..++.+||+.||++|||+.||+++|+.+
T Consensus 230 --------~~~~~--~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 230 --------MPPNC--PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp --------CCTTC--CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------CCCCC--CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11111 12344456689999999999999999999865
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-52 Score=399.76 Aligned_cols=246 Identities=24% Similarity=0.341 Sum_probs=198.1
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
.+|+.++.||+|+||+||+|.. .+++.||||++.... ....+.+.+|+.++++++|||||++++++.+.+..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 3589999999999999999965 467889999985433 233457889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
|||.+|+|..++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 95 E~~~~g~l~~~~~----~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 9999999877663 245699999999999999999999999 999999999999999999999999999986543
Q ss_pred CCceeeccccccCCCCchhhhcc---CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccc
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANT---GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV 373 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (463)
....+||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+... .+.+......... .+.
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~------~~~~~~i~~~~~~-~~~ 235 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNESP-ALQ 235 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCCC-CCS
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCCCC-CCC
Confidence 234579999999999864 4689999999999999999999999975432 1222222222111 111
Q ss_pred cCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 374 DPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
....... +..++.+||+.||++|||++|++++
T Consensus 236 -----~~~~s~~---~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 236 -----SGHWSEY---FRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp -----CTTSCHH---HHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred -----CCCCCHH---HHHHHHHHCcCChhHCcCHHHHHhC
Confidence 1111222 3344568999999999999999873
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-51 Score=387.32 Aligned_cols=251 Identities=24% Similarity=0.329 Sum_probs=203.6
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc------hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV------GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHR 212 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 212 (463)
.++|++.+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+.++++++|||||+++++|.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46899999999999999999976 568999999985322 22357889999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCC----CEEEeec
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDF----NAKVSDF 288 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~----~~kl~Df 288 (463)
|+|||||++|+|.+++... +.+++..++.++.||+.||+|||+. +|+||||||+|||++.++ .+||+||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence 9999999999999999642 4699999999999999999999999 999999999999998776 5999999
Q ss_pred ccceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCC
Q 012462 289 GLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRR 368 (463)
Q Consensus 289 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 368 (463)
|++....... ......||+.|+|||++.+..++.++|||||||+||||++|+.||.+.... +.+........
T Consensus 162 G~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i~~~~~ 233 (293)
T d1jksa_ 162 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANVSAVNY 233 (293)
T ss_dssp TTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHTTCC
T ss_pred hhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH------HHHHHHHhcCC
Confidence 9998875433 234467899999999999999999999999999999999999999864322 22222222111
Q ss_pred c-cccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 369 S-EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 369 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
. .....+ .. ...+..++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~-----~~---s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 234 EFEDEYFS-----NT---SALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp CCCHHHHT-----TS---CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCchhcC-----CC---CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 000000 01 1223445668999999999999999874
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.7e-52 Score=395.62 Aligned_cols=267 Identities=23% Similarity=0.351 Sum_probs=211.7
Q ss_pred hHHHHHHhcCCCccCeEeecCcEEEEEEEEc------CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeE
Q 012462 133 LRDLELATNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGY 205 (463)
Q Consensus 133 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~ 205 (463)
+.++++.+++|++.+.||+|+||+||+|++. ++..||||++.... ....+++.+|+.++++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 4566777889999999999999999999764 34689999986543 3345679999999999999999999999
Q ss_pred EEECcEEEEEEeecCCCCHHHHHhhhh--------------------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 012462 206 CIEGIHRMLVYEYVNNGNLEQWLHGAM--------------------RHHGYLTWEARMKVLLGTAKALAYLHEAIEPKV 265 (463)
Q Consensus 206 ~~~~~~~~lV~e~~~~g~L~~~l~~~~--------------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i 265 (463)
|.+....++||||+++|+|.+++.... .....+++..++.++.|++.||+|||++ +|
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence 999999999999999999999996421 1123488999999999999999999999 99
Q ss_pred EEccCCCCceeEcCCCCEEEeecccceecCCCC-ceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCC-C
Q 012462 266 VHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK-SHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGR-D 343 (463)
Q Consensus 266 ~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~-~ 343 (463)
+||||||+|||++.++.+||+|||+++...... ....+...||+.|+|||++.+..|+.++|||||||+||||++|. .
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 999999999999999999999999998664332 22334567899999999999999999999999999999999986 5
Q ss_pred CCCCCCCcccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCC
Q 012462 344 PVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEE 418 (463)
Q Consensus 344 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~ 418 (463)
||..... .+.+........ ... +.. ....+..++.+||+.||++||||.||++.|+++.
T Consensus 242 p~~~~~~------~e~~~~v~~~~~-~~~-------p~~--~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 242 PYYGMAH------EEVIYYVRDGNI-LAC-------PEN--CPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTTSCH------HHHHHHHHTTCC-CCC-------CTT--CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCH------HHHHHHHHcCCC-CCC-------Ccc--chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 6764332 222222222221 111 111 1123455677899999999999999999999874
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-51 Score=394.30 Aligned_cols=248 Identities=25% Similarity=0.284 Sum_probs=203.1
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+.++++++||||++++++|.+.+..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5699999999999999999965 578999999985432 234567888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+++|+|.+++.. .+.+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+|+....
T Consensus 85 ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 85 EYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 99999999999864 34689999999999999999999999 999999999999999999999999999987543
Q ss_pred CCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (463)
.. ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.... ..........
T Consensus 158 ~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~------~~~~~i~~~~--------- 221 (337)
T d1o6la_ 158 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELILMEE--------- 221 (337)
T ss_dssp TT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCC---------
T ss_pred CC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH------HHHHHHhcCC---------
Confidence 32 2345578999999999999999999999999999999999999999865421 1222222211
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 012462 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPK-----MSQVVRM 413 (463)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs-----~~ell~~ 413 (463)
...+... ......++.+||++||.+||+ ++|++++
T Consensus 222 ~~~p~~~--s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 222 IRFPRTL--SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CCCCTTS--CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCccC--CHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 1111111 112334556899999999995 8888874
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-52 Score=385.33 Aligned_cols=251 Identities=30% Similarity=0.431 Sum_probs=194.7
Q ss_pred HhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEE-CcEEEEEEe
Q 012462 139 ATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE-GIHRMLVYE 217 (463)
Q Consensus 139 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e 217 (463)
..++|++.+.||+|+||.||+|++ .|..||||++... ...+.+.+|++++++++||||++++|+|.+ .+..++|||
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred CHHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 346788899999999999999988 5789999998553 334678999999999999999999999865 456799999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
|+++|+|.+++.... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 y~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 82 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp CCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred ccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC
Confidence 999999999996532 23489999999999999999999999 9999999999999999999999999999865432
Q ss_pred CceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCccccccCC
Q 012462 298 KSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (463)
.....+|..|+|||++.+..++.++|||||||++|||+| |+.||...... ++... .. .+....+..
T Consensus 157 ----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~---i~-~~~~~~~~~-- 223 (262)
T d1byga_ 157 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPR---VE-KGYKMDAPD-- 223 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHH---HT-TTCCCCCCT--
T ss_pred ----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHH---HH-cCCCCCCCc--
Confidence 223467899999999999999999999999999999998 67777654322 22222 11 111111111
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.... .+..++.+||+.||.+|||+.+++++|+.+
T Consensus 224 ----~~~~---~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 224 ----GCPP---AVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp ----TCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----cCCH---HHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1112 334556689999999999999999999864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.8e-51 Score=388.59 Aligned_cols=244 Identities=24% Similarity=0.337 Sum_probs=201.3
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4589999999999999999976 568999999985432 234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||++||+|..++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 99999999998853 44588999999999999999999999 999999999999999999999999999988654
Q ss_pred CCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (463)
. ....+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.... ...........
T Consensus 157 ~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~i~~~~~-------- 218 (316)
T d1fota_ 157 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYEKILNAEL-------- 218 (316)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHCCC--------
T ss_pred c----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH------HHHHHHHcCCC--------
Confidence 3 33568999999999999999999999999999999999999999764321 22222222111
Q ss_pred CCCCC-CHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 012462 377 IEVRP-STRALKRSLLTALRCVDPDSEKRP-----KMSQVVRM 413 (463)
Q Consensus 377 ~~~~~-~~~~~~~~~~~~~~cl~~dP~~RP-----s~~ell~~ 413 (463)
..++ .... +..++.+||+.||.+|+ |++|++++
T Consensus 219 -~~p~~~s~~---~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 219 -RFPPFFNED---VKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -CCCTTSCHH---HHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCCCHH---HHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 1111 1122 33445579999999996 89999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=389.37 Aligned_cols=254 Identities=28% Similarity=0.476 Sum_probs=198.1
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCC----eEEEEEEccc-chhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGS----PVAVKKILNN-VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 214 (463)
.+|+++++||+|+||+||+|.+. +|+ .||+|++... .....+++.+|+.++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999664 343 5888988543 334567899999999999999999999999875 4678
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceec
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLL 294 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~ 294 (463)
++||+.+|+|.+++.. ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 8899999999998864 355699999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCce-eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCcccc
Q 012462 295 GAGKSH-VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV 372 (463)
Q Consensus 295 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (463)
...... ......||+.|+|||++.++.|+.++|||||||+||||+| |..||.+..... +...+ ....+..
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~~i---~~~~~~~-- 233 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSIL---EKGERLP-- 233 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHHHH---HHTCCCC--
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHHHH---HcCCCCC--
Confidence 544332 2334568999999999999999999999999999999998 788887654322 22221 1111111
Q ss_pred ccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 373 VDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.+.. ....+..++.+||+.||++|||+.|++++|+..
T Consensus 234 ------~p~~--~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 234 ------QPPI--CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp ------CCTT--BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCcc--cCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 1111 112344456689999999999999999998764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-51 Score=389.26 Aligned_cols=267 Identities=26% Similarity=0.395 Sum_probs=199.1
Q ss_pred hHHHHHHhcCCCccCeEeecCcEEEEEEEEcC------CCeEEEEEEcccc-hhhHHHHHHHHHHHcCC-CCCCcceEee
Q 012462 133 LRDLELATNRFSKENVLGEGGYGVVYRGNLIN------GSPVAVKKILNNV-GQAEKEFRVEVEAIGHV-RHKNLVRLLG 204 (463)
Q Consensus 133 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~ 204 (463)
...+++..++|++.++||+|+||+||+|.+.. ++.||||++.... ....+.+..|...+.++ +|+||+.+++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 45667778899999999999999999997532 3579999986433 33445677788877776 7899999999
Q ss_pred EEEEC-cEEEEEEeecCCCCHHHHHhhhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCC
Q 012462 205 YCIEG-IHRMLVYEYVNNGNLEQWLHGAMR------------HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIK 271 (463)
Q Consensus 205 ~~~~~-~~~~lV~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik 271 (463)
++.+. ...++|||||++|+|.++++.... ....+++..++.++.||+.||+|||++ +|+|||||
T Consensus 85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlK 161 (299)
T d1ywna1 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 161 (299)
T ss_dssp EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCC
T ss_pred eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCC
Confidence 98764 467999999999999999975432 134589999999999999999999999 99999999
Q ss_pred CCceeEcCCCCEEEeecccceecCCCCc-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCC-CCCCCCC
Q 012462 272 SSNILIDDDFNAKVSDFGLAKLLGAGKS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGR-DPVDHGR 349 (463)
Q Consensus 272 p~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~-~pf~~~~ 349 (463)
|+||||+.++++||+|||+|+....... .......||+.|+|||++.+..++.++|||||||++|||+||. .||....
T Consensus 162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987654332 2334567999999999999999999999999999999999975 5776543
Q ss_pred CcccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 350 PAHEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
... .+. ......... ... ....+ .+..++.+||+.||++|||+.|++++|+++
T Consensus 242 ~~~--~~~---~~~~~~~~~-~~~------~~~~~---~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 242 IDE--EFC---RRLKEGTRM-RAP------DYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp CSH--HHH---HHHHHTCCC-CCC------TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH--HHH---HHHhcCCCC-CCC------ccCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 221 111 111111111 110 01112 344556689999999999999999999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.3e-50 Score=375.88 Aligned_cols=258 Identities=26% Similarity=0.363 Sum_probs=197.6
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECc----E
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGI----H 211 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~ 211 (463)
.++|++.+.||+|+||+||+|.. .+|+.||||++.... ......+.+|+.++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46899999999999999999965 578999999986433 233457889999999999999999999987643 4
Q ss_pred EEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccc
Q 012462 212 RMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA 291 (463)
Q Consensus 212 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a 291 (463)
.|+||||++|++|.+++.. .+.+++..++.++.||+.||+|||++ +|+||||||+|||++.++.++|+|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence 7899999999999998854 34699999999999999999999999 9999999999999999999999999998
Q ss_pred eecCCCCc--eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCc
Q 012462 292 KLLGAGKS--HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369 (463)
Q Consensus 292 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 369 (463)
........ ......+||+.|+|||++.+..++.++|||||||++|||+||+.||....+ .+.+.........
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~~~~~~~~ 232 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPI 232 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH------HHHHHHHHhcCCC
Confidence 76543321 234456899999999999999999999999999999999999999975432 1222222222211
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHhcC
Q 012462 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRP-KMSQVVRMLESE 417 (463)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP-s~~ell~~L~~~ 417 (463)
... ......... +..++.+||+.||++|| |++++++.|...
T Consensus 233 ~~~----~~~~~~s~~---l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 233 PPS----ARHEGLSAD---LDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp CGG----GTSSSCCHH---HHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCc----hhccCCCHH---HHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 110 001111222 33445589999999999 899999888653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.9e-50 Score=378.06 Aligned_cols=252 Identities=25% Similarity=0.356 Sum_probs=201.2
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---------hhhHHHHHHHHHHHcCCC-CCCcceEeeEEEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---------GQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIE 208 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~ 208 (463)
.++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 36899999999999999999966 578899999985432 112346788999999996 9999999999999
Q ss_pred CcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeec
Q 012462 209 GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDF 288 (463)
Q Consensus 209 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Df 288 (463)
++..|+||||+++|+|.+++.. .+.+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred CcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccc
Confidence 9999999999999999999964 34699999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCceeeccccccCCCCchhhhcc------CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 012462 289 GLAKLLGAGKSHVTTRVMGTFGYVAPEYANT------GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKM 362 (463)
Q Consensus 289 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~ 362 (463)
|+++...... .....+||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.+.... .....
T Consensus 155 G~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~------~~~~~ 226 (277)
T d1phka_ 155 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM------LMLRM 226 (277)
T ss_dssp TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH
T ss_pred hheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH------HHHHH
Confidence 9999876533 2345689999999998853 45788999999999999999999999864321 11222
Q ss_pred HhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 363 MVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
....... ...+ ...... ..+..++.+||+.||++|||++|++++
T Consensus 227 i~~~~~~--~~~~--~~~~~s---~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 227 IMSGNYQ--FGSP--EWDDYS---DTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHTCCC--CCTT--TGGGSC---HHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHhCCCC--CCCc--ccccCC---HHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 2222111 0000 000111 233445668999999999999999875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.2e-50 Score=390.30 Aligned_cols=248 Identities=23% Similarity=0.309 Sum_probs=196.3
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc---hhhHHHH---HHHHHHHcCCCCCCcceEeeEEEECcEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV---GQAEKEF---RVEVEAIGHVRHKNLVRLLGYCIEGIHRM 213 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 213 (463)
++|++.++||+|+||+||+|+.. +|+.||||++.... ......+ ..++.+++.++|||||+++++|.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57999999999999999999764 68999999985322 1122223 34578888899999999999999999999
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 99999999999999964 34589999999999999999999999 999999999999999999999999999997
Q ss_pred cCCCCceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccc
Q 012462 294 LGAGKSHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV 372 (463)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (463)
..... ....+||+.|+|||++.. ..|+.++|||||||+||||+||+.||......... .... .....
T Consensus 157 ~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~~~~-~~~~~----- 224 (364)
T d1omwa3 157 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDR-MTLTM----- 224 (364)
T ss_dssp CSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH---HHHH-HSSSC-----
T ss_pred cCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH---HHHH-hcccC-----
Confidence 65432 344689999999999864 56899999999999999999999999865433221 1111 11110
Q ss_pred ccCCCCCCC-CHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 012462 373 VDPNIEVRP-STRALKRSLLTALRCVDPDSEKRPK-----MSQVVRM 413 (463)
Q Consensus 373 ~~~~~~~~~-~~~~~~~~~~~~~~cl~~dP~~RPs-----~~ell~~ 413 (463)
...... .... +..++.+||+.||++||| ++|++++
T Consensus 225 ---~~~~~~~~s~~---~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 225 ---AVELPDSFSPE---LRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp ---CCCCCSSSCHH---HHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred ---CCCCCCCCCHH---HHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 011111 1122 334556899999999999 6888864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.7e-50 Score=389.80 Aligned_cols=245 Identities=23% Similarity=0.279 Sum_probs=201.0
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 216 (463)
++|++++.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5799999999999999999976 468999999985432 233467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 296 (463)
||+.+|+|.+++.. .+.+++..++.++.||+.||.|||++ +|+||||||+|||++.++++||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 99999999999864 24599999999999999999999999 999999999999999999999999999998754
Q ss_pred CCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (463)
. ....+||+.|||||++.+..|+.++|||||||+||||+||+.||.+... ............ . . +
T Consensus 194 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~~~~~-~-~--p- 258 (350)
T d1rdqe_ 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIVSGKV-R-F--P- 258 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC-C-C--C-
T ss_pred c----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH------HHHHHHHhcCCC-C-C--C-
Confidence 3 2346799999999999999999999999999999999999999975432 122222222110 0 0 0
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 012462 377 IEVRPSTRALKRSLLTALRCVDPDSEKRP-----KMSQVVRM 413 (463)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~cl~~dP~~RP-----s~~ell~~ 413 (463)
...... +..++.+||+.||.+|+ |++|++++
T Consensus 259 ---~~~s~~---~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 259 ---SHFSSD---LKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ---TTCCHH---HHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---ccCCHH---HHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 111122 33445579999999994 89999874
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-50 Score=377.04 Aligned_cols=256 Identities=26% Similarity=0.382 Sum_probs=194.7
Q ss_pred hcCCCccCeEeecCcEEEEEEEEcC--C--CeEEEEEEccc---chhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLIN--G--SPVAVKKILNN---VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHR 212 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 212 (463)
.++|++.+.||+|+||+||+|++.. + ..||||++... .....++|.+|+.++++++||||++++|+|.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 4669999999999999999996532 2 36899988543 23345678999999999999999999999976 467
Q ss_pred EEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccce
Q 012462 213 MLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292 (463)
Q Consensus 213 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~ 292 (463)
++||||+++|+|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 86 ~lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred heeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhh
Confidence 8999999999999988643 34599999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCce--eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhcCCCc
Q 012462 293 LLGAGKSH--VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369 (463)
Q Consensus 293 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 369 (463)
........ ......||..|+|||++.+..++.++|||||||++|||+| |+.||.+... .+.+..+......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~------~~~~~~i~~~~~~ 233 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------SQILHKIDKEGER 233 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTSCCC
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH------HHHHHHHHhCCCC
Confidence 87554322 2234567889999999999999999999999999999998 8999975432 2222333333211
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.... ..... .+..++.+||+.||++||||.||++.|++.
T Consensus 234 ~~~~------~~~~~---~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 234 LPRP------EDCPQ---DIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCCC------TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCc------ccccH---HHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1110 11112 334456689999999999999999999764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=379.70 Aligned_cols=255 Identities=28% Similarity=0.424 Sum_probs=200.6
Q ss_pred cCeEeecCcEEEEEEEEcCC----CeEEEEEEccc-chhhHHHHHHHHHHHcCCCCCCcceEeeEEEE-CcEEEEEEeec
Q 012462 146 ENVLGEGGYGVVYRGNLING----SPVAVKKILNN-VGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE-GIHRMLVYEYV 219 (463)
Q Consensus 146 ~~~lG~G~~g~V~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e~~ 219 (463)
.++||+|+||+||+|.+.++ ..||||++... .....++|.+|++++++++||||++++|++.+ +...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 56899999999999976442 25899998643 34455789999999999999999999999876 45889999999
Q ss_pred CCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCCc
Q 012462 220 NNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKS 299 (463)
Q Consensus 220 ~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 299 (463)
++|+|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999999864 344578899999999999999999999 999999999999999999999999999987654332
Q ss_pred e---eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccCC
Q 012462 300 H---VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDPN 376 (463)
Q Consensus 300 ~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (463)
. ......||+.|+|||.+....++.++||||||++||||+||+.||....... ++........+.. .+
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-----~~~~~i~~g~~~~---~p- 256 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----DITVYLLQGRRLL---QP- 256 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHHHHTTCCCC---CC-
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-----HHHHHHHcCCCCC---Cc-
Confidence 2 2233568999999999999999999999999999999999888886543221 2222222222211 11
Q ss_pred CCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCCCC
Q 012462 377 IEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPI 421 (463)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 421 (463)
..... .+..++.+||+.||++||++.||+++|+.+....
T Consensus 257 ---~~~~~---~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 257 ---EYCPD---PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp ---TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred ---ccCcH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence 11112 3445566899999999999999999998875443
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=379.78 Aligned_cols=251 Identities=17% Similarity=0.259 Sum_probs=202.7
Q ss_pred hcCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
.++|++.+.||+|+||+||+|... +++.||||.+.... .....+.+|+.+|++++||||+++++++.+.+..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 468999999999999999999664 68899999986543 3345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC--CCCEEEeecccceecCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD--DFNAKVSDFGLAKLLGA 296 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~--~~~~kl~Dfg~a~~~~~ 296 (463)
|+||+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++. ...+||+|||+++....
T Consensus 83 ~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 83 ISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 999999999953 234699999999999999999999999 9999999999999985 45899999999987654
Q ss_pred CCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCC-CccccccC
Q 012462 297 GKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR-RSEEVVDP 375 (463)
Q Consensus 297 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 375 (463)
.. ......+|+.|+|||.+.+..|+.++|||||||++|+|++|..||...... +.+....... .......+
T Consensus 157 ~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~------~~~~~i~~~~~~~~~~~~~ 228 (321)
T d1tkia_ 157 GD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMNAEYTFDEEAFK 228 (321)
T ss_dssp TC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCCCCHHHHT
T ss_pred CC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCCCChhhcc
Confidence 33 233457899999999999999999999999999999999999999865422 2222222211 11100000
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
... ..+..++.+||+.||.+|||+.|++++
T Consensus 229 -----~~s---~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 229 -----EIS---IEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp -----TSC---HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----CCC---HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011 223445668999999999999999984
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=380.30 Aligned_cols=268 Identities=23% Similarity=0.379 Sum_probs=213.7
Q ss_pred HHHHHhcCCCccCeEeecCcEEEEEEEEc------CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEE
Q 012462 135 DLELATNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCI 207 (463)
Q Consensus 135 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 207 (463)
++++..++|++.+.||+|+||+||+|.+. ++..||||++.... ......+.+|+.++++++||||++++++|.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 45666788999999999999999999653 35789999986543 344467889999999999999999999999
Q ss_pred ECcEEEEEEeecCCCCHHHHHhhhh------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCC
Q 012462 208 EGIHRMLVYEYVNNGNLEQWLHGAM------RHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDF 281 (463)
Q Consensus 208 ~~~~~~lV~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~ 281 (463)
.....++||||+++|+|.+++.... .....+++..+..++.|++.||.|||++ +|+||||||+|||++.++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCc
Confidence 9999999999999999999986432 1223578999999999999999999999 999999999999999999
Q ss_pred CEEEeecccceecCCCCc-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCC-CCCCCCCCcccccHHHH
Q 012462 282 NAKVSDFGLAKLLGAGKS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGR-DPVDHGRPAHEVNLVDW 359 (463)
Q Consensus 282 ~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~-~pf~~~~~~~~~~~~~~ 359 (463)
++||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||+||. .||.... ....
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~------~~~~ 244 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------NEQV 244 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC------HHHH
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC------HHHH
Confidence 999999999987654332 2233456899999999999999999999999999999999985 6665432 2233
Q ss_pred HHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcCCCCC
Q 012462 360 LKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESEEYPI 421 (463)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 421 (463)
+..+........ ... ....+..++.+||+.||++|||++||+++|++...+.
T Consensus 245 ~~~i~~~~~~~~--------p~~--~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~ 296 (308)
T d1p4oa_ 245 LRFVMEGGLLDK--------PDN--CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296 (308)
T ss_dssp HHHHHTTCCCCC--------CTT--CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred HHHHHhCCCCCC--------ccc--chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 333333222111 111 1123455566899999999999999999999875544
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=378.31 Aligned_cols=266 Identities=25% Similarity=0.347 Sum_probs=197.7
Q ss_pred cCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEECc----EEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGI----HRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lV~ 216 (463)
.+|.+.+.||+|+||+||+|++ +|+.||||++.... ........|+..+.+++||||++++++|.+.+ ..|+||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4577889999999999999986 78999999985432 22222334556666789999999999998653 679999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEEccCCCCceeEcCCCCEEEeecccc
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI-----EPKVVHRDIKSSNILIDDDFNAKVSDFGLA 291 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a 291 (463)
||+++|+|.++++. ..+++..++.++.|++.||+|||+.. .++|+||||||+||||+.++.+||+|||++
T Consensus 81 Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 99999999999964 24899999999999999999999631 349999999999999999999999999999
Q ss_pred eecCCCCce---eeccccccCCCCchhhhccCC------CCccchhhhHHHHHHHHHhCCCCCCCCCCcccc--------
Q 012462 292 KLLGAGKSH---VTTRVMGTFGYVAPEYANTGL------LNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEV-------- 354 (463)
Q Consensus 292 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~-------- 354 (463)
+........ .....+||+.|+|||++.+.. ++.++|||||||+||||+||..||.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 877544322 234567999999999987643 577899999999999999999887543221110
Q ss_pred cHHHHHHHHhcCCCccccccCCC-CCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 355 NLVDWLKMMVGSRRSEEVVDPNI-EVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.....+......... .+.+ ...........+..++.+||+.||++|||+.||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CCHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred chHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 111112222222111 1111 1111223444566677899999999999999999999865
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-50 Score=385.37 Aligned_cols=264 Identities=25% Similarity=0.355 Sum_probs=208.0
Q ss_pred HHHHhcCCCccCeEeecCcEEEEEEEEc------CCCeEEEEEEcccc-hhhHHHHHHHHHHHcCC-CCCCcceEeeEEE
Q 012462 136 LELATNRFSKENVLGEGGYGVVYRGNLI------NGSPVAVKKILNNV-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCI 207 (463)
Q Consensus 136 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 207 (463)
+++..++|++.++||+|+||.||+|.+. +++.||||++.... ......+.+|+.++.++ +|||||+++++|.
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 3556688999999999999999999752 34689999986543 34456788999999998 7999999999999
Q ss_pred ECcEEEEEEeecCCCCHHHHHhhhhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCC
Q 012462 208 EGIHRMLVYEYVNNGNLEQWLHGAMR--------------HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSS 273 (463)
Q Consensus 208 ~~~~~~lV~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~ 273 (463)
+....++|||||++|+|.++++.... ....+++..++.++.||+.||+|||++ +++||||||+
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~ 174 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAAR 174 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccc
Confidence 99999999999999999999975431 223589999999999999999999999 9999999999
Q ss_pred ceeEcCCCCEEEeecccceecCCCCc-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCC-CCCCCCc
Q 012462 274 NILIDDDFNAKVSDFGLAKLLGAGKS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDP-VDHGRPA 351 (463)
Q Consensus 274 Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p-f~~~~~~ 351 (463)
|||++.++.+||+|||+++....... ......+||+.|+|||++.+..++.++|||||||++|||+|+..| |......
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999997754432 334456889999999999999999999999999999999995555 5443322
Q ss_pred ccccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 352 HEVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.. +... ...+.... .... ....+..++.+||+.||++||||.||+++|+++
T Consensus 255 ~~--~~~~----i~~~~~~~-------~~~~--~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 255 SK--FYKM----IKEGFRML-------SPEH--APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp HH--HHHH----HHHTCCCC-------CCTT--SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH--HHHH----HhcCCCCC-------Cccc--ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 11 1111 11111000 0111 112344556689999999999999999999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=384.15 Aligned_cols=262 Identities=28% Similarity=0.433 Sum_probs=203.7
Q ss_pred HHHhcCCCccCeEeecCcEEEEEEEEcC--------CCeEEEEEEcccch-hhHHHHHHHHHHHcCC-CCCCcceEeeEE
Q 012462 137 ELATNRFSKENVLGEGGYGVVYRGNLIN--------GSPVAVKKILNNVG-QAEKEFRVEVEAIGHV-RHKNLVRLLGYC 206 (463)
Q Consensus 137 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 206 (463)
++..++|++.+.||+|+||.||+|+... +..||||++..... ....++.+|...+.++ +|||||+++++|
T Consensus 9 ~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp BCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence 4556789999999999999999996532 23799999865443 3456788898888887 899999999999
Q ss_pred EECcEEEEEEeecCCCCHHHHHhhhhc------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCc
Q 012462 207 IEGIHRMLVYEYVNNGNLEQWLHGAMR------------HHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSN 274 (463)
Q Consensus 207 ~~~~~~~lV~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~N 274 (463)
.++...++||||+++|+|.+++..... ....+++..++.++.||+.||+|||+. +|+||||||+|
T Consensus 89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~N 165 (299)
T d1fgka_ 89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 165 (299)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccc
Confidence 999999999999999999999975421 234589999999999999999999999 99999999999
Q ss_pred eeEcCCCCEEEeecccceecCCCCc-eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHh-CCCCCCCCCCcc
Q 012462 275 ILIDDDFNAKVSDFGLAKLLGAGKS-HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAIT-GRDPVDHGRPAH 352 (463)
Q Consensus 275 ill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~pf~~~~~~~ 352 (463)
||++.++.+||+|||+++....... .......+|+.|+|||++.++.|+.++|||||||++|||++ |..||......
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~- 244 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE- 244 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH-
Confidence 9999999999999999987654332 23345678999999999999999999999999999999998 68888754321
Q ss_pred cccHHHHHHHHhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 353 EVNLVDWLKMMVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
.....+....... .. ..... .+..++.+||+.||++|||+.||++.|+.+
T Consensus 245 -----~~~~~i~~~~~~~-~p------~~~~~---~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 245 -----ELFKLLKEGHRMD-KP------SNCTN---ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp -----HHHHHHHTTCCCC-CC------SSCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----HHHHHHHcCCCCC-CC------ccchH---HHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1112222221111 10 01112 344556689999999999999999999875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-50 Score=381.66 Aligned_cols=256 Identities=25% Similarity=0.389 Sum_probs=199.1
Q ss_pred cCCCccCeEeecCcEEEEEEEEcC-CC--eEEEEEEcccc-hhhHHHHHHHHHHHcCC-CCCCcceEeeEEEECcEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLIN-GS--PVAVKKILNNV-GQAEKEFRVEVEAIGHV-RHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV 215 (463)
++|++.++||+|+||+||+|.+.+ |. .||||++.... ....+.+.+|++++.++ +||||++++++|.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 678889999999999999997644 33 57888875432 33456789999999998 799999999999999999999
Q ss_pred EeecCCCCHHHHHhhh------------hcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCE
Q 012462 216 YEYVNNGNLEQWLHGA------------MRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNA 283 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~------------~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~ 283 (463)
|||+++|+|.++|+.. ......+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 9999999999999643 12345699999999999999999999999 99999999999999999999
Q ss_pred EEeecccceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCC-CCCCCCCcccccHHHHHHH
Q 012462 284 KVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRD-PVDHGRPAHEVNLVDWLKM 362 (463)
Q Consensus 284 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~-pf~~~~~~~~~~~~~~~~~ 362 (463)
||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|.. ||.... ..+....
T Consensus 167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~------~~~~~~~ 238 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------CAELYEK 238 (309)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHH
T ss_pred EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC------HHHHHHH
Confidence 999999998654322 2234568999999999999999999999999999999999765 565432 2222222
Q ss_pred HhcCCCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 363 MVGSRRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
+....+.... ....+ .+..++.+||+.||++|||++||+++|+.+
T Consensus 239 i~~~~~~~~~-------~~~~~---~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 239 LPQGYRLEKP-------LNCDD---EVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp GGGTCCCCCC-------TTBCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhcCCCCCC-------ccCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 2222111100 11122 334456689999999999999999999876
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-50 Score=385.06 Aligned_cols=247 Identities=24% Similarity=0.318 Sum_probs=197.3
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc---hhhHHHHHHHHHHHc-CCCCCCcceEeeEEEECcEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV---GQAEKEFRVEVEAIG-HVRHKNLVRLLGYCIEGIHRMLV 215 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lV 215 (463)
++|++.+.||+|+||+||+|.. .+|+.||||++.... ......+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 4799999999999999999966 468899999985432 223345566666654 68999999999999999999999
Q ss_pred EeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecC
Q 012462 216 YEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 216 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 295 (463)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999964 34589999999999999999999999 99999999999999999999999999998655
Q ss_pred CCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccC
Q 012462 296 AGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP 375 (463)
Q Consensus 296 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (463)
... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.... .......... .
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~i~~~~-~------ 220 (320)
T d1xjda_ 155 LGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE------ELFHSIRMDN-P------ 220 (320)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCC-C------
T ss_pred ccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHHcCC-C------
Confidence 432 2344568999999999999999999999999999999999999999864422 1111221111 0
Q ss_pred CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 012462 376 NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMS-QVVR 412 (463)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~-ell~ 412 (463)
..+... ...+..++.+||+.||++||++. |+++
T Consensus 221 --~~p~~~--s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 --FYPRWL--EKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp --CCCTTS--CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --CCCccC--CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 111111 12234455689999999999996 6764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=381.97 Aligned_cols=250 Identities=20% Similarity=0.256 Sum_probs=194.8
Q ss_pred cCCCccC-eEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcC-CCCCCcceEeeEEEE----CcEEE
Q 012462 141 NRFSKEN-VLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGH-VRHKNLVRLLGYCIE----GIHRM 213 (463)
Q Consensus 141 ~~~~~~~-~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~----~~~~~ 213 (463)
++|++.. .||+|+||+||+|.. .+++.||||++... ..+.+|+.++.+ ++||||++++++|.+ ...+|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 5788765 599999999999965 56899999998542 346678888655 489999999999976 46689
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC---CCCEEEeeccc
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD---DFNAKVSDFGL 290 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~---~~~~kl~Dfg~ 290 (463)
+|||||+||+|.+++... ....+++..++.++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+
T Consensus 86 ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccce
Confidence 999999999999999642 235699999999999999999999999 9999999999999985 56799999999
Q ss_pred ceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 291 AKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 291 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
++...... .....+||+.|+|||++.+..|+.++|||||||+||+|+||+.||.+........ . +. .
T Consensus 161 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~---~~-----~ 227 (335)
T d2ozaa1 161 AKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---G---MK-----T 227 (335)
T ss_dssp CEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------------
T ss_pred eeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH---H---HH-----H
Confidence 98765443 2345689999999999999999999999999999999999999997644322111 0 00 0
Q ss_pred ccccCCCCCCCCH--HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 371 EVVDPNIEVRPST--RALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 371 ~~~~~~~~~~~~~--~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.+.......+... .....+..++.+||+.||++|||+.|++++
T Consensus 228 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 228 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1111111111111 112344555668999999999999999984
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-49 Score=373.99 Aligned_cols=271 Identities=24% Similarity=0.355 Sum_probs=201.9
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccch--hhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVG--QAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
++|++++.||+|+||+||+|.. .+|+.||||++..... .....+.+|++++++++||||+++++++.++.+.|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5799999999999999999965 5689999999854332 234678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
|+.+ ++.+++.. .....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~-~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSE-EHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCC-chhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 9975 55555533 2345699999999999999999999999 9999999999999999999999999999876543
Q ss_pred CceeeccccccCCCCchhhhccCC-CCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcc---c--
Q 012462 298 KSHVTTRVMGTFGYVAPEYANTGL-LNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE---E-- 371 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~-- 371 (463)
. .......||+.|+|||++.... ++.++|||||||++|+|++|+.||......+. +..... ........ .
T Consensus 156 ~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~--~~~i~~-~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 156 V-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFR-TLGTPDEVVWPGVT 231 (298)
T ss_dssp S-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHH-HHCCCCTTTSTTGG
T ss_pred c-ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH--HHHHHH-hcCCCchhhccccc
Confidence 3 2344467999999999887665 57899999999999999999999976432111 111111 11110000 0
Q ss_pred -cccCCC----CCCCCHH-----HHHHHHHHHhhccCCCCCCCCCHHHHHHH--HhcCCCCC
Q 012462 372 -VVDPNI----EVRPSTR-----ALKRSLLTALRCVDPDSEKRPKMSQVVRM--LESEEYPI 421 (463)
Q Consensus 372 -~~~~~~----~~~~~~~-----~~~~~~~~~~~cl~~dP~~RPs~~ell~~--L~~~~~~~ 421 (463)
..+... ....... ....+..++.+||+.||++|||++|++++ ++++..|+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p~ 293 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCCC
Confidence 000000 0000000 01233445668999999999999999986 76665553
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=377.17 Aligned_cols=258 Identities=23% Similarity=0.257 Sum_probs=192.6
Q ss_pred ccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchh-----hHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 145 KENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQ-----AEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 145 ~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
.+++||+|+||+||+|.. .+|+.||||++...... ..+.+.+|+.++++++|||||++++++.+++..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 357899999999999975 46899999998543221 124678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+.++++..+. .....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~----~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIK----DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHT----TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred hcchHHhhhh----hcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 9887666554 3455689999999999999999999999 99999999999999999999999999998765433
Q ss_pred ceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccccC--
Q 012462 299 SHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVVDP-- 375 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 375 (463)
. .....+||+.|+|||++.+ ..|+.++|||||||++|||++|..||......+ ....+.............+.
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~---~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 155 R-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp C-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSSSTTS
T ss_pred c-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH---HHHHHHHhcCCCChhhccchhc
Confidence 2 2334679999999999865 468999999999999999999999997654221 11212222111111100000
Q ss_pred -----CC-CCC-CCHH-----HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 376 -----NI-EVR-PSTR-----ALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 376 -----~~-~~~-~~~~-----~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.. ... .... ....+..++.+||+.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00 000 0000 01234455668999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=8.1e-49 Score=371.35 Aligned_cols=259 Identities=24% Similarity=0.341 Sum_probs=196.9
Q ss_pred cCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEee
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 218 (463)
++|++.++||+|+||+||+|++.+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..+++||+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5899999999999999999998899999999985543 22346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCCC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGK 298 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 298 (463)
+.++.+..+. ...+.+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLD----VCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHH----TSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHH----hhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 9886666655 3456799999999999999999999999 99999999999999999999999999998765432
Q ss_pred ceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCccccc----
Q 012462 299 SHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEVV---- 373 (463)
Q Consensus 299 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 373 (463)
. ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+....+. ...+.............
T Consensus 155 ~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGG
T ss_pred c-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH---HHHHHHhhCCCChhhccchhh
Confidence 2 2334568999999999865 4578999999999999999999999976432211 11111111111000000
Q ss_pred ----cCC---------CC-CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 374 ----DPN---------IE-VRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 374 ----~~~---------~~-~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
... .. ...... .+..++.+||+.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~---~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDE---SGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCH---HHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhcccccccccCcchhhhcccCCH---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 00 011112 33345668999999999999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=374.19 Aligned_cols=241 Identities=25% Similarity=0.387 Sum_probs=192.0
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccch------hhHHHHHHHHHHHcCCC--CCCcceEeeEEEECc
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVG------QAEKEFRVEVEAIGHVR--HKNLVRLLGYCIEGI 210 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~ 210 (463)
.++|++.++||+|+||+||+|.. .+|+.||||++..... .....+.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 36899999999999999999965 4689999999854321 11234567999998885 899999999999999
Q ss_pred EEEEEEeecCC-CCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC-CCCEEEeec
Q 012462 211 HRMLVYEYVNN-GNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD-DFNAKVSDF 288 (463)
Q Consensus 211 ~~~lV~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~-~~~~kl~Df 288 (463)
..++||||+.+ +++.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++. ++.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred eEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcc
Confidence 99999999976 688888753 34699999999999999999999999 9999999999999985 479999999
Q ss_pred ccceecCCCCceeeccccccCCCCchhhhccCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCC
Q 012462 289 GLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLL-NEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR 367 (463)
Q Consensus 289 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 367 (463)
|+++..... ..+..+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... . .....
T Consensus 156 G~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~-------i~~~~ 220 (273)
T d1xwsa_ 156 GSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----E-------IIRGQ 220 (273)
T ss_dssp TTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H-------HHHCC
T ss_pred ccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----H-------Hhhcc
Confidence 999876433 2345689999999999987765 577999999999999999999997421 0 11110
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 368 RSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
. .... .... .+..++.+||+.||++|||++|++++
T Consensus 221 ~---~~~~-----~~s~---~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 221 V---FFRQ-----RVSS---ECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp C---CCSS-----CCCH---HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred c---CCCC-----CCCH---HHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0 0111 1112 23345568999999999999999874
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-47 Score=362.13 Aligned_cols=261 Identities=24% Similarity=0.329 Sum_probs=192.0
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cC-CCeEEEEEEcccch--hhHHHHHHHHHHHcCC---CCCCcceEeeEEEE----
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-IN-GSPVAVKKILNNVG--QAEKEFRVEVEAIGHV---RHKNLVRLLGYCIE---- 208 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~-~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~---- 208 (463)
.++|+++++||+|+||+||+|.. .+ ++.||||++..... .....+.+|+.+++.| +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47899999999999999999976 34 56799999854322 1123345566666554 89999999999863
Q ss_pred -CcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEee
Q 012462 209 -GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSD 287 (463)
Q Consensus 209 -~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~D 287 (463)
....+++|||+.++.+..... .....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 246789999998876654443 3455689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCC
Q 012462 288 FGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSR 367 (463)
Q Consensus 288 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 367 (463)
||+++..... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+....+ ....+.......
T Consensus 160 fg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~ 234 (305)
T d1blxa_ 160 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLP 234 (305)
T ss_dssp CCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCC
T ss_pred hhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhhCCC
Confidence 9998865432 23445689999999999999999999999999999999999999998654221 111111111111
Q ss_pred Cccccc----------c-----CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 368 RSEEVV----------D-----PNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 368 ~~~~~~----------~-----~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
....+. . +......... .....++.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s--~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDID--ELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCC--HHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhcccccccchhhhhccccccchhhccccCC--HHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000 0 0000011111 123344568999999999999999875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-47 Score=364.47 Aligned_cols=263 Identities=21% Similarity=0.282 Sum_probs=193.9
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEE--------C
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE--------G 209 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~ 209 (463)
++|++.++||+|+||+||+|.+ .+|+.||||++.... ......+.+|+.++++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 7899999999999999999976 578999999874332 2334678889999999999999999999864 3
Q ss_pred cEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecc
Q 012462 210 IHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFG 289 (463)
Q Consensus 210 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg 289 (463)
.+.|+||||+.++.+..+. .....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT----CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCCCccchhh----hcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence 4579999999876655443 3445689999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCc---eeeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhc
Q 012462 290 LAKLLGAGKS---HVTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVG 365 (463)
Q Consensus 290 ~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 365 (463)
+++....... ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+..... ....+.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~---~~~~i~~~~~ 239 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH---QLALISQLCG 239 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH---HHHHHHHhcC
Confidence 9987654322 122335799999999998765 68999999999999999999999997543221 1111222221
Q ss_pred CCCccccc-----------cCCCCCCCCHHH-------HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 366 SRRSEEVV-----------DPNIEVRPSTRA-------LKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 366 ~~~~~~~~-----------~~~~~~~~~~~~-------~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
........ ............ ......++.+||+.||++|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 11110000 000001111111 1123345678999999999999999976
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=365.76 Aligned_cols=259 Identities=24% Similarity=0.303 Sum_probs=190.6
Q ss_pred CCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC------cEEEE
Q 012462 142 RFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG------IHRML 214 (463)
Q Consensus 142 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~l 214 (463)
+|+..++||+|+||+||+|++ .+|+.||||++..... ...+|+.++++++||||++++++|... .+.|+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 578889999999999999976 4689999999865432 223589999999999999999998643 34789
Q ss_pred EEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCC-CEEEeeccccee
Q 012462 215 VYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDF-NAKVSDFGLAKL 293 (463)
Q Consensus 215 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~-~~kl~Dfg~a~~ 293 (463)
||||++++ +.+.+.........+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||++..
T Consensus 97 v~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhh
Confidence 99999765 5444544445566799999999999999999999999 999999999999999775 899999999987
Q ss_pred cCCCCceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHH---------HHHHHH
Q 012462 294 LGAGKSHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLV---------DWLKMM 363 (463)
Q Consensus 294 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~---------~~~~~~ 363 (463)
..... .....+||+.|+|||.+.+ ..|+.++|||||||++|||++|+.||......+....+ .+....
T Consensus 173 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 173 LVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CCTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred ccCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 75433 2334579999999998765 57899999999999999999999999765422111000 000000
Q ss_pred hcCCCcccccc---C---CCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 364 VGSRRSEEVVD---P---NIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 364 ~~~~~~~~~~~---~---~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
........... . ......... ....++.+||+.||++|||+.|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~---~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPP---EAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCH---HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccchhhccccccccCchhhhcccCCCH---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000000 0 000011122 23445668999999999999999974
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.9e-46 Score=353.37 Aligned_cols=259 Identities=19% Similarity=0.227 Sum_probs=193.6
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCCCCc-ceEeeEEEECcEEEEEEee
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRHKNL-VRLLGYCIEGIHRMLVYEY 218 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~ 218 (463)
++|++.+.||+|+||+||+|.+ .+|+.||||++..... ..++..|+++++.++|+|+ +.+.+++.+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 6799999999999999999965 5688999998754332 2457789999999977665 4555666788889999999
Q ss_pred cCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEc---CCCCEEEeecccceecC
Q 012462 219 VNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILID---DDFNAKVSDFGLAKLLG 295 (463)
Q Consensus 219 ~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~---~~~~~kl~Dfg~a~~~~ 295 (463)
+ +++|.+.+.. ....+++..++.++.|++.||+|||++ +|+||||||+|||++ .+..+||+|||+|+...
T Consensus 85 ~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 85 L-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp C-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred c-CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 9 5577776643 345699999999999999999999999 999999999999985 45679999999999875
Q ss_pred CCCce------eeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCc
Q 012462 296 AGKSH------VTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369 (463)
Q Consensus 296 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 369 (463)
..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||........................
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence 43321 234568999999999999999999999999999999999999999875543332222111111000000
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
... ...... .+..++.+||+.||++||++.++.+.|+..
T Consensus 238 ~~~------~~~~p~---~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 238 EVL------CKGYPS---EFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HHH------TTTSCH---HHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred hHh------ccCCCH---HHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 000 001112 234455579999999999999998887753
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=360.45 Aligned_cols=253 Identities=25% Similarity=0.322 Sum_probs=198.4
Q ss_pred cCCCccCeEeecCcEEEEEEEEc----CCCeEEEEEEcccc----hhhHHHHHHHHHHHcCCCC-CCcceEeeEEEECcE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI----NGSPVAVKKILNNV----GQAEKEFRVEVEAIGHVRH-KNLVRLLGYCIEGIH 211 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~ 211 (463)
++|++.+.||+|+||+||+|... +|+.||||.+.... ....+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56999999999999999999652 47899999985322 2234567789999999966 899999999999999
Q ss_pred EEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccc
Q 012462 212 RMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA 291 (463)
Q Consensus 212 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a 291 (463)
.++||||+.+|+|.+++.. .+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 9999999999999999864 33578899999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCceeeccccccCCCCchhhhccC--CCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCc
Q 012462 292 KLLGAGKSHVTTRVMGTFGYVAPEYANTG--LLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRS 369 (463)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 369 (463)
+.+............|++.|+|||.+.+. .++.++|||||||+||||++|+.||........... .........
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~--i~~~~~~~~-- 252 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE--ISRRILKSE-- 252 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH--HHHHHHHCC--
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHhcccCC--
Confidence 87755444444556899999999998764 468899999999999999999999987654332221 111111110
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 012462 370 EEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRP-----KMSQVVRM 413 (463)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RP-----s~~ell~~ 413 (463)
...... ....+..++.+||+.||++|| |++|++++
T Consensus 253 -------~~~~~~--~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 253 -------PPYPQE--MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp -------CCCCTT--SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -------CCCccc--CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 011111 112333445689999999999 47888763
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=349.19 Aligned_cols=261 Identities=21% Similarity=0.305 Sum_probs=200.5
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECcEEEEEEe
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 217 (463)
++|+++++||+|+||+||+|++ .+++.||||++.... ......+.+|+.+++.++||||++++++|.+....++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999975 568899999985432 3345788899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccceecCCC
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAG 297 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 297 (463)
++.+++|..++. ..+.+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eccccccccccc----cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999988888774 455689999999999999999999999 9999999999999999999999999999886543
Q ss_pred CceeeccccccCCCCchhhhccCC-CCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcccc----
Q 012462 298 KSHVTTRVMGTFGYVAPEYANTGL-LNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSEEV---- 372 (463)
Q Consensus 298 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 372 (463)
.. ......+++.|+|||++.+.. ++.++|||||||++|||++|+.||....... .....+............
T Consensus 155 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGG
T ss_pred Cc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH--HHHHHHHhhcCCCChhhhhhhh
Confidence 32 233345788999999987654 6899999999999999999999986543221 111222222111110000
Q ss_pred ----------cc---CCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 373 ----------VD---PNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 373 ----------~~---~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
.. ........ .......++.+||+.||.+|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~--~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPK--LNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTT--CCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hcccccccccccccchhhhcccc--CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 00000011 11223344568999999999999999874
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.1e-45 Score=348.57 Aligned_cols=260 Identities=18% Similarity=0.223 Sum_probs=201.1
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCC-CCcceEeeEEEECcEEEEEEe
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRH-KNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e 217 (463)
.++|++.++||+|+||+||+|.+ .+|+.||||++.... ....+..|++.+..+.| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 47899999999999999999975 468899999874432 22346678888888865 899999999999999999999
Q ss_pred ecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcC-----CCCEEEeecccce
Q 012462 218 YVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDD-----DFNAKVSDFGLAK 292 (463)
Q Consensus 218 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~-----~~~~kl~Dfg~a~ 292 (463)
|+ +++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+|+
T Consensus 82 ~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 82 LL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeE
Confidence 99 6899998864 344699999999999999999999999 9999999999999974 5789999999999
Q ss_pred ecCCCCc------eeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcC
Q 012462 293 LLGAGKS------HVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGS 366 (463)
Q Consensus 293 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 366 (463)
....... ......+||+.|||||++.+..++.++|||||||++|||+||+.||.+............+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 7654321 1233568999999999999999999999999999999999999999865544332222222111111
Q ss_pred CCccccccCCCCCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHhcC
Q 012462 367 RRSEEVVDPNIEVRPSTRALKRSLLTALRCVDPDSEKRPKMSQVVRMLESE 417 (463)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ell~~L~~~ 417 (463)
....++. ....+++ ..++..|++.+|++||+++.+.+.|++.
T Consensus 235 ~~~~~l~------~~~p~~l---~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 235 TPLRELC------AGFPEEF---YKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp SCHHHHT------TTSCHHH---HHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CChHHhc------CCCCHHH---HHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 1111110 0111233 3344569999999999999988887764
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-46 Score=359.77 Aligned_cols=197 Identities=26% Similarity=0.394 Sum_probs=165.2
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECc------
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGI------ 210 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 210 (463)
.++|+++++||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+.+|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 57899999999999999999965 468999999986432 234467888999999999999999999998654
Q ss_pred EEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccc
Q 012462 211 HRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGL 290 (463)
Q Consensus 211 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~ 290 (463)
+.|+||||+ +.+|..+... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 469999999 5688877642 3599999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeccccccCCCCchhhhcc-CCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 291 AKLLGAGKSHVTTRVMGTFGYVAPEYANT-GLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 291 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
++..... .+...||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+..
T Consensus 168 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~ 223 (346)
T d1cm8a_ 168 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 223 (346)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC
Confidence 9876543 344678999999999876 457899999999999999999999997654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-46 Score=360.84 Aligned_cols=262 Identities=23% Similarity=0.322 Sum_probs=192.9
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc-hhhHHHHHHHHHHHcCCCCCCcceEeeEEEECc----EEE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV-GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGI----HRM 213 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~ 213 (463)
+.+|+++++||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 35799999999999999999965 579999999985433 344567889999999999999999999997643 234
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
++++|+.+|+|.+++.. ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 87 ~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 55566779999999853 2599999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCc--eeeccccccCCCCchhhh-ccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhcCCCcc
Q 012462 294 LGAGKS--HVTTRVMGTFGYVAPEYA-NTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDWLKMMVGSRRSE 370 (463)
Q Consensus 294 ~~~~~~--~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (463)
...... ......+||+.|+|||++ .+..++.++||||+||++|||++|+.||......+.. .............
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~---~~~~~~~~~~~~~ 235 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL---NHILGILGSPSQE 235 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH---HHHhhhccCCChh
Confidence 644322 123446799999999998 4456789999999999999999999999765422111 1111100000000
Q ss_pred c-------------cccCCCCCCCCHHH-----HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 012462 371 E-------------VVDPNIEVRPSTRA-----LKRSLLTALRCVDPDSEKRPKMSQVVRM 413 (463)
Q Consensus 371 ~-------------~~~~~~~~~~~~~~-----~~~~~~~~~~cl~~dP~~RPs~~ell~~ 413 (463)
. ...+. ........ ...+..++.+||+.||.+|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 236 DLNCIINLKARNYLLSLPH-KNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHTCCCHHHHHHHHTSCC-CCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhcccccCCc-cCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00000 00000000 1234455668999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.8e-45 Score=353.75 Aligned_cols=194 Identities=26% Similarity=0.402 Sum_probs=167.4
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCC-CCCcceEeeEEEE--CcEEEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIE--GIHRMLVY 216 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lV~ 216 (463)
++|+++++||+|+||+||+|+. .+|+.||||++... ..+.+.+|+.+|.++. ||||++++++|.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999976 56899999998543 2456788999999985 9999999999984 35689999
Q ss_pred eecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCC-CEEEeecccceecC
Q 012462 217 EYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDF-NAKVSDFGLAKLLG 295 (463)
Q Consensus 217 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~-~~kl~Dfg~a~~~~ 295 (463)
||+.+++|..+. +.+++..++.++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||+|+...
T Consensus 112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceecc
Confidence 999999986542 3599999999999999999999999 999999999999998655 69999999998765
Q ss_pred CCCceeeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 296 AGKSHVTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 296 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
... .....++|+.|+|||.+.+. .++.++||||+||++|||++|+.||....
T Consensus 182 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 182 PGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp TTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred CCC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 433 23446789999999998765 57999999999999999999999997654
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=352.43 Aligned_cols=197 Identities=27% Similarity=0.322 Sum_probs=160.0
Q ss_pred cCCCccCeEeecCcEEEEEEEEc-CCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEE------CcE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNLI-NGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIE------GIH 211 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~ 211 (463)
++|+++++||+|+||+||+|.+. +|+.||||++.... ......+.+|+.++++++||||++++++|.. ..+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 68999999999999999999764 68999999986433 3334578899999999999999999999963 368
Q ss_pred EEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccc
Q 012462 212 RMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA 291 (463)
Q Consensus 212 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a 291 (463)
.|+||||+.++ +.+.+. ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~~-l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchH-HHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 89999999764 544442 3489999999999999999999999 9999999999999999999999999998
Q ss_pred eecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 292 KLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
+...... .....++|+.|+|||++.+..++.++||||+||++|||++|+.||.+..
T Consensus 167 ~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~ 222 (355)
T d2b1pa1 167 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC
Confidence 8654432 3345678999999999999999999999999999999999999997543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=350.20 Aligned_cols=198 Identities=27% Similarity=0.394 Sum_probs=165.9
Q ss_pred hcCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccc--hhhHHHHHHHHHHHcCCCCCCcceEeeEEEEC-----cE
Q 012462 140 TNRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNV--GQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG-----IH 211 (463)
Q Consensus 140 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 211 (463)
.+||++.++||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 47899999999999999999965 578999999985433 23445788899999999999999999998643 33
Q ss_pred EEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEEeecccc
Q 012462 212 RMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLA 291 (463)
Q Consensus 212 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a 291 (463)
.+++++|+.+|+|.+++. .+.+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 467778888999999884 23599999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCceeeccccccCCCCchhhhccC-CCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 012462 292 KLLGAGKSHVTTRVMGTFGYVAPEYANTG-LLNEKSDVYSFGVLLLEAITGRDPVDHGR 349 (463)
Q Consensus 292 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~pf~~~~ 349 (463)
..... ......|++.|+|||++.+. .++.++|||||||++|+|++|+.||.+..
T Consensus 169 ~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~ 223 (348)
T d2gfsa1 169 RHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223 (348)
T ss_dssp -CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC
Confidence 76432 23345789999999987665 56899999999999999999999997643
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-39 Score=317.38 Aligned_cols=264 Identities=19% Similarity=0.193 Sum_probs=187.2
Q ss_pred cCCCccCeEeecCcEEEEEEEE-cCCCeEEEEEEcccchhhHHHHHHHHHHHcCCC-----------CCCcceEeeEEEE
Q 012462 141 NRFSKENVLGEGGYGVVYRGNL-INGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR-----------HKNLVRLLGYCIE 208 (463)
Q Consensus 141 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~ 208 (463)
+||+++++||+|+||+||+|+. .+|+.||||++.... ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 5799999999999999999976 578999999986543 23456677888877664 5789999998864
Q ss_pred --CcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEccCCCCceeEcCCCC---
Q 012462 209 --GIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHE-AIEPKVVHRDIKSSNILIDDDFN--- 282 (463)
Q Consensus 209 --~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dikp~Nill~~~~~--- 282 (463)
....+++++++..+........ ......+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTT
T ss_pred ccccceeeeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccc
Confidence 3556677777655443332222 2345668999999999999999999998 6 9999999999999986654
Q ss_pred ---EEEeecccceecCCCCceeeccccccCCCCchhhhccCCCCccchhhhHHHHHHHHHhCCCCCCCCCCcccccHHHH
Q 012462 283 ---AKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLLLEAITGRDPVDHGRPAHEVNLVDW 359 (463)
Q Consensus 283 ---~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~pf~~~~~~~~~~~~~~ 359 (463)
++++|||.+...... ....+||+.|+|||++.+..++.++||||+||++++|++|+.||............+.
T Consensus 168 ~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 999999999865432 2346799999999999999999999999999999999999999975433222221111
Q ss_pred HHHH---hcCC---------Ccccccc--------CCC-----------CCCCCHHHHHHHHHHHhhccCCCCCCCCCHH
Q 012462 360 LKMM---VGSR---------RSEEVVD--------PNI-----------EVRPSTRALKRSLLTALRCVDPDSEKRPKMS 408 (463)
Q Consensus 360 ~~~~---~~~~---------~~~~~~~--------~~~-----------~~~~~~~~~~~~~~~~~~cl~~dP~~RPs~~ 408 (463)
+... .... ......+ ... ..............++.+||+.||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 1111 1000 0000000 000 0111223344566677799999999999999
Q ss_pred HHHHH
Q 012462 409 QVVRM 413 (463)
Q Consensus 409 ell~~ 413 (463)
|+|++
T Consensus 324 e~L~H 328 (362)
T d1q8ya_ 324 GLVNH 328 (362)
T ss_dssp HHHTC
T ss_pred HHhcC
Confidence 99875
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=3.8e-25 Score=194.93 Aligned_cols=163 Identities=17% Similarity=0.188 Sum_probs=120.4
Q ss_pred CccCeEeecCcEEEEEEEEcCCCeEEEEEEcccch------------------hhHHHHHHHHHHHcCCCCCCcceEeeE
Q 012462 144 SKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVG------------------QAEKEFRVEVEAIGHVRHKNLVRLLGY 205 (463)
Q Consensus 144 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~niv~l~~~ 205 (463)
.+.++||+|+||+||+|...+|+.||||++..... ........|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45689999999999999888899999998642110 112234568888999999999988765
Q ss_pred EEECcEEEEEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEccCCCCceeEcCCCCEEE
Q 012462 206 CIEGIHRMLVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAKV 285 (463)
Q Consensus 206 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dikp~Nill~~~~~~kl 285 (463)
. . .+++|||+++..+.+ ++......++.|++.+|.|||++ +|+||||||+|||++++ .++|
T Consensus 83 ~--~--~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 83 E--G--NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp E--T--TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred c--C--CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEE
Confidence 3 2 379999998754322 44455678999999999999999 99999999999999975 4899
Q ss_pred eecccceecCCCCceeeccccccCCCCch------hhhccCCCCccchhhhHHHHH
Q 012462 286 SDFGLAKLLGAGKSHVTTRVMGTFGYVAP------EYANTGLLNEKSDVYSFGVLL 335 (463)
Q Consensus 286 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~sDvwSlGvvl 335 (463)
+|||+|......... .|... +. ....|+.++|+||+.--+
T Consensus 144 iDFG~a~~~~~~~~~---------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGWR---------EILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTHH---------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCcH---------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 999999876533211 01111 11 135678899999986544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.69 E-value=2.3e-08 Score=90.36 Aligned_cols=149 Identities=13% Similarity=0.069 Sum_probs=98.0
Q ss_pred HHHHHhcCCCccCeEeecCcEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCC-CCCcceEeeEEEECcEEE
Q 012462 135 DLELATNRFSKENVLGEGGYGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGIHRM 213 (463)
Q Consensus 135 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~ 213 (463)
++...-..|+..+..+-++.+.||+... ++..+++|+...........+.+|...+..+. +--+.+++.++.+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4444445666655444444568999864 66778889875544333344566777665542 333677888888889999
Q ss_pred EEEeecCCCCHHHHHhhhhcCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------
Q 012462 214 LVYEYVNNGNLEQWLHGAMRHHGYLTWEARMKVLLGTAKALAYLHEAI-------------------------------- 261 (463)
Q Consensus 214 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-------------------------------- 261 (463)
+||++++|.++.+.... ......++.+++..+..||+..
T Consensus 87 lv~~~l~G~~~~~~~~~---------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEECCSSEEHHHHTTT---------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred EEEEecccccccccccc---------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence 99999999887654311 0112234555555566666420
Q ss_pred ------------------------CCCeEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 262 ------------------------EPKVVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 262 ------------------------~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
.+.++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12378999999999999877777999998753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.10 E-value=5.5e-06 Score=73.81 Aligned_cols=74 Identities=18% Similarity=0.109 Sum_probs=50.1
Q ss_pred eEeecCc-EEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCC--CCCcceEeeEEEECcEEEEEEeecCCCCH
Q 012462 148 VLGEGGY-GVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVR--HKNLVRLLGYCIEGIHRMLVYEYVNNGNL 224 (463)
Q Consensus 148 ~lG~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lV~e~~~~g~L 224 (463)
.+..|.. +.||+....++..+++|....... ..+..|...++.+. .-.+.+++.++.+.+..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3445553 678999877788889997644322 23445665555442 23367788888888888999999987654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.53 E-value=6.6e-05 Score=71.29 Aligned_cols=76 Identities=14% Similarity=0.143 Sum_probs=46.1
Q ss_pred cCeEeecCcEEEEEEEEcC-CCeEEEEEEcccc-------hhhHHHHHHHHHHHcCC-CC--CCcceEeeEEEECcEEEE
Q 012462 146 ENVLGEGGYGVVYRGNLIN-GSPVAVKKILNNV-------GQAEKEFRVEVEAIGHV-RH--KNLVRLLGYCIEGIHRML 214 (463)
Q Consensus 146 ~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l-~h--~niv~l~~~~~~~~~~~l 214 (463)
.+.||.|....||+....+ ++.++||.-.... .....+...|.+.+..+ .+ ..+++++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3468999999999997644 6789999753211 11223344566666544 22 245556544 4556689
Q ss_pred EEeecCCCC
Q 012462 215 VYEYVNNGN 223 (463)
Q Consensus 215 V~e~~~~g~ 223 (463)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997643
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.20 E-value=0.00055 Score=62.89 Aligned_cols=137 Identities=16% Similarity=0.097 Sum_probs=75.3
Q ss_pred cEEEEEEEEcCCCeEEEEEEcccchhhHHHHHHHHHHHcCCCC-----CCcceEe--eEEEECcEEEEEEeecCCCC---
Q 012462 154 YGVVYRGNLINGSPVAVKKILNNVGQAEKEFRVEVEAIGHVRH-----KNLVRLL--GYCIEGIHRMLVYEYVNNGN--- 223 (463)
Q Consensus 154 ~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-----~niv~l~--~~~~~~~~~~lV~e~~~~g~--- 223 (463)
.-.||++...+|..+++|..... .....++..|...+..|.. +..+..- ..+......+.++++++|..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 45899999889999999976543 2234556667766655531 2112211 12345667788999987632
Q ss_pred --HHHH---------HhhhhcC-----CCCCCHH-------------------HHHHHHHHHHHHHHHHHhc----CCCC
Q 012462 224 --LEQW---------LHGAMRH-----HGYLTWE-------------------ARMKVLLGTAKALAYLHEA----IEPK 264 (463)
Q Consensus 224 --L~~~---------l~~~~~~-----~~~~~~~-------------------~~~~i~~~i~~~l~~LH~~----~~~~ 264 (463)
...+ ++..... ....+.. ....+...+...++.+... ...+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 1111 1111110 0111111 1111222223333333322 2447
Q ss_pred eEEccCCCCceeEcCCCCEEEeeccccee
Q 012462 265 VVHRDIKSSNILIDDDFNAKVSDFGLAKL 293 (463)
Q Consensus 265 i~H~Dikp~Nill~~~~~~kl~Dfg~a~~ 293 (463)
++|+|+.+.|||++++ ..++||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999754 45899998764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.29 E-value=0.035 Score=49.88 Aligned_cols=31 Identities=26% Similarity=0.309 Sum_probs=27.5
Q ss_pred CCCeEEccCCCCceeEcCCCCEEEeecccce
Q 012462 262 EPKVVHRDIKSSNILIDDDFNAKVSDFGLAK 292 (463)
Q Consensus 262 ~~~i~H~Dikp~Nill~~~~~~kl~Dfg~a~ 292 (463)
..++||+|+.+.||+++.+...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 4479999999999999998877899999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.14 E-value=0.0045 Score=58.13 Aligned_cols=71 Identities=14% Similarity=0.132 Sum_probs=45.5
Q ss_pred CeEeecCcEEEEEEEEcCC--------CeEEEEEEcccchhhHHHHHHHHHHHcCCC-CCCcceEeeEEEECcEEEEEEe
Q 012462 147 NVLGEGGYGVVYRGNLING--------SPVAVKKILNNVGQAEKEFRVEVEAIGHVR-HKNLVRLLGYCIEGIHRMLVYE 217 (463)
Q Consensus 147 ~~lG~G~~g~V~~~~~~~~--------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e 217 (463)
+.|+-|-.-.+|++...++ ..|++++.- .. .......+|..+++.+. +.-..++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 5688888899999976543 356666543 22 22234556777777663 3334577777642 68999
Q ss_pred ecCCCC
Q 012462 218 YVNNGN 223 (463)
Q Consensus 218 ~~~~g~ 223 (463)
|++|..
T Consensus 122 fi~g~~ 127 (395)
T d1nw1a_ 122 YIPSRP 127 (395)
T ss_dssp CCCEEE
T ss_pred Eecccc
Confidence 998753
|